celltype,cluster,Term,Overlap,n.hit,n.tot,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
beta,1,positive regulation of hormone metabolic process (GO:0032352),2/6,2,6,0.00138254753905422,0.38709361627647,0,0,34.1880341880342,225.088117567965,EGR1;HPN
beta,1,aromatic compound catabolic process (GO:0019439),2/6,2,6,0.00138254753905422,0.38709361627647,0,0,34.1880341880342,225.088117567965,PON3;PON1
beta,1,regulation of high voltage-gated calcium channel activity (GO:1901841),2/7,2,7,0.00192315544905583,0.38709361627647,0,0,29.3040293040293,183.261186194875,PDE4B;SRI
beta,1,positive regulation of cell death (GO:0010942),4/58,4,58,0.00246506687831859,0.38709361627647,0,0,7.07338638373121,42.4794789792523,NTRK1;EGR1;CIDEB;FOS
beta,1,potassium ion export (GO:0071435),2/9,2,9,0.00325473981032248,0.38709361627647,0,0,22.7920227920228,130.544568476385,KCNH2;KCNA5
beta,1,regulation of actin filament-based movement (GO:1903115),2/10,2,10,0.00404239520470533,0.38709361627647,0,0,20.5128205128205,113.044469543317,PDE4B;SRI
beta,1,carboxylic acid metabolic process (GO:0019752),3/34,3,34,0.00437235951655601,0.38709361627647,0,0,9.04977375565611,49.1624658864117,PON3;ST6GAL1;PON1
beta,1,protein localization to cell periphery (GO:1990778),5/118,5,118,0.00602546600380986,0.38709361627647,0,0,4.34593654932638,22.2153866039362,EHD3;ZDHHC22;ANK1;MRAP2;WNT4
beta,1,membrane repolarization during cardiac muscle cell action potential (GO:0086013),2/15,2,15,0.00913503402830994,0.38709361627647,0,0,13.6752136752137,64.2138579707555,KCNH2;KCNA5
beta,1,positive regulation of small GTPase mediated signal transduction (GO:0051057),2/15,2,15,0.00913503402830994,0.38709361627647,0,0,13.6752136752137,64.2138579707555,NTRK1;RASGRF1
beta,1,lipoxygenase pathway (GO:0019372),2/15,2,15,0.00913503402830994,0.38709361627647,0,0,13.6752136752137,64.2138579707555,PON3;PON1
beta,1,nitric oxide mediated signal transduction (GO:0007263),2/15,2,15,0.00913503402830994,0.38709361627647,0,0,13.6752136752137,64.2138579707555,NDNF;KLRG1
beta,1,protein localization to plasma membrane (GO:0072659),5/131,5,131,0.00926674291411153,0.38709361627647,0,0,3.91466040321002,18.3257910309101,EHD3;ZDHHC22;ANK1;MRAP2;WNT4
beta,1,regulation of systemic arterial blood pressure by hormone (GO:0001990),2/16,2,16,0.0103735537446034,0.38709361627647,0,0,12.8205128205128,58.5704566755476,ACE;CORIN
beta,1,protein localization to chromatin (GO:0071168),2/16,2,16,0.0103735537446034,0.38709361627647,0,0,12.8205128205128,58.5704566755476,H2AFY2;RAD21
beta,1,regulation of cardiac muscle cell membrane repolarization (GO:0099623),2/18,2,18,0.0130585579412458,0.38709361627647,0,0,11.3960113960114,49.4394481960732,KCNH2;KCNA5
beta,1,insulin secretion (GO:0030073),2/19,2,19,0.0145021349145756,0.38709361627647,0,0,10.7962213225371,45.7053646953384,FAM3B;KLRG1
beta,1,acetylcholine receptor signaling pathway (GO:0095500),2/19,2,19,0.0145021349145756,0.38709361627647,0,0,10.7962213225371,45.7053646953384,LYNX1;AGRN
beta,1,positive regulation of toll-like receptor signaling pathway (GO:0034123),2/19,2,19,0.0145021349145756,0.38709361627647,0,0,10.7962213225371,45.7053646953384,RSAD2;TLR5
beta,1,entrainment of circadian clock by photoperiod (GO:0043153),2/20,2,20,0.0160111926220627,0.38709361627647,0,0,10.2564102564103,42.4047924351457,ID2;BHLHE40
beta,1,positive regulation of neuron differentiation (GO:0045666),4/99,4,99,0.0160827504996863,0.38709361627647,0,0,4.14400414400414,17.1147701792628,NTRK1;IMPACT;DPYSL3;NDNF
beta,1,action potential (GO:0001508),3/55,3,55,0.0165175910892489,0.38709361627647,0,0,5.59440559440559,22.9556886118257,KCNH2;SRI;NALCN
beta,1,photoperiodism (GO:0009648),2/21,2,21,0.0175843306434588,0.38709361627647,0,0,9.76800976800977,39.47005692643,ID2;BHLHE40
beta,1,fatty acid metabolic process (GO:0006631),4/107,4,107,0.020774584693236,0.38709361627647,0,0,3.83417205847112,14.8536781371256,GHR;PON3;ACOT11;PON1
beta,1,potassium ion transport (GO:0006813),3/62,3,62,0.0226664447176069,0.38709361627647,0,0,4.96277915632754,18.7933977885477,KCNA5;KCNK17;KCNA6
beta,1,macromolecule modification (GO:0043412),2/25,2,25,0.024490400982595,0.38709361627647,0,0,8.20512820512821,30.4367100293956,ST6GAL1;ZFP64
beta,1,negative regulation of neuron apoptotic process (GO:0043524),3/64,3,64,0.0246218929730251,0.38709361627647,0,0,4.80769230769231,17.8082657383116,NTRK1;NDNF;TP73
beta,1,positive regulation of cell projection organization (GO:0031346),3/64,3,64,0.0246218929730251,0.38709361627647,0,0,4.80769230769231,17.8082657383116,NTRK1;DPYSL3;NDNF
beta,1,negative regulation of neuron differentiation (GO:0045665),3/65,3,65,0.0256327230044098,0.38709361627647,0,0,4.73372781065089,17.3438366929852,ID2;DPYSL3;ID3
beta,1,regulation of voltage-gated calcium channel activity (GO:1901385),2/26,2,26,0.0263636540956643,0.38709361627647,0,0,7.88954635108481,28.6845677018229,PDE4B;SRI
beta,1,peptide hormone secretion (GO:0030072),2/26,2,26,0.0263636540956643,0.38709361627647,0,0,7.88954635108481,28.6845677018229,FAM3B;KLRG1
beta,1,negative regulation of epithelial to mesenchymal transition (GO:0010719),2/26,2,26,0.0263636540956643,0.38709361627647,0,0,7.88954635108481,28.6845677018229,HPN;OVOL2
beta,1,positive regulation of filopodium assembly (GO:0051491),2/26,2,26,0.0263636540956643,0.38709361627647,0,0,7.88954635108481,28.6845677018229,DPYSL3;AGRN
beta,1,regulation of cardiac muscle cell contraction (GO:0086004),2/27,2,27,0.0282930132144908,0.38709361627647,0,0,7.59734093067426,27.0855869910255,PDE4B;SRI
beta,1,endocrine system development (GO:0035270),2/27,2,27,0.0282930132144908,0.38709361627647,0,0,7.59734093067426,27.0855869910255,THRB;WNT4
beta,1,phosphatidylcholine acyl-chain remodeling (GO:0036151),2/28,2,28,0.0302772182155184,0.38709361627647,0,0,7.32600732600733,25.6216829548805,LPCAT1;PLBD1
beta,1,response to hexose (GO:0009746),2/28,2,28,0.0302772182155184,0.38709361627647,0,0,7.32600732600733,25.6216829548805,EIF2B2;KLRG1
beta,1,carboxylic acid catabolic process (GO:0046395),2/29,2,29,0.0323150280024013,0.38709361627647,0,0,7.07338638373121,24.2774386823884,PON3;PON1
beta,1,cardiac muscle cell action potential involved in contraction (GO:0086002),2/29,2,29,0.0323150280024013,0.38709361627647,0,0,7.07338638373121,24.2774386823884,KCNH2;KCNA5
beta,1,phosphatidylcholine metabolic process (GO:0046470),3/72,3,72,0.0333238494575025,0.38709361627647,0,0,4.27350427350427,14.5362476000834,PON1;LPCAT1;PLBD1
beta,1,lysosomal transport (GO:0007041),3/73,3,73,0.034509940638,0.38709361627647,0,0,4.21496311907271,14.1897064784522,EHD3;SNAPIN;M6PR
beta,1,cellular response to drug (GO:0035690),2/31,2,31,0.036546591110058,0.38709361627647,0,0,6.61703887510339,21.8968890892878,KCNH2;PDE4B
beta,1,regulation of protein polymerization (GO:0032271),2/31,2,31,0.036546591110058,0.38709361627647,0,0,6.61703887510339,21.8968890892878,TPPP3;TTBK1
beta,1,chondroitin sulfate metabolic process (GO:0030204),2/31,2,31,0.036546591110058,0.38709361627647,0,0,6.61703887510339,21.8968890892878,NDNF;CHST3
beta,1,positive regulation of interleukin-1 beta production (GO:0032731),2/32,2,32,0.0387379550862471,0.38709361627647,0,0,6.41025641025641,20.8393295383744,GSDMD;EGR1
beta,1,generation of neurons (GO:0048699),4/131,4,131,0.0394976370817785,0.38709361627647,0,0,3.13172832256802,10.1202252638993,ID2;ID3;NDNF;WNT4
beta,1,negative regulation of neurogenesis (GO:0050768),2/34,2,34,0.0432660102127996,0.38709361627647,0,0,6.03318250377074,18.9465335491567,ID2;ID3
beta,1,regulation of neurotransmitter receptor activity (GO:0099601),2/34,2,34,0.0432660102127996,0.38709361627647,0,0,6.03318250377074,18.9465335491567,LYNX1;SHISA6
beta,1,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),2/34,2,34,0.0432660102127996,0.38709361627647,0,0,6.03318250377074,18.9465335491567,ANK1;PARD3B
beta,1,peptidyl-tyrosine phosphorylation (GO:0018108),3/80,3,80,0.0434146557643852,0.38709361627647,0,0,3.84615384615385,12.0652238632951,GHR;NTRK1;TTBK1
beta,1,negative regulation of DNA binding (GO:0043392),2/35,2,35,0.0456004195679788,0.38709361627647,0,0,5.86080586080586,18.0972211660188,ID2;ID3
beta,1,negative regulation of binding (GO:0051100),3/83,3,83,0.0475485706654917,0.38709361627647,0,0,3.70713623725672,11.2919501392165,ID2;ID3;TTBK1
beta,1,regulation of heart rate by cardiac conduction (GO:0086091),2/36,2,36,0.0479802579894448,0.38709361627647,0,0,5.6980056980057,17.3046475473762,KCNH2;KCNA5
beta,1,regulation of cardiac muscle contraction (GO:0055117),2/36,2,36,0.0479802579894448,0.38709361627647,0,0,5.6980056980057,17.3046475473762,PDE4B;SRI
beta,1,negative regulation of neuron death (GO:1901215),3/84,3,84,0.048968135198994,0.38709361627647,0,0,3.66300366300366,11.0497637160108,NTRK1;NDNF;TP73
beta,1,regulation of potassium ion transport (GO:0043266),2/37,2,37,0.0504044278170213,0.38709361627647,0,0,5.54400554400554,16.5636937172634,KCNH2;KCNA5
beta,1,regulation of filopodium assembly (GO:0051489),2/37,2,37,0.0504044278170213,0.38709361627647,0,0,5.54400554400554,16.5636937172634,DPYSL3;AGRN
beta,1,regulation of blood circulation (GO:1903522),2/37,2,37,0.0504044278170213,0.38709361627647,0,0,5.54400554400554,16.5636937172634,ACE;SRI
beta,1,regulation of cysteine-type endopeptidase activity (GO:2000116),2/37,2,37,0.0504044278170213,0.38709361627647,0,0,5.54400554400554,16.5636937172634,CST3;TTBK1
beta,1,regulation of neuron differentiation (GO:0045664),3/85,3,85,0.0504083042602592,0.38709361627647,0,0,3.61990950226244,10.8148392774979,IMPACT;ID2;ID3
beta,1,regulation of metal ion transport (GO:0010959),2/38,2,38,0.0528718482862906,0.38709361627647,0,0,5.39811066126856,15.869820514283,KCNA5;SRI
beta,1,membrane depolarization during action potential (GO:0086010),2/39,2,39,0.0553814553140186,0.38709361627647,0,0,5.25969756738988,15.218990048082,KCNH2;NALCN
beta,1,positive regulation of neuron death (GO:1901216),2/39,2,39,0.0553814553140186,0.38709361627647,0,0,5.25969756738988,15.218990048082,EGR1;FOS
beta,1,mRNA 5'-splice site recognition (GO:0000395),1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,SRSF12
beta,1,regulation of cellular carbohydrate catabolic process (GO:0043471),1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,PPP1R3B
beta,1,response to heparin (GO:0071503),1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,EGR1
beta,1,dosage compensation by inactivation of X chromosome (GO:0009048),1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,PCGF3
beta,1,positive regulation of microglial cell activation (GO:1903980),1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,TTBK1
beta,1,regulation of aldosterone biosynthetic process (GO:0032347),1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,WNT4
beta,1,"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,NDST3
beta,1,regulation of male gonad development (GO:2000018),1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,WNT4
beta,1,regulation of cortisol biosynthetic process (GO:2000064),1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,WNT4
beta,1,negative regulation of neural precursor cell proliferation (GO:2000178),1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,ID2
beta,1,choline catabolic process (GO:0042426),1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,DMGDH
beta,1,mesenchymal cell differentiation involved in kidney development (GO:0072161),1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,WNT4
beta,1,hematopoietic stem cell differentiation (GO:0060218),1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,ACE
beta,1,regulation of relaxation of cardiac muscle (GO:1901897),1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,PDE4B
beta,1,citrate metabolic process (GO:0006101),1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,GHR
beta,1,regulation of renal sodium excretion (GO:0035813),1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,CORIN
beta,1,regulation of blood vessel remodeling (GO:0060312),1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,CST3
beta,1,positive regulation of blood pressure (GO:0045777),1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,ID2
beta,1,alpha-beta T cell activation (GO:0046631),1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,RSAD2
beta,1,pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),1/6,1,6,0.0570991779681553,0.38709361627647,0,0,17.0940170940171,48.9395822013393,CMPK2
beta,1,regulation of neuron apoptotic process (GO:0043523),3/90,3,90,0.0579138676415762,0.38709361627647,0,0,3.41880341880342,9.73948175338111,NTRK1;NDNF;TP73
beta,1,peptidyl-threonine modification (GO:0018210),3/90,3,90,0.0579138676415762,0.38709361627647,0,0,3.41880341880342,9.73948175338111,GALNT12;STK33;TTBK1
beta,1,regulation of Ras protein signal transduction (GO:0046578),3/91,3,91,0.0594750065500517,0.38709361627647,0,0,3.38123415046492,9.54251601914437,NTRK1;RASGRF1;AGAP3
beta,1,phosphatidic acid biosynthetic process (GO:0006654),2/41,2,41,0.0605230546727095,0.38709361627647,0,0,5.00312695434647,14.0324248533497,GPD1;LPCAT1
beta,1,positive regulation of Ras protein signal transduction (GO:0046579),2/41,2,41,0.0605230546727095,0.38709361627647,0,0,5.00312695434647,14.0324248533497,NTRK1;RASGRF1
beta,1,phosphatidic acid metabolic process (GO:0046473),2/42,2,42,0.0631530001913171,0.38709361627647,0,0,4.88400488400488,13.490573491313,GPD1;LPCAT1
beta,1,positive regulation of multicellular organism growth (GO:0040018),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,GHR
beta,1,regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,KCNA5
beta,1,regulation of hormone biosynthetic process (GO:0046885),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,EGR1
beta,1,thiamine-containing compound metabolic process (GO:0042723),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,THTPA
beta,1,regulation of cardiac muscle cell membrane potential (GO:0086036),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,EHD3
beta,1,oxaloacetate metabolic process (GO:0006107),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,GHR
beta,1,regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,FGF18
beta,1,regulation of tube diameter (GO:0035296),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,ACE
beta,1,nucleoside diphosphate metabolic process (GO:0009132),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,CMPK2
beta,1,female gonad development (GO:0008585),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,WNT4
beta,1,valine metabolic process (GO:0006573),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,GHR
beta,1,negative regulation of synapse organization (GO:1905809),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,SLIT1
beta,1,AMP metabolic process (GO:0046033),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,ADSSL1
beta,1,regulation of toll-like receptor 9 signaling pathway (GO:0034163),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,RSAD2
beta,1,SA node cell action potential (GO:0086015),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,KCNA5
beta,1,regulation of chemokine biosynthetic process (GO:0045073),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,EGR1
beta,1,regulation of microglial cell activation (GO:1903978),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,TTBK1
beta,1,excitatory chemical synaptic transmission (GO:0098976),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,SHISA6
beta,1,regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,ACE
beta,1,negative regulation of heart rate (GO:0010459),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,SRI
beta,1,regulation of relaxation of muscle (GO:1901077),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,SRI
beta,1,L-methionine salvage (GO:0071267),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,BHMT2
beta,1,cAMP catabolic process (GO:0006198),1/7,1,7,0.0662952001514259,0.38709361627647,0,0,14.6520146520147,39.760260517467,PDE4B
beta,1,membrane depolarization (GO:0051899),2/44,2,44,0.0685261847488262,0.38709361627647,0,0,4.66200466200466,12.4966869354285,KCNH2;NALCN
beta,1,ciliary basal body-plasma membrane docking (GO:0097711),3/97,3,97,0.0692501751794319,0.38709361627647,0,0,3.17208564631245,8.46956258287392,C2CD3;CEP41;CC2D2A
beta,1,positive regulation of neuron projection development (GO:0010976),3/98,3,98,0.0709460250364715,0.38709361627647,0,0,3.13971742543171,8.3071770857189,NTRK1;DPYSL3;NDNF
beta,1,heart contraction (GO:0060047),2/45,2,45,0.0712674711817085,0.38709361627647,0,0,4.55840455840456,12.0401836140148,KCNH2;ACE
beta,1,regulation of steroid biosynthetic process (GO:0050810),2/45,2,45,0.0712674711817085,0.38709361627647,0,0,4.55840455840456,12.0401836140148,EGR1;WNT4
beta,1,metal ion homeostasis (GO:0055065),2/46,2,46,0.0740439441007982,0.38709361627647,0,0,4.45930880713489,11.6080112500812,KCNH2;SLC7A8
beta,1,exocyst localization (GO:0051601),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,EXOC3
beta,1,Golgi to lysosome transport (GO:0090160),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,EHD3
beta,1,establishment of protein localization to chromatin (GO:0071169),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,H2AFY2
beta,1,neuron projection extension involved in neuron projection guidance (GO:1902284),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,SLIT1
beta,1,histone H2A-K119 monoubiquitination (GO:0036353),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,PCGF3
beta,1,nucleoside diphosphate phosphorylation (GO:0006165),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,CMPK2
beta,1,response to epinephrine (GO:0071871),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,PDE4B
beta,1,cellular biogenic amine catabolic process (GO:0042402),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,DMGDH
beta,1,development of primary female sexual characteristics (GO:0046545),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,WNT4
beta,1,organophosphate catabolic process (GO:0046434),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,PON1
beta,1,asymmetric protein localization (GO:0008105),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,PARD3B
beta,1,nucleotide phosphorylation (GO:0046939),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,CMPK2
beta,1,arachidonic acid secretion (GO:0050482),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,ACE
beta,1,axon extension involved in axon guidance (GO:0048846),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,SLIT1
beta,1,atrial cardiac muscle cell to AV node cell signaling (GO:0086026),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,KCNA5
beta,1,mammary gland epithelial cell differentiation (GO:0060644),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,ID2
beta,1,regulation of T-helper 2 cell cytokine production (GO:2000551),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,RSAD2
beta,1,cellular response to epinephrine stimulus (GO:0071872),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,PDE4B
beta,1,angiogenesis involved in wound healing (GO:0060055),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,NDNF
beta,1,succinate metabolic process (GO:0006105),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,GHR
beta,1,arachidonate transport (GO:1903963),1/8,1,8,0.0754019913034441,0.38709361627647,0,0,12.8205128205128,33.1400204417559,ACE
beta,1,icosanoid metabolic process (GO:0006690),2/47,2,47,0.0768546650601394,0.38709361627647,0,0,4.36442989634479,11.1984249095028,PON3;PON1
beta,1,metal ion transport (GO:0030001),3/102,3,102,0.0779140961899669,0.38709361627647,0,0,3.01659125188537,7.69878850709178,KCNA5;KCNK17;KCNA6
beta,1,response to glucose (GO:0009749),2/48,2,48,0.0796987104196546,0.38709361627647,0,0,4.27350427350427,10.8098370672983,EIF2B2;KLRG1
beta,1,endosome to lysosome transport (GO:0008333),2/49,2,49,0.0825751711274607,0.38709361627647,0,0,4.18628990057561,10.4408005664853,SNAPIN;M6PR
beta,1,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),2/49,2,49,0.0825751711274607,0.38709361627647,0,0,4.18628990057561,10.4408005664853,CIDEB;TP73
beta,1,regulation of cell cycle arrest (GO:0071156),2/49,2,49,0.0825751711274607,0.38709361627647,0,0,4.18628990057561,10.4408005664853,ID2;TP73
beta,1,monovalent inorganic cation transport (GO:0015672),3/105,3,105,0.0833294360983888,0.38709361627647,0,0,2.93040293040293,7.2819147771456,KCNA5;KCNK17;KCNA6
beta,1,myeloid leukocyte mediated immunity (GO:0002444),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,ACE
beta,1,nucleoside triphosphate biosynthetic process (GO:0009142),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,CMPK2
beta,1,regulation of Rac protein signal transduction (GO:0035020),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,RASGRF1
beta,1,membrane disruption in other organism (GO:0051673),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,GSDMD
beta,1,response to UV-C (GO:0010225),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,IMPACT
beta,1,positive regulation of cell activation (GO:0050867),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,TTBK1
beta,1,ventricular cardiac muscle cell membrane repolarization (GO:0099625),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,KCNH2
beta,1,neuronal ion channel clustering (GO:0045161),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,AGRN
beta,1,basement membrane organization (GO:0071711),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,HPN
beta,1,actin crosslink formation (GO:0051764),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,DPYSL3
beta,1,regulation of muscle system process (GO:0090257),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,SRI
beta,1,regulation of endothelial cell differentiation (GO:0045601),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,ATOH8
beta,1,neurotrophin TRK receptor signaling pathway (GO:0048011),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,NTRK1
beta,1,ATP synthesis coupled electron transport (GO:0042773),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,NDUFS2
beta,1,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,SRI
beta,1,negative regulation of potassium ion transmembrane transport (GO:1901380),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,KCNH2
beta,1,cellular response to acidic pH (GO:0071468),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,IMPACT
beta,1,protein polyglutamylation (GO:0018095),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,CEP41
beta,1,detection of mechanical stimulus involved in sensory perception (GO:0050974),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,HPN
beta,1,nucleoside phosphate biosynthetic process (GO:1901293),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,CMPK2
beta,1,positive regulation of astrocyte differentiation (GO:0048711),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,TTBK1
beta,1,early endosome to Golgi transport (GO:0034498),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,EHD3
beta,1,receptor recycling (GO:0001881),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,EHD3
beta,1,cyclic nucleotide catabolic process (GO:0009214),1/9,1,9,0.0844204124867777,0.38709361627647,0,0,11.3960113960114,28.170325384769,PDE4B
beta,1,positive regulation of cell cycle process (GO:0090068),3/108,3,108,0.0889019195005047,0.38709361627647,0,0,2.84900284900285,6.89521807696199,RAD21;ID2;TP73
beta,1,peptidyl-tyrosine modification (GO:0018212),2/52,2,52,0.0913901694336052,0.38709361627647,0,0,3.94477317554241,9.43833278791933,NTRK1;TTBK1
beta,1,coenzyme metabolic process (GO:0006732),2/52,2,52,0.0913901694336052,0.38709361627647,0,0,3.94477317554241,9.43833278791933,THTPA;ACOT11
beta,1,positive regulation of developmental growth (GO:0048639),2/52,2,52,0.0913901694336052,0.38709361627647,0,0,3.94477317554241,9.43833278791933,GHR;AGRN
beta,1,adrenal gland development (GO:0030325),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,WNT4
beta,1,thyroid gland development (GO:0030878),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,THRB
beta,1,cellular response to growth hormone stimulus (GO:0071378),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,GHR
beta,1,amino sugar metabolic process (GO:0006040),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,ST6GAL1
beta,1,regulation of myeloid leukocyte differentiation (GO:0002761),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,FAM213A
beta,1,maintenance of apical/basal cell polarity (GO:0035090),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,ANK1
beta,1,regulation of gene expression by genetic imprinting (GO:0006349),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,PCGF3
beta,1,N-acetylneuraminate metabolic process (GO:0006054),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,ST6GAL1
beta,1,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,IMPACT
beta,1,response to acidic pH (GO:0010447),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,IMPACT
beta,1,pyroptosis (GO:0070269),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,GSDMD
beta,1,nerve growth factor signaling pathway (GO:0038180),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,NTRK1
beta,1,embryonic digestive tract morphogenesis (GO:0048557),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,ID2
beta,1,epithelial cell morphogenesis (GO:0003382),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,SIPA1L3
beta,1,negative regulation of protein autophosphorylation (GO:0031953),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,IMPACT
beta,1,creatine metabolic process (GO:0006600),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,GHR
beta,1,androgen biosynthetic process (GO:0006702),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,WNT4
beta,1,mitotic G1/S transition checkpoint (GO:0044819),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,TP73
beta,1,cell differentiation involved in metanephros development (GO:0072202),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,WNT4
beta,1,mitotic G1 DNA damage checkpoint (GO:0031571),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,TP73
beta,1,cellular response to leucine starvation (GO:1990253),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,IMPACT
beta,1,DNA dealkylation involved in DNA repair (GO:0006307),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,ALKBH3
beta,1,G1 DNA damage checkpoint (GO:0044783),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,TP73
beta,1,regulation of plasminogen activation (GO:0010755),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,HPN
beta,1,maintenance of epithelial cell apical/basal polarity (GO:0045199),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,ANK1
beta,1,motor neuron axon guidance (GO:0008045),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,SLIT1
beta,1,insulin-like growth factor receptor signaling pathway (GO:0048009),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,GHR
beta,1,positive regulation of type 2 immune response (GO:0002830),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,RSAD2
beta,1,DNA dealkylation (GO:0035510),1/10,1,10,0.0933513166113739,0.38709361627647,0,0,10.2564102564103,24.3219005647386,ALKBH3
beta,1,regulation of DNA binding (GO:0051101),2/53,2,53,0.0943874859161038,0.38709361627647,0,0,3.870343492985,9.13535279754689,ID2;ID3
beta,1,negative regulation of potassium ion transport (GO:0043267),1/11,1,11,0.102195548425662,0.38709361627647,0,0,9.32400932400932,21.2668266633103,KCNH2
beta,1,carnitine metabolic process (GO:0009437),1/11,1,11,0.102195548425662,0.38709361627647,0,0,9.32400932400932,21.2668266633103,TMLHE
beta,1,metanephric mesenchyme development (GO:0072075),1/11,1,11,0.102195548425662,0.38709361627647,0,0,9.32400932400932,21.2668266633103,WNT4
beta,1,negative regulation of JUN kinase activity (GO:0043508),1/11,1,11,0.102195548425662,0.38709361627647,0,0,9.32400932400932,21.2668266633103,TP73
beta,1,negative regulation of heart contraction (GO:0045822),1/11,1,11,0.102195548425662,0.38709361627647,0,0,9.32400932400932,21.2668266633103,SRI
beta,1,heart process (GO:0003015),1/11,1,11,0.102195548425662,0.38709361627647,0,0,9.32400932400932,21.2668266633103,ACE
beta,1,angiotensin maturation (GO:0002003),1/11,1,11,0.102195548425662,0.38709361627647,0,0,9.32400932400932,21.2668266633103,ACE
beta,1,establishment of synaptic vesicle localization (GO:0097480),1/11,1,11,0.102195548425662,0.38709361627647,0,0,9.32400932400932,21.2668266633103,SNAPIN
beta,1,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),1/11,1,11,0.102195548425662,0.38709361627647,0,0,9.32400932400932,21.2668266633103,SRI
beta,1,response to thyroid hormone (GO:0097066),1/11,1,11,0.102195548425662,0.38709361627647,0,0,9.32400932400932,21.2668266633103,HPN
beta,1,icosanoid secretion (GO:0032309),1/11,1,11,0.102195548425662,0.38709361627647,0,0,9.32400932400932,21.2668266633103,ACE
beta,1,regulation of hemopoiesis (GO:1903706),1/11,1,11,0.102195548425662,0.38709361627647,0,0,9.32400932400932,21.2668266633103,ACE
beta,1,negative regulation of peptide secretion (GO:0002792),1/11,1,11,0.102195548425662,0.38709361627647,0,0,9.32400932400932,21.2668266633103,RSAD2
beta,1,positive regulation of chromosome segregation (GO:0051984),1/11,1,11,0.102195548425662,0.38709361627647,0,0,9.32400932400932,21.2668266633103,RAD21
beta,1,regulation of short-term neuronal synaptic plasticity (GO:0048172),1/11,1,11,0.102195548425662,0.38709361627647,0,0,9.32400932400932,21.2668266633103,SHISA6
beta,1,cardiac muscle cell membrane repolarization (GO:0099622),1/11,1,11,0.102195548425662,0.38709361627647,0,0,9.32400932400932,21.2668266633103,KCNH2
beta,1,cochlea morphogenesis (GO:0090103),1/11,1,11,0.102195548425662,0.38709361627647,0,0,9.32400932400932,21.2668266633103,HPN
beta,1,hepatocyte growth factor receptor signaling pathway (GO:0048012),1/11,1,11,0.102195548425662,0.38709361627647,0,0,9.32400932400932,21.2668266633103,HPN
beta,1,positive regulation of cysteine-type endopeptidase activity (GO:2001056),2/56,2,56,0.103544639469556,0.38709361627647,0,0,3.66300366300366,8.30678556790008,CIDEB;TTBK1
beta,1,protein O-linked glycosylation (GO:0006493),3/116,3,116,0.104493775126026,0.38709361627647,0,0,2.6525198938992,5.99105511279451,GALNT12;ADAMTS5;ST6GAL1
beta,1,tRNA modification (GO:0006400),2/58,2,58,0.109778988250827,0.38709361627647,0,0,3.53669319186561,7.81356722212173,YRDC;THUMPD3
beta,1,regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901836),1/12,1,12,0.110953944655119,0.38709361627647,0,0,8.54700854700855,18.7917955280938,H2AFY2
beta,1,activation of cysteine-type endopeptidase activity (GO:0097202),1/12,1,12,0.110953944655119,0.38709361627647,0,0,8.54700854700855,18.7917955280938,CIDEB
beta,1,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),1/12,1,12,0.110953944655119,0.38709361627647,0,0,8.54700854700855,18.7917955280938,SRI
beta,1,purine nucleoside monophosphate biosynthetic process (GO:0009127),1/12,1,12,0.110953944655119,0.38709361627647,0,0,8.54700854700855,18.7917955280938,ADSSL1
beta,1,oligodendrocyte development (GO:0014003),1/12,1,12,0.110953944655119,0.38709361627647,0,0,8.54700854700855,18.7917955280938,EIF2B2
beta,1,regulation of angiotensin levels in blood (GO:0002002),1/12,1,12,0.110953944655119,0.38709361627647,0,0,8.54700854700855,18.7917955280938,ACE
beta,1,regulation of histone methylation (GO:0031060),1/12,1,12,0.110953944655119,0.38709361627647,0,0,8.54700854700855,18.7917955280938,ZFP64
beta,1,regulation of blood vessel size (GO:0050880),1/12,1,12,0.110953944655119,0.38709361627647,0,0,8.54700854700855,18.7917955280938,ACE
beta,1,positive regulation of keratinocyte differentiation (GO:0045618),1/12,1,12,0.110953944655119,0.38709361627647,0,0,8.54700854700855,18.7917955280938,H2AFY2
beta,1,response to axon injury (GO:0048678),1/12,1,12,0.110953944655119,0.38709361627647,0,0,8.54700854700855,18.7917955280938,DPYSL3
beta,1,regulation of cell communication by electrical coupling (GO:0010649),1/12,1,12,0.110953944655119,0.38709361627647,0,0,8.54700854700855,18.7917955280938,SRI
beta,1,regulation of sister chromatid cohesion (GO:0007063),1/12,1,12,0.110953944655119,0.38709361627647,0,0,8.54700854700855,18.7917955280938,RAD21
beta,1,membrane repolarization during action potential (GO:0086011),1/12,1,12,0.110953944655119,0.38709361627647,0,0,8.54700854700855,18.7917955280938,KCNH2
beta,1,positive regulation of T cell cytokine production (GO:0002726),1/12,1,12,0.110953944655119,0.38709361627647,0,0,8.54700854700855,18.7917955280938,RSAD2
beta,1,spliceosomal tri-snRNP complex assembly (GO:0000244),1/12,1,12,0.110953944655119,0.38709361627647,0,0,8.54700854700855,18.7917955280938,SRSF12
beta,1,regulation of neuron projection development (GO:0010975),3/120,3,120,0.112667010587889,0.38709361627647,0,0,2.56410256410256,5.59825287081194,NTRK1;DPYSL3;NDNF
beta,1,renal system development (GO:0072001),2/60,2,60,0.116109691776993,0.38709361627647,0,0,3.41880341880342,7.36143560999783,ACE;WNT4
beta,1,atrial cardiac muscle cell action potential (GO:0086014),1/13,1,13,0.119627333975523,0.38709361627647,0,0,7.88954635108481,16.7524569517332,KCNA5
beta,1,RNA interference (GO:0016246),1/13,1,13,0.119627333975523,0.38709361627647,0,0,7.88954635108481,16.7524569517332,NRDE2
beta,1,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",1/13,1,13,0.119627333975523,0.38709361627647,0,0,7.88954635108481,16.7524569517332,SRSF12
beta,1,mammary gland epithelium development (GO:0061180),1/13,1,13,0.119627333975523,0.38709361627647,0,0,7.88954635108481,16.7524569517332,WNT4
beta,1,tricarboxylic acid metabolic process (GO:0072350),1/13,1,13,0.119627333975523,0.38709361627647,0,0,7.88954635108481,16.7524569517332,GHR
beta,1,positive regulation of cholesterol efflux (GO:0010875),1/13,1,13,0.119627333975523,0.38709361627647,0,0,7.88954635108481,16.7524569517332,PON1
beta,1,positive regulation of actin nucleation (GO:0051127),1/13,1,13,0.119627333975523,0.38709361627647,0,0,7.88954635108481,16.7524569517332,WIPF1
beta,1,positive regulation of endothelial cell chemotaxis (GO:2001028),1/13,1,13,0.119627333975523,0.38709361627647,0,0,7.88954635108481,16.7524569517332,FGF18
beta,1,synaptic vesicle localization (GO:0097479),1/13,1,13,0.119627333975523,0.38709361627647,0,0,7.88954635108481,16.7524569517332,SNAPIN
beta,1,neuron fate commitment (GO:0048663),1/13,1,13,0.119627333975523,0.38709361627647,0,0,7.88954635108481,16.7524569517332,ID2
beta,1,membrane repolarization (GO:0086009),1/13,1,13,0.119627333975523,0.38709361627647,0,0,7.88954635108481,16.7524569517332,KCNH2
beta,1,negative regulation of macromolecule metabolic process (GO:0010605),3/125,3,125,0.123213416002448,0.38709361627647,0,0,2.46153846153846,5.15406113892357,ID2;TTBK1;WNT4
beta,1,negative regulation of peptidase activity (GO:0010466),2/63,2,63,0.12577325808665,0.38709361627647,0,0,3.25600325600326,6.75058862723951,CST3;SERPINB1
beta,1,second-messenger-mediated signaling (GO:0019932),2/63,2,63,0.12577325808665,0.38709361627647,0,0,3.25600325600326,6.75058862723951,NDNF;KLRG1
beta,1,regulation of translational initiation (GO:0006446),2/63,2,63,0.12577325808665,0.38709361627647,0,0,3.25600325600326,6.75058862723951,IMPACT;EIF2B2
beta,1,cytoskeleton organization (GO:0007010),3/127,3,127,0.127529718505358,0.38709361627647,0,0,2.42277407631738,4.98947511866145,ZMYM3;ANK1;SIPA1L3
beta,1,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),1/14,1,14,0.128216537156879,0.38709361627647,0,0,7.32600732600733,15.0478736104853,KCNH2
beta,1,ribonucleoside monophosphate biosynthetic process (GO:0009156),1/14,1,14,0.128216537156879,0.38709361627647,0,0,7.32600732600733,15.0478736104853,ADSSL1
beta,1,Golgi to vacuole transport (GO:0006896),1/14,1,14,0.128216537156879,0.38709361627647,0,0,7.32600732600733,15.0478736104853,EHD3
beta,1,regulation of Golgi organization (GO:1903358),1/14,1,14,0.128216537156879,0.38709361627647,0,0,7.32600732600733,15.0478736104853,EHD3
beta,1,pore complex assembly (GO:0046931),1/14,1,14,0.128216537156879,0.38709361627647,0,0,7.32600732600733,15.0478736104853,GSDMD
beta,1,regulation of extracellular matrix disassembly (GO:0010715),1/14,1,14,0.128216537156879,0.38709361627647,0,0,7.32600732600733,15.0478736104853,CST3
beta,1,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",1/14,1,14,0.128216537156879,0.38709361627647,0,0,7.32600732600733,15.0478736104853,TP73
beta,1,regulation of histone modification (GO:0031056),1/14,1,14,0.128216537156879,0.38709361627647,0,0,7.32600732600733,15.0478736104853,ZFP64
beta,1,nucleoside triphosphate metabolic process (GO:0009141),1/14,1,14,0.128216537156879,0.38709361627647,0,0,7.32600732600733,15.0478736104853,CMPK2
beta,1,regulation of protein modification by small protein conjugation or removal (GO:1903320),1/14,1,14,0.128216537156879,0.38709361627647,0,0,7.32600732600733,15.0478736104853,EGR1
beta,1,oligodendrocyte differentiation (GO:0048709),1/14,1,14,0.128216537156879,0.38709361627647,0,0,7.32600732600733,15.0478736104853,EIF2B2
beta,1,positive regulation of transporter activity (GO:0032411),1/14,1,14,0.128216537156879,0.38709361627647,0,0,7.32600732600733,15.0478736104853,PON1
beta,1,regulation of neural precursor cell proliferation (GO:2000177),1/14,1,14,0.128216537156879,0.38709361627647,0,0,7.32600732600733,15.0478736104853,ID2
beta,1,establishment of protein localization to chromosome (GO:0070199),1/14,1,14,0.128216537156879,0.38709361627647,0,0,7.32600732600733,15.0478736104853,H2AFY2
beta,1,negative regulation of cation transmembrane transport (GO:1904063),1/14,1,14,0.128216537156879,0.38709361627647,0,0,7.32600732600733,15.0478736104853,KCNH2
beta,1,amyloid-beta metabolic process (GO:0050435),1/14,1,14,0.128216537156879,0.38709361627647,0,0,7.32600732600733,15.0478736104853,ACE
beta,1,kidney development (GO:0001822),2/64,2,64,0.129036207474564,0.38709361627647,0,0,3.20512820512821,6.56301998687755,ACE;WNT4
beta,1,oligosaccharide metabolic process (GO:0009311),2/64,2,64,0.129036207474564,0.38709361627647,0,0,3.20512820512821,6.56301998687755,GALNT12;ST6GAL1
beta,1,regulation of viral genome replication (GO:0045069),2/64,2,64,0.129036207474564,0.38709361627647,0,0,3.20512820512821,6.56301998687755,RSAD2;PPIE
beta,1,positive regulation of protein polymerization (GO:0032273),2/65,2,65,0.132318859845554,0.38709361627647,0,0,3.15581854043393,6.38277132745948,TPPP3;TTBK1
beta,1,O-glycan processing (GO:0016266),2/66,2,66,0.135620526274396,0.38709361627647,0,0,3.10800310800311,6.20946244359503,GALNT12;ST6GAL1
beta,1,cellular response to type I interferon (GO:0071357),2/66,2,66,0.135620526274396,0.38709361627647,0,0,3.10800310800311,6.20946244359503,EGR1;RSAD2
beta,1,cellular response to reactive oxygen species (GO:0034614),2/66,2,66,0.135620526274396,0.38709361627647,0,0,3.10800310800311,6.20946244359503,IMPACT;FOS
beta,1,type I interferon signaling pathway (GO:0060337),2/66,2,66,0.135620526274396,0.38709361627647,0,0,3.10800310800311,6.20946244359503,EGR1;RSAD2
beta,1,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",1/15,1,15,0.136722367112762,0.38709361627647,0,0,6.83760683760684,13.6054900973943,TP73
beta,1,heparan sulfate proteoglycan biosynthetic process (GO:0015012),1/15,1,15,0.136722367112762,0.38709361627647,0,0,6.83760683760684,13.6054900973943,NDST3
beta,1,digestive tract morphogenesis (GO:0048546),1/15,1,15,0.136722367112762,0.38709361627647,0,0,6.83760683760684,13.6054900973943,ID2
beta,1,autonomic nervous system development (GO:0048483),1/15,1,15,0.136722367112762,0.38709361627647,0,0,6.83760683760684,13.6054900973943,NTRK1
beta,1,response to X-ray (GO:0010165),1/15,1,15,0.136722367112762,0.38709361627647,0,0,6.83760683760684,13.6054900973943,TP73
beta,1,positive regulation of collagen metabolic process (GO:0010714),1/15,1,15,0.136722367112762,0.38709361627647,0,0,6.83760683760684,13.6054900973943,WNT4
beta,1,positive regulation of potassium ion transmembrane transport (GO:1901381),1/15,1,15,0.136722367112762,0.38709361627647,0,0,6.83760683760684,13.6054900973943,KCNH2
beta,1,anterograde synaptic vesicle transport (GO:0048490),1/15,1,15,0.136722367112762,0.38709361627647,0,0,6.83760683760684,13.6054900973943,SNAPIN
beta,1,protein O-linked fucosylation (GO:0036066),1/15,1,15,0.136722367112762,0.38709361627647,0,0,6.83760683760684,13.6054900973943,ADAMTS5
beta,1,JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397),1/15,1,15,0.136722367112762,0.38709361627647,0,0,6.83760683760684,13.6054900973943,GHR
beta,1,negative regulation of mRNA processing (GO:0050686),1/15,1,15,0.136722367112762,0.38709361627647,0,0,6.83760683760684,13.6054900973943,SRSF12
beta,1,positive regulation of collagen biosynthetic process (GO:0032967),1/15,1,15,0.136722367112762,0.38709361627647,0,0,6.83760683760684,13.6054900973943,WNT4
beta,1,positive regulation of potassium ion transport (GO:0043268),1/15,1,15,0.136722367112762,0.38709361627647,0,0,6.83760683760684,13.6054900973943,KCNH2
beta,1,synaptic vesicle transport along microtubule (GO:0099517),1/15,1,15,0.136722367112762,0.38709361627647,0,0,6.83760683760684,13.6054900973943,SNAPIN
beta,1,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),1/15,1,15,0.136722367112762,0.38709361627647,0,0,6.83760683760684,13.6054900973943,ETFDH
beta,1,negative regulation of epithelial cell proliferation (GO:0050680),2/67,2,67,0.138940529279916,0.38709361627647,0,0,3.06161500191351,6.04273795426291,HPN;ATOH8
beta,1,regulation of cardiac conduction (GO:1903779),2/68,2,68,0.142278202680383,0.38709361627647,0,0,3.01659125188537,5.88226535219719,SRI;CORIN
beta,1,cellular response to UV (GO:0034644),2/68,2,68,0.142278202680383,0.38709361627647,0,0,3.01659125188537,5.88226535219719,IMPACT;TP73
beta,1,protein localization to microtubule organizing center (GO:1905508),1/16,1,16,0.145145628912699,0.38709361627647,0,0,6.41025641025641,12.3719083541148,C2CD3
beta,1,regulation of actin nucleation (GO:0051125),1/16,1,16,0.145145628912699,0.38709361627647,0,0,6.41025641025641,12.3719083541148,WIPF1
beta,1,DNA alkylation (GO:0006305),1/16,1,16,0.145145628912699,0.38709361627647,0,0,6.41025641025641,12.3719083541148,FOS
beta,1,phosphatidylinositol acyl-chain remodeling (GO:0036149),1/16,1,16,0.145145628912699,0.38709361627647,0,0,6.41025641025641,12.3719083541148,PLBD1
beta,1,G-protein coupled acetylcholine receptor signaling pathway (GO:0007213),1/16,1,16,0.145145628912699,0.38709361627647,0,0,6.41025641025641,12.3719083541148,AGRN
beta,1,regulation of stem cell proliferation (GO:0072091),1/16,1,16,0.145145628912699,0.38709361627647,0,0,6.41025641025641,12.3719083541148,ACE
beta,1,epithelial cell development (GO:0002064),1/16,1,16,0.145145628912699,0.38709361627647,0,0,6.41025641025641,12.3719083541148,SIPA1L3
beta,1,stabilization of membrane potential (GO:0030322),1/16,1,16,0.145145628912699,0.38709361627647,0,0,6.41025641025641,12.3719083541148,KCNK17
beta,1,sympathetic nervous system development (GO:0048485),1/16,1,16,0.145145628912699,0.38709361627647,0,0,6.41025641025641,12.3719083541148,NTRK1
beta,1,negative regulation of steroid biosynthetic process (GO:0010894),1/16,1,16,0.145145628912699,0.38709361627647,0,0,6.41025641025641,12.3719083541148,WNT4
beta,1,ventricular cardiac muscle cell action potential (GO:0086005),1/16,1,16,0.145145628912699,0.38709361627647,0,0,6.41025641025641,12.3719083541148,KCNH2
beta,1,DNA methylation or demethylation (GO:0044728),1/16,1,16,0.145145628912699,0.38709361627647,0,0,6.41025641025641,12.3719083541148,FOS
beta,1,regulation of membrane repolarization (GO:0060306),1/16,1,16,0.145145628912699,0.38709361627647,0,0,6.41025641025641,12.3719083541148,KCNH2
beta,1,cellular response to pH (GO:0071467),1/16,1,16,0.145145628912699,0.38709361627647,0,0,6.41025641025641,12.3719083541148,IMPACT
beta,1,pyrimidine-containing compound metabolic process (GO:0072527),1/16,1,16,0.145145628912699,0.38709361627647,0,0,6.41025641025641,12.3719083541148,THTPA
beta,1,peptidyl-threonine phosphorylation (GO:0018107),2/69,2,69,0.145632891380359,0.38709361627647,0,0,2.97287253808993,5.72773323342702,STK33;TTBK1
beta,1,regulation of epithelial to mesenchymal transition (GO:0010717),2/69,2,69,0.145632891380359,0.38709361627647,0,0,2.97287253808993,5.72773323342702,HPN;OVOL2
beta,1,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),2/70,2,70,0.149003951235153,0.38709361627647,0,0,2.93040293040293,5.57884968507415,DPYSL3;AGRN
beta,1,positive regulation of endothelial cell migration (GO:0010595),2/71,2,71,0.152390749018704,0.38709361627647,0,0,2.88912964969303,5.43534081487625,ATOH8;FGF18
beta,1,phospholipid metabolic process (GO:0006644),2/71,2,71,0.152390749018704,0.38709361627647,0,0,2.88912964969303,5.43534081487625,LPCAT1;PLBD1
beta,1,neuropeptide signaling pathway (GO:0007218),2/71,2,71,0.152390749018704,0.38709361627647,0,0,2.88912964969303,5.43534081487625,LTB4R2;LTB4R
beta,1,regulation of protein sumoylation (GO:0033233),1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,EGR1
beta,1,3'-UTR-mediated mRNA stabilization (GO:0070935),1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,ANGEL2
beta,1,positive regulation of protein processing (GO:0010954),1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,HPN
beta,1,regulation of collagen biosynthetic process (GO:0032965),1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,WNT4
beta,1,positive regulation of cholesterol transport (GO:0032376),1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,PON1
beta,1,regulation of tissue remodeling (GO:0034103),1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,CST3
beta,1,sialylation (GO:0097503),1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,ST6GAL1
beta,1,positive regulation of epidermal cell differentiation (GO:0045606),1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,H2AFY2
beta,1,positive regulation of nitrogen compound metabolic process (GO:0051173),1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,HPN
beta,1,2-oxoglutarate metabolic process (GO:0006103),1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,GHR
beta,1,positive regulation of macrophage activation (GO:0043032),1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,TTBK1
beta,1,long-term memory (GO:0007616),1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,RASGRF1
beta,1,"mRNA cis splicing, via spliceosome (GO:0045292)",1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,SRSF12
beta,1,neurotrophin signaling pathway (GO:0038179),1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,NTRK1
beta,1,negative regulation of lipid biosynthetic process (GO:0051055),1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,WNT4
beta,1,positive regulation by host of viral transcription (GO:0043923),1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,HPN
beta,1,histone H2A monoubiquitination (GO:0035518),1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,PCGF3
beta,1,synaptic vesicle transport (GO:0048489),1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,SNAPIN
beta,1,positive regulation of cation transmembrane transport (GO:1904064),1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,KCNH2
beta,1,N-glycan processing (GO:0006491),1/17,1,17,0.153487119942182,0.38709361627647,0,0,6.03318250377074,11.3070203598607,EDEM3
beta,1,cellular response to growth factor stimulus (GO:0071363),3/140,3,140,0.156822221323925,0.388555759008892,0,0,2.1978021978022,4.07174167797748,NTRK1;SMAD9;WNT4
beta,1,neuron differentiation (GO:0030182),3/140,3,140,0.156822221323925,0.388555759008892,0,0,2.1978021978022,4.07174167797748,ID2;ID3;WNT4
beta,1,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),3/141,3,141,0.15915708382439,0.388555759008892,0,0,2.1822149481724,4.01061345527735,ID2;BHLHE40;ID3
beta,1,regulation of neuron death (GO:1901214),2/73,2,73,0.159209078389896,0.388555759008892,0,0,2.80997541271514,5.16343373975571,EGR1;FOS
beta,1,regulation of multicellular organism growth (GO:0040014),1/18,1,18,0.161747629913004,0.388555759008892,0,0,5.6980056980057,10.3801595355409,GHR
beta,1,regulation of cardiac muscle cell proliferation (GO:0060043),1/18,1,18,0.161747629913004,0.388555759008892,0,0,5.6980056980057,10.3801595355409,TP73
beta,1,regulation of cholesterol efflux (GO:0010874),1/18,1,18,0.161747629913004,0.388555759008892,0,0,5.6980056980057,10.3801595355409,PON1
beta,1,protein localization to centrosome (GO:0071539),1/18,1,18,0.161747629913004,0.388555759008892,0,0,5.6980056980057,10.3801595355409,C2CD3
beta,1,phosphatidylglycerol acyl-chain remodeling (GO:0036148),1/18,1,18,0.161747629913004,0.388555759008892,0,0,5.6980056980057,10.3801595355409,LPCAT1
beta,1,negative regulation of protein transport (GO:0051224),1/18,1,18,0.161747629913004,0.388555759008892,0,0,5.6980056980057,10.3801595355409,RSAD2
beta,1,DNA methylation (GO:0006306),1/18,1,18,0.161747629913004,0.388555759008892,0,0,5.6980056980057,10.3801595355409,FOS
beta,1,regulation of peptidase activity (GO:0052547),1/18,1,18,0.161747629913004,0.388555759008892,0,0,5.6980056980057,10.3801595355409,CST3
beta,1,establishment of epithelial cell polarity (GO:0090162),1/18,1,18,0.161747629913004,0.388555759008892,0,0,5.6980056980057,10.3801595355409,SIPA1L3
beta,1,establishment or maintenance of apical/basal cell polarity (GO:0035088),1/18,1,18,0.161747629913004,0.388555759008892,0,0,5.6980056980057,10.3801595355409,PARD3B
beta,1,negative regulation of RNA splicing (GO:0033119),1/18,1,18,0.161747629913004,0.388555759008892,0,0,5.6980056980057,10.3801595355409,SRSF12
beta,1,regulation of smooth muscle cell migration (GO:0014910),1/18,1,18,0.161747629913004,0.388555759008892,0,0,5.6980056980057,10.3801595355409,ACE
beta,1,negative regulation of calcium-mediated signaling (GO:0050849),1/18,1,18,0.161747629913004,0.388555759008892,0,0,5.6980056980057,10.3801595355409,SRI
beta,1,"regulation of gene expression, epigenetic (GO:0040029)",2/75,2,75,0.1660830241145,0.396038019588992,0,0,2.73504273504274,4.91013325234456,H2AFY2;POLR1B
beta,1,gland development (GO:0048732),2/76,2,76,0.169539380710817,0.396038019588992,0,0,2.69905533063428,4.78993264391373,THRB;WNT4
beta,1,positive regulation of chromosome organization (GO:2001252),1/19,1,19,0.169927940963184,0.396038019588992,0,0,5.39811066126856,9.56750773808447,RAD21
beta,1,negative regulation of cell junction assembly (GO:1901889),1/19,1,19,0.169927940963184,0.396038019588992,0,0,5.39811066126856,9.56750773808447,ACE
beta,1,negative regulation of protein localization to plasma membrane (GO:1903077),1/19,1,19,0.169927940963184,0.396038019588992,0,0,5.39811066126856,9.56750773808447,MRAP2
beta,1,negative regulation of protein localization to cell periphery (GO:1904376),1/19,1,19,0.169927940963184,0.396038019588992,0,0,5.39811066126856,9.56750773808447,MRAP2
beta,1,posttranscriptional gene silencing by RNA (GO:0035194),1/19,1,19,0.169927940963184,0.396038019588992,0,0,5.39811066126856,9.56750773808447,NRDE2
beta,1,positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),1/19,1,19,0.169927940963184,0.396038019588992,0,0,5.39811066126856,9.56750773808447,FOS
beta,1,positive regulation of epithelial cell differentiation (GO:0030858),1/19,1,19,0.169927940963184,0.396038019588992,0,0,5.39811066126856,9.56750773808447,ATOH8
beta,1,cellular polysaccharide biosynthetic process (GO:0033692),1/19,1,19,0.169927940963184,0.396038019588992,0,0,5.39811066126856,9.56750773808447,NDST3
beta,1,purine ribonucleotide catabolic process (GO:0009154),1/19,1,19,0.169927940963184,0.396038019588992,0,0,5.39811066126856,9.56750773808447,PDE4B
beta,1,positive regulation of interleukin-2 production (GO:0032743),1/20,1,20,0.178028827720883,0.39871039541656,0,0,5.12820512820513,8.85030660674357,PDE4B
beta,1,covalent chromatin modification (GO:0016569),1/20,1,20,0.178028827720883,0.39871039541656,0,0,5.12820512820513,8.85030660674357,ZFP64
beta,1,regulation of toll-like receptor signaling pathway (GO:0034121),1/20,1,20,0.178028827720883,0.39871039541656,0,0,5.12820512820513,8.85030660674357,TLR5
beta,1,negative regulation of macromolecule biosynthetic process (GO:0010558),1/20,1,20,0.178028827720883,0.39871039541656,0,0,5.12820512820513,8.85030660674357,APBB1
beta,1,embryonic digestive tract development (GO:0048566),1/20,1,20,0.178028827720883,0.39871039541656,0,0,5.12820512820513,8.85030660674357,ID2
beta,1,negative regulation of cyclase activity (GO:0031280),1/20,1,20,0.178028827720883,0.39871039541656,0,0,5.12820512820513,8.85030660674357,LTB4R2
beta,1,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),1/20,1,20,0.178028827720883,0.39871039541656,0,0,5.12820512820513,8.85030660674357,CLDN9
beta,1,heparan sulfate proteoglycan metabolic process (GO:0030201),1/20,1,20,0.178028827720883,0.39871039541656,0,0,5.12820512820513,8.85030660674357,NDST3
beta,1,axon extension (GO:0048675),1/20,1,20,0.178028827720883,0.39871039541656,0,0,5.12820512820513,8.85030660674357,SLIT1
beta,1,androgen metabolic process (GO:0008209),1/20,1,20,0.178028827720883,0.39871039541656,0,0,5.12820512820513,8.85030660674357,WNT4
beta,1,negative regulation of adenylate cyclase activity (GO:0007194),1/20,1,20,0.178028827720883,0.39871039541656,0,0,5.12820512820513,8.85030660674357,LTB4R2
beta,1,chondroitin sulfate biosynthetic process (GO:0030206),1/20,1,20,0.178028827720883,0.39871039541656,0,0,5.12820512820513,8.85030660674357,CHST3
beta,1,glial cell development (GO:0021782),1/20,1,20,0.178028827720883,0.39871039541656,0,0,5.12820512820513,8.85030660674357,EIF2B2
beta,1,growth hormone receptor signaling pathway (GO:0060396),1/20,1,20,0.178028827720883,0.39871039541656,0,0,5.12820512820513,8.85030660674357,GHR
beta,1,regulation of transport (GO:0051049),1/20,1,20,0.178028827720883,0.39871039541656,0,0,5.12820512820513,8.85030660674357,YRDC
beta,1,fibroblast growth factor receptor signaling pathway (GO:0008543),2/79,2,79,0.179979157938279,0.400989833748498,0,0,2.59655955858488,4.45287692055254,FIBP;FGF18
beta,1,extracellular matrix disassembly (GO:0022617),2/79,2,79,0.179979157938279,0.400989833748498,0,0,2.59655955858488,4.45287692055254,ADAMTS5;HPN
beta,1,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/21,1,21,0.186051057359254,0.403032517201406,0,0,4.88400488400488,8.21359775827217,SMAD9
beta,1,non-motile cilium assembly (GO:1905515),1/21,1,21,0.186051057359254,0.403032517201406,0,0,4.88400488400488,8.21359775827217,C2CD3
beta,1,regulation of interleukin-2 production (GO:0032663),1/21,1,21,0.186051057359254,0.403032517201406,0,0,4.88400488400488,8.21359775827217,PDE4B
beta,1,viral budding via host ESCRT complex (GO:0039702),1/21,1,21,0.186051057359254,0.403032517201406,0,0,4.88400488400488,8.21359775827217,VPS37C
beta,1,cortical actin cytoskeleton organization (GO:0030866),1/21,1,21,0.186051057359254,0.403032517201406,0,0,4.88400488400488,8.21359775827217,WIPF1
beta,1,energy reserve metabolic process (GO:0006112),1/21,1,21,0.186051057359254,0.403032517201406,0,0,4.88400488400488,8.21359775827217,MRAP2
beta,1,cellular protein complex localization (GO:0034629),1/21,1,21,0.186051057359254,0.403032517201406,0,0,4.88400488400488,8.21359775827217,EXOC3
beta,1,negative regulation of cAMP biosynthetic process (GO:0030818),1/21,1,21,0.186051057359254,0.403032517201406,0,0,4.88400488400488,8.21359775827217,LTB4R2
beta,1,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),1/21,1,21,0.186051057359254,0.403032517201406,0,0,4.88400488400488,8.21359775827217,TP73
beta,1,protein O-linked glycosylation via threonine (GO:0018243),1/21,1,21,0.186051057359254,0.403032517201406,0,0,4.88400488400488,8.21359775827217,GALNT12
beta,1,hepaticobiliary system development (GO:0061008),1/21,1,21,0.186051057359254,0.403032517201406,0,0,4.88400488400488,8.21359775827217,WNT4
beta,1,positive regulation of binding (GO:0051099),2/82,2,82,0.190513505744413,0.404061536321179,0,0,2.50156347717323,4.14767277206323,GPSM1;PON1
beta,1,STAT cascade (GO:0097696),1/22,1,22,0.193995389740415,0.404061536321179,0,0,4.66200466200466,7.64531880851212,GHR
beta,1,branched-chain amino acid metabolic process (GO:0009081),1/22,1,22,0.193995389740415,0.404061536321179,0,0,4.66200466200466,7.64531880851212,GHR
beta,1,positive regulation of protein autophosphorylation (GO:0031954),1/22,1,22,0.193995389740415,0.404061536321179,0,0,4.66200466200466,7.64531880851212,ACE
beta,1,protein O-linked glycosylation via serine (GO:0018242),1/22,1,22,0.193995389740415,0.404061536321179,0,0,4.66200466200466,7.64531880851212,GALNT12
beta,1,cellular response to nerve growth factor stimulus (GO:1990090),1/22,1,22,0.193995389740415,0.404061536321179,0,0,4.66200466200466,7.64531880851212,NTRK1
beta,1,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),1/22,1,22,0.193995389740415,0.404061536321179,0,0,4.66200466200466,7.64531880851212,ZDHHC22
beta,1,peptidyl-L-cysteine S-palmitoylation (GO:0018230),1/22,1,22,0.193995389740415,0.404061536321179,0,0,4.66200466200466,7.64531880851212,ZDHHC22
beta,1,hematopoietic progenitor cell differentiation (GO:0002244),1/22,1,22,0.193995389740415,0.404061536321179,0,0,4.66200466200466,7.64531880851212,ACE
beta,1,inner ear morphogenesis (GO:0042472),1/22,1,22,0.193995389740415,0.404061536321179,0,0,4.66200466200466,7.64531880851212,HPN
beta,1,negative regulation of nervous system development (GO:0051961),1/22,1,22,0.193995389740415,0.404061536321179,0,0,4.66200466200466,7.64531880851212,SLIT1
beta,1,negative regulation of GTPase activity (GO:0034260),1/22,1,22,0.193995389740415,0.404061536321179,0,0,4.66200466200466,7.64531880851212,GPSM1
beta,1,negative regulation of lyase activity (GO:0051350),1/22,1,22,0.193995389740415,0.404061536321179,0,0,4.66200466200466,7.64531880851212,LTB4R2
beta,1,sulfur amino acid metabolic process (GO:0000096),1/22,1,22,0.193995389740415,0.404061536321179,0,0,4.66200466200466,7.64531880851212,BHMT2
beta,1,phosphatidylglycerol metabolic process (GO:0046471),1/22,1,22,0.193995389740415,0.404061536321179,0,0,4.66200466200466,7.64531880851212,LPCAT1
beta,1,positive regulation of cell cycle arrest (GO:0071158),2/83,2,83,0.19404350523331,0.404061536321179,0,0,2.47142415817115,4.05232719500767,ID2;TP73
beta,1,negative regulation of endopeptidase activity (GO:0010951),2/84,2,84,0.19758192993019,0.410435893091699,0,0,2.44200244200244,3.95995591104195,CST3;SERPINB1
beta,1,cellular response to catecholamine stimulus (GO:0071870),1/23,1,23,0.201862577343833,0.413337658370706,0,0,4.45930880713489,7.13564380502097,PDE4B
beta,1,microtubule polymerization or depolymerization (GO:0031109),1/23,1,23,0.201862577343833,0.413337658370706,0,0,4.45930880713489,7.13564380502097,TPPP3
beta,1,melanosome organization (GO:0032438),1/23,1,23,0.201862577343833,0.413337658370706,0,0,4.45930880713489,7.13564380502097,SNAPIN
beta,1,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),1/23,1,23,0.201862577343833,0.413337658370706,0,0,4.45930880713489,7.13564380502097,SRI
beta,1,viral budding (GO:0046755),1/23,1,23,0.201862577343833,0.413337658370706,0,0,4.45930880713489,7.13564380502097,VPS37C
beta,1,regulation of ion homeostasis (GO:2000021),1/23,1,23,0.201862577343833,0.413337658370706,0,0,4.45930880713489,7.13564380502097,CORIN
beta,1,positive regulation of protein complex assembly (GO:0031334),2/89,2,89,0.215383359263909,0.430730191989781,0,0,2.30481129357534,3.53865922739586,TPPP3;TTBK1
beta,1,negative regulation of protein localization to membrane (GO:1905476),1/25,1,25,0.217368492236704,0.430730191989781,0,0,4.1025641025641,6.26117433728144,MRAP2
beta,1,receptor clustering (GO:0043113),1/25,1,25,0.217368492236704,0.430730191989781,0,0,4.1025641025641,6.26117433728144,AGRN
beta,1,regulation of neuronal synaptic plasticity (GO:0048168),1/25,1,25,0.217368492236704,0.430730191989781,0,0,4.1025641025641,6.26117433728144,SHISA6
beta,1,positive regulation of endopeptidase activity (GO:0010950),1/25,1,25,0.217368492236704,0.430730191989781,0,0,4.1025641025641,6.26117433728144,TTBK1
beta,1,mRNA splice site selection (GO:0006376),1/25,1,25,0.217368492236704,0.430730191989781,0,0,4.1025641025641,6.26117433728144,SRSF12
beta,1,mammary gland development (GO:0030879),1/25,1,25,0.217368492236704,0.430730191989781,0,0,4.1025641025641,6.26117433728144,WNT4
beta,1,"protein alpha-1,2-demannosylation (GO:0036508)",1/25,1,25,0.217368492236704,0.430730191989781,0,0,4.1025641025641,6.26117433728144,EDEM3
beta,1,proteoglycan biosynthetic process (GO:0030166),1/25,1,25,0.217368492236704,0.430730191989781,0,0,4.1025641025641,6.26117433728144,NDST3
beta,1,cellular senescence (GO:0090398),1/25,1,25,0.217368492236704,0.430730191989781,0,0,4.1025641025641,6.26117433728144,ID2
beta,1,negative regulation of endothelial cell apoptotic process (GO:2000352),1/25,1,25,0.217368492236704,0.430730191989781,0,0,4.1025641025641,6.26117433728144,NDNF
beta,1,regulation of AMPA receptor activity (GO:2000311),1/25,1,25,0.217368492236704,0.430730191989781,0,0,4.1025641025641,6.26117433728144,SHISA6
beta,1,regulation of cell cycle G1/S phase transition (GO:1902806),1/25,1,25,0.217368492236704,0.430730191989781,0,0,4.1025641025641,6.26117433728144,ID2
beta,1,cAMP metabolic process (GO:0046058),1/25,1,25,0.217368492236704,0.430730191989781,0,0,4.1025641025641,6.26117433728144,PDE4B
beta,1,"negative regulation of gene expression, epigenetic (GO:0045814)",1/26,1,26,0.225008688680216,0.437799711006756,0,0,3.94477317554241,5.88408781525362,H2AFY2
beta,1,potassium ion homeostasis (GO:0055075),1/26,1,26,0.225008688680216,0.437799711006756,0,0,3.94477317554241,5.88408781525362,KCNH2
beta,1,neutral amino acid transport (GO:0015804),1/26,1,26,0.225008688680216,0.437799711006756,0,0,3.94477317554241,5.88408781525362,SLC7A8
beta,1,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),1/26,1,26,0.225008688680216,0.437799711006756,0,0,3.94477317554241,5.88408781525362,SRI
beta,1,peptide catabolic process (GO:0043171),1/26,1,26,0.225008688680216,0.437799711006756,0,0,3.94477317554241,5.88408781525362,ACE
beta,1,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),1/26,1,26,0.225008688680216,0.437799711006756,0,0,3.94477317554241,5.88408781525362,CHST3
beta,1,positive regulation of embryonic development (GO:0040019),1/26,1,26,0.225008688680216,0.437799711006756,0,0,3.94477317554241,5.88408781525362,WNT4
beta,1,positive regulation of interleukin-1 beta secretion (GO:0050718),1/26,1,26,0.225008688680216,0.437799711006756,0,0,3.94477317554241,5.88408781525362,GSDMD
beta,1,phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200),2/92,2,92,0.226134870335908,0.438627683724652,0,0,2.22965440356745,3.31465704862713,LTB4R2;LTB4R
beta,1,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1/27,1,27,0.232574678812141,0.438627683724652,0,0,3.79867046533713,5.54052765939654,ID2
beta,1,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),1/27,1,27,0.232574678812141,0.438627683724652,0,0,3.79867046533713,5.54052765939654,TTBK1
beta,1,positive regulation of synapse assembly (GO:0051965),1/27,1,27,0.232574678812141,0.438627683724652,0,0,3.79867046533713,5.54052765939654,AGRN
beta,1,regulation of muscle contraction (GO:0006937),1/27,1,27,0.232574678812141,0.438627683724652,0,0,3.79867046533713,5.54052765939654,SRI
beta,1,response to gamma radiation (GO:0010332),1/27,1,27,0.232574678812141,0.438627683724652,0,0,3.79867046533713,5.54052765939654,TP73
beta,1,monovalent inorganic cation homeostasis (GO:0055067),1/27,1,27,0.232574678812141,0.438627683724652,0,0,3.79867046533713,5.54052765939654,KCNH2
beta,1,nucleotide biosynthetic process (GO:0009165),1/27,1,27,0.232574678812141,0.438627683724652,0,0,3.79867046533713,5.54052765939654,RRM1
beta,1,regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),1/27,1,27,0.232574678812141,0.438627683724652,0,0,3.79867046533713,5.54052765939654,FOS
beta,1,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),1/27,1,27,0.232574678812141,0.438627683724652,0,0,3.79867046533713,5.54052765939654,PLBD1
beta,1,positive regulation of release of cytochrome c from mitochondria (GO:0090200),1/27,1,27,0.232574678812141,0.438627683724652,0,0,3.79867046533713,5.54052765939654,CIDEB
beta,1,GPI anchor metabolic process (GO:0006505),1/27,1,27,0.232574678812141,0.438627683724652,0,0,3.79867046533713,5.54052765939654,MPPE1
beta,1,negative chemotaxis (GO:0050919),1/27,1,27,0.232574678812141,0.438627683724652,0,0,3.79867046533713,5.54052765939654,SLIT1
beta,1,tRNA methylation (GO:0030488),1/27,1,27,0.232574678812141,0.438627683724652,0,0,3.79867046533713,5.54052765939654,THUMPD3
beta,1,axon development (GO:0061564),2/95,2,95,0.236924795077231,0.44294239755937,0,0,2.15924426450742,3.10933874991201,SLIT1;APBB1
beta,1,cellular response to fibroblast growth factor stimulus (GO:0044344),2/95,2,95,0.236924795077231,0.44294239755937,0,0,2.15924426450742,3.10933874991201,FIBP;FGF18
beta,1,respiratory electron transport chain (GO:0022904),2/95,2,95,0.236924795077231,0.44294239755937,0,0,2.15924426450742,3.10933874991201,ETFDH;NDUFS2
beta,1,microtubule polymerization (GO:0046785),1/28,1,28,0.240067179653283,0.44294239755937,0,0,3.66300366300366,5.22650725123476,TPPP3
beta,1,peptidyl-glutamic acid modification (GO:0018200),1/28,1,28,0.240067179653283,0.44294239755937,0,0,3.66300366300366,5.22650725123476,CEP41
beta,1,endocytic recycling (GO:0032456),1/28,1,28,0.240067179653283,0.44294239755937,0,0,3.66300366300366,5.22650725123476,EHD3
beta,1,cardiac muscle cell development (GO:0055013),1/28,1,28,0.240067179653283,0.44294239755937,0,0,3.66300366300366,5.22650725123476,SORBS2
beta,1,modulation by host of viral transcription (GO:0043921),1/28,1,28,0.240067179653283,0.44294239755937,0,0,3.66300366300366,5.22650725123476,HPN
beta,1,regulation of blood vessel diameter (GO:0097746),1/28,1,28,0.240067179653283,0.44294239755937,0,0,3.66300366300366,5.22650725123476,ACE
beta,1,protein localization to chromosome (GO:0034502),1/28,1,28,0.240067179653283,0.44294239755937,0,0,3.66300366300366,5.22650725123476,RAD21
beta,1,regulation of heart contraction (GO:0008016),2/96,2,96,0.240528022860728,0.44294239755937,0,0,2.13675213675214,3.04469802789044,SRI;CORIN
beta,1,regulation of cell death (GO:0010941),2/97,2,97,0.244133872744703,0.442991251069546,0,0,2.1147237642083,2.98184202031694,IMPACT;CIDEB
beta,1,neuron projection extension (GO:1990138),1/29,1,29,0.247486901424419,0.442991251069546,0,0,3.53669319186561,4.93862996255205,IMPACT
beta,1,cellular response to hydrogen peroxide (GO:0070301),1/29,1,29,0.247486901424419,0.442991251069546,0,0,3.53669319186561,4.93862996255205,IMPACT
beta,1,negative regulation of JNK cascade (GO:0046329),1/29,1,29,0.247486901424419,0.442991251069546,0,0,3.53669319186561,4.93862996255205,TP73
beta,1,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),1/29,1,29,0.247486901424419,0.442991251069546,0,0,3.53669319186561,4.93862996255205,ACE
beta,1,calcium ion import (GO:0070509),1/29,1,29,0.247486901424419,0.442991251069546,0,0,3.53669319186561,4.93862996255205,NALCN
beta,1,regulation of adenylate cyclase activity (GO:0045761),1/29,1,29,0.247486901424419,0.442991251069546,0,0,3.53669319186561,4.93862996255205,LTB4R2
beta,1,positive regulation of protein tyrosine kinase activity (GO:0061098),1/29,1,29,0.247486901424419,0.442991251069546,0,0,3.53669319186561,4.93862996255205,ACE
beta,1,regulation of cell morphogenesis (GO:0022604),1/29,1,29,0.247486901424419,0.442991251069546,0,0,3.53669319186561,4.93862996255205,ZMYM3
beta,1,transcription elongation from RNA polymerase I promoter (GO:0006362),1/29,1,29,0.247486901424419,0.442991251069546,0,0,3.53669319186561,4.93862996255205,POLR1B
beta,1,cell morphogenesis involved in neuron differentiation (GO:0048667),2/98,2,98,0.247741953327786,0.442991251069546,0,0,2.09314495028781,2.92070661496462,SLIT1;APBB1
beta,1,cellular response to organonitrogen compound (GO:0071417),2/98,2,98,0.247741953327786,0.442991251069546,0,0,2.09314495028781,2.92070661496462,EGR1;IMPACT
beta,1,negative regulation of cell motility (GO:2000146),2/98,2,98,0.247741953327786,0.442991251069546,0,0,2.09314495028781,2.92070661496462,DPYSL3;SRGAP3
beta,1,phosphatidylinositol biosynthetic process (GO:0006661),2/99,2,99,0.25135188048349,0.442991251069546,0,0,2.07200207200207,2.86123057723462,VAC14;MPPE1
beta,1,regulation of striated muscle contraction (GO:0006942),1/30,1,30,0.254834547411389,0.442991251069546,0,0,3.41880341880342,4.67398556611353,SRI
beta,1,cellular response to cadmium ion (GO:0071276),1/30,1,30,0.254834547411389,0.442991251069546,0,0,3.41880341880342,4.67398556611353,FOS
beta,1,regulation of keratinocyte differentiation (GO:0045616),1/30,1,30,0.254834547411389,0.442991251069546,0,0,3.41880341880342,4.67398556611353,H2AFY2
beta,1,negative regulation of epithelial cell apoptotic process (GO:1904036),1/30,1,30,0.254834547411389,0.442991251069546,0,0,3.41880341880342,4.67398556611353,NDNF
beta,1,cardiac muscle cell action potential (GO:0086001),1/30,1,30,0.254834547411389,0.442991251069546,0,0,3.41880341880342,4.67398556611353,KCNH2
beta,1,regulation of vasoconstriction (GO:0019229),1/30,1,30,0.254834547411389,0.442991251069546,0,0,3.41880341880342,4.67398556611353,ACE
beta,1,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),1/30,1,30,0.254834547411389,0.442991251069546,0,0,3.41880341880342,4.67398556611353,TLR5
beta,1,amino acid transmembrane transport (GO:0003333),1/30,1,30,0.254834547411389,0.442991251069546,0,0,3.41880341880342,4.67398556611353,SLC7A8
beta,1,positive regulation of interleukin-1 secretion (GO:0050716),1/30,1,30,0.254834547411389,0.442991251069546,0,0,3.41880341880342,4.67398556611353,GSDMD
beta,1,carbohydrate derivative biosynthetic process (GO:1901137),1/30,1,30,0.254834547411389,0.442991251069546,0,0,3.41880341880342,4.67398556611353,RRM1
beta,1,lysosome localization (GO:0032418),1/30,1,30,0.254834547411389,0.442991251069546,0,0,3.41880341880342,4.67398556611353,SNAPIN
beta,1,glycosaminoglycan biosynthetic process (GO:0006024),2/100,2,100,0.254963277350062,0.442991251069546,0,0,2.05128205128205,2.8033553940228,AGRN;CHST3
beta,1,cellular response to transforming growth factor beta stimulus (GO:0071560),2/101,2,101,0.258575774086677,0.442991251069546,0,0,2.03097232800203,2.74702512933987,FOS;WNT4
beta,1,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),1/31,1,31,0.262110814213566,0.442991251069546,0,0,3.3085194375517,4.43006752564992,TP73
beta,1,regulation of developmental growth (GO:0048638),1/31,1,31,0.262110814213566,0.442991251069546,0,0,3.3085194375517,4.43006752564992,GHR
beta,1,smoothened signaling pathway (GO:0007224),1/31,1,31,0.262110814213566,0.442991251069546,0,0,3.3085194375517,4.43006752564992,CC2D2A
beta,1,negative regulation of cation channel activity (GO:2001258),1/31,1,31,0.262110814213566,0.442991251069546,0,0,3.3085194375517,4.43006752564992,SRI
beta,1,negative regulation of endothelial cell proliferation (GO:0001937),1/31,1,31,0.262110814213566,0.442991251069546,0,0,3.3085194375517,4.43006752564992,ATOH8
beta,1,replication fork processing (GO:0031297),1/31,1,31,0.262110814213566,0.442991251069546,0,0,3.3085194375517,4.43006752564992,BHLHE40
beta,1,aminoglycan metabolic process (GO:0006022),1/31,1,31,0.262110814213566,0.442991251069546,0,0,3.3085194375517,4.43006752564992,AGRN
beta,1,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),1/31,1,31,0.262110814213566,0.442991251069546,0,0,3.3085194375517,4.43006752564992,TP73
beta,1,negative regulation of secretion by cell (GO:1903531),1/31,1,31,0.262110814213566,0.442991251069546,0,0,3.3085194375517,4.43006752564992,RSAD2
beta,1,multivesicular body assembly (GO:0036258),1/31,1,31,0.262110814213566,0.442991251069546,0,0,3.3085194375517,4.43006752564992,VPS37C
beta,1,protein palmitoylation (GO:0018345),1/31,1,31,0.262110814213566,0.442991251069546,0,0,3.3085194375517,4.43006752564992,ZDHHC22
beta,1,regulation of cation transmembrane transport (GO:1904062),1/31,1,31,0.262110814213566,0.442991251069546,0,0,3.3085194375517,4.43006752564992,KCNH2
beta,1,regulation of ARF protein signal transduction (GO:0032012),1/31,1,31,0.262110814213566,0.442991251069546,0,0,3.3085194375517,4.43006752564992,AGAP3
beta,1,regulation of kinase activity (GO:0043549),2/102,2,102,0.262189007900464,0.442991251069546,0,0,2.01106083459025,2.69218628679282,NTRK1;VAC14
beta,1,intrinsic apoptotic signaling pathway (GO:0097193),2/102,2,102,0.262189007900464,0.442991251069546,0,0,2.01106083459025,2.69218628679282,CIDEB;TP73
beta,1,response to cadmium ion (GO:0046686),1/32,1,32,0.269316391663975,0.445407878521189,0,0,3.20512820512821,4.2047064530298,FOS
beta,1,alpha-amino acid metabolic process (GO:1901605),1/32,1,32,0.269316391663975,0.445407878521189,0,0,3.20512820512821,4.2047064530298,GHR
beta,1,nucleobase-containing small molecule interconversion (GO:0015949),1/32,1,32,0.269316391663975,0.445407878521189,0,0,3.20512820512821,4.2047064530298,RRM1
beta,1,regulation of protein tyrosine kinase activity (GO:0061097),1/32,1,32,0.269316391663975,0.445407878521189,0,0,3.20512820512821,4.2047064530298,ACE
beta,1,termination of RNA polymerase I transcription (GO:0006363),1/32,1,32,0.269316391663975,0.445407878521189,0,0,3.20512820512821,4.2047064530298,POLR1B
beta,1,liver development (GO:0001889),1/32,1,32,0.269316391663975,0.445407878521189,0,0,3.20512820512821,4.2047064530298,WNT4
beta,1,positive regulation of bone mineralization (GO:0030501),1/32,1,32,0.269316391663975,0.445407878521189,0,0,3.20512820512821,4.2047064530298,WNT4
beta,1,anterograde axonal transport (GO:0008089),1/32,1,32,0.269316391663975,0.445407878521189,0,0,3.20512820512821,4.2047064530298,SNAPIN
beta,1,multivesicular body organization (GO:0036257),1/32,1,32,0.269316391663975,0.445407878521189,0,0,3.20512820512821,4.2047064530298,VPS37C
beta,1,positive regulation of viral genome replication (GO:0045070),1/32,1,32,0.269316391663975,0.445407878521189,0,0,3.20512820512821,4.2047064530298,PPIE
beta,1,regulation of protein autophosphorylation (GO:0031952),1/32,1,32,0.269316391663975,0.445407878521189,0,0,3.20512820512821,4.2047064530298,IMPACT
beta,1,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),1/33,1,33,0.276451963043268,0.449430412508904,0,0,3.10800310800311,3.99601617816737,SRI
beta,1,regulation of glutamate receptor signaling pathway (GO:1900449),1/33,1,33,0.276451963043268,0.449430412508904,0,0,3.10800310800311,3.99601617816737,SHISA6
beta,1,phosphatidylcholine biosynthetic process (GO:0006656),1/33,1,33,0.276451963043268,0.449430412508904,0,0,3.10800310800311,3.99601617816737,LPCAT1
beta,1,mismatch repair (GO:0006298),1/33,1,33,0.276451963043268,0.449430412508904,0,0,3.10800310800311,3.99601617816737,TP73
beta,1,microtubule bundle formation (GO:0001578),1/33,1,33,0.276451963043268,0.449430412508904,0,0,3.10800310800311,3.99601617816737,TPPP3
beta,1,regulation of potassium ion transmembrane transport (GO:1901379),1/33,1,33,0.276451963043268,0.449430412508904,0,0,3.10800310800311,3.99601617816737,KCNH2
beta,1,negative regulation of receptor activity (GO:2000272),1/33,1,33,0.276451963043268,0.449430412508904,0,0,3.10800310800311,3.99601617816737,SRI
beta,1,aminoglycan catabolic process (GO:0006026),1/33,1,33,0.276451963043268,0.449430412508904,0,0,3.10800310800311,3.99601617816737,AGRN
beta,1,GPI anchor biosynthetic process (GO:0006506),1/33,1,33,0.276451963043268,0.449430412508904,0,0,3.10800310800311,3.99601617816737,MPPE1
beta,1,positive regulation of biomineral tissue development (GO:0070169),1/34,1,34,0.283518204986958,0.451244749018767,0,0,3.01659125188537,3.8023497518989,WNT4
beta,1,transcription from RNA polymerase I promoter (GO:0006360),1/34,1,34,0.283518204986958,0.451244749018767,0,0,3.01659125188537,3.8023497518989,POLR1B
beta,1,activation of MAPKK activity (GO:0000186),1/34,1,34,0.283518204986958,0.451244749018767,0,0,3.01659125188537,3.8023497518989,NTRK1
beta,1,oligosaccharide biosynthetic process (GO:0009312),1/34,1,34,0.283518204986958,0.451244749018767,0,0,3.01659125188537,3.8023497518989,GALNT12
beta,1,stem cell differentiation (GO:0048863),1/34,1,34,0.283518204986958,0.451244749018767,0,0,3.01659125188537,3.8023497518989,ACE
beta,1,regulation of cell-substrate adhesion (GO:0010810),1/34,1,34,0.283518204986958,0.451244749018767,0,0,3.01659125188537,3.8023497518989,NDNF
beta,1,platelet aggregation (GO:0070527),1/34,1,34,0.283518204986958,0.451244749018767,0,0,3.01659125188537,3.8023497518989,FIBP
beta,1,cellular response to glucose starvation (GO:0042149),1/34,1,34,0.283518204986958,0.451244749018767,0,0,3.01659125188537,3.8023497518989,IMPACT
beta,1,embryonic organ morphogenesis (GO:0048562),1/34,1,34,0.283518204986958,0.451244749018767,0,0,3.01659125188537,3.8023497518989,ID2
beta,1,mRNA stabilization (GO:0048255),1/34,1,34,0.283518204986958,0.451244749018767,0,0,3.01659125188537,3.8023497518989,ANGEL2
beta,1,transcription initiation from RNA polymerase I promoter (GO:0006361),1/34,1,34,0.283518204986958,0.451244749018767,0,0,3.01659125188537,3.8023497518989,POLR1B
beta,1,regulation of protein secretion (GO:0050708),2/108,2,108,0.283864429324597,0.451244749018767,0,0,1.89933523266857,2.39175406709844,RSAD2;KCNA5
beta,1,"DNA-templated transcription, elongation (GO:0006354)",2/109,2,109,0.28747323139042,0.45446135844809,0,0,1.88191013879087,2.3460372266042,POLR1B;MLLT1
beta,1,monocarboxylic acid metabolic process (GO:0032787),2/109,2,109,0.28747323139042,0.45446135844809,0,0,1.88191013879087,2.3460372266042,GHR;ACOT11
beta,1,negative regulation of hydrolase activity (GO:0051346),2/109,2,109,0.28747323139042,0.45446135844809,0,0,1.88191013879087,2.3460372266042,GPSM1;CST3
beta,1,regulation of interleukin-8 production (GO:0032677),1/35,1,35,0.290515787697519,0.455088483460594,0,0,2.93040293040293,3.62226331877427,TLR5
beta,1,positive regulation of chemokine production (GO:0032722),1/35,1,35,0.290515787697519,0.455088483460594,0,0,2.93040293040293,3.62226331877427,EGR1
beta,1,regulation of interleukin-1 beta secretion (GO:0050706),1/35,1,35,0.290515787697519,0.455088483460594,0,0,2.93040293040293,3.62226331877427,GSDMD
beta,1,regulation of JUN kinase activity (GO:0043506),1/35,1,35,0.290515787697519,0.455088483460594,0,0,2.93040293040293,3.62226331877427,TP73
beta,1,response to peptide (GO:1901652),1/35,1,35,0.290515787697519,0.455088483460594,0,0,2.93040293040293,3.62226331877427,EIF2B2
beta,1,regulation of cyclin-dependent protein kinase activity (GO:1904029),1/36,1,36,0.29744537481085,0.458428355443245,0,0,2.84900284900285,3.45448628187111,TTBK1
beta,1,regulation of synapse assembly (GO:0051963),1/36,1,36,0.29744537481085,0.458428355443245,0,0,2.84900284900285,3.45448628187111,SLIT1
beta,1,regulation of endothelial cell apoptotic process (GO:2000351),1/36,1,36,0.29744537481085,0.458428355443245,0,0,2.84900284900285,3.45448628187111,NDNF
beta,1,regulation of ion transmembrane transport (GO:0034765),1/36,1,36,0.29744537481085,0.458428355443245,0,0,2.84900284900285,3.45448628187111,KCNH2
beta,1,negative regulation of protein complex assembly (GO:0031333),1/36,1,36,0.29744537481085,0.458428355443245,0,0,2.84900284900285,3.45448628187111,IMPACT
beta,1,carboxylic acid transmembrane transport (GO:1905039),1/36,1,36,0.29744537481085,0.458428355443245,0,0,2.84900284900285,3.45448628187111,SLC7A8
beta,1,actin filament bundle organization (GO:0061572),1/36,1,36,0.29744537481085,0.458428355443245,0,0,2.84900284900285,3.45448628187111,DPYSL3
beta,1,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),1/36,1,36,0.29744537481085,0.458428355443245,0,0,2.84900284900285,3.45448628187111,BHLHE40
beta,1,positive regulation of osteoblast differentiation (GO:0045669),1/36,1,36,0.29744537481085,0.458428355443245,0,0,2.84900284900285,3.45448628187111,WNT4
beta,1,regulation of protein binding (GO:0043393),2/112,2,112,0.298286876047868,0.458902886227489,0,0,1.83150183150183,2.21556700411358,SNAPIN;TTBK1
beta,1,phosphatidylinositol metabolic process (GO:0046488),2/113,2,113,0.3018861766143,0.460747458567144,0,0,1.81529385069208,2.17418694128351,VAC14;PLBD1
beta,1,protein acylation (GO:0043543),1/37,1,37,0.304307623797834,0.460747458567144,0,0,2.77200277200277,3.29789651790604,ZDHHC22
beta,1,carbohydrate biosynthetic process (GO:0016051),1/37,1,37,0.304307623797834,0.460747458567144,0,0,2.77200277200277,3.29789651790604,GALNT12
beta,1,cardiac muscle contraction (GO:0060048),1/37,1,37,0.304307623797834,0.460747458567144,0,0,2.77200277200277,3.29789651790604,KCNH2
beta,1,axonal transport (GO:0098930),1/37,1,37,0.304307623797834,0.460747458567144,0,0,2.77200277200277,3.29789651790604,SNAPIN
beta,1,sodium ion transmembrane transport (GO:0035725),1/37,1,37,0.304307623797834,0.460747458567144,0,0,2.77200277200277,3.29789651790604,NALCN
beta,1,organophosphate biosynthetic process (GO:0090407),1/37,1,37,0.304307623797834,0.460747458567144,0,0,2.77200277200277,3.29789651790604,LPCAT1
beta,1,vesicle-mediated transport in synapse (GO:0099003),1/37,1,37,0.304307623797834,0.460747458567144,0,0,2.77200277200277,3.29789651790604,SNAPIN
beta,1,zymogen activation (GO:0031638),1/37,1,37,0.304307623797834,0.460747458567144,0,0,2.77200277200277,3.29789651790604,CIDEB
beta,1,positive regulation of kinase activity (GO:0033674),2/114,2,114,0.30548237129507,0.461713250112057,0,0,1.79937022042285,2.13380693921831,NTRK1;VAC14
beta,1,regulation of osteoclast differentiation (GO:0045670),1/38,1,38,0.31110318552967,0.462887092656603,0,0,2.69905533063428,3.15149969112756,FAM213A
beta,1,epithelial to mesenchymal transition (GO:0001837),1/38,1,38,0.31110318552967,0.462887092656603,0,0,2.69905533063428,3.15149969112756,WNT4
beta,1,spliceosomal snRNP assembly (GO:0000387),1/38,1,38,0.31110318552967,0.462887092656603,0,0,2.69905533063428,3.15149969112756,SRSF12
beta,1,myelination (GO:0042552),1/38,1,38,0.31110318552967,0.462887092656603,0,0,2.69905533063428,3.15149969112756,EIF2B2
beta,1,protein peptidyl-prolyl isomerization (GO:0000413),1/38,1,38,0.31110318552967,0.462887092656603,0,0,2.69905533063428,3.15149969112756,PPIE
beta,1,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),1/38,1,38,0.31110318552967,0.462887092656603,0,0,2.69905533063428,3.15149969112756,TP73
beta,1,actin filament bundle assembly (GO:0051017),1/38,1,38,0.31110318552967,0.462887092656603,0,0,2.69905533063428,3.15149969112756,DPYSL3
beta,1,positive regulation of smooth muscle cell proliferation (GO:0048661),1/38,1,38,0.31110318552967,0.462887092656603,0,0,2.69905533063428,3.15149969112756,ID2
beta,1,phospholipid biosynthetic process (GO:0008654),1/38,1,38,0.31110318552967,0.462887092656603,0,0,2.69905533063428,3.15149969112756,LPCAT1
beta,1,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),2/117,2,117,0.316249543811211,0.469649701360039,0,0,1.75323252246329,2.01836279892289,GHR;ACE
beta,1,homotypic cell-cell adhesion (GO:0034109),1/39,1,39,0.317832704873887,0.469649701360039,0,0,2.62984878369494,3.01441188674722,FIBP
beta,1,positive regulation of innate immune response (GO:0045089),1/39,1,39,0.317832704873887,0.469649701360039,0,0,2.62984878369494,3.01441188674722,TLR5
beta,1,regulation of cellular pH (GO:0030641),1/39,1,39,0.317832704873887,0.469649701360039,0,0,2.62984878369494,3.01441188674722,SLC4A8
beta,1,plasma membrane bounded cell projection organization (GO:0120036),2/119,2,119,0.323407137909247,0.472195034606407,0,0,1.72376642964878,1.94586211700157,SNAPIN;RASGRF1
beta,1,negative regulation of protein catabolic process (GO:0042177),1/40,1,40,0.324496820293473,0.472195034606407,0,0,2.56410256410256,2.88584497864987,CST3
beta,1,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",1/40,1,40,0.324496820293473,0.472195034606407,0,0,2.56410256410256,2.88584497864987,SRSF12
beta,1,inositol lipid-mediated signaling (GO:0048017),1/40,1,40,0.324496820293473,0.472195034606407,0,0,2.56410256410256,2.88584497864987,NTRK1
beta,1,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),1/40,1,40,0.324496820293473,0.472195034606407,0,0,2.56410256410256,2.88584497864987,ADSSL1
beta,1,mitotic DNA damage checkpoint (GO:0044773),1/40,1,40,0.324496820293473,0.472195034606407,0,0,2.56410256410256,2.88584497864987,TP73
beta,1,cellular response to amino acid starvation (GO:0034198),1/40,1,40,0.324496820293473,0.472195034606407,0,0,2.56410256410256,2.88584497864987,IMPACT
beta,1,acyl-CoA metabolic process (GO:0006637),1/40,1,40,0.324496820293473,0.472195034606407,0,0,2.56410256410256,2.88584497864987,ACOT11
beta,1,purine ribonucleoside monophosphate metabolic process (GO:0009167),1/40,1,40,0.324496820293473,0.472195034606407,0,0,2.56410256410256,2.88584497864987,ADSSL1
beta,1,peptidyl-proline modification (GO:0018208),1/41,1,41,0.331096164322407,0.473781532973827,0,0,2.50156347717323,2.76509423175978,PPIE
beta,1,negative regulation of transport (GO:0051051),1/41,1,41,0.331096164322407,0.473781532973827,0,0,2.50156347717323,2.76509423175978,YRDC
beta,1,response to peptide hormone (GO:0043434),1/41,1,41,0.331096164322407,0.473781532973827,0,0,2.50156347717323,2.76509423175978,EIF2B2
beta,1,regulation of release of cytochrome c from mitochondria (GO:0090199),1/41,1,41,0.331096164322407,0.473781532973827,0,0,2.50156347717323,2.76509423175978,CIDEB
beta,1,negative regulation of catabolic process (GO:0009895),1/41,1,41,0.331096164322407,0.473781532973827,0,0,2.50156347717323,2.76509423175978,CST3
beta,1,neuron migration (GO:0001764),1/41,1,41,0.331096164322407,0.473781532973827,0,0,2.50156347717323,2.76509423175978,NDNF
beta,1,cognition (GO:0050890),1/41,1,41,0.331096164322407,0.473781532973827,0,0,2.50156347717323,2.76509423175978,JAKMIP1
beta,1,sensory organ development (GO:0007423),1/41,1,41,0.331096164322407,0.473781532973827,0,0,2.50156347717323,2.76509423175978,SIPA1L3
beta,1,positive regulation of cytokine biosynthetic process (GO:0042108),1/41,1,41,0.331096164322407,0.473781532973827,0,0,2.50156347717323,2.76509423175978,EGR1
beta,1,JAK-STAT cascade (GO:0007259),1/41,1,41,0.331096164322407,0.473781532973827,0,0,2.50156347717323,2.76509423175978,GHR
beta,1,negative regulation of cell migration (GO:0030336),2/122,2,122,0.334107637434647,0.477296624906638,0,0,1.68137873055906,1.84328216923773,DPYSL3;SRGAP3
beta,1,bicarbonate transport (GO:0015701),1/42,1,42,0.337631363133737,0.477616736309101,0,0,2.44200244200244,2.65152776629461,SLC4A8
beta,1,mesenchymal cell differentiation (GO:0048762),1/42,1,42,0.337631363133737,0.477616736309101,0,0,2.44200244200244,2.65152776629461,WNT4
beta,1,positive regulation of viral transcription (GO:0050434),1/42,1,42,0.337631363133737,0.477616736309101,0,0,2.44200244200244,2.65152776629461,HPN
beta,1,negative regulation of proteolysis (GO:0045861),1/42,1,42,0.337631363133737,0.477616736309101,0,0,2.44200244200244,2.65152776629461,CST3
beta,1,negative regulation of cell projection organization (GO:0031345),1/42,1,42,0.337631363133737,0.477616736309101,0,0,2.44200244200244,2.65152776629461,DPYSL3
beta,1,sulfur compound biosynthetic process (GO:0044272),2/123,2,123,0.337663925204574,0.477616736309101,0,0,1.66770898478216,1.81063861959702,NDST3;CHST3
beta,1,glycolipid biosynthetic process (GO:0009247),1/43,1,43,0.344103037134527,0.483852565891979,0,0,2.38521168753727,2.54457755492905,MPPE1
beta,1,negative regulation of protein secretion (GO:0050709),1/43,1,43,0.344103037134527,0.483852565891979,0,0,2.38521168753727,2.54457755492905,RSAD2
beta,1,negative regulation of multicellular organismal process (GO:0051241),2/126,2,126,0.34829790326485,0.483852565891979,0,0,1.62800162800163,1.71704863091531,HPN;OVOL2
beta,1,"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",2/126,2,126,0.34829790326485,0.483852565891979,0,0,1.62800162800163,1.71704863091531,LTB4R2;LTB4R
beta,1,positive regulation of interferon-gamma production (GO:0032729),1/44,1,44,0.350511800640353,0.483852565891979,0,0,2.33100233100233,2.44373171341754,PDE4B
beta,1,male gonad development (GO:0008584),1/44,1,44,0.350511800640353,0.483852565891979,0,0,2.33100233100233,2.44373171341754,WNT4
beta,1,negative regulation of protein metabolic process (GO:0051248),1/44,1,44,0.350511800640353,0.483852565891979,0,0,2.33100233100233,2.44373171341754,APBB1
beta,1,eye development (GO:0001654),1/44,1,44,0.350511800640353,0.483852565891979,0,0,2.33100233100233,2.44373171341754,SIPA1L3
beta,1,RNA catabolic process (GO:0006401),1/44,1,44,0.350511800640353,0.483852565891979,0,0,2.33100233100233,2.44373171341754,RNASET2
beta,1,substantia nigra development (GO:0021762),1/44,1,44,0.350511800640353,0.483852565891979,0,0,2.33100233100233,2.44373171341754,TTBK1
beta,1,nucleobase-containing compound catabolic process (GO:0034655),1/44,1,44,0.350511800640353,0.483852565891979,0,0,2.33100233100233,2.44373171341754,RNASET2
beta,1,development of primary male sexual characteristics (GO:0046546),1/44,1,44,0.350511800640353,0.483852565891979,0,0,2.33100233100233,2.44373171341754,WNT4
beta,1,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),1/44,1,44,0.350511800640353,0.483852565891979,0,0,2.33100233100233,2.44373171341754,TP73
beta,1,response to hydrogen peroxide (GO:0042542),1/44,1,44,0.350511800640353,0.483852565891979,0,0,2.33100233100233,2.44373171341754,IMPACT
beta,1,regulation of interferon-gamma production (GO:0032649),1/44,1,44,0.350511800640353,0.483852565891979,0,0,2.33100233100233,2.44373171341754,PDE4B
beta,1,G2/M transition of mitotic cell cycle (GO:0000086),2/127,2,127,0.351830193640136,0.484831130071826,0,0,1.61518271754492,1.68723056605681,PPME1;CEP41
beta,1,cell cycle G2/M phase transition (GO:0044839),2/128,2,128,0.355355941412355,0.484831130071826,0,0,1.6025641025641,1.65806945506502,PPME1;CEP41
beta,1,protein lipidation (GO:0006497),2/128,2,128,0.355355941412355,0.484831130071826,0,0,1.6025641025641,1.65806945506502,MPPE1;ZDHHC22
beta,1,positive regulation of transport (GO:0051050),1/45,1,45,0.356858262017984,0.484831130071826,0,0,2.27920227920228,2.34852786597735,PON1
beta,1,protein N-linked glycosylation via asparagine (GO:0018279),1/45,1,45,0.356858262017984,0.484831130071826,0,0,2.27920227920228,2.34852786597735,ST6GAL1
beta,1,positive regulation of viral life cycle (GO:1903902),1/45,1,45,0.356858262017984,0.484831130071826,0,0,2.27920227920228,2.34852786597735,PPIE
beta,1,regulation of intracellular pH (GO:0051453),1/45,1,45,0.356858262017984,0.484831130071826,0,0,2.27920227920228,2.34852786597735,SLC4A8
beta,1,positive regulation of macroautophagy (GO:0016239),1/45,1,45,0.356858262017984,0.484831130071826,0,0,2.27920227920228,2.34852786597735,GPSM1
beta,1,positive regulation of interleukin-8 production (GO:0032757),1/45,1,45,0.356858262017984,0.484831130071826,0,0,2.27920227920228,2.34852786597735,TLR5
beta,1,regulation of smooth muscle cell proliferation (GO:0048660),1/45,1,45,0.356858262017984,0.484831130071826,0,0,2.27920227920228,2.34852786597735,ID2
beta,1,regulation of macromolecule metabolic process (GO:0060255),2/130,2,130,0.362386982423781,0.489503135700056,0,0,1.57790927021696,1.60164516910871,ZFP64;TP73
beta,1,protein polymerization (GO:0051258),1/46,1,46,0.363143023926321,0.489503135700056,0,0,2.22965440356745,2.25854741808322,TPPP3
beta,1,positive regulation of blood vessel endothelial cell migration (GO:0043536),1/46,1,46,0.363143023926321,0.489503135700056,0,0,2.22965440356745,2.25854741808322,FGF18
beta,1,peptidyl-asparagine modification (GO:0018196),1/46,1,46,0.363143023926321,0.489503135700056,0,0,2.22965440356745,2.25854741808322,ST6GAL1
beta,1,peptidyl-tyrosine autophosphorylation (GO:0038083),1/46,1,46,0.363143023926321,0.489503135700056,0,0,2.22965440356745,2.25854741808322,NTRK1
beta,1,regulation of G1/S transition of mitotic cell cycle (GO:2000045),1/47,1,47,0.369366683035482,0.494790260764041,0,0,2.1822149481724,2.17341059987359,ID2
beta,1,tRNA aminoacylation for protein translation (GO:0006418),1/47,1,47,0.369366683035482,0.494790260764041,0,0,2.1822149481724,2.17341059987359,MRPL39
beta,1,aminoglycan biosynthetic process (GO:0006023),1/47,1,47,0.369366683035482,0.494790260764041,0,0,2.1822149481724,2.17341059987359,AGRN
beta,1,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",1/47,1,47,0.369366683035482,0.494790260764041,0,0,2.1822149481724,2.17341059987359,NDUFS2
beta,1,peptide cross-linking (GO:0018149),1/48,1,48,0.375529830438121,0.499931353214836,0,0,2.13675213675214,2.09277215602746,NDNF
beta,1,"positive regulation of gene expression, epigenetic (GO:0045815)",1/48,1,48,0.375529830438121,0.499931353214836,0,0,2.13675213675214,2.09277215602746,POLR1B
beta,1,histone H4 acetylation (GO:0043967),1/48,1,48,0.375529830438121,0.499931353214836,0,0,2.13675213675214,2.09277215602746,APBB1
beta,1,negative regulation of cellular biosynthetic process (GO:0031327),1/48,1,48,0.375529830438121,0.499931353214836,0,0,2.13675213675214,2.09277215602746,WNT4
beta,1,cellular response to organic substance (GO:0071310),2/134,2,134,0.376361715400696,0.50026441305193,0,0,1.53080750095675,1.49591211478299,GHR;DPYSL3
beta,1,adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),2/135,2,135,0.379836100453814,0.502610144376515,0,0,1.51946818613485,1.47086865549831,LTB4R2;LTB4R
beta,1,negative regulation of mitotic cell cycle (GO:0045930),1/49,1,49,0.381633051485888,0.502610144376515,0,0,2.09314495028781,2.01631759340696,ANGEL2
beta,1,glycoprotein metabolic process (GO:0009100),1/49,1,49,0.381633051485888,0.502610144376515,0,0,2.09314495028781,2.01631759340696,EDEM3
beta,1,cellular macromolecule catabolic process (GO:0044265),1/49,1,49,0.381633051485888,0.502610144376515,0,0,2.09314495028781,2.01631759340696,RNASET2
beta,1,amino acid transport (GO:0006865),1/49,1,49,0.381633051485888,0.502610144376515,0,0,2.09314495028781,2.01631759340696,SLC7A8
beta,1,cellular response to mechanical stimulus (GO:0071260),1/49,1,49,0.381633051485888,0.502610144376515,0,0,2.09314495028781,2.01631759340696,TLR5
beta,1,cellular response to organic cyclic compound (GO:0071407),2/136,2,136,0.383302406145292,0.504036803187999,0,0,1.50829562594268,1.44635147687587,EGR1;IMPACT
beta,1,RNA methylation (GO:0001510),1/50,1,50,0.387676925856526,0.507461425017675,0,0,2.05128205128205,1.94375990058547,THUMPD3
beta,1,gonad development (GO:0008406),1/50,1,50,0.387676925856526,0.507461425017675,0,0,2.05128205128205,1.94375990058547,WNT4
beta,1,regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/50,1,50,0.387676925856526,0.507461425017675,0,0,2.05128205128205,1.94375990058547,SRI
beta,1,muscle contraction (GO:0006936),2/138,2,138,0.390210093001259,0.509096757661409,0,0,1.48643626904496,1.39884055726789,P2RX6;LTB4R
beta,1,positive regulation of transferase activity (GO:0051347),2/138,2,138,0.390210093001259,0.509096757661409,0,0,1.48643626904496,1.39884055726789,NTRK1;VAC14
beta,1,regulation of signal transduction by p53 class mediator (GO:1901796),2/139,2,139,0.39365114101719,0.509096757661409,0,0,1.47574248293673,1.37582024098622,BANP;TP73
beta,1,regulation of bone mineralization (GO:0030500),1/51,1,51,0.393662027726555,0.509096757661409,0,0,2.01106083459025,1.87483667260226,WNT4
beta,1,fatty acid beta-oxidation (GO:0006635),1/51,1,51,0.393662027726555,0.509096757661409,0,0,2.01106083459025,1.87483667260226,ETFDH
beta,1,blood circulation (GO:0008015),1/51,1,51,0.393662027726555,0.509096757661409,0,0,2.01106083459025,1.87483667260226,ACE
beta,1,regulation of blood vessel endothelial cell migration (GO:0043535),1/51,1,51,0.393662027726555,0.509096757661409,0,0,2.01106083459025,1.87483667260226,FGF18
beta,1,negative regulation of viral genome replication (GO:0045071),1/51,1,51,0.393662027726555,0.509096757661409,0,0,2.01106083459025,1.87483667260226,RSAD2
beta,1,negative regulation of neuron projection development (GO:0010977),1/52,1,52,0.399588925643855,0.514440832415741,0,0,1.9723865877712,1.80930758618488,DPYSL3
beta,1,carboxylic acid transport (GO:0046942),1/52,1,52,0.399588925643855,0.514440832415741,0,0,1.9723865877712,1.80930758618488,SLC7A8
beta,1,positive regulation of actin filament polymerization (GO:0030838),1/52,1,52,0.399588925643855,0.514440832415741,0,0,1.9723865877712,1.80930758618488,WIPF1
beta,1,regulation of small GTPase mediated signal transduction (GO:0051056),2/141,2,141,0.400506843265546,0.514851846350329,0,0,1.45480996544826,1.33118665330328,RASGRF1;SRGAP3
beta,1,positive regulation of cell-substrate adhesion (GO:0010811),1/53,1,53,0.405458182751464,0.518889936259315,0,0,1.9351717464925,1.74695217396217,NDNF
beta,1,positive regulation of ossification (GO:0045778),1/53,1,53,0.405458182751464,0.518889936259315,0,0,1.9351717464925,1.74695217396217,WNT4
beta,1,regulation of calcium ion transport (GO:0051924),1/53,1,53,0.405458182751464,0.518889936259315,0,0,1.9351717464925,1.74695217396217,SRI
beta,1,negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),1/54,1,54,0.411270356773561,0.523988899000389,0,0,1.89933523266857,1.68756786016009,ADAMTSL2
beta,1,neutrophil chemotaxis (GO:0030593),1/54,1,54,0.411270356773561,0.523988899000389,0,0,1.89933523266857,1.68756786016009,PDE4B
beta,1,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),1/54,1,54,0.411270356773561,0.523988899000389,0,0,1.89933523266857,1.68756786016009,GHR
beta,1,neuron development (GO:0048666),2/145,2,145,0.41410841997129,0.526046146492333,0,0,1.41467727674624,1.24721832778614,SNAPIN;RASGRF1
beta,1,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),2/145,2,145,0.41410841997129,0.526046146492333,0,0,1.41467727674624,1.24721832778614,SMAD9;FOS
beta,1,cell morphogenesis involved in differentiation (GO:0000904),1/55,1,55,0.417025999999948,0.526447475476973,0,0,1.86480186480186,1.63096822192493,SIPA1L3
beta,1,intracellular transport of virus (GO:0075733),1/55,1,55,0.417025999999948,0.526447475476973,0,0,1.86480186480186,1.63096822192493,VPS37C
beta,1,transport of virus (GO:0046794),1/55,1,55,0.417025999999948,0.526447475476973,0,0,1.86480186480186,1.63096822192493,VPS37C
beta,1,negative regulation of cellular component organization (GO:0051129),1/55,1,55,0.417025999999948,0.526447475476973,0,0,1.86480186480186,1.63096822192493,IMPACT
beta,1,peptidyl-serine phosphorylation (GO:0018105),2/146,2,146,0.417485091017785,0.526447475476973,0,0,1.40498770635757,1.22726581730367,STK33;TTBK1
beta,1,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),1/56,1,56,0.422725659560641,0.531497174301391,0,0,1.83150183150183,1.57698144560347,ADAMTSL2
beta,1,DNA recombination (GO:0006310),1/56,1,56,0.422725659560641,0.531497174301391,0,0,1.83150183150183,1.57698144560347,RAD21
beta,1,negative regulation of canonical Wnt signaling pathway (GO:0090090),2/149,2,149,0.427556002970654,0.533137618451917,0,0,1.37669936327654,1.1697401453578,SHISA6;WNT4
beta,1,granulocyte chemotaxis (GO:0071621),1/57,1,57,0.428369877151482,0.533137618451917,0,0,1.79937022042285,1.52544895664092,PDE4B
beta,1,cellular defense response (GO:0006968),1/57,1,57,0.428369877151482,0.533137618451917,0,0,1.79937022042285,1.52544895664092,KLRG1
beta,1,phosphatidylinositol-mediated signaling (GO:0048015),1/57,1,57,0.428369877151482,0.533137618451917,0,0,1.79937022042285,1.52544895664092,NTRK1
beta,1,negative regulation of cellular catabolic process (GO:0031330),1/57,1,57,0.428369877151482,0.533137618451917,0,0,1.79937022042285,1.52544895664092,CST3
beta,1,organonitrogen compound catabolic process (GO:1901565),1/57,1,57,0.428369877151482,0.533137618451917,0,0,1.79937022042285,1.52544895664092,ACE
beta,1,glycosaminoglycan catabolic process (GO:0006027),1/57,1,57,0.428369877151482,0.533137618451917,0,0,1.79937022042285,1.52544895664092,AGRN
beta,1,cellular respiration (GO:0045333),1/58,1,58,0.433959189329774,0.539313443386713,0,0,1.7683465959328,1.47622419647312,ETFDH
beta,1,neutrophil migration (GO:1990266),1/59,1,59,0.439494127440785,0.543834459854785,0,0,1.73837461973055,1.4291715321263,PDE4B
beta,1,receptor metabolic process (GO:0043112),1/59,1,59,0.439494127440785,0.543834459854785,0,0,1.73837461973055,1.4291715321263,EHD3
beta,1,sodium ion transport (GO:0006814),1/59,1,59,0.439494127440785,0.543834459854785,0,0,1.73837461973055,1.4291715321263,NALCN
beta,1,regulation of protein metabolic process (GO:0051246),1/60,1,60,0.444975217791931,0.549036854090475,0,0,1.70940170940171,1.38416527986645,ACE
beta,1,dicarboxylic acid metabolic process (GO:0043648),1/60,1,60,0.444975217791931,0.549036854090475,0,0,1.70940170940171,1.38416527986645,GHR
beta,1,"regulation of mRNA splicing, via spliceosome (GO:0048024)",1/61,1,61,0.450402981554838,0.552562858968845,0,0,1.68137873055906,1.34108883124912,SRSF12
beta,1,response to reactive oxygen species (GO:0000302),1/61,1,61,0.450402981554838,0.552562858968845,0,0,1.68137873055906,1.34108883124912,FOS
beta,1,muscle organ development (GO:0007517),1/61,1,61,0.450402981554838,0.552562858968845,0,0,1.68137873055906,1.34108883124912,SRI
beta,1,membrane lipid biosynthetic process (GO:0046467),1/61,1,61,0.450402981554838,0.552562858968845,0,0,1.68137873055906,1.34108883124912,SPTSSB
beta,1,striated muscle contraction (GO:0006941),1/62,1,62,0.455777934900836,0.554411632269758,0,0,1.65425971877585,1.29983386757648,KCNH2
beta,1,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),1/62,1,62,0.455777934900836,0.554411632269758,0,0,1.65425971877585,1.29983386757648,GHR
beta,1,negative regulation of MAP kinase activity (GO:0043407),1/62,1,62,0.455777934900836,0.554411632269758,0,0,1.65425971877585,1.29983386757648,TP73
beta,1,glycosaminoglycan metabolic process (GO:0030203),1/62,1,62,0.455777934900836,0.554411632269758,0,0,1.65425971877585,1.29983386757648,AGRN
beta,1,negative regulation of viral life cycle (GO:1903901),1/62,1,62,0.455777934900836,0.554411632269758,0,0,1.65425971877585,1.29983386757648,RSAD2
beta,1,protein targeting to membrane (GO:0006612),1/62,1,62,0.455777934900836,0.554411632269758,0,0,1.65425971877585,1.29983386757648,ZDHHC22
beta,1,diterpenoid metabolic process (GO:0016101),1/63,1,63,0.461100589040447,0.55930395849758,0,0,1.62800162800163,1.26029965372796,AGRN
beta,1,cellular amide metabolic process (GO:0043603),1/63,1,63,0.461100589040447,0.55930395849758,0,0,1.62800162800163,1.26029965372796,GHR
beta,1,negative regulation of protein modification process (GO:0031400),1/64,1,64,0.466371450215517,0.564106114184732,0,0,1.6025641025641,1.2223924020961,IMPACT
beta,1,regulation of proteolysis (GO:0030162),1/64,1,64,0.466371450215517,0.564106114184732,0,0,1.6025641025641,1.2223924020961,CST3
beta,1,glycerophospholipid metabolic process (GO:0006650),1/65,1,65,0.471591019897601,0.564858324668436,0,0,1.57790927021696,1.18602469787455,PON1
beta,1,positive regulation of JAK-STAT cascade (GO:0046427),1/65,1,65,0.471591019897601,0.564858324668436,0,0,1.57790927021696,1.18602469787455,GHR
beta,1,NADH dehydrogenase complex assembly (GO:0010257),1/65,1,65,0.471591019897601,0.564858324668436,0,0,1.57790927021696,1.18602469787455,NDUFS2
beta,1,cellular response to decreased oxygen levels (GO:0036294),1/65,1,65,0.471591019897601,0.564858324668436,0,0,1.57790927021696,1.18602469787455,NDNF
beta,1,mitochondrial respiratory chain complex I biogenesis (GO:0097031),1/65,1,65,0.471591019897601,0.564858324668436,0,0,1.57790927021696,1.18602469787455,NDUFS2
beta,1,mitochondrial respiratory chain complex I assembly (GO:0032981),1/65,1,65,0.471591019897601,0.564858324668436,0,0,1.57790927021696,1.18602469787455,NDUFS2
beta,1,positive regulation of cell adhesion (GO:0045785),1/65,1,65,0.471591019897601,0.564858324668436,0,0,1.57790927021696,1.18602469787455,NDNF
beta,1,defense response to Gram-positive bacterium (GO:0050830),1/66,1,66,0.476759794611419,0.569463088008084,0,0,1.55400155400155,1.15111498083684,GSDMD
beta,1,negative regulation of blood vessel morphogenesis (GO:2000181),1/66,1,66,0.476759794611419,0.569463088008084,0,0,1.55400155400155,1.15111498083684,WNT4
beta,1,cellular response to light stimulus (GO:0071482),1/67,1,67,0.481878266217863,0.573188532430654,0,0,1.53080750095675,1.11758707469436,TP73
beta,1,purine ribonucleotide metabolic process (GO:0009150),1/67,1,67,0.481878266217863,0.573188532430654,0,0,1.53080750095675,1.11758707469436,ADSSL1
beta,1,sphingolipid biosynthetic process (GO:0030148),1/67,1,67,0.481878266217863,0.573188532430654,0,0,1.53080750095675,1.11758707469436,SPTSSB
beta,1,negative regulation of protein binding (GO:0032091),1/68,1,68,0.486946921711031,0.576824177233453,0,0,1.50829562594268,1.08536976193944,TTBK1
beta,1,positive regulation of autophagy (GO:0010508),1/68,1,68,0.486946921711031,0.576824177233453,0,0,1.50829562594268,1.08536976193944,GPSM1
beta,1,regulation of protein localization to plasma membrane (GO:1903076),1/68,1,68,0.486946921711031,0.576824177233453,0,0,1.50829562594268,1.08536976193944,MRAP2
beta,1,regulation of endopeptidase activity (GO:0052548),1/69,1,69,0.491966243496881,0.581968321055457,0,0,1.48643626904496,1.05439639631714,SERPINB1
beta,1,regulation of endothelial cell migration (GO:0010594),1/70,1,70,0.496936709208606,0.585432287560824,0,0,1.46520146520147,1.02460455187016,ATOH8
beta,1,positive regulation of neurogenesis (GO:0050769),1/70,1,70,0.496936709208606,0.585432287560824,0,0,1.46520146520147,1.02460455187016,IMPACT
beta,1,regulation of osteoblast differentiation (GO:0045667),1/70,1,70,0.496936709208606,0.585432287560824,0,0,1.46520146520147,1.02460455187016,WNT4
beta,1,stress-activated protein kinase signaling cascade (GO:0031098),1/71,1,71,0.501858792065097,0.588811133937222,0,0,1.44456482484652,0.995935701794203,NEK1
beta,1,negative regulation of developmental process (GO:0051093),1/71,1,71,0.501858792065097,0.588811133937222,0,0,1.44456482484652,0.995935701794203,CST3
beta,1,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),1/71,1,71,0.501858792065097,0.588811133937222,0,0,1.44456482484652,0.995935701794203,KLHL35
beta,1,regulation of cation channel activity (GO:2001257),1/72,1,72,0.506732960631137,0.590501824041705,0,0,1.42450142450142,0.968334927376411,SHISA6
beta,1,regulation of cell communication (GO:0010646),1/72,1,72,0.506732960631137,0.590501824041705,0,0,1.42450142450142,0.968334927376411,SRI
beta,1,histone acetylation (GO:0016573),1/72,1,72,0.506732960631137,0.590501824041705,0,0,1.42450142450142,0.968334927376411,APBB1
beta,1,defense response to Gram-negative bacterium (GO:0050829),1/72,1,72,0.506732960631137,0.590501824041705,0,0,1.42450142450142,0.968334927376411,GSDMD
beta,1,positive regulation of growth (GO:0045927),1/72,1,72,0.506732960631137,0.590501824041705,0,0,1.42450142450142,0.968334927376411,HPN
beta,1,negative regulation of cysteine-type endopeptidase activity (GO:2000117),1/73,1,73,0.511559678840676,0.592912835313991,0,0,1.40498770635757,0.941750651522358,CST3
beta,1,lipid biosynthetic process (GO:0008610),1/73,1,73,0.511559678840676,0.592912835313991,0,0,1.40498770635757,0.941750651522358,LPCAT1
beta,1,regulation of epithelial cell proliferation (GO:0050678),1/73,1,73,0.511559678840676,0.592912835313991,0,0,1.40498770635757,0.941750651522358,HPN
beta,1,negative regulation of cell cycle (GO:0045786),1/73,1,73,0.511559678840676,0.592912835313991,0,0,1.40498770635757,0.941750651522358,ANGEL2
beta,1,protein N-linked glycosylation (GO:0006487),1/74,1,74,0.51633940635291,0.594446973846724,0,0,1.38600138600139,0.916134394293607,ST6GAL1
beta,1,transcription-coupled nucleotide-excision repair (GO:0006283),1/74,1,74,0.51633940635291,0.594446973846724,0,0,1.38600138600139,0.916134394293607,PPIE
beta,1,canonical Wnt signaling pathway (GO:0060070),1/74,1,74,0.51633940635291,0.594446973846724,0,0,1.38600138600139,0.916134394293607,WNT4
beta,1,regulation of peptide hormone secretion (GO:0090276),1/74,1,74,0.51633940635291,0.594446973846724,0,0,1.38600138600139,0.916134394293607,KCNA5
beta,1,regulation of protein complex assembly (GO:0043254),1/74,1,74,0.51633940635291,0.594446973846724,0,0,1.38600138600139,0.916134394293607,IMPACT
beta,1,positive regulation of epithelial cell migration (GO:0010634),1/75,1,75,0.521072598288449,0.598294305110903,0,0,1.36752136752137,0.891440550854781,ATOH8
beta,1,nitrogen compound transport (GO:0071705),1/75,1,75,0.521072598288449,0.598294305110903,0,0,1.36752136752137,0.891440550854781,SLC7A8
beta,1,retinoid metabolic process (GO:0001523),1/76,1,76,0.525759705393777,0.601267748189692,0,0,1.34952766531714,0.867626186878457,AGRN
beta,1,negative regulation of phosphorylation (GO:0042326),1/76,1,76,0.525759705393777,0.601267748189692,0,0,1.34952766531714,0.867626186878457,IMPACT
beta,1,purine ribonucleotide biosynthetic process (GO:0009152),1/76,1,76,0.525759705393777,0.601267748189692,0,0,1.34952766531714,0.867626186878457,ADSSL1
beta,1,transforming growth factor beta receptor signaling pathway (GO:0007179),1/77,1,77,0.53040117417862,0.603366415070917,0,0,1.33200133200133,0.844650850952167,FOS
beta,1,regulation of hematopoietic stem cell differentiation (GO:1902036),1/77,1,77,0.53040117417862,0.603366415070917,0,0,1.33200133200133,0.844650850952167,TP73
beta,1,nucleic acid-templated transcription (GO:0097659),1/77,1,77,0.53040117417862,0.603366415070917,0,0,1.33200133200133,0.844650850952167,THRB
beta,1,positive regulation of apoptotic signaling pathway (GO:2001235),1/77,1,77,0.53040117417862,0.603366415070917,0,0,1.33200133200133,0.844650850952167,CIDEB
beta,1,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),1/78,1,78,0.534997446547549,0.605391847409069,0,0,1.31492439184747,0.822476403557975,ADAMTSL2
beta,1,response to ionizing radiation (GO:0010212),1/78,1,78,0.534997446547549,0.605391847409069,0,0,1.31492439184747,0.822476403557975,TP73
beta,1,regulation of hematopoietic progenitor cell differentiation (GO:1901532),1/78,1,78,0.534997446547549,0.605391847409069,0,0,1.31492439184747,0.822476403557975,TP73
beta,1,water-soluble vitamin metabolic process (GO:0006767),1/78,1,78,0.534997446547549,0.605391847409069,0,0,1.31492439184747,0.822476403557975,THTPA
beta,1,negative regulation of cell communication (GO:0010648),1/79,1,79,0.539548960575604,0.609739955446806,0,0,1.29827977929244,0.801066857045934,NTRK1
beta,1,steroid biosynthetic process (GO:0006694),1/80,1,80,0.544056149774106,0.611618678177426,0,0,1.28205128205128,0.780388231995042,WNT4
beta,1,regulation of endothelial cell proliferation (GO:0001936),1/80,1,80,0.544056149774106,0.611618678177426,0,0,1.28205128205128,0.780388231995042,ATOH8
beta,1,cation transport (GO:0006812),1/80,1,80,0.544056149774106,0.611618678177426,0,0,1.28205128205128,0.780388231995042,P2RX6
beta,1,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),1/80,1,80,0.544056149774106,0.611618678177426,0,0,1.28205128205128,0.780388231995042,ADAMTSL2
beta,1,cellular response to hormone stimulus (GO:0032870),1/81,1,81,0.548519443587511,0.615831229093028,0,0,1.26622348844571,0.760408421955932,GHR
beta,1,sensory perception of sound (GO:0007605),1/82,1,82,0.552939267368748,0.61837161240198,0,0,1.25078173858662,0.741097069940221,HPN
beta,1,BMP signaling pathway (GO:0030509),1/82,1,82,0.552939267368748,0.61837161240198,0,0,1.25078173858662,0.741097069940221,SMAD9
beta,1,negative regulation of cell death (GO:0060548),1/82,1,82,0.552939267368748,0.61837161240198,0,0,1.25078173858662,0.741097069940221,IMPACT
beta,1,regulation of anatomical structure morphogenesis (GO:0022603),1/83,1,83,0.55731604233362,0.620844295863877,0,0,1.23571207908557,0.722425454442863,ZMYM3
beta,1,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",1/83,1,83,0.55731604233362,0.620844295863877,0,0,1.23571207908557,0.722425454442863,TP73
beta,1,"retrograde transport, endosome to Golgi (GO:0042147)",1/83,1,83,0.55731604233362,0.620844295863877,0,0,1.23571207908557,0.722425454442863,EHD3
beta,1,negative regulation of signaling (GO:0023057),1/84,1,84,0.561650185603732,0.624055761781924,0,0,1.22100122100122,0.704366383923149,NTRK1
beta,1,establishment of protein localization to membrane (GO:0090150),1/84,1,84,0.561650185603732,0.624055761781924,0,0,1.22100122100122,0.704366383923149,ZDHHC22
beta,1,activation of GTPase activity (GO:0090630),1/85,1,85,0.565942110322485,0.626396672943806,0,0,1.20663650075415,0.686894099055139,RASGRF1
beta,1,cellular response to molecule of bacterial origin (GO:0071219),1/85,1,85,0.565942110322485,0.626396672943806,0,0,1.20663650075415,0.686894099055139,PDE4B
beta,1,regulation of cell cycle G2/M phase transition (GO:1902749),1/85,1,85,0.565942110322485,0.626396672943806,0,0,1.20663650075415,0.686894099055139,CEP41
beta,1,mitochondrial ATP synthesis coupled electron transport (GO:0042775),1/86,1,86,0.570192225656264,0.62948050585929,0,0,1.19260584376863,0.669984182483061,NDUFS2
beta,1,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/86,1,86,0.570192225656264,0.62948050585929,0,0,1.19260584376863,0.669984182483061,GHR
beta,1,toll-like receptor signaling pathway (GO:0002224),1/87,1,87,0.574400936723913,0.632502952090352,0,0,1.17889773062187,0.653613475346532,TLR5
beta,1,calcium ion transmembrane transport (GO:0070588),1/87,1,87,0.574400936723913,0.632502952090352,0,0,1.17889773062187,0.653613475346532,NALCN
beta,1,mitochondrial translational elongation (GO:0070125),1/88,1,88,0.578568644962692,0.634654380953973,0,0,1.16550116550117,0.63775999897906,MRPL39
beta,1,cellular response to BMP stimulus (GO:0071773),1/88,1,88,0.578568644962692,0.634654380953973,0,0,1.16550116550117,0.63775999897906,SMAD9
beta,1,regulation of MAP kinase activity (GO:0043405),1/88,1,88,0.578568644962692,0.634654380953973,0,0,1.16550116550117,0.63775999897906,FGF18
beta,1,regulation of stem cell differentiation (GO:2000736),1/89,1,89,0.582695747743071,0.637555143841019,0,0,1.15240564678767,0.622402883740765,TP73
beta,1,divalent metal ion transport (GO:0070838),1/89,1,89,0.582695747743071,0.637555143841019,0,0,1.15240564678767,0.622402883740765,NALCN
beta,1,mitochondrial translational termination (GO:0070126),1/90,1,90,0.58678263863808,0.64039729597557,0,0,1.13960113960114,0.607522301603806,MRPL39
beta,1,negative regulation of cellular protein metabolic process (GO:0032269),1/90,1,90,0.58678263863808,0.64039729597557,0,0,1.13960113960114,0.607522301603806,CST3
beta,1,cellular response to acid chemical (GO:0071229),1/92,1,92,0.594837340150168,0.647544446239424,0,0,1.11482720178372,0.579116263890673,EGR1
beta,1,cellular response to lipopolysaccharide (GO:0071222),1/92,1,92,0.594837340150168,0.647544446239424,0,0,1.11482720178372,0.579116263890673,PDE4B
beta,1,positive regulation of cellular metabolic process (GO:0031325),1/93,1,93,0.598805919156399,0.651040569500004,0,0,1.10283981251723,0.565555821841515,HPN
beta,1,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/94,1,94,0.602735823104695,0.654485868522774,0,0,1.0911074740862,0.552401835847976,IMPACT
beta,1,positive regulation of protein localization to membrane (GO:1905477),1/96,1,96,0.610481101979937,0.660394651198422,0,0,1.06837606837607,0.527252073609308,TP73
beta,1,transcription elongation from RNA polymerase II promoter (GO:0006368),1/96,1,96,0.610481101979937,0.660394651198422,0,0,1.06837606837607,0.527252073609308,MLLT1
beta,1,interleukin-1-mediated signaling pathway (GO:0070498),1/96,1,96,0.610481101979937,0.660394651198422,0,0,1.06837606837607,0.527252073609308,EGR1
beta,1,translational termination (GO:0006415),1/97,1,97,0.61429721599951,0.663687946934144,0,0,1.05736188210415,0.515227494381128,MRPL39
beta,1,mitochondrial respiratory chain complex assembly (GO:0033108),1/98,1,98,0.618076133313662,0.666932841467691,0,0,1.0465724751439,0.503551686078399,NDUFS2
beta,1,positive regulation of cell growth (GO:0030307),1/99,1,99,0.621818214597265,0.66845458069206,0,0,1.03600103600104,0.492211850245028,HPN
beta,1,regulation of insulin secretion (GO:0050796),1/99,1,99,0.621818214597265,0.66845458069206,0,0,1.03600103600104,0.492211850245028,KCNA5
beta,1,response to UV (GO:0009411),1/99,1,99,0.621818214597265,0.66845458069206,0,0,1.03600103600104,0.492211850245028,TP73
beta,1,regulation of lipid metabolic process (GO:0019216),1/101,1,101,0.629193294522951,0.673855832241268,0,0,1.01548616400102,0.470491764409293,ID2
beta,1,cellular response to metal ion (GO:0071248),1/101,1,101,0.629193294522951,0.673855832241268,0,0,1.01548616400102,0.470491764409293,FOS
beta,1,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),1/101,1,101,0.629193294522951,0.673855832241268,0,0,1.01548616400102,0.470491764409293,UPF2
beta,1,positive regulation of angiogenesis (GO:0045766),1/104,1,104,0.639988463697131,0.684564774601409,0,0,0.986193293885602,0.440143124520822,FGF18
beta,1,regulation of cellular response to stress (GO:0080135),1/105,1,105,0.643516911208386,0.684931365890114,0,0,0.976800976800977,0.430580681071705,IMPACT
beta,1,positive regulation of vasculature development (GO:1904018),1/105,1,105,0.643516911208386,0.684931365890114,0,0,0.976800976800977,0.430580681071705,FGF18
beta,1,peptide metabolic process (GO:0006518),1/105,1,105,0.643516911208386,0.684931365890114,0,0,0.976800976800977,0.430580681071705,ACE
beta,1,mRNA transport (GO:0051028),1/105,1,105,0.643516911208386,0.684931365890114,0,0,0.976800976800977,0.430580681071705,UPF2
beta,1,translational elongation (GO:0006414),1/106,1,106,0.647010952139763,0.686949899802712,0,0,0.96758587324625,0.421279203726615,MRPL39
beta,1,mRNA export from nucleus (GO:0006406),1/106,1,106,0.647010952139763,0.686949899802712,0,0,0.96758587324625,0.421279203726615,UPF2
beta,1,"DNA-templated transcription, termination (GO:0006353)",1/107,1,107,0.650470920227963,0.688922403197103,0,0,0.958543014617781,0.412229749103442,POLR1B
beta,1,response to endoplasmic reticulum stress (GO:0034976),1/107,1,107,0.650470920227963,0.688922403197103,0,0,0.958543014617781,0.412229749103442,RASGRF1
beta,1,positive regulation of epithelial cell proliferation (GO:0050679),1/108,1,108,0.653897146035962,0.689156305871235,0,0,0.949667616334283,0.40342375019105,HPN
beta,1,viral life cycle (GO:0019058),1/108,1,108,0.653897146035962,0.689156305871235,0,0,0.949667616334283,0.40342375019105,VPS37C
beta,1,mitochondrial translation (GO:0032543),1/108,1,108,0.653897146035962,0.689156305871235,0,0,0.949667616334283,0.40342375019105,MRPL39
beta,1,cellular response to starvation (GO:0009267),1/108,1,108,0.653897146035962,0.689156305871235,0,0,0.949667616334283,0.40342375019105,IMPACT
beta,1,nucleotide-excision repair (GO:0006289),1/109,1,109,0.657289956978126,0.691884165240132,0,0,0.940955069395436,0.394852997445293,PPIE
beta,1,Wnt signaling pathway (GO:0016055),1/110,1,110,0.660649677285448,0.693722493852852,0,0,0.932400932400932,0.386509621074492,WNT4
beta,1,regulation of Wnt signaling pathway (GO:0030111),1/110,1,110,0.660649677285448,0.693722493852852,0,0,0.932400932400932,0.386509621074492,AMER3
beta,1,macroautophagy (GO:0016236),1/111,1,111,0.663976628020091,0.695517539704358,0,0,0.924000924000924,0.378386074280543,VPS37C
beta,1,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),1/111,1,111,0.663976628020091,0.695517539704358,0,0,0.924000924000924,0.378386074280543,TP73
beta,1,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",1/113,1,113,0.670533489707499,0.701531388258454,0,0,0.90764692534604,0.362769802717337,UPF2
beta,1,regulation of organelle organization (GO:0033043),1/114,1,114,0.673764027422457,0.702347955858561,0,0,0.899685110211426,0.355263461136885,EHD3
beta,1,positive regulation of developmental process (GO:0051094),1/114,1,114,0.673764027422457,0.702347955858561,0,0,0.899685110211426,0.355263461136885,HPN
beta,1,positive regulation of canonical Wnt signaling pathway (GO:0090263),1/114,1,114,0.673764027422457,0.702347955858561,0,0,0.899685110211426,0.355263461136885,WNT4
beta,1,negative regulation of cell growth (GO:0030308),1/116,1,116,0.680130861085148,0.706416111755106,0,0,0.884173297966401,0.340822331171037,APBB1
beta,1,epithelium development (GO:0060429),1/116,1,116,0.680130861085148,0.706416111755106,0,0,0.884173297966401,0.340822331171037,WNT4
beta,1,cellular response to oxidative stress (GO:0034599),1/116,1,116,0.680130861085148,0.706416111755106,0,0,0.884173297966401,0.340822331171037,FOS
beta,1,regulation of macroautophagy (GO:0016241),1/117,1,117,0.683267765835315,0.707964191106471,0,0,0.876616261231646,0.333875478902167,GPSM1
beta,1,sphingolipid metabolic process (GO:0006665),1/117,1,117,0.683267765835315,0.707964191106471,0,0,0.876616261231646,0.333875478902167,SPTSSB
beta,1,activation of MAPK activity (GO:0000187),1/118,1,118,0.686374063501335,0.710326948990551,0,0,0.869187309865276,0.327103448758438,GHR
beta,1,calcium ion transport (GO:0006816),1/119,1,119,0.689450051265605,0.710943697947746,0,0,0.861883214824391,0.320500776847354,NALCN
beta,1,cytosolic transport (GO:0016482),1/119,1,119,0.689450051265605,0.710943697947746,0,0,0.861883214824391,0.320500776847354,EHD3
beta,1,positive regulation of protein serine/threonine kinase activity (GO:0071902),1/119,1,119,0.689450051265605,0.710943697947746,0,0,0.861883214824391,0.320500776847354,FGF18
beta,1,RNA export from nucleus (GO:0006405),1/120,1,120,0.692496023228684,0.71237629183812,0,0,0.854700854700855,0.314062208177087,UPF2
beta,1,brain development (GO:0007420),1/120,1,120,0.692496023228684,0.71237629183812,0,0,0.854700854700855,0.314062208177087,H2AFY2
beta,1,actin filament organization (GO:0007015),1/121,1,121,0.695512270914665,0.712920802129454,0,0,0.847637211273575,0.307782686564931,DPYSL3
beta,1,negative regulation of growth (GO:0045926),1/121,1,121,0.695512270914665,0.712920802129454,0,0,0.847637211273575,0.307782686564931,APBB1
beta,1,macromolecular complex assembly (GO:0065003),1/121,1,121,0.695512270914665,0.712920802129454,0,0,0.847637211273575,0.307782686564931,WIPF1
beta,1,dephosphorylation (GO:0016311),1/125,1,125,0.707285748522052,0.723264855801385,0,0,0.82051282051282,0.2841604301709,THTPA
beta,1,organic anion transport (GO:0015711),1/125,1,125,0.707285748522052,0.723264855801385,0,0,0.82051282051282,0.2841604301709,SLC4A8
beta,1,positive regulation of protein kinase B signaling (GO:0051897),1/128,1,128,0.715817617059119,0.729387619278249,0,0,0.801282051282051,0.267892523435197,FGF18
beta,1,negative regulation of response to stimulus (GO:0048585),1/128,1,128,0.715817617059119,0.729387619278249,0,0,0.801282051282051,0.267892523435197,NTRK1
beta,1,non-canonical Wnt signaling pathway (GO:0035567),1/128,1,128,0.715817617059119,0.729387619278249,0,0,0.801282051282051,0.267892523435197,WNT4
beta,1,positive regulation of NF-kappaB transcription factor activity (GO:0051092),1/129,1,129,0.718606228474789,0.730498057314797,0,0,0.795070562512423,0.262724497576907,NTRK1
beta,1,positive regulation of mitochondrion organization (GO:0010822),1/129,1,129,0.718606228474789,0.730498057314797,0,0,0.795070562512423,0.262724497576907,CIDEB
beta,1,cellular response to hypoxia (GO:0071456),1/133,1,133,0.729491053990012,0.740687492835195,0,0,0.771158665895508,0.243229746907384,NDNF
beta,1,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),1/134,1,134,0.732146158503869,0.741632151134661,0,0,0.765403750478377,0.238633842223492,WIPF1
beta,1,protein targeting (GO:0006605),1/134,1,134,0.732146158503869,0.741632151134661,0,0,0.765403750478377,0.238633842223492,ZDHHC22
beta,1,Fc-gamma receptor signaling pathway (GO:0038094),1/135,1,135,0.734775334744047,0.743419750446918,0,0,0.759734093067427,0.234142825078736,WIPF1
beta,1,Fc receptor mediated stimulatory signaling pathway (GO:0002431),1/136,1,136,0.737378834594018,0.745177200647304,0,0,0.754147812971342,0.229753767980008,WIPF1
beta,1,response to cytokine (GO:0034097),1/139,1,139,0.745037758715392,0.752033418421639,0,0,0.737871241468364,0.217170543477187,DPYSL3
beta,1,regulation of primary metabolic process (GO:0080090),1/140,1,140,0.747541023769152,0.753524601615353,0,0,0.732600732600733,0.213161973572669,ID2
beta,1,regulation of cellular component organization (GO:0051128),1/141,1,141,0.750019836026444,0.753524601615353,0,0,0.727404982724132,0.209242134763604,ZMYM3
beta,1,positive regulation of Wnt signaling pathway (GO:0030177),1/141,1,141,0.750019836026444,0.753524601615353,0,0,0.727404982724132,0.209242134763604,WNT4
beta,1,inorganic cation transmembrane transport (GO:0098662),1/141,1,141,0.750019836026444,0.753524601615353,0,0,0.727404982724132,0.209242134763604,NALCN
beta,1,double-strand break repair (GO:0006302),1/142,1,142,0.752474432966023,0.755108532497993,0,0,0.722282412423258,0.20540863781957,RAD21
beta,1,positive regulation of macromolecule biosynthetic process (GO:0010557),1/143,1,143,0.754905050095542,0.755783868547342,0,0,0.717231486462256,0.201659170955428,WNT4
beta,1,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),1/143,1,143,0.754905050095542,0.755783868547342,0,0,0.717231486462256,0.201659170955428,CLDN9
beta,1,regulation of G2/M transition of mitotic cell cycle (GO:0010389),1/150,1,150,0.771267229648191,0.771267229648191,0,0,0.683760683760684,0.177586573751563,CEP41
beta,2,response to glucose (GO:0009749),6/48,6,48,7.20681598666908e-07,0.0005988864084922,0,0,18.9393939393939,267.861144089502,NEUROD1;SLC30A8;INS-IGF2;PDX1;GCK;INS
beta,2,regulation of peptide hormone secretion (GO:0090276),6/74,6,74,9.45594718346554e-06,0.00261929736981996,0,0,12.2850122850123,142.123669322126,NEUROD1;G6PC2;KCNJ11;ABCC8;GCK;INS
beta,2,regulation of protein secretion (GO:0050708),7/108,7,108,7.45172061305123e-06,0.00261929736981996,0,0,9.82042648709315,115.950419728209,NEUROD1;G6PC2;KCNJ11;ABCC8;DNM1L;GCK;INS
beta,2,response to hexose (GO:0009746),4/28,4,28,3.28234134765489e-05,0.00681906414975303,0,0,21.6450216450216,223.471179041599,NEUROD1;SLC30A8;INS-IGF2;INS
beta,2,regulation of insulin secretion (GO:0050796),6/99,6,99,4.99945920845097e-05,0.00830910120444551,0,0,9.18273645546373,90.9421094278739,NEUROD1;G6PC2;SLC30A8;KCNJ11;ABCC8;GCK
beta,2,carbohydrate homeostasis (GO:0033500),5/64,5,64,6.4760341779547e-05,0.00896930733646726,0,0,11.8371212121212,114.166869691468,NEUROD1;G6PC2;INS-IGF2;GCK;INS
beta,2,glucose homeostasis (GO:0042593),5/75,5,75,0.000138343929694222,0.0164234007965569,0,0,10.1010101010101,89.7552295872337,NEUROD1;G6PC2;INS-IGF2;GCK;INS
beta,2,Golgi organization (GO:0007030),6/122,6,122,0.000159383834593119,0.0165559958183603,0,0,7.45156482861401,65.1579374876809,ATP8B4;HACE1;PDCD10;ATP8B1;COG1;SYNE1
beta,2,insulin secretion (GO:0030073),3/19,3,19,0.000252025369392231,0.0232703424405493,0,0,23.9234449760766,198.229205821258,NEUROD1;SLC30A8;PDX1
beta,2,membrane fusion (GO:0061025),4/55,4,55,0.000476418549342985,0.039590381450402,0,0,11.0192837465565,84.2888571322636,HACE1;DNM1L;GDAP1;NAPG
beta,2,peptide metabolic process (GO:0006518),5/105,5,105,0.000661125744846556,0.0422611918436529,0,0,7.21500721500722,52.8251551366795,BACE1;PCSK1;GSTM2;PROS1;GDAP1
beta,2,regulation of transmembrane transport (GO:0034762),3/25,3,25,0.000581139677088874,0.0422611918436529,0,0,18.1818181818182,135.463989489735,KCNJ8;KCNJ11;INS
beta,2,peptide hormone secretion (GO:0030072),3/26,3,26,0.000653782776941813,0.0422611918436529,0,0,17.4825174825175,128.19467494805,NEUROD1;SLC30A8;PDX1
beta,2,positive regulation of insulin receptor signaling pathway (GO:0046628),2/7,2,7,0.000888370813768772,0.0527311533029892,0,0,43.2900432900433,304.161096063321,INS-IGF2;INS
beta,2,actomyosin structure organization (GO:0031032),4/72,4,72,0.00131823949615832,0.0730304680871707,0,0,8.41750841750842,55.8203547778192,EPB41L4A;MYBPHL;EPB41L3;F11R
beta,2,positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409),2/9,2,9,0.00150979173688468,0.0738021725500687,0,0,33.6700336700337,218.71325118722,CCNH;CCNC
beta,2,positive regulation of peptide hormone secretion (GO:0090277),3/40,3,40,0.00232265704114416,0.0772051200476319,0,0,11.3636363636364,68.9209485486061,SLC30A8;GCK;INS
beta,2,neural crest cell development (GO:0014032),3/36,3,36,0.00171106315466936,0.0772051200476319,0,0,12.6262626262626,80.4373784568618,PDCD6;SEMA4B;SEMA4C
beta,2,regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),2/11,2,11,0.00228675822530772,0.0772051200476319,0,0,27.5482093663912,167.510195220165,CCNH;CCNC
beta,2,negative regulation of gluconeogenesis (GO:0045721),2/10,2,10,0.00187909233239018,0.0772051200476319,0,0,30.3030303030303,190.211103655963,GCK;INS
beta,2,cytoskeletal anchoring at plasma membrane (GO:0007016),2/9,2,9,0.00150979173688468,0.0738021725500687,0,0,33.6700336700337,218.71325118722,EPB41L3;ANK3
beta,2,relaxation of cardiac muscle (GO:0055119),2/11,2,11,0.00228675822530772,0.0772051200476319,0,0,27.5482093663912,167.510195220165,CHGA;GSTM2
beta,2,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),2/11,2,11,0.00228675822530772,0.0772051200476319,0,0,27.5482093663912,167.510195220165,PDCD10;ZNF622
beta,2,negative regulation of blood vessel diameter (GO:0097756),2/11,2,11,0.00228675822530772,0.0772051200476319,0,0,27.5482093663912,167.510195220165,CHGA;INS
beta,2,positive regulation of protein secretion (GO:0050714),4/83,4,83,0.00222703026521254,0.0772051200476319,0,0,7.30193501277839,44.5935472849389,SLC30A8;DNM1L;GCK;INS
beta,2,positive regulation of glycogen biosynthetic process (GO:0045725),2/13,2,13,0.00321513196949913,0.102760564102068,0,0,23.3100233100233,133.796896831685,GCK;INS
beta,2,positive regulation of glycogen metabolic process (GO:0070875),2/14,2,14,0.00373482538577275,0.113229644621673,0,0,21.6450216450216,120.996844421804,GCK;INS
beta,2,carboxylic acid transport (GO:0046942),3/52,3,52,0.00490525536267174,0.113229644621673,0,0,8.74125874125874,46.4811899092063,SLC16A12;SLC25A21;SLC16A14
beta,2,glutathione metabolic process (GO:0006749),3/50,3,50,0.00439216741874777,0.113229644621673,0,0,9.09090909090909,49.3448405134428,GSTM2;MGST2;GDAP1
beta,2,nitric oxide mediated signal transduction (GO:0007263),2/15,2,15,0.004290855146678,0.113229644621673,0,0,20.2020202020202,110.126651131652,NEUROD1;PDX1
beta,2,negative regulation of cellular carbohydrate metabolic process (GO:0010677),2/17,2,17,0.00550994906767712,0.114469191880992,0,0,17.825311942959,92.7130106858432,GCK;INS
beta,2,regulation of RIG-I signaling pathway (GO:0039535),2/16,2,16,0.00488272637765971,0.113229644621673,0,0,18.9393939393939,100.796430514701,RNF125;DDX60
beta,2,monovalent inorganic cation transport (GO:0015672),4/105,4,105,0.00518422064285713,0.114469191880992,0,0,5.77200577200577,30.3730779714769,KCNJ8;ABCC8;KCNK16;SLC4A4
beta,2,metal ion transport (GO:0030001),4/102,4,102,0.00467891463933529,0.113229644621673,0,0,5.941770647653,31.8757522912709,KCNJ8;ABCC8;KCNK16;SLC4A4
beta,2,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),2/15,2,15,0.004290855146678,0.113229644621673,0,0,20.2020202020202,110.126651131652,PDCD10;SEMA4C
beta,2,negative regulation of axon guidance (GO:1902668),2/17,2,17,0.00550994906767712,0.114469191880992,0,0,17.825311942959,92.7130106858432,SEMA4B;SEMA4C
beta,2,glucose 6-phosphate metabolic process (GO:0051156),2/16,2,16,0.00488272637765971,0.113229644621673,0,0,18.9393939393939,100.796430514701,G6PC2;GCK
beta,2,monocarboxylic acid transport (GO:0015718),3/54,3,54,0.00545305849450447,0.114469191880992,0,0,8.41750841750842,43.8685070375752,ATP8B1;SLC16A12;SLC16A14
beta,2,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),2/18,2,18,0.00617203802406722,0.119278223209299,0,0,16.8350168350168,85.6519559556137,HTRA2;INS
beta,2,positive regulation of cellular response to insulin stimulus (GO:1900078),2/15,2,15,0.004290855146678,0.113229644621673,0,0,20.2020202020202,110.126651131652,INS-IGF2;INS
beta,2,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),2/18,2,18,0.00617203802406722,0.119278223209299,0,0,16.8350168350168,85.6519559556137,HTRA2;INS
beta,2,negative regulation of axon extension involved in axon guidance (GO:0048843),2/15,2,15,0.004290855146678,0.113229644621673,0,0,20.2020202020202,110.126651131652,SEMA4B;SEMA4C
beta,2,response to nutrient levels (GO:0031667),2/18,2,18,0.00617203802406722,0.119278223209299,0,0,16.8350168350168,85.6519559556137,INS-IGF2;INS
beta,2,regulation of transport (GO:0051049),2/20,2,20,0.00759889782323582,0.137275741111064,0,0,15.1515151515152,73.9356373555331,SLC30A8;WWC1
beta,2,second-messenger-mediated signaling (GO:0019932),3/63,3,63,0.00836338253576109,0.138999417744349,0,0,7.21500721500722,34.5158176347554,NEUROD1;MCTP1;PDX1
beta,2,regulation of glycogen biosynthetic process (GO:0005979),2/20,2,20,0.00759889782323582,0.137275741111064,0,0,15.1515151515152,73.9356373555331,GCK;INS
beta,2,potassium ion transport (GO:0006813),3/62,3,62,0.00800316922241557,0.138999417744349,0,0,7.33137829912023,35.3952907840774,KCNJ8;ABCC8;KCNK16
beta,2,phospholipid translocation (GO:0045332),2/21,2,21,0.00836272201116519,0.138999417744349,0,0,14.4300144300144,69.0327749705605,ATP8B4;ATP8B1
beta,2,regulation of gluconeogenesis (GO:0006111),2/20,2,20,0.00759889782323582,0.137275741111064,0,0,15.1515151515152,73.9356373555331,GCK;INS
beta,2,glutathione derivative metabolic process (GO:1901685),2/22,2,22,0.00915951908045854,0.143614346337001,0,0,13.7741046831956,64.6413444050652,GSTM2;MGST2
beta,2,mitochondrial fission (GO:0000266),2/21,2,21,0.00836272201116519,0.138999417744349,0,0,14.4300144300144,69.0327749705605,DNM1L;GDAP1
beta,2,lipid translocation (GO:0034204),2/22,2,22,0.00915951908045854,0.143614346337001,0,0,13.7741046831956,64.6413444050652,ATP8B4;ATP8B1
beta,2,negative regulation of axon extension (GO:0030517),2/23,2,23,0.00998882732228884,0.148227062586108,0,0,13.1752305665349,60.6889074883811,SEMA4B;SEMA4C
beta,2,regulation of protein oligomerization (GO:0032459),2/23,2,23,0.00998882732228884,0.148227062586108,0,0,13.1752305665349,60.6889074883811,DNM1L;INS
beta,2,glutathione derivative biosynthetic process (GO:1901687),2/22,2,22,0.00915951908045854,0.143614346337001,0,0,13.7741046831956,64.6413444050652,GSTM2;MGST2
beta,2,regulation of axon extension involved in axon guidance (GO:0048841),2/23,2,23,0.00998882732228884,0.148227062586108,0,0,13.1752305665349,60.6889074883811,SEMA4B;SEMA4C
beta,2,negative regulation of oxidative stress-induced cell death (GO:1903202),2/25,2,25,0.0117431533578285,0.171202814743079,0,0,12.1212121212121,53.8725442566576,HTRA2;INS
beta,2,response to insulin (GO:0032868),3/72,3,72,0.0120341126755043,0.172419786781794,0,0,6.31313131313131,27.904103151081,INS-IGF2;GCK;INS
beta,2,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),2/27,2,27,0.0136220973098662,0.185573161713096,0,0,11.2233445566779,48.2161840921111,CCNH;CCNC
beta,2,bile acid biosynthetic process (GO:0006699),2/27,2,27,0.0136220973098662,0.185573161713096,0,0,11.2233445566779,48.2161840921111,CYP7B1;SLC27A2
beta,2,negative chemotaxis (GO:0050919),2/27,2,27,0.0136220973098662,0.185573161713096,0,0,11.2233445566779,48.2161840921111,SEMA4B;SEMA4C
beta,2,peptidyl-glutamic acid modification (GO:0018200),2/28,2,28,0.014607194669027,0.189665293280647,0,0,10.8225108225108,45.7385398928244,TTLL3;PROS1
beta,2,regulation of blood vessel diameter (GO:0097746),2/28,2,28,0.014607194669027,0.189665293280647,0,0,10.8225108225108,45.7385398928244,CHGA;INS
beta,2,regulation of autophagy of mitochondrion (GO:1903146),2/28,2,28,0.014607194669027,0.189665293280647,0,0,10.8225108225108,45.7385398928244,HTRA2;DNM1L
beta,2,neural crest cell migration (GO:0001755),2/29,2,29,0.0156221277189777,0.19669678991622,0,0,10.4493207941484,43.4594245166475,SEMA4B;SEMA4C
beta,2,organelle fission (GO:0048285),2/29,2,29,0.0156221277189777,0.19669678991622,0,0,10.4493207941484,43.4594245166475,DNM1L;GDAP1
beta,2,positive regulation of stress-activated MAPK cascade (GO:0032874),3/81,3,81,0.0164962746202785,0.203674017972059,0,0,5.61167227833894,23.0337862186143,PDCD10;SEMA4C;ZNF622
beta,2,semaphorin-plexin signaling pathway (GO:0071526),2/30,2,30,0.0166664659712395,0.203674017972059,0,0,10.1010101010101,41.3571374143458,SEMA4B;SEMA4C
beta,2,positive regulation of cation channel activity (GO:2001259),2/31,2,31,0.0177397832508016,0.204746665019669,0,0,9.77517106549365,39.4129571874998,GSTM2;ANK3
beta,2,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),2/31,2,31,0.0177397832508016,0.204746665019669,0,0,9.77517106549365,39.4129571874998,CCNH;CCNC
beta,2,negative regulation of secretion by cell (GO:1903531),2/31,2,31,0.0177397832508016,0.204746665019669,0,0,9.77517106549365,39.4129571874998,CHGA;INS
beta,2,bile acid metabolic process (GO:0008206),2/31,2,31,0.0177397832508016,0.204746665019669,0,0,9.77517106549365,39.4129571874998,CYP7B1;SLC27A2
beta,2,positive regulation of insulin secretion (GO:0032024),2/32,2,32,0.0188416576459791,0.21448517128505,0,0,9.46969696969697,37.6106536766008,SLC30A8;GCK
beta,2,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),3/86,3,86,0.0193242629593686,0.217006250259936,0,0,5.28541226215645,20.8583183111341,INS-IGF2;BANK1;INS
beta,2,regulation of DNA recombination (GO:0000018),2/34,2,34,0.0211294112764471,0.231033431193783,0,0,8.9126559714795,34.3769100687908,SMARCAD1;USP51
beta,2,intra-Golgi vesicle-mediated transport (GO:0006891),2/34,2,34,0.0211294112764471,0.231033431193783,0,0,8.9126559714795,34.3769100687908,COG1;NAPG
beta,2,regulation of insulin receptor signaling pathway (GO:0046626),2/35,2,35,0.0223144677072467,0.240822372269117,0,0,8.65800865800866,32.9222513832951,INS-IGF2;INS
beta,2,positive regulation of peptide secretion (GO:0002793),2/36,2,36,0.0235264355761192,0.244380849546939,0,0,8.41750841750842,31.5625469018989,DNM1L;INS
beta,2,regulation of ion transmembrane transport (GO:0034765),2/36,2,36,0.0235264355761192,0.244380849546939,0,0,8.41750841750842,31.5625469018989,KCNJ8;KCNJ11
beta,2,negative regulation of protein complex assembly (GO:0031333),2/36,2,36,0.0235264355761192,0.244380849546939,0,0,8.41750841750842,31.5625469018989,SMAD6;INS
beta,2,muscle cell differentiation (GO:0042692),2/37,2,37,0.0247649137739763,0.247947510194871,0,0,8.19000819000819,30.2893316520687,SEMA4C;SYNE1
beta,2,regulation of nitric-oxide synthase activity (GO:0050999),2/37,2,37,0.0247649137739763,0.247947510194871,0,0,8.19000819000819,30.2893316520687,ZDHHC21;INS
beta,2,plasma membrane organization (GO:0007009),2/37,2,37,0.0247649137739763,0.247947510194871,0,0,8.19000819000819,30.2893316520687,EPB41L3;ANK3
beta,2,potassium ion import (GO:0010107),2/39,2,39,0.0273198169192019,0.254822936663076,0,0,7.77000777000777,27.9731386608309,KCNJ8;KCNJ11
beta,2,response to peptide hormone (GO:0043434),2/41,2,41,0.0299760486410903,0.254822936663076,0,0,7.3909830007391,25.9228129698763,INS-IGF2;INS
beta,2,regulation of cellular localization (GO:0060341),2/41,2,41,0.0299760486410903,0.254822936663076,0,0,7.3909830007391,25.9228129698763,MCTP1;WWC1
beta,2,ameboidal-type cell migration (GO:0001667),2/41,2,41,0.0299760486410903,0.254822936663076,0,0,7.3909830007391,25.9228129698763,SEMA4B;SEMA4C
beta,2,regulation of stress-activated MAPK cascade (GO:0032872),2/42,2,42,0.0313412023620041,0.254822936663076,0,0,7.21500721500722,24.984283388871,PDCD10;SEMA4C
beta,2,negative regulation of protein secretion (GO:0050709),2/43,2,43,0.0327305435888062,0.254822936663076,0,0,7.04721634954193,24.0975798614025,KCNJ11;INS
beta,2,unsaturated fatty acid metabolic process (GO:0033559),2/45,2,45,0.0355802984491767,0.254822936663076,0,0,6.73400673400673,22.4643987115378,GSTM2;SCD5
beta,2,cellular response to insulin stimulus (GO:0032869),3/111,3,111,0.0372318615812166,0.254822936663076,0,0,4.0950040950041,13.4749811227113,GAB1;GCK;INS
beta,2,positive regulation of action potential (GO:0045760),1/6,1,6,0.0389569000517089,0.254822936663076,0,0,25.2525252525253,81.9520043140084,ANK3
beta,2,neuron projection maintenance (GO:1990535),1/6,1,6,0.0389569000517089,0.254822936663076,0,0,25.2525252525253,81.9520043140084,INS
beta,2,B cell chemotaxis (GO:0035754),1/6,1,6,0.0389569000517089,0.254822936663076,0,0,25.2525252525253,81.9520043140084,CYP7B1
beta,2,positive regulation of cardiac muscle contraction (GO:0060452),1/6,1,6,0.0389569000517089,0.254822936663076,0,0,25.2525252525253,81.9520043140084,CHGA
beta,2,negative regulation of catecholamine secretion (GO:0033604),1/6,1,6,0.0389569000517089,0.254822936663076,0,0,25.2525252525253,81.9520043140084,CHGA
beta,2,negative regulation of acute inflammatory response (GO:0002674),1/6,1,6,0.0389569000517089,0.254822936663076,0,0,25.2525252525253,81.9520043140084,INS
beta,2,indolalkylamine metabolic process (GO:0006586),1/6,1,6,0.0389569000517089,0.254822936663076,0,0,25.2525252525253,81.9520043140084,DDC
beta,2,establishment of endothelial intestinal barrier (GO:0090557),1/6,1,6,0.0389569000517089,0.254822936663076,0,0,25.2525252525253,81.9520043140084,F11R
beta,2,regulation of digestive system process (GO:0044058),1/6,1,6,0.0389569000517089,0.254822936663076,0,0,25.2525252525253,81.9520043140084,NEUROD1
beta,2,regulation of NAD(P)H oxidase activity (GO:0033860),1/6,1,6,0.0389569000517089,0.254822936663076,0,0,25.2525252525253,81.9520043140084,INS
beta,2,positive regulation of sodium ion transmembrane transport (GO:1902307),1/6,1,6,0.0389569000517089,0.254822936663076,0,0,25.2525252525253,81.9520043140084,ANK3
beta,2,cellular response to magnesium ion (GO:0071286),1/6,1,6,0.0389569000517089,0.254822936663076,0,0,25.2525252525253,81.9520043140084,ANK3
beta,2,negative regulation of delayed rectifier potassium channel activity (GO:1902260),1/6,1,6,0.0389569000517089,0.254822936663076,0,0,25.2525252525253,81.9520043140084,ANK3
beta,2,positive regulation of fever generation (GO:0031622),1/6,1,6,0.0389569000517089,0.254822936663076,0,0,25.2525252525253,81.9520043140084,TNFRSF11A
beta,2,surfactant homeostasis (GO:0043129),1/6,1,6,0.0389569000517089,0.254822936663076,0,0,25.2525252525253,81.9520043140084,SFTPA1
beta,2,regulation of relaxation of cardiac muscle (GO:1901897),1/6,1,6,0.0389569000517089,0.254822936663076,0,0,25.2525252525253,81.9520043140084,CHGA
beta,2,chemical homeostasis within a tissue (GO:0048875),1/6,1,6,0.0389569000517089,0.254822936663076,0,0,25.2525252525253,81.9520043140084,SFTPA1
beta,2,alpha-beta T cell activation (GO:0046631),1/6,1,6,0.0389569000517089,0.254822936663076,0,0,25.2525252525253,81.9520043140084,INS
beta,2,positive regulation of developmental process (GO:0051094),3/114,3,114,0.0397985006598655,0.254822936663076,0,0,3.98724082934609,12.8545695345456,NEUROD1;DNM1L;INS
beta,2,negative regulation of cellular biosynthetic process (GO:0031327),2/48,2,48,0.040027123080113,0.254822936663076,0,0,6.31313131313131,20.3169064245942,GCK;INS
beta,2,cellular response to heat (GO:0034605),2/48,2,48,0.040027123080113,0.254822936663076,0,0,6.31313131313131,20.3169064245942,PDCD6;HTRA2
beta,2,regulation of mitochondrion organization (GO:0010821),2/49,2,49,0.0415538783891098,0.254822936663076,0,0,6.18429189857761,19.6707756297999,HTRA2;DNM1L
beta,2,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),3/117,3,117,0.0424527818345944,0.254822936663076,0,0,3.88500388500389,12.2741368933325,INS-IGF2;BANK1;INS
beta,2,organic hydroxy compound biosynthetic process (GO:1901617),2/50,2,50,0.0431022856735813,0.254822936663076,0,0,6.06060606060606,19.0556318267208,CYP7B1;SLC27A2
beta,2,protein localization to cell periphery (GO:1990778),3/118,3,118,0.0433568850839992,0.254822936663076,0,0,3.85208012326656,12.0889436167177,EPB41L3;ANK3;F11R
beta,2,positive regulation of protein serine/threonine kinase activity (GO:0071902),3/119,3,119,0.0442706091502339,0.254822936663076,0,0,3.81970970206264,11.9076939360005,CCNH;PDCD10;CCNC
beta,2,regulation of ion transport (GO:0043269),2/51,2,51,0.0446719974219448,0.254822936663076,0,0,5.941770647653,18.4694499676351,KCNJ8;KCNJ11
beta,2,myeloid leukocyte differentiation (GO:0002573),2/51,2,51,0.0446719974219448,0.254822936663076,0,0,5.941770647653,18.4694499676351,TNFRSF11A;DHRS2
beta,2,cellular response to caffeine (GO:0071313),1/7,1,7,0.0453016709363037,0.254822936663076,0,0,21.6450216450216,66.9786008909589,GSTM2
beta,2,protein C-linked glycosylation via tryptophan (GO:0018317),1/7,1,7,0.0453016709363037,0.254822936663076,0,0,21.6450216450216,66.9786008909589,DPY19L2
beta,2,positive regulation of RIG-I signaling pathway (GO:1900246),1/7,1,7,0.0453016709363037,0.254822936663076,0,0,21.6450216450216,66.9786008909589,DDX60
beta,2,regulation of dendritic spine maintenance (GO:1902950),1/7,1,7,0.0453016709363037,0.254822936663076,0,0,21.6450216450216,66.9786008909589,INS
beta,2,regulation of MDA-5 signaling pathway (GO:0039533),1/7,1,7,0.0453016709363037,0.254822936663076,0,0,21.6450216450216,66.9786008909589,DDX60
beta,2,positive regulation of striated muscle contraction (GO:0045989),1/7,1,7,0.0453016709363037,0.254822936663076,0,0,21.6450216450216,66.9786008909589,CHGA
beta,2,mitral valve development (GO:0003174),1/7,1,7,0.0453016709363037,0.254822936663076,0,0,21.6450216450216,66.9786008909589,SMAD6
beta,2,positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),1/7,1,7,0.0453016709363037,0.254822936663076,0,0,21.6450216450216,66.9786008909589,GAB1
beta,2,translational readthrough (GO:0006451),1/7,1,7,0.0453016709363037,0.254822936663076,0,0,21.6450216450216,66.9786008909589,SECISBP2L
beta,2,negative regulation of glycogen metabolic process (GO:0070874),1/7,1,7,0.0453016709363037,0.254822936663076,0,0,21.6450216450216,66.9786008909589,INS
beta,2,cellular response to leptin stimulus (GO:0044320),1/7,1,7,0.0453016709363037,0.254822936663076,0,0,21.6450216450216,66.9786008909589,GCK
beta,2,xenobiotic catabolic process (GO:0042178),1/7,1,7,0.0453016709363037,0.254822936663076,0,0,21.6450216450216,66.9786008909589,GSTM2
beta,2,positive regulation of membrane depolarization (GO:1904181),1/7,1,7,0.0453016709363037,0.254822936663076,0,0,21.6450216450216,66.9786008909589,ANK3
beta,2,response to caffeine (GO:0031000),1/7,1,7,0.0453016709363037,0.254822936663076,0,0,21.6450216450216,66.9786008909589,GSTM2
beta,2,negative regulation of RIG-I signaling pathway (GO:0039536),1/7,1,7,0.0453016709363037,0.254822936663076,0,0,21.6450216450216,66.9786008909589,RNF125
beta,2,selenocysteine incorporation (GO:0001514),1/7,1,7,0.0453016709363037,0.254822936663076,0,0,21.6450216450216,66.9786008909589,SECISBP2L
beta,2,long-chain fatty acid import (GO:0044539),1/7,1,7,0.0453016709363037,0.254822936663076,0,0,21.6450216450216,66.9786008909589,SLC27A2
beta,2,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),1/7,1,7,0.0453016709363037,0.254822936663076,0,0,21.6450216450216,66.9786008909589,DPY19L2
beta,2,vascular endothelial growth factor signaling pathway (GO:0038084),1/7,1,7,0.0453016709363037,0.254822936663076,0,0,21.6450216450216,66.9786008909589,GAB1
beta,2,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),2/54,2,54,0.0495055379599483,0.254822936663076,0,0,5.61167227833894,16.8668391564905,INS-IGF2;INS
beta,2,negative regulation of multicellular organismal process (GO:0051241),3/126,3,126,0.0509332912691267,0.254822936663076,0,0,3.60750360750361,10.7403986897045,WWC1;SMAD6;INS
beta,2,fatty acid alpha-oxidation (GO:0001561),1/8,1,8,0.0516048704884672,0.254822936663076,0,0,18.9393939393939,56.1390004098036,SLC27A2
beta,2,regulation of brown fat cell differentiation (GO:0090335),1/8,1,8,0.0516048704884672,0.254822936663076,0,0,18.9393939393939,56.1390004098036,INS
beta,2,mast cell activation involved in immune response (GO:0002279),1/8,1,8,0.0516048704884672,0.254822936663076,0,0,18.9393939393939,56.1390004098036,CHGA
beta,2,positive regulation of membrane potential (GO:0045838),1/8,1,8,0.0516048704884672,0.254822936663076,0,0,18.9393939393939,56.1390004098036,ANK3
beta,2,myelin maintenance (GO:0043217),1/8,1,8,0.0516048704884672,0.254822936663076,0,0,18.9393939393939,56.1390004098036,EPB41L3
beta,2,response to magnesium ion (GO:0032026),1/8,1,8,0.0516048704884672,0.254822936663076,0,0,18.9393939393939,56.1390004098036,ANK3
beta,2,cellular response to purine-containing compound (GO:0071415),1/8,1,8,0.0516048704884672,0.254822936663076,0,0,18.9393939393939,56.1390004098036,GSTM2
beta,2,membrane lipid catabolic process (GO:0046466),1/8,1,8,0.0516048704884672,0.254822936663076,0,0,18.9393939393939,56.1390004098036,MGST2
beta,2,cytoskeletal anchoring at nuclear membrane (GO:0090286),1/8,1,8,0.0516048704884672,0.254822936663076,0,0,18.9393939393939,56.1390004098036,SYNE1
beta,2,positive regulation of respiratory burst (GO:0060267),1/8,1,8,0.0516048704884672,0.254822936663076,0,0,18.9393939393939,56.1390004098036,INS
beta,2,regulation of response to oxidative stress (GO:1902882),1/8,1,8,0.0516048704884672,0.254822936663076,0,0,18.9393939393939,56.1390004098036,MCTP1
beta,2,mast cell degranulation (GO:0043303),1/8,1,8,0.0516048704884672,0.254822936663076,0,0,18.9393939393939,56.1390004098036,CHGA
beta,2,positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),1/8,1,8,0.0516048704884672,0.254822936663076,0,0,18.9393939393939,56.1390004098036,GSTM2
beta,2,negative regulation of voltage-gated potassium channel activity (GO:1903817),1/8,1,8,0.0516048704884672,0.254822936663076,0,0,18.9393939393939,56.1390004098036,ANK3
beta,2,response to leptin (GO:0044321),1/8,1,8,0.0516048704884672,0.254822936663076,0,0,18.9393939393939,56.1390004098036,GCK
beta,2,negative regulation of hippo signaling (GO:0035331),1/8,1,8,0.0516048704884672,0.254822936663076,0,0,18.9393939393939,56.1390004098036,WWC1
beta,2,negative regulation of biosynthetic process (GO:0009890),1/8,1,8,0.0516048704884672,0.254822936663076,0,0,18.9393939393939,56.1390004098036,INS
beta,2,histone H4 deacetylation (GO:0070933),1/8,1,8,0.0516048704884672,0.254822936663076,0,0,18.9393939393939,56.1390004098036,SMARCAD1
beta,2,cytoskeleton organization (GO:0007010),3/127,3,127,0.0519227705581832,0.254822936663076,0,0,3.57909806728704,10.586964373477,EPB41L3;ANK3;SYNE1
beta,2,positive regulation of cysteine-type endopeptidase activity (GO:2001056),2/56,2,56,0.0528282094677492,0.254822936663076,0,0,5.41125541125541,15.9129326878729,PDCD6;HTRA2
beta,2,negative regulation of cellular response to growth factor stimulus (GO:0090288),2/56,2,56,0.0528282094677492,0.254822936663076,0,0,5.41125541125541,15.9129326878729,PDCD6;SMAD6
beta,2,long-chain fatty acid metabolic process (GO:0001676),2/56,2,56,0.0528282094677492,0.254822936663076,0,0,5.41125541125541,15.9129326878729,GSTM2;SLC27A2
beta,2,positive regulation of NF-kappaB transcription factor activity (GO:0051092),3/129,3,129,0.0539296083391917,0.254822936663076,0,0,3.52360817477097,10.2892023680462,EDA;TNFRSF11A;INS
beta,2,regulation of secretion by cell (GO:1903530),2/57,2,57,0.0545186488005772,0.254822936663076,0,0,5.31632110579479,15.466307581159,MCTP1;INS
beta,2,positive regulation of protein transport (GO:0051222),2/57,2,57,0.0545186488005772,0.254822936663076,0,0,5.31632110579479,15.466307581159,PDCD10;DNM1L
beta,2,protein localization to plasma membrane (GO:0072659),3/131,3,131,0.0559733561244223,0.254822936663076,0,0,3.46981263011797,10.0030516480233,EPB41L3;ANK3;F11R
beta,2,regulation of glycolytic process (GO:0006110),2/58,2,58,0.0562280586045162,0.254822936663076,0,0,5.22466039707419,15.0383457849919,GCK;INS
beta,2,type B pancreatic cell differentiation (GO:0003309),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,PDX1
beta,2,regulation of organ growth (GO:0046620),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,WWC1
beta,2,ventricular cardiac muscle cell membrane repolarization (GO:0099625),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,KCNJ8
beta,2,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,PDCD6
beta,2,peroxisome fission (GO:0016559),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,DNM1L
beta,2,regulation of microvillus organization (GO:0032530),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,ATP8B1
beta,2,protein autoprocessing (GO:0016540),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,HTRA2
beta,2,establishment of Golgi localization (GO:0051683),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,PDCD10
beta,2,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,HTRA2
beta,2,positive regulation of long-term synaptic potentiation (GO:1900273),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,INS
beta,2,mitochondrion morphogenesis (GO:0070584),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,DNM1L
beta,2,potassium ion import across plasma membrane (GO:1990573),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,KCNJ8
beta,2,regulation of homotypic cell-cell adhesion (GO:0034110),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,ANK3
beta,2,mitral valve morphogenesis (GO:0003183),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,SMAD6
beta,2,dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,DNM1L
beta,2,myelin assembly (GO:0032288),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,EPB41L3
beta,2,mast cell mediated immunity (GO:0002448),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,CHGA
beta,2,neuron projection organization (GO:0106027),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,INS
beta,2,mitochondrial fragmentation involved in apoptotic process (GO:0043653),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,DNM1L
beta,2,fatty acid homeostasis (GO:0055089),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,INS
beta,2,Golgi inheritance (GO:0048313),1/9,1,9,0.0578667687196003,0.254822936663076,0,0,16.8350168350168,47.9732660242086,PDCD10
beta,2,phospholipid transport (GO:0015914),2/59,2,59,0.0579561191688583,0.254822936663076,0,0,5.13610683102209,14.6279872667202,ATP8B4;ATP8B1
beta,2,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),1/10,1,10,0.0640876340063741,0.264219394312046,0,0,15.1515151515152,41.6288462255104,RNF125
beta,2,dynamin family protein polymerization involved in membrane fission (GO:0003373),1/10,1,10,0.0640876340063741,0.264219394312046,0,0,15.1515151515152,41.6288462255104,DNM1L
beta,2,cellular response to thyroid hormone stimulus (GO:0097067),1/10,1,10,0.0640876340063741,0.264219394312046,0,0,15.1515151515152,41.6288462255104,LMO2
beta,2,dorsal/ventral axis specification (GO:0009950),1/10,1,10,0.0640876340063741,0.264219394312046,0,0,15.1515151515152,41.6288462255104,SMAD6
beta,2,regulation of sequestering of zinc ion (GO:0061088),1/10,1,10,0.0640876340063741,0.264219394312046,0,0,15.1515151515152,41.6288462255104,SLC30A8
beta,2,response to laminar fluid shear stress (GO:0034616),1/10,1,10,0.0640876340063741,0.264219394312046,0,0,15.1515151515152,41.6288462255104,SMAD6
beta,2,regulation of respiratory burst (GO:0060263),1/10,1,10,0.0640876340063741,0.264219394312046,0,0,15.1515151515152,41.6288462255104,INS
beta,2,positive regulation of glucose import in response to insulin stimulus (GO:2001275),1/10,1,10,0.0640876340063741,0.264219394312046,0,0,15.1515151515152,41.6288462255104,INS
beta,2,negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),1/10,1,10,0.0640876340063741,0.264219394312046,0,0,15.1515151515152,41.6288462255104,SMAD6
beta,2,pulmonary valve development (GO:0003177),1/10,1,10,0.0640876340063741,0.264219394312046,0,0,15.1515151515152,41.6288462255104,SMAD6
beta,2,myeloid dendritic cell differentiation (GO:0043011),1/10,1,10,0.0640876340063741,0.264219394312046,0,0,15.1515151515152,41.6288462255104,DHRS2
beta,2,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),2/63,2,63,0.0650485907195723,0.264219394312046,0,0,4.81000481000481,13.1439188976941,HTRA2;INS
beta,2,positive regulation of cell projection organization (GO:0031346),2/64,2,64,0.0668652250030493,0.264219394312046,0,0,4.73484848484849,12.8081261961566,SERPINI1;INS
beta,2,modification-dependent protein catabolic process (GO:0019941),3/142,3,142,0.0678587261388479,0.264219394312046,0,0,3.20102432778489,8.61180311044339,RNF125;HACE1;RNF217
beta,2,glucose metabolic process (GO:0006006),2/65,2,65,0.0686986607729506,0.264219394312046,0,0,4.66200466200466,12.4849677099644,G6PC2;KCNJ11
beta,2,cellular response to interferon-beta (GO:0035458),1/11,1,11,0.0702677330240217,0.264219394312046,0,0,13.7741046831956,36.5763440114946,HTRA2
beta,2,regulation of hippo signaling (GO:0035330),1/11,1,11,0.0702677330240217,0.264219394312046,0,0,13.7741046831956,36.5763440114946,WWC1
beta,2,cell part morphogenesis (GO:0032990),1/11,1,11,0.0702677330240217,0.264219394312046,0,0,13.7741046831956,36.5763440114946,DNM1L
beta,2,drug transmembrane transport (GO:0006855),1/11,1,11,0.0702677330240217,0.264219394312046,0,0,13.7741046831956,36.5763440114946,ATP8B1
beta,2,regulation of feeding behavior (GO:0060259),1/11,1,11,0.0702677330240217,0.264219394312046,0,0,13.7741046831956,36.5763440114946,INS
beta,2,myosin filament assembly (GO:0031034),1/11,1,11,0.0702677330240217,0.264219394312046,0,0,13.7741046831956,36.5763440114946,MYBPHL
beta,2,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),1/11,1,11,0.0702677330240217,0.264219394312046,0,0,13.7741046831956,36.5763440114946,ANK3
beta,2,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),1/11,1,11,0.0702677330240217,0.264219394312046,0,0,13.7741046831956,36.5763440114946,GSTM2
beta,2,response to thyroid hormone (GO:0097066),1/11,1,11,0.0702677330240217,0.264219394312046,0,0,13.7741046831956,36.5763440114946,LMO2
beta,2,mitochondrion distribution (GO:0048311),1/11,1,11,0.0702677330240217,0.264219394312046,0,0,13.7741046831956,36.5763440114946,DNM1L
beta,2,negative regulation of peptide secretion (GO:0002792),1/11,1,11,0.0702677330240217,0.264219394312046,0,0,13.7741046831956,36.5763440114946,INS
beta,2,glutathione biosynthetic process (GO:0006750),1/11,1,11,0.0702677330240217,0.264219394312046,0,0,13.7741046831956,36.5763440114946,MGST2
beta,2,protein carboxylation (GO:0018214),1/11,1,11,0.0702677330240217,0.264219394312046,0,0,13.7741046831956,36.5763440114946,PROS1
beta,2,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),1/11,1,11,0.0702677330240217,0.264219394312046,0,0,13.7741046831956,36.5763440114946,PDCD10
beta,2,peptidyl-glutamic acid carboxylation (GO:0017187),1/11,1,11,0.0702677330240217,0.264219394312046,0,0,13.7741046831956,36.5763440114946,PROS1
beta,2,relaxation of muscle (GO:0090075),1/11,1,11,0.0702677330240217,0.264219394312046,0,0,13.7741046831956,36.5763440114946,GSTM2
beta,2,icosanoid biosynthetic process (GO:0046456),1/11,1,11,0.0702677330240217,0.264219394312046,0,0,13.7741046831956,36.5763440114946,MGST2
beta,2,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),3/145,3,145,0.0712845539549597,0.264560382840649,0,0,3.13479623824451,8.27923388590389,ID1;F11R;SMAD6
beta,2,positive regulation of cellular protein localization (GO:1903829),2/67,2,67,0.0724147519706284,0.264560382840649,0,0,4.52284034373587,11.8740173851,PDCD10;INS
beta,2,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),2/68,2,68,0.0742968228303722,0.264560382840649,0,0,4.45632798573975,11.5850583312857,CCNH;CCNC
beta,2,insulin receptor signaling pathway (GO:0008286),2/68,2,68,0.0742968228303722,0.264560382840649,0,0,4.45632798573975,11.5850583312857,GAB1;INS
beta,2,monocarboxylic acid biosynthetic process (GO:0072330),2/69,2,69,0.0761945259475603,0.264560382840649,0,0,4.39174352217831,11.3063928714472,CYP7B1;SLC27A2
beta,2,pulmonary valve morphogenesis (GO:0003184),1/12,1,12,0.0764073307843029,0.264560382840649,0,0,12.6262626262626,32.4706645800342,SMAD6
beta,2,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),1/12,1,12,0.0764073307843029,0.264560382840649,0,0,12.6262626262626,32.4706645800342,USP51
beta,2,lysine metabolic process (GO:0006553),1/12,1,12,0.0764073307843029,0.264560382840649,0,0,12.6262626262626,32.4706645800342,SLC25A21
beta,2,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),1/12,1,12,0.0764073307843029,0.264560382840649,0,0,12.6262626262626,32.4706645800342,GSTM2
beta,2,negative regulation of protein oligomerization (GO:0032460),1/12,1,12,0.0764073307843029,0.264560382840649,0,0,12.6262626262626,32.4706645800342,INS
beta,2,import across plasma membrane (GO:0098739),1/12,1,12,0.0764073307843029,0.264560382840649,0,0,12.6262626262626,32.4706645800342,KCNJ8
beta,2,negative regulation of oxidoreductase activity (GO:0051354),1/12,1,12,0.0764073307843029,0.264560382840649,0,0,12.6262626262626,32.4706645800342,INS
beta,2,Golgi localization (GO:0051645),1/12,1,12,0.0764073307843029,0.264560382840649,0,0,12.6262626262626,32.4706645800342,PDCD10
beta,2,lysine catabolic process (GO:0006554),1/12,1,12,0.0764073307843029,0.264560382840649,0,0,12.6262626262626,32.4706645800342,SLC25A21
beta,2,nonribosomal peptide biosynthetic process (GO:0019184),1/12,1,12,0.0764073307843029,0.264560382840649,0,0,12.6262626262626,32.4706645800342,MGST2
beta,2,regulation of cell communication by electrical coupling (GO:0010649),1/12,1,12,0.0764073307843029,0.264560382840649,0,0,12.6262626262626,32.4706645800342,ANK3
beta,2,histone H3 deacetylation (GO:0070932),1/12,1,12,0.0764073307843029,0.264560382840649,0,0,12.6262626262626,32.4706645800342,SMARCAD1
beta,2,regulation of protein localization to cell periphery (GO:1904375),1/12,1,12,0.0764073307843029,0.264560382840649,0,0,12.6262626262626,32.4706645800342,INS
beta,2,negative regulation of fatty acid metabolic process (GO:0045922),1/12,1,12,0.0764073307843029,0.264560382840649,0,0,12.6262626262626,32.4706645800342,INS
beta,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),2/71,2,71,0.0800356936219501,0.2719749168806,0,0,4.26803243704652,10.7779879365695,RNF125;RNF217
beta,2,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),2/71,2,71,0.0800356936219501,0.2719749168806,0,0,4.26803243704652,10.7779879365695,HACE1;RNF217
beta,2,organelle membrane fusion (GO:0090174),2/72,2,72,0.0819785979990365,0.2719749168806,0,0,4.20875420875421,10.5273445530137,SNAP47;SYT17
beta,2,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),1/13,1,13,0.0825066905956246,0.2719749168806,0,0,11.6550116550117,29.0778075850932,INS
beta,2,positive regulation of sodium ion transport (GO:0010765),1/13,1,13,0.0825066905956246,0.2719749168806,0,0,11.6550116550117,29.0778075850932,ANK3
beta,2,intestinal absorption (GO:0050892),1/13,1,13,0.0825066905956246,0.2719749168806,0,0,11.6550116550117,29.0778075850932,F11R
beta,2,regulation of neurotransmitter transport (GO:0051588),1/13,1,13,0.0825066905956246,0.2719749168806,0,0,11.6550116550117,29.0778075850932,MCTP1
beta,2,nucleotide metabolic process (GO:0009117),1/13,1,13,0.0825066905956246,0.2719749168806,0,0,11.6550116550117,29.0778075850932,SMARCAD1
beta,2,regulation of glucose import in response to insulin stimulus (GO:2001273),1/13,1,13,0.0825066905956246,0.2719749168806,0,0,11.6550116550117,29.0778075850932,INS
beta,2,striated muscle myosin thick filament assembly (GO:0071688),1/13,1,13,0.0825066905956246,0.2719749168806,0,0,11.6550116550117,29.0778075850932,MYBPHL
beta,2,regulation of cAMP metabolic process (GO:0030814),1/13,1,13,0.0825066905956246,0.2719749168806,0,0,11.6550116550117,29.0778075850932,CHGA
beta,2,catecholamine biosynthetic process (GO:0042423),1/13,1,13,0.0825066905956246,0.2719749168806,0,0,11.6550116550117,29.0778075850932,DDC
beta,2,response to metal ion (GO:0010038),2/73,2,73,0.0839360142782621,0.2719749168806,0,0,4.151100041511,10.2851826699409,SLC30A8;PDCD6
beta,2,regulation of neuron death (GO:1901214),2/73,2,73,0.0839360142782621,0.2719749168806,0,0,4.151100041511,10.2851826699409,CHGA;HTRA2
beta,2,positive regulation of proteasomal protein catabolic process (GO:1901800),2/74,2,74,0.0859076697755576,0.2719749168806,0,0,4.0950040950041,10.0511145238275,RNF125;RNF217
beta,2,ncRNA transcription (GO:0098781),1/14,1,14,0.0885660740976256,0.2719749168806,0,0,10.8225108225108,26.2338355580325,SNAPC3
beta,2,regulation of fatty acid metabolic process (GO:0019217),1/14,1,14,0.0885660740976256,0.2719749168806,0,0,10.8225108225108,26.2338355580325,INS
beta,2,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),1/14,1,14,0.0885660740976256,0.2719749168806,0,0,10.8225108225108,26.2338355580325,PDCD10
beta,2,necroptotic process (GO:0070266),1/14,1,14,0.0885660740976256,0.2719749168806,0,0,10.8225108225108,26.2338355580325,DNM1L
beta,2,myeloid dendritic cell activation (GO:0001773),1/14,1,14,0.0885660740976256,0.2719749168806,0,0,10.8225108225108,26.2338355580325,DHRS2
beta,2,epiboly involved in wound healing (GO:0090505),1/14,1,14,0.0885660740976256,0.2719749168806,0,0,10.8225108225108,26.2338355580325,PDCD10
beta,2,stem cell development (GO:0048864),1/14,1,14,0.0885660740976256,0.2719749168806,0,0,10.8225108225108,26.2338355580325,PDCD6
beta,2,regulation of calcineurin-NFAT signaling cascade (GO:0070884),1/14,1,14,0.0885660740976256,0.2719749168806,0,0,10.8225108225108,26.2338355580325,RCAN3
beta,2,acyl-CoA biosynthetic process (GO:0071616),1/14,1,14,0.0885660740976256,0.2719749168806,0,0,10.8225108225108,26.2338355580325,SCD5
beta,2,modified amino acid transport (GO:0072337),1/14,1,14,0.0885660740976256,0.2719749168806,0,0,10.8225108225108,26.2338355580325,SLC16A12
beta,2,positive regulation of purine nucleotide metabolic process (GO:1900544),1/14,1,14,0.0885660740976256,0.2719749168806,0,0,10.8225108225108,26.2338355580325,CHGA
beta,2,positive regulation of mitochondrial fission (GO:0090141),1/14,1,14,0.0885660740976256,0.2719749168806,0,0,10.8225108225108,26.2338355580325,DNM1L
beta,2,amyloid-beta metabolic process (GO:0050435),1/14,1,14,0.0885660740976256,0.2719749168806,0,0,10.8225108225108,26.2338355580325,BACE1
beta,2,positive regulation of blood vessel diameter (GO:0097755),1/14,1,14,0.0885660740976256,0.2719749168806,0,0,10.8225108225108,26.2338355580325,INS
beta,2,response to ATP (GO:0033198),1/14,1,14,0.0885660740976256,0.2719749168806,0,0,10.8225108225108,26.2338355580325,KCNJ11
beta,2,transforming growth factor beta receptor signaling pathway (GO:0007179),2/77,2,77,0.0919053885607952,0.2719749168806,0,0,3.93545848091303,9.39392214204142,ID1;F11R
beta,2,positive regulation of JNK cascade (GO:0046330),2/77,2,77,0.0919053885607952,0.2719749168806,0,0,3.93545848091303,9.39392214204142,TNFRSF11A;ZNF622
beta,2,positive regulation of apoptotic signaling pathway (GO:2001235),2/77,2,77,0.0919053885607952,0.2719749168806,0,0,3.93545848091303,9.39392214204142,HTRA2;DNM1L
beta,2,atrioventricular valve morphogenesis (GO:0003181),1/15,1,15,0.0945857412496912,0.2719749168806,0,0,10.1010101010101,23.8206923336583,SMAD6
beta,2,neural crest cell differentiation (GO:0014033),1/15,1,15,0.0945857412496912,0.2719749168806,0,0,10.1010101010101,23.8206923336583,PDCD6
beta,2,membrane repolarization during cardiac muscle cell action potential (GO:0086013),1/15,1,15,0.0945857412496912,0.2719749168806,0,0,10.1010101010101,23.8206923336583,KCNJ8
beta,2,mesenchymal cell development (GO:0014031),1/15,1,15,0.0945857412496912,0.2719749168806,0,0,10.1010101010101,23.8206923336583,PDCD6
beta,2,regulation of delayed rectifier potassium channel activity (GO:1902259),1/15,1,15,0.0945857412496912,0.2719749168806,0,0,10.1010101010101,23.8206923336583,ANK3
beta,2,catecholamine metabolic process (GO:0006584),1/15,1,15,0.0945857412496912,0.2719749168806,0,0,10.1010101010101,23.8206923336583,DDC
beta,2,maintenance of protein location in nucleus (GO:0051457),1/15,1,15,0.0945857412496912,0.2719749168806,0,0,10.1010101010101,23.8206923336583,SYNE1
beta,2,embryonic axis specification (GO:0000578),1/15,1,15,0.0945857412496912,0.2719749168806,0,0,10.1010101010101,23.8206923336583,SMAD6
beta,2,positive regulation of glycolytic process (GO:0045821),1/15,1,15,0.0945857412496912,0.2719749168806,0,0,10.1010101010101,23.8206923336583,INS
beta,2,positive regulation of coenzyme metabolic process (GO:0051197),1/15,1,15,0.0945857412496912,0.2719749168806,0,0,10.1010101010101,23.8206923336583,INS
beta,2,negative regulation of insulin secretion (GO:0046676),1/15,1,15,0.0945857412496912,0.2719749168806,0,0,10.1010101010101,23.8206923336583,KCNJ11
beta,2,unsaturated fatty acid biosynthetic process (GO:0006636),1/15,1,15,0.0945857412496912,0.2719749168806,0,0,10.1010101010101,23.8206923336583,SCD5
beta,2,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),1/15,1,15,0.0945857412496912,0.2719749168806,0,0,10.1010101010101,23.8206923336583,HTRA2
beta,2,regulation of peptide secretion (GO:0002791),1/15,1,15,0.0945857412496912,0.2719749168806,0,0,10.1010101010101,23.8206923336583,INS
beta,2,negative regulation of lipid catabolic process (GO:0050995),1/15,1,15,0.0945857412496912,0.2719749168806,0,0,10.1010101010101,23.8206923336583,INS
beta,2,cellular biogenic amine biosynthetic process (GO:0042401),1/15,1,15,0.0945857412496912,0.2719749168806,0,0,10.1010101010101,23.8206923336583,DDC
beta,2,steroid biosynthetic process (GO:0006694),2/80,2,80,0.0980217214388774,0.273105571039504,0,0,3.78787878787879,8.79759915733418,CYP7B1;SLC27A2
beta,2,cell-cell junction assembly (GO:0007043),2/80,2,80,0.0980217214388774,0.273105571039504,0,0,3.78787878787879,8.79759915733418,EPB41L3;F11R
beta,2,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),2/81,2,81,0.100085658614016,0.273105571039504,0,0,3.74111485222596,8.61103207450216,INS-IGF2;INS
beta,2,cellular response to hormone stimulus (GO:0032870),2/81,2,81,0.100085658614016,0.273105571039504,0,0,3.74111485222596,8.61103207450216,LMO2;GCK
beta,2,positive regulation of cyclic nucleotide metabolic process (GO:0030801),1/16,1,16,0.100565950346677,0.273105571039504,0,0,9.46969696969697,21.751340382081,CHGA
beta,2,positive regulation of nitric-oxide synthase activity (GO:0051000),1/16,1,16,0.100565950346677,0.273105571039504,0,0,9.46969696969697,21.751340382081,INS
beta,2,negative regulation of peptide hormone secretion (GO:0090278),1/16,1,16,0.100565950346677,0.273105571039504,0,0,9.46969696969697,21.751340382081,KCNJ11
beta,2,mRNA transcription from RNA polymerase II promoter (GO:0042789),1/16,1,16,0.100565950346677,0.273105571039504,0,0,9.46969696969697,21.751340382081,LMO2
beta,2,odontogenesis of dentin-containing tooth (GO:0042475),1/16,1,16,0.100565950346677,0.273105571039504,0,0,9.46969696969697,21.751340382081,EDA
beta,2,regulation of reactive oxygen species biosynthetic process (GO:1903426),1/16,1,16,0.100565950346677,0.273105571039504,0,0,9.46969696969697,21.751340382081,INS
beta,2,stabilization of membrane potential (GO:0030322),1/16,1,16,0.100565950346677,0.273105571039504,0,0,9.46969696969697,21.751340382081,KCNK16
beta,2,ventricular cardiac muscle cell action potential (GO:0086005),1/16,1,16,0.100565950346677,0.273105571039504,0,0,9.46969696969697,21.751340382081,KCNJ8
beta,2,mitochondrial fusion (GO:0008053),1/16,1,16,0.100565950346677,0.273105571039504,0,0,9.46969696969697,21.751340382081,GDAP1
beta,2,endoplasmic reticulum to cytosol transport (GO:1903513),1/16,1,16,0.100565950346677,0.273105571039504,0,0,9.46969696969697,21.751340382081,AUP1
beta,2,linoleic acid metabolic process (GO:0043651),1/16,1,16,0.100565950346677,0.273105571039504,0,0,9.46969696969697,21.751340382081,GSTM2
beta,2,inner dynein arm assembly (GO:0036159),1/16,1,16,0.100565950346677,0.273105571039504,0,0,9.46969696969697,21.751340382081,DNAH7
beta,2,programmed necrotic cell death (GO:0097300),1/16,1,16,0.100565950346677,0.273105571039504,0,0,9.46969696969697,21.751340382081,DNM1L
beta,2,protein catabolic process (GO:0030163),2/82,2,82,0.102161756531471,0.273772573788536,0,0,3.69549150036955,8.43014735210553,BACE1;HTRA2
beta,2,negative regulation of cell death (GO:0060548),2/82,2,82,0.102161756531471,0.273772573788536,0,0,3.69549150036955,8.43014735210553,CHGA;HTRA2
beta,2,positive regulation of cell cycle (GO:0045787),2/83,2,83,0.104249767866684,0.273772573788536,0,0,3.65096750638919,8.25471210297254,CCNH;CCNC
beta,2,establishment of protein localization to membrane (GO:0090150),2/84,2,84,0.106349447963068,0.273772573788536,0,0,3.60750360750361,8.08450551264667,ZDHHC21;ANK3
beta,2,negative regulation of neuron death (GO:1901215),2/84,2,84,0.106349447963068,0.273772573788536,0,0,3.60750360750361,8.08450551264667,CHGA;HTRA2
beta,2,regulation of protein localization to membrane (GO:1905475),1/17,1,17,0.10650695802526,0.273772573788536,0,0,8.9126559714795,19.9602937824981,INS
beta,2,negative regulation of immune effector process (GO:0002698),1/17,1,17,0.10650695802526,0.273772573788536,0,0,8.9126559714795,19.9602937824981,INS
beta,2,response to purine-containing compound (GO:0014074),1/17,1,17,0.10650695802526,0.273772573788536,0,0,8.9126559714795,19.9602937824981,KCNJ11
beta,2,positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745),1/17,1,17,0.10650695802526,0.273772573788536,0,0,8.9126559714795,19.9602937824981,CHGA
beta,2,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),1/17,1,17,0.10650695802526,0.273772573788536,0,0,8.9126559714795,19.9602937824981,GSTM2
beta,2,positive regulation of response to biotic stimulus (GO:0002833),1/17,1,17,0.10650695802526,0.273772573788536,0,0,8.9126559714795,19.9602937824981,DDX60
beta,2,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),1/17,1,17,0.10650695802526,0.273772573788536,0,0,8.9126559714795,19.9602937824981,GSTM2
beta,2,positive regulation of dendrite extension (GO:1903861),1/17,1,17,0.10650695802526,0.273772573788536,0,0,8.9126559714795,19.9602937824981,SYT17
beta,2,positive regulation of hormone secretion (GO:0046887),1/17,1,17,0.10650695802526,0.273772573788536,0,0,8.9126559714795,19.9602937824981,INS
beta,2,positive regulation of cation transmembrane transport (GO:1904064),1/17,1,17,0.10650695802526,0.273772573788536,0,0,8.9126559714795,19.9602937824981,ANK3
beta,2,positive regulation of transcription of Notch receptor target (GO:0007221),1/17,1,17,0.10650695802526,0.273772573788536,0,0,8.9126559714795,19.9602937824981,WWC1
beta,2,negative regulation of reactive oxygen species metabolic process (GO:2000378),1/17,1,17,0.10650695802526,0.273772573788536,0,0,8.9126559714795,19.9602937824981,INS
beta,2,regulation of neuron differentiation (GO:0045664),2/85,2,85,0.10846055485075,0.273772573788536,0,0,3.5650623885918,7.91931808151349,NEUROD1;ID1
beta,2,membrane lipid metabolic process (GO:0006643),1/18,1,18,0.112409019277768,0.273772573788536,0,0,8.41750841750842,18.3973998489651,MGST2
beta,2,"retrograde protein transport, ER to cytosol (GO:0030970)",1/18,1,18,0.112409019277768,0.273772573788536,0,0,8.41750841750842,18.3973998489651,AUP1
beta,2,membrane protein ectodomain proteolysis (GO:0006509),1/18,1,18,0.112409019277768,0.273772573788536,0,0,8.41750841750842,18.3973998489651,BACE1
beta,2,regulation of lipid catabolic process (GO:0050994),1/18,1,18,0.112409019277768,0.273772573788536,0,0,8.41750841750842,18.3973998489651,INS
beta,2,release of cytochrome c from mitochondria (GO:0001836),1/18,1,18,0.112409019277768,0.273772573788536,0,0,8.41750841750842,18.3973998489651,DNM1L
beta,2,acute-phase response (GO:0006953),1/18,1,18,0.112409019277768,0.273772573788536,0,0,8.41750841750842,18.3973998489651,INS
beta,2,leukotriene biosynthetic process (GO:0019370),1/18,1,18,0.112409019277768,0.273772573788536,0,0,8.41750841750842,18.3973998489651,MGST2
beta,2,protein mannosylation (GO:0035268),1/18,1,18,0.112409019277768,0.273772573788536,0,0,8.41750841750842,18.3973998489651,DPY19L2
beta,2,blood vessel endothelial cell migration (GO:0043534),1/18,1,18,0.112409019277768,0.273772573788536,0,0,8.41750841750842,18.3973998489651,ID1
beta,2,negative regulation of protein transport (GO:0051224),1/18,1,18,0.112409019277768,0.273772573788536,0,0,8.41750841750842,18.3973998489651,INS
beta,2,positive regulation of carbohydrate metabolic process (GO:0045913),1/18,1,18,0.112409019277768,0.273772573788536,0,0,8.41750841750842,18.3973998489651,INS
beta,2,regulation of dendrite extension (GO:1903859),1/18,1,18,0.112409019277768,0.273772573788536,0,0,8.41750841750842,18.3973998489651,SYT17
beta,2,positive regulation of metabolic process (GO:0009893),1/18,1,18,0.112409019277768,0.273772573788536,0,0,8.41750841750842,18.3973998489651,INS
beta,2,anion homeostasis (GO:0055081),1/18,1,18,0.112409019277768,0.273772573788536,0,0,8.41750841750842,18.3973998489651,INS
beta,2,snRNA metabolic process (GO:0016073),1/18,1,18,0.112409019277768,0.273772573788536,0,0,8.41750841750842,18.3973998489651,SNAPC3
beta,2,response to organophosphorus (GO:0046683),1/18,1,18,0.112409019277768,0.273772573788536,0,0,8.41750841750842,18.3973998489651,KCNJ11
beta,2,negative regulation of calcium-mediated signaling (GO:0050849),1/18,1,18,0.112409019277768,0.273772573788536,0,0,8.41750841750842,18.3973998489651,GSTM2
beta,2,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),2/89,2,89,0.117014502665952,0.273772573788536,0,0,3.40483486550902,7.30492814932329,RNF125;RNF217
beta,2,histone deubiquitination (GO:0016578),1/19,1,19,0.118272387473026,0.273772573788536,0,0,7.97448165869218,17.0236439098115,USP51
beta,2,fatty-acyl-CoA metabolic process (GO:0035337),1/19,1,19,0.118272387473026,0.273772573788536,0,0,7.97448165869218,17.0236439098115,SCD5
beta,2,organelle fusion (GO:0048284),1/19,1,19,0.118272387473026,0.273772573788536,0,0,7.97448165869218,17.0236439098115,GDAP1
beta,2,positive regulation of heart contraction (GO:0045823),1/19,1,19,0.118272387473026,0.273772573788536,0,0,7.97448165869218,17.0236439098115,CHGA
beta,2,regulation of long-term synaptic potentiation (GO:1900271),1/19,1,19,0.118272387473026,0.273772573788536,0,0,7.97448165869218,17.0236439098115,INS
beta,2,protein exit from endoplasmic reticulum (GO:0032527),1/19,1,19,0.118272387473026,0.273772573788536,0,0,7.97448165869218,17.0236439098115,AUP1
beta,2,DNA double-strand break processing (GO:0000729),1/19,1,19,0.118272387473026,0.273772573788536,0,0,7.97448165869218,17.0236439098115,SMARCAD1
beta,2,aspartate family amino acid catabolic process (GO:0009068),1/19,1,19,0.118272387473026,0.273772573788536,0,0,7.97448165869218,17.0236439098115,SLC25A21
beta,2,Rac protein signal transduction (GO:0016601),1/19,1,19,0.118272387473026,0.273772573788536,0,0,7.97448165869218,17.0236439098115,HACE1
beta,2,drug transport (GO:0015893),1/19,1,19,0.118272387473026,0.273772573788536,0,0,7.97448165869218,17.0236439098115,ATP8B1
beta,2,negative regulation of lipid metabolic process (GO:0045833),1/19,1,19,0.118272387473026,0.273772573788536,0,0,7.97448165869218,17.0236439098115,INS
beta,2,regulation of mitochondrial fission (GO:0090140),1/19,1,19,0.118272387473026,0.273772573788536,0,0,7.97448165869218,17.0236439098115,DNM1L
beta,2,osteoclast differentiation (GO:0030316),1/19,1,19,0.118272387473026,0.273772573788536,0,0,7.97448165869218,17.0236439098115,TNFRSF11A
beta,2,leukotriene metabolic process (GO:0006691),1/19,1,19,0.118272387473026,0.273772573788536,0,0,7.97448165869218,17.0236439098115,MGST2
beta,2,positive regulation of transcription regulatory region DNA binding (GO:2000679),1/19,1,19,0.118272387473026,0.273772573788536,0,0,7.97448165869218,17.0236439098115,NEUROD1
beta,2,gamma-aminobutyric acid signaling pathway (GO:0007214),1/19,1,19,0.118272387473026,0.273772573788536,0,0,7.97448165869218,17.0236439098115,GABBR1
beta,2,response to interferon-beta (GO:0035456),1/19,1,19,0.118272387473026,0.273772573788536,0,0,7.97448165869218,17.0236439098115,HTRA2
beta,2,regulation of cell cycle process (GO:0010564),2/91,2,91,0.12135393778086,0.278715859880231,0,0,3.33000333000333,7.02312320198314,NEUROD1;USP51
beta,2,positive regulation of response to external stimulus (GO:0032103),2/91,2,91,0.12135393778086,0.278715859880231,0,0,3.33000333000333,7.02312320198314,MGST2;DDX60
beta,2,protein-DNA complex assembly (GO:0065004),2/92,2,92,0.123538475701956,0.278715859880231,0,0,3.29380764163373,6.88801919396745,CCNH;HIST1H2BD
beta,2,negative regulation of innate immune response (GO:0045824),1/20,1,20,0.124097314266769,0.278715859880231,0,0,7.57575757575758,15.8082517325132,INS
beta,2,"wound healing, spreading of cells (GO:0044319)",1/20,1,20,0.124097314266769,0.278715859880231,0,0,7.57575757575758,15.8082517325132,PDCD10
beta,2,negative regulation of cyclase activity (GO:0031280),1/20,1,20,0.124097314266769,0.278715859880231,0,0,7.57575757575758,15.8082517325132,GABBR1
beta,2,neuromuscular junction development (GO:0007528),1/20,1,20,0.124097314266769,0.278715859880231,0,0,7.57575757575758,15.8082517325132,ANK3
beta,2,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),1/20,1,20,0.124097314266769,0.278715859880231,0,0,7.57575757575758,15.8082517325132,CHGA
beta,2,negative regulation of adenylate cyclase activity (GO:0007194),1/20,1,20,0.124097314266769,0.278715859880231,0,0,7.57575757575758,15.8082517325132,GABBR1
beta,2,cellular response to estradiol stimulus (GO:0071392),1/20,1,20,0.124097314266769,0.278715859880231,0,0,7.57575757575758,15.8082517325132,SSTR1
beta,2,regulation of cell development (GO:0060284),1/20,1,20,0.124097314266769,0.278715859880231,0,0,7.57575757575758,15.8082517325132,INS
beta,2,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),2/94,2,94,0.127936084716426,0.283712110315348,0,0,3.22372662798195,6.62870560259914,PDCD6;HTRA2
beta,2,mRNA transcription (GO:0009299),1/21,1,21,0.129884049827347,0.283712110315348,0,0,7.21500721500722,14.7266461106265,LMO2
beta,2,dendritic cell differentiation (GO:0097028),1/21,1,21,0.129884049827347,0.283712110315348,0,0,7.21500721500722,14.7266461106265,DHRS2
beta,2,cellular response to alkaloid (GO:0071312),1/21,1,21,0.129884049827347,0.283712110315348,0,0,7.21500721500722,14.7266461106265,GSTM2
beta,2,negative regulation of cAMP biosynthetic process (GO:0030818),1/21,1,21,0.129884049827347,0.283712110315348,0,0,7.21500721500722,14.7266461106265,GABBR1
beta,2,positive regulation of lipid metabolic process (GO:0045834),1/21,1,21,0.129884049827347,0.283712110315348,0,0,7.21500721500722,14.7266461106265,INS
beta,2,zinc II ion transport (GO:0006829),1/21,1,21,0.129884049827347,0.283712110315348,0,0,7.21500721500722,14.7266461106265,SLC30A8
beta,2,protein O-linked glycosylation via threonine (GO:0018243),1/21,1,21,0.129884049827347,0.283712110315348,0,0,7.21500721500722,14.7266461106265,GALNT14
beta,2,establishment of endothelial barrier (GO:0061028),1/21,1,21,0.129884049827347,0.283712110315348,0,0,7.21500721500722,14.7266461106265,F11R
beta,2,axon development (GO:0061564),2/95,2,95,0.130148720158944,0.283712110315348,0,0,3.18979266347687,6.50423438971187,LRRN1;ANK3
beta,2,vesicle fusion (GO:0006906),2/95,2,95,0.130148720158944,0.283712110315348,0,0,3.18979266347687,6.50423438971187,SNAP47;SYT17
beta,2,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),1/22,1,22,0.135632842593002,0.283712110315348,0,0,6.8870523415978,13.7589788621813,PDCD6
beta,2,positive regulation of protein autophosphorylation (GO:0031954),1/22,1,22,0.135632842593002,0.283712110315348,0,0,6.8870523415978,13.7589788621813,INS
beta,2,protein O-linked glycosylation via serine (GO:0018242),1/22,1,22,0.135632842593002,0.283712110315348,0,0,6.8870523415978,13.7589788621813,GALNT14
beta,2,positive regulation of biosynthetic process (GO:0009891),1/22,1,22,0.135632842593002,0.283712110315348,0,0,6.8870523415978,13.7589788621813,INS
beta,2,protein homotrimerization (GO:0070207),1/22,1,22,0.135632842593002,0.283712110315348,0,0,6.8870523415978,13.7589788621813,HTRA2
beta,2,regulation of catecholamine secretion (GO:0050433),1/22,1,22,0.135632842593002,0.283712110315348,0,0,6.8870523415978,13.7589788621813,CHGA
beta,2,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),1/22,1,22,0.135632842593002,0.283712110315348,0,0,6.8870523415978,13.7589788621813,ZDHHC21
beta,2,peptidyl-L-cysteine S-palmitoylation (GO:0018230),1/22,1,22,0.135632842593002,0.283712110315348,0,0,6.8870523415978,13.7589788621813,ZDHHC21
beta,2,positive regulation of protein targeting to membrane (GO:0090314),1/22,1,22,0.135632842593002,0.283712110315348,0,0,6.8870523415978,13.7589788621813,ANK3
beta,2,C21-steroid hormone metabolic process (GO:0008207),1/22,1,22,0.135632842593002,0.283712110315348,0,0,6.8870523415978,13.7589788621813,DHRS2
beta,2,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),1/22,1,22,0.135632842593002,0.283712110315348,0,0,6.8870523415978,13.7589788621813,GSTM2
beta,2,outflow tract septum morphogenesis (GO:0003148),1/22,1,22,0.135632842593002,0.283712110315348,0,0,6.8870523415978,13.7589788621813,SMAD6
beta,2,negative regulation of GTPase activity (GO:0034260),1/22,1,22,0.135632842593002,0.283712110315348,0,0,6.8870523415978,13.7589788621813,F11R
beta,2,peripheral nervous system development (GO:0007422),1/22,1,22,0.135632842593002,0.283712110315348,0,0,6.8870523415978,13.7589788621813,SERPINI1
beta,2,negative regulation of lyase activity (GO:0051350),1/22,1,22,0.135632842593002,0.283712110315348,0,0,6.8870523415978,13.7589788621813,GABBR1
beta,2,negative regulation of sprouting angiogenesis (GO:1903671),1/22,1,22,0.135632842593002,0.283712110315348,0,0,6.8870523415978,13.7589788621813,PDCD10
beta,2,cell morphogenesis involved in neuron differentiation (GO:0048667),2/98,2,98,0.136839386833509,0.283712110315348,0,0,3.09214594928881,6.15011564558986,LRRN1;ANK3
beta,2,positive regulation of neuron projection development (GO:0010976),2/98,2,98,0.136839386833509,0.283712110315348,0,0,3.09214594928881,6.15011564558986,SERPINI1;SYT17
beta,2,positive regulation of cell growth (GO:0030307),2/99,2,99,0.13908649766743,0.283712110315348,0,0,3.06091215182124,6.03813668201259,INS;SYT17
beta,2,positive regulation of neuron differentiation (GO:0045666),2/99,2,99,0.13908649766743,0.283712110315348,0,0,3.06091215182124,6.03813668201259,NEUROD1;SERPINI1
beta,2,steroid metabolic process (GO:0008202),2/100,2,100,0.141341709574619,0.283712110315348,0,0,3.03030303030303,5.92901469186755,CYP7B1;DHRS2
beta,2,positive regulation of ATP metabolic process (GO:1903580),1/23,1,23,0.141343939435083,0.283712110315348,0,0,6.58761528326746,12.8890584457255,INS
beta,2,neuronal action potential (GO:0019228),1/23,1,23,0.141343939435083,0.283712110315348,0,0,6.58761528326746,12.8890584457255,ANK3
beta,2,glycolytic process (GO:0006096),1/23,1,23,0.141343939435083,0.283712110315348,0,0,6.58761528326746,12.8890584457255,GCK
beta,2,zinc II ion transmembrane transport (GO:0071577),1/23,1,23,0.141343939435083,0.283712110315348,0,0,6.58761528326746,12.8890584457255,SLC30A8
beta,2,divalent inorganic cation homeostasis (GO:0072507),1/23,1,23,0.141343939435083,0.283712110315348,0,0,6.58761528326746,12.8890584457255,ANK3
beta,2,regulation of monooxygenase activity (GO:0032768),1/23,1,23,0.141343939435083,0.283712110315348,0,0,6.58761528326746,12.8890584457255,ZDHHC21
beta,2,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),1/23,1,23,0.141343939435083,0.283712110315348,0,0,6.58761528326746,12.8890584457255,GSTM2
beta,2,positive regulation of ion transmembrane transporter activity (GO:0032414),1/23,1,23,0.141343939435083,0.283712110315348,0,0,6.58761528326746,12.8890584457255,ANK3
beta,2,positive regulation of monooxygenase activity (GO:0032770),1/23,1,23,0.141343939435083,0.283712110315348,0,0,6.58761528326746,12.8890584457255,INS
beta,2,membrane assembly (GO:0071709),1/23,1,23,0.141343939435083,0.283712110315348,0,0,6.58761528326746,12.8890584457255,ANK3
beta,2,peroxisome organization (GO:0007031),1/23,1,23,0.141343939435083,0.283712110315348,0,0,6.58761528326746,12.8890584457255,DNM1L
beta,2,regulation of ion homeostasis (GO:2000021),1/23,1,23,0.141343939435083,0.283712110315348,0,0,6.58761528326746,12.8890584457255,SLC30A8
beta,2,cellular response to transforming growth factor beta stimulus (GO:0071560),2/101,2,101,0.143604820065053,0.287555675841107,0,0,3.000300030003,5.82265243629975,ID1;F11R
beta,2,protein processing (GO:0016485),2/102,2,102,0.145875628974334,0.290701792992019,0,0,2.9708853238265,5.71895685279196,PROS1;HTRA2
beta,2,intrinsic apoptotic signaling pathway (GO:0097193),2/102,2,102,0.145875628974334,0.290701792992019,0,0,2.9708853238265,5.71895685279196,HTRA2;ZNF622
beta,2,positive regulation of angiogenesis (GO:0045766),2/104,2,104,0.150439552547426,0.295164007073006,0,0,2.91375291375291,5.5192130526719,PDCD6;GAB1
beta,2,cilium-dependent cell motility (GO:0060285),1/25,1,25,0.152654025012426,0.295164007073006,0,0,6.06060606060606,11.3914011670309,DNAH7
beta,2,positive regulation of immune effector process (GO:0002699),1/25,1,25,0.152654025012426,0.295164007073006,0,0,6.06060606060606,11.3914011670309,DDX60
beta,2,cellular lipid catabolic process (GO:0044242),1/25,1,25,0.152654025012426,0.295164007073006,0,0,6.06060606060606,11.3914011670309,MGST2
beta,2,Golgi to plasma membrane protein transport (GO:0043001),1/25,1,25,0.152654025012426,0.295164007073006,0,0,6.06060606060606,11.3914011670309,ANK3
beta,2,cellular modified amino acid biosynthetic process (GO:0042398),1/25,1,25,0.152654025012426,0.295164007073006,0,0,6.06060606060606,11.3914011670309,MGST2
beta,2,negative regulation of developmental growth (GO:0048640),1/25,1,25,0.152654025012426,0.295164007073006,0,0,6.06060606060606,11.3914011670309,WWC1
beta,2,regulation of neuronal synaptic plasticity (GO:0048168),1/25,1,25,0.152654025012426,0.295164007073006,0,0,6.06060606060606,11.3914011670309,MCTP1
beta,2,ATP generation from ADP (GO:0006757),1/25,1,25,0.152654025012426,0.295164007073006,0,0,6.06060606060606,11.3914011670309,GCK
beta,2,mRNA splice site selection (GO:0006376),1/25,1,25,0.152654025012426,0.295164007073006,0,0,6.06060606060606,11.3914011670309,YTHDC1
beta,2,fatty acid derivative biosynthetic process (GO:1901570),1/25,1,25,0.152654025012426,0.295164007073006,0,0,6.06060606060606,11.3914011670309,SCD5
beta,2,axoneme assembly (GO:0035082),1/25,1,25,0.152654025012426,0.295164007073006,0,0,6.06060606060606,11.3914011670309,TTLL3
beta,2,positive regulation of vasculature development (GO:1904018),2/105,2,105,0.15273227802815,0.295164007073006,0,0,2.88600288600289,5.42299771173697,PDCD6;GAB1
beta,2,glycolytic process through glucose-6-phosphate (GO:0061620),1/26,1,26,0.158253499582407,0.299564141578542,0,0,5.82750582750583,10.7433397665359,GCK
beta,2,cellular response to vascular endothelial growth factor stimulus (GO:0035924),1/26,1,26,0.158253499582407,0.299564141578542,0,0,5.82750582750583,10.7433397665359,GAB1
beta,2,signal peptide processing (GO:0006465),1/26,1,26,0.158253499582407,0.299564141578542,0,0,5.82750582750583,10.7433397665359,PROS1
beta,2,canonical glycolysis (GO:0061621),1/26,1,26,0.158253499582407,0.299564141578542,0,0,5.82750582750583,10.7433397665359,GCK
beta,2,long-chain fatty acid transport (GO:0015909),1/26,1,26,0.158253499582407,0.299564141578542,0,0,5.82750582750583,10.7433397665359,SLC27A2
beta,2,glucose catabolic process to pyruvate (GO:0061718),1/26,1,26,0.158253499582407,0.299564141578542,0,0,5.82750582750583,10.7433397665359,GCK
beta,2,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),1/26,1,26,0.158253499582407,0.299564141578542,0,0,5.82750582750583,10.7433397665359,GSTM2
beta,2,positive regulation of nuclear division (GO:0051785),1/26,1,26,0.158253499582407,0.299564141578542,0,0,5.82750582750583,10.7433397665359,INS
beta,2,positive regulation of glucose transport (GO:0010828),1/26,1,26,0.158253499582407,0.299564141578542,0,0,5.82750582750583,10.7433397665359,INS
beta,2,positive regulation of glucose import (GO:0046326),1/27,1,27,0.16381624996852,0.306602035414055,0,0,5.61167227833894,10.1515707425744,INS
beta,2,response to growth factor (GO:0070848),1/27,1,27,0.16381624996852,0.306602035414055,0,0,5.61167227833894,10.1515707425744,HTRA2
beta,2,regulation of transcription regulatory region DNA binding (GO:2000677),1/27,1,27,0.16381624996852,0.306602035414055,0,0,5.61167227833894,10.1515707425744,NEUROD1
beta,2,positive regulation of release of cytochrome c from mitochondria (GO:0090200),1/27,1,27,0.16381624996852,0.306602035414055,0,0,5.61167227833894,10.1515707425744,DNM1L
beta,2,positive regulation of cAMP metabolic process (GO:0030816),1/27,1,27,0.16381624996852,0.306602035414055,0,0,5.61167227833894,10.1515707425744,CHGA
beta,2,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),2/110,2,110,0.16429595665974,0.306808853897177,0,0,2.75482093663912,4.97544315079379,PDCD6;HTRA2
beta,2,regulation of double-strand break repair via homologous recombination (GO:0010569),1/28,1,28,0.169342515145925,0.310648190035902,0,0,5.41125541125541,9.60947996882624,USP51
beta,2,regulation of protein transport (GO:0051223),1/28,1,28,0.169342515145925,0.310648190035902,0,0,5.41125541125541,9.60947996882624,INS
beta,2,regulation of protein localization to nucleus (GO:1900180),1/28,1,28,0.169342515145925,0.310648190035902,0,0,5.41125541125541,9.60947996882624,INS
beta,2,regulation of neurotransmitter secretion (GO:0046928),1/28,1,28,0.169342515145925,0.310648190035902,0,0,5.41125541125541,9.60947996882624,MCTP1
beta,2,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),1/28,1,28,0.169342515145925,0.310648190035902,0,0,5.41125541125541,9.60947996882624,HTRA2
beta,2,regulation of protein targeting to membrane (GO:0090313),1/28,1,28,0.169342515145925,0.310648190035902,0,0,5.41125541125541,9.60947996882624,ANK3
beta,2,transition metal ion transport (GO:0000041),1/28,1,28,0.169342515145925,0.310648190035902,0,0,5.41125541125541,9.60947996882624,SLC30A8
beta,2,transcription from RNA polymerase III promoter (GO:0006383),1/28,1,28,0.169342515145925,0.310648190035902,0,0,5.41125541125541,9.60947996882624,SNAPC3
beta,2,negative regulation of endocytosis (GO:0045806),1/29,1,29,0.174832532629676,0.312442655086582,0,0,5.22466039707419,9.11142486747951,MCTP1
beta,2,positive regulation of cell communication (GO:0010647),1/29,1,29,0.174832532629676,0.312442655086582,0,0,5.22466039707419,9.11142486747951,ANK3
beta,2,positive regulation of calcium-mediated signaling (GO:0050850),1/29,1,29,0.174832532629676,0.312442655086582,0,0,5.22466039707419,9.11142486747951,GSTM2
beta,2,acute inflammatory response (GO:0002526),1/29,1,29,0.174832532629676,0.312442655086582,0,0,5.22466039707419,9.11142486747951,INS
beta,2,regulation of lipid biosynthetic process (GO:0046890),1/29,1,29,0.174832532629676,0.312442655086582,0,0,5.22466039707419,9.11142486747951,INS
beta,2,regulation of mRNA processing (GO:0050684),1/29,1,29,0.174832532629676,0.312442655086582,0,0,5.22466039707419,9.11142486747951,YTHDC1
beta,2,positive regulation of lipid biosynthetic process (GO:0046889),1/29,1,29,0.174832532629676,0.312442655086582,0,0,5.22466039707419,9.11142486747951,INS
beta,2,regulation of adenylate cyclase activity (GO:0045761),1/29,1,29,0.174832532629676,0.312442655086582,0,0,5.22466039707419,9.11142486747951,GABBR1
beta,2,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),1/29,1,29,0.174832532629676,0.312442655086582,0,0,5.22466039707419,9.11142486747951,HTRA2
beta,2,primary neural tube formation (GO:0014020),1/29,1,29,0.174832532629676,0.312442655086582,0,0,5.22466039707419,9.11142486747951,SEMA4C
beta,2,bicellular tight junction assembly (GO:0070830),1/29,1,29,0.174832532629676,0.312442655086582,0,0,5.22466039707419,9.11142486747951,F11R
beta,2,transcription elongation from RNA polymerase I promoter (GO:0006362),1/29,1,29,0.174832532629676,0.312442655086582,0,0,5.22466039707419,9.11142486747951,CCNH
beta,2,cellular response to oxidative stress (GO:0034599),2/116,2,116,0.178368434769962,0.316071969165063,0,0,2.6123301985371,4.50340650375405,HTRA2;DHRS2
beta,2,dicarboxylic acid transport (GO:0006835),1/30,1,30,0.18028653836852,0.316071969165063,0,0,5.05050505050505,8.65256471699222,SLC25A21
beta,2,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",1/30,1,30,0.18028653836852,0.316071969165063,0,0,5.05050505050505,8.65256471699222,CCNH
beta,2,synaptic vesicle endocytosis (GO:0048488),1/30,1,30,0.18028653836852,0.316071969165063,0,0,5.05050505050505,8.65256471699222,SYT17
beta,2,tube closure (GO:0060606),1/30,1,30,0.18028653836852,0.316071969165063,0,0,5.05050505050505,8.65256471699222,SEMA4C
beta,2,negative regulation of epithelial cell apoptotic process (GO:1904036),1/30,1,30,0.18028653836852,0.316071969165063,0,0,5.05050505050505,8.65256471699222,NEUROD1
beta,2,cortical cytoskeleton organization (GO:0030865),1/30,1,30,0.18028653836852,0.316071969165063,0,0,5.05050505050505,8.65256471699222,EPB41L3
beta,2,synaptic vesicle recycling (GO:0036465),1/30,1,30,0.18028653836852,0.316071969165063,0,0,5.05050505050505,8.65256471699222,SYT17
beta,2,lysosome localization (GO:0032418),1/30,1,30,0.18028653836852,0.316071969165063,0,0,5.05050505050505,8.65256471699222,CHGA
beta,2,activation of MAPK activity (GO:0000187),2/118,2,118,0.183100726650835,0.317532224658397,0,0,2.56805341551104,4.3598327136841,INS-IGF2;INS
beta,2,regulation of actin cytoskeleton reorganization (GO:2000249),1/31,1,31,0.185704766767727,0.317532224658397,0,0,4.88758553274682,8.22872503307691,F11R
beta,2,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),1/31,1,31,0.185704766767727,0.317532224658397,0,0,4.88758553274682,8.22872503307691,PDCD10
beta,2,negative regulation of cation channel activity (GO:2001258),1/31,1,31,0.185704766767727,0.317532224658397,0,0,4.88758553274682,8.22872503307691,GSTM2
beta,2,negative regulation of endothelial cell proliferation (GO:0001937),1/31,1,31,0.185704766767727,0.317532224658397,0,0,4.88758553274682,8.22872503307691,PDCD10
beta,2,hippo signaling (GO:0035329),1/31,1,31,0.185704766767727,0.317532224658397,0,0,4.88758553274682,8.22872503307691,WWC1
beta,2,bile acid and bile salt transport (GO:0015721),1/31,1,31,0.185704766767727,0.317532224658397,0,0,4.88758553274682,8.22872503307691,ATP8B1
beta,2,response to estradiol (GO:0032355),1/31,1,31,0.185704766767727,0.317532224658397,0,0,4.88758553274682,8.22872503307691,SSTR1
beta,2,ATP-dependent chromatin remodeling (GO:0043044),1/31,1,31,0.185704766767727,0.317532224658397,0,0,4.88758553274682,8.22872503307691,SMARCAD1
beta,2,activation of protein kinase B activity (GO:0032148),1/31,1,31,0.185704766767727,0.317532224658397,0,0,4.88758553274682,8.22872503307691,INS
beta,2,protein palmitoylation (GO:0018345),1/31,1,31,0.185704766767727,0.317532224658397,0,0,4.88758553274682,8.22872503307691,ZDHHC21
beta,2,fatty-acyl-CoA biosynthetic process (GO:0046949),1/31,1,31,0.185704766767727,0.317532224658397,0,0,4.88758553274682,8.22872503307691,SCD5
beta,2,cellular zinc ion homeostasis (GO:0006882),1/32,1,32,0.191087450743381,0.320558026804322,0,0,4.73484848484849,7.83628834481529,SLC30A8
beta,2,negative regulation of blood vessel endothelial cell migration (GO:0043537),1/32,1,32,0.191087450743381,0.320558026804322,0,0,4.73484848484849,7.83628834481529,PDCD10
beta,2,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),1/32,1,32,0.191087450743381,0.320558026804322,0,0,4.73484848484849,7.83628834481529,GSTM2
beta,2,regulation of glucose import (GO:0046324),1/32,1,32,0.191087450743381,0.320558026804322,0,0,4.73484848484849,7.83628834481529,INS
beta,2,termination of RNA polymerase I transcription (GO:0006363),1/32,1,32,0.191087450743381,0.320558026804322,0,0,4.73484848484849,7.83628834481529,CCNH
beta,2,regulation of cytokine secretion (GO:0050707),1/32,1,32,0.191087450743381,0.320558026804322,0,0,4.73484848484849,7.83628834481529,INS
beta,2,sarcomere organization (GO:0045214),1/32,1,32,0.191087450743381,0.320558026804322,0,0,4.73484848484849,7.83628834481529,MYBPHL
beta,2,zinc ion homeostasis (GO:0055069),1/32,1,32,0.191087450743381,0.320558026804322,0,0,4.73484848484849,7.83628834481529,SLC30A8
beta,2,regulation of protein autophosphorylation (GO:0031952),1/32,1,32,0.191087450743381,0.320558026804322,0,0,4.73484848484849,7.83628834481529,INS
beta,2,regulation of acute inflammatory response (GO:0002673),2/122,2,122,0.192619520061024,0.320558026804322,0,0,2.48385494287134,4.09100455660403,PROS1;INS
beta,2,regulation of cell differentiation (GO:0045595),2/122,2,122,0.192619520061024,0.320558026804322,0,0,2.48385494287134,4.09100455660403,NEUROD1;INS
beta,2,sulfur compound biosynthetic process (GO:0044272),2/123,2,123,0.19500957787576,0.320558026804322,0,0,2.46366100024637,4.02736290789115,GSTM2;MGST2
beta,2,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),1/33,1,33,0.196434821701777,0.320558026804322,0,0,4.59136822773187,7.47210559628249,GSTM2
beta,2,7-methylguanosine mRNA capping (GO:0006370),1/33,1,33,0.196434821701777,0.320558026804322,0,0,4.59136822773187,7.47210559628249,CCNH
beta,2,response to zinc ion (GO:0010043),1/33,1,33,0.196434821701777,0.320558026804322,0,0,4.59136822773187,7.47210559628249,SLC30A8
beta,2,negative regulation of fat cell differentiation (GO:0045599),1/33,1,33,0.196434821701777,0.320558026804322,0,0,4.59136822773187,7.47210559628249,RUNX1T1
beta,2,protein trimerization (GO:0070206),1/33,1,33,0.196434821701777,0.320558026804322,0,0,4.59136822773187,7.47210559628249,HTRA2
beta,2,microtubule bundle formation (GO:0001578),1/33,1,33,0.196434821701777,0.320558026804322,0,0,4.59136822773187,7.47210559628249,TTLL3
beta,2,negative regulation of BMP signaling pathway (GO:0030514),1/33,1,33,0.196434821701777,0.320558026804322,0,0,4.59136822773187,7.47210559628249,SMAD6
beta,2,7-methylguanosine RNA capping (GO:0009452),1/33,1,33,0.196434821701777,0.320558026804322,0,0,4.59136822773187,7.47210559628249,CCNH
beta,2,negative regulation of receptor activity (GO:2000272),1/33,1,33,0.196434821701777,0.320558026804322,0,0,4.59136822773187,7.47210559628249,GSTM2
beta,2,tumor necrosis factor-mediated signaling pathway (GO:0033209),2/124,2,124,0.197403466701643,0.320558026804322,0,0,2.44379276637341,3.96506742503714,EDA;TNFRSF11A
beta,2,organic anion transport (GO:0015711),2/125,2,125,0.199801033418125,0.320558026804322,0,0,2.42424242424242,3.90408058307436,SLCO4C1;SLC4A4
beta,2,axonemal dynein complex assembly (GO:0070286),1/34,1,34,0.201747109529074,0.320558026804322,0,0,4.45632798573975,7.13342379201492,DNAH7
beta,2,transcription from RNA polymerase I promoter (GO:0006360),1/34,1,34,0.201747109529074,0.320558026804322,0,0,4.45632798573975,7.13342379201492,CCNH
beta,2,activation of MAPKK activity (GO:0000186),1/34,1,34,0.201747109529074,0.320558026804322,0,0,4.45632798573975,7.13342379201492,MAP3K7CL
beta,2,positive regulation of cell-cell adhesion (GO:0022409),1/34,1,34,0.201747109529074,0.320558026804322,0,0,4.45632798573975,7.13342379201492,ANK3
beta,2,negative regulation of neurogenesis (GO:0050768),1/34,1,34,0.201747109529074,0.320558026804322,0,0,4.45632798573975,7.13342379201492,ID1
beta,2,oligosaccharide biosynthetic process (GO:0009312),1/34,1,34,0.201747109529074,0.320558026804322,0,0,4.45632798573975,7.13342379201492,GALNT14
beta,2,neural tube closure (GO:0001843),1/34,1,34,0.201747109529074,0.320558026804322,0,0,4.45632798573975,7.13342379201492,SEMA4C
beta,2,positive regulation of Notch signaling pathway (GO:0045747),1/34,1,34,0.201747109529074,0.320558026804322,0,0,4.45632798573975,7.13342379201492,PDCD10
beta,2,cellular glucose homeostasis (GO:0001678),1/34,1,34,0.201747109529074,0.320558026804322,0,0,4.45632798573975,7.13342379201492,GCK
beta,2,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),1/34,1,34,0.201747109529074,0.320558026804322,0,0,4.45632798573975,7.13342379201492,DNM1L
beta,2,regulation of intracellular protein transport (GO:0033157),1/34,1,34,0.201747109529074,0.320558026804322,0,0,4.45632798573975,7.13342379201492,PDCD10
beta,2,positive regulation of organelle organization (GO:0010638),1/34,1,34,0.201747109529074,0.320558026804322,0,0,4.45632798573975,7.13342379201492,HTRA2
beta,2,embryonic organ morphogenesis (GO:0048562),1/34,1,34,0.201747109529074,0.320558026804322,0,0,4.45632798573975,7.13342379201492,NEUROD1
beta,2,transcription initiation from RNA polymerase I promoter (GO:0006361),1/34,1,34,0.201747109529074,0.320558026804322,0,0,4.45632798573975,7.13342379201492,CCNH
beta,2,vesicle organization (GO:0016050),2/128,2,128,0.207014296758252,0.323378561957841,0,0,2.36742424242424,3.72861605501127,SNAP47;SYT17
beta,2,positive regulation of protein kinase B signaling (GO:0051897),2/128,2,128,0.207014296758252,0.323378561957841,0,0,2.36742424242424,3.72861605501127,GAB1;INS
beta,2,regulation of double-strand break repair (GO:2000779),1/35,1,35,0.207024542673371,0.323378561957841,0,0,4.32900432900433,6.81782653292383,USP51
beta,2,apoptotic mitochondrial changes (GO:0008637),1/35,1,35,0.207024542673371,0.323378561957841,0,0,4.32900432900433,6.81782653292383,DNM1L
beta,2,negative regulation of DNA binding (GO:0043392),1/35,1,35,0.207024542673371,0.323378561957841,0,0,4.32900432900433,6.81782653292383,ID1
beta,2,negative regulation of cellular metabolic process (GO:0031324),1/35,1,35,0.207024542673371,0.323378561957841,0,0,4.32900432900433,6.81782653292383,INS
beta,2,regulation of JUN kinase activity (GO:0043506),1/35,1,35,0.207024542673371,0.323378561957841,0,0,4.32900432900433,6.81782653292383,TNFRSF11A
beta,2,macromolecule catabolic process (GO:0009057),1/35,1,35,0.207024542673371,0.323378561957841,0,0,4.32900432900433,6.81782653292383,BACE1
beta,2,positive regulation of DNA binding (GO:0043388),1/35,1,35,0.207024542673371,0.323378561957841,0,0,4.32900432900433,6.81782653292383,NEUROD1
beta,2,positive regulation of mitochondrion organization (GO:0010822),2/129,2,129,0.209425079858984,0.325450491184741,0,0,2.34907211651398,3.67251401836354,HTRA2;DNM1L
beta,2,regulation of macromolecule metabolic process (GO:0060255),2/130,2,130,0.211838802183,0.325450491184741,0,0,2.33100233100233,3.6175516564035,INS-IGF2;INS
beta,2,negative regulation of protein kinase B signaling (GO:0051898),1/36,1,36,0.212267348041071,0.325450491184741,0,0,4.20875420875421,6.5231848616698,PDCD6
beta,2,positive regulation of DNA replication (GO:0045740),1/36,1,36,0.212267348041071,0.325450491184741,0,0,4.20875420875421,6.5231848616698,INS
beta,2,endothelial cell migration (GO:0043542),1/36,1,36,0.212267348041071,0.325450491184741,0,0,4.20875420875421,6.5231848616698,ID1
beta,2,apical junction assembly (GO:0043297),1/36,1,36,0.212267348041071,0.325450491184741,0,0,4.20875420875421,6.5231848616698,F11R
beta,2,membrane protein proteolysis (GO:0033619),1/36,1,36,0.212267348041071,0.325450491184741,0,0,4.20875420875421,6.5231848616698,BACE1
beta,2,regulation of cardiac muscle contraction (GO:0055117),1/36,1,36,0.212267348041071,0.325450491184741,0,0,4.20875420875421,6.5231848616698,CHGA
beta,2,carbohydrate catabolic process (GO:0016052),1/36,1,36,0.212267348041071,0.325450491184741,0,0,4.20875420875421,6.5231848616698,GCK
beta,2,regulation of sodium ion transport (GO:0002028),1/36,1,36,0.212267348041071,0.325450491184741,0,0,4.20875420875421,6.5231848616698,ANK3
beta,2,regulation of potassium ion transport (GO:0043266),1/37,1,37,0.217475751178113,0.328586089507294,0,0,4.0950040950041,6.24761639436939,ANK3
beta,2,protein acylation (GO:0043543),1/37,1,37,0.217475751178113,0.328586089507294,0,0,4.0950040950041,6.24761639436939,ZDHHC21
beta,2,organic hydroxy compound transport (GO:0015850),1/37,1,37,0.217475751178113,0.328586089507294,0,0,4.0950040950041,6.24761639436939,ATP8B1
beta,2,carbohydrate biosynthetic process (GO:0016051),1/37,1,37,0.217475751178113,0.328586089507294,0,0,4.0950040950041,6.24761639436939,GALNT14
beta,2,regulation of response to DNA damage stimulus (GO:2001020),1/37,1,37,0.217475751178113,0.328586089507294,0,0,4.0950040950041,6.24761639436939,USP51
beta,2,histone deacetylation (GO:0016575),1/37,1,37,0.217475751178113,0.328586089507294,0,0,4.0950040950041,6.24761639436939,SMARCAD1
beta,2,vesicle-mediated transport in synapse (GO:0099003),1/37,1,37,0.217475751178113,0.328586089507294,0,0,4.0950040950041,6.24761639436939,SYT17
beta,2,spermatid development (GO:0007286),1/37,1,37,0.217475751178113,0.328586089507294,0,0,4.0950040950041,6.24761639436939,DPY19L2
beta,2,protein targeting (GO:0006605),2/134,2,134,0.221520260668255,0.330987710413259,0,0,2.26142017186793,3.40850570645528,ZDHHC21;GDAP1
beta,2,sodium-independent organic anion transport (GO:0043252),1/38,1,38,0.222649976078233,0.330987710413259,0,0,3.98724082934609,5.98945117486267,SLCO4C1
beta,2,myelination (GO:0042552),1/38,1,38,0.222649976078233,0.330987710413259,0,0,3.98724082934609,5.98945117486267,EPB41L3
beta,2,regulation of regulated secretory pathway (GO:1903305),1/38,1,38,0.222649976078233,0.330987710413259,0,0,3.98724082934609,5.98945117486267,SYT17
beta,2,positive regulation of receptor activity (GO:2000273),1/38,1,38,0.222649976078233,0.330987710413259,0,0,3.98724082934609,5.98945117486267,GSTM2
beta,2,regulation of carbohydrate catabolic process (GO:0043470),1/38,1,38,0.222649976078233,0.330987710413259,0,0,3.98724082934609,5.98945117486267,GCK
beta,2,regulation of metal ion transport (GO:0010959),1/38,1,38,0.222649976078233,0.330987710413259,0,0,3.98724082934609,5.98945117486267,ANK3
beta,2,regulation of sodium ion transmembrane transporter activity (GO:2000649),1/38,1,38,0.222649976078233,0.330987710413259,0,0,3.98724082934609,5.98945117486267,ANK3
beta,2,positive regulation of multi-organism process (GO:0043902),1/38,1,38,0.222649976078233,0.330987710413259,0,0,3.98724082934609,5.98945117486267,DDX60
beta,2,mitochondrial transport (GO:0006839),2/136,2,136,0.226375002936553,0.335924334714778,0,0,2.22816399286988,3.31007653700198,SLC25A21;GDAP1
beta,2,positive regulation of innate immune response (GO:0045089),1/39,1,39,0.22779024532247,0.336223257305458,0,0,3.88500388500389,5.74720299192609,DDX60
beta,2,regulation of ossification (GO:0030278),1/39,1,39,0.22779024532247,0.336223257305458,0,0,3.88500388500389,5.74720299192609,SMAD6
beta,2,regulation of cellular pH (GO:0030641),1/39,1,39,0.22779024532247,0.336223257305458,0,0,3.88500388500389,5.74720299192609,SLC4A4
beta,2,positive regulation of fat cell differentiation (GO:0045600),1/40,1,40,0.232896780005707,0.338944350586239,0,0,3.78787878787879,5.51954518120898,INS
beta,2,negative regulation of protein catabolic process (GO:0042177),1/40,1,40,0.232896780005707,0.338944350586239,0,0,3.78787878787879,5.51954518120898,INS
beta,2,clathrin-dependent endocytosis (GO:0072583),1/40,1,40,0.232896780005707,0.338944350586239,0,0,3.78787878787879,5.51954518120898,SYT17
beta,2,regulation of plasma membrane bounded cell projection assembly (GO:0120032),1/40,1,40,0.232896780005707,0.338944350586239,0,0,3.78787878787879,5.51954518120898,ATP8B1
beta,2,Golgi to plasma membrane transport (GO:0006893),1/40,1,40,0.232896780005707,0.338944350586239,0,0,3.78787878787879,5.51954518120898,ANK3
beta,2,positive regulation of phagocytosis (GO:0050766),1/40,1,40,0.232896780005707,0.338944350586239,0,0,3.78787878787879,5.51954518120898,SFTPA1
beta,2,ERBB2 signaling pathway (GO:0038128),1/40,1,40,0.232896780005707,0.338944350586239,0,0,3.78787878787879,5.51954518120898,GAB1
beta,2,regulation of coenzyme metabolic process (GO:0051196),1/40,1,40,0.232896780005707,0.338944350586239,0,0,3.78787878787879,5.51954518120898,GCK
beta,2,neuron differentiation (GO:0030182),2/140,2,140,0.236107186615277,0.340953282291703,0,0,2.16450216450216,3.12439263309977,NEUROD1;ID1
beta,2,negative regulation of transport (GO:0051051),1/41,1,41,0.237969799914786,0.340953282291703,0,0,3.69549150036955,5.30529011262515,MCTP1
beta,2,negative regulation of TOR signaling (GO:0032007),1/41,1,41,0.237969799914786,0.340953282291703,0,0,3.69549150036955,5.30529011262515,PDCD6
beta,2,regulation of release of cytochrome c from mitochondria (GO:0090199),1/41,1,41,0.237969799914786,0.340953282291703,0,0,3.69549150036955,5.30529011262515,DNM1L
beta,2,negative regulation of catabolic process (GO:0009895),1/41,1,41,0.237969799914786,0.340953282291703,0,0,3.69549150036955,5.30529011262515,INS
beta,2,cognition (GO:0050890),1/41,1,41,0.237969799914786,0.340953282291703,0,0,3.69549150036955,5.30529011262515,INS
beta,2,regulation of intracellular transport (GO:0032386),1/41,1,41,0.237969799914786,0.340953282291703,0,0,3.69549150036955,5.30529011262515,WWC1
beta,2,positive regulation of mitotic nuclear division (GO:0045840),1/41,1,41,0.237969799914786,0.340953282291703,0,0,3.69549150036955,5.30529011262515,INS
beta,2,tRNA aminoacylation (GO:0043039),1/41,1,41,0.237969799914786,0.340953282291703,0,0,3.69549150036955,5.30529011262515,MARS2
beta,2,inorganic cation transmembrane transport (GO:0098662),2/141,2,141,0.238544210774499,0.341116408574346,0,0,2.1491510853213,3.0801646587341,SLC30A8;TRPM6
beta,2,double-strand break repair (GO:0006302),2/142,2,142,0.24098257521125,0.341116408574346,0,0,2.13401621852326,3.03677048684039,SMARCAD1;REC8
beta,2,odontogenesis (GO:0042476),1/42,1,42,0.243009523316501,0.341116408574346,0,0,3.60750360750361,5.10337173811917,EDA
beta,2,bicarbonate transport (GO:0015701),1/42,1,42,0.243009523316501,0.341116408574346,0,0,3.60750360750361,5.10337173811917,SLC4A4
beta,2,regulation of phagocytosis (GO:0050764),1/42,1,42,0.243009523316501,0.341116408574346,0,0,3.60750360750361,5.10337173811917,SFTPA1
beta,2,regulation of calcium-mediated signaling (GO:0050848),1/42,1,42,0.243009523316501,0.341116408574346,0,0,3.60750360750361,5.10337173811917,RCAN3
beta,2,spliceosomal complex assembly (GO:0000245),1/42,1,42,0.243009523316501,0.341116408574346,0,0,3.60750360750361,5.10337173811917,YTHDC1
beta,2,negative regulation of STAT cascade (GO:1904893),1/42,1,42,0.243009523316501,0.341116408574346,0,0,3.60750360750361,5.10337173811917,LRRTM1
beta,2,monocyte chemotaxis (GO:0002548),1/42,1,42,0.243009523316501,0.341116408574346,0,0,3.60750360750361,5.10337173811917,TNFRSF11A
beta,2,regulation of protein localization (GO:0032880),1/42,1,42,0.243009523316501,0.341116408574346,0,0,3.60750360750361,5.10337173811917,INS
beta,2,negative regulation of proteolysis (GO:0045861),1/42,1,42,0.243009523316501,0.341116408574346,0,0,3.60750360750361,5.10337173811917,INS
beta,2,gluconeogenesis (GO:0006094),1/42,1,42,0.243009523316501,0.341116408574346,0,0,3.60750360750361,5.10337173811917,G6PC2
beta,2,positive regulation of macromolecule biosynthetic process (GO:0010557),2/143,2,143,0.243422157081055,0.341119414054564,0,0,2.11909302818394,2.99418959740305,GCK;INS
beta,2,positive regulation of protein localization to nucleus (GO:1900182),1/43,1,43,0.248016167064178,0.346388966101398,0,0,3.52360817477097,4.91283067359763,INS
beta,2,cellular response to retinoic acid (GO:0071300),1/43,1,43,0.248016167064178,0.346388966101398,0,0,3.52360817477097,4.91283067359763,HTRA2
beta,2,regulation of ATP metabolic process (GO:1903578),1/44,1,44,0.252989946677567,0.351562952657288,0,0,3.4435261707989,4.73280140322464,GCK
beta,2,negative regulation of protein metabolic process (GO:0051248),1/44,1,44,0.252989946677567,0.351562952657288,0,0,3.4435261707989,4.73280140322464,INS
beta,2,response to hydrogen peroxide (GO:0042542),1/44,1,44,0.252989946677567,0.351562952657288,0,0,3.4435261707989,4.73280140322464,PDCD10
beta,2,negative regulation of type I interferon production (GO:0032480),1/45,1,45,0.257931076205052,0.354282188969253,0,0,3.36700336700337,4.56250126680993,RNF125
beta,2,lymphocyte chemotaxis (GO:0048247),1/45,1,45,0.257931076205052,0.354282188969253,0,0,3.36700336700337,4.56250126680993,CYP7B1
beta,2,amide biosynthetic process (GO:0043604),1/45,1,45,0.257931076205052,0.354282188969253,0,0,3.36700336700337,4.56250126680993,PCSK1
beta,2,regulation of intracellular pH (GO:0051453),1/45,1,45,0.257931076205052,0.354282188969253,0,0,3.36700336700337,4.56250126680993,SLC4A4
beta,2,hexose biosynthetic process (GO:0019319),1/45,1,45,0.257931076205052,0.354282188969253,0,0,3.36700336700337,4.56250126680993,G6PC2
beta,2,posttranscriptional regulation of gene expression (GO:0010608),1/45,1,45,0.257931076205052,0.354282188969253,0,0,3.36700336700337,4.56250126680993,YTHDC1
beta,2,positive regulation of intracellular transport (GO:0032388),1/45,1,45,0.257931076205052,0.354282188969253,0,0,3.36700336700337,4.56250126680993,PDCD10
beta,2,hexose metabolic process (GO:0019318),1/46,1,46,0.262839768365955,0.358065323790342,0,0,3.29380764163373,4.40122094277605,KCNJ11
beta,2,nicotinamide nucleotide metabolic process (GO:0046496),1/46,1,46,0.262839768365955,0.358065323790342,0,0,3.29380764163373,4.40122094277605,GCK
beta,2,metal ion homeostasis (GO:0055065),1/46,1,46,0.262839768365955,0.358065323790342,0,0,3.29380764163373,4.40122094277605,ANK3
beta,2,nucleus organization (GO:0006997),1/46,1,46,0.262839768365955,0.358065323790342,0,0,3.29380764163373,4.40122094277605,SYNE1
beta,2,negative regulation of ossification (GO:0030279),1/46,1,46,0.262839768365955,0.358065323790342,0,0,3.29380764163373,4.40122094277605,SMAD6
beta,2,tRNA aminoacylation for protein translation (GO:0006418),1/47,1,47,0.267716234475682,0.361743399754946,0,0,3.22372662798195,4.24831620247397,MARS2
beta,2,pyruvate metabolic process (GO:0006090),1/47,1,47,0.267716234475682,0.361743399754946,0,0,3.22372662798195,4.24831620247397,GCK
beta,2,regulation of DNA metabolic process (GO:0051052),1/47,1,47,0.267716234475682,0.361743399754946,0,0,3.22372662798195,4.24831620247397,SMARCAD1
beta,2,regulation of generation of precursor metabolites and energy (GO:0043467),1/47,1,47,0.267716234475682,0.361743399754946,0,0,3.22372662798195,4.24831620247397,GCK
beta,2,positive regulation of ion transport (GO:0043270),1/47,1,47,0.267716234475682,0.361743399754946,0,0,3.22372662798195,4.24831620247397,ANK3
beta,2,myofibril assembly (GO:0030239),1/48,1,48,0.272560684496144,0.365909416504516,0,0,3.15656565656566,4.10320073949838,MYBPHL
beta,2,fatty acid biosynthetic process (GO:0006633),1/48,1,48,0.272560684496144,0.365909416504516,0,0,3.15656565656566,4.10320073949838,SCD5
beta,2,regulation of intrinsic apoptotic signaling pathway (GO:2001242),1/48,1,48,0.272560684496144,0.365909416504516,0,0,3.15656565656566,4.10320073949838,DNM1L
beta,2,negative regulation of JAK-STAT cascade (GO:0046426),1/48,1,48,0.272560684496144,0.365909416504516,0,0,3.15656565656566,4.10320073949838,LRRTM1
beta,2,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),1/49,1,49,0.277373327056731,0.368795575654629,0,0,3.09214594928881,3.96533991678659,HTRA2
beta,2,protein K48-linked ubiquitination (GO:0070936),1/49,1,49,0.277373327056731,0.368795575654629,0,0,3.09214594928881,3.96533991678659,HACE1
beta,2,pattern recognition receptor signaling pathway (GO:0002221),1/49,1,49,0.277373327056731,0.368795575654629,0,0,3.09214594928881,3.96533991678659,SFTPA1
beta,2,regulation of cell cycle arrest (GO:0071156),1/49,1,49,0.277373327056731,0.368795575654629,0,0,3.09214594928881,3.96533991678659,NEUROD1
beta,2,cellular macromolecule catabolic process (GO:0044265),1/49,1,49,0.277373327056731,0.368795575654629,0,0,3.09214594928881,3.96533991678659,HTRA2
beta,2,amino acid transport (GO:0006865),1/49,1,49,0.277373327056731,0.368795575654629,0,0,3.09214594928881,3.96533991678659,SLC16A12
beta,2,cilium movement (GO:0003341),1/50,1,50,0.282154369399051,0.372766742401607,0,0,3.03030303030303,3.83424529879182,DNAH7
beta,2,establishment of protein localization to mitochondrion (GO:0072655),1/50,1,50,0.282154369399051,0.372766742401607,0,0,3.03030303030303,3.83424529879182,GDAP1
beta,2,lipid homeostasis (GO:0055088),1/50,1,50,0.282154369399051,0.372766742401607,0,0,3.03030303030303,3.83424529879182,INS
beta,2,regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/50,1,50,0.282154369399051,0.372766742401607,0,0,3.03030303030303,3.83424529879182,GSTM2
beta,2,regulation of cellular protein metabolic process (GO:0032268),1/51,1,51,0.286904017440751,0.375460218099629,0,0,2.9708853238265,3.70946985490906,INS
beta,2,fatty acid oxidation (GO:0019395),1/51,1,51,0.286904017440751,0.375460218099629,0,0,2.9708853238265,3.70946985490906,SLC27A2
beta,2,neurogenesis (GO:0022008),1/51,1,51,0.286904017440751,0.375460218099629,0,0,2.9708853238265,3.70946985490906,NEUROD1
beta,2,fatty acid beta-oxidation (GO:0006635),1/51,1,51,0.286904017440751,0.375460218099629,0,0,2.9708853238265,3.70946985490906,SLC27A2
beta,2,positive regulation of JUN kinase activity (GO:0043507),1/51,1,51,0.286904017440751,0.375460218099629,0,0,2.9708853238265,3.70946985490906,TNFRSF11A
beta,2,wound healing (GO:0042060),1/51,1,51,0.286904017440751,0.375460218099629,0,0,2.9708853238265,3.70946985490906,INS
beta,2,regulation of cellular amine metabolic process (GO:0033238),1/52,1,52,0.291622475747229,0.379840560103366,0,0,2.91375291375291,3.59060374270245,INS
beta,2,regulation of cellular amino acid metabolic process (GO:0006521),1/52,1,52,0.291622475747229,0.379840560103366,0,0,2.91375291375291,3.59060374270245,INS
beta,2,positive regulation of developmental growth (GO:0048639),1/52,1,52,0.291622475747229,0.379840560103366,0,0,2.91375291375291,3.59060374270245,SYT17
beta,2,plasma membrane bounded cell projection morphogenesis (GO:0120039),1/53,1,53,0.29630994755956,0.383541380719618,0,0,2.8587764436821,3.47727058997229,EPB41L3
beta,2,positive regulation of mitotic cell cycle (GO:0045931),1/53,1,53,0.29630994755956,0.383541380719618,0,0,2.8587764436821,3.47727058997229,INS
beta,2,regulation of DNA binding (GO:0051101),1/53,1,53,0.29630994755956,0.383541380719618,0,0,2.8587764436821,3.47727058997229,ID1
beta,2,positive regulation of secretion by cell (GO:1903532),1/53,1,53,0.29630994755956,0.383541380719618,0,0,2.8587764436821,3.47727058997229,DNM1L
beta,2,negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),1/54,1,54,0.300966634876067,0.387757013305444,0,0,2.80583613916947,3.36912420865636,SMAD6
beta,2,regulation of calcium ion-dependent exocytosis (GO:0017158),1/54,1,54,0.300966634876067,0.387757013305444,0,0,2.80583613916947,3.36912420865636,SYT17
beta,2,embryonic organ development (GO:0048568),1/54,1,54,0.300966634876067,0.387757013305444,0,0,2.80583613916947,3.36912420865636,NEUROD1
beta,2,protein targeting to mitochondrion (GO:0006626),1/55,1,55,0.305592738371316,0.39189439133729,0,0,2.75482093663912,3.26584568552632,GDAP1
beta,2,action potential (GO:0001508),1/55,1,55,0.305592738371316,0.39189439133729,0,0,2.75482093663912,3.26584568552632,ANK3
beta,2,negative regulation of cellular component organization (GO:0051129),1/55,1,55,0.305592738371316,0.39189439133729,0,0,2.75482093663912,3.26584568552632,MCTP1
beta,2,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),1/56,1,56,0.310188457249454,0.395347558242785,0,0,2.70562770562771,3.16714079979526,SMAD6
beta,2,fat cell differentiation (GO:0045444),1/56,1,56,0.310188457249454,0.395347558242785,0,0,2.70562770562771,3.16714079979526,SMAD6
beta,2,regulation of RNA splicing (GO:0043484),1/56,1,56,0.310188457249454,0.395347558242785,0,0,2.70562770562771,3.16714079979526,YTHDC1
beta,2,Notch signaling pathway (GO:0007219),1/56,1,56,0.310188457249454,0.395347558242785,0,0,2.70562770562771,3.16714079979526,WWC1
beta,2,negative regulation of cellular catabolic process (GO:0031330),1/57,1,57,0.31475398968878,0.399329107528818,0,0,2.6581605528974,3.07273772035949,INS
beta,2,regulation of BMP signaling pathway (GO:0030510),1/57,1,57,0.31475398968878,0.399329107528818,0,0,2.6581605528974,3.07273772035949,SMAD6
beta,2,organonitrogen compound catabolic process (GO:1901565),1/57,1,57,0.31475398968878,0.399329107528818,0,0,2.6581605528974,3.07273772035949,BACE1
beta,2,positive regulation of cell death (GO:0010942),1/58,1,58,0.31928953241753,0.402624584884624,0,0,2.6123301985371,2.9823849600486,HTRA2
beta,2,epidermal growth factor receptor signaling pathway (GO:0007173),1/58,1,58,0.31928953241753,0.402624584884624,0,0,2.6123301985371,2.9823849600486,GAB1
beta,2,protein homotetramerization (GO:0051289),1/58,1,58,0.31928953241753,0.402624584884624,0,0,2.6123301985371,2.9823849600486,DNM1L
beta,2,response to retinoic acid (GO:0032526),1/58,1,58,0.31928953241753,0.402624584884624,0,0,2.6123301985371,2.9823849600486,HTRA2
beta,2,sterol homeostasis (GO:0055092),1/59,1,59,0.323795280909091,0.40584295389963,0,0,2.56805341551104,2.89584954272356,CYP7B1
beta,2,sodium ion transport (GO:0006814),1/59,1,59,0.323795280909091,0.40584295389963,0,0,2.56805341551104,2.89584954272356,SLC4A4
beta,2,ubiquitin-dependent ERAD pathway (GO:0030433),1/59,1,59,0.323795280909091,0.40584295389963,0,0,2.56805341551104,2.89584954272356,AUP1
beta,2,cholesterol homeostasis (GO:0042632),1/59,1,59,0.323795280909091,0.40584295389963,0,0,2.56805341551104,2.89584954272356,CYP7B1
beta,2,mitotic cytokinesis (GO:0000281),1/60,1,60,0.328271429448075,0.409599936743769,0,0,2.52525252525253,2.81291536365169,ANK3
beta,2,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),1/60,1,60,0.328271429448075,0.409599936743769,0,0,2.52525252525253,2.81291536365169,SMAD6
beta,2,sterol metabolic process (GO:0016125),1/60,1,60,0.328271429448075,0.409599936743769,0,0,2.52525252525253,2.81291536365169,CYP7B1
beta,2,"regulation of mRNA splicing, via spliceosome (GO:0048024)",1/61,1,61,0.332718170974048,0.413286696680768,0,0,2.48385494287134,2.73338172070363,YTHDC1
beta,2,response to reactive oxygen species (GO:0000302),1/61,1,61,0.332718170974048,0.413286696680768,0,0,2.48385494287134,2.73338172070363,PDCD10
beta,2,nucleosome assembly (GO:0006334),1/61,1,61,0.332718170974048,0.413286696680768,0,0,2.48385494287134,2.73338172070363,HIST1H2BD
beta,2,striated muscle contraction (GO:0006941),1/62,1,62,0.337135697241589,0.415667306242968,0,0,2.44379276637341,2.65706199227417,MYBPHL
beta,2,actin cytoskeleton reorganization (GO:0031532),1/62,1,62,0.337135697241589,0.415667306242968,0,0,2.44379276637341,2.65706199227417,GAB1
beta,2,regulation of DNA replication (GO:0006275),1/62,1,62,0.337135697241589,0.415667306242968,0,0,2.44379276637341,2.65706199227417,INS
beta,2,regulation of cellular ketone metabolic process (GO:0010565),1/62,1,62,0.337135697241589,0.415667306242968,0,0,2.44379276637341,2.65706199227417,INS
beta,2,protein targeting to membrane (GO:0006612),1/62,1,62,0.337135697241589,0.415667306242968,0,0,2.44379276637341,2.65706199227417,ZDHHC21
beta,2,negative regulation of peptidase activity (GO:0010466),1/63,1,63,0.341524198755524,0.419832262079646,0,0,2.40500240500241,2.58378244898962,SERPINI1
beta,2,cellular protein catabolic process (GO:0044257),1/63,1,63,0.341524198755524,0.419832262079646,0,0,2.40500240500241,2.58378244898962,HTRA2
beta,2,vesicle coating (GO:0006901),1/64,1,64,0.345883864675908,0.420833808998067,0,0,2.36742424242424,2.51338118251324,PDCD6
beta,2,ribosomal large subunit biogenesis (GO:0042273),1/64,1,64,0.345883864675908,0.420833808998067,0,0,2.36742424242424,2.51338118251324,ZNF622
beta,2,COPII vesicle coating (GO:0048208),1/64,1,64,0.345883864675908,0.420833808998067,0,0,2.36742424242424,2.51338118251324,PDCD6
beta,2,oligosaccharide metabolic process (GO:0009311),1/64,1,64,0.345883864675908,0.420833808998067,0,0,2.36742424242424,2.51338118251324,GALNT14
beta,2,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193),1/64,1,64,0.345883864675908,0.420833808998067,0,0,2.36742424242424,2.51338118251324,GABBR1
beta,2,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",1/64,1,64,0.345883864675908,0.420833808998067,0,0,2.36742424242424,2.51338118251324,PDCD6
beta,2,regulation of proteolysis (GO:0030162),1/64,1,64,0.345883864675908,0.420833808998067,0,0,2.36742424242424,2.51338118251324,INS
beta,2,positive regulation of endocytosis (GO:0045807),1/65,1,65,0.350214883164629,0.424859223225995,0,0,2.33100233100233,2.44570713517739,SFTPA1
beta,2,negative regulation of neuron differentiation (GO:0045665),1/65,1,65,0.350214883164629,0.424859223225995,0,0,2.33100233100233,2.44570713517739,ID1
beta,2,O-glycan processing (GO:0016266),1/66,1,66,0.354517440968076,0.426962309339813,0,0,2.29568411386593,2.38061922736129,GALNT14
beta,2,chromatin assembly (GO:0031497),1/66,1,66,0.354517440968076,0.426962309339813,0,0,2.29568411386593,2.38061922736129,HIST1H2BD
beta,2,regulation of JAK-STAT cascade (GO:0046425),1/66,1,66,0.354517440968076,0.426962309339813,0,0,2.29568411386593,2.38061922736129,LRRTM1
beta,2,defense response to Gram-positive bacterium (GO:0050830),1/66,1,66,0.354517440968076,0.426962309339813,0,0,2.29568411386593,2.38061922736129,CHGA
beta,2,fatty acid catabolic process (GO:0009062),1/66,1,66,0.354517440968076,0.426962309339813,0,0,2.29568411386593,2.38061922736129,SLC27A2
beta,2,positive regulation of synaptic transmission (GO:0050806),1/68,1,68,0.36303791578897,0.434078428806668,0,0,2.22816399286988,2.25768270713603,INS
beta,2,positive regulation of endothelial cell proliferation (GO:0001938),1/68,1,68,0.36303791578897,0.434078428806668,0,0,2.22816399286988,2.25768270713603,PDCD6
beta,2,regulation of cardiac conduction (GO:1903779),1/68,1,68,0.36303791578897,0.434078428806668,0,0,2.22816399286988,2.25768270713603,KCNJ11
beta,2,regulation of TOR signaling (GO:0032006),1/68,1,68,0.36303791578897,0.434078428806668,0,0,2.22816399286988,2.25768270713603,PDCD6
beta,2,regulation of protein localization to plasma membrane (GO:1903076),1/68,1,68,0.36303791578897,0.434078428806668,0,0,2.22816399286988,2.25768270713603,INS
beta,2,regulation of endopeptidase activity (GO:0052548),1/69,1,69,0.367256200367462,0.437862126980432,0,0,2.19587176108915,2.19959503916838,SERPINI1
beta,2,COPII-coated vesicle budding (GO:0090114),1/69,1,69,0.367256200367462,0.437862126980432,0,0,2.19587176108915,2.19959503916838,PDCD6
beta,2,regulation of endothelial cell migration (GO:0010594),1/70,1,70,0.371446759563925,0.440864014617353,0,0,2.16450216450216,2.14361414971873,PDCD6
beta,2,positive regulation of neurogenesis (GO:0050769),1/70,1,70,0.371446759563925,0.440864014617353,0,0,2.16450216450216,2.14361414971873,NEUROD1
beta,2,regulation of endocytosis (GO:0030100),1/70,1,70,0.371446759563925,0.440864014617353,0,0,2.16450216450216,2.14361414971873,MCTP1
beta,2,positive regulation of endothelial cell migration (GO:0010595),1/71,1,71,0.375609774186625,0.440864014617353,0,0,2.13401621852326,2.08963830372499,PDCD6
beta,2,regulation of Notch signaling pathway (GO:0008593),1/71,1,71,0.375609774186625,0.440864014617353,0,0,2.13401621852326,2.08963830372499,PDCD10
beta,2,neuropeptide signaling pathway (GO:0007218),1/71,1,71,0.375609774186625,0.440864014617353,0,0,2.13401621852326,2.08963830372499,SSTR1
beta,2,snRNA transcription (GO:0009301),1/71,1,71,0.375609774186625,0.440864014617353,0,0,2.13401621852326,2.08963830372499,SNAPC3
beta,2,snRNA transcription from RNA polymerase II promoter (GO:0042795),1/71,1,71,0.375609774186625,0.440864014617353,0,0,2.13401621852326,2.08963830372499,SNAPC3
beta,2,vascular endothelial growth factor receptor signaling pathway (GO:0048010),1/71,1,71,0.375609774186625,0.440864014617353,0,0,2.13401621852326,2.08963830372499,PDCD6
beta,2,calcium-mediated signaling (GO:0019722),1/71,1,71,0.375609774186625,0.440864014617353,0,0,2.13401621852326,2.08963830372499,MCTP1
beta,2,cytoskeleton-dependent cytokinesis (GO:0061640),1/71,1,71,0.375609774186625,0.440864014617353,0,0,2.13401621852326,2.08963830372499,ANK3
beta,2,regulation of cation channel activity (GO:2001257),1/72,1,72,0.379745423861188,0.443837478521304,0,0,2.1043771043771,2.0375719443967,ANK3
beta,2,defense response to Gram-negative bacterium (GO:0050829),1/72,1,72,0.379745423861188,0.443837478521304,0,0,2.1043771043771,2.0375719443967,CHGA
beta,2,positive regulation of growth (GO:0045927),1/72,1,72,0.379745423861188,0.443837478521304,0,0,2.1043771043771,2.0375719443967,INS
beta,2,regulation of fat cell differentiation (GO:0045598),1/73,1,73,0.383853887184964,0.447380897967328,0,0,2.0755500207555,1.98732524061063,RUNX1T1
beta,2,negative regulation of cell cycle (GO:0045786),1/73,1,73,0.383853887184964,0.447380897967328,0,0,2.0755500207555,1.98732524061063,HTRA2
beta,2,positive regulation of inflammatory response (GO:0050729),1/74,1,74,0.387935341460928,0.448989232247954,0,0,2.04750204750205,1.93881367519464,MGST2
beta,2,B cell activation (GO:0042113),1/74,1,74,0.387935341460928,0.448989232247954,0,0,2.04750204750205,1.93881367519464,BANK1
beta,2,transcription-coupled nucleotide-excision repair (GO:0006283),1/74,1,74,0.387935341460928,0.448989232247954,0,0,2.04750204750205,1.93881367519464,CCNH
beta,2,regulation of protein complex assembly (GO:0043254),1/74,1,74,0.387935341460928,0.448989232247954,0,0,2.04750204750205,1.93881367519464,DNM1L
beta,2,positive regulation of cytokine secretion (GO:0050715),1/74,1,74,0.387935341460928,0.448989232247954,0,0,2.04750204750205,1.93881367519464,INS
beta,2,positive regulation of epithelial cell migration (GO:0010634),1/75,1,75,0.391989962980387,0.452421748939863,0,0,2.02020202020202,1.89195766497242,PDCD6
beta,2,positive regulation of defense response (GO:0031349),1/75,1,75,0.391989962980387,0.452421748939863,0,0,2.02020202020202,1.89195766497242,MGST2
beta,2,regulation of actin cytoskeleton organization (GO:0032956),1/76,1,76,0.396017926689806,0.456436750456628,0,0,1.99362041467305,1.84668221557732,F11R
beta,2,regulation of hematopoietic stem cell differentiation (GO:1902036),1/77,1,77,0.400019406576623,0.459773342828733,0,0,1.96772924045651,1.80291660096317,LMO2
beta,2,response to interleukin-1 (GO:0070555),1/77,1,77,0.400019406576623,0.459773342828733,0,0,1.96772924045651,1.80291660096317,TNFRSF11A
beta,2,ERAD pathway (GO:0036503),1/78,1,78,0.403994575526492,0.462423543061315,0,0,1.94250194250194,1.7605940715341,AUP1
beta,2,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),1/78,1,78,0.403994575526492,0.462423543061315,0,0,1.94250194250194,1.7605940715341,SMAD6
beta,2,regulation of hematopoietic progenitor cell differentiation (GO:1901532),1/78,1,78,0.403994575526492,0.462423543061315,0,0,1.94250194250194,1.7605940715341,LMO2
beta,2,sensory perception of mechanical stimulus (GO:0050954),1/79,1,79,0.407943605126851,0.465660900907161,0,0,1.91791331031837,1.71965158584565,TSPEAR
beta,2,negative regulation of inflammatory response (GO:0050728),1/79,1,79,0.407943605126851,0.465660900907161,0,0,1.91791331031837,1.71965158584565,INS
beta,2,nucleosome organization (GO:0034728),1/80,1,80,0.411866666004323,0.466932059276388,0,0,1.89393939393939,1.68002956101131,HIST1H2BD
beta,2,regulation of endothelial cell proliferation (GO:0001936),1/80,1,80,0.411866666004323,0.466932059276388,0,0,1.89393939393939,1.68002956101131,PDCD6
beta,2,response to calcium ion (GO:0051592),1/80,1,80,0.411866666004323,0.466932059276388,0,0,1.89393939393939,1.68002956101131,PDCD6
beta,2,cation transport (GO:0006812),1/80,1,80,0.411866666004323,0.466932059276388,0,0,1.89393939393939,1.68002956101131,TMEM63C
beta,2,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),1/80,1,80,0.411866666004323,0.466932059276388,0,0,1.89393939393939,1.68002956101131,SMAD6
beta,2,regulation of protein serine/threonine kinase activity (GO:0071900),1/81,1,81,0.415763927636697,0.470067787572919,0,0,1.87055742611298,1.64167164504691,PDCD10
beta,2,ERBB signaling pathway (GO:0038127),1/81,1,81,0.415763927636697,0.470067787572919,0,0,1.87055742611298,1.64167164504691,GAB1
beta,2,sensory perception of sound (GO:0007605),1/82,1,82,0.419635558328502,0.472516462020305,0,0,1.84774575018477,1.60452450601554,TSPEAR
beta,2,positive regulation of protein targeting to mitochondrion (GO:1903955),1/82,1,82,0.419635558328502,0.472516462020305,0,0,1.84774575018477,1.60452450601554,HTRA2
beta,2,BMP signaling pathway (GO:0030509),1/82,1,82,0.419635558328502,0.472516462020305,0,0,1.84774575018477,1.60452450601554,SMAD6
beta,2,modulation of chemical synaptic transmission (GO:0050804),1/83,1,83,0.423481725504253,0.474916752893433,0,0,1.8254837531946,1.56853763587555,MCTP1
beta,2,positive regulation of DNA metabolic process (GO:0051054),1/83,1,83,0.423481725504253,0.474916752893433,0,0,1.8254837531946,1.56853763587555,INS
beta,2,negative regulation of binding (GO:0051100),1/83,1,83,0.423481725504253,0.474916752893433,0,0,1.8254837531946,1.56853763587555,ID1
beta,2,positive regulation of protein ubiquitination (GO:0031398),1/84,1,84,0.427302595204316,0.477269430933853,0,0,1.8037518037518,1.53366317253938,PDCD6
beta,2,negative regulation of endopeptidase activity (GO:0010951),1/84,1,84,0.427302595204316,0.477269430933853,0,0,1.8037518037518,1.53366317253938,SERPINI1
beta,2,positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/84,1,84,0.427302595204316,0.477269430933853,0,0,1.8037518037518,1.53366317253938,PDCD10
beta,2,regulation of mitotic nuclear division (GO:0007088),1/85,1,85,0.431098332711516,0.480862704004388,0,0,1.7825311942959,1.49985573040632,INS
beta,2,regulation of type I interferon production (GO:0032479),1/86,1,86,0.434869101979136,0.484418530488823,0,0,1.76180408738548,1.4670722483579,RNF125
beta,2,toll-like receptor signaling pathway (GO:0002224),1/87,1,87,0.438615066009953,0.486634338924261,0,0,1.7415534656914,1.4352718449328,SFTPA1
beta,2,regulation of peptidyl-serine phosphorylation (GO:0033135),1/87,1,87,0.438615066009953,0.486634338924261,0,0,1.7415534656914,1.4352718449328,PDCD10
beta,2,calcium ion transmembrane transport (GO:0070588),1/87,1,87,0.438615066009953,0.486634338924261,0,0,1.7415534656914,1.4352718449328,TRPM6
beta,2,cellular response to BMP stimulus (GO:0071773),1/88,1,88,0.442336386823127,0.48880523597077,0,0,1.72176308539945,1.4044156856059,SMAD6
beta,2,positive regulation of cellular component biogenesis (GO:0044089),1/88,1,88,0.442336386823127,0.48880523597077,0,0,1.72176308539945,1.4044156856059,CHGA
beta,2,regulation of MAP kinase activity (GO:0043405),1/88,1,88,0.442336386823127,0.48880523597077,0,0,1.72176308539945,1.4044156856059,PDCD10
beta,2,T cell activation (GO:0042110),1/89,1,89,0.446033225197197,0.490282553093745,0,0,1.70241743275451,1.37446686036588,INS
beta,2,regulation of stem cell differentiation (GO:2000736),1/89,1,89,0.446033225197197,0.490282553093745,0,0,1.70241743275451,1.37446686036588,LMO2
beta,2,divalent metal ion transport (GO:0070838),1/89,1,89,0.446033225197197,0.490282553093745,0,0,1.70241743275451,1.37446686036588,SLC30A8
beta,2,regulation of protein targeting to mitochondrion (GO:1903214),1/89,1,89,0.446033225197197,0.490282553093745,0,0,1.70241743275451,1.37446686036588,HTRA2
beta,2,negative regulation of cellular protein metabolic process (GO:0032269),1/90,1,90,0.449705741076403,0.493015133027033,0,0,1.68350168350168,1.34539026738793,INS
beta,2,peptidyl-threonine modification (GO:0018210),1/90,1,90,0.449705741076403,0.493015133027033,0,0,1.68350168350168,1.34539026738793,GALNT14
beta,2,protein tetramerization (GO:0051262),1/91,1,91,0.453354093179864,0.495706909779562,0,0,1.66500166500167,1.31715250780809,DNM1L
beta,2,regulation of JNK cascade (GO:0046328),1/91,1,91,0.453354093179864,0.495706909779562,0,0,1.66500166500167,1.31715250780809,ZNF622
beta,2,lipid transport (GO:0006869),1/92,1,92,0.456978439351911,0.496404030197958,0,0,1.64690382081686,1.28972178501632,ATP8B1
beta,2,positive regulation of cellular protein metabolic process (GO:0032270),1/92,1,92,0.456978439351911,0.496404030197958,0,0,1.64690382081686,1.28972178501632,INS
beta,2,regulation of protein catabolic process (GO:0042176),1/92,1,92,0.456978439351911,0.496404030197958,0,0,1.64690382081686,1.28972178501632,INS
beta,2,cellular response to acid chemical (GO:0071229),1/92,1,92,0.456978439351911,0.496404030197958,0,0,1.64690382081686,1.28972178501632,HTRA2
beta,2,negative regulation of kinase activity (GO:0033673),1/92,1,92,0.456978439351911,0.496404030197958,0,0,1.64690382081686,1.28972178501632,LRRTM1
beta,2,positive regulation of cellular metabolic process (GO:0031325),1/93,1,93,0.460578936324683,0.499010555522571,0,0,1.62919517758227,1.26306781295323,INS
beta,2,cell cycle G1/S phase transition (GO:0044843),1/93,1,93,0.460578936324683,0.499010555522571,0,0,1.62919517758227,1.26306781295323,CCNH
beta,2,cellular transition metal ion homeostasis (GO:0046916),1/94,1,94,0.464155739838701,0.502231015372344,0,0,1.61186331399097,1.23716172931717,SLC30A8
beta,2,positive regulation of protein localization to membrane (GO:1905477),1/96,1,96,0.471238884523329,0.507911171256662,0,0,1.57828282828283,1.18748441874447,ANK3
beta,2,transcription elongation from RNA polymerase II promoter (GO:0006368),1/96,1,96,0.471238884523329,0.507911171256662,0,0,1.57828282828283,1.18748441874447,CCNH
beta,2,regulation of heart contraction (GO:0008016),1/96,1,96,0.471238884523329,0.507911171256662,0,0,1.57828282828283,1.18748441874447,KCNJ11
beta,2,regulation of cell death (GO:0010941),1/97,1,97,0.474745532176588,0.510366801085052,0,0,1.56201187129022,1.1636618872714,HTRA2
beta,2,positive regulation of protein metabolic process (GO:0051247),1/97,1,97,0.474745532176588,0.510366801085052,0,0,1.56201187129022,1.1636618872714,INS
beta,2,response to tumor necrosis factor (GO:0034612),1/98,1,98,0.478229099255485,0.512785008362978,0,0,1.5460729746444,1.1404844993301,TNFRSF11A
beta,2,negative regulation of cell motility (GO:2000146),1/98,1,98,0.478229099255485,0.512785008362978,0,0,1.5460729746444,1.1404844993301,MCTP1
beta,2,histone modification (GO:0016570),1/99,1,99,0.48168973663343,0.515166243426487,0,0,1.53045607591062,1.11792940331486,USP51
beta,2,response to molecule of bacterial origin (GO:0002237),1/99,1,99,0.48168973663343,0.515166243426487,0,0,1.53045607591062,1.11792940331486,TNFRSF11A
beta,2,cellular response to metal ion (GO:0071248),1/101,1,101,0.488542820343492,0.521824015045555,0,0,1.5001500150015,1.07459969179073,ANK3
beta,2,cellular divalent inorganic cation homeostasis (GO:0072503),1/102,1,102,0.491935563307791,0.524100580908685,0,0,1.48544266191325,1.05378422453001,SLC30A8
beta,2,regulation of kinase activity (GO:0043549),1/102,1,102,0.491935563307791,0.524100580908685,0,0,1.48544266191325,1.05378422453001,ZNF622
beta,2,regulation of cellular response to stress (GO:0080135),1/105,1,105,0.501980356732321,0.534117383411727,0,0,1.44300144300144,0.994508355081248,USP51
beta,2,G1/S transition of mitotic cell cycle (GO:0000082),1/106,1,106,0.505284625966304,0.53694568309207,0,0,1.42938822184105,0.975748131365972,CCNH
beta,2,"DNA-templated transcription, termination (GO:0006353)",1/107,1,107,0.508567136903524,0.538368523269845,0,0,1.41602945341263,0.957459703907995,CCNH
beta,2,fatty acid metabolic process (GO:0006631),1/107,1,107,0.508567136903524,0.538368523269845,0,0,1.41602945341263,0.957459703907995,SLC27A2
beta,2,positive regulation of cellular catabolic process (GO:0031331),1/107,1,107,0.508567136903524,0.538368523269845,0,0,1.41602945341263,0.957459703907995,INS
beta,2,positive regulation of epithelial cell proliferation (GO:0050679),1/108,1,108,0.511828031746649,0.540443576088266,0,0,1.40291806958474,0.939627645701827,PDCD6
beta,2,positive regulation of cell cycle process (GO:0090068),1/108,1,108,0.511828031746649,0.540443576088266,0,0,1.40291806958474,0.939627645701827,INS
beta,2,regulation of protein activation cascade (GO:2000257),1/109,1,109,0.515067451734039,0.541113846259148,0,0,1.39004726160689,0.922237159652385,PROS1
beta,2,nucleotide-excision repair (GO:0006289),1/109,1,109,0.515067451734039,0.541113846259148,0,0,1.39004726160689,0.922237159652385,CCNH
beta,2,"DNA-templated transcription, elongation (GO:0006354)",1/109,1,109,0.515067451734039,0.541113846259148,0,0,1.39004726160689,0.922237159652385,CCNH
beta,2,negative regulation of hydrolase activity (GO:0051346),1/109,1,109,0.515067451734039,0.541113846259148,0,0,1.39004726160689,0.922237159652385,F11R
beta,2,regulation of cell motility (GO:2000145),1/110,1,110,0.518285537265927,0.542437382201493,0,0,1.37741046831956,0.905274047315611,HACE1
beta,2,regulation of complement activation (GO:0030449),1/110,1,110,0.518285537265927,0.542437382201493,0,0,1.37741046831956,0.905274047315611,PROS1
beta,2,negative regulation of protein kinase activity (GO:0006469),1/110,1,110,0.518285537265927,0.542437382201493,0,0,1.37741046831956,0.905274047315611,LRRTM1
beta,2,negative regulation of cytokine production (GO:0001818),1/111,1,111,0.521482427706554,0.543728854986381,0,0,1.36500136500137,0.88872468029208,RNF125
beta,2,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),1/111,1,111,0.521482427706554,0.543728854986381,0,0,1.36500136500137,0.88872468029208,HTRA2
beta,2,cellular response to peptide hormone stimulus (GO:0071375),1/111,1,111,0.521482427706554,0.543728854986381,0,0,1.36500136500137,0.88872468029208,GCK
beta,2,regulation of organelle organization (GO:0033043),1/114,1,114,0.530947309642423,0.551521517891067,0,0,1.3290802764487,0.841430743233678,DNM1L
beta,2,positive regulation of kinase activity (GO:0033674),1/114,1,114,0.530947309642423,0.551521517891067,0,0,1.3290802764487,0.841430743233678,ZNF622
beta,2,regulation of humoral immune response (GO:0002920),1/114,1,114,0.530947309642423,0.551521517891067,0,0,1.3290802764487,0.841430743233678,PROS1
beta,2,regulation of immune effector process (GO:0002697),1/115,1,115,0.534060796369842,0.554063073387439,0,0,1.31752305665349,0.826410534417138,PROS1
beta,2,protein O-linked glycosylation (GO:0006493),1/116,1,116,0.537153771685479,0.556577037743931,0,0,1.30616509926855,0.811743563522374,GALNT14
beta,2,chromatin remodeling (GO:0006338),1/117,1,117,0.540226369924922,0.559063653060536,0,0,1.2950012950013,0.797419093111128,SMARCAD1
beta,2,calcium ion transport (GO:0006816),1/119,1,119,0.546310966709979,0.564657230517403,0,0,1.27323656735421,0.769756721750063,TRPM6
beta,2,regulation of neuron projection development (GO:0010975),1/120,1,120,0.549323229215231,0.566361790915456,0,0,1.26262626262626,0.756399306526346,SERPINI1
beta,2,regulation of phosphorylation (GO:0042325),1/120,1,120,0.549323229215231,0.566361790915456,0,0,1.26262626262626,0.756399306526346,GCK
beta,2,actin filament organization (GO:0007015),1/121,1,121,0.552315642341157,0.568037498496907,0,0,1.25219133483596,0.743345329694455,MYBPHL
beta,2,macromolecular complex assembly (GO:0065003),1/121,1,121,0.552315642341157,0.568037498496907,0,0,1.25219133483596,0.743345329694455,NAPG
beta,2,negative regulation of cell migration (GO:0030336),1/122,1,122,0.555288335781714,0.570388883849943,0,0,1.24192747143567,0.730585911836216,MCTP1
beta,2,platelet degranulation (GO:0002576),1/125,1,125,0.564089383908771,0.578000342821441,0,0,1.21212121212121,0.693990979313079,PROS1
beta,2,negative regulation of macromolecule metabolic process (GO:0010605),1/125,1,125,0.564089383908771,0.578000342821441,0,0,1.21212121212121,0.693990979313079,PDCD10
beta,2,"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",1/126,1,126,0.566984480150091,0.580251358380204,0,0,1.2025012025012,0.682327257693998,SSTR1
beta,2,G2/M transition of mitotic cell cycle (GO:0000086),1/127,1,127,0.569860493335105,0.582477330825919,0,0,1.19303268909568,0.670918273257285,CCNH
beta,2,negative regulation of response to stimulus (GO:0048585),1/128,1,128,0.572717548152032,0.583245444257768,0,0,1.18371212121212,0.659756887975997,MCTP1
beta,2,cell cycle G2/M phase transition (GO:0044839),1/128,1,128,0.572717548152032,0.583245444257768,0,0,1.18371212121212,0.659756887975997,CCNH
beta,2,protein lipidation (GO:0006497),1/128,1,128,0.572717548152032,0.583245444257768,0,0,1.18371212121212,0.659756887975997,ZDHHC21
beta,2,regulation of protein processing (GO:0070613),1/129,1,129,0.575555768751659,0.585418413503829,0,0,1.17453605825699,0.64883621170655,PROS1
beta,2,generation of neurons (GO:0048699),1/131,1,131,0.581176199181733,0.590412495745746,0,0,1.15660421003932,0.627690607554409,ID1
beta,2,cellular response to organic substance (GO:0071310),1/134,1,134,0.589468642348908,0.598105545533507,0,0,1.13071008593397,0.597618446472267,HTRA2
beta,2,adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),1/135,1,135,0.59219641710733,0.600140515385599,0,0,1.12233445566779,0.588010003897358,GABBR1
beta,2,cellular response to organic cyclic compound (GO:0071407),1/136,1,136,0.594906203416291,0.602152320388475,0,0,1.11408199643494,0.578600186252634,SSTR1
beta,2,muscle contraction (GO:0006936),1/138,1,138,0.600272281195354,0.606107248691785,0,0,1.09793588054458,0.560355648562491,MYBPHL
beta,2,positive regulation of transferase activity (GO:0051347),1/138,1,138,0.600272281195354,0.606107248691785,0,0,1.09793588054458,0.560355648562491,ZNF622
beta,2,regulation of vesicle-mediated transport (GO:0060627),1/139,1,139,0.602928805732787,0.607313742501753,0,0,1.09003706126008,0.551510961416517,SLC30A8
beta,2,response to cytokine (GO:0034097),1/139,1,139,0.602928805732787,0.607313742501753,0,0,1.09003706126008,0.551510961416517,TNFRSF11A
beta,2,cellular response to growth factor stimulus (GO:0071363),1/140,1,140,0.605567808232413,0.608496794003791,0,0,1.08225108225108,0.542844951393367,HTRA2
beta,2,regulation of primary metabolic process (GO:0080090),1/140,1,140,0.605567808232413,0.608496794003791,0,0,1.08225108225108,0.542844951393367,INS
beta,2,response to lipid (GO:0033993),1/141,1,141,0.608189403453687,0.609656687901102,0,0,1.07457554266065,0.534353026745743,TNFRSF11A
beta,2,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),1/141,1,141,0.608189403453687,0.609656687901102,0,0,1.07457554266065,0.534353026745743,ID1
beta,2,regulation of protein kinase activity (GO:0045859),1/148,1,148,0.626062643567562,0.62681693590921,0,0,1.02375102375102,0.479427562747668,LRRTM1
beta,2,regulated exocytosis (GO:0045055),1/149,1,149,0.628549020733151,0.628549020733151,0,0,1.01688021151108,0.47217943624177,PROS1
beta,3,response to unfolded protein (GO:0006986),6/44,6,44,1.94746558224546e-05,0.0303999377388517,0,0,10.6534090909091,115.551100559143,DNAJB2;HSP90AB1;DDIT3;HSPB2;HYOU1;STT3B
beta,3,regulation of organelle organization (GO:0033043),8/114,8,114,0.000110487393397803,0.0693605554023809,0,0,5.48245614035088,49.9485149693672,SCARB2;RHOT1;TAOK1;TBC1D30;RDX;RUNDC1;TBC1D9;MAPT
beta,3,positive regulation of neuron death (GO:1901216),5/39,5,39,0.000133300234597785,0.0693605554023809,0,0,10.0160256410256,89.3720610061878,DDIT3;CTNNB1;MAPT;FOXO3;MAP3K5
beta,3,regulation of microtubule cytoskeleton organization (GO:0070507),4/23,4,23,0.000191688569617823,0.0748064642933553,0,0,13.5869565217391,116.299436631755,PHLDB1;TAOK1;MAPT;PHLDB2
beta,3,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),4/25,4,25,0.000268389424664807,0.0837911783803526,0,0,12.5,102.788394438011,CEBPB;DDIT3;TRIB3;MAP3K5
beta,3,regulation of microtubule-based process (GO:0032886),4/27,4,27,0.000364943987322486,0.0949462607017334,0,0,11.5740740740741,91.6176698558834,PHLDB1;TAOK1;MAPT;PHLDB2
beta,3,response to endoplasmic reticulum stress (GO:0034976),7/107,7,107,0.000455763146031743,0.101635181565079,0,0,5.11098130841122,39.3215253358158,CEBPB;DDIT3;ATP2A2;TRIB3;HYOU1;TTC23L;MAP3K5
beta,3,branching involved in blood vessel morphogenesis (GO:0001569),3/14,3,14,0.000679625329861221,0.132611892489171,0,0,16.7410714285714,122.108854304809,CTNNB1;NRARP;VEGFA
beta,3,L-alpha-amino acid transmembrane transport (GO:1902475),3/15,3,15,0.000841525460397454,0.145957915964492,0,0,15.625,110.629598262854,SLC7A5;SLC1A1;SLC7A1
beta,3,negative regulation of protein kinase B signaling (GO:0051898),4/36,4,36,0.00111924029825752,0.174279564265896,0,0,8.68055555555556,58.9852875777375,PHLPP2;FLCN;DDIT3;TRIB3
beta,3,positive regulation of autophagy (GO:0010508),5/68,5,68,0.00178633762220009,0.174279564265896,0,0,5.74448529411765,36.3487349276617,EPM2A;FLCN;BNIP3L;EIF2AK4;TRIM65
beta,3,positive regulation of axon extension (GO:0045773),3/19,3,19,0.0017256611456045,0.174279564265896,0,0,12.3355263157895,78.4804074315157,RUFY3;MAPT;VEGFA
beta,3,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),5/69,5,69,0.00190610706024505,0.175025477708384,0,0,5.66123188405797,35.4545533582967,LAMP3;TRIAP1;KLF4;BIRC2;VEGFA
beta,3,positive regulation of neurogenesis (GO:0050769),5/70,5,70,0.00203164583600174,0.176188841666596,0,0,5.58035714285714,34.5921264384094,ZEB1;TCF12;LIG4;CTNNB1;VEGFA
beta,3,positive regulation of neuron apoptotic process (GO:0043525),3/19,3,19,0.0017256611456045,0.174279564265896,0,0,12.3355263157895,78.4804074315157,DDIT3;CTNNB1;FOXO3
beta,3,protein targeting to lysosome (GO:0006622),3/19,3,19,0.0017256611456045,0.174279564265896,0,0,12.3355263157895,78.4804074315157,SCARB2;NEDD4;VPS4A
beta,3,regulation of cytoskeleton organization (GO:0051493),6/96,6,96,0.00147094119367212,0.174279564265896,0,0,4.8828125,31.8449844495669,EPHA5;PHLDB1;TAOK1;MAPT;PHLDB2;RHOQ
beta,3,regulation of sprouting angiogenesis (GO:1903670),3/19,3,19,0.0017256611456045,0.174279564265896,0,0,12.3355263157895,78.4804074315157,TMEM2;KLF4;VEGFA
beta,3,positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),2/8,2,8,0.00434302740070563,0.218692444274241,0,0,19.53125,106.234055005545,BNIP3L;RHOT1
beta,3,mitochondrial gene expression (GO:0140053),4/46,4,46,0.00280603765693137,0.218692444274241,0,0,6.79347826086957,39.9183551443296,MRPS16;MRPS34;GATC;FOXO3
beta,3,amino acid import across plasma membrane (GO:0089718),2/7,2,7,0.00328493738293855,0.218692444274241,0,0,22.3214285714286,127.643028766464,SLC1A1;SLC7A1
beta,3,regulation of mitochondrion organization (GO:0010821),4/49,4,49,0.00353609527259211,0.218692444274241,0,0,6.37755102040816,35.9995675444091,FLCN;RHOT1;MAPT;PPARGC1A
beta,3,regulation of ATP biosynthetic process (GO:2001169),2/8,2,8,0.00434302740070563,0.218692444274241,0,0,19.53125,106.234055005545,FLCN;PPARGC1A
beta,3,protein complex disassembly (GO:0043241),4/47,4,47,0.00303666810087943,0.218692444274241,0,0,6.64893617021277,38.5438456388305,VPS4A;LIX1L;CTNNB1;GABARAP
beta,3,positive regulation of microtubule polymerization or depolymerization (GO:0031112),3/25,3,25,0.00387079393072974,0.218692444274241,0,0,9.375,52.0715216523889,CLIP1;PSRC1;MAPT
beta,3,positive regulation of neuroblast proliferation (GO:0002052),2/7,2,7,0.00328493738293855,0.218692444274241,0,0,22.3214285714286,127.643028766464,CTNNB1;VEGFA
beta,3,positive regulation of extracellular matrix assembly (GO:1901203),2/8,2,8,0.00434302740070563,0.218692444274241,0,0,19.53125,106.234055005545,PHLDB1;PHLDB2
beta,3,regulation of cell differentiation (GO:0045595),6/122,6,122,0.0048759513388244,0.237855001247028,0,0,3.8422131147541,20.4537911647492,PHLDB1;HSP90AB1;SRF;KLF4;PHLDB2;BIRC2
beta,3,regulation of cellular protein localization (GO:1903827),3/26,3,26,0.0043347232189729,0.218692444274241,0,0,9.01442307692308,49.0483550370415,SETD2;CTNNB1;MAPT
beta,3,positive regulation of microtubule polymerization (GO:0031116),3/25,3,25,0.00387079393072974,0.218692444274241,0,0,9.375,52.0715216523889,CLIP1;PSRC1;MAPT
beta,3,regulation of response to biotic stimulus (GO:0002831),2/7,2,7,0.00328493738293855,0.218692444274241,0,0,22.3214285714286,127.643028766464,SCARB2;CD55
beta,3,in utero embryonic development (GO:0001701),3/26,3,26,0.0043347232189729,0.218692444274241,0,0,9.01442307692308,49.0483550370415,FLCN;LIG4;VEGFA
beta,3,protein targeting to vacuole (GO:0006623),3/28,3,28,0.00536008128845798,0.253548087614634,0,0,8.37053571428571,43.767657407288,SCARB2;NEDD4;VPS4A
beta,3,actin filament reorganization (GO:0090527),2/9,2,9,0.00553691079504749,0.25420934561968,0,0,17.3611111111111,90.2138637495188,NEDD9;WHAMM
beta,3,chordate embryonic development (GO:0043009),4/57,4,57,0.00608897620241399,0.256888968972115,0,0,5.48245614035088,27.9675182163086,FLCN;LIG4;SULF1;VEGFA
beta,3,regulation of neuron apoptotic process (GO:0043523),5/90,5,90,0.00600518894161637,0.256888968972115,0,0,4.34027777777778,22.2010909717701,DDIT3;LIG4;CTNNB1;FOXO3;PPARGC1A
beta,3,cytoskeleton organization (GO:0007010),6/127,6,127,0.00591676739742696,0.256888968972115,0,0,3.69094488188976,18.9344181605186,SUN2;ARHGAP10;PALLD;MAST2;NEDD9;RHOQ
beta,3,regulation of neuroblast proliferation (GO:1902692),2/10,2,10,0.00686296545234263,0.267561805816742,0,0,15.625,77.8377445151337,CTNNB1;VEGFA
beta,3,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),3/30,3,30,0.00651933773019922,0.267561805816742,0,0,7.8125,39.3201756509805,CEBPB;DDIT3;VEGFA
beta,3,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),5/94,5,94,0.0071989723538137,0.267561805816742,0,0,4.15558510638298,20.5028964086761,LAMP3;TRIAP1;KLF4;MAP3K5;VEGFA
beta,3,negative regulation of embryonic development (GO:0045992),2/10,2,10,0.00686296545234263,0.267561805816742,0,0,15.625,77.8377445151337,CTNNB1;SULF1
beta,3,protein localization to lysosome (GO:0061462),3/31,3,31,0.00715049457481314,0.267561805816742,0,0,7.56048387096774,37.3531281756495,SCARB2;NEDD4;VPS4A
beta,3,organelle transport along microtubule (GO:0072384),3/32,3,32,0.00781663168154743,0.282257274335527,0,0,7.32421875,35.5334586070034,ARHGAP21;RHOT1;MAPT
beta,3,positive regulation of fatty acid oxidation (GO:0046321),2/11,2,11,0.00831763908996428,0.282257274335527,0,0,14.2045454545455,68.0309208471998,MLYCD;PPARGC1A
beta,3,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),2/11,2,11,0.00831763908996428,0.282257274335527,0,0,14.2045454545455,68.0309208471998,CEBPB;DDIT3
beta,3,regulation of actin filament-based process (GO:0032970),4/63,4,63,0.00865246129705764,0.287372172015042,0,0,4.96031746031746,23.5610687276815,EPHA5;TAOK1;ABRACL;RHOQ
beta,3,negative regulation of morphogenesis of an epithelium (GO:1905331),2/11,2,11,0.00831763908996428,0.282257274335527,0,0,14.2045454545455,68.0309208471998,SULF1;PHLDB2
beta,3,negative regulation of mitochondrion organization (GO:0010823),3/34,3,34,0.00925551737929736,0.287396857082169,0,0,6.89338235294118,32.2785071128665,FLCN;TRIAP1;MAPT
beta,3,regulation of fatty acid oxidation (GO:0046320),2/13,2,13,0.0115989762947961,0.287396857082169,0,0,12.0192307692308,53.5677696539992,MLYCD;PPARGC1A
beta,3,activation of MAPKK activity (GO:0000186),3/34,3,34,0.00925551737929736,0.287396857082169,0,0,6.89338235294118,32.2785071128665,TAOK1;MAP3K4;MAP3K5
beta,3,regulation of protein localization to cell periphery (GO:1904375),2/12,2,12,0.009897448081777,0.287396857082169,0,0,13.0208333333333,60.0973740180643,VPS4A;SPTBN1
beta,3,intrinsic apoptotic signaling pathway (GO:0097193),5/102,5,102,0.0100654035263294,0.287396857082169,0,0,3.8296568627451,17.6112558542407,CEBPB;ZMAT3;DDIT3;TRIB3;MAP3K5
beta,3,B cell activation involved in immune response (GO:0002312),2/13,2,13,0.0115989762947961,0.287396857082169,0,0,12.0192307692308,53.5677696539992,GPR183;LIG4
beta,3,mitochondrion transport along microtubule (GO:0047497),2/12,2,12,0.009897448081777,0.287396857082169,0,0,13.0208333333333,60.0973740180643,RHOT1;MAPT
beta,3,regulation of viral life cycle (GO:1903900),2/13,2,13,0.0115989762947961,0.287396857082169,0,0,12.0192307692308,53.5677696539992,LAMP3;VPS4A
beta,3,positive regulation of telomerase activity (GO:0051973),3/36,3,36,0.0108389981948972,0.287396857082169,0,0,6.51041666666667,29.4570618794681,HSP90AB1;KLF4;MAP3K4
beta,3,regulation of cellular response to stress (GO:0080135),5/105,5,105,0.0113169007042055,0.287396857082169,0,0,3.7202380952381,16.6720908968579,NUAK1;HSP90AB1;EIF2AK4;MAPT;CRYAB
beta,3,neuron development (GO:0048666),6/145,6,145,0.0110195863861241,0.287396857082169,0,0,3.23275862068966,14.5735377445518,EPHA5;SRF;NEDD4;DTNBP1;MAPT;POU3F2
beta,3,positive regulation of synaptic transmission (GO:0050806),4/68,4,68,0.0112595840466482,0.287396857082169,0,0,4.59558823529412,20.6182702102387,RIMS2;UNC13B;DTNBP1;EIF2AK4
beta,3,fatty acid metabolic process (GO:0006631),5/107,5,107,0.0122077351344936,0.297754289764758,0,0,3.65070093457944,16.0838401749996,SCARB2;GPX4;MLYCD;PPARGC1A;ALOXE3
beta,3,modulation by virus of host process (GO:0019054),2/13,2,13,0.0115989762947961,0.287396857082169,0,0,12.0192307692308,53.5677696539992,KPNA4;EIF2AK4
beta,3,regulation of microtubule polymerization (GO:0031113),3/36,3,36,0.0108389981948972,0.287396857082169,0,0,6.51041666666667,29.4570618794681,CLIP1;PSRC1;MAPT
beta,3,mitochondrial outer membrane permeabilization (GO:0097345),2/12,2,12,0.009897448081777,0.287396857082169,0,0,13.0208333333333,60.0973740180643,BNIP3L;RHOT1
beta,3,regulation of protein modification by small protein conjugation or removal (GO:1903320),2/14,2,14,0.0134188739459224,0.299240888994069,0,0,11.1607142857143,48.1148778974189,DNAJB2;HSP90AB1
beta,3,cellular response to amino acid starvation (GO:0034198),3/40,3,40,0.0144491979668688,0.304799973328137,0,0,5.859375,24.8268537303927,RRAGA;EIF2AK4;MAP3K5
beta,3,intracellular steroid hormone receptor signaling pathway (GO:0030518),4/67,4,67,0.0107023330152616,0.287396857082169,0,0,4.66417910447761,21.1627496383945,NCOA1;NEDD4;CTNNB1;PPARGC1A
beta,3,positive regulation of heart rate (GO:0010460),2/14,2,14,0.0134188739459224,0.299240888994069,0,0,11.1607142857143,48.1148778974189,ATP2A2;ADM
beta,3,mitotic DNA damage checkpoint (GO:0044773),3/40,3,40,0.0144491979668688,0.304799973328137,0,0,5.859375,24.8268537303927,MDC1;EME2;TAOK1
beta,3,androgen receptor signaling pathway (GO:0030521),3/41,3,41,0.0154454199457998,0.305193677663208,0,0,5.71646341463415,23.840183478796,NCOA1;CTNNB1;PPARGC1A
beta,3,intra-S DNA damage checkpoint (GO:0031573),2/15,2,15,0.0153538564734708,0.305193677663208,0,0,10.4166666666667,43.5040479213197,MDC1;EME2
beta,3,positive regulation of purine nucleotide metabolic process (GO:1900544),2/14,2,14,0.0134188739459224,0.299240888994069,0,0,11.1607142857143,48.1148778974189,BEND3;ADM
beta,3,negative regulation of cysteine-type endopeptidase activity (GO:2000117),4/73,4,73,0.0143251006601914,0.304799973328137,0,0,4.28082191780822,18.1752653660812,LAMP3;TRIAP1;KLF4;VEGFA
beta,3,lipoxygenase pathway (GO:0019372),2/15,2,15,0.0153538564734708,0.305193677663208,0,0,10.4166666666667,43.5040479213197,GPX4;ALOXE3
beta,3,regulation of gastrulation (GO:0010470),2/14,2,14,0.0134188739459224,0.299240888994069,0,0,11.1607142857143,48.1148778974189,PHLDB1;PHLDB2
beta,3,regulation of telomerase activity (GO:0051972),3/43,3,43,0.0175514279981673,0.307840214664484,0,0,5.45058139534884,22.0346291694957,HSP90AB1;KLF4;MAP3K4
beta,3,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",2/16,2,16,0.0174007034329066,0.307840214664484,0,0,9.765625,39.5629360000026,SRF;CTNNB1
beta,3,cell-cell junction organization (GO:0045216),4/73,4,73,0.0143251006601914,0.304799973328137,0,0,4.28082191780822,18.1752653660812,CDH6;FLCN;SDK1;PERP
beta,3,positive regulation of CREB transcription factor activity (GO:0032793),2/15,2,15,0.0153538564734708,0.305193677663208,0,0,10.4166666666667,43.5040479213197,EPHA5;VEGFA
beta,3,regulation of cytokinesis (GO:0032465),4/78,4,78,0.0178731431674193,0.309999738714906,0,0,4.00641025641026,16.1236220935241,FLCN;SETD2;VPS4A;RAB11FIP4
beta,3,cell migration involved in sprouting angiogenesis (GO:0002042),2/14,2,14,0.0134188739459224,0.299240888994069,0,0,11.1607142857143,48.1148778974189,SRF;VEGFA
beta,3,regulation of glucose transport (GO:0010827),2/16,2,16,0.0174007034329066,0.307840214664484,0,0,9.765625,39.5629360000026,SLC2A1;TRIB3
beta,3,sprouting angiogenesis (GO:0002040),3/45,3,45,0.0198095676536825,0.31397115651903,0,0,5.20833333333333,20.4249491831244,SRF;NRARP;VEGFA
beta,3,negative regulation of adherens junction organization (GO:1903392),2/15,2,15,0.0153538564734708,0.305193677663208,0,0,10.4166666666667,43.5040479213197,RDX;PHLDB2
beta,3,chaperone-mediated protein complex assembly (GO:0051131),2/17,2,17,0.0195562573945375,0.31397115651903,0,0,9.19117647058824,36.1623159230774,HSP90AB1;PTGES3L
beta,3,regulation of actin cytoskeleton organization (GO:0032956),4/76,4,76,0.0163946517264898,0.307840214664484,0,0,4.11184210526316,16.9029609851037,EPHA5;TAOK1;RDX;RHOQ
beta,3,mRNA transcription from RNA polymerase II promoter (GO:0042789),2/16,2,16,0.0174007034329066,0.307840214664484,0,0,9.765625,39.5629360000026,SRF;DDIT3
beta,3,positive regulation of neural precursor cell proliferation (GO:2000179),2/14,2,14,0.0134188739459224,0.299240888994069,0,0,11.1607142857143,48.1148778974189,CTNNB1;VEGFA
beta,3,actin filament organization (GO:0007015),5/121,5,121,0.0197978619318165,0.31397115651903,0,0,3.22830578512397,12.6620006790865,RUFY3;DSTN;NEDD9;WHAMM;RHOQ
beta,3,branching morphogenesis of an epithelial tube (GO:0048754),3/44,3,44,0.0186614402383852,0.31397115651903,0,0,5.32670454545455,21.2071869851644,CTNNB1;NRARP;VEGFA
beta,3,regulation of protein localization to membrane (GO:1905475),2/17,2,17,0.0195562573945375,0.31397115651903,0,0,9.19117647058824,36.1623159230774,VPS4A;SPTBN1
beta,3,regulation of anatomical structure morphogenesis (GO:0022603),4/83,4,83,0.0219236746063896,0.31397115651903,0,0,3.76506024096386,14.3832386814723,PHLDB1;CTNNB1;MAPT;PHLDB2
beta,3,positive regulation of stress-activated MAPK cascade (GO:0032874),4/81,4,81,0.0202420595825168,0.31397115651903,0,0,3.85802469135802,15.0462680621543,TAOK1;MAP3K4;MAP3K5;VEGFA
beta,3,regulation of energy homeostasis (GO:2000505),2/16,2,16,0.0174007034329066,0.307840214664484,0,0,9.765625,39.5629360000026,FLCN;PPARGC1A
beta,3,focal adhesion assembly (GO:0048041),2/18,2,18,0.02181742288338,0.31397115651903,0,0,8.68055555555556,33.203527895445,TESK2;WHAMM
beta,3,peptidyl-lysine trimethylation (GO:0018023),2/17,2,17,0.0195562573945375,0.31397115651903,0,0,9.19117647058824,36.1623159230774,SETD2;BEND3
beta,3,cell-substrate adherens junction assembly (GO:0007045),2/18,2,18,0.02181742288338,0.31397115651903,0,0,8.68055555555556,33.203527895445,TESK2;WHAMM
beta,3,cytoplasmic sequestering of transcription factor (GO:0042994),2/16,2,16,0.0174007034329066,0.307840214664484,0,0,9.765625,39.5629360000026,G3BP2;NFKBIE
beta,3,positive regulation of stem cell proliferation (GO:2000648),2/17,2,17,0.0195562573945375,0.31397115651903,0,0,9.19117647058824,36.1623159230774,CTNNB1;VEGFA
beta,3,blood vessel endothelial cell migration (GO:0043534),2/18,2,18,0.02181742288338,0.31397115651903,0,0,8.68055555555556,33.203527895445,SRF;VEGFA
beta,3,C21-steroid hormone biosynthetic process (GO:0006700),2/16,2,16,0.0174007034329066,0.307840214664484,0,0,9.765625,39.5629360000026,FDX1;ADM
beta,3,nucleic acid-templated transcription (GO:0097659),4/77,4,77,0.0171239141392643,0.307840214664484,0,0,4.05844155844156,16.5068153602694,NCOA1;BAZ1A;BAZ2B;NR3C1
beta,3,positive regulation of fatty acid metabolic process (GO:0045923),2/17,2,17,0.0195562573945375,0.31397115651903,0,0,9.19117647058824,36.1623159230774,MLYCD;PPARGC1A
beta,3,acute-phase response (GO:0006953),2/18,2,18,0.02181742288338,0.31397115651903,0,0,8.68055555555556,33.203527895445,CEBPB;IL6R
beta,3,regulation of macroautophagy (GO:0016241),5/117,5,117,0.0173780634817039,0.307840214664484,0,0,3.33867521367521,13.530136844215,EPM2A;BNIP3L;RRAGA;NEDD4;ATP6V1E2
beta,3,positive regulation of p38MAPK cascade (GO:1900745),2/18,2,18,0.02181742288338,0.31397115651903,0,0,8.68055555555556,33.203527895445,MAP3K4;VEGFA
beta,3,modulation by virus of host morphology or physiology (GO:0019048),2/18,2,18,0.02181742288338,0.31397115651903,0,0,8.68055555555556,33.203527895445,RRAGA;KPNA4
beta,3,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),2/18,2,18,0.02181742288338,0.31397115651903,0,0,8.68055555555556,33.203527895445,NEDD4;VPS4A
beta,3,histone H4 acetylation (GO:0043967),3/48,3,48,0.0234830547190964,0.33324589469554,0,0,4.8828125,18.3177548521257,KANSL1;BEND3;YEATS4
beta,3,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),2/18,2,18,0.02181742288338,0.31397115651903,0,0,8.68055555555556,33.203527895445,SCARB2;CD55
beta,3,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),2/19,2,19,0.0241811653080765,0.33404246943281,0,0,8.22368421052632,30.6100431077423,FLCN;HSP90AB1
beta,3,membrane lipid metabolic process (GO:0006643),2/18,2,18,0.02181742288338,0.31397115651903,0,0,8.68055555555556,33.203527895445,KDELC2;ALOXE3
beta,3,positive regulation of heart contraction (GO:0045823),2/19,2,19,0.0241811653080765,0.33404246943281,0,0,8.22368421052632,30.6100431077423,ATP2A2;ADM
beta,3,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),2/19,2,19,0.0241811653080765,0.33404246943281,0,0,8.22368421052632,30.6100431077423,FLCN;HSP90AB1
beta,3,amino acid transport (GO:0006865),3/49,3,49,0.0247839458813216,0.339366136146868,0,0,4.78316326530612,17.6860292359227,SLC7A5;SLC7A11;SLC7A1
beta,3,regulation of transport (GO:0051049),2/20,2,20,0.0266445099264503,0.349513277270495,0,0,7.8125,28.3216574695682,SLC2A1;TRIB3
beta,3,dopaminergic neuron differentiation (GO:0071542),2/20,2,20,0.0266445099264503,0.349513277270495,0,0,7.8125,28.3216574695682,CTNNB1;VEGFA
beta,3,non-recombinational repair (GO:0000726),3/50,3,50,0.0261229956178482,0.349513277270495,0,0,4.6875,17.0856529425108,BARD1;MDC1;LIG4
beta,3,heparan sulfate proteoglycan metabolic process (GO:0030201),2/20,2,20,0.0266445099264503,0.349513277270495,0,0,7.8125,28.3216574695682,EXT1;SULF1
beta,3,double-strand break repair via nonhomologous end joining (GO:0006303),3/51,3,51,0.0275001502738736,0.35477466592989,0,0,4.59558823529412,16.5145395671877,BARD1;MDC1;LIG4
beta,3,neuromuscular junction development (GO:0007528),2/20,2,20,0.0266445099264503,0.349513277270495,0,0,7.8125,28.3216574695682,UNC13B;NEDD4
beta,3,positive regulation of JUN kinase activity (GO:0043507),3/51,3,51,0.0275001502738736,0.35477466592989,0,0,4.59558823529412,16.5145395671877,TAOK1;MAP3K4;MAP3K5
beta,3,positive regulation of developmental growth (GO:0048639),3/52,3,52,0.0289153370729853,0.367647485684764,0,0,4.50721153846154,15.9707773290205,RIMS2;RUFY3;MAPT
beta,3,mRNA transcription (GO:0009299),2/21,2,21,0.0292045408231331,0.367647485684764,0,0,7.44047619047619,26.2904097779495,SRF;DDIT3
beta,3,positive regulation of defense response to virus by host (GO:0002230),2/21,2,21,0.0292045408231331,0.367647485684764,0,0,7.44047619047619,26.2904097779495,TRAF3IP2;EIF2AK4
beta,3,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),2/22,2,22,0.0318583998947526,0.387775660406882,0,0,7.10227272727273,24.4776576617622,NEDD4;VEGFA
beta,3,lymphocyte activation involved in immune response (GO:0002285),2/22,2,22,0.0318583998947526,0.387775660406882,0,0,7.10227272727273,24.4776576617622,GPR183;EIF2AK4
beta,3,positive regulation of transferase activity (GO:0051347),5/138,5,138,0.0325038227295421,0.387775660406882,0,0,2.83061594202899,9.69881559702212,EPHA5;HSP90AB1;TRIB3;KLF4;MAP3K4
beta,3,response to cytokine (GO:0034097),5/139,5,139,0.0333784632727772,0.387775660406882,0,0,2.81025179856115,9.55441883760278,SETD2;LAMP3;SRF;IL6R;NFKB2
beta,3,cellular response to growth factor stimulus (GO:0071363),5/140,5,140,0.0342676380803861,0.387775660406882,0,0,2.79017857142857,9.41281770753794,CTNNB1;MAPT;NR3C1;KLF4;VEGFA
beta,3,neuron differentiation (GO:0030182),5/140,5,140,0.0342676380803861,0.387775660406882,0,0,2.79017857142857,9.41281770753794,EPHA5;SRF;CTNNB1;POU3F2;VEGFA
beta,3,melanosome organization (GO:0032438),2/23,2,23,0.0346032858551815,0.387775660406882,0,0,6.79347826086957,22.8519472453449,HPS4;DTNBP1
beta,3,positive regulation of ATP metabolic process (GO:1903580),2/23,2,23,0.0346032858551815,0.387775660406882,0,0,6.79347826086957,22.8519472453449,BEND3;PPARGC1A
beta,3,autophagosome maturation (GO:0097352),2/23,2,23,0.0346032858551815,0.387775660406882,0,0,6.79347826086957,22.8519472453449,LIX1L;GABARAP
beta,3,regulation of cellular catabolic process (GO:0031329),3/56,3,56,0.0349543179282207,0.387775660406882,0,0,4.18526785714286,14.036188359633,RRAGA;LAMP3;MAPT
beta,3,positive regulation of DNA biosynthetic process (GO:2000573),3/56,3,56,0.0349543179282207,0.387775660406882,0,0,4.18526785714286,14.036188359633,HSP90AB1;KLF4;MAP3K4
beta,3,fat cell differentiation (GO:0045444),3/56,3,56,0.0349543179282207,0.387775660406882,0,0,4.18526785714286,14.036188359633,KLF4;PPARGC1A;ALOXE3
beta,3,regulation of small GTPase mediated signal transduction (GO:0051056),5/141,5,141,0.0351713968109782,0.387775660406882,0,0,2.77039007092199,9.27394203597628,ARHGAP21;ARHGAP10;DEPDC1B;RHOT1;RHOQ
beta,3,response to UV (GO:0009411),4/99,4,99,0.0384200121305922,0.387775660406882,0,0,3.15656565656566,10.2878055741963,NEDD4;EIF2AK4;TRIAP1;MAP3K4
beta,3,regulation of chromosome organization (GO:0033044),2/25,2,25,0.0403552115912841,0.387775660406882,0,0,6.25,20.0627170810705,LIG4;MAPT
beta,3,regulation of cellular senescence (GO:2000772),2/25,2,25,0.0403552115912841,0.387775660406882,0,0,6.25,20.0627170810705,NUAK1;ARG2
beta,3,cell junction assembly (GO:0034329),3/60,3,60,0.0415914613876432,0.387775660406882,0,0,3.90625,12.421329640185,CDH6;FLCN;CTNNB1
beta,3,neutral amino acid transport (GO:0015804),2/26,2,26,0.043356924199571,0.387775660406882,0,0,6.00961538461539,18.8599090187717,SLC7A5;SLC1A1
beta,3,negative regulation of cellular protein localization (GO:1903828),2/26,2,26,0.043356924199571,0.387775660406882,0,0,6.00961538461539,18.8599090187717,FLCN;MAPT
beta,3,respiratory tube development (GO:0030323),2/26,2,26,0.043356924199571,0.387775660406882,0,0,6.00961538461539,18.8599090187717,HECA;VEGFA
beta,3,protein depolymerization (GO:0051261),2/26,2,26,0.043356924199571,0.387775660406882,0,0,6.00961538461539,18.8599090187717,VPS4A;DSTN
beta,3,positive regulation of embryonic development (GO:0040019),2/26,2,26,0.043356924199571,0.387775660406882,0,0,6.00961538461539,18.8599090187717,PHLDB1;PHLDB2
beta,3,L-amino acid transport (GO:0015807),2/26,2,26,0.043356924199571,0.387775660406882,0,0,6.00961538461539,18.8599090187717,SLC7A5;SLC1A1
beta,3,positive regulation of nitric oxide biosynthetic process (GO:0045429),2/26,2,26,0.043356924199571,0.387775660406882,0,0,6.00961538461539,18.8599090187717,HSP90AB1;KLF4
beta,3,positive regulation of nitric oxide metabolic process (GO:1904407),2/26,2,26,0.043356924199571,0.387775660406882,0,0,6.00961538461539,18.8599090187717,HSP90AB1;KLF4
beta,3,actin cytoskeleton reorganization (GO:0031532),3/62,3,62,0.0451305851204362,0.387775660406882,0,0,3.78024193548387,11.7119270413533,DTNBP1;NEDD9;WHAMM
beta,3,regulation of vesicle fusion (GO:0031338),3/62,3,62,0.0451305851204362,0.387775660406882,0,0,3.78024193548387,11.7119270413533,TBC1D30;RUNDC1;TBC1D9
beta,3,response to growth factor (GO:0070848),2/27,2,27,0.0464390074860943,0.387775660406882,0,0,5.78703703703704,17.7639785552235,CTNNB1;KLF4
beta,3,response to gamma radiation (GO:0010332),2/27,2,27,0.0464390074860943,0.387775660406882,0,0,5.78703703703704,17.7639785552235,LIG4;CRYAB
beta,3,regulation of p38MAPK cascade (GO:1900744),2/27,2,27,0.0464390074860943,0.387775660406882,0,0,5.78703703703704,17.7639785552235,MAP3K4;VEGFA
beta,3,regulation of supramolecular fiber organization (GO:1902903),2/27,2,27,0.0464390074860943,0.387775660406882,0,0,5.78703703703704,17.7639785552235,RDX;MAPT
beta,3,regulation of histone acetylation (GO:0035065),2/27,2,27,0.0464390074860943,0.387775660406882,0,0,5.78703703703704,17.7639785552235,FLCN;PPARGC1A
beta,3,positive regulation of type I interferon production (GO:0032481),3/63,3,63,0.0469544937333477,0.387775660406882,0,0,3.7202380952381,11.3786323092922,SETD2;CTNNB1;NFKB2
beta,3,cellular protein catabolic process (GO:0044257),3/63,3,63,0.0469544937333477,0.387775660406882,0,0,3.7202380952381,11.3786323092922,BNIP3L;UBE2G1;CTSV
beta,3,regulation of cilium assembly (GO:1902017),2/28,2,28,0.0495989299368744,0.387775660406882,0,0,5.58035714285714,16.7621987686234,CEP120;TBC1D30
beta,3,negative regulation of cell-matrix adhesion (GO:0001953),2/28,2,28,0.0495989299368744,0.387775660406882,0,0,5.58035714285714,16.7621987686234,ADAM15;PHLDB2
beta,3,regulation of neurotransmitter secretion (GO:0046928),2/28,2,28,0.0495989299368744,0.387775660406882,0,0,5.58035714285714,16.7621987686234,RIMS2;DTNBP1
beta,3,regulation of protein localization to cell surface (GO:2000008),2/28,2,28,0.0495989299368744,0.387775660406882,0,0,5.58035714285714,16.7621987686234,HSP90AB1;CTNNB1
beta,3,viral life cycle (GO:0019058),4/108,4,108,0.0501258169929716,0.387775660406882,0,0,2.89351851851852,8.66093487956186,HSP90AB1;VPS4A;KPNA4;DEK
beta,3,cellular response to starvation (GO:0009267),4/108,4,108,0.0501258169929716,0.387775660406882,0,0,2.89351851851852,8.66093487956186,RRAGA;EIF2AK4;GABARAP;MAP3K5
beta,3,positive regulation of protein polymerization (GO:0032273),3/65,3,65,0.050709733814461,0.387775660406882,0,0,3.60576923076923,10.7510963883228,CLIP1;PSRC1;MAPT
beta,3,cellular response to decreased oxygen levels (GO:0036294),3/65,3,65,0.050709733814461,0.387775660406882,0,0,3.60576923076923,10.7510963883228,BNIP3L;HYOU1;VEGFA
beta,3,negative regulation of blood vessel morphogenesis (GO:2000181),3/66,3,66,0.0526405226550416,0.387775660406882,0,0,3.55113636363636,10.4555009345071,CTNNB1;SULF1;KLF4
beta,3,regulation of cell division (GO:0051302),3/66,3,66,0.0526405226550416,0.387775660406882,0,0,3.55113636363636,10.4555009345071,FLCN;SETD2;RAB11FIP4
beta,3,neuron projection extension (GO:1990138),2/29,2,29,0.0528342112266506,0.387775660406882,0,0,5.38793103448276,15.8437303781986,CTNNB1;EIF2AK4
beta,3,negative regulation of proteasomal protein catabolic process (GO:1901799),2/29,2,29,0.0528342112266506,0.387775660406882,0,0,5.38793103448276,15.8437303781986,HSP90AB1;LAMP3
beta,3,acute inflammatory response (GO:0002526),2/29,2,29,0.0528342112266506,0.387775660406882,0,0,5.38793103448276,15.8437303781986,CEBPB;IL6R
beta,3,positive regulation of sprouting angiogenesis (GO:1903672),2/29,2,29,0.0528342112266506,0.387775660406882,0,0,5.38793103448276,15.8437303781986,KLF4;VEGFA
beta,3,cellular response to light stimulus (GO:0071482),3/67,3,67,0.0546063776418722,0.387775660406882,0,0,3.49813432835821,10.1711914520462,NEDD4;TRIAP1;EIF2AK4
beta,3,positive regulation of cellular protein localization (GO:1903829),3/67,3,67,0.0546063776418722,0.387775660406882,0,0,3.49813432835821,10.1711914520462,HSP90AB1;RUFY3;MAPT
beta,3,regulation of embryonic development (GO:0045995),2/30,2,30,0.0561424213258379,0.387775660406882,0,0,5.20833333333333,14.9992894731376,PHLDB1;PHLDB2
beta,3,amino acid transmembrane transport (GO:0003333),2/30,2,30,0.0561424213258379,0.387775660406882,0,0,5.20833333333333,14.9992894731376,SLC7A5;SLC7A11
beta,3,regulation of TOR signaling (GO:0032006),3/68,3,68,0.0566070012156688,0.387775660406882,0,0,3.44669117647059,9.89759629492024,EPM2A;FLCN;RRAGA
beta,3,cellular response to UV (GO:0034644),3/68,3,68,0.0566070012156688,0.387775660406882,0,0,3.44669117647059,9.89759629492024,NEDD4;TRIAP1;EIF2AK4
beta,3,regulation of protein localization to plasma membrane (GO:1903076),3/68,3,68,0.0566070012156688,0.387775660406882,0,0,3.44669117647059,9.89759629492024,VPS4A;RHOQ;SPTBN1
beta,3,regulation of epithelial to mesenchymal transition (GO:0010717),3/69,3,69,0.0586420861267429,0.387775660406882,0,0,3.39673913043478,9.63418018643827,PHLDB1;CTNNB1;PHLDB2
beta,3,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),2/31,2,31,0.0595211796348791,0.387775660406882,0,0,5.04032258064516,14.2208824068513,KLF4;VEGFA
beta,3,regulation of defense response to virus by host (GO:0050691),2/31,2,31,0.0595211796348791,0.387775660406882,0,0,5.04032258064516,14.2208824068513,TRAF3IP2;EIF2AK4
beta,3,cyclic purine nucleotide metabolic process (GO:0052652),2/31,2,31,0.0595211796348791,0.387775660406882,0,0,5.04032258064516,14.2208824068513,ADM;AMPD2
beta,3,activation of JUN kinase activity (GO:0007257),2/31,2,31,0.0595211796348791,0.387775660406882,0,0,5.04032258064516,14.2208824068513,TAOK1;MAP3K5
beta,3,nuclear envelope organization (GO:0006998),2/31,2,31,0.0595211796348791,0.387775660406882,0,0,5.04032258064516,14.2208824068513,SUN2;VPS4A
beta,3,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),2/31,2,31,0.0595211796348791,0.387775660406882,0,0,5.04032258064516,14.2208824068513,HSP90AB1;KLF4
beta,3,negative regulation of angiogenesis (GO:0016525),3/70,3,70,0.0607113158894244,0.387775660406882,0,0,3.34821428571429,9.38044143439226,CTNNB1;SULF1;KLF4
beta,3,negative regulation of cell growth (GO:0030308),4/116,4,116,0.0619957857154388,0.387775660406882,0,0,2.69396551724138,7.49107992612851,DNAJB2;FLCN;PSRC1;ADAM15
beta,3,cellular response to oxidative stress (GO:0034599),4/116,4,116,0.0619957857154388,0.387775660406882,0,0,2.69396551724138,7.49107992612851,VRK2;MAPT;FOXO3;PPARGC1A
beta,3,stress-activated protein kinase signaling cascade (GO:0031098),3/71,3,71,0.0628143652029876,0.387775660406882,0,0,3.30105633802817,9.13590939611254,TAOK1;MAP3K4;MAP3K5
beta,3,vascular endothelial growth factor receptor signaling pathway (GO:0048010),3/71,3,71,0.0628143652029876,0.387775660406882,0,0,3.30105633802817,9.13590939611254,ELMO1;SULF1;VEGFA
beta,3,negative regulation of cell-cell adhesion (GO:0022408),2/32,2,32,0.0629681541381154,0.387775660406882,0,0,4.8828125,13.5015926282464,RDX;KLF4
beta,3,regulation of protein export from nucleus (GO:0046825),2/32,2,32,0.0629681541381154,0.387775660406882,0,0,4.8828125,13.5015926282464,BARD1;SETD2
beta,3,liver development (GO:0001889),2/32,2,32,0.0629681541381154,0.387775660406882,0,0,4.8828125,13.5015926282464,CEBPB;CEBPG
beta,3,central nervous system neuron differentiation (GO:0021953),2/33,2,33,0.0664810605246276,0.387775660406882,0,0,4.73484848484848,12.8354080304246,CTNNB1;MAPT
beta,3,microtubule bundle formation (GO:0001578),2/33,2,33,0.0664810605246276,0.387775660406882,0,0,4.73484848484848,12.8354080304246,CLIP1;PSRC1
beta,3,cyclic-nucleotide-mediated signaling (GO:0019935),2/33,2,33,0.0664810605246276,0.387775660406882,0,0,4.73484848484848,12.8354080304246,RIMS2;EPHA5
beta,3,positive regulation of TOR signaling (GO:0032008),2/33,2,33,0.0664810605246276,0.387775660406882,0,0,4.73484848484848,12.8354080304246,FLCN;RRAGA
beta,3,regulation of nitric oxide biosynthetic process (GO:0045428),2/33,2,33,0.0664810605246276,0.387775660406882,0,0,4.73484848484848,12.8354080304246,HSP90AB1;KLF4
beta,3,vasculogenesis (GO:0001570),2/33,2,33,0.0664810605246276,0.387775660406882,0,0,4.73484848484848,12.8354080304246,ADM;VEGFA
beta,3,lysosomal transport (GO:0007041),3/73,3,73,0.0671205797253898,0.387775660406882,0,0,3.21061643835616,8.6727244639734,SCARB2;NEDD4;VPS4A
beta,3,regulation of neuron death (GO:1901214),3/73,3,73,0.0671205797253898,0.387775660406882,0,0,3.21061643835616,8.6727244639734,MAPT;PPARGC1A;MAP3K5
beta,3,regulation of fat cell differentiation (GO:0045598),3/73,3,73,0.0671205797253898,0.387775660406882,0,0,3.21061643835616,8.6727244639734,CEBPB;CREB1;TRIB3
beta,3,B cell activation (GO:0042113),3/74,3,74,0.0693230539515452,0.387775660406882,0,0,3.16722972972973,8.45326570709933,KLF6;GPR183;CEBPG
beta,3,protein acetylation (GO:0006473),2/34,2,34,0.0700576613899032,0.387775660406882,0,0,4.59558823529412,12.2170801556713,NAA16;MAPT
beta,3,positive regulation of cell-matrix adhesion (GO:0001954),2/34,2,34,0.0700576613899032,0.387775660406882,0,0,4.59558823529412,12.2170801556713,UTRN;VEGFA
beta,3,cellular glucose homeostasis (GO:0001678),2/34,2,34,0.0700576613899032,0.387775660406882,0,0,4.59558823529412,12.2170801556713,UNC13B;PPARGC1A
beta,3,positive regulation of organelle organization (GO:0010638),2/34,2,34,0.0700576613899032,0.387775660406882,0,0,4.59558823529412,12.2170801556713,LIG4;PPARGC1A
beta,3,negative regulation of growth (GO:0045926),4/121,4,121,0.0701020723154812,0.387775660406882,0,0,2.58264462809917,6.86416044189952,DNAJB2;FLCN;PSRC1;ADAM15
beta,3,negative regulation of cell migration (GO:0030336),4/122,4,122,0.0717856845986866,0.387775660406882,0,0,2.56147540983607,6.74710604932105,FLCN;ADAM15;SULF1;PHLDB2
beta,3,epithelial tube morphogenesis (GO:0060562),2/35,2,35,0.0736957653993391,0.387775660406882,0,0,4.46428571428571,11.6420086549362,CTNNB1;VEGFA
beta,3,regulation of double-strand break repair (GO:2000779),2/35,2,35,0.0736957653993391,0.387775660406882,0,0,4.46428571428571,11.6420086549362,SETD2;DEK
beta,3,positive regulation of leukocyte migration (GO:0002687),2/35,2,35,0.0736957653993391,0.387775660406882,0,0,4.46428571428571,11.6420086549362,IL6R;VEGFA
beta,3,regulation of JUN kinase activity (GO:0043506),2/35,2,35,0.0736957653993391,0.387775660406882,0,0,4.46428571428571,11.6420086549362,MAP3K4;MAP3K5
beta,3,regulation of axon extension (GO:0030516),2/35,2,35,0.0736957653993391,0.387775660406882,0,0,4.46428571428571,11.6420086549362,RUFY3;MAPT
beta,3,cAMP-mediated signaling (GO:0019933),3/76,3,76,0.0738249542564852,0.387775660406882,0,0,3.08388157894737,8.03677571229421,RIMS2;EPHA5;ADM
beta,3,regulation of protein localization to early endosome (GO:1902965),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,RDX
beta,3,negative regulation of membrane potential (GO:0045837),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,MAPT
beta,3,polyamine biosynthetic process (GO:0006596),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,AMD1
beta,3,positive regulation of adaptive immune response (GO:0002821),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,EIF2AK4
beta,3,mesodermal cell fate commitment (GO:0001710),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,KLF4
beta,3,negative regulation of transforming growth factor beta production (GO:0071635),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,HSP90AB1
beta,3,positive regulation of deacetylase activity (GO:0090045),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,VEGFA
beta,3,amylin receptor signaling pathway (GO:0097647),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,ADM
beta,3,negative regulation of translation in response to stress (GO:0032055),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,EIF2AK4
beta,3,regulation of translational initiation in response to stress (GO:0043558),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,EIF2AK4
beta,3,viral release from host cell (GO:0019076),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,VPS4A
beta,3,N-terminal peptidyl-methionine acetylation (GO:0017196),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,NAA16
beta,3,positive regulation of protein localization to early endosome (GO:1902966),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,RDX
beta,3,"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,RHOT1
beta,3,positive regulation of ATP biosynthetic process (GO:2001171),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,PPARGC1A
beta,3,negative regulation of cellular response to hypoxia (GO:1900038),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,HYOU1
beta,3,regulation of nuclear cell cycle DNA replication (GO:0033262),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,CDC7
beta,3,"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,EXT1
beta,3,negative regulation of necroptotic process (GO:0060546),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,BIRC2
beta,3,vascular smooth muscle cell development (GO:0097084),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,VEGFA
beta,3,"regulation of wound healing, spreading of epidermal cells (GO:1903689)",1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,PHLDB2
beta,3,spermine metabolic process (GO:0008215),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,AMD1
beta,3,regulation of histone deacetylase activity (GO:1901725),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,VEGFA
beta,3,regulation of ribonucleoprotein complex localization (GO:2000197),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,SETD2
beta,3,nucleus localization (GO:0051647),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,SUN2
beta,3,negative regulation of complement activation (GO:0045916),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,CD55
beta,3,negative regulation of cell size (GO:0045792),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,RDX
beta,3,blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,NRARP
beta,3,regulation of protein K63-linked ubiquitination (GO:1900044),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,BIRC2
beta,3,embryonic skeletal joint morphogenesis (GO:0060272),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,CTNNB1
beta,3,chemical homeostasis within a tissue (GO:0048875),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,VEGFA
beta,3,lymphoid progenitor cell differentiation (GO:0002320),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,LIG4
beta,3,acetyl-CoA biosynthetic process (GO:0006085),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,MLYCD
beta,3,response to lead ion (GO:0010288),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,MAPT
beta,3,positive regulation of axon guidance (GO:1902669),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,VEGFA
beta,3,corticosteroid receptor signaling pathway (GO:0031958),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,NEDD4
beta,3,positive regulation of protein localization to endosome (GO:1905668),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,RDX
beta,3,plus-end-directed organelle transport along microtubule (GO:0072386),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,MAPT
beta,3,positive regulation of phospholipid transport (GO:2001140),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,TRIAP1
beta,3,morphogenesis of an endothelium (GO:0003159),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,CTNNB1
beta,3,positive regulation of centrosome cycle (GO:0046607),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,CEP120
beta,3,venous blood vessel morphogenesis (GO:0048845),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,VEGFA
beta,3,surfactant homeostasis (GO:0043129),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,VEGFA
beta,3,cellular response to cold (GO:0070417),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,EIF2AK4
beta,3,chondrocyte development (GO:0002063),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,SULF1
beta,3,nucleoside phosphate catabolic process (GO:1901292),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,SMPDL3A
beta,3,regulation of mRNA export from nucleus (GO:0010793),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,SETD2
beta,3,astrocyte activation (GO:0048143),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,MAPT
beta,3,L-amino acid import (GO:0043092),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,SLC1A1
beta,3,single strand break repair (GO:0000012),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,LIG4
beta,3,glucocorticoid receptor signaling pathway (GO:0042921),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,NEDD4
beta,3,endoplasmic reticulum membrane organization (GO:0090158),1/6,1,6,0.0743926647226729,0.387775660406882,0,0,13.0208333333333,33.8333064380317,ATL2
beta,3,positive regulation of JNK cascade (GO:0046330),3/77,3,77,0.0761236471794441,0.387775660406882,0,0,3.04383116883117,7.83907160354637,TAOK1;MAP3K4;MAP3K5
beta,3,negative regulation of macromolecule metabolic process (GO:0010605),4/125,4,125,0.0769594774396378,0.387775660406882,0,0,2.5,6.41119065668309,FLCN;MAPT;KLF4;VEGFA
beta,3,erythrocyte differentiation (GO:0030218),2/36,2,36,0.0773932264944143,0.387775660406882,0,0,4.34027777777778,11.1061458993403,CEBPG;VEGFA
beta,3,regulation of phosphoprotein phosphatase activity (GO:0043666),2/36,2,36,0.0773932264944143,0.387775660406882,0,0,4.34027777777778,11.1061458993403,NUAK1;HSP90AB1
beta,3,carboxylic acid transmembrane transport (GO:1905039),2/36,2,36,0.0773932264944143,0.387775660406882,0,0,4.34027777777778,11.1061458993403,SLC7A5;SLC7A11
beta,3,protein kinase B signaling (GO:0043491),2/36,2,36,0.0773932264944143,0.387775660406882,0,0,4.34027777777778,11.1061458993403,CREB1;FOXO3
beta,3,regulation of cellular response to heat (GO:1900034),3/79,3,79,0.0808146392806934,0.387775660406882,0,0,2.96677215189873,7.46320357194291,HSP90AB1;MAPT;CRYAB
beta,3,regulation of muscle cell differentiation (GO:0051147),2/37,2,37,0.0811479430815823,0.387775660406882,0,0,4.22297297297297,10.6059177890972,SRF;CTNNB1
beta,3,plasma membrane organization (GO:0007009),2/37,2,37,0.0811479430815823,0.387775660406882,0,0,4.22297297297297,10.6059177890972,WHAMM;SPTBN1
beta,3,regulation of cell morphogenesis involved in differentiation (GO:0010769),2/37,2,37,0.0811479430815823,0.387775660406882,0,0,4.22297297297297,10.6059177890972,RUFY3;NEDD4
beta,3,axonal transport (GO:0098930),2/37,2,37,0.0811479430815823,0.387775660406882,0,0,4.22297297297297,10.6059177890972,DTNBP1;MAPT
beta,3,regulation of endothelial cell proliferation (GO:0001936),3/80,3,80,0.0832061696026678,0.387775660406882,0,0,2.9296875,7.28447396491997,NRARP;SULF1;VEGFA
beta,3,regulation of DNA repair (GO:0006282),2/38,2,38,0.0849578572770576,0.387775660406882,0,0,4.11184210526316,10.1381576569908,CEBPG;DEK
beta,3,regulation of sodium ion transmembrane transporter activity (GO:2000649),2/38,2,38,0.0849578572770576,0.387775660406882,0,0,4.11184210526316,10.1381576569908,NEDD4;UTRN
beta,3,protein K63-linked ubiquitination (GO:0070534),2/38,2,38,0.0849578572770576,0.387775660406882,0,0,4.11184210526316,10.1381576569908,NEDD4;UBE2G1
beta,3,positive regulation of axonogenesis (GO:0050772),2/38,2,38,0.0849578572770576,0.387775660406882,0,0,4.11184210526316,10.1381576569908,RUFY3;MAPT
beta,3,cellular response to hormone stimulus (GO:0032870),3/81,3,81,0.0856278681349706,0.387775660406882,0,0,2.89351851851852,7.11152918545698,NCOA1;RDX;NR3C1
beta,3,regulation of cyclic nucleotide metabolic process (GO:0030799),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,VEGFA
beta,3,adherens junction assembly (GO:0034333),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,CTNNB1
beta,3,purine nucleotide biosynthetic process (GO:0006164),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,AMPD2
beta,3,intracellular sterol transport (GO:0032366),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,VPS4A
beta,3,modulation by symbiont of host cellular process (GO:0044068),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,KPNA4
beta,3,progesterone receptor signaling pathway (GO:0050847),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,NEDD4
beta,3,positive regulation of lipid transport (GO:0032370),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,TRIAP1
beta,3,regulation of myosin-light-chain-phosphatase activity (GO:0035507),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,NUAK1
beta,3,regulation of chromatin assembly or disassembly (GO:0001672),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,TLK1
beta,3,brown fat cell differentiation (GO:0050873),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,PPARGC1A
beta,3,hemostasis (GO:0007599),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,HPS4
beta,3,regulation of cardiac muscle cell membrane potential (GO:0086036),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,ATP2A2
beta,3,ornithine transport (GO:0015822),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,SLC7A1
beta,3,cellular response to laminar fluid shear stress (GO:0071499),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,KLF4
beta,3,positive regulation of cellular senescence (GO:2000774),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,ARG2
beta,3,pri-miRNA transcription from RNA polymerase II promoter (GO:0061614),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,KLF4
beta,3,positive regulation of protein kinase C signaling (GO:0090037),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,VEGFA
beta,3,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,HYOU1
beta,3,cytoplasmic sequestering of NF-kappaB (GO:0007253),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,G3BP2
beta,3,negative regulation of cytokinesis (GO:0032466),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,VPS4A
beta,3,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,VEGFA
beta,3,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,SRF
beta,3,exit from host cell (GO:0035891),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,VPS4A
beta,3,regulation of smooth muscle cell differentiation (GO:0051150),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,SRF
beta,3,response to type I interferon (GO:0034340),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,SETD2
beta,3,vascular endothelial growth factor signaling pathway (GO:0038084),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,VEGFA
beta,3,protein localization to cytoplasmic stress granule (GO:1903608),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,YBX1
beta,3,modification by symbiont of host morphology or physiology (GO:0044003),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,RRAGA
beta,3,peroxisome proliferator activated receptor signaling pathway (GO:0035357),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,ALOXE3
beta,3,V(D)J recombination (GO:0033151),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,LIG4
beta,3,positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,VEGFA
beta,3,cellular response to histamine (GO:0071420),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,GABRB3
beta,3,protein maturation by iron-sulfur cluster transfer (GO:0097428),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,ISCA1
beta,3,regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,DDIT3
beta,3,spermidine metabolic process (GO:0008216),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,AMD1
beta,3,store-operated calcium entry (GO:0002115),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,STIM2
beta,3,negative regulation of necrotic cell death (GO:0060547),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,BIRC2
beta,3,regulation of transcription involved in cell fate commitment (GO:0060850),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,CEBPB
beta,3,calcitonin family receptor signaling pathway (GO:0097646),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,ADM
beta,3,neuron fate specification (GO:0048665),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,POU3F2
beta,3,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,CD55
beta,3,microglial cell activation (GO:0001774),1/7,1,7,0.0862439721321662,0.387775660406882,0,0,11.1607142857143,27.3501686812018,MAPT
beta,3,negative regulation of cell death (GO:0060548),3/82,3,82,0.0880793378232014,0.387775660406882,0,0,2.85823170731707,6.9441233931913,BNIP3L;CTNNB1;PPARGC1A
beta,3,negative regulation of cell cycle process (GO:0010948),3/82,3,82,0.0880793378232014,0.387775660406882,0,0,2.85823170731707,6.9441233931913,HSP90AB1;VPS4A;CDC7
beta,3,positive regulation of protein catabolic process (GO:0045732),3/82,3,82,0.0880793378232014,0.387775660406882,0,0,2.85823170731707,6.9441233931913,BARD1;NEDD4;RDX
beta,3,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),3/83,3,83,0.0905601771264205,0.387775660406882,0,0,2.82379518072289,6.78202383836942,FLCN;HSP90AB1;SULF1
beta,3,signal transduction by p53 class mediator (GO:0072331),2/40,2,40,0.0927352608281736,0.387775660406882,0,0,3.90625,9.28908790244678,ZMAT3;TRIAP1
beta,3,positive regulation of fat cell differentiation (GO:0045600),2/40,2,40,0.0927352608281736,0.387775660406882,0,0,3.90625,9.28908790244678,CEBPB;CREB1
beta,3,cellular response to organic substance (GO:0071310),4/134,4,134,0.0935606415807349,0.387775660406882,0,0,2.33208955223881,5.5250594213249,NCOA1;CTNNB1;MAPK6;KLF4
beta,3,positive regulation of supramolecular fiber organization (GO:1902905),3/85,3,85,0.0956083377688686,0.387775660406882,0,0,2.75735294117647,6.47287292529119,CLIP1;PSRC1;MAPT
beta,3,activation of GTPase activity (GO:0090630),3/85,3,85,0.0956083377688686,0.387775660406882,0,0,2.75735294117647,6.47287292529119,TBC1D30;RUNDC1;TBC1D9
beta,3,regulation of neuron differentiation (GO:0045664),3/85,3,85,0.0956083377688686,0.387775660406882,0,0,2.75735294117647,6.47287292529119,ZEB1;TCF12;EIF2AK4
beta,3,negative regulation of TOR signaling (GO:0032007),2/41,2,41,0.096698846058165,0.387775660406882,0,0,3.8109756097561,8.90302518981904,EPM2A;FLCN
beta,3,positive regulation of mitotic cell cycle phase transition (GO:1901992),2/41,2,41,0.096698846058165,0.387775660406882,0,0,3.8109756097561,8.90302518981904,RDX;CDC7
beta,3,regulation of establishment of protein localization to mitochondrion (GO:1903747),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,MAPT
beta,3,positive regulation of cell aging (GO:0090343),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,ARG2
beta,3,negative regulation of protein homooligomerization (GO:0032463),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,CRYAB
beta,3,establishment of integrated proviral latency (GO:0075713),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,LIG4
beta,3,amyloid fibril formation (GO:1990000),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,MAPT
beta,3,cytoskeletal anchoring at nuclear membrane (GO:0090286),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,SUN2
beta,3,lagging strand elongation (GO:0006273),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,LIG4
beta,3,coronary vasculature morphogenesis (GO:0060977),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,VEGFA
beta,3,desmosome organization (GO:0002934),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,PERP
beta,3,protein K6-linked ubiquitination (GO:0085020),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,BARD1
beta,3,positive regulation of early endosome to late endosome transport (GO:2000643),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,RDX
beta,3,desensitization of G-protein coupled receptor protein signaling pathway (GO:0002029),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,ADM
beta,3,regulation of positive chemotaxis (GO:0050926),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,VEGFA
beta,3,dimeric G-protein coupled receptor signaling pathway (GO:0038042),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,ADM
beta,3,positive regulation of protein localization to cell surface (GO:2000010),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,HSP90AB1
beta,3,ketone biosynthetic process (GO:0042181),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,ADM
beta,3,angiogenesis involved in wound healing (GO:0060055),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,SRF
beta,3,negative regulation of establishment of protein localization (GO:1904950),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,MAPT
beta,3,regulation of cytoplasmic mRNA processing body assembly (GO:0010603),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,CNOT6L
beta,3,negative regulation of cilium assembly (GO:1902018),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,TBC1D30
beta,3,regulation of amyloid fibril formation (GO:1905906),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,CRYAB
beta,3,positive regulation of TORC1 signaling (GO:1904263),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,RRAGA
beta,3,regulation of long term synaptic depression (GO:1900452),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,MAPT
beta,3,regulation of dopamine receptor signaling pathway (GO:0060159),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,DTNBP1
beta,3,peptidyl-lysine monomethylation (GO:0018026),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,SETD2
beta,3,aldehyde biosynthetic process (GO:0046184),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,TPI1
beta,3,arginine catabolic process (GO:0006527),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,ARG2
beta,3,regulation of receptor binding (GO:1900120),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,ADAM15
beta,3,regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),1/8,1,8,0.0979441241058752,0.387775660406882,0,0,9.765625,22.6890441904373,ATP2A2
beta,3,regulation of calcium-mediated signaling (GO:0050848),2/42,2,42,0.10070981915033,0.387775660406882,0,0,3.7202380952381,8.53985109773286,TMBIM4;MAPT
beta,3,gluconeogenesis (GO:0006094),2/42,2,42,0.10070981915033,0.387775660406882,0,0,3.7202380952381,8.53985109773286,TPI1;PPARGC1A
beta,3,regulation of vesicle-mediated transport (GO:0060627),4/139,4,139,0.103457569885991,0.387775660406882,0,0,2.24820143884892,5.10025562752403,RIMS2;TBC1D30;RUNDC1;TBC1D9
beta,3,regulation of ion transmembrane transporter activity (GO:0032412),2/43,2,43,0.104766329462666,0.387775660406882,0,0,3.63372093023256,8.19775742176985,NEDD4;UTRN
beta,3,ceramide metabolic process (GO:0006672),2/43,2,43,0.104766329462666,0.387775660406882,0,0,3.63372093023256,8.19775742176985,FUT5;ALOXE3
beta,3,positive regulation of protein complex assembly (GO:0031334),3/89,3,89,0.106038996906099,0.387775660406882,0,0,2.63342696629214,5.90927411478163,UNC13B;CTNNB1;VEGFA
beta,3,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),4/141,4,141,0.10754574308646,0.387775660406882,0,0,2.21631205673759,4.94201907100575,DDIT3;CEBPG;EIF2AK4;KLF4
beta,3,mitotic metaphase plate congression (GO:0007080),2/44,2,44,0.108866565598474,0.387775660406882,0,0,3.55113636363636,7.87511475667989,PSRC1;VPS4A
beta,3,regulation of multicellular organismal development (GO:2000026),2/44,2,44,0.108866565598474,0.387775660406882,0,0,3.55113636363636,7.87511475667989,PHLDB1;PHLDB2
beta,3,L-fucose metabolic process (GO:0042354),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,FUT5
beta,3,acidic amino acid transport (GO:0015800),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,SLC1A1
beta,3,ornithine metabolic process (GO:0006591),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,ARG2
beta,3,response to UV-C (GO:0010225),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,MAP3K4
beta,3,ATF6-mediated unfolded protein response (GO:0036500),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,DDIT3
beta,3,lactation (GO:0007595),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,VEGFA
beta,3,long-chain fatty acid biosynthetic process (GO:0042759),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,ALOXE3
beta,3,negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,SRF
beta,3,sarcoplasmic reticulum calcium ion transport (GO:0070296),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,ATP2A2
beta,3,regulation of endothelial cell differentiation (GO:0045601),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,ZEB1
beta,3,mature B cell differentiation involved in immune response (GO:0002313),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,GPR183
beta,3,establishment of Golgi localization (GO:0051683),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,ARHGAP21
beta,3,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,NAMPT
beta,3,L-fucose catabolic process (GO:0042355),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,FUT5
beta,3,positive regulation of long-term synaptic potentiation (GO:1900273),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,EIF2AK4
beta,3,nuclear migration (GO:0007097),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,SUN2
beta,3,Cdc42 protein signal transduction (GO:0032488),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,RHOQ
beta,3,negative regulation of mRNA 3'-end processing (GO:0031441),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,BARD1
beta,3,somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,LIG4
beta,3,small nucleolar ribonucleoprotein complex assembly (GO:0000491),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,SHQ1
beta,3,central nervous system neuron development (GO:0021954),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,MAPT
beta,3,establishment of viral latency (GO:0019043),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,LIG4
beta,3,L-ascorbic acid metabolic process (GO:0019852),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,SLC2A1
beta,3,protein polyglutamylation (GO:0018095),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,TTLL4
beta,3,peptidyl-amino acid modification (GO:0018193),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,TTLL4
beta,3,negative regulation of protein sumoylation (GO:0033234),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,CTNNB1
beta,3,negative regulation of heterotypic cell-cell adhesion (GO:0034115),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,KLF4
beta,3,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,KLF4
beta,3,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,NEDD4
beta,3,endothelial cell chemotaxis (GO:0035767),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,VEGFA
beta,3,fucose catabolic process (GO:0019317),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,FUT5
beta,3,regulation of homotypic cell-cell adhesion (GO:0034110),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,RDX
beta,3,negative regulation of transcription by competitive promoter binding (GO:0010944),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,CREB1
beta,3,axonal transport of mitochondrion (GO:0019896),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,MAPT
beta,3,regulation of nephron tubule epithelial cell differentiation (GO:0072182),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,CTNNB1
beta,3,histone H3-K4 trimethylation (GO:0080182),1/9,1,9,0.109495040713884,0.387775660406882,0,0,8.68055555555556,19.2003126825988,BEND3
beta,3,double-strand break repair (GO:0006302),4/142,4,142,0.109616931357318,0.387775660406882,0,0,2.20070422535211,4.86523642872428,BARD1;MDC1;EME2;LIG4
beta,3,regulation of cell cycle process (GO:0010564),3/91,3,91,0.111414761666771,0.387775660406882,0,0,2.57554945054945,5.65203154995016,FLCN;SETD2;RAB11FIP4
beta,3,cell-matrix adhesion (GO:0007160),3/91,3,91,0.111414761666771,0.387775660406882,0,0,2.57554945054945,5.65203154995016,ADAM15;TESK2;WHAMM
beta,3,regulation of cytokine-mediated signaling pathway (GO:0001959),3/91,3,91,0.111414761666771,0.387775660406882,0,0,2.57554945054945,5.65203154995016,HSP90AB1;VRK2;BIRC2
beta,3,regulation of focal adhesion assembly (GO:0051893),2/45,2,45,0.113008754752816,0.387775660406882,0,0,3.47222222222222,7.57045134577168,PHLDB2;VEGFA
beta,3,adherens junction organization (GO:0034332),2/45,2,45,0.113008754752816,0.387775660406882,0,0,3.47222222222222,7.57045134577168,CDH6;CTNNB1
beta,3,amide biosynthetic process (GO:0043604),2/45,2,45,0.113008754752816,0.387775660406882,0,0,3.47222222222222,7.57045134577168,ARG2;ALOXE3
beta,3,hexose biosynthetic process (GO:0019319),2/45,2,45,0.113008754752816,0.387775660406882,0,0,3.47222222222222,7.57045134577168,TPI1;PPARGC1A
beta,3,positive regulation of macroautophagy (GO:0016239),2/45,2,45,0.113008754752816,0.387775660406882,0,0,3.47222222222222,7.57045134577168,EPM2A;BNIP3L
beta,3,positive regulation of intracellular transport (GO:0032388),2/45,2,45,0.113008754752816,0.387775660406882,0,0,3.47222222222222,7.57045134577168,RUFY3;NEDD4
beta,3,regulation of smooth muscle cell proliferation (GO:0048660),2/45,2,45,0.113008754752816,0.387775660406882,0,0,3.47222222222222,7.57045134577168,CTNNB1;IL6R
beta,3,microtubule cytoskeleton organization involved in mitosis (GO:1902850),2/45,2,45,0.113008754752816,0.387775660406882,0,0,3.47222222222222,7.57045134577168,SUN2;SETD2
beta,3,metaphase plate congression (GO:0051310),2/45,2,45,0.113008754752816,0.387775660406882,0,0,3.47222222222222,7.57045134577168,PSRC1;VPS4A
beta,3,lipid transport (GO:0006869),3/92,3,92,0.114141259641605,0.387775660406882,0,0,2.54755434782609,5.5290042747952,NCOA1;CHKA;TRIAP1
beta,3,positive regulation of cellular protein metabolic process (GO:0032270),3/92,3,92,0.114141259641605,0.387775660406882,0,0,2.54755434782609,5.5290042747952,PERP;RDX;KLF4
beta,3,protein polymerization (GO:0051258),2/46,2,46,0.117191162028117,0.387775660406882,0,0,3.39673913043478,7.28243483015985,GPX4;MAPT
beta,3,nucleus organization (GO:0006997),2/46,2,46,0.117191162028117,0.387775660406882,0,0,3.39673913043478,7.28243483015985,SUN2;VPS4A
beta,3,negative regulation of response to cytokine stimulus (GO:0060761),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,KLF4
beta,3,induction of positive chemotaxis (GO:0050930),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,VEGFA
beta,3,glomerular filtration (GO:0003094),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,SULF1
beta,3,regulation of chromatin organization (GO:1902275),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,TLK1
beta,3,ganglion development (GO:0061548),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,CTNNB1
beta,3,negative regulation of sodium ion transmembrane transport (GO:1902306),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,NEDD4
beta,3,cellular response to thyroid hormone stimulus (GO:0097067),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,RDX
beta,3,regulation of myeloid leukocyte differentiation (GO:0002761),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,CEBPB
beta,3,positive regulation of cytoplasmic transport (GO:1903651),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,RDX
beta,3,cellular biogenic amine metabolic process (GO:0006576),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,AMD1
beta,3,response to laminar fluid shear stress (GO:0034616),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,KLF4
beta,3,L-glutamate transport (GO:0015813),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,SLC1A1
beta,3,hair cell differentiation (GO:0035315),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,CTNNB1
beta,3,ESCRT III complex disassembly (GO:1904903),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,VPS4A
beta,3,negative regulation of inclusion body assembly (GO:0090084),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,DNAJB2
beta,3,regulation of amyloid-beta clearance (GO:1900221),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,SRF
beta,3,"regulation of DNA-templated transcription, initiation (GO:2000142)",1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,CTNNB1
beta,3,astrocyte development (GO:0014002),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,MAPT
beta,3,peptidyl-lysine dimethylation (GO:0018027),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,SETD2
beta,3,T cell chemotaxis (GO:0010818),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,GPR183
beta,3,regulation of urine volume (GO:0035809),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,ADM
beta,3,glycoprotein catabolic process (GO:0006516),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,STT3B
beta,3,actin filament depolymerization (GO:0030042),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,DSTN
beta,3,negative regulation of reproductive process (GO:2000242),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,SULF1
beta,3,virion attachment to host cell (GO:0019062),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,HSP90AB1
beta,3,endosomal vesicle fusion (GO:0034058),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,VPS4A
beta,3,sympathetic ganglion development (GO:0061549),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,CTNNB1
beta,3,negative regulation by host of viral process (GO:0044793),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,EIF2AK4
beta,3,actin filament-based transport (GO:0099515),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,SUN2
beta,3,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,NEDD4
beta,3,ESCRT complex disassembly (GO:1904896),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,VPS4A
beta,3,regulation of mRNA 3'-end processing (GO:0031440),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,BARD1
beta,3,cellular response to leucine starvation (GO:1990253),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,EIF2AK4
beta,3,protein kinase A signaling (GO:0010737),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,RDX
beta,3,negative regulation of homotypic cell-cell adhesion (GO:0034111),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,RDX
beta,3,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,CTNNB1
beta,3,endothelial tube morphogenesis (GO:0061154),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,CTNNB1
beta,3,response to histamine (GO:0034776),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,GABRB3
beta,3,intracellular cholesterol transport (GO:0032367),1/10,1,10,0.120898617793195,0.387775660406882,0,0,7.8125,16.5062730786871,VPS4A
beta,3,nucleocytoplasmic transport (GO:0006913),2/47,2,47,0.121412089721609,0.387775660406882,0,0,3.32446808510638,7.00985644770568,ATXN1;RSRC1
beta,3,regulation of G1/S transition of mitotic cell cycle (GO:2000045),2/47,2,47,0.121412089721609,0.387775660406882,0,0,3.32446808510638,7.00985644770568,RDX;KLF4
beta,3,regulation of fibroblast proliferation (GO:0048145),2/47,2,47,0.121412089721609,0.387775660406882,0,0,3.32446808510638,7.00985644770568,LIG4;CTNNB1
beta,3,icosanoid metabolic process (GO:0006690),2/47,2,47,0.121412089721609,0.387775660406882,0,0,3.32446808510638,7.00985644770568,GPX4;ALOXE3
beta,3,aminoglycan biosynthetic process (GO:0006023),2/47,2,47,0.121412089721609,0.387775660406882,0,0,3.32446808510638,7.00985644770568,EXT1;UGDH
beta,3,positive regulation of organelle assembly (GO:1902117),2/48,2,48,0.125669876748691,0.387775660406882,0,0,3.25520833333333,6.75161730504297,CNOT6L;CEP120
beta,3,cellular response to heat (GO:0034605),2/48,2,48,0.125669876748691,0.387775660406882,0,0,3.25520833333333,6.75161730504297,HYOU1;MAPT
beta,3,positive regulation of protein metabolic process (GO:0051247),3/97,3,97,0.12814261256182,0.387775660406882,0,0,2.41623711340206,4.964428498646,BARD1;NEDD4;KLF4
beta,3,regulation of cell death (GO:0010941),3/97,3,97,0.12814261256182,0.387775660406882,0,0,2.41623711340206,4.964428498646,BNIP3L;CTNNB1;CRYAB
beta,3,negative regulation of mitotic cell cycle (GO:0045930),2/49,2,49,0.129962897864335,0.387775660406882,0,0,3.18877551020408,6.50671642316569,CTNNB1;HECA
beta,3,cytoplasmic microtubule organization (GO:0031122),2/49,2,49,0.129962897864335,0.387775660406882,0,0,3.18877551020408,6.50671642316569,VPS4A;MAPT
beta,3,protein K48-linked ubiquitination (GO:0070936),2/49,2,49,0.129962897864335,0.387775660406882,0,0,3.18877551020408,6.50671642316569,UBE2G1;RNF187
beta,3,glycoprotein metabolic process (GO:0009100),2/49,2,49,0.129962897864335,0.387775660406882,0,0,3.18877551020408,6.50671642316569,MAN1A2;STT3B
beta,3,positive regulation of chemotaxis (GO:0050921),2/49,2,49,0.129962897864335,0.387775660406882,0,0,3.18877551020408,6.50671642316569,IL6R;VEGFA
beta,3,cellular macromolecule catabolic process (GO:0044265),2/49,2,49,0.129962897864335,0.387775660406882,0,0,3.18877551020408,6.50671642316569,UBE2G1;STT3B
beta,3,cellular response to organonitrogen compound (GO:0071417),3/98,3,98,0.131013608651771,0.387775660406882,0,0,2.39158163265306,4.86077984296514,GABRB3;RRAGA;CTNNB1
beta,3,negative regulation of cell motility (GO:2000146),3/98,3,98,0.131013608651771,0.387775660406882,0,0,2.39158163265306,4.86077984296514,FLCN;ADAM15;SULF1
beta,3,isotype switching (GO:0045190),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,LIG4
beta,3,nitric oxide biosynthetic process (GO:0006809),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,ARG2
beta,3,regulation of feeding behavior (GO:0060259),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,EIF2AK4
beta,3,negative regulation of protein localization to nucleus (GO:1900181),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,FLCN
beta,3,mononuclear cell differentiation (GO:1903131),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,VEGFA
beta,3,intracellular protein transmembrane transport (GO:0065002),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,HYOU1
beta,3,positive regulation of superoxide anion generation (GO:0032930),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,MAPT
beta,3,T-helper cell differentiation (GO:0042093),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,GPR183
beta,3,T cell differentiation in thymus (GO:0033077),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,LIG4
beta,3,negative regulation of fatty acid biosynthetic process (GO:0045717),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,TRIB3
beta,3,calcineurin-NFAT signaling cascade (GO:0033173),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,NFAT5
beta,3,chromatin silencing at rDNA (GO:0000183),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,BEND3
beta,3,positive regulation of cytolysis (GO:0045919),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,RRAGA
beta,3,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,MAP3K5
beta,3,urea cycle (GO:0000050),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,ARG2
beta,3,positive regulation of histone deacetylation (GO:0031065),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,VEGFA
beta,3,regulation of protein kinase C signaling (GO:0090036),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,VEGFA
beta,3,internal protein amino acid acetylation (GO:0006475),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,MAPT
beta,3,calcium ion regulated exocytosis (GO:0017156),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,RIMS2
beta,3,mitochondrion distribution (GO:0048311),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,MAPT
beta,3,stress granule assembly (GO:0034063),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,MAPT
beta,3,monocyte differentiation (GO:0030224),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,VEGFA
beta,3,positive regulation of mesenchymal cell proliferation (GO:0002053),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,VEGFA
beta,3,renal filtration (GO:0097205),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,SULF1
beta,3,regulation of short-term neuronal synaptic plasticity (GO:0048172),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,PPFIA3
beta,3,transcytosis (GO:0045056),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,USO1
beta,3,negative regulation of cell division (GO:0051782),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,VPS4A
beta,3,negative regulation of nucleocytoplasmic transport (GO:0046823),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,BARD1
beta,3,macrophage differentiation (GO:0030225),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,VEGFA
beta,3,negative regulation of receptor binding (GO:1900121),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,ADAM15
beta,3,progesterone metabolic process (GO:0042448),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,ADM
beta,3,protein kinase C signaling (GO:0070528),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,ADAM15
beta,3,camera-type eye morphogenesis (GO:0048593),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,VEGFA
beta,3,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,TRIAP1
beta,3,photoreceptor cell development (GO:0042461),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,VEGFA
beta,3,regulation of synaptic vesicle cycle (GO:0098693),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,RIMS2
beta,3,modulation by host of viral genome replication (GO:0044827),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,EIF2AK4
beta,3,glycerol metabolic process (GO:0006071),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,TPI1
beta,3,carbohydrate phosphorylation (GO:0046835),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,GNPTG
beta,3,inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,BIRC2
beta,3,positive regulation of glucose metabolic process (GO:0010907),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,PPARGC1A
beta,3,response to thyroid hormone (GO:0097066),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,RDX
beta,3,carbohydrate derivative catabolic process (GO:1901136),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,STT3B
beta,3,midbrain dopaminergic neuron differentiation (GO:1904948),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,CTNNB1
beta,3,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,VEGFA
beta,3,positive regulation of interferon-gamma biosynthetic process (GO:0045078),1/11,1,11,0.132156727313556,0.387775660406882,0,0,7.10227272727273,14.3733432711603,CEBPG
beta,3,positive regulation of neuron differentiation (GO:0045666),3/99,3,99,0.133907159945221,0.38895020978526,0,0,2.36742424242424,4.75996343603896,SCARB2;ZEB1;TCF12
beta,3,positive regulation of cell growth (GO:0030307),3/99,3,99,0.133907159945221,0.38895020978526,0,0,2.36742424242424,4.75996343603896,RIMS2;RUFY3;MAPT
beta,3,small GTPase mediated signal transduction (GO:0007264),3/100,3,100,0.136822828193845,0.38895020978526,0,0,2.34375,4.66187909754698,G3BP2;RALGDS;RASGRP3
beta,3,regulation of ion transport (GO:0043269),2/51,2,51,0.138648317265529,0.38895020978526,0,0,3.06372549019608,6.05335368736849,NEDD4;DTNBP1
beta,3,regulation of cellular protein metabolic process (GO:0032268),2/51,2,51,0.138648317265529,0.38895020978526,0,0,3.06372549019608,6.05335368736849,FOXO3;KLF4
beta,3,myeloid leukocyte differentiation (GO:0002573),2/51,2,51,0.138648317265529,0.38895020978526,0,0,3.06372549019608,6.05335368736849,GPR183;VEGFA
beta,3,receptor internalization (GO:0031623),2/51,2,51,0.138648317265529,0.38895020978526,0,0,3.06372549019608,6.05335368736849,NEDD4;ADM
beta,3,carboxylic acid transport (GO:0046942),2/52,2,52,0.143037638930119,0.38895020978526,0,0,3.00480769230769,5.84329168886476,SLC7A11;SLC7A1
beta,3,regulation of systemic arterial blood pressure (GO:0003073),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,ADM
beta,3,regulation of mesenchymal cell proliferation (GO:0010464),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,VEGFA
beta,3,regulation of inclusion body assembly (GO:0090083),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,DNAJB2
beta,3,negative regulation of protein oligomerization (GO:0032460),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,CRYAB
beta,3,vesicle budding from membrane (GO:0006900),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,VPS4A
beta,3,carbohydrate derivative transport (GO:1901264),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,SLC29A1
beta,3,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,TRIAP1
beta,3,regulation of cytokine biosynthetic process (GO:0042035),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,MAST2
beta,3,entry of bacterium into host cell (GO:0035635),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,CTNNB1
beta,3,Golgi localization (GO:0051645),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,ARHGAP21
beta,3,regulation of rRNA processing (GO:2000232),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,SHQ1
beta,3,lysine catabolic process (GO:0006554),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,AASS
beta,3,DNA ligation involved in DNA repair (GO:0051103),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,LIG4
beta,3,polyamine metabolic process (GO:0006595),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,AMD1
beta,3,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,VEGFA
beta,3,eye photoreceptor cell development (GO:0042462),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,VEGFA
beta,3,regulation of interleukin-8 biosynthetic process (GO:0045414),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,KLF4
beta,3,nitric oxide metabolic process (GO:0046209),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,ARG2
beta,3,cellular response to fluid shear stress (GO:0071498),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,KLF4
beta,3,lysine metabolic process (GO:0006553),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,AASS
beta,3,activation of cysteine-type endopeptidase activity (GO:0097202),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,PERP
beta,3,negative regulation of epithelial cell differentiation (GO:0030857),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,ZEB1
beta,3,positive regulation of DNA-dependent DNA replication (GO:2000105),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,CDC7
beta,3,cardiac muscle fiber development (GO:0048739),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,VEGFA
beta,3,negative regulation of ATP metabolic process (GO:1903579),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,FLCN
beta,3,peptidyl-methionine modification (GO:0018206),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,NAA16
beta,3,PERK-mediated unfolded protein response (GO:0036499),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,DDIT3
beta,3,transcription from mitochondrial promoter (GO:0006390),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,FOXO3
beta,3,plasma membrane tubulation (GO:0097320),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,WHAMM
beta,3,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,SULF1
beta,3,regulation of sister chromatid cohesion (GO:0007063),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,CTNNB1
beta,3,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,VEGFA
beta,3,negative regulation of fatty acid metabolic process (GO:0045922),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,TRIB3
beta,3,calcineurin-mediated signaling (GO:0097720),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,NFAT5
beta,3,eye photoreceptor cell differentiation (GO:0001754),1/12,1,12,0.143271217569843,0.38895020978526,0,0,6.51041666666667,12.6498425695607,VEGFA
beta,3,regulation of calcium ion transport (GO:0051924),2/53,2,53,0.147456040303076,0.39754555943541,0,0,2.94811320754717,5.64335253380344,STIM2;CTNNB1
beta,3,regulation of cell-matrix adhesion (GO:0001952),2/53,2,53,0.147456040303076,0.39754555943541,0,0,2.94811320754717,5.64335253380344,ADAM15;UTRN
beta,3,B cell differentiation (GO:0030183),2/53,2,53,0.147456040303076,0.39754555943541,0,0,2.94811320754717,5.64335253380344,KLF6;CEBPG
beta,3,positive regulation of secretion by cell (GO:1903532),2/53,2,53,0.147456040303076,0.39754555943541,0,0,2.94811320754717,5.64335253380344,UNC13B;DTNBP1
beta,3,positive regulation of histone H3-K4 methylation (GO:0051571),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,CTNNB1
beta,3,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,NAMPT
beta,3,nucleotide-sugar metabolic process (GO:0009225),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,UGDH
beta,3,regulation of superoxide anion generation (GO:0032928),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,MAPT
beta,3,cellular response to nitrogen starvation (GO:0006995),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,GABARAP
beta,3,regulation of cell aging (GO:0090342),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,NUAK1
beta,3,DNA replication-independent nucleosome organization (GO:0034724),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,UBN1
beta,3,"Notch receptor processing, ligand-dependent (GO:0035333)",1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,YBX1
beta,3,viral translation (GO:0019081),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,EIF2AK4
beta,3,regulation of DNA-templated transcription in response to stress (GO:0043620),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,DDIT3
beta,3,positive regulation of actin nucleation (GO:0051127),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,WHAMM
beta,3,regulation of axon guidance (GO:1902667),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,VEGFA
beta,3,positive regulation of endothelial cell chemotaxis (GO:2001028),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,VEGFA
beta,3,regulation of cAMP metabolic process (GO:0030814),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,ADM
beta,3,neuron fate commitment (GO:0048663),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,POU3F2
beta,3,positive regulation of muscle contraction (GO:0045933),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,SRF
beta,3,regulation of necrotic cell death (GO:0010939),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,BIRC2
beta,3,positive regulation of alpha-beta T cell proliferation (GO:0046641),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,CD55
beta,3,regulation of cytolysis (GO:0042268),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,RRAGA
beta,3,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,SRF
beta,3,regulation of leukocyte migration (GO:0002685),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,VEGFA
beta,3,negative regulation of chemokine production (GO:0032682),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,KLF4
beta,3,regulation of synaptic vesicle transport (GO:1902803),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,RIMS2
beta,3,cellular response to nitrogen levels (GO:0043562),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,GABARAP
beta,3,regulation of cellular carbohydrate metabolic process (GO:0010675),1/13,1,13,0.154243913497847,0.398633690347913,0,0,6.00961538461539,11.2332937239189,MLYCD
beta,3,negative regulation of cellular component organization (GO:0051129),2/55,2,55,0.156374293965847,0.401725765878002,0,0,2.84090909090909,5.27131484435178,DNAJB2;RDX
beta,3,positive regulation of cellular catabolic process (GO:0031331),3/107,3,107,0.1578149605452,0.401725765878002,0,0,2.19042056074766,4.04424372384738,FLCN;RDX;TRIM65
beta,3,positive regulation of cysteine-type endopeptidase activity (GO:2001056),2/56,2,56,0.160871332221538,0.401725765878002,0,0,2.79017857142857,5.09807592706324,PERP;MAP3K5
beta,3,negative regulation of cellular response to growth factor stimulus (GO:0090288),2/56,2,56,0.160871332221538,0.401725765878002,0,0,2.79017857142857,5.09807592706324,NEDD4;SULF1
beta,3,DNA recombination (GO:0006310),2/56,2,56,0.160871332221538,0.401725765878002,0,0,2.79017857142857,5.09807592706324,BARD1;LIG4
beta,3,Notch signaling pathway (GO:0007219),2/56,2,56,0.160871332221538,0.401725765878002,0,0,2.79017857142857,5.09807592706324,NRARP;YBX1
beta,3,mitochondrial translation (GO:0032543),3/108,3,108,0.160891794310012,0.401725765878002,0,0,2.17013888888889,3.96489415143021,MRPS16;MRPS34;GATC
beta,3,regulation of response to external stimulus (GO:0032101),3/108,3,108,0.160891794310012,0.401725765878002,0,0,2.17013888888889,3.96489415143021,SCARB2;BIRC2;CD55
beta,3,acetyl-CoA metabolic process (GO:0006084),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,MLYCD
beta,3,regulation of nucleocytoplasmic transport (GO:0046822),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,NEDD4
beta,3,regulation of phosphate metabolic process (GO:0019220),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,BARD1
beta,3,endoplasmic reticulum tubular network organization (GO:0071786),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,ATL2
beta,3,negative regulation of Rho protein signal transduction (GO:0035024),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,FLCN
beta,3,acyl-CoA biosynthetic process (GO:0071616),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,MLYCD
beta,3,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,TRIAP1
beta,3,negative regulation of focal adhesion assembly (GO:0051895),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,PHLDB2
beta,3,purine-containing compound salvage (GO:0043101),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,AMPD2
beta,3,cAMP biosynthetic process (GO:0006171),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,ADM
beta,3,metallo-sulfur cluster assembly (GO:0031163),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,ISCA1
beta,3,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,KLF4
beta,3,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,ALG3
beta,3,necroptotic process (GO:0070266),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,TRPM7
beta,3,regulation of synapse organization (GO:0050807),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,NEDD4
beta,3,regulation of histone modification (GO:0031056),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,FLCN
beta,3,nucleoside triphosphate metabolic process (GO:0009141),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,SMPDL3A
beta,3,interleukin-6-mediated signaling pathway (GO:0070102),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,IL6R
beta,3,histone H4-K16 acetylation (GO:0043984),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,KANSL1
beta,3,regulation of interferon-gamma biosynthetic process (GO:0045072),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,CEBPG
beta,3,regulation of response to interferon-gamma (GO:0060330),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,HSP90AB1
beta,3,regulation of adaptive immune response (GO:0002819),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,EIF2AK4
beta,3,positive regulation of smooth muscle contraction (GO:0045987),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,SRF
beta,3,positive regulation of blood vessel diameter (GO:0097755),1/14,1,14,0.165076616960808,0.401725765878002,0,0,5.58035714285714,10.0521516051307,ADM
beta,3,DNA-dependent DNA replication (GO:0006261),2/57,2,57,0.165391820812016,0.401725765878002,0,0,2.74122807017544,4.93266981516022,CDC7;BAZ1A
beta,3,positive regulation of protein transport (GO:0051222),2/57,2,57,0.165391820812016,0.401725765878002,0,0,2.74122807017544,4.93266981516022,UNC13B;RUFY3
beta,3,IRE1-mediated unfolded protein response (GO:0036498),2/58,2,58,0.169934430097547,0.401725765878002,0,0,2.69396551724138,4.77462990744571,SRPRB;HYOU1
beta,3,positive regulation of cell death (GO:0010942),2/58,2,58,0.169934430097547,0.401725765878002,0,0,2.69396551724138,4.77462990744571,MAPT;MAP3K5
beta,3,chloride transmembrane transport (GO:1902476),2/58,2,58,0.169934430097547,0.401725765878002,0,0,2.69396551724138,4.77462990744571,GABRB3;SLC1A1
beta,3,I-kappaB kinase/NF-kappaB signaling (GO:0007249),2/58,2,58,0.169934430097547,0.401725765878002,0,0,2.69396551724138,4.77462990744571,BIRC2;NFKB2
beta,3,regulation of neurogenesis (GO:0050767),2/58,2,58,0.169934430097547,0.401725765878002,0,0,2.69396551724138,4.77462990744571,LIG4;CTNNB1
beta,3,macroautophagy (GO:0016236),3/111,3,111,0.170229654653192,0.401725765878002,0,0,2.11148648648649,3.73861242370102,LIX1L;VPS4A;GABARAP
beta,3,cellular response to insulin stimulus (GO:0032869),3/111,3,111,0.170229654653192,0.401725765878002,0,0,2.11148648648649,3.73861242370102,TRIB3;ATP6V1E2;RHOQ
beta,3,receptor metabolic process (GO:0043112),2/59,2,59,0.174497860417914,0.401725765878002,0,0,2.64830508474576,4.62352436077918,NEDD4;ADM
beta,3,integrin-mediated signaling pathway (GO:0007229),2/59,2,59,0.174497860417914,0.401725765878002,0,0,2.64830508474576,4.62352436077918,ADAM15;NEDD9
beta,3,positive regulation of peptidyl-lysine acetylation (GO:2000758),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,PPARGC1A
beta,3,positive regulation of alpha-beta T cell activation (GO:0046635),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,CD55
beta,3,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,NAMPT
beta,3,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,VEGFA
beta,3,vitamin D metabolic process (GO:0042359),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,CYP2R1
beta,3,heparan sulfate proteoglycan biosynthetic process (GO:0015012),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,EXT1
beta,3,maintenance of protein location in nucleus (GO:0051457),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,SUN2
beta,3,histone H4-K8 acetylation (GO:0043982),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,KANSL1
beta,3,phosphatidylethanolamine biosynthetic process (GO:0006646),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,CHKA
beta,3,regulation of protein homooligomerization (GO:0032462),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,CRYAB
beta,3,positive regulation of mesonephros development (GO:0061213),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,VEGFA
beta,3,response to X-ray (GO:0010165),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,LIG4
beta,3,transport along microtubule (GO:0010970),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,ARHGAP21
beta,3,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,TAOK1
beta,3,positive regulation of cytokine production involved in immune response (GO:0002720),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,RAET1G
beta,3,regulation of interleukin-4 production (GO:0032673),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,CEBPB
beta,3,anterograde synaptic vesicle transport (GO:0048490),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,DTNBP1
beta,3,regulation of establishment of cell polarity (GO:2000114),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,RUFY3
beta,3,unsaturated fatty acid biosynthetic process (GO:0006636),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,ALOXE3
beta,3,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,SHQ1
beta,3,negative regulation of release of cytochrome c from mitochondria (GO:0090201),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,TRIAP1
beta,3,positive regulation of phosphoprotein phosphatase activity (GO:0032516),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,HSP90AB1
beta,3,N-terminal protein amino acid acetylation (GO:0006474),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,NAA16
beta,3,positive regulation of viral release from host cell (GO:1902188),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,VPS4A
beta,3,body fluid secretion (GO:0007589),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,VEGFA
beta,3,positive regulation of interleukin-4 production (GO:0032753),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,CEBPB
beta,3,negative regulation of RNA metabolic process (GO:0051253),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,SHQ1
beta,3,positive regulation of exosomal secretion (GO:1903543),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,VPS4A
beta,3,negative regulation of mRNA processing (GO:0050686),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,BARD1
beta,3,negative regulation of protein processing (GO:0010955),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,CD55
beta,3,regulation of RNA export from nucleus (GO:0046831),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,SETD2
beta,3,synaptic vesicle transport along microtubule (GO:0099517),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,DTNBP1
beta,3,cytoplasmic sequestering of protein (GO:0051220),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,NFKBIE
beta,3,inhibition of cysteine-type endopeptidase activity (GO:0097340),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,BIRC2
beta,3,histone H4-K5 acetylation (GO:0043981),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,KANSL1
beta,3,cellular response to corticosteroid stimulus (GO:0071384),1/15,1,15,0.175771107043354,0.401725765878002,0,0,5.20833333333333,9.05506592983042,NR3C1
beta,3,renal system development (GO:0072001),2/60,2,60,0.179080841394869,0.403411633883817,0,0,2.60416666666667,4.47895298747467,SULF1;VEGFA
beta,3,muscle organ development (GO:0007517),2/61,2,61,0.183682131630096,0.403411633883817,0,0,2.56147540983607,4.34054446923481,TCF12;UTRN
beta,3,regulation of actin nucleation (GO:0051125),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,WHAMM
beta,3,negative regulation of NF-kappaB import into nucleus (GO:0042347),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,G3BP2
beta,3,dendritic cell chemotaxis (GO:0002407),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,GPR183
beta,3,DNA strand elongation involved in DNA replication (GO:0006271),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,LIG4
beta,3,Notch receptor processing (GO:0007220),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,YBX1
beta,3,glucose transmembrane transport (GO:1904659),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,SLC2A1
beta,3,DNA alkylation (GO:0006305),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,BEND3
beta,3,establishment of skin barrier (GO:0061436),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,ALOXE3
beta,3,regulation of dopamine secretion (GO:0014059),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,DTNBP1
beta,3,hyaluronan catabolic process (GO:0030214),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,TMEM2
beta,3,regulation of RIG-I signaling pathway (GO:0039535),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,BIRC2
beta,3,histone H2A acetylation (GO:0043968),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,YEATS4
beta,3,regulation of exosomal secretion (GO:1903541),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,VPS4A
beta,3,regulation of water loss via skin (GO:0033561),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,ALOXE3
beta,3,stabilization of membrane potential (GO:0030322),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,KCNK1
beta,3,sympathetic nervous system development (GO:0048485),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,CTNNB1
beta,3,regulation of histone H3-K4 methylation (GO:0051569),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,CTNNB1
beta,3,guanosine-containing compound metabolic process (GO:1901068),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,RHOQ
beta,3,DNA methylation or demethylation (GO:0044728),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,BEND3
beta,3,negative regulation of transcription regulatory region DNA binding (GO:2000678),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,DDIT3
beta,3,negative regulation of translational initiation (GO:0045947),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,EIF2AK4
beta,3,positive regulation of immune system process (GO:0002684),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,VEGFA
beta,3,neuron apoptotic process (GO:0051402),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,LIG4
beta,3,positive regulation of cilium assembly (GO:0045724),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,CEP120
beta,3,T cell migration (GO:0072678),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,GPR183
beta,3,positive regulation of cyclic nucleotide metabolic process (GO:0030801),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,ADM
beta,3,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,CDC7
beta,3,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,VEGFA
beta,3,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,RDX
beta,3,artery development (GO:0060840),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,VEGFA
beta,3,regulation of necroptotic process (GO:0060544),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,BIRC2
beta,3,linoleic acid metabolic process (GO:0043651),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,ALOXE3
beta,3,positive regulation of positive chemotaxis (GO:0050927),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,VEGFA
beta,3,positive regulation of response to endoplasmic reticulum stress (GO:1905898),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,DDIT3
beta,3,regulation of interferon-alpha production (GO:0032647),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,SETD2
beta,3,programmed necrotic cell death (GO:0097300),1/16,1,16,0.18632914031405,0.403411633883817,0,0,4.8828125,8.2042997926523,TRPM7
beta,3,positive regulation of leukocyte chemotaxis (GO:0002690),2/62,2,62,0.188300518047992,0.406552017528237,0,0,2.52016129032258,4.20795386123633,IL6R;VEGFA
beta,3,glycosaminoglycan metabolic process (GO:0030203),2/62,2,62,0.188300518047992,0.406552017528237,0,0,2.52016129032258,4.20795386123633,EXT1;UGDH
beta,3,positive regulation of catabolic process (GO:0009896),2/63,2,63,0.192934815391655,0.407334981621767,0,0,2.48015873015873,4.08086034526369,BARD1;NEDD4
beta,3,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",2/63,2,63,0.192934815391655,0.407334981621767,0,0,2.48015873015873,4.08086034526369,CNOT6L;TRIAP1
beta,3,plasma membrane bounded cell projection organization (GO:0120036),3/119,3,119,0.195842347277471,0.407334981621767,0,0,1.96953781512605,3.21122366210669,NEDD4;DTNBP1;MAPT
beta,3,calcium ion transport (GO:0006816),3/119,3,119,0.195842347277471,0.407334981621767,0,0,1.96953781512605,3.21122366210669,STIM2;ATP2A2;TRPM7
beta,3,regulation of protein sumoylation (GO:0033233),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,CTNNB1
beta,3,regulation of cellular protein catabolic process (GO:1903362),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,RDX
beta,3,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,SRF
beta,3,positive regulation of cell cycle G2/M phase transition (GO:1902751),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,CDC7
beta,3,positive regulation of focal adhesion assembly (GO:0051894),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,VEGFA
beta,3,negative regulation of immune effector process (GO:0002698),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,CD55
beta,3,response to interferon-alpha (GO:0035455),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,LAMP3
beta,3,positive regulation of nitrogen compound metabolic process (GO:0051173),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,KLF4
beta,3,N-terminal protein amino acid modification (GO:0031365),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,NAA16
beta,3,negative regulation of lipid biosynthetic process (GO:0051055),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,TRIB3
beta,3,positive regulation of dendrite extension (GO:1903861),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,RIMS2
beta,3,negative regulation of interleukin-8 production (GO:0032717),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,KLF4
beta,3,N-glycan processing (GO:0006491),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,MAN1A2
beta,3,peptidyl-lysine methylation (GO:0018022),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,SETD2
beta,3,negative regulation of intracellular transport (GO:0032387),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,CRYAB
beta,3,negative regulation of stress fiber assembly (GO:0051497),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,PHLDB2
beta,3,positive regulation of cellular protein catabolic process (GO:1903364),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,RDX
beta,3,long-term memory (GO:0007616),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,EIF2AK4
beta,3,macrophage activation (GO:0042116),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,MAPT
beta,3,regulation of synaptic vesicle exocytosis (GO:2000300),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,RIMS2
beta,3,positive chemotaxis (GO:0050918),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,VEGFA
beta,3,regulation of establishment or maintenance of cell polarity (GO:0032878),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,RUFY3
beta,3,positive regulation of telomere capping (GO:1904355),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,MAP3K4
beta,3,regulation of early endosome to late endosome transport (GO:2000641),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,RDX
beta,3,nucleobase-containing compound biosynthetic process (GO:0034654),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,AMPD2
beta,3,cellular response to glucocorticoid stimulus (GO:0071385),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,NR3C1
beta,3,mitotic G2 DNA damage checkpoint (GO:0007095),1/17,1,17,0.196752451084441,0.407334981621767,0,0,4.59558823529412,7.47154840946578,TAOK1
beta,3,kidney development (GO:0001822),2/64,2,64,0.197583865680878,0.407435157632564,0,0,2.44140625,3.9589652060903,SULF1;VEGFA
beta,3,negative regulation of neuron apoptotic process (GO:0043524),2/64,2,64,0.197583865680878,0.407435157632564,0,0,2.44140625,3.9589652060903,LIG4;PPARGC1A
beta,3,signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),2/64,2,64,0.197583865680878,0.407435157632564,0,0,2.44140625,3.9589652060903,CNOT6L;TRIAP1
beta,3,inorganic anion transmembrane transport (GO:0098661),2/65,2,65,0.202246537839524,0.411187958705901,0,0,2.40384615384615,3.84199000339528,GABRB3;SLC1A1
beta,3,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),2/65,2,65,0.202246537839524,0.411187958705901,0,0,2.40384615384615,3.84199000339528,CDH6;SDK1
beta,3,NADH dehydrogenase complex assembly (GO:0010257),2/65,2,65,0.202246537839524,0.411187958705901,0,0,2.40384615384615,3.84199000339528,NDUFA11;NDUFAF3
beta,3,mitochondrial respiratory chain complex I biogenesis (GO:0097031),2/65,2,65,0.202246537839524,0.411187958705901,0,0,2.40384615384615,3.84199000339528,NDUFA11;NDUFAF3
beta,3,mitochondrial respiratory chain complex I assembly (GO:0032981),2/65,2,65,0.202246537839524,0.411187958705901,0,0,2.40384615384615,3.84199000339528,NDUFA11;NDUFAF3
beta,3,glucose metabolic process (GO:0006006),2/65,2,65,0.202246537839524,0.411187958705901,0,0,2.40384615384615,3.84199000339528,TPI1;PPARGC1A
beta,3,positive regulation of cell adhesion (GO:0045785),2/65,2,65,0.202246537839524,0.411187958705901,0,0,2.40384615384615,3.84199000339528,FLCN;VEGFA
beta,3,DNA replication (GO:0006260),3/121,3,121,0.202388937581677,0.411187958705901,0,0,1.93698347107438,3.09445506058795,BARD1;CDC7;BAZ1A
beta,3,cellular response to reactive oxygen species (GO:0034614),2/66,2,66,0.206921727000045,0.411187958705901,0,0,2.36742424242424,3.7296749234391,MAPT;MAP3K5
beta,3,regulation of adherens junction organization (GO:1903391),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,RDX
beta,3,regulation of telomerase RNA localization to Cajal body (GO:1904872),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,SHQ1
beta,3,regulation of viral process (GO:0050792),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,LAMP3
beta,3,iron-sulfur cluster assembly (GO:0016226),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,ISCA1
beta,3,regulation of spindle organization (GO:0090224),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,PSRC1
beta,3,nuclear envelope reassembly (GO:0031468),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,VPS4A
beta,3,cellular response to gamma radiation (GO:0071480),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,CRYAB
beta,3,endoplasmic reticulum calcium ion homeostasis (GO:0032469),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,ATP2A2
beta,3,anterior/posterior axis specification (GO:0009948),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,DDIT3
beta,3,regulation of chemokine production (GO:0032642),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,IL6R
beta,3,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,ALG3
beta,3,regulation of cellular response to growth factor stimulus (GO:0090287),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,SULF1
beta,3,regulation of epithelial cell differentiation (GO:0030856),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,CEBPB
beta,3,DNA methylation (GO:0006306),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,BEND3
beta,3,regulation of microtubule polymerization or depolymerization (GO:0031110),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,MAPT
beta,3,glyceraldehyde-3-phosphate metabolic process (GO:0019682),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,TPI1
beta,3,regulation of dendrite extension (GO:1903859),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,RIMS2
beta,3,positive regulation of natural killer cell mediated immunity (GO:0002717),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,RAET1G
beta,3,positive regulation of morphogenesis of an epithelium (GO:1905332),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,VEGFA
beta,3,DNA ligation (GO:0006266),1/18,1,18,0.207042751789134,0.411187958705901,0,0,4.34027777777778,6.8351995514711,LIG4
beta,3,JNK cascade (GO:0007254),2/67,2,67,0.211608354253206,0.416014607870817,0,0,2.33208955223881,3.62177728178523,TAOK1;MAP3K5
beta,3,positive regulation of endothelial cell proliferation (GO:0001938),2/68,2,68,0.216305365979435,0.416014607870817,0,0,2.29779411764706,3.51807017070098,NRARP;VEGFA
beta,3,negative regulation of protein binding (GO:0032091),2/68,2,68,0.216305365979435,0.416014607870817,0,0,2.29779411764706,3.51807017070098,DNAJB2;ADAM15
beta,3,extrinsic apoptotic signaling pathway (GO:0097191),2/68,2,68,0.216305365979435,0.416014607870817,0,0,2.29779411764706,3.51807017070098,IL6R;GABARAP
beta,3,insulin receptor signaling pathway (GO:0008286),2/68,2,68,0.216305365979435,0.416014607870817,0,0,2.29779411764706,3.51807017070098,ATP6V1E2;RHOQ
beta,3,positive regulation of chromosome organization (GO:2001252),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,LIG4
beta,3,negative regulation of cell junction assembly (GO:1901889),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,PHLDB2
beta,3,negative regulation of protein localization to plasma membrane (GO:1903077),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,RHOQ
beta,3,regulation of long-term synaptic potentiation (GO:1900271),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,EIF2AK4
beta,3,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,LAMP3
beta,3,endothelial cell development (GO:0001885),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,RDX
beta,3,regulation of heterotypic cell-cell adhesion (GO:0034114),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,KLF4
beta,3,cyclic nucleotide biosynthetic process (GO:0009190),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,AMPD2
beta,3,Rac protein signal transduction (GO:0016601),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,ELMO1
beta,3,regulation of mitochondrial fission (GO:0090140),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,MAPT
beta,3,osteoclast differentiation (GO:0030316),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,GPR183
beta,3,gamma-aminobutyric acid signaling pathway (GO:0007214),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,GABRB3
beta,3,cellular polysaccharide biosynthetic process (GO:0033692),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,EXT1
beta,3,histone deubiquitination (GO:0016578),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,USP3
beta,3,insulin secretion (GO:0030073),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,RIMS2
beta,3,positive regulation of excitatory postsynaptic potential (GO:2000463),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,RIMS2
beta,3,negative regulation of protein localization to cell periphery (GO:1904376),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,RHOQ
beta,3,nucleotide-sugar biosynthetic process (GO:0009226),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,UGDH
beta,3,positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,SRF
beta,3,DNA double-strand break processing (GO:0000729),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,BARD1
beta,3,aspartate family amino acid catabolic process (GO:0009068),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,AASS
beta,3,positive regulation of adherens junction organization (GO:1903393),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,VEGFA
beta,3,hexose transmembrane transport (GO:0035428),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,SLC2A1
beta,3,positive regulation of transcription regulatory region DNA binding (GO:2000679),1/19,1,19,0.217201733129222,0.416014607870817,0,0,4.11184210526316,6.27848976783669,CTNNB1
beta,3,protein dephosphorylation (GO:0006470),3/126,3,126,0.218970199865657,0.418375130955068,0,0,1.86011904761905,2.82518532756194,PHLPP2;PTPRH;DUSP14
beta,3,negative regulation of multicellular organismal process (GO:0051241),3/126,3,126,0.218970199865657,0.418375130955068,0,0,1.86011904761905,2.82518532756194,FLCN;DDIT3;SRF
beta,3,monocarboxylic acid biosynthetic process (GO:0072330),2/69,2,69,0.221011733502645,0.420269776651279,0,0,2.26449275362319,3.41834122758516,OSBPL3;MLYCD
beta,3,regulation of innate immune response (GO:0045088),2/70,2,70,0.225726452570532,0.420269776651279,0,0,2.23214285714286,3.32239151713326,HSP90AB1;BIRC2
beta,3,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),2/70,2,70,0.225726452570532,0.420269776651279,0,0,2.23214285714286,3.32239151713326,CEP120;RHOQ
beta,3,positive regulation of interleukin-2 production (GO:0032743),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,SPTBN1
beta,3,regulation of vacuole organization (GO:0044088),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,SCARB2
beta,3,cell projection assembly (GO:0030031),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,RHOQ
beta,3,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,DDIT3
beta,3,regulation of gluconeogenesis (GO:0006111),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,PPARGC1A
beta,3,proteoglycan metabolic process (GO:0006029),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,SULF1
beta,3,negative regulation of intracellular protein transport (GO:0090317),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,BARD1
beta,3,regulation of epidermal cell differentiation (GO:0045604),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,CTSV
beta,3,negative regulation of actin filament bundle assembly (GO:0032232),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,PHLDB2
beta,3,negative regulation of ion transport (GO:0043271),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,NEDD4
beta,3,phosphatidylethanolamine metabolic process (GO:0046337),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,CHKA
beta,3,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,CLDN12
beta,3,Arp2/3 complex-mediated actin nucleation (GO:0034314),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,WHAMM
beta,3,regulation of cell development (GO:0060284),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,CTNNB1
beta,3,regulation of response to cytokine stimulus (GO:0060759),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,KLF4
beta,3,positive regulation of interferon-alpha production (GO:0032727),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,SETD2
beta,3,regulation of toll-like receptor signaling pathway (GO:0034121),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,BIRC2
beta,3,telomere maintenance via telomerase (GO:0007004),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,HSP90AB1
beta,3,inositol phosphate-mediated signaling (GO:0048016),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,NFAT5
beta,3,eye morphogenesis (GO:0048592),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,VEGFA
beta,3,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,SULF1
beta,3,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,TBC1D30
beta,3,cellular response to steroid hormone stimulus (GO:0071383),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,NR3C1
beta,3,mitochondrial RNA metabolic process (GO:0000959),1/20,1,20,0.227231064377758,0.420269776651279,0,0,3.90625,5.78823388463535,FOXO3
beta,3,cytoskeleton-dependent cytokinesis (GO:0061640),2/71,2,71,0.2304485428457,0.424499617809492,0,0,2.20070422535211,3.23003451346356,VPS4A;SPTBN1
beta,3,negative regulation of developmental process (GO:0051093),2/71,2,71,0.2304485428457,0.424499617809492,0,0,2.20070422535211,3.23003451346356,DDIT3;MAPT
beta,3,regulation of cell communication (GO:0010646),2/72,2,72,0.235177047643998,0.424499617809492,0,0,2.17013888888889,3.14109516985063,SAMD5;BIRC2
beta,3,histone acetylation (GO:0016573),2/72,2,72,0.235177047643998,0.424499617809492,0,0,2.17013888888889,3.14109516985063,BEND3;YEATS4
beta,3,response to insulin (GO:0032868),2/72,2,72,0.235177047643998,0.424499617809492,0,0,2.17013888888889,3.14109516985063,TRIB3;RHOQ
beta,3,generation of neurons (GO:0048699),3/131,3,131,0.235818197301243,0.424499617809492,0,0,1.78912213740458,2.58473423410189,CTNNB1;MAPT;POU3F2
beta,3,protein glycosylation (GO:0006486),3/131,3,131,0.235818197301243,0.424499617809492,0,0,1.78912213740458,2.58473423410189,GALNT7;FUT5;ALG3
beta,3,hyaluronan metabolic process (GO:0030212),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,TMEM2
beta,3,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,VEGFA
beta,3,positive regulation of cellular component movement (GO:0051272),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,VEGFA
beta,3,RNA-dependent DNA biosynthetic process (GO:0006278),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,HSP90AB1
beta,3,viral budding via host ESCRT complex (GO:0039702),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,VPS4A
beta,3,regulation of ruffle assembly (GO:1900027),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,RDX
beta,3,cortical actin cytoskeleton organization (GO:0030866),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,RHOQ
beta,3,mesoderm development (GO:0007498),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,VEGFA
beta,3,negative regulation of ion transmembrane transporter activity (GO:0032413),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,NEDD4
beta,3,positive regulation of histone acetylation (GO:0035066),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,PPARGC1A
beta,3,protein O-linked glycosylation via threonine (GO:0018243),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,GALNT7
beta,3,negative regulation of cytokine biosynthetic process (GO:0042036),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,KLF4
beta,3,establishment of endothelial barrier (GO:0061028),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,RDX
beta,3,vesicle docking (GO:0048278),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,USO1
beta,3,positive regulation of BMP signaling pathway (GO:0030513),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,SULF1
beta,3,positive regulation of lipid metabolic process (GO:0045834),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,CREB1
beta,3,positive regulation of receptor internalization (GO:0002092),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,VEGFA
beta,3,embryonic skeletal system development (GO:0048706),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,SULF1
beta,3,"synaptic transmission, glutamatergic (GO:0035249)",1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,UNC13B
beta,3,negative regulation of cell cycle arrest (GO:0071157),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,HSP90AB1
beta,3,hepaticobiliary system development (GO:0061008),1/21,1,21,0.237132393805174,0.424499617809492,0,0,3.7202380952381,5.35393106461529,CEBPG
beta,3,glycoprotein biosynthetic process (GO:0009101),2/73,2,73,0.239911033333903,0.425411005800858,0,0,2.14041095890411,3.05540907278764,FUT5;ALG3
beta,3,response to metal ion (GO:0010038),2/73,2,73,0.239911033333903,0.425411005800858,0,0,2.14041095890411,3.05540907278764,NEDD4;MAPT
beta,3,Rho protein signal transduction (GO:0007266),2/73,2,73,0.239911033333903,0.425411005800858,0,0,2.14041095890411,3.05540907278764,RHOT1;RHOQ
beta,3,cellular response to hypoxia (GO:0071456),3/133,3,133,0.242621131241069,0.425411005800858,0,0,1.76221804511278,2.49574867782991,BNIP3L;HYOU1;VEGFA
beta,3,lymphocyte differentiation (GO:0030098),2/74,2,74,0.244649588888675,0.425411005800858,0,0,2.11148648648649,2.9728216673446,KLF6;CEBPG
beta,3,chloride transport (GO:0006821),2/74,2,74,0.244649588888675,0.425411005800858,0,0,2.11148648648649,2.9728216673446,GABRB3;SLC1A1
beta,3,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,HSP90AB1
beta,3,regulation of calcium ion import (GO:0090279),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,CTNNB1
beta,3,positive regulation of protein autophosphorylation (GO:0031954),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,VEGFA
beta,3,GTP metabolic process (GO:0046039),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,RHOQ
beta,3,NAD biosynthetic process (GO:0009435),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,NAMPT
beta,3,cellular response to nerve growth factor stimulus (GO:1990090),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,MAPT
beta,3,regulation of catecholamine secretion (GO:0050433),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,DTNBP1
beta,3,cellular response to hexose stimulus (GO:0071331),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,UNC13B
beta,3,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,ATP2A2
beta,3,nuclear transport (GO:0051169),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,RSRC1
beta,3,negative regulation of cell cycle G1/S phase transition (GO:1902807),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,KLF4
beta,3,cytosolic calcium ion transport (GO:0060401),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,ATP2A2
beta,3,positive regulation of erythrocyte differentiation (GO:0045648),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,FOXO3
beta,3,negative regulation of sprouting angiogenesis (GO:1903671),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,KLF4
beta,3,protein localization to cell surface (GO:0034394),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,CTNNB1
beta,3,rRNA modification (GO:0000154),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,TSR3
beta,3,purine-containing compound biosynthetic process (GO:0072522),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,AMPD2
beta,3,protein O-linked glycosylation via serine (GO:0018242),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,GALNT7
beta,3,beta-catenin destruction complex disassembly (GO:1904886),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,CTNNB1
beta,3,positive regulation of biosynthetic process (GO:0009891),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,CREB1
beta,3,C21-steroid hormone metabolic process (GO:0008207),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,FDX1
beta,3,cellular response to unfolded protein (GO:0034620),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,HYOU1
beta,3,viral genome replication (GO:0019079),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,DEK
beta,3,negative regulation of GTPase activity (GO:0034260),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,RDX
beta,3,positive regulation of phosphatase activity (GO:0010922),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,HSP90AB1
beta,3,NLS-bearing protein import into nucleus (GO:0006607),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,KPNA4
beta,3,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,EPHA5
beta,3,glucose transport (GO:0015758),1/22,1,22,0.246907348658281,0.425411005800858,0,0,3.55113636363636,4.96712400344776,SLC2A1
beta,3,mitotic spindle organization (GO:0007052),2/75,2,75,0.249391825618545,0.428273531122716,0,0,2.08333333333333,2.89318754679588,SUN2;BIRC2
beta,3,regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),2/75,2,75,0.249391825618545,0.428273531122716,0,0,2.08333333333333,2.89318754679588,USP20;DTNBP1
beta,3,nitrogen compound transport (GO:0071705),2/75,2,75,0.249391825618545,0.428273531122716,0,0,2.08333333333333,2.89318754679588,SLC7A11;SLC7A1
beta,3,phagocytosis (GO:0006909),3/136,3,136,0.25288432649147,0.428327607574657,0,0,1.72334558823529,2.36929532803789,SCARB2;ELMO1;CDC7
beta,3,cellular response to organic cyclic compound (GO:0071407),3/136,3,136,0.25288432649147,0.428327607574657,0,0,1.72334558823529,2.36929532803789,GABRB3;CTNNB1;NR3C1
beta,3,C-terminal protein lipidation (GO:0006501),2/76,2,76,0.254136876669511,0.428327607574657,0,0,2.05592105263158,2.81636980383242,RAET1G;ULBP2
beta,3,purine ribonucleotide biosynthetic process (GO:0009152),2/76,2,76,0.254136876669511,0.428327607574657,0,0,2.05592105263158,2.81636980383242,ADM;AMPD2
beta,3,exogenous drug catabolic process (GO:0042738),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,CYP2R1
beta,3,mitotic G2/M transition checkpoint (GO:0044818),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,TAOK1
beta,3,regulation of axon extension involved in axon guidance (GO:0048841),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,VEGFA
beta,3,"nucleotide-excision repair, DNA gap filling (GO:0006297)",1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,LIG4
beta,3,microtubule polymerization or depolymerization (GO:0031109),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,MAPT
beta,3,glycolytic process (GO:0006096),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,TPI1
beta,3,regulation of telomere capping (GO:1904353),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,MAP3K4
beta,3,cell-cell adhesion mediated by cadherin (GO:0044331),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,CDH6
beta,3,TOR signaling (GO:0031929),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,FLCN
beta,3,lamellipodium assembly (GO:0030032),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,WHAMM
beta,3,protein K48-linked deubiquitination (GO:0071108),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,USP20
beta,3,membrane assembly (GO:0071709),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,SPTBN1
beta,3,cellular nitrogen compound biosynthetic process (GO:0044271),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,ARG2
beta,3,cellular response to ammonium ion (GO:0071242),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,GABRB3
beta,3,regulation of smooth muscle contraction (GO:0006940),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,SRF
beta,3,cellular response to interleukin-6 (GO:0071354),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,IL6R
beta,3,histone H3-K4 methylation (GO:0051568),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,BEND3
beta,3,negative regulation of axonogenesis (GO:0050771),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,RUFY3
beta,3,negative regulation of transcription factor import into nucleus (GO:0042992),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,NFKBIE
beta,3,regulation of cell size (GO:0008361),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,RDX
beta,3,viral budding (GO:0046755),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,VPS4A
beta,3,positive regulation of cell junction assembly (GO:1901890),1/23,1,23,0.256557535606858,0.428327607574657,0,0,3.39673913043478,4.62093182461617,VEGFA
beta,3,positive regulation of cell cycle G1/S phase transition (GO:1902808),1/24,1,24,0.266084541136656,0.442883401579496,0,0,3.25520833333333,4.30970441690662,RDX
beta,3,extracellular matrix disassembly (GO:0022617),2/79,2,79,0.268380565393458,0.442883401579496,0,0,1.97784810126582,2.60156108706796,ADAM15;CTSV
beta,3,positive regulation of Wnt signaling pathway (GO:0030177),3/141,3,141,0.270121929160078,0.442883401579496,0,0,1.66223404255319,2.17566793955757,DEPDC1B;NRARP;SULF1
beta,3,inorganic cation transmembrane transport (GO:0098662),3/141,3,141,0.270121929160078,0.442883401579496,0,0,1.66223404255319,2.17566793955757,ATP2A2;TRPM7;KCNK1
beta,3,steroid biosynthetic process (GO:0006694),2/80,2,80,0.273128626997331,0.442883401579496,0,0,1.953125,2.53478990936789,OSBPL3;FDX1
beta,3,cell-cell junction assembly (GO:0007043),2/80,2,80,0.273128626997331,0.442883401579496,0,0,1.953125,2.53478990936789,CDH6;FLCN
beta,3,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),2/80,2,80,0.273128626997331,0.442883401579496,0,0,1.953125,2.53478990936789,FLCN;HSP90AB1
beta,3,positive regulation of histone methylation (GO:0031062),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,CTNNB1
beta,3,membrane protein intracellular domain proteolysis (GO:0031293),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,YBX1
beta,3,negative regulation of protein localization to membrane (GO:1905476),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,RHOQ
beta,3,response to glucocorticoid (GO:0051384),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,NR3C1
beta,3,Golgi to plasma membrane protein transport (GO:0043001),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,SPTBN1
beta,3,positive regulation of purine nucleotide biosynthetic process (GO:1900373),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,PPARGC1A
beta,3,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,KLF4
beta,3,regulation of actin filament bundle assembly (GO:0032231),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,RDX
beta,3,ATP generation from ADP (GO:0006757),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,TPI1
beta,3,drug catabolic process (GO:0042737),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,CYP2R1
beta,3,camera-type eye development (GO:0043010),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,VEGFA
beta,3,receptor catabolic process (GO:0032801),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,NEDD4
beta,3,sensory perception of pain (GO:0019233),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,ALOXE3
beta,3,regulation of transmembrane transport (GO:0034762),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,NEDD4
beta,3,regulation of chemotaxis (GO:0050920),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,GPR183
beta,3,cellular senescence (GO:0090398),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,SRF
beta,3,DNA replication initiation (GO:0006270),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,CDC7
beta,3,positive regulation of vascular endothelial growth factor production (GO:0010575),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,SULF1
beta,3,chaperone mediated protein folding requiring cofactor (GO:0051085),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,HYOU1
beta,3,regulation of neuronal synaptic plasticity (GO:0048168),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,PPFIA3
beta,3,mammary gland development (GO:0030879),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,VEGFA
beta,3,"protein alpha-1,2-demannosylation (GO:0036508)",1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,MAN1A2
beta,3,actin nucleation (GO:0045010),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,WHAMM
beta,3,regulation of cardiac muscle cell action potential (GO:0098901),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,ATP2A2
beta,3,proteoglycan biosynthetic process (GO:0030166),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,EXT1
beta,3,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,HSP90AB1
beta,3,negative regulation of T cell proliferation (GO:0042130),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,CEBPB
beta,3,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,TRIAP1
beta,3,cAMP metabolic process (GO:0046058),1/25,1,25,0.275489931411717,0.442883401579496,0,0,3.125,4.02876311767796,ADM
beta,3,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),3/143,3,143,0.277054924937298,0.444941088299509,0,0,1.63898601398601,2.10370330115571,CDH6;SDK1;CLDN12
beta,3,NIK/NF-kappaB signaling (GO:0038061),2/81,2,81,0.277875481765674,0.445342532891393,0,0,1.92901234567901,2.47025882127636,BIRC2;NFKB2
beta,3,regulation of hydrolase activity (GO:0051336),2/81,2,81,0.277875481765674,0.445342532891393,0,0,1.92901234567901,2.47025882127636,EPHA5;RDX
beta,3,positive regulation of binding (GO:0051099),2/82,2,82,0.282620385432123,0.446768009773978,0,0,1.90548780487805,2.40787095283208,CEBPG;TRIB3
beta,3,protein catabolic process (GO:0030163),2/82,2,82,0.282620385432123,0.446768009773978,0,0,1.90548780487805,2.40787095283208,UBE2G1;STT3B
beta,3,cellular protein complex assembly (GO:0043623),3/145,3,145,0.284005443088286,0.446768009773978,0,0,1.61637931034483,2.03463665172538,HSP90AB1;GPX4;PTGES3L
beta,3,glycolytic process through glucose-6-phosphate (GO:0061620),1/26,1,26,0.284775252866821,0.446768009773978,0,0,3.00480769230769,3.77420371467409,TPI1
beta,3,negative regulation of wound healing (GO:0061045),1/26,1,26,0.284775252866821,0.446768009773978,0,0,3.00480769230769,3.77420371467409,PHLDB2
beta,3,regulation of centrosome duplication (GO:0010824),1/26,1,26,0.284775252866821,0.446768009773978,0,0,3.00480769230769,3.77420371467409,CEP120
beta,3,organophosphate ester transport (GO:0015748),1/26,1,26,0.284775252866821,0.446768009773978,0,0,3.00480769230769,3.77420371467409,TRIAP1
beta,3,canonical glycolysis (GO:0061621),1/26,1,26,0.284775252866821,0.446768009773978,0,0,3.00480769230769,3.77420371467409,TPI1
beta,3,glucose catabolic process to pyruvate (GO:0061718),1/26,1,26,0.284775252866821,0.446768009773978,0,0,3.00480769230769,3.77420371467409,TPI1
beta,3,lamellipodium organization (GO:0097581),1/26,1,26,0.284775252866821,0.446768009773978,0,0,3.00480769230769,3.77420371467409,WHAMM
beta,3,positive regulation of filopodium assembly (GO:0051491),1/26,1,26,0.284775252866821,0.446768009773978,0,0,3.00480769230769,3.77420371467409,RHOQ
beta,3,positive regulation of glucose transport (GO:0010828),1/26,1,26,0.284775252866821,0.446768009773978,0,0,3.00480769230769,3.77420371467409,RHOQ
beta,3,regulation of glucose metabolic process (GO:0010906),1/26,1,26,0.284775252866821,0.446768009773978,0,0,3.00480769230769,3.77420371467409,MLYCD
beta,3,modulation of excitatory postsynaptic potential (GO:0098815),1/26,1,26,0.284775252866821,0.446768009773978,0,0,3.00480769230769,3.77420371467409,RIMS2
beta,3,cellular response to vascular endothelial growth factor stimulus (GO:0035924),1/26,1,26,0.284775252866821,0.446768009773978,0,0,3.00480769230769,3.77420371467409,VEGFA
beta,3,regulation of viral release from host cell (GO:1902186),1/26,1,26,0.284775252866821,0.446768009773978,0,0,3.00480769230769,3.77420371467409,VPS4A
beta,3,regulation of potassium ion transmembrane transporter activity (GO:1901016),1/26,1,26,0.284775252866821,0.446768009773978,0,0,3.00480769230769,3.77420371467409,NEDD4
beta,3,peptide hormone secretion (GO:0030072),1/26,1,26,0.284775252866821,0.446768009773978,0,0,3.00480769230769,3.77420371467409,RIMS2
beta,3,regulation of nervous system development (GO:0051960),1/26,1,26,0.284775252866821,0.446768009773978,0,0,3.00480769230769,3.77420371467409,CTNNB1
beta,3,peptidyl-tyrosine dephosphorylation (GO:0035335),1/26,1,26,0.284775252866821,0.446768009773978,0,0,3.00480769230769,3.77420371467409,DUSP14
beta,3,signal transduction in response to DNA damage (GO:0042770),1/26,1,26,0.284775252866821,0.446768009773978,0,0,3.00480769230769,3.77420371467409,TRIAP1
beta,3,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",2/83,2,83,0.287362612789304,0.448317994829403,0,0,1.88253012048193,2.34753464141424,CNOT6L;TRIAP1
beta,3,mitotic sister chromatid segregation (GO:0000070),2/83,2,83,0.287362612789304,0.448317994829403,0,0,1.88253012048193,2.34753464141424,PSRC1;VPS4A
beta,3,positive regulation of cell cycle (GO:0045787),2/83,2,83,0.287362612789304,0.448317994829403,0,0,1.88253012048193,2.34753464141424,HSP90AB1;PSRC1
beta,3,C-terminal protein amino acid modification (GO:0018410),2/83,2,83,0.287362612789304,0.448317994829403,0,0,1.88253012048193,2.34753464141424,RAET1G;ULBP2
beta,3,positive regulation of cell cycle arrest (GO:0071158),2/83,2,83,0.287362612789304,0.448317994829403,0,0,1.88253012048193,2.34753464141424,CNOT6L;TRIAP1
beta,3,peptidyl-serine phosphorylation (GO:0018105),3/146,3,146,0.287486427177599,0.448317994829403,0,0,1.60530821917808,2.00114452537917,MAST2;CDC7;VRK2
beta,3,positive regulation of protein ubiquitination (GO:0031398),2/84,2,84,0.292101457418778,0.452062574019535,0,0,1.86011904761905,2.28916309551601,TRIB3;BIRC2
beta,3,negative regulation of neuron death (GO:1901215),2/84,2,84,0.292101457418778,0.452062574019535,0,0,1.86011904761905,2.28916309551601,LIG4;PPARGC1A
beta,3,positive regulation of homeostatic process (GO:0032846),2/84,2,84,0.292101457418778,0.452062574019535,0,0,1.86011904761905,2.28916309551601,FOXO3;PPARGC1A
beta,3,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),1/27,1,27,0.293942032434227,0.452062574019535,0,0,2.89351851851852,3.54274508007755,PSRC1
beta,3,bile acid biosynthetic process (GO:0006699),1/27,1,27,0.293942032434227,0.452062574019535,0,0,2.89351851851852,3.54274508007755,OSBPL3
beta,3,positive regulation of glucose import (GO:0046326),1/27,1,27,0.293942032434227,0.452062574019535,0,0,2.89351851851852,3.54274508007755,RHOQ
beta,3,regulation of centrosome cycle (GO:0046605),1/27,1,27,0.293942032434227,0.452062574019535,0,0,2.89351851851852,3.54274508007755,CTNNB1
beta,3,regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),1/27,1,27,0.293942032434227,0.452062574019535,0,0,2.89351851851852,3.54274508007755,SRF
beta,3,positive regulation of cAMP metabolic process (GO:0030816),1/27,1,27,0.293942032434227,0.452062574019535,0,0,2.89351851851852,3.54274508007755,ADM
beta,3,regulation of cardiac muscle cell contraction (GO:0086004),1/27,1,27,0.293942032434227,0.452062574019535,0,0,2.89351851851852,3.54274508007755,ATP2A2
beta,3,fat-soluble vitamin metabolic process (GO:0006775),1/27,1,27,0.293942032434227,0.452062574019535,0,0,2.89351851851852,3.54274508007755,CYP2R1
beta,3,T cell activation involved in immune response (GO:0002286),1/27,1,27,0.293942032434227,0.452062574019535,0,0,2.89351851851852,3.54274508007755,EIF2AK4
beta,3,strand displacement (GO:0000732),1/27,1,27,0.293942032434227,0.452062574019535,0,0,2.89351851851852,3.54274508007755,BARD1
beta,3,cation transmembrane transport (GO:0098655),1/27,1,27,0.293942032434227,0.452062574019535,0,0,2.89351851851852,3.54274508007755,SLC7A1
beta,3,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),2/86,2,86,0.30156626429488,0.458748947428772,0,0,1.81686046511628,2.17798965278138,IL6R;VEGFA
beta,3,regulation of type I interferon production (GO:0032479),2/86,2,86,0.30156626429488,0.458748947428772,0,0,1.81686046511628,2.17798965278138,CTNNB1;NFKB2
beta,3,telomere maintenance via telomere lengthening (GO:0010833),1/28,1,28,0.302991777577876,0.458748947428772,0,0,2.79017857142857,3.3316116365727,HSP90AB1
beta,3,peptidyl-glutamic acid modification (GO:0018200),1/28,1,28,0.302991777577876,0.458748947428772,0,0,2.79017857142857,3.3316116365727,TTLL4
beta,3,endocytic recycling (GO:0032456),1/28,1,28,0.302991777577876,0.458748947428772,0,0,2.79017857142857,3.3316116365727,RAB11FIP4
beta,3,cardiac muscle cell development (GO:0055013),1/28,1,28,0.302991777577876,0.458748947428772,0,0,2.79017857142857,3.3316116365727,VEGFA
beta,3,regulation of double-strand break repair via homologous recombination (GO:0010569),1/28,1,28,0.302991777577876,0.458748947428772,0,0,2.79017857142857,3.3316116365727,SETD2
beta,3,regulation of protein localization to nucleus (GO:1900180),1/28,1,28,0.302991777577876,0.458748947428772,0,0,2.79017857142857,3.3316116365727,FLCN
beta,3,phagosome acidification (GO:0090383),1/28,1,28,0.302991777577876,0.458748947428772,0,0,2.79017857142857,3.3316116365727,ATP6V1E2
beta,3,microtubule polymerization (GO:0046785),1/28,1,28,0.302991777577876,0.458748947428772,0,0,2.79017857142857,3.3316116365727,MAPT
beta,3,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),1/28,1,28,0.302991777577876,0.458748947428772,0,0,2.79017857142857,3.3316116365727,GABARAP
beta,3,regulation of vascular endothelial growth factor production (GO:0010574),1/28,1,28,0.302991777577876,0.458748947428772,0,0,2.79017857142857,3.3316116365727,SULF1
beta,3,negative regulation of organelle assembly (GO:1902116),1/28,1,28,0.302991777577876,0.458748947428772,0,0,2.79017857142857,3.3316116365727,TBC1D30
beta,3,muscle fiber development (GO:0048747),1/28,1,28,0.302991777577876,0.458748947428772,0,0,2.79017857142857,3.3316116365727,VEGFA
beta,3,cellular response to topologically incorrect protein (GO:0035967),1/28,1,28,0.302991777577876,0.458748947428772,0,0,2.79017857142857,3.3316116365727,HYOU1
beta,3,cellular response to glucose stimulus (GO:0071333),1/28,1,28,0.302991777577876,0.458748947428772,0,0,2.79017857142857,3.3316116365727,UNC13B
beta,3,calcium ion transmembrane transport (GO:0070588),2/87,2,87,0.306290904190367,0.461970066071376,0,0,1.79597701149425,2.12503585010584,ATP2A2;TRPM7
beta,3,mitochondrial translational elongation (GO:0070125),2/88,2,88,0.311009515949441,0.461970066071376,0,0,1.77556818181818,2.07374248821527,MRPS16;MRPS34
beta,3,calcium ion homeostasis (GO:0055074),2/88,2,88,0.311009515949441,0.461970066071376,0,0,1.77556818181818,2.07374248821527,STIM2;ATP2A2
beta,3,positive regulation of cellular component biogenesis (GO:0044089),2/88,2,88,0.311009515949441,0.461970066071376,0,0,1.77556818181818,2.07374248821527,VPS4A;VEGFA
beta,3,regulation of MAP kinase activity (GO:0043405),2/88,2,88,0.311009515949441,0.461970066071376,0,0,1.77556818181818,2.07374248821527,TRIB3;VEGFA
beta,3,regulation of vasculature development (GO:1901342),1/29,1,29,0.311925976706746,0.461970066071376,0,0,2.69396551724138,3.13844120007251,CTNNB1
beta,3,regulation of TORC1 signaling (GO:1903432),1/29,1,29,0.311925976706746,0.461970066071376,0,0,2.69396551724138,3.13844120007251,RRAGA
beta,3,cellular response to ketone (GO:1901655),1/29,1,29,0.311925976706746,0.461970066071376,0,0,2.69396551724138,3.13844120007251,NR3C1
beta,3,cellular response to hydrogen peroxide (GO:0070301),1/29,1,29,0.311925976706746,0.461970066071376,0,0,2.69396551724138,3.13844120007251,MAP3K5
beta,3,cellular response to alcohol (GO:0097306),1/29,1,29,0.311925976706746,0.461970066071376,0,0,2.69396551724138,3.13844120007251,CTNNB1
beta,3,negative regulation of homeostatic process (GO:0032845),1/29,1,29,0.311925976706746,0.461970066071376,0,0,2.69396551724138,3.13844120007251,FLCN
beta,3,carboxylic acid catabolic process (GO:0046395),1/29,1,29,0.311925976706746,0.461970066071376,0,0,2.69396551724138,3.13844120007251,TMEM2
beta,3,regulation of receptor internalization (GO:0002090),1/29,1,29,0.311925976706746,0.461970066071376,0,0,2.69396551724138,3.13844120007251,VEGFA
beta,3,chondrocyte differentiation (GO:0002062),1/29,1,29,0.311925976706746,0.461970066071376,0,0,2.69396551724138,3.13844120007251,SULF1
beta,3,lytic vacuole organization (GO:0080171),1/29,1,29,0.311925976706746,0.461970066071376,0,0,2.69396551724138,3.13844120007251,HPS4
beta,3,positive regulation of cell communication (GO:0010647),1/29,1,29,0.311925976706746,0.461970066071376,0,0,2.69396551724138,3.13844120007251,RIMS2
beta,3,regulation of lipid biosynthetic process (GO:0046890),1/29,1,29,0.311925976706746,0.461970066071376,0,0,2.69396551724138,3.13844120007251,CREB1
beta,3,regulation of fatty acid biosynthetic process (GO:0042304),1/29,1,29,0.311925976706746,0.461970066071376,0,0,2.69396551724138,3.13844120007251,TRIB3
beta,3,regulation of defense response to virus by virus (GO:0050690),1/29,1,29,0.311925976706746,0.461970066071376,0,0,2.69396551724138,3.13844120007251,ELMO1
beta,3,positive regulation of lipid biosynthetic process (GO:0046889),1/29,1,29,0.311925976706746,0.461970066071376,0,0,2.69396551724138,3.13844120007251,CREB1
beta,3,calcium ion import (GO:0070509),1/29,1,29,0.311925976706746,0.461970066071376,0,0,2.69396551724138,3.13844120007251,ATP2A2
beta,3,protein K63-linked deubiquitination (GO:0070536),1/29,1,29,0.311925976706746,0.461970066071376,0,0,2.69396551724138,3.13844120007251,USP20
beta,3,positive regulation of fibroblast proliferation (GO:0048146),1/29,1,29,0.311925976706746,0.461970066071376,0,0,2.69396551724138,3.13844120007251,LIG4
beta,3,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),2/89,2,89,0.315721481540092,0.466705712769018,0,0,1.75561797752809,2.0240429100719,HSP90AB1;TRIB3
beta,3,negative regulation of translation (GO:0017148),2/89,2,89,0.315721481540092,0.466705712769018,0,0,1.75561797752809,2.0240429100719,MEX3B;EIF2AK4
beta,3,mitochondrial translational termination (GO:0070126),2/90,2,90,0.320426199690928,0.467492680751768,0,0,1.73611111111111,1.97587377658279,MRPS16;MRPS34
beta,3,dicarboxylic acid transport (GO:0006835),1/30,1,30,0.320746099349868,0.467492680751768,0,0,2.60416666666667,2.96121207445205,SLC1A1
beta,3,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),1/30,1,30,0.320746099349868,0.467492680751768,0,0,2.60416666666667,2.96121207445205,BIRC2
beta,3,lung development (GO:0030324),1/30,1,30,0.320746099349868,0.467492680751768,0,0,2.60416666666667,2.96121207445205,VEGFA
beta,3,regulation of vasoconstriction (GO:0019229),1/30,1,30,0.320746099349868,0.467492680751768,0,0,2.60416666666667,2.96121207445205,ADM
beta,3,vacuolar transport (GO:0007034),1/30,1,30,0.320746099349868,0.467492680751768,0,0,2.60416666666667,2.96121207445205,NEDD4
beta,3,cortical cytoskeleton organization (GO:0030865),1/30,1,30,0.320746099349868,0.467492680751768,0,0,2.60416666666667,2.96121207445205,RHOQ
beta,3,positive regulation of myeloid cell differentiation (GO:0045639),1/30,1,30,0.320746099349868,0.467492680751768,0,0,2.60416666666667,2.96121207445205,FOXO3
beta,3,positive regulation of histone modification (GO:0031058),1/30,1,30,0.320746099349868,0.467492680751768,0,0,2.60416666666667,2.96121207445205,PPARGC1A
beta,3,negative regulation of Notch signaling pathway (GO:0045746),1/30,1,30,0.320746099349868,0.467492680751768,0,0,2.60416666666667,2.96121207445205,NRARP
beta,3,negative regulation of lymphocyte proliferation (GO:0050672),1/30,1,30,0.320746099349868,0.467492680751768,0,0,2.60416666666667,2.96121207445205,CEBPB
beta,3,regulation of keratinocyte differentiation (GO:0045616),1/30,1,30,0.320746099349868,0.467492680751768,0,0,2.60416666666667,2.96121207445205,CTSV
beta,3,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),1/30,1,30,0.320746099349868,0.467492680751768,0,0,2.60416666666667,2.96121207445205,CNOT6L
beta,3,respiratory system development (GO:0060541),1/30,1,30,0.320746099349868,0.467492680751768,0,0,2.60416666666667,2.96121207445205,VEGFA
beta,3,carbohydrate derivative biosynthetic process (GO:1901137),1/30,1,30,0.320746099349868,0.467492680751768,0,0,2.60416666666667,2.96121207445205,TPI1
beta,3,regulation of JNK cascade (GO:0046328),2/91,2,91,0.325123085524723,0.471030064801745,0,0,1.71703296703297,1.92917486892005,TAOK1;MAP3K5
beta,3,negative regulation of endothelial cell proliferation (GO:0001937),1/31,1,31,0.329453596456077,0.471030064801745,0,0,2.52016129032258,2.79818489197556,SULF1
beta,3,beta-catenin-TCF complex assembly (GO:1904837),1/31,1,31,0.329453596456077,0.471030064801745,0,0,2.52016129032258,2.79818489197556,CTNNB1
beta,3,replication fork processing (GO:0031297),1/31,1,31,0.329453596456077,0.471030064801745,0,0,2.52016129032258,2.79818489197556,EME2
beta,3,connective tissue development (GO:0061448),1/31,1,31,0.329453596456077,0.471030064801745,0,0,2.52016129032258,2.79818489197556,SULF1
beta,3,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),1/31,1,31,0.329453596456077,0.471030064801745,0,0,2.52016129032258,2.79818489197556,PSRC1
beta,3,bile acid and bile salt transport (GO:0015721),1/31,1,31,0.329453596456077,0.471030064801745,0,0,2.52016129032258,2.79818489197556,NCOA1
beta,3,negative regulation of transferase activity (GO:0051348),1/31,1,31,0.329453596456077,0.471030064801745,0,0,2.52016129032258,2.79818489197556,MAPT
beta,3,regulation of leukocyte chemotaxis (GO:0002688),1/31,1,31,0.329453596456077,0.471030064801745,0,0,2.52016129032258,2.79818489197556,IL6R
beta,3,multivesicular body assembly (GO:0036258),1/31,1,31,0.329453596456077,0.471030064801745,0,0,2.52016129032258,2.79818489197556,VPS4A
beta,3,'de novo' posttranslational protein folding (GO:0051084),1/31,1,31,0.329453596456077,0.471030064801745,0,0,2.52016129032258,2.79818489197556,HYOU1
beta,3,MyD88-independent toll-like receptor signaling pathway (GO:0002756),1/31,1,31,0.329453596456077,0.471030064801745,0,0,2.52016129032258,2.79818489197556,BIRC2
beta,3,artery morphogenesis (GO:0048844),1/31,1,31,0.329453596456077,0.471030064801745,0,0,2.52016129032258,2.79818489197556,VEGFA
beta,3,response to estradiol (GO:0032355),1/31,1,31,0.329453596456077,0.471030064801745,0,0,2.52016129032258,2.79818489197556,CTNNB1
beta,3,positive regulation of B cell proliferation (GO:0030890),1/31,1,31,0.329453596456077,0.471030064801745,0,0,2.52016129032258,2.79818489197556,GPR183
beta,3,regulation of protein polymerization (GO:0032271),1/31,1,31,0.329453596456077,0.471030064801745,0,0,2.52016129032258,2.79818489197556,MAPT
beta,3,bile acid metabolic process (GO:0008206),1/31,1,31,0.329453596456077,0.471030064801745,0,0,2.52016129032258,2.79818489197556,OSBPL3
beta,3,regulation of sodium ion transmembrane transport (GO:1902305),1/31,1,31,0.329453596456077,0.471030064801745,0,0,2.52016129032258,2.79818489197556,UTRN
beta,3,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),1/31,1,31,0.329453596456077,0.471030064801745,0,0,2.52016129032258,2.79818489197556,RUFY3
beta,3,regulation of protein catabolic process (GO:0042176),2/92,2,92,0.329811570037352,0.471030064801745,0,0,1.69836956521739,1.88388890538543,BARD1;NEDD4
beta,3,cellular response to acid chemical (GO:0071229),2/92,2,92,0.329811570037352,0.471030064801745,0,0,1.69836956521739,1.88388890538543,RRAGA;VEGFA
beta,3,negative regulation of kinase activity (GO:0033673),2/92,2,92,0.329811570037352,0.471030064801745,0,0,1.69836956521739,1.88388890538543,TRIB3;MAPT
beta,3,positive regulation of cellular metabolic process (GO:0031325),2/93,2,93,0.334491100079546,0.476690058666026,0,0,1.68010752688172,1.83996136828956,KLF4;VEGFA
beta,3,cell cycle G1/S phase transition (GO:0044843),2/93,2,93,0.334491100079546,0.476690058666026,0,0,1.68010752688172,1.83996136828956,WEE1;CDC7
beta,3,positive regulation of ubiquitin-protein transferase activity (GO:0051443),1/32,1,32,0.338049900668348,0.476690058666026,0,0,2.44140625,2.64785585762367,TRIB3
beta,3,negative regulation of blood vessel endothelial cell migration (GO:0043537),1/32,1,32,0.338049900668348,0.476690058666026,0,0,2.44140625,2.64785585762367,KLF4
beta,3,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),1/32,1,32,0.338049900668348,0.476690058666026,0,0,2.44140625,2.64785585762367,ARG2
beta,3,regulation of ubiquitin-protein transferase activity (GO:0051438),1/32,1,32,0.338049900668348,0.476690058666026,0,0,2.44140625,2.64785585762367,TRIB3
beta,3,regulation of glucose import (GO:0046324),1/32,1,32,0.338049900668348,0.476690058666026,0,0,2.44140625,2.64785585762367,RHOQ
beta,3,positive regulation of protein dephosphorylation (GO:0035307),1/32,1,32,0.338049900668348,0.476690058666026,0,0,2.44140625,2.64785585762367,HSP90AB1
beta,3,secondary alcohol metabolic process (GO:1902652),1/32,1,32,0.338049900668348,0.476690058666026,0,0,2.44140625,2.64785585762367,FDX1
beta,3,anterograde axonal transport (GO:0008089),1/32,1,32,0.338049900668348,0.476690058666026,0,0,2.44140625,2.64785585762367,DTNBP1
beta,3,multivesicular body organization (GO:0036257),1/32,1,32,0.338049900668348,0.476690058666026,0,0,2.44140625,2.64785585762367,VPS4A
beta,3,regulation of protein autophosphorylation (GO:0031952),1/32,1,32,0.338049900668348,0.476690058666026,0,0,2.44140625,2.64785585762367,VEGFA
beta,3,cofactor biosynthetic process (GO:0051188),1/32,1,32,0.338049900668348,0.476690058666026,0,0,2.44140625,2.64785585762367,ISCA1
beta,3,lysosome organization (GO:0007040),1/32,1,32,0.338049900668348,0.476690058666026,0,0,2.44140625,2.64785585762367,HPS4
beta,3,proteolysis involved in cellular protein catabolic process (GO:0051603),2/94,2,94,0.339161137924384,0.47782539377253,0,0,1.66223404255319,1.79734034479124,VPS4A;CTSV
beta,3,respiratory electron transport chain (GO:0022904),2/95,2,95,0.34382116095631,0.481694889989583,0,0,1.64473684210526,1.75597637785304,NDUFA11;PPARGC1A
beta,3,cellular response to amino acid stimulus (GO:0071230),1/33,1,33,0.346536426302563,0.481694889989583,0,0,2.36742424242424,2.50891889077474,RRAGA
beta,3,phosphatidylcholine biosynthetic process (GO:0006656),1/33,1,33,0.346536426302563,0.481694889989583,0,0,2.36742424242424,2.50891889077474,CHKA
beta,3,oxoacid metabolic process (GO:0043436),1/33,1,33,0.346536426302563,0.481694889989583,0,0,2.36742424242424,2.50891889077474,SULF1
beta,3,ceramide biosynthetic process (GO:0046513),1/33,1,33,0.346536426302563,0.481694889989583,0,0,2.36742424242424,2.50891889077474,ALOXE3
beta,3,regulation of potassium ion transmembrane transport (GO:1901379),1/33,1,33,0.346536426302563,0.481694889989583,0,0,2.36742424242424,2.50891889077474,NEDD4
beta,3,phagosome maturation (GO:0090382),1/33,1,33,0.346536426302563,0.481694889989583,0,0,2.36742424242424,2.50891889077474,ATP6V1E2
beta,3,endodermal cell differentiation (GO:0035987),1/33,1,33,0.346536426302563,0.481694889989583,0,0,2.36742424242424,2.50891889077474,SETD2
beta,3,purine ribonucleoside triphosphate metabolic process (GO:0009205),1/33,1,33,0.346536426302563,0.481694889989583,0,0,2.36742424242424,2.50891889077474,RHOQ
beta,3,negative regulation of fat cell differentiation (GO:0045599),1/33,1,33,0.346536426302563,0.481694889989583,0,0,2.36742424242424,2.50891889077474,TRIB3
beta,3,G2 DNA damage checkpoint (GO:0031572),1/33,1,33,0.346536426302563,0.481694889989583,0,0,2.36742424242424,2.50891889077474,TAOK1
beta,3,positive regulation of telomere maintenance via telomerase (GO:0032212),1/33,1,33,0.346536426302563,0.481694889989583,0,0,2.36742424242424,2.50891889077474,MAP3K4
beta,3,regulation of erythrocyte differentiation (GO:0045646),1/33,1,33,0.346536426302563,0.481694889989583,0,0,2.36742424242424,2.50891889077474,FOXO3
beta,3,positive regulation of telomere maintenance (GO:0032206),1/33,1,33,0.346536426302563,0.481694889989583,0,0,2.36742424242424,2.50891889077474,MAP3K4
beta,3,mismatch repair (GO:0006298),1/33,1,33,0.346536426302563,0.481694889989583,0,0,2.36742424242424,2.50891889077474,SETD2
beta,3,transcription elongation from RNA polymerase II promoter (GO:0006368),2/96,2,96,0.348470661354398,0.483952582183466,0,0,1.62760416666667,1.71582232718434,SETD2;EAF2
beta,3,translational termination (GO:0006415),2/97,2,97,0.353109145841156,0.485983897915518,0,0,1.61082474226804,1.67683323908236,MRPS16;MRPS34
beta,3,cellular metal ion homeostasis (GO:0006875),2/97,2,97,0.353109145841156,0.485983897915518,0,0,1.61082474226804,1.67683323908236,STIM2;ATP2A2
beta,3,intracellular pH reduction (GO:0051452),1/34,1,34,0.354914569906272,0.485983897915518,0,0,2.29779411764706,2.38023475785497,ATP6V1E2
beta,3,negative regulation of neurogenesis (GO:0050768),1/34,1,34,0.354914569906272,0.485983897915518,0,0,2.29779411764706,2.38023475785497,EIF2AK4
beta,3,oligosaccharide biosynthetic process (GO:0009312),1/34,1,34,0.354914569906272,0.485983897915518,0,0,2.29779411764706,2.38023475785497,GALNT7
beta,3,entry into host cell (GO:0030260),1/34,1,34,0.354914569906272,0.485983897915518,0,0,2.29779411764706,2.38023475785497,CTNNB1
beta,3,stem cell differentiation (GO:0048863),1/34,1,34,0.354914569906272,0.485983897915518,0,0,2.29779411764706,2.38023475785497,SETD2
beta,3,positive regulation of calcium ion transport (GO:0051928),1/34,1,34,0.354914569906272,0.485983897915518,0,0,2.29779411764706,2.38023475785497,STIM2
beta,3,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),1/34,1,34,0.354914569906272,0.485983897915518,0,0,2.29779411764706,2.38023475785497,DDIT3
beta,3,mRNA stabilization (GO:0048255),1/34,1,34,0.354914569906272,0.485983897915518,0,0,2.29779411764706,2.38023475785497,YBX1
beta,3,carboxylic acid metabolic process (GO:0019752),1/34,1,34,0.354914569906272,0.485983897915518,0,0,2.29779411764706,2.38023475785497,SLC2A1
beta,3,regulation of DNA recombination (GO:0000018),1/34,1,34,0.354914569906272,0.485983897915518,0,0,2.29779411764706,2.38023475785497,SETD2
beta,3,positive regulation of nucleocytoplasmic transport (GO:0046824),1/34,1,34,0.354914569906272,0.485983897915518,0,0,2.29779411764706,2.38023475785497,NEDD4
beta,3,positive regulation of locomotion (GO:0040017),1/34,1,34,0.354914569906272,0.485983897915518,0,0,2.29779411764706,2.38023475785497,VPS4A
beta,3,regulation of intracellular protein transport (GO:0033157),1/34,1,34,0.354914569906272,0.485983897915518,0,0,2.29779411764706,2.38023475785497,RUFY3
beta,3,regulation of interleukin-12 production (GO:0032655),1/34,1,34,0.354914569906272,0.485983897915518,0,0,2.29779411764706,2.38023475785497,MAST2
beta,3,positive regulation of neuron projection development (GO:0010976),2/98,2,98,0.357736135396653,0.487894056496558,0,0,1.59438775510204,1.63896622497199,SCARB2;RIMS2
beta,3,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),2/98,2,98,0.357736135396653,0.487894056496558,0,0,1.59438775510204,1.63896622497199,DCTN6;CTSV
beta,3,antigen processing and presentation of exogenous peptide antigen (GO:0002478),2/98,2,98,0.357736135396653,0.487894056496558,0,0,1.59438775510204,1.63896622497199,DCTN6;CTSV
beta,3,mitochondrial respiratory chain complex assembly (GO:0033108),2/98,2,98,0.357736135396653,0.487894056496558,0,0,1.59438775510204,1.63896622497199,NDUFA11;NDUFAF3
beta,3,regulation of insulin secretion (GO:0050796),2/99,2,99,0.36235116499293,0.487894056496558,0,0,1.57828282828283,1.60218034773994,EPHA5;SLC2A1
beta,3,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),2/99,2,99,0.36235116499293,0.487894056496558,0,0,1.57828282828283,1.60218034773994,DCTN6;CTSV
beta,3,embryonic limb morphogenesis (GO:0030326),1/35,1,35,0.363185710217169,0.487894056496558,0,0,2.23214285714286,2.26080575255519,CTNNB1
beta,3,regulation of interleukin-8 production (GO:0032677),1/35,1,35,0.363185710217169,0.487894056496558,0,0,2.23214285714286,2.26080575255519,DDIT3
beta,3,ncRNA metabolic process (GO:0034660),1/35,1,35,0.363185710217169,0.487894056496558,0,0,2.23214285714286,2.26080575255519,MAPT
beta,3,response to amino acid (GO:0043200),1/35,1,35,0.363185710217169,0.487894056496558,0,0,2.23214285714286,2.26080575255519,RRAGA
beta,3,positive regulation of exocytosis (GO:0045921),1/35,1,35,0.363185710217169,0.487894056496558,0,0,2.23214285714286,2.26080575255519,VPS4A
beta,3,positive regulation of muscle cell differentiation (GO:0051149),1/35,1,35,0.363185710217169,0.487894056496558,0,0,2.23214285714286,2.26080575255519,CTNNB1
beta,3,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),1/35,1,35,0.363185710217169,0.487894056496558,0,0,2.23214285714286,2.26080575255519,MAP3K4
beta,3,positive regulation of DNA binding (GO:0043388),1/35,1,35,0.363185710217169,0.487894056496558,0,0,2.23214285714286,2.26080575255519,CEBPG
beta,3,bone development (GO:0060348),1/35,1,35,0.363185710217169,0.487894056496558,0,0,2.23214285714286,2.26080575255519,SULF1
beta,3,negative regulation of T cell activation (GO:0050868),1/35,1,35,0.363185710217169,0.487894056496558,0,0,2.23214285714286,2.26080575255519,CEBPB
beta,3,endoplasmic reticulum organization (GO:0007029),1/35,1,35,0.363185710217169,0.487894056496558,0,0,2.23214285714286,2.26080575255519,ATL2
beta,3,positive regulation of cell development (GO:0010720),1/35,1,35,0.363185710217169,0.487894056496558,0,0,2.23214285714286,2.26080575255519,LIG4
beta,3,positive regulation of chemokine production (GO:0032722),1/35,1,35,0.363185710217169,0.487894056496558,0,0,2.23214285714286,2.26080575255519,IL6R
beta,3,response to glucagon (GO:0033762),1/35,1,35,0.363185710217169,0.487894056496558,0,0,2.23214285714286,2.26080575255519,CREB1
beta,3,cellular macromolecular complex assembly (GO:0034622),1/35,1,35,0.363185710217169,0.487894056496558,0,0,2.23214285714286,2.26080575255519,SHQ1
beta,3,macromolecule catabolic process (GO:0009057),1/35,1,35,0.363185710217169,0.487894056496558,0,0,2.23214285714286,2.26080575255519,NEDD4
beta,3,steroid metabolic process (GO:0008202),2/100,2,100,0.366953783239148,0.491508038075064,0,0,1.5625,1.56643651575945,FDX1;CYP2R1
beta,3,glycosaminoglycan biosynthetic process (GO:0006024),2/100,2,100,0.366953783239148,0.491508038075064,0,0,1.5625,1.56643651575945,EXT1;UGDH
beta,3,negative regulation of cell-substrate adhesion (GO:0010812),1/36,1,36,0.371351208577081,0.491508038075064,0,0,2.17013888888889,2.14975479670636,ADAM15
beta,3,positive regulation of peptide secretion (GO:0002793),1/36,1,36,0.371351208577081,0.491508038075064,0,0,2.17013888888889,2.14975479670636,UNC13B
beta,3,endothelial cell migration (GO:0043542),1/36,1,36,0.371351208577081,0.491508038075064,0,0,2.17013888888889,2.14975479670636,VEGFA
beta,3,regulation of mitotic spindle organization (GO:0060236),1/36,1,36,0.371351208577081,0.491508038075064,0,0,2.17013888888889,2.14975479670636,PSRC1
beta,3,regulation of sodium ion transport (GO:0002028),1/36,1,36,0.371351208577081,0.491508038075064,0,0,2.17013888888889,2.14975479670636,NEDD4
beta,3,regulation of mitochondrial membrane potential (GO:0051881),1/36,1,36,0.371351208577081,0.491508038075064,0,0,2.17013888888889,2.14975479670636,MAPT
beta,3,regulation of ion transmembrane transport (GO:0034765),1/36,1,36,0.371351208577081,0.491508038075064,0,0,2.17013888888889,2.14975479670636,NEDD4
beta,3,positive regulation of ATPase activity (GO:0032781),1/36,1,36,0.371351208577081,0.491508038075064,0,0,2.17013888888889,2.14975479670636,DNAJB2
beta,3,negative regulation of tumor necrosis factor production (GO:0032720),1/36,1,36,0.371351208577081,0.491508038075064,0,0,2.17013888888889,2.14975479670636,ARG2
beta,3,regulation of cardiac muscle contraction (GO:0055117),1/36,1,36,0.371351208577081,0.491508038075064,0,0,2.17013888888889,2.14975479670636,ATP2A2
beta,3,carbohydrate catabolic process (GO:0016052),1/36,1,36,0.371351208577081,0.491508038075064,0,0,2.17013888888889,2.14975479670636,TPI1
beta,3,actin filament bundle organization (GO:0061572),1/36,1,36,0.371351208577081,0.491508038075064,0,0,2.17013888888889,2.14975479670636,NEDD9
beta,3,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),1/36,1,36,0.371351208577081,0.491508038075064,0,0,2.17013888888889,2.14975479670636,EME2
beta,3,positive regulation of osteoblast differentiation (GO:0045669),1/36,1,36,0.371351208577081,0.491508038075064,0,0,2.17013888888889,2.14975479670636,IL6R
beta,3,sulfur compound catabolic process (GO:0044273),1/36,1,36,0.371351208577081,0.491508038075064,0,0,2.17013888888889,2.14975479670636,MLYCD
beta,3,regulation of lipid metabolic process (GO:0019216),2/101,2,101,0.371543552164366,0.491508038075064,0,0,1.5470297029703,1.53169738306518,NCOA1;TRIB3
beta,3,cellular divalent inorganic cation homeostasis (GO:0072503),2/102,2,102,0.37612004704184,0.493552308801156,0,0,1.53186274509804,1.49792725567082,STIM2;ATP2A2
beta,3,regulation of protein ubiquitination (GO:0031396),2/102,2,102,0.37612004704184,0.493552308801156,0,0,1.53186274509804,1.49792725567082,DNAJB2;HSP90AB1
beta,3,regulation of kinase activity (GO:0043549),2/102,2,102,0.37612004704184,0.493552308801156,0,0,1.53186274509804,1.49792725567082,EPHA5;MAPT
beta,3,actin polymerization or depolymerization (GO:0008154),1/37,1,37,0.379412409071997,0.493552308801156,0,0,2.11148648648649,2.0463080973832,DSTN
beta,3,organic hydroxy compound transport (GO:0015850),1/37,1,37,0.379412409071997,0.493552308801156,0,0,2.11148648648649,2.0463080973832,NCOA1
beta,3,carbohydrate biosynthetic process (GO:0016051),1/37,1,37,0.379412409071997,0.493552308801156,0,0,2.11148648648649,2.0463080973832,GALNT7
beta,3,transferrin transport (GO:0033572),1/37,1,37,0.379412409071997,0.493552308801156,0,0,2.11148648648649,2.0463080973832,ATP6V1E2
beta,3,positive regulation of signaling (GO:0023056),1/37,1,37,0.379412409071997,0.493552308801156,0,0,2.11148648648649,2.0463080973832,RIMS2
beta,3,natural killer cell activation (GO:0030101),1/37,1,37,0.379412409071997,0.493552308801156,0,0,2.11148648648649,2.0463080973832,ULBP2
beta,3,endoderm formation (GO:0001706),1/37,1,37,0.379412409071997,0.493552308801156,0,0,2.11148648648649,2.0463080973832,SETD2
beta,3,sodium ion transmembrane transport (GO:0035725),1/37,1,37,0.379412409071997,0.493552308801156,0,0,2.11148648648649,2.0463080973832,KCNK1
beta,3,regulation of filopodium assembly (GO:0051489),1/37,1,37,0.379412409071997,0.493552308801156,0,0,2.11148648648649,2.0463080973832,RHOQ
beta,3,regulation of response to DNA damage stimulus (GO:2001020),1/37,1,37,0.379412409071997,0.493552308801156,0,0,2.11148648648649,2.0463080973832,MAPT
beta,3,organophosphate biosynthetic process (GO:0090407),1/37,1,37,0.379412409071997,0.493552308801156,0,0,2.11148648648649,2.0463080973832,TPI1
beta,3,heart looping (GO:0001947),1/37,1,37,0.379412409071997,0.493552308801156,0,0,2.11148648648649,2.0463080973832,SRF
beta,3,vesicle-mediated transport in synapse (GO:0099003),1/37,1,37,0.379412409071997,0.493552308801156,0,0,2.11148648648649,2.0463080973832,UNC13B
beta,3,zymogen activation (GO:0031638),1/37,1,37,0.379412409071997,0.493552308801156,0,0,2.11148648648649,2.0463080973832,PERP
beta,3,ferric iron transport (GO:0015682),1/37,1,37,0.379412409071997,0.493552308801156,0,0,2.11148648648649,2.0463080973832,ATP6V1E2
beta,3,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",1/37,1,37,0.379412409071997,0.493552308801156,0,0,2.11148648648649,2.0463080973832,CTNNB1
beta,3,regulation of cysteine-type endopeptidase activity (GO:2000116),1/37,1,37,0.379412409071997,0.493552308801156,0,0,2.11148648648649,2.0463080973832,BIRC2
beta,3,positive regulation of angiogenesis (GO:0045766),2/104,2,104,0.38523157941088,0.498915484386674,0,0,1.50240384615385,1.43315898522029,KLF4;VEGFA
beta,3,plasma membrane invagination (GO:0099024),2/104,2,104,0.38523157941088,0.498915484386674,0,0,1.50240384615385,1.43315898522029,SCARB2;ELMO1
beta,3,protein import into nucleus (GO:0006606),2/104,2,104,0.38523157941088,0.498915484386674,0,0,1.50240384615385,1.43315898522029,CTNNB1;KPNA4
beta,3,epithelial to mesenchymal transition (GO:0001837),1/38,1,38,0.387370638742248,0.498915484386674,0,0,2.05592105263158,1.94978067727814,CTNNB1
beta,3,protein peptidyl-prolyl isomerization (GO:0000413),1/38,1,38,0.387370638742248,0.498915484386674,0,0,2.05592105263158,1.94978067727814,FKBP7
beta,3,regulation of dendrite development (GO:0050773),1/38,1,38,0.387370638742248,0.498915484386674,0,0,2.05592105263158,1.94978067727814,NEDD4
beta,3,positive regulation of smooth muscle cell proliferation (GO:0048661),1/38,1,38,0.387370638742248,0.498915484386674,0,0,2.05592105263158,1.94978067727814,IL6R
beta,3,regulation of osteoclast differentiation (GO:0045670),1/38,1,38,0.387370638742248,0.498915484386674,0,0,2.05592105263158,1.94978067727814,CEBPB
beta,3,negative regulation of G0 to G1 transition (GO:0070317),1/38,1,38,0.387370638742248,0.498915484386674,0,0,2.05592105263158,1.94978067727814,CDC7
beta,3,negative regulation of Ras protein signal transduction (GO:0046580),1/38,1,38,0.387370638742248,0.498915484386674,0,0,2.05592105263158,1.94978067727814,FLCN
beta,3,actin filament bundle assembly (GO:0051017),1/38,1,38,0.387370638742248,0.498915484386674,0,0,2.05592105263158,1.94978067727814,NEDD9
beta,3,response to steroid hormone (GO:0048545),1/38,1,38,0.387370638742248,0.498915484386674,0,0,2.05592105263158,1.94978067727814,NR3C1
beta,3,"phagocytosis, engulfment (GO:0006911)",2/105,2,105,0.389765830762062,0.501586530766347,0,0,1.48809523809524,1.40209695555733,SCARB2;ELMO1
beta,3,translational elongation (GO:0006414),2/106,2,106,0.3942852351898,0.505696451928097,0,0,1.47405660377358,1.37187600888167,MRPS16;MRPS34
beta,3,G1/S transition of mitotic cell cycle (GO:0000082),2/106,2,106,0.3942852351898,0.505696451928097,0,0,1.47405660377358,1.37187600888167,WEE1;CDC7
beta,3,T cell differentiation (GO:0030217),1/39,1,39,0.395227207784931,0.505696451928097,0,0,2.00320512820513,1.8595642425251,LIG4
beta,3,mitochondrion disassembly (GO:0061726),1/39,1,39,0.395227207784931,0.505696451928097,0,0,2.00320512820513,1.8595642425251,GABARAP
beta,3,regulation of cellular amide metabolic process (GO:0034248),1/39,1,39,0.395227207784931,0.505696451928097,0,0,2.00320512820513,1.8595642425251,FOXO3
beta,3,DNA damage checkpoint (GO:0000077),1/39,1,39,0.395227207784931,0.505696451928097,0,0,2.00320512820513,1.8595642425251,TAOK1
beta,3,positive regulation of DNA repair (GO:0045739),1/39,1,39,0.395227207784931,0.505696451928097,0,0,2.00320512820513,1.8595642425251,CEBPG
beta,3,RNA splicing (GO:0008380),2/107,2,107,0.398789429682097,0.509836445318389,0,0,1.46028037383178,1.34246750373308,RSRC1;PPARGC1A
beta,3,regulation of type I interferon-mediated signaling pathway (GO:0060338),1/40,1,40,0.402983409778842,0.510143481770469,0,0,1.953125,1.77511696227483,HSP90AB1
beta,3,regulation of proteasomal protein catabolic process (GO:0061136),1/40,1,40,0.402983409778842,0.510143481770469,0,0,1.953125,1.77511696227483,LAMP3
beta,3,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),1/40,1,40,0.402983409778842,0.510143481770469,0,0,1.953125,1.77511696227483,AMPD2
beta,3,positive regulation of reactive oxygen species metabolic process (GO:2000379),1/40,1,40,0.402983409778842,0.510143481770469,0,0,1.953125,1.77511696227483,MAPT
beta,3,regulation of G0 to G1 transition (GO:0070316),1/40,1,40,0.402983409778842,0.510143481770469,0,0,1.953125,1.77511696227483,CDC7
beta,3,inositol lipid-mediated signaling (GO:0048017),1/40,1,40,0.402983409778842,0.510143481770469,0,0,1.953125,1.77511696227483,PITPNM2
beta,3,regulation of plasma membrane bounded cell projection assembly (GO:0120032),1/40,1,40,0.402983409778842,0.510143481770469,0,0,1.953125,1.77511696227483,RDX
beta,3,Golgi to plasma membrane transport (GO:0006893),1/40,1,40,0.402983409778842,0.510143481770469,0,0,1.953125,1.77511696227483,SPTBN1
beta,3,DNA replication-independent nucleosome assembly (GO:0006336),1/40,1,40,0.402983409778842,0.510143481770469,0,0,1.953125,1.77511696227483,UBN1
beta,3,acyl-CoA metabolic process (GO:0006637),1/40,1,40,0.402983409778842,0.510143481770469,0,0,1.953125,1.77511696227483,MLYCD
beta,3,DNA biosynthetic process (GO:0071897),1/40,1,40,0.402983409778842,0.510143481770469,0,0,1.953125,1.77511696227483,BARD1
beta,3,positive regulation of epithelial cell proliferation (GO:0050679),2/108,2,108,0.403278063103625,0.510143481770469,0,0,1.44675925925926,1.3138439989537,NRARP;VEGFA
beta,3,regulation of protein secretion (GO:0050708),2/108,2,108,0.403278063103625,0.510143481770469,0,0,1.44675925925926,1.3138439989537,UNC13B;SLC2A1
beta,3,"DNA-templated transcription, elongation (GO:0006354)",2/109,2,109,0.407750795552561,0.512397965536478,0,0,1.43348623853211,1.2859791949594,SETD2;EAF2
beta,3,negative regulation of transport (GO:0051051),1/41,1,41,0.410640522028273,0.512397965536478,0,0,1.90548780487805,1.69595481988492,CRYAB
beta,3,embryonic heart tube morphogenesis (GO:0003143),1/41,1,41,0.410640522028273,0.512397965536478,0,0,1.90548780487805,1.69595481988492,SRF
beta,3,intraciliary transport involved in cilium assembly (GO:0035735),1/41,1,41,0.410640522028273,0.512397965536478,0,0,1.90548780487805,1.69595481988492,IFT172
beta,3,regulation of cellular localization (GO:0060341),1/41,1,41,0.410640522028273,0.512397965536478,0,0,1.90548780487805,1.69595481988492,EPHA5
beta,3,positive regulation of epithelial to mesenchymal transition (GO:0010718),1/41,1,41,0.410640522028273,0.512397965536478,0,0,1.90548780487805,1.69595481988492,CTNNB1
beta,3,autophagy of mitochondrion (GO:0000422),1/41,1,41,0.410640522028273,0.512397965536478,0,0,1.90548780487805,1.69595481988492,GABARAP
beta,3,tRNA aminoacylation (GO:0043039),1/41,1,41,0.410640522028273,0.512397965536478,0,0,1.90548780487805,1.69595481988492,GATC
beta,3,peptidyl-proline modification (GO:0018208),1/41,1,41,0.410640522028273,0.512397965536478,0,0,1.90548780487805,1.69595481988492,FKBP7
beta,3,response to peptide hormone (GO:0043434),1/41,1,41,0.410640522028273,0.512397965536478,0,0,1.90548780487805,1.69595481988492,CREB1
beta,3,negative regulation of ERK1 and ERK2 cascade (GO:0070373),1/41,1,41,0.410640522028273,0.512397965536478,0,0,1.90548780487805,1.69595481988492,FLCN
beta,3,regulation of release of cytochrome c from mitochondria (GO:0090199),1/41,1,41,0.410640522028273,0.512397965536478,0,0,1.90548780487805,1.69595481988492,TRIAP1
beta,3,neuron migration (GO:0001764),1/41,1,41,0.410640522028273,0.512397965536478,0,0,1.90548780487805,1.69595481988492,VEGFA
beta,3,regulation of intracellular transport (GO:0032386),1/41,1,41,0.410640522028273,0.512397965536478,0,0,1.90548780487805,1.69595481988492,CRYAB
beta,3,positive regulation of cytokine biosynthetic process (GO:0042108),1/41,1,41,0.410640522028273,0.512397965536478,0,0,1.90548780487805,1.69595481988492,CEBPG
beta,3,regulation of ATPase activity (GO:0043462),1/41,1,41,0.410640522028273,0.512397965536478,0,0,1.90548780487805,1.69595481988492,DNAJB2
beta,3,determination of heart left/right asymmetry (GO:0061371),1/41,1,41,0.410640522028273,0.512397965536478,0,0,1.90548780487805,1.69595481988492,SRF
beta,3,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),2/110,2,110,0.412207298365408,0.513122482255504,0,0,1.42045454545455,1.25884787613419,MAPT;MAP3K5
beta,3,Wnt signaling pathway (GO:0016055),2/110,2,110,0.412207298365408,0.513122482255504,0,0,1.42045454545455,1.25884787613419,CTNNB1;VRK2
beta,3,regulation of Wnt signaling pathway (GO:0030111),2/110,2,110,0.412207298365408,0.513122482255504,0,0,1.42045454545455,1.25884787613419,DEPDC1B;SULF1
beta,3,cellular response to peptide hormone stimulus (GO:0071375),2/111,2,111,0.416647253814066,0.517692225424819,0,0,1.40765765765766,1.23242585766544,TRIB3;RHOQ
beta,3,mesenchymal cell differentiation (GO:0048762),1/42,1,42,0.41819980542005,0.517692225424819,0,0,1.86011904761905,1.62164426575031,CTNNB1
beta,3,regulation of stress-activated MAPK cascade (GO:0032872),1/42,1,42,0.41819980542005,0.517692225424819,0,0,1.86011904761905,1.62164426575031,TAOK1
beta,3,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),1/42,1,42,0.41819980542005,0.517692225424819,0,0,1.86011904761905,1.62164426575031,CDH6
beta,3,positive regulation of receptor-mediated endocytosis (GO:0048260),1/42,1,42,0.41819980542005,0.517692225424819,0,0,1.86011904761905,1.62164426575031,VEGFA
beta,3,monocyte chemotaxis (GO:0002548),1/42,1,42,0.41819980542005,0.517692225424819,0,0,1.86011904761905,1.62164426575031,IL6R
beta,3,regulation of protein localization (GO:0032880),1/42,1,42,0.41819980542005,0.517692225424819,0,0,1.86011904761905,1.62164426575031,VPS4A
beta,3,regulation of protein binding (GO:0043393),2/112,2,112,0.42107035487455,0.520832665577791,0,0,1.39508928571429,1.20668993519172,DNAJB2;TRIB3
beta,3,regulation of interleukin-6 production (GO:0032675),1/43,1,43,0.425662505141437,0.525679723517234,0,0,1.81686046511628,1.55179594504705,IL6R
beta,3,regulation of protein modification process (GO:0031399),1/43,1,43,0.425662505141437,0.525679723517234,0,0,1.81686046511628,1.55179594504705,FLCN
beta,3,positive regulation of kinase activity (GO:0033674),2/114,2,114,0.42986481809215,0.530030790712359,0,0,1.37061403508772,1.15718818016868,EPHA5;MAPT
beta,3,positive regulation of developmental process (GO:0051094),2/114,2,114,0.42986481809215,0.530030790712359,0,0,1.37061403508772,1.15718818016868,HSP90AB1;SRF
beta,3,positive regulation of interferon-gamma production (GO:0032729),1/44,1,44,0.433029850348501,0.530580530921514,0,0,1.77556818181818,1.48605933044496,CEBPG
beta,3,regulation of B cell proliferation (GO:0030888),1/44,1,44,0.433029850348501,0.530580530921514,0,0,1.77556818181818,1.48605933044496,GPR183
beta,3,negative regulation of protein metabolic process (GO:0051248),1/44,1,44,0.433029850348501,0.530580530921514,0,0,1.77556818181818,1.48605933044496,CRYAB
beta,3,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),1/44,1,44,0.433029850348501,0.530580530921514,0,0,1.77556818181818,1.48605933044496,ZMAT3
beta,3,response to hydrogen peroxide (GO:0042542),1/44,1,44,0.433029850348501,0.530580530921514,0,0,1.77556818181818,1.48605933044496,MAP3K5
beta,3,positive regulation of interleukin-6 production (GO:0032755),1/44,1,44,0.433029850348501,0.530580530921514,0,0,1.77556818181818,1.48605933044496,IL6R
beta,3,regulation of ATP metabolic process (GO:1903578),1/44,1,44,0.433029850348501,0.530580530921514,0,0,1.77556818181818,1.48605933044496,BEND3
beta,3,positive regulation of protein localization to plasma membrane (GO:1903078),1/44,1,44,0.433029850348501,0.530580530921514,0,0,1.77556818181818,1.48605933044496,SPTBN1
beta,3,ribosomal small subunit biogenesis (GO:0042274),1/45,1,45,0.440303054747402,0.534873983237895,0,0,1.73611111111111,1.42411810480405,TSR3
beta,3,cholesterol transport (GO:0030301),1/45,1,45,0.440303054747402,0.534873983237895,0,0,1.73611111111111,1.42411810480405,VPS4A
beta,3,lymphocyte chemotaxis (GO:0048247),1/45,1,45,0.440303054747402,0.534873983237895,0,0,1.73611111111111,1.42411810480405,GPR183
beta,3,positive regulation of viral life cycle (GO:1903902),1/45,1,45,0.440303054747402,0.534873983237895,0,0,1.73611111111111,1.42411810480405,VPS4A
beta,3,unsaturated fatty acid metabolic process (GO:0033559),1/45,1,45,0.440303054747402,0.534873983237895,0,0,1.73611111111111,1.42411810480405,ALOXE3
beta,3,regulation of dendrite morphogenesis (GO:0048814),1/45,1,45,0.440303054747402,0.534873983237895,0,0,1.73611111111111,1.42411810480405,NEDD4
beta,3,positive regulation of interleukin-8 production (GO:0032757),1/45,1,45,0.440303054747402,0.534873983237895,0,0,1.73611111111111,1.42411810480405,DDIT3
beta,3,protein N-linked glycosylation via asparagine (GO:0018279),1/45,1,45,0.440303054747402,0.534873983237895,0,0,1.73611111111111,1.42411810480405,STT3B
beta,3,carboxylic acid biosynthetic process (GO:0046394),1/45,1,45,0.440303054747402,0.534873983237895,0,0,1.73611111111111,1.42411810480405,UGDH
beta,3,posttranscriptional regulation of gene expression (GO:0010608),1/45,1,45,0.440303054747402,0.534873983237895,0,0,1.73611111111111,1.42411810480405,FOXO3
beta,3,positive regulation of viral process (GO:0048524),1/45,1,45,0.440303054747402,0.534873983237895,0,0,1.73611111111111,1.42411810480405,VPS4A
beta,3,sphingolipid metabolic process (GO:0006665),2/117,2,117,0.442923021982077,0.536803445119583,0,0,1.33547008547009,1.08755246970274,FUT5;ALOXE3
beta,3,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),2/117,2,117,0.442923021982077,0.536803445119583,0,0,1.33547008547009,1.08755246970274,IL6R;VEGFA
beta,3,chromatin remodeling (GO:0006338),2/117,2,117,0.442923021982077,0.536803445119583,0,0,1.33547008547009,1.08755246970274,BAZ1A;DEK
beta,3,protein localization to cell periphery (GO:1990778),2/118,2,118,0.447239122507566,0.540233145609713,0,0,1.32415254237288,1.06549507113584,RDX;SPTBN1
beta,3,activation of MAPK activity (GO:0000187),2/118,2,118,0.447239122507566,0.540233145609713,0,0,1.32415254237288,1.06549507113584,TAOK1;MAP3K5
beta,3,positive regulation of blood vessel endothelial cell migration (GO:0043536),1/46,1,46,0.447483316638923,0.540233145609713,0,0,1.69836956521739,1.36568618073368,VEGFA
beta,3,nicotinamide nucleotide metabolic process (GO:0046496),1/46,1,46,0.447483316638923,0.540233145609713,0,0,1.69836956521739,1.36568618073368,TPI1
beta,3,peptidyl-asparagine modification (GO:0018196),1/46,1,46,0.447483316638923,0.540233145609713,0,0,1.69836956521739,1.36568618073368,STT3B
beta,3,positive regulation of protein serine/threonine kinase activity (GO:0071902),2/119,2,119,0.45153650165849,0.543328184994672,0,0,1.31302521008403,1.04398511565209,PSRC1;VEGFA
beta,3,intraciliary transport (GO:0042073),1/47,1,47,0.454571819092276,0.543328184994672,0,0,1.66223404255319,1.31050425539115,IFT172
beta,3,cellular response to ionizing radiation (GO:0071479),1/47,1,47,0.454571819092276,0.543328184994672,0,0,1.66223404255319,1.31050425539115,CRYAB
beta,3,positive regulation of protein localization to cell periphery (GO:1904377),1/47,1,47,0.454571819092276,0.543328184994672,0,0,1.66223404255319,1.31050425539115,SPTBN1
beta,3,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),1/47,1,47,0.454571819092276,0.543328184994672,0,0,1.66223404255319,1.31050425539115,CTNNB1
beta,3,cartilage development (GO:0051216),1/47,1,47,0.454571819092276,0.543328184994672,0,0,1.66223404255319,1.31050425539115,SULF1
beta,3,pyruvate metabolic process (GO:0006090),1/47,1,47,0.454571819092276,0.543328184994672,0,0,1.66223404255319,1.31050425539115,TPI1
beta,3,positive regulation of ion transport (GO:0043270),1/47,1,47,0.454571819092276,0.543328184994672,0,0,1.66223404255319,1.31050425539115,STIM2
beta,3,maturation of SSU-rRNA (GO:0030490),1/47,1,47,0.454571819092276,0.543328184994672,0,0,1.66223404255319,1.31050425539115,TSR3
beta,3,mitotic spindle assembly (GO:0090307),1/47,1,47,0.454571819092276,0.543328184994672,0,0,1.66223404255319,1.31050425539115,BIRC2
beta,3,regulation of cellular component movement (GO:0051270),1/47,1,47,0.454571819092276,0.543328184994672,0,0,1.66223404255319,1.31050425539115,VEGFA
beta,3,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",1/47,1,47,0.454571819092276,0.543328184994672,0,0,1.66223404255319,1.31050425539115,NDUFA11
beta,3,negative regulation of autophagy (GO:0010507),1/47,1,47,0.454571819092276,0.543328184994672,0,0,1.66223404255319,1.31050425539115,RRAGA
beta,3,regulation of neuron projection development (GO:0010975),2/120,2,120,0.45581493065941,0.543980968470442,0,0,1.30208333333333,1.02300573654399,SCARB2;RUFY3
beta,3,regulation of phosphorylation (GO:0042325),2/120,2,120,0.45581493065941,0.543980968470442,0,0,1.30208333333333,1.02300573654399,BARD1;FLCN
beta,3,macromolecular complex assembly (GO:0065003),2/121,2,121,0.460074189333001,0.547084547295113,0,0,1.29132231404959,1.00254070421579,SLC2A1;PPARGC1A
beta,3,response to glucose (GO:0009749),1/48,1,48,0.461569730165063,0.547084547295113,0,0,1.62760416666667,1.25833681939673,UNC13B
beta,3,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),1/48,1,48,0.461569730165063,0.547084547295113,0,0,1.62760416666667,1.25833681939673,G3BP2
beta,3,polyol metabolic process (GO:0019751),1/48,1,48,0.461569730165063,0.547084547295113,0,0,1.62760416666667,1.25833681939673,ITPKC
beta,3,negative regulation of cellular biosynthetic process (GO:0031327),1/48,1,48,0.461569730165063,0.547084547295113,0,0,1.62760416666667,1.25833681939673,TRIB3
beta,3,regulation of organelle assembly (GO:1902115),1/48,1,48,0.461569730165063,0.547084547295113,0,0,1.62760416666667,1.25833681939673,RDX
beta,3,"positive regulation of gene expression, epigenetic (GO:0045815)",1/48,1,48,0.461569730165063,0.547084547295113,0,0,1.62760416666667,1.25833681939673,DEK
beta,3,fatty acid biosynthetic process (GO:0006633),1/48,1,48,0.461569730165063,0.547084547295113,0,0,1.62760416666667,1.25833681939673,MLYCD
beta,3,inositol phosphate metabolic process (GO:0043647),1/48,1,48,0.461569730165063,0.547084547295113,0,0,1.62760416666667,1.25833681939673,ITPKC
beta,3,Golgi organization (GO:0007030),2/122,2,122,0.464314066552016,0.549919770779739,0,0,1.28073770491803,0.982574395694697,ARHGAP21;ATL2
beta,3,regulation of cell cycle arrest (GO:0071156),1/49,1,49,0.468478203156835,0.554430989482804,0,0,1.59438775510204,1.20896955218631,HSP90AB1
beta,3,tumor necrosis factor-mediated signaling pathway (GO:0033209),2/124,2,124,0.472734873299252,0.558621602740448,0,0,1.26008064516129,0.944078338214729,FOXO3;BIRC2
beta,3,cellular calcium ion homeostasis (GO:0006874),2/124,2,124,0.472734873299252,0.558621602740448,0,0,1.26008064516129,0.944078338214729,STIM2;ATP2A2
beta,3,organic hydroxy compound biosynthetic process (GO:1901617),1/50,1,50,0.475298376767612,0.560378222155772,0,0,1.5625,1.16220704772249,OSBPL3
beta,3,protein autoubiquitination (GO:0051865),1/50,1,50,0.475298376767612,0.560378222155772,0,0,1.5625,1.16220704772249,RNF187
beta,3,positive regulation of response to DNA damage stimulus (GO:2001022),1/50,1,50,0.475298376767612,0.560378222155772,0,0,1.5625,1.16220704772249,CEBPG
beta,3,dephosphorylation (GO:0016311),2/125,2,125,0.476915421976656,0.561860357513631,0,0,1.25,0.925520145291765,PHLPP2;PTPRH
beta,3,fatty acid oxidation (GO:0019395),1/51,1,51,0.482031375161153,0.564903135605525,0,0,1.53186274509804,1.11787082315365,PPARGC1A
beta,3,blood circulation (GO:0008015),1/51,1,51,0.482031375161153,0.564903135605525,0,0,1.53186274509804,1.11787082315365,ADM
beta,3,regulation of blood vessel endothelial cell migration (GO:0043535),1/51,1,51,0.482031375161153,0.564903135605525,0,0,1.53186274509804,1.11787082315365,VEGFA
beta,3,wound healing (GO:0042060),1/51,1,51,0.482031375161153,0.564903135605525,0,0,1.53186274509804,1.11787082315365,SRF
beta,3,negative regulation of viral genome replication (GO:0045071),1/51,1,51,0.482031375161153,0.564903135605525,0,0,1.53186274509804,1.11787082315365,EIF2AK4
beta,3,heart morphogenesis (GO:0003007),1/51,1,51,0.482031375161153,0.564903135605525,0,0,1.53186274509804,1.11787082315365,VEGFA
beta,3,neurogenesis (GO:0022008),1/51,1,51,0.482031375161153,0.564903135605525,0,0,1.53186274509804,1.11787082315365,MAPT
beta,3,negative regulation of neuron projection development (GO:0010977),1/52,1,52,0.488678308211331,0.57003937626064,0,0,1.50240384615385,1.075797569724,RUFY3
beta,3,regulation of exocytosis (GO:0017157),1/52,1,52,0.488678308211331,0.57003937626064,0,0,1.50240384615385,1.075797569724,RIMS2
beta,3,positive regulation of actin filament polymerization (GO:0030838),1/52,1,52,0.488678308211331,0.57003937626064,0,0,1.50240384615385,1.075797569724,WHAMM
beta,3,regulation of telomere maintenance via telomerase (GO:0032210),1/52,1,52,0.488678308211331,0.57003937626064,0,0,1.50240384615385,1.075797569724,MAP3K4
beta,3,arachidonic acid metabolic process (GO:0019369),1/52,1,52,0.488678308211331,0.57003937626064,0,0,1.50240384615385,1.075797569724,ALOXE3
beta,3,coenzyme metabolic process (GO:0006732),1/52,1,52,0.488678308211331,0.57003937626064,0,0,1.50240384615385,1.075797569724,MLYCD
beta,3,negative regulation of response to stimulus (GO:0048585),2/128,2,128,0.489335531191069,0.57003937626064,0,0,1.220703125,0.872444905946035,EPHA5;KLF4
beta,3,protein lipidation (GO:0006497),2/128,2,128,0.489335531191069,0.57003937626064,0,0,1.220703125,0.872444905946035,RAET1G;ULBP2
beta,3,positive regulation of mitochondrion organization (GO:0010822),2/129,2,129,0.493434511752049,0.573919869760378,0,0,1.21124031007752,0.855577919732512,HPS4;PPARGC1A
beta,3,positive regulation of proteolysis (GO:0045862),1/53,1,53,0.495240271984131,0.573919869760378,0,0,1.47405660377358,1.03583761237203,PERP
beta,3,positive regulation of ossification (GO:0045778),1/53,1,53,0.495240271984131,0.573919869760378,0,0,1.47405660377358,1.03583761237203,IL6R
beta,3,plasma membrane bounded cell projection morphogenesis (GO:0120039),1/53,1,53,0.495240271984131,0.573919869760378,0,0,1.47405660377358,1.03583761237203,DTNBP1
beta,3,positive regulation of nervous system development (GO:0051962),1/53,1,53,0.495240271984131,0.573919869760378,0,0,1.47405660377358,1.03583761237203,LIG4
beta,3,positive regulation of cell-substrate adhesion (GO:0010811),1/53,1,53,0.495240271984131,0.573919869760378,0,0,1.47405660377358,1.03583761237203,UTRN
beta,3,regulation of DNA binding (GO:0051101),1/53,1,53,0.495240271984131,0.573919869760378,0,0,1.47405660377358,1.03583761237203,CEBPG
beta,3,protein localization to plasma membrane (GO:0072659),2/131,2,131,0.501569988662823,0.579276879959481,0,0,1.19274809160305,0.823010642495053,RDX;SPTBN1
beta,3,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/54,1,54,0.501718348305713,0.579276879959481,0,0,1.44675925925926,0.997853553088768,NEDD4
beta,3,regulation of calcium ion-dependent exocytosis (GO:0017158),1/54,1,54,0.501718348305713,0.579276879959481,0,0,1.44675925925926,0.997853553088768,RIMS2
beta,3,monocarboxylic acid transport (GO:0015718),1/54,1,54,0.501718348305713,0.579276879959481,0,0,1.44675925925926,0.997853553088768,NCOA1
beta,3,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),1/54,1,54,0.501718348305713,0.579276879959481,0,0,1.44675925925926,0.997853553088768,IL6R
beta,3,sensory perception (GO:0007600),1/55,1,55,0.508113605501892,0.582353405424709,0,0,1.42045454545455,0.961719067511392,ALOXE3
beta,3,RNA modification (GO:0009451),1/55,1,55,0.508113605501892,0.582353405424709,0,0,1.42045454545455,0.961719067511392,TSR3
beta,3,cellular response to nutrient levels (GO:0031669),1/55,1,55,0.508113605501892,0.582353405424709,0,0,1.42045454545455,0.961719067511392,RRAGA
beta,3,intracellular transport of virus (GO:0075733),1/55,1,55,0.508113605501892,0.582353405424709,0,0,1.42045454545455,0.961719067511392,KPNA4
beta,3,action potential (GO:0001508),1/55,1,55,0.508113605501892,0.582353405424709,0,0,1.42045454545455,0.961719067511392,SCARB2
beta,3,positive regulation of immune response (GO:0050778),1/55,1,55,0.508113605501892,0.582353405424709,0,0,1.42045454545455,0.961719067511392,EIF2AK4
beta,3,positive regulation of response to stimulus (GO:0048584),1/55,1,55,0.508113605501892,0.582353405424709,0,0,1.42045454545455,0.961719067511392,ARG2
beta,3,membrane fusion (GO:0061025),1/55,1,55,0.508113605501892,0.582353405424709,0,0,1.42045454545455,0.961719067511392,USO1
beta,3,transport of virus (GO:0046794),1/55,1,55,0.508113605501892,0.582353405424709,0,0,1.42045454545455,0.961719067511392,KPNA4
beta,3,negative regulation of supramolecular fiber organization (GO:1902904),1/55,1,55,0.508113605501892,0.582353405424709,0,0,1.42045454545455,0.961719067511392,CRYAB
beta,3,protein targeting (GO:0006605),2/134,2,134,0.513614980153565,0.587795442829702,0,0,1.1660447761194,0.776913899330772,HPS4;GABARAP
beta,3,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),2/134,2,134,0.513614980153565,0.587795442829702,0,0,1.1660447761194,0.776913899330772,HSP90AB1;ELMO1
beta,3,long-chain fatty acid metabolic process (GO:0001676),1/56,1,56,0.514427098266843,0.587862884622651,0,0,1.39508928571429,0.927317840511086,ALOXE3
beta,3,regulation of axonogenesis (GO:0050770),1/56,1,56,0.514427098266843,0.587862884622651,0,0,1.39508928571429,0.927317840511086,RUFY3
beta,3,Fc-gamma receptor signaling pathway (GO:0038094),2/135,2,135,0.517587294846819,0.591041526887991,0,0,1.15740740740741,0.762241993488552,HSP90AB1;ELMO1
beta,3,chromosome organization (GO:0051276),1/57,1,57,0.520659867869197,0.591090948177321,0,0,1.37061403508772,0.894542619525123,LIG4
beta,3,regulation of secretion by cell (GO:1903530),1/57,1,57,0.520659867869197,0.591090948177321,0,0,1.37061403508772,0.894542619525123,RIMS2
beta,3,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),1/57,1,57,0.520659867869197,0.591090948177321,0,0,1.37061403508772,0.894542619525123,BIRC2
beta,3,regulation of BMP signaling pathway (GO:0030510),1/57,1,57,0.520659867869197,0.591090948177321,0,0,1.37061403508772,0.894542619525123,SULF1
beta,3,phosphatidylinositol-mediated signaling (GO:0048015),1/57,1,57,0.520659867869197,0.591090948177321,0,0,1.37061403508772,0.894542619525123,PITPNM2
beta,3,negative regulation of cellular catabolic process (GO:0031330),1/57,1,57,0.520659867869197,0.591090948177321,0,0,1.37061403508772,0.894542619525123,RRAGA
beta,3,autophagosome organization (GO:1905037),1/57,1,57,0.520659867869197,0.591090948177321,0,0,1.37061403508772,0.894542619525123,GABARAP
beta,3,glycosaminoglycan catabolic process (GO:0006027),1/57,1,57,0.520659867869197,0.591090948177321,0,0,1.37061403508772,0.894542619525123,TMEM2
beta,3,Fc receptor mediated stimulatory signaling pathway (GO:0002431),2/136,2,136,0.521538083344888,0.591657665771345,0,0,1.14889705882353,0.747900942853188,HSP90AB1;ELMO1
beta,3,regulation of Rho protein signal transduction (GO:0035023),1/58,1,58,0.526812942467531,0.596774312911332,0,0,1.34698275862069,0.863294371402387,FLCN
beta,3,cellular respiration (GO:0045333),1/58,1,58,0.526812942467531,0.596774312911332,0,0,1.34698275862069,0.863294371402387,PPARGC1A
beta,3,muscle contraction (GO:0006936),2/138,2,138,0.529374681967997,0.599241391263265,0,0,1.13224637681159,0.720175287981019,UTRN;CRYAB
beta,3,phospholipid transport (GO:0015914),1/59,1,59,0.532887337194623,0.60145906029299,0,0,1.32415254237288,0.833481530758056,TRIAP1
beta,3,ubiquitin-dependent ERAD pathway (GO:0030433),1/59,1,59,0.532887337194623,0.60145906029299,0,0,1.32415254237288,0.833481530758056,STT3B
beta,3,autophagosome assembly (GO:0000045),1/59,1,59,0.532887337194623,0.60145906029299,0,0,1.32415254237288,0.833481530758056,GABARAP
beta,3,sodium ion transport (GO:0006814),1/59,1,59,0.532887337194623,0.60145906029299,0,0,1.32415254237288,0.833481530758056,KCNK1
beta,3,regulation of signal transduction by p53 class mediator (GO:1901796),2/139,2,139,0.533260307139973,0.60145906029299,0,0,1.12410071942446,0.706773373324962,BARD1;NUAK1
beta,3,regulation of primary metabolic process (GO:0080090),2/140,2,140,0.537124036068744,0.605379509244267,0,0,1.11607142857143,0.693667669086071,NCOA1;TRIB3
beta,3,regulation of protein metabolic process (GO:0051246),1/60,1,60,0.538884054098816,0.605614116953385,0,0,1.30208333333333,0.805019328388629,KLF4
beta,3,mitotic cytokinesis (GO:0000281),1/60,1,60,0.538884054098816,0.605614116953385,0,0,1.30208333333333,0.805019328388629,SPTBN1
beta,3,sterol metabolic process (GO:0016125),1/60,1,60,0.538884054098816,0.605614116953385,0,0,1.30208333333333,0.805019328388629,FDX1
beta,3,cell morphogenesis (GO:0000902),1/60,1,60,0.538884054098816,0.605614116953385,0,0,1.30208333333333,0.805019328388629,CDH6
beta,3,modification-dependent protein catabolic process (GO:0019941),2/142,2,142,0.54478549904405,0.609633815853473,0,0,1.10035211267606,0.668313315941257,NEDD4;UBE2G1
beta,3,cell chemotaxis (GO:0060326),1/61,1,61,0.544804082713385,0.609633815853473,0,0,1.28073770491803,0.777829188278194,VEGFA
beta,3,nucleosome assembly (GO:0006334),1/61,1,61,0.544804082713385,0.609633815853473,0,0,1.28073770491803,0.777829188278194,UBN1
beta,3,positive regulation of protein binding (GO:0032092),1/61,1,61,0.544804082713385,0.609633815853473,0,0,1.28073770491803,0.777829188278194,TRIB3
beta,3,regulation of stress fiber assembly (GO:0051492),1/61,1,61,0.544804082713385,0.609633815853473,0,0,1.28073770491803,0.777829188278194,PHLDB2
beta,3,response to reactive oxygen species (GO:0000302),1/61,1,61,0.544804082713385,0.609633815853473,0,0,1.28073770491803,0.777829188278194,MAPT
beta,3,positive regulation of macromolecule biosynthetic process (GO:0010557),2/143,2,143,0.548583093622593,0.613422785920393,0,0,1.09265734265734,0.656049517335639,NAMPT;KLF4
beta,3,potassium ion transport (GO:0006813),1/62,1,62,0.550648399992919,0.614411831586095,0,0,1.26008064516129,0.751838188061008,KCNK1
beta,3,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),1/62,1,62,0.550648399992919,0.614411831586095,0,0,1.26008064516129,0.751838188061008,IL6R
beta,3,regulation of tumor necrosis factor production (GO:0032680),1/62,1,62,0.550648399992919,0.614411831586095,0,0,1.26008064516129,0.751838188061008,ARG2
beta,3,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),1/63,1,63,0.556417970542208,0.618198186488531,0,0,1.24007936507937,0.726978573377013,VPS4A
beta,3,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),1/63,1,63,0.556417970542208,0.618198186488531,0,0,1.24007936507937,0.726978573377013,HYOU1
beta,3,cellular amide metabolic process (GO:0043603),1/63,1,63,0.556417970542208,0.618198186488531,0,0,1.24007936507937,0.726978573377013,FUT5
beta,3,stress-activated MAPK cascade (GO:0051403),1/63,1,63,0.556417970542208,0.618198186488531,0,0,1.24007936507937,0.726978573377013,MAP3K5
beta,3,regulation of T cell proliferation (GO:0042129),1/63,1,63,0.556417970542208,0.618198186488531,0,0,1.24007936507937,0.726978573377013,CEBPB
beta,3,regulation of translational initiation (GO:0006446),1/63,1,63,0.556417970542208,0.618198186488531,0,0,1.24007936507937,0.726978573377013,EIF2AK4
beta,3,synapse assembly (GO:0007416),1/64,1,64,0.562113746450112,0.620551314150371,0,0,1.220703125,0.703187321470962,SDK1
beta,3,negative regulation of protein modification process (GO:0031400),1/64,1,64,0.562113746450112,0.620551314150371,0,0,1.220703125,0.703187321470962,MAPT
beta,3,vesicle coating (GO:0006901),1/64,1,64,0.562113746450112,0.620551314150371,0,0,1.220703125,0.703187321470962,USO1
beta,3,COPII vesicle coating (GO:0048208),1/64,1,64,0.562113746450112,0.620551314150371,0,0,1.220703125,0.703187321470962,USO1
beta,3,oligosaccharide metabolic process (GO:0009311),1/64,1,64,0.562113746450112,0.620551314150371,0,0,1.220703125,0.703187321470962,GALNT7
beta,3,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",1/64,1,64,0.562113746450112,0.620551314150371,0,0,1.220703125,0.703187321470962,USO1
beta,3,regulation of proteolysis (GO:0030162),1/64,1,64,0.562113746450112,0.620551314150371,0,0,1.220703125,0.703187321470962,PERP
beta,3,positive regulation of cell projection organization (GO:0031346),1/64,1,64,0.562113746450112,0.620551314150371,0,0,1.220703125,0.703187321470962,SCARB2
beta,3,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",1/64,1,64,0.562113746450112,0.620551314150371,0,0,1.220703125,0.703187321470962,CNOT6L
beta,3,skeletal system development (GO:0001501),2/147,2,147,0.56355117933411,0.621698509498619,0,0,1.06292517006803,0.609584529771063,EXT1;SULF1
beta,3,positive regulation of JAK-STAT cascade (GO:0046427),1/65,1,65,0.567736668040742,0.6254318551952,0,0,1.20192307692308,0.68040574563325,IL6R
beta,3,negative regulation of neuron differentiation (GO:0045665),1/65,1,65,0.567736668040742,0.6254318551952,0,0,1.20192307692308,0.68040574563325,EIF2AK4
beta,3,regulated exocytosis (GO:0045055),2/149,2,149,0.570901177056955,0.628474426929413,0,0,1.04865771812081,0.587813710420776,RIMS2;VEGFA
beta,3,O-glycan processing (GO:0016266),1/66,1,66,0.573287663553009,0.629326331087375,0,0,1.18371212121212,0.658579140162277,GALNT7
beta,3,glycolipid metabolic process (GO:0006664),1/66,1,66,0.573287663553009,0.629326331087375,0,0,1.18371212121212,0.658579140162277,KDELC2
beta,3,DNA synthesis involved in DNA repair (GO:0000731),1/66,1,66,0.573287663553009,0.629326331087375,0,0,1.18371212121212,0.658579140162277,BARD1
beta,3,negative regulation of apoptotic signaling pathway (GO:2001234),1/66,1,66,0.573287663553009,0.629326331087375,0,0,1.18371212121212,0.658579140162277,TRIAP1
beta,3,heart development (GO:0007507),2/150,2,150,0.574542530835473,0.630260639939686,0,0,1.04166666666667,0.577272034779458,SRF;VEGFA
beta,3,purine ribonucleotide metabolic process (GO:0009150),1/67,1,67,0.578767649439079,0.633559818214868,0,0,1.1660447761194,0.637656457854029,RHOQ
beta,3,negative regulation of epithelial cell proliferation (GO:0050680),1/67,1,67,0.578767649439079,0.633559818214868,0,0,1.1660447761194,0.637656457854029,SULF1
beta,3,sphingolipid biosynthetic process (GO:0030148),1/67,1,67,0.578767649439079,0.633559818214868,0,0,1.1660447761194,0.637656457854029,ALOXE3
beta,3,epidermal cell differentiation (GO:0009913),1/68,1,68,0.58417753059258,0.63813934587475,0,0,1.14889705882353,0.61759001793315,CTNNB1
beta,3,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),1/68,1,68,0.58417753059258,0.63813934587475,0,0,1.14889705882353,0.61759001793315,PSRC1
beta,3,regulation of cardiac conduction (GO:1903779),1/68,1,68,0.58417753059258,0.63813934587475,0,0,1.14889705882353,0.61759001793315,ATP2A2
beta,3,regulation of endopeptidase activity (GO:0052548),1/69,1,69,0.589518200355168,0.642624239353643,0,0,1.13224637681159,0.598335241459588,BIRC2
beta,3,COPII-coated vesicle budding (GO:0090114),1/69,1,69,0.589518200355168,0.642624239353643,0,0,1.13224637681159,0.598335241459588,USO1
beta,3,cholesterol metabolic process (GO:0008203),1/69,1,69,0.589518200355168,0.642624239353643,0,0,1.13224637681159,0.598335241459588,FDX1
beta,3,regulation of endothelial cell migration (GO:0010594),1/70,1,70,0.594790540832516,0.647016051734884,0,0,1.11607142857143,0.579850410299834,VEGFA
beta,3,regulation of osteoblast differentiation (GO:0045667),1/70,1,70,0.594790540832516,0.647016051734884,0,0,1.11607142857143,0.579850410299834,IL6R
beta,3,response to organic cyclic compound (GO:0014070),1/70,1,70,0.594790540832516,0.647016051734884,0,0,1.11607142857143,0.579850410299834,CTNNB1
beta,3,positive regulation of endothelial cell migration (GO:0010595),1/71,1,71,0.599995422733041,0.649960343432531,0,0,1.10035211267606,0.562096448694273,VEGFA
beta,3,regulation of Notch signaling pathway (GO:0008593),1/71,1,71,0.599995422733041,0.649960343432531,0,0,1.10035211267606,0.562096448694273,NRARP
beta,3,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/71,1,71,0.599995422733041,0.649960343432531,0,0,1.10035211267606,0.562096448694273,TRIB3
beta,3,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),1/71,1,71,0.599995422733041,0.649960343432531,0,0,1.10035211267606,0.562096448694273,NEDD4
beta,3,phospholipid metabolic process (GO:0006644),1/71,1,71,0.599995422733041,0.649960343432531,0,0,1.10035211267606,0.562096448694273,GPX4
beta,3,calcium-mediated signaling (GO:0019722),1/71,1,71,0.599995422733041,0.649960343432531,0,0,1.10035211267606,0.562096448694273,ATP2A2
beta,3,phosphatidylcholine metabolic process (GO:0046470),1/72,1,72,0.60513370592718,0.654164622543163,0,0,1.08506944444444,0.545036722912335,CHKA
beta,3,positive regulation of lymphocyte proliferation (GO:0050671),1/72,1,72,0.60513370592718,0.654164622543163,0,0,1.08506944444444,0.545036722912335,GPR183
beta,3,defense response to Gram-negative bacterium (GO:0050829),1/72,1,72,0.60513370592718,0.654164622543163,0,0,1.08506944444444,0.545036722912335,IL6R
beta,3,lipid biosynthetic process (GO:0008610),1/73,1,73,0.610206239233454,0.65828053866166,0,0,1.07020547945205,0.528636859859486,MLYCD
beta,3,regulation of epithelial cell proliferation (GO:0050678),1/73,1,73,0.610206239233454,0.65828053866166,0,0,1.07020547945205,0.528636859859486,VEGFA
beta,3,negative regulation of cell cycle (GO:0045786),1/73,1,73,0.610206239233454,0.65828053866166,0,0,1.07020547945205,0.528636859859486,HECA
beta,3,protein N-linked glycosylation (GO:0006487),1/74,1,74,0.61521386068323,0.660942076067806,0,0,1.05574324324324,0.512864580526972,STT3B
beta,3,regulation of peptide hormone secretion (GO:0090276),1/74,1,74,0.61521386068323,0.660942076067806,0,0,1.05574324324324,0.512864580526972,SLC2A1
beta,3,regulation of protein complex assembly (GO:0043254),1/74,1,74,0.61521386068323,0.660942076067806,0,0,1.05574324324324,0.512864580526972,VEGFA
beta,3,positive regulation of cytokine secretion (GO:0050715),1/74,1,74,0.61521386068323,0.660942076067806,0,0,1.05574324324324,0.512864580526972,SPTBN1
beta,3,canonical Wnt signaling pathway (GO:0060070),1/74,1,74,0.61521386068323,0.660942076067806,0,0,1.05574324324324,0.512864580526972,CTNNB1
beta,3,positive regulation of proteasomal protein catabolic process (GO:1901800),1/74,1,74,0.61521386068323,0.660942076067806,0,0,1.05574324324324,0.512864580526972,TRIB3
beta,3,positive regulation of epithelial cell migration (GO:0010634),1/75,1,75,0.620157397802864,0.66442395193567,0,0,1.04166666666667,0.497689547643654,VEGFA
beta,3,"regulation of gene expression, epigenetic (GO:0040029)",1/75,1,75,0.620157397802864,0.66442395193567,0,0,1.04166666666667,0.497689547643654,DEK
beta,3,glucose homeostasis (GO:0042593),1/75,1,75,0.620157397802864,0.66442395193567,0,0,1.04166666666667,0.497689547643654,PPARGC1A
beta,3,mitotic nuclear division (GO:0140014),1/75,1,75,0.620157397802864,0.66442395193567,0,0,1.04166666666667,0.497689547643654,BIRC2
beta,3,negative regulation of phosphorylation (GO:0042326),1/76,1,76,0.625037667589055,0.667819164343953,0,0,1.02796052631579,0.483083226685135,MAPT
beta,3,negative regulation of cellular amide metabolic process (GO:0034249),1/76,1,76,0.625037667589055,0.667819164343953,0,0,1.02796052631579,0.483083226685135,MEX3B
beta,3,regulation of defense response (GO:0031347),1/76,1,76,0.625037667589055,0.667819164343953,0,0,1.02796052631579,0.483083226685135,BIRC2
beta,3,gland development (GO:0048732),1/76,1,76,0.625037667589055,0.667819164343953,0,0,1.02796052631579,0.483083226685135,CEBPG
beta,3,double-strand break repair via homologous recombination (GO:0000724),1/77,1,77,0.629855476386162,0.671587703988251,0,0,1.01461038961039,0.469018758598822,CDC7
beta,3,regulation of hematopoietic stem cell differentiation (GO:1902036),1/77,1,77,0.629855476386162,0.671587703988251,0,0,1.01461038961039,0.469018758598822,TCF12
beta,3,hemopoiesis (GO:0030097),1/77,1,77,0.629855476386162,0.671587703988251,0,0,1.01461038961039,0.469018758598822,FLCN
beta,3,water-soluble vitamin metabolic process (GO:0006767),1/78,1,78,0.63461162073433,0.674815217960688,0,0,1.00160256410256,0.455470841442929,SLC2A1
beta,3,ERAD pathway (GO:0036503),1/78,1,78,0.63461162073433,0.674815217960688,0,0,1.00160256410256,0.455470841442929,STT3B
beta,3,response to ionizing radiation (GO:0010212),1/78,1,78,0.63461162073433,0.674815217960688,0,0,1.00160256410256,0.455470841442929,LIG4
beta,3,regulation of hematopoietic progenitor cell differentiation (GO:1901532),1/78,1,78,0.63461162073433,0.674815217960688,0,0,1.00160256410256,0.455470841442929,TCF12
beta,3,adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189),1/79,1,79,0.639306886725374,0.677960631914612,0,0,0.988924050632911,0.442415623988219,ADM
beta,3,negative regulation of cell communication (GO:0010648),1/79,1,79,0.639306886725374,0.677960631914612,0,0,0.988924050632911,0.442415623988219,EPHA5
beta,3,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),1/79,1,79,0.639306886725374,0.677960631914612,0,0,0.988924050632911,0.442415623988219,VEGFA
beta,3,negative regulation of inflammatory response (GO:0050728),1/79,1,79,0.639306886725374,0.677960631914612,0,0,0.988924050632911,0.442415623988219,KLF4
beta,3,nucleosome organization (GO:0034728),1/80,1,80,0.643942050552275,0.680564347266148,0,0,0.9765625,0.429830605997102,SETD2
beta,3,negative regulation of mitotic cell cycle phase transition (GO:1901991),1/80,1,80,0.643942050552275,0.680564347266148,0,0,0.9765625,0.429830605997102,KLF4
beta,3,cation transport (GO:0006812),1/80,1,80,0.643942050552275,0.680564347266148,0,0,0.9765625,0.429830605997102,SLC1A1
beta,3,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),1/80,1,80,0.643942050552275,0.680564347266148,0,0,0.9765625,0.429830605997102,MAPT
beta,3,response to calcium ion (GO:0051592),1/80,1,80,0.643942050552275,0.680564347266148,0,0,0.9765625,0.429830605997102,NEDD4
beta,3,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/81,1,81,0.648517878626669,0.683087994963718,0,0,0.964506172839506,0.417694547072664,NEDD4
beta,3,spindle assembly (GO:0051225),1/81,1,81,0.648517878626669,0.683087994963718,0,0,0.964506172839506,0.417694547072664,BIRC2
beta,3,regulation of protein serine/threonine kinase activity (GO:0071900),1/81,1,81,0.648517878626669,0.683087994963718,0,0,0.964506172839506,0.417694547072664,TRIB3
beta,3,negative regulation of MAPK cascade (GO:0043409),1/81,1,81,0.648517878626669,0.683087994963718,0,0,0.964506172839506,0.417694547072664,FLCN
beta,3,negative regulation of defense response (GO:0031348),1/81,1,81,0.648517878626669,0.683087994963718,0,0,0.964506172839506,0.417694547072664,KLF4
beta,3,positive regulation of protein targeting to mitochondrion (GO:1903955),1/82,1,82,0.653035127596899,0.686919025726926,0,0,0.952743902439024,0.405987382790211,HPS4
beta,3,epidermis development (GO:0008544),1/82,1,82,0.653035127596899,0.686919025726926,0,0,0.952743902439024,0.405987382790211,ATP2A2
beta,3,modulation of chemical synaptic transmission (GO:0050804),1/83,1,83,0.657494544404792,0.688824821352939,0,0,0.941265060240964,0.394690147258893,RIMS2
beta,3,negative regulation of NF-kappaB transcription factor activity (GO:0032088),1/83,1,83,0.657494544404792,0.688824821352939,0,0,0.941265060240964,0.394690147258893,KLF4
beta,3,positive regulation of protein secretion (GO:0050714),1/83,1,83,0.657494544404792,0.688824821352939,0,0,0.941265060240964,0.394690147258893,UNC13B
beta,3,positive regulation of DNA metabolic process (GO:0051054),1/83,1,83,0.657494544404792,0.688824821352939,0,0,0.941265060240964,0.394690147258893,CEBPG
beta,3,ephrin receptor signaling pathway (GO:0048013),1/83,1,83,0.657494544404792,0.688824821352939,0,0,0.941265060240964,0.394690147258893,EPHA5
beta,3,negative regulation of binding (GO:0051100),1/83,1,83,0.657494544404792,0.688824821352939,0,0,0.941265060240964,0.394690147258893,DNAJB2
beta,3,negative regulation of signaling (GO:0023057),1/84,1,84,0.661896866703365,0.691580327258335,0,0,0.930059523809524,0.383784901097495,EPHA5
beta,3,establishment of protein localization to membrane (GO:0090150),1/84,1,84,0.661896866703365,0.691580327258335,0,0,0.930059523809524,0.383784901097495,SPTBN1
beta,3,positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/84,1,84,0.661896866703365,0.691580327258335,0,0,0.930059523809524,0.383784901097495,VEGFA
beta,3,protein maturation (GO:0051604),1/84,1,84,0.661896866703365,0.691580327258335,0,0,0.930059523809524,0.383784901097495,ISCA1
beta,3,mitochondrial ATP synthesis coupled electron transport (GO:0042775),1/86,1,86,0.670533130853337,0.700135262382649,0,0,0.908430232558139,0.36308336239195,NDUFA11
beta,3,toll-like receptor signaling pathway (GO:0002224),1/87,1,87,0.674768501488925,0.703616319855853,0,0,0.897988505747127,0.353255754033088,BIRC2
beta,3,regulation of peptidyl-serine phosphorylation (GO:0033135),1/87,1,87,0.674768501488925,0.703616319855853,0,0,0.897988505747127,0.353255754033088,VEGFA
beta,3,organic substance transport (GO:0071702),1/88,1,88,0.67894963511917,0.707503591736331,0,0,0.887784090909091,0.343757394581652,CHKA
beta,3,T cell activation (GO:0042110),1/89,1,89,0.683077223545852,0.710382109230563,0,0,0.877808988764045,0.334574579162457,EIF2AK4
beta,3,regulation of stem cell differentiation (GO:2000736),1/89,1,89,0.683077223545852,0.710382109230563,0,0,0.877808988764045,0.334574579162457,TCF12
beta,3,regulation of protein targeting to mitochondrion (GO:1903214),1/89,1,89,0.683077223545852,0.710382109230563,0,0,0.877808988764045,0.334574579162457,HPS4
beta,3,negative regulation of cellular protein metabolic process (GO:0032269),1/90,1,90,0.687151949958968,0.713668791673951,0,0,0.868055555555556,0.32569429881656,MEX3B
beta,3,peptidyl-threonine modification (GO:0018210),1/90,1,90,0.687151949958968,0.713668791673951,0,0,0.868055555555556,0.32569429881656,GALNT7
beta,3,protein tetramerization (GO:0051262),1/91,1,91,0.691174488736851,0.71689260924799,0,0,0.858516483516484,0.317104198857837,AASS
beta,3,regulation of Ras protein signal transduction (GO:0046578),1/91,1,91,0.691174488736851,0.71689260924799,0,0,0.858516483516484,0.317104198857837,RDX
beta,3,nuclear export (GO:0051168),1/93,1,93,0.699065657936016,0.724595944248421,0,0,0.84005376344086,0.300748160215603,ATXN1
beta,3,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/94,1,94,0.70293559474132,0.728123731513736,0,0,0.831117021276596,0.292960444020598,VEGFA
beta,3,vesicle fusion (GO:0006906),1/95,1,95,0.706755956772863,0.731110701472789,0,0,0.822368421052632,0.285419287863742,VPS4A
beta,3,skin development (GO:0043588),1/95,1,95,0.706755956772863,0.731110701472789,0,0,0.822368421052632,0.285419287863742,ALOXE3
beta,3,positive regulation of protein localization to membrane (GO:1905477),1/96,1,96,0.710527376631677,0.734039202463301,0,0,0.813802083333333,0.278115072172848,SPTBN1
beta,3,regulation of heart contraction (GO:0008016),1/96,1,96,0.710527376631677,0.734039202463301,0,0,0.813802083333333,0.278115072172848,ATP2A2
beta,3,epithelial cell differentiation (GO:0030855),1/97,1,97,0.714250478929741,0.736910110779462,0,0,0.805412371134021,0.271038633486079,VEGFA
beta,3,ciliary basal body-plasma membrane docking (GO:0097711),1/97,1,97,0.714250478929741,0.736910110779462,0,0,0.805412371134021,0.271038633486079,IQCB1
beta,3,mRNA metabolic process (GO:0016071),1/98,1,98,0.717925880234646,0.739724289799527,0,0,0.79719387755102,0.264181238945753,PPARGC1A
beta,3,protein localization to organelle (GO:0033365),1/98,1,98,0.717925880234646,0.739724289799527,0,0,0.79719387755102,0.264181238945753,YBX1
beta,3,phosphatidylinositol biosynthetic process (GO:0006661),1/99,1,99,0.721554189342399,0.742482590351671,0,0,0.789141414141414,0.257534562093507,PITPNM2
beta,3,histone modification (GO:0016570),1/99,1,99,0.721554189342399,0.742482590351671,0,0,0.789141414141414,0.257534562093507,USP3
beta,3,cellular response to transforming growth factor beta stimulus (GO:0071560),1/101,1,101,0.728671927482401,0.749312831884076,0,0,0.773514851485149,0.244841954792783,NR3C1
beta,3,metal ion transport (GO:0030001),1/102,1,102,0.732162535837636,0.752406661252501,0,0,0.76593137254902,0.238781208773587,KCNK1
beta,3,monovalent inorganic cation transport (GO:0015672),1/105,1,105,0.742368236894227,0.761891398942727,0,0,0.744047619047619,0.221659138974152,KCNK1
beta,3,positive regulation of vasculature development (GO:1904018),1/105,1,105,0.742368236894227,0.761891398942727,0,0,0.744047619047619,0.221659138974152,VEGFA
beta,3,positive regulation of cellular component organization (GO:0051130),1/107,1,107,0.748955887998962,0.768147267520618,0,0,0.730140186915888,0.21106541452007,VEGFA
beta,3,positive regulation of cell cycle process (GO:0090068),1/108,1,108,0.752186517474466,0.770448263633623,0,0,0.72337962962963,0.205997509570185,CDC7
beta,3,negative regulation of response to external stimulus (GO:0032102),1/108,1,108,0.752186517474466,0.770448263633623,0,0,0.72337962962963,0.205997509570185,KLF4
beta,3,regulation of protein activation cascade (GO:2000257),1/109,1,109,0.755375732674399,0.771689475592105,0,0,0.716743119266055,0.201075110631436,CD55
beta,3,nucleotide-excision repair (GO:0006289),1/109,1,109,0.755375732674399,0.771689475592105,0,0,0.716743119266055,0.201075110631436,LIG4
beta,3,monocarboxylic acid metabolic process (GO:0032787),1/109,1,109,0.755375732674399,0.771689475592105,0,0,0.716743119266055,0.201075110631436,SCARB2
beta,3,negative regulation of hydrolase activity (GO:0051346),1/109,1,109,0.755375732674399,0.771689475592105,0,0,0.716743119266055,0.201075110631436,RDX
beta,3,circulatory system development (GO:0072359),1/110,1,110,0.758524062515383,0.773387368769766,0,0,0.710227272727273,0.196293151192821,SRF
beta,3,negative regulation of protein kinase activity (GO:0006469),1/110,1,110,0.758524062515383,0.773387368769766,0,0,0.710227272727273,0.196293151192821,TRIB3
beta,3,regulation of complement activation (GO:0030449),1/110,1,110,0.758524062515383,0.773387368769766,0,0,0.710227272727273,0.196293151192821,CD55
beta,3,viral gene expression (GO:0019080),1/111,1,111,0.761632029098276,0.775543116387742,0,0,0.703828828828829,0.191646777432275,EIF2AK4
beta,3,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),1/111,1,111,0.761632029098276,0.775543116387742,0,0,0.703828828828829,0.191646777432275,HPS4
beta,3,phosphatidylinositol metabolic process (GO:0046488),1/113,1,113,0.767728927699417,0.781241757587216,0,0,0.691371681415929,0.182742372002057,PITPNM2
beta,3,positive regulation of canonical Wnt signaling pathway (GO:0090263),1/114,1,114,0.770718871085577,0.783263123544652,0,0,0.68530701754386,0.178475603655624,NRARP
beta,3,regulation of humoral immune response (GO:0002920),1/114,1,114,0.770718871085577,0.783263123544652,0,0,0.68530701754386,0.178475603655624,CD55
beta,3,regulation of immune effector process (GO:0002697),1/115,1,115,0.773670474122886,0.785751210218493,0,0,0.679347826086957,0.174326929398376,CD55
beta,3,protein O-linked glycosylation (GO:0006493),1/116,1,116,0.776584226446109,0.78768549544014,0,0,0.673491379310345,0.170292411726249,GALNT7
beta,3,epithelium development (GO:0060429),1/116,1,116,0.776584226446109,0.78768549544014,0,0,0.673491379310345,0.170292411726249,VEGFA
beta,3,positive regulation of B cell activation (GO:0050871),1/120,1,120,0.787870307623536,0.79809574964331,0,0,0.651041666666667,0.155222517515508,GPR183
beta,3,brain development (GO:0007420),1/120,1,120,0.787870307623536,0.79809574964331,0,0,0.651041666666667,0.155222517515508,ATXN1
beta,3,enzyme linked receptor protein signaling pathway (GO:0007167),1/121,1,121,0.790601937345841,0.800343465756717,0,0,0.645661157024794,0.151704982985,NEDD9
beta,3,regulation of acute inflammatory response (GO:0002673),1/122,1,122,0.793298526844484,0.802552819445392,0,0,0.640368852459016,0.148281042310865,CD55
beta,3,sulfur compound biosynthetic process (GO:0044272),1/123,1,123,0.79596052369621,0.804724337752451,0,0,0.635162601626016,0.144947718314288,EXT1
beta,3,platelet degranulation (GO:0002576),1/125,1,125,0.801182502087773,0.808955941629374,0,0,0.625,0.138541571912375,VEGFA
beta,3,organic anion transport (GO:0015711),1/125,1,125,0.801182502087773,0.808955941629374,0,0,0.625,0.138541571912375,TRIAP1
beta,3,G2/M transition of mitotic cell cycle (GO:0000086),1/127,1,127,0.806271341864929,0.813567915094476,0,0,0.615157480314961,0.132464899540077,WEE1
beta,3,vesicle organization (GO:0016050),1/128,1,128,0.808766894954921,0.814506530983633,0,0,0.6103515625,0.129543788560921,VPS4A
beta,3,non-canonical Wnt signaling pathway (GO:0035567),1/128,1,128,0.808766894954921,0.814506530983633,0,0,0.6103515625,0.129543788560921,CTNNB1
beta,3,cell cycle G2/M phase transition (GO:0044839),1/128,1,128,0.808766894954921,0.814506530983633,0,0,0.6103515625,0.129543788560921,WEE1
beta,3,positive regulation of NF-kappaB transcription factor activity (GO:0051092),1/129,1,129,0.811230424548536,0.815934724690892,0,0,0.60562015503876,0.126697638833192,NFKB2
beta,3,regulation of protein processing (GO:0070613),1/129,1,129,0.811230424548536,0.815934724690892,0,0,0.60562015503876,0.126697638833192,CD55
beta,3,regulation of macromolecule metabolic process (GO:0060255),1/130,1,130,0.813662340264761,0.817853775372371,0,0,0.600961538461538,0.123924167331046,MAPK6
beta,3,positive regulation of cytosolic calcium ion concentration (GO:0007204),1/134,1,134,0.823081868774903,0.826789444760376,0,0,0.583022388059701,0.113514229955568,CD55
beta,3,adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),1/135,1,135,0.825361674477709,0.828546349749006,0,0,0.578703703703704,0.111072682527437,ADM
beta,3,regulation of cytosolic calcium ion concentration (GO:0051480),1/138,1,138,0.832026992764475,0.83470060135305,0,0,0.566123188405797,0.104104616995395,CD55
beta,3,response to lipid (GO:0033993),1/141,1,141,0.838438872413953,0.840053324671489,0,0,0.554078014184397,0.097636082387314,CTNNB1
beta,3,regulation of cellular component organization (GO:0051128),1/141,1,141,0.838438872413953,0.840053324671489,0,0,0.554078014184397,0.097636082387314,NEDD4
beta,3,regulation of protein kinase activity (GO:0045859),1/148,1,148,0.85246758143361,0.853561189620183,0,0,0.527871621621622,0.0842589200756934,TRIB3
beta,3,negative regulation of canonical Wnt signaling pathway (GO:0090090),1/149,1,149,0.85437005251434,0.854917725624926,0,0,0.524328859060403,0.0825245712492877,DDIT3
beta,3,regulation of G2/M transition of mitotic cell cycle (GO:0010389),1/150,1,150,0.856248084937733,0.856248084937733,0,0,0.520833333333333,0.08083079477983,CDC7
beta,4,cellular response to glucocorticoid stimulus (GO:0071385),3/17,3,17,0.000270634484887206,0.0729359936771019,0,0,23.2198142414861,190.744769622437,REST;KLF9;PCK2
beta,4,autophagy of mitochondrion (GO:0000422),4/41,4,41,0.000260920265756197,0.0729359936771019,0,0,12.8369704749679,105.921639184875,ATG3;GABARAPL1;FBXO7;SQSTM1
beta,4,mitochondrion disassembly (GO:0061726),4/39,4,39,0.000214430608979268,0.0729359936771019,0,0,13.4952766531714,114.001678450691,ATG3;GABARAPL1;FBXO7;SQSTM1
beta,4,liver development (GO:0001889),4/32,4,32,9.77006961224578e-05,0.0729359936771019,0,0,16.4473684210526,151.868451872352,PROX1;MET;E2F7;PCK2
beta,4,ventricular septum morphogenesis (GO:0060412),3/21,3,21,0.00051765927146958,0.111607338928841,0,0,18.796992481203,142.221678744752,PROX1;TGFBR1;TGFBR2
beta,4,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),2/6,2,6,0.000843649642294248,0.11368178929915,0,0,43.859649122807,310.428651987624,TGFBR1;TGFBR2
beta,4,retinal ganglion cell axon guidance (GO:0031290),2/6,2,6,0.000843649642294248,0.11368178929915,0,0,43.859649122807,310.428651987624,ROBO2;ALCAM
beta,4,negative regulation of calcium ion-dependent exocytosis (GO:0045955),2/6,2,6,0.000843649642294248,0.11368178929915,0,0,43.859649122807,310.428651987624,SYT4;REST
beta,4,negative regulation of secretion by cell (GO:1903531),3/31,3,31,0.00165491018285905,0.148666098093504,0,0,12.7334465195246,81.5451002776094,SYT4;SERGEF;SNCA
beta,4,kidney development (GO:0001822),4/64,4,64,0.00143006924121921,0.148666098093504,0,0,8.22368421052632,53.8653981533679,ROBO2;C1GALT1;PROX1;TGFBR1
beta,4,ventricular trabecula myocardium morphogenesis (GO:0003222),2/8,2,8,0.00155915007461018,0.148666098093504,0,0,32.8947368421053,212.618895728915,DLL4;TGFBR1
beta,4,cellular response to oxidative stress (GO:0034599),5/116,5,116,0.00193499168664344,0.160455464477048,0,0,5.67150635208712,35.4335994148022,DAPK1;TXNRD1;SESN2;ARNTL;SNCA
beta,4,ventricular septum development (GO:0003281),3/29,3,29,0.00136030458876632,0.148666098093504,0,0,13.6116152450091,89.8372954897707,PROX1;TGFBR1;TGFBR2
beta,4,ventricular cardiac muscle tissue morphogenesis (GO:0055010),3/35,3,35,0.0023567781778099,0.17101503336158,0,0,11.2781954887218,68.2382681001249,DLL4;PROX1;TGFBR1
beta,4,regulation of transforming growth factor beta production (GO:0071634),2/10,2,10,0.00248088195653985,0.17101503336158,0,0,26.3157894736842,157.872135641809,SMAD3;PTGS2
beta,4,response to sterol (GO:0036314),2/11,2,11,0.00301710175481558,0.17101503336158,0,0,23.9234449760766,138.838722301977,TGFBR1;TGFBR2
beta,4,hemopoiesis (GO:0030097),4/77,4,77,0.00282273540352882,0.17101503336158,0,0,6.83526999316473,40.1233688511823,CD164;CDK13;RUNX1;TGFBR2
beta,4,positive regulation of protein kinase B signaling (GO:0051897),5/128,5,128,0.00296871365991597,0.17101503336158,0,0,5.13980263157895,29.9117317594914,OSBPL8;IRS2;MET;RTN4;TGFBR1
beta,4,regulation of cell morphogenesis involved in differentiation (GO:0010769),3/37,3,37,0.00276705201388995,0.17101503336158,0,0,10.6685633001422,62.8375474440006,SDC2;TNIK;SSH2
beta,4,regulation of neural precursor cell proliferation (GO:2000177),2/14,2,14,0.00491787201689144,0.17101503336158,0,0,18.796992481203,99.9037473483518,DLL4;PROX1
beta,4,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),4/94,4,94,0.00576046929859915,0.177422454396854,0,0,5.59910414333707,28.8731037633933,REST;DAPK1;SH3RF1;SNCA
beta,4,endoderm development (GO:0007492),2/15,2,15,0.00564629878421816,0.177422454396854,0,0,17.5438596491228,90.8202637004089,DUSP4;LAMC1
beta,4,branching morphogenesis of an epithelial tube (GO:0048754),3/44,3,44,0.00453730306351783,0.17101503336158,0,0,8.97129186602871,48.4039098293595,DLL4;MET;TGFBR2
beta,4,positive regulation of epithelial to mesenchymal transition (GO:0010718),3/41,3,41,0.00371311369407611,0.17101503336158,0,0,9.62772785622593,53.8756529240662,SMAD3;TGFBR1;TGFBR2
beta,4,positive regulation of neural precursor cell proliferation (GO:2000179),2/14,2,14,0.00491787201689144,0.17101503336158,0,0,18.796992481203,99.9037473483518,DLL4;PROX1
beta,4,positive regulation of SMAD protein import into nucleus (GO:0060391),2/12,2,12,0.00360251775531864,0.17101503336158,0,0,21.9298245614035,123.379875032729,SMAD3;TGFBR1
beta,4,embryonic cranial skeleton morphogenesis (GO:0048701),2/15,2,15,0.00564629878421816,0.177422454396854,0,0,17.5438596491228,90.8202637004089,TGFBR1;TGFBR2
beta,4,neuron fate commitment (GO:0048663),2/13,2,13,0.00423636119497933,0.17101503336158,0,0,20.2429149797571,110.608311476549,DLL4;TGFBR1
beta,4,negative regulation of lipid storage (GO:0010888),2/16,2,16,0.00642089859624638,0.182150754914568,0,0,16.4473684210526,83.0295592567802,OSBPL8;ABHD5
beta,4,cardiac ventricle morphogenesis (GO:0003208),3/44,3,44,0.00453730306351783,0.17101503336158,0,0,8.97129186602871,48.4039098293595,DLL4;PROX1;TGFBR2
beta,4,response to cholesterol (GO:0070723),2/15,2,15,0.00564629878421816,0.177422454396854,0,0,17.5438596491228,90.8202637004089,TGFBR1;TGFBR2
beta,4,branching involved in blood vessel morphogenesis (GO:0001569),2/14,2,14,0.00491787201689144,0.17101503336158,0,0,18.796992481203,99.9037473483518,DLL4;TGFBR2
beta,4,aorta morphogenesis (GO:0035909),2/16,2,16,0.00642089859624638,0.182150754914568,0,0,16.4473684210526,83.0295592567802,DLL4;PROX1
beta,4,positive regulation of transport (GO:0051050),3/45,3,45,0.00483461538751812,0.17101503336158,0,0,8.7719298245614,46.7715236912896,C2CD5;SGK1;SNCA
beta,4,regulation of sequestering of triglyceride (GO:0010889),2/12,2,12,0.00360251775531864,0.17101503336158,0,0,21.9298245614035,123.379875032729,OSBPL8;ABHD5
beta,4,pathway-restricted SMAD protein phosphorylation (GO:0060389),2/13,2,13,0.00423636119497933,0.17101503336158,0,0,20.2429149797571,110.608311476549,TGFBR1;TGFBR2
beta,4,regulation of SMAD protein import into nucleus (GO:0060390),2/16,2,16,0.00642089859624638,0.182150754914568,0,0,16.4473684210526,83.0295592567802,SMAD3;TGFBR1
beta,4,wound healing (GO:0042060),3/51,3,51,0.0068641742413194,0.189732816208777,0,0,7.73993808049536,38.5560335318193,SMAD3;TGFBR1;DCBLD2
beta,4,positive regulation of cellular carbohydrate metabolic process (GO:0010676),2/13,2,13,0.00423636119497933,0.17101503336158,0,0,20.2429149797571,110.608311476549,IRS2;SNCA
beta,4,cardiac atrium morphogenesis (GO:0003209),2/17,2,17,0.00724093700202408,0.195143252204549,0,0,15.4798761609907,76.2849018698066,DLL4;PROX1
beta,4,positive regulation of cellular catabolic process (GO:0031331),4/107,4,107,0.00903912568677602,0.198860765109072,0,0,4.91883915395967,23.1490055352678,DAPK1;IRS2;ABHD5;SNCA
beta,4,positive regulation of lipid catabolic process (GO:0050996),2/18,2,18,0.00810568791811713,0.19858935399387,0,0,14.6198830409357,70.3975036787439,IRS2;ABHD5
beta,4,activin receptor signaling pathway (GO:0032924),2/19,2,19,0.00901443354721816,0.198860765109072,0,0,13.8504155124654,65.2206130024222,SMAD3;TGFBR1
beta,4,positive regulation of epithelial cell proliferation (GO:0050679),4/108,4,108,0.00933249768076252,0.20120864999724,0,0,4.87329434697856,22.7790087509137,LAMC1;PROX1;RTN4;TGFBR1
beta,4,heart trabecula morphogenesis (GO:0061384),2/18,2,18,0.00810568791811713,0.19858935399387,0,0,14.6198830409357,70.3975036787439,DLL4;TGFBR1
beta,4,sulfur compound transport (GO:0072348),2/19,2,19,0.00901443354721816,0.198860765109072,0,0,13.8504155124654,65.2206130024222,SLC25A26;SLC19A2
beta,4,regulation of axonogenesis (GO:0050770),3/56,3,56,0.00888874344721708,0.198860765109072,0,0,7.04887218045113,33.2916089095377,ROBO2;SSH2;RTN4
beta,4,tRNA metabolic process (GO:0006399),2/18,2,18,0.00810568791811713,0.19858935399387,0,0,14.6198830409357,70.3975036787439,SARS;DTD2
beta,4,negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),3/54,3,54,0.00804171518002584,0.19858935399387,0,0,7.30994152046784,35.2566731556584,SMAD3;TGFBR1;TGFBR2
beta,4,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),3/56,3,56,0.00888874344721708,0.198860765109072,0,0,7.04887218045113,33.2916089095377,SMAD3;TGFBR1;TGFBR2
beta,4,hepaticobiliary system development (GO:0061008),2/21,2,21,0.0109610786653184,0.203724875882987,0,0,12.531328320802,56.5589546859219,PROX1;MET
beta,4,neuromuscular junction development (GO:0007528),2/20,2,20,0.00996646428845589,0.203724875882987,0,0,13.1578947368421,60.6385446442877,CACNB2;GPHN
beta,4,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),4/110,4,110,0.00993770076105305,0.203724875882987,0,0,4.78468899521531,22.0642085972997,REST;SMAD3;DAPK1;SNCA
beta,4,negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744),2/21,2,21,0.0109610786653184,0.203724875882987,0,0,12.531328320802,56.5589546859219,MET;SNCA
beta,4,cellular response to peptide hormone stimulus (GO:0071375),4/111,4,111,0.0102496273345975,0.203724875882987,0,0,4.74158368895211,21.7188901453718,C2CD5;GNG5;IRS2;PCK2
beta,4,phosphatidylserine acyl-chain remodeling (GO:0036150),2/21,2,21,0.0109610786653184,0.203724875882987,0,0,12.531328320802,56.5589546859219,OSBPL8;OSBPL10
beta,4,renal system development (GO:0072001),3/60,3,60,0.0107344085051953,0.203724875882987,0,0,6.57894736842105,29.8309272949027,C1GALT1;PROX1;TGFBR1
beta,4,embryonic skeletal system morphogenesis (GO:0048704),2/22,2,22,0.0119975832364343,0.208603140788325,0,0,11.9617224880383,52.9072972062325,TGFBR1;TGFBR2
beta,4,positive regulation of cellular component movement (GO:0051272),2/21,2,21,0.0109610786653184,0.203724875882987,0,0,12.531328320802,56.5589546859219,ETS1;TGFBR1
beta,4,negative regulation of nervous system development (GO:0051961),2/22,2,22,0.0119975832364343,0.208603140788325,0,0,11.9617224880383,52.9072972062325,ROBO2;REST
beta,4,regulation of catecholamine secretion (GO:0050433),2/22,2,22,0.0119975832364343,0.208603140788325,0,0,11.9617224880383,52.9072972062325,SYT4;SNCA
beta,4,negative regulation of cell growth (GO:0030308),4/116,4,116,0.0119043496976994,0.208603140788325,0,0,4.53720508166969,20.1036816008895,SMAD3;SESN2;RTN4;DCBLD2
beta,4,positive regulation of protein serine/threonine kinase activity (GO:0071902),4/119,4,119,0.0129748314811656,0.222013783122167,0,0,4.42282176028306,19.2160275894677,MAP2K1;MAPRE3;PROX1;SNCA
beta,4,glucose metabolic process (GO:0006006),3/65,3,65,0.0133310530889592,0.223908965790706,0,0,6.07287449392713,26.2206021041883,IRS2;OMA1;PCK2
beta,4,negative regulation of growth (GO:0045926),4/121,4,121,0.0137215327932267,0.223908965790706,0,0,4.34971726837756,18.6550193271058,SMAD3;SESN2;RTN4;DCBLD2
beta,4,negative regulation of apoptotic signaling pathway (GO:2001234),3/66,3,66,0.0138895209930745,0.223908965790706,0,0,5.98086124401914,25.5778744530521,TMBIM6;SH3RF1;TGFBR1
beta,4,generation of neurons (GO:0048699),4/131,4,131,0.0178628674007428,0.223908965790706,0,0,4.01767778224186,16.171278295165,MAP2K1;PROX1;RUNX1;ARNTL
beta,4,regulation of Notch signaling pathway (GO:0008593),3/71,3,71,0.0168797530733589,0.223908965790706,0,0,5.5596738324685,22.6925894270395,DLL4;CHAC1;MAML3
beta,4,regulation of histone acetylation (GO:0035065),2/27,2,27,0.0177847413009564,0.223908965790706,0,0,9.74658869395711,39.2730450253356,RPS6KA5;SNCA
beta,4,regulation of fat cell differentiation (GO:0045598),3/73,3,73,0.0181687427987529,0.225125341805238,0,0,5.40735400144196,21.6729592105838,SMAD3;TMEM64;ARNTL
beta,4,positive regulation of endothelial cell migration (GO:0010595),3/71,3,71,0.0168797530733589,0.223908965790706,0,0,5.5596738324685,22.6925894270395,PROX1;ETS1;MET
beta,4,positive regulation of nitric oxide metabolic process (GO:1904407),2/26,2,26,0.0165489115664886,0.223908965790706,0,0,10.1214574898785,41.5124994503753,SMAD3;PTGS2
beta,4,positive regulation of glucose import (GO:0046326),2/27,2,27,0.0177847413009564,0.223908965790706,0,0,9.74658869395711,39.2730450253356,OSBPL8;IRS2
beta,4,response to insulin (GO:0032868),3/72,3,72,0.0175175886165784,0.223908965790706,0,0,5.48245614035088,22.1740670997075,C2CD5;IRS2;PCK2
beta,4,signal transduction in response to DNA damage (GO:0042770),2/26,2,26,0.0165489115664886,0.223908965790706,0,0,10.1214574898785,41.5124994503753,SESN2;E2F7
beta,4,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),2/27,2,27,0.0177847413009564,0.223908965790706,0,0,9.74658869395711,39.2730450253356,MAPRE3;PROX1
beta,4,regulation of glucose metabolic process (GO:0010906),2/26,2,26,0.0165489115664886,0.223908965790706,0,0,10.1214574898785,41.5124994503753,IRS2;PDK1
beta,4,regulation of vascular endothelial growth factor production (GO:0010574),2/28,2,28,0.01905846496125,0.230842980092444,0,0,9.3984962406015,37.2203376051182,SARS;PTGS2
beta,4,positive regulation of glucose transport (GO:0010828),2/26,2,26,0.0165489115664886,0.223908965790706,0,0,10.1214574898785,41.5124994503753,C2CD5;IRS2
beta,4,phosphatidylserine metabolic process (GO:0006658),2/28,2,28,0.01905846496125,0.230842980092444,0,0,9.3984962406015,37.2203376051182,OSBPL8;OSBPL10
beta,4,positive regulation of autophagy (GO:0010508),3/68,3,68,0.0150459354771031,0.223908965790706,0,0,5.80495356037152,24.3613432211421,DAPK1;SESN2;FBXO7
beta,4,positive regulation of epithelial cell migration (GO:0010634),3/75,3,75,0.0195110752702579,0.233699323792645,0,0,5.26315789473684,20.7198579582358,PROX1;ETS1;RTN4
beta,4,positive regulation of nitric oxide biosynthetic process (GO:0045429),2/26,2,26,0.0165489115664886,0.223908965790706,0,0,10.1214574898785,41.5124994503753,SMAD3;PTGS2
beta,4,regulation of epithelial to mesenchymal transition (GO:0010717),3/69,3,69,0.0156439518407386,0.223908965790706,0,0,5.720823798627,23.785302634685,SMAD3;TGFBR1;TGFBR2
beta,4,response to alcohol (GO:0097305),2/26,2,26,0.0165489115664886,0.223908965790706,0,0,10.1214574898785,41.5124994503753,TGFBR1;TGFBR2
beta,4,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),2/30,2,30,0.0217170439806355,0.236474478900253,0,0,8.7719298245614,33.5934902617037,SESN2;ATF3
beta,4,positive regulation of phosphate metabolic process (GO:0045937),2/29,2,29,0.0203694431745012,0.236110319807659,0,0,9.07441016333938,35.3332067575681,BTBD10;SNCA
beta,4,neuron differentiation (GO:0030182),4/140,4,140,0.0221907786266743,0.239216593595549,0,0,3.7593984962406,14.3160844119313,MAP2K1;PROX1;TGFBR1;RUNX1
beta,4,negative regulation of Notch signaling pathway (GO:0045746),2/30,2,30,0.0217170439806355,0.236474478900253,0,0,8.7719298245614,33.5934902617037,DLL4;CHAC1
beta,4,peptidyl-threonine phosphorylation (GO:0018107),3/69,3,69,0.0156439518407386,0.223908965790706,0,0,5.720823798627,23.785302634685,MAP2K1;TGFBR1;TGFBR2
beta,4,positive regulation of calcium ion transmembrane transport (GO:1904427),2/26,2,26,0.0165489115664886,0.223908965790706,0,0,10.1214574898785,41.5124994503753,CACNB2;SNCA
beta,4,cellular response to ketone (GO:1901655),2/29,2,29,0.0203694431745012,0.236110319807659,0,0,9.07441016333938,35.3332067575681,KLF9;PCK2
beta,4,gland development (GO:0048732),3/76,3,76,0.0202022804160722,0.236110319807659,0,0,5.19390581717452,20.2664116467903,PROX1;MET;TGFBR1
beta,4,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),3/80,3,80,0.0231008764939404,0.23944946981219,0,0,4.93421052631579,18.5915364410211,SMAD3;TGFBR1;TGFBR2
beta,4,synaptic vesicle recycling (GO:0036465),2/30,2,30,0.0217170439806355,0.236474478900253,0,0,8.7719298245614,33.5934902617037,STON2;SNCA
beta,4,transforming growth factor beta receptor signaling pathway (GO:0007179),3/77,3,77,0.0209068580180457,0.236474478900253,0,0,5.12645249487355,19.8274677324049,SMAD3;TGFBR1;TGFBR2
beta,4,regulation of nervous system development (GO:0051960),2/26,2,26,0.0165489115664886,0.223908965790706,0,0,10.1214574898785,41.5124994503753,RTN4;ARNTL
beta,4,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),2/31,2,31,0.0231006427672299,0.23944946981219,0,0,8.48896434634975,31.9855249271672,SMAD3;PTGS2
beta,4,synaptic vesicle endocytosis (GO:0048488),2/30,2,30,0.0217170439806355,0.236474478900253,0,0,8.7719298245614,33.5934902617037,STON2;SNCA
beta,4,regulation of endothelial cell migration (GO:0010594),3/70,3,70,0.0162552154106178,0.223908965790706,0,0,5.6390977443609,23.2293692106405,DLL4;PROX1;ETS1
beta,4,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),3/78,3,78,0.0216248145161719,0.236474478900253,0,0,5.06072874493927,19.4023977909303,SMAD3;TGFBR1;TGFBR2
beta,4,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),2/31,2,31,0.0231006427672299,0.23944946981219,0,0,8.48896434634975,31.9855249271672,MAPRE3;PROX1
beta,4,regulation of apoptotic signaling pathway (GO:2001233),2/26,2,26,0.0165489115664886,0.223908965790706,0,0,10.1214574898785,41.5124994503753,TMBIM6;TGFBR1
beta,4,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),4/143,4,143,0.0237635503769306,0.243972450536487,0,0,3.68052999631947,13.7637186934569,ROBO2;CD164;ALCAM;TGFBR2
beta,4,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),2/31,2,31,0.0231006427672299,0.23944946981219,0,0,8.48896434634975,31.9855249271672,DLL4;PTGS2
beta,4,negative regulation of fat cell differentiation (GO:0045599),2/33,2,33,0.0259733720779601,0.250629786944812,0,0,7.97448165869219,29.1123079474416,SMAD3;ARNTL
beta,4,regulation of nitric oxide biosynthetic process (GO:0045428),2/33,2,33,0.0259733720779601,0.250629786944812,0,0,7.97448165869219,29.1123079474416,SMAD3;PTGS2
beta,4,negative regulation of neuron death (GO:1901215),3/84,3,84,0.0262135373034144,0.250629786944812,0,0,4.69924812030075,17.1122148058453,FBXO7;BTBD10;SNCA
beta,4,activation of MAPKK activity (GO:0000186),2/34,2,34,0.0274612894254046,0.250629786944812,0,0,7.73993808049536,27.8249065266861,TNIK;TGFBR1
beta,4,positive regulation of Notch signaling pathway (GO:0045747),2/34,2,34,0.0274612894254046,0.250629786944812,0,0,7.73993808049536,27.8249065266861,DLL4;MAML3
beta,4,response to amino acid (GO:0043200),2/35,2,35,0.0289827782444761,0.250629786944812,0,0,7.5187969924812,26.624462248386,SESN2;TMBIM6
beta,4,regulation of microtubule polymerization (GO:0031113),2/36,2,36,0.0305372495345787,0.250629786944812,0,0,7.30994152046784,25.5029827801801,MET;SNCA
beta,4,regulation of synapse assembly (GO:0051963),2/36,2,36,0.0305372495345787,0.250629786944812,0,0,7.30994152046784,25.5029827801801,ROBO2;SNCA
beta,4,sulfur compound catabolic process (GO:0044273),2/36,2,36,0.0305372495345787,0.250629786944812,0,0,7.30994152046784,25.5029827801801,HEXB;CHAC1
beta,4,peptidyl-threonine modification (GO:0018210),3/90,3,90,0.0312826621446893,0.250629786944812,0,0,4.3859649122807,15.1960142982413,MAP2K1;TGFBR1;TGFBR2
beta,4,vesicle-mediated transport in synapse (GO:0099003),2/37,2,37,0.0321241212058392,0.250629786944812,0,0,7.11237553342817,24.453400367007,STON2;SNCA
beta,4,regulation of cell cycle process (GO:0010564),3/91,3,91,0.0321739728768415,0.250629786944812,0,0,4.33776749566223,14.9071607100746,TIPIN;KLHL21;CDK13
beta,4,regulation of dendrite development (GO:0050773),2/38,2,38,0.0337428180173688,0.250629786944812,0,0,6.92520775623269,23.4694437935872,SDC2;TNIK
beta,4,chemical homeostasis (GO:0048878),2/39,2,39,0.0353927714795604,0.250629786944812,0,0,6.7476383265857,22.545530871699,IRS2;ABHD5
beta,4,signal transduction by p53 class mediator (GO:0072331),2/40,2,40,0.0370734198156625,0.250629786944812,0,0,6.57894736842105,21.6766777181365,SESN2;E2F7
beta,4,positive regulation of fat cell differentiation (GO:0045600),2/40,2,40,0.0370734198156625,0.250629786944812,0,0,6.57894736842105,21.6766777181365,TMEM64;PTGS2
beta,4,inositol lipid-mediated signaling (GO:0048017),2/40,2,40,0.0370734198156625,0.250629786944812,0,0,6.57894736842105,21.6766777181365,IRS2;GAB2
beta,4,clathrin-dependent endocytosis (GO:0072583),2/40,2,40,0.0370734198156625,0.250629786944812,0,0,6.57894736842105,21.6766777181365,STON2;SNCA
beta,4,regulation of plasma membrane bounded cell projection assembly (GO:0120032),2/40,2,40,0.0370734198156625,0.250629786944812,0,0,6.57894736842105,21.6766777181365,ATG3;SSH2
beta,4,epithelial cell differentiation (GO:0030855),3/97,3,97,0.037798151782475,0.250629786944812,0,0,4.06945198046663,13.3294699085546,PROX1;E2F7;PCK2
beta,4,negative regulation of TOR signaling (GO:0032007),2/41,2,41,0.0387842078881282,0.250629786944812,0,0,6.41848523748395,20.8584218767512,SESN2;ARNTL
beta,4,regulation of insulin secretion (GO:0050796),3/99,3,99,0.0397773244862933,0.250629786944812,0,0,3.98724082934609,12.8566916490373,REST;IRS2;ARNTL
beta,4,phosphatidic acid metabolic process (GO:0046473),2/42,2,42,0.0405245871075195,0.250629786944812,0,0,6.265664160401,20.086756892225,ABHD5;DGKH
beta,4,regulation of lipid metabolic process (GO:0019216),3/101,3,101,0.0418082002357202,0.250629786944812,0,0,3.90828556539865,12.4074887212236,TGS1;TXNRD1;IRS2
beta,4,cellular response to transforming growth factor beta stimulus (GO:0071560),3/101,3,101,0.0418082002357202,0.250629786944812,0,0,3.90828556539865,12.4074887212236,SMAD3;TGFBR1;TGFBR2
beta,4,regulation of protein modification process (GO:0031399),2/43,2,43,0.0422940154119196,0.250629786944812,0,0,6.11995104039168,19.3580763926728,PPP1R14C;SESN2
beta,4,negative regulation of protein secretion (GO:0050709),2/43,2,43,0.0422940154119196,0.250629786944812,0,0,6.11995104039168,19.3580763926728,REST;SERGEF
beta,4,regulation of kinase activity (GO:0043549),3/102,3,102,0.0428429173857085,0.250629786944812,0,0,3.86996904024768,12.1912342730195,LMO4;IRS2;MET
beta,4,smooth muscle tissue development (GO:0048745),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,PROX1
beta,4,histone-serine phosphorylation (GO:0035404),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,RPS6KA5
beta,4,positive regulation of histone phosphorylation (GO:0033129),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,RPS6KA5
beta,4,regulation of transforming growth factor beta2 production (GO:0032909),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,SMAD3
beta,4,negative regulation of translation in response to stress (GO:0032055),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,SESN2
beta,4,peripheral nervous system neuron development (GO:0048935),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,RUNX1
beta,4,regulation of aldosterone biosynthetic process (GO:0032347),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,REST
beta,4,negative regulation of catecholamine secretion (GO:0033604),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,SYT4
beta,4,negative regulation of cellular response to hypoxia (GO:1900038),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,TMBIM6
beta,4,ventricular compact myocardium morphogenesis (GO:0003223),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,TGFBR1
beta,4,regulation of nuclear cell cycle DNA replication (GO:0033262),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,TIPIN
beta,4,regulation of T cell tolerance induction (GO:0002664),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,TGFBR2
beta,4,ventricular cardiac muscle cell development (GO:0055015),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,PROX1
beta,4,regulation of digestive system process (GO:0044058),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,SGK1
beta,4,regulation of cortisol biosynthetic process (GO:2000064),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,REST
beta,4,aggrephagy (GO:0035973),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,SQSTM1
beta,4,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,ATF3
beta,4,negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,ARNTL
beta,4,regulation of inositol phosphate biosynthetic process (GO:0010919),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,SNCA
beta,4,positive regulation of protein acetylation (GO:1901985),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,ARNTL
beta,4,positive regulation of vesicle fusion (GO:0031340),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,C2CD5
beta,4,regulation of mesenchymal stem cell differentiation (GO:2000739),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,REST
beta,4,regulation of biosynthetic process (GO:0009889),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,SNCA
beta,4,positive regulation of fever generation (GO:0031622),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,PTGS2
beta,4,azole transport (GO:0045117),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,SLC19A2
beta,4,phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,CDK13
beta,4,positive regulation of granulocyte differentiation (GO:0030854),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,RUNX1
beta,4,venous blood vessel morphogenesis (GO:0048845),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,PROX1
beta,4,pyrimidine-containing compound transmembrane transport (GO:0072531),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,SLC19A2
beta,4,nucleus localization (GO:0051647),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,DCTN4
beta,4,spinal cord dorsal/ventral patterning (GO:0021513),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,DLL4
beta,4,regulation of sarcomere organization (GO:0060297),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,PROX1
beta,4,lens fiber cell development (GO:0070307),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,PROX1
beta,4,endoplasmic reticulum membrane organization (GO:0090158),1/6,1,6,0.0447475921851276,0.250629786944812,0,0,21.9298245614035,68.1297728427149,RTN4
beta,4,regulation of dendrite morphogenesis (GO:0048814),2/45,2,45,0.0459178830409848,0.250629786944812,0,0,5.84795321637427,18.0169627430255,SDC2;TNIK
beta,4,hexose metabolic process (GO:0019318),2/46,2,46,0.0477712701212978,0.250629786944812,0,0,5.720823798627,17.3989179843894,IRS2;OMA1
beta,4,positive regulation of blood vessel endothelial cell migration (GO:0043536),2/46,2,46,0.0477712701212978,0.250629786944812,0,0,5.720823798627,17.3989179843894,PTGS2;ETS1
beta,4,intraciliary transport (GO:0042073),2/47,2,47,0.0496516016512573,0.250629786944812,0,0,5.59910414333707,16.8125679181089,ICK;TNPO1
beta,4,regulation of cellular component movement (GO:0051270),2/47,2,47,0.0496516016512573,0.250629786944812,0,0,5.59910414333707,16.8125679181089,ETS1;TGFBR1
beta,4,negative regulation of autophagy (GO:0010507),2/47,2,47,0.0496516016512573,0.250629786944812,0,0,5.59910414333707,16.8125679181089,MET;SNCA
beta,4,response to glucose (GO:0009749),2/48,2,48,0.0515583670832979,0.250629786944812,0,0,5.48245614035088,16.2557059848451,IRS2;PCK2
beta,4,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),2/48,2,48,0.0515583670832979,0.250629786944812,0,0,5.48245614035088,16.2557059848451,CD164;ALCAM
beta,4,cardiac atrium development (GO:0003230),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,DLL4
beta,4,regulation of high voltage-gated calcium channel activity (GO:1901841),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,CACNB2
beta,4,replication fork protection (GO:0048478),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,TIPIN
beta,4,positive regulation of inositol phosphate biosynthetic process (GO:0060732),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,SNCA
beta,4,venous blood vessel development (GO:0060841),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,PROX1
beta,4,zinc II ion transmembrane import (GO:0071578),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,SLC39A14
beta,4,negative regulation of keratinocyte proliferation (GO:0010839),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,KLF9
beta,4,AV node cell action potential (GO:0086016),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,CACNB2
beta,4,positive regulation of triglyceride catabolic process (GO:0010898),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,ABHD5
beta,4,positive regulation of fatty acid beta-oxidation (GO:0032000),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,IRS2
beta,4,regulation of mitochondrial fusion (GO:0010635),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,OMA1
beta,4,pericardium morphogenesis (GO:0003344),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,DLL4
beta,4,regulation of glucocorticoid receptor signaling pathway (GO:2000322),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,ARNTL
beta,4,thiamine-containing compound metabolic process (GO:0042723),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,SLC19A2
beta,4,regulation of DNA endoreduplication (GO:0032875),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,E2F7
beta,4,dorsal aorta development (GO:0035907),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,DLL4
beta,4,positive regulation of mast cell degranulation (GO:0043306),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,GAB2
beta,4,negative regulation of B cell apoptotic process (GO:0002903),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,IRS2
beta,4,pri-miRNA transcription from RNA polymerase II promoter (GO:0061614),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,ETS1
beta,4,ribosomal protein import into nucleus (GO:0006610),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,TNPO1
beta,4,negative regulation of transporter activity (GO:0032410),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,SNCA
beta,4,nucleic acid transport (GO:0050657),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,CKAP5
beta,4,negative regulation of cytokinesis (GO:0032466),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,E2F7
beta,4,dorsal aorta morphogenesis (GO:0035912),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,DLL4
beta,4,nuclear body organization (GO:0030575),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,ETS1
beta,4,positive regulation of autophagy of mitochondrion (GO:1903599),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,FBXO7
beta,4,negative regulation of synapse organization (GO:1905809),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,ROBO2
beta,4,molybdopterin cofactor biosynthetic process (GO:0032324),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,GPHN
beta,4,molybdopterin cofactor metabolic process (GO:0043545),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,GPHN
beta,4,lymphatic endothelial cell differentiation (GO:0060836),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,PROX1
beta,4,regulation of transcription involved in cell fate commitment (GO:0060850),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,PROX1
beta,4,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,TGFBR2
beta,4,microglial cell activation (GO:0001774),1/7,1,7,0.052009671210746,0.250629786944812,0,0,18.796992481203,55.5700299411975,SNCA
beta,4,macroautophagy (GO:0016236),3/111,3,111,0.0527248892976129,0.250629786944812,0,0,3.55618776671408,10.4646787063942,ATG3;GABARAPL1;SQSTM1
beta,4,cellular response to insulin stimulus (GO:0032869),3/111,3,111,0.0527248892976129,0.250629786944812,0,0,3.55618776671408,10.4646787063942,C2CD5;IRS2;PCK2
beta,4,organic hydroxy compound biosynthetic process (GO:1901617),2/50,2,50,0.0554491879134877,0.250629786944812,0,0,5.26315789473684,15.2225695298761,OSBPL6;PSAT1
beta,4,regulation of reactive oxygen species metabolic process (GO:2000377),2/50,2,50,0.0554491879134877,0.250629786944812,0,0,5.26315789473684,15.2225695298761,TGFBR2;SNCA
beta,4,lipid homeostasis (GO:0055088),2/50,2,50,0.0554491879134877,0.250629786944812,0,0,5.26315789473684,15.2225695298761,IRS2;ABHD5
beta,4,positive regulation of kinase activity (GO:0033674),3/114,3,114,0.0562424254286023,0.250629786944812,0,0,3.46260387811634,9.96566449450146,LMO4;MAPRE3;MET
beta,4,myeloid leukocyte differentiation (GO:0002573),2/51,2,51,0.05743225250948,0.250629786944812,0,0,5.15995872033024,14.7427721519549,GAB2;TGFBR2
beta,4,negative regulation of viral genome replication (GO:0045071),2/51,2,51,0.05743225250948,0.250629786944812,0,0,5.15995872033024,14.7427721519549,ISG20;PROX1
beta,4,regulation of stress-activated protein kinase signaling cascade (GO:0070302),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,MAP2K1
beta,4,neuron projection extension involved in neuron projection guidance (GO:1902284),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,ALCAM
beta,4,positive regulation of extracellular matrix assembly (GO:1901203),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,SMAD3
beta,4,regulation of brown fat cell differentiation (GO:0090335),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,PTGS2
beta,4,aminoglycoside antibiotic metabolic process (GO:0030647),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,AKR7A2
beta,4,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,CACNB2
beta,4,stress-induced premature senescence (GO:0090400),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,ARNTL
beta,4,neurotransmitter receptor diffusion trapping (GO:0099628),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,GPHN
beta,4,regulation of chaperone-mediated autophagy (GO:1904714),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,SNCA
beta,4,response to epinephrine (GO:0071871),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,SNCA
beta,4,regulation of dopamine uptake involved in synaptic transmission (GO:0051584),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,SNCA
beta,4,response to magnesium ion (GO:0032026),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,SNCA
beta,4,negative regulation of anion transmembrane transport (GO:1903960),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,IRS2
beta,4,negative regulation of exocytosis (GO:0045920),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,SNCA
beta,4,microvillus organization (GO:0032528),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,TNIK
beta,4,positive regulation of alpha-beta T cell differentiation (GO:0046638),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,TGFBR2
beta,4,positive regulation of transforming growth factor beta production (GO:0071636),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,PTGS2
beta,4,daunorubicin metabolic process (GO:0044597),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,AKR7A2
beta,4,response to hydroperoxide (GO:0033194),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,DAPK1
beta,4,SMAD protein complex assembly (GO:0007183),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,SMAD3
beta,4,negative regulation of monooxygenase activity (GO:0032769),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,SNCA
beta,4,coronary vasculature morphogenesis (GO:0060977),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,TGFBR1
beta,4,short-chain fatty acid catabolic process (GO:0019626),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,PCK2
beta,4,negative regulation of cAMP-dependent protein kinase activity (GO:2000480),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,PKIB
beta,4,microvillus assembly (GO:0030033),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,TNIK
beta,4,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,MAP2K1
beta,4,axon extension involved in axon guidance (GO:0048846),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,ALCAM
beta,4,regulation of cytoplasmic transport (GO:1903649),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,MAP2K1
beta,4,regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,SESN2
beta,4,insulin metabolic process (GO:1901142),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,PCSK2
beta,4,nodal signaling pathway (GO:0038092),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,SMAD3
beta,4,nose development (GO:0043584),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,PROX1
beta,4,postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,GPHN
beta,4,cellular response to epinephrine stimulus (GO:0071872),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,SNCA
beta,4,histone H4 deacetylation (GO:0070933),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,REST
beta,4,regulation of type B pancreatic cell development (GO:2000074),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,ARNTL
beta,4,negative regulation of double-strand break repair via homologous recombination (GO:2000042),1/8,1,8,0.0592169038679493,0.250629786944812,0,0,16.4473684210526,46.4892802556008,HELB
beta,4,plasma membrane bounded cell projection morphogenesis (GO:0120039),2/53,2,53,0.0614712576334358,0.250629786944812,0,0,4.96524329692155,13.8489849501897,TNIK;SGK1
beta,4,regulation of calcium ion-dependent exocytosis (GO:0017158),2/54,2,54,0.0635262427463539,0.250629786944812,0,0,4.87329434697856,13.4322718657922,SYT4;REST
beta,4,positive regulation of protein import into nucleus (GO:0042307),2/54,2,54,0.0635262427463539,0.250629786944812,0,0,4.87329434697856,13.4322718657922,SMAD3;TGFBR1
beta,4,brain development (GO:0007420),3/120,3,120,0.0636029667908563,0.250629786944812,0,0,3.28947368421053,9.0628130331219,ROBO2;PROX1;TGFBR2
beta,4,cell morphogenesis involved in differentiation (GO:0000904),2/55,2,55,0.0656042555663192,0.250629786944812,0,0,4.78468899521531,13.0340416923367,LAMC1;PROX1
beta,4,mitochondrial protein processing (GO:0034982),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,OMA1
beta,4,regulation of protein acetylation (GO:1901983),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,ARNTL
beta,4,Notch signaling involved in heart development (GO:0061314),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,DLL4
beta,4,atrioventricular valve development (GO:0003171),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,TGFBR2
beta,4,actin filament reorganization (GO:0090527),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,FRY
beta,4,doxorubicin metabolic process (GO:0044598),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,AKR7A2
beta,4,regulation of bile acid biosynthetic process (GO:0070857),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,PROX1
beta,4,negative regulation of lymphocyte apoptotic process (GO:0070229),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,IRS2
beta,4,pericardium development (GO:0060039),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,DLL4
beta,4,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,GAB2
beta,4,sphingomyelin metabolic process (GO:0006684),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,SGMS2
beta,4,positive regulation of long-term synaptic potentiation (GO:1900273),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,SQSTM1
beta,4,nuclear migration (GO:0007097),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,DCTN4
beta,4,regulation of hair cycle (GO:0042634),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,ARNTL
beta,4,cellular response to leucine (GO:0071233),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,SESN2
beta,4,response to leucine (GO:0043201),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,SESN2
beta,4,negative regulation of microtubule polymerization (GO:0031115),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,SNCA
beta,4,regulation of skeletal muscle cell differentiation (GO:2001014),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,ARNTL
beta,4,mitochondrial fragmentation involved in apoptotic process (GO:0043653),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,ATG3
beta,4,histone phosphorylation (GO:0016572),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,RPS6KA5
beta,4,negative regulation of peptidyl-lysine acetylation (GO:2000757),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,SNCA
beta,4,histone H3-K4 trimethylation (GO:0080182),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,WDR82
beta,4,vitamin transmembrane transport (GO:0035461),1/9,1,9,0.0663697013463757,0.250629786944812,0,0,14.6198830409357,39.6566466617402,SLC19A2
beta,4,positive regulation of cysteine-type endopeptidase activity (GO:2001056),2/56,2,56,0.067704832725444,0.250629786944812,0,0,4.69924812030075,12.6531847612244,REST;DAPK1
beta,4,Notch signaling pathway (GO:0007219),2/56,2,56,0.067704832725444,0.250629786944812,0,0,4.69924812030075,12.6531847612244,DLL4;MAML3
beta,4,chordate embryonic development (GO:0043009),2/57,2,57,0.0698275164931172,0.250629786944812,0,0,4.61680517082179,12.2886755669374,PROX1;TGFBR1
beta,4,phosphatidylinositol-mediated signaling (GO:0048015),2/57,2,57,0.0698275164931172,0.250629786944812,0,0,4.61680517082179,12.2886755669374,IRS2;GAB2
beta,4,autophagosome organization (GO:1905037),2/57,2,57,0.0698275164931172,0.250629786944812,0,0,4.61680517082179,12.2886755669374,ATG3;GABARAPL1
beta,4,glycosaminoglycan catabolic process (GO:0006027),2/57,2,57,0.0698275164931172,0.250629786944812,0,0,4.61680517082179,12.2886755669374,HEXB;SDC2
beta,4,negative regulation of macromolecule metabolic process (GO:0010605),3/125,3,125,0.0700596024304439,0.250629786944812,0,0,3.15789473684211,8.39497558714723,DLL4;MAP2K1;REST
beta,4,regulation of neurogenesis (GO:0050767),2/58,2,58,0.0719718546757665,0.250629786944812,0,0,4.53720508166969,11.9395650801782,REST;ARNTL
beta,4,regulation of B cell apoptotic process (GO:0002902),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,IRS2
beta,4,cellular response to thyroid hormone stimulus (GO:0097067),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,KLF9
beta,4,negative regulation of protein maturation (GO:1903318),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,CHAC1
beta,4,intraciliary retrograde transport (GO:0035721),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,ICK
beta,4,negative regulation of oxidative stress-induced neuron death (GO:1903204),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,FBXO7
beta,4,negative regulation of cytosolic calcium ion concentration (GO:0051481),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,SMAD3
beta,4,regulation of mammary gland epithelial cell proliferation (GO:0033599),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,RTN4
beta,4,regulation of actin filament length (GO:0030832),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,SSH2
beta,4,negative regulation of stem cell differentiation (GO:2000737),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,REST
beta,4,neuron projection fasciculation (GO:0106030),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,RTN4
beta,4,positive regulation of alcohol biosynthetic process (GO:1902932),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,SNCA
beta,4,positive regulation of receptor recycling (GO:0001921),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,SNCA
beta,4,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,SNCA
beta,4,skeletal muscle thin filament assembly (GO:0030240),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,PROX1
beta,4,regulation of phospholipase activity (GO:0010517),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,SNCA
beta,4,regulation of triglyceride catabolic process (GO:0010896),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,ABHD5
beta,4,positive regulation of glucose import in response to insulin stimulus (GO:2001275),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,OSBPL8
beta,4,epithelial cell morphogenesis (GO:0003382),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,MET
beta,4,nuclear pore complex assembly (GO:0051292),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,RTN4
beta,4,cellular response to leucine starvation (GO:1990253),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,SESN2
beta,4,regulation of granulocyte differentiation (GO:0030852),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,RUNX1
beta,4,primary miRNA processing (GO:0031053),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,SMAD3
beta,4,regulation of histone phosphorylation (GO:0033127),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,RPS6KA5
beta,4,quinone metabolic process (GO:1901661),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,AKR7A2
beta,4,regulation of fatty acid beta-oxidation (GO:0031998),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,IRS2
beta,4,myeloid dendritic cell differentiation (GO:0043011),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,TGFBR2
beta,4,positive regulation of circadian rhythm (GO:0042753),1/10,1,10,0.0734684718687947,0.250629786944812,0,0,13.1578947368421,34.3539331441653,ARNTL
beta,4,autophagosome assembly (GO:0000045),2/59,2,59,0.0741374006572022,0.25156161265147,0,0,4.46030330062444,11.604973870645,ATG3;GABARAPL1
beta,4,regulation of extrinsic apoptotic signaling pathway (GO:2001236),2/60,2,60,0.076323713214089,0.25156161265147,0,0,4.3859649122807,11.2840859640403,SH3RF1;TGFBR1
beta,4,regulation of stress fiber assembly (GO:0051492),2/61,2,61,0.0785303565647469,0.25156161265147,0,0,4.31406384814495,10.9761433180104,MET;TGFBR1
beta,4,morphogenesis of an epithelial sheet (GO:0002011),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,DLL4
beta,4,intracellular protein transmembrane transport (GO:0065002),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,C2CD5
beta,4,positive regulation of extracellular matrix organization (GO:1903055),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,SMAD3
beta,4,positive regulation of leukocyte degranulation (GO:0043302),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,GAB2
beta,4,regulation of synaptic vesicle cycle (GO:0098693),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,SNCA
beta,4,negative regulation of chemotaxis (GO:0050922),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,ROBO2
beta,4,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,PDK1
beta,4,cell-substrate junction assembly (GO:0007044),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,LAMC1
beta,4,carbohydrate phosphorylation (GO:0046835),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,ADK
beta,4,positive regulation of fatty acid oxidation (GO:0046321),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,IRS2
beta,4,cyclooxygenase pathway (GO:0019371),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,PTGS2
beta,4,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,ATF3
beta,4,positive regulation of glucose metabolic process (GO:0010907),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,IRS2
beta,4,response to thyroid hormone (GO:0097066),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,KLF9
beta,4,regulation of hemopoiesis (GO:1903706),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,RUNX1
beta,4,embryonic hemopoiesis (GO:0035162),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,TGFBR2
beta,4,hemidesmosome assembly (GO:0031581),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,LAMC1
beta,4,negative regulation of peptide secretion (GO:0002792),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,SERGEF
beta,4,glutathione biosynthetic process (GO:0006750),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,CHAC1
beta,4,positive regulation of mesenchymal cell proliferation (GO:0002053),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,TGFBR2
beta,4,negative regulation of histone acetylation (GO:0035067),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,SNCA
beta,4,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,DLL4
beta,4,negative regulation of cell division (GO:0051782),1/11,1,11,0.0805136206673202,0.25156161265147,0,0,11.9617224880383,30.1355132539975,E2F7
beta,4,actin cytoskeleton reorganization (GO:0031532),2/62,2,62,0.0807569002590761,0.25156161265147,0,0,4.24448217317487,10.6804408675951,TNIK;FRY
beta,4,negative regulation of MAP kinase activity (GO:0043407),2/62,2,62,0.0807569002590761,0.25156161265147,0,0,4.24448217317487,10.6804408675951,DUSP4;UCHL1
beta,4,negative regulation of viral life cycle (GO:1903901),2/62,2,62,0.0807569002590761,0.25156161265147,0,0,4.24448217317487,10.6804408675951,ISG20;PROX1
beta,4,regulation of viral genome replication (GO:0045069),2/64,2,64,0.0852679933065263,0.25156161265147,0,0,4.11184210526316,10.123174835158,ISG20;PROX1
beta,4,regulation of mesenchymal cell proliferation (GO:0010464),1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,TGFBR2
beta,4,axonal fasciculation (GO:0007413),1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,RTN4
beta,4,negative regulation of chondrocyte differentiation (GO:0032331),1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,TGFBR1
beta,4,regulation of DNA-dependent DNA replication (GO:0090329),1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,TIPIN
beta,4,negative regulation of histone modification (GO:0031057),1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,SNCA
beta,4,skeletal myofibril assembly (GO:0014866),1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,PROX1
beta,4,negative regulation of oxidoreductase activity (GO:0051354),1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,SNCA
beta,4,cellular modified amino acid catabolic process (GO:0042219),1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,CHAC1
beta,4,cell differentiation in hindbrain (GO:0021533),1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,PROX1
beta,4,entry of bacterium into host cell (GO:0035635),1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,MET
beta,4,positive regulation of DNA-dependent DNA replication (GO:2000105),1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,E2F7
beta,4,cellular response to arsenic-containing substance (GO:0071243),1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,ATF3
beta,4,aromatic compound biosynthetic process (GO:0019438),1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,PSAT1
beta,4,L-serine metabolic process (GO:0006563),1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,PSAT1
beta,4,nonribosomal peptide biosynthetic process (GO:0019184),1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,CHAC1
beta,4,PERK-mediated unfolded protein response (GO:0036499),1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,ATF3
beta,4,regulation of antigen receptor-mediated signaling pathway (GO:0050854),1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,RUNX1
beta,4,"alternative mRNA splicing, via spliceosome (GO:0000380)",1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,CDK13
beta,4,keratan sulfate catabolic process (GO:0042340),1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,HEXB
beta,4,negative regulation by host of viral transcription (GO:0043922),1/12,1,12,0.0875055499955368,0.25156161265147,0,0,10.9649122807018,26.7111081042725,REST
beta,4,positive regulation of transferase activity (GO:0051347),3/138,3,138,0.0881515083446861,0.25156161265147,0,0,2.8604118993135,6.94707740037414,PKIB;LMO4;MET
beta,4,cellular response to growth factor stimulus (GO:0071363),3/140,3,140,0.0910942728619208,0.25156161265147,0,0,2.81954887218045,6.75524532854782,DLL4;SMAD3;TGFBR1
beta,4,regulation of primary metabolic process (GO:0080090),3/140,3,140,0.0910942728619208,0.25156161265147,0,0,2.81954887218045,6.75524532854782,TGS1;TXNRD1;IRS2
beta,4,positive regulation of cellular protein localization (GO:1903829),2/67,2,67,0.092173425573212,0.25156161265147,0,0,3.92772977219167,9.36403541182924,SESN2;RTN4
beta,4,modification-dependent protein catabolic process (GO:0019941),3/142,3,142,0.0940776793184967,0.25156161265147,0,0,2.77983691623425,6.57051833462901,FBXO7;FBXO11;SQSTM1
beta,4,response to iron ion (GO:0010039),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,SNCA
beta,4,regulation of acyl-CoA biosynthetic process (GO:0050812),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,PDK1
beta,4,regulation of endothelial cell chemotaxis (GO:2001026),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,MET
beta,4,regulation of plasma membrane bounded cell projection organization (GO:0120035),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,FBXO7
beta,4,prostanoid biosynthetic process (GO:0046457),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,PTGS2
beta,4,atrial cardiac muscle cell action potential (GO:0086014),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,CACNB2
beta,4,cellular response to nitrogen starvation (GO:0006995),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,GABARAPL1
beta,4,regulation of NMDA receptor activity (GO:2000310),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,DAPK1
beta,4,regulation of cell aging (GO:0090342),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,ARNTL
beta,4,"Notch receptor processing, ligand-dependent (GO:0035333)",1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,DLL4
beta,4,renal absorption (GO:0070293),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,SGK1
beta,4,regulation of cAMP-dependent protein kinase activity (GO:2000479),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,PKIB
beta,4,regulation of glucose import in response to insulin stimulus (GO:2001273),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,OSBPL8
beta,4,chondroitin sulfate catabolic process (GO:0030207),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,HEXB
beta,4,positive regulation of glycogen biosynthetic process (GO:0045725),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,IRS2
beta,4,positive regulation of skeletal muscle tissue development (GO:0048643),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,ARNTL
beta,4,positive regulation of alpha-beta T cell proliferation (GO:0046641),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,TGFBR2
beta,4,serine family amino acid biosynthetic process (GO:0009070),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,PSAT1
beta,4,placenta development (GO:0001890),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,E2F7
beta,4,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,MAP2K1
beta,4,positive regulation of endothelial cell chemotaxis (GO:2001028),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,MET
beta,4,catecholamine biosynthetic process (GO:0042423),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,SNCA
beta,4,cardiocyte differentiation (GO:0035051),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,PROX1
beta,4,negative regulation of cartilage development (GO:0061037),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,TGFBR1
beta,4,endothelial cell differentiation (GO:0045446),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,PROX1
beta,4,tetrahydrofolate metabolic process (GO:0046653),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,MTHFD2
beta,4,regulation of synaptic vesicle transport (GO:1902803),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,SNCA
beta,4,protein kinase C-activating G-protein coupled receptor signaling pathway (GO:0007205),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,DGKH
beta,4,cellular response to nitrogen levels (GO:0043562),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,GABARAPL1
beta,4,regulation of cellular carbohydrate metabolic process (GO:0010675),1/13,1,13,0.0944446591214453,0.25156161265147,0,0,10.1214574898785,23.8840205848784,PDK1
beta,4,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),2/68,2,68,0.0945106244191517,0.25156161265147,0,0,3.86996904024768,9.12942346395539,MAPRE3;PROX1
beta,4,negative regulation of protein serine/threonine kinase activity (GO:0071901),2/68,2,68,0.0945106244191517,0.25156161265147,0,0,3.86996904024768,9.12942346395539,PKIB;UCHL1
beta,4,positive regulation of endothelial cell proliferation (GO:0001938),2/68,2,68,0.0945106244191517,0.25156161265147,0,0,3.86996904024768,9.12942346395539,PROX1;TGFBR1
beta,4,insulin receptor signaling pathway (GO:0008286),2/68,2,68,0.0945106244191517,0.25156161265147,0,0,3.86996904024768,9.12942346395539,C2CD5;IRS2
beta,4,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),2/69,2,69,0.0968648555986775,0.252418074833016,0,0,3.813882532418,8.9032742684688,SH3RF1;SNCA
beta,4,response to interferon-gamma (GO:0034341),2/69,2,69,0.0968648555986775,0.252418074833016,0,0,3.813882532418,8.9032742684688,DAPK1;SNCA
beta,4,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),3/145,3,145,0.0986275081232991,0.252418074833016,0,0,2.72232304900182,6.30600291079351,SMAD3;TGFBR1;TGFBR2
beta,4,regulation of endocytosis (GO:0030100),2/70,2,70,0.099235729469658,0.252418074833016,0,0,3.7593984962406,8.68517726854786,STON2;SNCA
beta,4,peptidyl-serine phosphorylation (GO:0018105),3/146,3,146,0.100163699995127,0.252418074833016,0,0,2.70367700072098,6.22102405767862,SGK1;TGFBR1;TGFBR2
beta,4,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,MET
beta,4,ribonucleoside monophosphate biosynthetic process (GO:0009156),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,ADK
beta,4,regulation of Golgi organization (GO:1903358),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,MAP2K1
beta,4,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,TMBIM6
beta,4,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,DLL4
beta,4,myeloid dendritic cell activation (GO:0001773),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,TGFBR2
beta,4,regulation of lipase activity (GO:0060191),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,SNCA
beta,4,pore complex assembly (GO:0046931),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,RTN4
beta,4,glycoside metabolic process (GO:0016137),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,AKR7A2
beta,4,endoplasmic reticulum tubular network organization (GO:0071786),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,RTN4
beta,4,regulation of secretion (GO:0051046),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,SGK1
beta,4,regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,PDK1
beta,4,negative regulation of Rho protein signal transduction (GO:0035024),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,MET
beta,4,regulation of protein modification by small protein conjugation or removal (GO:1903320),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,TGFBR1
beta,4,cell surface receptor signaling pathway involved in heart development (GO:0061311),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,DLL4
beta,4,thymus development (GO:0048538),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,TGFBR1
beta,4,pancreas development (GO:0031016),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,PROX1
beta,4,positive regulation of calcium ion-dependent exocytosis (GO:0045956),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,SYT4
beta,4,cardiac left ventricle morphogenesis (GO:0003214),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,TGFBR2
beta,4,positive regulation of transporter activity (GO:0032411),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,SGK1
beta,4,purine-containing compound salvage (GO:0043101),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,ADK
beta,4,positive regulation of glycogen metabolic process (GO:0070875),1/14,1,14,0.101331344382835,0.252418074833016,0,0,9.3984962406015,21.5165365999777,IRS2
beta,4,stress-activated protein kinase signaling cascade (GO:0031098),2/71,2,71,0.101622861296409,0.252418074833016,0,0,3.70644922164566,8.4747470585226,MAP2K1;TNIK
beta,4,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),2/71,2,71,0.101622861296409,0.252418074833016,0,0,3.70644922164566,8.4747470585226,RNF19A;FBXO7
beta,4,regulation of cation channel activity (GO:2001257),2/72,2,72,0.104025871115097,0.252934809316431,0,0,3.65497076023392,8.27162152797697,CACNB2;DAPK1
beta,4,negative regulation of cysteine-type endopeptidase activity (GO:2000117),2/73,2,73,0.106444383760398,0.252934809316431,0,0,3.60490266762797,8.07546016023181,SH3RF1;SNCA
beta,4,response to metal ion (GO:0010038),2/73,2,73,0.106444383760398,0.252934809316431,0,0,3.60490266762797,8.07546016023181,GPHN;SNCA
beta,4,regulation of neuron death (GO:1901214),2/73,2,73,0.106444383760398,0.252934809316431,0,0,3.60490266762797,8.07546016023181,BTBD10;SNCA
beta,4,positive regulation of acute inflammatory response (GO:0002675),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,PTGS2
beta,4,positive regulation of peptidyl-lysine acetylation (GO:2000758),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,RPS6KA5
beta,4,atrioventricular valve morphogenesis (GO:0003181),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,TGFBR2
beta,4,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,PTGS2
beta,4,regulation of mast cell degranulation (GO:0043304),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,GAB2
beta,4,nuclear pore organization (GO:0006999),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,RTN4
beta,4,selective autophagy (GO:0061912),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,SQSTM1
beta,4,positive regulation of cellular response to insulin stimulus (GO:1900078),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,OSBPL8
beta,4,endocardial cushion morphogenesis (GO:0003203),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,TGFBR2
beta,4,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,SNCA
beta,4,negative regulation of DNA-dependent DNA replication (GO:2000104),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,TIPIN
beta,4,negative regulation of TORC1 signaling (GO:1904262),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,SESN2
beta,4,positive regulation of CREB transcription factor activity (GO:0032793),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,RPS6KA5
beta,4,microtubule depolymerization (GO:0007019),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,CKAP5
beta,4,lipoxygenase pathway (GO:0019372),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,PTGS2
beta,4,negative regulation of insulin secretion (GO:0046676),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,REST
beta,4,cardiac muscle cell differentiation (GO:0055007),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,PROX1
beta,4,negative regulation of mRNA processing (GO:0050686),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,TMBIM6
beta,4,negative regulation of protein processing (GO:0010955),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,CHAC1
beta,4,negative regulation of anoikis (GO:2000811),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,TLE1
beta,4,intra-S DNA damage checkpoint (GO:0031573),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,TIPIN
beta,4,regulation of cell junction assembly (GO:1901888),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,RUNX1
beta,4,cellular response to corticosteroid stimulus (GO:0071384),1/15,1,15,0.108165999160366,0.252934809316431,0,0,8.7719298245614,19.5095456369803,REST
beta,4,positive regulation of inflammatory response (GO:0050729),2/74,2,74,0.10887802877415,0.253924256157793,0,0,3.55618776671408,7.88594247999744,ETS1;SNCA
beta,4,positive regulation of defense response (GO:0031349),2/75,2,75,0.111326440369643,0.253924256157793,0,0,3.50877192982456,7.70276662960612,ETS1;SNCA
beta,4,negative regulation of cellular amide metabolic process (GO:0034249),2/76,2,76,0.113789257384467,0.253924256157793,0,0,3.46260387811634,7.52564806380816,DAPK1;SNCA
beta,4,peptidyl-threonine dephosphorylation (GO:0035970),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,DUSP4
beta,4,neural tube development (GO:0021915),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,PROX1
beta,4,postsynaptic membrane organization (GO:0001941),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,GPHN
beta,4,positive regulation of triglyceride metabolic process (GO:0090208),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,ABHD5
beta,4,Notch receptor processing (GO:0007220),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,DLL4
beta,4,establishment of skin barrier (GO:0061436),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,MET
beta,4,protein transport along microtubule (GO:0098840),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,ICK
beta,4,regulation of dopamine secretion (GO:0014059),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,SNCA
beta,4,negative regulation of peptide hormone secretion (GO:0090278),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,REST
beta,4,positive regulation of regulated secretory pathway (GO:1903307),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,SYT4
beta,4,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,PTGS2
beta,4,hyaluronan catabolic process (GO:0030214),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,HEXB
beta,4,cardiac epithelial to mesenchymal transition (GO:0060317),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,TGFBR1
beta,4,regulation of reactive oxygen species biosynthetic process (GO:1903426),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,SNCA
beta,4,regulation of water loss via skin (GO:0033561),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,MET
beta,4,cardiac ventricle development (GO:0003231),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,DLL4
beta,4,artery development (GO:0060840),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,TGFBR1
beta,4,negative regulation of steroid biosynthetic process (GO:0010894),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,PROX1
beta,4,regulation of bicellular tight junction assembly (GO:2000810),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,RUNX1
beta,4,myoblast differentiation (GO:0045445),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,REST
beta,4,regulation of glucose transport (GO:0010827),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,C2CD5
beta,4,mesenchyme development (GO:0060485),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,TGFBR1
beta,4,pyrimidine-containing compound metabolic process (GO:0072527),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,SLC19A2
beta,4,negative regulation of DNA recombination (GO:0045910),1/16,1,16,0.114949013919298,0.253924256157793,0,0,8.22368421052632,17.7900214321896,HELB
beta,4,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),2/77,2,77,0.116266123205643,0.254702673313099,0,0,3.41763499658237,7.3543183523231,SH3RF1;TGFBR1
beta,4,regulation of cytokinesis (GO:0032465),2/78,2,78,0.118756685770793,0.254702673313099,0,0,3.37381916329285,7.18852407700577,KLHL21;E2F7
beta,4,water-soluble vitamin metabolic process (GO:0006767),2/78,2,78,0.118756685770793,0.254702673313099,0,0,3.37381916329285,7.18852407700577,MTHFD2;SLC19A2
beta,4,peptidyl-lysine trimethylation (GO:0018023),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,WDR82
beta,4,cardiac myofibril assembly (GO:0055003),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,PROX1
beta,4,regulation of receptor recycling (GO:0001919),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,SNCA
beta,4,pharyngeal system development (GO:0060037),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,TGFBR1
beta,4,DNA catabolic process (GO:0006308),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,ISG20
beta,4,ureteric bud development (GO:0001657),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,ROBO2
beta,4,long-term memory (GO:0007616),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,SGK1
beta,4,macrophage activation (GO:0042116),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,SNCA
beta,4,heterocycle biosynthetic process (GO:0018130),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,GPHN
beta,4,positive regulation of striated muscle cell differentiation (GO:0051155),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,PROX1
beta,4,positive regulation of dendrite extension (GO:1903861),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,SYT4
beta,4,serine family amino acid metabolic process (GO:0009069),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,SARS
beta,4,negative regulation of cell development (GO:0010721),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,REST
beta,4,regulation of lamellipodium organization (GO:1902743),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,SSH2
beta,4,positive chemotaxis (GO:0050918),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,MET
beta,4,regulation of B cell receptor signaling pathway (GO:0050855),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,RUNX1
beta,4,positive regulation of telomere capping (GO:1904355),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,PKIB
beta,4,mesonephric tubule development (GO:0072164),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,ROBO2
beta,4,regulation of early endosome to late endosome transport (GO:2000641),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,MAP2K1
beta,4,nucleobase-containing compound biosynthetic process (GO:0034654),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,ADK
beta,4,positive regulation of transcription of Notch receptor target (GO:0007221),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,MAML3
beta,4,membrane depolarization during cardiac muscle cell action potential (GO:0086012),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,CACNB2
beta,4,negative regulation of stress fiber assembly (GO:0051497),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,MET
beta,4,DNA replication checkpoint (GO:0000076),1/17,1,17,0.121680776211731,0.254702673313099,0,0,7.73993808049536,16.3030514855115,TIPIN
beta,4,regulation of endothelial cell proliferation (GO:0001936),2/80,2,80,0.123777515127257,0.258089286861089,0,0,3.28947368421053,6.87259722955764,PROX1;TGFBR1
beta,4,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),2/80,2,80,0.123777515127257,0.258089286861089,0,0,3.28947368421053,6.87259722955764,SMAD3;SNCA
beta,4,RNA transport (GO:0050658),2/81,2,81,0.126307099942252,0.259613285301775,0,0,3.24886289798571,6.72202415952784,CKAP5;TGFBR2
beta,4,regulation of protein serine/threonine kinase activity (GO:0071900),2/81,2,81,0.126307099942252,0.259613285301775,0,0,3.24886289798571,6.72202415952784,MAP2K1;SNCA
beta,4,cellular response to hormone stimulus (GO:0032870),2/81,2,81,0.126307099942252,0.259613285301775,0,0,3.24886289798571,6.72202415952784,ROBO2;KLF9
beta,4,negative regulation of MAPK cascade (GO:0043409),2/81,2,81,0.126307099942252,0.259613285301775,0,0,3.24886289798571,6.72202415952784,DUSP4;UCHL1
beta,4,modulation by virus of host morphology or physiology (GO:0019048),1/18,1,18,0.128361670747538,0.259613285301775,0,0,7.30994152046784,15.0066041426744,SMAD3
beta,4,regulation of cardiac muscle cell proliferation (GO:0060043),1/18,1,18,0.128361670747538,0.259613285301775,0,0,7.30994152046784,15.0066041426744,TGFBR1
beta,4,receptor localization to synapse (GO:0097120),1/18,1,18,0.128361670747538,0.259613285301775,0,0,7.30994152046784,15.0066041426744,GPHN
beta,4,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),1/18,1,18,0.128361670747538,0.259613285301775,0,0,7.30994152046784,15.0066041426744,SMAD3
beta,4,regulation of keratinocyte proliferation (GO:0010837),1/18,1,18,0.128361670747538,0.259613285301775,0,0,7.30994152046784,15.0066041426744,KLF9
beta,4,negative regulation of protein transport (GO:0051224),1/18,1,18,0.128361670747538,0.259613285301775,0,0,7.30994152046784,15.0066041426744,SERGEF
beta,4,regulation of epithelial cell differentiation (GO:0030856),1/18,1,18,0.128361670747538,0.259613285301775,0,0,7.30994152046784,15.0066041426744,ARNTL
beta,4,regulation of dendrite extension (GO:1903859),1/18,1,18,0.128361670747538,0.259613285301775,0,0,7.30994152046784,15.0066041426744,SYT4
beta,4,negative regulation of RNA splicing (GO:0033119),1/18,1,18,0.128361670747538,0.259613285301775,0,0,7.30994152046784,15.0066041426744,TMBIM6
beta,4,regulation of dephosphorylation (GO:0035303),1/18,1,18,0.128361670747538,0.259613285301775,0,0,7.30994152046784,15.0066041426744,PPP1R14C
beta,4,anion homeostasis (GO:0055081),1/18,1,18,0.128361670747538,0.259613285301775,0,0,7.30994152046784,15.0066041426744,PQLC2
beta,4,prostaglandin biosynthetic process (GO:0001516),1/18,1,18,0.128361670747538,0.259613285301775,0,0,7.30994152046784,15.0066041426744,PTGS2
beta,4,negative regulation of cell death (GO:0060548),2/82,2,82,0.12884901748449,0.260110937918127,0,0,3.20924261874198,6.57610387412942,BTBD10;SNCA
beta,4,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",2/83,2,83,0.131402937577452,0.263294361911697,0,0,3.17057704502219,6.43464431575376,SESN2;E2F7
beta,4,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),2/83,2,83,0.131402937577452,0.263294361911697,0,0,3.17057704502219,6.43464431575376,SMAD3;TGFBR1
beta,4,positive regulation of cell cycle (GO:0045787),2/83,2,83,0.131402937577452,0.263294361911697,0,0,3.17057704502219,6.43464431575376,MAPRE3;PROX1
beta,4,ephrin receptor signaling pathway (GO:0048013),2/83,2,83,0.131402937577452,0.263294361911697,0,0,3.17057704502219,6.43464431575376,SDC2;ARHGEF28
beta,4,striated muscle cell differentiation (GO:0051146),1/19,1,19,0.134992079321435,0.263625836066136,0,0,6.92520775623269,13.867999819654,PROX1
beta,4,cellular response to interleukin-7 (GO:0098761),1/19,1,19,0.134992079321435,0.263625836066136,0,0,6.92520775623269,13.867999819654,IRS2
beta,4,histone deubiquitination (GO:0016578),1/19,1,19,0.134992079321435,0.263625836066136,0,0,6.92520775623269,13.867999819654,ATXN7L3
beta,4,regulation of long-term synaptic potentiation (GO:1900271),1/19,1,19,0.134992079321435,0.263625836066136,0,0,6.92520775623269,13.867999819654,SQSTM1
beta,4,negative regulation of double-strand break repair (GO:2000780),1/19,1,19,0.134992079321435,0.263625836066136,0,0,6.92520775623269,13.867999819654,HELB
beta,4,positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),1/19,1,19,0.134992079321435,0.263625836066136,0,0,6.92520775623269,13.867999819654,SMAD3
beta,4,endothelial cell development (GO:0001885),1/19,1,19,0.134992079321435,0.263625836066136,0,0,6.92520775623269,13.867999819654,MET
beta,4,muscle tissue morphogenesis (GO:0060415),1/19,1,19,0.134992079321435,0.263625836066136,0,0,6.92520775623269,13.867999819654,PROX1
beta,4,interleukin-7-mediated signaling pathway (GO:0038111),1/19,1,19,0.134992079321435,0.263625836066136,0,0,6.92520775623269,13.867999819654,IRS2
beta,4,negative regulation of calcium ion transport (GO:0051926),1/19,1,19,0.134992079321435,0.263625836066136,0,0,6.92520775623269,13.867999819654,TMBIM6
beta,4,osteoclast differentiation (GO:0030316),1/19,1,19,0.134992079321435,0.263625836066136,0,0,6.92520775623269,13.867999819654,GAB2
beta,4,regulation of transcription factor import into nucleus (GO:0042990),1/19,1,19,0.134992079321435,0.263625836066136,0,0,6.92520775623269,13.867999819654,SMAD3
beta,4,triglyceride biosynthetic process (GO:0019432),1/19,1,19,0.134992079321435,0.263625836066136,0,0,6.92520775623269,13.867999819654,PCK2
beta,4,folic acid metabolic process (GO:0046655),1/19,1,19,0.134992079321435,0.263625836066136,0,0,6.92520775623269,13.867999819654,MTHFD2
beta,4,regulation of neuron differentiation (GO:0045664),2/85,2,85,0.136545485923271,0.26521807896448,0,0,3.09597523219814,6.16438851287574,REST;FBXO7
beta,4,positive regulation of supramolecular fiber organization (GO:1902905),2/85,2,85,0.136545485923271,0.26521807896448,0,0,3.09597523219814,6.16438851287574,PROX1;MET
beta,4,protein modification process (GO:0036211),2/85,2,85,0.136545485923271,0.26521807896448,0,0,3.09597523219814,6.16438851287574,ATG3;FBXO11
beta,4,positive regulation of interleukin-2 production (GO:0032743),1/20,1,20,0.14157238091539,0.268216215512813,0,0,6.57894736842105,12.8614747814461,RUNX1
beta,4,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),1/20,1,20,0.14157238091539,0.268216215512813,0,0,6.57894736842105,12.8614747814461,TMBIM6
beta,4,regulation of epidermal cell differentiation (GO:0045604),1/20,1,20,0.14157238091539,0.268216215512813,0,0,6.57894736842105,12.8614747814461,RUNX1
beta,4,regulation of regulatory T cell differentiation (GO:0045589),1/20,1,20,0.14157238091539,0.268216215512813,0,0,6.57894736842105,12.8614747814461,RUNX1
beta,4,negative regulation of actin filament bundle assembly (GO:0032232),1/20,1,20,0.14157238091539,0.268216215512813,0,0,6.57894736842105,12.8614747814461,MET
beta,4,negative regulation of ion transport (GO:0043271),1/20,1,20,0.14157238091539,0.268216215512813,0,0,6.57894736842105,12.8614747814461,SNCA
beta,4,inactivation of MAPK activity (GO:0000188),1/20,1,20,0.14157238091539,0.268216215512813,0,0,6.57894736842105,12.8614747814461,DUSP4
beta,4,axon extension (GO:0048675),1/20,1,20,0.14157238091539,0.268216215512813,0,0,6.57894736842105,12.8614747814461,ALCAM
beta,4,autophagy of nucleus (GO:0044804),1/20,1,20,0.14157238091539,0.268216215512813,0,0,6.57894736842105,12.8614747814461,ATG3
beta,4,regulation of anoikis (GO:2000209),1/20,1,20,0.14157238091539,0.268216215512813,0,0,6.57894736842105,12.8614747814461,TLE1
beta,4,regulation of cell development (GO:0060284),1/20,1,20,0.14157238091539,0.268216215512813,0,0,6.57894736842105,12.8614747814461,ARNTL
beta,4,positive regulation of gene silencing by miRNA (GO:2000637),1/20,1,20,0.14157238091539,0.268216215512813,0,0,6.57894736842105,12.8614747814461,MAP2K1
beta,4,regulation of response to cytokine stimulus (GO:0060759),1/20,1,20,0.14157238091539,0.268216215512813,0,0,6.57894736842105,12.8614747814461,RUNX1
beta,4,regulation of glycogen biosynthetic process (GO:0005979),1/20,1,20,0.14157238091539,0.268216215512813,0,0,6.57894736842105,12.8614747814461,IRS2
beta,4,hyaluronan metabolic process (GO:0030212),1/21,1,21,0.148102951692341,0.272914499015971,0,0,6.265664160401,11.9664638314932,HEXB
beta,4,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/21,1,21,0.148102951692341,0.272914499015971,0,0,6.265664160401,11.9664638314932,SESN2
beta,4,regulation of nuclear division (GO:0051783),1/21,1,21,0.148102951692341,0.272914499015971,0,0,6.265664160401,11.9664638314932,CDK13
beta,4,dendritic cell differentiation (GO:0097028),1/21,1,21,0.148102951692341,0.272914499015971,0,0,6.265664160401,11.9664638314932,TGFBR2
beta,4,regulation of interleukin-2 production (GO:0032663),1/21,1,21,0.148102951692341,0.272914499015971,0,0,6.265664160401,11.9664638314932,RUNX1
beta,4,positive regulation of leukocyte cell-cell adhesion (GO:1903039),1/21,1,21,0.148102951692341,0.272914499015971,0,0,6.265664160401,11.9664638314932,ETS1
beta,4,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",1/21,1,21,0.148102951692341,0.272914499015971,0,0,6.265664160401,11.9664638314932,COX5A
beta,4,cellular protein complex localization (GO:0034629),1/21,1,21,0.148102951692341,0.272914499015971,0,0,6.265664160401,11.9664638314932,KLHL21
beta,4,histone ubiquitination (GO:0016574),1/21,1,21,0.148102951692341,0.272914499015971,0,0,6.265664160401,11.9664638314932,ATXN7L3
beta,4,ventricular cardiac muscle tissue development (GO:0003229),1/21,1,21,0.148102951692341,0.272914499015971,0,0,6.265664160401,11.9664638314932,PROX1
beta,4,cellular response to copper ion (GO:0071280),1/21,1,21,0.148102951692341,0.272914499015971,0,0,6.265664160401,11.9664638314932,SNCA
beta,4,dopamine metabolic process (GO:0042417),1/21,1,21,0.148102951692341,0.272914499015971,0,0,6.265664160401,11.9664638314932,SNCA
beta,4,zinc II ion transport (GO:0006829),1/21,1,21,0.148102951692341,0.272914499015971,0,0,6.265664160401,11.9664638314932,SLC39A14
beta,4,positive regulation of histone acetylation (GO:0035066),1/21,1,21,0.148102951692341,0.272914499015971,0,0,6.265664160401,11.9664638314932,RPS6KA5
beta,4,ERK1 and ERK2 cascade (GO:0070371),1/21,1,21,0.148102951692341,0.272914499015971,0,0,6.265664160401,11.9664638314932,MAP2K1
beta,4,branched-chain amino acid catabolic process (GO:0009083),1/21,1,21,0.148102951692341,0.272914499015971,0,0,6.265664160401,11.9664638314932,PPM1K
beta,4,positive regulation of response to external stimulus (GO:0032103),2/91,2,91,0.152228150683441,0.276813504753265,0,0,2.89184499710816,5.44353641457191,ETS1;SNCA
beta,4,regulation of calcium ion transport into cytosol (GO:0010522),1/22,1,22,0.154584164992083,0.276813504753265,0,0,5.98086124401914,11.1663670678252,TMBIM6
beta,4,purine-containing compound biosynthetic process (GO:0072522),1/22,1,22,0.154584164992083,0.276813504753265,0,0,5.98086124401914,11.1663670678252,ADK
beta,4,branched-chain amino acid metabolic process (GO:0009081),1/22,1,22,0.154584164992083,0.276813504753265,0,0,5.98086124401914,11.1663670678252,PPM1K
beta,4,GTP metabolic process (GO:0046039),1/22,1,22,0.154584164992083,0.276813504753265,0,0,5.98086124401914,11.1663670678252,GPHN
beta,4,negative regulation of protein polymerization (GO:0032272),1/22,1,22,0.154584164992083,0.276813504753265,0,0,5.98086124401914,11.1663670678252,SNCA
beta,4,NAD biosynthetic process (GO:0009435),1/22,1,22,0.154584164992083,0.276813504753265,0,0,5.98086124401914,11.1663670678252,PTGS2
beta,4,positive regulation of protein targeting to membrane (GO:0090314),1/22,1,22,0.154584164992083,0.276813504753265,0,0,5.98086124401914,11.1663670678252,C2CD5
beta,4,protein complex localization (GO:0031503),1/22,1,22,0.154584164992083,0.276813504753265,0,0,5.98086124401914,11.1663670678252,ICK
beta,4,cellular response to hexose stimulus (GO:0071331),1/22,1,22,0.154584164992083,0.276813504753265,0,0,5.98086124401914,11.1663670678252,PCK2
beta,4,outflow tract septum morphogenesis (GO:0003148),1/22,1,22,0.154584164992083,0.276813504753265,0,0,5.98086124401914,11.1663670678252,TGFBR2
beta,4,negative regulation of response to endoplasmic reticulum stress (GO:1903573),1/22,1,22,0.154584164992083,0.276813504753265,0,0,5.98086124401914,11.1663670678252,TMBIM6
beta,4,negative regulation of cell cycle G1/S phase transition (GO:1902807),1/22,1,22,0.154584164992083,0.276813504753265,0,0,5.98086124401914,11.1663670678252,E2F7
beta,4,histone lysine methylation (GO:0034968),1/22,1,22,0.154584164992083,0.276813504753265,0,0,5.98086124401914,11.1663670678252,WDR82
beta,4,positive regulation of erythrocyte differentiation (GO:0045648),1/22,1,22,0.154584164992083,0.276813504753265,0,0,5.98086124401914,11.1663670678252,ETS1
beta,4,NLS-bearing protein import into nucleus (GO:0006607),1/22,1,22,0.154584164992083,0.276813504753265,0,0,5.98086124401914,11.1663670678252,TNPO1
beta,4,negative regulation of sprouting angiogenesis (GO:1903671),1/22,1,22,0.154584164992083,0.276813504753265,0,0,5.98086124401914,11.1663670678252,DLL4
beta,4,positive regulation of cellular metabolic process (GO:0031325),2/93,2,93,0.157532620798642,0.280413037020478,0,0,2.82965478211658,5.22954930950819,TGFBR2;SNCA
beta,4,cellular response to catecholamine stimulus (GO:0071870),1/23,1,23,0.161016391387454,0.280413037020478,0,0,5.720823798627,10.4476493668191,SNCA
beta,4,negative regulation of viral transcription (GO:0032897),1/23,1,23,0.161016391387454,0.280413037020478,0,0,5.720823798627,10.4476493668191,REST
beta,4,microtubule polymerization or depolymerization (GO:0031109),1/23,1,23,0.161016391387454,0.280413037020478,0,0,5.720823798627,10.4476493668191,CKAP5
beta,4,positive regulation of ERBB signaling pathway (GO:1901186),1/23,1,23,0.161016391387454,0.280413037020478,0,0,5.720823798627,10.4476493668191,RTN4
beta,4,folic acid-containing compound metabolic process (GO:0006760),1/23,1,23,0.161016391387454,0.280413037020478,0,0,5.720823798627,10.4476493668191,MTHFD2
beta,4,regulation of telomere capping (GO:1904353),1/23,1,23,0.161016391387454,0.280413037020478,0,0,5.720823798627,10.4476493668191,PKIB
beta,4,cellular amino acid catabolic process (GO:0009063),1/23,1,23,0.161016391387454,0.280413037020478,0,0,5.720823798627,10.4476493668191,PPM1K
beta,4,zinc II ion transmembrane transport (GO:0071577),1/23,1,23,0.161016391387454,0.280413037020478,0,0,5.720823798627,10.4476493668191,SLC39A14
beta,4,histone H3-K4 methylation (GO:0051568),1/23,1,23,0.161016391387454,0.280413037020478,0,0,5.720823798627,10.4476493668191,WDR82
beta,4,autophagosome maturation (GO:0097352),1/23,1,23,0.161016391387454,0.280413037020478,0,0,5.720823798627,10.4476493668191,GABARAPL1
beta,4,negative regulation of axonogenesis (GO:0050771),1/23,1,23,0.161016391387454,0.280413037020478,0,0,5.720823798627,10.4476493668191,RTN4
beta,4,regulation of monooxygenase activity (GO:0032768),1/23,1,23,0.161016391387454,0.280413037020478,0,0,5.720823798627,10.4476493668191,SNCA
beta,4,vitamin transport (GO:0051180),1/23,1,23,0.161016391387454,0.280413037020478,0,0,5.720823798627,10.4476493668191,SLC19A2
beta,4,metanephros development (GO:0001656),1/23,1,23,0.161016391387454,0.280413037020478,0,0,5.720823798627,10.4476493668191,ROBO2
beta,4,regulation of chondrocyte differentiation (GO:0032330),1/23,1,23,0.161016391387454,0.280413037020478,0,0,5.720823798627,10.4476493668191,TGFBR1
beta,4,negative regulation of axon extension (GO:0030517),1/23,1,23,0.161016391387454,0.280413037020478,0,0,5.720823798627,10.4476493668191,RTN4
beta,4,positive regulation of protein localization to membrane (GO:1905477),2/96,2,96,0.165553439766531,0.287385842300033,0,0,2.74122807017544,4.92999242706749,C2CD5;SQSTM1
beta,4,interleukin-1-mediated signaling pathway (GO:0070498),2/96,2,96,0.165553439766531,0.287385842300033,0,0,2.74122807017544,4.92999242706749,RPS6KA5;SQSTM1
beta,4,cell morphogenesis involved in neuron differentiation (GO:0048667),2/98,2,98,0.170940147289703,0.29263548344422,0,0,2.68528464017186,4.74339903222076,SDC2;RTN4
beta,4,positive regulation of neuron projection development (GO:0010976),2/98,2,98,0.170940147289703,0.29263548344422,0,0,2.68528464017186,4.74339903222076,ROBO2;SYT4
beta,4,positive regulation of cell growth (GO:0030307),2/99,2,99,0.17364453647004,0.29263548344422,0,0,2.6581605528974,4.65376119928736,SYT4;TGFBR1
beta,4,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),2/99,2,99,0.17364453647004,0.29263548344422,0,0,2.6581605528974,4.65376119928736,MARCH1;DCTN4
beta,4,histone modification (GO:0016570),2/99,2,99,0.17364453647004,0.29263548344422,0,0,2.6581605528974,4.65376119928736,RPS6KA5;ATXN7L3
beta,4,positive regulation of microtubule polymerization (GO:0031116),1/25,1,25,0.173735351952041,0.29263548344422,0,0,5.26315789473684,9.21169528106905,MET
beta,4,membrane protein intracellular domain proteolysis (GO:0031293),1/25,1,25,0.173735351952041,0.29263548344422,0,0,5.26315789473684,9.21169528106905,DLL4
beta,4,histone monoubiquitination (GO:0010390),1/25,1,25,0.173735351952041,0.29263548344422,0,0,5.26315789473684,9.21169528106905,ATXN7L3
beta,4,response to glucocorticoid (GO:0051384),1/25,1,25,0.173735351952041,0.29263548344422,0,0,5.26315789473684,9.21169528106905,REST
beta,4,positive regulation of vascular endothelial growth factor production (GO:0010575),1/25,1,25,0.173735351952041,0.29263548344422,0,0,5.26315789473684,9.21169528106905,PTGS2
beta,4,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),1/25,1,25,0.173735351952041,0.29263548344422,0,0,5.26315789473684,9.21169528106905,E2F7
beta,4,cellular modified amino acid biosynthetic process (GO:0042398),1/25,1,25,0.173735351952041,0.29263548344422,0,0,5.26315789473684,9.21169528106905,CHAC1
beta,4,negative regulation of developmental growth (GO:0048640),1/25,1,25,0.173735351952041,0.29263548344422,0,0,5.26315789473684,9.21169528106905,RTN4
beta,4,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),1/25,1,25,0.173735351952041,0.29263548344422,0,0,5.26315789473684,9.21169528106905,CHAC1
beta,4,positive regulation of microtubule polymerization or depolymerization (GO:0031112),1/25,1,25,0.173735351952041,0.29263548344422,0,0,5.26315789473684,9.21169528106905,MET
beta,4,mRNA splice site selection (GO:0006376),1/25,1,25,0.173735351952041,0.29263548344422,0,0,5.26315789473684,9.21169528106905,CELF2
beta,4,negative regulation of oxidative stress-induced cell death (GO:1903202),1/25,1,25,0.173735351952041,0.29263548344422,0,0,5.26315789473684,9.21169528106905,FBXO7
beta,4,cellular senescence (GO:0090398),1/25,1,25,0.173735351952041,0.29263548344422,0,0,5.26315789473684,9.21169528106905,MAP2K1
beta,4,regulation of cellular senescence (GO:2000772),1/25,1,25,0.173735351952041,0.29263548344422,0,0,5.26315789473684,9.21169528106905,ARNTL
beta,4,cellular response to vascular endothelial growth factor stimulus (GO:0035924),1/26,1,26,0.180022813559029,0.29718926955074,0,0,5.06072874493927,8.67748833060935,DLL4
beta,4,organophosphate ester transport (GO:0015748),1/26,1,26,0.180022813559029,0.29718926955074,0,0,5.06072874493927,8.67748833060935,OSBPL8
beta,4,regulation of voltage-gated calcium channel activity (GO:1901385),1/26,1,26,0.180022813559029,0.29718926955074,0,0,5.06072874493927,8.67748833060935,CACNB2
beta,4,response to copper ion (GO:0046688),1/26,1,26,0.180022813559029,0.29718926955074,0,0,5.06072874493927,8.67748833060935,SNCA
beta,4,"protein import into nucleus, translocation (GO:0000060)",1/26,1,26,0.180022813559029,0.29718926955074,0,0,5.06072874493927,8.67748833060935,TNPO1
beta,4,respiratory tube development (GO:0030323),1/26,1,26,0.180022813559029,0.29718926955074,0,0,5.06072874493927,8.67748833060935,PROX1
beta,4,misfolded or incompletely synthesized protein catabolic process (GO:0006515),1/26,1,26,0.180022813559029,0.29718926955074,0,0,5.06072874493927,8.67748833060935,OMA1
beta,4,peptide catabolic process (GO:0043171),1/26,1,26,0.180022813559029,0.29718926955074,0,0,5.06072874493927,8.67748833060935,CHAC1
beta,4,protein depolymerization (GO:0051261),1/26,1,26,0.180022813559029,0.29718926955074,0,0,5.06072874493927,8.67748833060935,CKAP5
beta,4,prostaglandin metabolic process (GO:0006693),1/26,1,26,0.180022813559029,0.29718926955074,0,0,5.06072874493927,8.67748833060935,PTGS2
beta,4,in utero embryonic development (GO:0001701),1/26,1,26,0.180022813559029,0.29718926955074,0,0,5.06072874493927,8.67748833060935,TGFBR1
beta,4,peptidyl-tyrosine dephosphorylation (GO:0035335),1/26,1,26,0.180022813559029,0.29718926955074,0,0,5.06072874493927,8.67748833060935,DUSP4
beta,4,regulation of lamellipodium assembly (GO:0010591),1/26,1,26,0.180022813559029,0.29718926955074,0,0,5.06072874493927,8.67748833060935,SSH2
beta,4,intrinsic apoptotic signaling pathway (GO:0097193),2/102,2,102,0.181798690619614,0.299662061908171,0,0,2.57997936016512,4.39849148497691,CHAC1;PDK1
beta,4,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1/27,1,27,0.186262743123984,0.304229147102507,0,0,4.87329434697856,8.19004388209231,E2F7
beta,4,bile acid biosynthetic process (GO:0006699),1/27,1,27,0.186262743123984,0.304229147102507,0,0,4.87329434697856,8.19004388209231,OSBPL6
beta,4,regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),1/27,1,27,0.186262743123984,0.304229147102507,0,0,4.87329434697856,8.19004388209231,SMAD3
beta,4,endocrine system development (GO:0035270),1/27,1,27,0.186262743123984,0.304229147102507,0,0,4.87329434697856,8.19004388209231,TGFBR1
beta,4,RNA biosynthetic process (GO:0032774),1/27,1,27,0.186262743123984,0.304229147102507,0,0,4.87329434697856,8.19004388209231,HELB
beta,4,regulation of supramolecular fiber organization (GO:1902903),1/27,1,27,0.186262743123984,0.304229147102507,0,0,4.87329434697856,8.19004388209231,SSH2
beta,4,positive regulation of angiogenesis (GO:0045766),2/104,2,104,0.18726638983545,0.304944362904252,0,0,2.53036437246964,4.2389249272621,ETS1;RUNX1
beta,4,protein import into nucleus (GO:0006606),2/104,2,104,0.18726638983545,0.304944362904252,0,0,2.53036437246964,4.2389249272621,TGS1;TNPO1
beta,4,positive regulation of vasculature development (GO:1904018),2/105,2,105,0.190008968748146,0.306903885249615,0,0,2.5062656641604,4.16211529824088,ETS1;RUNX1
beta,4,regulation of calcium ion transmembrane transporter activity (GO:1901019),1/28,1,28,0.192455497614786,0.306903885249615,0,0,4.69924812030075,7.7438455507645,CACNB2
beta,4,negative regulation of osteoblast differentiation (GO:0045668),1/28,1,28,0.192455497614786,0.306903885249615,0,0,4.69924812030075,7.7438455507645,TMEM64
beta,4,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),1/28,1,28,0.192455497614786,0.306903885249615,0,0,4.69924812030075,7.7438455507645,RUNX1
beta,4,regulation of cilium assembly (GO:1902017),1/28,1,28,0.192455497614786,0.306903885249615,0,0,4.69924812030075,7.7438455507645,ATG3
beta,4,response to hexose (GO:0009746),1/28,1,28,0.192455497614786,0.306903885249615,0,0,4.69924812030075,7.7438455507645,IRS2
beta,4,microtubule polymerization (GO:0046785),1/28,1,28,0.192455497614786,0.306903885249615,0,0,4.69924812030075,7.7438455507645,CKAP5
beta,4,negative regulation of microtubule polymerization or depolymerization (GO:0031111),1/28,1,28,0.192455497614786,0.306903885249615,0,0,4.69924812030075,7.7438455507645,SNCA
beta,4,regulation of double-strand break repair via homologous recombination (GO:0010569),1/28,1,28,0.192455497614786,0.306903885249615,0,0,4.69924812030075,7.7438455507645,HELB
beta,4,modulation by host of viral transcription (GO:0043921),1/28,1,28,0.192455497614786,0.306903885249615,0,0,4.69924812030075,7.7438455507645,REST
beta,4,regulation of protein localization to nucleus (GO:1900180),1/28,1,28,0.192455497614786,0.306903885249615,0,0,4.69924812030075,7.7438455507645,SESN2
beta,4,regulation of protein targeting to membrane (GO:0090313),1/28,1,28,0.192455497614786,0.306903885249615,0,0,4.69924812030075,7.7438455507645,C2CD5
beta,4,regulation of autophagy of mitochondrion (GO:1903146),1/28,1,28,0.192455497614786,0.306903885249615,0,0,4.69924812030075,7.7438455507645,FBXO7
beta,4,cellular response to glucose stimulus (GO:0071333),1/28,1,28,0.192455497614786,0.306903885249615,0,0,4.69924812030075,7.7438455507645,PCK2
beta,4,response to endoplasmic reticulum stress (GO:0034976),2/107,2,107,0.195510369496795,0.308935559835375,0,0,2.45941957697983,4.01412164303741,CHAC1;ATF3
beta,4,positive regulation of cellular component organization (GO:0051130),2/107,2,107,0.195510369496795,0.308935559835375,0,0,2.45941957697983,4.01412164303741,TGFBR1;SNCA
beta,4,regulation of protein secretion (GO:0050708),2/108,2,108,0.198268715047755,0.308935559835375,0,0,2.43664717348928,3.94281681694197,SERGEF;ARNTL
beta,4,cellular response to starvation (GO:0009267),2/108,2,108,0.198268715047755,0.308935559835375,0,0,2.43664717348928,3.94281681694197,GABARAPL1;SESN2
beta,4,regulation of vasculature development (GO:1901342),1/29,1,29,0.198601431322741,0.308935559835375,0,0,4.53720508166969,7.33418929371093,ETS1
beta,4,neuron projection extension (GO:1990138),1/29,1,29,0.198601431322741,0.308935559835375,0,0,4.53720508166969,7.33418929371093,ALCAM
beta,4,regulation of TORC1 signaling (GO:1903432),1/29,1,29,0.198601431322741,0.308935559835375,0,0,4.53720508166969,7.33418929371093,SESN2
beta,4,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),1/29,1,29,0.198601431322741,0.308935559835375,0,0,4.53720508166969,7.33418929371093,ARNTL
beta,4,negative regulation of homeostatic process (GO:0032845),1/29,1,29,0.198601431322741,0.308935559835375,0,0,4.53720508166969,7.33418929371093,TMBIM6
beta,4,carboxylic acid catabolic process (GO:0046395),1/29,1,29,0.198601431322741,0.308935559835375,0,0,4.53720508166969,7.33418929371093,HEXB
beta,4,production of miRNAs involved in gene silencing by miRNA (GO:0035196),1/29,1,29,0.198601431322741,0.308935559835375,0,0,4.53720508166969,7.33418929371093,SMAD3
beta,4,positive regulation of sprouting angiogenesis (GO:1903672),1/29,1,29,0.198601431322741,0.308935559835375,0,0,4.53720508166969,7.33418929371093,PTGS2
beta,4,chondrocyte differentiation (GO:0002062),1/29,1,29,0.198601431322741,0.308935559835375,0,0,4.53720508166969,7.33418929371093,RUNX1
beta,4,calcium ion import (GO:0070509),1/29,1,29,0.198601431322741,0.308935559835375,0,0,4.53720508166969,7.33418929371093,CACNB2
beta,4,regulation of actin polymerization or depolymerization (GO:0008064),1/29,1,29,0.198601431322741,0.308935559835375,0,0,4.53720508166969,7.33418929371093,SSH2
beta,4,primary neural tube formation (GO:0014020),1/29,1,29,0.198601431322741,0.308935559835375,0,0,4.53720508166969,7.33418929371093,LMO4
beta,4,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),1/29,1,29,0.198601431322741,0.308935559835375,0,0,4.53720508166969,7.33418929371093,SMAD3
beta,4,circulatory system development (GO:0072359),2/110,2,110,0.203799529983503,0.313003639413843,0,0,2.39234449760766,3.80530733124318,TGFBR1;TGFBR2
beta,4,regulation of cell motility (GO:2000145),2/110,2,110,0.203799529983503,0.313003639413843,0,0,2.39234449760766,3.80530733124318,LMO4;SGK1
beta,4,regulation of Wnt signaling pathway (GO:0030111),2/110,2,110,0.203799529983503,0.313003639413843,0,0,2.39234449760766,3.80530733124318,TLE1;RUNX1
beta,4,collagen fibril organization (GO:0030199),1/30,1,30,0.204700895906085,0.313003639413843,0,0,4.3859649122807,6.95704127037715,TGFBR1
beta,4,regulation of keratinocyte differentiation (GO:0045616),1/30,1,30,0.204700895906085,0.313003639413843,0,0,4.3859649122807,6.95704127037715,RUNX1
beta,4,coenzyme biosynthetic process (GO:0009108),1/30,1,30,0.204700895906085,0.313003639413843,0,0,4.3859649122807,6.95704127037715,GPHN
beta,4,tube closure (GO:0060606),1/30,1,30,0.204700895906085,0.313003639413843,0,0,4.3859649122807,6.95704127037715,LMO4
beta,4,lung development (GO:0030324),1/30,1,30,0.204700895906085,0.313003639413843,0,0,4.3859649122807,6.95704127037715,PROX1
beta,4,positive regulation of myeloid cell differentiation (GO:0045639),1/30,1,30,0.204700895906085,0.313003639413843,0,0,4.3859649122807,6.95704127037715,ETS1
beta,4,positive regulation of histone modification (GO:0031058),1/30,1,30,0.204700895906085,0.313003639413843,0,0,4.3859649122807,6.95704127037715,RPS6KA5
beta,4,semaphorin-plexin signaling pathway (GO:0071526),1/30,1,30,0.204700895906085,0.313003639413843,0,0,4.3859649122807,6.95704127037715,MET
beta,4,respiratory system development (GO:0060541),1/30,1,30,0.204700895906085,0.313003639413843,0,0,4.3859649122807,6.95704127037715,PROX1
beta,4,negative regulation of cytokine production (GO:0001818),2/111,2,111,0.206571542480145,0.315416604523508,0,0,2.37079184447606,3.73899590776095,RPS6KA5;SARS
beta,4,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),1/31,1,31,0.210754240420059,0.316424890212847,0,0,4.24448217317487,6.60892428559195,RUNX1
beta,4,negative regulation of endothelial cell proliferation (GO:0001937),1/31,1,31,0.210754240420059,0.316424890212847,0,0,4.24448217317487,6.60892428559195,DLL4
beta,4,beta-catenin-TCF complex assembly (GO:1904837),1/31,1,31,0.210754240420059,0.316424890212847,0,0,4.24448217317487,6.60892428559195,TLE1
beta,4,aminoglycan metabolic process (GO:0006022),1/31,1,31,0.210754240420059,0.316424890212847,0,0,4.24448217317487,6.60892428559195,SDC2
beta,4,cellular response to drug (GO:0035690),1/31,1,31,0.210754240420059,0.316424890212847,0,0,4.24448217317487,6.60892428559195,REST
beta,4,negative regulation of transferase activity (GO:0051348),1/31,1,31,0.210754240420059,0.316424890212847,0,0,4.24448217317487,6.60892428559195,IRS2
beta,4,artery morphogenesis (GO:0048844),1/31,1,31,0.210754240420059,0.316424890212847,0,0,4.24448217317487,6.60892428559195,TGFBR1
beta,4,positive regulation of B cell proliferation (GO:0030890),1/31,1,31,0.210754240420059,0.316424890212847,0,0,4.24448217317487,6.60892428559195,IRS2
beta,4,activation of protein kinase B activity (GO:0032148),1/31,1,31,0.210754240420059,0.316424890212847,0,0,4.24448217317487,6.60892428559195,OSBPL8
beta,4,bile acid metabolic process (GO:0008206),1/31,1,31,0.210754240420059,0.316424890212847,0,0,4.24448217317487,6.60892428559195,OSBPL6
beta,4,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),1/31,1,31,0.210754240420059,0.316424890212847,0,0,4.24448217317487,6.60892428559195,RTN4
beta,4,chondroitin sulfate metabolic process (GO:0030204),1/31,1,31,0.210754240420059,0.316424890212847,0,0,4.24448217317487,6.60892428559195,HEXB
beta,4,cellular zinc ion homeostasis (GO:0006882),1/32,1,32,0.216761811284632,0.32097422055609,0,0,4.11184210526316,6.28682636572161,SLC39A14
beta,4,positive regulation of insulin secretion (GO:0032024),1/32,1,32,0.216761811284632,0.32097422055609,0,0,4.11184210526316,6.28682636572161,IRS2
beta,4,negative regulation of blood vessel endothelial cell migration (GO:0043537),1/32,1,32,0.216761811284632,0.32097422055609,0,0,4.11184210526316,6.28682636572161,DLL4
beta,4,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),1/32,1,32,0.216761811284632,0.32097422055609,0,0,4.11184210526316,6.28682636572161,SNCA
beta,4,regulation of glucose import (GO:0046324),1/32,1,32,0.216761811284632,0.32097422055609,0,0,4.11184210526316,6.28682636572161,IRS2
beta,4,nucleobase-containing small molecule interconversion (GO:0015949),1/32,1,32,0.216761811284632,0.32097422055609,0,0,4.11184210526316,6.28682636572161,TXNRD1
beta,4,skeletal system morphogenesis (GO:0048705),1/32,1,32,0.216761811284632,0.32097422055609,0,0,4.11184210526316,6.28682636572161,TGFBR1
beta,4,zinc ion homeostasis (GO:0055069),1/32,1,32,0.216761811284632,0.32097422055609,0,0,4.11184210526316,6.28682636572161,SLC39A14
beta,4,protein destabilization (GO:0031648),1/32,1,32,0.216761811284632,0.32097422055609,0,0,4.11184210526316,6.28682636572161,SNCA
beta,4,cofactor biosynthetic process (GO:0051188),1/32,1,32,0.216761811284632,0.32097422055609,0,0,4.11184210526316,6.28682636572161,GPHN
beta,4,dendrite morphogenesis (GO:0048813),1/33,1,33,0.222723952350542,0.322651736641936,0,0,3.98724082934609,5.98812661948465,SDC2
beta,4,positive regulation of calcium ion transport into cytosol (GO:0010524),1/33,1,33,0.222723952350542,0.322651736641936,0,0,3.98724082934609,5.98812661948465,SNCA
beta,4,cellular response to amino acid stimulus (GO:0071230),1/33,1,33,0.222723952350542,0.322651736641936,0,0,3.98724082934609,5.98812661948465,SESN2
beta,4,regulation of glutamate receptor signaling pathway (GO:1900449),1/33,1,33,0.222723952350542,0.322651736641936,0,0,3.98724082934609,5.98812661948465,DAPK1
beta,4,cellular response to glucagon stimulus (GO:0071377),1/33,1,33,0.222723952350542,0.322651736641936,0,0,3.98724082934609,5.98812661948465,GNG5
beta,4,central nervous system neuron differentiation (GO:0021953),1/33,1,33,0.222723952350542,0.322651736641936,0,0,3.98724082934609,5.98812661948465,PROX1
beta,4,substrate adhesion-dependent cell spreading (GO:0034446),1/33,1,33,0.222723952350542,0.322651736641936,0,0,3.98724082934609,5.98812661948465,LAMC1
beta,4,positive regulation of telomere maintenance via telomerase (GO:0032212),1/33,1,33,0.222723952350542,0.322651736641936,0,0,3.98724082934609,5.98812661948465,PKIB
beta,4,positive regulation of transcription factor import into nucleus (GO:0042993),1/33,1,33,0.222723952350542,0.322651736641936,0,0,3.98724082934609,5.98812661948465,SMAD3
beta,4,ceramide biosynthetic process (GO:0046513),1/33,1,33,0.222723952350542,0.322651736641936,0,0,3.98724082934609,5.98812661948465,SGMS2
beta,4,regulation of erythrocyte differentiation (GO:0045646),1/33,1,33,0.222723952350542,0.322651736641936,0,0,3.98724082934609,5.98812661948465,ETS1
beta,4,positive regulation of telomere maintenance (GO:0032206),1/33,1,33,0.222723952350542,0.322651736641936,0,0,3.98724082934609,5.98812661948465,PKIB
beta,4,aminoglycan catabolic process (GO:0006026),1/33,1,33,0.222723952350542,0.322651736641936,0,0,3.98724082934609,5.98812661948465,SDC2
beta,4,positive regulation of myeloid leukocyte differentiation (GO:0002763),1/33,1,33,0.222723952350542,0.322651736641936,0,0,3.98724082934609,5.98812661948465,RUNX1
beta,4,vasculogenesis (GO:0001570),1/33,1,33,0.222723952350542,0.322651736641936,0,0,3.98724082934609,5.98812661948465,TGFBR2
beta,4,regulation of macroautophagy (GO:0016241),2/117,2,117,0.223282185097295,0.322651736641936,0,0,2.24921277552857,3.37228723222487,UCHL1;SESN2
beta,4,cellular response to interferon-gamma (GO:0071346),2/117,2,117,0.223282185097295,0.322651736641936,0,0,2.24921277552857,3.37228723222487,DAPK1;NCAM1
beta,4,sphingolipid metabolic process (GO:0006665),2/117,2,117,0.223282185097295,0.322651736641936,0,0,2.24921277552857,3.37228723222487,HEXB;SGMS2
beta,4,protein localization to cell periphery (GO:1990778),2/118,2,118,0.22607839836235,0.325500869125093,0,0,2.23015165031222,3.3159532659579,CACNB2;TNIK
beta,4,negative regulation of neurogenesis (GO:0050768),1/34,1,34,0.228641004905514,0.325500869125093,0,0,3.86996904024768,5.71053471233421,REST
beta,4,regulation of T cell differentiation (GO:0045580),1/34,1,34,0.228641004905514,0.325500869125093,0,0,3.86996904024768,5.71053471233421,RUNX1
beta,4,entry into host cell (GO:0030260),1/34,1,34,0.228641004905514,0.325500869125093,0,0,3.86996904024768,5.71053471233421,MET
beta,4,negative regulation of mitochondrion organization (GO:0010823),1/34,1,34,0.228641004905514,0.325500869125093,0,0,3.86996904024768,5.71053471233421,OMA1
beta,4,neural tube closure (GO:0001843),1/34,1,34,0.228641004905514,0.325500869125093,0,0,3.86996904024768,5.71053471233421,LMO4
beta,4,positive regulation of calcium ion transport (GO:0051928),1/34,1,34,0.228641004905514,0.325500869125093,0,0,3.86996904024768,5.71053471233421,CACNB2
beta,4,cellular glucose homeostasis (GO:0001678),1/34,1,34,0.228641004905514,0.325500869125093,0,0,3.86996904024768,5.71053471233421,PCK2
beta,4,cellular response to glucose starvation (GO:0042149),1/34,1,34,0.228641004905514,0.325500869125093,0,0,3.86996904024768,5.71053471233421,SESN2
beta,4,regulation of neurotransmitter receptor activity (GO:0099601),1/34,1,34,0.228641004905514,0.325500869125093,0,0,3.86996904024768,5.71053471233421,DAPK1
beta,4,positive regulation of organelle organization (GO:0010638),1/34,1,34,0.228641004905514,0.325500869125093,0,0,3.86996904024768,5.71053471233421,C2CD5
beta,4,calcium ion transport (GO:0006816),2/119,2,119,0.2288772345054,0.325500869125093,0,0,2.21141088014153,3.2608790646627,CACNB2;MCOLN3
beta,4,regulation of neuron projection development (GO:0010975),2/120,2,120,0.231678493760401,0.326621893614161,0,0,2.19298245614035,3.2070277876873,SSH2;FBXO7
beta,4,regulation of phosphorylation (GO:0042325),2/120,2,120,0.231678493760401,0.326621893614161,0,0,2.19298245614035,3.2070277876873,SESN2;BTBD10
beta,4,actin filament organization (GO:0007015),2/121,2,121,0.234481979127365,0.326621893614161,0,0,2.17485863418878,3.1543639454539,PROX1;FRY
beta,4,DNA replication (GO:0006260),2/121,2,121,0.234481979127365,0.326621893614161,0,0,2.17485863418878,3.1543639454539,HELB;TIPIN
beta,4,epithelial tube morphogenesis (GO:0060562),1/35,1,35,0.234513307659889,0.326621893614161,0,0,3.7593984962406,5.45204114144094,MET
beta,4,regulation of double-strand break repair (GO:2000779),1/35,1,35,0.234513307659889,0.326621893614161,0,0,3.7593984962406,5.45204114144094,HELB
beta,4,apoptotic mitochondrial changes (GO:0008637),1/35,1,35,0.234513307659889,0.326621893614161,0,0,3.7593984962406,5.45204114144094,ATG3
beta,4,ncRNA metabolic process (GO:0034660),1/35,1,35,0.234513307659889,0.326621893614161,0,0,3.7593984962406,5.45204114144094,DTD2
beta,4,keratan sulfate metabolic process (GO:0042339),1/35,1,35,0.234513307659889,0.326621893614161,0,0,3.7593984962406,5.45204114144094,HEXB
beta,4,regulation of axon extension (GO:0030516),1/35,1,35,0.234513307659889,0.326621893614161,0,0,3.7593984962406,5.45204114144094,RTN4
beta,4,negative regulation of endothelial cell migration (GO:0010596),1/35,1,35,0.234513307659889,0.326621893614161,0,0,3.7593984962406,5.45204114144094,DLL4
beta,4,endoplasmic reticulum organization (GO:0007029),1/35,1,35,0.234513307659889,0.326621893614161,0,0,3.7593984962406,5.45204114144094,RTN4
beta,4,positive regulation of cell development (GO:0010720),1/35,1,35,0.234513307659889,0.326621893614161,0,0,3.7593984962406,5.45204114144094,PROX1
beta,4,response to glucagon (GO:0033762),1/35,1,35,0.234513307659889,0.326621893614161,0,0,3.7593984962406,5.45204114144094,GNG5
beta,4,anterior/posterior pattern specification (GO:0009952),1/35,1,35,0.234513307659889,0.326621893614161,0,0,3.7593984962406,5.45204114144094,TGFBR1
beta,4,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),1/35,1,35,0.234513307659889,0.326621893614161,0,0,3.7593984962406,5.45204114144094,PKIB
beta,4,regulation of cell differentiation (GO:0045595),2/122,2,122,0.237287496514783,0.330059253216691,0,0,2.15703192407248,3.10285333812169,TGFBR1;RUNX1
beta,4,positive regulation of RNA metabolic process (GO:0051254),1/36,1,36,0.240341196834522,0.33216385921489,0,0,3.65497076023392,5.21087613945735,MAP2K1
beta,4,regulation of heart rate by cardiac conduction (GO:0086091),1/36,1,36,0.240341196834522,0.33216385921489,0,0,3.65497076023392,5.21087613945735,CACNB2
beta,4,negative regulation of epithelial cell migration (GO:0010633),1/36,1,36,0.240341196834522,0.33216385921489,0,0,3.65497076023392,5.21087613945735,DLL4
beta,4,positive regulation of telomerase activity (GO:0051973),1/36,1,36,0.240341196834522,0.33216385921489,0,0,3.65497076023392,5.21087613945735,PKIB
beta,4,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),1/36,1,36,0.240341196834522,0.33216385921489,0,0,3.65497076023392,5.21087613945735,TIPIN
beta,4,dephosphorylation (GO:0016311),2/125,2,125,0.245714340693709,0.335851590635191,0,0,2.10526315789474,2.9549171252137,DUSP4;SSH2
beta,4,endosome organization (GO:0007032),1/37,1,37,0.246125006124119,0.335851590635191,0,0,3.55618776671408,4.98547552325995,SQSTM1
beta,4,positive regulation of signaling (GO:0023056),1/37,1,37,0.246125006124119,0.335851590635191,0,0,3.55618776671408,4.98547552325995,SNCA
beta,4,endoderm formation (GO:0001706),1/37,1,37,0.246125006124119,0.335851590635191,0,0,3.55618776671408,4.98547552325995,DUSP4
beta,4,cardiac muscle tissue morphogenesis (GO:0055008),1/37,1,37,0.246125006124119,0.335851590635191,0,0,3.55618776671408,4.98547552325995,PROX1
beta,4,organophosphate biosynthetic process (GO:0090407),1/37,1,37,0.246125006124119,0.335851590635191,0,0,3.55618776671408,4.98547552325995,GPHN
beta,4,heart looping (GO:0001947),1/37,1,37,0.246125006124119,0.335851590635191,0,0,3.55618776671408,4.98547552325995,TGFBR2
beta,4,histone deacetylation (GO:0016575),1/37,1,37,0.246125006124119,0.335851590635191,0,0,3.55618776671408,4.98547552325995,REST
beta,4,cardiac muscle tissue development (GO:0048738),1/37,1,37,0.246125006124119,0.335851590635191,0,0,3.55618776671408,4.98547552325995,PROX1
beta,4,regulation of blood circulation (GO:1903522),1/37,1,37,0.246125006124119,0.335851590635191,0,0,3.55618776671408,4.98547552325995,CELF2
beta,4,protein dephosphorylation (GO:0006470),2/126,2,126,0.248526099791181,0.338699286441078,0,0,2.08855472013367,2.90770135676667,DUSP4;SSH2
beta,4,positive regulation of stress fiber assembly (GO:0051496),1/38,1,38,0.251865066768608,0.3393881774707,0,0,3.46260387811634,4.77445216137749,TGFBR1
beta,4,epithelial to mesenchymal transition (GO:0001837),1/38,1,38,0.251865066768608,0.3393881774707,0,0,3.46260387811634,4.77445216137749,TGFBR1
beta,4,protein monoubiquitination (GO:0006513),1/38,1,38,0.251865066768608,0.3393881774707,0,0,3.46260387811634,4.77445216137749,ATXN7L3
beta,4,spliceosomal snRNP assembly (GO:0000387),1/38,1,38,0.251865066768608,0.3393881774707,0,0,3.46260387811634,4.77445216137749,TGS1
beta,4,regulation of regulated secretory pathway (GO:1903305),1/38,1,38,0.251865066768608,0.3393881774707,0,0,3.46260387811634,4.77445216137749,SYT4
beta,4,negative regulation of Ras protein signal transduction (GO:0046580),1/38,1,38,0.251865066768608,0.3393881774707,0,0,3.46260387811634,4.77445216137749,MET
beta,4,phospholipid biosynthetic process (GO:0008654),1/38,1,38,0.251865066768608,0.3393881774707,0,0,3.46260387811634,4.77445216137749,SGMS2
beta,4,positive regulation of axonogenesis (GO:0050772),1/38,1,38,0.251865066768608,0.3393881774707,0,0,3.46260387811634,4.77445216137749,ROBO2
beta,4,organic cyclic compound biosynthetic process (GO:1901362),1/38,1,38,0.251865066768608,0.3393881774707,0,0,3.46260387811634,4.77445216137749,GPHN
beta,4,vesicle organization (GO:0016050),2/128,2,128,0.254152747375529,0.342043272997279,0,0,2.05592105263158,2.81624141671968,SYT4;SQSTM1
beta,4,T cell differentiation (GO:0030217),1/39,1,39,0.257561707444763,0.345767771638175,0,0,3.37381916329285,4.57657202100328,DLL4
beta,4,positive regulation of neuron death (GO:1901216),1/39,1,39,0.257561707444763,0.345767771638175,0,0,3.37381916329285,4.57657202100328,SNCA
beta,4,regulation of macromolecule metabolic process (GO:0060255),2/130,2,130,0.259782394498183,0.348315200583384,0,0,2.02429149797571,2.72856466121,ICK;PROX1
beta,4,protein localization to plasma membrane (GO:0072659),2/131,2,131,0.262597912694293,0.349871817926591,0,0,2.00883889112093,2.68608128918798,CACNB2;TNIK
beta,4,positive regulation of reactive oxygen species metabolic process (GO:2000379),1/40,1,40,0.263215254488373,0.349871817926591,0,0,3.28947368421053,4.39073395864438,TGFBR2
beta,4,negative regulation of protein catabolic process (GO:0042177),1/40,1,40,0.263215254488373,0.349871817926591,0,0,3.28947368421053,4.39073395864438,SNCA
beta,4,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",1/40,1,40,0.263215254488373,0.349871817926591,0,0,3.28947368421053,4.39073395864438,EFCAB5
beta,4,mitotic DNA damage checkpoint (GO:0044773),1/40,1,40,0.263215254488373,0.349871817926591,0,0,3.28947368421053,4.39073395864438,TIPIN
beta,4,cellular response to amino acid starvation (GO:0034198),1/40,1,40,0.263215254488373,0.349871817926591,0,0,3.28947368421053,4.39073395864438,SESN2
beta,4,positive regulation of peptide hormone secretion (GO:0090277),1/40,1,40,0.263215254488373,0.349871817926591,0,0,3.28947368421053,4.39073395864438,IRS2
beta,4,negative regulation of transport (GO:0051051),1/41,1,41,0.268826031718954,0.353839392177084,0,0,3.20924261874198,4.21595260214924,SNCA
beta,4,embryonic heart tube morphogenesis (GO:0003143),1/41,1,41,0.268826031718954,0.353839392177084,0,0,3.20924261874198,4.21595260214924,TGFBR2
beta,4,negative regulation of ERK1 and ERK2 cascade (GO:0070373),1/41,1,41,0.268826031718954,0.353839392177084,0,0,3.20924261874198,4.21595260214924,DUSP4
beta,4,intraciliary transport involved in cilium assembly (GO:0035735),1/41,1,41,0.268826031718954,0.353839392177084,0,0,3.20924261874198,4.21595260214924,TNPO1
beta,4,phosphatidic acid biosynthetic process (GO:0006654),1/41,1,41,0.268826031718954,0.353839392177084,0,0,3.20924261874198,4.21595260214924,ABHD5
beta,4,regulation of protein dephosphorylation (GO:0035304),1/41,1,41,0.268826031718954,0.353839392177084,0,0,3.20924261874198,4.21595260214924,PPP1R14C
beta,4,tRNA aminoacylation (GO:0043039),1/41,1,41,0.268826031718954,0.353839392177084,0,0,3.20924261874198,4.21595260214924,SARS
beta,4,determination of heart left/right asymmetry (GO:0061371),1/41,1,41,0.268826031718954,0.353839392177084,0,0,3.20924261874198,4.21595260214924,TGFBR2
beta,4,protein targeting (GO:0006605),2/134,2,134,0.271045241548587,0.355891315943211,0,0,1.96386488609584,2.56376576797359,ATG3;FBXO7
beta,4,cellular response to organic substance (GO:0071310),2/134,2,134,0.271045241548587,0.355891315943211,0,0,1.96386488609584,2.56376576797359,ROBO2;SMAD3
beta,4,mesenchymal cell differentiation (GO:0048762),1/42,1,42,0.274394360568625,0.358107894301426,0,0,3.1328320802005,4.05134378197121,TGFBR1
beta,4,spliceosomal complex assembly (GO:0000245),1/42,1,42,0.274394360568625,0.358107894301426,0,0,3.1328320802005,4.05134378197121,CELF2
beta,4,regulation of stress-activated MAPK cascade (GO:0032872),1/42,1,42,0.274394360568625,0.358107894301426,0,0,3.1328320802005,4.05134378197121,MAP2K1
beta,4,negative regulation of proteolysis (GO:0045861),1/42,1,42,0.274394360568625,0.358107894301426,0,0,3.1328320802005,4.05134378197121,CHAC1
beta,4,gluconeogenesis (GO:0006094),1/42,1,42,0.274394360568625,0.358107894301426,0,0,3.1328320802005,4.05134378197121,PCK2
beta,4,mitochondrial transport (GO:0006839),2/136,2,136,0.276675818427197,0.360648769364593,0,0,1.93498452012384,2.48627861601039,SLC25A26;FBXO7
beta,4,regulation of telomerase activity (GO:0051972),1/43,1,43,0.279920560107178,0.363559474452455,0,0,3.05997552019584,3.8961120868122,PKIB
beta,4,positive regulation of protein localization to nucleus (GO:1900182),1/43,1,43,0.279920560107178,0.363559474452455,0,0,3.05997552019584,3.8961120868122,SESN2
beta,4,ceramide metabolic process (GO:0006672),1/43,1,43,0.279920560107178,0.363559474452455,0,0,3.05997552019584,3.8961120868122,SGMS2
beta,4,regulation of vesicle-mediated transport (GO:0060627),2/139,2,139,0.285117086876684,0.367582476430751,0,0,1.89322226429383,2.37572009075206,MAP2K1;STON2
beta,4,response to cytokine (GO:0034097),2/139,2,139,0.285117086876684,0.367582476430751,0,0,1.89322226429383,2.37572009075206,SMAD3;SNCA
beta,4,regulation of B cell proliferation (GO:0030888),1/44,1,44,0.285404946913301,0.367582476430751,0,0,2.99043062200957,3.74954019385908,IRS2
beta,4,positive regulation of protein localization to plasma membrane (GO:1903078),1/44,1,44,0.285404946913301,0.367582476430751,0,0,2.99043062200957,3.74954019385908,SQSTM1
beta,4,RNA catabolic process (GO:0006401),1/44,1,44,0.285404946913301,0.367582476430751,0,0,2.99043062200957,3.74954019385908,ISG20
beta,4,nucleobase-containing compound catabolic process (GO:0034655),1/44,1,44,0.285404946913301,0.367582476430751,0,0,2.99043062200957,3.74954019385908,ISG20
beta,4,regulation of multicellular organismal development (GO:2000026),1/44,1,44,0.285404946913301,0.367582476430751,0,0,2.99043062200957,3.74954019385908,TGFBR1
beta,4,response to lipid (GO:0033993),2/141,2,141,0.290739775364526,0.37016997221652,0,0,1.86636804777902,2.3055741967484,PCK2;SNCA
beta,4,regulation of small GTPase mediated signal transduction (GO:0051056),2/141,2,141,0.290739775364526,0.37016997221652,0,0,1.86636804777902,2.3055741967484,SYDE2;SQSTM1
beta,4,regulation of cellular component organization (GO:0051128),2/141,2,141,0.290739775364526,0.37016997221652,0,0,1.86636804777902,2.3055741967484,STON2;SGK1
beta,4,inorganic cation transmembrane transport (GO:0098662),2/141,2,141,0.290739775364526,0.37016997221652,0,0,1.86636804777902,2.3055741967484,MCOLN3;SLC39A14
beta,4,sprouting angiogenesis (GO:0002040),1/45,1,45,0.29084783531298,0.37016997221652,0,0,2.92397660818713,3.61097968209496,E2F7
beta,4,amide biosynthetic process (GO:0043604),1/45,1,45,0.29084783531298,0.37016997221652,0,0,2.92397660818713,3.61097968209496,SGMS2
beta,4,hexose biosynthetic process (GO:0019319),1/45,1,45,0.29084783531298,0.37016997221652,0,0,2.92397660818713,3.61097968209496,PCK2
beta,4,positive regulation of macroautophagy (GO:0016239),1/45,1,45,0.29084783531298,0.37016997221652,0,0,2.92397660818713,3.61097968209496,SESN2
beta,4,positive regulation of actin filament bundle assembly (GO:0032233),1/45,1,45,0.29084783531298,0.37016997221652,0,0,2.92397660818713,3.61097968209496,TGFBR1
beta,4,positive regulation of intracellular transport (GO:0032388),1/45,1,45,0.29084783531298,0.37016997221652,0,0,2.92397660818713,3.61097968209496,GAB2
beta,4,protein polymerization (GO:0051258),1/46,1,46,0.296249537268353,0.375272621827596,0,0,2.8604118993135,3.47984310210922,CKAP5
beta,4,protein complex subunit organization (GO:0071822),1/46,1,46,0.296249537268353,0.375272621827596,0,0,2.8604118993135,3.47984310210922,TGFBR1
beta,4,peptidyl-tyrosine autophosphorylation (GO:0038083),1/46,1,46,0.296249537268353,0.375272621827596,0,0,2.8604118993135,3.47984310210922,FRK
beta,4,negative regulation of ossification (GO:0030279),1/46,1,46,0.296249537268353,0.375272621827596,0,0,2.8604118993135,3.47984310210922,TMEM64
beta,4,protein complex disassembly (GO:0043241),1/47,1,47,0.301610362316692,0.377635620852199,0,0,2.79955207166853,3.35559710421216,GABARAPL1
beta,4,regulation of G1/S transition of mitotic cell cycle (GO:2000045),1/47,1,47,0.301610362316692,0.377635620852199,0,0,2.79955207166853,3.35559710421216,E2F7
beta,4,positive regulation of protein localization to cell periphery (GO:1904377),1/47,1,47,0.301610362316692,0.377635620852199,0,0,2.79955207166853,3.35559710421216,SQSTM1
beta,4,cartilage development (GO:0051216),1/47,1,47,0.301610362316692,0.377635620852199,0,0,2.79955207166853,3.35559710421216,RUNX1
beta,4,icosanoid metabolic process (GO:0006690),1/47,1,47,0.301610362316692,0.377635620852199,0,0,2.79955207166853,3.35559710421216,PTGS2
beta,4,tRNA aminoacylation for protein translation (GO:0006418),1/47,1,47,0.301610362316692,0.377635620852199,0,0,2.79955207166853,3.35559710421216,SARS
beta,4,pyruvate metabolic process (GO:0006090),1/47,1,47,0.301610362316692,0.377635620852199,0,0,2.79955207166853,3.35559710421216,PCK2
beta,4,aminoglycan biosynthetic process (GO:0006023),1/47,1,47,0.301610362316692,0.377635620852199,0,0,2.79955207166853,3.35559710421216,SDC2
beta,4,positive regulation of ion transport (GO:0043270),1/47,1,47,0.301610362316692,0.377635620852199,0,0,2.79955207166853,3.35559710421216,CACNB2
beta,4,cellular protein complex assembly (GO:0043623),2/145,2,145,0.30196837214712,0.377635620852199,0,0,1.81488203266788,2.17319962809672,SMAD3;RTN4
beta,4,neuron development (GO:0048666),2/145,2,145,0.30196837214712,0.377635620852199,0,0,1.81488203266788,2.17319962809672,FRY;RUNX1
beta,4,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),1/48,1,48,0.306930617839149,0.381627688616612,0,0,2.74122807017544,3.23775646233786,TLE1
beta,4,positive regulation of organelle assembly (GO:1902117),1/48,1,48,0.306930617839149,0.381627688616612,0,0,2.74122807017544,3.23775646233786,PROX1
beta,4,negative regulation of cellular biosynthetic process (GO:0031327),1/48,1,48,0.306930617839149,0.381627688616612,0,0,2.74122807017544,3.23775646233786,PROX1
beta,4,regulation of organelle assembly (GO:1902115),1/48,1,48,0.306930617839149,0.381627688616612,0,0,2.74122807017544,3.23775646233786,ATG3
beta,4,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),1/48,1,48,0.306930617839149,0.381627688616612,0,0,2.74122807017544,3.23775646233786,TGFBR1
beta,4,negative regulation of mitotic cell cycle (GO:0045930),1/49,1,49,0.312210608763107,0.385966784686501,0,0,2.68528464017186,3.12587886899773,SMAD3
beta,4,positive regulation of chemotaxis (GO:0050921),1/49,1,49,0.312210608763107,0.385966784686501,0,0,2.68528464017186,3.12587886899773,MET
beta,4,regulation of epithelial cell migration (GO:0010632),1/49,1,49,0.312210608763107,0.385966784686501,0,0,2.68528464017186,3.12587886899773,RTN4
beta,4,cellular macromolecule catabolic process (GO:0044265),1/49,1,49,0.312210608763107,0.385966784686501,0,0,2.68528464017186,3.12587886899773,ISG20
beta,4,regulation of mitochondrion organization (GO:0010821),1/49,1,49,0.312210608763107,0.385966784686501,0,0,2.68528464017186,3.12587886899773,SQSTM1
beta,4,heart development (GO:0007507),2/150,2,150,0.315961365803397,0.389762856076778,0,0,1.75438596491228,2.02129005786918,TGFBR1;TGFBR2
beta,4,regulation of megakaryocyte differentiation (GO:0045652),1/50,1,50,0.317450637880715,0.389762856076778,0,0,2.63157894736842,3.01956037888984,RUNX1
beta,4,RNA methylation (GO:0001510),1/50,1,50,0.317450637880715,0.389762856076778,0,0,2.63157894736842,3.01956037888984,TGS1
beta,4,establishment of protein localization to mitochondrion (GO:0072655),1/50,1,50,0.317450637880715,0.389762856076778,0,0,2.63157894736842,3.01956037888984,FBXO7
beta,4,glutathione metabolic process (GO:0006749),1/50,1,50,0.317450637880715,0.389762856076778,0,0,2.63157894736842,3.01956037888984,CHAC1
beta,4,regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/50,1,50,0.317450637880715,0.389762856076778,0,0,2.63157894736842,3.01956037888984,SNCA
beta,4,regulation of ion transport (GO:0043269),1/51,1,51,0.32265100559266,0.393014445230382,0,0,2.57997936016512,2.91843141882864,SNCA
beta,4,heart morphogenesis (GO:0003007),1/51,1,51,0.32265100559266,0.393014445230382,0,0,2.57997936016512,2.91843141882864,TGFBR1
beta,4,neurogenesis (GO:0022008),1/51,1,51,0.32265100559266,0.393014445230382,0,0,2.57997936016512,2.91843141882864,CHAC1
beta,4,receptor internalization (GO:0031623),1/51,1,51,0.32265100559266,0.393014445230382,0,0,2.57997936016512,2.91843141882864,SNCA
beta,4,positive regulation of JUN kinase activity (GO:0043507),1/51,1,51,0.32265100559266,0.393014445230382,0,0,2.57997936016512,2.91843141882864,TNIK
beta,4,blood circulation (GO:0008015),1/51,1,51,0.32265100559266,0.393014445230382,0,0,2.57997936016512,2.91843141882864,DLL4
beta,4,regulation of blood vessel endothelial cell migration (GO:0043535),1/51,1,51,0.32265100559266,0.393014445230382,0,0,2.57997936016512,2.91843141882864,ETS1
beta,4,negative regulation of neuron projection development (GO:0010977),1/52,1,52,0.327812010142519,0.39705769318386,0,0,2.53036437246964,2.82215327610018,RTN4
beta,4,regulation of telomere maintenance via telomerase (GO:0032210),1/52,1,52,0.327812010142519,0.39705769318386,0,0,2.53036437246964,2.82215327610018,PKIB
beta,4,regulation of exocytosis (GO:0017157),1/52,1,52,0.327812010142519,0.39705769318386,0,0,2.53036437246964,2.82215327610018,SNCA
beta,4,arachidonic acid metabolic process (GO:0019369),1/52,1,52,0.327812010142519,0.39705769318386,0,0,2.53036437246964,2.82215327610018,PTGS2
beta,4,positive regulation of developmental growth (GO:0048639),1/52,1,52,0.327812010142519,0.39705769318386,0,0,2.53036437246964,2.82215327610018,SYT4
beta,4,regulation of calcium ion transport (GO:0051924),1/53,1,53,0.332933947543977,0.402808973571725,0,0,2.48262164846077,2.73041500595975,CACNB2
beta,4,embryonic organ development (GO:0048568),1/54,1,54,0.33801711155694,0.408500500289665,0,0,2.43664717348928,2.64293069900697,TGFBR2
beta,4,protein targeting to mitochondrion (GO:0006626),1/55,1,55,0.343061793818967,0.412286079974187,0,0,2.39234449760766,2.55943706013372,FBXO7
beta,4,membrane fusion (GO:0061025),1/55,1,55,0.343061793818967,0.412286079974187,0,0,2.39234449760766,2.55943706013372,RABIF
beta,4,negative regulation of supramolecular fiber organization (GO:1902904),1/55,1,55,0.343061793818967,0.412286079974187,0,0,2.39234449760766,2.55943706013372,SNCA
beta,4,glycosphingolipid metabolic process (GO:0006687),1/55,1,55,0.343061793818967,0.412286079974187,0,0,2.39234449760766,2.55943706013372,HEXB
beta,4,positive regulation of response to stimulus (GO:0048584),1/55,1,55,0.343061793818967,0.412286079974187,0,0,2.39234449760766,2.55943706013372,MAP2K1
beta,4,regulation of cellular catabolic process (GO:0031329),1/56,1,56,0.348068283666735,0.416908455325267,0,0,2.34962406015038,2.47969126180131,DAPK1
beta,4,fat cell differentiation (GO:0045444),1/56,1,56,0.348068283666735,0.416908455325267,0,0,2.34962406015038,2.47969126180131,OSBPL8
beta,4,positive regulation of DNA biosynthetic process (GO:2000573),1/56,1,56,0.348068283666735,0.416908455325267,0,0,2.34962406015038,2.47969126180131,PKIB
beta,4,DNA-dependent DNA replication (GO:0006261),1/57,1,57,0.353036868369247,0.421922110977881,0,0,2.3084025854109,2.40346903169496,HELB
beta,4,negative regulation of cellular catabolic process (GO:0031330),1/57,1,57,0.353036868369247,0.421922110977881,0,0,2.3084025854109,2.40346903169496,MET
beta,4,positive regulation of cell death (GO:0010942),1/58,1,58,0.357967832989926,0.426397043053193,0,0,2.26860254083485,2.33056295054859,SNCA
beta,4,regulation of Rho protein signal transduction (GO:0035023),1/58,1,58,0.357967832989926,0.426397043053193,0,0,2.26860254083485,2.33056295054859,MET
beta,4,epidermal growth factor receptor signaling pathway (GO:0007173),1/58,1,58,0.357967832989926,0.426397043053193,0,0,2.26860254083485,2.33056295054859,RPS6KA5
beta,4,phospholipid transport (GO:0015914),1/59,1,59,0.362861460595225,0.429851268705112,0,0,2.23015165031222,2.2607809295662,OSBPL8
beta,4,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1/59,1,59,0.362861460595225,0.429851268705112,0,0,2.23015165031222,2.2607809295662,ROBO2
beta,4,receptor metabolic process (GO:0043112),1/59,1,59,0.362861460595225,0.429851268705112,0,0,2.23015165031222,2.2607809295662,SNCA
beta,4,sodium ion transport (GO:0006814),1/59,1,59,0.362861460595225,0.429851268705112,0,0,2.23015165031222,2.2607809295662,SGK1
beta,4,post-Golgi vesicle-mediated transport (GO:0006892),1/59,1,59,0.362861460595225,0.429851268705112,0,0,2.23015165031222,2.2607809295662,RABIF
beta,4,cell morphogenesis (GO:0000902),1/60,1,60,0.367718031958389,0.434173097974966,0,0,2.19298245614035,2.19394485090405,FRY
beta,4,dicarboxylic acid metabolic process (GO:0043648),1/60,1,60,0.367718031958389,0.434173097974966,0,0,2.19298245614035,2.19394485090405,MTHFD2
beta,4,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),1/60,1,60,0.367718031958389,0.434173097974966,0,0,2.19298245614035,2.19394485090405,TGFBR1
beta,4,"regulation of mRNA splicing, via spliceosome (GO:0048024)",1/61,1,61,0.372537825857752,0.438423336544385,0,0,2.15703192407248,2.12988934510593,EFCAB5
beta,4,response to reactive oxygen species (GO:0000302),1/61,1,61,0.372537825857752,0.438423336544385,0,0,2.15703192407248,2.12988934510593,TXNRD1
beta,4,membrane lipid biosynthetic process (GO:0046467),1/61,1,61,0.372537825857752,0.438423336544385,0,0,2.15703192407248,2.12988934510593,SGMS2
beta,4,regulation of vesicle fusion (GO:0031338),1/62,1,62,0.37732111898679,0.442603010084613,0,0,2.12224108658744,2.06846069521943,C2CD5
beta,4,glycosaminoglycan metabolic process (GO:0030203),1/62,1,62,0.37732111898679,0.442603010084613,0,0,2.12224108658744,2.06846069521943,SDC2
beta,4,protein targeting to membrane (GO:0006612),1/62,1,62,0.37732111898679,0.442603010084613,0,0,2.12224108658744,2.06846069521943,ATG3
beta,4,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",1/63,1,63,0.38206818593741,0.446229148906314,0,0,2.08855472013367,2.00951585022127,E2F7
beta,4,tRNA processing (GO:0008033),1/63,1,63,0.38206818593741,0.446229148906314,0,0,2.08855472013367,2.00951585022127,SARS
beta,4,diterpenoid metabolic process (GO:0016101),1/63,1,63,0.38206818593741,0.446229148906314,0,0,2.08855472013367,2.00951585022127,SDC2
beta,4,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),1/63,1,63,0.38206818593741,0.446229148906314,0,0,2.08855472013367,2.00951585022127,TMBIM6
beta,4,signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),1/64,1,64,0.386779299275949,0.45124251582194,0,0,2.05592105263158,1.95292153523024,E2F7
beta,4,positive regulation of protein polymerization (GO:0032273),1/65,1,65,0.391454729509466,0.45375075097979,0,0,2.02429149797571,1.89855344873322,MET
beta,4,glycerophospholipid metabolic process (GO:0006650),1/65,1,65,0.391454729509466,0.45375075097979,0,0,2.02429149797571,1.89855344873322,DGKH
beta,4,positive regulation of endocytosis (GO:0045807),1/65,1,65,0.391454729509466,0.45375075097979,0,0,2.02429149797571,1.89855344873322,SNCA
beta,4,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/65,1,65,0.391454729509466,0.45375075097979,0,0,2.02429149797571,1.89855344873322,ROBO2
beta,4,cellular response to decreased oxygen levels (GO:0036294),1/65,1,65,0.391454729509466,0.45375075097979,0,0,2.02429149797571,1.89855344873322,PTGS2
beta,4,negative regulation of neuron differentiation (GO:0045665),1/65,1,65,0.391454729509466,0.45375075097979,0,0,2.02429149797571,1.89855344873322,REST
beta,4,O-glycan processing (GO:0016266),1/66,1,66,0.39609474514011,0.455213363817738,0,0,1.99362041467305,1.84629553616497,C1GALT1
beta,4,glycolipid metabolic process (GO:0006664),1/66,1,66,0.39609474514011,0.455213363817738,0,0,1.99362041467305,1.84629553616497,HEXB
beta,4,cellular response to type I interferon (GO:0071357),1/66,1,66,0.39609474514011,0.455213363817738,0,0,1.99362041467305,1.84629553616497,ISG20
beta,4,regulation of myeloid cell differentiation (GO:0045637),1/66,1,66,0.39609474514011,0.455213363817738,0,0,1.99362041467305,1.84629553616497,RUNX1
beta,4,regulation of cell division (GO:0051302),1/66,1,66,0.39609474514011,0.455213363817738,0,0,1.99362041467305,1.84629553616497,KLHL21
beta,4,type I interferon signaling pathway (GO:0060337),1/66,1,66,0.39609474514011,0.455213363817738,0,0,1.99362041467305,1.84629553616497,ISG20
beta,4,negative regulation of cell adhesion (GO:0007162),1/66,1,66,0.39609474514011,0.455213363817738,0,0,1.99362041467305,1.84629553616497,CD164
beta,4,negative regulation of blood vessel morphogenesis (GO:2000181),1/66,1,66,0.39609474514011,0.455213363817738,0,0,1.99362041467305,1.84629553616497,SARS
beta,4,sphingolipid biosynthetic process (GO:0030148),1/67,1,67,0.400699612599279,0.459037388291203,0,0,1.96386488609584,1.79603933258129,SGMS2
beta,4,negative regulation of epithelial cell proliferation (GO:0050680),1/67,1,67,0.400699612599279,0.459037388291203,0,0,1.96386488609584,1.79603933258129,KLF9
beta,4,JNK cascade (GO:0007254),1/67,1,67,0.400699612599279,0.459037388291203,0,0,1.96386488609584,1.79603933258129,TNIK
beta,4,extrinsic apoptotic signaling pathway (GO:0097191),1/68,1,68,0.405269596460818,0.461818842478607,0,0,1.93498452012384,1.74768336505835,SMAD3
beta,4,positive regulation of synaptic transmission (GO:0050806),1/68,1,68,0.405269596460818,0.461818842478607,0,0,1.93498452012384,1.74768336505835,SQSTM1
beta,4,negative regulation of protein binding (GO:0032091),1/68,1,68,0.405269596460818,0.461818842478607,0,0,1.93498452012384,1.74768336505835,TMBIM6
beta,4,regulation of TOR signaling (GO:0032006),1/68,1,68,0.405269596460818,0.461818842478607,0,0,1.93498452012384,1.74768336505835,ARNTL
beta,4,regulation of protein localization to plasma membrane (GO:1903076),1/68,1,68,0.405269596460818,0.461818842478607,0,0,1.93498452012384,1.74768336505835,SQSTM1
beta,4,monocarboxylic acid biosynthetic process (GO:0072330),1/69,1,69,0.409804959216901,0.466493924008257,0,0,1.906941266209,1.70113261193056,OSBPL6
beta,4,negative regulation of angiogenesis (GO:0016525),1/70,1,70,0.414305961420649,0.470623631624299,0,0,1.8796992481203,1.65629800913991,SARS
beta,4,regulation of osteoblast differentiation (GO:0045667),1/70,1,70,0.414305961420649,0.470623631624299,0,0,1.8796992481203,1.65629800913991,TMEM64
beta,4,snRNA transcription (GO:0009301),1/71,1,71,0.418772861715653,0.473204554433411,0,0,1.85322461082283,1.61309600109574,NABP1
beta,4,interferon-gamma-mediated signaling pathway (GO:0060333),1/71,1,71,0.418772861715653,0.473204554433411,0,0,1.85322461082283,1.61309600109574,NCAM1
beta,4,snRNA transcription from RNA polymerase II promoter (GO:0042795),1/71,1,71,0.418772861715653,0.473204554433411,0,0,1.85322461082283,1.61309600109574,NABP1
beta,4,negative regulation of developmental process (GO:0051093),1/71,1,71,0.418772861715653,0.473204554433411,0,0,1.85322461082283,1.61309600109574,OMA1
beta,4,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/71,1,71,0.418772861715653,0.473204554433411,0,0,1.85322461082283,1.61309600109574,RNF19A
beta,4,recombinational repair (GO:0000725),1/72,1,72,0.423205916707709,0.47621709625356,0,0,1.82748538011696,1.57144813168394,NABP1
beta,4,organelle membrane fusion (GO:0090174),1/72,1,72,0.423205916707709,0.47621709625356,0,0,1.82748538011696,1.57144813168394,SYT4
beta,4,positive regulation of lymphocyte proliferation (GO:0050671),1/72,1,72,0.423205916707709,0.47621709625356,0,0,1.82748538011696,1.57144813168394,IRS2
beta,4,positive regulation of growth (GO:0045927),1/72,1,72,0.423205916707709,0.47621709625356,0,0,1.82748538011696,1.57144813168394,TGFBR1
beta,4,cell-cell junction organization (GO:0045216),1/73,1,73,0.427605381191352,0.479166944827731,0,0,1.80245133381399,1.53128066919989,SMAD3
beta,4,Rho protein signal transduction (GO:0007266),1/73,1,73,0.427605381191352,0.479166944827731,0,0,1.80245133381399,1.53128066919989,CTNNAL1
beta,4,regulation of epithelial cell proliferation (GO:0050678),1/73,1,73,0.427605381191352,0.479166944827731,0,0,1.80245133381399,1.53128066919989,LAMC1
beta,4,negative regulation of cell cycle (GO:0045786),1/73,1,73,0.427605381191352,0.479166944827731,0,0,1.80245133381399,1.53128066919989,SMAD3
beta,4,nucleic acid phosphodiester bond hydrolysis (GO:0090305),1/74,1,74,0.431971508002701,0.481556655250167,0,0,1.77809388335704,1.49252426495469,ISG20
beta,4,lymphocyte differentiation (GO:0030098),1/74,1,74,0.431971508002701,0.481556655250167,0,0,1.77809388335704,1.49252426495469,DLL4
beta,4,canonical Wnt signaling pathway (GO:0060070),1/74,1,74,0.431971508002701,0.481556655250167,0,0,1.77809388335704,1.49252426495469,TMEM64
beta,4,regulation of peptide hormone secretion (GO:0090276),1/74,1,74,0.431971508002701,0.481556655250167,0,0,1.77809388335704,1.49252426495469,ARNTL
beta,4,positive regulation of proteasomal protein catabolic process (GO:1901800),1/74,1,74,0.431971508002701,0.481556655250167,0,0,1.77809388335704,1.49252426495469,RNF19A
beta,4,retinoid metabolic process (GO:0001523),1/76,1,76,0.440604750692651,0.489661774481111,0,0,1.73130193905817,1.41898729630617,SDC2
beta,4,negative regulation of phosphorylation (GO:0042326),1/76,1,76,0.440604750692651,0.489661774481111,0,0,1.73130193905817,1.41898729630617,IRS2
beta,4,regulation of defense response (GO:0031347),1/76,1,76,0.440604750692651,0.489661774481111,0,0,1.73130193905817,1.41898729630617,PTGS2
beta,4,double-strand break repair via homologous recombination (GO:0000724),1/77,1,77,0.444872362801601,0.492374134599719,0,0,1.70881749829118,1.38408725755817,NABP1
beta,4,regulation of hematopoietic stem cell differentiation (GO:1902036),1/77,1,77,0.444872362801601,0.492374134599719,0,0,1.70881749829118,1.38408725755817,RUNX1
beta,4,positive regulation of apoptotic signaling pathway (GO:2001235),1/77,1,77,0.444872362801601,0.492374134599719,0,0,1.70881749829118,1.38408725755817,TGFBR1
beta,4,response to interleukin-1 (GO:0070555),1/77,1,77,0.444872362801601,0.492374134599719,0,0,1.70881749829118,1.38408725755817,SNCA
beta,4,response to ionizing radiation (GO:0010212),1/78,1,78,0.449107629937935,0.495535337843494,0,0,1.68690958164642,1.35035882192365,NABP1
beta,4,positive regulation of cytoskeleton organization (GO:0051495),1/78,1,78,0.449107629937935,0.495535337843494,0,0,1.68690958164642,1.35035882192365,PROX1
beta,4,regulation of hematopoietic progenitor cell differentiation (GO:1901532),1/78,1,78,0.449107629937935,0.495535337843494,0,0,1.68690958164642,1.35035882192365,RUNX1
beta,4,negative regulation of cell communication (GO:0010648),1/79,1,79,0.453310795595773,0.49915121312793,0,0,1.6655562958028,1.31775034269415,MET
beta,4,extracellular matrix disassembly (GO:0022617),1/79,1,79,0.453310795595773,0.49915121312793,0,0,1.6655562958028,1.31775034269415,LAMC1
beta,4,steroid biosynthetic process (GO:0006694),1/80,1,80,0.457482101445071,0.501694512062855,0,0,1.64473684210526,1.28621302229655,OSBPL6
beta,4,negative regulation of mitotic cell cycle phase transition (GO:1901991),1/80,1,80,0.457482101445071,0.501694512062855,0,0,1.64473684210526,1.28621302229655,E2F7
beta,4,cation transport (GO:0006812),1/80,1,80,0.457482101445071,0.501694512062855,0,0,1.64473684210526,1.28621302229655,PQLC2
beta,4,peptidyl-tyrosine phosphorylation (GO:0018108),1/80,1,80,0.457482101445071,0.501694512062855,0,0,1.64473684210526,1.28621302229655,FRK
beta,4,regulation of hydrolase activity (GO:0051336),1/81,1,81,0.461621787432711,0.505206382591332,0,0,1.62443144899285,1.25570072302018,SYDE2
beta,4,ERBB signaling pathway (GO:0038127),1/81,1,81,0.461621787432711,0.505206382591332,0,0,1.62443144899285,1.25570072302018,RPS6KA5
beta,4,positive regulation of binding (GO:0051099),1/82,1,82,0.465730091734971,0.508669745582876,0,0,1.60462130937099,1.22616979291464,MET
beta,4,negative regulation of cell cycle process (GO:0010948),1/82,1,82,0.465730091734971,0.508669745582876,0,0,1.60462130937099,1.22616979291464,E2F7
beta,4,positive regulation of protein secretion (GO:0050714),1/83,1,83,0.469807250565861,0.511051681241169,0,0,1.5852885225111,1.19757890547429,IRS2
beta,4,regulation of anatomical structure morphogenesis (GO:0022603),1/83,1,83,0.469807250565861,0.511051681241169,0,0,1.5852885225111,1.19757890547429,ETS1
beta,4,negative regulation of binding (GO:0051100),1/83,1,83,0.469807250565861,0.511051681241169,0,0,1.5852885225111,1.19757890547429,TMBIM6
beta,4,positive regulation of cell cycle arrest (GO:0071158),1/83,1,83,0.469807250565861,0.511051681241169,0,0,1.5852885225111,1.19757890547429,E2F7
beta,4,negative regulation of signaling (GO:0023057),1/84,1,84,0.473853498546086,0.513380976314252,0,0,1.56641604010025,1.1698889095517,MET
beta,4,establishment of protein localization to membrane (GO:0090150),1/84,1,84,0.473853498546086,0.513380976314252,0,0,1.56641604010025,1.1698889095517,ATG3
beta,4,positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/84,1,84,0.473853498546086,0.513380976314252,0,0,1.56641604010025,1.1698889095517,SNCA
beta,4,positive regulation of homeostatic process (GO:0032846),1/84,1,84,0.473853498546086,0.513380976314252,0,0,1.56641604010025,1.1698889095517,ETS1
beta,4,activation of GTPase activity (GO:0090630),1/85,1,85,0.47786906853807,0.516175206296633,0,0,1.54798761609907,1.14306269226721,SYDE2
beta,4,regulation of mitotic nuclear division (GO:0007088),1/85,1,85,0.47786906853807,0.516175206296633,0,0,1.54798761609907,1.14306269226721,CDK13
beta,4,regulation of cell cycle G2/M phase transition (GO:1902749),1/85,1,85,0.47786906853807,0.516175206296633,0,0,1.54798761609907,1.14306269226721,CKAP5
beta,4,mitochondrial ATP synthesis coupled electron transport (GO:0042775),1/86,1,86,0.481854191516413,0.519958777231925,0,0,1.52998776009792,1.11706505190244,COX5A
beta,4,regulation of peptidyl-serine phosphorylation (GO:0033135),1/87,1,87,0.485809096873967,0.523179027402733,0,0,1.5124016938899,1.09186257869892,SNCA
beta,4,calcium ion transmembrane transport (GO:0070588),1/87,1,87,0.485809096873967,0.523179027402733,0,0,1.5124016938899,1.09186257869892,MCOLN3
beta,4,positive regulation of cellular component biogenesis (GO:0044089),1/88,1,88,0.489734012231164,0.525829945403581,0,0,1.49521531100478,1.06742354582161,SMAD3
beta,4,organic substance transport (GO:0071702),1/88,1,88,0.489734012231164,0.525829945403581,0,0,1.49521531100478,1.06742354582161,SLC25A26
beta,4,regulation of MAP kinase activity (GO:0043405),1/88,1,88,0.489734012231164,0.525829945403581,0,0,1.49521531100478,1.06742354582161,UCHL1
beta,4,T cell activation (GO:0042110),1/89,1,89,0.493629163462028,0.527908966480225,0,0,1.47841513897102,1.04371780743262,DLL4
beta,4,regulation of stem cell differentiation (GO:2000736),1/89,1,89,0.493629163462028,0.527908966480225,0,0,1.47841513897102,1.04371780743262,RUNX1
beta,4,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),1/89,1,89,0.493629163462028,0.527908966480225,0,0,1.47841513897102,1.04371780743262,RNF19A
beta,4,negative regulation of translation (GO:0017148),1/89,1,89,0.493629163462028,0.527908966480225,0,0,1.47841513897102,1.04371780743262,DAPK1
beta,4,negative regulation of cellular protein metabolic process (GO:0032269),1/90,1,90,0.497494774819848,0.531515725724278,0,0,1.46198830409357,1.02071670367445,DAPK1
beta,4,regulation of Ras protein signal transduction (GO:0046578),1/91,1,91,0.50133106888029,0.534554789567708,0,0,1.44592249855408,0.9983929728337,SQSTM1
beta,4,regulation of cytokine-mediated signaling pathway (GO:0001959),1/91,1,91,0.50133106888029,0.534554789567708,0,0,1.44592249855408,0.9983929728337,RUNX1
beta,4,lipid transport (GO:0006869),1/92,1,92,0.505138266518599,0.537020760657839,0,0,1.43020594965675,0.976720669472938,OSBPL8
beta,4,cellular response to acid chemical (GO:0071229),1/92,1,92,0.505138266518599,0.537020760657839,0,0,1.43020594965675,0.976720669472938,SESN2
beta,4,negative regulation of kinase activity (GO:0033673),1/92,1,92,0.505138266518599,0.537020760657839,0,0,1.43020594965675,0.976720669472938,IRS2
beta,4,cellular transition metal ion homeostasis (GO:0046916),1/94,1,94,0.512666247761391,0.543416140694965,0,0,1.39977603583427,0.935232691342963,SLC39A14
beta,4,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/94,1,94,0.512666247761391,0.543416140694965,0,0,1.39977603583427,0.935232691342963,ATF3
beta,4,proteolysis involved in cellular protein catabolic process (GO:0051603),1/94,1,94,0.512666247761391,0.543416140694965,0,0,1.39977603583427,0.935232691342963,OMA1
beta,4,axon development (GO:0061564),1/95,1,95,0.516387464954477,0.544682668513627,0,0,1.38504155124654,0.915371044613802,RTN4
beta,4,cellular response to fibroblast growth factor stimulus (GO:0044344),1/95,1,95,0.516387464954477,0.544682668513627,0,0,1.38504155124654,0.915371044613802,DLL4
beta,4,vesicle fusion (GO:0006906),1/95,1,95,0.516387464954477,0.544682668513627,0,0,1.38504155124654,0.915371044613802,SYT4
beta,4,skin development (GO:0043588),1/95,1,95,0.516387464954477,0.544682668513627,0,0,1.38504155124654,0.915371044613802,MET
beta,4,respiratory electron transport chain (GO:0022904),1/95,1,95,0.516387464954477,0.544682668513627,0,0,1.38504155124654,0.915371044613802,COX5A
beta,4,transcription elongation from RNA polymerase II promoter (GO:0006368),1/96,1,96,0.520080452788294,0.547506570415802,0,0,1.37061403508772,0.896068753390247,CDK13
beta,4,regulation of heart contraction (GO:0008016),1/96,1,96,0.520080452788294,0.547506570415802,0,0,1.37061403508772,0.896068753390247,CELF2
beta,4,ciliary basal body-plasma membrane docking (GO:0097711),1/97,1,97,0.523745424116781,0.550826894827209,0,0,1.35648399348888,0.877305404983485,CKAP5
beta,4,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),1/98,1,98,0.527382589993278,0.55303349417583,0,0,1.34264232008593,0.85906151533018,DCTN4
beta,4,cellular response to organonitrogen compound (GO:0071417),1/98,1,98,0.527382589993278,0.55303349417583,0,0,1.34264232008593,0.85906151533018,SESN2
beta,4,antigen processing and presentation of exogenous peptide antigen (GO:0002478),1/98,1,98,0.527382589993278,0.55303349417583,0,0,1.34264232008593,0.85906151533018,DCTN4
beta,4,response to molecule of bacterial origin (GO:0002237),1/99,1,99,0.530992160063618,0.55573742577532,0,0,1.3290802764487,0.841318477305277,SNCA
beta,4,positive regulation of neuron differentiation (GO:0045666),1/99,1,99,0.530992160063618,0.55573742577532,0,0,1.3290802764487,0.841318477305277,PROX1
beta,4,glycosaminoglycan biosynthetic process (GO:0006024),1/100,1,100,0.534574342306715,0.55894388070479,0,0,1.31578947368421,0.824058513970773,SDC2
beta,4,cellular response to metal ion (GO:0071248),1/101,1,101,0.538129343062498,0.562115728509082,0,0,1.30276185513288,0.807264634055507,SNCA
beta,4,protein processing (GO:0016485),1/102,1,102,0.541657367402278,0.563616449864533,0,0,1.28998968008256,0.790920589404664,OMA1
beta,4,cellular divalent inorganic cation homeostasis (GO:0072503),1/102,1,102,0.541657367402278,0.563616449864533,0,0,1.28998968008256,0.790920589404664,SLC39A14
beta,4,regulation of protein ubiquitination (GO:0031396),1/102,1,102,0.541657367402278,0.563616449864533,0,0,1.28998968008256,0.790920589404664,TGFBR1
beta,4,metal ion transport (GO:0030001),1/102,1,102,0.541657367402278,0.563616449864533,0,0,1.28998968008256,0.790920589404664,SGK1
beta,4,regulation of cellular response to stress (GO:0080135),1/105,1,105,0.552081607222697,0.573356428310277,0,0,1.2531328320802,0.744435343935617,ARNTL
beta,4,monovalent inorganic cation transport (GO:0015672),1/105,1,105,0.552081607222697,0.573356428310277,0,0,1.2531328320802,0.744435343935617,SGK1
beta,4,fatty acid metabolic process (GO:0006631),1/107,1,107,0.55889990572171,0.579878824223295,0,0,1.22970978848992,0.715426563443107,PTGS2
beta,4,regulation of response to external stimulus (GO:0032101),1/108,1,108,0.56227028865236,0.582254919469015,0,0,1.21832358674464,0.70147734410426,PTGS2
beta,4,positive regulation of cell cycle process (GO:0090068),1/108,1,108,0.56227028865236,0.582254919469015,0,0,1.21832358674464,0.70147734410426,E2F7
beta,4,"DNA-templated transcription, elongation (GO:0006354)",1/109,1,109,0.565615086952811,0.584035501662002,0,0,1.2071463061323,0.687882050351051,CDK13
beta,4,monocarboxylic acid metabolic process (GO:0032787),1/109,1,109,0.565615086952811,0.584035501662002,0,0,1.2071463061323,0.687882050351051,PCK2
beta,4,regulation of cytokine production (GO:0001817),1/109,1,109,0.565615086952811,0.584035501662002,0,0,1.2071463061323,0.687882050351051,RPS6KA5
beta,4,regulation of protein binding (GO:0043393),1/112,1,112,0.575497896633776,0.593671514422211,0,0,1.17481203007519,0.649106797082899,TMBIM6
beta,4,regulation of organelle organization (GO:0033043),1/114,1,114,0.581962012429684,0.598621230342748,0,0,1.15420129270545,0.62482698998188,SQSTM1
beta,4,positive regulation of developmental process (GO:0051094),1/114,1,114,0.581962012429684,0.598621230342748,0,0,1.15420129270545,0.62482698998188,RTN4
beta,4,positive regulation of canonical Wnt signaling pathway (GO:0090263),1/114,1,114,0.581962012429684,0.598621230342748,0,0,1.15420129270545,0.62482698998188,ARNTL
beta,4,protein O-linked glycosylation (GO:0006493),1/116,1,116,0.588328333096063,0.604017088645291,0,0,1.13430127041742,0.601712905292454,C1GALT1
beta,4,epithelium development (GO:0060429),1/116,1,116,0.588328333096063,0.604017088645291,0,0,1.13430127041742,0.601712905292454,PROX1
beta,4,activation of MAPK activity (GO:0000187),1/118,1,118,0.594598328609258,0.60987345217962,0,0,1.11507582515611,0.579693554161323,MAP2K1
beta,4,plasma membrane bounded cell projection organization (GO:0120036),1/119,1,119,0.597697657657042,0.612469652998376,0,0,1.10570544007077,0.569073686518236,FRY
beta,4,positive regulation of B cell activation (GO:0050871),1/120,1,120,0.600773446747426,0.615036823925665,0,0,1.09649122807018,0.558703263159217,IRS2
beta,4,enzyme linked receptor protein signaling pathway (GO:0007167),1/121,1,121,0.603825873404302,0.616989849791316,0,0,1.08742931709439,0.548574827834197,FRK
beta,4,macromolecular complex assembly (GO:0065003),1/121,1,121,0.603825873404302,0.616989849791316,0,0,1.08742931709439,0.548574827834197,LAMC1
beta,4,stimulatory C-type lectin receptor signaling pathway (GO:0002223),1/122,1,122,0.606855113992646,0.619497928867493,0,0,1.07851596203624,0.538681199691244,RPS6KA5
beta,4,sulfur compound biosynthetic process (GO:0044272),1/123,1,123,0.609861343377076,0.621977793907746,0,0,1.06974753958066,0.529015461694384,CHAC1
beta,4,innate immune response activating cell surface receptor signaling pathway (GO:0002220),1/125,1,125,0.615805461975797,0.626853907469225,0,0,1.05263157894737,0.510341235586807,RPS6KA5
beta,4,organic anion transport (GO:0015711),1/125,1,125,0.615805461975797,0.626853907469225,0,0,1.05263157894737,0.510341235586807,OSBPL8
beta,4,negative regulation of multicellular organismal process (GO:0051241),1/126,1,126,0.618743694606828,0.629250663005812,0,0,1.04427736006683,0.501320129162051,RPS6KA5
beta,4,G2/M transition of mitotic cell cycle (GO:0000086),1/127,1,127,0.621659602894877,0.631025472618341,0,0,1.03605470368835,0.492501655897713,CKAP5
beta,4,cytoskeleton organization (GO:0007010),1/127,1,127,0.621659602894877,0.631025472618341,0,0,1.03605470368835,0.492501655897713,TNIK
beta,4,negative regulation of response to stimulus (GO:0048585),1/128,1,128,0.624553355405533,0.6327711627135,0,0,1.02796052631579,0.483880053523423,MET
beta,4,cell cycle G2/M phase transition (GO:0044839),1/128,1,128,0.624553355405533,0.6327711627135,0,0,1.02796052631579,0.483880053523423,CKAP5
beta,4,regulation of mRNA stability (GO:0043488),1/129,1,129,0.62742511927177,0.63329988630615,0,0,1.01999184006528,0.475449762275219,TNPO1
beta,4,positive regulation of NF-kappaB transcription factor activity (GO:0051092),1/129,1,129,0.62742511927177,0.63329988630615,0,0,1.01999184006528,0.475449762275219,RPS6KA5
beta,4,positive regulation of mitochondrion organization (GO:0010822),1/129,1,129,0.62742511927177,0.63329988630615,0,0,1.01999184006528,0.475449762275219,FBXO7
beta,4,regulation of protein processing (GO:0070613),1/129,1,129,0.62742511927177,0.63329988630615,0,0,1.01999184006528,0.475449762275219,CHAC1
beta,4,cellular response to hypoxia (GO:0071456),1/133,1,133,0.638695590188682,0.644072821537324,0,0,0.989315393747527,0.443537121876813,PTGS2
beta,4,regulation of cytosolic calcium ion concentration (GO:0051480),1/138,1,138,0.652308489114134,0.65718556192994,0,0,0.9534706331045,0.407358587089209,SMAD3
beta,4,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),1/141,1,141,0.660230367481089,0.663925686702066,0,0,0.933184023889511,0.387426710735828,PROX1
beta,4,positive regulation of Wnt signaling pathway (GO:0030177),1/141,1,141,0.660230367481089,0.663925686702066,0,0,0.933184023889511,0.387426710735828,ARNTL
beta,4,double-strand break repair (GO:0006302),1/142,1,142,0.662830940473373,0.665919621463463,0,0,0.926612305411416,0.381055701498085,NABP1
beta,4,positive regulation of macromolecule biosynthetic process (GO:0010557),1/143,1,143,0.665411738717357,0.667889994727477,0,0,0.920132499079867,0.374815305445626,IRS2
beta,4,skeletal system development (GO:0001501),1/147,1,147,0.675540155068498,0.677425383408224,0,0,0.895094880057286,0.351094413168277,TGFBR1
beta,4,regulation of protein kinase activity (GO:0045859),1/148,1,148,0.67802429792504,0.679284566136796,0,0,0.889046941678521,0.345458885167446,MAPRE3
beta,4,negative regulation of canonical Wnt signaling pathway (GO:0090090),1/149,1,149,0.680489545667991,0.681121383686253,0,0,0.883080183680678,0.339935375953872,TMEM64
beta,4,regulation of G2/M transition of mitotic cell cycle (GO:0010389),1/150,1,150,0.682936041086427,0.682936041086427,0,0,0.87719298245614,0.334521112181035,CKAP5
alpha,1,regulation of protein secretion (GO:0050708),20/108,20,108,4.18151493649957e-07,0.00113862651720883,0,0,3.66340623511741,53.8059934977537,SNAP25;RSAD2;RFX3;ARL2;KCNA5;GCG;GCK;ARNTL;NEUROD1;PER2;G6PC2;RFX6;HNF4A;DPH3;ERP29;MYO18A;ARFIP1;ANG;CLOCK;LLGL2
alpha,1,regulation of insulin secretion (GO:0050796),18/99,18,99,2.06911273950242e-06,0.00281709699483254,0,0,3.59679884902437,47.0763085004372,SNAP25;SLC30A8;NLGN2;RFX3;ARL2;IRS2;KCNA5;GCG;GCK;ARNTL;NEUROD1;PER2;G6PC2;RFX6;CAPN10;HNF4A;CLOCK;MCU
alpha,1,regulation of peptide hormone secretion (GO:0090276),13/74,13,74,7.71837444466096e-05,0.070057112042706,0,0,3.47528537439517,32.9085951652068,SNAP25;RFX3;ARL2;KCNA5;GCG;GCK;ARNTL;NEUROD1;PER2;G6PC2;RFX6;HNF4A;CLOCK
alpha,1,positive regulation of insulin secretion (GO:0032024),8/32,8,32,0.000147212468906472,0.100214888208081,0,0,4.94559841740851,43.6381486054001,NLGN2;SLC30A8;RFX6;CAPN10;IRS2;GCG;GCK;MCU
alpha,1,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),5/14,5,14,0.000446069516880896,0.242929458893336,0,0,7.06514059629787,54.5078122837666,PCID2;ANAPC15;DUSP1;TPR;CDK5RAP2
alpha,1,regulation of hair cycle (GO:0042634),4/9,4,9,0.00066651816425013,0.302488160208851,0,0,8.79217496428179,64.3010719026564,PER1;NIPBL;CLOCK;ARNTL
alpha,1,protein localization to cell periphery (GO:1990778),15/118,15,118,0.000894538484292477,0.347975470389774,0,0,2.51471105969924,17.6512664907111,KCNB2;MYO5A;ANK2;LIN7A;EFR3B;RAB10;EHD3;TSPAN14;RAB40C;MAP7;PIP5K1A;INPP5K;SCN3B;SPTBN1;RAB8A
alpha,1,negative regulation of MAPK cascade (GO:0043409),11/81,11,81,0.00246837647520997,0.540637213502321,0,0,2.68649790575277,16.1302563313113,RGS2;DUSP1;CAMK2N1;SMPD1;SPRY4;DAG1;INPP5K;PIN1;PTPRJ;FOXO1;PTPN2
alpha,1,regulation of protein transport (GO:0051223),6/28,6,28,0.00237541201232518,0.540637213502321,0,0,4.23908435777872,25.6150249159283,HSPA8;SCFD1;NDFIP1;ARFIP1;NDEL1;LLGL2
alpha,1,glutamate catabolic process (GO:0006538),3/6,3,6,0.00229552228691554,0.540637213502321,0,0,9.89119683481701,60.1067743359353,ADHFE1;GAD1;GLUL
alpha,1,regulation of mitotic spindle checkpoint (GO:1903504),3/6,3,6,0.00229552228691554,0.540637213502321,0,0,9.89119683481701,60.1067743359353,ANAPC15;DUSP1;CDK5RAP2
alpha,1,photoperiodism (GO:0009648),5/21,5,21,0.00337525987129617,0.540637213502321,0,0,4.71009373086524,26.8064761844442,PPP1CB;PER2;PER1;CLOCK;PPP1CA
alpha,1,RNA phosphodiester bond hydrolysis (GO:0090501),6/29,6,29,0.00286883626516931,0.540637213502321,0,0,4.0929090350967,23.9592707007481,POP7;XRN1;PDE12;NHP2;RNASE4;DICER1
alpha,1,SA node cell action potential (GO:0086015),3/7,3,7,0.00386648879271619,0.554128893819273,0,0,8.47816871555744,47.0996903135209,KCNA5;ANK2;SCN3B
alpha,1,DNA replication-independent nucleosome organization (GO:0034724),4/13,4,13,0.00321474173261786,0.540637213502321,0,0,6.08689035988739,34.9388009222857,HIRA;SUPT16H;H3F3A;ASF1B
alpha,1,establishment of spindle orientation (GO:0051294),5/21,5,21,0.00337525987129617,0.540637213502321,0,0,4.71009373086524,26.8064761844442,NUMA1;MAP4;CDK5RAP2;NDEL1;LLGL2
alpha,1,negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),3/6,3,6,0.00229552228691554,0.540637213502321,0,0,9.89119683481701,60.1067743359353,PER1;CLOCK;ARNTL
alpha,1,regulation of glucocorticoid receptor signaling pathway (GO:2000322),3/7,3,7,0.00386648879271619,0.554128893819273,0,0,8.47816871555744,47.0996903135209,PER1;CLOCK;ARNTL
alpha,1,atrial cardiac muscle cell action potential (GO:0086014),4/13,4,13,0.00321474173261786,0.540637213502321,0,0,6.08689035988739,34.9388009222857,KCNA5;ANK2;SCN3B;KCNJ3
alpha,1,glucose homeostasis (GO:0042593),10/75,10,75,0.00436519761751399,0.59432165562453,0,0,2.63765248928454,14.3332458094726,NEUROD1;CRTC2;G6PC2;RFX6;HNF4A;INPP5K;FOXO1;GCK;PTPN2;MCU
alpha,1,carbohydrate homeostasis (GO:0033500),9/64,9,64,0.00469214509396103,0.60841481385028,0,0,2.78189910979229,14.9161686525707,NEUROD1;CRTC2;G6PC2;RFX6;HNF4A;INPP5K;GCK;PTPN2;MCU
alpha,1,regulation of type B pancreatic cell development (GO:2000074),3/8,3,8,0.00595495968640937,0.675639801087196,0,0,7.41839762611276,38.0083890645575,RFX3;CLOCK;ARNTL
alpha,1,atrial cardiac muscle cell to AV node cell signaling (GO:0086026),3/8,3,8,0.00595495968640937,0.675639801087196,0,0,7.41839762611276,38.0083890645575,KCNA5;ANK2;SCN3B
alpha,1,protein localization to plasma membrane (GO:0072659),14/131,14,131,0.00651419460469083,0.699431654213355,0,0,2.11414894179295,10.6421431079978,KCNB2;MYO5A;ANK2;EFR3B;RAB10;EHD3;TSPAN14;RAB40C;MAP7;PIP5K1A;INPP5K;SCN3B;SPTBN1;RAB8A
alpha,1,4-hydroxyproline metabolic process (GO:0019471),3/8,3,8,0.00595495968640937,0.675639801087196,0,0,7.41839762611276,38.0083890645575,ALDH4A1;EGLN3;EGLN2
alpha,1,cytosolic transport (GO:0016482),13/119,13,119,0.00715448815906066,0.699431654213355,0,0,2.16110182945582,10.6758763285348,AKTIP;AP2A1;VPS26B;BET1L;MYO1D;EHD3;WDR81;HEATR5A;AP1G1;STX5;TBC1D17;TBC1D10A;TBC1D10B
alpha,1,mitochondrial transport (GO:0006839),14/136,14,136,0.00898152923304001,0.699431654213355,0,0,2.03642287775644,9.59681614757748,DNAJC19;FIS1;TOMM40;TIMM44;COX5B;ATP5B;ABCB10;TOMM7;SLC25A43;CYC1;SLC25A34;SLC25A11;SLC25A22;SLC25A25
alpha,1,endoplasmic reticulum organization (GO:0007029),6/35,6,35,0.00757854601706203,0.699431654213355,0,0,3.39126748622298,16.5576393931561,RAB10;RTN3;LMAN1;ATL3;TOR1B;SEC31A
alpha,1,nucleus organization (GO:0006997),7/46,7,46,0.00787429246861686,0.699431654213355,0,0,3.01036425407474,14.582661852205,NDC1;CTDNEP1;SUN2;NUMA1;NUP133;TPR;SPAG4
alpha,1,early endosome to Golgi transport (GO:0034498),3/9,3,9,0.00859918999216946,0.699431654213355,0,0,6.59413122321134,31.3622635484048,EHD3;STX5;SNX8
alpha,1,negative regulation of locomotion (GO:0040013),5/26,5,26,0.00885291200130844,0.699431654213355,0,0,3.80430647492962,17.9829903157122,TRIM8;TRIM13;PIN1;TRIM26;PTPN2
alpha,1,peptidyl-tyrosine dephosphorylation (GO:0035335),5/26,5,26,0.00885291200130844,0.699431654213355,0,0,3.80430647492962,17.9829903157122,PTPRZ1;DUSP1;PTPRJ;PTPN6;PTPN2
alpha,1,positive regulation of protein secretion (GO:0050714),10/83,10,83,0.00893041360131848,0.699431654213355,0,0,2.38342092405229,11.2456772353012,SLC30A8;NLGN2;CAPN10;MYO18A;IRS2;ANG;MIF;GAPDH;GCK;MCU
alpha,1,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),9/71,9,71,0.00928165765627444,0.699431654213355,0,0,2.50762736657333,11.734981706145,CUL4A;SPSB3;MAEA;UBE3C;RNF19A;HECW2;CUL1;UBE3B;KLHL24
alpha,1,response to insulin (GO:0032868),9/72,9,72,0.0101455892926683,0.699431654213355,0,0,2.47279920870425,11.3519194371565,RAB10;CAPN10;INPP5K;MYO5A;IRS2;CPEB2;RAB8A;FOXO1;GCK
alpha,1,negative regulation of mitotic cell cycle (GO:0045930),7/49,7,49,0.0110931265064028,0.699431654213355,0,0,2.82605623851915,12.7212931923855,TOM1L2;FZD3;NME6;DUSP1;E4F1;CDC14A;ZFP36L2
alpha,1,protein K48-linked ubiquitination (GO:0070936),7/49,7,49,0.0110931265064028,0.699431654213355,0,0,2.82605623851915,12.7212931923855,RNF34;UBE2D4;TTC3;SYVN1;KLHL3;UBE2K;TOPORS
alpha,1,negative regulation of protein transport (GO:0051224),4/18,4,18,0.0112476690868625,0.699431654213355,0,0,4.3960874821409,19.7278574088488,NDFIP1;RSAD2;DPH3;ERP29
alpha,1,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",6/38,6,38,0.0113410792505577,0.699431654213355,0,0,3.12353584257379,13.9913284810378,POLD3;CUL4A;DDB1;PCNA;ERCC1;GTF2H4
alpha,1,regulation of cytoplasmic translational elongation (GO:1900247),3/10,3,10,0.0118274950983659,0.699431654213355,0,0,5.93471810089021,26.3342929666822,DPH3;CPEB3;CPEB2
alpha,1,insulin-like growth factor receptor signaling pathway (GO:0048009),3/10,3,10,0.0118274950983659,0.699431654213355,0,0,5.93471810089021,26.3342929666822,GHR;PLCB1;GIGYF2
alpha,1,IRES-dependent viral translational initiation (GO:0075522),3/10,3,10,0.0118274950983659,0.699431654213355,0,0,5.93471810089021,26.3342929666822,PTBP1;DENR;EIF3B
alpha,1,protein-cofactor linkage (GO:0018065),3/10,3,10,0.0118274950983659,0.699431654213355,0,0,5.93471810089021,26.3342929666822,LIPT2;SDHAF2;GAD1
alpha,1,nucleic acid phosphodiester bond hydrolysis (GO:0090305),9/74,9,74,0.0120531775231425,0.699431654213355,0,0,2.40596679765819,10.6305885610881,DDB1;POLD3;CUL4A;PCNA;PDE12;ERCC1;XRN2;DICER1;GTF2H4
alpha,1,protein import into mitochondrial matrix (GO:0030150),4/19,4,19,0.0136876414554197,0.699431654213355,0,0,4.16471445676506,17.8718806260244,DNAJC19;TOMM40;TOMM7;TIMM44
alpha,1,protein exit from endoplasmic reticulum (GO:0032527),4/19,4,19,0.0136876414554197,0.699431654213355,0,0,4.16471445676506,17.8718806260244,CTAGE5;SYVN1;DERL2;AUP1
alpha,1,intracellular estrogen receptor signaling pathway (GO:0030520),4/19,4,19,0.0136876414554197,0.699431654213355,0,0,4.16471445676506,17.8718806260244,DDX5;EGLN2;ARID1A;ESR2
alpha,1,intrinsic apoptotic signaling pathway (GO:0097193),11/102,11,102,0.0139743147439626,0.699431654213355,0,0,2.13339539574485,9.11073820352773,CASP9;CUL4A;DDX5;CDKN1A;BCL2L11;PPP1R13B;CUL1;HTRA2;ZNF385B;KRCC1;TOPORS
alpha,1,negative regulation of cell growth (GO:0030308),12/116,12,116,0.0143592185904255,0.699431654213355,0,0,2.04645451754835,8.68384965220747,DNAJB2;CDKN1A;SERTAD3;CDKN2C;NME6;SERTAD2;HNF4A;NAIF1;DACT3;PTPRJ;APBB1;ESR2
alpha,1,positive regulation of peptide hormone secretion (GO:0090277),6/40,6,40,0.0144824650663045,0.699431654213355,0,0,2.9673590504451,12.566221564178,NLGN2;SLC30A8;CAPN10;IRS2;GCK;MCU
alpha,1,vesicle coating (GO:0006901),8/64,8,64,0.0149425291019586,0.699431654213355,0,0,2.47279920870425,10.3945198557651,LMAN1;TRAPPC6A;SCFD1;TFG;PPP6R3;USO1;STX5;SEC31A
alpha,1,COPII vesicle coating (GO:0048208),8/64,8,64,0.0149425291019586,0.699431654213355,0,0,2.47279920870425,10.3945198557651,LMAN1;TRAPPC6A;SCFD1;TFG;PPP6R3;USO1;STX5;SEC31A
alpha,1,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",8/64,8,64,0.0149425291019586,0.699431654213355,0,0,2.47279920870425,10.3945198557651,LMAN1;TRAPPC6A;SCFD1;TFG;PPP6R3;USO1;STX5;SEC31A
alpha,1,carboxylic acid transport (GO:0046942),7/52,7,52,0.0151718248314296,0.699431654213355,0,0,2.66301453245073,11.1535442460503,SLC7A8;SLC17A5;SLC16A2;SLC7A1;SLC7A2;SLC16A14;SLC38A4
alpha,1,cellular protein complex assembly (GO:0043623),14/145,14,145,0.0152229319686334,0.699431654213355,0,0,1.91002421637846,7.99336024865888,NDC1;DNAAF2;PTGES3;PXN;MIS12;CUL1;CLTB;ARL2;DNAJC28;HOPX;SEPT2;CENPC;BBS10;NCK1
alpha,1,relaxation of cardiac muscle (GO:0055119),3/11,3,11,0.0156593950367301,0.699431654213355,0,0,5.39519827353655,22.4261355288981,CHGA;GSTM2;RGS2
alpha,1,negative regulation of peptide secretion (GO:0002792),3/11,3,11,0.0156593950367301,0.699431654213355,0,0,5.39519827353655,22.4261355288981,RSAD2;DPH3;ERP29
alpha,1,regulation of mRNA polyadenylation (GO:1900363),3/11,3,11,0.0156593950367301,0.699431654213355,0,0,5.39519827353655,22.4261355288981,CTR9;SUPT5H;CPEB3
alpha,1,"nucleotide-excision repair, DNA incision (GO:0033683)",6/41,6,41,0.0162600266939989,0.699431654213355,0,0,2.89498443945864,11.9245727239386,POLD3;CUL4A;DDB1;PCNA;ERCC1;GTF2H4
alpha,1,glucose metabolic process (GO:0006006),8/65,8,65,0.0163088018469319,0.699431654213355,0,0,2.43475614395496,10.021578820793,PER2;CRTC2;G6PC2;DCXR;IRS2;ALDOA;SLC25A11;GAPDH
alpha,1,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),4/20,4,20,0.0164390840505526,0.699431654213355,0,0,3.95647873392681,16.2535849875086,CREB3;BCL2L11;SYVN1;NCK1
alpha,1,negative regulation of phosphate metabolic process (GO:0045936),4/20,4,20,0.0164390840505526,0.699431654213355,0,0,3.95647873392681,16.2535849875086,CDKN1A;CDKN2C;INPP5K;DYNLL1
alpha,1,cellular polysaccharide catabolic process (GO:0044247),4/20,4,20,0.0164390840505526,0.699431654213355,0,0,3.95647873392681,16.2535849875086,PYGB;MANBA;GYG2;PHKA2
alpha,1,entrainment of circadian clock by photoperiod (GO:0043153),4/20,4,20,0.0164390840505526,0.699431654213355,0,0,3.95647873392681,16.2535849875086,PPP1CB;PER2;PER1;PPP1CA
alpha,1,telomere organization (GO:0032200),6/42,6,42,0.0181825352204461,0.750167324322345,0,0,2.82605623851915,11.3248374986168,POLD3;CTC1;PCNA;PTGES3;APEX1;H3F3A
alpha,1,gluconeogenesis (GO:0006094),6/42,6,42,0.0181825352204461,0.750167324322345,0,0,2.82605623851915,11.3248374986168,PER2;CRTC2;G6PC2;ALDOA;SLC25A11;GAPDH
alpha,1,negative regulation of secretion by cell (GO:1903531),5/31,5,31,0.0185834672778909,0.755265393995478,0,0,3.19070865639259,12.7165149470569,CHGA;GRM7;RSAD2;DPH3;ERP29
alpha,1,negative regulation of growth (GO:0045926),12/121,12,121,0.0194744402131728,0.759053026584298,0,0,1.96189028128602,7.72720392673582,DNAJB2;CDKN1A;SERTAD3;CDKN2C;NME6;SERTAD2;HNF4A;NAIF1;DACT3;PTPRJ;APBB1;ESR2
alpha,1,vesicle docking (GO:0048278),4/21,4,21,0.0195129312746606,0.759053026584298,0,0,3.7680749846922,14.8336974835056,STX12;USO1;STX5;STX3
alpha,1,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",4/21,4,21,0.0195129312746606,0.759053026584298,0,0,3.7680749846922,14.8336974835056,CUL4A;DDB1;ERCC1;GTF2H4
alpha,1,regulation of cholesterol homeostasis (GO:2000188),3/12,3,12,0.0201066566967808,0.760422585907418,0,0,4.94559841740851,19.3209908002,NR1H2;HNF4A;RALY
alpha,1,regulation of histone methylation (GO:0031060),3/12,3,12,0.0201066566967808,0.760422585907418,0,0,4.94559841740851,19.3209908002,CTR9;JARID2;PRDM10
alpha,1,protein catabolic process (GO:0030163),9/82,9,82,0.0224201007447722,0.787924837949583,0,0,2.17123832959398,8.24592321305454,BACE1;DDB1;HSPA8;MANBA;HTRA2;STT3B;PSMB10;PSMA7;RNF41
alpha,1,COPII-coated vesicle budding (GO:0090114),8/69,8,69,0.022680303185475,0.787924837949583,0,0,2.29361086024742,8.68420345990205,LMAN1;TRAPPC6A;SCFD1;TFG;PPP6R3;USO1;STX5;SEC31A
alpha,1,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",4/22,4,22,0.0229183352415894,0.787924837949583,0,0,3.59679884902437,13.5808579200145,CUL4A;DDB1;ERCC1;GTF2H4
alpha,1,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",4/22,4,22,0.0229183352415894,0.787924837949583,0,0,3.59679884902437,13.5808579200145,CUL4A;DDB1;RAD23B;GTF2H4
alpha,1,global genome nucleotide-excision repair (GO:0070911),5/33,5,33,0.0239019079373499,0.787924837949583,0,0,2.99733237418697,11.1914306064091,CUL4A;DDB1;ERCC1;RAD23B;GTF2H4
alpha,1,"retrograde transport, endosome to Golgi (GO:0042147)",9/83,9,83,0.024060740316019,0.787924837949583,0,0,2.14507883164706,7.99508161881691,EHD3;HEATR5A;STX5;VPS26B;TBC1D17;SNX8;TBC1D10A;BET1L;TBC1D10B
alpha,1,regulation of secretion by cell (GO:1903530),7/57,7,57,0.0241670793337927,0.787924837949583,0,0,2.42941676644628,9.04414510919545,RAB10;MCTP1;RAB3A;RAB40C;ARFIP1;RAB8A;LLGL2
alpha,1,cellular response to insulin stimulus (GO:0032869),11/111,11,111,0.0247543740739443,0.787924837949583,0,0,1.96041739068445,7.25109985270888,RAB10;CAPN10;INPP5K;MYO5A;IRS2;CPEB2;FOXO1;RAB8A;GCK;PTPN2;APPL1
alpha,1,hexose biosynthetic process (GO:0019319),6/45,6,45,0.0248679484744878,0.787924837949583,0,0,2.63765248928454,9.74395124177417,PER2;CRTC2;G6PC2;ALDOA;SLC25A11;GAPDH
alpha,1,positive regulation of intracellular transport (GO:0032388),6/45,6,45,0.0248679484744878,0.787924837949583,0,0,2.63765248928454,9.74395124177417,EHD1;NUMA1;CAPN10;RUFY3;TPR;PCNT
alpha,1,mitotic nuclear envelope disassembly (GO:0007077),6/45,6,45,0.0248679484744878,0.787924837949583,0,0,2.63765248928454,9.74395124177417,NDC1;CTDNEP1;NUP210;NUP133;TPR;EMD
alpha,1,regulation of cell aging (GO:0090342),3/13,3,13,0.0251742419763547,0.787924837949583,0,0,4.56516776991555,16.8086462040878,MIF;MARCH5;ARNTL
alpha,1,viral translation (GO:0019081),3/13,3,13,0.0251742419763547,0.787924837949583,0,0,4.56516776991555,16.8086462040878,PTBP1;DENR;EIF3B
alpha,1,negative regulation of viral release from host cell (GO:1902187),3/13,3,13,0.0251742419763547,0.787924837949583,0,0,4.56516776991555,16.8086462040878,TRIM8;TRIM13;TRIM26
alpha,1,prostanoid biosynthetic process (GO:0046457),3/13,3,13,0.0251742419763547,0.787924837949583,0,0,4.56516776991555,16.8086462040878,FAM213B;PTGES3;MIF
alpha,1,mRNA metabolic process (GO:0016071),10/98,10,98,0.026283315864213,0.789157437839392,0,0,2.01861159894225,7.34536611334045,PTBP1;ZNF473;DDX5;SF3B2;RNASE4;SRSF4;SRSF5;SUPT5H;PRPF8;ZFP36L2
alpha,1,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),10/98,10,98,0.026283315864213,0.789157437839392,0,0,2.01861159894225,7.34536611334045,ACTR1A;HLA-DMA;ACTR1B;AP1G1;DCTN4;AP2A1;KIF22;KLC1;DYNLL1;SEC31A
alpha,1,antigen processing and presentation of exogenous peptide antigen (GO:0002478),10/98,10,98,0.026283315864213,0.789157437839392,0,0,2.01861159894225,7.34536611334045,ACTR1A;HLA-DMA;ACTR1B;AP1G1;DCTN4;AP2A1;KIF22;KLC1;DYNLL1;SEC31A
alpha,1,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",4/23,4,23,0.0266626824389365,0.789157437839392,0,0,3.44041629037114,12.4697556536492,CUL4A;DDB1;COPS3;RAD23B
alpha,1,cellular response to interleukin-6 (GO:0071354),4/23,4,23,0.0266626824389365,0.789157437839392,0,0,3.44041629037114,12.4697556536492,CTR9;ST3GAL6;CBL;IL6R
alpha,1,phosphatidylinositol metabolic process (GO:0046488),11/113,11,113,0.0278009752068665,0.794721998810863,0,0,1.92571973775198,6.8992456386279,CDS1;INPP4B;MTMR12;PLEKHA1;MBOAT7;PIP5K1A;INPP5K;PIP4K2B;IP6K1;PLCB1;EFR3B
alpha,1,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),10/99,10,99,0.027964269818029,0.794721998810863,0,0,1.99822158279132,7.14729423136452,ACTR1A;HLA-DMA;ACTR1B;AP1G1;DCTN4;AP2A1;KIF22;KLC1;DYNLL1;SEC31A
alpha,1,ncRNA metabolic process (GO:0034660),5/35,5,35,0.030112051337518,0.794721998810863,0,0,2.82605623851915,9.89919403898524,EXD1;TDRKH;DGCR8;DICER1;DTD2
alpha,1,nuclear envelope disassembly (GO:0051081),6/47,6,47,0.030132871016633,0.794721998810863,0,0,2.52541195782562,8.8443428063342,NDC1;CTDNEP1;NUP210;NUP133;TPR;EMD
alpha,1,RNA secondary structure unwinding (GO:0010501),6/47,6,47,0.030132871016633,0.794721998810863,0,0,2.52541195782562,8.8443428063342,DDX6;DDX5;DDX39A;DDX46;DDX24;DDX21
alpha,1,mitotic cell cycle arrest (GO:0071850),3/14,3,14,0.0308611692274062,0.794721998810863,0,0,4.23908435777872,14.7446229107423,DUSP1;E4F1;CDC14A
alpha,1,glucosamine-containing compound metabolic process (GO:1901071),3/14,3,14,0.0308611692274062,0.794721998810863,0,0,4.23908435777872,14.7446229107423,CHST7;NAGK;CHST2
alpha,1,establishment of mitotic spindle orientation (GO:0000132),3/14,3,14,0.0308611692274062,0.794721998810863,0,0,4.23908435777872,14.7446229107423,NUMA1;CDK5RAP2;NDEL1
alpha,1,interleukin-6-mediated signaling pathway (GO:0070102),3/14,3,14,0.0308611692274062,0.794721998810863,0,0,4.23908435777872,14.7446229107423,CTR9;CBL;IL6R
alpha,1,cellular response to transforming growth factor beta stimulus (GO:0071560),10/101,10,101,0.0315529658080538,0.794721998810863,0,0,1.95865283857763,6.76927596632707,WWOX;MAPK7;USP9X;PXN;PDE3A;CBL;ZFP36L2;UBE2M;BMPR1A;LIMS1
alpha,1,transcription-coupled nucleotide-excision repair (GO:0006283),8/74,8,74,0.0328804135104235,0.794721998810863,0,0,2.13863715347395,7.30318524879762,DDB1;POLD3;CUL4A;COPS3;PCNA;ERCC1;POLR2I;GTF2H4
alpha,1,nucleus localization (GO:0051647),2/6,2,6,0.0334254574922248,0.794721998810863,0,0,6.59413122321134,22.4097426242048,SUN2;DCTN4
alpha,1,negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),2/6,2,6,0.0334254574922248,0.794721998810863,0,0,6.59413122321134,22.4097426242048,NR1H2;PTPN2
alpha,1,negative regulation of response to interferon-gamma (GO:0060331),2/6,2,6,0.0334254574922248,0.794721998810863,0,0,6.59413122321134,22.4097426242048,NR1H2;PTPN2
alpha,1,signal complex assembly (GO:0007172),2/6,2,6,0.0334254574922248,0.794721998810863,0,0,6.59413122321134,22.4097426242048,PXN;NCK1
alpha,1,pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),2/6,2,6,0.0334254574922248,0.794721998810863,0,0,6.59413122321134,22.4097426242048,DTYMK;CMPK2
alpha,1,negative regulation of cytoplasmic translation (GO:2000766),2/6,2,6,0.0334254574922248,0.794721998810863,0,0,6.59413122321134,22.4097426242048,CPEB3;CPEB2
alpha,1,positive regulation of cardiac muscle contraction (GO:0060452),2/6,2,6,0.0334254574922248,0.794721998810863,0,0,6.59413122321134,22.4097426242048,CHGA;RGS2
alpha,1,SREBP signaling pathway (GO:0032933),2/6,2,6,0.0334254574922248,0.794721998810863,0,0,6.59413122321134,22.4097426242048,INSIG1;ARHGEF10L
alpha,1,peptidyl-proline hydroxylation (GO:0019511),2/6,2,6,0.0334254574922248,0.794721998810863,0,0,6.59413122321134,22.4097426242048,EGLN3;EGLN2
alpha,1,regulation of heart rate by cardiac conduction (GO:0086091),5/36,5,36,0.0335633602141936,0.794721998810863,0,0,2.74755467633806,9.32608054957535,KCNH6;KCNA5;ANK2;SCN3B;KCNJ3
alpha,1,anatomical structure homeostasis (GO:0060249),5/36,5,36,0.0335633602141936,0.794721998810863,0,0,2.74755467633806,9.32608054957535,POLD3;CTC1;PCNA;PTGES3;APEX1
alpha,1,protein kinase B signaling (GO:0043491),5/36,5,36,0.0335633602141936,0.794721998810863,0,0,2.74755467633806,9.32608054957535,CASP9;CDKN1A;AKT1S1;MDM2;FOXO1
alpha,1,mRNA 3'-end processing (GO:0031124),8/75,8,75,0.0352420724391263,0.805023193324352,0,0,2.11012199142763,7.05944407857154,ZNF473;CPSF7;DDX39A;RBM8A;PAPOLA;TUT1;SRSF4;SRSF5
alpha,1,negative regulation of MAP kinase activity (GO:0043407),7/62,7,62,0.0362777204617568,0.805023193324352,0,0,2.23349605947481,7.40750467843032,RGS4;RGS2;DUSP1;SMPD1;SPRY4;INPP5K;PTPRJ
alpha,1,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),3/15,3,15,0.037161294909544,0.805023193324352,0,0,3.95647873392681,13.0266568497628,PNP;PARP16;NUDT12
alpha,1,nuclear pore organization (GO:0006999),3/15,3,15,0.037161294909544,0.805023193324352,0,0,3.95647873392681,13.0266568497628,NDC1;NUP133;TPR
alpha,1,maintenance of protein location in nucleus (GO:0051457),3/15,3,15,0.037161294909544,0.805023193324352,0,0,3.95647873392681,13.0266568497628,SUN2;ARL2;TOPORS
alpha,1,L-alpha-amino acid transmembrane transport (GO:1902475),3/15,3,15,0.037161294909544,0.805023193324352,0,0,3.95647873392681,13.0266568497628,SLC7A1;SLC25A22;SLC7A2
alpha,1,negative regulation of cell aging (GO:0090344),3/15,3,15,0.037161294909544,0.805023193324352,0,0,3.95647873392681,13.0266568497628,MAP3K3;MIF;MARCH5
alpha,1,N-acetylglucosamine metabolic process (GO:0006044),3/15,3,15,0.037161294909544,0.805023193324352,0,0,3.95647873392681,13.0266568497628,CHST7;NAGK;CHST2
alpha,1,mitotic chromosome condensation (GO:0007076),3/15,3,15,0.037161294909544,0.805023193324352,0,0,3.95647873392681,13.0266568497628,NIPBL;PHF13;NCAPD3
alpha,1,negative regulation of signal transduction by p53 class mediator (GO:1901797),3/15,3,15,0.037161294909544,0.805023193324352,0,0,3.95647873392681,13.0266568497628,RNF34;MDM2;MIF
alpha,1,regulation of cell morphogenesis involved in differentiation (GO:0010769),5/37,5,37,0.0372504305394302,0.805023193324352,0,0,2.67329644184244,8.79539063843092,FXR2;HECW2;RUFY3;CHN1;EPHB3
alpha,1,regulation of viral release from host cell (GO:1902186),4/26,4,26,0.0399775454191002,0.821421420404495,0,0,3.0434451799437,9.79818107590276,TRIM8;DDB1;TRIM13;TRIM26
alpha,1,regulation of cellular protein localization (GO:1903827),4/26,4,26,0.0399775454191002,0.821421420404495,0,0,3.0434451799437,9.79818107590276,DVL3;PIN1;SPIDR;NDEL1
alpha,1,regulation of phosphorylation (GO:0042325),11/120,11,120,0.0405829098115633,0.821421420404495,0,0,1.81338608638312,5.81082932040286,NDC1;CDKN1A;CDKN2C;NUP210;NUP133;PTGES3;TPR;ANG;MIF;DYNLL1;GCK
alpha,1,regulation of carbohydrate catabolic process (GO:0043470),5/38,5,38,0.0411760944273792,0.821421420404495,0,0,2.60294653547816,8.30313244669622,NDC1;NUP210;NUP133;TPR;GCK
alpha,1,regulation of metal ion transport (GO:0010959),5/38,5,38,0.0411760944273792,0.821421420404495,0,0,2.60294653547816,8.30313244669622,PER1;NKAIN3;WNK1;KCNA5;ANK2
alpha,1,regulation of protein catabolic process (GO:0042176),9/92,9,92,0.0428117744693114,0.821421420404495,0,0,1.93523416333376,6.09781081758258,DDB1;EGLN2;HECW2;MDM2;STX5;PIN1;FOXO1;AZIN1;RNF41
alpha,1,glutamine family amino acid catabolic process (GO:0009065),3/16,3,16,0.0440640217679242,0.821421420404495,0,0,3.70919881305638,11.5805328725112,ALDH4A1;GAD1;GLUL
alpha,1,endoplasmic reticulum to cytosol transport (GO:1903513),3/16,3,16,0.0440640217679242,0.821421420404495,0,0,3.70919881305638,11.5805328725112,SYVN1;DERL2;AUP1
alpha,1,ruffle organization (GO:0031529),3/16,3,16,0.0440640217679242,0.821421420404495,0,0,3.70919881305638,11.5805328725112,PLEKHA1;PIP5K1A;INPP5K
alpha,1,positive regulation of cell adhesion (GO:0045785),7/65,7,65,0.0451814464674611,0.821421420404495,0,0,2.13041162596059,6.59803127735596,EPB41L4B;SIRPA;ARL2;PTPRJ;CD47;STX3;LIMS1
alpha,1,protein localization to basolateral plasma membrane (GO:1903361),2/7,2,7,0.0452490683292965,0.821421420404495,0,0,5.65211247703829,17.4965278985784,RAB10;LIN7A
alpha,1,regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),2/7,2,7,0.0452490683292965,0.821421420404495,0,0,5.65211247703829,17.4965278985784,MAPK7;CALM3
alpha,1,cellular response to interferon-alpha (GO:0035457),2/7,2,7,0.0452490683292965,0.821421420404495,0,0,5.65211247703829,17.4965278985784,PDE12;TPR
alpha,1,ornithine transport (GO:0015822),2/7,2,7,0.0452490683292965,0.821421420404495,0,0,5.65211247703829,17.4965278985784,SLC7A1;SLC7A2
alpha,1,regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),2/7,2,7,0.0452490683292965,0.821421420404495,0,0,5.65211247703829,17.4965278985784,ACAA2;NAIF1
alpha,1,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),2/7,2,7,0.0452490683292965,0.821421420404495,0,0,5.65211247703829,17.4965278985784,PCID2;NUP133
alpha,1,cellular response to sterol depletion (GO:0071501),2/7,2,7,0.0452490683292965,0.821421420404495,0,0,5.65211247703829,17.4965278985784,INSIG1;ARHGEF10L
alpha,1,valine metabolic process (GO:0006573),2/7,2,7,0.0452490683292965,0.821421420404495,0,0,5.65211247703829,17.4965278985784,GHR;ALDH6A1
alpha,1,chromatin-mediated maintenance of transcription (GO:0048096),2/7,2,7,0.0452490683292965,0.821421420404495,0,0,5.65211247703829,17.4965278985784,ARID1A;ARID1B
alpha,1,positive regulation of striated muscle contraction (GO:0045989),2/7,2,7,0.0452490683292965,0.821421420404495,0,0,5.65211247703829,17.4965278985784,CHGA;RGS2
alpha,1,regulation of establishment of protein localization (GO:0070201),2/7,2,7,0.0452490683292965,0.821421420404495,0,0,5.65211247703829,17.4965278985784,SCFD1;SPIDR
alpha,1,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),2/7,2,7,0.0452490683292965,0.821421420404495,0,0,5.65211247703829,17.4965278985784,CASP9;CASP7
alpha,1,positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),2/7,2,7,0.0452490683292965,0.821421420404495,0,0,5.65211247703829,17.4965278985784,PCID2;TPR
alpha,1,amino acid import across plasma membrane (GO:0089718),2/7,2,7,0.0452490683292965,0.821421420404495,0,0,5.65211247703829,17.4965278985784,SLC7A1;SLC7A2
alpha,1,nucleotide-excision repair (GO:0006289),10/109,10,109,0.0491359246875363,0.822949425709792,0,0,1.81489850180129,5.4685883683514,DDB1;POLD3;CUL4A;COPS3;PCNA;ERCC1;MMS19;POLR2I;RAD23B;GTF2H4
alpha,1,DNA replication-independent nucleosome assembly (GO:0006336),5/40,5,40,0.0497510699387977,0.822949425709792,0,0,2.47279920870425,7.42018622478067,HIRA;H3F3A;CENPO;CENPC;ASF1B
alpha,1,regulation of coenzyme metabolic process (GO:0051196),5/40,5,40,0.0497510699387977,0.822949425709792,0,0,2.47279920870425,7.42018622478067,NDC1;NUP210;NUP133;TPR;GCK
alpha,1,positive regulation of nervous system development (GO:0051962),6/53,6,53,0.0500982508188142,0.822949425709792,0,0,2.23951626448687,6.70459478259211,CDC20;NLGN2;NUMB;DICER1;EPHB1;EPHB3
alpha,1,ATP synthesis coupled proton transport (GO:0015986),4/28,4,28,0.0506086877823555,0.822949425709792,0,0,2.82605623851915,8.43191188956677,ATP5B;VPS9D1;CYC1;COX5B
alpha,1,response to hexose (GO:0009746),4/28,4,28,0.0506086877823555,0.822949425709792,0,0,2.82605623851915,8.43191188956677,NEUROD1;SLC30A8;HNF4A;IRS2
alpha,1,axon development (GO:0061564),9/95,9,95,0.0507827015900313,0.822949425709792,0,0,1.87412150554428,5.58525597801475,RAB10;PARD6B;RAB3A;LRFN4;SLITRK1;LRRN1;APBB1;RAB8A;EPHB3
alpha,1,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),3/17,3,17,0.0515549394870728,0.822949425709792,0,0,3.49101064758248,10.351220994127,GSTM2;ANK2;CALM3
alpha,1,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),3/17,3,17,0.0515549394870728,0.822949425709792,0,0,3.49101064758248,10.351220994127,GSTM2;ANK2;CALM3
alpha,1,chaperone-mediated protein complex assembly (GO:0051131),3/17,3,17,0.0515549394870728,0.822949425709792,0,0,3.49101064758248,10.351220994127,BBS10;PTGES3;HOPX
alpha,1,protein dephosphorylation (GO:0006470),11/126,11,126,0.0543824163063634,0.822949425709792,0,0,1.72703436798392,5.02863085069931,PPP1CB;CTDNEP1;SDHAF2;PTPRZ1;DUSP1;CTDSP1;PTPRJ;PTPN6;PTPN2;NCK1;PPP1CA
alpha,1,viral gene expression (GO:0019080),10/111,10,111,0.0543865318003842,0.822949425709792,0,0,1.78219762789496,5.18911564318863,NDC1;RPS16;RPS15A;NUP210;NUP133;TPR;RPL13;RPL27;RPL15;RPS24
alpha,1,cellular response to peptide hormone stimulus (GO:0071375),10/111,10,111,0.0543865318003842,0.822949425709792,0,0,1.78219762789496,5.18911564318863,RAB10;CAPN10;INPP5K;MYO5A;IRS2;GCG;CPEB2;FOXO1;RAB8A;GCK
alpha,1,negative regulation of transport (GO:0051051),5/41,5,41,0.0544026082121057,0.822949425709792,0,0,2.4124870328822,7.02357767290076,YRDC;MCTP1;NDFIP1;NR1H2;INPP5K
alpha,1,regulation of protein dephosphorylation (GO:0035304),5/41,5,41,0.0544026082121057,0.822949425709792,0,0,2.4124870328822,7.02357767290076,PPP1R14C;SMPD1;PPP6R3;PIN1;CALM3
alpha,1,modification-dependent protein catabolic process (GO:0019941),12/142,12,142,0.056250669670073,0.822949425709792,0,0,1.67175157771555,4.81119627654571,DDB1;COPS3;RNF34;WDR81;TTC3;MDM2;SYVN1;UBE4B;KLHL3;CBL;UBE2K;TOPORS
alpha,1,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),4/29,4,29,0.0564485835796788,0.822949425709792,0,0,2.7286060233978,7.84317358789162,WWOX;PPP2R1B;TNFSF10;HTRA2
alpha,1,positive regulation of protein metabolic process (GO:0051247),9/97,9,97,0.0566047260674751,0.822949425709792,0,0,1.83547982501759,5.27087912967701,DDB1;MAPK7;EGLN2;PRMT1;HECW2;NR1H2;STX5;FOXO1;RNF41
alpha,1,G2/M transition of mitotic cell cycle (GO:0000086),11/127,11,127,0.0569529256271367,0.822949425709792,0,0,1.71343567217303,4.90990169615939,PPP1CB;CDKN1A;ACTR1A;CUL1;FBXL15;DYNLL1;PLCB1;PCNT;RAB8A;CDK5RAP2;SDCCAG8
alpha,1,Golgi to lysosome transport (GO:0090160),2/8,2,8,0.0583471257430516,0.822949425709792,0,0,4.94559841740851,14.052152227325,EHD3;AP1G1
alpha,1,positive regulation of mitochondrial calcium ion concentration (GO:0051561),2/8,2,8,0.0583471257430516,0.822949425709792,0,0,4.94559841740851,14.052152227325,FIS1;MCU
alpha,1,stress-induced premature senescence (GO:0090400),2/8,2,8,0.0583471257430516,0.822949425709792,0,0,4.94559841740851,14.052152227325,CDKN1A;ARNTL
alpha,1,"peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)",2/8,2,8,0.0583471257430516,0.822949425709792,0,0,4.94559841740851,14.052152227325,PRMT1;CARM1
alpha,1,cytoskeletal anchoring at nuclear membrane (GO:0090286),2/8,2,8,0.0583471257430516,0.822949425709792,0,0,4.94559841740851,14.052152227325,SUN2;SPAG4
alpha,1,negative regulation of execution phase of apoptosis (GO:1900118),2/8,2,8,0.0583471257430516,0.822949425709792,0,0,4.94559841740851,14.052152227325,FZD3;RNF34
alpha,1,cellular response to UV-B (GO:0071493),2/8,2,8,0.0583471257430516,0.822949425709792,0,0,4.94559841740851,14.052152227325,CDKN1A;HYAL3
alpha,1,positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),2/8,2,8,0.0583471257430516,0.822949425709792,0,0,4.94559841740851,14.052152227325,GSTM2;CALM3
alpha,1,positive regulation of spindle checkpoint (GO:0090232),2/8,2,8,0.0583471257430516,0.822949425709792,0,0,4.94559841740851,14.052152227325,PCID2;TPR
alpha,1,response to hydroxyurea (GO:0072710),2/8,2,8,0.0583471257430516,0.822949425709792,0,0,4.94559841740851,14.052152227325,KAT7;SPIDR
alpha,1,kinetochore assembly (GO:0051382),2/8,2,8,0.0583471257430516,0.822949425709792,0,0,4.94559841740851,14.052152227325,MIS12;CENPC
alpha,1,negative regulation of mRNA polyadenylation (GO:1900364),2/8,2,8,0.0583471257430516,0.822949425709792,0,0,4.94559841740851,14.052152227325,CTR9;SUPT5H
alpha,1,inositol phosphate catabolic process (GO:0071545),2/8,2,8,0.0583471257430516,0.822949425709792,0,0,4.94559841740851,14.052152227325,INPP5K;NUDT3
alpha,1,negative regulation of vascular permeability (GO:0043116),2/8,2,8,0.0583471257430516,0.822949425709792,0,0,4.94559841740851,14.052152227325,PDE3A;PTPRJ
alpha,1,histone H3-K36 demethylation (GO:0070544),2/8,2,8,0.0583471257430516,0.822949425709792,0,0,4.94559841740851,14.052152227325,KDM4B;KDM2A
alpha,1,succinate metabolic process (GO:0006105),2/8,2,8,0.0583471257430516,0.822949425709792,0,0,4.94559841740851,14.052152227325,GHR;GAD1
alpha,1,termination of RNA polymerase II transcription (GO:0006369),7/69,7,69,0.0590685538617653,0.822949425709792,0,0,2.0069095027165,5.67766053359088,ZNF473;CPSF7;DDX39A;RBM8A;PAPOLA;SRSF4;SRSF5
alpha,1,cell cycle G2/M phase transition (GO:0044839),11/128,11,128,0.0596027347890286,0.822949425709792,0,0,1.70004945598417,4.79423096294782,PPP1CB;CDKN1A;ACTR1A;CUL1;FBXL15;DYNLL1;PLCB1;PCNT;RAB8A;CDK5RAP2;SDCCAG8
alpha,1,glucan catabolic process (GO:0009251),3/18,3,18,0.0596164032647805,0.822949425709792,0,0,3.29706561160567,9.29714645636064,PYGB;GYG2;PHKA2
alpha,1,membrane protein ectodomain proteolysis (GO:0006509),3/18,3,18,0.0596164032647805,0.822949425709792,0,0,3.29706561160567,9.29714645636064,BACE1;DAG1;ADAM10
alpha,1,establishment of mitotic spindle localization (GO:0040001),3/18,3,18,0.0596164032647805,0.822949425709792,0,0,3.29706561160567,9.29714645636064,NUMA1;CDK5RAP2;NDEL1
alpha,1,negative regulation of RNA splicing (GO:0033119),3/18,3,18,0.0596164032647805,0.822949425709792,0,0,3.29706561160567,9.29714645636064,PTBP1;SRSF4;PTBP3
alpha,1,prostaglandin biosynthetic process (GO:0001516),3/18,3,18,0.0596164032647805,0.822949425709792,0,0,3.29706561160567,9.29714645636064,FAM213B;PTGES3;MIF
alpha,1,"retrograde protein transport, ER to cytosol (GO:0030970)",3/18,3,18,0.0596164032647805,0.822949425709792,0,0,3.29706561160567,9.29714645636064,SYVN1;DERL2;AUP1
alpha,1,glycogen catabolic process (GO:0005980),3/18,3,18,0.0596164032647805,0.822949425709792,0,0,3.29706561160567,9.29714645636064,PYGB;GYG2;PHKA2
alpha,1,cell-substrate adherens junction assembly (GO:0007045),3/18,3,18,0.0596164032647805,0.822949425709792,0,0,3.29706561160567,9.29714645636064,ACTN1;PIP5K1A;ARHGEF7
alpha,1,mRNA destabilization (GO:0061157),3/18,3,18,0.0596164032647805,0.822949425709792,0,0,3.29706561160567,9.29714645636064,CPEB3;ZFP36L2;GIGYF2
alpha,1,focal adhesion assembly (GO:0048041),3/18,3,18,0.0596164032647805,0.822949425709792,0,0,3.29706561160567,9.29714645636064,ACTN1;PIP5K1A;ARHGEF7
alpha,1,regulation of mRNA stability (GO:0043488),11/129,11,129,0.0623324601409661,0.822949425709792,0,0,1.68687077803081,4.68152685614861,HSPA8;PCID2;FXR2;XRN1;PDE12;PSMD2;APEX1;ZFP36L2;GIGYF2;PSMB10;PSMA7
alpha,1,regulation of gene silencing by RNA (GO:0060966),6/56,6,56,0.0625299586112973,0.822949425709792,0,0,2.11954217888936,5.87560300827613,NDC1;NUP210;NUP133;TPR;H3F3A;POLR2I
alpha,1,regulation of posttranscriptional gene silencing (GO:0060147),6/56,6,56,0.0625299586112973,0.822949425709792,0,0,2.11954217888936,5.87560300827613,NDC1;NUP210;NUP133;TPR;H3F3A;POLR2I
alpha,1,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",4/30,4,30,0.0626338722116248,0.822949425709792,0,0,2.63765248928454,7.3074818531348,CUL4A;DDB1;RAD23B;GTF2H4
alpha,1,phosphatidylinositol biosynthetic process (GO:0006661),9/99,9,99,0.0628416070090064,0.822949425709792,0,0,1.79839942451218,4.97641919412798,CDS1;INPP4B;PIGU;MTMR12;PLEKHA1;PIGP;PIP5K1A;INPP5K;PIP4K2B
alpha,1,viral transcription (GO:0019083),10/114,10,114,0.0629341270843948,0.822949425709792,0,0,1.73529769031877,4.79925503921522,NDC1;RPS16;RPS15A;NUP210;NUP133;TPR;RPL13;RPL27;RPL15;RPS24
alpha,1,chromosome organization (GO:0051276),6/57,6,57,0.0670432418750909,0.822949425709792,0,0,2.08235722838253,5.6273985457903,DDB1;CUL4A;COPS3;NUP133;H3F3A;RAD23B
alpha,1,positive regulation of heart contraction (GO:0045823),3/19,3,19,0.068228055362486,0.822949425709792,0,0,3.12353584257379,8.38637960259354,CHGA;RGS2;SCN3B
alpha,1,nucleosome disassembly (GO:0006337),3/19,3,19,0.068228055362486,0.822949425709792,0,0,3.12353584257379,8.38637960259354,SUPT16H;SMARCC2;ARID1A
alpha,1,chromatin disassembly (GO:0031498),3/19,3,19,0.068228055362486,0.822949425709792,0,0,3.12353584257379,8.38637960259354,SUPT16H;SMARCC2;ARID1A
alpha,1,mitochondrial calcium ion homeostasis (GO:0051560),3/19,3,19,0.068228055362486,0.822949425709792,0,0,3.12353584257379,8.38637960259354,SLC8A3;FIS1;MCU
alpha,1,regulation of ARF protein signal transduction (GO:0032012),4/31,4,31,0.0691598639896613,0.822949425709792,0,0,2.55256692511407,6.81876030700506,APLP2;AGAP1;ARAP1;APPL1
alpha,1,negative regulation of ERBB signaling pathway (GO:1901185),5/44,5,44,0.069812879102407,0.822949425709792,0,0,2.24799928064023,5.98403194828109,BTC;PTPRJ;CBL;ARHGEF7;PTPN2
alpha,1,response to unfolded protein (GO:0006986),5/44,5,44,0.069812879102407,0.822949425709792,0,0,2.24799928064023,5.98403194828109,DNAJB2;HSPA8;HSPA2;STT3B;TOR1B
alpha,1,regulation of ATP metabolic process (GO:1903578),5/44,5,44,0.069812879102407,0.822949425709792,0,0,2.24799928064023,5.98403194828109,NDC1;NUP210;NUP133;TPR;GCK
alpha,1,regulation of glycolytic process (GO:0006110),6/58,6,58,0.0717411853342752,0.822949425709792,0,0,2.04645451754835,5.3917738347966,NDC1;PFKFB4;NUP210;NUP133;TPR;GCK
alpha,1,type B pancreatic cell differentiation (GO:0003309),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,RFX6;RFX3
alpha,1,ornithine metabolic process (GO:0006591),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,HNF4A;AZIN1
alpha,1,positive regulation of triglyceride biosynthetic process (GO:0010867),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,CTDNEP1;NR1H2
alpha,1,negative regulation of mitotic nuclear division (GO:0045839),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,TOM1L2;NME6
alpha,1,negative regulation of catenin import into nucleus (GO:0035414),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,DACT3;EMD
alpha,1,sphingomyelin metabolic process (GO:0006684),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,SMPD1;SGMS2
alpha,1,nuclear migration (GO:0007097),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,SUN2;DCTN4
alpha,1,negative regulation of mRNA 3'-end processing (GO:0031441),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,CTR9;SUPT5H
alpha,1,positive regulation of ion transmembrane transport (GO:0034767),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,WNK1;PDZK1
alpha,1,peptidyl-arginine omega-N-methylation (GO:0035247),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,PRMT1;CARM1
alpha,1,maintenance of protein localization in endoplasmic reticulum (GO:0035437),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,RER1;INSIG1
alpha,1,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,INSIG1;DERL2
alpha,1,endosome to pigment granule transport (GO:0043485),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,AP1G1;BLOC1S3
alpha,1,regulation of skeletal muscle cell differentiation (GO:2001014),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,DDX5;ARNTL
alpha,1,Golgi vesicle budding (GO:0048194),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,MYO18A;SEC31A
alpha,1,podosome assembly (GO:0071800),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,FARP2;NOXO1
alpha,1,peptidyl-arginine methylation (GO:0018216),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,PRMT1;CARM1
alpha,1,regulation of leukocyte activation (GO:0002694),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,MYO18A;MIF
alpha,1,negative regulation of lipid localization (GO:1905953),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,NR1H2;PTPN2
alpha,1,endosome to melanosome transport (GO:0035646),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,AP1G1;BLOC1S3
alpha,1,cytoskeletal anchoring at plasma membrane (GO:0007016),2/9,2,9,0.0725608407043319,0.822949425709792,0,0,4.3960874821409,11.5323876773678,DAG1;TLN1
alpha,1,regulation of neuron death (GO:1901214),7/73,7,73,0.0753176721863531,0.822949425709792,0,0,1.89694185873203,4.90556843739514,CHGA;EGR1;EGLN3;EGLN2;AKT1S1;HTRA2;EPHB1
alpha,1,positive regulation of macroautophagy (GO:0016239),5/45,5,45,0.0754309995661683,0.822949425709792,0,0,2.19804374107045,5.68092527449428,WAC;TRIM13;PIP4K2B;SMCR8;SUPT5H
alpha,1,protein N-linked glycosylation via asparagine (GO:0018279),5/45,5,45,0.0754309995661683,0.822949425709792,0,0,2.19804374107045,5.68092527449428,LMAN1;OST4;SYVN1;ST3GAL6;STT3B
alpha,1,microtubule cytoskeleton organization involved in mitosis (GO:1902850),5/45,5,45,0.0754309995661683,0.822949425709792,0,0,2.19804374107045,5.68092527449428,SUN2;MAP4;PCNT;EML1;SPC25
alpha,1,positive regulation of ubiquitin-protein transferase activity (GO:0051443),4/32,4,32,0.0760207165066076,0.822949425709792,0,0,2.47279920870425,6.37178385318313,CDC20;ARRDC3;PIN1;TOPORS
alpha,1,ubiquitin-dependent ERAD pathway (GO:0030433),6/59,6,59,0.0766232376803377,0.822949425709792,0,0,2.01176884775939,5.16794223058504,TRIM13;SYVN1;DERL2;UBE4B;AUP1;STT3B
alpha,1,post-Golgi vesicle-mediated transport (GO:0006892),6/59,6,59,0.0766232376803377,0.822949425709792,0,0,2.01176884775939,5.16794223058504,RAB10;SCFD1;MYO5A;AP2A1;CCDC93;STEAP2
alpha,1,positive regulation of cellular component biogenesis (GO:0044089),8/88,8,88,0.0766498835904395,0.822949425709792,0,0,1.79839942451218,4.61920185663375,CHGA;NLGN2;ERCC1;TPR;CDC42EP2;EPHB1;SPIDR;EPHB3
alpha,1,endoplasmic reticulum mannose trimming (GO:1904380),3/20,3,20,0.0773672943794774,0.822949425709792,0,0,2.9673590504451,7.59403899383964,SYVN1;TRIM13;DERL2
alpha,1,regulation of cell development (GO:0060284),3/20,3,20,0.0773672943794774,0.822949425709792,0,0,2.9673590504451,7.59403899383964,PER2;CLOCK;ARNTL
alpha,1,regulation of glycogen biosynthetic process (GO:0005979),3/20,3,20,0.0773672943794774,0.822949425709792,0,0,2.9673590504451,7.59403899383964,INPP5K;IRS2;GCK
alpha,1,organelle disassembly (GO:1903008),3/20,3,20,0.0773672943794774,0.822949425709792,0,0,2.9673590504451,7.59403899383964,STX5;DENR;KLC1
alpha,1,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",8/89,8,89,0.0806915810524424,0.822949425709792,0,0,1.77819268940531,4.47592621950944,FZD3;DAAM1;FZD4;PSMD2;DVL3;AP2A1;PSMB10;PSMA7
alpha,1,peptidyl-asparagine modification (GO:0018196),5/46,5,46,0.0812863693386004,0.822949425709792,0,0,2.15026018148196,5.39667340836986,LMAN1;OST4;SYVN1;ST3GAL6;STT3B
alpha,1,7-methylguanosine mRNA capping (GO:0006370),4/33,4,33,0.0832095231341327,0.822949425709792,0,0,2.39786589934958,5.96203813076359,RNMT;POLR2I;SUPT5H;GTF2H4
alpha,1,7-methylguanosine RNA capping (GO:0009452),4/33,4,33,0.0832095231341327,0.822949425709792,0,0,2.39786589934958,5.96203813076359,RNMT;POLR2I;SUPT5H;GTF2H4
alpha,1,negative regulation of fat cell differentiation (GO:0045599),4/33,4,33,0.0832095231341327,0.822949425709792,0,0,2.39786589934958,5.96203813076359,TRIO;FOXO1;ZFP36L2;ARNTL
alpha,1,regulation of cellular response to stress (GO:0080135),9/105,9,105,0.0840856423014667,0.822949425709792,0,0,1.69563374311149,4.19825256179774,CASP9;NDC1;HSPA8;NUP210;NUP133;PTGES3;TPR;AKT1S1;ARNTL
alpha,1,regulation of establishment of planar polarity (GO:0090175),8/90,8,90,0.0848573245033361,0.822949425709792,0,0,1.75843499285636,4.33767924926324,FZD3;DAAM1;FZD4;PSMD2;DVL3;AP2A1;PSMB10;PSMA7
alpha,1,"regulation of mRNA splicing, via spliceosome (GO:0048024)",6/61,6,61,0.0869357398283539,0.822949425709792,0,0,1.94580921340663,4.75280645212097,HNRNPL;PTBP1;DDX5;RBM8A;SRSF4;JMJD6
alpha,1,positive regulation of leukocyte cell-cell adhesion (GO:1903039),3/21,3,21,0.0870096964954857,0.822949425709792,0,0,2.82605623851915,6.90048244331493,FAM49B;SIRPA;CD47
alpha,1,histone lysine demethylation (GO:0070076),3/21,3,21,0.0870096964954857,0.822949425709792,0,0,2.82605623851915,6.90048244331493,KDM4B;KDM3A;KDM2A
alpha,1,histone ubiquitination (GO:0016574),3/21,3,21,0.0870096964954857,0.822949425709792,0,0,2.82605623851915,6.90048244331493,PHC1;CTR9;WAC
alpha,1,negative regulation of macroautophagy (GO:0016242),3/21,3,21,0.0870096964954857,0.822949425709792,0,0,2.82605623851915,6.90048244331493,NRBP2;SCFD1;SMCR8
alpha,1,mitochondrial ATP synthesis coupled proton transport (GO:0042776),3/21,3,21,0.0870096964954857,0.822949425709792,0,0,2.82605623851915,6.90048244331493,ATP5B;CYC1;COX5B
alpha,1,protein-DNA complex disassembly (GO:0032986),3/21,3,21,0.0870096964954857,0.822949425709792,0,0,2.82605623851915,6.90048244331493,SUPT16H;SMARCC2;ARID1A
alpha,1,cellular response to alkaloid (GO:0071312),3/21,3,21,0.0870096964954857,0.822949425709792,0,0,2.82605623851915,6.90048244331493,GSTM2;CASP7;SPIDR
alpha,1,negative regulation of cell cycle arrest (GO:0071157),3/21,3,21,0.0870096964954857,0.822949425709792,0,0,2.82605623851915,6.90048244331493,MDM2;MIF;ZNF268
alpha,1,hepaticobiliary system development (GO:0061008),3/21,3,21,0.0870096964954857,0.822949425709792,0,0,2.82605623851915,6.90048244331493,NIPBL;PROX1;GFER
alpha,1,cellular response to ionizing radiation (GO:0071479),5/47,5,47,0.0873760754025935,0.822949425709792,0,0,2.10450996485468,5.1298141099098,CDKN1A;NIPBL;MDM2;SPIDR;CLOCK
alpha,1,regulation of G1/S transition of mitotic cell cycle (GO:2000045),5/47,5,47,0.0873760754025935,0.822949425709792,0,0,2.10450996485468,5.1298141099098,CDKN1A;CDC45;CDK2AP2;PTPN6;PLCB1
alpha,1,regulation of generation of precursor metabolites and energy (GO:0043467),5/47,5,47,0.0873760754025935,0.822949425709792,0,0,2.10450996485468,5.1298141099098,NDC1;NUP210;NUP133;TPR;GCK
alpha,1,low-density lipoprotein particle receptor catabolic process (GO:0032802),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,AP2A1;VLDLR
alpha,1,peptidyl-serine dephosphorylation (GO:0070262),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,NCK1;PPP1CA
alpha,1,cellular response to growth hormone stimulus (GO:0071378),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,GHR;PXN
alpha,1,3'-UTR-mediated mRNA destabilization (GO:0061158),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,CPEB3;ZFP36L2
alpha,1,phosphatidylglycerol biosynthetic process (GO:0006655),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,CDS1;CDS2
alpha,1,establishment of spindle localization (GO:0051293),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,MAP4;LLGL2
alpha,1,N-acetylneuraminate metabolic process (GO:0006054),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,NAGK;GNE
alpha,1,negative regulation of inclusion body assembly (GO:0090084),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,DNAJB2;HSPA2
alpha,1,regulation of protein exit from endoplasmic reticulum (GO:0070861),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,TMEM30A;INSIG1
alpha,1,positive regulation of acrosome reaction (GO:2000344),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,HYAL3;PLCB1
alpha,1,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,POP7;DICER1
alpha,1,glycoprotein catabolic process (GO:0006516),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,MANBA;STT3B
alpha,1,negative regulation of autophagosome assembly (GO:1902902),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,SCFD1;SMCR8
alpha,1,regulation of cytoplasmic translation (GO:2000765),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,CPEB3;CPEB2
alpha,1,nuclear mRNA surveillance (GO:0071028),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,PCID2;XRN1
alpha,1,negative regulation of centrosome duplication (GO:0010826),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,CCNF;CDK5RAP2
alpha,1,actin filament-based transport (GO:0099515),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,SUN2;MYO5A
alpha,1,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,RFX6;GCG
alpha,1,detection of light stimulus involved in visual perception (GO:0050908),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,REEP6;EYS
alpha,1,histone H2B ubiquitination (GO:0033523),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,CTR9;WAC
alpha,1,positive regulation of nuclease activity (GO:0032075),2/10,2,10,0.0877441940095754,0.822949425709792,0,0,3.95647873392681,9.62741675156564,PCNA;PARP16
alpha,1,mRNA export from nucleus (GO:0006406),9/106,9,106,0.0879984128081905,0.822949425709792,0,0,1.67963719836515,4.08225155523848,NDC1;PCID2;DDX39A;NUP210;RBM8A;NUP133;TPR;SRSF4;SRSF5
alpha,1,glycogen metabolic process (GO:0005977),4/34,4,34,0.090718401393282,0.822949425709792,0,0,2.32734043172165,5.58560554019715,PER2;PYGB;GYG2;PHKA2
alpha,1,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),4/34,4,34,0.090718401393282,0.822949425709792,0,0,2.32734043172165,5.58560554019715,NDC1;NUP210;NUP133;TPR
alpha,1,tRNA export from nucleus (GO:0006409),4/34,4,34,0.090718401393282,0.822949425709792,0,0,2.32734043172165,5.58560554019715,NDC1;NUP210;NUP133;TPR
alpha,1,regulation of intracellular protein transport (GO:0033157),4/34,4,34,0.090718401393282,0.822949425709792,0,0,2.32734043172165,5.58560554019715,RUFY3;TPR;PCNT;NDEL1
alpha,1,positive regulation of organelle organization (GO:0010638),4/34,4,34,0.090718401393282,0.822949425709792,0,0,2.32734043172165,5.58560554019715,LMAN1;ATL3;HTRA2;SMCR8
alpha,1,"DNA-templated transcription, termination (GO:0006353)",9/107,9,107,0.0920174315046254,0.822949425709792,0,0,1.6639396544552,3.96978936798766,ZNF473;CPSF7;DDX39A;RBM8A;PAPOLA;UBTF;SRSF4;SRSF5;GTF2H4
alpha,1,actin cytoskeleton reorganization (GO:0031532),6/62,6,62,0.0923633877325317,0.822949425709792,0,0,1.91442519383555,4.56020793628391,FARP2;CAPN10;NEDD9;PIP5K1A;CDC42BPB;CDC42BPA
alpha,1,negative regulation of viral life cycle (GO:1903901),6/62,6,62,0.0923633877325317,0.822949425709792,0,0,1.91442519383555,4.56020793628391,TRIM8;RSAD2;IFIT5;TRIM13;TRIM26;PROX1
alpha,1,RNA 3'-end processing (GO:0031123),6/62,6,62,0.0923633877325317,0.822949425709792,0,0,1.91442519383555,4.56020793628391,CPSF7;DDX39A;RBM8A;PAPOLA;SRSF4;SRSF5
alpha,1,response to glucose (GO:0009749),5/48,5,48,0.0936966714753413,0.822949425709792,0,0,2.06066600725354,4.87902368442438,NEUROD1;SLC30A8;HNF4A;IRS2;GCK
alpha,1,histone H4 acetylation (GO:0043967),5/48,5,48,0.0936966714753413,0.822949425709792,0,0,2.06066600725354,4.87902368442438,PER1;EPC1;KAT8;KAT7;APBB1
alpha,1,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),7/77,7,77,0.0939385279829214,0.822949425709792,0,0,1.79839942451218,4.25342085831164,CDC20;ANAPC15;PSMD2;CUL1;ANAPC5;PSMB10;PSMA7
alpha,1,regulation of vesicle-mediated transport (GO:0060627),11/139,11,139,0.0941168159137728,0.822949425709792,0,0,1.56551316810053,3.6996497524955,RAB10;SCFD1;RAB3A;SLC30A8;RAB40C;TBC1D17;TBC1D10A;RAB8A;BET1L;TBC1D10B;LLGL2
alpha,1,NAD biosynthetic process (GO:0009435),3/22,3,22,0.0971293928316533,0.822949425709792,0,0,2.69759913676828,6.29002223543884,PNP;PARP16;NUDT12
alpha,1,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),3/22,3,22,0.0971293928316533,0.822949425709792,0,0,2.69759913676828,6.29002223543884,GSTM2;ANK2;CALM3
alpha,1,negative regulation of response to endoplasmic reticulum stress (GO:1903573),3/22,3,22,0.0971293928316533,0.822949425709792,0,0,2.69759913676828,6.29002223543884,CREB3;SYVN1;NCK1
alpha,1,protein localization to cell surface (GO:0034394),3/22,3,22,0.0971293928316533,0.822949425709792,0,0,2.69759913676828,6.29002223543884,PIGU;ANK2;VCL
alpha,1,branched-chain amino acid metabolic process (GO:0009081),3/22,3,22,0.0971293928316533,0.822949425709792,0,0,2.69759913676828,6.29002223543884,GHR;ALDH6A1;PPM1K
alpha,1,negative regulation of GTPase activity (GO:0034260),3/22,3,22,0.0971293928316533,0.822949425709792,0,0,2.69759913676828,6.29002223543884,FICD;ARL2;CPEB2
alpha,1,positive regulation of catabolic process (GO:0009896),6/63,6,63,0.097969559328313,0.822949425709792,0,0,1.8840374923461,4.37680461148795,DDB1;EGLN2;HECW2;STX5;FOXO1;RNF41
alpha,1,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",6/63,6,63,0.097969559328313,0.822949425709792,0,0,1.8840374923461,4.37680461148795,CDKN1A;PCNA;PRMT1;PLAGL1;CARM1;MDM2
alpha,1,ERAD pathway (GO:0036503),7/78,7,78,0.0989600411223398,0.822949425709792,0,0,1.77534302163382,4.10643788771475,SDF2L1;TRIM13;SYVN1;DERL2;UBE4B;AUP1;STT3B
alpha,1,amino acid transport (GO:0006865),5/49,5,49,0.100244205175789,0.822949425709792,0,0,2.01861159894225,4.6431014315972,SLC7A8;SLC38A10;SLC7A1;SLC7A2;SLC38A4
alpha,1,signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),6/64,6,64,0.103752059739022,0.822949425709792,0,0,1.85459940652819,4.20206095541944,CDKN1A;PCNA;PRMT1;PLAGL1;CARM1;MDM2
alpha,1,regulation of hippo signaling (GO:0035330),2/11,2,11,0.103763053073559,0.822949425709792,0,0,3.59679884902437,8.14907046138978,NEK8;MARK3
alpha,1,negative regulation of nuclear division (GO:0051784),2/11,2,11,0.103763053073559,0.822949425709792,0,0,3.59679884902437,8.14907046138978,TOM1L2;NME6
alpha,1,UV-damage excision repair (GO:0070914),2/11,2,11,0.103763053073559,0.822949425709792,0,0,3.59679884902437,8.14907046138978,DDB1;ERCC1
alpha,1,Golgi ribbon formation (GO:0090161),2/11,2,11,0.103763053073559,0.822949425709792,0,0,3.59679884902437,8.14907046138978,MYO18A;TMED5
alpha,1,detection of light stimulus involved in sensory perception (GO:0050962),2/11,2,11,0.103763053073559,0.822949425709792,0,0,3.59679884902437,8.14907046138978,REEP6;EYS
alpha,1,relaxation of muscle (GO:0090075),2/11,2,11,0.103763053073559,0.822949425709792,0,0,3.59679884902437,8.14907046138978,GSTM2;RGS2
alpha,1,cytoplasmic mRNA processing body assembly (GO:0033962),2/11,2,11,0.103763053073559,0.822949425709792,0,0,3.59679884902437,8.14907046138978,DDX6;LSM14A
alpha,1,cellular response to interferon-beta (GO:0035458),2/11,2,11,0.103763053073559,0.822949425709792,0,0,3.59679884902437,8.14907046138978,HTRA2;UBE2K
alpha,1,negative regulation of cardiac muscle hypertrophy (GO:0010614),2/11,2,11,0.103763053073559,0.822949425709792,0,0,3.59679884902437,8.14907046138978,RGS2;FOXO1
alpha,1,carbohydrate phosphorylation (GO:0046835),2/11,2,11,0.103763053073559,0.822949425709792,0,0,3.59679884902437,8.14907046138978,ADK;IDNK
alpha,1,low-density lipoprotein receptor particle metabolic process (GO:0032799),2/11,2,11,0.103763053073559,0.822949425709792,0,0,3.59679884902437,8.14907046138978,AP2A1;VLDLR
alpha,1,positive regulation of glucose metabolic process (GO:0010907),2/11,2,11,0.103763053073559,0.822949425709792,0,0,3.59679884902437,8.14907046138978,IRS2;PTPN2
alpha,1,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),2/11,2,11,0.103763053073559,0.822949425709792,0,0,3.59679884902437,8.14907046138978,GSTM2;CALM3
alpha,1,carbohydrate derivative catabolic process (GO:1901136),2/11,2,11,0.103763053073559,0.822949425709792,0,0,3.59679884902437,8.14907046138978,MANBA;STT3B
alpha,1,regulation of chromatin silencing (GO:0031935),2/11,2,11,0.103763053073559,0.822949425709792,0,0,3.59679884902437,8.14907046138978,HIRA;CDC45
alpha,1,regulation of cellular response to heat (GO:1900034),7/79,7,79,0.104125858314743,0.822949425709792,0,0,1.75287032515745,3.96526425718921,NDC1;HSPA8;NUP210;NUP133;PTGES3;AKT1S1;TPR
alpha,1,negative regulation of protein kinase B signaling (GO:0051898),4/36,4,36,0.106660487778767,0.822949425709792,0,0,2.19804374107045,4.91945158942384,PLEKHA1;DAG1;INPP5K;PTPRJ
alpha,1,tRNA transport (GO:0051031),4/36,4,36,0.106660487778767,0.822949425709792,0,0,2.19804374107045,4.91945158942384,NDC1;NUP210;NUP133;TPR
alpha,1,regulation of sodium ion transport (GO:0002028),4/36,4,36,0.106660487778767,0.822949425709792,0,0,2.19804374107045,4.91945158942384,PER1;NKAIN3;WNK1;SCN3B
alpha,1,regulation of cardiac muscle contraction (GO:0055117),4/36,4,36,0.106660487778767,0.822949425709792,0,0,2.19804374107045,4.91945158942384,CHGA;RGS2;ANK2;CALM3
alpha,1,protein autoubiquitination (GO:0051865),5/50,5,50,0.107014246108618,0.822949425709792,0,0,1.9782393669634,4.42095610718239,TRIM13;MDM2;KLHL24;MARCH5;RNF41
alpha,1,establishment of protein localization to mitochondrion (GO:0072655),5/50,5,50,0.107014246108618,0.822949425709792,0,0,1.9782393669634,4.42095610718239,DNAJC19;FIS1;TOMM40;TOMM7;TIMM44
alpha,1,chromosome condensation (GO:0030261),3/23,3,23,0.107699406546816,0.822949425709792,0,0,2.58031221777835,5.74999665869718,NIPBL;PHF13;NCAPD3
alpha,1,melanosome organization (GO:0032438),3/23,3,23,0.107699406546816,0.822949425709792,0,0,2.58031221777835,5.74999665869718,TRAPPC6A;AP1G1;BLOC1S3
alpha,1,vesicle-mediated transport between endosomal compartments (GO:0098927),3/23,3,23,0.107699406546816,0.822949425709792,0,0,2.58031221777835,5.74999665869718,MYO1D;WDR81;AKTIP
alpha,1,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),3/23,3,23,0.107699406546816,0.822949425709792,0,0,2.58031221777835,5.74999665869718,GSTM2;ANK2;CALM3
alpha,1,positive regulation of ion transmembrane transporter activity (GO:0032414),3/23,3,23,0.107699406546816,0.822949425709792,0,0,2.58031221777835,5.74999665869718,WNK1;ANK2;PDZK1
alpha,1,negative regulation of mitotic cell cycle phase transition (GO:1901991),7/80,7,80,0.109434512417376,0.822949425709792,0,0,1.73095944609298,3.82962482226783,CDKN1A;PSMD2;CUL1;CDK2AP2;PSMB10;ZFP36L2;PSMA7
alpha,1,positive regulation of protein polymerization (GO:0032273),6/65,6,65,0.109708395943398,0.822949425709792,0,0,1.82606710796622,4.03547935017269,NUMA1;CDC42EP3;CDC42EP2;ARL2;CDK5RAP2;NCK1
alpha,1,vesicle organization (GO:0016050),10/128,10,128,0.113793703479296,0.822949425709792,0,0,1.54549950544016,3.35893930595956,SNAP25;STX12;AKTIP;SYT10;STX5;SYT14;SNX11;STX3;LAMTOR1;SNX8
alpha,1,nucleic acid metabolic process (GO:0090304),7/81,7,81,0.114884339246225,0.822949425709792,0,0,1.70958957638813,3.69926019143449,HNRNPL;PTBP1;DDX24;PDE12;XRN2;MMS19;POLR2I
alpha,1,protein acylation (GO:0043543),4/37,4,37,0.115073832458576,0.822949425709792,0,0,2.13863715347395,4.62412133610826,NAT6;ZDHHC5;CLOCK;FOXO1
alpha,1,mRNA catabolic process (GO:0006402),4/37,4,37,0.115073832458576,0.822949425709792,0,0,2.13863715347395,4.62412133610826,DDX5;XRN1;PDE12;ZFP36L2
alpha,1,protein localization to nucleus (GO:0034504),8/97,8,97,0.117449083048802,0.822949425709792,0,0,1.63153762223786,3.49434631436854,IPO13;CTDNEP1;IPO9;NUP133;CSE1L;MDM2;ARL2;TOPORS
alpha,1,positive regulation of cell cycle G1/S phase transition (GO:1902808),3/24,3,24,0.118691953110313,0.822949425709792,0,0,2.47279920870425,5.27008845571214,PAGR1;CDC45;PLCB1
alpha,1,negative regulation of cell cycle process (GO:0010948),7/82,7,82,0.120473483313874,0.822949425709792,0,0,1.68874092301754,3.57392565686618,TOM1L2;PHC1;NME6;MDM2;EPC1;MIF;ZNF268
alpha,1,histone H3-K9 demethylation (GO:0033169),2/12,2,12,0.120494345207791,0.822949425709792,0,0,3.29706561160567,6.9770934879286,KDM4B;KDM3A
alpha,1,peptidyl-arginine modification (GO:0018195),2/12,2,12,0.120494345207791,0.822949425709792,0,0,3.29706561160567,6.9770934879286,KRTCAP2;PRMT1
alpha,1,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),2/12,2,12,0.120494345207791,0.822949425709792,0,0,3.29706561160567,6.9770934879286,GSTM2;CALM3
alpha,1,regulation of inclusion body assembly (GO:0090083),2/12,2,12,0.120494345207791,0.822949425709792,0,0,3.29706561160567,6.9770934879286,DNAJB2;HSPA2
alpha,1,regulation of IRE1-mediated unfolded protein response (GO:1903894),2/12,2,12,0.120494345207791,0.822949425709792,0,0,3.29706561160567,6.9770934879286,BCL2L11;FICD
alpha,1,negative regulation of ERAD pathway (GO:1904293),2/12,2,12,0.120494345207791,0.822949425709792,0,0,3.29706561160567,6.9770934879286,USP14;DERL2
alpha,1,carbohydrate derivative transport (GO:1901264),2/12,2,12,0.120494345207791,0.822949425709792,0,0,3.29706561160567,6.9770934879286,SLC17A5;VLDLR
alpha,1,cell differentiation in hindbrain (GO:0021533),2/12,2,12,0.120494345207791,0.822949425709792,0,0,3.29706561160567,6.9770934879286,PROX1;CBLN1
alpha,1,regulation of cholesterol storage (GO:0010885),2/12,2,12,0.120494345207791,0.822949425709792,0,0,3.29706561160567,6.9770934879286,EHD1;NR1H2
alpha,1,histone arginine methylation (GO:0034969),2/12,2,12,0.120494345207791,0.822949425709792,0,0,3.29706561160567,6.9770934879286,PRMT1;CARM1
alpha,1,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),2/12,2,12,0.120494345207791,0.822949425709792,0,0,3.29706561160567,6.9770934879286,MIS12;CENPC
alpha,1,pre-mRNA cleavage required for polyadenylation (GO:0098789),2/12,2,12,0.120494345207791,0.822949425709792,0,0,3.29706561160567,6.9770934879286,CPSF7;TUT1
alpha,1,eye photoreceptor cell development (GO:0042462),2/12,2,12,0.120494345207791,0.822949425709792,0,0,3.29706561160567,6.9770934879286,RORB;TOPORS
alpha,1,histone H3 deacetylation (GO:0070932),2/12,2,12,0.120494345207791,0.822949425709792,0,0,3.29706561160567,6.9770934879286,PER2;PER1
alpha,1,regulation of protein localization to cell periphery (GO:1904375),2/12,2,12,0.120494345207791,0.822949425709792,0,0,3.29706561160567,6.9770934879286,SPTBN1;APPL1
alpha,1,positive regulation of pseudopodium assembly (GO:0031274),2/12,2,12,0.120494345207791,0.822949425709792,0,0,3.29706561160567,6.9770934879286,CDC42EP3;CDC42EP2
alpha,1,kinetochore organization (GO:0051383),2/12,2,12,0.120494345207791,0.822949425709792,0,0,3.29706561160567,6.9770934879286,MIS12;CENPC
alpha,1,regulation of pseudopodium assembly (GO:0031272),2/12,2,12,0.120494345207791,0.822949425709792,0,0,3.29706561160567,6.9770934879286,CDC42EP3;CDC42EP2
alpha,1,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",2/12,2,12,0.120494345207791,0.822949425709792,0,0,3.29706561160567,6.9770934879286,MDM2;MIF
alpha,1,regulation of exocytosis (GO:0017157),5/52,5,52,0.12120191101862,0.822949425709792,0,0,1.90215323746481,4.01410910368802,RAB10;RAB3A;RAB40C;RAB8A;LLGL2
alpha,1,telomere maintenance (GO:0000723),5/52,5,52,0.12120191101862,0.822949425709792,0,0,1.90215323746481,4.01410910368802,POLD3;CTC1;PCNA;PTGES3;APEX1
alpha,1,positive regulation of cellular protein localization (GO:1903829),6/67,6,67,0.122131185021572,0.822949425709792,0,0,1.77155764205678,3.72498254996918,NUMA1;RUFY3;TPR;KAT7;STX3;PCNT
alpha,1,cell morphogenesis involved in neuron differentiation (GO:0048667),8/98,8,98,0.122584919848303,0.822949425709792,0,0,1.6148892791538,3.38957389679106,RAB10;PARD6B;RAB3A;LRFN4;SLITRK1;LRRN1;APBB1;RAB8A
alpha,1,negative regulation of cell motility (GO:2000146),8/98,8,98,0.122584919848303,0.822949425709792,0,0,1.6148892791538,3.38957389679106,DACH1;MCTP1;DAG1;PIN1;PTPRJ;SRGAP3;VCL;RNF41
alpha,1,protein localization to organelle (GO:0033365),8/98,8,98,0.122584919848303,0.822949425709792,0,0,1.6148892791538,3.38957389679106,CTDNEP1;EHD1;CEP68;TMEM30A;MDM2;ANK2;MARCH5;TOPORS
alpha,1,protein monoubiquitination (GO:0006513),4/38,4,38,0.123767688106755,0.822949425709792,0,0,2.08235722838253,4.35077089604134,CTR9;WAC;KLHL22;TOPORS
alpha,1,regulation of dendrite development (GO:0050773),4/38,4,38,0.123767688106755,0.822949425709792,0,0,2.08235722838253,4.35077089604134,FXR2;HECW2;VLDLR;CPEB3
alpha,1,mitotic sister chromatid segregation (GO:0000070),7/83,7,83,0.126199904025519,0.822949425709792,0,0,1.6683946468366,3.45339020785643,HIRA;NIPBL;MIS12;KLHL22;PHF13;KIF22;NCAPD3
alpha,1,positive regulation of ubiquitin protein ligase activity (GO:1904668),7/83,7,83,0.126199904025519,0.822949425709792,0,0,1.6683946468366,3.45339020785643,CDC20;ANAPC15;PSMD2;CUL1;ANAPC5;PSMB10;PSMA7
alpha,1,regulation of gene silencing by miRNA (GO:0060964),6/68,6,68,0.128591270738555,0.822949425709792,0,0,1.74550532379124,3.58023450629069,NDC1;NUP210;NUP133;TPR;H3F3A;POLR2I
alpha,1,negative regulation of protein serine/threonine kinase activity (GO:0071901),6/68,6,68,0.128591270738555,0.822949425709792,0,0,1.74550532379124,3.58023450629069,RGS2;DUSP1;SMPD1;SPRY4;INPP5K;PTPRJ
alpha,1,positive regulation of autophagy (GO:0010508),6/68,6,68,0.128591270738555,0.822949425709792,0,0,1.74550532379124,3.58023450629069,TRIM8;TFEB;TRIM13;WAC;SUPT5H;FOXO1
alpha,1,cellular response to UV (GO:0034644),6/68,6,68,0.128591270738555,0.822949425709792,0,0,1.74550532379124,3.58023450629069,CASP9;DDB1;CDKN1A;PCNA;ERCC1;HYAL3
alpha,1,positive regulation of microtubule polymerization (GO:0031116),3/25,3,25,0.130078707066916,0.822949425709792,0,0,2.37388724035608,4.84181738339349,NUMA1;ARL2;CDK5RAP2
alpha,1,histone monoubiquitination (GO:0010390),3/25,3,25,0.130078707066916,0.822949425709792,0,0,2.37388724035608,4.84181738339349,DDB1;CTR9;WAC
alpha,1,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",3/25,3,25,0.130078707066916,0.822949425709792,0,0,2.37388724035608,4.84181738339349,SUPT16H;CTR9;SUPT5H
alpha,1,macromolecule modification (GO:0043412),3/25,3,25,0.130078707066916,0.822949425709792,0,0,2.37388724035608,4.84181738339349,ST3GAL6;PRDM10;ADAT3
alpha,1,receptor catabolic process (GO:0032801),3/25,3,25,0.130078707066916,0.822949425709792,0,0,2.37388724035608,4.84181738339349,SNX25;AP2A1;VLDLR
alpha,1,positive regulation of microtubule polymerization or depolymerization (GO:0031112),3/25,3,25,0.130078707066916,0.822949425709792,0,0,2.37388724035608,4.84181738339349,NUMA1;ARL2;CDK5RAP2
alpha,1,regulation of chemotaxis (GO:0050920),3/25,3,25,0.130078707066916,0.822949425709792,0,0,2.37388724035608,4.84181738339349,USP14;STX3;PTPN2
alpha,1,positive regulation of dephosphorylation (GO:0035306),3/25,3,25,0.130078707066916,0.822949425709792,0,0,2.37388724035608,4.84181738339349,SMPD1;PIN1;CALM3
alpha,1,chaperone mediated protein folding requiring cofactor (GO:0051085),3/25,3,25,0.130078707066916,0.822949425709792,0,0,2.37388724035608,4.84181738339349,HSPA8;PTGES3;HSPA2
alpha,1,"protein alpha-1,2-demannosylation (GO:0036508)",3/25,3,25,0.130078707066916,0.822949425709792,0,0,2.37388724035608,4.84181738339349,SYVN1;TRIM13;DERL2
alpha,1,chemical homeostasis (GO:0048878),4/39,4,39,0.132730571676684,0.822949425709792,0,0,2.0289634532958,4.09735774640738,HNF4A;NR1H2;IRS2;KLHL3
alpha,1,protein sumoylation (GO:0016925),6/69,6,69,0.135212484042349,0.822949425709792,0,0,1.72020814518557,3.44197786443864,NDC1;PCNA;NUP210;NUP133;TPR;TOPORS
alpha,1,cellular response to hypoxia (GO:0071456),10/133,10,133,0.136309908408083,0.822949425709792,0,0,1.48739802027324,2.96412284024299,SLC8A3;EGLN3;ACAA2;TBL2;EGLN2;PSMD2;MDM2;CPEB2;PSMB10;PSMA7
alpha,1,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",2/13,2,13,0.137825284084191,0.822949425709792,0,0,3.0434451799437,6.03140364700171,PTBP1;SRSF4
alpha,1,mRNA cleavage involved in mRNA processing (GO:0098787),2/13,2,13,0.137825284084191,0.822949425709792,0,0,3.0434451799437,6.03140364700171,CPSF7;TUT1
alpha,1,positive regulation of glycogen biosynthetic process (GO:0045725),2/13,2,13,0.137825284084191,0.822949425709792,0,0,3.0434451799437,6.03140364700171,IRS2;GCK
alpha,1,regulation of triglyceride biosynthetic process (GO:0010866),2/13,2,13,0.137825284084191,0.822949425709792,0,0,3.0434451799437,6.03140364700171,CTDNEP1;NR1H2
alpha,1,response to UV-B (GO:0010224),2/13,2,13,0.137825284084191,0.822949425709792,0,0,3.0434451799437,6.03140364700171,CDKN1A;HYAL3
alpha,1,establishment of chromosome localization (GO:0051303),2/13,2,13,0.137825284084191,0.822949425709792,0,0,3.0434451799437,6.03140364700171,KIF22;NDEL1
alpha,1,protein localization to endoplasmic reticulum (GO:0070972),2/13,2,13,0.137825284084191,0.822949425709792,0,0,3.0434451799437,6.03140364700171,CTAGE5;ANK2
alpha,1,dicarboxylic acid catabolic process (GO:0043649),2/13,2,13,0.137825284084191,0.822949425709792,0,0,3.0434451799437,6.03140364700171,GAD1;GLUL
alpha,1,ribonucleoprotein complex disassembly (GO:0032988),2/13,2,13,0.137825284084191,0.822949425709792,0,0,3.0434451799437,6.03140364700171,DENR;KLC1
alpha,1,positive regulation of supramolecular fiber organization (GO:1902905),7/85,7,85,0.138055526561982,0.822949425709792,0,0,1.62913830220516,3.2258556254215,NUMA1;CDC42EP3;CDC42EP2;ARL2;PROX1;CDK5RAP2;NCK1
alpha,1,regulation of mitotic nuclear division (GO:0007088),7/85,7,85,0.138055526561982,0.822949425709792,0,0,1.62913830220516,3.2258556254215,TOM1L2;NME6;TPR;PIN1;KNTC1;CEP85;CDC14A
alpha,1,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),8/101,8,101,0.138684050020456,0.822949425709792,0,0,1.5669222708621,3.09554418939631,NDC1;DDX39A;NUP210;RBM8A;NUP133;TPR;SRSF4;SRSF5
alpha,1,glycolytic process through glucose-6-phosphate (GO:0061620),3/26,3,26,0.141831037869299,0.822949425709792,0,0,2.28258388495777,4.45815750742534,ALDOA;GAPDH;GCK
alpha,1,organophosphate ester transport (GO:0015748),3/26,3,26,0.141831037869299,0.822949425709792,0,0,2.28258388495777,4.45815750742534,PITPNA;STARD10;PITPNC1
alpha,1,canonical glycolysis (GO:0061621),3/26,3,26,0.141831037869299,0.822949425709792,0,0,2.28258388495777,4.45815750742534,ALDOA;GAPDH;GCK
alpha,1,glucose catabolic process to pyruvate (GO:0061718),3/26,3,26,0.141831037869299,0.822949425709792,0,0,2.28258388495777,4.45815750742534,ALDOA;GAPDH;GCK
alpha,1,"negative regulation of gene expression, epigenetic (GO:0045814)",3/26,3,26,0.141831037869299,0.822949425709792,0,0,2.28258388495777,4.45815750742534,H3F3A;EPC1;JARID2
alpha,1,prostaglandin metabolic process (GO:0006693),3/26,3,26,0.141831037869299,0.822949425709792,0,0,2.28258388495777,4.45815750742534,FAM213B;PTGES3;MIF
alpha,1,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",3/26,3,26,0.141831037869299,0.822949425709792,0,0,2.28258388495777,4.45815750742534,DDX5;MDM2;MIF
alpha,1,negative regulation of insulin receptor signaling pathway (GO:0046627),3/26,3,26,0.141831037869299,0.822949425709792,0,0,2.28258388495777,4.45815750742534,INPP5K;PTPN2;NCK1
alpha,1,signal transduction by p53 class mediator (GO:0072331),4/40,4,40,0.141950519829675,0.822949425709792,0,0,1.9782393669634,3.86207069042145,DDX5;PPP1R13B;ZNF385B;KRCC1
alpha,1,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",4/40,4,40,0.141950519829675,0.822949425709792,0,0,1.9782393669634,3.86207069042145,HNRNPL;PTBP1;DDX5;RBM8A
alpha,1,regulation of proteasomal protein catabolic process (GO:0061136),4/40,4,40,0.141950519829675,0.822949425709792,0,0,1.9782393669634,3.86207069042145,ALAD;USP14;RAD23B;UCHL5
alpha,1,Golgi to plasma membrane transport (GO:0006893),4/40,4,40,0.141950519829675,0.822949425709792,0,0,1.9782393669634,3.86207069042145,RAB10;CCDC93;STEAP2;SPTBN1
alpha,1,protein targeting to mitochondrion (GO:0006626),5/55,5,55,0.144017192052228,0.822949425709792,0,0,1.79839942451218,3.48497904375665,DNAJC19;FIS1;TOMM40;TOMM7;TIMM44
alpha,1,Rab protein signal transduction (GO:0032482),6/71,6,71,0.14892288869511,0.822949425709792,0,0,1.67175157771555,3.18356105242682,RAB2A;RAB10;RAB3A;RAB40C;RAB19;RAB8A
alpha,1,regulation of cellular localization (GO:0060341),4/41,4,41,0.151415162140117,0.822949425709792,0,0,1.92998962630576,3.64329892500963,PARD6B;MCTP1;NUMA1;DVL3
alpha,1,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),4/41,4,41,0.151415162140117,0.822949425709792,0,0,1.92998962630576,3.64329892500963,PTPRJ;CBL;ARHGEF7;PTPN2
alpha,1,regulation of intracellular transport (GO:0032386),4/41,4,41,0.151415162140117,0.822949425709792,0,0,1.92998962630576,3.64329892500963,SCFD1;NUMA1;CAPN10;NDEL1
alpha,1,positive regulation of synapse assembly (GO:0051965),3/27,3,27,0.153920218133819,0.822949425709792,0,0,2.19804374107045,4.11324513655605,NLGN2;EPHB1;EPHB3
alpha,1,response to growth factor (GO:0070848),3/27,3,27,0.153920218133819,0.822949425709792,0,0,2.19804374107045,4.11324513655605,MAPK7;HTRA2;EMD
alpha,1,negative regulation of cellular response to insulin stimulus (GO:1900077),3/27,3,27,0.153920218133819,0.822949425709792,0,0,2.19804374107045,4.11324513655605,INPP5K;PTPN2;NCK1
alpha,1,neuron cell-cell adhesion (GO:0007158),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,NLGN2;NCAM2
alpha,1,ribonucleoside monophosphate biosynthetic process (GO:0009156),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,ADK;PFAS
alpha,1,positive regulation of cardiac muscle cell proliferation (GO:0060045),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,PIM1;BMPR1A
alpha,1,positive regulation of neural precursor cell proliferation (GO:2000179),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,FZD3;PROX1
alpha,1,regulation of Golgi organization (GO:1903358),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,EHD3;STX5
alpha,1,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,CPEB3;ZFP36L2
alpha,1,ubiquinone metabolic process (GO:0006743),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,UBIAD1;COQ6
alpha,1,endoplasmic reticulum tubular network organization (GO:0071786),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,RAB10;RTN3
alpha,1,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,MDM2;MIF
alpha,1,oligodendrocyte differentiation (GO:0048709),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,SLC8A3;PTPRZ1
alpha,1,positive regulation of mitochondrial fission (GO:0090141),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,FIS1;MARCH5
alpha,1,regulation of neural precursor cell proliferation (GO:2000177),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,PTPRZ1;PROX1
alpha,1,purine-containing compound salvage (GO:0043101),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,PNP;ADK
alpha,1,positive regulation of glycogen metabolic process (GO:0070875),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,IRS2;GCK
alpha,1,quinone biosynthetic process (GO:1901663),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,UBIAD1;COQ6
alpha,1,Golgi to vacuole transport (GO:0006896),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,EHD3;AP1G1
alpha,1,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,CREB3;SYVN1
alpha,1,cellular response to nitrogen compound (GO:1901699),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,PDE12;SPIDR
alpha,1,nucleoside triphosphate metabolic process (GO:0009141),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,CMPK2;DCTPP1
alpha,1,regulation of protein modification by small protein conjugation or removal (GO:1903320),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,DNAJB2;EGR1
alpha,1,positive regulation of calcium ion-dependent exocytosis (GO:0045956),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,SYT10;HYAL3
alpha,1,positive regulation of transporter activity (GO:0032411),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,WNK1;PDZK1
alpha,1,negative regulation of T cell receptor signaling pathway (GO:0050860),2/14,2,14,0.155652645806718,0.822949425709792,0,0,2.82605623851915,5.25682742349018,PTPRJ;PTPN2
alpha,1,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),6/72,6,72,0.156003840596336,0.822949425709792,0,0,1.64853280580284,3.06276731425712,CDC20;ANAPC15;PSMD2;ANAPC5;PSMB10;PSMA7
alpha,1,nuclear import (GO:0051170),6/72,6,72,0.156003840596336,0.822949425709792,0,0,1.64853280580284,3.06276731425712,IPO13;IPO9;SNRPD2;NUP133;CSE1L;TPR
alpha,1,organelle membrane fusion (GO:0090174),6/72,6,72,0.156003840596336,0.822949425709792,0,0,1.64853280580284,3.06276731425712,SNAP25;STX12;SYT10;STX5;SYT14;STX3
alpha,1,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),7/88,7,88,0.156807617558183,0.822949425709792,0,0,1.57359949644816,2.9154637928602,CDC20;ANAPC15;PSMD2;CUL1;ANAPC5;PSMB10;PSMA7
alpha,1,positive regulation of protein transport (GO:0051222),5/57,5,57,0.160175650327021,0.822949425709792,0,0,1.73529769031877,3.17817039124395,RUFY3;TPR;MYO18A;ANG;PCNT
alpha,1,peptide transport (GO:0015833),4/42,4,42,0.161111790834244,0.822949425709792,0,0,1.8840374923461,3.4396058630144,NDC1;TOM1;ABCB9;LRP1B
alpha,1,DNA duplex unwinding (GO:0032508),4/42,4,42,0.161111790834244,0.822949425709792,0,0,1.8840374923461,3.4396058630144,CUL4A;DDB1;RAD23B;GTF2H4
alpha,1,regulation of stress-activated MAPK cascade (GO:0032872),4/42,4,42,0.161111790834244,0.822949425709792,0,0,1.8840374923461,3.4396058630144,PER1;NBR1;EPHB1;FOXO1
alpha,1,spliceosomal complex assembly (GO:0000245),4/42,4,42,0.161111790834244,0.822949425709792,0,0,1.8840374923461,3.4396058630144,SNRPD2;SRSF5;CRNKL1;LUC7L2
alpha,1,regulation of cellular metabolic process (GO:0031323),4/42,4,42,0.161111790834244,0.822949425709792,0,0,1.8840374923461,3.4396058630144,RNF34;CACYBP;LAMTOR1;RNF41
alpha,1,mRNA transport (GO:0051028),8/105,8,105,0.161697451620554,0.822949425709792,0,0,1.50722999387688,2.74621566192173,NDC1;DDX39A;NUP210;RBM8A;NUP133;TPR;SRSF4;SRSF5
alpha,1,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),6/73,6,73,0.163229469225889,0.822949425709792,0,0,1.62595016462745,2.94719447423452,PSMD2;CCNF;CUL1;FBXL15;PSMB10;PSMA7
alpha,1,regulation of fat cell differentiation (GO:0045598),6/73,6,73,0.163229469225889,0.822949425709792,0,0,1.62595016462745,2.94719447423452,TRIO;CARM1;ASXL2;FOXO1;ZFP36L2;ARNTL
alpha,1,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),6/73,6,73,0.163229469225889,0.822949425709792,0,0,1.62595016462745,2.94719447423452,CDC20;ANAPC15;PSMD2;ANAPC5;PSMB10;PSMA7
alpha,1,negative regulation of translation (GO:0017148),7/89,7,89,0.163305329316426,0.822949425709792,0,0,1.55591860322964,2.81953244887599,FXR2;TPR;EIF4E2;CPEB3;GAPDH;CPEB2;GIGYF2
alpha,1,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),3/28,3,28,0.166317605986435,0.822949425709792,0,0,2.11954217888936,3.80215351750091,DDX5;UFM1;CARM1
alpha,1,telomere maintenance via telomere lengthening (GO:0010833),3/28,3,28,0.166317605986435,0.822949425709792,0,0,2.11954217888936,3.80215351750091,CTC1;PTGES3;NHP2
alpha,1,endocytic recycling (GO:0032456),3/28,3,28,0.166317605986435,0.822949425709792,0,0,2.11954217888936,3.80215351750091,EHD1;EHD3;EHD4
alpha,1,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),3/28,3,28,0.166317605986435,0.822949425709792,0,0,2.11954217888936,3.80215351750091,MAPK7;PPP2R1B;HTRA2
alpha,1,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),3/28,3,28,0.166317605986435,0.822949425709792,0,0,2.11954217888936,3.80215351750091,ARHGEF7;CRKL;LIMS1
alpha,1,regulation of protein targeting to membrane (GO:0090313),3/28,3,28,0.166317605986435,0.822949425709792,0,0,2.11954217888936,3.80215351750091,FIS1;INPP5K;PDZK1
alpha,1,negative regulation of organelle assembly (GO:1902116),3/28,3,28,0.166317605986435,0.822949425709792,0,0,2.11954217888936,3.80215351750091,SCFD1;SMCR8;CDK5RAP2
alpha,1,protein N-linked glycosylation (GO:0006487),6/74,6,74,0.170595181087296,0.822949425709792,0,0,1.60397786510546,2.83657372872574,LMAN1;OST4;KRTCAP2;SYVN1;ST3GAL6;STT3B
alpha,1,regulation of ion transmembrane transporter activity (GO:0032412),4/43,4,43,0.171027427177237,0.822949425709792,0,0,1.8402226669427,3.24970688471777,WNK1;ANK2;PDZK1;SCN3B
alpha,1,cellular response to growth factor stimulus (GO:0071363),10/140,10,140,0.171439380686517,0.822949425709792,0,0,1.41302811925957,2.49191117739791,EHD1;WWOX;MAPK7;PDE3A;HTRA2;INPP5K;EMD;ZFP36L2;BMPR1A;LIMS1
alpha,1,neuron differentiation (GO:0030182),10/140,10,140,0.171439380686517,0.822949425709792,0,0,1.41302811925957,2.49191117739791,NEUROD1;NRBP2;FZD3;FXR2;MYT1L;FZD4;WNK1;PIN1;RORB;PROX1
alpha,1,membrane repolarization during cardiac muscle cell action potential (GO:0086013),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,KCNA5;KCNJ3
alpha,1,ubiquinone biosynthetic process (GO:0006744),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,UBIAD1;COQ6
alpha,1,catecholamine metabolic process (GO:0006584),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,DDC;LRTOMT
alpha,1,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,INPP5K;CALM3
alpha,1,digestive tract morphogenesis (GO:0048546),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,NIPBL;EPHB3
alpha,1,histone H4-K8 acetylation (GO:0043982),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,KAT8;KAT7
alpha,1,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,PTPRJ;PTPN2
alpha,1,transport along microtubule (GO:0010970),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,HSPA8;DYNLL1
alpha,1,regulation of mitotic metaphase/anaphase transition (GO:0030071),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,HECW2;ANAPC5
alpha,1,anterograde synaptic vesicle transport (GO:0048490),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,AP3M1;BLOC1S3
alpha,1,positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,SUPT16H;CTR9
alpha,1,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,CCT6A;NHP2
alpha,1,negative regulation of cellular component movement (GO:0051271),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,ACTN1;PIN1
alpha,1,regulation of mitotic sister chromatid separation (GO:0010965),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,HECW2;TPR
alpha,1,regulation of exit from mitosis (GO:0007096),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,KNTC1;CDC14A
alpha,1,negative regulation of RNA metabolic process (GO:0051253),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,PTBP1;PTBP3
alpha,1,positive regulation of double-strand break repair (GO:2000781),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,MMS19;SPIDR
alpha,1,negative regulation of mRNA processing (GO:0050686),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,PTBP1;SRSF4
alpha,1,synaptic vesicle transport along microtubule (GO:0099517),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,AP3M1;BLOC1S3
alpha,1,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,TNFSF10;HTRA2
alpha,1,positive regulation of protein export from nucleus (GO:0046827),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,TPR;EMD
alpha,1,regulation of peptide secretion (GO:0002791),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,ARFIP1;LLGL2
alpha,1,histone H4-K5 acetylation (GO:0043981),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,KAT8;KAT7
alpha,1,establishment of protein localization to endoplasmic reticulum (GO:0072599),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,RAB10;SPCS1
alpha,1,nucleobase-containing small molecule catabolic process (GO:0034656),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,ENTPD3;ADPRM
alpha,1,cellular response to corticosteroid stimulus (GO:0071384),2/15,2,15,0.173882092006311,0.822949425709792,0,0,2.63765248928454,4.61425081862627,BCL2L11;ZFP36L2
alpha,1,phospholipid transport (GO:0015914),5/59,5,59,0.177027351100843,0.822949425709792,0,0,1.67647403979949,2.90273270692343,TMEM30A;PITPNA;ATP10D;STARD10;PITPNC1
alpha,1,response to light stimulus (GO:0009416),5/59,5,59,0.177027351100843,0.822949425709792,0,0,1.67647403979949,2.90273270692343,PER2;COPS3;PER1;UBE4B;CLOCK
alpha,1,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),5/59,5,59,0.177027351100843,0.822949425709792,0,0,1.67647403979949,2.90273270692343,PTPRJ;ARAP1;ARHGEF7;CBL;PTPN2
alpha,1,cholesterol homeostasis (GO:0042632),5/59,5,59,0.177027351100843,0.822949425709792,0,0,1.67647403979949,2.90273270692343,EHD1;INSIG1;NR1H2;LAMTOR1;CYP7B1
alpha,1,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),5/59,5,59,0.177027351100843,0.822949425709792,0,0,1.67647403979949,2.90273270692343,SLITRK1;SS18L1;ARHGEF7;CRKL;LIMS1
alpha,1,sterol homeostasis (GO:0055092),5/59,5,59,0.177027351100843,0.822949425709792,0,0,1.67647403979949,2.90273270692343,EHD1;INSIG1;NR1H2;LAMTOR1;CYP7B1
alpha,1,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),3/29,3,29,0.178994804501005,0.822949425709792,0,0,2.04645451754835,3.5207172796412,PER1;CLOCK;ARNTL
alpha,1,regulation of mRNA processing (GO:0050684),3/29,3,29,0.178994804501005,0.822949425709792,0,0,2.04645451754835,3.5207172796412,SLTM;PAPOLA;JMJD6
alpha,1,positive regulation of phosphate metabolic process (GO:0045937),3/29,3,29,0.178994804501005,0.822949425709792,0,0,2.04645451754835,3.5207172796412,PTGES3;ANG;MIF
alpha,1,lytic vacuole organization (GO:0080171),3/29,3,29,0.178994804501005,0.822949425709792,0,0,2.04645451754835,3.5207172796412,AKTIP;TFEB;LAMTOR1
alpha,1,cardiac muscle cell action potential involved in contraction (GO:0086002),3/29,3,29,0.178994804501005,0.822949425709792,0,0,2.04645451754835,3.5207172796412,KCNA5;ANK2;SCN3B
alpha,1,eye development (GO:0001654),4/44,4,44,0.181148884250177,0.822949425709792,0,0,1.79839942451218,3.0724503568372,NIPBL;SALL2;BLOC1S3;FBN1
alpha,1,protein transmembrane import into intracellular organelle (GO:0044743),4/44,4,44,0.181148884250177,0.822949425709792,0,0,1.79839942451218,3.0724503568372,DNAJC19;TOMM40;TOMM7;TIMM44
alpha,1,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),4/44,4,44,0.181148884250177,0.822949425709792,0,0,1.79839942451218,3.0724503568372,DDX5;PPP1R13B;ZNF385B;KRCC1
alpha,1,dephosphorylation (GO:0016311),9/125,9,125,0.181708875125334,0.822949425709792,0,0,1.42433234421365,2.42898439382933,PPP1CB;CTDNEP1;SDHAF2;PTPRZ1;DUSP1;CTDSP1;INPP5K;PTPN6;PPP1CA
alpha,1,cell junction assembly (GO:0034329),5/60,5,60,0.185694520791036,0.822949425709792,0,0,1.64853280580284,2.775556077747,PARD6B;CDH15;TLN1;VCL;LIMS1
alpha,1,negative regulation of phosphorylation (GO:0042326),6/76,6,76,0.185727674206062,0.822949425709792,0,0,1.5617679212869,2.62919536983839,CDKN1A;CDKN2C;PDE12;INPP5K;IRS2;DYNLL1
alpha,1,"DNA-templated transcription, elongation (GO:0006354)",8/109,8,109,0.186356327346212,0.822949425709792,0,0,1.45191880144103,2.43936108245633,SUPT16H;PCID2;TAF15;CTR9;UBTF;SUPT5H;POLR2I;GTF2H4
alpha,1,negative regulation of hydrolase activity (GO:0051346),8/109,8,109,0.186356327346212,0.822949425709792,0,0,1.45191880144103,2.43936108245633,MYO1D;MAPK7;WDR81;FICD;WNK1;SLC7A14;ARL2;CPEB2
alpha,1,nuclear export (GO:0051168),7/93,7,93,0.190446776389627,0.822949425709792,0,0,1.48899737298321,2.46932720448788,DDX39A;NUP133;RBM8A;CSE1L;TPR;SRSF4;SRSF5
alpha,1,regulation of striated muscle contraction (GO:0006942),3/30,3,30,0.191923800016198,0.822949425709792,0,0,1.9782393669634,3.26539438307751,SLC8A3;ANK2;CALM3
alpha,1,regulation of embryonic development (GO:0045995),3/30,3,30,0.191923800016198,0.822949425709792,0,0,1.9782393669634,3.26539438307751,NIPBL;DAG1;PLCB1
alpha,1,lysosome localization (GO:0032418),3/30,3,30,0.191923800016198,0.822949425709792,0,0,1.9782393669634,3.26539438307751,CHGA;LAMTOR1;NDEL1
alpha,1,amino acid transmembrane transport (GO:0003333),3/30,3,30,0.191923800016198,0.822949425709792,0,0,1.9782393669634,3.26539438307751,SLC7A8;SLC38A10;SLC38A4
alpha,1,peptidyl-threonine dephosphorylation (GO:0035970),2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,DUSP1;PPP1CA
alpha,1,regulation of actin nucleation (GO:0051125),2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,WIPF2;ARFIP1
alpha,1,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,CPEB3;ZFP36L2
alpha,1,DNA strand elongation involved in DNA replication (GO:0006271),2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,PCNA;GINS4
alpha,1,positive regulation of cardiac muscle tissue growth (GO:0055023),2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,PIM1;BMPR1A
alpha,1,glucose 6-phosphate metabolic process (GO:0051156),2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,G6PC2;GCK
alpha,1,positive regulation of regulated secretory pathway (GO:1903307),2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,RAB3A;SYT10
alpha,1,stabilization of membrane potential (GO:0030322),2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,KCNK16;KCNK1
alpha,1,ventricular cardiac muscle cell action potential (GO:0086005),2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,ANK2;SCN3B
alpha,1,dendritic spine morphogenesis (GO:0060997),2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,EPHB1;EPHB3
alpha,1,miRNA metabolic process (GO:0010586),2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,DGCR8;DICER1
alpha,1,positive regulation of triglyceride metabolic process (GO:0090208),2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,CTDNEP1;NR1H2
alpha,1,positive regulation of cyclic nucleotide metabolic process (GO:0030801),2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,CHGA;CALM3
alpha,1,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,CDC45;PLCB1
alpha,1,aorta morphogenesis (GO:0035909),2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,PROX1;BMPR1A
alpha,1,detection of visible light (GO:0009584),2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,REEP6;EYS
alpha,1,neurotransmitter transport (GO:0006836),2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,SNAP25;GLUL
alpha,1,regulation of glucose transport (GO:0010827),2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,INPP5K;APPL1
alpha,1,positive regulation of response to endoplasmic reticulum stress (GO:1905898),2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,BCL2L11;NCK1
alpha,1,negative regulation of lipid storage (GO:0010888),2/16,2,16,0.192427536685059,0.822949425709792,0,0,2.47279920870425,4.07526119912908,NR1H2;PTPN2
alpha,1,double-strand break repair via homologous recombination (GO:0000724),6/77,6,77,0.193484504514914,0.822949425709792,0,0,1.54148522101044,2.53197865003686,NIPBL;CDC45;RNF138;MCM9;GINS4;SPIDR
alpha,1,positive regulation of apoptotic signaling pathway (GO:2001235),6/77,6,77,0.193484504514914,0.822949425709792,0,0,1.54148522101044,2.53197865003686,TRAF7;FIS1;WWOX;BCL2L11;TNFSF10;HTRA2
alpha,1,non-canonical Wnt signaling pathway (GO:0035567),9/128,9,128,0.199558222562323,0.822949425709792,0,0,1.39094955489614,2.24172279693844,FZD3;DAAM1;FZD4;PSMD2;DVL3;AP2A1;PLCB1;PSMB10;PSMA7
alpha,1,negative regulation of ubiquitin protein ligase activity (GO:1904667),6/78,6,78,0.20136154401047,0.822949425709792,0,0,1.52172258997185,2.43879367005085,CDC20;ANAPC15;PSMD2;ANAPC5;PSMB10;PSMA7
alpha,1,hexose metabolic process (GO:0019318),4/46,4,46,0.20195582370682,0.822949425709792,0,0,1.72020814518557,2.75182780719694,MAN2A2;DCXR;IRS2;ALDOA
alpha,1,potassium ion transport (GO:0006813),5/62,5,62,0.203472699871926,0.822949425709792,0,0,1.59535432819629,2.54016055017758,KCNB2;KCNK16;KCNA5;KCNK1;KCNJ3
alpha,1,vesicle fusion (GO:0006906),7/95,7,95,0.204659353076821,0.822949425709792,0,0,1.45765005986777,2.31242826176427,SNAP25;STX12;SYT10;STX5;SYT14;STX3;RAB8A
alpha,1,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),3/31,3,31,0.205077081355393,0.822949425709792,0,0,1.91442519383555,3.03315662660061,PPP1R13B;BCL2L11;DYNLL1
alpha,1,negative regulation of DNA biosynthetic process (GO:2000279),3/31,3,31,0.205077081355393,0.822949425709792,0,0,1.91442519383555,3.03315662660061,CTC1;DACH1;XRN1
alpha,1,'de novo' posttranslational protein folding (GO:0051084),3/31,3,31,0.205077081355393,0.822949425709792,0,0,1.91442519383555,3.03315662660061,HSPA8;PTGES3;HSPA2
alpha,1,positive regulation of cation channel activity (GO:2001259),3/31,3,31,0.205077081355393,0.822949425709792,0,0,1.91442519383555,3.03315662660061,GSTM2;ANK2;CALM3
alpha,1,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),3/31,3,31,0.205077081355393,0.822949425709792,0,0,1.91442519383555,3.03315662660061,PAGR1;UFM1;CARM1
alpha,1,regulation of developmental growth (GO:0048638),3/31,3,31,0.205077081355393,0.822949425709792,0,0,1.91442519383555,3.03315662660061,GHR;NIPBL;PLCB1
alpha,1,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),3/31,3,31,0.205077081355393,0.822949425709792,0,0,1.91442519383555,3.03315662660061,PPP1R13B;BCL2L11;DYNLL1
alpha,1,nuclear envelope organization (GO:0006998),3/31,3,31,0.205077081355393,0.822949425709792,0,0,1.91442519383555,3.03315662660061,CTDNEP1;SUN2;SPAG4
alpha,1,sensory perception of mechanical stimulus (GO:0050954),6/79,6,79,0.209353518925556,0.822949425709792,0,0,1.50246027870638,2.3494436807912,NIPBL;LRTOMT;GRM7;TSPEAR;SLC26A4;TPRN
alpha,1,positive regulation of focal adhesion assembly (GO:0051894),2/17,2,17,0.211210554267248,0.822949425709792,0,0,2.32734043172165,3.61878106834781,PTPRJ;LIMS1
alpha,1,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),2/17,2,17,0.211210554267248,0.822949425709792,0,0,2.32734043172165,3.61878106834781,PTPRJ;PTPN2
alpha,1,response to interferon-alpha (GO:0035455),2/17,2,17,0.211210554267248,0.822949425709792,0,0,2.32734043172165,3.61878106834781,PDE12;TPR
alpha,1,2-oxoglutarate metabolic process (GO:0006103),2/17,2,17,0.211210554267248,0.822949425709792,0,0,2.32734043172165,3.61878106834781,GHR;ADHFE1
alpha,1,pigment granule transport (GO:0051904),2/17,2,17,0.211210554267248,0.822949425709792,0,0,2.32734043172165,3.61878106834781,BLOC1S3;MYO5A
alpha,1,spindle assembly checkpoint (GO:0071173),2/17,2,17,0.211210554267248,0.822949425709792,0,0,2.32734043172165,3.61878106834781,TPR;KLHL22
alpha,1,negative regulation of intracellular transport (GO:0032387),2/17,2,17,0.211210554267248,0.822949425709792,0,0,2.32734043172165,3.61878106834781,ACAA2;INSIG1
alpha,1,negative regulation of stress fiber assembly (GO:0051497),2/17,2,17,0.211210554267248,0.822949425709792,0,0,2.32734043172165,3.61878106834781,INPP5K;ARAP1
alpha,1,regulation of protein localization to membrane (GO:1905475),2/17,2,17,0.211210554267248,0.822949425709792,0,0,2.32734043172165,3.61878106834781,SPTBN1;APPL1
alpha,1,nucleotide catabolic process (GO:0009166),2/17,2,17,0.211210554267248,0.822949425709792,0,0,2.32734043172165,3.61878106834781,PNP;NUDT3
alpha,1,regulation of establishment or maintenance of cell polarity (GO:0032878),2/17,2,17,0.211210554267248,0.822949425709792,0,0,2.32734043172165,3.61878106834781,RUFY3;LLGL2
alpha,1,melanosome transport (GO:0032402),2/17,2,17,0.211210554267248,0.822949425709792,0,0,2.32734043172165,3.61878106834781,BLOC1S3;MYO5A
alpha,1,cellular response to inorganic substance (GO:0071241),2/17,2,17,0.211210554267248,0.822949425709792,0,0,2.32734043172165,3.61878106834781,SPIDR;FOXO1
alpha,1,nucleobase-containing compound biosynthetic process (GO:0034654),2/17,2,17,0.211210554267248,0.822949425709792,0,0,2.32734043172165,3.61878106834781,PNP;ADK
alpha,1,positive regulation of cation transmembrane transport (GO:1904064),2/17,2,17,0.211210554267248,0.822949425709792,0,0,2.32734043172165,3.61878106834781,ANK2;PDZK1
alpha,1,cellular response to glucocorticoid stimulus (GO:0071385),2/17,2,17,0.211210554267248,0.822949425709792,0,0,2.32734043172165,3.61878106834781,BCL2L11;ZFP36L2
alpha,1,mitotic spindle assembly checkpoint (GO:0007094),2/17,2,17,0.211210554267248,0.822949425709792,0,0,2.32734043172165,3.61878106834781,TPR;KLHL22
alpha,1,mitotic spindle checkpoint (GO:0071174),2/17,2,17,0.211210554267248,0.822949425709792,0,0,2.32734043172165,3.61878106834781,TPR;KLHL22
alpha,1,membrane depolarization during cardiac muscle cell action potential (GO:0086012),2/17,2,17,0.211210554267248,0.822949425709792,0,0,2.32734043172165,3.61878106834781,ANK2;SCN3B
alpha,1,positive regulation of protein localization to membrane (GO:1905477),7/96,7,96,0.211913269799895,0.822949425709792,0,0,1.44246620507748,2.23809910755365,FIS1;PPP1R13B;BCL2L11;PDZK1;STX3;DYNLL1;SPTBN1
alpha,1,transcription elongation from RNA polymerase II promoter (GO:0006368),7/96,7,96,0.211913269799895,0.822949425709792,0,0,1.44246620507748,2.23809910755365,SUPT16H;PCID2;TAF15;CTR9;POLR2I;SUPT5H;GTF2H4
alpha,1,interleukin-1-mediated signaling pathway (GO:0070498),7/96,7,96,0.211913269799895,0.822949425709792,0,0,1.44246620507748,2.23809910755365,MAP3K3;EGR1;PSMD2;CUL1;PLCB1;PSMB10;PSMA7
alpha,1,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),5/63,5,63,0.212567799100506,0.822949425709792,0,0,1.57003124362175,2.43118441102498,CREB3;MAPK7;SYVN1;MDM2;HTRA2
alpha,1,protein complex disassembly (GO:0043241),4/47,4,47,0.212614406256352,0.822949425709792,0,0,1.68360797188375,2.60668822208579,GABARAPL1;SNX14;DVL3;PPP1CA
alpha,1,anaphase-promoting complex-dependent catabolic process (GO:0031145),6/80,6,80,0.217455060580686,0.822949425709792,0,0,1.48367952522255,2.26374342406777,CDC20;ANAPC15;PSMD2;ANAPC5;PSMB10;PSMA7
alpha,1,generation of neurons (GO:0048699),9/131,9,131,0.218106389861306,0.822949425709792,0,0,1.35909574829547,2.06959336990425,PER2;NRBP2;FZD3;MYT1L;FZD4;USP9X;PIN1;PROX1;ARNTL
alpha,1,regulation of ubiquitin-protein transferase activity (GO:0051438),3/32,3,32,0.218427741718227,0.822949425709792,0,0,1.85459940652819,2.82140211546497,ARRDC3;PIN1;TOPORS
alpha,1,alpha-amino acid metabolic process (GO:1901605),3/32,3,32,0.218427741718227,0.822949425709792,0,0,1.85459940652819,2.82140211546497,GHR;ALDH6A1;HNF4A
alpha,1,regulation of glucose import (GO:0046324),3/32,3,32,0.218427741718227,0.822949425709792,0,0,1.85459940652819,2.82140211546497,CAPN10;IRS2;APPL1
alpha,1,positive regulation of protein dephosphorylation (GO:0035307),3/32,3,32,0.218427741718227,0.822949425709792,0,0,1.85459940652819,2.82140211546497,SMPD1;PIN1;CALM3
alpha,1,anterograde axonal transport (GO:0008089),3/32,3,32,0.218427741718227,0.822949425709792,0,0,1.85459940652819,2.82140211546497,AP3M1;FXR2;BLOC1S3
alpha,1,lysosome organization (GO:0007040),3/32,3,32,0.218427741718227,0.822949425709792,0,0,1.85459940652819,2.82140211546497,AKTIP;TFEB;LAMTOR1
alpha,1,nucleobase-containing small molecule interconversion (GO:0015949),3/32,3,32,0.218427741718227,0.822949425709792,0,0,1.85459940652819,2.82140211546497,DTYMK;NME6;GSR
alpha,1,vesicle-mediated transport to the plasma membrane (GO:0098876),3/32,3,32,0.218427741718227,0.822949425709792,0,0,1.85459940652819,2.82140211546497,RAB10;CCDC93;STEAP2
alpha,1,positive regulation of developmental process (GO:0051094),8/114,8,114,0.219250290502665,0.822949425709792,0,0,1.38823815225502,2.10670876186103,NEUROD1;FIS1;JUND;ARHGEF7;PLCB1;ZNF268;MARCH5;BMPR1A
alpha,1,regulation of cell death (GO:0010941),7/97,7,97,0.219260484733379,0.822949425709792,0,0,1.42759541945813,2.16636866545911,JUND;PDE12;TRIM13;HTRA2;PARP16;EPHB1;NCK1
alpha,1,ciliary basal body-plasma membrane docking (GO:0097711),7/97,7,97,0.219260484733379,0.822949425709792,0,0,1.42759541945813,2.16636866545911,ACTR1A;B9D1;DYNLL1;PCNT;RAB8A;CDK5RAP2;SDCCAG8
alpha,1,regulation of viral genome replication (GO:0045069),5/64,5,64,0.221789472634907,0.822949425709792,0,0,1.54549950544016,2.32756347137043,DDB1;RSAD2;PDE12;IFIT5;PROX1
alpha,1,negative regulation of dephosphorylation (GO:0035305),5/64,5,64,0.221789472634907,0.822949425709792,0,0,1.54549950544016,2.32756347137043,MYO1D;WDR81;WNK1;SLC7A14;INPP5K
alpha,1,polyol metabolic process (GO:0019751),4/48,4,48,0.223425110416803,0.822949425709792,0,0,1.64853280580284,2.47062149276962,INPP4B;IP6K1;PLCB1;NUDT3
alpha,1,"positive regulation of gene expression, epigenetic (GO:0045815)",4/48,4,48,0.223425110416803,0.822949425709792,0,0,1.64853280580284,2.47062149276962,H3F3A;DDX21;ARID1A;ARID1B
alpha,1,inositol phosphate metabolic process (GO:0043647),4/48,4,48,0.223425110416803,0.822949425709792,0,0,1.64853280580284,2.47062149276962,INPP4B;IP6K1;PLCB1;NUDT3
alpha,1,cellular response to heat (GO:0034605),4/48,4,48,0.223425110416803,0.822949425709792,0,0,1.64853280580284,2.47062149276962,HSPA8;TPR;HTRA2;HSPA2
alpha,1,RNA transport (GO:0050658),6/81,6,81,0.22566071872362,0.822949425709792,0,0,1.46536249404697,2.1815183387073,DDX39A;NUP133;RBM8A;TPR;SRSF4;SRSF5
alpha,1,"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",6/81,6,81,0.22566071872362,0.822949425709792,0,0,1.46536249404697,2.1815183387073,SCFD1;RER1;KIF22;KLC1;ARF5;DNAJC28
alpha,1,protein targeting to ER (GO:0045047),7/98,7,98,0.226697066968637,0.822949425709792,0,0,1.41302811925957,2.09713248480141,RPS16;RPS15A;SPCS1;RPL13;RPL27;RPL15;RPS24
alpha,1,mitochondrial respiratory chain complex assembly (GO:0033108),7/98,7,98,0.226697066968637,0.822949425709792,0,0,1.41302811925957,2.09713248480141,NDUFA6;NDUFA11;SCO1;SDHAF2;TMEM126B;NDUFV3;COA5
alpha,1,establishment of melanosome localization (GO:0032401),2/18,2,18,0.230159826464101,0.822949425709792,0,0,2.19804374107045,3.22888518236846,BLOC1S3;MYO5A
alpha,1,regulation of telomerase RNA localization to Cajal body (GO:1904872),2/18,2,18,0.230159826464101,0.822949425709792,0,0,2.19804374107045,3.22888518236846,CCT6A;NHP2
alpha,1,glucan biosynthetic process (GO:0009250),2/18,2,18,0.230159826464101,0.822949425709792,0,0,2.19804374107045,3.22888518236846,PER2;GYG2
alpha,1,maintenance of protein localization in organelle (GO:0072595),2/18,2,18,0.230159826464101,0.822949425709792,0,0,2.19804374107045,3.22888518236846,ARL2;TOPORS
alpha,1,regulation of dephosphorylation (GO:0035303),2/18,2,18,0.230159826464101,0.822949425709792,0,0,2.19804374107045,3.22888518236846,PPP1R14C;INPP5K
alpha,1,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),2/18,2,18,0.230159826464101,0.822949425709792,0,0,2.19804374107045,3.22888518236846,MAPK7;HTRA2
alpha,1,regulation of cardiac muscle cell proliferation (GO:0060043),2/18,2,18,0.230159826464101,0.822949425709792,0,0,2.19804374107045,3.22888518236846,PIM1;BMPR1A
alpha,1,regulation of cholesterol efflux (GO:0010874),2/18,2,18,0.230159826464101,0.822949425709792,0,0,2.19804374107045,3.22888518236846,NR1H2;LAMTOR1
alpha,1,regulation of cardiac muscle cell membrane repolarization (GO:0099623),2/18,2,18,0.230159826464101,0.822949425709792,0,0,2.19804374107045,3.22888518236846,KCNA5;ANK2
alpha,1,tRNA metabolic process (GO:0006399),2/18,2,18,0.230159826464101,0.822949425709792,0,0,2.19804374107045,3.22888518236846,POP7;DTD2
alpha,1,negative regulation of peptidyl-serine phosphorylation (GO:0033137),2/18,2,18,0.230159826464101,0.822949425709792,0,0,2.19804374107045,3.22888518236846,INPP5K;NCK1
alpha,1,glycogen biosynthetic process (GO:0005978),2/18,2,18,0.230159826464101,0.822949425709792,0,0,2.19804374107045,3.22888518236846,PER2;GYG2
alpha,1,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),2/18,2,18,0.230159826464101,0.822949425709792,0,0,2.19804374107045,3.22888518236846,MAPK7;HTRA2
alpha,1,regulation of epithelial cell differentiation (GO:0030856),2/18,2,18,0.230159826464101,0.822949425709792,0,0,2.19804374107045,3.22888518236846,CLOCK;ARNTL
alpha,1,piRNA metabolic process (GO:0034587),2/18,2,18,0.230159826464101,0.822949425709792,0,0,2.19804374107045,3.22888518236846,TDRKH;EXD1
alpha,1,DNA ligation (GO:0006266),2/18,2,18,0.230159826464101,0.822949425709792,0,0,2.19804374107045,3.22888518236846,POLD3;PCNA
alpha,1,negative regulation of calcium-mediated signaling (GO:0050849),2/18,2,18,0.230159826464101,0.822949425709792,0,0,2.19804374107045,3.22888518236846,GSTM2;CALM3
alpha,1,cellular response to decreased oxygen levels (GO:0036294),5/65,5,65,0.231129562854544,0.822949425709792,0,0,1.52172258997185,2.22898401816253,SLC8A3;ACAA2;TBL2;MDM2;CPEB2
alpha,1,positive regulation of dendrite development (GO:1900006),3/33,3,33,0.23194956495845,0.822949425709792,0,0,1.79839942451218,2.62788476462451,SS18L1;VLDLR;CPEB3
alpha,1,oxoacid metabolic process (GO:0043436),3/33,3,33,0.23194956495845,0.822949425709792,0,0,1.79839942451218,2.62788476462451,B3GAT2;MARC1;MIF
alpha,1,sister chromatid segregation (GO:0000819),3/33,3,33,0.23194956495845,0.822949425709792,0,0,1.79839942451218,2.62788476462451,HIRA;MIS12;KLHL22
alpha,1,protein trimerization (GO:0070206),3/33,3,33,0.23194956495845,0.822949425709792,0,0,1.79839942451218,2.62788476462451,TRIM4;HTRA2;MIF
alpha,1,microtubule bundle formation (GO:0001578),3/33,3,33,0.23194956495845,0.822949425709792,0,0,1.79839942451218,2.62788476462451,SPAG16;NUMA1;CDK5RAP2
alpha,1,cyclic-nucleotide-mediated signaling (GO:0019935),3/33,3,33,0.23194956495845,0.822949425709792,0,0,1.79839942451218,2.62788476462451,MAPK7;KSR1;PDE3A
alpha,1,ATP biosynthetic process (GO:0006754),3/33,3,33,0.23194956495845,0.822949425709792,0,0,1.79839942451218,2.62788476462451,ATP5B;VPS9D1;ALDOA
alpha,1,negative regulation of receptor activity (GO:2000272),3/33,3,33,0.23194956495845,0.822949425709792,0,0,1.79839942451218,2.62788476462451,GSTM2;CALM3;CBL
alpha,1,regulation of cell-cell adhesion (GO:0022407),3/33,3,33,0.23194956495845,0.822949425709792,0,0,1.79839942451218,2.62788476462451,SIRPA;CD47;EPHB3
alpha,1,peptidyl-lysine modification (GO:0018205),8/116,8,116,0.232980122786739,0.822949425709792,0,0,1.3643030116989,1.98751954566485,LIPT2;NDC1;PCNA;NUP210;NUP133;TPR;MDM2;TOPORS
alpha,1,cellular response to oxidative stress (GO:0034599),8/116,8,116,0.232980122786739,0.822949425709792,0,0,1.3643030116989,1.98751954566485,ERCC6L2;PXN;GSR;HTRA2;CPEB2;DHRS2;FOXO1;ARNTL
alpha,1,sensory perception of sound (GO:0007605),6/82,6,82,0.233964974446863,0.822949425709792,0,0,1.44749221972932,2.10260383104711,NIPBL;LRTOMT;GRM7;TSPEAR;SLC26A4;TPRN
alpha,1,positive regulation of protein catabolic process (GO:0045732),6/82,6,82,0.233964974446863,0.822949425709792,0,0,1.44749221972932,2.10260383104711,DDB1;EGLN2;HECW2;STX5;FOXO1;RNF41
alpha,1,regulation of cell cycle arrest (GO:0071156),4/49,4,49,0.234374524930212,0.822949425709792,0,0,1.6148892791538,2.34293774072782,NEUROD1;MDM2;MIF;ZNF268
alpha,1,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),4/49,4,49,0.234374524930212,0.822949425709792,0,0,1.6148892791538,2.34293774072782,CASP9;BCL2L11;HTRA2;TOPORS
alpha,1,cellular macromolecule catabolic process (GO:0044265),4/49,4,49,0.234374524930212,0.822949425709792,0,0,1.6148892791538,2.34293774072782,MANBA;XRN2;HTRA2;STT3B
alpha,1,regulation of macroautophagy (GO:0016241),8/117,8,117,0.239955691228767,0.822949425709792,0,0,1.3526423021972,1.93062770051097,NRBP2;TRIM13;WAC;SMCR8;VPS26B;LAMTOR1;SUPT5H;GAPDH
alpha,1,cellular response to reactive oxygen species (GO:0034614),5/66,5,66,0.240579872510406,0.822949425709792,0,0,1.49866618709349,2.13515441408497,MAPK7;PLEKHA1;ERCC6L2;PXN;FOXO1
alpha,1,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",6/83,6,83,0.24236225276978,0.822949425709792,0,0,1.43005255443138,2.02684460306745,CDKN1A;PCNA;PRMT1;PLAGL1;CARM1;MDM2
alpha,1,positive regulation of cell cycle (GO:0045787),6/83,6,83,0.24236225276978,0.822949425709792,0,0,1.43005255443138,2.02684460306745,CCND3;RPS15A;MDM2;MIF;PROX1;ZNF268
alpha,1,ephrin receptor signaling pathway (GO:0048013),6/83,6,83,0.24236225276978,0.822949425709792,0,0,1.43005255443138,2.02684460306745,EPHB6;CHN1;AP2A1;ARHGEF7;EPHB1;EPHB3
alpha,1,positive regulation of cell cycle arrest (GO:0071158),6/83,6,83,0.24236225276978,0.822949425709792,0,0,1.43005255443138,2.02684460306745,CDKN1A;PCNA;PRMT1;PLAGL1;CARM1;MDM2
alpha,1,protein acetylation (GO:0006473),3/34,3,34,0.24561709779696,0.822949425709792,0,0,1.74550532379124,2.45065712811159,NAT6;CLOCK;FOXO1
alpha,1,regulation of cell-substrate adhesion (GO:0010810),3/34,3,34,0.24561709779696,0.822949425709792,0,0,1.74550532379124,2.45065712811159,FZD4;ARL2;LIMS1
alpha,1,regulation of autophagosome assembly (GO:2000785),3/34,3,34,0.24561709779696,0.822949425709792,0,0,1.74550532379124,2.45065712811159,SCFD1;PIP4K2B;SMCR8
alpha,1,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),3/34,3,34,0.24561709779696,0.822949425709792,0,0,1.74550532379124,2.45065712811159,FIS1;BCL2L11;NCK1
alpha,1,embryonic organ morphogenesis (GO:0048562),3/34,3,34,0.24561709779696,0.822949425709792,0,0,1.74550532379124,2.45065712811159,NEUROD1;NIPBL;FBN1
alpha,1,carboxylic acid metabolic process (GO:0019752),3/34,3,34,0.24561709779696,0.822949425709792,0,0,1.74550532379124,2.45065712811159,CYP4F3;MIF;GNE
alpha,1,regulation of protein kinase A signaling (GO:0010738),2/19,2,19,0.249210625126739,0.822949425709792,0,0,2.08235722838253,2.89334552768512,SPHKAP;MIF
alpha,1,histone methylation (GO:0016571),2/19,2,19,0.249210625126739,0.822949425709792,0,0,2.08235722838253,2.89334552768512,PRMT1;CARM1
alpha,1,protein targeting to lysosome (GO:0006622),2/19,2,19,0.249210625126739,0.822949425709792,0,0,2.08235722838253,2.89334552768512,HSPA8;AP3M1
alpha,1,regulation of mitochondrial fission (GO:0090140),2/19,2,19,0.249210625126739,0.822949425709792,0,0,2.08235722838253,2.89334552768512,FIS1;MARCH5
alpha,1,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),2/19,2,19,0.249210625126739,0.822949425709792,0,0,2.08235722838253,2.89334552768512,CASP9;APPL1
alpha,1,purine ribonucleotide catabolic process (GO:0009154),2/19,2,19,0.249210625126739,0.822949425709792,0,0,2.08235722838253,2.89334552768512,PDE3A;NUDT3
alpha,1,histone deubiquitination (GO:0016578),2/19,2,19,0.249210625126739,0.822949425709792,0,0,2.08235722838253,2.89334552768512,USP3;UIMC1
alpha,1,insulin secretion (GO:0030073),2/19,2,19,0.249210625126739,0.822949425709792,0,0,2.08235722838253,2.89334552768512,NEUROD1;SLC30A8
alpha,1,macromolecule biosynthetic process (GO:0009059),2/19,2,19,0.249210625126739,0.822949425709792,0,0,2.08235722838253,2.89334552768512,GLT8D1;EIF4G2
alpha,1,drug transport (GO:0015893),2/19,2,19,0.249210625126739,0.822949425709792,0,0,2.08235722838253,2.89334552768512,TMEM30A;PDZK1
alpha,1,positive regulation of adherens junction organization (GO:1903393),2/19,2,19,0.249210625126739,0.822949425709792,0,0,2.08235722838253,2.89334552768512,PTPRJ;LIMS1
alpha,1,regulation of catenin import into nucleus (GO:0035412),2/19,2,19,0.249210625126739,0.822949425709792,0,0,2.08235722838253,2.89334552768512,DACT3;EMD
alpha,1,response to interferon-beta (GO:0035456),2/19,2,19,0.249210625126739,0.822949425709792,0,0,2.08235722838253,2.89334552768512,HTRA2;UBE2K
alpha,1,intracellular steroid hormone receptor signaling pathway (GO:0030518),5/67,5,67,0.250132186067545,0.822949425709792,0,0,1.47629803504732,2.04580326348334,KDM3A;DDX5;EGLN2;ARID1A;ESR2
alpha,1,positive regulation of homeostatic process (GO:0032846),6/84,6,84,0.250846935099062,0.822949425709792,0,0,1.41302811925957,1.95409403163608,RFX6;PRMT1;HNF4A;INPP5K;ANKRD54;GCG
alpha,1,plasma membrane bounded cell projection organization (GO:0120036),8/119,8,119,0.254112541211457,0.822949425709792,0,0,1.32990881812666,1.82194586866414,EHD1;CNTNAP2;PLEKHA1;PRMT1;BLOC1S3;FAM161B;MAP4;STX3
alpha,1,negative regulation of viral genome replication (GO:0045071),4/51,4,51,0.256636346523579,0.822949425709792,0,0,1.55156028781443,2.11026968477427,RSAD2;IFIT5;INPP5K;PROX1
alpha,1,neurogenesis (GO:0022008),4/51,4,51,0.256636346523579,0.822949425709792,0,0,1.55156028781443,2.11026968477427,NEUROD1;ZNHIT2;EPHB1;CDK5RAP2
alpha,1,metal ion transport (GO:0030001),7/102,7,102,0.257256410596341,0.822949425709792,0,0,1.35761525183763,1.84320976979764,KCNB2;SLC41A1;KCNK16;KCNA5;SCN3B;KCNK1;KCNJ3
alpha,1,keratan sulfate metabolic process (GO:0042339),3/35,3,35,0.259405709151482,0.822949425709792,0,0,1.69563374311149,2.28802373595067,GLB1;ST3GAL6;CHST2
alpha,1,regulation of insulin receptor signaling pathway (GO:0046626),3/35,3,35,0.259405709151482,0.822949425709792,0,0,1.69563374311149,2.28802373595067,INPP5K;PTPN2;NCK1
alpha,1,positive regulation of cell development (GO:0010720),3/35,3,35,0.259405709151482,0.822949425709792,0,0,1.69563374311149,2.28802373595067,NUMB;RFX3;PROX1
alpha,1,RNA export from nucleus (GO:0006405),8/120,8,120,0.261287468966337,0.822949425709792,0,0,1.31882624464227,1.77004162757183,NDC1;DDX39A;NUP210;RBM8A;NUP133;TPR;SRSF4;SRSF5
alpha,1,cellular response to lipoteichoic acid (GO:0071223),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,CD14
alpha,1,negative regulation of cholesterol storage (GO:0010887),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,NR1H2
alpha,1,smooth muscle tissue development (GO:0048745),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,PROX1
alpha,1,regulation of fat cell proliferation (GO:0070344),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,PER2
alpha,1,granzyme-mediated apoptotic signaling pathway (GO:0008626),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,UBE4B
alpha,1,vocal learning (GO:0042297),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,CNTNAP2
alpha,1,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,TRIO
alpha,1,negative regulation of chromosome organization (GO:2001251),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,ERCC1
alpha,1,response to granulocyte macrophage colony-stimulating factor (GO:0097012),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,ZFP36L2
alpha,1,regulation of non-motile cilium assembly (GO:1902855),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,MAP4
alpha,1,B cell chemotaxis (GO:0035754),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,CYP7B1
alpha,1,regulation of hydrogen peroxide metabolic process (GO:0010310),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,NOXO1
alpha,1,positive regulation of hormone metabolic process (GO:0032352),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,EGR1
alpha,1,vitamin K metabolic process (GO:0042373),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,UBIAD1
alpha,1,SCF complex assembly (GO:0010265),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,CUL1
alpha,1,regulation of translational initiation in response to stress (GO:0043558),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,PPP1CA
alpha,1,regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,MDM2
alpha,1,protein retention in ER lumen (GO:0006621),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,RER1
alpha,1,positive regulation of myelination (GO:0031643),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,DICER1
alpha,1,regulation of skeletal muscle satellite cell proliferation (GO:0014842),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,EPHB1
alpha,1,negative regulation of catecholamine secretion (GO:0033604),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,CHGA
alpha,1,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,PTPN2
alpha,1,indolalkylamine metabolic process (GO:0006586),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,DDC
alpha,1,astral microtubule organization (GO:0030953),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,NUMA1
alpha,1,ventricular cardiac muscle cell development (GO:0055015),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,PROX1
alpha,1,snRNA modification (GO:0040031),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,NHP2
alpha,1,N-acetylneuraminate catabolic process (GO:0019262),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,NAGK
alpha,1,negative regulation of meiotic cell cycle (GO:0051447),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,DUSP1
alpha,1,regulation of digestive system process (GO:0044058),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,NEUROD1
alpha,1,response to lipoteichoic acid (GO:0070391),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,CD14
alpha,1,negative regulation of protein targeting to membrane (GO:0090315),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,INPP5K
alpha,1,negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,FIS1
alpha,1,inner ear receptor cell development (GO:0060119),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,LRTOMT
alpha,1,histone H4-K12 acetylation (GO:0043983),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,KAT7
alpha,1,nucleobase metabolic process (GO:0009112),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,TTR
alpha,1,positive regulation of fibroblast migration (GO:0010763),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,ARHGEF7
alpha,1,amino sugar catabolic process (GO:0046348),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,NAGK
alpha,1,protein localization to endoplasmic reticulum exit site (GO:0070973),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,CTAGE5
alpha,1,regulation of skeletal muscle contraction (GO:0014819),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,SLC8A3
alpha,1,positive regulation of protein acetylation (GO:1901985),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,ARNTL
alpha,1,retinal ganglion cell axon guidance (GO:0031290),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,EPHB1
alpha,1,ear development (GO:0043583),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,NIPBL
alpha,1,choline catabolic process (GO:0042426),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,DMGDH
alpha,1,iron ion import across plasma membrane (GO:0098711),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,STEAP2
alpha,1,azole transport (GO:0045117),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,SLC15A4
alpha,1,phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,GTF2H4
alpha,1,platelet dense granule organization (GO:0060155),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,BLOC1S3
alpha,1,regulation of relaxation of cardiac muscle (GO:1901897),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,CHGA
alpha,1,citrate metabolic process (GO:0006101),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,GHR
alpha,1,regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,SCN3B
alpha,1,negative regulation of cell size (GO:0045792),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,AKT1S1
alpha,1,lens fiber cell development (GO:0070307),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,PROX1
alpha,1,regulation of protein localization to cell cortex (GO:1904776),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,NUMA1
alpha,1,alpha-beta T cell activation (GO:0046631),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,RSAD2
alpha,1,negative regulation of cellular extravasation (GO:0002692),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,PLCB1
alpha,1,Golgi disassembly (GO:0090166),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,STX5
alpha,1,negative regulation of amino acid transport (GO:0051956),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,GRM7
alpha,1,definitive hemopoiesis (GO:0060216),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,ZFP36L2
alpha,1,response to lead ion (GO:0010288),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,PPP1CA
alpha,1,regulation of hyaluronan biosynthetic process (GO:1900125),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,AP2A1
alpha,1,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway (GO:0007196),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,GRM7
alpha,1,positive regulation of microtubule motor activity (GO:2000576),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,DYNLL1
alpha,1,purine ribonucleoside monophosphate catabolic process (GO:0009169),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,NUDT3
alpha,1,white fat cell differentiation (GO:0050872),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,PER2
alpha,1,corticosteroid receptor signaling pathway (GO:0031958),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,ARID1A
alpha,1,positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,TOMM7
alpha,1,hormone transport (GO:0009914),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,SLC16A2
alpha,1,response to heparin (GO:0071503),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,EGR1
alpha,1,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,BCL2L11
alpha,1,NADH metabolic process (GO:0006734),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,NUDT12
alpha,1,positive regulation of cholesterol storage (GO:0010886),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,EHD1
alpha,1,negative regulation of T cell differentiation in thymus (GO:0033085),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,PTPN2
alpha,1,ventricular compact myocardium morphogenesis (GO:0003223),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,BMPR1A
alpha,1,regulation of respiratory system process (GO:0044065),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,NLGN2
alpha,1,cellular response to bacterial lipopeptide (GO:0071221),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,CD14
alpha,1,aggrephagy (GO:0035973),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,WDR81
alpha,1,negative regulation of phospholipase activity (GO:0010519),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,RGS2
alpha,1,regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,FOXO1
alpha,1,positive regulation of keratinocyte migration (GO:0051549),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,EPB41L4B
alpha,1,imitative learning (GO:0098596),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,CNTNAP2
alpha,1,cellular response to magnesium ion (GO:0071286),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,SLC41A1
alpha,1,positive regulation of autophagosome maturation (GO:1901098),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,SMCR8
alpha,1,maintenance of protein location in extracellular region (GO:0071694),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,FBN1
alpha,1,venous blood vessel morphogenesis (GO:0048845),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,PROX1
alpha,1,positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,PAGR1
alpha,1,cellular response to cold (GO:0070417),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,FOXO1
alpha,1,negative regulation of cell cycle phase transition (GO:1901988),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,ZFP36L2
alpha,1,negative regulation of myeloid cell apoptotic process (GO:0033033),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,MAEA
alpha,1,negative regulation of mononuclear cell migration (GO:0071676),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,PLCB1
alpha,1,negative regulation of glial cell proliferation (GO:0060253),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,DICER1
alpha,1,cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,ZFP36L2
alpha,1,heterocycle catabolic process (GO:0046700),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,ALDH4A1
alpha,1,nucleoside phosphate catabolic process (GO:1901292),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,DCTPP1
alpha,1,regulation of sarcomere organization (GO:0060297),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,PROX1
alpha,1,positive regulation of fibroblast apoptotic process (GO:2000271),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,BCL2L11
alpha,1,regulation of t-circle formation (GO:1904429),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,ERCC1
alpha,1,glucocorticoid receptor signaling pathway (GO:0042921),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,ARID1A
alpha,1,regulation of osteoclast development (GO:2001204),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,FBN1
alpha,1,negative regulation of glycogen biosynthetic process (GO:0045719),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,INPP5K
alpha,1,neuron remodeling (GO:0016322),1/6,1,6,0.2674866923534,0.822949425709792,0,0,3.29706561160567,4.34779248959825,FARP2
alpha,1,positive regulation of actin filament polymerization (GO:0030838),4/52,4,52,0.267922549270724,0.822949425709792,0,0,1.52172258997185,2.00419589971384,WIPF2;CDC42EP3;CDC42EP2;NCK1
alpha,1,regulation of cellular amine metabolic process (GO:0033238),4/52,4,52,0.267922549270724,0.822949425709792,0,0,1.52172258997185,2.00419589971384,PSMD2;PSMB10;PSMA7;AZIN1
alpha,1,regulation of cellular amino acid metabolic process (GO:0006521),4/52,4,52,0.267922549270724,0.822949425709792,0,0,1.52172258997185,2.00419589971384,PSMD2;PSMB10;PSMA7;AZIN1
alpha,1,mitochondrial ATP synthesis coupled electron transport (GO:0042775),6/86,6,86,0.268055889909143,0.822949425709792,0,0,1.38016700020703,1.81707235632675,NDUFA6;NDUFA11;SDHAF2;NDUFV3;CYC1;COX5B
alpha,1,regulation of gluconeogenesis (GO:0006111),2/20,2,20,0.268304329482614,0.822949425709792,0,0,1.9782393669634,2.60263775461598,GCK;PTPN2
alpha,1,negative regulation of intracellular protein transport (GO:0090317),2/20,2,20,0.268304329482614,0.822949425709792,0,0,1.9782393669634,2.60263775461598,INSIG1;INPP5K
alpha,1,negative regulation of macromolecule biosynthetic process (GO:0010558),2/20,2,20,0.268304329482614,0.822949425709792,0,0,1.9782393669634,2.60263775461598,AP2A1;APBB1
alpha,1,negative regulation of actin filament bundle assembly (GO:0032232),2/20,2,20,0.268304329482614,0.822949425709792,0,0,1.9782393669634,2.60263775461598,INPP5K;ARAP1
alpha,1,error-prone translesion synthesis (GO:0042276),2/20,2,20,0.268304329482614,0.822949425709792,0,0,1.9782393669634,2.60263775461598,PCNA;REV3L
alpha,1,regulation of cholesterol transport (GO:0032374),2/20,2,20,0.268304329482614,0.822949425709792,0,0,1.9782393669634,2.60263775461598,NR1H2;LAMTOR1
alpha,1,"regulation of DNA-templated transcription, elongation (GO:0032784)",2/20,2,20,0.268304329482614,0.822949425709792,0,0,1.9782393669634,2.60263775461598,SUPT16H;SUPT5H
alpha,1,mitochondrial respiratory chain complex IV assembly (GO:0033617),2/20,2,20,0.268304329482614,0.822949425709792,0,0,1.9782393669634,2.60263775461598,SCO1;COA5
alpha,1,negative regulation of telomere maintenance via telomerase (GO:0032211),2/20,2,20,0.268304329482614,0.822949425709792,0,0,1.9782393669634,2.60263775461598,CTC1;XRN1
alpha,1,growth hormone receptor signaling pathway (GO:0060396),2/20,2,20,0.268304329482614,0.822949425709792,0,0,1.9782393669634,2.60263775461598,GHR;PXN
alpha,1,inactivation of MAPK activity (GO:0000188),2/20,2,20,0.268304329482614,0.822949425709792,0,0,1.9782393669634,2.60263775461598,RGS4;DUSP1
alpha,1,melanosome localization (GO:0032400),2/20,2,20,0.268304329482614,0.822949425709792,0,0,1.9782393669634,2.60263775461598,BLOC1S3;MYO5A
alpha,1,telomere maintenance via telomerase (GO:0007004),2/20,2,20,0.268304329482614,0.822949425709792,0,0,1.9782393669634,2.60263775461598,PTGES3;NHP2
alpha,1,vesicle cytoskeletal trafficking (GO:0099518),2/20,2,20,0.268304329482614,0.822949425709792,0,0,1.9782393669634,2.60263775461598,MYO5A;NDEL1
alpha,1,eye morphogenesis (GO:0048592),2/20,2,20,0.268304329482614,0.822949425709792,0,0,1.9782393669634,2.60263775461598,NIPBL;FBN1
alpha,1,regulation of transport (GO:0051049),2/20,2,20,0.268304329482614,0.822949425709792,0,0,1.9782393669634,2.60263775461598,YRDC;SLC30A8
alpha,1,positive regulation of T cell activation (GO:0050870),5/69,5,69,0.2695099936277,0.822949425709792,0,0,1.43350678765464,1.87954214827351,FAM49B;PNP;SIRPA;CD47;NCK1
alpha,1,regulation of cyclin-dependent protein kinase activity (GO:1904029),3/36,3,36,0.273291638216415,0.822949425709792,0,0,1.64853280580284,2.13850277306051,CDKN1A;CDKN2C;CAMK2N1
alpha,1,regulation of microtubule polymerization (GO:0031113),3/36,3,36,0.273291638216415,0.822949425709792,0,0,1.64853280580284,2.13850277306051,NUMA1;ARL2;CDK5RAP2
alpha,1,apical junction assembly (GO:0043297),3/36,3,36,0.273291638216415,0.822949425709792,0,0,1.64853280580284,2.13850277306051,PARD6B;ARL2;VCL
alpha,1,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",3/36,3,36,0.273291638216415,0.822949425709792,0,0,1.64853280580284,2.13850277306051,RPS16;PDCD11;RPS24
alpha,1,regulation of synapse assembly (GO:0051963),3/36,3,36,0.273291638216415,0.822949425709792,0,0,1.64853280580284,2.13850277306051,NLGN2;EPHB1;EPHB3
alpha,1,membrane protein proteolysis (GO:0033619),3/36,3,36,0.273291638216415,0.822949425709792,0,0,1.64853280580284,2.13850277306051,BACE1;DAG1;ADAM10
alpha,1,carboxylic acid transmembrane transport (GO:1905039),3/36,3,36,0.273291638216415,0.822949425709792,0,0,1.64853280580284,2.13850277306051,SLC7A8;SLC38A10;SLC38A4
alpha,1,carbohydrate catabolic process (GO:0016052),3/36,3,36,0.273291638216415,0.822949425709792,0,0,1.64853280580284,2.13850277306051,MANBA;ALDOA;GCK
alpha,1,Golgi organization (GO:0007030),8/122,8,122,0.275814211435747,0.822949425709792,0,0,1.29720614227108,1.67083755658519,RAB2A;LMAN1;ATL3;MYO18A;STX5;ARHGEF7;DNAJC28;TMED5
alpha,1,negative regulation of cell migration (GO:0030336),8/122,8,122,0.275814211435747,0.822949425709792,0,0,1.29720614227108,1.67083755658519,DACH1;MCTP1;DAG1;PTPRJ;SRGAP3;VCL;RNF41;BMPR1A
alpha,1,positive regulation of cell-substrate adhesion (GO:0010811),4/53,4,53,0.279295120526759,0.822949425709792,0,0,1.49301084299125,1.9043148409752,ARL2;ARHGEF7;CRKL;LIMS1
alpha,1,regulation of osteoblast differentiation (GO:0045667),5/70,5,70,0.279319144232036,0.822949425709792,0,0,1.41302811925957,1.80217643742221,DDX5;NBR1;RORB;IL6R;BMPR1A
alpha,1,negative regulation of cell cycle G2/M phase transition (GO:1902750),5/70,5,70,0.279319144232036,0.822949425709792,0,0,1.41302811925957,1.80217643742221,PSMD2;UIMC1;CUL1;PSMB10;PSMA7
alpha,1,peptide metabolic process (GO:0006518),7/105,7,105,0.280913949457003,0.822949425709792,0,0,1.31882624464227,1.67452276457192,BACE1;HSPA8;GSTM2;SPCS1;RNPEP;GSR;GLRX2
alpha,1,inorganic cation transmembrane transport (GO:0098662),9/141,9,141,0.284168849101869,0.822949425709792,0,0,1.26270597891281,1.58871984140184,SLC8A3;ATP5B;SLC30A8;TRPC4;SLC41A1;SCN3B;KCNK1;SLC39A1;TRPM6
alpha,1,regulation of MAP kinase activity (GO:0043405),6/88,6,88,0.285546459921835,0.822949425709792,0,0,1.34879956838414,1.69051865571918,RGS2;DUSP1;SMPD1;SPRY4;INPP5K;PTPRJ
alpha,1,sodium ion transmembrane transport (GO:0035725),3/37,3,37,0.287252032237259,0.822949425709792,0,0,1.60397786510546,2.0007944301467,SLC8A3;SCN3B;KCNK1
alpha,1,plasma membrane organization (GO:0007009),3/37,3,37,0.287252032237259,0.822949425709792,0,0,1.60397786510546,2.0007944301467,TMEM256-PLSCR3;ANK2;SPTBN1
alpha,1,centromere complex assembly (GO:0034508),3/37,3,37,0.287252032237259,0.822949425709792,0,0,1.60397786510546,2.0007944301467,MIS12;CENPO;CENPC
alpha,1,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",3/37,3,37,0.287252032237259,0.822949425709792,0,0,1.60397786510546,2.0007944301467,FZD3;FZD4;PLCB1
alpha,1,axonal transport (GO:0098930),3/37,3,37,0.287252032237259,0.822949425709792,0,0,1.60397786510546,2.0007944301467,AP3M1;FXR2;BLOC1S3
alpha,1,regulation of ubiquitin protein ligase activity (GO:1904666),3/37,3,37,0.287252032237259,0.822949425709792,0,0,1.60397786510546,2.0007944301467,CDC20;ANAPC15;ANAPC5
alpha,1,RNA-dependent DNA biosynthetic process (GO:0006278),2/21,2,21,0.287387974955577,0.822949425709792,0,0,1.8840374923461,2.34924807499855,PTGES3;NHP2
alpha,1,regulation of ruffle assembly (GO:1900027),2/21,2,21,0.287387974955577,0.822949425709792,0,0,1.8840374923461,2.34924807499855,SH3YL1;NDEL1
alpha,1,cortical actin cytoskeleton organization (GO:0030866),2/21,2,21,0.287387974955577,0.822949425709792,0,0,1.8840374923461,2.34924807499855,WIPF2;LLGL2
alpha,1,phospholipid translocation (GO:0045332),2/21,2,21,0.287387974955577,0.822949425709792,0,0,1.8840374923461,2.34924807499855,TMEM30A;ATP10D
alpha,1,zinc II ion transport (GO:0006829),2/21,2,21,0.287387974955577,0.822949425709792,0,0,1.8840374923461,2.34924807499855,SLC30A8;SLC39A1
alpha,1,regulation of macrophage activation (GO:0043030),2/21,2,21,0.287387974955577,0.822949425709792,0,0,1.8840374923461,2.34924807499855,MYO18A;MIF
alpha,1,branched-chain amino acid catabolic process (GO:0009083),2/21,2,21,0.287387974955577,0.822949425709792,0,0,1.8840374923461,2.34924807499855,ALDH6A1;PPM1K
alpha,1,positive regulation of BMP signaling pathway (GO:0030513),2/21,2,21,0.287387974955577,0.822949425709792,0,0,1.8840374923461,2.34924807499855,NUMA1;FBXL15
alpha,1,mitochondrial respiratory chain complex IV biogenesis (GO:0097034),2/21,2,21,0.287387974955577,0.822949425709792,0,0,1.8840374923461,2.34924807499855,SCO1;COA5
alpha,1,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),2/21,2,21,0.287387974955577,0.822949425709792,0,0,1.8840374923461,2.34924807499855,CDKN1A;CAMK2N1
alpha,1,mitochondrial calcium ion transmembrane transport (GO:0006851),2/21,2,21,0.287387974955577,0.822949425709792,0,0,1.8840374923461,2.34924807499855,SLC8A3;MCU
alpha,1,glutamate metabolic process (GO:0006536),2/21,2,21,0.287387974955577,0.822949425709792,0,0,1.8840374923461,2.34924807499855,GAD1;GLUL
alpha,1,G1/S transition of mitotic cell cycle (GO:0000082),7/106,7,106,0.288918006781811,0.822949425709792,0,0,1.30638448761734,1.62202310672644,CUL4A;CDKN1A;PCNA;CDC45;CDKN2C;CUL1;SPDYA
alpha,1,double-strand break repair (GO:0006302),9/142,9,142,0.291069035073822,0.822949425709792,0,0,1.25381368328666,1.54745033562357,NIPBL;KDM2A;RNF138;RAD21L1;MCM9;ERCC1;UIMC1;SPIDR;REC8
alpha,1,positive regulation of protein complex assembly (GO:0031334),6/89,6,89,0.294383167375107,0.822949425709792,0,0,1.33364451705398,1.63087796458863,DDB1;CUL4A;ERCC1;CDC42EP2;SPIDR;GTF2H4
alpha,1,response to endoplasmic reticulum stress (GO:0034976),7/107,7,107,0.296974126443932,0.822949425709792,0,0,1.29417528679849,1.57127149436069,TMX4;UFM1;BCL2L11;FICD;SYVN1;TXNDC11;NCK1
alpha,1,positive regulation of cellular component organization (GO:0051130),7/107,7,107,0.296974126443932,0.822949425709792,0,0,1.29417528679849,1.57127149436069,CDC20;LMAN1;NLGN2;CDC42EP2;EPHB1;SPIDR;EPHB3
alpha,1,RNA splicing (GO:0008380),7/107,7,107,0.296974126443932,0.822949425709792,0,0,1.29417528679849,1.57127149436069,MAPKBP1;PTBP1;SF3B2;SNRPD2;PRPF4B;SRSF4;PRPF8
alpha,1,actomyosin structure organization (GO:0031032),5/72,5,72,0.299137483116354,0.822949425709792,0,0,1.37377733816903,1.65794593020918,EPB41L4B;MYBPHL;MYO18A;CDC42BPB;CDC42BPA
alpha,1,histone acetylation (GO:0016573),5/72,5,72,0.299137483116354,0.822949425709792,0,0,1.37377733816903,1.65794593020918,PER1;EPC1;KAT8;KAT7;APBB1
alpha,1,positive regulation of growth (GO:0045927),5/72,5,72,0.299137483116354,0.822949425709792,0,0,1.37377733816903,1.65794593020918,H3F3A;ADAM10;DERL2;PLCB1;EIF4G2
alpha,1,regulation of regulated secretory pathway (GO:1903305),3/38,3,38,0.301264974934523,0.822949425709792,0,0,1.5617679212869,1.87375462452994,RAB3A;SYT10;SYT14
alpha,1,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),3/38,3,38,0.301264974934523,0.822949425709792,0,0,1.5617679212869,1.87375462452994,PPP1R13B;BCL2L11;DYNLL1
alpha,1,phospholipid biosynthetic process (GO:0008654),3/38,3,38,0.301264974934523,0.822949425709792,0,0,1.5617679212869,1.87375462452994,FDPS;PIP5K1A;SGMS2
alpha,1,regulation of peptidyl-threonine phosphorylation (GO:0010799),3/38,3,38,0.301264974934523,0.822949425709792,0,0,1.5617679212869,1.87375462452994,INPP5K;CALM3;UBE2K
alpha,1,intracellular transport of virus (GO:0075733),4/55,4,55,0.302249253356128,0.822949425709792,0,0,1.43871953960975,1.72143261904656,NDC1;NUP210;NUP133;TPR
alpha,1,negative regulation of cellular component organization (GO:0051129),4/55,4,55,0.302249253356128,0.822949425709792,0,0,1.43871953960975,1.72143261904656,DNAJB2;HSPA8;MCTP1;HSPA2
alpha,1,transport of virus (GO:0046794),4/55,4,55,0.302249253356128,0.822949425709792,0,0,1.43871953960975,1.72143261904656,NDC1;NUP210;NUP133;TPR
alpha,1,negative regulation of cellular protein metabolic process (GO:0032269),6/90,6,90,0.303273290727642,0.822949425709792,0,0,1.31882624464227,1.57351919602863,FXR2;CAMK2N1;EIF4E2;CPEB3;GAPDH;GIGYF2
alpha,1,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),6/90,6,90,0.303273290727642,0.822949425709792,0,0,1.31882624464227,1.57351919602863,RPS16;RPS15A;RPL13;RPL27;RPL15;RPS24
alpha,1,positive regulation of multicellular organism growth (GO:0040018),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,GHR
alpha,1,cellular response to caffeine (GO:0071313),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,GSTM2
alpha,1,regulation of cyclic nucleotide metabolic process (GO:0030799),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,CALM3
alpha,1,adherens junction assembly (GO:0034333),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,VCL
alpha,1,cardiac atrium development (GO:0003230),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,ANK2
alpha,1,negative regulation of muscle hypertrophy (GO:0014741),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,RGS2
alpha,1,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,ACAA2
alpha,1,venous blood vessel development (GO:0060841),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,PROX1
alpha,1,regulation of hormone biosynthetic process (GO:0046885),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,EGR1
alpha,1,positive regulation of lamellipodium morphogenesis (GO:2000394),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,ARHGEF7
alpha,1,positive regulation of transmembrane transport (GO:0034764),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,AZIN1
alpha,1,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,ANAPC5
alpha,1,negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,CD14
alpha,1,postsynaptic density assembly (GO:0097107),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,NLGN2
alpha,1,regulation of endocytic recycling (GO:2001135),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,EHD1
alpha,1,negative regulation of interleukin-8 secretion (GO:2000483),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,MAPKBP1
alpha,1,regulation of cardiac muscle cell membrane potential (GO:0086036),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,EHD3
alpha,1,positive regulation of histone H3-K9 methylation (GO:0051574),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,JARID2
alpha,1,oxaloacetate metabolic process (GO:0006107),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,GHR
alpha,1,regulation of ER to Golgi vesicle-mediated transport (GO:0060628),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,SCFD1
alpha,1,mitral valve development (GO:0003174),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,BMPR1A
alpha,1,dorsal aorta development (GO:0035907),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,BMPR1A
alpha,1,cellular response to laminar fluid shear stress (GO:0071499),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,MAPK7
alpha,1,negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,FOXO1
alpha,1,pri-miRNA transcription from RNA polymerase II promoter (GO:0061614),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,DDX5
alpha,1,vesicle transport along actin filament (GO:0030050),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,MYO5A
alpha,1,nucleoside diphosphate metabolic process (GO:0009132),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,CMPK2
alpha,1,positive regulation of histone H4 acetylation (GO:0090240),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,KAT7
alpha,1,cytoplasmic sequestering of NF-kappaB (GO:0007253),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,G3BP2
alpha,1,negative regulation of telomere capping (GO:1904354),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,ERCC1
alpha,1,miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,DICER1
alpha,1,cellular response to leptin stimulus (GO:0044320),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,GCK
alpha,1,lymphatic endothelial cell differentiation (GO:0060836),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,PROX1
alpha,1,regulation of toll-like receptor 9 signaling pathway (GO:0034163),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,RSAD2
alpha,1,central nervous system neuron axonogenesis (GO:0021955),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,EPHB1
alpha,1,regulation of chemokine biosynthetic process (GO:0045073),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,EGR1
alpha,1,activation of MAPKKK activity (GO:0000185),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,TRAF7
alpha,1,negative regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000587),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,PTPN2
alpha,1,formation of translation preinitiation complex (GO:0001731),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,DENR
alpha,1,carnitine transport (GO:0015879),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,PDZK1
alpha,1,amino-acid betaine transport (GO:0015838),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,PDZK1
alpha,1,phosphorylated carbohydrate dephosphorylation (GO:0046838),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,INPP5K
alpha,1,fructose metabolic process (GO:0006000),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,ALDOA
alpha,1,morphogenesis of a polarized epithelium (GO:0001738),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,RAB10
alpha,1,negative regulation of nitrogen compound metabolic process (GO:0051172),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,AP2A1
alpha,1,attachment of GPI anchor to protein (GO:0016255),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,PIGU
alpha,1,cellular response to hydroxyurea (GO:0072711),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,SPIDR
alpha,1,regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,KCNA5
alpha,1,inositol phosphate dephosphorylation (GO:0046855),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,INPP5K
alpha,1,positive regulation of urine volume (GO:0035810),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,INPP5K
alpha,1,modification by symbiont of host morphology or physiology (GO:0044003),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,DAG1
alpha,1,regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901213),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,BMPR1A
alpha,1,positive regulation of protein kinase A signaling (GO:0010739),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,MIF
alpha,1,regulation of alpha-beta T cell differentiation (GO:0046637),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,PNP
alpha,1,regulation by virus of viral protein levels in host cell (GO:0046719),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,DDB1
alpha,1,regulation of RNA biosynthetic process (GO:2001141),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,RALY
alpha,1,"retrograde transport, vesicle recycling within Golgi (GO:0000301)",1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,DNAJC28
alpha,1,regulation of pinocytosis (GO:0048548),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,NR1H2
alpha,1,positive regulation of fatty acid beta-oxidation (GO:0032000),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,IRS2
alpha,1,ion homeostasis (GO:0050801),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,KLHL3
alpha,1,positive regulation of neuroblast proliferation (GO:0002052),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,FZD3
alpha,1,auditory receptor cell differentiation (GO:0042491),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,LRTOMT
alpha,1,negative regulation of B cell apoptotic process (GO:0002903),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,IRS2
alpha,1,activation of signaling protein activity involved in unfolded protein response (GO:0006987),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,PARP16
alpha,1,negative regulation of transporter activity (GO:0032410),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,NDFIP1
alpha,1,pharyngeal arch artery morphogenesis (GO:0061626),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,BMPR1A
alpha,1,dorsal aorta morphogenesis (GO:0035912),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,BMPR1A
alpha,1,mannose metabolic process (GO:0006013),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,MAN2A2
alpha,1,negative regulation of glycogen metabolic process (GO:0070874),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,INPP5K
alpha,1,pentose metabolic process (GO:0019321),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,DCXR
alpha,1,regulation of anion transport (GO:0044070),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,PDZK1
alpha,1,proline metabolic process (GO:0006560),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,ALDH4A1
alpha,1,xenobiotic catabolic process (GO:0042178),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,GSTM2
alpha,1,lens fiber cell differentiation (GO:0070306),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,MAF
alpha,1,response to caffeine (GO:0031000),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,GSTM2
alpha,1,protein maturation by iron-sulfur cluster transfer (GO:0097428),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,MMS19
alpha,1,positive regulation of type I interferon-mediated signaling pathway (GO:0060340),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,UBE2K
alpha,1,"fructose 1,6-bisphosphate metabolic process (GO:0030388)",1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,ALDOA
alpha,1,outer mitochondrial membrane organization (GO:0007008),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,TOMM7
alpha,1,regulation of glycogen (starch) synthase activity (GO:2000465),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,INPP5K
alpha,1,sensory organ morphogenesis (GO:0090596),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,NIPBL
alpha,1,glyoxylate metabolic process (GO:0046487),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,ALDH4A1
alpha,1,regulation of transcription involved in cell fate commitment (GO:0060850),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,PROX1
alpha,1,neuron fate specification (GO:0048665),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,MYT1L
alpha,1,L-methionine salvage (GO:0071267),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,BHMT2
alpha,1,cAMP catabolic process (GO:0006198),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,PDE3A
alpha,1,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031658),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,CDKN2C
alpha,1,positive regulation of neurological system process (GO:0031646),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,DICER1
alpha,1,chondroitin sulfate proteoglycan metabolic process (GO:0050654),1/7,1,7,0.304526298435273,0.822949425709792,0,0,2.82605623851915,3.36017473392687,B3GAT2
alpha,1,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),2/22,2,22,0.306413832053745,0.822949425709792,0,0,1.79839942451218,2.12718046642588,NR1H2;PTPN2
alpha,1,glutathione derivative biosynthetic process (GO:1901687),2/22,2,22,0.306413832053745,0.822949425709792,0,0,1.79839942451218,2.12718046642588,GSTM2;ESD
alpha,1,protein homotrimerization (GO:0070207),2/22,2,22,0.306413832053745,0.822949425709792,0,0,1.79839942451218,2.12718046642588,HTRA2;MIF
alpha,1,positive regulation of protein targeting to membrane (GO:0090314),2/22,2,22,0.306413832053745,0.822949425709792,0,0,1.79839942451218,2.12718046642588,FIS1;PDZK1
alpha,1,early endosome to late endosome transport (GO:0045022),2/22,2,22,0.306413832053745,0.822949425709792,0,0,1.79839942451218,2.12718046642588,WDR81;AKTIP
alpha,1,lipid translocation (GO:0034204),2/22,2,22,0.306413832053745,0.822949425709792,0,0,1.79839942451218,2.12718046642588,TMEM30A;ATP10D
alpha,1,negative regulation of cell cycle G1/S phase transition (GO:1902807),2/22,2,22,0.306413832053745,0.822949425709792,0,0,1.79839942451218,2.12718046642588,CDKN1A;CDK2AP2
alpha,1,negative regulation of myeloid cell differentiation (GO:0045638),2/22,2,22,0.306413832053745,0.822949425709792,0,0,1.79839942451218,2.12718046642588,PRMT1;CTR9
alpha,1,positive regulation of erythrocyte differentiation (GO:0045648),2/22,2,22,0.306413832053745,0.822949425709792,0,0,1.79839942451218,2.12718046642588,PRMT1;ANKRD54
alpha,1,rRNA modification (GO:0000154),2/22,2,22,0.306413832053745,0.822949425709792,0,0,1.79839942451218,2.12718046642588,NSUN4;NHP2
alpha,1,phosphatidylglycerol metabolic process (GO:0046471),2/22,2,22,0.306413832053745,0.822949425709792,0,0,1.79839942451218,2.12718046642588,CDS1;CDS2
alpha,1,purine-containing compound biosynthetic process (GO:0072522),2/22,2,22,0.306413832053745,0.822949425709792,0,0,1.79839942451218,2.12718046642588,PNP;ADK
alpha,1,STAT cascade (GO:0097696),2/22,2,22,0.306413832053745,0.822949425709792,0,0,1.79839942451218,2.12718046642588,GHR;CTR9
alpha,1,beta-catenin destruction complex disassembly (GO:1904886),2/22,2,22,0.306413832053745,0.822949425709792,0,0,1.79839942451218,2.12718046642588,DVL3;PPP1CA
alpha,1,negative regulation of protein import into nucleus (GO:0042308),2/22,2,22,0.306413832053745,0.822949425709792,0,0,1.79839942451218,2.12718046642588,DACT3;EMD
alpha,1,cellular response to unfolded protein (GO:0034620),2/22,2,22,0.306413832053745,0.822949425709792,0,0,1.79839942451218,2.12718046642588,HSPA8;HSPA2
alpha,1,glutathione derivative metabolic process (GO:1901685),2/22,2,22,0.306413832053745,0.822949425709792,0,0,1.79839942451218,2.12718046642588,GSTM2;ESD
alpha,1,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),2/22,2,22,0.306413832053745,0.822949425709792,0,0,1.79839942451218,2.12718046642588,RFX6;GCG
alpha,1,cell-cell junction organization (GO:0045216),5/73,5,73,0.30913071828133,0.822949425709792,0,0,1.35495847052288,1.59070912433092,PARD6B;NLGN2;ANG;CDH15;TLN1
alpha,1,regulation of phosphatase activity (GO:0010921),5/73,5,73,0.30913071828133,0.822949425709792,0,0,1.35495847052288,1.59070912433092,MYO1D;WDR81;WNK1;PPP6R3;SLC7A14
alpha,1,negative regulation of cell cycle (GO:0045786),5/73,5,73,0.30913071828133,0.822949425709792,0,0,1.35495847052288,1.59070912433092,RNF167;PPP1R13B;DUSP1;CAMK2N1;HTRA2
alpha,1,neuron development (GO:0048666),9/145,9,145,0.31201688297581,0.822949425709792,0,0,1.22787271052901,1.43010086630681,EHD1;CNTNAP2;FXR2;MYT1L;WNK1;PRMT1;BLOC1S3;MAP4;STX3
alpha,1,regulation of Ras protein signal transduction (GO:0046578),6/91,6,91,0.312211217635624,0.822949425709792,0,0,1.3043336485473,1.51834263621302,APLP2;SPRY4;AGAP1;ARAP1;RALGPS1;APPL1
alpha,1,regulation of cellular catabolic process (GO:0031329),4/56,4,56,0.313806414663083,0.822949425709792,0,0,1.41302811925957,1.63766991240428,KAT8;PIP4K2B;SMCR8;RAB8A
alpha,1,positive regulation of cysteine-type endopeptidase activity (GO:2001056),4/56,4,56,0.313806414663083,0.822949425709792,0,0,1.41302811925957,1.63766991240428,FIS1;TNFSF10;HTRA2;TBC1D10A
alpha,1,regulation of axonogenesis (GO:0050770),4/56,4,56,0.313806414663083,0.822949425709792,0,0,1.41302811925957,1.63766991240428,SLITRK1;RUFY3;CHN1;EPHB3
alpha,1,regulation of RNA splicing (GO:0043484),4/56,4,56,0.313806414663083,0.822949425709792,0,0,1.41302811925957,1.63766991240428,PTBP1;ESRP1;JMJD6;PTBP3
alpha,1,T cell differentiation (GO:0030217),3/39,3,39,0.315309507008185,0.822949425709792,0,0,1.52172258997185,1.75637306645936,CD8A;ZFP36L2;PTPN2
alpha,1,positive regulation of DNA repair (GO:0045739),3/39,3,39,0.315309507008185,0.822949425709792,0,0,1.52172258997185,1.75637306645936,PCNA;UIMC1;SPIDR
alpha,1,regulation of protein complex assembly (GO:0043254),5/74,5,74,0.319169523976264,0.822949425709792,0,0,1.33664822092122,1.52649623630533,FARP2;HSPA8;BBS10;CDC42EP2;SPIDR
alpha,1,cellular response to acid chemical (GO:0071229),6/92,6,92,0.321191376290258,0.822949425709792,0,0,1.29015610888918,1.46525370362709,EGR1;FZD4;HTRA2;RORB;LAMTOR1;CPEB3
alpha,1,negative regulation of kinase activity (GO:0033673),6/92,6,92,0.321191376290258,0.822949425709792,0,0,1.29015610888918,1.46525370362709,CAMK2N1;AKT1S1;INPP5K;IRS2;SMCR8;CEP85
alpha,1,protein-DNA complex assembly (GO:0065004),6/92,6,92,0.321191376290258,0.822949425709792,0,0,1.29015610888918,1.46525370362709,DDB1;CUL4A;H3F3A;RAD23B;GTF2H4;HIST1H2BD
alpha,1,negative regulation of viral transcription (GO:0032897),2/23,2,23,0.325339013455284,0.822949425709792,0,0,1.72020814518557,1.93160026146876,TRIM13;INPP5K
alpha,1,"nucleotide-excision repair, DNA gap filling (GO:0006297)",2/23,2,23,0.325339013455284,0.822949425709792,0,0,1.72020814518557,1.93160026146876,POLD3;PCNA
alpha,1,positive regulation of ERBB signaling pathway (GO:1901186),2/23,2,23,0.325339013455284,0.822949425709792,0,0,1.72020814518557,1.93160026146876,ARAP1;CBL
alpha,1,glycolytic process (GO:0006096),2/23,2,23,0.325339013455284,0.822949425709792,0,0,1.72020814518557,1.93160026146876,ALDOA;GCK
alpha,1,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),2/23,2,23,0.325339013455284,0.822949425709792,0,0,1.72020814518557,1.93160026146876,USP14;UCHL5
alpha,1,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),2/23,2,23,0.325339013455284,0.822949425709792,0,0,1.72020814518557,1.93160026146876,SUPT16H;CTR9
alpha,1,cellular amino acid catabolic process (GO:0009063),2/23,2,23,0.325339013455284,0.822949425709792,0,0,1.72020814518557,1.93160026146876,ALDH6A1;PPM1K
alpha,1,lamellipodium assembly (GO:0030032),2/23,2,23,0.325339013455284,0.822949425709792,0,0,1.72020814518557,1.93160026146876,ARHGEF7;VCL
alpha,1,zinc II ion transmembrane transport (GO:0071577),2/23,2,23,0.325339013455284,0.822949425709792,0,0,1.72020814518557,1.93160026146876,SLC30A8;SLC39A1
alpha,1,positive regulation of mRNA catabolic process (GO:0061014),2/23,2,23,0.325339013455284,0.822949425709792,0,0,1.72020814518557,1.93160026146876,CPEB3;ZFP36L2
alpha,1,membrane assembly (GO:0071709),2/23,2,23,0.325339013455284,0.822949425709792,0,0,1.72020814518557,1.93160026146876,NLGN2;SPTBN1
alpha,1,regulation of interleukin-8 secretion (GO:2000482),2/23,2,23,0.325339013455284,0.822949425709792,0,0,1.72020814518557,1.93160026146876,MAPKBP1;CD14
alpha,1,rRNA methylation (GO:0031167),2/23,2,23,0.325339013455284,0.822949425709792,0,0,1.72020814518557,1.93160026146876,NSUN4;FDXACB1
alpha,1,maturation of LSU-rRNA (GO:0000470),2/23,2,23,0.325339013455284,0.822949425709792,0,0,1.72020814518557,1.93160026146876,RPL7L1;NHP2
alpha,1,autophagosome maturation (GO:0097352),2/23,2,23,0.325339013455284,0.822949425709792,0,0,1.72020814518557,1.93160026146876,GABARAPL1;SNX14
alpha,1,positive regulation of cell junction assembly (GO:1901890),2/23,2,23,0.325339013455284,0.822949425709792,0,0,1.72020814518557,1.93160026146876,PTPRJ;LIMS1
alpha,1,regulation of ion homeostasis (GO:2000021),2/23,2,23,0.325339013455284,0.822949425709792,0,0,1.72020814518557,1.93160026146876,SLC30A8;WNK1
alpha,1,DNA-dependent DNA replication (GO:0006261),4/57,4,57,0.325401187712956,0.822949425709792,0,0,1.38823815225502,1.55857002334986,CDC45;GINS4;REV3L;CDK2AP1
alpha,1,protein import (GO:0017038),4/57,4,57,0.325401187712956,0.822949425709792,0,0,1.38823815225502,1.55857002334986,IPO13;IPO9;NUP133;CSE1L
alpha,1,mitotic spindle organization (GO:0007052),5/75,5,75,0.32924618712864,0.822949425709792,0,0,1.31882624464227,1.46514938199894,SUN2;MAP4;PCNT;EML1;SPC25
alpha,1,nitrogen compound transport (GO:0071705),5/75,5,75,0.32924618712864,0.822949425709792,0,0,1.31882624464227,1.46514938199894,TMEM30A;SLC7A8;SLC7A1;SLC7A2;SLC38A4
alpha,1,regulation of type I interferon-mediated signaling pathway (GO:0060338),3/40,3,40,0.329365639143507,0.822949425709792,0,0,1.48367952522255,1.64775486668848,PTPN6;UBE2K;PTPN2
alpha,1,clathrin-dependent endocytosis (GO:0072583),3/40,3,40,0.329365639143507,0.822949425709792,0,0,1.48367952522255,1.64775486668848,NLGN2;CLTB;AP2A1
alpha,1,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),3/40,3,40,0.329365639143507,0.822949425709792,0,0,1.48367952522255,1.64775486668848,ATP5B;ALDOA;PFAS
alpha,1,macroautophagy (GO:0016236),7/111,7,111,0.329634837287179,0.822949425709792,0,0,1.24753833952647,1.38448036217028,GABARAPL1;TOMM40;SNX14;NBR1;TOMM7;DYNLL1;TOMM6
alpha,1,cell cycle G1/S phase transition (GO:0044843),6/93,6,93,0.330208243843421,0.822949425709792,0,0,1.27628346255703,1.41416263883743,CUL4A;CDKN1A;CDC45;CDKN2C;CUL1;SPDYA
alpha,1,IRE1-mediated unfolded protein response (GO:0036498),4/58,4,58,0.337022123713393,0.822949425709792,0,0,1.3643030116989,1.48382509878701,SYVN1;TLN1;YIF1A;SEC31A
alpha,1,tRNA modification (GO:0006400),4/58,4,58,0.337022123713393,0.822949425709792,0,0,1.3643030116989,1.48382509878701,TRMT10A;YRDC;OSGEP;ADAT3
alpha,1,regulation of neurogenesis (GO:0050767),4/58,4,58,0.337022123713393,0.822949425709792,0,0,1.3643030116989,1.48382509878701,PER2;NUMB;CDK5RAP2;ARNTL
alpha,1,cotranslational protein targeting to membrane (GO:0006613),6/94,6,94,0.339256354764588,0.822949425709792,0,0,1.26270597891281,1.36498421445591,RPS16;RPS15A;RPL13;RPL27;RPL15;RPS24
alpha,1,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),6/94,6,94,0.339256354764588,0.822949425709792,0,0,1.26270597891281,1.36498421445591,EGLN3;MAPK7;EGLN2;PSMD2;PSMB10;PSMA7
alpha,1,negative regulation of cellular amide metabolic process (GO:0034249),5/76,5,76,0.339353122951277,0.822949425709792,0,0,1.30147326773908,1.40652045021919,FXR2;EIF4E2;CPEB3;GAPDH;GIGYF2
alpha,1,protein insertion into mitochondrial membrane (GO:0051204),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,BCL2L11
alpha,1,regulation of stress-activated protein kinase signaling cascade (GO:0070302),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,NBR1
alpha,1,positive regulation of extracellular matrix assembly (GO:1901203),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,DAG1
alpha,1,cellular response to nitric oxide (GO:0071732),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,FOXO1
alpha,1,regulation of fibroblast apoptotic process (GO:2000269),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,BCL2L11
alpha,1,mast cell activation involved in immune response (GO:0002279),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,CHGA
alpha,1,mRNA cleavage (GO:0006379),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,RNASE4
alpha,1,nucleoside diphosphate phosphorylation (GO:0006165),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,CMPK2
alpha,1,protein lipoylation (GO:0009249),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,LIPT2
alpha,1,positive regulation of protein localization to Cajal body (GO:1904871),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,CCT6A
alpha,1,response to magnesium ion (GO:0032026),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,SLC41A1
alpha,1,negative regulation of anion transmembrane transport (GO:1903960),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,IRS2
alpha,1,endodermal cell fate commitment (GO:0001711),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,CTR9
alpha,1,amyloid fibril formation (GO:1990000),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,MDM2
alpha,1,negative regulation of lipase activity (GO:0060192),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,RGS2
alpha,1,regulation of histone H4 acetylation (GO:0090239),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,KAT7
alpha,1,positive regulation of alpha-beta T cell differentiation (GO:0046638),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,PNP
alpha,1,positive regulation of DNA recombination (GO:0045911),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,MMS19
alpha,1,regulation of PERK-mediated unfolded protein response (GO:1903897),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,NCK1
alpha,1,protein K6-linked ubiquitination (GO:0085020),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,UBE2D4
alpha,1,sequestering of extracellular ligand from receptor (GO:0035581),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,FBN1
alpha,1,regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,CD14
alpha,1,spleen development (GO:0048536),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,PCID2
alpha,1,"negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,DERL2
alpha,1,peptidyl-lysine hydroxylation (GO:0017185),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,JMJD6
alpha,1,TORC1 signaling (GO:0038202),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,AKT1S1
alpha,1,positive regulation of IRE1-mediated unfolded protein response (GO:1903896),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,BCL2L11
alpha,1,positive regulation of protein localization to cell surface (GO:2000010),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,STX3
alpha,1,regulation of metaphase/anaphase transition of cell cycle (GO:1902099),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,HECW2
alpha,1,negative regulation of hippo signaling (GO:0035331),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,MARK3
alpha,1,negative regulation of centriole replication (GO:0046600),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,CDK5RAP2
alpha,1,negative regulation of establishment of protein localization (GO:1904950),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,NDFIP1
alpha,1,protein localization to endosome (GO:0036010),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,TMEM30A
alpha,1,heterochromatin assembly (GO:0031507),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,BAHD1
alpha,1,positive regulation of mRNA 3'-end processing (GO:0031442),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,CPEB3
alpha,1,establishment of protein localization to chromatin (GO:0071169),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,NIPBL
alpha,1,phospholipid homeostasis (GO:0055091),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,HNF4A
alpha,1,regulation of nitrogen compound metabolic process (GO:0051171),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,CACYBP
alpha,1,catecholamine catabolic process (GO:0042424),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,LRTOMT
alpha,1,positive regulation of mitotic sister chromatid separation (GO:1901970),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,ANAPC5
alpha,1,ketone body biosynthetic process (GO:0046951),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,ACSS3
alpha,1,phospholipid scrambling (GO:0017121),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,TMEM256-PLSCR3
alpha,1,cGMP-mediated signaling (GO:0019934),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,PDE3A
alpha,1,regulation of lipid transport (GO:0032368),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,NR1H2
alpha,1,cellular response to purine-containing compound (GO:0071415),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,GSTM2
alpha,1,cellular biogenic amine catabolic process (GO:0042402),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,DMGDH
alpha,1,ventricular trabecula myocardium morphogenesis (GO:0003222),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,BMPR1A
alpha,1,rRNA pseudouridine synthesis (GO:0031118),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,NHP2
alpha,1,pyrimidine nucleobase metabolic process (GO:0006206),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,ALDH6A1
alpha,1,monocyte activation (GO:0042117),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,ADAM10
alpha,1,actin filament network formation (GO:0051639),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,ACTN1
alpha,1,peptidyl-diphthamide metabolic process (GO:0017182),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,DPH3
alpha,1,regulation of response to oxidative stress (GO:1902882),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,MCTP1
alpha,1,mast cell degranulation (GO:0043303),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,CHGA
alpha,1,negative regulation of cilium assembly (GO:1902018),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,MAP4
alpha,1,nucleotide phosphorylation (GO:0046939),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,CMPK2
alpha,1,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,DDX5
alpha,1,regulation of protein localization to Cajal body (GO:1904869),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,CCT6A
alpha,1,regulation of long term synaptic depression (GO:1900452),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,CBLN1
alpha,1,peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,DPH3
alpha,1,copper ion import (GO:0015677),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,STEAP2
alpha,1,positive regulation of lipoprotein lipase activity (GO:0051006),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,NR1H2
alpha,1,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,INPP5K
alpha,1,ribosome disassembly (GO:0032790),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,DENR
alpha,1,aldehyde biosynthetic process (GO:0046184),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,KDM3A
alpha,1,nose development (GO:0043584),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,PROX1
alpha,1,regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,ASXL2
alpha,1,response to leptin (GO:0044321),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,GCK
alpha,1,regulation of T-helper 2 cell cytokine production (GO:2000551),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,RSAD2
alpha,1,regulation of keratinocyte migration (GO:0051547),1/8,1,8,0.339694749446014,0.822949425709792,0,0,2.47279920870425,2.66990074277678,EPB41L4B
alpha,1,positive regulation of mitotic cell cycle phase transition (GO:1901992),3/41,3,41,0.343414358679488,0.822949425709792,0,0,1.44749221972932,1.54710504178249,CDC45;ANAPC5;PLCB1
alpha,1,androgen receptor signaling pathway (GO:0030521),3/41,3,41,0.343414358679488,0.822949425709792,0,0,1.44749221972932,1.54710504178249,KDM3A;DDX5;ARID1A
alpha,1,negative regulation of ERK1 and ERK2 cascade (GO:0070373),3/41,3,41,0.343414358679488,0.822949425709792,0,0,1.44749221972932,1.54710504178249,CAMK2N1;PIN1;PTPN2
alpha,1,regulation of viral transcription (GO:0046782),3/41,3,41,0.343414358679488,0.822949425709792,0,0,1.44749221972932,1.54710504178249,TRIM13;POLR2I;SUPT5H
alpha,1,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",7/113,7,113,0.346168311943028,0.822949425709792,0,0,1.22545801493308,1.3000028361485,RPS16;RPS15A;RBM8A;RPL13;RPL27;RPL15;RPS24
alpha,1,regulation of G2/M transition of mitotic cell cycle (GO:0010389),9/150,9,150,0.347593756466654,0.822949425709792,0,0,1.18694362017804,1.25426806835107,ACTR1A;PSMD2;CUL1;DYNLL1;PCNT;PSMB10;PSMA7;CDK5RAP2;SDCCAG8
alpha,1,cellular response to fibroblast growth factor stimulus (GO:0044344),6/95,6,95,0.348330308254777,0.822949425709792,0,0,1.24941433702952,1.31763746709367,PTBP1;ESRP1;CBL;POLR2I;FRS3;ZFP36L2
alpha,1,respiratory electron transport chain (GO:0022904),6/95,6,95,0.348330308254777,0.822949425709792,0,0,1.24941433702952,1.31763746709367,NDUFA6;NDUFA11;SDHAF2;NDUFV3;CYC1;COX5B
alpha,1,transforming growth factor beta receptor signaling pathway (GO:0007179),5/77,5,77,0.349482886230104,0.822949425709792,0,0,1.2845710175087,1.35047039056693,USP9X;PXN;CBL;BMPR1A;UBE2M
alpha,1,regulation of organelle organization (GO:0033043),7/114,7,114,0.354471358494771,0.822949425709792,0,0,1.21470838322314,1.25980774854742,FIS1;LMAN1;EHD3;STX5;TBC1D17;TBC1D10A;TBC1D10B
alpha,1,positive regulation of canonical Wnt signaling pathway (GO:0090263),7/114,7,114,0.354471358494771,0.822949425709792,0,0,1.21470838322314,1.25980774854742,WNK1;PSMD2;USP34;PIN1;PSMB10;PSMA7;ARNTL
alpha,1,regulation of substrate adhesion-dependent cell spreading (GO:1900024),3/42,3,42,0.357437630334132,0.822949425709792,0,0,1.41302811925957,1.453715405782,ARHGEF7;CRKL;LIMS1
alpha,1,response to ionizing radiation (GO:0010212),5/78,5,78,0.35962818155992,0.822949425709792,0,0,1.26810215830987,1.29686856155065,CDKN1A;UIMC1;TRIM13;SPIDR;CLOCK
alpha,1,positive regulation of cytoskeleton organization (GO:0051495),5/78,5,78,0.35962818155992,0.822949425709792,0,0,1.26810215830987,1.29686856155065,NUMA1;CDC42EP3;CDC42EP2;PROX1;NCK1
alpha,1,positive regulation of histone methylation (GO:0031062),2/25,2,25,0.362737833875157,0.822949425709792,0,0,1.58259149357072,1.60486635232271,CTR9;JARID2
alpha,1,dendritic spine organization (GO:0097061),2/25,2,25,0.362737833875157,0.822949425709792,0,0,1.58259149357072,1.60486635232271,EPHB1;EPHB3
alpha,1,negative regulation of protein localization to membrane (GO:1905476),2/25,2,25,0.362737833875157,0.822949425709792,0,0,1.58259149357072,1.60486635232271,NUMB;INPP5K
alpha,1,response to glucocorticoid (GO:0051384),2/25,2,25,0.362737833875157,0.822949425709792,0,0,1.58259149357072,1.60486635232271,BCL2L11;ZFP36L2
alpha,1,histone mRNA metabolic process (GO:0008334),2/25,2,25,0.362737833875157,0.822949425709792,0,0,1.58259149357072,1.60486635232271,ZNF473;XRN1
alpha,1,Golgi to plasma membrane protein transport (GO:0043001),2/25,2,25,0.362737833875157,0.822949425709792,0,0,1.58259149357072,1.60486635232271,RAB10;SPTBN1
alpha,1,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),2/25,2,25,0.362737833875157,0.822949425709792,0,0,1.58259149357072,1.60486635232271,CDKN1A;CDK2AP2
alpha,1,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),2/25,2,25,0.362737833875157,0.822949425709792,0,0,1.58259149357072,1.60486635232271,PSMA7;PSMB10
alpha,1,ATP generation from ADP (GO:0006757),2/25,2,25,0.362737833875157,0.822949425709792,0,0,1.58259149357072,1.60486635232271,ALDOA;GCK
alpha,1,axoneme assembly (GO:0035082),2/25,2,25,0.362737833875157,0.822949425709792,0,0,1.58259149357072,1.60486635232271,SPAG16;DNAAF2
alpha,1,negative regulation of oxidative stress-induced cell death (GO:1903202),2/25,2,25,0.362737833875157,0.822949425709792,0,0,1.58259149357072,1.60486635232271,MAPK7;HTRA2
alpha,1,cilium-dependent cell motility (GO:0060285),2/25,2,25,0.362737833875157,0.822949425709792,0,0,1.58259149357072,1.60486635232271,DNAAF2;RFX3
alpha,1,DNA replication initiation (GO:0006270),2/25,2,25,0.362737833875157,0.822949425709792,0,0,1.58259149357072,1.60486635232271,CDC45;GINS4
alpha,1,regulation of neuronal synaptic plasticity (GO:0048168),2/25,2,25,0.362737833875157,0.822949425709792,0,0,1.58259149357072,1.60486635232271,RAB3A;MCTP1
alpha,1,mRNA splice site selection (GO:0006376),2/25,2,25,0.362737833875157,0.822949425709792,0,0,1.58259149357072,1.60486635232271,SRSF5;LUC7L2
alpha,1,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),2/25,2,25,0.362737833875157,0.822949425709792,0,0,1.58259149357072,1.60486635232271,USP14;WAC
alpha,1,regulation of cell cycle G1/S phase transition (GO:1902806),2/25,2,25,0.362737833875157,0.822949425709792,0,0,1.58259149357072,1.60486635232271,PAGR1;PTPN6
alpha,1,regulation of cellular senescence (GO:2000772),2/25,2,25,0.362737833875157,0.822949425709792,0,0,1.58259149357072,1.60486635232271,MAP3K3;ARNTL
alpha,1,cellular response to organic substance (GO:0071310),8/134,8,134,0.366547728966548,0.822949425709792,0,0,1.18103842803785,1.1853215076318,GHR;JUND;MAPK7;HTRA2;INPP5K;PTPN6;EMD;PTPN2
alpha,1,fibroblast growth factor receptor signaling pathway (GO:0008543),5/79,5,79,0.369781872722573,0.822949425709792,0,0,1.25205023225532,1.24559213257849,PTBP1;ESRP1;CBL;POLR2I;FRS3
alpha,1,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),5/79,5,79,0.369781872722573,0.822949425709792,0,0,1.25205023225532,1.24559213257849,EGLN3;EGLN2;PSMD2;PSMB10;PSMA7
alpha,1,cellular response to radiation (GO:0071478),3/43,3,43,0.371418392432909,0.822949425709792,0,0,1.38016700020703,1.36695343232589,CDKN1A;SPIDR;CLOCK
alpha,1,positive regulation of protein localization to nucleus (GO:1900182),3/43,3,43,0.371418392432909,0.822949425709792,0,0,1.38016700020703,1.36695343232589,CCT6A;TPR;KAT7
alpha,1,negative regulation of protein secretion (GO:0050709),3/43,3,43,0.371418392432909,0.822949425709792,0,0,1.38016700020703,1.36695343232589,RSAD2;DPH3;ERP29
alpha,1,ceramide metabolic process (GO:0006672),3/43,3,43,0.371418392432909,0.822949425709792,0,0,1.38016700020703,1.36695343232589,FUT5;SMPD1;SGMS2
alpha,1,cellular response to retinoic acid (GO:0071300),3/43,3,43,0.371418392432909,0.822949425709792,0,0,1.38016700020703,1.36695343232589,FZD4;HTRA2;RORB
alpha,1,translesion synthesis (GO:0019985),3/43,3,43,0.371418392432909,0.822949425709792,0,0,1.38016700020703,1.36695343232589,POLD3;PCNA;REV3L
alpha,1,nucleosome assembly (GO:0006334),4/61,4,61,0.371932467435322,0.822949425709792,0,0,1.29720614227108,1.28299262906919,HIRA;H3F3A;HIST1H2BD;ASF1B
alpha,1,regulation of stress fiber assembly (GO:0051492),4/61,4,61,0.371932467435322,0.822949425709792,0,0,1.29720614227108,1.28299262906919,PXN;INPP5K;ARHGEF10L;ARAP1
alpha,1,negative regulation of circadian rhythm (GO:0042754),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,PER2
alpha,1,secretory granule organization (GO:0033363),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,BLOC1S3
alpha,1,small RNA loading onto RISC (GO:0070922),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,DICER1
alpha,1,negative regulation of leukocyte chemotaxis (GO:0002689),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,MIF
alpha,1,RNA destabilization (GO:0050779),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,GIGYF2
alpha,1,L-fucose metabolic process (GO:0042354),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,FUT5
alpha,1,acidic amino acid transport (GO:0015800),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,SLC25A22
alpha,1,manganese ion transport (GO:0006828),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,TRPC4
alpha,1,regulation of protein acetylation (GO:1901983),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,ARNTL
alpha,1,actin filament reorganization (GO:0090527),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,NEDD9
alpha,1,ventricular cardiac muscle cell membrane repolarization (GO:0099625),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,KCNJ3
alpha,1,neuronal ion channel clustering (GO:0045161),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,CNTNAP2
alpha,1,neuron maturation (GO:0042551),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,FARP2
alpha,1,microtubule anchoring at centrosome (GO:0034454),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,CCDC68
alpha,1,regulation of amyloid precursor protein biosynthetic process (GO:0042984),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,NECAB3
alpha,1,postsynaptic membrane assembly (GO:0097104),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,NLGN2
alpha,1,sarcoplasmic reticulum calcium ion transport (GO:0070296),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,ANK2
alpha,1,oligosaccharide catabolic process (GO:0009313),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,MANBA
alpha,1,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,ANAPC5
alpha,1,cellular response to reactive nitrogen species (GO:1902170),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,FOXO1
alpha,1,potassium ion export (GO:0071435),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,KCNA5
alpha,1,regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,USP14
alpha,1,embryonic forelimb morphogenesis (GO:0035115),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,NIPBL
alpha,1,positive regulation of synapse maturation (GO:0090129),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,CDC20
alpha,1,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,HTRA2
alpha,1,L-fucose catabolic process (GO:0042355),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,FUT5
alpha,1,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,PTPN2
alpha,1,mitochondrion morphogenesis (GO:0070584),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,FIS1
alpha,1,regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,PTPN2
alpha,1,regulation of integrin activation (GO:0033623),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,FARP2
alpha,1,ATP synthesis coupled electron transport (GO:0042773),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,NDUFV3
alpha,1,regulation of endoplasmic reticulum unfolded protein response (GO:1900101),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,FICD
alpha,1,myelin assembly (GO:0032288),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,DICER1
alpha,1,epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,RFX3
alpha,1,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,RPL7L1
alpha,1,heterochromatin organization (GO:0070828),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,BAHD1
alpha,1,nucleoside phosphate biosynthetic process (GO:1901293),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,CMPK2
alpha,1,cell junction maintenance (GO:0034331),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,NLGN2
alpha,1,positive regulation of T cell chemotaxis (GO:0010820),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,ADAM10
alpha,1,mitochondrial calcium uptake (GO:0036444),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,MCU
alpha,1,peptidyl-amino acid modification (GO:0018193),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,MDM2
alpha,1,positive regulation of autophagosome assembly (GO:2000786),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,PIP4K2B
alpha,1,negative regulation of histone methylation (GO:0031061),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,JARID2
alpha,1,receptor recycling (GO:0001881),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,EHD3
alpha,1,positive regulation of epidermis development (GO:0045684),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,NUMA1
alpha,1,nucleoside triphosphate biosynthetic process (GO:0009142),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,CMPK2
alpha,1,positive regulation of establishment of protein localization to telomere (GO:1904851),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,CCT6A
alpha,1,production of siRNA involved in RNA interference (GO:0030422),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,DICER1
alpha,1,regulation of sequestering of calcium ion (GO:0051282),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,ANK2
alpha,1,negative regulation of heterotypic cell-cell adhesion (GO:0034115),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,MAPK7
alpha,1,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,MAPK7
alpha,1,regulation of bile acid biosynthetic process (GO:0070857),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,PROX1
alpha,1,negative regulation of lymphocyte apoptotic process (GO:0070229),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,IRS2
alpha,1,peroxisome fission (GO:0016559),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,FIS1
alpha,1,postsynaptic density organization (GO:0097106),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,NLGN2
alpha,1,fucose catabolic process (GO:0019317),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,FUT5
alpha,1,protein autoprocessing (GO:0016540),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,HTRA2
alpha,1,protein hexamerization (GO:0034214),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,MAT2A
alpha,1,ether lipid metabolic process (GO:0046485),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,TMEM86B
alpha,1,potassium ion import across plasma membrane (GO:1990573),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,KCNJ3
alpha,1,regulation of oxidative phosphorylation (GO:0002082),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,PDE12
alpha,1,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,CALM3
alpha,1,mitral valve morphogenesis (GO:0003183),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,BMPR1A
alpha,1,T cell mediated immunity (GO:0002456),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,CD8A
alpha,1,mast cell mediated immunity (GO:0002448),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,CHGA
alpha,1,positive regulation of protein homooligomerization (GO:0032464),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,BCL2L11
alpha,1,negative regulation of transcription by competitive promoter binding (GO:0010944),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,DACH1
alpha,1,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,HLA-C
alpha,1,mitochondrial fragmentation involved in apoptotic process (GO:0043653),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,FIS1
alpha,1,nuclear RNA surveillance (GO:0071027),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,XRN1
alpha,1,DNA topological change (GO:0006265),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,TOP3A
alpha,1,positive regulation of triglyceride lipase activity (GO:0061365),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,NR1H2
alpha,1,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,SUPT5H
alpha,1,Golgi inheritance (GO:0048313),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,STX5
alpha,1,regulation of glycoprotein biosynthetic process (GO:0010559),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,NECAB3
alpha,1,histone H3-K4 trimethylation (GO:0080182),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,CTR9
alpha,1,cyclic nucleotide catabolic process (GO:0009214),1/9,1,9,0.373086482697327,0.822949425709792,0,0,2.19804374107045,2.16715030028714,PDE3A
alpha,1,chromatin remodeling (GO:0006338),7/117,7,117,0.379477253576642,0.822949425709792,0,0,1.18356201442255,1.14682498545416,TOX3;SMARCC2;BAHD1;UBTF;CHD4;ARID1A;ARID1B
alpha,1,nucleosome organization (GO:0034728),5/80,5,80,0.379936991106801,0.822949425709792,0,0,1.23639960435213,1.19652553522134,SUPT16H;SMARCC2;H3F3A;ARID1A;HIST1H2BD
alpha,1,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),5/80,5,80,0.379936991106801,0.822949425709792,0,0,1.23639960435213,1.19652553522134,IFI27L1;CASP9;CASP7;EGLN3;TNFSF10
alpha,1,cell-cell junction assembly (GO:0007043),5/80,5,80,0.379936991106801,0.822949425709792,0,0,1.23639960435213,1.19652553522134,PARD6B;ARL2;CDH15;TLN1;VCL
alpha,1,regulation of spindle assembly (GO:0090169),2/26,2,26,0.381146729186008,0.822949425709792,0,0,1.52172258997185,1.46780927036412,NUMA1;TPR
alpha,1,glial cell differentiation (GO:0010001),2/26,2,26,0.381146729186008,0.822949425709792,0,0,1.52172258997185,1.46780927036412,SLC8A3;PTPRZ1
alpha,1,respiratory chain complex IV assembly (GO:0008535),2/26,2,26,0.381146729186008,0.822949425709792,0,0,1.52172258997185,1.46780927036412,SCO1;COA5
alpha,1,lamellipodium organization (GO:0097581),2/26,2,26,0.381146729186008,0.822949425709792,0,0,1.52172258997185,1.46780927036412,ARHGEF7;VCL
alpha,1,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),2/26,2,26,0.381146729186008,0.822949425709792,0,0,1.52172258997185,1.46780927036412,GSTM2;CALM3
alpha,1,in utero embryonic development (GO:0001701),2/26,2,26,0.381146729186008,0.822949425709792,0,0,1.52172258997185,1.46780927036412,ARNT2;ADAM10
alpha,1,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),2/26,2,26,0.381146729186008,0.822949425709792,0,0,1.52172258997185,1.46780927036412,CHST7;B3GAT2
alpha,1,"RNA splicing, via transesterification reactions (GO:0000375)",2/26,2,26,0.381146729186008,0.822949425709792,0,0,1.52172258997185,1.46780927036412,SRSF4;PRPF8
alpha,1,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),2/26,2,26,0.381146729186008,0.822949425709792,0,0,1.52172258997185,1.46780927036412,FAM49B;AP1G1
alpha,1,positive regulation of glucose transport (GO:0010828),2/26,2,26,0.381146729186008,0.822949425709792,0,0,1.52172258997185,1.46780927036412,CAPN10;IRS2
alpha,1,regulation of glucose metabolic process (GO:0010906),2/26,2,26,0.381146729186008,0.822949425709792,0,0,1.52172258997185,1.46780927036412,SIK3;IRS2
alpha,1,modulation of excitatory postsynaptic potential (GO:0098815),2/26,2,26,0.381146729186008,0.822949425709792,0,0,1.52172258997185,1.46780927036412,NLGN2;CBLN1
alpha,1,cellular response to epidermal growth factor stimulus (GO:0071364),2/26,2,26,0.381146729186008,0.822949425709792,0,0,1.52172258997185,1.46780927036412,INPP5K;ZFP36L2
alpha,1,female gamete generation (GO:0007292),2/26,2,26,0.381146729186008,0.822949425709792,0,0,1.52172258997185,1.46780927036412,USP9X;MCM9
alpha,1,peptide hormone secretion (GO:0030072),2/26,2,26,0.381146729186008,0.822949425709792,0,0,1.52172258997185,1.46780927036412,NEUROD1;SLC30A8
alpha,1,regulation of nervous system development (GO:0051960),2/26,2,26,0.381146729186008,0.822949425709792,0,0,1.52172258997185,1.46780927036412,PER2;ARNTL
alpha,1,positive regulation of embryonic development (GO:0040019),2/26,2,26,0.381146729186008,0.822949425709792,0,0,1.52172258997185,1.46780927036412,DAG1;PLCB1
alpha,1,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),2/26,2,26,0.381146729186008,0.822949425709792,0,0,1.52172258997185,1.46780927036412,CALM3;UBE2K
alpha,1,regulation of vesicle fusion (GO:0031338),4/62,4,62,0.383550379564537,0.822949425709792,0,0,1.27628346255703,1.22304240320131,RAB3A;TBC1D17;TBC1D10A;TBC1D10B
alpha,1,regulation of cellular ketone metabolic process (GO:0010565),4/62,4,62,0.383550379564537,0.822949425709792,0,0,1.27628346255703,1.22304240320131,PSMD2;PSMB10;PSMA7;AZIN1
alpha,1,mitotic metaphase plate congression (GO:0007080),3/44,3,44,0.385340548036511,0.822949425709792,0,0,1.34879956838414,1.28625275872007,MIS12;KIF22;CENPC
alpha,1,negative regulation of protein metabolic process (GO:0051248),3/44,3,44,0.385340548036511,0.822949425709792,0,0,1.34879956838414,1.28625275872007,PIN1;APBB1;AZIN1
alpha,1,response to hydrogen peroxide (GO:0042542),3/44,3,44,0.385340548036511,0.822949425709792,0,0,1.34879956838414,1.28625275872007,MAPK7;PLEKHA1;GLRX2
alpha,1,nucleobase-containing compound catabolic process (GO:0034655),3/44,3,44,0.385340548036511,0.822949425709792,0,0,1.34879956838414,1.28625275872007,ENTPD3;XRN2;ADPRM
alpha,1,NIK/NF-kappaB signaling (GO:0038061),5/81,5,81,0.390086743263921,0.822949425709792,0,0,1.2211354117058,1.14955995892633,PSMD2;CUL1;PSMB10;PSMA7;UBE2M
alpha,1,small GTPase mediated signal transduction (GO:0007264),6/100,6,100,0.39390410065073,0.822949425709792,0,0,1.18694362017804,1.10581341088933,CDKN1A;KSR1;G3BP2;RALGDS;RGL2;CRKL
alpha,1,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),4/63,4,63,0.395142415775364,0.822949425709792,0,0,1.2560249948974,1.1662305531791,PSMD2;CUL1;PSMB10;PSMA7
alpha,1,cellular protein catabolic process (GO:0044257),4/63,4,63,0.395142415775364,0.822949425709792,0,0,1.2560249948974,1.1662305531791,MDM2;HTRA2;AP2A1;VLDLR
alpha,1,establishment of protein localization to organelle (GO:0072594),4/63,4,63,0.395142415775364,0.822949425709792,0,0,1.2560249948974,1.1662305531791,IPO13;IPO9;NUP133;CSE1L
alpha,1,regulation of translational initiation (GO:0006446),4/63,4,63,0.395142415775364,0.822949425709792,0,0,1.2560249948974,1.1662305531791,TPR;EIF4G2;NCK1;EIF3B
alpha,1,positive regulation of transferase activity (GO:0051347),8/138,8,138,0.397525845318534,0.822949425709792,0,0,1.14680543012371,1.05792265064828,EPHB6;LMO4;PTGES3;ARRDC3;PIN1;EPHB1;TOPORS;EPHB3
alpha,1,adherens junction organization (GO:0034332),3/45,3,45,0.399188952896853,0.822949425709792,0,0,1.31882624464227,1.21110505510295,ANG;CDH15;VCL
alpha,1,regulation of dendrite morphogenesis (GO:0048814),3/45,3,45,0.399188952896853,0.822949425709792,0,0,1.31882624464227,1.21110505510295,FXR2;SS18L1;HECW2
alpha,1,regulation of T cell activation (GO:0050863),3/45,3,45,0.399188952896853,0.822949425709792,0,0,1.31882624464227,1.21110505510295,FAM49B;SIRPA;CD47
alpha,1,positive regulation of transport (GO:0051050),3/45,3,45,0.399188952896853,0.822949425709792,0,0,1.31882624464227,1.21110505510295,NUMA1;CAPN10;INPP5K
alpha,1,positive regulation of viral process (GO:0048524),3/45,3,45,0.399188952896853,0.822949425709792,0,0,1.31882624464227,1.21110505510295,DDB1;POLR2I;SUPT5H
alpha,1,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),2/27,2,27,0.399324845137605,0.822949425709792,0,0,1.46536249404697,1.34517352839742,CCND3;PROX1
alpha,1,positive regulation of glucose import (GO:0046326),2/27,2,27,0.399324845137605,0.822949425709792,0,0,1.46536249404697,1.34517352839742,CAPN10;IRS2
alpha,1,response to gamma radiation (GO:0010332),2/27,2,27,0.399324845137605,0.822949425709792,0,0,1.46536249404697,1.34517352839742,MDM2;TRIM13
alpha,1,regulation of transcription regulatory region DNA binding (GO:2000677),2/27,2,27,0.399324845137605,0.822949425709792,0,0,1.46536249404697,1.34517352839742,NEUROD1;PER2
alpha,1,regulation of p38MAPK cascade (GO:1900744),2/27,2,27,0.399324845137605,0.822949425709792,0,0,1.46536249404697,1.34517352839742,PER1;PRMT1
alpha,1,regulation of supramolecular fiber organization (GO:1902903),2/27,2,27,0.399324845137605,0.822949425709792,0,0,1.46536249404697,1.34517352839742,HSPA8;ARL2
alpha,1,positive regulation of cAMP metabolic process (GO:0030816),2/27,2,27,0.399324845137605,0.822949425709792,0,0,1.46536249404697,1.34517352839742,CHGA;CALM3
alpha,1,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),2/27,2,27,0.399324845137605,0.822949425709792,0,0,1.46536249404697,1.34517352839742,PCNA;CDC45
alpha,1,fat-soluble vitamin metabolic process (GO:0006775),2/27,2,27,0.399324845137605,0.822949425709792,0,0,1.46536249404697,1.34517352839742,UBIAD1;CYP2R1
alpha,1,positive regulation of release of cytochrome c from mitochondria (GO:0090200),2/27,2,27,0.399324845137605,0.822949425709792,0,0,1.46536249404697,1.34517352839742,BCL2L11;TNFSF10
alpha,1,GPI anchor metabolic process (GO:0006505),2/27,2,27,0.399324845137605,0.822949425709792,0,0,1.46536249404697,1.34517352839742,PIGU;PIGP
alpha,1,regulation of T cell receptor signaling pathway (GO:0050856),2/27,2,27,0.399324845137605,0.822949425709792,0,0,1.46536249404697,1.34517352839742,PTPRJ;PTPN2
alpha,1,cation transmembrane transport (GO:0098655),2/27,2,27,0.399324845137605,0.822949425709792,0,0,1.46536249404697,1.34517352839742,SLC7A1;SLC7A2
alpha,1,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),2/27,2,27,0.399324845137605,0.822949425709792,0,0,1.46536249404697,1.34517352839742,CTC1;XRN1
alpha,1,negative regulation of cell death (GO:0060548),5/82,5,82,0.400224517698287,0.822949425709792,0,0,1.2062435164411,1.10459288689674,CHGA;PDE12;HTRA2;PARP16;NCK1
alpha,1,brain development (GO:0007420),7/120,7,120,0.404545790582397,0.822949425709792,0,0,1.15397296406199,1.04433439198354,CNTNAP2;ARNT2;NIPBL;PROX1;CIC;EML1;CDK5RAP2
alpha,1,negative regulation of response to cytokine stimulus (GO:0060761),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,MAPK7
alpha,1,regulation of B cell apoptotic process (GO:0002902),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,IRS2
alpha,1,regulation of synapse maturation (GO:0090128),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,CDC20
alpha,1,protein deglycosylation (GO:0006517),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,MAN2A2
alpha,1,regulation of chromatin organization (GO:1902275),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,HIRA
alpha,1,ganglion development (GO:0061548),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,FZD3
alpha,1,negative regulation of sodium ion transmembrane transport (GO:1902306),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,HECW2
alpha,1,dorsal/ventral axis specification (GO:0009950),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,CXXC4
alpha,1,amino sugar metabolic process (GO:0006040),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,GNE
alpha,1,regulation of sequestering of zinc ion (GO:0061088),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,SLC30A8
alpha,1,epithelial cell apoptotic process (GO:1904019),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,CAPN10
alpha,1,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,ARFIP1
alpha,1,oxalate transport (GO:0019532),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,SLC26A4
alpha,1,presynaptic membrane assembly (GO:0097105),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,NLGN2
alpha,1,mitotic nuclear envelope reassembly (GO:0007084),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,EMD
alpha,1,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,PTPRJ
alpha,1,skeletal muscle thin filament assembly (GO:0030240),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,PROX1
alpha,1,response to laminar fluid shear stress (GO:0034616),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,MAPK7
alpha,1,embryonic digestive tract morphogenesis (GO:0048557),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,NIPBL
alpha,1,L-glutamate transport (GO:0015813),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,SLC25A22
alpha,1,regulation of respiratory burst (GO:0060263),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,NOXO1
alpha,1,regulation of actin filament-based movement (GO:1903115),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,ANK2
alpha,1,regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,INPP5K
alpha,1,glutamine metabolic process (GO:0006541),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,GLUL
alpha,1,positive regulation of glial cell differentiation (GO:0045687),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,DICER1
alpha,1,positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,PAGR1
alpha,1,creatine metabolic process (GO:0006600),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,GHR
alpha,1,negative regulation of gluconeogenesis (GO:0045721),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,GCK
alpha,1,chylomicron assembly (GO:0034378),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,PLAGL2
alpha,1,nuclear pore complex assembly (GO:0051292),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,NDC1
alpha,1,positive regulation of fertilization (GO:1905516),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,PLCB1
alpha,1,regulation of urine volume (GO:0035809),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,INPP5K
alpha,1,regulation of pH (GO:0006885),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,SLC26A4
alpha,1,positive regulation of natural killer cell activation (GO:0032816),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,AP1G1
alpha,1,telomere maintenance in response to DNA damage (GO:0043247),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,APEX1
alpha,1,glycerolipid metabolic process (GO:0046486),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,PIP5K1A
alpha,1,primary miRNA processing (GO:0031053),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,DGCR8
alpha,1,negative regulation of reproductive process (GO:2000242),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,DUSP1
alpha,1,G1 DNA damage checkpoint (GO:0044783),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,WAC
alpha,1,protein localization to synapse (GO:0035418),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,NLGN2
alpha,1,regulation of establishment of protein localization to telomere (GO:0070203),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,CCT6A
alpha,1,central nervous system projection neuron axonogenesis (GO:0021952),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,EPHB1
alpha,1,motor neuron axon guidance (GO:0008045),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,CHN1
alpha,1,sympathetic ganglion development (GO:0061549),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,FZD3
alpha,1,regulation of fatty acid beta-oxidation (GO:0031998),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,IRS2
alpha,1,myeloid dendritic cell differentiation (GO:0043011),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,DHRS2
alpha,1,DNA replication-dependent nucleosome assembly (GO:0006335),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,ASF1B
alpha,1,positive regulation of circadian rhythm (GO:0042753),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,ARNTL
alpha,1,protein deneddylation (GO:0000338),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,COPS3
alpha,1,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,TMEM30A
alpha,1,cytochrome complex assembly (GO:0017004),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,SCO1
alpha,1,maintenance of apical/basal cell polarity (GO:0035090),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,LIN7A
alpha,1,negative regulation of stem cell differentiation (GO:2000737),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,ZFP36L2
alpha,1,telomere maintenance via recombination (GO:0000722),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,ERCC1
alpha,1,neuron projection fasciculation (GO:0106030),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,EPHB3
alpha,1,polarized epithelial cell differentiation (GO:0030859),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,RAB10
alpha,1,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,NCK1
alpha,1,regulation of phospholipase activity (GO:0010517),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,RGS2
alpha,1,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,HECW2
alpha,1,negative regulation of embryonic development (GO:0045992),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,FZD3
alpha,1,negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,SNX25
alpha,1,regulation of mRNA 3'-end processing (GO:0031440),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,PAPOLA
alpha,1,chaperone-mediated protein transport (GO:0072321),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,HSPA8
alpha,1,DNA replication-dependent nucleosome organization (GO:0034723),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,ASF1B
alpha,1,protein kinase A signaling (GO:0010737),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,GCG
alpha,1,regulation of neuroblast proliferation (GO:1902692),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,FZD3
alpha,1,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,NCK1
alpha,1,positive regulation of vacuole organization (GO:0044090),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,PIP4K2B
alpha,1,regulation of phospholipid metabolic process (GO:1903725),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,WDR81
alpha,1,maintenance of epithelial cell apical/basal polarity (GO:0045199),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,LIN7A
alpha,1,forelimb morphogenesis (GO:0035136),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,NIPBL
alpha,1,ketone body metabolic process (GO:1902224),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,ACSS3
alpha,1,smooth muscle cell differentiation (GO:0051145),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,MKL1
alpha,1,negative regulation of glucose transport (GO:0010829),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,INPP5K
alpha,1,positive regulation of type 2 immune response (GO:0002830),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,RSAD2
alpha,1,regulation of T cell chemotaxis (GO:0010819),1/10,1,10,0.404791173634959,0.822949425709792,0,0,1.9782393669634,1.78908796341852,ADAM10
alpha,1,regulation of signal transduction by p53 class mediator (GO:1901796),8/139,8,139,0.405282654102413,0.822949425709792,0,0,1.13855503134584,1.02830936696454,SUPT16H;PPP1R13B;RNF34;TAF15;TOP3A;MDM2;PIN1;CHD4
alpha,1,actin filament organization (GO:0007015),7/121,7,121,0.412898099073287,0.822949425709792,0,0,1.14443599741684,1.01231595419064,MYBPHL;ACTN1;RUFY3;CDC42EP2;NEDD9;PROX1;ALDOA
alpha,1,protein complex subunit organization (GO:0071822),3/46,3,46,0.412949399546541,0.822949425709792,0,0,1.29015610888918,1.14105304191069,NDC1;NUP133;TPR
alpha,1,regulation of primary metabolic process (GO:0080090),8/140,8,140,0.41303830901555,0.822949425709792,0,0,1.13042249540766,0.999536450378356,PSMD2;HNF4A;CARM1;IRS2;CACYBP;AZIN1;PSMB10;PSMA7
alpha,1,mRNA polyadenylation (GO:0006378),2/28,2,28,0.417248473340146,0.822949425709792,0,0,1.41302811925957,1.23509025760651,PAPOLA;TUT1
alpha,1,phosphatidylinositol phosphorylation (GO:0046854),2/28,2,28,0.417248473340146,0.822949425709792,0,0,1.41302811925957,1.23509025760651,IP6K1;EFR3B
alpha,1,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),2/28,2,28,0.417248473340146,0.822949425709792,0,0,1.41302811925957,1.23509025760651,PTPN6;PTPN2
alpha,1,regulation of double-strand break repair via homologous recombination (GO:0010569),2/28,2,28,0.417248473340146,0.822949425709792,0,0,1.41302811925957,1.23509025760651,MMS19;SPIDR
alpha,1,regulation of protein localization to nucleus (GO:1900180),2/28,2,28,0.417248473340146,0.822949425709792,0,0,1.41302811925957,1.23509025760651,PIN1;KAT7
alpha,1,transition metal ion transport (GO:0000041),2/28,2,28,0.417248473340146,0.822949425709792,0,0,1.41302811925957,1.23509025760651,SLC30A8;TRPC4
alpha,1,negative regulation of myeloid leukocyte differentiation (GO:0002762),2/28,2,28,0.417248473340146,0.822949425709792,0,0,1.41302811925957,1.23509025760651,PTPN2;FBN1
alpha,1,negative regulation of osteoblast differentiation (GO:0045668),2/28,2,28,0.417248473340146,0.822949425709792,0,0,1.41302811925957,1.23509025760651,NBR1;RORB
alpha,1,purine ribonucleoside triphosphate biosynthetic process (GO:0009206),2/28,2,28,0.417248473340146,0.822949425709792,0,0,1.41302811925957,1.23509025760651,ATP5B;ALDOA
alpha,1,cargo loading into vesicle (GO:0035459),2/28,2,28,0.417248473340146,0.822949425709792,0,0,1.41302811925957,1.23509025760651,CTAGE5;SEC31A
alpha,1,regulation of blood vessel diameter (GO:0097746),2/28,2,28,0.417248473340146,0.822949425709792,0,0,1.41302811925957,1.23509025760651,CHGA;PER2
alpha,1,cellular response to topologically incorrect protein (GO:0035967),2/28,2,28,0.417248473340146,0.822949425709792,0,0,1.41302811925957,1.23509025760651,HSPA8;HSPA2
alpha,1,NADH dehydrogenase complex assembly (GO:0010257),4/65,4,65,0.4182120397471,0.822949425709792,0,0,1.21737807197748,1.06126966805648,NDUFA6;NDUFA11;TMEM126B;NDUFV3
alpha,1,mitochondrial respiratory chain complex I biogenesis (GO:0097031),4/65,4,65,0.4182120397471,0.822949425709792,0,0,1.21737807197748,1.06126966805648,NDUFA6;NDUFA11;TMEM126B;NDUFV3
alpha,1,mitochondrial respiratory chain complex I assembly (GO:0032981),4/65,4,65,0.4182120397471,0.822949425709792,0,0,1.21737807197748,1.06126966805648,NDUFA6;NDUFA11;TMEM126B;NDUFV3
alpha,1,interleukin-12-mediated signaling pathway (GO:0035722),3/47,3,47,0.426608599093001,0.822949425709792,0,0,1.26270597891281,1.07568446982038,PITPNA;MIF;PLCB1
alpha,1,protein methylation (GO:0006479),3/47,3,47,0.426608599093001,0.822949425709792,0,0,1.26270597891281,1.07568446982038,HSPA8;PRMT1;CARM1
alpha,1,positive regulation of protein localization to cell periphery (GO:1904377),3/47,3,47,0.426608599093001,0.822949425709792,0,0,1.26270597891281,1.07568446982038,NUMA1;STX3;SPTBN1
alpha,1,cellular response to interleukin-12 (GO:0071349),3/47,3,47,0.426608599093001,0.822949425709792,0,0,1.26270597891281,1.07568446982038,PITPNA;MIF;PLCB1
alpha,1,maturation of SSU-rRNA (GO:0030490),3/47,3,47,0.426608599093001,0.822949425709792,0,0,1.26270597891281,1.07568446982038,RPS16;PDCD11;RPS24
alpha,1,regulation of fibroblast proliferation (GO:0048145),3/47,3,47,0.426608599093001,0.822949425709792,0,0,1.26270597891281,1.07568446982038,CDKN1A;MIF;EMD
alpha,1,regulation of cellular component movement (GO:0051270),3/47,3,47,0.426608599093001,0.822949425709792,0,0,1.26270597891281,1.07568446982038,BTC;ACTN1;ARAP1
alpha,1,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",3/47,3,47,0.426608599093001,0.822949425709792,0,0,1.26270597891281,1.07568446982038,NDUFA6;NDUFA11;NDUFV3
alpha,1,negative regulation of autophagy (GO:0010507),3/47,3,47,0.426608599093001,0.822949425709792,0,0,1.26270597891281,1.07568446982038,NRBP2;SMCR8;EIF4G2
alpha,1,sulfur compound biosynthetic process (GO:0044272),7/123,7,123,0.429574915139956,0.822949425709792,0,0,1.12582728201169,0.951278039268009,GSTM2;CHST7;MAT2A;B3GAT2;ESD;ST3GAL6;CHST2
alpha,1,protein import into nucleus (GO:0006606),6/104,6,104,0.430308318654643,0.822949425709792,0,0,1.14129194247889,0.96239820486598,IPO13;IPO9;NUP133;CSE1L;TPR;DAG1
alpha,1,regulation of cell cycle G2/M phase transition (GO:1902749),5/85,5,85,0.43050270707374,0.822949425709792,0,0,1.16367021586083,0.980743197679255,ACTR1A;DYNLL1;PCNT;CDK5RAP2;SDCCAG8
alpha,1,formation of extrachromosomal circular DNA (GO:0001325),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,ERCC1
alpha,1,sulfate transmembrane transport (GO:1902358),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,SLC26A4
alpha,1,regulation of stem cell population maintenance (GO:2000036),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,ZNF706
alpha,1,regulation of histone H3-K9 methylation (GO:0051570),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,JARID2
alpha,1,microtubule anchoring at microtubule organizing center (GO:0072393),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,CCDC68
alpha,1,positive regulation of cell cycle phase transition (GO:1901989),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,PAGR1
alpha,1,drug transmembrane transport (GO:0006855),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,TMEM30A
alpha,1,negative regulation of blood vessel diameter (GO:0097756),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,CHGA
alpha,1,regulation of histone deacetylation (GO:0031063),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,NIPBL
alpha,1,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,CCT6A
alpha,1,postsynapse assembly (GO:0099068),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,NLGN2
alpha,1,regulation of lipid kinase activity (GO:0043550),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,WDR81
alpha,1,carnitine metabolic process (GO:0009437),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,TMLHE
alpha,1,mitotic spindle midzone assembly (GO:0051256),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,CDC14A
alpha,1,regulation of lamellipodium morphogenesis (GO:2000392),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,ARHGEF7
alpha,1,embryonic eye morphogenesis (GO:0048048),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,FBN1
alpha,1,positive regulation of leukocyte degranulation (GO:0043302),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,AP1G1
alpha,1,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,CPEB3
alpha,1,T cell differentiation in thymus (GO:0033077),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,ZFP36L2
alpha,1,chromatin silencing at rDNA (GO:0000183),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,H3F3A
alpha,1,cellular response to sterol (GO:0036315),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,INSIG1
alpha,1,myosin filament assembly (GO:0031034),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,MYBPHL
alpha,1,positive regulation of protein deacetylation (GO:0090312),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,NIPBL
alpha,1,regulation of mitotic centrosome separation (GO:0046602),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,CEP85
alpha,1,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,TNFSF10
alpha,1,positive regulation of histone deacetylation (GO:0031065),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,NIPBL
alpha,1,cell-cell junction maintenance (GO:0045217),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,NLGN2
alpha,1,purine nucleobase metabolic process (GO:0006144),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,TTR
alpha,1,positive regulation of myoblast fusion (GO:1901741),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,EHD1
alpha,1,phosphatidylinositol dephosphorylation (GO:0046856),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,INPP5K
alpha,1,rRNA base methylation (GO:0070475),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,FDXACB1
alpha,1,organic cyclic compound catabolic process (GO:1901361),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,ALDH4A1
alpha,1,lymphocyte mediated immunity (GO:0002449),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,CD8A
alpha,1,positive regulation of chromosome segregation (GO:0051984),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,NUMA1
alpha,1,regulation of short-term neuronal synaptic plasticity (GO:0048172),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,RAB3A
alpha,1,sphingolipid catabolic process (GO:0030149),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,SMPD1
alpha,1,negative regulation of cellular senescence (GO:2000773),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,MAP3K3
alpha,1,positive regulation of glycoprotein biosynthetic process (GO:0010560),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,PLCB1
alpha,1,transcytosis (GO:0045056),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,USO1
alpha,1,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,CPEB3
alpha,1,response to sterol (GO:0036314),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,INSIG1
alpha,1,negative regulation of nucleocytoplasmic transport (GO:0046823),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,TPR
alpha,1,histone mRNA catabolic process (GO:0071044),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,XRN1
alpha,1,positive regulation of fatty acid biosynthetic process (GO:0045723),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,NR1H2
alpha,1,regulation of cholesterol esterification (GO:0010872),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,LAMTOR1
alpha,1,cell part morphogenesis (GO:0032990),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,FIS1
alpha,1,protein localization to mitochondrion (GO:0070585),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,MARCH5
alpha,1,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,MIF
alpha,1,t-circle formation (GO:0090656),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,ERCC1
alpha,1,response to nitric oxide (GO:0071731),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,FOXO1
alpha,1,photoreceptor cell development (GO:0042461),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,RORB
alpha,1,negative regulation of chemotaxis (GO:0050922),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,PTPN2
alpha,1,cellular response to increased oxygen levels (GO:0036295),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,FOXO1
alpha,1,mitotic spindle elongation (GO:0000022),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,CDC14A
alpha,1,positive regulation of fatty acid oxidation (GO:0046321),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,IRS2
alpha,1,cyclooxygenase pathway (GO:0019371),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,PTGES3
alpha,1,magnesium ion transport (GO:0015693),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,SLC41A1
alpha,1,"regulation of synaptic transmission, GABAergic (GO:0032228)",1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,NLGN2
alpha,1,epithelial cell-cell adhesion (GO:0090136),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,VCL
alpha,1,regulation of autophagosome maturation (GO:1901096),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,SMCR8
alpha,1,telomere maintenance via telomere trimming (GO:0090737),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,ERCC1
alpha,1,presynaptic membrane organization (GO:0097090),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,NLGN2
alpha,1,urate metabolic process (GO:0046415),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,PNP
alpha,1,cardiac muscle cell membrane repolarization (GO:0099622),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,KCNJ3
alpha,1,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),1/11,1,11,0.43489397600275,0.822949425709792,0,0,1.79839942451218,1.49744269567172,NAGK
alpha,1,negative regulation of endocytosis (GO:0045806),2/29,2,29,0.43489688710848,0.822949425709792,0,0,1.3643030116989,1.13598187812964,MCTP1;NR1H2
alpha,1,RNA polyadenylation (GO:0043631),2/29,2,29,0.43489688710848,0.822949425709792,0,0,1.3643030116989,1.13598187812964,PAPOLA;TUT1
alpha,1,cellular response to hydrogen peroxide (GO:0070301),2/29,2,29,0.43489688710848,0.822949425709792,0,0,1.3643030116989,1.13598187812964,MAPK7;PLEKHA1
alpha,1,carboxylic acid catabolic process (GO:0046395),2/29,2,29,0.43489688710848,0.822949425709792,0,0,1.3643030116989,1.13598187812964,NAGK;HYAL3
alpha,1,negative regulation of proteasomal protein catabolic process (GO:1901799),2/29,2,29,0.43489688710848,0.822949425709792,0,0,1.3643030116989,1.13598187812964,ALAD;WAC
alpha,1,negative regulation of response to DNA damage stimulus (GO:2001021),2/29,2,29,0.43489688710848,0.822949425709792,0,0,1.3643030116989,1.13598187812964,MDM2;MIF
alpha,1,protein K11-linked ubiquitination (GO:0070979),2/29,2,29,0.43489688710848,0.822949425709792,0,0,1.3643030116989,1.13598187812964,UBE2D4;ANAPC5
alpha,1,regulation of NIK/NF-kappaB signaling (GO:1901222),2/29,2,29,0.43489688710848,0.822949425709792,0,0,1.3643030116989,1.13598187812964,CD14;LIMS1
alpha,1,positive regulation of calcium-mediated signaling (GO:0050850),2/29,2,29,0.43489688710848,0.822949425709792,0,0,1.3643030116989,1.13598187812964,GSTM2;CALM3
alpha,1,production of miRNAs involved in gene silencing by miRNA (GO:0035196),2/29,2,29,0.43489688710848,0.822949425709792,0,0,1.3643030116989,1.13598187812964,DGCR8;DICER1
alpha,1,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),2/29,2,29,0.43489688710848,0.822949425709792,0,0,1.3643030116989,1.13598187812964,HLA-C;SEC31A
alpha,1,regulation of defense response to virus by virus (GO:0050690),2/29,2,29,0.43489688710848,0.822949425709792,0,0,1.3643030116989,1.13598187812964,AP1G1;AP2A1
alpha,1,positive regulation of lipid biosynthetic process (GO:0046889),2/29,2,29,0.43489688710848,0.822949425709792,0,0,1.3643030116989,1.13598187812964,CTDNEP1;NR1H2
alpha,1,calcium ion import (GO:0070509),2/29,2,29,0.43489688710848,0.822949425709792,0,0,1.3643030116989,1.13598187812964,TRPC4;MCU
alpha,1,positive regulation of fibroblast proliferation (GO:0048146),2/29,2,29,0.43489688710848,0.822949425709792,0,0,1.3643030116989,1.13598187812964,CDKN1A;MIF
alpha,1,bicellular tight junction assembly (GO:0070830),2/29,2,29,0.43489688710848,0.822949425709792,0,0,1.3643030116989,1.13598187812964,PARD6B;ARL2
alpha,1,transcription elongation from RNA polymerase I promoter (GO:0006362),2/29,2,29,0.43489688710848,0.822949425709792,0,0,1.3643030116989,1.13598187812964,UBTF;GTF2H4
alpha,1,monovalent inorganic cation transport (GO:0015672),6/105,6,105,0.439362519861449,0.830013696698618,0,0,1.13042249540766,0.92969384894038,KCNB2;KCNK16;KCNA5;SCN3B;KCNK1;KCNJ3
alpha,1,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),3/48,3,48,0.440154160129564,0.830013696698618,0,0,1.23639960435213,1.0146269158038,MAPKBP1;PER1;G3BP2
alpha,1,negative regulation of cellular biosynthetic process (GO:0031327),3/48,3,48,0.440154160129564,0.830013696698618,0,0,1.23639960435213,1.0146269158038,AP2A1;PROX1;GCK
alpha,1,postreplication repair (GO:0006301),3/48,3,48,0.440154160129564,0.830013696698618,0,0,1.23639960435213,1.0146269158038,POLD3;PCNA;TMEM189-UBE2V1
alpha,1,positive regulation of organelle assembly (GO:1902117),3/48,3,48,0.440154160129564,0.830013696698618,0,0,1.23639960435213,1.0146269158038,NUMA1;PIP4K2B;PROX1
alpha,1,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),5/86,5,86,0.44053028496476,0.830148073328056,0,0,1.15013916683919,0.942856582971414,GHR;BANK1;PTPN6;MIF;IL6R
alpha,1,dicarboxylic acid transport (GO:0006835),2/30,2,30,0.452252100915899,0.830292076089756,0,0,1.31882624464227,1.04650907912021,SLC26A4;SLC25A22
alpha,1,keratan sulfate biosynthetic process (GO:0018146),2/30,2,30,0.452252100915899,0.830292076089756,0,0,1.31882624464227,1.04650907912021,ST3GAL6;CHST2
alpha,1,cardiac muscle cell action potential (GO:0086001),2/30,2,30,0.452252100915899,0.830292076089756,0,0,1.31882624464227,1.04650907912021,ANK2;SCN3B
alpha,1,positive regulation of myeloid cell differentiation (GO:0045639),2/30,2,30,0.452252100915899,0.830292076089756,0,0,1.31882624464227,1.04650907912021,PRMT1;ANKRD54
alpha,1,protein alkylation (GO:0008213),2/30,2,30,0.452252100915899,0.830292076089756,0,0,1.31882624464227,1.04650907912021,HSPA8;PRMT1
alpha,1,negative regulation of epithelial cell apoptotic process (GO:1904036),2/30,2,30,0.452252100915899,0.830292076089756,0,0,1.31882624464227,1.04650907912021,NEUROD1;MAPK7
alpha,1,synaptic vesicle recycling (GO:0036465),2/30,2,30,0.452252100915899,0.830292076089756,0,0,1.31882624464227,1.04650907912021,RAB3A;NLGN2
alpha,1,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),2/30,2,30,0.452252100915899,0.830292076089756,0,0,1.31882624464227,1.04650907912021,ARAP1;CBL
alpha,1,semaphorin-plexin signaling pathway (GO:0071526),2/30,2,30,0.452252100915899,0.830292076089756,0,0,1.31882624464227,1.04650907912021,FARP2;SEMA3D
alpha,1,regulation of TOR signaling (GO:0032006),4/68,4,68,0.452402359801739,0.830292076089756,0,0,1.16367021586083,0.923003803537046,AKT1S1;SMCR8;LAMTOR1;ARNTL
alpha,1,extrinsic apoptotic signaling pathway (GO:0097191),4/68,4,68,0.452402359801739,0.830292076089756,0,0,1.16367021586083,0.923003803537046,CASP9;IL6R;APPL1;RNF41
alpha,1,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),4/68,4,68,0.452402359801739,0.830292076089756,0,0,1.16367021586083,0.923003803537046,CDKN1A;CCND3;CDKN2C;PROX1
alpha,1,insulin receptor signaling pathway (GO:0008286),4/68,4,68,0.452402359801739,0.830292076089756,0,0,1.16367021586083,0.923003803537046,IRS2;FOXO1;PTPN2;APPL1
alpha,1,regulation of protein localization to plasma membrane (GO:1903076),4/68,4,68,0.452402359801739,0.830292076089756,0,0,1.16367021586083,0.923003803537046,NUMB;STX3;SPTBN1;APPL1
alpha,1,glycoprotein metabolic process (GO:0009100),3/49,3,49,0.453574566018866,0.830292076089756,0,0,1.21116695936535,0.95754326836751,MANBA;MAN2A2;STT3B
alpha,1,regulation of mitochondrion organization (GO:0010821),3/49,3,49,0.453574566018866,0.830292076089756,0,0,1.21116695936535,0.95754326836751,FIS1;HTRA2;MARCH5
alpha,1,cytoskeleton organization (GO:0007010),7/127,7,127,0.462719813615851,0.830292076089756,0,0,1.0903681550192,0.840274295469703,SUN2;FGD6;SPAG4;DAG1;NEDD9;CDC42BPB;TLN1
alpha,1,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,DERL2
alpha,1,cardiac right ventricle morphogenesis (GO:0003215),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,BMPR1A
alpha,1,regulation of myoblast fusion (GO:1901739),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,EHD1
alpha,1,axonal fasciculation (GO:0007413),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,EPHB3
alpha,1,signal transduction involved in G2 DNA damage checkpoint (GO:0072425),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,UIMC1
alpha,1,import across plasma membrane (GO:0098739),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,KCNJ3
alpha,1,protein localization to kinetochore (GO:0034501),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,MIS12
alpha,1,fatty acid elongation (GO:0030497),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,TECR
alpha,1,skeletal myofibril assembly (GO:0014866),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,PROX1
alpha,1,positive regulation of establishment of protein localization (GO:1904951),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,CCT6A
alpha,1,vesicle budding from membrane (GO:0006900),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,MYO18A
alpha,1,mitochondrial outer membrane permeabilization (GO:0097345),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,BCL2L11
alpha,1,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,MIF
alpha,1,cellular modified amino acid catabolic process (GO:0042219),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,ALDH4A1
alpha,1,amino sugar biosynthetic process (GO:0046349),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,NAGK
alpha,1,UDP-N-acetylglucosamine metabolic process (GO:0006047),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,NAGK
alpha,1,entry of bacterium into host cell (GO:0035635),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,CBL
alpha,1,cellular response to arsenic-containing substance (GO:0071243),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,CPEB2
alpha,1,cell wall macromolecule catabolic process (GO:0016998),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,MANBA
alpha,1,positive regulation of keratinocyte differentiation (GO:0045618),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,NUMA1
alpha,1,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,ANK2
alpha,1,"alternative mRNA splicing, via spliceosome (GO:0000380)",1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,DDX5
alpha,1,regulation of cell communication by electrical coupling (GO:0010649),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,CALM3
alpha,1,positive regulation of ruffle assembly (GO:1900029),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,NDEL1
alpha,1,spliceosomal tri-snRNP complex assembly (GO:0000244),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,PRPF8
alpha,1,tRNA 5'-leader removal (GO:0001682),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,POP7
alpha,1,negative regulation by host of viral transcription (GO:0043922),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,INPP5K
alpha,1,cargo loading into COPII-coated vesicle (GO:0090110),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,SEC31A
alpha,1,cellular response to fluid shear stress (GO:0071498),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,MAPK7
alpha,1,cytoplasmic translational initiation (GO:0002183),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,DENR
alpha,1,regulation of skeletal muscle tissue development (GO:0048641),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,DDX5
alpha,1,activation of cysteine-type endopeptidase activity (GO:0097202),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,TBC1D10A
alpha,1,negative regulation of histone modification (GO:0031057),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,JARID2
alpha,1,response to interleukin-6 (GO:0070741),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,ST3GAL6
alpha,1,purine nucleoside monophosphate biosynthetic process (GO:0009127),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,PFAS
alpha,1,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,BCL2L11
alpha,1,negative regulation of ATP metabolic process (GO:1903579),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,PDE12
alpha,1,protein hydroxylation (GO:0018126),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,EGLN3
alpha,1,establishment of protein localization to mitochondrial membrane (GO:0090151),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,TOMM7
alpha,1,L-serine metabolic process (GO:0006563),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,PSPH
alpha,1,protein O-linked mannosylation (GO:0035269),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,ISPD
alpha,1,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,DCTPP1
alpha,1,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,SPRY4
alpha,1,keratan sulfate catabolic process (GO:0042340),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,GLB1
alpha,1,positive regulation of neuron migration (GO:2001224),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,NIPBL
alpha,1,positive regulation of T cell cytokine production (GO:0002726),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,RSAD2
alpha,1,regulation of catabolic process (GO:0009894),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,MDM2
alpha,1,microtubule anchoring (GO:0034453),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,DAG1
alpha,1,positive regulation of SMAD protein import into nucleus (GO:0060391),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,BMPR1A
alpha,1,eye photoreceptor cell differentiation (GO:0001754),1/12,1,12,0.463475749453493,0.830292076089756,0,0,1.64853280580284,1.26772373200409,RORB
alpha,1,negative regulation of phosphatase activity (GO:0010923),4/69,4,69,0.463657270216481,0.830292076089756,0,0,1.14680543012371,0.881445710472857,MYO1D;WDR81;WNK1;SLC7A14
alpha,1,regulation of actin filament polymerization (GO:0030833),4/69,4,69,0.463657270216481,0.830292076089756,0,0,1.14680543012371,0.881445710472857,PLEKHG2;CDC42EP3;CDC42EP2;NCK1
alpha,1,non-recombinational repair (GO:0000726),3/50,3,50,0.466859149978122,0.830292076089756,0,0,1.18694362017804,0.904127801600066,KDM2A;ERCC1;UIMC1
alpha,1,glutathione metabolic process (GO:0006749),3/50,3,50,0.466859149978122,0.830292076089756,0,0,1.18694362017804,0.904127801600066,GSTM2;GSR;GLRX2
alpha,1,regulation of reactive oxygen species metabolic process (GO:2000377),3/50,3,50,0.466859149978122,0.830292076089756,0,0,1.18694362017804,0.904127801600066,CDKN1A;NOXO1;RNF41
alpha,1,positive regulation of response to DNA damage stimulus (GO:2001022),3/50,3,50,0.466859149978122,0.830292076089756,0,0,1.18694362017804,0.904127801600066,DDX5;PCNA;UIMC1
alpha,1,lipid homeostasis (GO:0055088),3/50,3,50,0.466859149978122,0.830292076089756,0,0,1.18694362017804,0.904127801600066,HNF4A;NR1H2;IRS2
alpha,1,regulation of release of sequestered calcium ion into cytosol (GO:0051279),3/50,3,50,0.466859149978122,0.830292076089756,0,0,1.18694362017804,0.904127801600066,GSTM2;ANK2;CALM3
alpha,1,negative regulation of stress-activated MAPK cascade (GO:0032873),2/31,2,31,0.46929864685033,0.830292076089756,0,0,1.27628346255703,0.965528782772857,PER1;FOXO1
alpha,1,smoothened signaling pathway (GO:0007224),2/31,2,31,0.46929864685033,0.830292076089756,0,0,1.27628346255703,0.965528782772857,B9D1;SEPT2
alpha,1,negative regulation of cation channel activity (GO:2001258),2/31,2,31,0.46929864685033,0.830292076089756,0,0,1.27628346255703,0.965528782772857,GSTM2;CALM3
alpha,1,hippo signaling (GO:0035329),2/31,2,31,0.46929864685033,0.830292076089756,0,0,1.27628346255703,0.965528782772857,AMOTL1;TEAD1
alpha,1,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),2/31,2,31,0.46929864685033,0.830292076089756,0,0,1.27628346255703,0.965528782772857,CCND3;PROX1
alpha,1,negative regulation of transferase activity (GO:0051348),2/31,2,31,0.46929864685033,0.830292076089756,0,0,1.27628346255703,0.965528782772857,INPP5K;IRS2
alpha,1,ATP-dependent chromatin remodeling (GO:0043044),2/31,2,31,0.46929864685033,0.830292076089756,0,0,1.27628346255703,0.965528782772857,SMARCC2;CHD4
alpha,1,positive regulation of B cell proliferation (GO:0030890),2/31,2,31,0.46929864685033,0.830292076089756,0,0,1.27628346255703,0.965528782772857,IRS2;MIF
alpha,1,regulation of protein polymerization (GO:0032271),2/31,2,31,0.46929864685033,0.830292076089756,0,0,1.27628346255703,0.965528782772857,PLEKHG2;ARL2
alpha,1,CENP-A containing nucleosome assembly (GO:0034080),2/31,2,31,0.46929864685033,0.830292076089756,0,0,1.27628346255703,0.965528782772857,CENPO;CENPC
alpha,1,CENP-A containing chromatin organization (GO:0061641),2/31,2,31,0.46929864685033,0.830292076089756,0,0,1.27628346255703,0.965528782772857,CENPO;CENPC
alpha,1,chondroitin sulfate metabolic process (GO:0030204),2/31,2,31,0.46929864685033,0.830292076089756,0,0,1.27628346255703,0.965528782772857,CHST7;B3GAT2
alpha,1,regulation of stem cell differentiation (GO:2000736),5/89,5,89,0.470338784945139,0.830292076089756,0,0,1.11137043087832,0.83830896643782,PSMD2;H3F3A;PSMB10;ZFP36L2;PSMA7
alpha,1,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),5/89,5,89,0.470338784945139,0.830292076089756,0,0,1.11137043087832,0.83830896643782,RNF138;RNF19A;WAC;MDM2;RAD23B
alpha,1,positive regulation of neurogenesis (GO:0050769),4/70,4,70,0.474829273234305,0.830292076089756,0,0,1.13042249540766,0.841938634252869,NEUROD1;NIPBL;FZD3;NUMB
alpha,1,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),4/70,4,70,0.474829273234305,0.830292076089756,0,0,1.13042249540766,0.841938634252869,CDC42EP3;CDC42EP2;ARAP1;NDEL1
alpha,1,positive regulation of mitochondrion organization (GO:0010822),7/129,7,129,0.479135010835899,0.830292076089756,0,0,1.07346322238324,0.789825106851748,FIS1;BCL2L11;TNFSF10;TOMM7;HTRA2;PLAGL2;MARCH5
alpha,1,fatty acid oxidation (GO:0019395),3/51,3,51,0.47999806946452,0.830292076089756,0,0,1.16367021586083,0.854102748632345,ACAA2;ECHDC1;ECHDC2
alpha,1,fatty acid beta-oxidation (GO:0006635),3/51,3,51,0.47999806946452,0.830292076089756,0,0,1.16367021586083,0.854102748632345,ACAA2;ECHDC1;ECHDC2
alpha,1,double-strand break repair via nonhomologous end joining (GO:0006303),3/51,3,51,0.47999806946452,0.830292076089756,0,0,1.16367021586083,0.854102748632345,KDM2A;ERCC1;UIMC1
alpha,1,regulation of neuron apoptotic process (GO:0043523),5/90,5,90,0.480166162912889,0.830292076089756,0,0,1.09902187053522,0.806267790140644,NRBP2;TOX3;EGLN3;EGLN2;AKT1S1
alpha,1,negative regulation of protein kinase activity (GO:0006469),6/110,6,110,0.484138753727752,0.830292076089756,0,0,1.07903965470731,0.78271781181013,CDKN1A;CAMK2N1;AKT1S1;INPP5K;SMCR8;CEP85
alpha,1,Wnt signaling pathway (GO:0016055),6/110,6,110,0.484138753727752,0.830292076089756,0,0,1.07903965470731,0.78271781181013,FZD3;FZD4;USP34;CUL1;DVL3;VRK3
alpha,1,vascular endothelial growth factor receptor signaling pathway (GO:0048010),4/71,4,71,0.485911753530066,0.830292076089756,0,0,1.11450105181037,0.804366892261061,PXN;ELMO2;SHB;NCK1
alpha,1,phospholipid metabolic process (GO:0006644),4/71,4,71,0.485911753530066,0.830292076089756,0,0,1.11450105181037,0.804366892261061,SMPD1;PIP5K1A;PIP4K2B;AGPAT2
alpha,1,negative regulation of developmental process (GO:0051093),4/71,4,71,0.485911753530066,0.830292076089756,0,0,1.11450105181037,0.804366892261061,ZNF706;MIF;MARCH5;HOPX
alpha,1,calcium-mediated signaling (GO:0019722),4/71,4,71,0.485911753530066,0.830292076089756,0,0,1.11450105181037,0.804366892261061,FIS1;MCTP1;ANK2;MCU
alpha,1,regulation of dendritic spine development (GO:0060998),2/32,2,32,0.486023366283845,0.830292076089756,0,0,1.23639960435213,0.892060555717169,FXR2;CPEB3
alpha,1,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),2/32,2,32,0.486023366283845,0.830292076089756,0,0,1.23639960435213,0.892060555717169,GSTM2;CALM3
alpha,1,skeletal system morphogenesis (GO:0048705),2/32,2,32,0.486023366283845,0.830292076089756,0,0,1.23639960435213,0.892060555717169,WWOX;ANKRD11
alpha,1,regulation of protein export from nucleus (GO:0046825),2/32,2,32,0.486023366283845,0.830292076089756,0,0,1.23639960435213,0.892060555717169,TPR;EMD
alpha,1,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),2/32,2,32,0.486023366283845,0.830292076089756,0,0,1.23639960435213,0.892060555717169,RNF34;TNFSF10
alpha,1,positive regulation of viral genome replication (GO:0045070),2/32,2,32,0.486023366283845,0.830292076089756,0,0,1.23639960435213,0.892060555717169,DDB1;PDE12
alpha,1,termination of RNA polymerase I transcription (GO:0006363),2/32,2,32,0.486023366283845,0.830292076089756,0,0,1.23639960435213,0.892060555717169,UBTF;GTF2H4
alpha,1,regulation of cytokine secretion (GO:0050707),2/32,2,32,0.486023366283845,0.830292076089756,0,0,1.23639960435213,0.892060555717169,MIF;GAPDH
alpha,1,liver development (GO:0001889),2/32,2,32,0.486023366283845,0.830292076089756,0,0,1.23639960435213,0.892060555717169,PROX1;GFER
alpha,1,regulation of cell cycle process (GO:0010564),5/91,5,91,0.489930981117939,0.830292076089756,0,0,1.08694470712275,0.775524997184586,NEUROD1;NUMA1;PIN1;E4F1;CALM3
alpha,1,cell-matrix adhesion (GO:0007160),5/91,5,91,0.489930981117939,0.830292076089756,0,0,1.08694470712275,0.775524997184586,ACTN1;PIP5K1A;ARHGEF7;VCL;TMEM8B
alpha,1,DNA strand elongation (GO:0022616),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,GINS4
alpha,1,positive regulation of histone H3-K4 methylation (GO:0051571),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,CTR9
alpha,1,negative regulation of macrophage derived foam cell differentiation (GO:0010745),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,NR1H2
alpha,1,signal transduction involved in DNA damage checkpoint (GO:0072422),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,UIMC1
alpha,1,regulation of plasma membrane bounded cell projection organization (GO:0120035),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,NDEL1
alpha,1,positive regulation of sodium ion transport (GO:0010765),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,SCN3B
alpha,1,cellular response to nitrogen starvation (GO:0006995),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,GABARAPL1
alpha,1,"Notch receptor processing, ligand-dependent (GO:0035333)",1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,ADAM10
alpha,1,positive regulation of cellular carbohydrate metabolic process (GO:0010676),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,IRS2
alpha,1,renal absorption (GO:0070293),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,KLHL3
alpha,1,very long-chain fatty acid biosynthetic process (GO:0042761),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,TECR
alpha,1,muscle cell development (GO:0055001),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,ANK2
alpha,1,chromatin assembly or disassembly (GO:0006333),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,SUPT16H
alpha,1,synaptic vesicle cycle (GO:0099504),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,RAB3A
alpha,1,striated muscle myosin thick filament assembly (GO:0071688),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,MYBPHL
alpha,1,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,CBL
alpha,1,regulation of biomineral tissue development (GO:0070167),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,NBR1
alpha,1,positive regulation of skeletal muscle tissue development (GO:0048643),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,ARNTL
alpha,1,myelination in peripheral nervous system (GO:0022011),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,DICER1
alpha,1,tricarboxylic acid metabolic process (GO:0072350),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,GHR
alpha,1,serine family amino acid biosynthetic process (GO:0009070),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,PSPH
alpha,1,placenta development (GO:0001890),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,ANG
alpha,1,atrial septum development (GO:0003283),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,ANK2
alpha,1,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,DDX5
alpha,1,positive regulation of cholesterol efflux (GO:0010875),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,NR1H2
alpha,1,positive regulation of actin nucleation (GO:0051127),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,WIPF2
alpha,1,positive regulation of protein complex disassembly (GO:0043243),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,SMCR8
alpha,1,regulation of macrophage differentiation (GO:0045649),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,PTPN2
alpha,1,glutamine family amino acid biosynthetic process (GO:0009084),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,GLUL
alpha,1,regulation of cAMP metabolic process (GO:0030814),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,CHGA
alpha,1,catecholamine biosynthetic process (GO:0042423),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,DDC
alpha,1,cardiocyte differentiation (GO:0035051),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,PROX1
alpha,1,poly(A)+ mRNA export from nucleus (GO:0016973),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,PCID2
alpha,1,cellular response to interleukin-15 (GO:0071350),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,PLCB1
alpha,1,tetrahydrofolate metabolic process (GO:0046653),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,MTHFD2
alpha,1,regulation of execution phase of apoptosis (GO:1900117),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,FZD3
alpha,1,neuron fate commitment (GO:0048663),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,MYT1L
alpha,1,ER-associated misfolded protein catabolic process (GO:0071712),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,SDF2L1
alpha,1,protein neddylation (GO:0045116),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,UBE2M
alpha,1,regulation of neurotransmitter transport (GO:0051588),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,MCTP1
alpha,1,RNA interference (GO:0016246),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,DICER1
alpha,1,diacylglycerol metabolic process (GO:0046339),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,ANG
alpha,1,negative regulation of blood pressure (GO:0045776),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,RNPEP
alpha,1,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,VPS9D1
alpha,1,interleukin-15-mediated signaling pathway (GO:0035723),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,PLCB1
alpha,1,endothelial cell differentiation (GO:0045446),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,PROX1
alpha,1,cellular response to nitrogen levels (GO:0043562),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,GABARAPL1
alpha,1,detection of calcium ion (GO:0005513),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,CALM3
alpha,1,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,TSEN34
alpha,1,pre-miRNA processing (GO:0031054),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,DICER1
alpha,1,regulation of cellular carbohydrate metabolic process (GO:0010675),1/13,1,13,0.490613275956084,0.830292076089756,0,0,1.52172258997185,1.08361726679061,SIK3
alpha,1,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),6/111,6,111,0.492967545224612,0.832748601584666,0,0,1.06931857673697,0.756341795165413,BCL2L11;PPP1R13B;TOMM7;HTRA2;PLAGL2;DYNLL1
alpha,1,regulation of telomere maintenance via telomerase (GO:0032210),3/52,3,52,0.492982279013765,0.832748601584666,0,0,1.14129194247889,0.807215305627524,CTC1;CCT6A;XRN1
alpha,1,positive regulation of developmental growth (GO:0048639),3/52,3,52,0.492982279013765,0.832748601584666,0,0,1.14129194247889,0.807215305627524,GHR;RUFY3;PLCB1
alpha,1,positive regulation of lymphocyte proliferation (GO:0050671),4/72,4,72,0.4968984703175,0.83884348088937,0,0,1.09902187053522,0.768622440740739,PNP;IRS2;MIF;NCK1
alpha,1,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),2/33,2,33,0.502415216364288,0.840896892863501,0,0,1.19893294967479,0.825259571306538,GSTM2;CALM3
alpha,1,dendrite morphogenesis (GO:0048813),2/33,2,33,0.502415216364288,0.840896892863501,0,0,1.19893294967479,0.825259571306538,EPHB1;EPHB3
alpha,1,cellular response to amino acid stimulus (GO:0071230),2/33,2,33,0.502415216364288,0.840896892863501,0,0,1.19893294967479,0.825259571306538,LAMTOR1;CPEB3
alpha,1,central nervous system neuron differentiation (GO:0021953),2/33,2,33,0.502415216364288,0.840896892863501,0,0,1.19893294967479,0.825259571306538,PROX1;CBLN1
alpha,1,chromatin remodeling at centromere (GO:0031055),2/33,2,33,0.502415216364288,0.840896892863501,0,0,1.19893294967479,0.825259571306538,CENPO;CENPC
alpha,1,ceramide biosynthetic process (GO:0046513),2/33,2,33,0.502415216364288,0.840896892863501,0,0,1.19893294967479,0.825259571306538,SMPD1;SGMS2
alpha,1,GPI anchor biosynthetic process (GO:0006506),2/33,2,33,0.502415216364288,0.840896892863501,0,0,1.19893294967479,0.825259571306538,PIGU;PIGP
alpha,1,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),2/33,2,33,0.502415216364288,0.840896892863501,0,0,1.19893294967479,0.825259571306538,CD14;MIF
alpha,1,positive regulation of TOR signaling (GO:0032008),2/33,2,33,0.502415216364288,0.840896892863501,0,0,1.19893294967479,0.825259571306538,SMCR8;LAMTOR1
alpha,1,G2 DNA damage checkpoint (GO:0031572),2/33,2,33,0.502415216364288,0.840896892863501,0,0,1.19893294967479,0.825259571306538,UIMC1;FOXN3
alpha,1,regulation of erythrocyte differentiation (GO:0045646),2/33,2,33,0.502415216364288,0.840896892863501,0,0,1.19893294967479,0.825259571306538,PRMT1;ANKRD54
alpha,1,mismatch repair (GO:0006298),2/33,2,33,0.502415216364288,0.840896892863501,0,0,1.19893294967479,0.825259571306538,POLD3;PCNA
alpha,1,positive regulation of mitotic cell cycle (GO:0045931),3/53,3,53,0.505803502297961,0.840896892863501,0,0,1.11975813224344,0.763235004194508,PCID2;TPR;MDM2
alpha,1,positive regulation of secretion by cell (GO:1903532),3/53,3,53,0.505803502297961,0.840896892863501,0,0,1.11975813224344,0.763235004194508,RAB3A;MYO18A;ANG
alpha,1,lysosomal transport (GO:0007041),4/73,4,73,0.507783552185697,0.840896892863501,0,0,1.0839667764183,0.734604285002453,AP3M1;EHD3;AP1G1;AKTIP
alpha,1,response to metal ion (GO:0010038),4/73,4,73,0.507783552185697,0.840896892863501,0,0,1.0839667764183,0.734604285002453,SLC30A8;CALM3;SEC31A;PPP1CA
alpha,1,regulation of fibroblast migration (GO:0010762),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,ARHGEF7
alpha,1,ncRNA transcription (GO:0098781),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,ANG
alpha,1,intermediate filament organization (GO:0045109),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,KLHL24
alpha,1,clathrin coat assembly (GO:0048268),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,CLTB
alpha,1,myeloid dendritic cell activation (GO:0001773),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,DHRS2
alpha,1,positive regulation of myoblast differentiation (GO:0045663),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,PLCB1
alpha,1,pore complex assembly (GO:0046931),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,NDC1
alpha,1,positive regulation of T cell mediated cytotoxicity (GO:0001916),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,FAM49B
alpha,1,positive regulation of response to cytokine stimulus (GO:0060760),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,AGPAT2
alpha,1,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,CYC1
alpha,1,negative regulation of hemopoiesis (GO:1903707),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,CTR9
alpha,1,cell surface receptor signaling pathway involved in heart development (GO:0061311),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,BMPR1A
alpha,1,thymus development (GO:0048538),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,EPHB3
alpha,1,pancreas development (GO:0031016),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,PROX1
alpha,1,copper ion transport (GO:0006825),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,STEAP2
alpha,1,regulation of lymphocyte differentiation (GO:0045619),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,ZFP36L2
alpha,1,cellular protein complex disassembly (GO:0043624),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,MTRF1
alpha,1,amyloid-beta metabolic process (GO:0050435),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,BACE1
alpha,1,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031657),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,CDKN2C
alpha,1,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,ANK2
alpha,1,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,DDX5
alpha,1,metallo-sulfur cluster assembly (GO:0031163),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,MMS19
alpha,1,necroptotic process (GO:0070266),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,CD14
alpha,1,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,CD8A
alpha,1,positive regulation of vascular smooth muscle cell proliferation (GO:1904707),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,BMPR1A
alpha,1,regulation of gastrulation (GO:0010470),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,DAG1
alpha,1,regulation of synapse organization (GO:0050807),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,FXR2
alpha,1,regulation of histone modification (GO:0031056),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,PRDM10
alpha,1,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,TSEN34
alpha,1,negative regulation of smooth muscle cell migration (GO:0014912),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,BMPR1A
alpha,1,purine nucleotide catabolic process (GO:0006195),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,PNP
alpha,1,positive regulation of purine nucleotide metabolic process (GO:1900544),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,CHGA
alpha,1,positive regulation of heart rate (GO:0010460),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,SCN3B
alpha,1,histone H4-K16 acetylation (GO:0043984),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,KAT8
alpha,1,regulation of response to interferon-gamma (GO:0060330),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,PTPN2
alpha,1,establishment of protein localization to chromosome (GO:0070199),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,NIPBL
alpha,1,positive regulation of interleukin-8 secretion (GO:2000484),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,CD14
alpha,1,purine-containing compound catabolic process (GO:0072523),1/14,1,14,0.516379464938931,0.840896892863501,0,0,1.41302811925957,0.933889199666672,PNP
alpha,1,positive regulation of cell-cell adhesion (GO:0022409),2/34,2,34,0.518465090366709,0.840896892863501,0,0,1.16367021586083,0.76439469564801,SIRPA;CD47
alpha,1,positive regulation of cytokine-mediated signaling pathway (GO:0001961),2/34,2,34,0.518465090366709,0.840896892863501,0,0,1.16367021586083,0.76439469564801,AGPAT2;UBE2K
alpha,1,neural tube closure (GO:0001843),2/34,2,34,0.518465090366709,0.840896892863501,0,0,1.16367021586083,0.76439469564801,LMO4;DVL3
alpha,1,positive regulation of cell-matrix adhesion (GO:0001954),2/34,2,34,0.518465090366709,0.840896892863501,0,0,1.16367021586083,0.76439469564801,PTPRJ;LIMS1
alpha,1,platelet aggregation (GO:0070527),2/34,2,34,0.518465090366709,0.840896892863501,0,0,1.16367021586083,0.76439469564801,TLN1;VCL
alpha,1,transcription initiation from RNA polymerase I promoter (GO:0006361),2/34,2,34,0.518465090366709,0.840896892863501,0,0,1.16367021586083,0.76439469564801,UBTF;GTF2H4
alpha,1,transcription from RNA polymerase I promoter (GO:0006360),2/34,2,34,0.518465090366709,0.840896892863501,0,0,1.16367021586083,0.76439469564801,UBTF;GTF2H4
alpha,1,positive regulation of nucleocytoplasmic transport (GO:0046824),2/34,2,34,0.518465090366709,0.840896892863501,0,0,1.16367021586083,0.76439469564801,TPR;EMD
alpha,1,positive regulation of locomotion (GO:0040017),2/34,2,34,0.518465090366709,0.840896892863501,0,0,1.16367021586083,0.76439469564801,DDB1;STX3
alpha,1,cellular glucose homeostasis (GO:0001678),2/34,2,34,0.518465090366709,0.840896892863501,0,0,1.16367021586083,0.76439469564801,FOXO1;GCK
alpha,1,positive regulation of cytokine secretion (GO:0050715),4/74,4,74,0.518561491290568,0.840896892863501,0,0,1.06931857673697,0.702217941842671,MIF;CD14;GAPDH;SPTBN1
alpha,1,canonical Wnt signaling pathway (GO:0060070),4/74,4,74,0.518561491290568,0.840896892863501,0,0,1.06931857673697,0.702217941842671,FZD3;FZD4;DVL3;PPP1CA
alpha,1,proteolysis involved in cellular protein catabolic process (GO:0051603),5/94,5,94,0.518805280944062,0.840896892863501,0,0,1.05225498242734,0.690517759369959,DDB1;MDM2;PSMB10;PSMA7;RNF41
alpha,1,positive regulation of kinase activity (GO:0033674),6/114,6,114,0.519136144085261,0.840932611745488,0,0,1.04117861419126,0.682585361243157,EPHB6;CDKN1A;LMO4;SPDYA;EPHB1;EPHB3
alpha,1,"regulation of gene expression, epigenetic (GO:0040029)",4/75,4,75,0.529227136702794,0.843963887539599,0,0,1.05506099571381,0.671374949505484,H3F3A;EPC1;DDX21;JARID2
alpha,1,regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),4/75,4,75,0.529227136702794,0.843963887539599,0,0,1.05506099571381,0.671374949505484,RGS4;RGS2;GRK6;PLCB1
alpha,1,mitotic nuclear division (GO:0140014),4/75,4,75,0.529227136702794,0.843963887539599,0,0,1.05506099571381,0.671374949505484,HIRA;MIS12;KLHL22;NDEL1
alpha,1,cell morphogenesis involved in differentiation (GO:0000904),3/55,3,55,0.530927559494854,0.843963887539599,0,0,1.07903965470731,0.683172041913699,ACTN1;PROX1;EPHB3
alpha,1,positive regulation of response to stimulus (GO:0048584),3/55,3,55,0.530927559494854,0.843963887539599,0,0,1.07903965470731,0.683172041913699,DDX5;RFX6;GCG
alpha,1,apoptotic mitochondrial changes (GO:0008637),2/35,2,35,0.534165650119224,0.843963887539599,0,0,1.13042249540766,0.708830614000473,FIS1;NAIF1
alpha,1,response to amino acid (GO:0043200),2/35,2,35,0.534165650119224,0.843963887539599,0,0,1.13042249540766,0.708830614000473,LAMTOR1;CPEB3
alpha,1,positive regulation of muscle cell differentiation (GO:0051149),2/35,2,35,0.534165650119224,0.843963887539599,0,0,1.13042249540766,0.708830614000473,CDH15;PLCB1
alpha,1,positive regulation of DNA binding (GO:0043388),2/35,2,35,0.534165650119224,0.843963887539599,0,0,1.13042249540766,0.708830614000473,NEUROD1;NIPBL
alpha,1,ventricular cardiac muscle tissue morphogenesis (GO:0055010),2/35,2,35,0.534165650119224,0.843963887539599,0,0,1.13042249540766,0.708830614000473,PROX1;BMPR1A
alpha,1,positive regulation of chemokine production (GO:0032722),2/35,2,35,0.534165650119224,0.843963887539599,0,0,1.13042249540766,0.708830614000473,EGR1;IL6R
alpha,1,macromolecule catabolic process (GO:0009057),2/35,2,35,0.534165650119224,0.843963887539599,0,0,1.13042249540766,0.708830614000473,BACE1;SNX25
alpha,1,cellular response to organic cyclic compound (GO:0071407),7/136,7,136,0.535354919334735,0.843963887539599,0,0,1.01821143887822,0.636204320110208,EGR1;CASP7;PDE12;INSIG1;PDE3A;INPP5K;SPIDR
alpha,1,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",4/76,4,76,0.539775687370288,0.843963887539599,0,0,1.04117861419126,0.641992419680807,PSMD2;HLA-C;PSMB10;PSMA7
alpha,1,atrioventricular valve morphogenesis (GO:0003181),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,BMPR1A
alpha,1,positive regulation of alpha-beta T cell activation (GO:0046635),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,PNP
alpha,1,pseudouridine synthesis (GO:0001522),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,NHP2
alpha,1,regulation of mRNA metabolic process (GO:1903311),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,SLTM
alpha,1,apoptotic DNA fragmentation (GO:0006309),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,DICER1
alpha,1,vitamin D metabolic process (GO:0042359),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,CYP2R1
alpha,1,selective autophagy (GO:0061912),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,WDR81
alpha,1,septin ring assembly (GO:0000921),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,SEPT2
alpha,1,regulation of protein homooligomerization (GO:0032462),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,BCL2L11
alpha,1,regulation of B cell differentiation (GO:0045577),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,ZFP36L2
alpha,1,epithelial cilium movement (GO:0003351),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,RFX3
alpha,1,embryonic axis specification (GO:0000578),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,CXXC4
alpha,1,endocardial cushion morphogenesis (GO:0003203),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,BMPR1A
alpha,1,positive regulation of glycolytic process (GO:0045821),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,PFKFB4
alpha,1,mitotic sister chromatid cohesion (GO:0007064),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,NIPBL
alpha,1,response to X-ray (GO:0010165),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,NIPBL
alpha,1,positive regulation of CREB transcription factor activity (GO:0032793),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,CRTC2
alpha,1,positive regulation of coenzyme metabolic process (GO:0051197),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,PFKFB4
alpha,1,G-protein coupled glutamate receptor signaling pathway (GO:0007216),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,GRM7
alpha,1,positive regulation of protein import (GO:1904591),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,TPR
alpha,1,"protein localization to chromosome, centromeric region (GO:0071459)",1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,MIS12
alpha,1,positive regulation of potassium ion transmembrane transport (GO:1901381),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,ANK2
alpha,1,regulation of establishment of cell polarity (GO:2000114),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,RUFY3
alpha,1,cardiac muscle cell differentiation (GO:0055007),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,PROX1
alpha,1,regulation of centriole replication (GO:0046599),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,CDK5RAP2
alpha,1,presynapse assembly (GO:0099054),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,NLGN2
alpha,1,mesenchyme morphogenesis (GO:0072132),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,BMPR1A
alpha,1,regulation of clathrin-dependent endocytosis (GO:2000369),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,SNAP91
alpha,1,nitric oxide mediated signal transduction (GO:0007263),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,NEUROD1
alpha,1,positive regulation of phosphoprotein phosphatase activity (GO:0032516),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,CALM3
alpha,1,cellular biogenic amine biosynthetic process (GO:0042401),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,DDC
alpha,1,negative regulation of muscle cell differentiation (GO:0051148),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,PTBP1
alpha,1,positive regulation of viral release from host cell (GO:1902188),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,DDB1
alpha,1,regulation of macrophage chemotaxis (GO:0010758),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,MIF
alpha,1,negative regulation of viral entry into host cell (GO:0046597),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,TRIM26
alpha,1,negative regulation of axon extension involved in axon guidance (GO:0048843),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,SEMA3D
alpha,1,amide transport (GO:0042886),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,ABCB9
alpha,1,filopodium assembly (GO:0046847),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,FGD6
alpha,1,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,EHD1
alpha,1,protein O-linked fucosylation (GO:0036066),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,POFUT1
alpha,1,JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,GHR
alpha,1,regulation of protein complex disassembly (GO:0043244),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,MTRF1
alpha,1,regulation of RNA export from nucleus (GO:0046831),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,TPR
alpha,1,toll-like receptor 4 signaling pathway (GO:0034142),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,CD14
alpha,1,regulation of T cell mediated cytotoxicity (GO:0001914),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,FAM49B
alpha,1,regulation of fertilization (GO:0080154),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,PLCB1
alpha,1,positive regulation of potassium ion transport (GO:0043268),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,ANK2
alpha,1,embryonic cranial skeleton morphogenesis (GO:0048701),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,NIPBL
alpha,1,sulfate transport (GO:0008272),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,SLC26A4
alpha,1,endoderm development (GO:0007492),1/15,1,15,0.540843548937422,0.843963887539599,0,0,1.31882624464227,0.810583884753274,DUSP1
alpha,1,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),3/56,3,56,0.543217428686215,0.846697800980288,0,0,1.05977108944468,0.646720663461325,SNX25;PIN1;FBN1
alpha,1,DNA recombination (GO:0006310),3/56,3,56,0.543217428686215,0.846697800980288,0,0,1.05977108944468,0.646720663461325,ERCC1;TOP3A;THAP9
alpha,1,epithelial cell differentiation (GO:0030855),5/97,5,97,0.546964024870993,0.846810991492753,0,0,1.01971101389866,0.615265325525724,RAB10;EHF;MAF;PCNA;PROX1
alpha,1,lipid phosphorylation (GO:0046834),2/36,2,36,0.549511171090108,0.846810991492753,0,0,1.09902187053522,0.65801316165597,IP6K1;EFR3B
alpha,1,positive regulation of NIK/NF-kappaB signaling (GO:1901224),2/36,2,36,0.549511171090108,0.846810991492753,0,0,1.09902187053522,0.65801316165597,CD14;LIMS1
alpha,1,positive regulation of peptide secretion (GO:0002793),2/36,2,36,0.549511171090108,0.846810991492753,0,0,1.09902187053522,0.65801316165597,MYO18A;ANG
alpha,1,positive regulation of DNA replication (GO:0045740),2/36,2,36,0.549511171090108,0.846810991492753,0,0,1.09902187053522,0.65801316165597,CTC1;PCNA
alpha,1,endothelial cell migration (GO:0043542),2/36,2,36,0.549511171090108,0.846810991492753,0,0,1.09902187053522,0.65801316165597,PXN;PRSS3
alpha,1,regulation of mitotic spindle organization (GO:0060236),2/36,2,36,0.549511171090108,0.846810991492753,0,0,1.09902187053522,0.65801316165597,NUMA1;TPR
alpha,1,cholesterol biosynthetic process (GO:0006695),2/36,2,36,0.549511171090108,0.846810991492753,0,0,1.09902187053522,0.65801316165597,FDPS;ACAA2
alpha,1,positive regulation of ATPase activity (GO:0032781),2/36,2,36,0.549511171090108,0.846810991492753,0,0,1.09902187053522,0.65801316165597,DNAJB2;DYNLL1
alpha,1,regulation of phosphoprotein phosphatase activity (GO:0043666),2/36,2,36,0.549511171090108,0.846810991492753,0,0,1.09902187053522,0.65801316165597,PPP6R3;CALM3
alpha,1,positive regulation of osteoblast differentiation (GO:0045669),2/36,2,36,0.549511171090108,0.846810991492753,0,0,1.09902187053522,0.65801316165597,IL6R;BMPR1A
alpha,1,regulation of hematopoietic stem cell differentiation (GO:1902036),4/77,4,77,0.55020268434498,0.846810991492753,0,0,1.02765681400696,0.613992628258462,PSMD2;H3F3A;PSMB10;PSMA7
alpha,1,nucleic acid-templated transcription (GO:0097659),4/77,4,77,0.55020268434498,0.846810991492753,0,0,1.02765681400696,0.613992628258462,EPC1;MMS19;POLR2I;TOPORS
alpha,1,muscle contraction (GO:0006936),7/138,7,138,0.55097784930043,0.846810991492753,0,0,1.00345475135825,0.598119912958577,MYLPF;MYBPHL;PXN;TLN1;ALDOA;EMD;VCL
alpha,1,chordate embryonic development (GO:0043009),3/57,3,57,0.555318323825067,0.846810991492753,0,0,1.04117861419126,0.612435601243969,ARNT2;ADAM10;PROX1
alpha,1,organonitrogen compound catabolic process (GO:1901565),3/57,3,57,0.555318323825067,0.846810991492753,0,0,1.04117861419126,0.612435601243969,BACE1;LRTOMT;RNPEP
alpha,1,ATP metabolic process (GO:0046034),3/57,3,57,0.555318323825067,0.846810991492753,0,0,1.04117861419126,0.612435601243969,ATP5B;HSPA8;ALDOA
alpha,1,cellular response to organonitrogen compound (GO:0071417),5/98,5,98,0.556174218017888,0.846810991492753,0,0,1.00930579947112,0.592133159787278,EGR1;PDE3A;INPP5K;LAMTOR1;CPEB3
alpha,1,regulation of hematopoietic progenitor cell differentiation (GO:1901532),4/78,4,78,0.560504002818867,0.846810991492753,0,0,1.0144817266479,0.587302640169359,PSMD2;H3F3A;PSMB10;PSMA7
alpha,1,neural tube development (GO:0021915),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,PROX1
alpha,1,negative regulation of NF-kappaB import into nucleus (GO:0042347),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,G3BP2
alpha,1,postsynaptic membrane organization (GO:0001941),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,NLGN2
alpha,1,Notch receptor processing (GO:0007220),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,ADAM10
alpha,1,cellular response to dsRNA (GO:0071359),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,PDE12
alpha,1,DNA alkylation (GO:0006305),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,GATAD2A
alpha,1,positive regulation of dendrite morphogenesis (GO:0050775),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,SS18L1
alpha,1,phosphatidylinositol acyl-chain remodeling (GO:0036149),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,MBOAT7
alpha,1,hyaluronan catabolic process (GO:0030214),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,HYAL3
alpha,1,histone H2A acetylation (GO:0043968),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,EPC1
alpha,1,regulation of cell cycle phase transition (GO:1901987),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,DDB1
alpha,1,cytoplasmic sequestering of transcription factor (GO:0042994),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,G3BP2
alpha,1,sympathetic nervous system development (GO:0048485),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,FZD3
alpha,1,negative regulation of steroid biosynthetic process (GO:0010894),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,PROX1
alpha,1,regulation of histone H3-K4 methylation (GO:0051569),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,CTR9
alpha,1,regulation of energy homeostasis (GO:2000505),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,FOXO1
alpha,1,heme biosynthetic process (GO:0006783),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,ALAD
alpha,1,DNA methylation or demethylation (GO:0044728),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,GATAD2A
alpha,1,negative regulation of transcription regulatory region DNA binding (GO:2000678),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,PER2
alpha,1,negative regulation of translational initiation (GO:0045947),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,TPR
alpha,1,neuron apoptotic process (GO:0051402),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,GAPDH
alpha,1,positive regulation of myotube differentiation (GO:0010831),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,EHD1
alpha,1,rRNA transcription (GO:0009303),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,ANG
alpha,1,regulation of steroid metabolic process (GO:0019218),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,LAMTOR1
alpha,1,regulation of SMAD protein import into nucleus (GO:0060390),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,BMPR1A
alpha,1,genitalia development (GO:0048806),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,DNAJC19
alpha,1,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,MAP3K3
alpha,1,odontogenesis of dentin-containing tooth (GO:0042475),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,ANKRD11
alpha,1,G-protein coupled acetylcholine receptor signaling pathway (GO:0007213),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,PLCB1
alpha,1,regulation of acrosome reaction (GO:0060046),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,PLCB1
alpha,1,protein localization to chromatin (GO:0071168),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,NIPBL
alpha,1,mitochondrial fusion (GO:0008053),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,FIS1
alpha,1,myoblast differentiation (GO:0045445),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,DDX5
alpha,1,linoleic acid metabolic process (GO:0043651),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,GSTM2
alpha,1,programmed necrotic cell death (GO:0097300),1/16,1,16,0.56407126838602,0.846810991492753,0,0,1.23639960435213,0.707931099258868,CD14
alpha,1,regulation of potassium ion transport (GO:0043266),2/37,2,37,0.564497398118631,0.846810991492753,0,0,1.06931857673697,0.611457218789778,KCNA5;ANK2
alpha,1,regulation of receptor-mediated endocytosis (GO:0048259),2/37,2,37,0.564497398118631,0.846810991492753,0,0,1.06931857673697,0.611457218789778,CBL;SNAP91
alpha,1,histone exchange (GO:0043486),2/37,2,37,0.564497398118631,0.846810991492753,0,0,1.06931857673697,0.611457218789778,CENPO;CENPC
alpha,1,muscle cell differentiation (GO:0042692),2/37,2,37,0.564497398118631,0.846810991492753,0,0,1.06931857673697,0.611457218789778,DDX5;MKL1
alpha,1,carbohydrate biosynthetic process (GO:0016051),2/37,2,37,0.564497398118631,0.846810991492753,0,0,1.06931857673697,0.611457218789778,GLT8D1;GALNT8
alpha,1,regulation of muscle cell differentiation (GO:0051147),2/37,2,37,0.564497398118631,0.846810991492753,0,0,1.06931857673697,0.611457218789778,PTBP1;CDH15
alpha,1,histone deacetylation (GO:0016575),2/37,2,37,0.564497398118631,0.846810991492753,0,0,1.06931857673697,0.611457218789778,PER2;PER1
alpha,1,zymogen activation (GO:0031638),2/37,2,37,0.564497398118631,0.846810991492753,0,0,1.06931857673697,0.611457218789778,PRSS3;TBC1D10A
alpha,1,endosome organization (GO:0007032),2/37,2,37,0.564497398118631,0.846810991492753,0,0,1.06931857673697,0.611457218789778,AKTIP;LAMTOR1
alpha,1,epithelial cell migration (GO:0010631),2/37,2,37,0.564497398118631,0.846810991492753,0,0,1.06931857673697,0.611457218789778,PXN;PRSS3
alpha,1,glutamate receptor signaling pathway (GO:0007215),2/37,2,37,0.564497398118631,0.846810991492753,0,0,1.06931857673697,0.611457218789778,GRM7;PLCB1
alpha,1,cardiac muscle tissue development (GO:0048738),2/37,2,37,0.564497398118631,0.846810991492753,0,0,1.06931857673697,0.611457218789778,PROX1;BMPR1A
alpha,1,secondary alcohol biosynthetic process (GO:1902653),2/37,2,37,0.564497398118631,0.846810991492753,0,0,1.06931857673697,0.611457218789778,FDPS;ACAA2
alpha,1,histone modification (GO:0016570),5/99,5,99,0.565290969337933,0.846810991492753,0,0,0.999110791395658,0.56990747276812,PHC1;PRMT1;USP3;CARM1;KAT8
alpha,1,positive regulation of cell growth (GO:0030307),5/99,5,99,0.565290969337933,0.846810991492753,0,0,0.999110791395658,0.56990747276812,RUFY3;H3F3A;ADAM10;DERL2;EIF4G2
alpha,1,positive regulation of cell death (GO:0010942),3/58,3,58,0.567225381939704,0.846810991492753,0,0,1.02322725877417,0.580168377391143,EGR1;TRIM13;HTRA2
alpha,1,epidermal growth factor receptor signaling pathway (GO:0007173),3/58,3,58,0.567225381939704,0.846810991492753,0,0,1.02322725877417,0.580168377391143,BTC;PXN;CBL
alpha,1,response to retinoic acid (GO:0032526),3/58,3,58,0.567225381939704,0.846810991492753,0,0,1.02322725877417,0.580168377391143,FZD4;HTRA2;RORB
alpha,1,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),4/79,4,79,0.570675843613238,0.846810991492753,0,0,1.00164018580425,0.561853965848972,PSMD2;HLA-C;PSMB10;PSMA7
alpha,1,visual perception (GO:0007601),4/79,4,79,0.570675843613238,0.846810991492753,0,0,1.00164018580425,0.561853965848972,DNAJC19;PITPNA;REEP6;EYS
alpha,1,positive regulation of Wnt signaling pathway (GO:0030177),7/141,7,141,0.573975688868563,0.846810991492753,0,0,0.982104650265519,0.545233307676454,WNK1;PSMD2;USP34;PIN1;PSMB10;PSMA7;ARNTL
alpha,1,integrin-mediated signaling pathway (GO:0007229),3/59,3,59,0.578934335660836,0.846810991492753,0,0,1.0058844238797,0.549782445056312,ADAM10;NEDD9;CD47
alpha,1,sodium ion transport (GO:0006814),3/59,3,59,0.578934335660836,0.846810991492753,0,0,1.0058844238797,0.549782445056312,SLC8A3;SCN3B;KCNK1
alpha,1,spliceosomal snRNP assembly (GO:0000387),2/38,2,38,0.579121411822022,0.846810991492753,0,0,1.04117861419126,0.568736666276723,SNRPD2;PRPF8
alpha,1,sodium-independent organic anion transport (GO:0043252),2/38,2,38,0.579121411822022,0.846810991492753,0,0,1.04117861419126,0.568736666276723,SLCO4C1;SLC16A2
alpha,1,base-excision repair (GO:0006284),2/38,2,38,0.579121411822022,0.846810991492753,0,0,1.04117861419126,0.568736666276723,APEX1;APEX2
alpha,1,regulation of DNA repair (GO:0006282),2/38,2,38,0.579121411822022,0.846810991492753,0,0,1.04117861419126,0.568736666276723,PCNA;UIMC1
alpha,1,positive regulation of receptor activity (GO:2000273),2/38,2,38,0.579121411822022,0.846810991492753,0,0,1.04117861419126,0.568736666276723,GSTM2;CALM3
alpha,1,positive regulation of smooth muscle cell proliferation (GO:0048661),2/38,2,38,0.579121411822022,0.846810991492753,0,0,1.04117861419126,0.568736666276723,IL6R;BMPR1A
alpha,1,regulation of sodium ion transmembrane transporter activity (GO:2000649),2/38,2,38,0.579121411822022,0.846810991492753,0,0,1.04117861419126,0.568736666276723,HECW2;SCN3B
alpha,1,protein K63-linked ubiquitination (GO:0070534),2/38,2,38,0.579121411822022,0.846810991492753,0,0,1.04117861419126,0.568736666276723,UBE2D4;TMEM189-UBE2V1
alpha,1,positive regulation of axonogenesis (GO:0050772),2/38,2,38,0.579121411822022,0.846810991492753,0,0,1.04117861419126,0.568736666276723,SLITRK1;RUFY3
alpha,1,positive regulation of stress fiber assembly (GO:0051496),2/38,2,38,0.579121411822022,0.846810991492753,0,0,1.04117861419126,0.568736666276723,PXN;ARHGEF10L
alpha,1,negative regulation of G0 to G1 transition (GO:0070317),2/38,2,38,0.579121411822022,0.846810991492753,0,0,1.04117861419126,0.568736666276723,PHC1;EPC1
alpha,1,regulation of cell differentiation (GO:0045595),6/122,6,122,0.586053423310825,0.846810991492753,0,0,0.972904606703313,0.519866057791574,NEUROD1;DDX5;JUND;DAG1;ZNF268;HOPX
alpha,1,regulation of protein sumoylation (GO:0033233),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,EGR1
alpha,1,cardiac myofibril assembly (GO:0055003),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,PROX1
alpha,1,positive regulation of cholesterol transport (GO:0032376),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,NR1H2
alpha,1,negative regulation of axon guidance (GO:1902668),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,SEMA3D
alpha,1,regulation of membrane depolarization (GO:0003254),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,SCN3B
alpha,1,sialylation (GO:0097503),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,ST3GAL6
alpha,1,DNA catabolic process (GO:0006308),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,XRN2
alpha,1,positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,CHGA
alpha,1,positive regulation of epidermal cell differentiation (GO:0045606),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,NUMA1
alpha,1,microtubule nucleation (GO:0007020),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,NDEL1
alpha,1,positive regulation of nitrogen compound metabolic process (GO:0051173),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,MAPK7
alpha,1,preassembly of GPI anchor in ER membrane (GO:0016254),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,PIGP
alpha,1,positive regulation of fatty acid metabolic process (GO:0045923),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,NR1H2
alpha,1,negative regulation of telomere maintenance (GO:0032205),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,ERCC1
alpha,1,positive regulation of monocyte chemotaxis (GO:0090026),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,CREB3
alpha,1,histone H2A ubiquitination (GO:0033522),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,DDB1
alpha,1,DNA packaging (GO:0006323),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,NIPBL
alpha,1,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,ACAA2
alpha,1,positive regulation of striated muscle cell differentiation (GO:0051155),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,PROX1
alpha,1,histone H2A monoubiquitination (GO:0035518),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,DDB1
alpha,1,negative regulation of cell development (GO:0010721),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,FBN1
alpha,1,negative regulation of interleukin-8 production (GO:0032717),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,MAPKBP1
alpha,1,cardiac atrium morphogenesis (GO:0003209),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,PROX1
alpha,1,regulation of myelination (GO:0031641),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,DICER1
alpha,1,N-glycan processing (GO:0006491),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,MAN2A2
alpha,1,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,PTPN2
alpha,1,positive regulation of stem cell proliferation (GO:2000648),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,FZD3
alpha,1,maturation of 5.8S rRNA (GO:0000460),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,PDCD11
alpha,1,negative regulation of cellular carbohydrate metabolic process (GO:0010677),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,GCK
alpha,1,DNA replication checkpoint (GO:0000076),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,CDC45
alpha,1,peptidyl-lysine trimethylation (GO:0018023),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,CTR9
alpha,1,rRNA catabolic process (GO:0016075),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,XRN1
alpha,1,regulation of receptor recycling (GO:0001919),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,LAMTOR1
alpha,1,pharyngeal system development (GO:0060037),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,BMPR1A
alpha,1,response to purine-containing compound (GO:0014074),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,JUND
alpha,1,phospholipid catabolic process (GO:0009395),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,SMPD1
alpha,1,positive regulation of signal transduction by p53 class mediator (GO:1901798),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,DDX5
alpha,1,long-term memory (GO:0007616),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,CPEB3
alpha,1,regulation of transcription from RNA polymerase I promoter (GO:0006356),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,UBTF
alpha,1,regulation of synaptic vesicle exocytosis (GO:2000300),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,RAB3A
alpha,1,defense response to fungus (GO:0050832),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,GAPDH
alpha,1,serine family amino acid metabolic process (GO:0009069),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,PSPH
alpha,1,positive chemotaxis (GO:0050918),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,PTPRJ
alpha,1,synaptic vesicle transport (GO:0048489),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,RAB3A
alpha,1,purine-containing compound metabolic process (GO:0072521),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,TTR
alpha,1,septin ring organization (GO:0031106),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,SEPT2
alpha,1,platelet-derived growth factor receptor signaling pathway (GO:0048008),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,PTPRJ
alpha,1,mitotic G2 DNA damage checkpoint (GO:0007095),1/17,1,17,0.586125047743137,0.846810991492753,0,0,1.16367021586083,0.621658369833986,FOXN3
alpha,1,positive regulation of macromolecule biosynthetic process (GO:0010557),7/143,7,143,0.588993084856545,0.846810991492753,0,0,0.968368920891176,0.512597214025444,CTC1;FXR2;PCNA;PRMT1;IRS2;CPEB3;GCK
alpha,1,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),3/60,3,60,0.590441484568746,0.846810991492753,0,0,0.989119683481701,0.52115207020118,SNX25;PIN1;BMPR1A
alpha,1,dicarboxylic acid metabolic process (GO:0043648),3/60,3,60,0.590441484568746,0.846810991492753,0,0,0.989119683481701,0.52115207020118,GHR;MTHFD2;ADHFE1
alpha,1,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),4/81,4,81,0.590617470160044,0.846810991492753,0,0,0.976908329364643,0.514426962426419,PIP5K1A;PIP4K2B;PTPN6;CBL
alpha,1,regulation of hydrolase activity (GO:0051336),4/81,4,81,0.590617470160044,0.846810991492753,0,0,0.976908329364643,0.514426962426419,FGD6;CHN1;EPHB3;TBC1D10B
alpha,1,regulation of protein serine/threonine kinase activity (GO:0071900),4/81,4,81,0.590617470160044,0.846810991492753,0,0,0.976908329364643,0.514426962426419,CDKN1A;CDKN2C;PARP16;CALM3
alpha,1,cellular response to hormone stimulus (GO:0032870),4/81,4,81,0.590617470160044,0.846810991492753,0,0,0.976908329364643,0.514426962426419,GHR;JUND;INPP5K;GCK
alpha,1,cellular divalent inorganic cation homeostasis (GO:0072503),5/102,5,102,0.592051997546726,0.846810991492753,0,0,0.969725179884021,0.508291939897879,SLC8A3;SLC30A8;SLC41A1;ANK2;ATP13A3
alpha,1,regulation of kinase activity (GO:0043549),5/102,5,102,0.592051997546726,0.846810991492753,0,0,0.969725179884021,0.508291939897879,EPHB6;LMO4;IRS2;EPHB1;EPHB3
alpha,1,mitochondrion disassembly (GO:0061726),2/39,2,39,0.593381504736501,0.846810991492753,0,0,1.0144817266479,0.529476009943459,FIS1;GABARAPL1
alpha,1,DNA damage checkpoint (GO:0000077),2/39,2,39,0.593381504736501,0.846810991492753,0,0,1.0144817266479,0.529476009943459,WAC;CLOCK
alpha,1,homotypic cell-cell adhesion (GO:0034109),2/39,2,39,0.593381504736501,0.846810991492753,0,0,1.0144817266479,0.529476009943459,TLN1;VCL
alpha,1,regulation of ossification (GO:0030278),2/39,2,39,0.593381504736501,0.846810991492753,0,0,1.0144817266479,0.529476009943459,DDX5;NBR1
alpha,1,regulation of cellular pH (GO:0030641),2/39,2,39,0.593381504736501,0.846810991492753,0,0,1.0144817266479,0.529476009943459,ATP5B;SLC26A4
alpha,1,cell chemotaxis (GO:0060326),3/61,3,61,0.601743667188576,0.846810991492753,0,0,0.972904606703313,0.494161333234487,ELMO2;PIP5K1A;EPHB1
alpha,1,response to reactive oxygen species (GO:0000302),3/61,3,61,0.601743667188576,0.846810991492753,0,0,0.972904606703313,0.494161333234487,ERCC6L2;PXN;GLRX2
alpha,1,regulation of multicellular organism growth (GO:0040014),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,GHR
alpha,1,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,TECR
alpha,1,porphyrin-containing compound biosynthetic process (GO:0006779),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,ALAD
alpha,1,membrane lipid metabolic process (GO:0006643),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,ST3GAL6
alpha,1,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,NLGN2
alpha,1,homologous chromosome segregation (GO:0045143),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,CENPC
alpha,1,mitotic recombination (GO:0006312),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,ERCC1
alpha,1,receptor localization to synapse (GO:0097120),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,RAB8A
alpha,1,iron-sulfur cluster assembly (GO:0016226),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,MMS19
alpha,1,regulation of spindle organization (GO:0090224),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,NUMA1
alpha,1,nuclear envelope reassembly (GO:0031468),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,EMD
alpha,1,actin filament polymerization (GO:0030041),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,ANG
alpha,1,cellular response to gamma radiation (GO:0071480),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,MDM2
alpha,1,cardiac muscle cell contraction (GO:0086003),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,SCN3B
alpha,1,negative regulation of osteoclast differentiation (GO:0045671),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,FBN1
alpha,1,release of cytochrome c from mitochondria (GO:0001836),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,FIS1
alpha,1,calcium-mediated signaling using intracellular calcium source (GO:0035584),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,FIS1
alpha,1,positive regulation of lipid catabolic process (GO:0050996),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,IRS2
alpha,1,endoplasmic reticulum calcium ion homeostasis (GO:0032469),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,FIS1
alpha,1,protein mannosylation (GO:0035268),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,ISPD
alpha,1,positive regulation of cyclic nucleotide biosynthetic process (GO:0030804),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,CALM3
alpha,1,negative regulation of fibroblast proliferation (GO:0048147),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,EMD
alpha,1,regulation of mitochondrial membrane permeability (GO:0046902),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,NAIF1
alpha,1,regulation of chemokine production (GO:0032642),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,IL6R
alpha,1,anion homeostasis (GO:0055081),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,HNF4A
alpha,1,modulation by virus of host morphology or physiology (GO:0019048),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,DAG1
alpha,1,heart trabecula morphogenesis (GO:0061384),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,BMPR1A
alpha,1,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,AP1G1
alpha,1,positive regulation of p38MAPK cascade (GO:1900745),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,PRMT1
alpha,1,acute-phase response (GO:0006953),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,IL6R
alpha,1,DNA conformation change (GO:0071103),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,TOP3A
alpha,1,regulation of cellular response to growth factor stimulus (GO:0090287),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,FBN1
alpha,1,DNA methylation (GO:0006306),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,GATAD2A
alpha,1,regulation of microtubule polymerization or depolymerization (GO:0031110),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,ARL2
alpha,1,positive regulation of carbohydrate metabolic process (GO:0045913),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,PFKFB4
alpha,1,establishment of epithelial cell polarity (GO:0090162),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,MYO18A
alpha,1,regulation of smooth muscle cell migration (GO:0014910),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,BMPR1A
alpha,1,snRNA metabolic process (GO:0016073),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,TUT1
alpha,1,response to organophosphorus (GO:0046683),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,JUND
alpha,1,positive regulation of natural killer cell mediated immunity (GO:0002717),1/18,1,18,0.607064162666049,0.846810991492753,0,0,1.09902187053522,0.548544663097102,AP1G1
alpha,1,negative regulation of protein catabolic process (GO:0042177),2/40,2,40,0.60727706628171,0.846810991492753,0,0,0.989119683481701,0.49334336320541,PIN1;AZIN1
alpha,1,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),2/40,2,40,0.60727706628171,0.846810991492753,0,0,0.989119683481701,0.49334336320541,RNF34;TNFSF10
alpha,1,positive regulation of phagocytosis (GO:0050766),2/40,2,40,0.60727706628171,0.846810991492753,0,0,0.989119683481701,0.49334336320541,MYO18A;SIRPA
alpha,1,purine ribonucleoside monophosphate metabolic process (GO:0009167),2/40,2,40,0.60727706628171,0.846810991492753,0,0,0.989119683481701,0.49334336320541,HSPA8;PFAS
alpha,1,positive regulation of fat cell differentiation (GO:0045600),2/40,2,40,0.60727706628171,0.846810991492753,0,0,0.989119683481701,0.49334336320541,CARM1;ASXL2
alpha,1,positive regulation of reactive oxygen species metabolic process (GO:2000379),2/40,2,40,0.60727706628171,0.846810991492753,0,0,0.989119683481701,0.49334336320541,CDKN1A;RNF41
alpha,1,regulation of G0 to G1 transition (GO:0070316),2/40,2,40,0.60727706628171,0.846810991492753,0,0,0.989119683481701,0.49334336320541,PHC1;EPC1
alpha,1,alpha-amino acid catabolic process (GO:1901606),2/40,2,40,0.60727706628171,0.846810991492753,0,0,0.989119683481701,0.49334336320541,ALDH4A1;ALDH6A1
alpha,1,DNA biosynthetic process (GO:0071897),2/40,2,40,0.60727706628171,0.846810991492753,0,0,0.989119683481701,0.49334336320541,POLD3;TOP3A
alpha,1,platelet degranulation (GO:0002576),6/125,6,125,0.609876483312222,0.846810991492753,0,0,0.949554896142433,0.469553783920541,FAM49B;APLP2;ACTN1;TLN1;ALDOA;VCL
alpha,1,organic anion transport (GO:0015711),6/125,6,125,0.609876483312222,0.846810991492753,0,0,0.949554896142433,0.469553783920541,PITPNA;STARD10;SLCO4C1;SLC16A2;SLC26A4;PITPNC1
alpha,1,positive regulation of DNA metabolic process (GO:0051054),4/83,4,83,0.610003340542661,0.846810991492753,0,0,0.953368369620917,0.471241257521797,CTC1;PCNA;USP9X;UIMC1
alpha,1,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),3/62,3,62,0.612838233062158,0.846810991492753,0,0,0.957212596917775,0.468703237039102,GHR;IL6R;PTPN2
alpha,1,positive regulation of leukocyte chemotaxis (GO:0002690),3/62,3,62,0.612838233062158,0.846810991492753,0,0,0.957212596917775,0.468703237039102,CREB3;ADAM10;IL6R
alpha,1,striated muscle contraction (GO:0006941),3/62,3,62,0.612838233062158,0.846810991492753,0,0,0.957212596917775,0.468703237039102,MYBPHL;ALDOA;SCN3B
alpha,1,positive regulation of protein ubiquitination (GO:0031398),4/84,4,84,0.61948156915595,0.846810991492753,0,0,0.942018746173049,0.451106711427825,NDFIP1;ARRDC3;PIN1;TOPORS
alpha,1,negative regulation of neuron death (GO:1901215),4/84,4,84,0.61948156915595,0.846810991492753,0,0,0.942018746173049,0.451106711427825,CHGA;NRBP2;TOX3;HTRA2
alpha,1,protein maturation (GO:0051604),4/84,4,84,0.61948156915595,0.846810991492753,0,0,0.942018746173049,0.451106711427825,LIPT2;TSPAN14;MMS19;PCSK4
alpha,1,negative regulation of TOR signaling (GO:0032007),2/41,2,41,0.620808476651339,0.846810991492753,0,0,0.964994813152879,0.460044540114005,AKT1S1;ARNTL
alpha,1,cognition (GO:0050890),2/41,2,41,0.620808476651339,0.846810991492753,0,0,0.964994813152879,0.460044540114005,METTL23;NIPBL
alpha,1,sensory organ development (GO:0007423),2/41,2,41,0.620808476651339,0.846810991492753,0,0,0.964994813152879,0.460044540114005,SALL2;BLOC1S3
alpha,1,autophagy of mitochondrion (GO:0000422),2/41,2,41,0.620808476651339,0.846810991492753,0,0,0.964994813152879,0.460044540114005,FIS1;GABARAPL1
alpha,1,ameboidal-type cell migration (GO:0001667),2/41,2,41,0.620808476651339,0.846810991492753,0,0,0.964994813152879,0.460044540114005,SEMA3D;AMOTL1
alpha,1,positive regulation of mitotic nuclear division (GO:0045840),2/41,2,41,0.620808476651339,0.846810991492753,0,0,0.964994813152879,0.460044540114005,NIPBL;NUMA1
alpha,1,response to cAMP (GO:0051591),2/41,2,41,0.620808476651339,0.846810991492753,0,0,0.964994813152879,0.460044540114005,JUND;INPP5K
alpha,1,sterol biosynthetic process (GO:0016126),2/41,2,41,0.620808476651339,0.846810991492753,0,0,0.964994813152879,0.460044540114005,FDPS;ACAA2
alpha,1,regulation of release of cytochrome c from mitochondria (GO:0090199),2/41,2,41,0.620808476651339,0.846810991492753,0,0,0.964994813152879,0.460044540114005,BCL2L11;TNFSF10
alpha,1,negative regulation of catabolic process (GO:0009895),2/41,2,41,0.620808476651339,0.846810991492753,0,0,0.964994813152879,0.460044540114005,PIN1;AZIN1
alpha,1,negative regulation of cytokine-mediated signaling pathway (GO:0001960),2/41,2,41,0.620808476651339,0.846810991492753,0,0,0.964994813152879,0.460044540114005,NR1H2;PTPN2
alpha,1,JAK-STAT cascade (GO:0007259),2/41,2,41,0.620808476651339,0.846810991492753,0,0,0.964994813152879,0.460044540114005,GHR;CTR9
alpha,1,cellular amide metabolic process (GO:0043603),3/63,3,63,0.623723015645618,0.846810991492753,0,0,0.942018746173049,0.444678907580618,GHR;FUT5;SMPD1
alpha,1,tRNA processing (GO:0008033),3/63,3,63,0.623723015645618,0.846810991492753,0,0,0.942018746173049,0.444678907580618,TSEN34;POP7;ADAT3
alpha,1,second-messenger-mediated signaling (GO:0019932),3/63,3,63,0.623723015645618,0.846810991492753,0,0,0.942018746173049,0.444678907580618,NEUROD1;MCTP1;MCU
alpha,1,regulation of protein kinase activity (GO:0045859),7/148,7,148,0.625334367966169,0.846810991492753,0,0,0.935653754644853,0.439260230022092,CDKN1A;CAMK2N1;AKT1S1;SPDYA;INPP5K;SMCR8;CEP85
alpha,1,regulation of mitotic spindle assembly (GO:1901673),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,TPR
alpha,1,positive regulation of chromosome organization (GO:2001252),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,NUMA1
alpha,1,protein ADP-ribosylation (GO:0006471),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,PARP16
alpha,1,error-free translesion synthesis (GO:0070987),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,PCNA
alpha,1,negative regulation of protein localization to plasma membrane (GO:1903077),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,NUMB
alpha,1,organelle fusion (GO:0048284),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,FIS1
alpha,1,NADP metabolic process (GO:0006739),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,NUDT12
alpha,1,acetylcholine receptor signaling pathway (GO:0095500),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,PLCB1
alpha,1,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,ALAD
alpha,1,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,PDCD11
alpha,1,vesicle transport along microtubule (GO:0047496),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,NDEL1
alpha,1,production of small RNA involved in gene silencing by RNA (GO:0070918),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,DICER1
alpha,1,sulfur compound transport (GO:0072348),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,SLC26A4
alpha,1,acylglycerol biosynthetic process (GO:0046463),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,ANG
alpha,1,regulation of heterotypic cell-cell adhesion (GO:0034114),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,MAPK7
alpha,1,muscle tissue morphogenesis (GO:0060415),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,PROX1
alpha,1,morphogenesis of an epithelium (GO:0002009),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,VCL
alpha,1,positive regulation of mononuclear cell migration (GO:0071677),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,CREB3
alpha,1,cyclic nucleotide biosynthetic process (GO:0009190),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,GUCY1A2
alpha,1,Rac protein signal transduction (GO:0016601),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,FARP2
alpha,1,endocardial cushion development (GO:0003197),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,BMPR1A
alpha,1,positive regulation of toll-like receptor signaling pathway (GO:0034123),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,RSAD2
alpha,1,positive regulation of lipid storage (GO:0010884),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,EHD1
alpha,1,osteoclast differentiation (GO:0030316),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,FARP2
alpha,1,leukotriene metabolic process (GO:0006691),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,CYP4F3
alpha,1,folic acid metabolic process (GO:0046655),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,MTHFD2
alpha,1,striated muscle cell differentiation (GO:0051146),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,PROX1
alpha,1,cellular response to interleukin-7 (GO:0098761),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,IRS2
alpha,1,positive regulation of excitatory postsynaptic potential (GO:2000463),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,NLGN2
alpha,1,regulation of neuron migration (GO:2001222),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,NIPBL
alpha,1,negative regulation of protein localization to cell periphery (GO:1904376),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,NUMB
alpha,1,nucleotide-sugar biosynthetic process (GO:0009226),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,NAGK
alpha,1,positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,TEAD1
alpha,1,DNA double-strand break processing (GO:0000729),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,RNF138
alpha,1,interleukin-7-mediated signaling pathway (GO:0038111),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,IRS2
alpha,1,negative regulation of calcium ion transport (GO:0051926),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,INPP5K
alpha,1,telomere capping (GO:0016233),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,CTC1
alpha,1,positive regulation of epithelial cell differentiation (GO:0030858),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,RFX3
alpha,1,protein heterotetramerization (GO:0051290),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,CPSF7
alpha,1,regulation of cAMP biosynthetic process (GO:0030817),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,CALM3
alpha,1,positive regulation of transcription regulatory region DNA binding (GO:2000679),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,NEUROD1
alpha,1,positive regulation of axon extension (GO:0045773),1/19,1,19,0.626944898585894,0.846810991492753,0,0,1.04117861419126,0.486122779170402,RUFY3
alpha,1,activation of GTPase activity (GO:0090630),4/85,4,85,0.628813851677375,0.848493616510155,0,0,0.93093617268866,0.431879917947996,PIP5K1A;TBC1D17;TBC1D10A;TBC1D10B
alpha,1,protein modification process (GO:0036211),4/85,4,85,0.628813851677375,0.848493616510155,0,0,0.93093617268866,0.431879917947996,MANBA;ST3GAL6;PHKA2;UBE2M
alpha,1,regulated exocytosis (GO:0045055),7/149,7,149,0.632384563845752,0.852847572167484,0,0,0.929374199244552,0.425892774053926,FAM49B;APLP2;ACTN1;TLN1;ALDOA;STEAP2;VCL
alpha,1,negative regulation of response to stimulus (GO:0048585),6/128,6,128,0.632921979396544,0.852847572167484,0,0,0.927299703264095,0.424154413698292,EPHB6;MAP3K3;MCTP1;MAPK7;EPHB1;EPHB3
alpha,1,positive regulation of viral transcription (GO:0050434),2/42,2,42,0.633977008123524,0.852847572167484,0,0,0.942018746173049,0.429318063201817,POLR2I;SUPT5H
alpha,1,regulation of protein localization (GO:0032880),2/42,2,42,0.633977008123524,0.852847572167484,0,0,0.942018746173049,0.429318063201817,DVL3;SLC26A4
alpha,1,synapse assembly (GO:0007416),3/64,3,64,0.63439630595838,0.852847572167484,0,0,0.927299703264095,0.421996876454723,NLGN2;SLITRK1;PCDH17
alpha,1,oligosaccharide metabolic process (GO:0009311),3/64,3,64,0.63439630595838,0.852847572167484,0,0,0.927299703264095,0.421996876454723,MANBA;ST3GAL6;GALNT8
alpha,1,iron ion homeostasis (GO:0055072),3/64,3,64,0.63439630595838,0.852847572167484,0,0,0.927299703264095,0.421996876454723,NDFIP1;CUL1;NEO1
alpha,1,positive regulation of cellular catabolic process (GO:0031331),5/107,5,107,0.634546155420978,0.852847572167484,0,0,0.924410919141777,0.420463916999984,TRIM8;PFKFB4;TFEB;IRS2;FOXO1
alpha,1,mitochondrial translation (GO:0032543),5/108,5,108,0.642711335756315,0.858257574472071,0,0,0.915851558779353,0.404860963705065,MTRF1;MRPL40;MRPS22;TUFM;MRPL55
alpha,1,cellular response to starvation (GO:0009267),5/108,5,108,0.642711335756315,0.858257574472071,0,0,0.915851558779353,0.404860963705065,HSPA8;GABARAPL1;CDKN1A;TBL2;FOXO1
alpha,1,glycerophospholipid metabolic process (GO:0006650),3/65,3,65,0.644856826380421,0.858257574472071,0,0,0.913033553983109,0.400572436822983,PIGP;PIP5K1A;PLCB1
alpha,1,negative regulation of innate immune response (GO:0045824),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,PTPN2
alpha,1,positive regulation of interleukin-2 production (GO:0032743),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,SPTBN1
alpha,1,Golgi to endosome transport (GO:0006895),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,AP2A1
alpha,1,positive regulation of dendritic spine development (GO:0060999),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,CPEB3
alpha,1,negative regulation of ion transport (GO:0043271),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,INPP5K
alpha,1,regulation of lipoprotein lipase activity (GO:0051004),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,NR1H2
alpha,1,embryonic digestive tract development (GO:0048566),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,NIPBL
alpha,1,purine nucleotide metabolic process (GO:0006163),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,PNP
alpha,1,regulation of calcium ion transmembrane transport (GO:1903169),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,ANK2
alpha,1,axon extension (GO:0048675),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,USP9X
alpha,1,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,CHGA
alpha,1,negative regulation of response to biotic stimulus (GO:0002832),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,MAPKBP1
alpha,1,positive regulation of gene silencing by miRNA (GO:2000637),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,DDX5
alpha,1,regulation of response to cytokine stimulus (GO:0060759),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,MAPK7
alpha,1,covalent chromatin modification (GO:0016569),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,PRDM10
alpha,1,positive regulation of T cell migration (GO:2000406),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,ADAM10
alpha,1,dorsal/ventral pattern formation (GO:0009953),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,FBXL15
alpha,1,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,SPRY4
alpha,1,chondroitin sulfate biosynthetic process (GO:0030206),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,CHST7
alpha,1,positive regulation of cAMP biosynthetic process (GO:0030819),1/20,1,20,0.645820701466498,0.858257574472071,0,0,0.989119683481701,0.432476128223187,CALM3
alpha,1,glycolipid biosynthetic process (GO:0009247),2/43,2,43,0.646784734458029,0.859031104664462,0,0,0.92011133347135,0.400930925585622,PIGU;PIGP
alpha,1,calcium ion transmembrane transport (GO:0070588),4/87,4,87,0.647033711225418,0.859031104664462,0,0,0.909535341132599,0.39597247012547,SLC8A3;TRPC4;TRPM6;MCU
alpha,1,regulation of macromolecule metabolic process (GO:0060255),6/130,6,130,0.64783335542273,0.859424793174446,0,0,0.913033553983109,0.396367754631933,DDX39A;MAPK7;DDX46;PROX1;LAMTOR1;PRDM10
alpha,1,glycolipid metabolic process (GO:0006664),3/66,3,66,0.655103705786485,0.859424793174446,0,0,0.899199712256092,0.380327062705381,GLB1;SMPD1;ST3GAL6
alpha,1,cellular response to type I interferon (GO:0071357),3/66,3,66,0.655103705786485,0.859424793174446,0,0,0.899199712256092,0.380327062705381,EGR1;RSAD2;HLA-C
alpha,1,chromatin assembly (GO:0031497),3/66,3,66,0.655103705786485,0.859424793174446,0,0,0.899199712256092,0.380327062705381,BAHD1;H3F3A;HIST1H2BD
alpha,1,regulation of myeloid cell differentiation (GO:0045637),3/66,3,66,0.655103705786485,0.859424793174446,0,0,0.899199712256092,0.380327062705381,PRMT1;CTR9;H3F3A
alpha,1,DNA synthesis involved in DNA repair (GO:0000731),3/66,3,66,0.655103705786485,0.859424793174446,0,0,0.899199712256092,0.380327062705381,POLD3;PCNA;TOP3A
alpha,1,regulation of cell division (GO:0051302),3/66,3,66,0.655103705786485,0.859424793174446,0,0,0.899199712256092,0.380327062705381,CDK2AP2;PIN1;CALM3
alpha,1,type I interferon signaling pathway (GO:0060337),3/66,3,66,0.655103705786485,0.859424793174446,0,0,0.899199712256092,0.380327062705381,EGR1;RSAD2;HLA-C
alpha,1,fatty acid catabolic process (GO:0009062),3/66,3,66,0.655103705786485,0.859424793174446,0,0,0.899199712256092,0.380327062705381,ACAA2;ECHDC1;ECHDC2
alpha,1,mitochondrial translational elongation (GO:0070125),4/88,4,88,0.655918469148298,0.859424793174446,0,0,0.899199712256092,0.379209407964176,MRPL40;MRPS22;TUFM;MRPL55
alpha,1,regulation of cell motility (GO:2000145),5/110,5,110,0.658696162093714,0.859424793174446,0,0,0.899199712256092,0.375409504395648,BTC;PARD6B;LMO4;PIN1;AMOTL1
alpha,1,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),5/110,5,110,0.658696162093714,0.859424793174446,0,0,0.899199712256092,0.375409504395648,IFI27L1;FIS1;EGLN3;TNFSF10;HTRA2
alpha,1,regulation of Wnt signaling pathway (GO:0030111),5/110,5,110,0.658696162093714,0.859424793174446,0,0,0.899199712256092,0.375409504395648,WWOX;DACT3;EMD;CXXC4;PPP1CA
alpha,1,positive regulation of interferon-gamma production (GO:0032729),2/44,2,44,0.659234446369802,0.859424793174446,0,0,0.899199712256092,0.374674981515648,FAM49B;CD14
alpha,1,regulation of B cell proliferation (GO:0030888),2/44,2,44,0.659234446369802,0.859424793174446,0,0,0.899199712256092,0.374674981515648,IRS2;MIF
alpha,1,cardiac ventricle morphogenesis (GO:0003208),2/44,2,44,0.659234446369802,0.859424793174446,0,0,0.899199712256092,0.374674981515648,PROX1;BMPR1A
alpha,1,RNA catabolic process (GO:0006401),2/44,2,44,0.659234446369802,0.859424793174446,0,0,0.899199712256092,0.374674981515648,XRN2;ZFP36L2
alpha,1,negative regulation of DNA metabolic process (GO:0051053),2/44,2,44,0.659234446369802,0.859424793174446,0,0,0.899199712256092,0.374674981515648,DACH1;ERCC1
alpha,1,positive regulation of protein localization to plasma membrane (GO:1903078),2/44,2,44,0.659234446369802,0.859424793174446,0,0,0.899199712256092,0.374674981515648,STX3;SPTBN1
alpha,1,substantia nigra development (GO:0021762),2/44,2,44,0.659234446369802,0.859424793174446,0,0,0.899199712256092,0.374674981515648,CALM3;DYNLL1
alpha,1,histone H3 acetylation (GO:0043966),2/44,2,44,0.659234446369802,0.859424793174446,0,0,0.899199712256092,0.374674981515648,PER1;KAT7
alpha,1,digestive tract development (GO:0048565),2/44,2,44,0.659234446369802,0.859424793174446,0,0,0.899199712256092,0.374674981515648,NIPBL;EPHB3
alpha,1,regulation of multicellular organismal development (GO:2000026),2/44,2,44,0.659234446369802,0.859424793174446,0,0,0.899199712256092,0.374674981515648,NIPBL;DAG1
alpha,1,regulation of interferon-gamma production (GO:0032649),2/44,2,44,0.659234446369802,0.859424793174446,0,0,0.899199712256092,0.374674981515648,FAM49B;CD14
alpha,1,cobalamin metabolic process (GO:0009235),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,PRSS3
alpha,1,hyaluronan metabolic process (GO:0030212),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,HYAL3
alpha,1,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,CREB3
alpha,1,positive regulation of transcription from RNA polymerase I promoter (GO:0045943),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,UBTF
alpha,1,mRNA transcription (GO:0009299),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,DDX5
alpha,1,dendritic cell differentiation (GO:0097028),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,DHRS2
alpha,1,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,COX5B
alpha,1,ventricular cardiac muscle tissue development (GO:0003229),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,PROX1
alpha,1,tetrapyrrole metabolic process (GO:0033013),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,PRSS3
alpha,1,negative regulation of ion transmembrane transporter activity (GO:0032413),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,HECW2
alpha,1,positive regulation of T cell mediated immunity (GO:0002711),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,FAM49B
alpha,1,mitochondrial fission (GO:0000266),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,FIS1
alpha,1,dopamine metabolic process (GO:0042417),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,LRTOMT
alpha,1,regulation of cardiac muscle hypertrophy (GO:0010611),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,RGS2
alpha,1,positive regulation of histone acetylation (GO:0035066),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,KAT7
alpha,1,positive regulation of lamellipodium organization (GO:1902745),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,ARHGEF7
alpha,1,protein O-linked glycosylation via threonine (GO:0018243),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,GALNT8
alpha,1,negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,RGS2
alpha,1,negative regulation of protein tyrosine kinase activity (GO:0061099),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,CBL
alpha,1,regulation of nuclear division (GO:0051783),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,PIN1
alpha,1,non-motile cilium assembly (GO:1905515),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,BBS10
alpha,1,ventricular septum morphogenesis (GO:0060412),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,PROX1
alpha,1,negative regulation of viral process (GO:0048525),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,TRIM13
alpha,1,limb morphogenesis (GO:0035108),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,NIPBL
alpha,1,meiosis I (GO:0007127),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,BCL2L11
alpha,1,cellular response to misfolded protein (GO:0071218),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,SDF2L1
alpha,1,long-term synaptic potentiation (GO:0060291),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,SLC8A3
alpha,1,ERK1 and ERK2 cascade (GO:0070371),1/21,1,21,0.66374232098636,0.859424793174446,0,0,0.942018746173049,0.386097004972294,ZFP36L2
alpha,1,ribosomal small subunit biogenesis (GO:0042274),2/45,2,45,0.671329574190487,0.864725842251985,0,0,0.879217496428179,0.350363858802121,RPS16;RPS24
alpha,1,regulation of focal adhesion assembly (GO:0051893),2/45,2,45,0.671329574190487,0.864725842251985,0,0,0.879217496428179,0.350363858802121,PTPRJ;LIMS1
alpha,1,amide biosynthetic process (GO:0043604),2/45,2,45,0.671329574190487,0.864725842251985,0,0,0.879217496428179,0.350363858802121,SMPD1;SGMS2
alpha,1,positive regulation of viral life cycle (GO:1903902),2/45,2,45,0.671329574190487,0.864725842251985,0,0,0.879217496428179,0.350363858802121,DDB1;PDE12
alpha,1,regulation of smooth muscle cell proliferation (GO:0048660),2/45,2,45,0.671329574190487,0.864725842251985,0,0,0.879217496428179,0.350363858802121,ANG;IL6R
alpha,1,regulation of intracellular pH (GO:0051453),2/45,2,45,0.671329574190487,0.864725842251985,0,0,0.879217496428179,0.350363858802121,ATP5B;SLC26A4
alpha,1,inorganic anion transport (GO:0015698),2/45,2,45,0.671329574190487,0.864725842251985,0,0,0.879217496428179,0.350363858802121,SLC26A4;ANO5
alpha,1,regulation of steroid biosynthetic process (GO:0050810),2/45,2,45,0.671329574190487,0.864725842251985,0,0,0.879217496428179,0.350363858802121,FDPS;EGR1
alpha,1,posttranscriptional regulation of gene expression (GO:0010608),2/45,2,45,0.671329574190487,0.864725842251985,0,0,0.879217496428179,0.350363858802121,DDX6;PER1
alpha,1,positive regulation of actin filament bundle assembly (GO:0032233),2/45,2,45,0.671329574190487,0.864725842251985,0,0,0.879217496428179,0.350363858802121,PXN;ARHGEF10L
alpha,1,myeloid cell differentiation (GO:0030099),2/45,2,45,0.671329574190487,0.864725842251985,0,0,0.879217496428179,0.350363858802121,KAT8;PTPN2
alpha,1,mitochondrial translational termination (GO:0070126),4/90,4,90,0.673232334981062,0.866621733288143,0,0,0.879217496428179,0.347875402623262,MTRF1;MRPL40;MRPS22;MRPL55
alpha,1,negative regulation of protein binding (GO:0032091),3/68,3,68,0.674954942541988,0.866621733288143,0,0,0.872752661895619,0.343087224757597,DNAJB2;PIN1;PPP1CA
alpha,1,regulation of cardiac conduction (GO:1903779),3/68,3,68,0.674954942541988,0.866621733288143,0,0,0.872752661895619,0.343087224757597,SLC8A3;ANK2;CALM3
alpha,1,protein targeting (GO:0006605),6/134,6,134,0.676527961401779,0.866621733288143,0,0,0.885778821028389,0.346145976151656,DNAJC19;FIS1;TOMM40;SPCS1;TOMM7;TIMM44
alpha,1,regulation of calcium ion transport into cytosol (GO:0010522),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,ANK2
alpha,1,positive regulation of protein autophosphorylation (GO:0031954),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,CALM3
alpha,1,acylglycerol homeostasis (GO:0055090),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,HNF4A
alpha,1,cellular response to nerve growth factor stimulus (GO:1990090),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,EHD1
alpha,1,regulation of catecholamine secretion (GO:0050433),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,CHGA
alpha,1,activation of phospholipase C activity (GO:0007202),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,ANG
alpha,1,outflow tract septum morphogenesis (GO:0003148),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,BMPR1A
alpha,1,regulation of DNA biosynthetic process (GO:2000278),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,DACH1
alpha,1,sulfur amino acid metabolic process (GO:0000096),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,BHMT2
alpha,1,"DNA catabolic process, endonucleolytic (GO:0000737)",1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,DICER1
alpha,1,cytosolic calcium ion transport (GO:0060401),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,MCU
alpha,1,regulation of cytokine production involved in inflammatory response (GO:1900015),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,PER1
alpha,1,protein O-linked glycosylation via serine (GO:0018242),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,GALNT8
alpha,1,urogenital system development (GO:0001655),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,EPHB3
alpha,1,regulation of ERBB signaling pathway (GO:1901184),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,BTC
alpha,1,C21-steroid hormone metabolic process (GO:0008207),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,DHRS2
alpha,1,ncRNA catabolic process (GO:0034661),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,XRN1
alpha,1,regulation of monocyte chemotaxis (GO:0090025),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,CREB3
alpha,1,positive regulation of phosphatase activity (GO:0010922),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,CALM3
alpha,1,NLS-bearing protein import into nucleus (GO:0006607),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,DAG1
alpha,1,digestive system development (GO:0055123),1/22,1,22,0.680757946200271,0.866621733288143,0,0,0.899199712256092,0.345785877872563,NIPBL
alpha,1,protein tetramerization (GO:0051262),4/91,4,91,0.681659975851381,0.866733838711762,0,0,0.869555765698199,0.333234912314834,CPSF7;KCNC3;DCXR;ALDOA
alpha,1,protein polymerization (GO:0051258),2/46,2,46,0.683074116002733,0.866733838711762,0,0,0.860104072592784,0.32783030999988,ANG;UBE2K
alpha,1,positive regulation of blood vessel endothelial cell migration (GO:0043536),2/46,2,46,0.683074116002733,0.866733838711762,0,0,0.860104072592784,0.32783030999988,ATP5B;MAP3K3
alpha,1,nicotinamide nucleotide metabolic process (GO:0046496),2/46,2,46,0.683074116002733,0.866733838711762,0,0,0.860104072592784,0.32783030999988,ALDOA;GCK
alpha,1,"regulation of synaptic transmission, glutamatergic (GO:0051966)",2/46,2,46,0.683074116002733,0.866733838711762,0,0,0.860104072592784,0.32783030999988,NLGN2;GRM7
alpha,1,metal ion homeostasis (GO:0055065),2/46,2,46,0.683074116002733,0.866733838711762,0,0,0.860104072592784,0.32783030999988,SLC7A8;CNNM2
alpha,1,negative regulation of ossification (GO:0030279),2/46,2,46,0.683074116002733,0.866733838711762,0,0,0.860104072592784,0.32783030999988,NBR1;RORB
alpha,1,cholesterol metabolic process (GO:0008203),3/69,3,69,0.68455937306334,0.868213867187459,0,0,0.860104072592784,0.325962154300111,FDPS;ACAA2;NR0B2
alpha,1,positive regulation of cellular protein metabolic process (GO:0032270),4/92,4,92,0.689934119080397,0.871701888421383,0,0,0.860104072592784,0.31923550986361,FXR2;NR1H2;CPEB3;TBC1D10A
alpha,1,pyruvate metabolic process (GO:0006090),2/47,2,47,0.694472571617569,0.871701888421383,0,0,0.841803985941873,0.306923931459343,ALDOA;GCK
alpha,1,positive regulation of ion transport (GO:0043270),2/47,2,47,0.694472571617569,0.871701888421383,0,0,0.841803985941873,0.306923931459343,ANK2;SCN3B
alpha,1,regulation of natural killer cell mediated cytotoxicity (GO:0042269),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,AP1G1
alpha,1,exogenous drug catabolic process (GO:0042738),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,CYP2R1
alpha,1,mitotic G2/M transition checkpoint (GO:0044818),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,FOXN3
alpha,1,regulation of axon extension involved in axon guidance (GO:0048841),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,SEMA3D
alpha,1,cholesterol efflux (GO:0033344),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,STX12
alpha,1,protein localization to cilium (GO:0061512),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,EHD1
alpha,1,cell-cell adhesion mediated by cadherin (GO:0044331),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,CDH15
alpha,1,positive regulation of protein oligomerization (GO:0032461),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,BCL2L11
alpha,1,TOR signaling (GO:0031929),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,AKT1S1
alpha,1,glutamine family amino acid metabolic process (GO:0009064),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,ALDH4A1
alpha,1,protein K48-linked deubiquitination (GO:0071108),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,USP34
alpha,1,metanephros development (GO:0001656),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,NIPBL
alpha,1,peroxisome organization (GO:0007031),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,FIS1
alpha,1,positive regulation of ATP metabolic process (GO:1903580),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,PFKFB4
alpha,1,cellular response to ammonium ion (GO:0071242),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,CASP7
alpha,1,regulation of smooth muscle contraction (GO:0006940),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,KCNB2
alpha,1,negative regulation of signal transduction in absence of ligand (GO:1901099),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,MAPK7
alpha,1,apoptotic nuclear changes (GO:0030262),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,DICER1
alpha,1,folic acid-containing compound metabolic process (GO:0006760),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,MTHFD2
alpha,1,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,MAPK7
alpha,1,histone H3-K4 methylation (GO:0051568),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,CTR9
alpha,1,negative regulation of axonogenesis (GO:0050771),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,RUFY3
alpha,1,divalent inorganic cation homeostasis (GO:0072507),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,CNNM2
alpha,1,regulation of cell size (GO:0008361),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,AKT1S1
alpha,1,regulation of microtubule cytoskeleton organization (GO:0070507),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,CDK2AP2
alpha,1,NAD metabolic process (GO:0019674),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,NUDT12
alpha,1,negative regulation of axon extension (GO:0030517),1/23,1,23,0.696913334958998,0.871701888421383,0,0,0.860104072592784,0.310578605805706,SEMA3D
alpha,1,positive regulation of cellular metabolic process (GO:0031325),4/93,4,93,0.698054529641682,0.872728413321534,0,0,0.850855641704689,0.305846915393351,LIPT2;CDKN1A;NR1H2;RNF41
alpha,1,regulation of Notch signaling pathway (GO:0008593),3/71,3,71,0.703128423985174,0.877460448447126,0,0,0.835875788857776,0.294408596090948,TSPAN14;POFUT1;LLGL2
alpha,1,stress-activated protein kinase signaling cascade (GO:0031098),3/71,3,71,0.703128423985174,0.877460448447126,0,0,0.835875788857776,0.294408596090948,MAP3K3;CUL1;KAT7
alpha,1,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),3/71,3,71,0.703128423985174,0.877460448447126,0,0,0.835875788857776,0.294408596090948,RNF138;RNF19A;MDM2
alpha,1,interferon-gamma-mediated signaling pathway (GO:0060333),3/71,3,71,0.703128423985174,0.877460448447126,0,0,0.835875788857776,0.294408596090948,TRIM8;HLA-C;TRIM26
alpha,1,regulation of intrinsic apoptotic signaling pathway (GO:2001242),2/48,2,48,0.705529881898218,0.87965103864874,0,0,0.824266402901418,0.28750919300566,FIS1;BCL2L11
alpha,1,positive regulation of tumor necrosis factor production (GO:0032760),2/48,2,48,0.705529881898218,0.87965103864874,0,0,0.824266402901418,0.28750919300566,CD14;MIF
alpha,1,cellular response to interferon-gamma (GO:0071346),5/117,5,117,0.710918514103581,0.885963896523593,0,0,0.845401438873249,0.288448826325873,TRIM8;PDE12;HLA-C;TRIM26;GAPDH
alpha,1,regulation of cell communication (GO:0010646),3/72,3,72,0.712094934228136,0.88600366450709,0,0,0.824266402901418,0.279874746017433,NLGN2;ANK2;GLRX2
alpha,1,recombinational repair (GO:0000725),3/72,3,72,0.712094934228136,0.88600366450709,0,0,0.824266402901418,0.279874746017433,RNF138;MCM9;SPIDR
alpha,1,phospholipid dephosphorylation (GO:0046839),1/24,1,24,0.712251935955204,0.88600366450709,0,0,0.824266402901418,0.279693032908002,INPP5K
alpha,1,regulation of androgen receptor signaling pathway (GO:0060765),1/24,1,24,0.712251935955204,0.88600366450709,0,0,0.824266402901418,0.279693032908002,DDX5
alpha,1,interstrand cross-link repair (GO:0036297),2/49,2,49,0.716251372693418,0.890165444018337,0,0,0.807444639576899,0.269463731165034,ERCC6L2;ERCC1
alpha,1,positive regulation of chemotaxis (GO:0050921),2/49,2,49,0.716251372693418,0.890165444018337,0,0,0.807444639576899,0.269463731165034,STX3;IL6R
alpha,1,regulation of small GTPase mediated signal transduction (GO:0051056),6/141,6,141,0.722995268822293,0.89270061393684,0,0,0.841803985941873,0.273041312085392,TRIO;PLEKHG2;CHN1;SRGAP3;ARAP1;ARHGEF7
alpha,1,protein heterooligomerization (GO:0051291),2/50,2,50,0.726642703084699,0.89270061393684,0,0,0.791295746785361,0.252676866324238,CPSF7;MAT2A
alpha,1,RNA methylation (GO:0001510),2/50,2,50,0.726642703084699,0.89270061393684,0,0,0.791295746785361,0.252676866324238,TRMT10A;NSUN4
alpha,1,organic hydroxy compound biosynthetic process (GO:1901617),2/50,2,50,0.726642703084699,0.89270061393684,0,0,0.791295746785361,0.252676866324238,PER2;CYP7B1
alpha,1,regulation of megakaryocyte differentiation (GO:0045652),2/50,2,50,0.726642703084699,0.89270061393684,0,0,0.791295746785361,0.252676866324238,PRMT1;H3F3A
alpha,1,membrane protein intracellular domain proteolysis (GO:0031293),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,ADAM10
alpha,1,positive regulation of immune effector process (GO:0002699),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,MYO18A
alpha,1,ear morphogenesis (GO:0042471),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,NIPBL
alpha,1,positive regulation of purine nucleotide biosynthetic process (GO:1900373),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,CALM3
alpha,1,response to dsRNA (GO:0043331),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,PDE12
alpha,1,drug catabolic process (GO:0042737),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,CYP2R1
alpha,1,camera-type eye development (GO:0043010),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,FBN1
alpha,1,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,CDKN2C
alpha,1,regulation of epidermal growth factor-activated receptor activity (GO:0007176),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,CBL
alpha,1,sensory perception of pain (GO:0019233),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,EPHB1
alpha,1,regulation of transmembrane transport (GO:0034762),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,KCNJ3
alpha,1,cellular senescence (GO:0090398),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,CDKN1A
alpha,1,negative regulation of endothelial cell apoptotic process (GO:2000352),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,MAPK7
alpha,1,regulation of AMPA receptor activity (GO:2000311),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,NLGN2
alpha,1,fatty acid derivative biosynthetic process (GO:1901570),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,ACSS3
alpha,1,regulation of cardiac muscle cell action potential (GO:0098901),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,ANK2
alpha,1,transition metal ion homeostasis (GO:0055076),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,NEO1
alpha,1,proteoglycan biosynthetic process (GO:0030166),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,B3GAT2
alpha,1,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,MIF
alpha,1,cGMP biosynthetic process (GO:0006182),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,GUCY1A2
alpha,1,cAMP metabolic process (GO:0046058),1/25,1,25,0.726815005911853,0.89270061393684,0,0,0.791295746785361,0.252489255093336,PDE3A
alpha,1,translational termination (GO:0006415),4/97,4,97,0.729000342980417,0.894577707947578,0,0,0.815768811118929,0.257849083987811,MTRF1;MRPL40;MRPS22;MRPL55
alpha,1,cellular metal ion homeostasis (GO:0006875),4/97,4,97,0.729000342980417,0.894577707947578,0,0,0.815768811118929,0.257849083987811,SLC8A3;SLC41A1;ANK2;ATP13A3
alpha,1,positive regulation of proteasomal protein catabolic process (GO:1901800),3/74,3,74,0.729398566419986,0.894663196559289,0,0,0.801988932552731,0.253055550591984,RNF138;RNF19A;MDM2
alpha,1,regulation of neuron projection development (GO:0010975),5/120,5,120,0.731496974594642,0.896739617990125,0,0,0.824266402901418,0.257716942320312,LRRC7;RUFY3;CHN1;EPHB3;NDEL1
alpha,1,response to tumor necrosis factor (GO:0034612),4/98,4,98,0.736354638020285,0.896739617990125,0,0,0.807444639576899,0.247113127973592,HYAL3;ADAM10;INPP5K;ZFP36L2
alpha,1,regulation of ion transport (GO:0043269),2/51,2,51,0.736709818638199,0.896739617990125,0,0,0.775780143907217,0.237048309782286,PDZK1;KCNJ3
alpha,1,regulation of bone mineralization (GO:0030500),2/51,2,51,0.736709818638199,0.896739617990125,0,0,0.775780143907217,0.237048309782286,NBR1;BMPR1A
alpha,1,regulation of cellular protein metabolic process (GO:0032268),2/51,2,51,0.736709818638199,0.896739617990125,0,0,0.775780143907217,0.237048309782286,DDX6;NR1H2
alpha,1,myeloid leukocyte differentiation (GO:0002573),2/51,2,51,0.736709818638199,0.896739617990125,0,0,0.775780143907217,0.237048309782286,FARP2;DHRS2
alpha,1,heart morphogenesis (GO:0003007),2/51,2,51,0.736709818638199,0.896739617990125,0,0,0.775780143907217,0.237048309782286,NIPBL;BMPR1A
alpha,1,macromolecular complex assembly (GO:0065003),5/121,5,121,0.738115459286996,0.896739617990125,0,0,0.817454283869175,0.248224095053705,PARD6B;MDM2;KNTC1;LIN7A;TEAD1
alpha,1,DNA replication (GO:0006260),5/121,5,121,0.738115459286996,0.896739617990125,0,0,0.817454283869175,0.248224095053705,CDC45;TOP3A;REV3L;CDK2AP1;KAT7
alpha,1,signal peptide processing (GO:0006465),1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,SPCS1
alpha,1,regulation of centrosome duplication (GO:0010824),1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,CCNF
alpha,1,regulation of telomere maintenance (GO:0032204),1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,ERCC1
alpha,1,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,RNF34
alpha,1,cyclic nucleotide metabolic process (GO:0009187),1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,GUCY1A2
alpha,1,neutral amino acid transport (GO:0015804),1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,SLC7A8
alpha,1,positive regulation of interleukin-12 production (GO:0032735),1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,PLCB1
alpha,1,misfolded or incompletely synthesized protein catabolic process (GO:0006515),1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,SDF2L1
alpha,1,peptide catabolic process (GO:0043171),1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,RNPEP
alpha,1,positive regulation of filopodium assembly (GO:0051491),1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,ARAP1
alpha,1,regulation of apoptotic signaling pathway (GO:2001233),1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,TRAF7
alpha,1,regulation of potassium ion transmembrane transporter activity (GO:1901016),1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,ANK2
alpha,1,long-chain fatty-acyl-CoA metabolic process (GO:0035336),1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,TECR
alpha,1,respiratory tube development (GO:0030323),1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,PROX1
alpha,1,negative regulation of epithelial to mesenchymal transition (GO:0010719),1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,SDHAF2
alpha,1,regulation of vascular smooth muscle cell proliferation (GO:1904705),1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,BMPR1A
alpha,1,positive regulation of calcium ion transmembrane transport (GO:1904427),1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,ANK2
alpha,1,L-amino acid transport (GO:0015807),1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,SLC25A22
alpha,1,signal transduction in response to DNA damage (GO:0042770),1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,CASP9
alpha,1,regulation of protein import into nucleus (GO:0042306),1/26,1,26,0.74064171900837,0.896739617990125,0,0,0.760861294985924,0.228439687076708,TPR
alpha,1,gland development (GO:0048732),3/76,3,76,0.745874502976806,0.901872234283234,0,0,0.780883960643448,0.228953552633687,PROX1;GFER;EPHB3
alpha,1,purine ribonucleotide biosynthetic process (GO:0009152),3/76,3,76,0.745874502976806,0.901872234283234,0,0,0.780883960643448,0.228953552633687,GUCY1A2;ATP5B;ALDOA
alpha,1,cAMP-mediated signaling (GO:0019933),3/76,3,76,0.745874502976806,0.901872234283234,0,0,0.780883960643448,0.228953552633687,MAPK7;KSR1;PDE3A
alpha,1,response to organonitrogen compound (GO:0010243),2/52,2,52,0.746458907755416,0.902178253802928,0,0,0.760861294985924,0.222487034970192,SYVN1;KAT7
alpha,1,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),6/145,6,145,0.747364474092976,0.902871988888719,0,0,0.818581807019339,0.238372901435688,DDX5;USP9X;PXN;CBL;UBE2M;BMPR1A
alpha,1,steroid metabolic process (GO:0008202),4/100,4,100,0.750609218232947,0.903440504748166,0,0,0.791295746785361,0.226999098875797,WWOX;CYP2R1;CYP7B1;DHRS2
alpha,1,glycosaminoglycan biosynthetic process (GO:0006024),4/100,4,100,0.750609218232947,0.903440504748166,0,0,0.791295746785361,0.226999098875797,CHST7;B3GAT2;ST3GAL6;CHST2
alpha,1,bile acid biosynthetic process (GO:0006699),1/27,1,27,0.7537692730432,0.903440504748166,0,0,0.732681247023483,0.207106247371081,CYP7B1
alpha,1,cytoskeleton-dependent intracellular transport (GO:0030705),1/27,1,27,0.7537692730432,0.903440504748166,0,0,0.732681247023483,0.207106247371081,DYNLL1
alpha,1,monovalent inorganic cation homeostasis (GO:0055067),1/27,1,27,0.7537692730432,0.903440504748166,0,0,0.732681247023483,0.207106247371081,SLC26A4
alpha,1,snRNA processing (GO:0016180),1/27,1,27,0.7537692730432,0.903440504748166,0,0,0.732681247023483,0.207106247371081,TUT1
alpha,1,regulation of centrosome cycle (GO:0046605),1/27,1,27,0.7537692730432,0.903440504748166,0,0,0.732681247023483,0.207106247371081,CEP85
alpha,1,nucleotide biosynthetic process (GO:0009165),1/27,1,27,0.7537692730432,0.903440504748166,0,0,0.732681247023483,0.207106247371081,GUCY1A2
alpha,1,regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),1/27,1,27,0.7537692730432,0.903440504748166,0,0,0.732681247023483,0.207106247371081,TEAD1
alpha,1,negative chemotaxis (GO:0050919),1/27,1,27,0.7537692730432,0.903440504748166,0,0,0.732681247023483,0.207106247371081,SEMA3D
alpha,1,tRNA methylation (GO:0030488),1/27,1,27,0.7537692730432,0.903440504748166,0,0,0.732681247023483,0.207106247371081,TRMT10A
alpha,1,internal peptidyl-lysine acetylation (GO:0018393),1/27,1,27,0.7537692730432,0.903440504748166,0,0,0.732681247023483,0.207106247371081,KAT8
alpha,1,regulation of cardiac muscle cell contraction (GO:0086004),1/27,1,27,0.7537692730432,0.903440504748166,0,0,0.732681247023483,0.207106247371081,ANK2
alpha,1,regulation of muscle contraction (GO:0006937),1/27,1,27,0.7537692730432,0.903440504748166,0,0,0.732681247023483,0.207106247371081,KCNB2
alpha,1,regulation of microtubule-based process (GO:0032886),1/27,1,27,0.7537692730432,0.903440504748166,0,0,0.732681247023483,0.207106247371081,CDK2AP2
alpha,1,regulation of viral entry into host cell (GO:0046596),1/27,1,27,0.7537692730432,0.903440504748166,0,0,0.732681247023483,0.207106247371081,TRIM26
alpha,1,strand displacement (GO:0000732),1/27,1,27,0.7537692730432,0.903440504748166,0,0,0.732681247023483,0.207106247371081,TOP3A
alpha,1,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),3/77,3,77,0.75380713433266,0.903440504748166,0,0,0.770742610505222,0.217826300592516,RNF34;MAPK7;TNFSF10
alpha,1,positive regulation of ossification (GO:0045778),2/53,2,53,0.75589636205959,0.904749799511324,0,0,0.746505421495624,0.20891028828,IL6R;BMPR1A
alpha,1,regulation of calcium ion transport (GO:0051924),2/53,2,53,0.75589636205959,0.904749799511324,0,0,0.746505421495624,0.20891028828,INPP5K;ANK2
alpha,1,plasma membrane bounded cell projection morphogenesis (GO:0120039),2/53,2,53,0.75589636205959,0.904749799511324,0,0,0.746505421495624,0.20891028828,CNTNAP2;DICER1
alpha,1,cellular calcium ion homeostasis (GO:0006874),5/124,5,124,0.757251818086244,0.905973945803533,0,0,0.797677164098146,0.221801656114547,SLC8A3;TRPC4;ANK2;ATP13A3;MCU
alpha,1,negative regulation of macromolecule metabolic process (GO:0010605),5/125,5,125,0.763392449762427,0.907547815072505,0,0,0.791295746785361,0.213636422549605,NDFIP1;ERP29;SMCR8;MIF;NR0B2
alpha,1,protein processing (GO:0016485),4/102,4,102,0.764264775722111,0.907547815072505,0,0,0.775780143907217,0.208561497856229,SPCS1;HTRA2;PRSS3;PCSK4
alpha,1,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),2/54,2,54,0.765028740090654,0.907547815072505,0,0,0.732681247023483,0.196242720529974,PTPN6;CBL
alpha,1,negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),2/54,2,54,0.765028740090654,0.907547815072505,0,0,0.732681247023483,0.196242720529974,SNX25;PIN1
alpha,1,regulation of calcium ion-dependent exocytosis (GO:0017158),2/54,2,54,0.765028740090654,0.907547815072505,0,0,0.732681247023483,0.196242720529974,SYT10;SYT14
alpha,1,monocarboxylic acid transport (GO:0015718),2/54,2,54,0.765028740090654,0.907547815072505,0,0,0.732681247023483,0.196242720529974,SLC16A2;SLC16A14
alpha,1,positive regulation of protein import into nucleus (GO:0042307),2/54,2,54,0.765028740090654,0.907547815072505,0,0,0.732681247023483,0.196242720529974,TPR;BMPR1A
alpha,1,embryonic organ development (GO:0048568),2/54,2,54,0.765028740090654,0.907547815072505,0,0,0.732681247023483,0.196242720529974,NEUROD1;TEAD1
alpha,1,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),2/54,2,54,0.765028740090654,0.907547815072505,0,0,0.732681247023483,0.196242720529974,GHR;IL6R
alpha,1,regulation of calcium ion transmembrane transporter activity (GO:1901019),1/28,1,28,0.76623298819379,0.907547815072505,0,0,0.706514059629787,0.188122787449898,ANK2
alpha,1,phosphatidylcholine acyl-chain remodeling (GO:0036151),1/28,1,28,0.76623298819379,0.907547815072505,0,0,0.706514059629787,0.188122787449898,TMEM86B
alpha,1,negative regulation of smooth muscle cell proliferation (GO:0048662),1/28,1,28,0.76623298819379,0.907547815072505,0,0,0.706514059629787,0.188122787449898,ANG
alpha,1,negative regulation of synaptic transmission (GO:0050805),1/28,1,28,0.76623298819379,0.907547815072505,0,0,0.706514059629787,0.188122787449898,CBLN1
alpha,1,cristae formation (GO:0042407),1/28,1,28,0.76623298819379,0.907547815072505,0,0,0.706514059629787,0.188122787449898,ATP5B
alpha,1,negative regulation of small GTPase mediated signal transduction (GO:0051058),1/28,1,28,0.76623298819379,0.907547815072505,0,0,0.706514059629787,0.188122787449898,SPRY4
alpha,1,cardiac muscle cell development (GO:0055013),1/28,1,28,0.76623298819379,0.907547815072505,0,0,0.706514059629787,0.188122787449898,SORBS2
alpha,1,modulation by host of viral transcription (GO:0043921),1/28,1,28,0.76623298819379,0.907547815072505,0,0,0.706514059629787,0.188122787449898,INPP5K
alpha,1,transcription from RNA polymerase III promoter (GO:0006383),1/28,1,28,0.76623298819379,0.907547815072505,0,0,0.706514059629787,0.188122787449898,TROVE2
alpha,1,microtubule polymerization (GO:0046785),1/28,1,28,0.76623298819379,0.907547815072505,0,0,0.706514059629787,0.188122787449898,NDEL1
alpha,1,regulation of neurotransmitter secretion (GO:0046928),1/28,1,28,0.76623298819379,0.907547815072505,0,0,0.706514059629787,0.188122787449898,MCTP1
alpha,1,protein targeting to vacuole (GO:0006623),1/28,1,28,0.76623298819379,0.907547815072505,0,0,0.706514059629787,0.188122787449898,AP3M1
alpha,1,regulation of autophagy of mitochondrion (GO:1903146),1/28,1,28,0.76623298819379,0.907547815072505,0,0,0.706514059629787,0.188122787449898,HTRA2
alpha,1,regulation of protein localization to cell surface (GO:2000008),1/28,1,28,0.76623298819379,0.907547815072505,0,0,0.706514059629787,0.188122787449898,STX3
alpha,1,negative regulation of cell communication (GO:0010648),3/79,3,79,0.769073321271522,0.910120231995807,0,0,0.751230139353191,0.197249722243777,EPHB6;EPHB1;EPHB3
alpha,1,extracellular matrix disassembly (GO:0022617),3/79,3,79,0.769073321271522,0.910120231995807,0,0,0.751230139353191,0.197249722243777,ADAM10;NOXO1;FBN1
alpha,1,RNA modification (GO:0009451),2/55,2,55,0.773862734092623,0.910474779930742,0,0,0.719359769804874,0.184415622518591,NSUN4;ADAT3
alpha,1,cellular response to nutrient levels (GO:0031669),2/55,2,55,0.773862734092623,0.910474779930742,0,0,0.719359769804874,0.184415622518591,HSPA8;FOXO1
alpha,1,cytoplasmic translation (GO:0002181),2/55,2,55,0.773862734092623,0.910474779930742,0,0,0.719359769804874,0.184415622518591,RPL7L1;RPL15
alpha,1,membrane fusion (GO:0061025),2/55,2,55,0.773862734092623,0.910474779930742,0,0,0.719359769804874,0.184415622518591,FIS1;USO1
alpha,1,glycosphingolipid metabolic process (GO:0006687),2/55,2,55,0.773862734092623,0.910474779930742,0,0,0.719359769804874,0.184415622518591,GLB1;SMPD1
alpha,1,cation transport (GO:0006812),3/80,3,80,0.776411957755732,0.910474779930742,0,0,0.741839762611276,0.187738891888566,ATP10D;SLC39A1;SLC15A4
alpha,1,neuron projection extension (GO:1990138),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,USP9X
alpha,1,regulation of TORC1 signaling (GO:1903432),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,SMCR8
alpha,1,hydrogen ion transmembrane transport (GO:1902600),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,ATP5B
alpha,1,cellular response to alcohol (GO:0097306),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,SPIDR
alpha,1,negative regulation of homeostatic process (GO:0032845),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,ERCC1
alpha,1,acute inflammatory response (GO:0002526),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,IL6R
alpha,1,cellular amino acid biosynthetic process (GO:0008652),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,GLUL
alpha,1,positive regulation of sprouting angiogenesis (GO:1903672),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,MAP3K3
alpha,1,organelle fission (GO:0048285),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,FIS1
alpha,1,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,PIN1
alpha,1,negative regulation of JNK cascade (GO:0046329),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,PER1
alpha,1,neural crest cell migration (GO:0001755),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,SEMA3D
alpha,1,triglyceride homeostasis (GO:0070328),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,HNF4A
alpha,1,cGMP metabolic process (GO:0046068),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,GUCY1A2
alpha,1,regulation of fatty acid biosynthetic process (GO:0042304),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,NR1H2
alpha,1,ventricular septum development (GO:0003281),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,PROX1
alpha,1,protein K63-linked deubiquitination (GO:0070536),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,UIMC1
alpha,1,protein export from nucleus (GO:0006611),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,CSE1L
alpha,1,regulation of actin polymerization or depolymerization (GO:0008064),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,PLEKHG2
alpha,1,primary neural tube formation (GO:0014020),1/29,1,29,0.778066402092852,0.910474779930742,0,0,0.682151505849449,0.171181424135942,LMO4
alpha,1,positive regulation of DNA biosynthetic process (GO:2000573),2/56,2,56,0.782405139990302,0.912277493478985,0,0,0.706514059629787,0.173366250364456,CCT6A;PTGES3
alpha,1,fat cell differentiation (GO:0045444),2/56,2,56,0.782405139990302,0.912277493478985,0,0,0.706514059629787,0.173366250364456,PER2;FOXO1
alpha,1,Notch signaling pathway (GO:0007219),2/56,2,56,0.782405139990302,0.912277493478985,0,0,0.706514059629787,0.173366250364456,POFUT1;ADAM10
alpha,1,ERBB signaling pathway (GO:0038127),3/81,3,81,0.783557889369128,0.912277493478985,0,0,0.732681247023483,0.178708527906743,BTC;PXN;CBL
alpha,1,negative regulation of defense response (GO:0031348),3/81,3,81,0.783557889369128,0.912277493478985,0,0,0.732681247023483,0.178708527906743,MAPKBP1;MAPK7;PTPN2
alpha,1,regulation of macrophage derived foam cell differentiation (GO:0010743),1/30,1,30,0.789301359576506,0.912277493478985,0,0,0.659413122321134,0.156021813227874,NR1H2
alpha,1,very long-chain fatty acid metabolic process (GO:0000038),1/30,1,30,0.789301359576506,0.912277493478985,0,0,0.659413122321134,0.156021813227874,TECR
alpha,1,synaptic vesicle endocytosis (GO:0048488),1/30,1,30,0.789301359576506,0.912277493478985,0,0,0.659413122321134,0.156021813227874,NLGN2
alpha,1,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),1/30,1,30,0.789301359576506,0.912277493478985,0,0,0.659413122321134,0.156021813227874,CD14
alpha,1,tube closure (GO:0060606),1/30,1,30,0.789301359576506,0.912277493478985,0,0,0.659413122321134,0.156021813227874,LMO4
alpha,1,lung development (GO:0030324),1/30,1,30,0.789301359576506,0.912277493478985,0,0,0.659413122321134,0.156021813227874,PROX1
alpha,1,superoxide metabolic process (GO:0006801),1/30,1,30,0.789301359576506,0.912277493478985,0,0,0.659413122321134,0.156021813227874,NOXO1
alpha,1,regulation of vasoconstriction (GO:0019229),1/30,1,30,0.789301359576506,0.912277493478985,0,0,0.659413122321134,0.156021813227874,PER2
alpha,1,cortical cytoskeleton organization (GO:0030865),1/30,1,30,0.789301359576506,0.912277493478985,0,0,0.659413122321134,0.156021813227874,LLGL2
alpha,1,positive regulation of histone modification (GO:0031058),1/30,1,30,0.789301359576506,0.912277493478985,0,0,0.659413122321134,0.156021813227874,NIPBL
alpha,1,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),1/30,1,30,0.789301359576506,0.912277493478985,0,0,0.659413122321134,0.156021813227874,MAPK7
alpha,1,regulation of chromosome segregation (GO:0051983),1/30,1,30,0.789301359576506,0.912277493478985,0,0,0.659413122321134,0.156021813227874,NUMA1
alpha,1,regulation of keratinocyte differentiation (GO:0045616),1/30,1,30,0.789301359576506,0.912277493478985,0,0,0.659413122321134,0.156021813227874,NUMA1
alpha,1,coenzyme biosynthetic process (GO:0009108),1/30,1,30,0.789301359576506,0.912277493478985,0,0,0.659413122321134,0.156021813227874,MAT2A
alpha,1,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),1/30,1,30,0.789301359576506,0.912277493478985,0,0,0.659413122321134,0.156021813227874,CD14
alpha,1,skeletal muscle organ development (GO:0060538),1/30,1,30,0.789301359576506,0.912277493478985,0,0,0.659413122321134,0.156021813227874,MYLPF
alpha,1,respiratory system development (GO:0060541),1/30,1,30,0.789301359576506,0.912277493478985,0,0,0.659413122321134,0.156021813227874,PROX1
alpha,1,striated muscle tissue development (GO:0014706),1/30,1,30,0.789301359576506,0.912277493478985,0,0,0.659413122321134,0.156021813227874,MYLPF
alpha,1,regulation of myoblast differentiation (GO:0045661),1/30,1,30,0.789301359576506,0.912277493478985,0,0,0.659413122321134,0.156021813227874,PLCB1
alpha,1,translational elongation (GO:0006414),4/106,4,106,0.789817140124907,0.912277493478985,0,0,0.746505421495624,0.176140812205579,MRPL40;MRPS22;TUFM;MRPL55
alpha,1,positive regulation of protein targeting to mitochondrion (GO:1903955),3/82,3,82,0.790513955762094,0.912277493478985,0,0,0.72374610986466,0.170132422479877,TOMM7;HTRA2;PLAGL2
alpha,1,BMP signaling pathway (GO:0030509),3/82,3,82,0.790513955762094,0.912277493478985,0,0,0.72374610986466,0.170132422479877,DDX5;USP9X;BMPR1A
alpha,1,anion transport (GO:0006820),2/57,2,57,0.79066282945663,0.912277493478985,0,0,0.69411907612751,0.163037229546449,SLC17A5;SLC26A4
alpha,1,regulation of BMP signaling pathway (GO:0030510),2/57,2,57,0.79066282945663,0.912277493478985,0,0,0.69411907612751,0.163037229546449,NUMA1;FBXL15
alpha,1,phosphatidylinositol-mediated signaling (GO:0048015),2/57,2,57,0.79066282945663,0.912277493478985,0,0,0.69411907612751,0.163037229546449,PLEKHA1;IRS2
alpha,1,cellular iron ion homeostasis (GO:0006879),2/57,2,57,0.79066282945663,0.912277493478985,0,0,0.69411907612751,0.163037229546449,NDFIP1;CUL1
alpha,1,autophagosome organization (GO:1905037),2/57,2,57,0.79066282945663,0.912277493478985,0,0,0.69411907612751,0.163037229546449,STX12;GABARAPL1
alpha,1,glycosaminoglycan catabolic process (GO:0006027),2/57,2,57,0.79066282945663,0.912277493478985,0,0,0.69411907612751,0.163037229546449,GLB1;HYAL3
alpha,1,modulation of chemical synaptic transmission (GO:0050804),3/83,3,83,0.797283093418232,0.914105384544768,0,0,0.715026277215688,0.161985960095742,MCTP1;NLGN2;GRM7
alpha,1,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),3/83,3,83,0.797283093418232,0.914105384544768,0,0,0.715026277215688,0.161985960095742,NUMA1;FBXL15;BMPR1A
alpha,1,negative regulation of binding (GO:0051100),3/83,3,83,0.797283093418232,0.914105384544768,0,0,0.715026277215688,0.161985960095742,DNAJB2;PIN1;PPP1CA
alpha,1,protein homotetramerization (GO:0051289),2/58,2,58,0.798642725295621,0.914105384544768,0,0,0.682151505849449,0.153376026153107,DCXR;ALDOA
alpha,1,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),1/31,1,31,0.799968098189564,0.914105384544768,0,0,0.638141731278517,0.142422660012364,MAP3K3
alpha,1,replication fork processing (GO:0031297),1/31,1,31,0.799968098189564,0.914105384544768,0,0,0.638141731278517,0.142422660012364,PCNA
alpha,1,connective tissue development (GO:0061448),1/31,1,31,0.799968098189564,0.914105384544768,0,0,0.638141731278517,0.142422660012364,HYAL3
alpha,1,cellular response to cAMP (GO:0071320),1/31,1,31,0.799968098189564,0.914105384544768,0,0,0.638141731278517,0.142422660012364,INPP5K
alpha,1,regulation of leukocyte chemotaxis (GO:0002688),1/31,1,31,0.799968098189564,0.914105384544768,0,0,0.638141731278517,0.142422660012364,IL6R
alpha,1,activation of protein kinase B activity (GO:0032148),1/31,1,31,0.799968098189564,0.914105384544768,0,0,0.638141731278517,0.142422660012364,ANG
alpha,1,cyclic purine nucleotide metabolic process (GO:0052652),1/31,1,31,0.799968098189564,0.914105384544768,0,0,0.638141731278517,0.142422660012364,GUCY1A2
alpha,1,protein palmitoylation (GO:0018345),1/31,1,31,0.799968098189564,0.914105384544768,0,0,0.638141731278517,0.142422660012364,ZDHHC5
alpha,1,fatty-acyl-CoA biosynthetic process (GO:0046949),1/31,1,31,0.799968098189564,0.914105384544768,0,0,0.638141731278517,0.142422660012364,TECR
alpha,1,regulation of cation transmembrane transport (GO:1904062),1/31,1,31,0.799968098189564,0.914105384544768,0,0,0.638141731278517,0.142422660012364,PDZK1
alpha,1,MyD88-independent toll-like receptor signaling pathway (GO:0002756),1/31,1,31,0.799968098189564,0.914105384544768,0,0,0.638141731278517,0.142422660012364,CD14
alpha,1,protein localization to lysosome (GO:0061462),1/31,1,31,0.799968098189564,0.914105384544768,0,0,0.638141731278517,0.142422660012364,AP3M1
alpha,1,positive regulation of phospholipase C activity (GO:0010863),1/31,1,31,0.799968098189564,0.914105384544768,0,0,0.638141731278517,0.142422660012364,ANG
alpha,1,aminoglycan metabolic process (GO:0006022),1/31,1,31,0.799968098189564,0.914105384544768,0,0,0.638141731278517,0.142422660012364,B3GAT2
alpha,1,phosphatidylinositol 3-kinase signaling (GO:0014065),1/31,1,31,0.799968098189564,0.914105384544768,0,0,0.638141731278517,0.142422660012364,PLEKHA1
alpha,1,artery morphogenesis (GO:0048844),1/31,1,31,0.799968098189564,0.914105384544768,0,0,0.638141731278517,0.142422660012364,BMPR1A
alpha,1,bile acid metabolic process (GO:0008206),1/31,1,31,0.799968098189564,0.914105384544768,0,0,0.638141731278517,0.142422660012364,CYP7B1
alpha,1,regulation of sodium ion transmembrane transport (GO:1902305),1/31,1,31,0.799968098189564,0.914105384544768,0,0,0.638141731278517,0.142422660012364,SCN3B
alpha,1,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),1/31,1,31,0.799968098189564,0.914105384544768,0,0,0.638141731278517,0.142422660012364,RUFY3
alpha,1,viral life cycle (GO:0019058),4/108,4,108,0.801736899856847,0.915742272781121,0,0,0.732681247023483,0.161904077355598,NDC1;NUP210;NUP133;TPR
alpha,1,negative regulation of signaling (GO:0023057),3/84,3,84,0.803868324637369,0.917407145007357,0,0,0.706514059629787,0.154246007165798,EPHB6;EPHB1;EPHB3
alpha,1,negative regulation of endopeptidase activity (GO:0010951),3/84,3,84,0.803868324637369,0.917407145007357,0,0,0.706514059629787,0.154246007165798,PCID2;SERPINB1;GAPDH
alpha,1,receptor metabolic process (GO:0043112),2/59,2,59,0.806351778548306,0.917792299355353,0,0,0.670589615919798,0.144334477949492,EHD3;SNX25
alpha,1,autophagosome assembly (GO:0000045),2/59,2,59,0.806351778548306,0.917792299355353,0,0,0.670589615919798,0.144334477949492,STX12;GABARAPL1
alpha,1,negative regulation of toll-like receptor signaling pathway (GO:0034122),1/32,1,32,0.810095329141595,0.917792299355353,0,0,0.618199802176063,0.130194948035575,CD14
alpha,1,negative regulation of cell-cell adhesion (GO:0022408),1/32,1,32,0.810095329141595,0.917792299355353,0,0,0.618199802176063,0.130194948035575,MAPK7
alpha,1,organelle transport along microtubule (GO:0072384),1/32,1,32,0.810095329141595,0.917792299355353,0,0,0.618199802176063,0.130194948035575,NDEL1
alpha,1,secondary alcohol metabolic process (GO:1902652),1/32,1,32,0.810095329141595,0.917792299355353,0,0,0.618199802176063,0.130194948035575,NR0B2
alpha,1,zinc ion homeostasis (GO:0055069),1/32,1,32,0.810095329141595,0.917792299355353,0,0,0.618199802176063,0.130194948035575,SLC30A8
alpha,1,regulation of protein autophosphorylation (GO:0031952),1/32,1,32,0.810095329141595,0.917792299355353,0,0,0.618199802176063,0.130194948035575,CALM3
alpha,1,cofactor biosynthetic process (GO:0051188),1/32,1,32,0.810095329141595,0.917792299355353,0,0,0.618199802176063,0.130194948035575,MMS19
alpha,1,positive regulation of interleukin-1 beta production (GO:0032731),1/32,1,32,0.810095329141595,0.917792299355353,0,0,0.618199802176063,0.130194948035575,EGR1
alpha,1,cellular zinc ion homeostasis (GO:0006882),1/32,1,32,0.810095329141595,0.917792299355353,0,0,0.618199802176063,0.130194948035575,SLC30A8
alpha,1,sarcomere organization (GO:0045214),1/32,1,32,0.810095329141595,0.917792299355353,0,0,0.618199802176063,0.130194948035575,MYBPHL
alpha,1,positive regulation of bone mineralization (GO:0030501),1/32,1,32,0.810095329141595,0.917792299355353,0,0,0.618199802176063,0.130194948035575,BMPR1A
alpha,1,protein destabilization (GO:0031648),1/32,1,32,0.810095329141595,0.917792299355353,0,0,0.618199802176063,0.130194948035575,MDM2
alpha,1,gene silencing by miRNA (GO:0035195),1/32,1,32,0.810095329141595,0.917792299355353,0,0,0.618199802176063,0.130194948035575,DICER1
alpha,1,proton transport (GO:0015992),1/32,1,32,0.810095329141595,0.917792299355353,0,0,0.618199802176063,0.130194948035575,ATP5B
alpha,1,regulation of neuron differentiation (GO:0045664),3/85,3,85,0.810272746107333,0.917792299355353,0,0,0.698202129516495,0.146890811244557,NEUROD1;CDK5RAP2;NDEL1
alpha,1,cellular response to molecule of bacterial origin (GO:0071219),3/85,3,85,0.810272746107333,0.917792299355353,0,0,0.698202129516495,0.146890811244557,NR1H2;CTR9;CD14
alpha,1,regulation of protein metabolic process (GO:0051246),2/60,2,60,0.813796947931602,0.919870937823891,0,0,0.659413122321134,0.135868377060883,MAPK7;MDM2
alpha,1,mitotic cytokinesis (GO:0000281),2/60,2,60,0.813796947931602,0.919870937823891,0,0,0.659413122321134,0.135868377060883,SEPT2;SPTBN1
alpha,1,regulation of extrinsic apoptotic signaling pathway (GO:2001236),2/60,2,60,0.813796947931602,0.919870937823891,0,0,0.659413122321134,0.135868377060883,WWOX;TNFSF10
alpha,1,sterol metabolic process (GO:0016125),2/60,2,60,0.813796947931602,0.919870937823891,0,0,0.659413122321134,0.135868377060883,CYP7B1;NR0B2
alpha,1,cell morphogenesis (GO:0000902),2/60,2,60,0.813796947931602,0.919870937823891,0,0,0.659413122321134,0.135868377060883,SCFD1;CDH15
alpha,1,response to zinc ion (GO:0010043),1/33,1,33,0.81971031401877,0.921571428995946,0,0,0.599466474837395,0.119176498952267,SLC30A8
alpha,1,regulation of glutamate receptor signaling pathway (GO:1900449),1/33,1,33,0.81971031401877,0.921571428995946,0,0,0.599466474837395,0.119176498952267,NLGN2
alpha,1,phosphatidylcholine biosynthetic process (GO:0006656),1/33,1,33,0.81971031401877,0.921571428995946,0,0,0.599466474837395,0.119176498952267,STARD10
alpha,1,cellular response to glucagon stimulus (GO:0071377),1/33,1,33,0.81971031401877,0.921571428995946,0,0,0.599466474837395,0.119176498952267,GCG
alpha,1,negative regulation of BMP signaling pathway (GO:0030514),1/33,1,33,0.81971031401877,0.921571428995946,0,0,0.599466474837395,0.119176498952267,FBN1
alpha,1,mitochondrial transmembrane transport (GO:1990542),1/33,1,33,0.81971031401877,0.921571428995946,0,0,0.599466474837395,0.119176498952267,MCU
alpha,1,endodermal cell differentiation (GO:0035987),1/33,1,33,0.81971031401877,0.921571428995946,0,0,0.599466474837395,0.119176498952267,CTR9
alpha,1,purine ribonucleoside triphosphate metabolic process (GO:0009205),1/33,1,33,0.81971031401877,0.921571428995946,0,0,0.599466474837395,0.119176498952267,HSPA8
alpha,1,substrate adhesion-dependent cell spreading (GO:0034446),1/33,1,33,0.81971031401877,0.921571428995946,0,0,0.599466474837395,0.119176498952267,EPHB3
alpha,1,positive regulation of telomere maintenance via telomerase (GO:0032212),1/33,1,33,0.81971031401877,0.921571428995946,0,0,0.599466474837395,0.119176498952267,CCT6A
alpha,1,positive regulation of T cell differentiation (GO:0045582),1/33,1,33,0.81971031401877,0.921571428995946,0,0,0.599466474837395,0.119176498952267,PNP
alpha,1,positive regulation of telomere maintenance (GO:0032206),1/33,1,33,0.81971031401877,0.921571428995946,0,0,0.599466474837395,0.119176498952267,ERCC1
alpha,1,aminoglycan catabolic process (GO:0006026),1/33,1,33,0.81971031401877,0.921571428995946,0,0,0.599466474837395,0.119176498952267,GLB1
alpha,1,regulation of peptidyl-serine phosphorylation (GO:0033135),3/87,3,87,0.822551858697709,0.921571428995946,0,0,0.682151505849449,0.133254032021408,INPP5K;MIF;NCK1
alpha,1,regulation of protein binding (GO:0043393),4/112,4,112,0.823930123159279,0.921571428995946,0,0,0.706514059629787,0.136830263289334,DNAJB2;AKTIP;PIN1;PPP1CA
alpha,1,positive regulation of T cell proliferation (GO:0042102),2/62,2,62,0.827923399988282,0.921571428995946,0,0,0.638141731278517,0.120503264712569,PNP;NCK1
alpha,1,glycosaminoglycan metabolic process (GO:0030203),2/62,2,62,0.827923399988282,0.921571428995946,0,0,0.638141731278517,0.120503264712569,GLB1;B3GAT2
alpha,1,regulation of tumor necrosis factor production (GO:0032680),2/62,2,62,0.827923399988282,0.921571428995946,0,0,0.638141731278517,0.120503264712569,MIF;CD14
alpha,1,regulation of DNA replication (GO:0006275),2/62,2,62,0.827923399988282,0.921571428995946,0,0,0.638141731278517,0.120503264712569,CTC1;PCNA
alpha,1,positive regulation of cellular amide metabolic process (GO:0034250),2/62,2,62,0.827923399988282,0.921571428995946,0,0,0.638141731278517,0.120503264712569,FXR2;CPEB3
alpha,1,cellular response to BMP stimulus (GO:0071773),3/88,3,88,0.828433026574265,0.921571428995946,0,0,0.674399784192069,0.126935043396469,DDX5;USP9X;BMPR1A
alpha,1,calcium ion homeostasis (GO:0055074),3/88,3,88,0.828433026574265,0.921571428995946,0,0,0.674399784192069,0.126935043396469,SLC8A3;ANK2;ATP13A3
alpha,1,axonemal dynein complex assembly (GO:0070286),1/34,1,34,0.828838938527753,0.921571428995946,0,0,0.581835107930413,0.1092275712842,DNAAF2
alpha,1,activation of MAPKK activity (GO:0000186),1/34,1,34,0.828838938527753,0.921571428995946,0,0,0.581835107930413,0.1092275712842,CRKL
alpha,1,oligosaccharide biosynthetic process (GO:0009312),1/34,1,34,0.828838938527753,0.921571428995946,0,0,0.581835107930413,0.1092275712842,GALNT8
alpha,1,entry into host cell (GO:0030260),1/34,1,34,0.828838938527753,0.921571428995946,0,0,0.581835107930413,0.1092275712842,CBL
alpha,1,negative regulation of mitochondrion organization (GO:0010823),1/34,1,34,0.828838938527753,0.921571428995946,0,0,0.581835107930413,0.1092275712842,ACAA2
alpha,1,stem cell differentiation (GO:0048863),1/34,1,34,0.828838938527753,0.921571428995946,0,0,0.581835107930413,0.1092275712842,JARID2
alpha,1,positive regulation of calcium ion transport (GO:0051928),1/34,1,34,0.828838938527753,0.921571428995946,0,0,0.581835107930413,0.1092275712842,ANK2
alpha,1,intra-Golgi vesicle-mediated transport (GO:0006891),1/34,1,34,0.828838938527753,0.921571428995946,0,0,0.581835107930413,0.1092275712842,DNAJC28
alpha,1,cellular response to glucose starvation (GO:0042149),1/34,1,34,0.828838938527753,0.921571428995946,0,0,0.581835107930413,0.1092275712842,TBL2
alpha,1,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),1/34,1,34,0.828838938527753,0.921571428995946,0,0,0.581835107930413,0.1092275712842,LIN7A
alpha,1,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay (GO:0043928),1/34,1,34,0.828838938527753,0.921571428995946,0,0,0.581835107930413,0.1092275712842,DDX6
alpha,1,regulation of DNA recombination (GO:0000018),1/34,1,34,0.828838938527753,0.921571428995946,0,0,0.581835107930413,0.1092275712842,SPIDR
alpha,1,positive regulation of biomineral tissue development (GO:0070169),1/34,1,34,0.828838938527753,0.921571428995946,0,0,0.581835107930413,0.1092275712842,BMPR1A
alpha,1,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),1/34,1,34,0.828838938527753,0.921571428995946,0,0,0.581835107930413,0.1092275712842,WDR81
alpha,1,positive regulation of Notch signaling pathway (GO:0045747),1/34,1,34,0.828838938527753,0.921571428995946,0,0,0.581835107930413,0.1092275712842,TSPAN14
alpha,1,negative regulation of multi-organism process (GO:0043901),1/34,1,34,0.828838938527753,0.921571428995946,0,0,0.581835107930413,0.1092275712842,MAPKBP1
alpha,1,regulation of neurotransmitter receptor activity (GO:0099601),1/34,1,34,0.828838938527753,0.921571428995946,0,0,0.581835107930413,0.1092275712842,NLGN2
alpha,1,regulation of interleukin-12 production (GO:0032655),1/34,1,34,0.828838938527753,0.921571428995946,0,0,0.581835107930413,0.1092275712842,PLCB1
alpha,1,T cell activation (GO:0042110),3/89,3,89,0.834146320744934,0.92403899607624,0,0,0.66682225852699,0.120925847680254,CD8A;PTPN2;NCK1
alpha,1,divalent metal ion transport (GO:0070838),3/89,3,89,0.834146320744934,0.92403899607624,0,0,0.66682225852699,0.120925847680254,SLC30A8;TRPC4;SLC41A1
alpha,1,regulation of protein targeting to mitochondrion (GO:1903214),3/89,3,89,0.834146320744934,0.92403899607624,0,0,0.66682225852699,0.120925847680254,TOMM7;HTRA2;PLAGL2
alpha,1,stress-activated MAPK cascade (GO:0051403),2/63,2,63,0.834618481283505,0.92403899607624,0,0,0.628012497448699,0.113532455490148,CUL1;CRKL
alpha,1,negative regulation of peptidase activity (GO:0010466),2/63,2,63,0.834618481283505,0.92403899607624,0,0,0.628012497448699,0.113532455490148,SERPINB1;GAPDH
alpha,1,regulation of T cell proliferation (GO:0042129),2/63,2,63,0.834618481283505,0.92403899607624,0,0,0.628012497448699,0.113532455490148,PNP;NCK1
alpha,1,response to cytokine (GO:0034097),5/139,5,139,0.837369325593761,0.92403899607624,0,0,0.711596894591152,0.126301373096305,JUND;ADAM10;PTPN6;IL6R;PTPN2
alpha,1,regulation of double-strand break repair (GO:2000779),1/35,1,35,0.837505781239868,0.92403899607624,0,0,0.565211247703829,0.100227278413884,SPIDR
alpha,1,embryonic limb morphogenesis (GO:0030326),1/35,1,35,0.837505781239868,0.92403899607624,0,0,0.565211247703829,0.100227278413884,NIPBL
alpha,1,positive regulation of leukocyte migration (GO:0002687),1/35,1,35,0.837505781239868,0.92403899607624,0,0,0.565211247703829,0.100227278413884,IL6R
alpha,1,negative regulation of DNA binding (GO:0043392),1/35,1,35,0.837505781239868,0.92403899607624,0,0,0.565211247703829,0.100227278413884,PER2
alpha,1,positive regulation of exocytosis (GO:0045921),1/35,1,35,0.837505781239868,0.92403899607624,0,0,0.565211247703829,0.100227278413884,RAB3A
alpha,1,regulation of JUN kinase activity (GO:0043506),1/35,1,35,0.837505781239868,0.92403899607624,0,0,0.565211247703829,0.100227278413884,DVL3
alpha,1,response to peptide (GO:1901652),1/35,1,35,0.837505781239868,0.92403899607624,0,0,0.565211247703829,0.100227278413884,KAT7
alpha,1,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),1/35,1,35,0.837505781239868,0.92403899607624,0,0,0.565211247703829,0.100227278413884,CCT6A
alpha,1,regulation of alcohol biosynthetic process (GO:1902930),1/35,1,35,0.837505781239868,0.92403899607624,0,0,0.565211247703829,0.100227278413884,FDPS
alpha,1,regulation of axon extension (GO:0030516),1/35,1,35,0.837505781239868,0.92403899607624,0,0,0.565211247703829,0.100227278413884,RUFY3
alpha,1,response to glucagon (GO:0033762),1/35,1,35,0.837505781239868,0.92403899607624,0,0,0.565211247703829,0.100227278413884,GCG
alpha,1,cellular macromolecular complex assembly (GO:0034622),1/35,1,35,0.837505781239868,0.92403899607624,0,0,0.565211247703829,0.100227278413884,CTAGE5
alpha,1,kidney development (GO:0001822),2/64,2,64,0.84107724786361,0.925244745722542,0,0,0.618199802176063,0.106992934491257,NIPBL;PROX1
alpha,1,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193),2/64,2,64,0.84107724786361,0.925244745722542,0,0,0.618199802176063,0.106992934491257,GRM7;HTR1F
alpha,1,regulation of proteolysis (GO:0030162),2/64,2,64,0.84107724786361,0.925244745722542,0,0,0.618199802176063,0.106992934491257,CAMK2N1;TBC1D10A
alpha,1,negative regulation of neuron apoptotic process (GO:0043524),2/64,2,64,0.84107724786361,0.925244745722542,0,0,0.618199802176063,0.106992934491257,NRBP2;TOX3
alpha,1,ribosomal large subunit biogenesis (GO:0042273),2/64,2,64,0.84107724786361,0.925244745722542,0,0,0.618199802176063,0.106992934491257,WDR74;NHP2
alpha,1,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",2/64,2,64,0.84107724786361,0.925244745722542,0,0,0.618199802176063,0.106992934491257,DDX6;PDE12
alpha,1,protein O-linked glycosylation (GO:0006493),4/116,4,116,0.844027756585426,0.925244745722542,0,0,0.682151505849449,0.115672361252012,POFUT1;DAG1;ISPD;GALNT8
alpha,1,epithelium development (GO:0060429),4/116,4,116,0.844027756585426,0.925244745722542,0,0,0.682151505849449,0.115672361252012,EHF;PCNA;PROX1;VCL
alpha,1,regulation of cytokine-mediated signaling pathway (GO:0001959),3/91,3,91,0.845082617557731,0.925244745722542,0,0,0.652166824273649,0.109773296472879,PTPN6;AGPAT2;PTPN2
alpha,1,regulation of JNK cascade (GO:0046328),3/91,3,91,0.845082617557731,0.925244745722542,0,0,0.652166824273649,0.109773296472879,PER1;PLCB1;EPHB1
alpha,1,positive regulation of RNA metabolic process (GO:0051254),1/36,1,36,0.845734179986562,0.925244745722542,0,0,0.549510935267612,0.0920706543594441,DDX5
alpha,1,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",1/36,1,36,0.845734179986562,0.925244745722542,0,0,0.549510935267612,0.0920706543594441,DDX6
alpha,1,negative regulation of cell-substrate adhesion (GO:0010812),1/36,1,36,0.845734179986562,0.925244745722542,0,0,0.549510935267612,0.0920706543594441,FZD4
alpha,1,regulation of endothelial cell apoptotic process (GO:2000351),1/36,1,36,0.845734179986562,0.925244745722542,0,0,0.549510935267612,0.0920706543594441,MAPK7
alpha,1,erythrocyte differentiation (GO:0030218),1/36,1,36,0.845734179986562,0.925244745722542,0,0,0.549510935267612,0.0920706543594441,PTPN2
alpha,1,regulation of ion transmembrane transport (GO:0034765),1/36,1,36,0.845734179986562,0.925244745722542,0,0,0.549510935267612,0.0920706543594441,KCNJ3
alpha,1,positive regulation of telomerase activity (GO:0051973),1/36,1,36,0.845734179986562,0.925244745722542,0,0,0.549510935267612,0.0920706543594441,PTGES3
alpha,1,neural crest cell development (GO:0014032),1/36,1,36,0.845734179986562,0.925244745722542,0,0,0.549510935267612,0.0920706543594441,SEMA3D
alpha,1,actin filament bundle organization (GO:0061572),1/36,1,36,0.845734179986562,0.925244745722542,0,0,0.549510935267612,0.0920706543594441,NEDD9
alpha,1,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),1/36,1,36,0.845734179986562,0.925244745722542,0,0,0.549510935267612,0.0920706543594441,PCNA
alpha,1,sulfur compound catabolic process (GO:0044273),1/36,1,36,0.845734179986562,0.925244745722542,0,0,0.549510935267612,0.0920706543594441,GLB1
alpha,1,positive regulation of JAK-STAT cascade (GO:0046427),2/65,2,65,0.847306454237376,0.926220584057959,0,0,0.608689035988739,0.100855414069718,GHR;IL6R
alpha,1,positive regulation of endocytosis (GO:0045807),2/65,2,65,0.847306454237376,0.926220584057959,0,0,0.608689035988739,0.100855414069718,SIRPA;CBL
alpha,1,sphingolipid metabolic process (GO:0006665),4/117,4,117,0.84873957910136,0.926347771515134,0,0,0.676321151098599,0.110918615314378,FUT5;GLB1;SMPD1;SGMS2
alpha,1,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),4/117,4,117,0.84873957910136,0.926347771515134,0,0,0.676321151098599,0.110918615314378,GHR;BANK1;MIF;IL6R
alpha,1,lipid transport (GO:0006869),3/92,3,92,0.85031233150825,0.926347771515134,0,0,0.645078054444588,0.104600405210508,PITPNA;STARD10;PITPNC1
alpha,1,cellular response to lipopolysaccharide (GO:0071222),3/92,3,92,0.85031233150825,0.926347771515134,0,0,0.645078054444588,0.104600405210508,NR1H2;CTR9;CD14
alpha,1,O-glycan processing (GO:0016266),2/66,2,66,0.853312776793384,0.926347771515134,0,0,0.599466474837395,0.0950928394701032,POFUT1;GALNT8
alpha,1,negative regulation of cell adhesion (GO:0007162),2/66,2,66,0.853312776793384,0.926347771515134,0,0,0.599466474837395,0.0950928394701032,FZD4;ADAM10
alpha,1,actin polymerization or depolymerization (GO:0008154),1/37,1,37,0.853546294062237,0.926347771515134,0,0,0.534659288368487,0.0846662378475729,ANG
alpha,1,endoderm formation (GO:0001706),1/37,1,37,0.853546294062237,0.926347771515134,0,0,0.534659288368487,0.0846662378475729,DUSP1
alpha,1,regulation of filopodium assembly (GO:0051489),1/37,1,37,0.853546294062237,0.926347771515134,0,0,0.534659288368487,0.0846662378475729,ARAP1
alpha,1,regulation of response to DNA damage stimulus (GO:2001020),1/37,1,37,0.853546294062237,0.926347771515134,0,0,0.534659288368487,0.0846662378475729,CASP9
alpha,1,organophosphate biosynthetic process (GO:0090407),1/37,1,37,0.853546294062237,0.926347771515134,0,0,0.534659288368487,0.0846662378475729,PIP5K1A
alpha,1,regulation of blood circulation (GO:1903522),1/37,1,37,0.853546294062237,0.926347771515134,0,0,0.534659288368487,0.0846662378475729,PER2
alpha,1,vesicle-mediated transport in synapse (GO:0099003),1/37,1,37,0.853546294062237,0.926347771515134,0,0,0.534659288368487,0.0846662378475729,NLGN2
alpha,1,cardiac muscle contraction (GO:0060048),1/37,1,37,0.853546294062237,0.926347771515134,0,0,0.534659288368487,0.0846662378475729,SCN3B
alpha,1,cardiac muscle tissue morphogenesis (GO:0055008),1/37,1,37,0.853546294062237,0.926347771515134,0,0,0.534659288368487,0.0846662378475729,PROX1
alpha,1,inner mitochondrial membrane organization (GO:0007007),1/37,1,37,0.853546294062237,0.926347771515134,0,0,0.534659288368487,0.0846662378475729,ATP5B
alpha,1,regulation of cysteine-type endopeptidase activity (GO:2000116),1/37,1,37,0.853546294062237,0.926347771515134,0,0,0.534659288368487,0.0846662378475729,PCID2
alpha,1,spermatid development (GO:0007286),1/37,1,37,0.853546294062237,0.926347771515134,0,0,0.534659288368487,0.0846662378475729,RFX2
alpha,1,calcium ion transport (GO:0006816),4/119,4,119,0.857802554367204,0.929949502418255,0,0,0.664954409063329,0.101991591047525,SLC8A3;TRPC4;ANK2;TRPM6
alpha,1,positive regulation of protein serine/threonine kinase activity (GO:0071902),4/119,4,119,0.857802554367204,0.929949502418255,0,0,0.664954409063329,0.101991591047525,CCND3;PARP16;CALM3;PROX1
alpha,1,cellular response to light stimulus (GO:0071482),2/67,2,67,0.859102804016459,0.929949502418255,0,0,0.590519214018926,0.0896801957237483,CASP9;PCNA
alpha,1,sphingolipid biosynthetic process (GO:0030148),2/67,2,67,0.859102804016459,0.929949502418255,0,0,0.590519214018926,0.0896801957237483,SMPD1;SGMS2
alpha,1,cellular transition metal ion homeostasis (GO:0046916),3/94,3,94,0.860311738031889,0.929949502418255,0,0,0.631352989456405,0.0949936671085299,SLC30A8;NDFIP1;CUL1
alpha,1,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),3/94,3,94,0.860311738031889,0.929949502418255,0,0,0.631352989456405,0.0949936671085299,FIS1;TNFSF10;HTRA2
alpha,1,epithelial to mesenchymal transition (GO:0001837),1/38,1,38,0.860963164008969,0.929949502418255,0,0,0.520589307095632,0.0779340716694702,DDX5
alpha,1,myelination (GO:0042552),1/38,1,38,0.860963164008969,0.929949502418255,0,0,0.520589307095632,0.0779340716694702,SLC8A3
alpha,1,protein peptidyl-prolyl isomerization (GO:0000413),1/38,1,38,0.860963164008969,0.929949502418255,0,0,0.520589307095632,0.0779340716694702,PIN1
alpha,1,regulation of osteoclast differentiation (GO:0045670),1/38,1,38,0.860963164008969,0.929949502418255,0,0,0.520589307095632,0.0779340716694702,FBN1
alpha,1,negative regulation of Ras protein signal transduction (GO:0046580),1/38,1,38,0.860963164008969,0.929949502418255,0,0,0.520589307095632,0.0779340716694702,SPRY4
alpha,1,actin filament bundle assembly (GO:0051017),1/38,1,38,0.860963164008969,0.929949502418255,0,0,0.520589307095632,0.0779340716694702,NEDD9
alpha,1,positive regulation of synaptic transmission (GO:0050806),2/68,2,68,0.864683028914022,0.933227066085169,0,0,0.581835107930413,0.0845943327909648,SLC8A3;NLGN2
alpha,1,positive regulation of endothelial cell proliferation (GO:0001938),2/68,2,68,0.864683028914022,0.933227066085169,0,0,0.581835107930413,0.0845943327909648,ANG;PROX1
alpha,1,potassium ion import (GO:0010107),1/39,1,39,0.868004767896054,0.934589554361786,0,0,0.507240863323949,0.0718040383317196,KCNJ3
alpha,1,positive regulation of neuron death (GO:1901216),1/39,1,39,0.868004767896054,0.934589554361786,0,0,0.507240863323949,0.0718040383317196,EGR1
alpha,1,regulation of cellular amide metabolic process (GO:0034248),1/39,1,39,0.868004767896054,0.934589554361786,0,0,0.507240863323949,0.0718040383317196,DDX6
alpha,1,membrane depolarization during action potential (GO:0086010),1/39,1,39,0.868004767896054,0.934589554361786,0,0,0.507240863323949,0.0718040383317196,SCN3B
alpha,1,positive regulation of innate immune response (GO:0045089),1/39,1,39,0.868004767896054,0.934589554361786,0,0,0.507240863323949,0.0718040383317196,UBE2K
alpha,1,retina homeostasis (GO:0001895),1/39,1,39,0.868004767896054,0.934589554361786,0,0,0.507240863323949,0.0718040383317196,BBS10
alpha,1,regulation of heart contraction (GO:0008016),3/96,3,96,0.869720240486304,0.934718024378098,0,0,0.618199802176063,0.0862906044172148,SLC8A3;ANK2;CALM3
alpha,1,regulation of epithelial to mesenchymal transition (GO:0010717),2/69,2,69,0.870059841086692,0.934718024378098,0,0,0.573402715061856,0.0798138085928258,SDHAF2;DAG1
alpha,1,monocarboxylic acid biosynthetic process (GO:0072330),2/69,2,69,0.870059841086692,0.934718024378098,0,0,0.573402715061856,0.0798138085928258,PER2;CYP7B1
alpha,1,response to interferon-gamma (GO:0034341),2/69,2,69,0.870059841086692,0.934718024378098,0,0,0.573402715061856,0.0798138085928258,PDE12;GAPDH
alpha,1,regulation of endopeptidase activity (GO:0052548),2/69,2,69,0.870059841086692,0.934718024378098,0,0,0.573402715061856,0.0798138085928258,SERPINB1;GAPDH
alpha,1,skeletal system development (GO:0001501),5/147,5,147,0.870371216688502,0.934718024378098,0,0,0.672870532980749,0.0934182983704261,WWOX;ANKRD11;HYAL3;HAPLN1;FBN1
alpha,1,stimulatory C-type lectin receptor signaling pathway (GO:0002223),4/122,4,122,0.870526959171082,0.934718024378098,0,0,0.648603071135542,0.0899330644868334,PSMD2;CUL1;PSMB10;PSMA7
alpha,1,skeletal muscle tissue development (GO:0007519),1/40,1,40,0.874690074863688,0.936602860343619,0,0,0.494559841740851,0.066214468607319,MYLPF
alpha,1,ERBB2 signaling pathway (GO:0038128),1/40,1,40,0.874690074863688,0.936602860343619,0,0,0.494559841740851,0.066214468607319,BTC
alpha,1,inositol lipid-mediated signaling (GO:0048017),1/40,1,40,0.874690074863688,0.936602860343619,0,0,0.494559841740851,0.066214468607319,IRS2
alpha,1,regulation of plasma membrane bounded cell projection assembly (GO:0120032),1/40,1,40,0.874690074863688,0.936602860343619,0,0,0.494559841740851,0.066214468607319,SH3YL1
alpha,1,regulation of RNA metabolic process (GO:0051252),1/40,1,40,0.874690074863688,0.936602860343619,0,0,0.494559841740851,0.066214468607319,ESRP1
alpha,1,mitotic DNA damage checkpoint (GO:0044773),1/40,1,40,0.874690074863688,0.936602860343619,0,0,0.494559841740851,0.066214468607319,FOXN3
alpha,1,cellular response to amino acid starvation (GO:0034198),1/40,1,40,0.874690074863688,0.936602860343619,0,0,0.494559841740851,0.066214468607319,CDKN1A
alpha,1,negative regulation of canonical Wnt signaling pathway (GO:0090090),5/149,5,149,0.877677998895706,0.937867088719675,0,0,0.663838713746108,0.0866146857510634,SDHAF2;PSMD2;DVL3;PSMB10;PSMA7
alpha,1,tumor necrosis factor-mediated signaling pathway (GO:0033209),4/124,4,124,0.878454677234509,0.937867088719675,0,0,0.638141731278517,0.0826974019768345,PSMD2;PSMB10;PSMA7;LIMS1
alpha,1,positive regulation of neuron projection development (GO:0010976),3/98,3,98,0.878564647541645,0.937867088719675,0,0,0.605583479682674,0.0784023408901804,LRRC7;SLITRK1;VLDLR
alpha,1,positive regulation of endothelial cell migration (GO:0010595),2/71,2,71,0.880228235170384,0.937867088719675,0,0,0.557250525905184,0.0710907047766021,ATP5B;PROX1
alpha,1,cytoskeleton-dependent cytokinesis (GO:0061640),2/71,2,71,0.880228235170384,0.937867088719675,0,0,0.557250525905184,0.0710907047766021,SEPT2;SPTBN1
alpha,1,snRNA transcription (GO:0009301),2/71,2,71,0.880228235170384,0.937867088719675,0,0,0.557250525905184,0.0710907047766021,POU2F1;POLR2I
alpha,1,snRNA transcription from RNA polymerase II promoter (GO:0042795),2/71,2,71,0.880228235170384,0.937867088719675,0,0,0.557250525905184,0.0710907047766021,POU2F1;POLR2I
alpha,1,intraciliary transport involved in cilium assembly (GO:0035735),1/41,1,41,0.881037096197183,0.937867088719675,0,0,0.48249740657644,0.0611109729616543,DYNLL1
alpha,1,negative regulation of cytokine secretion (GO:0050710),1/41,1,41,0.881037096197183,0.937867088719675,0,0,0.48249740657644,0.0611109729616543,MAPKBP1
alpha,1,peptidyl-proline modification (GO:0018208),1/41,1,41,0.881037096197183,0.937867088719675,0,0,0.48249740657644,0.0611109729616543,PIN1
alpha,1,phosphatidic acid biosynthetic process (GO:0006654),1/41,1,41,0.881037096197183,0.937867088719675,0,0,0.48249740657644,0.0611109729616543,AGPAT2
alpha,1,neuron migration (GO:0001764),1/41,1,41,0.881037096197183,0.937867088719675,0,0,0.48249740657644,0.0611109729616543,USP9X
alpha,1,regulation of cholesterol biosynthetic process (GO:0045540),1/41,1,41,0.881037096197183,0.937867088719675,0,0,0.48249740657644,0.0611109729616543,FDPS
alpha,1,positive regulation of cytokine biosynthetic process (GO:0042108),1/41,1,41,0.881037096197183,0.937867088719675,0,0,0.48249740657644,0.0611109729616543,EGR1
alpha,1,regulation of ATPase activity (GO:0043462),1/41,1,41,0.881037096197183,0.937867088719675,0,0,0.48249740657644,0.0611109729616543,DNAJB2
alpha,1,innate immune response activating cell surface receptor signaling pathway (GO:0002220),4/125,4,125,0.882258378190374,0.938047521301587,0,0,0.633036597428289,0.0793006971831533,PSMD2;CUL1;PSMB10;PSMA7
alpha,1,response to UV (GO:0009411),3/99,3,99,0.882783616041867,0.938047521301587,0,0,0.599466474837395,0.0747385809755675,CASP9;PCNA;UBE4B
alpha,1,positive regulation of neuron differentiation (GO:0045666),3/99,3,99,0.882783616041867,0.938047521301587,0,0,0.599466474837395,0.0747385809755675,NEUROD1;LRRC7;PROX1
alpha,1,phosphatidylcholine metabolic process (GO:0046470),2/72,2,72,0.885032030398725,0.938047521301587,0,0,0.549510935267612,0.0671125629674741,TMEM86B;STARD10
alpha,1,defense response to Gram-negative bacterium (GO:0050829),2/72,2,72,0.885032030398725,0.938047521301587,0,0,0.549510935267612,0.0671125629674741,CHGA;IL6R
alpha,1,regulation of cation channel activity (GO:2001257),2/72,2,72,0.885032030398725,0.938047521301587,0,0,0.549510935267612,0.0671125629674741,NLGN2;ANK2
alpha,1,odontogenesis (GO:0042476),1/42,1,42,0.887062933291071,0.938047521301587,0,0,0.471009373086524,0.0564454563923983,ANKRD11
alpha,1,bicarbonate transport (GO:0015701),1/42,1,42,0.887062933291071,0.938047521301587,0,0,0.471009373086524,0.0564454563923983,SLC26A4
alpha,1,regulation of phagocytosis (GO:0050764),1/42,1,42,0.887062933291071,0.938047521301587,0,0,0.471009373086524,0.0564454563923983,SIRPA
alpha,1,mesenchymal cell differentiation (GO:0048762),1/42,1,42,0.887062933291071,0.938047521301587,0,0,0.471009373086524,0.0564454563923983,DDX5
alpha,1,regulation of cholesterol metabolic process (GO:0090181),1/42,1,42,0.887062933291071,0.938047521301587,0,0,0.471009373086524,0.0564454563923983,FDPS
alpha,1,phosphatidic acid metabolic process (GO:0046473),1/42,1,42,0.887062933291071,0.938047521301587,0,0,0.471009373086524,0.0564454563923983,AGPAT2
alpha,1,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),1/42,1,42,0.887062933291071,0.938047521301587,0,0,0.471009373086524,0.0564454563923983,CDH15
alpha,1,positive regulation of receptor-mediated endocytosis (GO:0048260),1/42,1,42,0.887062933291071,0.938047521301587,0,0,0.471009373086524,0.0564454563923983,CBL
alpha,1,cellular response to peptide (GO:1901653),1/42,1,42,0.887062933291071,0.938047521301587,0,0,0.471009373086524,0.0564454563923983,MDM2
alpha,1,monocyte chemotaxis (GO:0002548),1/42,1,42,0.887062933291071,0.938047521301587,0,0,0.471009373086524,0.0564454563923983,IL6R
alpha,1,negative regulation of proteolysis (GO:0045861),1/42,1,42,0.887062933291071,0.938047521301587,0,0,0.471009373086524,0.0564454563923983,CAMK2N1
alpha,1,Rho protein signal transduction (GO:0007266),2/73,2,73,0.889656831201857,0.94042529167805,0,0,0.541983388209151,0.0633684124121899,CDC42EP3;CDC42EP2
alpha,1,regulation of lipid metabolic process (GO:0019216),3/101,3,101,0.890831466583538,0.941301545792384,0,0,0.587595851573288,0.0679260923482295,HNF4A;CARM1;IRS2
alpha,1,regulation of interleukin-6 production (GO:0032675),1/43,1,43,0.89278382419481,0.941902500303164,0,0,0.460055666735675,0.0521752837764101,IL6R
alpha,1,regulation of protein modification process (GO:0031399),1/43,1,43,0.89278382419481,0.941902500303164,0,0,0.460055666735675,0.0521752837764101,PPP1R14C
alpha,1,determination of left/right symmetry (GO:0007368),1/43,1,43,0.89278382419481,0.941902500303164,0,0,0.460055666735675,0.0521752837764101,RFX3
alpha,1,regulation of telomerase activity (GO:0051972),1/43,1,43,0.89278382419481,0.941902500303164,0,0,0.460055666735675,0.0521752837764101,PTGES3
alpha,1,B cell activation (GO:0042113),2/74,2,74,0.894108436292603,0.94256959815128,0,0,0.534659288368487,0.0598434612622764,BANK1;PTPN2
alpha,1,chloride transport (GO:0006821),2/74,2,74,0.894108436292603,0.94256959815128,0,0,0.534659288368487,0.0598434612622764,SLC26A4;ANO5
alpha,1,regulation of protein ubiquitination (GO:0031396),3/102,3,102,0.894666810153911,0.942793236861107,0,0,0.581835107930413,0.0647605220096652,DNAJB2;PER2;NDFIP1
alpha,1,membrane depolarization (GO:0051899),1/44,1,44,0.898215186506645,0.945621500389419,0,0,0.449599856128046,0.0482625711535551,SCN3B
alpha,1,positive regulation of interleukin-6 production (GO:0032755),1/44,1,44,0.898215186506645,0.945621500389419,0,0,0.449599856128046,0.0482625711535551,IL6R
alpha,1,positive regulation of epithelial cell migration (GO:0010634),2/75,2,75,0.898392516161376,0.945621500389419,0,0,0.527530497856907,0.0565239463385782,EPB41L4B;PROX1
alpha,1,protein glycosylation (GO:0006486),4/131,4,131,0.902972269986167,0.947201011936242,0,0,0.604042554797986,0.061650657908418,FUT5;POFUT1;DAG1;PARP16
alpha,1,sprouting angiogenesis (GO:0002040),1/45,1,45,0.903371659198832,0.947201011936242,0,0,0.43960874821409,0.0446735806216629,JMJD6
alpha,1,cholesterol transport (GO:0030301),1/45,1,45,0.903371659198832,0.947201011936242,0,0,0.43960874821409,0.0446735806216629,STX12
alpha,1,lymphocyte chemotaxis (GO:0048247),1/45,1,45,0.903371659198832,0.947201011936242,0,0,0.43960874821409,0.0446735806216629,CYP7B1
alpha,1,unsaturated fatty acid metabolic process (GO:0033559),1/45,1,45,0.903371659198832,0.947201011936242,0,0,0.43960874821409,0.0446735806216629,GSTM2
alpha,1,positive regulation of interleukin-8 production (GO:0032757),1/45,1,45,0.903371659198832,0.947201011936242,0,0,0.43960874821409,0.0446735806216629,CD14
alpha,1,negative regulation of type I interferon production (GO:0032480),1/45,1,45,0.903371659198832,0.947201011936242,0,0,0.43960874821409,0.0446735806216629,PIN1
alpha,1,heart contraction (GO:0060047),1/45,1,45,0.903371659198832,0.947201011936242,0,0,0.43960874821409,0.0446735806216629,SCN3B
alpha,1,carboxylic acid biosynthetic process (GO:0046394),1/45,1,45,0.903371659198832,0.947201011936242,0,0,0.43960874821409,0.0446735806216629,GLUL
alpha,1,metaphase plate congression (GO:0051310),1/45,1,45,0.903371659198832,0.947201011936242,0,0,0.43960874821409,0.0446735806216629,KIF22
alpha,1,positive regulation of lymphocyte activation (GO:0051251),3/105,3,105,0.905456527225313,0.949021602630688,0,0,0.565211247703829,0.0561345273430008,FAM49B;SIRPA;CD47
alpha,1,positive regulation of JNK cascade (GO:0046330),2/77,2,77,0.90648013081815,0.949363613929932,0,0,0.513828407003481,0.0504508420853213,DVL3;PLCB1
alpha,1,hemopoiesis (GO:0030097),2/77,2,77,0.90648013081815,0.949363613929932,0,0,0.513828407003481,0.0504508420853213,KAT8;ZFP36L2
alpha,1,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),2/78,2,78,0.910294351300057,0.952259515401481,0,0,0.507240863323949,0.0476741833711293,SNX25;PIN1
alpha,1,water-soluble vitamin metabolic process (GO:0006767),2/78,2,78,0.910294351300057,0.952259515401481,0,0,0.507240863323949,0.0476741833711293,MTHFD2;PRSS3
alpha,1,regulation of cytokinesis (GO:0032465),2/78,2,78,0.910294351300057,0.952259515401481,0,0,0.507240863323949,0.0476741833711293,PIN1;CALM3
alpha,1,nucleocytoplasmic transport (GO:0006913),1/47,1,47,0.912914831410469,0.952439496525176,0,0,0.420901992970937,0.0383495115703029,SNRPD2
alpha,1,intraciliary transport (GO:0042073),1/47,1,47,0.912914831410469,0.952439496525176,0,0,0.420901992970937,0.0383495115703029,DYNLL1
alpha,1,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),1/47,1,47,0.912914831410469,0.952439496525176,0,0,0.420901992970937,0.0383495115703029,PER2
alpha,1,cartilage development (GO:0051216),1/47,1,47,0.912914831410469,0.952439496525176,0,0,0.420901992970937,0.0383495115703029,HYAL3
alpha,1,tRNA aminoacylation for protein translation (GO:0006418),1/47,1,47,0.912914831410469,0.952439496525176,0,0,0.420901992970937,0.0383495115703029,FDXACB1
alpha,1,mitotic spindle assembly (GO:0090307),1/47,1,47,0.912914831410469,0.952439496525176,0,0,0.420901992970937,0.0383495115703029,CDC14A
alpha,1,icosanoid metabolic process (GO:0006690),1/47,1,47,0.912914831410469,0.952439496525176,0,0,0.420901992970937,0.0383495115703029,CYP4F3
alpha,1,positive regulation of translation (GO:0045727),2/79,2,79,0.913962416785366,0.952467963650077,0,0,0.500820092902127,0.0450566942689972,FXR2;CPEB3
alpha,1,negative regulation of inflammatory response (GO:0050728),2/79,2,79,0.913962416785366,0.952467963650077,0,0,0.500820092902127,0.0450566942689972,MAPK7;PTPN2
alpha,1,positive regulation of cell cycle process (GO:0090068),3/108,3,108,0.915236364669885,0.952467963650077,0,0,0.549510935267612,0.0486717908684581,PCID2;NUMA1;TPR
alpha,1,negative regulation of response to external stimulus (GO:0032102),3/108,3,108,0.915236364669885,0.952467963650077,0,0,0.549510935267612,0.0486717908684581,MAPKBP1;MAPK7;PTPN2
alpha,1,myofibril assembly (GO:0030239),1/48,1,48,0.917327258834228,0.952467963650077,0,0,0.412133201450709,0.0355633821831931,MYBPHL
alpha,1,negative regulation of JAK-STAT cascade (GO:0046426),1/48,1,48,0.917327258834228,0.952467963650077,0,0,0.412133201450709,0.0355633821831931,PTPN2
alpha,1,fatty acid biosynthetic process (GO:0006633),1/48,1,48,0.917327258834228,0.952467963650077,0,0,0.412133201450709,0.0355633821831931,TECR
alpha,1,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/48,1,48,0.917327258834228,0.952467963650077,0,0,0.412133201450709,0.0355633821831931,CBLN1
alpha,1,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),1/48,1,48,0.917327258834228,0.952467963650077,0,0,0.412133201450709,0.0355633821831931,BMPR1A
alpha,1,peptidyl-tyrosine phosphorylation (GO:0018108),2/80,2,80,0.917489338470126,0.952467963650077,0,0,0.494559841740851,0.0425886841330242,GHR;PTPN6
alpha,1,regulation of endothelial cell proliferation (GO:0001936),2/80,2,80,0.917489338470126,0.952467963650077,0,0,0.494559841740851,0.0425886841330242,ANG;PROX1
alpha,1,response to calcium ion (GO:0051592),2/80,2,80,0.917489338470126,0.952467963650077,0,0,0.494559841740851,0.0425886841330242,CALM3;SEC31A
alpha,1,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),2/80,2,80,0.917489338470126,0.952467963650077,0,0,0.494559841740851,0.0425886841330242,SNX25;PIN1
alpha,1,monocarboxylic acid metabolic process (GO:0032787),3/109,3,109,0.918285826832929,0.952931519232495,0,0,0.544469550540386,0.0464141663451113,GHR;ALDH4A1;PER2
alpha,1,positive regulation of stress-activated MAPK cascade (GO:0032874),2/81,2,81,0.920879994958451,0.954465174554648,0,0,0.488454164682322,0.0402611031004814,PRMT1;PLCB1
alpha,1,circulatory system development (GO:0072359),3/110,3,110,0.921234864204208,0.954465174554648,0,0,0.539519827353655,0.0442623497397578,NIPBL;CACYBP;FBN1
alpha,1,endosome to lysosome transport (GO:0008333),1/49,1,49,0.92151632166881,0.954465174554648,0,0,0.403722319788449,0.0329981590113348,AKTIP
alpha,1,cytoplasmic microtubule organization (GO:0031122),1/49,1,49,0.92151632166881,0.954465174554648,0,0,0.403722319788449,0.0329981590113348,NUMA1
alpha,1,pattern recognition receptor signaling pathway (GO:0002221),1/49,1,49,0.92151632166881,0.954465174554648,0,0,0.403722319788449,0.0329981590113348,CD14
alpha,1,sensory perception of light stimulus (GO:0050953),2/82,2,82,0.924139132914663,0.956454146304305,0,0,0.48249740657644,0.0380654951284758,DNAJC19;PITPNA
alpha,1,positive regulation of binding (GO:0051099),2/82,2,82,0.924139132914663,0.956454146304305,0,0,0.48249740657644,0.0380654951284758,AKTIP;DPH3
alpha,1,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/50,1,50,0.925493316182491,0.957491755305822,0,0,0.395647873392681,0.03063436947166,GAPDH
alpha,1,regulation of anatomical structure morphogenesis (GO:0022603),2/83,2,83,0.927271367690395,0.958966932860214,0,0,0.476684184810459,0.0359939550369841,DAG1;MARCH5
alpha,1,positive regulation of JUN kinase activity (GO:0043507),1/51,1,51,0.929268968120018,0.959575047474709,0,0,0.387890071953608,0.0284544743987137,DVL3
alpha,1,regulation of blood vessel endothelial cell migration (GO:0043535),1/51,1,51,0.929268968120018,0.959575047474709,0,0,0.387890071953608,0.0284544743987137,ATP5B
alpha,1,wound healing (GO:0042060),1/51,1,51,0.929268968120018,0.959575047474709,0,0,0.387890071953608,0.0284544743987137,EPB41L4B
alpha,1,negative regulation of protein ubiquitination (GO:0031397),1/51,1,51,0.929268968120018,0.959575047474709,0,0,0.387890071953608,0.0284544743987137,PER2
alpha,1,establishment of protein localization to membrane (GO:0090150),2/84,2,84,0.930281185014269,0.960014509166141,0,0,0.471009373086524,0.0340390886230133,RAB10;SPTBN1
alpha,1,regulation of cellular component organization (GO:0051128),4/141,4,141,0.93039966569572,0.960014509166141,0,0,0.561202657294582,0.0404857417149913,HSPA8;BBS10;EGLN2;LAMTOR1
alpha,1,peptidyl-tyrosine modification (GO:0018212),1/52,1,52,0.932853461199113,0.961453434839207,0,0,0.380430647492962,0.0264426510012785,PTPN6
alpha,1,negative regulation of neuron projection development (GO:0010977),1/52,1,52,0.932853461199113,0.961453434839207,0,0,0.380430647492962,0.0264426510012785,RUFY3
alpha,1,arachidonic acid metabolic process (GO:0019369),1/52,1,52,0.932853461199113,0.961453434839207,0,0,0.380430647492962,0.0264426510012785,PTGES3
alpha,1,positive regulation of proteolysis (GO:0045862),1/53,1,53,0.936256464532686,0.964230844524397,0,0,0.373252710747812,0.0245846031266394,TBC1D10A
alpha,1,B cell differentiation (GO:0030183),1/53,1,53,0.936256464532686,0.964230844524397,0,0,0.373252710747812,0.0245846031266394,PTPN2
alpha,1,action potential (GO:0001508),1/55,1,55,0.942554259976225,0.969983087647491,0,0,0.359679884902437,0.0212793061956745,SCN3B
alpha,1,negative regulation of supramolecular fiber organization (GO:1902904),1/55,1,55,0.942554259976225,0.969983087647491,0,0,0.359679884902437,0.0212793061956745,HSPA8
alpha,1,long-chain fatty acid metabolic process (GO:0001676),1/56,1,56,0.945466044730128,0.9722447280212,0,0,0.353257029814893,0.0198097018615519,GSTM2
alpha,1,negative regulation of cellular response to growth factor stimulus (GO:0090288),1/56,1,56,0.945466044730128,0.9722447280212,0,0,0.353257029814893,0.0198097018615519,SPRY4
alpha,1,peptidyl-threonine modification (GO:0018210),2/90,2,90,0.946004506105788,0.972431208050608,0,0,0.43960874821409,0.0244017789279024,WNK1;GALNT8
alpha,1,enzyme linked receptor protein signaling pathway (GO:0007167),3/121,3,121,0.947813732205683,0.973616628552579,0,0,0.490472570321505,0.026287996197821,TRIO;CD8A;NEDD9
alpha,1,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),1/57,1,57,0.94823037051834,0.973616628552579,0,0,0.347059538063755,0.0184489212947463,PTPN2
alpha,1,negative regulation of cellular catabolic process (GO:0031330),1/57,1,57,0.94823037051834,0.973616628552579,0,0,0.347059538063755,0.0184489212947463,EIF4G2
alpha,1,regulation of Rho protein signal transduction (GO:0035023),1/58,1,58,0.950854697965382,0.975208038628902,0,0,0.341075752924725,0.0171881772195713,ARAP1
alpha,1,chloride transmembrane transport (GO:1902476),1/58,1,58,0.950854697965382,0.975208038628902,0,0,0.341075752924725,0.0171881772195713,SLC26A4
alpha,1,I-kappaB kinase/NF-kappaB signaling (GO:0007249),1/58,1,58,0.950854697965382,0.975208038628902,0,0,0.341075752924725,0.0171881772195713,CD14
alpha,1,renal system development (GO:0072001),1/60,1,60,0.955711333586231,0.97945124627599,0,0,0.329706561160567,0.0149354974754941,PROX1
alpha,1,keratinocyte differentiation (GO:0030216),1/60,1,60,0.955711333586231,0.97945124627599,0,0,0.329706561160567,0.0149354974754941,PIP5K1A
alpha,1,positive regulation of protein binding (GO:0032092),1/61,1,61,0.957956752634601,0.980645202039104,0,0,0.324301535567771,0.0139296088657398,AKTIP
alpha,1,muscle organ development (GO:0007517),1/61,1,61,0.957956752634601,0.980645202039104,0,0,0.324301535567771,0.0139296088657398,EMD
alpha,1,membrane lipid biosynthetic process (GO:0046467),1/61,1,61,0.957956752634601,0.980645202039104,0,0,0.324301535567771,0.0139296088657398,SGMS2
alpha,1,positive regulation of protein kinase B signaling (GO:0051897),3/128,3,128,0.960097412964897,0.982098142563266,0,0,0.463649851632048,0.0188800666866373,BTC;IRS2;PTPRJ
alpha,1,protein lipidation (GO:0006497),3/128,3,128,0.960097412964897,0.982098142563266,0,0,0.463649851632048,0.0188800666866373,PIGU;PIGP;ZDHHC5
alpha,1,positive regulation of NF-kappaB transcription factor activity (GO:0051092),3/129,3,129,0.961612695078205,0.983278771572644,0,0,0.460055666735675,0.0180081950874968,TRIM8;TRIM13;CLOCK
alpha,1,diterpenoid metabolic process (GO:0016101),1/63,1,63,0.962112122590922,0.983420161341997,0,0,0.31400624872435,0.0121282663897821,TTR
alpha,1,response to molecule of bacterial origin (GO:0002237),2/99,2,99,0.963410536054688,0.984275463606078,0,0,0.399644316558263,0.0148970010777074,JUND;CD14
alpha,1,negative regulation of protein modification process (GO:0031400),1/64,1,64,0.964033294688729,0.984275463606078,0,0,0.309099901088032,0.0113221584165334,INPP5K
alpha,1,positive regulation of cell projection organization (GO:0031346),1/64,1,64,0.964033294688729,0.984275463606078,0,0,0.309099901088032,0.0113221584165334,LRRC7
alpha,1,inorganic anion transmembrane transport (GO:0098661),1/65,1,65,0.965857135247168,0.985398643416275,0,0,0.30434451799437,0.0105727303738136,SLC26A4
alpha,1,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/65,1,65,0.965857135247168,0.985398643416275,0,0,0.30434451799437,0.0105727303738136,CDH15
alpha,1,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),1/66,1,66,0.967588570787918,0.985687870653012,0,0,0.299733237418697,0.00987570429345654,NDFIP1
alpha,1,regulation of JAK-STAT cascade (GO:0046425),1/66,1,66,0.967588570787918,0.985687870653012,0,0,0.299733237418697,0.00987570429345654,PIGU
alpha,1,negative regulation of apoptotic signaling pathway (GO:2001234),1/66,1,66,0.967588570787918,0.985687870653012,0,0,0.299733237418697,0.00987570429345654,ACAA2
alpha,1,defense response to Gram-positive bacterium (GO:0050830),1/66,1,66,0.967588570787918,0.985687870653012,0,0,0.299733237418697,0.00987570429345654,CHGA
alpha,1,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),3/134,3,134,0.968410481442759,0.985886998193809,0,0,0.442889410514195,0.014216409279675,WIPF2;ELMO2;NCK1
alpha,1,purine ribonucleotide metabolic process (GO:0009150),1/67,1,67,0.969232278429977,0.985886998193809,0,0,0.295259607009463,0.00922715396165261,HSPA8
alpha,1,negative regulation of epithelial cell proliferation (GO:0050680),1/67,1,67,0.969232278429977,0.985886998193809,0,0,0.295259607009463,0.00922715396165261,MAGED1
alpha,1,JNK cascade (GO:0007254),1/67,1,67,0.969232278429977,0.985886998193809,0,0,0.295259607009463,0.00922715396165261,CRKL
alpha,1,Fc-gamma receptor signaling pathway (GO:0038094),3/135,3,135,0.969626007303613,0.985919200107445,0,0,0.43960874821409,0.0135596620783329,WIPF2;ELMO2;NCK1
alpha,1,epidermal cell differentiation (GO:0009913),1/68,1,68,0.970792699175054,0.986373428895822,0,0,0.290917553965206,0.00862347285134576,PIP5K1A
alpha,1,Fc receptor mediated stimulatory signaling pathway (GO:0002431),3/136,3,136,0.970797205082924,0.986373428895822,0,0,0.436376330947809,0.0129331838528651,WIPF2;ELMO2;NCK1
alpha,1,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),1/69,1,69,0.972274049018015,0.987137298835219,0,0,0.286701357530928,0.00806134572631675,RNF34
alpha,1,peptidyl-threonine phosphorylation (GO:0018107),1/69,1,69,0.972274049018015,0.987137298835219,0,0,0.286701357530928,0.00806134572631675,WNK1
alpha,1,regulation of endothelial cell migration (GO:0010594),1/70,1,70,0.973680330898862,0.987460536699293,0,0,0.282605623851915,0.00753772264302644,PROX1
alpha,1,regulation of endocytosis (GO:0030100),1/70,1,70,0.973680330898862,0.987460536699293,0,0,0.282605623851915,0.00753772264302644,MCTP1
alpha,1,regulation of innate immune response (GO:0045088),1/70,1,70,0.973680330898862,0.987460536699293,0,0,0.282605623851915,0.00753772264302644,PTPN6
alpha,1,fatty acid metabolic process (GO:0006631),2/107,2,107,0.974242009856883,0.987662320491546,0,0,0.369764367656711,0.00964919941364414,GHR;PER2
alpha,1,neuropeptide signaling pathway (GO:0007218),1/71,1,71,0.975015345372225,0.988008127300476,0,0,0.278625262952592,0.00704979570215969,GALR1
alpha,1,positive regulation of epithelial cell proliferation (GO:0050679),2/108,2,108,0.975355312661966,0.988008127300476,0,0,0.366340623511741,0.00914146284473376,ANG;PROX1
alpha,1,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),3/141,3,141,0.976038885753587,0.988008127300476,0,0,0.420901992970937,0.0102080734903603,PIM1;PROX1;NR0B2
alpha,1,regulation of cytokine production (GO:0001817),2/109,2,109,0.976422020760516,0.988008127300476,0,0,0.362979700360257,0.00866083638002446,PER1;AGPAT2
alpha,1,lipid biosynthetic process (GO:0008610),1/73,1,73,0.977485822602821,0.988008127300476,0,0,0.270991694104576,0.00617088491224622,PIP5K1A
alpha,1,glycoprotein biosynthetic process (GO:0009101),1/73,1,73,0.977485822602821,0.988008127300476,0,0,0.270991694104576,0.00617088491224622,FUT5
alpha,1,negative regulation of cysteine-type endopeptidase activity (GO:2000117),1/73,1,73,0.977485822602821,0.988008127300476,0,0,0.270991694104576,0.00617088491224622,PCID2
alpha,1,regulation of epithelial cell proliferation (GO:0050678),1/73,1,73,0.977485822602821,0.988008127300476,0,0,0.270991694104576,0.00617088491224622,MAGED1
alpha,1,lymphocyte differentiation (GO:0030098),1/74,1,74,0.978627963528785,0.988795526786227,0,0,0.267329644184244,0.00577531625119595,PTPN2
alpha,1,retinoid metabolic process (GO:0001523),1/76,1,76,0.980741498052819,0.990563464094149,0,0,0.260294653547816,0.00506178425531101,TTR
alpha,1,response to interleukin-1 (GO:0070555),1/77,1,77,0.981718606684347,0.991182708936403,0,0,0.256914203501741,0.00474021167912892,HYAL3
alpha,1,heart development (GO:0007507),3/150,3,150,0.983298488705995,0.992409853501269,0,0,0.395647873392681,0.00666372073529811,NIPBL;CACYBP;FBN1
alpha,1,activation of MAPK activity (GO:0000187),2/118,2,118,0.984210803314679,0.992747940089535,0,0,0.335294807959899,0.00533627516411575,GHR;ERP29
alpha,1,steroid biosynthetic process (GO:0006694),1/80,1,80,0.984362628807104,0.992747940089535,0,0,0.247279920870425,0.00389736018994772,CYP7B1
alpha,1,spindle assembly (GO:0051225),1/81,1,81,0.985156147694049,0.99318037399885,0,0,0.244227082341161,0.00365244649502036,NUMA1
alpha,1,positive regulation of B cell activation (GO:0050871),2/120,2,120,0.985566049798193,0.993225889563464,0,0,0.329706561160567,0.00479364755148338,IRS2;MIF
alpha,1,positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/84,1,84,0.98730333640945,0.994608577522358,0,0,0.235504686543262,0.00300926829719311,MIF
alpha,1,regulation of type I interferon production (GO:0032479),1/86,1,86,0.988559446809744,0.994986549470418,0,0,0.230027833367838,0.00264681521366077,PIN1
alpha,1,negative regulation of multicellular organismal process (GO:0051241),2/126,2,126,0.988986976685267,0.994986549470418,0,0,0.31400624872435,0.00347734150084601,ZNF706;SDHAF2
alpha,1,"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",2/126,2,126,0.988986976685267,0.994986549470418,0,0,0.31400624872435,0.00347734150084601,HTR1F;GCG
alpha,1,toll-like receptor signaling pathway (GO:0002224),1/87,1,87,0.98914013566523,0.994986549470418,0,0,0.22738383528315,0.00248286392090593,CD14
alpha,1,organic substance transport (GO:0071702),1/88,1,88,0.989691370975125,0.995173413281117,0,0,0.224799928064023,0.00232940629132117,ABCB9
alpha,1,positive regulation of response to external stimulus (GO:0032103),1/91,1,91,0.991182906948022,0.996305299231991,0,0,0.21738894142455,0.00192523855657468,STX3
alpha,1,adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),2/135,2,135,0.992684445885144,0.996498689475523,0,0,0.293072498809393,0.00215186841164432,HTR1F;GCG
alpha,1,skin development (GO:0043588),1/95,1,95,0.992841635376684,0.996498689475523,0,0,0.208235722838253,0.00149598805677704,PIP5K1A
alpha,1,phagocytosis (GO:0006909),2/136,2,136,0.993011111964065,0.996498689475523,0,0,0.290917553965206,0.00204032835964306,PIP5K1A;CD14
alpha,1,regulation of B cell activation (GO:0050864),1/96,1,96,0.993205083818057,0.996498689475523,0,0,0.206066600725354,0.00140498407857753,ZFP36L2
alpha,1,regulation of cytoskeleton organization (GO:0051493),1/96,1,96,0.993205083818057,0.996498689475523,0,0,0.206066600725354,0.00140498407857753,CDK2AP2
alpha,1,regulation of cytosolic calcium ion concentration (GO:0051480),2/138,2,138,0.993622162680055,0.996549962791082,0,0,0.286701357530928,0.0018343905780896,FIS1;TRPC4
alpha,1,response to lipid (GO:0033993),2/141,2,141,0.994441798354977,0.996760125028704,0,0,0.280601328647291,0.00156398928806818,JUND;NR1H2
alpha,1,cellular response to metal ion (GO:0071248),1/101,1,101,0.994763681655596,0.996760125028704,0,0,0.195865283857763,0.00102830760766295,SLC41A1
alpha,1,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),2/143,2,143,0.994929864057297,0.996760125028704,0,0,0.276676834540336,0.00140635739525189,CDH15;CBLN1
alpha,1,B cell receptor signaling pathway (GO:0050853),1/105,1,105,0.995749009351075,0.997213884686641,0,0,0.18840374923461,0.000802609730682785,PLEKHA1
alpha,1,regulation of response to external stimulus (GO:0032101),1/108,1,108,0.996364330825628,0.997463262072862,0,0,0.183170311755871,0.00066716017918083,USP14
alpha,1,negative regulation of cytokine production (GO:0001818),1/111,1,111,0.996890599288741,0.997623337693217,0,0,0.178219762789496,0.00055501999483635,PIN1
alpha,1,positive regulation of cytosolic calcium ion concentration (GO:0007204),1/134,1,134,0.999061976925594,0.999429009246286,0,0,0.147629803504732,0.000138545151595484,FIS1
alpha,1,peptidyl-serine phosphorylation (GO:0018105),1/146,1,146,0.999497479516313,0.999497479516313,0,0,0.135495847052288,6.81065525007113e-05,VRK3
alpha,2,glucocorticoid receptor signaling pathway (GO:0042921),4/6,4,6,4.05336904204477e-05,0.0511129836201846,0,0,16.1420500403551,163.25063869934,NCOA6;NEDD4;CALR;YWHAH
alpha,2,corticosteroid receptor signaling pathway (GO:0031958),4/6,4,6,4.05336904204477e-05,0.0511129836201846,0,0,16.1420500403551,163.25063869934,NCOA6;NEDD4;CALR;YWHAH
alpha,2,progesterone receptor signaling pathway (GO:0050847),4/7,4,7,9.14774986548744e-05,0.0717575545216148,0,0,13.836042891733,128.667139844557,YAP1;WBP2;NEDD4;PHB
alpha,2,termination of RNA polymerase II transcription (GO:0006369),11/69,11,69,0.000113810554356249,0.0717575545216148,0,0,3.86005544443275,35.0530681312738,LSM10;SLBP;NCBP1;POLDIP3;U2AF2;SRSF1;SSU72;RNPS1;SNRPD3;THOC5;SNRPB
alpha,2,mRNA metabolic process (GO:0016071),13/98,13,98,0.000194091906051073,0.097899957412161,0,0,3.21193852843801,27.4530127961538,SLBP;SF3B3;SF3A2;NCBP1;SRSF1;ELAVL4;EFTUD2;LSM10;U2AF2;SNRPD3;METTL16;SNRPB;HSPA1A
alpha,2,RNA splicing (GO:0008380),13/107,13,107,0.000465641903416975,0.167764125773944,0,0,2.94177547464416,22.5695769883088,SF3B3;SF3A2;DHX8;NCBP1;WDR83;EFTUD2;RRAGC;RNPS1;SNRPD3;SNRNP25;CDK12;TARDBP;SNRPB
alpha,2,"DNA-templated transcription, termination (GO:0006353)",13/107,13,107,0.000465641903416975,0.167764125773944,0,0,2.94177547464416,22.5695769883088,SLBP;NCBP1;POLDIP3;SRSF1;SSU72;THOC5;LSM10;TAF1B;U2AF2;RNPS1;SNRPD3;POLR3K;SNRPB
alpha,2,spliceosomal snRNP assembly (GO:0000387),7/38,7,38,0.000822344201537521,0.230439119586403,0,0,4.46030330062444,31.6831022029,USP4;DDX20;SNRPD3;GEMIN7;SNRPC;SNRPB;RBM22
alpha,2,response to UV (GO:0009411),12/99,12,99,0.000776726087337988,0.230439119586403,0,0,2.93491818915548,21.0152551051348,FEN1;TP53I13;DCUN1D3;POLD1;NEDD4;BCL3;SDF4;BMF;RPL26;UBE2A;MAP2K7;CDC25A
alpha,2,RNA export from nucleus (GO:0006405),13/120,13,120,0.00137979532794916,0.248560272649128,0,0,2.62308313155771,17.2751536219949,EIF5A;SLBP;RANBP1;NCBP1;POLDIP3;SRSF1;THOC5;SMG6;XPOT;U2AF2;RNPS1;NUP54;NUP62CL
alpha,2,positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),3/6,3,6,0.00127818388527248,0.247967673742861,0,0,12.1065375302663,80.6575671693407,YAP1;FOXA1;WBP2
alpha,2,mitochondrial ribosome assembly (GO:0061668),3/6,3,6,0.00127818388527248,0.247967673742861,0,0,12.1065375302663,80.6575671693407,DDX28;DHX30;FASTKD2
alpha,2,vacuolar transport (GO:0007034),6/30,6,30,0.00123603235845642,0.247967673742861,0,0,4.84261501210654,32.4254176286121,BECN1;VPS51;TMEM50A;VPS53;NEDD4;ATP6V0D1
alpha,2,nuclear export (GO:0051168),11/93,11,93,0.00155313052113505,0.261133011620174,0,0,2.86391210393397,18.5223019688433,EIF5A;RANBP1;NCBP1;POLDIP3;U2AF2;SRSF1;NUTF2;RNPS1;CALR;CCHCR1;THOC5
alpha,2,nucleic acid-templated transcription (GO:0097659),10/77,10,77,0.00122562303440993,0.247967673742861,0,0,3.14455520266658,21.0820602017548,GTF3C4;RRAGC;TAF1B;BCL3;E2F1;ARNT;BAZ2A;RNPS1;BAZ1A;ILF2
alpha,2,protein localization to nucleus (GO:0034504),11/97,11,97,0.00218435947493372,0.324056152693108,0,0,2.74581263573051,16.8220361545723,RANBP1;BCL3;LMNA;TAF8;NUTF2;CALR;NUP62CL;IPO7;GPN1;SUPT7L;TNPO3
alpha,2,positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),3/7,3,7,0.00216821890646282,0.324056152693108,0,0,10.3770321687997,63.6511507667209,CASP4;CPNE1;HSPA1A
alpha,2,chaperone mediated protein folding requiring cofactor (GO:0051085),5/25,5,25,0.0031665754185373,0.347221878502221,0,0,4.84261501210654,27.8697558579064,DNAJB1;HSPA5;HSPA1L;HSPA6;HSPA1A
alpha,2,cellular senescence (GO:0090398),5/25,5,25,0.0031665754185373,0.347221878502221,0,0,4.84261501210654,27.8697558579064,OPA1;CALR;MAPK14;HRAS;TBX3
alpha,2,nuclear import (GO:0051170),9/72,9,72,0.00277116282905993,0.347221878502221,0,0,3.02663438256659,17.8223010078306,RANBP1;DDX20;NUTF2;SNRPD3;GEMIN7;NUP62CL;IPO7;TNPO3;SNRPB
alpha,2,lysosomal transport (GO:0007041),9/73,9,73,0.00304768218820336,0.347221878502221,0,0,2.98517363759992,17.2942270854776,VPS18;VPS51;HOOK2;HGS;LARS;VPS53;NEDD4;VPS35;NAGPA
alpha,2,histone mRNA metabolic process (GO:0008334),5/25,5,25,0.0031665754185373,0.347221878502221,0,0,4.84261501210654,27.8697558579064,LSM10;SLBP;NCBP1;SNRPD3;SNRPB
alpha,2,nucleocytoplasmic transport (GO:0006913),7/47,7,47,0.00297197922740088,0.347221878502221,0,0,3.60620266858997,20.9827881052487,EIF5A;NCBP1;DDX20;NUTF2;SNRPD3;GEMIN7;SNRPB
alpha,2,regulation of cell cycle process (GO:0010564),10/91,10,91,0.00428833837616645,0.450632891028824,0,0,2.66077747917942,14.5061755207801,CDC42;BECN1;PLK3;AHCTF1;YTHDF2;SPAG5;AKT2;RPRD1B;RAB11FIP3;MYO19
alpha,2,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),3/9,3,9,0.0048904133349518,0.491123846659489,0,0,8.07102502017756,42.9417147093827,PTPN1;HGS;NEDD4
alpha,2,protein export from nucleus (GO:0006611),5/29,5,29,0.00617743149129437,0.491123846659489,0,0,4.17466811388495,21.2359218093026,EIF5A;NUTF2;CALR;CCHCR1;NUP62CL
alpha,2,protein targeting to vacuole (GO:0006623),5/28,5,28,0.00528893875077369,0.491123846659489,0,0,4.32376340366655,22.6657630035374,LARS;TMEM50A;HGS;NEDD4;NAGPA
alpha,2,outer dynein arm assembly (GO:0036158),4/18,4,18,0.0055600049948496,0.491123846659489,0,0,5.38068334678504,27.9373487886242,CCDC103;DNAAF1;TMEM141;DNAL1
alpha,2,RNA transport (GO:0050658),9/81,9,81,0.00612230651792359,0.491123846659489,0,0,2.69034167339252,13.7094871440582,SLBP;RANBP1;NCBP1;POLDIP3;U2AF2;SRSF1;RNPS1;THOC5;TGFBR2
alpha,2,protein targeting to lysosome (GO:0006622),4/19,4,19,0.00681575520740766,0.491123846659489,0,0,5.09748948642793,25.4289201198227,HGS;LARS;NEDD4;NAGPA
alpha,2,maintenance of protein localization in organelle (GO:0072595),4/18,4,18,0.0055600049948496,0.491123846659489,0,0,5.38068334678504,27.9373487886242,HSPA5;BCL3;TAF8;SUPT7L
alpha,2,positive regulation of chromosome organization (GO:2001252),4/19,4,19,0.00681575520740766,0.491123846659489,0,0,5.09748948642793,25.4289201198227,BECN1;FEN1;RTEL1;DDX11
alpha,2,regulation of DNA binding (GO:0051101),7/53,7,53,0.00588671985375452,0.491123846659489,0,0,3.19795330988168,16.4216704104129,DOT1L;CEBPG;BCL3;CPNE1;E2F1;ID4;RSF1
alpha,2,mitotic G1/S transition checkpoint (GO:0044819),3/10,3,10,0.00677341305666958,0.491123846659489,0,0,7.26392251815981,36.2814782675422,PLK3;RPS27L;FBXO31
alpha,2,positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),3/10,3,10,0.00677341305666958,0.491123846659489,0,0,7.26392251815981,36.2814782675422,YAP1;FOXA1;WBP2
alpha,2,regulation of macroautophagy (GO:0016241),11/117,11,117,0.00910057845132185,0.502861763343165,0,0,2.27644295440906,10.6979554056006,ATP6V1G2;MTMR3;PRKAA2;RRAGC;NEDD4;TBC1D25;TBC1D14;VPS35;VPS26A;ATP6V0D1;ATP6V0A1
alpha,2,liver development (GO:0001889),5/32,5,32,0.00946298247762019,0.502861763343165,0,0,3.78329297820823,17.6315362936235,CEBPB;DNAAF1;CEBPG;RARA;MET
alpha,2,embryonic hemopoiesis (GO:0035162),3/11,3,11,0.00903025992426145,0.502861763343165,0,0,6.60356592559982,31.0841346738439,KITLG;THOC5;TGFBR2
alpha,2,IRE1-mediated unfolded protein response (GO:0036498),7/58,7,58,0.00962252128603085,0.502861763343165,0,0,2.92226767971946,13.5699852738123,ACADVL;HSPA5;FKBP14;DDX11;LMNA;SRPRB;ATP6V0D1
alpha,2,regulation of stress fiber assembly (GO:0051492),7/61,7,61,0.0125615745799442,0.502861763343165,0,0,2.77854959711031,12.1620248990118,CDC42;ARHGEF10;FHOD1;NF2;PFN1;MET;PPM1F
alpha,2,'de novo' posttranslational protein folding (GO:0051084),5/31,5,31,0.00825915979475001,0.502861763343165,0,0,3.90533468718269,18.7316738904436,DNAJB1;HSPA1L;HSPA5;HSPA6;HSPA1A
alpha,2,cofactor biosynthetic process (GO:0051188),5/32,5,32,0.00946298247762019,0.502861763343165,0,0,3.78329297820823,17.6315362936235,NFU1;SLC25A16;NFS1;PANK1;ISCU
alpha,2,positive regulation of chromosome segregation (GO:0051984),3/11,3,11,0.00903025992426145,0.502861763343165,0,0,6.60356592559982,31.0841346738439,FEN1;DDX11;CDC6
alpha,2,RNA secondary structure unwinding (GO:0010501),6/47,6,47,0.0123604547131052,0.502861763343165,0,0,3.09103085879141,13.5796807126159,DDX28;DDX3Y;DDX49;DDX55;DDX20;DDX31
alpha,2,nucleosome assembly (GO:0006334),7/61,7,61,0.0125615745799442,0.502861763343165,0,0,2.77854959711031,12.1620248990118,HIST1H2BN;NAA60;CHAF1A;H2AFX;HAT1;RSF1;HIST3H2BB
alpha,2,mRNA export from nucleus (GO:0006406),10/106,10,106,0.0122820221910188,0.502861763343165,0,0,2.2842523642012,10.0498394085719,EIF5A;SLBP;NCBP1;POLDIP3;U2AF2;SRSF1;RNPS1;NUP54;THOC5;SMG6
alpha,2,positive regulation of actin filament bundle assembly (GO:0032233),6/45,6,45,0.0100478877402019,0.502861763343165,0,0,3.22841000807102,14.8519542911097,CDC42;ARHGEF10;FHOD1;NF2;PFN1;PPM1F
alpha,2,ribosomal large subunit assembly (GO:0000027),5/31,5,31,0.00825915979475001,0.502861763343165,0,0,3.90533468718269,18.7316738904436,DDX28;DHX30;FASTKD2;RPL23A;RPL6
alpha,2,regulation of trophoblast cell migration (GO:1901163),3/11,3,11,0.00903025992426145,0.502861763343165,0,0,6.60356592559982,31.0841346738439,SMURF2;CALR;ACVR1B
alpha,2,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),10/101,10,101,0.00888967624439447,0.502861763343165,0,0,2.39733416440918,11.3222847747054,EIF5A;SLBP;NCBP1;POLDIP3;U2AF2;SRSF1;RNPS1;NUP54;THOC5;SMG6
alpha,2,translational elongation (GO:0006414),10/106,10,106,0.0122820221910188,0.502861763343165,0,0,2.2842523642012,10.0498394085719,EFTUD2;MRPL41;MRPL42;MRPS23;MRPL27;MRPL34;MRPS7;MRPL13;ZNF598;MRPL10
alpha,2,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),8/71,8,71,0.00875920532677436,0.502861763343165,0,0,2.72823380963749,12.9254171654208,RMND5B;SPSB1;BTBD1;SMURF2;NEDD4;SPOP;KLHL11;FBXO7
alpha,2,intra-Golgi vesicle-mediated transport (GO:0006891),5/34,5,34,0.0122216820971434,0.502861763343165,0,0,3.56074633243128,15.6834627672495,COG8;COG4;COG2;COG1;COPE
alpha,2,positive regulation of RNA splicing (GO:0033120),4/22,4,22,0.0116629792326912,0.502861763343165,0,0,4.40237728373322,19.5964588240787,NCBP1;U2AF2;HSPA1A;RBM22
alpha,2,mRNA 3'-end processing (GO:0031124),8/75,8,75,0.0120392840755871,0.502861763343165,0,0,2.58272800645682,11.4145738254204,SLBP;NCBP1;POLDIP3;U2AF2;SRSF1;SSU72;RNPS1;THOC5
alpha,2,negative regulation of DNA binding (GO:0043392),5/35,5,35,0.013785997602897,0.518929641112032,0,0,3.45901072293324,14.8187543009277,MAD2L2;E2F1;CPNE1;ID4;RSF1
alpha,2,axonemal dynein complex assembly (GO:0070286),5/34,5,34,0.0122216820971434,0.502861763343165,0,0,3.56074633243128,15.6834627672495,CCDC103;DNAAF1;PIH1D3;TMEM141;DNAL1
alpha,2,protein import into nucleus (GO:0006606),10/104,10,104,0.0108248003957456,0.502861763343165,0,0,2.32818029428199,10.5371471513682,RANBP1;BCL3;NUTF2;NUP54;NUP62CL;IPO7;GDF5;GPN1;TNPO3;RBM22
alpha,2,positive regulation of cellular amide metabolic process (GO:0034250),7/62,7,62,0.0136708896094472,0.518929641112032,0,0,2.73373428102788,11.7345176404103,EPHA4;PLK3;RPS6KB1;POLDIP3;BCL3;RPS27L;RPL26
alpha,2,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),7/59,7,59,0.0105395804943119,0.502861763343165,0,0,2.87273771904625,13.0784761216883,CDC42;CUX1;ARHGDIA;PLXNA2;CIB1;CALR;TRIOBP
alpha,2,cellular response to unfolded protein (GO:0034620),4/22,4,22,0.0116629792326912,0.502861763343165,0,0,4.40237728373322,19.5964588240787,HSPA5;HSPA1L;HSPA6;HSPA1A
alpha,2,regulation of telomere capping (GO:1904353),4/23,4,23,0.0136663059202384,0.518929641112032,0,0,4.21096957574482,18.0769424039349,RTEL1;MAPK1;MAP2K7;SMG6
alpha,2,positive regulation of erythrocyte differentiation (GO:0045648),4/22,4,22,0.0116629792326912,0.502861763343165,0,0,4.40237728373322,19.5964588240787,ARNT;ACVR1B;MAPK14;HSPA1A
alpha,2,cellular response to heat (GO:0034605),6/48,6,48,0.0136465489586731,0.518929641112032,0,0,3.02663438256659,12.9971810316491,YWHAE;HSPA5;HSPA1L;HSPA6;IER5;HSPA1A
alpha,2,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),4/22,4,22,0.0116629792326912,0.502861763343165,0,0,4.40237728373322,19.5964588240787,PTPN1;HGS;NEDD4;ARNT
alpha,2,mRNA transport (GO:0051028),10/105,10,105,0.0115360254936203,0.502861763343165,0,0,2.30600714862216,10.2900507056922,EIF5A;SLBP;NCBP1;POLDIP3;U2AF2;SRSF1;RNPS1;NUP54;THOC5;SMG6
alpha,2,regulation of protein metabolic process (GO:0051246),7/60,7,60,0.0115185294288669,0.502861763343165,0,0,2.82485875706215,12.609599676856,BTBD1;HGS;SPOP;KLHL11;VPS35;KLF4;SSH1
alpha,2,double-strand break repair (GO:0006302),12/142,12,142,0.0147708927062038,0.547826344191853,0,0,2.04617535722811,8.62482708542242,MAD2L2;FEN1;RAD51D;PAXIP1;EME1;ACTR5;H2AFX;CIB1;TRIP13;ORAOV1;NHEJ1;FAN1
alpha,2,response to ionizing radiation (GO:0010212),8/78,8,78,0.0150342830555328,0.549513940087734,0,0,2.48339231390079,10.4238459023067,RAD51D;PAXIP1;BRAT1;DCUN1D3;H2AFX;MAPK14;NHEJ1;CLK2
alpha,2,cotranslational protein targeting to membrane (GO:0006613),9/94,9,94,0.01560139513306,0.55417913416306,0,0,2.31827314409356,9.64493185154578,RPS28;ARL6IP1;RPL31;RPL27A;RPL23A;RPL26;SRP68;RPL8;RPL6
alpha,2,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),5/36,5,36,0.0154795328309529,0.55417913416306,0,0,3.36292709174065,14.0174757538168,RTEL1;EME1;POLD1;DDX11;BOD1L1
alpha,2,nucleosome organization (GO:0034728),8/80,8,80,0.017309744306776,0.56823625971434,0,0,2.42130750605327,9.82199922837741,HIST1H2BN;NAA60;SMARCD2;CHAF1A;HIST3H2A;H2AFX;RSF1;HIST3H2BB
alpha,2,centromere complex assembly (GO:0034508),5/37,5,37,0.0173064099990002,0.56823625971434,0,0,3.27203717034226,13.2736022705668,CENPT;CENPF;CENPL;RSF1;CENPQ
alpha,2,mRNA splice site selection (GO:0006376),4/25,4,25,0.0182960577537903,0.56823625971434,0,0,3.87409200968523,15.5005120218183,SF3A2;SRSF1;SNRPC;SF1
alpha,2,endoplasmic reticulum membrane organization (GO:0090158),2/6,2,6,0.022874663733867,0.56823625971434,0,0,8.07102502017756,30.4901159651931,ARL6IP1;ATL2
alpha,2,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",10/113,10,113,0.0185617046303844,0.56823625971434,0,0,2.14275000535688,8.54240440449122,RPS28;NCBP1;RPL31;RPL27A;RNPS1;RPL23A;RPL26;RPL8;RPL6;SMG6
alpha,2,endosome organization (GO:0007032),5/37,5,37,0.0173064099990002,0.56823625971434,0,0,3.27203717034226,13.2736022705668,SNX3;VPS18;HOOK2;SQSTM1;PLEKHJ1
alpha,2,regulation of cell division (GO:0051302),7/66,7,66,0.0188128881971158,0.56823625971434,0,0,2.56805341551104,10.203423476177,BECN1;PLK3;AHCTF1;ORC6;CIB1;RAB11FIP3;MYO19
alpha,2,positive regulation of trophoblast cell migration (GO:1901165),2/6,2,6,0.022874663733867,0.56823625971434,0,0,8.07102502017756,30.4901159651931,SMURF2;ACVR1B
alpha,2,regulation of synapse organization (GO:0050807),3/14,3,14,0.0181664355016989,0.56823625971434,0,0,5.18851608439986,20.7965042757132,EPHA4;NEDD4;VPS35
alpha,2,response to gamma radiation (GO:0010332),4/27,4,27,0.0237926316896571,0.56823625971434,0,0,3.58712223119003,13.4100236359431,YAP1;DCUN1D3;RPL26;HRAS
alpha,2,mRNA 5'-splice site recognition (GO:0000395),2/6,2,6,0.022874663733867,0.56823625971434,0,0,8.07102502017756,30.4901159651931,SRSF1;SNRPC
alpha,2,mitotic DNA damage checkpoint (GO:0044773),5/40,5,40,0.0236243064002494,0.56823625971434,0,0,3.02663438256659,11.3361960192279,EME1;TAOK1;RPS27L;ORAOV1;FBXO31
alpha,2,regulation of neuron differentiation (GO:0045664),8/85,8,85,0.0240629422828387,0.56823625971434,0,0,2.27887765275602,8.49356453272765,BRINP2;BMP2;CPNE1;ID4;TCF4;CALR;FBXO7;YWHAH
alpha,2,activation of MAPK activity (GO:0000187),10/118,10,118,0.0243075857702974,0.56823625971434,0,0,2.05195551360446,7.62705053091041,BMP2;MAPKAPK3;TAOK1;MADD;PEA15;MAPK1;UBE2V1;MAP2K7;MAPK14;MAPK8IP3
alpha,2,positive regulation of stress fiber assembly (GO:0051496),5/38,5,38,0.0192704882201716,0.56823625971434,0,0,3.18593092901746,12.5818161753308,CDC42;ARHGEF10;FHOD1;NF2;PPM1F
alpha,2,endoplasmic reticulum tubular network organization (GO:0071786),3/14,3,14,0.0181664355016989,0.56823625971434,0,0,5.18851608439986,20.7965042757132,ARL6IP1;ATL2;TMEM170A
alpha,2,DNA replication-independent nucleosome assembly (GO:0006336),5/40,5,40,0.0236243064002494,0.56823625971434,0,0,3.02663438256659,11.3361960192279,CENPT;HAT1;CENPL;RSF1;CENPQ
alpha,2,positive regulation of T-helper 2 cell differentiation (GO:0045630),2/6,2,6,0.022874663733867,0.56823625971434,0,0,8.07102502017756,30.4901159651931,RARA;PRKCZ
alpha,2,cytoplasmic sequestering of protein (GO:0051220),3/15,3,15,0.0220237786206989,0.56823625971434,0,0,4.84261501210654,18.4776395298902,NFKBIL1;KEAP1;NFKBIE
alpha,2,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),2/6,2,6,0.022874663733867,0.56823625971434,0,0,8.07102502017756,30.4901159651931,STX4;CALR
alpha,2,G1/S transition of mitotic cell cycle (GO:0000082),9/106,9,106,0.031318334694803,0.56823625971434,0,0,2.05582712778108,7.12046329650382,PLK3;KLF11;RANBP1;ORC6;RPS6KB1;E2F1;CDC6;ACVR1B;CDC25A
alpha,2,positive regulation of interleukin-4 production (GO:0032753),3/15,3,15,0.0220237786206989,0.56823625971434,0,0,4.84261501210654,18.4776395298902,CEBPB;RARA;PRKCZ
alpha,2,mRNA 3'-splice site recognition (GO:0000389),2/6,2,6,0.022874663733867,0.56823625971434,0,0,8.07102502017756,30.4901159651931,SF3A2;SF1
alpha,2,regulation of ion transmembrane transporter activity (GO:0032412),5/43,5,43,0.0312643437676092,0.56823625971434,0,0,2.81547384424799,9.75639677781623,YWHAE;FXYD2;NEDD4;UTRN;YWHAH
alpha,2,membrane invagination (GO:0010324),2/7,2,7,0.03115726193457,0.56823625971434,0,0,6.91802144586648,23.9965958699633,SNX3;HGS
alpha,2,cellular response to virus (GO:0098586),3/15,3,15,0.0220237786206989,0.56823625971434,0,0,4.84261501210654,18.4776395298902,RRP1B;MAPK14;LGALS8
alpha,2,protein targeting to ER (GO:0045047),9/98,9,98,0.0199889536977424,0.56823625971434,0,0,2.22364975045708,8.70019747445492,RPS28;RPL31;RPL27A;PMM2;RPL23A;RPL26;SRP68;RPL8;RPL6
alpha,2,protein localization to nuclear envelope (GO:0090435),2/6,2,6,0.022874663733867,0.56823625971434,0,0,8.07102502017756,30.4901159651931,NUP54;NUTF2
alpha,2,glyoxylate metabolic process (GO:0046487),2/7,2,7,0.03115726193457,0.56823625971434,0,0,6.91802144586648,23.9965958699633,GRHPR;GOT2
alpha,2,regulation of interleukin-4 production (GO:0032673),3/15,3,15,0.0220237786206989,0.56823625971434,0,0,4.84261501210654,18.4776395298902,CEBPB;RARA;PRKCZ
alpha,2,regulation of establishment of planar polarity (GO:0090175),8/90,8,90,0.032476235788144,0.576737518554214,0,0,2.15227333871402,7.37637161932088,CDC42;SMURF2;PSMD13;PSME3;FZD7;PSMD3;PFN1;AP2M1
alpha,2,cellular response to topologically incorrect protein (GO:0035967),4/28,4,28,0.0268765857002251,0.56823625971434,0,0,3.45901072293324,12.5095115582007,HSPA5;HSPA1L;HSPA6;HSPA1A
alpha,2,cytoplasmic translation (GO:0002181),6/55,6,55,0.0253380712759963,0.56823625971434,0,0,2.64142637023993,9.70842321144155,RPS28;RPL31;RPL27A;RPL26;RPL8;RPL6
alpha,2,negative regulation of cardiac muscle tissue development (GO:0055026),2/7,2,7,0.03115726193457,0.56823625971434,0,0,6.91802144586648,23.9965958699633,BMP2;FZD7
alpha,2,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),8/90,8,90,0.032476235788144,0.576737518554214,0,0,2.15227333871402,7.37637161932088,RPS28;RPL31;RPL27A;RPL23A;RPL26;SRP68;RPL8;RPL6
alpha,2,protein N-linked glycosylation (GO:0006487),7/74,7,74,0.032876940141607,0.576737518554214,0,0,2.29042601923958,7.82176769242164,MCFD2;ALG6;TMEM258;DERL3;PMM2;MGAT2;ST6GALNAC4
alpha,2,protein maturation by iron-sulfur cluster transfer (GO:0097428),2/7,2,7,0.03115726193457,0.56823625971434,0,0,6.91802144586648,23.9965958699633,NFU1;ISCU
alpha,2,negative regulation of striated muscle cell differentiation (GO:0051154),3/16,3,16,0.0262912740821309,0.56823625971434,0,0,4.53995157384988,16.5186963323257,HDAC5;BMP2;FZD7
alpha,2,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),4/28,4,28,0.0268765857002251,0.56823625971434,0,0,3.45901072293324,12.5095115582007,CDC42;CIB1;CALR;TRIOBP
alpha,2,mitotic sister chromatid cohesion (GO:0007064),3/15,3,15,0.0220237786206989,0.56823625971434,0,0,4.84261501210654,18.4776395298902,MAU2;CHTF8;BOD1
alpha,2,CENP-A containing chromatin organization (GO:0061641),4/31,4,31,0.0375039464880615,0.576737518554214,0,0,3.12426774974615,10.2579367706364,CENPT;CENPL;RSF1;CENPQ
alpha,2,mitochondrial translational termination (GO:0070126),8/90,8,90,0.032476235788144,0.576737518554214,0,0,2.15227333871402,7.37637161932088,MRPL41;MRPL42;MRPS23;MRPL27;MRPL34;MRPS7;MRPL13;MRPL10
alpha,2,tRNA aminoacylation (GO:0043039),5/41,5,41,0.0260203615141289,0.56823625971434,0,0,2.95281403177228,10.7744519940122,YARS;PPA2;LARS;RARS;DARS2
alpha,2,positive regulation of interleukin-5 production (GO:0032754),2/7,2,7,0.03115726193457,0.56823625971434,0,0,6.91802144586648,23.9965958699633,RARA;PRKCZ
alpha,2,response to alcohol (GO:0097305),4/26,4,26,0.0209336783087802,0.56823625971434,0,0,3.72508847085118,14.4026672177057,ABCA2;GOT2;SDF4;TGFBR2
alpha,2,signal transduction in response to DNA damage (GO:0042770),4/26,4,26,0.0209336783087802,0.56823625971434,0,0,3.72508847085118,14.4026672177057,MAD2L2;PAXIP1;BCL3;MAPK14
alpha,2,mitochondrion disassembly (GO:0061726),5/39,5,39,0.021375352822859,0.56823625971434,0,0,3.10424039237599,11.9374084496274,BECN1;MAP1LC3B;WDR45B;FBXO7;SQSTM1
alpha,2,positive regulation of cell-substrate adhesion (GO:0010811),6/53,6,53,0.0214912001528899,0.56823625971434,0,0,2.74110283704144,10.5261411380522,CDC42;CIB1;CALR;UTRN;TRIOBP;PPM1F
alpha,2,cellular response to UV (GO:0034644),7/68,7,68,0.021834769401226,0.56823625971434,0,0,2.49252243270189,9.53203303357455,HIST3H2A;ACTR5;POLD1;NEDD4;BMF;RPL26;CDC25A
alpha,2,nuclear pore organization (GO:0006999),3/15,3,15,0.0220237786206989,0.56823625971434,0,0,4.84261501210654,18.4776395298902,AHCTF1;NUP54;TMEM170A
alpha,2,selective autophagy (GO:0061912),3/15,3,15,0.0220237786206989,0.56823625971434,0,0,4.84261501210654,18.4776395298902,BECN1;LGALS8;SQSTM1
alpha,2,maintenance of protein location in nucleus (GO:0051457),3/15,3,15,0.0220237786206989,0.56823625971434,0,0,4.84261501210654,18.4776395298902,BCL3;TAF8;SUPT7L
alpha,2,autophagy of mitochondrion (GO:0000422),5/41,5,41,0.0260203615141289,0.56823625971434,0,0,2.95281403177228,10.7744519940122,BECN1;MAP1LC3B;WDR45B;FBXO7;SQSTM1
alpha,2,cytoplasmic sequestering of transcription factor (GO:0042994),3/16,3,16,0.0262912740821309,0.56823625971434,0,0,4.53995157384988,16.5186963323257,NFKBIL1;KEAP1;NFKBIE
alpha,2,endocytic recycling (GO:0032456),4/28,4,28,0.0268765857002251,0.56823625971434,0,0,3.45901072293324,12.5095115582007,ARL4C;VPS51;VPS53;RAB11FIP3
alpha,2,spliceosomal complex assembly (GO:0000245),5/42,5,42,0.0285662350011791,0.56823625971434,0,0,2.8825089357777,10.2488465726139,SF3A2;NCBP1;SRSF1;SNRPD3;SF1
alpha,2,mitochondrial translational elongation (GO:0070125),8/88,8,88,0.0289013812036623,0.56823625971434,0,0,2.20118864186661,7.80071735085078,MRPL41;MRPL42;MRPS23;MRPL27;MRPL34;MRPS7;MRPL13;MRPL10
alpha,2,Golgi organization (GO:0007030),10/122,10,122,0.0297498203872335,0.56823625971434,0,0,1.98467828365022,6.976009574907,CDC42;PLK3;NSFL1C;TBC1D20;VPS51;COG4;ATL2;COG2;COG1;TMED2
alpha,2,lytic vacuole organization (GO:0080171),4/29,4,29,0.0301884555950229,0.56823625971434,0,0,3.33973449110796,11.6900582541494,VPS18;HOOK2;HPS4;NAGPA
alpha,2,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",8/89,8,89,0.0306530944512831,0.56823625971434,0,0,2.17645618521642,7.58499694927437,CDC42;SMURF2;PSMD13;PSME3;FZD7;PSMD3;PFN1;AP2M1
alpha,2,regulation of fat cell differentiation (GO:0045598),7/73,7,73,0.0308213183924678,0.56823625971434,0,0,2.32180171813327,8.07882208691018,CEBPB;BMP2;CCDC85B;E2F1;TAF8;AAMDC;PPARD
alpha,2,"mRNA cis splicing, via spliceosome (GO:0045292)",3/17,3,17,0.0309675587730286,0.56823625971434,0,0,4.27289559891753,14.8475222061409,SRSF1;SNRPC;RBM22
alpha,2,negative regulation of interleukin-8 production (GO:0032717),3/17,3,17,0.0309675587730286,0.56823625971434,0,0,4.27289559891753,14.8475222061409,BCL3;KLF4;CACTIN
alpha,2,spindle assembly checkpoint (GO:0071173),3/17,3,17,0.0309675587730286,0.56823625971434,0,0,4.27289559891753,14.8475222061409,MAD2L2;CENPF;TRIP13
alpha,2,regulation of lamellipodium organization (GO:1902743),3/17,3,17,0.0309675587730286,0.56823625971434,0,0,4.27289559891753,14.8475222061409,CDC42;SSH2;SSH1
alpha,2,positive regulation of telomere capping (GO:1904355),3/17,3,17,0.0309675587730286,0.56823625971434,0,0,4.27289559891753,14.8475222061409,RTEL1;MAPK1;MAP2K7
alpha,2,mitotic spindle assembly checkpoint (GO:0007094),3/17,3,17,0.0309675587730286,0.56823625971434,0,0,4.27289559891753,14.8475222061409,MAD2L2;CENPF;TRIP13
alpha,2,mitotic spindle checkpoint (GO:0071174),3/17,3,17,0.0309675587730286,0.56823625971434,0,0,4.27289559891753,14.8475222061409,MAD2L2;CENPF;TRIP13
alpha,2,cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),2/7,2,7,0.03115726193457,0.56823625971434,0,0,6.91802144586648,23.9965958699633,DSP;CXADR
alpha,2,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),2/7,2,7,0.03115726193457,0.56823625971434,0,0,6.91802144586648,23.9965958699633,SLC35F6;HSPA1A
alpha,2,negative regulation of cardiac muscle cell differentiation (GO:2000726),2/7,2,7,0.03115726193457,0.56823625971434,0,0,6.91802144586648,23.9965958699633,BMP2;FZD7
alpha,2,determination of digestive tract left/right asymmetry (GO:0071907),2/7,2,7,0.03115726193457,0.56823625971434,0,0,6.91802144586648,23.9965958699633,CCDC103;DNAAF1
alpha,2,negative regulation of cardiocyte differentiation (GO:1905208),2/7,2,7,0.03115726193457,0.56823625971434,0,0,6.91802144586648,23.9965958699633,BMP2;FZD7
alpha,2,positive regulation of myeloid cell differentiation (GO:0045639),4/30,4,30,0.0337304210779116,0.576737518554214,0,0,3.22841000807102,10.9422280749189,ARNT;ACVR1B;MAPK14;HSPA1A
alpha,2,negative regulation of ERBB signaling pathway (GO:1901185),5/44,5,44,0.0341168020613458,0.576737518554214,0,0,2.75148580233326,9.29442352787819,CDC42;ERBB3;HGS;NRG4;PTPN12
alpha,2,negative regulation of protein metabolic process (GO:0051248),5/44,5,44,0.0341168020613458,0.576737518554214,0,0,2.75148580233326,9.29442352787819,SNX3;MAD2L2;SF3B3;PHB;ASB1
alpha,2,response to unfolded protein (GO:0006986),5/44,5,44,0.0341168020613458,0.576737518554214,0,0,2.75148580233326,9.29442352787819,DNAJB1;HSPA5;HSPA1L;HSPA6;HSPA1A
alpha,2,mitochondrial translation (GO:0032543),9/108,9,108,0.0347322676814987,0.576737518554214,0,0,2.01775625504439,6.77983478562668,MRPL41;MRPL42;NDUFA7;MRPS23;MRPL27;MRPL34;MRPS7;MRPL13;MRPL10
alpha,2,protein dephosphorylation (GO:0006470),10/126,10,126,0.036002424646581,0.576737518554214,0,0,1.9216726238518,6.3879645480228,PTPN1;MTMR3;SSU72;RPRD1B;PTPN11;PTPN12;SSH2;RPAP2;PPM1F;SSH1
alpha,2,membrane lipid metabolic process (GO:0006643),3/18,3,18,0.036049078050348,0.576737518554214,0,0,4.03551251008878,13.4094995551697,KDELC2;TEX2;ST6GALNAC4
alpha,2,iron-sulfur cluster assembly (GO:0016226),3/18,3,18,0.036049078050348,0.576737518554214,0,0,4.03551251008878,13.4094995551697,NFU1;NFS1;ISCU
alpha,2,nuclear envelope reassembly (GO:0031468),3/18,3,18,0.036049078050348,0.576737518554214,0,0,4.03551251008878,13.4094995551697,NSFL1C;LMNA;BANF1
alpha,2,cellular response to gamma radiation (GO:0071480),3/18,3,18,0.036049078050348,0.576737518554214,0,0,4.03551251008878,13.4094995551697,YAP1;RPL26;HRAS
alpha,2,negative regulation of protein dephosphorylation (GO:0035308),3/18,3,18,0.036049078050348,0.576737518554214,0,0,4.03551251008878,13.4094995551697,YWHAE;BOD1;ARPP19
alpha,2,regulation of protein catabolic process (GO:0042176),8/92,8,92,0.0363411907106758,0.576737518554214,0,0,2.10548478787241,6.97926824025586,SNX3;MAD2L2;SF3B3;SMURF2;HGS;NEDD4;PHB;OAZ2
alpha,2,protein-DNA complex assembly (GO:0065004),8/92,8,92,0.0363411907106758,0.576737518554214,0,0,2.10548478787241,6.97926824025586,HIST1H2BN;NAA60;RAD51D;CHAF1A;H2AFX;RSF1;HIST3H2BB;TCF4
alpha,2,positive regulation of intracellular transport (GO:0032388),5/45,5,45,0.0371254200679333,0.576737518554214,0,0,2.69034167339252,8.8605148425131,PLK3;SPAG5;TBC1D20;NEDD4;OAZ2
alpha,2,metaphase plate congression (GO:0051310),5/45,5,45,0.0371254200679333,0.576737518554214,0,0,2.69034167339252,8.8605148425131,BECN1;CENPF;BOD1;CHMP1A;CENPQ
alpha,2,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),4/31,4,31,0.0375039464880615,0.576737518554214,0,0,3.12426774974615,10.2579367706364,YWHAE;E2F1;BMF;YWHAH
alpha,2,replication fork processing (GO:0031297),4/31,4,31,0.0375039464880615,0.576737518554214,0,0,3.12426774974615,10.2579367706364,RTEL1;EME1;DDX11;BOD1L1
alpha,2,protein localization to lysosome (GO:0061462),4/31,4,31,0.0375039464880615,0.576737518554214,0,0,3.12426774974615,10.2579367706364,LARS;HGS;NEDD4;NAGPA
alpha,2,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),4/31,4,31,0.0375039464880615,0.576737518554214,0,0,3.12426774974615,10.2579367706364,YWHAE;E2F1;BMF;YWHAH
alpha,2,CENP-A containing nucleosome assembly (GO:0034080),4/31,4,31,0.0375039464880615,0.576737518554214,0,0,3.12426774974615,10.2579367706364,CENPT;CENPL;RSF1;CENPQ
alpha,2,cellular protein complex assembly (GO:0043623),11/145,11,145,0.0381527196326535,0.5792294941421,0,0,1.83685397010938,5.99945572263985,CENPT;AHCTF1;CENPF;PSMD13;DNAAF1;COG4;CCDC103;PIH1D3;TBCD;TMEM170A;HSPA1A
alpha,2,"regulation of mRNA splicing, via spliceosome (GO:0048024)",6/61,6,61,0.0395355819485737,0.5792294941421,0,0,2.38161394038026,7.69393292676979,ZC3H10;NCBP1;U2AF2;EFCAB5;RNPS1;METTL16
alpha,2,peptidyl-serine phosphorylation (GO:0018105),11/146,11,146,0.0397922723503802,0.5792294941421,0,0,1.82427277853328,5.88160602732068,PNCK;PRKAA2;MAPKAPK3;AKT2;DAPK2;MAST2;MAPK1;MAPK14;PRKCZ;PSKH1;TGFBR2
alpha,2,protein insertion into mitochondrial membrane (GO:0051204),2/8,2,8,0.0404220424143575,0.5792294941421,0,0,6.05326876513317,19.4211866736512,COX18;BMF
alpha,2,histone H2A-K119 monoubiquitination (GO:0036353),2/8,2,8,0.0404220424143575,0.5792294941421,0,0,6.05326876513317,19.4211866736512,PCGF2;TRIM37
alpha,2,late endosome to vacuole transport (GO:0045324),2/8,2,8,0.0404220424143575,0.5792294941421,0,0,6.05326876513317,19.4211866736512,BECN1;TMEM50A
alpha,2,4-hydroxyproline metabolic process (GO:0019471),2/8,2,8,0.0404220424143575,0.5792294941421,0,0,6.05326876513317,19.4211866736512,GOT2;P4HB
alpha,2,regulation of PERK-mediated unfolded protein response (GO:1903897),2/8,2,8,0.0404220424143575,0.5792294941421,0,0,6.05326876513317,19.4211866736512,PTPN1;HSPA5
alpha,2,positive regulation of IRE1-mediated unfolded protein response (GO:1903896),2/8,2,8,0.0404220424143575,0.5792294941421,0,0,6.05326876513317,19.4211866736512,PTPN1;HSPA1A
alpha,2,kinetochore assembly (GO:0051382),2/8,2,8,0.0404220424143575,0.5792294941421,0,0,6.05326876513317,19.4211866736512,CENPT;CENPF
alpha,2,fatty acid alpha-oxidation (GO:0001561),2/8,2,8,0.0404220424143575,0.5792294941421,0,0,6.05326876513317,19.4211866736512,ALDH3A2;HACL1
alpha,2,regulation of T-helper 2 cell differentiation (GO:0045628),2/8,2,8,0.0404220424143575,0.5792294941421,0,0,6.05326876513317,19.4211866736512,RARA;PRKCZ
alpha,2,negative regulation of cell-cell adhesion (GO:0022408),4/32,4,32,0.0415098036911362,0.581886130926952,0,0,3.02663438256659,9.63022289988763,MAD2L2;BMP2;NF2;KLF4
alpha,2,lysosome organization (GO:0007040),4/32,4,32,0.0415098036911362,0.581886130926952,0,0,3.02663438256659,9.63022289988763,VPS18;HOOK2;HPS4;NAGPA
alpha,2,regulation of myotube differentiation (GO:0010830),3/19,3,19,0.0415303344832876,0.581886130926952,0,0,3.82311711482095,12.1626016338314,HDAC5;MAML1;MAPK14
alpha,2,ribosomal small subunit assembly (GO:0000028),3/19,3,19,0.0415303344832876,0.581886130926952,0,0,3.82311711482095,12.1626016338314,RPS28;RPS27L;MRPS7
alpha,2,regulation of cytokinesis (GO:0032465),7/78,7,78,0.0420058682678484,0.585297236306705,0,0,2.17296827466319,6.8881919813032,CDC42;BECN1;PLK3;AHCTF1;CDC6;RAB11FIP3;MYO19
alpha,2,RNA 3'-end processing (GO:0031123),6/62,6,62,0.0423068018536298,0.586251397114585,0,0,2.34320081230961,7.41109288182771,NCBP1;POLDIP3;U2AF2;SRSF1;RNPS1;THOC5
alpha,2,respiratory electron transport chain (GO:0022904),8/95,8,95,0.0427003151838376,0.588471010347751,0,0,2.03899579457117,6.43007310293419,COX7A2L;NDUFA7;NDUFS7;NDUFB6;NDUFS6;COX6A1;SLC25A12;COX5A
alpha,2,regulation of G1/S transition of mitotic cell cycle (GO:2000045),5/47,5,47,0.0436168562135157,0.58852821960595,0,0,2.57585904899284,8.06839316093956,LSM10;DCUN1D3;PSME3;E2F1;KLF4
alpha,2,protein methylation (GO:0006479),5/47,5,47,0.0436168562135157,0.58852821960595,0,0,2.57585904899284,8.06839316093956,EHMT1;LCMT2;SNRPD3;CAMKMT;SNRPB
alpha,2,tRNA aminoacylation for protein translation (GO:0006418),5/47,5,47,0.0436168562135157,0.58852821960595,0,0,2.57585904899284,8.06839316093956,YARS;PPA2;LARS;RARS;DARS2
alpha,2,regulation of cellular response to heat (GO:1900034),7/79,7,79,0.0445203072342989,0.58852821960595,0,0,2.14546234713581,6.67627086796534,YWHAE;DNAJB1;HSPA1L;MAPK1;NUP54;IER5;HSPA1A
alpha,2,positive regulation of protein localization to membrane (GO:1905477),8/96,8,96,0.0449734078187204,0.58852821960595,0,0,2.01775625504439,6.25844209290937,YWHAE;AKT2;E2F1;CIB1;STX4;BMF;SQSTM1;YWHAH
alpha,2,protein deacetylation (GO:0006476),4/33,4,33,0.0457480971484781,0.58852821960595,0,0,2.93491818915548,9.05306355714605,HDAC5;BAZ2A;PHB;SIRT3
alpha,2,chromatin remodeling at centromere (GO:0031055),4/33,4,33,0.0457480971484781,0.58852821960595,0,0,2.93491818915548,9.05306355714605,CENPT;CENPL;RSF1;CENPQ
alpha,2,regulation of erythrocyte differentiation (GO:0045646),4/33,4,33,0.0457480971484781,0.58852821960595,0,0,2.93491818915548,9.05306355714605,ARNT;ACVR1B;MAPK14;HSPA1A
alpha,2,histone H4 acetylation (GO:0043967),5/48,5,48,0.0471017793497864,0.58852821960595,0,0,2.52219531880549,7.7064278161477,NAA60;NAA40;KANSL3;HAT1;MSL1
alpha,2,translational termination (GO:0006415),8/97,8,97,0.0473245179429459,0.58852821960595,0,0,1.99695464416764,6.09216298751587,MRPL41;MRPL42;MRPS23;MRPL27;MRPL34;MRPS7;MRPL13;MRPL10
alpha,2,regulation of gluconeogenesis (GO:0006111),3/20,3,20,0.0474041170993507,0.58852821960595,0,0,3.6319612590799,11.0740176588995,MST1;ARPP19;CLK2
alpha,2,regulation of toll-like receptor signaling pathway (GO:0034121),3/20,3,20,0.0474041170993507,0.58852821960595,0,0,3.6319612590799,11.0740176588995,NFKBIL1;CACTIN;BIRC3
alpha,2,vesicle coating (GO:0006901),6/64,6,64,0.0482075206065375,0.58852821960595,0,0,2.26997578692494,6.88311192701784,MCFD2;TBC1D20;PPP6R1;TRAPPC6B;TMED2;SEC24C
alpha,2,COPII vesicle coating (GO:0048208),6/64,6,64,0.0482075206065375,0.58852821960595,0,0,2.26997578692494,6.88311192701784,MCFD2;TBC1D20;PPP6R1;TRAPPC6B;TMED2;SEC24C
alpha,2,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",6/64,6,64,0.0482075206065375,0.58852821960595,0,0,2.26997578692494,6.88311192701784,MCFD2;TBC1D20;PPP6R1;TRAPPC6B;TMED2;SEC24C
alpha,2,positive regulation of cytokine-mediated signaling pathway (GO:0001961),4/34,4,34,0.0502182909162192,0.58852821960595,0,0,2.84859706594502,8.52122477643327,MAVS;CASP4;CPNE1;HSPA1A
alpha,2,cellular response to glucose starvation (GO:0042149),4/34,4,34,0.0502182909162192,0.58852821960595,0,0,2.84859706594502,8.52122477643327,BECN1;PRKAA2;MTMR3;HSPA5
alpha,2,mRNA stabilization (GO:0048255),4/34,4,34,0.0502182909162192,0.58852821960595,0,0,2.84859706594502,8.52122477643327,E2F1;YBX1;MAPK14;TARDBP
alpha,2,positive regulation of catalytic activity (GO:0043085),4/34,4,34,0.0502182909162192,0.58852821960595,0,0,2.84859706594502,8.52122477643327,CIB1;STX4;MAPK14;NHEJ1
alpha,2,RNA destabilization (GO:0050779),2/9,2,9,0.050573954201082,0.58852821960595,0,0,5.38068334678504,16.0576732543526,YTHDF2;METTL16
alpha,2,response to UV-C (GO:0010225),2/9,2,9,0.050573954201082,0.58852821960595,0,0,5.38068334678504,16.0576732543526,DCUN1D3;BCL3
alpha,2,ATF6-mediated unfolded protein response (GO:0036500),2/9,2,9,0.050573954201082,0.58852821960595,0,0,5.38068334678504,16.0576732543526,HSPA5;CALR
alpha,2,anoikis (GO:0043276),2/9,2,9,0.050573954201082,0.58852821960595,0,0,5.38068334678504,16.0576732543526,DAPK2;BMF
alpha,2,ATP synthesis coupled electron transport (GO:0042773),2/9,2,9,0.050573954201082,0.58852821960595,0,0,5.38068334678504,16.0576732543526,NDUFB6;COA6
alpha,2,epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),2/9,2,9,0.050573954201082,0.58852821960595,0,0,5.38068334678504,16.0576732543526,CCDC103;DNAAF1
alpha,2,atrioventricular valve development (GO:0003171),2/9,2,9,0.050573954201082,0.58852821960595,0,0,5.38068334678504,16.0576732543526,BMP2;TGFBR2
alpha,2,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),2/9,2,9,0.050573954201082,0.58852821960595,0,0,5.38068334678504,16.0576732543526,FOXA1;MAD2L2
alpha,2,negative regulation of transcription by competitive promoter binding (GO:0010944),2/9,2,9,0.050573954201082,0.58852821960595,0,0,5.38068334678504,16.0576732543526,MAD2L2;PHB
alpha,2,tRNA wobble uridine modification (GO:0002098),2/9,2,9,0.050573954201082,0.58852821960595,0,0,5.38068334678504,16.0576732543526,CTU2;URM1
alpha,2,fatty acid homeostasis (GO:0055089),2/9,2,9,0.050573954201082,0.58852821960595,0,0,5.38068334678504,16.0576732543526,PRKAA2;POLD1
alpha,2,cytoskeletal anchoring at plasma membrane (GO:0007016),2/9,2,9,0.050573954201082,0.58852821960595,0,0,5.38068334678504,16.0576732543526,SPTBN4;FLNB
alpha,2,cytoplasmic microtubule organization (GO:0031122),5/49,5,49,0.0507470776294924,0.58852821960595,0,0,2.47072194495232,7.36497812515087,ATAD1;PLK3;HOOK2;CIB1;CAMSAP2
alpha,2,cellular response to organic substance (GO:0071310),10/134,10,134,0.0511252143462268,0.58852821960595,0,0,1.80694590003975,5.37291292695733,RPS6KB1;MAPK1;CIB1;PTPN11;PTPN12;MAPK6;MAPK14;KLF4;JUNB;MAPK4
alpha,2,NADH dehydrogenase complex assembly (GO:0010257),6/65,6,65,0.0513387027412011,0.58852821960595,0,0,2.23505308251071,6.63656629953912,NDUFA7;COA1;NDUFS7;NDUFB6;NDUFS6;NDUFAF4
alpha,2,mitochondrial respiratory chain complex I biogenesis (GO:0097031),6/65,6,65,0.0513387027412011,0.58852821960595,0,0,2.23505308251071,6.63656629953912,NDUFA7;COA1;NDUFS7;NDUFB6;NDUFS6;NDUFAF4
alpha,2,mitochondrial respiratory chain complex I assembly (GO:0032981),6/65,6,65,0.0513387027412011,0.58852821960595,0,0,2.23505308251071,6.63656629953912,NDUFA7;COA1;NDUFS7;NDUFB6;NDUFS6;NDUFAF4
alpha,2,glucose metabolic process (GO:0006006),6/65,6,65,0.0513387027412011,0.58852821960595,0,0,2.23505308251071,6.63656629953912,BRAT1;GOT2;SLC25A12;ENO3;GDPGP1;PPARD
alpha,2,positive regulation of binding (GO:0051099),7/82,7,82,0.0526354554705492,0.589976407224576,0,0,2.0669698222406,6.08591427850005,BMP2;NCBP1;DDX11;CEBPG;RARA;B2M;MET
alpha,2,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",3/21,3,21,0.0536617125667324,0.589976407224576,0,0,3.45901072293324,10.1177984065997,COX7A2L;COX6A1;COX5A
alpha,2,positive regulation of histone acetylation (GO:0035066),3/21,3,21,0.0536617125667324,0.589976407224576,0,0,3.45901072293324,10.1177984065997,PAXIP1;TADA2A;WBP2
alpha,2,negative regulation of cytokine biosynthetic process (GO:0042036),3/21,3,21,0.0536617125667324,0.589976407224576,0,0,3.45901072293324,10.1177984065997,BCL3;KLF4;ASB1
alpha,2,hepaticobiliary system development (GO:0061008),3/21,3,21,0.0536617125667324,0.589976407224576,0,0,3.45901072293324,10.1177984065997,CEBPG;RARA;MET
alpha,2,chromatin assembly (GO:0031497),6/66,6,66,0.0545912870118904,0.589976407224576,0,0,2.20118864186661,6.40079460158946,HIST1H2BN;NAA60;CHAF1A;H2AFX;RSF1;HIST3H2BB
alpha,2,negative regulation of cell adhesion (GO:0007162),6/66,6,66,0.0545912870118904,0.589976407224576,0,0,2.20118864186661,6.40079460158946,ERBB3;ARHGDIA;FZD7;PLXNA2;TBCD;NF2
alpha,2,fatty acid catabolic process (GO:0009062),6/66,6,66,0.0545912870118904,0.589976407224576,0,0,2.20118864186661,6.40079460158946,ALDH3A2;ACADVL;ECI1;HACL1;MUT;PPARD
alpha,2,regulation of interleukin-8 production (GO:0032677),4/35,4,35,0.0549192370086317,0.589976407224576,0,0,2.76720857834659,8.03013930392773,MAVS;ZNF580;CACTIN;HSPA1A
alpha,2,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),4/35,4,35,0.0549192370086317,0.589976407224576,0,0,2.76720857834659,8.03013930392773,RTEL1;MAPK1;CCT7;MAP2K7
alpha,2,intracellular steroid hormone receptor signaling pathway (GO:0030518),6/67,6,67,0.057965712496886,0.589976407224576,0,0,2.1683350800477,6.17520929584494,YAP1;NCOA6;WBP2;NEDD4;PHB;PIAS1
alpha,2,fatty acid oxidation (GO:0019395),5/51,5,51,0.0585197552272415,0.589976407224576,0,0,2.37383088828752,6.73785995717298,ALDH3A2;ACADVL;ECI1;HACL1;PPARD
alpha,2,positive regulation of homeostatic process (GO:0032846),7/84,7,84,0.0585287481785038,0.589976407224576,0,0,2.01775625504439,5.72687091121416,RTEL1;ARNT;STX4;ACVR1B;MAPK14;C2CD2L;HSPA1A
alpha,2,positive regulation of RNA metabolic process (GO:0051254),4/36,4,36,0.0598492049566982,0.589976407224576,0,0,2.69034167339252,7.57580610976032,U2AF2;HRAS;HSPA1A;RBM22
alpha,2,nuclear transport (GO:0051169),3/22,3,22,0.0602930992663899,0.589976407224576,0,0,3.30178296279991,9.27318167012258,EIF5A;NUTF2;BANF1
alpha,2,peripheral nervous system development (GO:0007422),3/22,3,22,0.0602930992663899,0.589976407224576,0,0,3.30178296279991,9.27318167012258,ALDH3A2;ERBB3;SCN8A
alpha,2,regulation of ERBB signaling pathway (GO:1901184),3/22,3,22,0.0602930992663899,0.589976407224576,0,0,3.30178296279991,9.27318167012258,ERBB3;NRG4;PTPN12
alpha,2,negative regulation of GTPase activity (GO:0034260),3/22,3,22,0.0602930992663899,0.589976407224576,0,0,3.30178296279991,9.27318167012258,TMED2;RRP1B;HRAS
alpha,2,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),3/22,3,22,0.0602930992663899,0.589976407224576,0,0,3.30178296279991,9.27318167012258,PIM3;STX4;C2CD2L
alpha,2,regulation of actin filament length (GO:0030832),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,SSH2;SSH1
alpha,2,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,CDC42;SPAG5
alpha,2,mitotic nuclear envelope reassembly (GO:0007084),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,LMNA;BANF1
alpha,2,negative regulation of inclusion body assembly (GO:0090084),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,DNAJB1;HSPA1A
alpha,2,negative regulation of gluconeogenesis (GO:0045721),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,MST1;CLK2
alpha,2,mitotic G1 DNA damage checkpoint (GO:0031571),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,RPS27L;FBXO31
alpha,2,nuclear pore complex assembly (GO:0051292),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,AHCTF1;TMEM170A
alpha,2,G1 DNA damage checkpoint (GO:0044783),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,RPS27L;FBXO31
alpha,2,central nervous system projection neuron axonogenesis (GO:0021952),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,SPTBN4;EPHA4
alpha,2,motor neuron axon guidance (GO:0008045),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,EPHA4;PLXNA2
alpha,2,positive regulation of reproductive process (GO:2000243),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,SMURF2;ACVR1B
alpha,2,negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,NFKBIL1;CACTIN
alpha,2,DNA replication-dependent nucleosome assembly (GO:0006335),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,CHAF1A;HAT1
alpha,2,cytochrome complex assembly (GO:0017004),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,COX18;COA6
alpha,2,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,DNAJB1;HSPA1A
alpha,2,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,STX4;C2CD2L
alpha,2,tRNA wobble base modification (GO:0002097),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,CTU2;URM1
alpha,2,UV protection (GO:0009650),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,FEN1;SDF4
alpha,2,regulation of astrocyte differentiation (GO:0048710),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,EPHA4;BMP2
alpha,2,positive regulation of interleukin-13 production (GO:0032736),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,RARA;PRKCZ
alpha,2,DNA replication-dependent nucleosome organization (GO:0034723),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,CHAF1A;HAT1
alpha,2,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,PTPN1;HSPA5
alpha,2,positive regulation of nuclease activity (GO:0032075),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,PTPN1;HSPA1A
alpha,2,positive regulation of type 2 immune response (GO:0002830),2/10,2,10,0.0615241059080347,0.589976407224576,0,0,4.84261501210654,13.5027903873315,RARA;PRKCZ
alpha,2,mitochondrial ATP synthesis coupled electron transport (GO:0042775),7/86,7,86,0.0648129778661802,0.612441764015657,0,0,1.97083169097359,5.39268707127267,COX7A2L;NDUFA7;NDUFS7;NDUFB6;NDUFS6;COX6A1;COX5A
alpha,2,histone exchange (GO:0043486),4/37,4,37,0.0650059121868731,0.612441764015657,0,0,2.6176297362738,7.15470730057375,CENPT;CENPL;RSF1;CENPQ
alpha,2,regulation of cell morphogenesis involved in differentiation (GO:0010769),4/37,4,37,0.0650059121868731,0.612441764015657,0,0,2.6176297362738,7.15470730057375,EPHA4;NEDD4;SSH2;SSH1
alpha,2,COPII-coated vesicle budding (GO:0090114),6/69,6,69,0.0650810439160174,0.612441764015657,0,0,2.10548478787241,5.75244121750855,MCFD2;TBC1D20;PPP6R1;TRAPPC6B;TMED2;SEC24C
alpha,2,peptidyl-threonine phosphorylation (GO:0018107),6/69,6,69,0.0650810439160174,0.612441764015657,0,0,2.10548478787241,5.75244121750855,PNCK;DAPK2;MAPK1;ACVR1B;PSKH1;TGFBR2
alpha,2,negative regulation of transcription factor import into nucleus (GO:0042992),3/23,3,23,0.067287125747917,0.630848071138463,0,0,3.15822718180861,8.52338043087415,NFKBIL1;KEAP1;NFKBIE
alpha,2,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),4/38,4,38,0.0703865550050087,0.63430830738638,0,0,2.54874474321397,6.76373904447468,YWHAE;E2F1;BMF;YWHAH
alpha,2,regulation of sodium ion transmembrane transporter activity (GO:2000649),4/38,4,38,0.0703865550050087,0.63430830738638,0,0,2.54874474321397,6.76373904447468,FXYD2;NEDD4;UTRN;YWHAH
alpha,2,negative regulation of G0 to G1 transition (GO:0070317),4/38,4,38,0.0703865550050087,0.63430830738638,0,0,2.54874474321397,6.76373904447468,PCGF2;E2F1;EHMT1;E2F6
alpha,2,positive regulation of macromolecule biosynthetic process (GO:0010557),10/143,10,143,0.0726053587593143,0.63430830738638,0,0,1.69322203220508,4.44084144290218,KITLG;RPS6KB1;POLDIP3;AKT2;BCL3;RPS27L;RPL26;CALR;KLF4;HRAS
alpha,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),6/71,6,71,0.0726850303173205,0.63430830738638,0,0,2.04617535722811,5.36429388397845,PLK3;SGTA;KEAP1;RNF166;PIAS1;HSPA1A
alpha,2,regulation of hippo signaling (GO:0035330),2/11,2,11,0.0731894200830438,0.63430830738638,0,0,4.40237728373322,11.5109152667648,DLG5;NF2
alpha,2,positive regulation by host of viral process (GO:0044794),2/11,2,11,0.0731894200830438,0.63430830738638,0,0,4.40237728373322,11.5109152667648,TBC1D20;YTHDC2
alpha,2,UV-damage excision repair (GO:0070914),2/11,2,11,0.0731894200830438,0.63430830738638,0,0,4.40237728373322,11.5109152667648,HIST3H2A;ACTR5
alpha,2,carnitine shuttle (GO:0006853),2/11,2,11,0.0731894200830438,0.63430830738638,0,0,4.40237728373322,11.5109152667648,PRKAA2;CPT2
alpha,2,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),2/11,2,11,0.0731894200830438,0.63430830738638,0,0,4.40237728373322,11.5109152667648,CEBPB;HSPA5
alpha,2,calcium ion regulated exocytosis (GO:0017156),2/11,2,11,0.0731894200830438,0.63430830738638,0,0,4.40237728373322,11.5109152667648,RIMS2;SDF4
alpha,2,synaptonemal complex assembly (GO:0007130),2/11,2,11,0.0731894200830438,0.63430830738638,0,0,4.40237728373322,11.5109152667648,STAG3;TRIP13
alpha,2,response to sterol (GO:0036314),2/11,2,11,0.0731894200830438,0.63430830738638,0,0,4.40237728373322,11.5109152667648,ABCA2;TGFBR2
alpha,2,fatty acid transmembrane transport (GO:1902001),2/11,2,11,0.0731894200830438,0.63430830738638,0,0,4.40237728373322,11.5109152667648,PRKAA2;CPT2
alpha,2,protein localization to mitochondrion (GO:0070585),2/11,2,11,0.0731894200830438,0.63430830738638,0,0,4.40237728373322,11.5109152667648,MTCH2;COX18
alpha,2,regulation of synaptic vesicle cycle (GO:0098693),2/11,2,11,0.0731894200830438,0.63430830738638,0,0,4.40237728373322,11.5109152667648,RIMS2;PREPL
alpha,2,modulation by host of viral genome replication (GO:0044827),2/11,2,11,0.0731894200830438,0.63430830738638,0,0,4.40237728373322,11.5109152667648,TBC1D20;YTHDC2
alpha,2,positive regulation of glucose metabolic process (GO:0010907),2/11,2,11,0.0731894200830438,0.63430830738638,0,0,4.40237728373322,11.5109152667648,AKT2;ARPP19
alpha,2,regulation of cardiac muscle cell differentiation (GO:2000725),2/11,2,11,0.0731894200830438,0.63430830738638,0,0,4.40237728373322,11.5109152667648,BMP2;FZD7
alpha,2,positive regulation of T-helper cell differentiation (GO:0045624),2/11,2,11,0.0731894200830438,0.63430830738638,0,0,4.40237728373322,11.5109152667648,RARA;PRKCZ
alpha,2,cardiac muscle cell membrane repolarization (GO:0099622),2/11,2,11,0.0731894200830438,0.63430830738638,0,0,4.40237728373322,11.5109152667648,YWHAE;KCND3
alpha,2,synaptonemal complex organization (GO:0070193),2/11,2,11,0.0731894200830438,0.63430830738638,0,0,4.40237728373322,11.5109152667648,STAG3;TRIP13
alpha,2,positive regulation of response to stimulus (GO:0048584),5/55,5,55,0.0759843245357205,0.644889389549685,0,0,2.20118864186661,5.67296547673005,MAVS;EID3;STX4;IER5;C2CD2L
alpha,2,DNA damage checkpoint (GO:0000077),4/39,4,39,0.0759878398199925,0.644889389549685,0,0,2.48339231390079,6.40015385575481,TAOK1;DOT1L;H2AFX;E2F1
alpha,2,histone acetylation (GO:0016573),6/72,6,72,0.0766696914364837,0.644889389549685,0,0,2.01775625504439,5.18210009278847,NAA60;NAA40;TADA2A;KANSL3;HAT1;SUPT7L
alpha,2,positive regulation of growth (GO:0045927),6/72,6,72,0.0766696914364837,0.644889389549685,0,0,2.01775625504439,5.18210009278847,CDC42;NCBP1;BRAT1;CIB1;PPM1F;CXCL16
alpha,2,cellular response to starvation (GO:0009267),8/108,8,108,0.0784904285289833,0.644889389549685,0,0,1.79356111559501,4.5642159289658,BECN1;MAP1LC3B;MTMR3;PRKAA2;RRAGC;HSPA5;LARS;MAPK1
alpha,2,peptidyl-threonine modification (GO:0018210),7/90,7,90,0.0785605393291032,0.644889389549685,0,0,1.88323917137476,4.79074529147332,PNCK;DAPK2;GALNT1;MAPK1;ACVR1B;PSKH1;TGFBR2
alpha,2,regulation of axonogenesis (GO:0050770),5/56,5,56,0.0807452587217089,0.644889389549685,0,0,2.16188170183328,5.44028025364024,EPHA4;ARHGDIA;PLXNA2;SSH2;SSH1
alpha,2,regulation of RNA splicing (GO:0043484),5/56,5,56,0.0807452587217089,0.644889389549685,0,0,2.16188170183328,5.44028025364024,U2AF2;RRP1B;METTL16;RBM22;CLK2
alpha,2,positive regulation of DNA biosynthetic process (GO:2000573),5/56,5,56,0.0807452587217089,0.644889389549685,0,0,2.16188170183328,5.44028025364024,RFC5;MAPK1;CCT7;MAP2K7;KLF4
alpha,2,negative regulation of cellular response to growth factor stimulus (GO:0090288),5/56,5,56,0.0807452587217089,0.644889389549685,0,0,2.16188170183328,5.44028025364024,PTPN1;SMURF2;HGS;NEDD4;LEMD3
alpha,2,negative regulation of protein catabolic process (GO:0042177),4/40,4,40,0.0818060146293648,0.644889389549685,0,0,2.42130750605327,6.06151212978252,SNX3;MAD2L2;SF3B3;PHB
alpha,2,regulation of type I interferon-mediated signaling pathway (GO:0060338),4/40,4,40,0.0818060146293648,0.644889389549685,0,0,2.42130750605327,6.06151212978252,PTPN1;MAVS;PTPN11;CACTIN
alpha,2,ERBB2 signaling pathway (GO:0038128),4/40,4,40,0.0818060146293648,0.644889389549685,0,0,2.42130750605327,6.06151212978252,ERBB3;NRG4;PTPN12;HRAS
alpha,2,positive regulation of fat cell differentiation (GO:0045600),4/40,4,40,0.0818060146293648,0.644889389549685,0,0,2.42130750605327,6.06151212978252,CEBPB;BMP2;AAMDC;PPARD
alpha,2,regulation of G0 to G1 transition (GO:0070316),4/40,4,40,0.0818060146293648,0.644889389549685,0,0,2.42130750605327,6.06151212978252,PCGF2;E2F1;EHMT1;E2F6
alpha,2,regulation of plasma membrane bounded cell projection assembly (GO:0120032),4/40,4,40,0.0818060146293648,0.644889389549685,0,0,2.42130750605327,6.06151212978252,CDC42;IFT140;SSH2;SSH1
alpha,2,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),3/25,3,25,0.0823138106291767,0.644889389549685,0,0,2.90556900726392,7.25583450945299,PLK3;DCUN1D3;KLF4
alpha,2,regulation of actin filament bundle assembly (GO:0032231),3/25,3,25,0.0823138106291767,0.644889389549685,0,0,2.90556900726392,7.25583450945299,CDC42;FHOD1;PFN1
alpha,2,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),3/25,3,25,0.0823138106291767,0.644889389549685,0,0,2.90556900726392,7.25583450945299,CEBPB;CASP4;CHAC1
alpha,2,receptor catabolic process (GO:0032801),3/25,3,25,0.0823138106291767,0.644889389549685,0,0,2.90556900726392,7.25583450945299,BECN1;NEDD4;AP2M1
alpha,2,axoneme assembly (GO:0035082),3/25,3,25,0.0823138106291767,0.644889389549685,0,0,2.90556900726392,7.25583450945299,CCDC103;DNAAF1;PIH1D3
alpha,2,negative regulation of T cell proliferation (GO:0042130),3/25,3,25,0.0823138106291767,0.644889389549685,0,0,2.90556900726392,7.25583450945299,CEBPB;DLG5;GLMN
alpha,2,circulatory system development (GO:0072359),8/110,8,110,0.0852193878241401,0.644889389549685,0,0,1.76095091349329,4.3363879628661,BMP2;CXADR;ERBB3;NCOA6;RARA;PTPN11;ZDHHC16;TGFBR2
alpha,2,regulation of inclusion body assembly (GO:0090083),2/12,2,12,0.0854923055328658,0.644889389549685,0,0,4.03551251008878,9.92465254583033,DNAJB1;HSPA1A
alpha,2,protein localization to kinetochore (GO:0034501),2/12,2,12,0.0854923055328658,0.644889389549685,0,0,4.03551251008878,9.92465254583033,CENPT;MTBP
alpha,2,regulation of IRE1-mediated unfolded protein response (GO:1903894),2/12,2,12,0.0854923055328658,0.644889389549685,0,0,4.03551251008878,9.92465254583033,PTPN1;HSPA5
alpha,2,negative regulation of ERAD pathway (GO:1904293),2/12,2,12,0.0854923055328658,0.644889389549685,0,0,4.03551251008878,9.92465254583033,DERL3;SGTA
alpha,2,cellular modified amino acid catabolic process (GO:0042219),2/12,2,12,0.0854923055328658,0.644889389549685,0,0,4.03551251008878,9.92465254583033,GOT2;CHAC1
alpha,2,regulation of cytokine biosynthetic process (GO:0042035),2/12,2,12,0.0854923055328658,0.644889389549685,0,0,4.03551251008878,9.92465254583033,MAST2;ASB1
alpha,2,regulation of actomyosin structure organization (GO:0110020),2/12,2,12,0.0854923055328658,0.644889389549685,0,0,4.03551251008878,9.92465254583033,CDC42;FHOD1
alpha,2,"alternative mRNA splicing, via spliceosome (GO:0000380)",2/12,2,12,0.0854923055328658,0.644889389549685,0,0,4.03551251008878,9.92465254583033,HNRNPM;SRSF1
alpha,2,positive regulation of ruffle assembly (GO:1900029),2/12,2,12,0.0854923055328658,0.644889389549685,0,0,4.03551251008878,9.92465254583033,PFN1;HRAS
alpha,2,regulation of interleukin-8 biosynthetic process (GO:0045414),2/12,2,12,0.0854923055328658,0.644889389549685,0,0,4.03551251008878,9.92465254583033,BCL3;KLF4
alpha,2,spliceosomal tri-snRNP complex assembly (GO:0000244),2/12,2,12,0.0854923055328658,0.644889389549685,0,0,4.03551251008878,9.92465254583033,USP4;DDX20
alpha,2,cargo loading into COPII-coated vesicle (GO:0090110),2/12,2,12,0.0854923055328658,0.644889389549685,0,0,4.03551251008878,9.92465254583033,TBC1D20;SEC24C
alpha,2,kinetochore organization (GO:0051383),2/12,2,12,0.0854923055328658,0.644889389549685,0,0,4.03551251008878,9.92465254583033,CENPT;CENPF
alpha,2,negative regulation of RNA biosynthetic process (GO:1902679),2/12,2,12,0.0854923055328658,0.644889389549685,0,0,4.03551251008878,9.92465254583033,NIF3L1;COPS2
alpha,2,regulation of sister chromatid cohesion (GO:0007063),2/12,2,12,0.0854923055328658,0.644889389549685,0,0,4.03551251008878,9.92465254583033,FEN1;DDX11
alpha,2,membrane repolarization during action potential (GO:0086011),2/12,2,12,0.0854923055328658,0.644889389549685,0,0,4.03551251008878,9.92465254583033,YWHAE;KCND3
alpha,2,positive regulation of T cell cytokine production (GO:0002726),2/12,2,12,0.0854923055328658,0.644889389549685,0,0,4.03551251008878,9.92465254583033,PRKCZ;B2M
alpha,2,ribosome assembly (GO:0042255),5/57,5,57,0.0856613582470835,0.644889389549685,0,0,2.12395395267831,5.21930557466197,RPS28;RPS27L;RPL23A;MRPS7;RPL6
alpha,2,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),5/57,5,57,0.0856613582470835,0.644889389549685,0,0,2.12395395267831,5.21930557466197,CASP4;MADD;CPNE1;BIRC3;HSPA1A
alpha,2,protein import (GO:0017038),5/57,5,57,0.0856613582470835,0.644889389549685,0,0,2.12395395267831,5.21930557466197,RANBP1;NUTF2;NUP62CL;IPO7;TNPO3
alpha,2,autophagosome organization (GO:1905037),5/57,5,57,0.0856613582470835,0.644889389549685,0,0,2.12395395267831,5.21930557466197,BECN1;NSFL1C;MAP1LC3B;WDR45B;ULK2
alpha,2,positive regulation of cellular protein metabolic process (GO:0032270),7/92,7,92,0.0860230717325289,0.645685080087613,0,0,1.84229918938836,4.51941735952202,RPS6KB1;POLDIP3;BCL3;RPS27L;VPS35;RPL26;KLF4
alpha,2,regulation of mRNA stability (GO:0043488),9/129,9,129,0.0865091701754852,0.647406905586272,0,0,1.68928430654879,4.13453154525692,YTHDF2;PSMD13;PSME3;PSMD3;E2F1;SAMD4B;METTL16;EXOSC1;HSPA1A
alpha,2,negative regulation of catabolic process (GO:0009895),4/41,4,41,0.0878369003106239,0.654559889787008,0,0,2.36225122541782,5.74564126792957,SNX3;MAD2L2;SF3B3;PHB
alpha,2,viral gene expression (GO:0019080),8/111,8,111,0.0887067492602308,0.654559889787008,0,0,1.7450864908492,4.22733119855275,RPS28;RPL31;RPL27A;NUP54;RPL23A;RPL26;RPL8;RPL6
alpha,2,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),8/111,8,111,0.0887067492602308,0.654559889787008,0,0,1.7450864908492,4.22733119855275,YWHAE;LRRC46;NBPF3;HSPA1L;HPS4;E2F1;BMF;YWHAH
alpha,2,cell cycle G1/S phase transition (GO:0044843),7/93,7,93,0.0899005861186202,0.654559889787008,0,0,1.82248952068526,4.39046987033465,PLK3;RANBP1;ORC6;RPS6KB1;CDC6;ACVR1B;CDC25A
alpha,2,regulation of spindle assembly (GO:0090169),3/26,3,26,0.0903199213504674,0.654559889787008,0,0,2.79381635313839,6.71744430041536,SPAG5;CHMP1A;HSPA1A
alpha,2,"protein import into nucleus, translocation (GO:0000060)",3/26,3,26,0.0903199213504674,0.654559889787008,0,0,2.79381635313839,6.71744430041536,BCL3;NUTF2;RBM22
alpha,2,respiratory chain complex IV assembly (GO:0008535),3/26,3,26,0.0903199213504674,0.654559889787008,0,0,2.79381635313839,6.71744430041536,COA1;COX18;COA6
alpha,2,regulation of lamellipodium assembly (GO:0010591),3/26,3,26,0.0903199213504674,0.654559889787008,0,0,2.79381635313839,6.71744430041536,CDC42;SSH2;SSH1
alpha,2,negative regulation of insulin receptor signaling pathway (GO:0046627),3/26,3,26,0.0903199213504674,0.654559889787008,0,0,2.79381635313839,6.71744430041536,PTPN1;RPS6KB1;PRKCZ
alpha,2,negative regulation of epithelial to mesenchymal transition (GO:0010719),3/26,3,26,0.0903199213504674,0.654559889787008,0,0,2.79381635313839,6.71744430041536,FOXA1;MAD2L2;FUZ
alpha,2,peptidyl-tyrosine dephosphorylation (GO:0035335),3/26,3,26,0.0903199213504674,0.654559889787008,0,0,2.79381635313839,6.71744430041536,PTPN1;PTPN11;PTPN12
alpha,2,telomere organization (GO:0032200),4/42,4,42,0.0940759218327598,0.670511011385602,0,0,2.30600714862216,5.45060104609118,RTEL1;RAD51D;POLD1;DOT1L
alpha,2,regulation of substrate adhesion-dependent cell spreading (GO:1900024),4/42,4,42,0.0940759218327598,0.670511011385602,0,0,2.30600714862216,5.45060104609118,CDC42;CIB1;CALR;TRIOBP
alpha,2,negative regulation of STAT cascade (GO:1904893),4/42,4,42,0.0940759218327598,0.670511011385602,0,0,2.30600714862216,5.45060104609118,HGS;BCL3;LRRC4;NF2
alpha,2,autophagosome assembly (GO:0000045),5/59,5,59,0.0959516473656284,0.670511011385602,0,0,2.05195551360446,4.80960086936224,BECN1;NSFL1C;MAP1LC3B;WDR45B;ULK2
alpha,2,regulation of plasma membrane bounded cell projection organization (GO:0120035),2/13,2,13,0.0983603467997008,0.670511011385602,0,0,3.72508847085118,8.6389179952315,VPS35;FBXO7
alpha,2,cellular response to nitrogen starvation (GO:0006995),2/13,2,13,0.0983603467997008,0.670511011385602,0,0,3.72508847085118,8.6389179952315,BECN1;MAP1LC3B
alpha,2,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",2/13,2,13,0.0983603467997008,0.670511011385602,0,0,3.72508847085118,8.6389179952315,U2AF2;RNPS1
alpha,2,chromatin assembly or disassembly (GO:0006333),2/13,2,13,0.0983603467997008,0.670511011385602,0,0,3.72508847085118,8.6389179952315,CHAF1A;HIRIP3
alpha,2,pathway-restricted SMAD protein phosphorylation (GO:0060389),2/13,2,13,0.0983603467997008,0.670511011385602,0,0,3.72508847085118,8.6389179952315,BMP2;TGFBR2
alpha,2,cardiocyte differentiation (GO:0035051),2/13,2,13,0.0983603467997008,0.670511011385602,0,0,3.72508847085118,8.6389179952315,BMP2;CBY1
alpha,2,establishment of chromosome localization (GO:0051303),2/13,2,13,0.0983603467997008,0.670511011385602,0,0,3.72508847085118,8.6389179952315,CENPF;CENPQ
alpha,2,motile cilium assembly (GO:0044458),2/13,2,13,0.0983603467997008,0.670511011385602,0,0,3.72508847085118,8.6389179952315,DNAAF1;SPATA6
alpha,2,regulation of cAMP-dependent protein kinase activity (GO:2000479),2/13,2,13,0.0983603467997008,0.670511011385602,0,0,3.72508847085118,8.6389179952315,PRKAR1B;MST1
alpha,2,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",2/13,2,13,0.0983603467997008,0.670511011385602,0,0,3.72508847085118,8.6389179952315,ATP5G1;ATP6V0A1
alpha,2,positive regulation of smoothened signaling pathway (GO:0045880),2/13,2,13,0.0983603467997008,0.670511011385602,0,0,3.72508847085118,8.6389179952315,DLG5;TUBD1
alpha,2,regulation of synaptic vesicle transport (GO:1902803),2/13,2,13,0.0983603467997008,0.670511011385602,0,0,3.72508847085118,8.6389179952315,RIMS2;PREPL
alpha,2,cellular response to nitrogen levels (GO:0043562),2/13,2,13,0.0983603467997008,0.670511011385602,0,0,3.72508847085118,8.6389179952315,BECN1;MAP1LC3B
alpha,2,positive regulation of glucose import (GO:0046326),3/27,3,27,0.0986358387089843,0.670511011385602,0,0,2.69034167339252,6.23169385973771,AKT2;PTPN11;ARPP19
alpha,2,response to growth factor (GO:0070848),3/27,3,27,0.0986358387089843,0.670511011385602,0,0,2.69034167339252,6.23169385973771,RPS6KB1;CIB1;KLF4
alpha,2,regulation of supramolecular fiber organization (GO:1902903),3/27,3,27,0.0986358387089843,0.670511011385602,0,0,2.69034167339252,6.23169385973771,SSH2;CAMSAP2;SSH1
alpha,2,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),3/27,3,27,0.0986358387089843,0.670511011385602,0,0,2.69034167339252,6.23169385973771,KLF11;E2F1;CDC6
alpha,2,negative regulation of cellular response to insulin stimulus (GO:1900077),3/27,3,27,0.0986358387089843,0.670511011385602,0,0,2.69034167339252,6.23169385973771,PTPN1;RPS6KB1;PRKCZ
alpha,2,RNA biosynthetic process (GO:0032774),3/27,3,27,0.0986358387089843,0.670511011385602,0,0,2.69034167339252,6.23169385973771,NCOA6;RSF1;TCF4
alpha,2,viral transcription (GO:0019083),8/114,8,114,0.0996574688988149,0.672021755515538,0,0,1.69916316214264,3.91829792075831,RPS28;RPL31;RPL27A;NUP54;RPL23A;RPL26;RPL8;RPL6
alpha,2,regulation of organelle organization (GO:0033043),8/114,8,114,0.0996574688988149,0.672021755515538,0,0,1.69916316214264,3.91829792075831,MAVS;TAOK1;TBC1D25;TBC1D14;MAPK1;VPS35;SQSTM1;CAMSAP2
alpha,2,positive regulation of developmental process (GO:0051094),8/114,8,114,0.0996574688988149,0.672021755515538,0,0,1.69916316214264,3.91829792075831,BMP2;PAXIP1;SMURF2;MST1;LMNA;VPS35;ACVR1B;JUNB
alpha,2,regulation of telomerase activity (GO:0051972),4/43,4,43,0.100518138918343,0.676017990272164,0,0,2.25237907539839,5.17465416075026,MAPK1;MAP2K7;KLF4;SMG6
alpha,2,water-soluble vitamin metabolic process (GO:0006767),6/78,6,78,0.103094559947379,0.691501277093858,0,0,1.86254423542559,4.23190287608161,BTD;SLC52A2;FASN;SLC2A1;AOX1;MUT
alpha,2,substantia nigra development (GO:0021762),4/44,4,44,0.107158276375713,0.707972353482163,0,0,2.20118864186661,4.91624107202633,YWHAE;CDC42;HSPA5;YWHAH
alpha,2,negative regulation of microtubule polymerization or depolymerization (GO:0031111),3/28,3,28,0.107246954851226,0.707972353482163,0,0,2.59425804219993,5.7919952816655,TBCD;CIB1;CAMSAP2
alpha,2,phagosome acidification (GO:0090383),3/28,3,28,0.107246954851226,0.707972353482163,0,0,2.59425804219993,5.7919952816655,ATP6V1G2;ATP6V0D1;ATP6V0A1
alpha,2,transcription from RNA polymerase III promoter (GO:0006383),3/28,3,28,0.107246954851226,0.707972353482163,0,0,2.59425804219993,5.7919952816655,GTF3C4;SNAPC2;POLR3K
alpha,2,regulation of neurotransmitter secretion (GO:0046928),3/28,3,28,0.107246954851226,0.707972353482163,0,0,2.59425804219993,5.7919952816655,RIMS2;PREPL;SLC30A1
alpha,2,cargo loading into vesicle (GO:0035459),3/28,3,28,0.107246954851226,0.707972353482163,0,0,2.59425804219993,5.7919952816655,TBC1D20;TMED2;SEC24C
alpha,2,positive regulation of translation (GO:0045727),6/79,6,79,0.107908884265281,0.707972353482163,0,0,1.83896772611641,4.09440292791839,EIF5A;RPS6KB1;POLDIP3;BCL3;RPS27L;RPL26
alpha,2,mitochondrial respiratory chain complex assembly (GO:0033108),7/98,7,98,0.110728627112768,0.707972353482163,0,0,1.72950536146662,3.80607553071769,NDUFA7;COA1;NDUFS7;NDUFB6;NDUFS6;COX18;NDUFAF4
alpha,2,ncRNA transcription (GO:0098781),2/14,2,14,0.111726009788224,0.707972353482163,0,0,3.45901072293324,7.581133677085,SNAPC2;RPAP2
alpha,2,regulation of Golgi organization (GO:1903358),2/14,2,14,0.111726009788224,0.707972353482163,0,0,3.45901072293324,7.581133677085,MAPK1;CAMSAP2
alpha,2,regulation of activin receptor signaling pathway (GO:0032925),2/14,2,14,0.111726009788224,0.707972353482163,0,0,3.45901072293324,7.581133677085,LEMD3;ACVR1B
alpha,2,regulation of nucleocytoplasmic transport (GO:0046822),2/14,2,14,0.111726009788224,0.707972353482163,0,0,3.45901072293324,7.581133677085,NEDD4;NUDT4
alpha,2,"retrograde transport, endosome to plasma membrane (GO:1990126)",2/14,2,14,0.111726009788224,0.707972353482163,0,0,3.45901072293324,7.581133677085,VPS26A;VPS35
alpha,2,pore complex assembly (GO:0046931),2/14,2,14,0.111726009788224,0.707972353482163,0,0,3.45901072293324,7.581133677085,AHCTF1;TMEM170A
alpha,2,modified amino acid transport (GO:0072337),2/14,2,14,0.111726009788224,0.707972353482163,0,0,3.45901072293324,7.581133677085,SLC6A8;CTNS
alpha,2,response to ethanol (GO:0045471),2/14,2,14,0.111726009788224,0.707972353482163,0,0,3.45901072293324,7.581133677085,GOT2;SDF4
alpha,2,metallo-sulfur cluster assembly (GO:0031163),2/14,2,14,0.111726009788224,0.707972353482163,0,0,3.45901072293324,7.581133677085,NFU1;ISCU
alpha,2,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),2/14,2,14,0.111726009788224,0.707972353482163,0,0,3.45901072293324,7.581133677085,OPA1;HSPA1A
alpha,2,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),2/14,2,14,0.111726009788224,0.707972353482163,0,0,3.45901072293324,7.581133677085,HDAC5;KLF4
alpha,2,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),2/14,2,14,0.111726009788224,0.707972353482163,0,0,3.45901072293324,7.581133677085,ALG6;ALG1
alpha,2,fatty acid transport (GO:0015908),2/14,2,14,0.111726009788224,0.707972353482163,0,0,3.45901072293324,7.581133677085,GOT2;PPARD
alpha,2,histone H4-K16 acetylation (GO:0043984),2/14,2,14,0.111726009788224,0.707972353482163,0,0,3.45901072293324,7.581133677085,KANSL3;MSL1
alpha,2,regulation of DNA replication (GO:0006275),5/62,5,62,0.112498842837452,0.711082911368557,0,0,1.95266734359135,4.2662117145979,KITLG;CDC6;NF2;CALR;HRAS
alpha,2,regulation of dendrite morphogenesis (GO:0048814),4/45,4,45,0.113990753751686,0.713012358609497,0,0,2.15227333871402,4.67395844243934,EPHA4;CUX1;NEDD4;YWHAH
alpha,2,histone modification (GO:0016570),7/99,7,99,0.1151770596423,0.713012358609497,0,0,1.71203561034069,3.70019634583092,HDAC5;KANSL3;EHMT1;BAZ2A;PHB;UBE2A;ATXN7L3
alpha,2,neuron projection extension (GO:1990138),3/29,3,29,0.116138325550719,0.713012358609497,0,0,2.50480086833097,5.39276948313264,CYFIP1;CPNE1;ULK2
alpha,2,regulation of TORC1 signaling (GO:1903432),3/29,3,29,0.116138325550719,0.713012358609497,0,0,2.50480086833097,5.39276948313264,DYRK3;RRAGC;LARS
alpha,2,aerobic respiration (GO:0009060),3/29,3,29,0.116138325550719,0.713012358609497,0,0,2.50480086833097,5.39276948313264,NDUFS7;COX6A1;SIRT3
alpha,2,positive regulation of protein tyrosine kinase activity (GO:0061098),3/29,3,29,0.116138325550719,0.713012358609497,0,0,2.50480086833097,5.39276948313264,PTPN1;EPHA4;ERBB3
alpha,2,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),3/29,3,29,0.116138325550719,0.713012358609497,0,0,2.50480086833097,5.39276948313264,CALR;B2M;SEC24C
alpha,2,regulation of actin polymerization or depolymerization (GO:0008064),3/29,3,29,0.116138325550719,0.713012358609497,0,0,2.50480086833097,5.39276948313264,SSH2;PFN1;SSH1
alpha,2,ERBB signaling pathway (GO:0038127),6/81,6,81,0.117877149663958,0.713012358609497,0,0,1.79356111559501,3.83483508453947,ERBB3;NRG4;MAPK1;PTPN11;PTPN12;HRAS
alpha,2,regulation of protein serine/threonine kinase activity (GO:0071900),6/81,6,81,0.117877149663958,0.713012358609497,0,0,1.79356111559501,3.83483508453947,HGS;MST1;CIB1;CDC6;CDK12;CDC25A
alpha,2,establishment of protein localization to organelle (GO:0072594),5/63,5,63,0.118300716273529,0.713012358609497,0,0,1.9216726238518,4.10185912851154,RANBP1;NUTF2;NUP62CL;IPO7;TNPO3
alpha,2,hexose metabolic process (GO:0019318),4/46,4,46,0.121009714290705,0.713012358609497,0,0,2.10548478787241,4.44654058998564,BRAT1;PMM2;GDPGP1;PPARD
alpha,2,nucleus organization (GO:0006997),4/46,4,46,0.121009714290705,0.713012358609497,0,0,2.10548478787241,4.44654058998564,CHMP1A;NUP54;LEMD3;TMEM170A
alpha,2,regulation of vesicle-mediated transport (GO:0060627),9/139,9,139,0.121917780608655,0.713012358609497,0,0,1.56775306147334,3.2991926973902,RAB3B;RIMS2;PTPN1;RAB4A;RAB3D;TBC1D25;TBC1D14;MAPK1;STX4
alpha,2,brain development (GO:0007420),8/120,8,120,0.123718725711492,0.713012358609497,0,0,1.61420500403551,3.37327624051025,SRR;CENPF;PITPNM1;NCOA6;RARA;CTNS;PTPN11;TGFBR2
alpha,2,oligosaccharide metabolic process (GO:0009311),5/64,5,64,0.124240820048632,0.713012358609497,0,0,1.89164648910412,3.94509212250922,GALNT1;NEU1;MAN1B1;MGAT2;ST6GALNAC4
alpha,2,ribosomal large subunit biogenesis (GO:0042273),5/64,5,64,0.124240820048632,0.713012358609497,0,0,1.89164648910412,3.94509212250922,EBNA1BP2;NIP7;RPL23A;RPL26;RPL6
alpha,2,very long-chain fatty acid metabolic process (GO:0000038),3/30,3,30,0.12529476439826,0.713012358609497,0,0,2.42130750605327,5.02926441279457,ACADVL;ELOVL4;ACOT2
alpha,2,protein alkylation (GO:0008213),3/30,3,30,0.12529476439826,0.713012358609497,0,0,2.42130750605327,5.02926441279457,SNRPD3;CAMKMT;SNRPB
alpha,2,negative regulation of lymphocyte proliferation (GO:0050672),3/30,3,30,0.12529476439826,0.713012358609497,0,0,2.42130750605327,5.02926441279457,CEBPB;DLG5;GLMN
alpha,2,regulation of chromosome segregation (GO:0051983),3/30,3,30,0.12529476439826,0.713012358609497,0,0,2.42130750605327,5.02926441279457,CDC42;SPAG5;CDC6
alpha,2,semaphorin-plexin signaling pathway (GO:0071526),3/30,3,30,0.12529476439826,0.713012358609497,0,0,2.42130750605327,5.02926441279457,ARHGDIA;PLXNA2;MET
alpha,2,positive regulation of peptidyl-lysine acetylation (GO:2000758),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,PAXIP1;TADA2A
alpha,2,atrioventricular valve morphogenesis (GO:0003181),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,BMP2;TGFBR2
alpha,2,membrane repolarization during cardiac muscle cell action potential (GO:0086013),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,YWHAE;KCND3
alpha,2,phosphatidylethanolamine biosynthetic process (GO:0006646),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,PCYT2;PISD
alpha,2,epithelial cilium movement (GO:0003351),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,CCDC103;DNAAF1
alpha,2,endocardial cushion morphogenesis (GO:0003203),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,BMP2;TGFBR2
alpha,2,positive regulation of glycolytic process (GO:0045821),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,PRKAA2;ARNT
alpha,2,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,HGS;PTPN12
alpha,2,positive regulation of coenzyme metabolic process (GO:0051197),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,PRKAA2;ARNT
alpha,2,"protein localization to chromosome, centromeric region (GO:0071459)",2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,MTBP;BOD1
alpha,2,intracellular lipid transport (GO:0032365),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,PRKAA2;CPT2
alpha,2,cardiac muscle cell differentiation (GO:0055007),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,BMP2;CBY1
alpha,2,regulation of centriole replication (GO:0046599),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,TRIM37;CEP76
alpha,2,intra-S DNA damage checkpoint (GO:0031573),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,EME1;ORAOV1
alpha,2,response to cholesterol (GO:0070723),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,ABCA2;TGFBR2
alpha,2,N-terminal protein amino acid acetylation (GO:0006474),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,NAA60;NAA40
alpha,2,regulation of mitotic sister chromatid separation (GO:0010965),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,CDC6;ANAPC1
alpha,2,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,MAD2L2;RPS27L
alpha,2,positive regulation of cellular response to insulin stimulus (GO:1900078),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,PTPN11;PRKCZ
alpha,2,JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,PTPN1;MAPK1
alpha,2,negative regulation of mRNA processing (GO:0050686),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,U2AF2;RNPS1
alpha,2,positive regulation of protein export from nucleus (GO:0046827),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,YWHAE;RBM22
alpha,2,establishment of protein localization to endoplasmic reticulum (GO:0072599),2/15,2,15,0.125526362895566,0.713012358609497,0,0,3.22841000807102,6.69972390494769,PMM2;SRP68
alpha,2,DNA replication (GO:0006260),8/121,8,121,0.128001861035085,0.71579670042175,0,0,1.60086446681208,3.29091385481218,RFC5;FEN1;ORC6;NCOA6;POLD1;CDC6;BAZ1A;CDC25A
alpha,2,cellular response to ionizing radiation (GO:0071479),4/47,4,47,0.128209053140128,0.71579670042175,0,0,2.06068723919427,4.23284347982312,YAP1;RPL26;MAPK14;HRAS
alpha,2,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",4/47,4,47,0.128209053140128,0.71579670042175,0,0,2.06068723919427,4.23284347982312,NDUFA7;NDUFB6;NDUFS7;NDUFS6
alpha,2,negative regulation of autophagy (GO:0010507),4/47,4,47,0.128209053140128,0.71579670042175,0,0,2.06068723919427,4.23284347982312,LARS;TBC1D14;BMF;MET
alpha,2,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",6/83,6,83,0.128287116808339,0.71579670042175,0,0,1.75034277546019,3.594301631303,PLK3;PAXIP1;BCL3;E2F1;RPS27L;RPL26
alpha,2,positive regulation of cell cycle (GO:0045787),6/83,6,83,0.128287116808339,0.71579670042175,0,0,1.75034277546019,3.594301631303,FOXA1;RPS6KB1;USP2;RARA;CALR;TBX3
alpha,2,"retrograde transport, endosome to Golgi (GO:0042147)",6/83,6,83,0.128287116808339,0.71579670042175,0,0,1.75034277546019,3.594301631303,VPS51;VPS53;TBC1D14;VPS35;VPS26A;PLEKHJ1
alpha,2,positive regulation of DNA metabolic process (GO:0051054),6/83,6,83,0.128287116808339,0.71579670042175,0,0,1.75034277546019,3.594301631303,RTEL1;KITLG;H2AFX;CEBPG;CALR;HRAS
alpha,2,modification-dependent protein catabolic process (GO:0019941),9/142,9,142,0.133867858788964,0.717964182430455,0,0,1.53463151792109,3.08599373293098,RANBP1;SMURF2;PSMD13;NEDD4;PSMD3;UBE2A;NTAN1;FBXO7;SQSTM1
alpha,2,regulation of actin cytoskeleton reorganization (GO:2000249),3/31,3,31,0.134700928092971,0.717964182430455,0,0,2.34320081230961,4.6974106979197,CDC42;ARHGDIA;HRAS
alpha,2,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),3/31,3,31,0.134700928092971,0.717964182430455,0,0,2.34320081230961,4.6974106979197,HDAC5;CIB1;KLF4
alpha,2,hippo signaling (GO:0035329),3/31,3,31,0.134700928092971,0.717964182430455,0,0,2.34320081230961,4.6974106979197,YAP1;YWHAE;NPHP4
alpha,2,regulation of leukocyte chemotaxis (GO:0002688),3/31,3,31,0.134700928092971,0.717964182430455,0,0,2.34320081230961,4.6974106979197,ZNF580;MST1;SLC8B1
alpha,2,activation of JUN kinase activity (GO:0007257),3/31,3,31,0.134700928092971,0.717964182430455,0,0,2.34320081230961,4.6974106979197,TAOK1;MAP2K7;MAPK8IP3
alpha,2,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),3/31,3,31,0.134700928092971,0.717964182430455,0,0,2.34320081230961,4.6974106979197,YAP1;FOXA1;WBP2
alpha,2,nuclear envelope organization (GO:0006998),3/31,3,31,0.134700928092971,0.717964182430455,0,0,2.34320081230961,4.6974106979197,NSFL1C;LEMD3;TMEM170A
alpha,2,regulation of sodium ion transmembrane transport (GO:1902305),3/31,3,31,0.134700928092971,0.717964182430455,0,0,2.34320081230961,4.6974106979197,FXYD2;UTRN;YWHAH
alpha,2,negative regulation of cellular biosynthetic process (GO:0031327),4/48,4,48,0.135582444694572,0.717964182430455,0,0,2.01775625504439,4.03183086311814,ACADVL;MST1;CLK2;ASB1
alpha,2,regulation of organelle assembly (GO:1902115),4/48,4,48,0.135582444694572,0.717964182430455,0,0,2.01775625504439,4.03183086311814,MTMR3;IFT140;TBC1D14;CEP76
alpha,2,postreplication repair (GO:0006301),4/48,4,48,0.135582444694572,0.717964182430455,0,0,2.01775625504439,4.03183086311814,RFC5;POLD1;UBE2A;UBE2V1
alpha,2,negative regulation of JAK-STAT cascade (GO:0046426),4/48,4,48,0.135582444694572,0.717964182430455,0,0,2.01775625504439,4.03183086311814,HGS;BCL3;LRRC4;NF2
alpha,2,regulation of JAK-STAT cascade (GO:0046425),5/66,5,66,0.136522944609347,0.717964182430455,0,0,1.83432386822217,3.65262048959369,HGS;DOT1L;BCL3;LRRC4;NF2
alpha,2,protein localization to microtubule organizing center (GO:1905508),2/16,2,16,0.1397028128214,0.717964182430455,0,0,3.02663438256659,5.95713643521383,SPAG5;KIAA0753
alpha,2,glucose transmembrane transport (GO:1904659),2/16,2,16,0.1397028128214,0.717964182430455,0,0,3.02663438256659,5.95713643521383,SLC2A1;PPARD
alpha,2,DNA alkylation (GO:0006305),2/16,2,16,0.1397028128214,0.717964182430455,0,0,3.02663438256659,5.95713643521383,EHMT1;BAZ2A
alpha,2,protein deacylation (GO:0035601),2/16,2,16,0.1397028128214,0.717964182430455,0,0,3.02663438256659,5.95713643521383,HDAC5;SIRT3
alpha,2,positive regulation of mRNA processing (GO:0050685),2/16,2,16,0.1397028128214,0.717964182430455,0,0,3.02663438256659,5.95713643521383,NCBP1;HSPA1A
alpha,2,DNA methylation or demethylation (GO:0044728),2/16,2,16,0.1397028128214,0.717964182430455,0,0,3.02663438256659,5.95713643521383,EHMT1;BAZ2A
alpha,2,positive regulation of myotube differentiation (GO:0010831),2/16,2,16,0.1397028128214,0.717964182430455,0,0,3.02663438256659,5.95713643521383,MAML1;MAPK14
alpha,2,negative regulation of DNA replication (GO:0008156),2/16,2,16,0.1397028128214,0.717964182430455,0,0,3.02663438256659,5.95713643521383,CDC6;NF2
alpha,2,rRNA transcription (GO:0009303),2/16,2,16,0.1397028128214,0.717964182430455,0,0,3.02663438256659,5.95713643521383,GTF3C4;TAF1B
alpha,2,genitalia development (GO:0048806),2/16,2,16,0.1397028128214,0.717964182430455,0,0,3.02663438256659,5.95713643521383,PTPN11;TBX3
alpha,2,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),2/16,2,16,0.1397028128214,0.717964182430455,0,0,3.02663438256659,5.95713643521383,LSM10;CDC6
alpha,2,activation of protein kinase A activity (GO:0034199),2/16,2,16,0.1397028128214,0.717964182430455,0,0,3.02663438256659,5.95713643521383,ADCY9;PRKAR1B
alpha,2,inner dynein arm assembly (GO:0036159),2/16,2,16,0.1397028128214,0.717964182430455,0,0,3.02663438256659,5.95713643521383,CCDC103;DNAAF1
alpha,2,cellular response to light stimulus (GO:0071482),5/67,5,67,0.142858207351031,0.717964182430455,0,0,1.80694590003975,3.51614090135134,POLD1;NEDD4;BMF;RPL26;CDC25A
alpha,2,positive regulation of cellular protein localization (GO:1903829),5/67,5,67,0.142858207351031,0.717964182430455,0,0,1.80694590003975,3.51614090135134,PLK3;CEP250;STX4;CENPQ;OAZ2
alpha,2,interstrand cross-link repair (GO:0036297),4/49,4,49,0.143123369016579,0.717964182430455,0,0,1.97657755596185,3.84256223799163,EME1;FANCL;FANCC;FAN1
alpha,2,positive regulation of chemotaxis (GO:0050921),4/49,4,49,0.143123369016579,0.717964182430455,0,0,1.97657755596185,3.84256223799163,ZNF580;STX4;MET;PPM1F
alpha,2,regulation of cellular response to stress (GO:0080135),7/105,7,105,0.143761206527387,0.717964182430455,0,0,1.61420500403551,3.1309146794058,YWHAE;DNAJB1;DYRK3;HSPA1L;MAPK1;NUP54;HSPA1A
alpha,2,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),3/32,3,32,0.144341393487648,0.717964182430455,0,0,2.26997578692494,4.39370610740398,NFKBIL1;RARA;CACTIN
alpha,2,alpha-amino acid metabolic process (GO:1901605),3/32,3,32,0.144341393487648,0.717964182430455,0,0,2.26997578692494,4.39370610740398,SRR;SLC6A8;MUT
alpha,2,regulation of glucose import (GO:0046324),3/32,3,32,0.144341393487648,0.717964182430455,0,0,2.26997578692494,4.39370610740398,AKT2;PEA15;ARPP19
alpha,2,regulation of protein tyrosine kinase activity (GO:0061097),3/32,3,32,0.144341393487648,0.717964182430455,0,0,2.26997578692494,4.39370610740398,PTPN1;EPHA4;ERBB3
alpha,2,skeletal system morphogenesis (GO:0048705),3/32,3,32,0.144341393487648,0.717964182430455,0,0,2.26997578692494,4.39370610740398,IFT140;RARA;FUZ
alpha,2,positive regulation of synaptic transmission (GO:0050806),5/68,5,68,0.14931820527107,0.717964182430455,0,0,1.78037316621564,3.38569228805588,RIMS2;UNC13B;STX4;SQSTM1;PRKCZ
alpha,2,cilium movement (GO:0003341),4/50,4,50,0.150825137464948,0.717964182430455,0,0,1.93704600484261,3.6641823597783,DNAAF1;CCDC103;PIH1D3;TMEM141
alpha,2,cellular response to glucagon stimulus (GO:0071377),3/33,3,33,0.154200726989887,0.717964182430455,0,0,2.20118864186661,4.11512239329367,ADCY9;PRKAR1B;GNB2
alpha,2,regulation of potassium ion transmembrane transport (GO:1901379),3/33,3,33,0.154200726989887,0.717964182430455,0,0,2.20118864186661,4.11512239329367,YWHAE;NEDD4;KCNAB2
alpha,2,phagosome maturation (GO:0090382),3/33,3,33,0.154200726989887,0.717964182430455,0,0,2.20118864186661,4.11512239329367,ATP6V1G2;ATP6V0D1;ATP6V0A1
alpha,2,purine ribonucleoside triphosphate metabolic process (GO:0009205),3/33,3,33,0.154200726989887,0.717964182430455,0,0,2.20118864186661,4.11512239329367,OPA1;CTNS;HSPA1A
alpha,2,positive regulation of telomere maintenance via telomerase (GO:0032212),3/33,3,33,0.154200726989887,0.717964182430455,0,0,2.20118864186661,4.11512239329367,MAPK1;CCT7;MAP2K7
alpha,2,positive regulation of telomere maintenance (GO:0032206),3/33,3,33,0.154200726989887,0.717964182430455,0,0,2.20118864186661,4.11512239329367,RTEL1;MAPK1;MAP2K7
alpha,2,positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,VPS35;PHB
alpha,2,regulation of telomere maintenance via telomere lengthening (GO:1904356),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,RTEL1;SMG6
alpha,2,N-terminal protein amino acid modification (GO:0031365),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,NAA60;NAA40
alpha,2,negative regulation of telomere maintenance (GO:0032205),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,RTEL1;SMG6
alpha,2,histone H2A ubiquitination (GO:0033522),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,TRIM37;UBE2A
alpha,2,DNA packaging (GO:0006323),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,CHAF1A;HAT1
alpha,2,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,SLC35F6;HSPA1A
alpha,2,positive regulation of striated muscle cell differentiation (GO:0051155),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,MAML1;MAPK14
alpha,2,negative regulation of lipid biosynthetic process (GO:0051055),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,ACADVL;BMP2
alpha,2,histone H2A monoubiquitination (GO:0035518),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,PCGF2;TRIM37
alpha,2,N-glycan processing (GO:0006491),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,MGAT4A;MAN1B1
alpha,2,negative regulation of intracellular transport (GO:0032387),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,SLC35F6;HSPA1A
alpha,2,negative regulation of stress fiber assembly (GO:0051497),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,PFN1;MET
alpha,2,negative regulation of cellular carbohydrate metabolic process (GO:0010677),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,MST1;CLK2
alpha,2,DNA replication checkpoint (GO:0000076),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,CDC6;ORAOV1
alpha,2,3'-UTR-mediated mRNA stabilization (GO:0070935),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,MAPK14;TARDBP
alpha,2,response to purine-containing compound (GO:0014074),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,VGF;JUNB
alpha,2,regulation of synaptic vesicle exocytosis (GO:2000300),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,RIMS2;PREPL
alpha,2,positive regulation of cartilage development (GO:0061036),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,BMP2;GDF5
alpha,2,regulation of early endosome to late endosome transport (GO:2000641),2/17,2,17,0.154200854226509,0.717964182430455,0,0,2.84859706594502,5.32545015848832,SNX3;MAPK1
alpha,2,regulation of cellular protein metabolic process (GO:0032268),4/51,4,51,0.158680917076643,0.717964182430455,0,0,1.89906471063001,3.49591208079299,CYFIP1;VPS35;KLF4;SSH1
alpha,2,myeloid leukocyte differentiation (GO:0002573),4/51,4,51,0.158680917076643,0.717964182430455,0,0,1.89906471063001,3.49591208079299,CDC42;THOC5;MAPK14;TGFBR2
alpha,2,negative regulation of protein ubiquitination (GO:0031397),4/51,4,51,0.158680917076643,0.717964182430455,0,0,1.89906471063001,3.49591208079299,USP4;U2AF2;SGTA;HSPA1A
alpha,2,positive regulation of epithelial cell proliferation (GO:0050679),7/108,7,108,0.159211378814539,0.717964182430455,0,0,1.56936597614564,2.88374534394283,BMP2;ZNF580;FZD7;MST1;ARNT;LAMC1;HRAS
alpha,2,non-canonical Wnt signaling pathway (GO:0035567),8/128,8,128,0.160056058084048,0.717964182430455,0,0,1.51331719128329,2.77274691598941,CDC42;SMURF2;PSMD13;PSME3;FZD7;PSMD3;PFN1;AP2M1
alpha,2,positive regulation of neurogenesis (GO:0050769),5/70,5,70,0.162597483401752,0.717964182430455,0,0,1.72950536146662,3.14160767765859,SPEN;BRINP2;BMP2;CPNE1;TCF4
alpha,2,response to organic cyclic compound (GO:0014070),5/70,5,70,0.162597483401752,0.717964182430455,0,0,1.72950536146662,3.14160767765859,FOXA1;ABCA2;TP53I13;MAPK1;HID1
alpha,2,intracellular pH reduction (GO:0051452),3/34,3,34,0.164263546857089,0.717964182430455,0,0,2.13644779945877,3.85902965665552,ATP6V1G2;ATP6V0D1;ATP6V0A1
alpha,2,protein acetylation (GO:0006473),3/34,3,34,0.164263546857089,0.717964182430455,0,0,2.13644779945877,3.85902965665552,NAA60;NAA40;HAT1
alpha,2,negative regulation of mitochondrion organization (GO:0010823),3/34,3,34,0.164263546857089,0.717964182430455,0,0,2.13644779945877,3.85902965665552,SLC35F6;OPA1;HSPA1A
alpha,2,regulation of cell-substrate adhesion (GO:0010810),3/34,3,34,0.164263546857089,0.717964182430455,0,0,2.13644779945877,3.85902965665552,FZD7;TBCD;PPM1F
alpha,2,positive regulation of cell-matrix adhesion (GO:0001954),3/34,3,34,0.164263546857089,0.717964182430455,0,0,2.13644779945877,3.85902965665552,CIB1;UTRN;PPM1F
alpha,2,positive regulation of nucleocytoplasmic transport (GO:0046824),3/34,3,34,0.164263546857089,0.717964182430455,0,0,2.13644779945877,3.85902965665552,YWHAE;NEDD4;RBM22
alpha,2,negative regulation of multi-organism process (GO:0043901),3/34,3,34,0.164263546857089,0.717964182430455,0,0,2.13644779945877,3.85902965665552,NFKBIL1;CALR;CACTIN
alpha,2,positive regulation of locomotion (GO:0040017),3/34,3,34,0.164263546857089,0.717964182430455,0,0,2.13644779945877,3.85902965665552,AKT2;STX4;PPM1F
alpha,2,regulation of intracellular protein transport (GO:0033157),3/34,3,34,0.164263546857089,0.717964182430455,0,0,2.13644779945877,3.85902965665552,PTPN1;PLK3;OAZ2
alpha,2,monocarboxylic acid metabolic process (GO:0032787),7/109,7,109,0.164522971931161,0.717964182430455,0,0,1.55496812315348,2.80625885792024,GNPAT;GRHPR;BTD;AASDH;FASN;GOT2;ACOT2
alpha,2,regulation of exocytosis (GO:0017157),4/52,4,52,0.166683754261319,0.717964182430455,0,0,1.86254423542559,3.33704032206282,RAB3B;RIMS2;RAB3D;STX4
alpha,2,regulation of cellular amine metabolic process (GO:0033238),4/52,4,52,0.166683754261319,0.717964182430455,0,0,1.86254423542559,3.33704032206282,PSMD13;PSME3;PSMD3;OAZ2
alpha,2,regulation of telomere maintenance via telomerase (GO:0032210),4/52,4,52,0.166683754261319,0.717964182430455,0,0,1.86254423542559,3.33704032206282,MAPK1;CCT7;MAP2K7;SMG6
alpha,2,regulation of cellular amino acid metabolic process (GO:0006521),4/52,4,52,0.166683754261319,0.717964182430455,0,0,1.86254423542559,3.33704032206282,PSMD13;PSME3;PSMD3;OAZ2
alpha,2,coenzyme metabolic process (GO:0006732),4/52,4,52,0.166683754261319,0.717964182430455,0,0,1.86254423542559,3.33704032206282,SLC25A16;PANK1;FASN;ACOT2
alpha,2,protein localization to centrosome (GO:0071539),2/18,2,18,0.168969832710465,0.717964182430455,0,0,2.69034167339252,4.7835218850275,SPAG5;KIAA0753
alpha,2,anion transmembrane transport (GO:0098656),2/18,2,18,0.168969832710465,0.717964182430455,0,0,2.69034167339252,4.7835218850275,SLC25A16;SLC35B1
alpha,2,glucan biosynthetic process (GO:0009250),2/18,2,18,0.168969832710465,0.717964182430455,0,0,2.69034167339252,4.7835218850275,NHLRC1;PGM2L1
alpha,2,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),2/18,2,18,0.168969832710465,0.717964182430455,0,0,2.69034167339252,4.7835218850275,NFKBIL1;CACTIN
alpha,2,negative regulation of RNA splicing (GO:0033119),2/18,2,18,0.168969832710465,0.717964182430455,0,0,2.69034167339252,4.7835218850275,U2AF2;RNPS1
alpha,2,regulation of dephosphorylation (GO:0035303),2/18,2,18,0.168969832710465,0.717964182430455,0,0,2.69034167339252,4.7835218850275,MTMR3;SMG6
alpha,2,anion homeostasis (GO:0055081),2/18,2,18,0.168969832710465,0.717964182430455,0,0,2.69034167339252,4.7835218850275,PRKAA2;POLD1
alpha,2,negative regulation of microtubule depolymerization (GO:0007026),2/18,2,18,0.168969832710465,0.717964182430455,0,0,2.69034167339252,4.7835218850275,CIB1;CAMSAP2
alpha,2,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),2/18,2,18,0.168969832710465,0.717964182430455,0,0,2.69034167339252,4.7835218850275,ALG6;ALG1
alpha,2,positive regulation of actin cytoskeleton reorganization (GO:2000251),2/18,2,18,0.168969832710465,0.717964182430455,0,0,2.69034167339252,4.7835218850275,CDC42;HRAS
alpha,2,glycogen biosynthetic process (GO:0005978),2/18,2,18,0.168969832710465,0.717964182430455,0,0,2.69034167339252,4.7835218850275,NHLRC1;PGM2L1
alpha,2,DNA methylation (GO:0006306),2/18,2,18,0.168969832710465,0.717964182430455,0,0,2.69034167339252,4.7835218850275,EHMT1;BAZ2A
alpha,2,positive regulation of carbohydrate metabolic process (GO:0045913),2/18,2,18,0.168969832710465,0.717964182430455,0,0,2.69034167339252,4.7835218850275,PRKAA2;ARNT
alpha,2,establishment of epithelial cell polarity (GO:0090162),2/18,2,18,0.168969832710465,0.717964182430455,0,0,2.69034167339252,4.7835218850275,CDC42;CYTH3
alpha,2,snRNA metabolic process (GO:0016073),2/18,2,18,0.168969832710465,0.717964182430455,0,0,2.69034167339252,4.7835218850275,SNAPC2;RPAP2
alpha,2,response to organophosphorus (GO:0046683),2/18,2,18,0.168969832710465,0.717964182430455,0,0,2.69034167339252,4.7835218850275,VGF;JUNB
alpha,2,mRNA destabilization (GO:0061157),2/18,2,18,0.168969832710465,0.717964182430455,0,0,2.69034167339252,4.7835218850275,YTHDF2;METTL16
alpha,2,snRNA transcription (GO:0009301),5/71,5,71,0.169409034448625,0.717964182430455,0,0,1.70514613102343,3.02738322501124,NCBP1;SNAPC2;TAF8;RPRD1B;RPAP2
alpha,2,snRNA transcription from RNA polymerase II promoter (GO:0042795),5/71,5,71,0.169409034448625,0.717964182430455,0,0,1.70514613102343,3.02738322501124,NCBP1;SNAPC2;TAF8;RPRD1B;RPAP2
alpha,2,regulation of double-strand break repair (GO:2000779),3/35,3,35,0.174514578999336,0.717964182430455,0,0,2.07540643375994,3.62313454214197,RTEL1;RNF169;DDX11
alpha,2,negative regulation of T cell activation (GO:0050868),3/35,3,35,0.174514578999336,0.717964182430455,0,0,2.07540643375994,3.62313454214197,CEBPB;DLG5;GLMN
alpha,2,regulation of insulin receptor signaling pathway (GO:0046626),3/35,3,35,0.174514578999336,0.717964182430455,0,0,2.07540643375994,3.62313454214197,PTPN1;RPS6KB1;PRKCZ
alpha,2,response to glucagon (GO:0033762),3/35,3,35,0.174514578999336,0.717964182430455,0,0,2.07540643375994,3.62313454214197,ADCY9;PRKAR1B;GNB2
alpha,2,regulation of interferon-beta production (GO:0032648),3/35,3,35,0.174514578999336,0.717964182430455,0,0,2.07540643375994,3.62313454214197,RNF135;MAVS;CACTIN
alpha,2,positive regulation of mitotic cell cycle (GO:0045931),4/53,4,53,0.174826597201003,0.717964182430455,0,0,1.82740189136096,3.18691702578476,FOXA1;DYNC1LI1;RPS6KB1;USP2
alpha,2,macroautophagy (GO:0016236),7/111,7,111,0.175378311968808,0.717964182430455,0,0,1.52695067949305,2.65813079198319,BECN1;MAP1LC3B;MTMR3;PRKAA2;HGS;LIX1L;SQSTM1
alpha,2,lipid transport (GO:0006869),6/92,6,92,0.180161654299741,0.717964182430455,0,0,1.57911359090431,2.70644397044054,ABCA2;PITPNM1;ABCA3;SLC10A3;GOT2;PPARD
alpha,2,negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),4/54,4,54,0.183102317434802,0.717964182430455,0,0,1.79356111559501,3.04494694775325,SMURF2;LEMD3;TGFBR2;HSPA1A
alpha,2,monocarboxylic acid transport (GO:0015718),4/54,4,54,0.183102317434802,0.717964182430455,0,0,1.79356111559501,3.04494694775325,SLC10A3;GOT2;PPARD;SLC16A13
alpha,2,negative regulation of cell cycle (GO:0045786),5/73,5,73,0.18335593983192,0.717964182430455,0,0,1.65842979866662,2.81323756816387,BRINP2;BMP2;TP53I13;CHMP1A;IPO7
alpha,2,regulation of mitotic spindle assembly (GO:1901673),2/19,2,19,0.183962720279711,0.717964182430455,0,0,2.54874474321397,4.31508130260288,CHMP1A;HSPA1A
alpha,2,organelle fusion (GO:0048284),2/19,2,19,0.183962720279711,0.717964182430455,0,0,2.54874474321397,4.31508130260288,OPA1;STX4
alpha,2,regulation of long-term synaptic potentiation (GO:1900271),2/19,2,19,0.183962720279711,0.717964182430455,0,0,2.54874474321397,4.31508130260288,EPHA4;SQSTM1
alpha,2,negative regulation of double-strand break repair (GO:2000780),2/19,2,19,0.183962720279711,0.717964182430455,0,0,2.54874474321397,4.31508130260288,RNF169;NUDT16L1
alpha,2,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),2/19,2,19,0.183962720279711,0.717964182430455,0,0,2.54874474321397,4.31508130260288,EPHA4;SGTA
alpha,2,sulfur compound transport (GO:0072348),2/19,2,19,0.183962720279711,0.717964182430455,0,0,2.54874474321397,4.31508130260288,SLC25A26;SLC35F3
alpha,2,regulation of mitochondrial fission (GO:0090140),2/19,2,19,0.183962720279711,0.717964182430455,0,0,2.54874474321397,4.31508130260288,VPS35;MYO19
alpha,2,nucleosome disassembly (GO:0006337),2/19,2,19,0.183962720279711,0.717964182430455,0,0,2.54874474321397,4.31508130260288,SMARCD2;HIST3H2A
alpha,2,regulation of transcription factor import into nucleus (GO:0042990),2/19,2,19,0.183962720279711,0.717964182430455,0,0,2.54874474321397,4.31508130260288,MAVS;BCL3
alpha,2,chromatin disassembly (GO:0031498),2/19,2,19,0.183962720279711,0.717964182430455,0,0,2.54874474321397,4.31508130260288,SMARCD2;HIST3H2A
alpha,2,striated muscle cell differentiation (GO:0051146),2/19,2,19,0.183962720279711,0.717964182430455,0,0,2.54874474321397,4.31508130260288,BMP2;CBY1
alpha,2,histone deubiquitination (GO:0016578),2/19,2,19,0.183962720279711,0.717964182430455,0,0,2.54874474321397,4.31508130260288,USP49;ATXN7L3
alpha,2,positive regulation of excitatory postsynaptic potential (GO:2000463),2/19,2,19,0.183962720279711,0.717964182430455,0,0,2.54874474321397,4.31508130260288,RIMS2;PRKCZ
alpha,2,positive regulation of immunoglobulin production (GO:0002639),2/19,2,19,0.183962720279711,0.717964182430455,0,0,2.54874474321397,4.31508130260288,PAXIP1;STX4
alpha,2,negative regulation of calcium ion transport (GO:0051926),2/19,2,19,0.183962720279711,0.717964182430455,0,0,2.54874474321397,4.31508130260288,YWHAE;SLC30A1
alpha,2,hexose transmembrane transport (GO:0035428),2/19,2,19,0.183962720279711,0.717964182430455,0,0,2.54874474321397,4.31508130260288,SLC2A1;PPARD
alpha,2,mitochondrial membrane organization (GO:0007006),2/19,2,19,0.183962720279711,0.717964182430455,0,0,2.54874474321397,4.31508130260288,OPA1;COX18
alpha,2,regulation of heart rate by cardiac conduction (GO:0086091),3/36,3,36,0.184938706632149,0.717964182430455,0,0,2.01775625504439,3.40542942756823,YWHAE;DSP;KCND3
alpha,2,negative regulation of cell-substrate adhesion (GO:0010812),3/36,3,36,0.184938706632149,0.717964182430455,0,0,2.01775625504439,3.40542942756823,FZD7;TBCD;NF2
alpha,2,regulation of microtubule polymerization (GO:0031113),3/36,3,36,0.184938706632149,0.717964182430455,0,0,2.01775625504439,3.40542942756823,TBCD;MET;CAMSAP2
alpha,2,anatomical structure homeostasis (GO:0060249),3/36,3,36,0.184938706632149,0.717964182430455,0,0,2.01775625504439,3.40542942756823,RTEL1;RAD51D;POLD1
alpha,2,positive regulation of DNA replication (GO:0045740),3/36,3,36,0.184938706632149,0.717964182430455,0,0,2.01775625504439,3.40542942756823,KITLG;CALR;HRAS
alpha,2,regulation of sodium ion transport (GO:0002028),3/36,3,36,0.184938706632149,0.717964182430455,0,0,2.01775625504439,3.40542942756823,SPTBN4;NEDD4;YWHAH
alpha,2,positive regulation of ATPase activity (GO:0032781),3/36,3,36,0.184938706632149,0.717964182430455,0,0,2.01775625504439,3.40542942756823,DNAJB1;DNAJC24;PFN1
alpha,2,positive regulation of telomerase activity (GO:0051973),3/36,3,36,0.184938706632149,0.717964182430455,0,0,2.01775625504439,3.40542942756823,MAPK1;MAP2K7;KLF4
alpha,2,negative regulation of tumor necrosis factor production (GO:0032720),3/36,3,36,0.184938706632149,0.717964182430455,0,0,2.01775625504439,3.40542942756823,NFKBIL1;RARA;CACTIN
alpha,2,positive regulation of cellular metabolic process (GO:0031325),6/93,6,93,0.186386556508789,0.717964182430455,0,0,1.56213387487308,2.62427946741468,ATAD1;FASN;ROMO1;MAPK14;KLF4;TGFBR2
alpha,2,nucleic acid phosphodiester bond hydrolysis (GO:0090305),5/74,5,74,0.190483047768876,0.717964182430455,0,0,1.63601858517113,2.71283305488016,RFC5;FEN1;ERI2;POLD1;FAN1
alpha,2,negative regulation of cellular component organization (GO:0051129),4/55,4,55,0.191503730240346,0.717964182430455,0,0,1.76095091349329,2.91058418047861,CDC42;DNAJB1;PRKCZ;HSPA1A
alpha,2,negative regulation of supramolecular fiber organization (GO:1902904),4/55,4,55,0.191503730240346,0.717964182430455,0,0,1.76095091349329,2.91058418047861,TBCD;CIB1;PFN1;CAMSAP2
alpha,2,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),6/94,6,94,0.192694164323933,0.717964182430455,0,0,1.5455154293957,2.54492450840828,DNAJB1;PSMD13;PSME3;PSMD3;ARNT;HSPA1A
alpha,2,regulation of smoothened signaling pathway (GO:0008589),3/37,3,37,0.195521014338644,0.717964182430455,0,0,1.96322230220535,3.2041504124929,DLG5;TUBD1;FUZ
alpha,2,transferrin transport (GO:0033572),3/37,3,37,0.195521014338644,0.717964182430455,0,0,1.96322230220535,3.2041504124929,ATP6V1G2;ATP6V0D1;ATP6V0A1
alpha,2,organophosphate biosynthetic process (GO:0090407),3/37,3,37,0.195521014338644,0.717964182430455,0,0,1.96322230220535,3.2041504124929,GNPAT;NFS1;PCYT2
alpha,2,mRNA catabolic process (GO:0006402),3/37,3,37,0.195521014338644,0.717964182430455,0,0,1.96322230220535,3.2041504124929,NBAS;METTL16;HSPA1A
alpha,2,heart looping (GO:0001947),3/37,3,37,0.195521014338644,0.717964182430455,0,0,1.96322230220535,3.2041504124929,CCDC103;DNAAF1;TGFBR2
alpha,2,histone deacetylation (GO:0016575),3/37,3,37,0.195521014338644,0.717964182430455,0,0,1.96322230220535,3.2041504124929,HDAC5;BAZ2A;PHB
alpha,2,ferric iron transport (GO:0015682),3/37,3,37,0.195521014338644,0.717964182430455,0,0,1.96322230220535,3.2041504124929,ATP6V1G2;ATP6V0D1;ATP6V0A1
alpha,2,cardiac muscle tissue development (GO:0048738),3/37,3,37,0.195521014338644,0.717964182430455,0,0,1.96322230220535,3.2041504124929,BMP2;MAML1;CBY1
alpha,2,"regulation of gene expression, epigenetic (GO:0040029)",5/75,5,75,0.197706984750918,0.717964182430455,0,0,1.61420500403551,2.61657662530991,HDAC5;TAF1B;WBP2;GLMN;SLC50A1
alpha,2,vacuolar acidification (GO:0007035),2/20,2,20,0.19913590286706,0.717964182430455,0,0,2.42130750605327,3.90742798636155,ATP6V0D1;ATP6V0A1
alpha,2,regulation of vacuole organization (GO:0044088),2/20,2,20,0.19913590286706,0.717964182430455,0,0,2.42130750605327,3.90742798636155,MTMR3;TBC1D14
alpha,2,cell projection assembly (GO:0030031),2/20,2,20,0.19913590286706,0.717964182430455,0,0,2.42130750605327,3.90742798636155,CDC42;CYFIP1
alpha,2,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),2/20,2,20,0.19913590286706,0.717964182430455,0,0,2.42130750605327,3.90742798636155,OPA1;HSPA1A
alpha,2,negative regulation of actin filament bundle assembly (GO:0032232),2/20,2,20,0.19913590286706,0.717964182430455,0,0,2.42130750605327,3.90742798636155,PFN1;MET
alpha,2,synapsis (GO:0007129),2/20,2,20,0.19913590286706,0.717964182430455,0,0,2.42130750605327,3.90742798636155,STAG3;TRIP13
alpha,2,response to progesterone (GO:0032570),2/20,2,20,0.19913590286706,0.717964182430455,0,0,2.42130750605327,3.90742798636155,YAP1;WBP2
alpha,2,error-prone translesion synthesis (GO:0042276),2/20,2,20,0.19913590286706,0.717964182430455,0,0,2.42130750605327,3.90742798636155,RFC5;MAD2L2
alpha,2,phosphatidylethanolamine metabolic process (GO:0046337),2/20,2,20,0.19913590286706,0.717964182430455,0,0,2.42130750605327,3.90742798636155,PCYT2;PISD
alpha,2,neuromuscular junction development (GO:0007528),2/20,2,20,0.19913590286706,0.717964182430455,0,0,2.42130750605327,3.90742798636155,UNC13B;NEDD4
alpha,2,mitochondrial respiratory chain complex IV assembly (GO:0033617),2/20,2,20,0.19913590286706,0.717964182430455,0,0,2.42130750605327,3.90742798636155,COA1;COX18
alpha,2,axon extension (GO:0048675),2/20,2,20,0.19913590286706,0.717964182430455,0,0,2.42130750605327,3.90742798636155,CYFIP1;ULK2
alpha,2,negative regulation of response to biotic stimulus (GO:0002832),2/20,2,20,0.19913590286706,0.717964182430455,0,0,2.42130750605327,3.90742798636155,NFKBIL1;CACTIN
alpha,2,autophagy of nucleus (GO:0044804),2/20,2,20,0.19913590286706,0.717964182430455,0,0,2.42130750605327,3.90742798636155,BECN1;WDR45B
alpha,2,negative regulation of protein depolymerization (GO:1901880),2/20,2,20,0.19913590286706,0.717964182430455,0,0,2.42130750605327,3.90742798636155,CIB1;CAMSAP2
alpha,2,regulation of response to cytokine stimulus (GO:0060759),2/20,2,20,0.19913590286706,0.717964182430455,0,0,2.42130750605327,3.90742798636155,MAVS;KLF4
alpha,2,growth hormone receptor signaling pathway (GO:0060396),2/20,2,20,0.19913590286706,0.717964182430455,0,0,2.42130750605327,3.90742798636155,PTPN1;MAPK1
alpha,2,organelle disassembly (GO:1903008),2/20,2,20,0.19913590286706,0.717964182430455,0,0,2.42130750605327,3.90742798636155,PLK3;DYRK3
alpha,2,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),4/56,4,56,0.200023614043707,0.717964182430455,0,0,1.72950536146662,2.78332730748064,SMURF2;LEMD3;TGFBR2;HSPA1A
alpha,2,fat cell differentiation (GO:0045444),4/56,4,56,0.200023614043707,0.717964182430455,0,0,1.72950536146662,2.78332730748064,AKT2;CBY1;SDF4;KLF4
alpha,2,mitochondrial transport (GO:0006839),8/136,8,136,0.200767928527183,0.717964182430455,0,0,1.42429853297251,2.28686173253247,SLC25A16;SLC25A26;SLC25A39;DNLZ;VPS35;SLC25A12;FBXO7;ATP5G1
alpha,2,negative regulation of cell growth (GO:0030308),7/116,7,116,0.203785189854906,0.717964182430455,0,0,1.46113383985973,2.32420927941213,EPHA4;CCDC85B;DCUN1D3;OSGIN1;PHB;ACVR1B;HSPA1A
alpha,2,cellular response to oxidative stress (GO:0034599),7/116,7,116,0.203785189854906,0.717964182430455,0,0,1.46113383985973,2.32420927941213,SRXN1;ARNT;MAPK1;FANCC;ROMO1;P4HB;HSPA1A
alpha,2,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",5/76,5,76,0.205023476038631,0.717964182430455,0,0,1.59296546450873,2.52426212109519,PSMD13;PSME3;PSMD3;CALR;B2M
alpha,2,interleukin-1-mediated signaling pathway (GO:0070498),6/96,6,96,0.205546345001485,0.717964182430455,0,0,1.51331719128329,2.39419453291583,PSMD13;PSME3;PSMD3;PELI1;UBE2V1;SQSTM1
alpha,2,protein monoubiquitination (GO:0006513),3/38,3,38,0.206246827123606,0.717964182430455,0,0,1.91155855741048,3.01774239364496,FANCL;ATXN7L3;ZNF598
alpha,2,regulation of DNA repair (GO:0006282),3/38,3,38,0.206246827123606,0.717964182430455,0,0,1.91155855741048,3.01774239364496,CEBPG;H2AFX;UBE2V1
alpha,2,phospholipid biosynthetic process (GO:0008654),3/38,3,38,0.206246827123606,0.717964182430455,0,0,1.91155855741048,3.01774239364496,GNPAT;PCYT2;CPNE1
alpha,2,response to steroid hormone (GO:0048545),3/38,3,38,0.206246827123606,0.717964182430455,0,0,1.91155855741048,3.01774239364496,YAP1;ABCA2;WBP2
alpha,2,regulation of secretion by cell (GO:1903530),4/57,4,57,0.208654728853722,0.717964182430455,0,0,1.69916316214264,2.66271510666988,RAB3B;RIMS2;RAB3D;STX4
alpha,2,DNA-dependent DNA replication (GO:0006261),4/57,4,57,0.208654728853722,0.717964182430455,0,0,1.69916316214264,2.66271510666988,RFC5;ORC6;POLD1;BAZ1A
alpha,2,negative regulation of cellular catabolic process (GO:0031330),4/57,4,57,0.208654728853722,0.717964182430455,0,0,1.69916316214264,2.66271510666988,LARS;TBC1D14;BMF;MET
alpha,2,chromatin remodeling (GO:0006338),7/117,7,117,0.209668510160336,0.717964182430455,0,0,1.44864551644213,2.26311389032425,FOXA1;HDAC5;SMARCD2;TADA2A;BAZ2A;RSF1;BAZ1A
alpha,2,positive regulation of transferase activity (GO:0051347),8/138,8,138,0.211550475219761,0.717964182430455,0,0,1.40365652524827,2.18028796778285,RFC5;EPHA4;ERBB3;DCUN1D3;MAPK1;MAP2K7;KLF4;MET
alpha,2,regulation of cell death (GO:0010941),6/97,6,97,0.212085226349821,0.717964182430455,0,0,1.49771598312573,2.3226086328512,DUS2;BECN1;VPS35;PHB;JUNB;HSPA1A
alpha,2,ciliary basal body-plasma membrane docking (GO:0097711),6/97,6,97,0.212085226349821,0.717964182430455,0,0,1.49771598312573,2.3226086328512,YWHAE;HAUS8;CEP250;NPHP4;MARK4;CEP76
alpha,2,regulation of hematopoietic stem cell differentiation (GO:1902036),5/77,5,77,0.212428202339639,0.717964182430455,0,0,1.57227760133329,2.4356957627935,YAP1;YTHDF2;PSMD13;PSME3;PSMD3
alpha,2,hemopoiesis (GO:0030097),5/77,5,77,0.212428202339639,0.717964182430455,0,0,1.57227760133329,2.4356957627935,KITLG;RRAS;NCOA6;PRRC2C;TGFBR2
alpha,2,regulation of ruffle assembly (GO:1900027),2/21,2,21,0.214448979076116,0.717964182430455,0,0,2.30600714862216,3.55052099317929,PFN1;HRAS
alpha,2,histone ubiquitination (GO:0016574),2/21,2,21,0.214448979076116,0.717964182430455,0,0,2.30600714862216,3.55052099317929,UBE2A;ATXN7L3
alpha,2,negative regulation of ion transmembrane transporter activity (GO:0032413),2/21,2,21,0.214448979076116,0.717964182430455,0,0,2.30600714862216,3.55052099317929,YWHAE;NEDD4
alpha,2,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),2/21,2,21,0.214448979076116,0.717964182430455,0,0,2.30600714862216,3.55052099317929,BCL3;RPS27L
alpha,2,zinc II ion transport (GO:0006829),2/21,2,21,0.214448979076116,0.717964182430455,0,0,2.30600714862216,3.55052099317929,SLC30A1;SLC39A3
alpha,2,non-motile cilium assembly (GO:1905515),2/21,2,21,0.214448979076116,0.717964182430455,0,0,2.30600714862216,3.55052099317929,CEP250;FUZ
alpha,2,protein-DNA complex disassembly (GO:0032986),2/21,2,21,0.214448979076116,0.717964182430455,0,0,2.30600714862216,3.55052099317929,SMARCD2;HIST3H2A
alpha,2,mitochondrial respiratory chain complex IV biogenesis (GO:0097034),2/21,2,21,0.214448979076116,0.717964182430455,0,0,2.30600714862216,3.55052099317929,COA1;COX18
alpha,2,long-term synaptic potentiation (GO:0060291),2/21,2,21,0.214448979076116,0.717964182430455,0,0,2.30600714862216,3.55052099317929,STX4;PRKCZ
alpha,2,mitochondrial calcium ion transmembrane transport (GO:0006851),2/21,2,21,0.214448979076116,0.717964182430455,0,0,2.30600714862216,3.55052099317929,PHB;SLC8B1
alpha,2,positive regulation of DNA repair (GO:0045739),3/39,3,39,0.217101744332068,0.717964182430455,0,0,1.86254423542559,2.84482988905972,DDX11;CEBPG;H2AFX
alpha,2,cellular respiration (GO:0045333),4/58,4,58,0.21738983359848,0.717964182430455,0,0,1.66986724555398,2.54832273351411,NDUFS7;FASTKD2;COX6A1;SIRT3
alpha,2,protein localization to organelle (GO:0033365),6/98,6,98,0.218695439786675,0.717964182430455,0,0,1.48243316697139,2.25340989717696,MTCH2;IFT140;LMNA;CEP250;CALR;YBX1
alpha,2,negative regulation of ubiquitin protein ligase activity (GO:1904667),5/78,5,78,0.219916808592107,0.717964182430455,0,0,1.55212019618799,2.35069526744107,MAD2L2;PSMD13;PSME3;PSMD3;ANAPC1
alpha,2,positive regulation of cytoskeleton organization (GO:0051495),5/78,5,78,0.219916808592107,0.717964182430455,0,0,1.55212019618799,2.35069526744107,CDC42;SPAG5;PFDN2;PFN1;HRAS
alpha,2,regulation of hematopoietic progenitor cell differentiation (GO:1901532),5/78,5,78,0.219916808592107,0.717964182430455,0,0,1.55212019618799,2.35069526744107,YAP1;YTHDF2;PSMD13;PSME3;PSMD3
alpha,2,cytosolic transport (GO:0016482),7/119,7,119,0.22162078712263,0.717964182430455,0,0,1.42429853297251,2.14611525965445,BECN1;HOOK2;VPS51;VPS53;VPS35;VPS26A;PLEKHJ1
alpha,2,cellular response to lipoteichoic acid (GO:0071223),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,MAPK14
alpha,2,positive regulation of DNA-directed DNA polymerase activity (GO:1900264),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,RFC5
alpha,2,macropinocytosis (GO:0044351),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,MAPKAPK3
alpha,2,regulation of fat cell proliferation (GO:0070344),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,E2F1
alpha,2,negative regulation of mRNA catabolic process (GO:1902373),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,NBAS
alpha,2,histone-serine phosphorylation (GO:0035404),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,PRKAA2
alpha,2,positive regulation of RNA binding (GO:1905216),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,NCBP1
alpha,2,mesodermal cell fate commitment (GO:0001710),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,KLF4
alpha,2,positive regulation of hormone metabolic process (GO:0032352),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,ARNT
alpha,2,vitamin K metabolic process (GO:0042373),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,VKORC1
alpha,2,COPI coating of Golgi vesicle (GO:0048205),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,TMED2
alpha,2,determination of liver left/right asymmetry (GO:0071910),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,DNAAF1
alpha,2,positive regulation of aspartic-type peptidase activity (GO:1905247),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,EPHA4
alpha,2,cellular response to iron ion (GO:0071281),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,B2M
alpha,2,N-terminal peptidyl-methionine acetylation (GO:0017196),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,NAA60
alpha,2,regulation of T cell tolerance induction (GO:0002664),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,TGFBR2
alpha,2,chromatin silencing at telomere (GO:0006348),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,DOT1L
alpha,2,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,CACTIN
alpha,2,"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,CSGALNACT1
alpha,2,negative regulation of necroptotic process (GO:0060546),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,BIRC3
alpha,2,snRNA modification (GO:0040031),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,METTL16
alpha,2,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway (GO:0007197),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,DHX8
alpha,2,response to lipoteichoic acid (GO:0070391),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,MAPK14
alpha,2,positive regulation of receptor binding (GO:1900122),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,B2M
alpha,2,positive regulation of humoral immune response (GO:0002922),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,PHB
alpha,2,5S class rRNA transcription from RNA polymerase III type 1 promoter (GO:0042791),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,GTF3C4
alpha,2,regulation of adiponectin secretion (GO:0070163),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,RAB11FIP3
alpha,2,bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,DSP
alpha,2,response to DNA damage checkpoint signaling (GO:0072423),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,EME1
alpha,2,negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,PHB
alpha,2,cardiolipin acyl-chain remodeling (GO:0035965),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,LCLAT1
alpha,2,Golgi transport vesicle coating (GO:0048200),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,TMED2
alpha,2,positive regulation of mitochondrial membrane potential (GO:0010918),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,AKT2
alpha,2,male genitalia development (GO:0030539),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,TBX3
alpha,2,positive regulation of vesicle fusion (GO:0031340),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,AKT2
alpha,2,azole transport (GO:0045117),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,SLC35F3
alpha,2,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,TGFBR2
alpha,2,phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,CDK12
alpha,2,queuosine metabolic process (GO:0046116),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,TXNDC9
alpha,2,transcription initiation from RNA polymerase III promoter (GO:0006384),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,GTF3C4
alpha,2,positive regulation of osteoblast proliferation (GO:0033690),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,BMP2
alpha,2,COPI-coated vesicle budding (GO:0035964),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,TMED2
alpha,2,rescue of stalled ribosome (GO:0072344),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,ZNF598
alpha,2,centromeric sister chromatid cohesion (GO:0070601),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,BOD1
alpha,2,regulation of interleukin-5 secretion (GO:2000662),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,PRKCZ
alpha,2,antigen processing and presentation of endogenous peptide antigen (GO:0002483),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,B2M
alpha,2,forebrain regionalization (GO:0021871),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,BMP2
alpha,2,regulation of interleukin-12 secretion (GO:2001182),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,MAPK14
alpha,2,regulation of interferon-alpha secretion (GO:1902739),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,MAVS
alpha,2,Golgi disassembly (GO:0090166),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,PLK3
alpha,2,regulation of glial cell differentiation (GO:0045685),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,EPHA4
alpha,2,purine ribonucleoside monophosphate catabolic process (GO:0009169),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,NUDT4
alpha,2,"positive regulation of protein import into nucleus, translocation (GO:0033160)",1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,MAVS
alpha,2,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,BMF
alpha,2,ribonucleoside biosynthetic process (GO:0042455),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,TXNDC9
alpha,2,NADH metabolic process (GO:0006734),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,MDH1B
alpha,2,regulation of aldosterone biosynthetic process (GO:0032347),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,BMP2
alpha,2,ventricular compact myocardium morphogenesis (GO:0003223),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,DSP
alpha,2,regulation of interleukin-10 secretion (GO:2001179),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,PRKCZ
alpha,2,regulation of cortisol biosynthetic process (GO:2000064),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,BMP2
alpha,2,aggrephagy (GO:0035973),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,SQSTM1
alpha,2,GDP-mannose metabolic process (GO:0019673),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,PMM2
alpha,2,positive regulation of interferon-alpha secretion (GO:1902741),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,MAVS
alpha,2,regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,LMNA
alpha,2,regulation of dendritic cell chemotaxis (GO:2000508),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,CALR
alpha,2,negative regulation of DNA repair (GO:0045738),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,RNF169
alpha,2,queuosine biosynthetic process (GO:0008616),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,TXNDC9
alpha,2,positive regulation of centrosome cycle (GO:0046607),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,RANBP1
alpha,2,regulation of interleukin-13 secretion (GO:2000665),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,PRKCZ
alpha,2,peptidyl-proline hydroxylation (GO:0019511),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,P4HB
alpha,2,regulation of DNA-directed DNA polymerase activity (GO:1900262),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,RFC5
alpha,2,regulation of t-circle formation (GO:1904429),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,RTEL1
alpha,2,positive regulation of protein localization to centrosome (GO:1904781),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,CEP250
alpha,2,regulation of microtubule nucleation (GO:0010968),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,HSPA1A
alpha,2,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),1/6,1,6,0.223605288425881,0.717964182430455,0,0,4.03551251008878,6.04468477281009,EPHA4
alpha,2,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),6/99,6,99,0.225374045328527,0.717964182430455,0,0,1.46745909457774,2.18650500167595,DYNC1LI1;MARCH1;KLC2;SEC24C;ACTR10;AP2M1
alpha,2,positive regulation of cell growth (GO:0030307),6/99,6,99,0.225374045328527,0.717964182430455,0,0,1.46745909457774,2.18650500167595,RIMS2;CDC42;NCBP1;BRAT1;CIB1;CXCL16
alpha,2,receptor metabolic process (GO:0043112),4/59,4,59,0.22622170245051,0.717964182430455,0,0,1.64156441088357,2.43975832275817,BECN1;NEDD4;AP2M1;PLEKHJ1
alpha,2,response to light stimulus (GO:0009416),4/59,4,59,0.22622170245051,0.717964182430455,0,0,1.64156441088357,2.43975832275817,TP53I13;POLD1;UBE2A;MAP2K7
alpha,2,ubiquitin-dependent ERAD pathway (GO:0030433),4/59,4,59,0.22622170245051,0.717964182430455,0,0,1.64156441088357,2.43975832275817,HSPA5;DERL3;SGTA;MAN1B1
alpha,2,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),5/79,5,79,0.227484912074989,0.717964182430455,0,0,1.53247310509701,2.26908904180577,PSMD13;PSME3;PSMD3;CALR;B2M
alpha,2,fibroblast growth factor receptor signaling pathway (GO:0008543),5/79,5,79,0.227484912074989,0.717964182430455,0,0,1.53247310509701,2.26908904180577,HNRNPM;NCBP1;MAPK1;PTPN11;FGFRL1
alpha,2,regulation of neuron projection development (GO:0010975),7/120,7,120,0.227685516851963,0.717964182430455,0,0,1.41242937853107,2.09009874887992,SNX3;EPHA4;CIB1;SSH2;FBXO7;CAMSAP2;SSH1
alpha,2,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),3/40,3,40,0.228071669607987,0.717964182430455,0,0,1.81598062953995,2.68419254062296,PEA15;MADD;STX4
alpha,2,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",3/40,3,40,0.228071669607987,0.717964182430455,0,0,1.81598062953995,2.68419254062296,ZC3H10;EFCAB5;RNPS1
alpha,2,positive regulation of reactive oxygen species metabolic process (GO:2000379),3/40,3,40,0.228071669607987,0.717964182430455,0,0,1.81598062953995,2.68419254062296,ROMO1;MAPK14;TGFBR2
alpha,2,cellular response to amino acid starvation (GO:0034198),3/40,3,40,0.228071669607987,0.717964182430455,0,0,1.81598062953995,2.68419254062296,RRAGC;LARS;MAPK1
alpha,2,GTP metabolic process (GO:0046039),2/22,2,22,0.229864569738462,0.717964182430455,0,0,2.20118864186661,3.23633055406086,NFS1;OPA1
alpha,2,negative regulation of protein polymerization (GO:0032272),2/22,2,22,0.229864569738462,0.717964182430455,0,0,2.20118864186661,3.23633055406086,TBCD;PFN1
alpha,2,positive regulation of protein targeting to membrane (GO:0090314),2/22,2,22,0.229864569738462,0.717964182430455,0,0,2.20118864186661,3.23633055406086,AKT2;CIB1
alpha,2,early endosome to late endosome transport (GO:0045022),2/22,2,22,0.229864569738462,0.717964182430455,0,0,2.20118864186661,3.23633055406086,BECN1;HOOK2
alpha,2,negative regulation of response to endoplasmic reticulum stress (GO:1903573),2/22,2,22,0.229864569738462,0.717964182430455,0,0,2.20118864186661,3.23633055406086,OPA1;HSPA1A
alpha,2,negative regulation of cell cycle G1/S phase transition (GO:1902807),2/22,2,22,0.229864569738462,0.717964182430455,0,0,2.20118864186661,3.23633055406086,DCUN1D3;KLF4
alpha,2,sulfur amino acid metabolic process (GO:0000096),2/22,2,22,0.229864569738462,0.717964182430455,0,0,2.20118864186661,3.23633055406086,NFS1;MUT
alpha,2,histone lysine methylation (GO:0034968),2/22,2,22,0.229864569738462,0.717964182430455,0,0,2.20118864186661,3.23633055406086,PAXIP1;DOT1L
alpha,2,embryonic skeletal system morphogenesis (GO:0048704),2/22,2,22,0.229864569738462,0.717964182430455,0,0,2.20118864186661,3.23633055406086,FUZ;TGFBR2
alpha,2,negative regulation of sprouting angiogenesis (GO:1903671),2/22,2,22,0.229864569738462,0.717964182430455,0,0,2.20118864186661,3.23633055406086,HDAC5;KLF4
alpha,2,regulation of microtubule depolymerization (GO:0031114),2/22,2,22,0.229864569738462,0.717964182430455,0,0,2.20118864186661,3.23633055406086,CIB1;CAMSAP2
alpha,2,glucose transport (GO:0015758),2/22,2,22,0.229864569738462,0.717964182430455,0,0,2.20118864186661,3.23633055406086,SLC2A1;PPARD
alpha,2,glycosaminoglycan biosynthetic process (GO:0006024),6/100,6,100,0.232118073535607,0.717964182430455,0,0,1.45278450363196,2.12180498662546,CSGALNACT1;ABCC5;GPC2;B3GALT6;B4GALT5;HS3ST2
alpha,2,small GTPase mediated signal transduction (GO:0007264),6/100,6,100,0.232118073535607,0.717964182430455,0,0,1.45278450363196,2.12180498662546,RASSF1;RRAGC;MAPKAPK3;RRAS;MAPK14;HRAS
alpha,2,negative regulation of mitotic cell cycle phase transition (GO:1901991),5/80,5,80,0.235128110474955,0.717964182430455,0,0,1.51331719128329,2.19071543949989,PSMD13;PSME3;DCUN1D3;PSMD3;KLF4
alpha,2,anaphase-promoting complex-dependent catabolic process (GO:0031145),5/80,5,80,0.235128110474955,0.717964182430455,0,0,1.51331719128329,2.19071543949989,PSMD13;PSME3;PSMD3;ANAPC1;FBXO31
alpha,2,embryonic heart tube morphogenesis (GO:0003143),3/41,3,41,0.239142836508183,0.717964182430455,0,0,1.77168841906337,2.53474445746295,CCDC103;DNAAF1;TGFBR2
alpha,2,"nucleotide-excision repair, DNA incision (GO:0033683)",3/41,3,41,0.239142836508183,0.717964182430455,0,0,1.77168841906337,2.53474445746295,RFC5;POLD1;FAN1
alpha,2,cognition (GO:0050890),3/41,3,41,0.239142836508183,0.717964182430455,0,0,1.77168841906337,2.53474445746295,CYFIP1;CTNS;DGCR2
alpha,2,phosphatidic acid biosynthetic process (GO:0006654),3/41,3,41,0.239142836508183,0.717964182430455,0,0,1.77168841906337,2.53474445746295,GNPAT;DGKA;LCLAT1
alpha,2,regulation of ATPase activity (GO:0043462),3/41,3,41,0.239142836508183,0.717964182430455,0,0,1.77168841906337,2.53474445746295,DNAJB1;DNAJC24;PFN1
alpha,2,determination of heart left/right asymmetry (GO:0061371),3/41,3,41,0.239142836508183,0.717964182430455,0,0,1.77168841906337,2.53474445746295,CCDC103;DNAAF1;TGFBR2
alpha,2,JAK-STAT cascade (GO:0007259),3/41,3,41,0.239142836508183,0.717964182430455,0,0,1.77168841906337,2.53474445746295,PTPN1;MAPK1;PIAS1
alpha,2,"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",5/81,5,81,0.242841989665777,0.717964182430455,0,0,1.49463426299584,2.1154220778909,NBAS;KLC2;COG4;TMED2;COPE
alpha,2,mitotic G2/M transition checkpoint (GO:0044818),2/23,2,23,0.245348137701075,0.717964182430455,0,0,2.10548478787241,2.95836847426411,TAOK1;ORAOV1
alpha,2,"nucleotide-excision repair, DNA gap filling (GO:0006297)",2/23,2,23,0.245348137701075,0.717964182430455,0,0,2.10548478787241,2.95836847426411,RFC5;POLD1
alpha,2,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),2/23,2,23,0.245348137701075,0.717964182430455,0,0,2.10548478787241,2.95836847426411,EPHA4;PSME3
alpha,2,TOR signaling (GO:0031929),2/23,2,23,0.245348137701075,0.717964182430455,0,0,2.10548478787241,2.95836847426411,RPS6KB1;RHEBL1
alpha,2,zinc II ion transmembrane transport (GO:0071577),2/23,2,23,0.245348137701075,0.717964182430455,0,0,2.10548478787241,2.95836847426411,SLC30A1;SLC39A3
alpha,2,vitamin transport (GO:0051180),2/23,2,23,0.245348137701075,0.717964182430455,0,0,2.10548478787241,2.95836847426411,SLC35F3;SLC52A2
alpha,2,vesicle-mediated transport between endosomal compartments (GO:0098927),2/23,2,23,0.245348137701075,0.717964182430455,0,0,2.10548478787241,2.95836847426411,BECN1;HOOK2
alpha,2,positive regulation of ATP metabolic process (GO:1903580),2/23,2,23,0.245348137701075,0.717964182430455,0,0,2.10548478787241,2.95836847426411,PRKAA2;ARNT
alpha,2,cellular response to ammonium ion (GO:0071242),2/23,2,23,0.245348137701075,0.717964182430455,0,0,2.10548478787241,2.95836847426411,DHX8;MAPK1
alpha,2,cellular response to interleukin-6 (GO:0071354),2/23,2,23,0.245348137701075,0.717964182430455,0,0,2.10548478787241,2.95836847426411,PTPN11;PHB
alpha,2,autophagosome maturation (GO:0097352),2/23,2,23,0.245348137701075,0.717964182430455,0,0,2.10548478787241,2.95836847426411,MAP1LC3B;LIX1L
alpha,2,negative regulation of axonogenesis (GO:0050771),2/23,2,23,0.245348137701075,0.717964182430455,0,0,2.10548478787241,2.95836847426411,EPHA4;ARHGDIA
alpha,2,cellular response to amyloid-beta (GO:1904646),2/23,2,23,0.245348137701075,0.717964182430455,0,0,2.10548478787241,2.95836847426411,EPHA4;CASP4
alpha,2,positive regulation of cell junction assembly (GO:1901890),2/23,2,23,0.245348137701075,0.717964182430455,0,0,2.10548478787241,2.95836847426411,NPHP4;PPM1F
alpha,2,phosphatidic acid metabolic process (GO:0046473),3/42,3,42,0.250301830503022,0.717964182430455,0,0,1.72950536146662,2.39551671970762,GNPAT;DGKA;LCLAT1
alpha,2,regulation of stress-activated MAPK cascade (GO:0032872),3/42,3,42,0.250301830503022,0.717964182430455,0,0,1.72950536146662,2.39551671970762,TAOK1;MAPK1;MAPK8IP3
alpha,2,cellular response to peptide (GO:1901653),3/42,3,42,0.250301830503022,0.717964182430455,0,0,1.72950536146662,2.39551671970762,EPHA4;DDX11;CASP4
alpha,2,regulation of cellular metabolic process (GO:0031323),3/42,3,42,0.250301830503022,0.717964182430455,0,0,1.72950536146662,2.39551671970762,FASN;VPS35;SSH1
alpha,2,gluconeogenesis (GO:0006094),3/42,3,42,0.250301830503022,0.717964182430455,0,0,1.72950536146662,2.39551671970762,GOT2;SLC25A12;ENO3
alpha,2,negative regulation of cell cycle process (GO:0010948),5/82,5,82,0.250622131163587,0.717964182430455,0,0,1.47640701588614,2.04306520952526,PCGF2;E2F1;EHMT1;CALR;E2F6
alpha,2,positive regulation of protein catabolic process (GO:0045732),5/82,5,82,0.250622131163587,0.717964182430455,0,0,1.47640701588614,2.04306520952526,PLK3;SMURF2;NEDD4;VPS35;OAZ2
alpha,2,regulation of vesicle fusion (GO:0031338),4/62,4,62,0.253226179718388,0.717964182430455,0,0,1.56213387487308,2.14554744769941,VPS18;AKT2;TBC1D25;TBC1D14
alpha,2,regulation of cellular ketone metabolic process (GO:0010565),4/62,4,62,0.253226179718388,0.717964182430455,0,0,1.56213387487308,2.14554744769941,PSMD13;PSME3;PSMD3;OAZ2
alpha,2,regulation of tumor necrosis factor production (GO:0032680),4/62,4,62,0.253226179718388,0.717964182430455,0,0,1.56213387487308,2.14554744769941,MAVS;NFKBIL1;RARA;CACTIN
alpha,2,adherens junction assembly (GO:0034333),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,TBCD
alpha,2,positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,FZD7
alpha,2,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,ZC3H10
alpha,2,regulation of hormone biosynthetic process (GO:0046885),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,ARNT
alpha,2,"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,ERI2
alpha,2,regulation of interleukin-13 production (GO:0032656),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,RARA
alpha,2,regulation of chromatin assembly or disassembly (GO:0001672),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,TLK1
alpha,2,tRNA transcription from RNA polymerase III promoter (GO:0042797),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,GTF3C4
alpha,2,flavin-containing compound metabolic process (GO:0042726),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,SLC52A2
alpha,2,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,CIB1
alpha,2,exonucleolytic trimming involved in rRNA processing (GO:0000459),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,ERI2
alpha,2,positive regulation of dendritic cell chemotaxis (GO:2000510),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,CALR
alpha,2,regulation of dendritic spine maintenance (GO:1902950),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,VPS35
alpha,2,"fatty acid elongation, unsaturated fatty acid (GO:0019368)",1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,ELOVL4
alpha,2,hemostasis (GO:0007599),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,HPS4
alpha,2,regulation of cardiac muscle cell membrane potential (GO:0086036),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,SLC8B1
alpha,2,oxaloacetate metabolic process (GO:0006107),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,MDH1B
alpha,2,radial glial cell differentiation (GO:0060019),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,GPR157
alpha,2,regulation of ER to Golgi vesicle-mediated transport (GO:0060628),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,TBC1D20
alpha,2,cellular response to laminar fluid shear stress (GO:0071499),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,KLF4
alpha,2,regulation of lymphocyte migration (GO:2000401),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,SLC8B1
alpha,2,pri-miRNA transcription from RNA polymerase II promoter (GO:0061614),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,KLF4
alpha,2,riboflavin metabolic process (GO:0006771),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,SLC52A2
alpha,2,positive regulation of activin receptor signaling pathway (GO:0032927),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,ACVR1B
alpha,2,reproductive system development (GO:0061458),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,TBX3
alpha,2,left/right pattern formation (GO:0060972),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,DNAAF1
alpha,2,negative regulation of telomere capping (GO:1904354),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,SMG6
alpha,2,positive regulation of autophagy of mitochondrion (GO:1903599),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,FBXO7
alpha,2,molybdopterin cofactor metabolic process (GO:0043545),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,NFS1
alpha,2,negative regulation of dendrite morphogenesis (GO:0050774),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,YWHAH
alpha,2,central nervous system neuron axonogenesis (GO:0021955),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,SPTBN4
alpha,2,strand invasion (GO:0042148),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,RAD51D
alpha,2,regulation of isotype switching (GO:0045191),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,PAXIP1
alpha,2,negative regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000587),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,PTPN12
alpha,2,box C/D snoRNP assembly (GO:0000492),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,PIH1D2
alpha,2,negative regulation of calcium ion import (GO:0090281),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,SLC30A1
alpha,2,"fatty acid elongation, saturated fatty acid (GO:0019367)",1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,ELOVL4
alpha,2,retinoic acid receptor signaling pathway (GO:0048384),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,RARA
alpha,2,glycosphingolipid catabolic process (GO:0046479),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,NEU1
alpha,2,"fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,ELOVL4
alpha,2,heme catabolic process (GO:0042167),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,BLVRB
alpha,2,positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,SGTA
alpha,2,negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,PPM1F
alpha,2,adenine nucleotide transport (GO:0051503),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,SLC25A16
alpha,2,carbohydrate transport (GO:0008643),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,SLC50A1
alpha,2,morphogenesis of a polarized epithelium (GO:0001738),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,FUZ
alpha,2,porphyrin-containing compound catabolic process (GO:0006787),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,BLVRB
alpha,2,cellular response to hydroxyurea (GO:0072711),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,DDX11
alpha,2,protein localization to cytoplasmic stress granule (GO:1903608),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,YBX1
alpha,2,cellular lipid biosynthetic process (GO:0097384),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,GNPAT
alpha,2,positive regulation of inositol phosphate biosynthetic process (GO:0060732),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,DHX8
alpha,2,peptidyl-lysine deacetylation (GO:0034983),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,SIRT3
alpha,2,regulation by virus of viral protein levels in host cell (GO:0046719),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,TBC1D20
alpha,2,tRNA transcription (GO:0009304),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,GTF3C4
alpha,2,"retrograde transport, vesicle recycling within Golgi (GO:0000301)",1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,COG4
alpha,2,positive regulation of fatty acid beta-oxidation (GO:0032000),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,AKT2
alpha,2,regulation of glucocorticoid receptor signaling pathway (GO:2000322),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,PHB
alpha,2,purine ribonucleotide transport (GO:0015868),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,SLC25A16
alpha,2,female genitalia development (GO:0030540),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,TBX3
alpha,2,negative regulation of axon regeneration (GO:0048681),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,EPHA4
alpha,2,activation of signaling protein activity involved in unfolded protein response (GO:0006987),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,PTPN1
alpha,2,cellular response to histamine (GO:0071420),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,DHX8
alpha,2,mannose metabolic process (GO:0006013),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,PMM2
alpha,2,hyaluronan biosynthetic process (GO:0030213),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,ABCC5
alpha,2,positive regulation of insulin receptor signaling pathway (GO:0046628),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,PRKCZ
alpha,2,positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,DYNC1LI1
alpha,2,G-quadruplex DNA unwinding (GO:0044806),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,DDX11
alpha,2,"fatty acid elongation, monounsaturated fatty acid (GO:0034625)",1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,ELOVL4
alpha,2,molybdopterin cofactor biosynthetic process (GO:0032324),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,NFS1
alpha,2,positive regulation of type I interferon-mediated signaling pathway (GO:0060340),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,MAVS
alpha,2,response to increased oxygen levels (GO:0036296),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,ATP6V0D1
alpha,2,negative regulation of retinoic acid receptor signaling pathway (GO:0048387),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,CALR
alpha,2,regulation of protein localization to centrosome (GO:1904779),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,CEP250
alpha,2,myoblast fusion (GO:0007520),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,KCNH1
alpha,2,negative regulation of necrotic cell death (GO:0060547),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,BIRC3
alpha,2,negative regulation of dendrite development (GO:2000171),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,YWHAH
alpha,2,regulation of transcription involved in cell fate commitment (GO:0060850),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,CEBPB
alpha,2,malate metabolic process (GO:0006108),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,MDH1B
alpha,2,neuron fate specification (GO:0048665),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,POU3F2
alpha,2,negative regulation of heart rate (GO:0010459),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,SPTBN4
alpha,2,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,TGFBR2
alpha,2,chondroitin sulfate proteoglycan metabolic process (GO:0050654),1/7,1,7,0.255679967655755,0.717964182430455,0,0,3.45901072293324,4.71749824596011,CSGALNACT1
alpha,2,mitotic sister chromatid segregation (GO:0000070),5/83,5,83,0.258464119187029,0.717964182430455,0,0,1.45861897955016,1.97350914347919,BECN1;CHTF8;SPAG5;BOD1;CHMP1A
alpha,2,ephrin receptor signaling pathway (GO:0048013),5/83,5,83,0.258464119187029,0.717964182430455,0,0,1.45861897955016,1.97350914347919,CDC42;EPHA4;PTPN11;HRAS;AP2M1
alpha,2,negative regulation of binding (GO:0051100),5/83,5,83,0.258464119187029,0.717964182430455,0,0,1.45861897955016,1.97350914347919,DDX11;CPNE1;E2F1;ID4;RSF1
alpha,2,cellular response to retinoic acid (GO:0071300),3/43,3,43,0.26153560761045,0.717964182430455,0,0,1.68928430654879,2.26564249897514,BRINP2;FZD7;RARA
alpha,2,translesion synthesis (GO:0019985),3/43,3,43,0.26153560761045,0.717964182430455,0,0,1.68928430654879,2.26564249897514,RFC5;MAD2L2;POLD1
alpha,2,positive regulation of type I interferon production (GO:0032481),4/63,4,63,0.262373668707896,0.717964182430455,0,0,1.53733809908144,2.0569362002527,RNF135;MAVS;POLR3E;POLR3K
alpha,2,stress-activated MAPK cascade (GO:0051403),4/63,4,63,0.262373668707896,0.717964182430455,0,0,1.53733809908144,2.0569362002527,MAPK1;UBE2V1;MAP2K7;MAPK14
alpha,2,tRNA processing (GO:0008033),4/63,4,63,0.262373668707896,0.717964182430455,0,0,1.53733809908144,2.0569362002527,CTU2;URM1;LCMT2;RPP25
alpha,2,regulation of translational initiation (GO:0006446),4/63,4,63,0.262373668707896,0.717964182430455,0,0,1.53733809908144,2.0569362002527,EIF5B;NCBP1;RPS6KB1;MIF4GD
alpha,2,negative regulation of protein modification process (GO:0031400),4/64,4,64,0.271582525063297,0.717964182430455,0,0,1.51331719128329,1.97259265447497,CIB1;CACTIN;TARDBP;ARPP19
alpha,2,G2/M transition of mitotic cell cycle (GO:0000086),7/127,7,127,0.271588804668212,0.717964182430455,0,0,1.33457894034432,1.73957841194814,YWHAE;PLK3;HAUS8;CEP250;ARPP19;CEP76;CDC25A
alpha,2,mitotic metaphase plate congression (GO:0007080),3/44,3,44,0.272831509813559,0.717964182430455,0,0,1.65089148139996,2.14434435587944,BECN1;BOD1;CHMP1A
alpha,2,RNA catabolic process (GO:0006401),3/44,3,44,0.272831509813559,0.717964182430455,0,0,1.65089148139996,2.14434435587944,FEN1;METTL16;HSPA1A
alpha,2,negative regulation of DNA metabolic process (GO:0051053),3/44,3,44,0.272831509813559,0.717964182430455,0,0,1.65089148139996,2.14434435587944,RTEL1;CDC6;NF2
alpha,2,positive regulation of protein localization to plasma membrane (GO:1903078),3/44,3,44,0.272831509813559,0.717964182430455,0,0,1.65089148139996,2.14434435587944,CIB1;STX4;SQSTM1
alpha,2,branching morphogenesis of an epithelial tube (GO:0048754),3/44,3,44,0.272831509813559,0.717964182430455,0,0,1.65089148139996,2.14434435587944,BMP2;MET;TGFBR2
alpha,2,regulation of cell cycle G2/M phase transition (GO:1902749),5/85,5,85,0.274316026415541,0.717964182430455,0,0,1.42429853297251,1.84229377032959,YWHAE;CENPF;HAUS8;CEP250;CEP76
alpha,2,positive regulation of microtubule polymerization (GO:0031116),2/25,2,25,0.276394253087976,0.717964182430455,0,0,1.93704600484261,2.49089971780425,MET;HSPA1A
alpha,2,histone monoubiquitination (GO:0010390),2/25,2,25,0.276394253087976,0.717964182430455,0,0,1.93704600484261,2.49089971780425,TRIM37;ATXN7L3
alpha,2,positive regulation of endopeptidase activity (GO:0010950),2/25,2,25,0.276394253087976,0.717964182430455,0,0,1.93704600484261,2.49089971780425,EPHA4;PSME3
alpha,2,DNA geometric change (GO:0032392),2/25,2,25,0.276394253087976,0.717964182430455,0,0,1.93704600484261,2.49089971780425,RTEL1;DDX11
alpha,2,regulation of chemotaxis (GO:0050920),2/25,2,25,0.276394253087976,0.717964182430455,0,0,1.93704600484261,2.49089971780425,STX4;PPM1F
alpha,2,regulation of cardiac muscle cell action potential (GO:0098901),2/25,2,25,0.276394253087976,0.717964182430455,0,0,1.93704600484261,2.49089971780425,DSP;CXADR
alpha,2,regulation of cell cycle G1/S phase transition (GO:1902806),2/25,2,25,0.276394253087976,0.717964182430455,0,0,1.93704600484261,2.49089971780425,PSME3;E2F1
alpha,2,negative regulation of response to stimulus (GO:0048585),7/128,7,128,0.278041111942329,0.717964182430455,0,0,1.32415254237288,1.69489710214609,EPHA4;ZC3H10;PTPN1;ERBB3;PIM3;KLF4;MET
alpha,2,cell cycle G2/M phase transition (GO:0044839),7/128,7,128,0.278041111942329,0.717964182430455,0,0,1.32415254237288,1.69489710214609,YWHAE;PLK3;HAUS8;CEP250;ARPP19;CEP76;CDC25A
alpha,2,regulation of G2/M transition of mitotic cell cycle (GO:0010389),8/150,8,150,0.280360175033559,0.717964182430455,0,0,1.29136400322841,1.64220198616051,YWHAE;CENPF;HAUS8;PSMD13;PSME3;PSMD3;CEP250;CEP76
alpha,2,heart development (GO:0007507),8/150,8,150,0.280360175033559,0.717964182430455,0,0,1.29136400322841,1.64220198616051,BMP2;CXADR;ERBB3;NCOA6;RARA;PTPN11;ZDHHC16;TGFBR2
alpha,2,negative regulation of neuron differentiation (GO:0045665),4/65,4,65,0.280845903392148,0.717964182430455,0,0,1.49003538834047,1.89226916978518,EPHA4;ID4;CIB1;CALR
alpha,2,positive regulation of cellular catabolic process (GO:0031331),6/107,6,107,0.280904533854695,0.717964182430455,0,0,1.35774252675884,1.72398054519342,PTPN1;PRKAA2;AKT2;ARNT;VPS35;TRIM65
alpha,2,fatty acid metabolic process (GO:0006631),6/107,6,107,0.280904533854695,0.717964182430455,0,0,1.35774252675884,1.72398054519342,GNPAT;ELOVL4;AASDH;FASN;ACOT2;PPARD
alpha,2,ribosomal small subunit biogenesis (GO:0042274),3/45,3,45,0.284177277688737,0.717964182430455,0,0,1.61420500403551,2.03092335488232,RPS28;RPS27L;MRPS7
alpha,2,hexose biosynthetic process (GO:0019319),3/45,3,45,0.284177277688737,0.717964182430455,0,0,1.61420500403551,2.03092335488232,GOT2;SLC25A12;ENO3
alpha,2,positive regulation of interleukin-8 production (GO:0032757),3/45,3,45,0.284177277688737,0.717964182430455,0,0,1.61420500403551,2.03092335488232,MAVS;ZNF580;HSPA1A
alpha,2,negative regulation of type I interferon production (GO:0032480),3/45,3,45,0.284177277688737,0.717964182430455,0,0,1.61420500403551,2.03092335488232,RNF135;MAVS;CACTIN
alpha,2,protein N-linked glycosylation via asparagine (GO:0018279),3/45,3,45,0.284177277688737,0.717964182430455,0,0,1.61420500403551,2.03092335488232,MCFD2;DERL3;ST6GALNAC4
alpha,2,carboxylic acid biosynthetic process (GO:0046394),3/45,3,45,0.284177277688737,0.717964182430455,0,0,1.61420500403551,2.03092335488232,ABCC5;PAH;GOT2
alpha,2,mitotic nuclear envelope disassembly (GO:0007077),3/45,3,45,0.284177277688737,0.717964182430455,0,0,1.61420500403551,2.03092335488232,LMNA;BANF1;NUP54
alpha,2,posttranscriptional regulation of gene expression (GO:0010608),3/45,3,45,0.284177277688737,0.717964182430455,0,0,1.61420500403551,2.03092335488232,CYFIP1;ZC3H10;METTL16
alpha,2,positive regulation of mitochondrion organization (GO:0010822),7/129,7,129,0.2845317437512,0.717964182430455,0,0,1.31388779398239,1.65143930404306,LRRC46;NBPF3;HSPA1L;HPS4;VPS35;BMF;FBXO7
alpha,2,biomineral tissue development (GO:0031214),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,CEMP1
alpha,2,regulation of stress-activated protein kinase signaling cascade (GO:0070302),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,MAPK1
alpha,2,barbed-end actin filament capping (GO:0051016),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,TRIOBP
alpha,2,positive regulation of cell aging (GO:0090343),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,LMNA
alpha,2,stress-induced premature senescence (GO:0090400),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,MAPK14
alpha,2,positive regulation of isotype switching (GO:0045830),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,PAXIP1
alpha,2,DNA recombinase assembly (GO:0000730),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,RAD51D
alpha,2,regulation of chaperone-mediated autophagy (GO:1904714),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,PLK3
alpha,2,regulation of dopamine uptake involved in synaptic transmission (GO:0051584),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,RAB3B
alpha,2,positive regulation of membrane potential (GO:0045838),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,AKT2
alpha,2,positive regulation of protein localization to Cajal body (GO:1904871),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,CCT7
alpha,2,establishment of integrated proviral latency (GO:0075713),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,BANF1
alpha,2,negative regulation of anion transmembrane transport (GO:1903960),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,AKT2
alpha,2,translocation of molecules into host (GO:0044417),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,THOC5
alpha,2,positive regulation of alpha-beta T cell differentiation (GO:0046638),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,TGFBR2
alpha,2,positive regulation of chromatin binding (GO:0035563),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,DDX11
alpha,2,DNA repair complex assembly (GO:0090735),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,RAD51D
alpha,2,positive regulation of DNA recombination (GO:0045911),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,PAXIP1
alpha,2,desmosome organization (GO:0002934),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,DSP
alpha,2,regulation of muscle organ development (GO:0048634),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,CENPF
alpha,2,negative regulation of glucose import (GO:0046325),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,PEA15
alpha,2,transepithelial transport (GO:0070633),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,CXADR
alpha,2,regulation of endodeoxyribonuclease activity (GO:0032071),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,DDX11
alpha,2,glycerolipid biosynthetic process (GO:0045017),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,CPNE1
alpha,2,Schwann cell development (GO:0014044),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,ARHGEF10
alpha,2,regulation of cytoplasmic transport (GO:1903649),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,MAPK1
alpha,2,positive regulation of spindle checkpoint (GO:0090232),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,DYNC1LI1
alpha,2,bundle of His cell to Purkinje myocyte communication (GO:0086069),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,DSP
alpha,2,regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,ARNT
alpha,2,nodal signaling pathway (GO:0038092),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,ACVR1B
alpha,2,regulation of striated muscle cell differentiation (GO:0051153),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,HDAC5
alpha,2,"negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,DERL3
alpha,2,negative regulation of calcium ion transmembrane transport (GO:1903170),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,YWHAE
alpha,2,regulation of store-operated calcium entry (GO:2001256),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,SLC8B1
alpha,2,positive regulation of protein localization to cell surface (GO:2000010),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,STX4
alpha,2,response to hydroxyurea (GO:0072710),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,DDX11
alpha,2,regulation of metaphase/anaphase transition of cell cycle (GO:1902099),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,CDC6
alpha,2,negative regulation of hippo signaling (GO:0035331),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,DLG5
alpha,2,negative regulation of centriole replication (GO:0046600),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,TRIM37
alpha,2,negative regulation of establishment of protein localization (GO:1904950),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,SNX3
alpha,2,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,EPHA4
alpha,2,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,TMEM50A
alpha,2,double-strand break repair via synthesis-dependent strand annealing (GO:0045003),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,RAD51D
alpha,2,positive regulation of mRNA 3'-end processing (GO:0031442),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,NCBP1
alpha,2,rRNA pseudouridine synthesis (GO:0031118),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,RPUSD2
alpha,2,positive regulation of interleukin-2 biosynthetic process (GO:0045086),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,GLMN
alpha,2,peripheral nervous system axon ensheathment (GO:0032292),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,ARHGEF10
alpha,2,negative regulation of neuron projection regeneration (GO:0070571),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,EPHA4
alpha,2,response to hydroperoxide (GO:0033194),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,STX4
alpha,2,short-chain fatty acid catabolic process (GO:0019626),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,MUT
alpha,2,negative regulation of cAMP-dependent protein kinase activity (GO:2000480),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,PRKAR1B
alpha,2,regulation of protein localization to Cajal body (GO:1904869),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,CCT7
alpha,2,bone resorption (GO:0045453),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,RAB3D
alpha,2,regulation of cilium movement (GO:0003352),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,DNAAF1
alpha,2,positive regulation of TORC1 signaling (GO:1904263),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,LARS
alpha,2,positive regulation of viral entry into host cell (GO:0046598),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,P4HB
alpha,2,mammary gland epithelial cell differentiation (GO:0060644),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,AKT2
alpha,2,regulation of dopamine receptor signaling pathway (GO:0060159),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,VPS35
alpha,2,peptidyl-lysine monomethylation (GO:0018026),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,EHMT1
alpha,2,glycerol-3-phosphate metabolic process (GO:0006072),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,GNPAT
alpha,2,viral mRNA export from host cell nucleus (GO:0046784),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,THOC5
alpha,2,regulation of T-helper 2 cell cytokine production (GO:2000551),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,PRKCZ
alpha,2,pantothenate metabolic process (GO:0015939),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,FASN
alpha,2,regulation of receptor binding (GO:1900120),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,B2M
alpha,2,tRNA aminoacylation for mitochondrial protein translation (GO:0070127),1/8,1,8,0.286431103678275,0.717964182430455,0,0,3.02663438256659,3.78407157252975,DARS2
alpha,2,positive regulation of cell cycle process (GO:0090068),6/108,6,108,0.288062954201193,0.717964182430455,0,0,1.34517083669626,1.67416765100532,CDC42;DYNC1LI1;FEN1;SPAG5;DDX11;CDC6
alpha,2,negative regulation of response to external stimulus (GO:0032102),6/108,6,108,0.288062954201193,0.717964182430455,0,0,1.34517083669626,1.67416765100532,EPHA4;NFKBIL1;VPS35;CACTIN;KLF4;PPARD
alpha,2,glycolipid metabolic process (GO:0006664),4/66,4,66,0.290157061388852,0.717964182430455,0,0,1.46745909457774,1.81573543416692,KDELC2;NEU1;PIGW;ST6GALNAC4
alpha,2,negative regulation of apoptotic signaling pathway (GO:2001234),4/66,4,66,0.290157061388852,0.717964182430455,0,0,1.46745909457774,1.81573543416692,SLC35F6;OPA1;PSME3;HSPA1A
alpha,2,regulation of macromolecule metabolic process (GO:0060255),7/130,7,130,0.291058425423659,0.717964182430455,0,0,1.30378096479791,1.60916721944124,DDX3Y;MTMR3;MAPK1;TOB2;MAPK6;MAPK14;MAPK4
alpha,2,glycolytic process through glucose-6-phosphate (GO:0061620),2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,ENO3;PGM2L1
alpha,2,heterotypic cell-cell adhesion (GO:0034113),2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,DSP;CXADR
alpha,2,regulation of centrosome duplication (GO:0010824),2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,CHMP1A;CEP76
alpha,2,canonical glycolysis (GO:0061621),2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,ENO3;PGM2L1
alpha,2,glucose catabolic process to pyruvate (GO:0061718),2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,ENO3;PGM2L1
alpha,2,regulation of telomere maintenance (GO:0032204),2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,RTEL1;SMG6
alpha,2,glial cell differentiation (GO:0010001),2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,ERBB3;GPR157
alpha,2,cyclic nucleotide metabolic process (GO:0009187),2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,ADCY9;NUDT4
alpha,2,response to amyloid-beta (GO:1904645),2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,EPHA4;CASP4
alpha,2,"RNA splicing, via transesterification reactions (GO:0000375)",2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,SF3B3;WDR83
alpha,2,positive regulation of glucose transport (GO:0010828),2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,AKT2;ARPP19
alpha,2,modulation of excitatory postsynaptic potential (GO:0098815),2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,RIMS2;PRKCZ
alpha,2,cellular response to epidermal growth factor stimulus (GO:0071364),2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,PTPN11;PTPN12
alpha,2,female gamete generation (GO:0007292),2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,TRIP13;TOB2
alpha,2,regulation of apoptotic signaling pathway (GO:2001233),2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,DAPK2;MADD
alpha,2,regulation of potassium ion transmembrane transporter activity (GO:1901016),2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,YWHAE;NEDD4
alpha,2,long-chain fatty acid transport (GO:0015909),2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,PRKAA2;CPT2
alpha,2,regulation of cellular protein localization (GO:1903827),2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,PTPN1;KCNAB2
alpha,2,L-amino acid transport (GO:0015807),2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,CTNS;SLC25A12
alpha,2,regulation of protein import into nucleus (GO:0042306),2/26,2,26,0.291900447102246,0.717964182430455,0,0,1.86254423542559,2.29342981826525,FZD7;RBM22
alpha,2,nucleotide-excision repair (GO:0006289),6/109,6,109,0.295259457400196,0.717964182430455,0,0,1.33282981984584,1.62592015360364,RFC5;COPS2;POLD1;FANCC;ORAOV1;FAN1
alpha,2,peptidyl-asparagine modification (GO:0018196),3/46,3,46,0.295561060462767,0.717964182430455,0,0,1.57911359090431,1.92474970379539,MCFD2;DERL3;ST6GALNAC4
alpha,2,mitochondrial gene expression (GO:0140053),3/46,3,46,0.295561060462767,0.717964182430455,0,0,1.57911359090431,1.92474970379539,NDUFA7;MRPS7;MRPL10
alpha,2,protein glycosylation (GO:0006486),7/131,7,131,0.297618881240011,0.717964182430455,0,0,1.29382843834907,1.5680444210232,ALG6;TMEM258;GALNT1;PMM2;B3GALT6;ALG1;MGAT2
alpha,2,JNK cascade (GO:0007254),4/67,4,67,0.299509368781766,0.717964182430455,0,0,1.4455567200318,1.74277703083756,TAOK1;UBE2V1;MAP2K7;MAPK8IP3
alpha,2,regulation of stem cell differentiation (GO:2000736),5/89,5,89,0.306569552594995,0.717964182430455,0,0,1.36028511576026,1.60827954414175,YAP1;YTHDF2;PSMD13;PSME3;PSMD3
alpha,2,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),5/89,5,89,0.306569552594995,0.717964182430455,0,0,1.36028511576026,1.60827954414175,GLMN;KEAP1;RNF166;PIAS1;HSPA1A
alpha,2,positive regulation of protein localization to cell periphery (GO:1904377),3/47,3,47,0.306971423575336,0.717964182430455,0,0,1.5455154293957,1.82525467808548,CIB1;STX4;SQSTM1
alpha,2,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),3/47,3,47,0.306971423575336,0.717964182430455,0,0,1.5455154293957,1.82525467808548,U2AF2;USP4;HSPA1A
alpha,2,nuclear envelope disassembly (GO:0051081),3/47,3,47,0.306971423575336,0.717964182430455,0,0,1.5455154293957,1.82525467808548,LMNA;BANF1;NUP54
alpha,2,aminoglycan biosynthetic process (GO:0006023),3/47,3,47,0.306971423575336,0.717964182430455,0,0,1.5455154293957,1.82525467808548,GPC2;B3GALT6;HS3ST2
alpha,2,regulation of transcription regulatory region DNA binding (GO:2000677),2/27,2,27,0.307361614886618,0.717964182430455,0,0,1.79356111559501,2.11591843945799,MAD2L2;DOT1L
alpha,2,positive regulation of interferon-beta production (GO:0032728),2/27,2,27,0.307361614886618,0.717964182430455,0,0,1.79356111559501,2.11591843945799,RNF135;MAVS
alpha,2,regulation of centrosome cycle (GO:0046605),2/27,2,27,0.307361614886618,0.717964182430455,0,0,1.79356111559501,2.11591843945799,CHMP1A;CEP250
alpha,2,response to ketone (GO:1901654),2/27,2,27,0.307361614886618,0.717964182430455,0,0,1.79356111559501,2.11591843945799,YAP1;WBP2
alpha,2,regulation of histone acetylation (GO:0035065),2/27,2,27,0.307361614886618,0.717964182430455,0,0,1.79356111559501,2.11591843945799,PAXIP1;TADA2A
alpha,2,regulation of viral entry into host cell (GO:0046596),2/27,2,27,0.307361614886618,0.717964182430455,0,0,1.79356111559501,2.11591843945799,SNX3;P4HB
alpha,2,strand displacement (GO:0000732),2/27,2,27,0.307361614886618,0.717964182430455,0,0,1.79356111559501,2.11591843945799,RTEL1;RAD51D
alpha,2,regulation of TOR signaling (GO:0032006),4/68,4,68,0.30889631551914,0.717964182430455,0,0,1.42429853297251,1.67319414168228,DYRK3;PRKAA2;RRAGC;TTI1
alpha,2,insulin receptor signaling pathway (GO:0008286),4/68,4,68,0.30889631551914,0.717964182430455,0,0,1.42429853297251,1.67319414168228,ATP6V1G2;AKT2;ATP6V0D1;ATP6V0A1
alpha,2,positive regulation of autophagy (GO:0010508),4/68,4,68,0.30889631551914,0.717964182430455,0,0,1.42429853297251,1.67319414168228,PLK3;PRKAA2;FBXO7;TRIM65
alpha,2,regulation of protein localization to plasma membrane (GO:1903076),4/68,4,68,0.30889631551914,0.717964182430455,0,0,1.42429853297251,1.67319414168228,CIB1;STX4;SQSTM1;AP2M1
alpha,2,cellular response to insulin stimulus (GO:0032869),6/111,6,111,0.309754591634569,0.717964182430455,0,0,1.3088148681369,1.53389821988582,HDAC5;ATP6V1G2;RPS6KB1;AKT2;ATP6V0D1;ATP6V0A1
alpha,2,cellular response to peptide hormone stimulus (GO:0071375),6/111,6,111,0.309754591634569,0.717964182430455,0,0,1.3088148681369,1.53389821988582,HDAC5;ADCY9;PRKAR1B;RPS6KB1;AKT2;GNB2
alpha,2,cellular response to hypoxia (GO:0071456),7/133,7,133,0.310832021429678,0.717964182430455,0,0,1.27437237160698,1.48910747641488,PLK3;PSMD13;PSME3;PSMD3;LMNA;ARNT;P4HB
alpha,2,regulation of immunoglobulin secretion (GO:0051023),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,STX4
alpha,2,negative regulation of NIK/NF-kappaB signaling (GO:1901223),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,CPNE1
alpha,2,positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901838),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,DDX11
alpha,2,negative regulation of phagocytosis (GO:0050765),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,SNX3
alpha,2,acidic amino acid transport (GO:0015800),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,SLC25A12
alpha,2,positive regulation of protein sumoylation (GO:0033235),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,PIAS1
alpha,2,ventricular cardiac muscle cell membrane repolarization (GO:0099625),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,KCND3
alpha,2,neuronal ion channel clustering (GO:0045161),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,SPTBN4
alpha,2,galactose catabolic process (GO:0019388),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,PGM2L1
alpha,2,cellular response to interleukin-4 (GO:0071353),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,SHPK
alpha,2,negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,PPARD
alpha,2,short-chain fatty acid metabolic process (GO:0046459),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,MUT
alpha,2,oligosaccharide catabolic process (GO:0009313),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,NEU1
alpha,2,pericardium development (GO:0060039),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,BMP2
alpha,2,regulation of SNARE complex assembly (GO:0035542),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,VPS18
alpha,2,potassium ion export (GO:0071435),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,KCND3
alpha,2,regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,SGTA
alpha,2,regulation of endothelial cell differentiation (GO:0045601),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,VEZF1
alpha,2,establishment of Golgi localization (GO:0051683),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,CDC42
alpha,2,homocysteine metabolic process (GO:0050667),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,MUT
alpha,2,embryonic forelimb morphogenesis (GO:0035115),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,TBX3
alpha,2,positive regulation of long-term synaptic potentiation (GO:1900273),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,SQSTM1
alpha,2,Cdc42 protein signal transduction (GO:0032488),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,CDC42
alpha,2,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,NF2
alpha,2,positive regulation of immunoglobulin secretion (GO:0051024),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,STX4
alpha,2,regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,PTPN12
alpha,2,small nucleolar ribonucleoprotein complex assembly (GO:0000491),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,PIH1D2
alpha,2,maintenance of protein localization in endoplasmic reticulum (GO:0035437),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,HSPA5
alpha,2,regulation of endoplasmic reticulum unfolded protein response (GO:1900101),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,HSPA5
alpha,2,response to dopamine (GO:1903350),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,MAPK1
alpha,2,semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,PLXNA2
alpha,2,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,DERL3
alpha,2,establishment of viral latency (GO:0019043),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,BANF1
alpha,2,L-ascorbic acid metabolic process (GO:0019852),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,SLC2A1
alpha,2,response to leucine (GO:0043201),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,LARS
alpha,2,cellular response to oxygen levels (GO:0071453),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,ATP6V0D1
alpha,2,positive regulation of astrocyte differentiation (GO:0048711),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,BMP2
alpha,2,receptor recycling (GO:0001881),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,PLEKHJ1
alpha,2,positive regulation of immunoglobulin mediated immune response (GO:0002891),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,PAXIP1
alpha,2,regulation of striated muscle tissue development (GO:0016202),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,CENPF
alpha,2,positive regulation of establishment of protein localization to telomere (GO:1904851),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,CCT7
alpha,2,negative regulation of activin receptor signaling pathway (GO:0032926),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,LEMD3
alpha,2,mitotic DNA replication checkpoint (GO:0033314),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,ORAOV1
alpha,2,oogenesis (GO:0048477),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,TRIP13
alpha,2,interleukin-23-mediated signaling pathway (GO:0038155),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,P4HB
alpha,2,pinocytosis (GO:0006907),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,MAPKAPK3
alpha,2,negative regulation of heterotypic cell-cell adhesion (GO:0034115),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,KLF4
alpha,2,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,KLF4
alpha,2,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,STX4
alpha,2,regulation of leukocyte activation (GO:0002694),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,SHPK
alpha,2,negative regulation of interferon-beta production (GO:0032688),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,CACTIN
alpha,2,response to interleukin-4 (GO:0070670),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,SHPK
alpha,2,ether lipid metabolic process (GO:0046485),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,GNPAT
alpha,2,potassium ion import across plasma membrane (GO:1990573),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,FXYD2
alpha,2,hexose catabolic process (GO:0019320),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,PGM2L1
alpha,2,cellular response to leucine (GO:0071233),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,LARS
alpha,2,dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,OPA1
alpha,2,positive regulation of protein homooligomerization (GO:0032464),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,BMF
alpha,2,axonal transport of mitochondrion (GO:0019896),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,OPA1
alpha,2,negative regulation of microtubule polymerization (GO:0031115),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,TBCD
alpha,2,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,B2M
alpha,2,regulation of oxidative stress-induced cell death (GO:1903201),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,P4HB
alpha,2,mitochondrial fragmentation involved in apoptotic process (GO:0043653),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,VPS35
alpha,2,proton-transporting V-type ATPase complex assembly (GO:0070070),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,ATP6V0A1
alpha,2,lipoprotein biosynthetic process (GO:0042158),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,WDR45B
alpha,2,"negative regulation of synaptic transmission, glutamatergic (GO:0051967)",1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,ATAD1
alpha,2,establishment of epithelial cell apical/basal polarity (GO:0045198),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,CDC42
alpha,2,histone phosphorylation (GO:0016572),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,PRKAA2
alpha,2,Golgi inheritance (GO:0048313),1/9,1,9,0.315913247869886,0.717964182430455,0,0,2.69034167339252,3.10004744456113,PLK3
alpha,2,regulation of epithelial to mesenchymal transition (GO:0010717),4/69,4,69,0.318311519262988,0.717964182430455,0,0,1.40365652524827,1.60680037252055,FOXA1;MAD2L2;BMP2;TGFBR2
alpha,2,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),4/69,4,69,0.318311519262988,0.717964182430455,0,0,1.40365652524827,1.60680037252055,YWHAE;ARL6IP1;KLF4;BIRC3
alpha,2,regulation of intrinsic apoptotic signaling pathway (GO:2001242),3/48,3,48,0.318397354237768,0.717964182430455,0,0,1.51331719128329,1.7319236298444,DAPK2;BMF;P4HB
alpha,2,"positive regulation of gene expression, epigenetic (GO:0045815)",3/48,3,48,0.318397354237768,0.717964182430455,0,0,1.51331719128329,1.7319236298444,TAF1B;WBP2;SLC50A1
alpha,2,ATP synthesis coupled proton transport (GO:0015986),2/28,2,28,0.322755048771508,0.717964182430455,0,0,1.72950536146662,1.95583121134317,ATP5G1;ATP6V0A1
alpha,2,regulation of cilium assembly (GO:1902017),2/28,2,28,0.322755048771508,0.717964182430455,0,0,1.72950536146662,1.95583121134317,IFT140;FUZ
alpha,2,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),2/28,2,28,0.322755048771508,0.717964182430455,0,0,1.72950536146662,1.95583121134317,NF2;PRKCZ
alpha,2,negative regulation of synaptic transmission (GO:0050805),2/28,2,28,0.322755048771508,0.717964182430455,0,0,1.72950536146662,1.95583121134317,ATAD1;SLC30A1
alpha,2,modulation by host of viral transcription (GO:0043921),2/28,2,28,0.322755048771508,0.717964182430455,0,0,1.72950536146662,1.95583121134317,RRP1B;TARDBP
alpha,2,regulation of protein transport (GO:0051223),2/28,2,28,0.322755048771508,0.717964182430455,0,0,1.72950536146662,1.95583121134317,SNX3;PTPN1
alpha,2,regulation of protein targeting to membrane (GO:0090313),2/28,2,28,0.322755048771508,0.717964182430455,0,0,1.72950536146662,1.95583121134317,AKT2;CIB1
alpha,2,regulation of protein localization to cell surface (GO:2000008),2/28,2,28,0.322755048771508,0.717964182430455,0,0,1.72950536146662,1.95583121134317,STX4;KCNAB2
alpha,2,regulation of cytokine-mediated signaling pathway (GO:0001959),5/91,5,91,0.32290266471472,0.717964182430455,0,0,1.33038873958971,1.50387721683507,PTPN1;MADD;PTPN11;PIAS1;BIRC3
alpha,2,regulation of innate immune response (GO:0045088),4/70,4,70,0.327748732217634,0.717964182430455,0,0,1.3836042891733,1.54342168728361,RNF135;PTPN1;PTPN11;BIRC3
alpha,2,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),4/70,4,70,0.327748732217634,0.717964182430455,0,0,1.3836042891733,1.54342168728361,CDC42;FUZ;PFN1;HRAS
alpha,2,protein K48-linked ubiquitination (GO:0070936),3/49,3,49,0.329828264697031,0.717964182430455,0,0,1.48243316697139,1.64428991944097,UBE2Q2;PELI1;UBE2A
alpha,2,regulation of mitochondrion organization (GO:0010821),3/49,3,49,0.329828264697031,0.717964182430455,0,0,1.48243316697139,1.64428991944097,VPS35;SQSTM1;MYO19
alpha,2,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),3/49,3,49,0.329828264697031,0.717964182430455,0,0,1.48243316697139,1.64428991944097,BCL3;E2F1;RPS27L
alpha,2,cellular response to acid chemical (GO:0071229),5/92,5,92,0.33110616981416,0.717964182430455,0,0,1.31592799242025,1.45451652846394,BRINP2;RRAGC;LARS;FZD7;RARA
alpha,2,vascular endothelial growth factor receptor signaling pathway (GO:0048010),4/71,4,71,0.337201846972062,0.717964182430455,0,0,1.36411690481874,1.48289544110881,CDC42;CYFIP1;MAPKAPK3;MAPK14
alpha,2,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),2/29,2,29,0.338059989176113,0.717964182430455,0,0,1.66986724555398,1.81102432408409,PHB;CALR
alpha,2,cellular amino acid biosynthetic process (GO:0008652),2/29,2,29,0.338059989176113,0.717964182430455,0,0,1.66986724555398,1.81102432408409,PAH;GOT2
alpha,2,negative regulation of response to DNA damage stimulus (GO:2001021),2/29,2,29,0.338059989176113,0.717964182430455,0,0,1.66986724555398,1.81102432408409,RTEL1;THOC5
alpha,2,positive regulation of phosphate metabolic process (GO:0045937),2/29,2,29,0.338059989176113,0.717964182430455,0,0,1.66986724555398,1.81102432408409,FZD7;GLMN
alpha,2,positive regulation of sprouting angiogenesis (GO:1903672),2/29,2,29,0.338059989176113,0.717964182430455,0,0,1.66986724555398,1.81102432408409,CIB1;KLF4
alpha,2,protein K11-linked ubiquitination (GO:0070979),2/29,2,29,0.338059989176113,0.717964182430455,0,0,1.66986724555398,1.81102432408409,UBE2A;ANAPC1
alpha,2,regulation of fatty acid biosynthetic process (GO:0042304),2/29,2,29,0.338059989176113,0.717964182430455,0,0,1.66986724555398,1.81102432408409,ACADVL;PRKAA2
alpha,2,regulation of defense response to virus by virus (GO:0050690),2/29,2,29,0.338059989176113,0.717964182430455,0,0,1.66986724555398,1.81102432408409,B2M;AP2M1
alpha,2,bicellular tight junction assembly (GO:0070830),2/29,2,29,0.338059989176113,0.717964182430455,0,0,1.66986724555398,1.81102432408409,TBCD;STRN
alpha,2,non-recombinational repair (GO:0000726),3/50,3,50,0.341253994392404,0.717964182430455,0,0,1.45278450363196,1.56192962814373,PAXIP1;H2AFX;NHEJ1
alpha,2,regulation of reactive oxygen species metabolic process (GO:2000377),3/50,3,50,0.341253994392404,0.717964182430455,0,0,1.45278450363196,1.56192962814373,ROMO1;MAPK14;TGFBR2
alpha,2,establishment of protein localization to mitochondrion (GO:0072655),3/50,3,50,0.341253994392404,0.717964182430455,0,0,1.45278450363196,1.56192962814373,COX18;DNLZ;FBXO7
alpha,2,positive regulation of response to DNA damage stimulus (GO:2001022),3/50,3,50,0.341253994392404,0.717964182430455,0,0,1.45278450363196,1.56192962814373,EID3;H2AFX;CEBPG
alpha,2,negative regulation of response to cytokine stimulus (GO:0060761),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,KLF4
alpha,2,regulation of response to stress (GO:0080134),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,DYRK3
alpha,2,low-density lipoprotein particle receptor catabolic process (GO:0032802),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,AP2M1
alpha,2,regulation of chromatin organization (GO:1902275),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,TLK1
alpha,2,negative regulation of cellular protein catabolic process (GO:1903363),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,EPHA4
alpha,2,negative regulation of sodium ion transmembrane transport (GO:1902306),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,NEDD4
alpha,2,dynamin family protein polymerization involved in membrane fission (GO:0003373),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,OPA1
alpha,2,vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,ATP6V0A1
alpha,2,amino sugar metabolic process (GO:0006040),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,CSGALNACT1
alpha,2,regulation of myeloid leukocyte differentiation (GO:0002761),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,CEBPB
alpha,2,regulation of sequestering of zinc ion (GO:0061088),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,SLC30A1
alpha,2,negative regulation of oxidative stress-induced neuron death (GO:1903204),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,FBXO7
alpha,2,regulation of mammary gland epithelial cell proliferation (GO:0033599),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,MST1
alpha,2,"energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)",1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,NDUFS7
alpha,2,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,CYFIP1
alpha,2,establishment of spindle localization (GO:0051293),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,SPAG5
alpha,2,cellular biogenic amine metabolic process (GO:0006576),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,OAZ2
alpha,2,positive regulation of amyloid-beta formation (GO:1902004),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,EPHA4
alpha,2,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,HGS
alpha,2,mesoderm morphogenesis (GO:0048332),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,TBX3
alpha,2,response to laminar fluid shear stress (GO:0034616),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,KLF4
alpha,2,galactose metabolic process (GO:0006012),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,PGM2L1
alpha,2,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,PVR
alpha,2,L-glutamate transport (GO:0015813),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,SLC25A12
alpha,2,cellular response to dopamine (GO:1903351),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,MAPK1
alpha,2,aspartate family amino acid metabolic process (GO:0009066),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,GOT2
alpha,2,positive regulation of glucose import in response to insulin stimulus (GO:2001275),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,PTPN11
alpha,2,mesenchymal to epithelial transition (GO:0060231),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,FZD7
alpha,2,ESCRT III complex disassembly (GO:1904903),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,CHMP1A
alpha,2,positive regulation of glial cell differentiation (GO:0045687),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,BMP2
alpha,2,epithelial cell morphogenesis (GO:0003382),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,MET
alpha,2,peptidyl-lysine dimethylation (GO:0018027),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,EHMT1
alpha,2,creatine metabolic process (GO:0006600),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,SLC6A8
alpha,2,chylomicron assembly (GO:0034378),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,P4HB
alpha,2,negative regulation of gene silencing by miRNA (GO:0060965),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,ZC3H10
alpha,2,T cell chemotaxis (GO:0010818),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,CXCL16
alpha,2,regulation of granulocyte differentiation (GO:0030852),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,RARA
alpha,2,telomere maintenance in response to DNA damage (GO:0043247),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,RTEL1
alpha,2,glycerolipid metabolic process (GO:0046486),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,DGKA
alpha,2,primary miRNA processing (GO:0031053),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,NCBP1
alpha,2,negative regulation of reproductive process (GO:2000242),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,CALR
alpha,2,regulation of establishment of protein localization to telomere (GO:0070203),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,CCT7
alpha,2,cellular response to ATP (GO:0071318),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,SSH1
alpha,2,nucleoside metabolic process (GO:0009116),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,MACROD2
alpha,2,positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,PVR
alpha,2,regulation of fatty acid beta-oxidation (GO:0031998),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,AKT2
alpha,2,myeloid dendritic cell differentiation (GO:0043011),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,TGFBR2
alpha,2,actin filament capping (GO:0051693),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,TRIOBP
alpha,2,protein deneddylation (GO:0000338),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,COPS2
alpha,2,regulation of DNA damage checkpoint (GO:2000001),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,THOC5
alpha,2,negative regulation of protein maturation (GO:1903318),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,CHAC1
alpha,2,intraciliary retrograde transport (GO:0035721),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,IFT140
alpha,2,negative regulation of centrosome duplication (GO:0010826),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,TRIM37
alpha,2,neuron projection fasciculation (GO:0106030),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,EPHA4
alpha,2,actin filament-based transport (GO:0099515),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,MYO19
alpha,2,polarized epithelial cell differentiation (GO:0030859),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,CDC42
alpha,2,ceramide catabolic process (GO:0046514),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,NEU1
alpha,2,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,NEDD4
alpha,2,negative regulation of embryonic development (GO:0045992),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,FUZ
alpha,2,ESCRT complex disassembly (GO:1904896),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,CHMP1A
alpha,2,glucocorticoid metabolic process (GO:0008211),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,YWHAH
alpha,2,regulation of mRNA 3'-end processing (GO:0031440),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,NCBP1
alpha,2,cellular response to leucine starvation (GO:1990253),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,LARS
alpha,2,very-low-density lipoprotein particle assembly (GO:0034379),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,P4HB
alpha,2,response to histamine (GO:0034776),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,DHX8
alpha,2,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,NCBP1
alpha,2,regulation of phospholipid metabolic process (GO:1903725),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,MTMR3
alpha,2,telomeric loop disassembly (GO:0090657),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,RTEL1
alpha,2,forelimb morphogenesis (GO:0035136),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,TBX3
alpha,2,regulation of axon regeneration (GO:0048679),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,EPHA4
alpha,2,negative regulation of glucose transport (GO:0010829),1/10,1,10,0.344178706010476,0.717964182430455,0,0,2.42130750605327,2.58255269317832,PEA15
alpha,2,regulation of cell communication (GO:0010646),4/72,4,72,0.34666490201022,0.721360464414005,0,0,1.34517083669626,1.42506949943896,PTPN1;CXADR;DHX8;BIRC3
alpha,2,recombinational repair (GO:0000725),4/72,4,72,0.34666490201022,0.721360464414005,0,0,1.34517083669626,1.42506949943896,FEN1;RAD51D;ORAOV1;FAN1
alpha,2,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),4/72,4,72,0.34666490201022,0.721360464414005,0,0,1.34517083669626,1.42506949943896,PSMD13;PSME3;PSMD3;ANAPC1
alpha,2,response to cytokine (GO:0034097),7/139,7,139,0.351046751066669,0.724178023284714,0,0,1.21936349225704,1.27647344282851,MAPKAPK3;YTHDC2;PTPN11;PTPN12;MAP2K7;JUNB;CXCL16
alpha,2,positive regulation of JUN kinase activity (GO:0043507),3/51,3,51,0.352664809603971,0.724178023284714,0,0,1.42429853297251,1.48445694490686,TAOK1;MAP2K7;MAPK8IP3
alpha,2,neurogenesis (GO:0022008),3/51,3,51,0.352664809603971,0.724178023284714,0,0,1.42429853297251,1.48445694490686,BTBD1;COPS2;CHAC1
alpha,2,fatty acid beta-oxidation (GO:0006635),3/51,3,51,0.352664809603971,0.724178023284714,0,0,1.42429853297251,1.48445694490686,ACADVL;ECI1;PPARD
alpha,2,double-strand break repair via nonhomologous end joining (GO:0006303),3/51,3,51,0.352664809603971,0.724178023284714,0,0,1.42429853297251,1.48445694490686,PAXIP1;H2AFX;NHEJ1
alpha,2,cardiac muscle cell action potential (GO:0086001),2/30,2,30,0.353257502619544,0.724178023284714,0,0,1.61420500403551,1.67967396094428,YWHAE;KCND3
alpha,2,positive regulation of histone modification (GO:0031058),2/30,2,30,0.353257502619544,0.724178023284714,0,0,1.61420500403551,1.67967396094428,PAXIP1;TADA2A
alpha,2,negative regulation of Notch signaling pathway (GO:0045746),2/30,2,30,0.353257502619544,0.724178023284714,0,0,1.61420500403551,1.67967396094428,YTHDF2;CHAC1
alpha,2,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),2/30,2,30,0.353257502619544,0.724178023284714,0,0,1.61420500403551,1.67967396094428,CEBPB;HSPA5
alpha,2,coenzyme biosynthetic process (GO:0009108),2/30,2,30,0.353257502619544,0.724178023284714,0,0,1.61420500403551,1.67967396094428,SLC25A16;PANK1
alpha,2,regulation of myoblast differentiation (GO:0045661),2/30,2,30,0.353257502619544,0.724178023284714,0,0,1.61420500403551,1.67967396094428,MAPK14;TBX3
alpha,2,cellular response to fibroblast growth factor stimulus (GO:0044344),5/95,5,95,0.355815946465372,0.724178023284714,0,0,1.27437237160698,1.31686209523852,HNRNPM;NCBP1;MAPK1;PTPN11;FGFRL1
alpha,2,lipid biosynthetic process (GO:0008610),4/73,4,73,0.356132086361707,0.724178023284714,0,0,1.3267438389333,1.36980143664926,GNPAT;PCYT2;PRKAA2;ELOVL4
alpha,2,glycoprotein biosynthetic process (GO:0009101),4/73,4,73,0.356132086361707,0.724178023284714,0,0,1.3267438389333,1.36980143664926,CSGALNACT1;PMM2;B3GALT6;ALG1
alpha,2,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),4/73,4,73,0.356132086361707,0.724178023284714,0,0,1.3267438389333,1.36980143664926,PSMD13;PSME3;PSMD3;FBXO31
alpha,2,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),4/73,4,73,0.356132086361707,0.724178023284714,0,0,1.3267438389333,1.36980143664926,PSMD13;PSME3;PSMD3;ANAPC1
alpha,2,cellular response to growth factor stimulus (GO:0071363),7/140,7,140,0.357809691565205,0.724178023284714,0,0,1.21065375302663,1.24425426359688,BMP2;RPS6KB1;CIB1;PTPN11;PTPN12;MAPK14;KLF4
alpha,2,regulation of primary metabolic process (GO:0080090),7/140,7,140,0.357809691565205,0.724178023284714,0,0,1.21065375302663,1.24425426359688,CPT2;PSMD13;NCOA6;PSME3;PSMD3;OAZ2;PPARD
alpha,2,negative regulation of neuron projection development (GO:0010977),3/52,3,52,0.364051402419748,0.724178023284714,0,0,1.39690817656919,1.41152012368666,EPHA4;ARHGDIA;CIB1
alpha,2,telomere maintenance (GO:0000723),3/52,3,52,0.364051402419748,0.724178023284714,0,0,1.39690817656919,1.41152012368666,RAD51D;RTEL1;POLD1
alpha,2,response to lipid (GO:0033993),7/141,7,141,0.364584067804411,0.724178023284714,0,0,1.20206755619666,1.21288389882343,FOXA1;ABCA2;SRR;MAPKAPK3;RARA;JUNB;PPARD
alpha,2,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),7/141,7,141,0.364584067804411,0.724178023284714,0,0,1.20206755619666,1.21288389882343,MAD2L2;NFKBIL1;CEBPG;KEAP1;TRIM37;CACTIN;KLF4
alpha,2,regulation of protein complex assembly (GO:0043254),4/74,4,74,0.365597743668394,0.724178023284714,0,0,1.3088148681369,1.31695780512603,CDC42;VPS18;PTPN11;PRKCZ
alpha,2,positive regulation of cytokine secretion (GO:0050715),4/74,4,74,0.365597743668394,0.724178023284714,0,0,1.3088148681369,1.31695780512603,MAVS;GLMN;MAPK14;PRKCZ
alpha,2,positive regulation of proteasomal protein catabolic process (GO:1901800),4/74,4,74,0.365597743668394,0.724178023284714,0,0,1.3088148681369,1.31695780512603,KEAP1;RNF166;PIAS1;HSPA1A
alpha,2,beta-catenin-TCF complex assembly (GO:1904837),2/31,2,31,0.368330366742402,0.724178023284714,0,0,1.56213387487308,1.56022027309826,TLE3;PYGO2
alpha,2,cellular response to drug (GO:0035690),2/31,2,31,0.368330366742402,0.724178023284714,0,0,1.56213387487308,1.56022027309826,PPM1F;RBM22
alpha,2,multivesicular body assembly (GO:0036258),2/31,2,31,0.368330366742402,0.724178023284714,0,0,1.56213387487308,1.56022027309826,HGS;CHMP1A
alpha,2,fatty-acyl-CoA biosynthetic process (GO:0046949),2/31,2,31,0.368330366742402,0.724178023284714,0,0,1.56213387487308,1.56022027309826,FASN;ACSL4
alpha,2,regulation of cell adhesion mediated by integrin (GO:0033628),2/31,2,31,0.368330366742402,0.724178023284714,0,0,1.56213387487308,1.56022027309826,CIB1;PTPN11
alpha,2,aminoglycan metabolic process (GO:0006022),2/31,2,31,0.368330366742402,0.724178023284714,0,0,1.56213387487308,1.56022027309826,GPC2;B3GALT6
alpha,2,regulation of protein polymerization (GO:0032271),2/31,2,31,0.368330366742402,0.724178023284714,0,0,1.56213387487308,1.56022027309826,PFN1;CAMSAP2
alpha,2,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),2/31,2,31,0.368330366742402,0.724178023284714,0,0,1.56213387487308,1.56022027309826,ARHGDIA;YWHAH
alpha,2,L-phenylalanine metabolic process (GO:0006558),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,PAH
alpha,2,L-phenylalanine catabolic process (GO:0006559),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,PAH
alpha,2,regulation of histone H3-K9 methylation (GO:0051570),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,ZNF274
alpha,2,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,CCT7
alpha,2,mononuclear cell differentiation (GO:1903131),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,THOC5
alpha,2,intracellular protein transmembrane transport (GO:0065002),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,AKT2
alpha,2,positive regulation of extracellular matrix organization (GO:1903055),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,COLGALT1
alpha,2,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000059),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,SGTA
alpha,2,protein localization to pre-autophagosomal structure (GO:0034497),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,WDR45B
alpha,2,positive regulation of leukocyte degranulation (GO:0043302),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,STX4
alpha,2,negative regulation of fatty acid biosynthetic process (GO:0045717),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,ACADVL
alpha,2,proteasome assembly (GO:0043248),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,PSMD13
alpha,2,chromatin silencing at rDNA (GO:0000183),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,BAZ2A
alpha,2,cell-substrate junction assembly (GO:0007044),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,LAMC1
alpha,2,positive regulation of tumor necrosis factor secretion (GO:1904469),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,MAVS
alpha,2,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,RCL1
alpha,2,regulation of mitotic centrosome separation (GO:0046602),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,RANBP1
alpha,2,biotin metabolic process (GO:0006768),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,BTD
alpha,2,regulation of ventricular cardiac muscle cell action potential (GO:0098911),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,DSP
alpha,2,cell-cell junction maintenance (GO:0045217),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,PLEKHA7
alpha,2,internal protein amino acid acetylation (GO:0006475),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,HAT1
alpha,2,positive regulation of myoblast fusion (GO:1901741),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,MAPK14
alpha,2,phosphatidylinositol dephosphorylation (GO:0046856),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,MTMR3
alpha,2,rRNA base methylation (GO:0070475),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,METTL16
alpha,2,negative regulation of myotube differentiation (GO:0010832),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,HDAC5
alpha,2,monocyte differentiation (GO:0030224),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,THOC5
alpha,2,positive regulation of mesenchymal cell proliferation (GO:0002053),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,TGFBR2
alpha,2,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,PVR
alpha,2,transcytosis (GO:0045056),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,VPS35
alpha,2,regulation of chromatin binding (GO:0035561),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,DDX11
alpha,2,negative regulation of cell division (GO:0051782),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,ORC6
alpha,2,macrophage differentiation (GO:0030225),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,CDC42
alpha,2,negative regulation of receptor binding (GO:1900121),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,B2M
alpha,2,negative regulation of heart contraction (GO:0045822),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,SPTBN4
alpha,2,negative regulation of cardiac muscle hypertrophy (GO:0010614),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,LMNA
alpha,2,cellular response to increased oxygen levels (GO:0036295),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,ATP6V0D1
alpha,2,positive regulation of fatty acid oxidation (GO:0046321),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,AKT2
alpha,2,inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,BIRC3
alpha,2,low-density lipoprotein receptor particle metabolic process (GO:0032799),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,AP2M1
alpha,2,epithelial cell-cell adhesion (GO:0090136),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,PLEKHA7
alpha,2,hemidesmosome assembly (GO:0031581),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,LAMC1
alpha,2,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,PAH
alpha,2,glutathione biosynthetic process (GO:0006750),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,CHAC1
alpha,2,regulation of autophagosome maturation (GO:1901096),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,TBC1D25
alpha,2,protein carboxylation (GO:0018214),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,VKORC1
alpha,2,peptidyl-glutamic acid carboxylation (GO:0017187),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,VKORC1
alpha,2,positive regulation of interferon-gamma biosynthetic process (GO:0045078),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,CEBPG
alpha,2,hepatocyte growth factor receptor signaling pathway (GO:0048012),1/11,1,11,0.371277630494502,0.724178023284714,0,0,2.20118864186661,2.18094907783459,MST1
alpha,2,positive regulation of epithelial cell migration (GO:0010634),4/75,4,75,0.375056375772795,0.725856703563338,0,0,1.29136400322841,1.2664134675278,ZNF580;CALR;PFN1;PPM1F
alpha,2,regulation of cell-matrix adhesion (GO:0001952),3/53,3,53,0.375404888101973,0.725856703563338,0,0,1.37055141852072,1.34279793576458,CIB1;NF2;UTRN
alpha,2,B cell differentiation (GO:0030183),3/53,3,53,0.375404888101973,0.725856703563338,0,0,1.37055141852072,1.34279793576458,HDAC5;CEBPG;NHEJ1
alpha,2,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),5/98,5,98,0.380592758572049,0.725856703563338,0,0,1.23536097247616,1.19339001661417,DYNC1LI1;KLC2;SEC24C;ACTR10;AP2M1
alpha,2,response to tumor necrosis factor (GO:0034612),5/98,5,98,0.380592758572049,0.725856703563338,0,0,1.23536097247616,1.19339001661417,YTHDC2;CIB1;MAP2K7;CACTIN;CXCL16
alpha,2,antigen processing and presentation of exogenous peptide antigen (GO:0002478),5/98,5,98,0.380592758572049,0.725856703563338,0,0,1.23536097247616,1.19339001661417,DYNC1LI1;KLC2;SEC24C;ACTR10;AP2M1
alpha,2,negative regulation of toll-like receptor signaling pathway (GO:0034122),2/32,2,32,0.383262961444328,0.725856703563338,0,0,1.51331719128329,1.45132255143234,NFKBIL1;CACTIN
alpha,2,regulation of dendritic spine development (GO:0060998),2/32,2,32,0.383262961444328,0.725856703563338,0,0,1.51331719128329,1.45132255143234,EPHA4;DLG5
alpha,2,negative regulation of blood vessel endothelial cell migration (GO:0043537),2/32,2,32,0.383262961444328,0.725856703563338,0,0,1.51331719128329,1.45132255143234,HDAC5;KLF4
alpha,2,renal water homeostasis (GO:0003091),2/32,2,32,0.383262961444328,0.725856703563338,0,0,1.51331719128329,1.45132255143234,ADCY9;PRKAR1B
alpha,2,regulation of protein export from nucleus (GO:0046825),2/32,2,32,0.383262961444328,0.725856703563338,0,0,1.51331719128329,1.45132255143234,YWHAE;RBM22
alpha,2,multivesicular body organization (GO:0036257),2/32,2,32,0.383262961444328,0.725856703563338,0,0,1.51331719128329,1.45132255143234,HGS;CHMP1A
alpha,2,positive regulation of viral genome replication (GO:0045070),2/32,2,32,0.383262961444328,0.725856703563338,0,0,1.51331719128329,1.45132255143234,TBC1D20;YTHDC2
alpha,2,positive regulation of insulin secretion (GO:0032024),2/32,2,32,0.383262961444328,0.725856703563338,0,0,1.51331719128329,1.45132255143234,STX4;C2CD2L
alpha,2,vesicle-mediated transport to the plasma membrane (GO:0098876),2/32,2,32,0.383262961444328,0.725856703563338,0,0,1.51331719128329,1.45132255143234,VPS26A;VPS35
alpha,2,macromolecular complex assembly (GO:0065003),6/121,6,121,0.383503760741038,0.725856703563338,0,0,1.20064835010906,1.15070840476787,YAP1;NFS1;SF3B3;SLC2A1;FANCC;LAMC1
alpha,2,negative regulation of growth (GO:0045926),6/121,6,121,0.383503760741038,0.725856703563338,0,0,1.20064835010906,1.15070840476787,CCDC85B;DCUN1D3;OSGIN1;PHB;ACVR1B;HSPA1A
alpha,2,regulation of defense response (GO:0031347),4/76,4,76,0.384502645635457,0.725856703563338,0,0,1.27437237160698,1.21805098680223,RNF135;SHPK;CASP4;BIRC3
alpha,2,gland development (GO:0048732),4/76,4,76,0.384502645635457,0.725856703563338,0,0,1.27437237160698,1.21805098680223,CEBPG;RARA;MET;TBX3
alpha,2,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),3/54,3,54,0.386716801153365,0.725856703563338,0,0,1.34517083669626,1.27799654802189,BECN1;ERBB3;NEDD4
alpha,2,embryonic organ development (GO:0048568),3/54,3,54,0.386716801153365,0.725856703563338,0,0,1.34517083669626,1.27799654802189,KITLG;RARA;TGFBR2
alpha,2,positive regulation of neuron differentiation (GO:0045666),5/99,5,99,0.388849071024699,0.725856703563338,0,0,1.22288257881478,1.15509086369332,SNX3;BRINP2;BMP2;CPNE1;TCF4
alpha,2,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),7/145,7,145,0.391753279891043,0.725856703563338,0,0,1.16890707188778,1.09540973158682,FAM83G;BMP2;SMURF2;ACVR1B;PRKCZ;GDF5;TGFBR2
alpha,2,double-strand break repair via homologous recombination (GO:0000724),4/77,4,77,0.393931379734557,0.725856703563338,0,0,1.25782208106663,1.17176006787537,FEN1;RAD51D;ORAOV1;FAN1
alpha,2,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),4/77,4,77,0.393931379734557,0.725856703563338,0,0,1.25782208106663,1.17176006787537,PSMD13;PSME3;PSMD3;ANAPC1
alpha,2,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,DERL3
alpha,2,rRNA 3'-end processing (GO:0031125),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,ERI2
alpha,2,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,NUDT16L1
alpha,2,regulation of mesenchymal cell proliferation (GO:0010464),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,TGFBR2
alpha,2,regulation of myoblast fusion (GO:1901739),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,MAPK14
alpha,2,axonal fasciculation (GO:0007413),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,EPHA4
alpha,2,regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901836),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,DDX11
alpha,2,negative regulation of chondrocyte differentiation (GO:0032331),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,GDF5
alpha,2,import across plasma membrane (GO:0098739),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,FXYD2
alpha,2,ribose phosphate metabolic process (GO:0019693),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,SHPK
alpha,2,fatty acid elongation (GO:0030497),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,ELOVL4
alpha,2,establishment of apical/basal cell polarity (GO:0035089),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,CDC42
alpha,2,positive regulation of establishment of protein localization (GO:1904951),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,CCT7
alpha,2,pentose-phosphate shunt (GO:0006098),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,SHPK
alpha,2,vesicle budding from membrane (GO:0006900),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,SNX3
alpha,2,mitochondrial outer membrane permeabilization (GO:0097345),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,BMF
alpha,2,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,RPL26
alpha,2,viral RNA genome replication (GO:0039694),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,CDC42
alpha,2,protein insertion into membrane (GO:0051205),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,COX18
alpha,2,entry of bacterium into host cell (GO:0035635),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,MET
alpha,2,Golgi localization (GO:0051645),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,CDC42
alpha,2,epithelial structure maintenance (GO:0010669),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,CXADR
alpha,2,oligodendrocyte development (GO:0014003),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,EIF2B3
alpha,2,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,BOD1
alpha,2,mitochondrion transport along microtubule (GO:0047497),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,OPA1
alpha,2,pre-mRNA cleavage required for polyadenylation (GO:0098789),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,NCBP1
alpha,2,nonribosomal peptide biosynthetic process (GO:0019184),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,CHAC1
alpha,2,regulation of interleukin-2 biosynthetic process (GO:0045076),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,GLMN
alpha,2,positive regulation of amyloid precursor protein catabolic process (GO:1902993),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,EPHA4
alpha,2,polyamine metabolic process (GO:0006595),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,OAZ2
alpha,2,tRNA 5'-leader removal (GO:0001682),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,RPP25
alpha,2,negative regulation by host of viral transcription (GO:0043922),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,TARDBP
alpha,2,positive regulation of pseudopodium assembly (GO:0031274),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,CDC42
alpha,2,positive regulation of chondrocyte differentiation (GO:0032332),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,GDF5
alpha,2,cellular response to fluid shear stress (GO:0071498),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,KLF4
alpha,2,regulation of pseudopodium assembly (GO:0031272),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,CDC42
alpha,2,positive regulation of peptidase activity (GO:0010952),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,PSME3
alpha,2,response to interleukin-6 (GO:0070741),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,PHB
alpha,2,"regulation of protein import into nucleus, translocation (GO:0033158)",1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,MAVS
alpha,2,cardiac muscle fiber development (GO:0048739),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,CXADR
alpha,2,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,PTPN1
alpha,2,peptidyl-methionine modification (GO:0018206),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,NAA60
alpha,2,L-serine metabolic process (GO:0006563),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,SRR
alpha,2,PERK-mediated unfolded protein response (GO:0036499),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,HSPA5
alpha,2,positive regulation of cyclase activity (GO:0031281),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,MAPK14
alpha,2,endosome transport via multivesicular body sorting pathway (GO:0032509),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,TMEM50A
alpha,2,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,FUZ
alpha,2,negative regulation of myoblast differentiation (GO:0045662),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,TBX3
alpha,2,negative regulation of androgen receptor signaling pathway (GO:0060766),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,PHB
alpha,2,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,ARNT
alpha,2,negative regulation of fatty acid metabolic process (GO:0045922),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,ACADVL
alpha,2,regulation of catabolic process (GO:0009894),1/12,1,12,0.397258108788347,0.725856703563338,0,0,2.01775625504439,1.86273014824086,HGS
alpha,2,cell morphogenesis involved in differentiation (GO:0000904),3/55,3,55,0.397979090616818,0.725856703563338,0,0,1.32071318511996,1.21684676806043,YTHDF2;TBCD;LAMC1
alpha,2,RNA modification (GO:0009451),3/55,3,55,0.397979090616818,0.725856703563338,0,0,1.32071318511996,1.21684676806043,CTU2;URM1;LCMT2
alpha,2,cellular response to nutrient levels (GO:0031669),3/55,3,55,0.397979090616818,0.725856703563338,0,0,1.32071318511996,1.21684676806043,MAP1LC3B;PRKAA2;RRAGC
alpha,2,cellular response to amino acid stimulus (GO:0071230),2/33,2,33,0.398041166149126,0.725856703563338,0,0,1.46745909457774,1.35182309268616,RRAGC;LARS
alpha,2,positive regulation of dendrite development (GO:1900006),2/33,2,33,0.398041166149126,0.725856703563338,0,0,1.46745909457774,1.35182309268616,CUX1;DLG5
alpha,2,negative regulation of BMP signaling pathway (GO:0030514),2/33,2,33,0.398041166149126,0.725856703563338,0,0,1.46745909457774,1.35182309268616,SMURF2;LEMD3
alpha,2,cyclic-nucleotide-mediated signaling (GO:0019935),2/33,2,33,0.398041166149126,0.725856703563338,0,0,1.46745909457774,1.35182309268616,RIMS2;NUDT4
alpha,2,ATP biosynthetic process (GO:0006754),2/33,2,33,0.398041166149126,0.725856703563338,0,0,1.46745909457774,1.35182309268616,ATP5G1;ATP6V0A1
alpha,2,positive regulation of TOR signaling (GO:0032008),2/33,2,33,0.398041166149126,0.725856703563338,0,0,1.46745909457774,1.35182309268616,RRAGC;LARS
alpha,2,activation of adenylate cyclase activity (GO:0007190),2/33,2,33,0.398041166149126,0.725856703563338,0,0,1.46745909457774,1.35182309268616,ADCY9;GIPR
alpha,2,mitochondrial transmembrane transport (GO:1990542),2/33,2,33,0.398041166149126,0.725856703563338,0,0,1.46745909457774,1.35182309268616,PRKAA2;CPT2
alpha,2,negative regulation of fat cell differentiation (GO:0045599),2/33,2,33,0.398041166149126,0.725856703563338,0,0,1.46745909457774,1.35182309268616,CCDC85B;E2F1
alpha,2,vasculogenesis (GO:0001570),2/33,2,33,0.398041166149126,0.725856703563338,0,0,1.46745909457774,1.35182309268616,GLMN;TGFBR2
alpha,2,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),4/78,4,78,0.403337570115583,0.728251216642757,0,0,1.24169615695039,1.12743704562716,SMURF2;LEMD3;TGFBR2;HSPA1A
alpha,2,ERAD pathway (GO:0036503),4/78,4,78,0.403337570115583,0.728251216642757,0,0,1.24169615695039,1.12743704562716,HSPA5;DERL3;SGTA;MAN1B1
alpha,2,regulation of cellular catabolic process (GO:0031329),3/56,3,56,0.409184114271254,0.728251216642757,0,0,1.29712902109997,1.15910160898552,RRAGC;DAPK2;ULK2
alpha,2,DNA recombination (GO:0006310),3/56,3,56,0.409184114271254,0.728251216642757,0,0,1.29712902109997,1.15910160898552,RAD51D;RTEL1;NCOA6
alpha,2,Notch signaling pathway (GO:0007219),3/56,3,56,0.409184114271254,0.728251216642757,0,0,1.29712902109997,1.15910160898552,BMP2;MAML1;YBX1
alpha,2,glycogen metabolic process (GO:0005977),2/34,2,34,0.412652263007662,0.728251216642757,0,0,1.42429853297251,1.26071787334214,NHLRC1;PGM2L1
alpha,2,positive regulation of adenylate cyclase activity (GO:0045762),2/34,2,34,0.412652263007662,0.728251216642757,0,0,1.42429853297251,1.26071787334214,ADCY9;GIPR
alpha,2,negative regulation of neurogenesis (GO:0050768),2/34,2,34,0.412652263007662,0.728251216642757,0,0,1.42429853297251,1.26071787334214,ID4;CALR
alpha,2,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),2/34,2,34,0.412652263007662,0.728251216642757,0,0,1.42429853297251,1.26071787334214,XPOT;NUP54
alpha,2,tRNA export from nucleus (GO:0006409),2/34,2,34,0.412652263007662,0.728251216642757,0,0,1.42429853297251,1.26071787334214,XPOT;NUP54
alpha,2,regulation of autophagosome assembly (GO:2000785),2/34,2,34,0.412652263007662,0.728251216642757,0,0,1.42429853297251,1.26071787334214,MTMR3;TBC1D14
alpha,2,carboxylic acid metabolic process (GO:0019752),2/34,2,34,0.412652263007662,0.728251216642757,0,0,1.42429853297251,1.26071787334214,CSGALNACT1;SLC2A1
alpha,2,positive regulation of organelle organization (GO:0010638),2/34,2,34,0.412652263007662,0.728251216642757,0,0,1.42429853297251,1.26071787334214,AKT2;PFDN2
alpha,2,negative regulation of cell communication (GO:0010648),4/79,4,79,0.412716375758585,0.728251216642757,0,0,1.2259784840776,1.0849844159018,EPHA4;PTPN1;ERBB3;MET
alpha,2,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),4/79,4,79,0.412716375758585,0.728251216642757,0,0,1.2259784840776,1.0849844159018,PSMD13;PSME3;PSMD3;ARNT
alpha,2,regulation of protein ubiquitination (GO:0031396),5/102,5,102,0.413560283089398,0.728251216642757,0,0,1.18691544414376,1.04798935069263,PAXIP1;USP4;U2AF2;BIRC3;HSPA1A
alpha,2,intrinsic apoptotic signaling pathway (GO:0097193),5/102,5,102,0.413560283089398,0.728251216642757,0,0,1.18691544414376,1.04798935069263,CEBPB;CASP4;E2F1;CHAC1;PPM1F
alpha,2,negative regulation of canonical Wnt signaling pathway (GO:0090090),7/149,7,149,0.418937826331261,0.728251216642757,0,0,1.13752701626664,0.989685764889675,MAD2L2;BMP2;PSMD13;PSME3;PSMD3;NPHP4;FUZ
alpha,2,chromosome organization (GO:0051276),3/57,3,57,0.420324632140996,0.728251216642757,0,0,1.27437237160698,1.10453413099921,CENPT;COPS2;DOT1L
alpha,2,regulation of BMP signaling pathway (GO:0030510),3/57,3,57,0.420324632140996,0.728251216642757,0,0,1.27437237160698,1.10453413099921,SMURF2;LEMD3;GDF5
alpha,2,positive regulation of protein transport (GO:0051222),3/57,3,57,0.420324632140996,0.728251216642757,0,0,1.27437237160698,1.10453413099921,UNC13B;PLK3;OAZ2
alpha,2,phosphatidylinositol-mediated signaling (GO:0048015),3/57,3,57,0.420324632140996,0.728251216642757,0,0,1.27437237160698,1.10453413099921,ERBB3;RPS6KB1;KCNH1
alpha,2,ATP metabolic process (GO:0046034),3/57,3,57,0.420324632140996,0.728251216642757,0,0,1.27437237160698,1.10453413099921,CTNS;ATP5G1;HSPA1A
alpha,2,negative regulation of multicellular organismal process (GO:0051241),6/126,6,126,0.420575173078773,0.728251216642757,0,0,1.15300357431108,0.998653343535205,FOXA1;MAD2L2;BMP2;FUZ;CALR;RAB11FIP3
alpha,2,response to calcium ion (GO:0051592),4/80,4,80,0.422063123602474,0.728251216642757,0,0,1.21065375302663,1.04431040452302,NEDD4;CPNE1;SLC25A12;KCNH1
alpha,2,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),4/80,4,80,0.422063123602474,0.728251216642757,0,0,1.21065375302663,1.04431040452302,SMURF2;LEMD3;TGFBR2;HSPA1A
alpha,2,DNA-templated transcriptional preinitiation complex assembly (GO:0070897),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,TAF1B
alpha,2,response to iron ion (GO:0010039),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,B2M
alpha,2,positive regulation of histone H3-K4 methylation (GO:0051571),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,PAXIP1
alpha,2,sodium ion export from cell (GO:0036376),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,FXYD2
alpha,2,nucleotide-sugar metabolic process (GO:0009225),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,CSGALNACT1
alpha,2,cellular response to exogenous dsRNA (GO:0071360),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,MAVS
alpha,2,mitochondrial genome maintenance (GO:0000002),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,OPA1
alpha,2,glycerolipid catabolic process (GO:0046503),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,ABHD6
alpha,2,regulation of cell aging (GO:0090342),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,LMNA
alpha,2,DNA replication-independent nucleosome organization (GO:0034724),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,HAT1
alpha,2,"Notch receptor processing, ligand-dependent (GO:0035333)",1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,YBX1
alpha,2,positive regulation of cellular carbohydrate metabolic process (GO:0010676),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,AKT2
alpha,2,steroid catabolic process (GO:0006706),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,YWHAH
alpha,2,very long-chain fatty acid biosynthetic process (GO:0042761),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,ELOVL4
alpha,2,regulation of glucose import in response to insulin stimulus (GO:2001273),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,PTPN11
alpha,2,mRNA cleavage involved in mRNA processing (GO:0098787),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,NCBP1
alpha,2,positive regulation of glycogen biosynthetic process (GO:0045725),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,AKT2
alpha,2,myelination in peripheral nervous system (GO:0022011),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,ARHGEF10
alpha,2,serine family amino acid biosynthetic process (GO:0009070),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,SRR
alpha,2,sodium ion export (GO:0071436),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,FXYD2
alpha,2,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,ZC3H10
alpha,2,positive regulation of actin nucleation (GO:0051127),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,CYFIP1
alpha,2,regulation of axon guidance (GO:1902667),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,PLXNA2
alpha,2,positive regulation of endothelial cell chemotaxis (GO:2001028),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,MET
alpha,2,catecholamine biosynthetic process (GO:0042423),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,PAH
alpha,2,cardiolipin metabolic process (GO:0032048),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,LCLAT1
alpha,2,poly(A)+ mRNA export from nucleus (GO:0016973),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,POLDIP3
alpha,2,leukocyte differentiation (GO:0002521),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,RRAS
alpha,2,neuron fate commitment (GO:0048663),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,POU3F2
alpha,2,membrane repolarization (GO:0086009),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,KCND3
alpha,2,protein neddylation (GO:0045116),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,DCUN1D3
alpha,2,protein localization to endoplasmic reticulum (GO:0070972),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,HSPA5
alpha,2,regulation of endothelial cell chemotaxis (GO:2001026),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,MET
alpha,2,regulation of necrotic cell death (GO:0010939),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,BIRC3
alpha,2,dicarboxylic acid catabolic process (GO:0043649),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,GOT2
alpha,2,cranial nerve development (GO:0021545),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,ERBB3
alpha,2,positive regulation of lamellipodium assembly (GO:0010592),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,CDC42
alpha,2,negative regulation of hormone secretion (GO:0046888),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,RAB11FIP3
alpha,2,positive regulation of ERAD pathway (GO:1904294),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,SGTA
alpha,2,mammary gland epithelium development (GO:0061180),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,AKT2
alpha,2,nucleotide metabolic process (GO:0009117),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,NUDT4
alpha,2,diacylglycerol metabolic process (GO:0046339),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,DGKA
alpha,2,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,PLXNA2
alpha,2,regulation of T cell cytokine production (GO:0002724),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,B2M
alpha,2,positive regulation of alpha-beta T cell proliferation (GO:0046641),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,TGFBR2
alpha,2,regulation of retinoic acid receptor signaling pathway (GO:0048385),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,CALR
alpha,2,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,PAXIP1
alpha,2,regulation of fatty acid oxidation (GO:0046320),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,ACADVL
alpha,2,negative regulation of cartilage development (GO:0061037),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,GDF5
alpha,2,negative regulation of ubiquitin-protein transferase activity (GO:0051444),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,MAD2L2
alpha,2,negative regulation of chemokine production (GO:0032682),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,KLF4
alpha,2,mitotic DNA integrity checkpoint (GO:0044774),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,ORAOV1
alpha,2,ribonucleoprotein complex disassembly (GO:0032988),1/13,1,13,0.422166248505833,0.728251216642757,0,0,1.86254423542559,1.60617636193008,DYRK3
alpha,2,response to amino acid (GO:0043200),2/35,2,35,0.427084845159884,0.731730964329639,0,0,1.3836042891733,1.1771325975555,RRAGC;LARS
alpha,2,positive regulation of exocytosis (GO:0045921),2/35,2,35,0.427084845159884,0.731730964329639,0,0,1.3836042891733,1.1771325975555,HGS;RAB3D
alpha,2,positive regulation of muscle cell differentiation (GO:0051149),2/35,2,35,0.427084845159884,0.731730964329639,0,0,1.3836042891733,1.1771325975555,CDC42;MAPK14
alpha,2,positive regulation of DNA binding (GO:0043388),2/35,2,35,0.427084845159884,0.731730964329639,0,0,1.3836042891733,1.1771325975555,MAU2;CEBPG
alpha,2,positive regulation of cytokinesis (GO:0032467),2/35,2,35,0.427084845159884,0.731730964329639,0,0,1.3836042891733,1.1771325975555,CDC42;CDC6
alpha,2,bone development (GO:0060348),2/35,2,35,0.427084845159884,0.731730964329639,0,0,1.3836042891733,1.1771325975555,VKORC1;RARA
alpha,2,regulation of axon extension (GO:0030516),2/35,2,35,0.427084845159884,0.731730964329639,0,0,1.3836042891733,1.1771325975555,EPHA4;PLXNA2
alpha,2,endoplasmic reticulum organization (GO:0007029),2/35,2,35,0.427084845159884,0.731730964329639,0,0,1.3836042891733,1.1771325975555,ATL2;TMEM170A
alpha,2,cellular macromolecular complex assembly (GO:0034622),2/35,2,35,0.427084845159884,0.731730964329639,0,0,1.3836042891733,1.1771325975555,TMED2;TCF4
alpha,2,macromolecule catabolic process (GO:0009057),2/35,2,35,0.427084845159884,0.731730964329639,0,0,1.3836042891733,1.1771325975555,BECN1;NEDD4
alpha,2,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),4/81,4,81,0.431373309241569,0.732852550019168,0,0,1.19570741039668,1.00532857087237,BECN1;ERBB3;NEDD4;MAPK1
alpha,2,nucleic acid metabolic process (GO:0090304),4/81,4,81,0.431373309241569,0.732852550019168,0,0,1.19570741039668,1.00532857087237,HNRNPM;FEN1;NCBP1;ERI2
alpha,2,NIK/NF-kappaB signaling (GO:0038061),4/81,4,81,0.431373309241569,0.732852550019168,0,0,1.19570741039668,1.00532857087237,PSMD13;PSME3;PSMD3;BIRC3
alpha,2,positive regulation of stress-activated MAPK cascade (GO:0032874),4/81,4,81,0.431373309241569,0.732852550019168,0,0,1.19570741039668,1.00532857087237,BMP2;FZD7;TAOK1;HRAS
alpha,2,regulation of glycolytic process (GO:0006110),3/58,3,58,0.431393799233593,0.732852550019168,0,0,1.25240043416548,1.05293552482213,PRKAA2;ARNT;NUP54
alpha,2,regulation of Rho protein signal transduction (GO:0035023),3/58,3,58,0.431393799233593,0.732852550019168,0,0,1.25240043416548,1.05293552482213,ARHGDIA;MYO9B;MET
alpha,2,tRNA modification (GO:0006400),3/58,3,58,0.431393799233593,0.732852550019168,0,0,1.25240043416548,1.05293552482213,CTU2;URM1;LCMT2
alpha,2,I-kappaB kinase/NF-kappaB signaling (GO:0007249),3/58,3,58,0.431393799233593,0.732852550019168,0,0,1.25240043416548,1.05293552482213,NFKBIL1;BCL3;BIRC3
alpha,2,regulation of neurogenesis (GO:0050767),3/58,3,58,0.431393799233593,0.732852550019168,0,0,1.25240043416548,1.05293552482213,YAP1;SPEN;YWHAH
alpha,2,protein homotetramerization (GO:0051289),3/58,3,58,0.431393799233593,0.732852550019168,0,0,1.25240043416548,1.05293552482213,SRR;CBY1;GNMT
alpha,2,response to retinoic acid (GO:0032526),3/58,3,58,0.431393799233593,0.732852550019168,0,0,1.25240043416548,1.05293552482213,BRINP2;FZD7;RARA
alpha,2,vesicle organization (GO:0016050),6/128,6,128,0.435336126145035,0.732852550019168,0,0,1.13498789346247,0.943897747987629,VPS18;HOOK2;STX4;SQSTM1;AP2M1;PLEKHJ1
alpha,2,positive regulation of protein kinase B signaling (GO:0051897),6/128,6,128,0.435336126145035,0.732852550019168,0,0,1.13498789346247,0.943897747987629,KITLG;ERBB3;NRG4;CPNE1;PTPN11;MET
alpha,2,positive regulation of protein targeting to mitochondrion (GO:1903955),4/82,4,82,0.440642597216221,0.732852550019168,0,0,1.18112561270891,0.967957443180118,NBPF3;LRRC46;HSPA1L;HPS4
alpha,2,BMP signaling pathway (GO:0030509),4/82,4,82,0.440642597216221,0.732852550019168,0,0,1.18112561270891,0.967957443180118,FAM83G;BMP2;SMURF2;GDF5
alpha,2,negative regulation of cell death (GO:0060548),4/82,4,82,0.440642597216221,0.732852550019168,0,0,1.18112561270891,0.967957443180118,DUS2;BECN1;VPS35;HSPA1A
alpha,2,regulation of cyclin-dependent protein kinase activity (GO:1904029),2/36,2,36,0.441328730525425,0.732852550019168,0,0,1.34517083669626,1.1003030138966,CDC6;CDC25A
alpha,2,erythrocyte differentiation (GO:0030218),2/36,2,36,0.441328730525425,0.732852550019168,0,0,1.34517083669626,1.1003030138966,DYRK3;CEBPG
alpha,2,negative regulation of protein complex assembly (GO:0031333),2/36,2,36,0.441328730525425,0.732852550019168,0,0,1.34517083669626,1.1003030138966,CDC42;PRKCZ
alpha,2,apical junction assembly (GO:0043297),2/36,2,36,0.441328730525425,0.732852550019168,0,0,1.34517083669626,1.1003030138966,TBCD;STRN
alpha,2,regulation of mitotic spindle organization (GO:0060236),2/36,2,36,0.441328730525425,0.732852550019168,0,0,1.34517083669626,1.1003030138966,CHMP1A;HSPA1A
alpha,2,tRNA transport (GO:0051031),2/36,2,36,0.441328730525425,0.732852550019168,0,0,1.34517083669626,1.1003030138966,XPOT;NUP54
alpha,2,regulation of synapse assembly (GO:0051963),2/36,2,36,0.441328730525425,0.732852550019168,0,0,1.34517083669626,1.1003030138966,DLG5;VPS35
alpha,2,regulation of mitochondrial membrane potential (GO:0051881),2/36,2,36,0.441328730525425,0.732852550019168,0,0,1.34517083669626,1.1003030138966,PPA2;AKT2
alpha,2,regulation of ion transmembrane transport (GO:0034765),2/36,2,36,0.441328730525425,0.732852550019168,0,0,1.34517083669626,1.1003030138966,YWHAE;NEDD4
alpha,2,regulation of phosphoprotein phosphatase activity (GO:0043666),2/36,2,36,0.441328730525425,0.732852550019168,0,0,1.34517083669626,1.1003030138966,PPP6R1;BOD1
alpha,2,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),3/59,3,59,0.44238515760128,0.732852550019168,0,0,1.23117330816268,1.00411340632332,CDC42;HGS;PTPN12
alpha,2,positive regulation of NF-kappaB transcription factor activity (GO:0051092),6/129,6,129,0.442692434967522,0.732852550019168,0,0,1.12618953769919,0.917709361771581,CIB1;TRIM37;UBE2V1;RHEBL1;PRKCZ;HSPA1A
alpha,2,neuron cell-cell adhesion (GO:0007158),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,NRXN3
alpha,2,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,MET
alpha,2,branching involved in blood vessel morphogenesis (GO:0001569),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,TGFBR2
alpha,2,positive regulation of cell adhesion mediated by integrin (GO:0033630),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,CIB1
alpha,2,intermediate filament organization (GO:0045109),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,DSP
alpha,2,myeloid dendritic cell activation (GO:0001773),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,TGFBR2
alpha,2,positive regulation of myoblast differentiation (GO:0045663),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,MAPK14
alpha,2,regulation of phosphate metabolic process (GO:0019220),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,SMG6
alpha,2,positive regulation of T cell mediated cytotoxicity (GO:0001916),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,PVR
alpha,2,positive regulation of response to cytokine stimulus (GO:0060760),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,MAVS
alpha,2,neurotransmitter biosynthetic process (GO:0042136),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,PAH
alpha,2,regulation of secretion (GO:0051046),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,ERBB3
alpha,2,negative regulation of Rho protein signal transduction (GO:0035024),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,MET
alpha,2,regulation of calcineurin-NFAT signaling cascade (GO:0070884),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,CIB1
alpha,2,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,RPS27L
alpha,2,acyl-CoA biosynthetic process (GO:0071616),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,FASN
alpha,2,pancreas development (GO:0031016),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,DNAAF1
alpha,2,oligodendrocyte differentiation (GO:0048709),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,EIF2B3
alpha,2,negative regulation of secretion (GO:0051048),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,ERBB3
alpha,2,cardiac left ventricle morphogenesis (GO:0003214),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,TGFBR2
alpha,2,positive regulation of mitochondrial fission (GO:0090141),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,VPS35
alpha,2,purine-containing compound salvage (GO:0043101),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,ADAL
alpha,2,positive regulation of glycogen metabolic process (GO:0070875),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,AKT2
alpha,2,monosaccharide transport (GO:0015749),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,SLC50A1
alpha,2,regulation of fatty acid metabolic process (GO:0019217),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,PRKAA2
alpha,2,cAMP biosynthetic process (GO:0006171),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,ADCY9
alpha,2,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,RPL26
alpha,2,regulation of transferase activity (GO:0051338),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,SMG6
alpha,2,cellular response to nitrogen compound (GO:1901699),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,DDX11
alpha,2,interleukin-6-mediated signaling pathway (GO:0070102),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,PTPN11
alpha,2,regulation of protein modification by small protein conjugation or removal (GO:1903320),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,HSPA1A
alpha,2,regulation of interferon-gamma biosynthetic process (GO:0045072),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,CEBPG
alpha,2,regulation of response to interferon-gamma (GO:0060330),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,PIAS1
alpha,2,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,DYNC1LI1
alpha,2,response to ATP (GO:0033198),1/14,1,14,0.446046258635774,0.732852550019168,0,0,1.72950536146662,1.3962860834075,SSH1
alpha,2,negative regulation of NF-kappaB transcription factor activity (GO:0032088),4/83,4,83,0.449866820566902,0.738167938496894,0,0,1.16689518364013,0.932120183572054,NFKBIL1;TRIM37;CACTIN;KLF4
alpha,2,positive regulation of ubiquitin protein ligase activity (GO:1904668),4/83,4,83,0.449866820566902,0.738167938496894,0,0,1.16689518364013,0.932120183572054,PSMD13;PSME3;PSMD3;ANAPC1
alpha,2,renal system development (GO:0072001),3/60,3,60,0.453292628031644,0.738677304515143,0,0,1.21065375302663,0.957890295470072,PYGO2;CENPF;IFT140
alpha,2,regulation of extrinsic apoptotic signaling pathway (GO:2001236),3/60,3,60,0.453292628031644,0.738677304515143,0,0,1.21065375302663,0.957890295470072,PSME3;MADD;STX4
alpha,2,response to endoplasmic reticulum stress (GO:0034976),5/107,5,107,0.454354646866555,0.738677304515143,0,0,1.13145210563237,0.892576797751617,CEBPB;HSPA5;CASP4;CHAC1;P4HB
alpha,2,regulation of muscle cell differentiation (GO:0051147),2/37,2,37,0.455374880253441,0.738677304515143,0,0,1.3088148681369,1.02955865010924,CDC42;MAPK14
alpha,2,regulation of response to DNA damage stimulus (GO:2001020),2/37,2,37,0.455374880253441,0.738677304515143,0,0,1.3088148681369,1.02955865010924,EID3;UBE2V1
alpha,2,acylglycerol metabolic process (GO:0006639),2/37,2,37,0.455374880253441,0.738677304515143,0,0,1.3088148681369,1.02955865010924,DGKA;ABHD6
alpha,2,regulation of ubiquitin protein ligase activity (GO:1904666),2/37,2,37,0.455374880253441,0.738677304515143,0,0,1.3088148681369,1.02955865010924,MAD2L2;ANAPC1
alpha,2,inner mitochondrial membrane organization (GO:0007007),2/37,2,37,0.455374880253441,0.738677304515143,0,0,1.3088148681369,1.02955865010924,OPA1;ATP5G1
alpha,2,spermatid development (GO:0007286),2/37,2,37,0.455374880253441,0.738677304515143,0,0,1.3088148681369,1.02955865010924,CIB1;IQCG
alpha,2,generation of neurons (GO:0048699),6/131,6,131,0.457345271981425,0.738677304515143,0,0,1.10899580429921,0.867585887794937,YAP1;NIF3L1;FZD7;ID4;POU3F2;MARK1
alpha,2,negative regulation of signaling (GO:0023057),4/84,4,84,0.459041980678802,0.738677304515143,0,0,1.15300357431108,0.897744277562608,EPHA4;PTPN1;ERBB3;MET
alpha,2,protein maturation (GO:0051604),4/84,4,84,0.459041980678802,0.738677304515143,0,0,1.15300357431108,0.897744277562608,NFU1;DDI2;ISCU;LMF2
alpha,2,response to reactive oxygen species (GO:0000302),3/61,3,61,0.464110501163286,0.738677304515143,0,0,1.19080697019013,0.914102257829629,PLK3;MAPK1;ROMO1
alpha,2,activation of GTPase activity (GO:0090630),4/85,4,85,0.468164246416882,0.738677304515143,0,0,1.13943882637801,0.864761248542569,ARHGEF10;RALGAPB;TBC1D25;TBC1D14
alpha,2,cellular response to molecule of bacterial origin (GO:0071219),4/85,4,85,0.468164246416882,0.738677304515143,0,0,1.13943882637801,0.864761248542569,NFKBIL1;SHPK;CACTIN;MAPK14
alpha,2,myotube differentiation (GO:0014902),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,KCNH1
alpha,2,catecholamine metabolic process (GO:0006584),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,PAH
alpha,2,heparan sulfate proteoglycan biosynthetic process (GO:0015012),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,CSGALNACT1
alpha,2,histone H4-K8 acetylation (GO:0043982),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,KANSL3
alpha,2,positive regulation of response to wounding (GO:1903036),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,HRAS
alpha,2,regulation of protein homooligomerization (GO:0032462),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,BMF
alpha,2,embryonic axis specification (GO:0000578),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,TBX3
alpha,2,transport along microtubule (GO:0010970),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,CDC42
alpha,2,L-alpha-amino acid transmembrane transport (GO:1902475),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,SLC25A12
alpha,2,regulation of mitotic metaphase/anaphase transition (GO:0030071),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,CDC6
alpha,2,positive regulation of protein import (GO:1904591),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,RBM22
alpha,2,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,TAOK1
alpha,2,negative regulation of insulin secretion (GO:0046676),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,PIM3
alpha,2,positive regulation of cytokine production involved in immune response (GO:0002720),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,B2M
alpha,2,sodium ion import (GO:0097369),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,SLC9A5
alpha,2,regulation of tumor necrosis factor secretion (GO:1904467),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,MAVS
alpha,2,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,CCT7
alpha,2,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,CSGALNACT1
alpha,2,mitochondrion localization (GO:0051646),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,BRAT1
alpha,2,mesenchyme morphogenesis (GO:0072132),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,BMP2
alpha,2,mitotic chromosome condensation (GO:0007076),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,CHMP1A
alpha,2,negative regulation of release of cytochrome c from mitochondria (GO:0090201),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,OPA1
alpha,2,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,ACADVL
alpha,2,ganglioside metabolic process (GO:0001573),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,NEU1
alpha,2,negative regulation of muscle cell differentiation (GO:0051148),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,TBX3
alpha,2,sodium ion import across plasma membrane (GO:0098719),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,SLC9A5
alpha,2,regulation of macrophage chemotaxis (GO:0010758),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,MST1
alpha,2,negative regulation of viral entry into host cell (GO:0046597),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,SNX3
alpha,2,negative regulation of RNA metabolic process (GO:0051253),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,ZC3H10
alpha,2,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,MAPK14
alpha,2,positive regulation of double-strand break repair (GO:2000781),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,DDX11
alpha,2,positive regulation of exosomal secretion (GO:1903543),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,HGS
alpha,2,regulation of protein complex disassembly (GO:0043244),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,TBC1D25
alpha,2,negative regulation of protein processing (GO:0010955),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,CHAC1
alpha,2,regulation of RNA export from nucleus (GO:0046831),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,NUDT4
alpha,2,embryonic cranial skeleton morphogenesis (GO:0048701),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,TGFBR2
alpha,2,endoderm development (GO:0007492),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,LAMC1
alpha,2,inhibition of cysteine-type endopeptidase activity (GO:0097340),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,BIRC3
alpha,2,histone H4-K5 acetylation (GO:0043981),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,KANSL3
alpha,2,regulation of cartilage development (GO:0061035),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,BMP2
alpha,2,nucleobase-containing small molecule catabolic process (GO:0034656),1/15,1,15,0.468940527758216,0.738677304515143,0,0,1.61420500403551,1.22240407596797,ENTPD4
alpha,2,epithelial to mesenchymal transition (GO:0001837),2/38,2,38,0.469215321900578,0.738677304515143,0,0,1.27437237160698,0.964309299558959,BMP2;DLG5
alpha,2,myelination (GO:0042552),2/38,2,38,0.469215321900578,0.738677304515143,0,0,1.27437237160698,0.964309299558959,ARHGEF10;SCN8A
alpha,2,protein peptidyl-prolyl isomerization (GO:0000413),2/38,2,38,0.469215321900578,0.738677304515143,0,0,1.27437237160698,0.964309299558959,FKBP14;PPIL3
alpha,2,regulation of dendrite development (GO:0050773),2/38,2,38,0.469215321900578,0.738677304515143,0,0,1.27437237160698,0.964309299558959,NEDD4;CAMSAP2
alpha,2,protein K63-linked ubiquitination (GO:0070534),2/38,2,38,0.469215321900578,0.738677304515143,0,0,1.27437237160698,0.964309299558959,NEDD4;UBE2V1
alpha,2,positive regulation of axonogenesis (GO:0050772),2/38,2,38,0.469215321900578,0.738677304515143,0,0,1.27437237160698,0.964309299558959,ARHGDIA;PLXNA2
alpha,2,regulation of metal ion transport (GO:0010959),2/38,2,38,0.469215321900578,0.738677304515143,0,0,1.27437237160698,0.964309299558959,SPTBN4;YWHAH
alpha,2,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",2/38,2,38,0.469215321900578,0.738677304515143,0,0,1.27437237160698,0.964309299558959,RFC5;POLD1
alpha,2,positive regulation of multi-organism process (GO:0043902),2/38,2,38,0.469215321900578,0.738677304515143,0,0,1.27437237160698,0.964309299558959,SMURF2;ACVR1B
alpha,2,glycosaminoglycan metabolic process (GO:0030203),3/62,3,62,0.474833428247669,0.745797482207819,0,0,1.17160040615481,0.872597688614988,GPC2;B3GALT6;HS3ST2
alpha,2,negative regulation of viral life cycle (GO:1903901),3/62,3,62,0.474833428247669,0.745797482207819,0,0,1.17160040615481,0.872597688614988,SNX3;MAVS;BANF1
alpha,2,regulation of type I interferon production (GO:0032479),4/86,4,86,0.477229952779301,0.745797482207819,0,0,1.12618953769919,0.83310639445839,RNF135;MAVS;POLR3E;POLR3K
alpha,2,regulation of cell motility (GO:2000145),5/110,5,110,0.478462665211464,0.745797482207819,0,0,1.1005943209333,0.811332925126181,ERBB3;NRG4;AKT2;LMNA;PLXNA2
alpha,2,Wnt signaling pathway (GO:0016055),5/110,5,110,0.478462665211464,0.745797482207819,0,0,1.1005943209333,0.811332925126181,SNX3;FZD7;VPS35;VPS26A;STRN
alpha,2,protein targeting (GO:0006605),6/134,6,134,0.479142381307314,0.745797482207819,0,0,1.08416754002385,0.797684375792951,TMEM50A;PMM2;HPS4;AP4E1;SRP68;FBXO7
alpha,2,membrane depolarization during action potential (GO:0086010),2/39,2,39,0.482843076757979,0.745797482207819,0,0,1.24169615695039,0.904033738075745,SCN8A;YWHAH
alpha,2,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),3/63,3,63,0.485456411476027,0.745797482207819,0,0,1.15300357431108,0.833236222724756,PSMD13;PSME3;PSMD3
alpha,2,positive regulation of catabolic process (GO:0009896),3/63,3,63,0.485456411476027,0.745797482207819,0,0,1.15300357431108,0.833236222724756,SMURF2;NEDD4;OAZ2
alpha,2,diterpenoid metabolic process (GO:0016101),3/63,3,63,0.485456411476027,0.745797482207819,0,0,1.15300357431108,0.833236222724756,ALDH3A2;E2F1;GPC2
alpha,2,cellular amide metabolic process (GO:0043603),3/63,3,63,0.485456411476027,0.745797482207819,0,0,1.15300357431108,0.833236222724756,BTD;FASN;THOP1
alpha,2,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",3/63,3,63,0.485456411476027,0.745797482207819,0,0,1.15300357431108,0.833236222724756,PLK3;E2F1;RPL26
alpha,2,regulation of T cell proliferation (GO:0042129),3/63,3,63,0.485456411476027,0.745797482207819,0,0,1.15300357431108,0.833236222724756,CEBPB;DLG5;GLMN
alpha,2,negative regulation of cytokine production (GO:0001818),5/111,5,111,0.48642058991295,0.745797482207819,0,0,1.09067905678075,0.786032347349232,RNF135;MAVS;RARA;CACTIN;ASB1
alpha,2,peptidyl-threonine dephosphorylation (GO:0035970),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,PPM1F
alpha,2,Notch receptor processing (GO:0007220),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,YBX1
alpha,2,cellular response to dsRNA (GO:0071359),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,MAVS
alpha,2,establishment of skin barrier (GO:0061436),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,MET
alpha,2,positive regulation of dendrite morphogenesis (GO:0050775),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,CUX1
alpha,2,embryonic digit morphogenesis (GO:0042733),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,TBX3
alpha,2,glucose 6-phosphate metabolic process (GO:0051156),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,SHPK
alpha,2,positive regulation of regulated secretory pathway (GO:1903307),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,RAB3D
alpha,2,negative regulation of response to wounding (GO:1903035),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,EPHA4
alpha,2,regulation of RIG-I signaling pathway (GO:0039535),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,BIRC3
alpha,2,histone H2A acetylation (GO:0043968),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,NAA40
alpha,2,regulation of exosomal secretion (GO:1903541),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,HGS
alpha,2,regulation of water loss via skin (GO:0033561),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,MET
alpha,2,negative regulation of steroid biosynthetic process (GO:0010894),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,BMP2
alpha,2,regulation of histone H3-K4 methylation (GO:0051569),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,PAXIP1
alpha,2,guanosine-containing compound metabolic process (GO:1901068),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,OPA1
alpha,2,regulation of bicellular tight junction assembly (GO:2000810),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,NPHP4
alpha,2,regulation of energy homeostasis (GO:2000505),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,PRKAA2
alpha,2,negative regulation of transcription regulatory region DNA binding (GO:2000678),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,MAD2L2
alpha,2,hexose transport (GO:0008645),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,SLC50A1
alpha,2,neuron apoptotic process (GO:0051402),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,ERBB3
alpha,2,dendritic spine morphogenesis (GO:0060997),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,CDC42
alpha,2,negative regulation of DNA recombination (GO:0045910),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,RTEL1
alpha,2,positive regulation of cilium assembly (GO:0045724),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,FUZ
alpha,2,T cell migration (GO:0072678),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,CXCL16
alpha,2,regulation of osteoblast proliferation (GO:0033688),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,BMP2
alpha,2,regulation of steroid metabolic process (GO:0019218),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,ACADVL
alpha,2,bone morphogenesis (GO:0060349),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,RARA
alpha,2,regulation of protein homodimerization activity (GO:0043496),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,HSPA5
alpha,2,mRNA transcription from RNA polymerase II promoter (GO:0042789),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,ARNT
alpha,2,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,CIB1
alpha,2,cardiac epithelial to mesenchymal transition (GO:0060317),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,BMP2
alpha,2,odontogenesis of dentin-containing tooth (GO:0042475),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,BMP2
alpha,2,G-protein coupled acetylcholine receptor signaling pathway (GO:0007213),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,DHX8
alpha,2,regulation of stem cell proliferation (GO:0072091),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,YAP1
alpha,2,regulation of necroptotic process (GO:0060544),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,BIRC3
alpha,2,protein localization to chromatin (GO:0071168),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,MAU2
alpha,2,mitochondrial fusion (GO:0008053),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,OPA1
alpha,2,regulation of membrane repolarization (GO:0060306),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,YWHAE
alpha,2,ruffle organization (GO:0031529),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,CYFIP1
alpha,2,regulation of glucose transport (GO:0010827),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,SLC2A1
alpha,2,mesenchyme development (GO:0060485),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,BMP2
alpha,2,regulation of interferon-alpha production (GO:0032647),1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,MAVS
alpha,2,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",1/16,1,16,0.490889698836233,0.745797482207819,0,0,1.51331719128329,1.07677939222006,PAXIP1
alpha,2,regulation of protein binding (GO:0043393),5/112,5,112,0.494335230817234,0.747192701826306,0,0,1.08094085091664,0.761567566422967,HDAC5;BMP2;BTBD1;DDX11;B2M
alpha,2,cellular response to BMP stimulus (GO:0071773),4/88,4,88,0.495177851340831,0.747192701826306,0,0,1.1005943209333,0.773539825342973,FAM83G;BMP2;SMURF2;GDF5
alpha,2,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),4/88,4,88,0.495177851340831,0.747192701826306,0,0,1.1005943209333,0.773539825342973,PSMD13;PSME3;PSMD3;ANAPC1
alpha,2,organic substance transport (GO:0071702),4/88,4,88,0.495177851340831,0.747192701826306,0,0,1.1005943209333,0.773539825342973,SLC25A26;ABCA2;ABCA3;SLC50A1
alpha,2,regulation of MAP kinase activity (GO:0043405),4/88,4,88,0.495177851340831,0.747192701826306,0,0,1.1005943209333,0.773539825342973,PTPN1;HGS;CDK12;HRAS
alpha,2,carbohydrate homeostasis (GO:0033500),3/64,3,64,0.495974794475245,0.747192701826306,0,0,1.13498789346247,0.79588775477304,PRKAA2;VGF;SLC8B1
alpha,2,iron ion homeostasis (GO:0055072),3/64,3,64,0.495974794475245,0.747192701826306,0,0,1.13498789346247,0.79588775477304,ATP6V0D1;B2M;ISCU
alpha,2,regulation of proteolysis (GO:0030162),3/64,3,64,0.495974794475245,0.747192701826306,0,0,1.13498789346247,0.79588775477304,BTBD1;SPOP;KLHL11
alpha,2,signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),3/64,3,64,0.495974794475245,0.747192701826306,0,0,1.13498789346247,0.79588775477304,PLK3;E2F1;RPL26
alpha,2,signal transduction by p53 class mediator (GO:0072331),2/40,2,40,0.496252091815647,0.747192701826306,0,0,1.21065375302663,0.84827025634865,PAXIP1;BCL3
alpha,2,regulation of proteasomal protein catabolic process (GO:0061136),2/40,2,40,0.496252091815647,0.747192701826306,0,0,1.21065375302663,0.84827025634865,PSME3;GLMN
alpha,2,purine ribonucleoside monophosphate metabolic process (GO:0009167),2/40,2,40,0.496252091815647,0.747192701826306,0,0,1.21065375302663,0.84827025634865,CTNS;HSPA1A
alpha,2,inositol lipid-mediated signaling (GO:0048017),2/40,2,40,0.496252091815647,0.747192701826306,0,0,1.21065375302663,0.84827025634865,RPS6KB1;KCNH1
alpha,2,regulation of RNA metabolic process (GO:0051252),2/40,2,40,0.496252091815647,0.747192701826306,0,0,1.21065375302663,0.84827025634865,RRP1B;CLK2
alpha,2,DNA biosynthetic process (GO:0071897),2/40,2,40,0.496252091815647,0.747192701826306,0,0,1.21065375302663,0.84827025634865,RAD51D;POLD1
alpha,2,negative regulation of translation (GO:0017148),4/89,4,89,0.504053531846349,0.751072933654846,0,0,1.08822809260821,0.745515469238756,YTHDF2;SAMD4B;CALR;METTL16
alpha,2,regulation of protein targeting to mitochondrion (GO:1903214),4/89,4,89,0.504053531846349,0.751072933654846,0,0,1.08822809260821,0.745515469238756,NBPF3;LRRC46;HSPA1L;HPS4
alpha,2,positive regulation of cell adhesion (GO:0045785),3/65,3,65,0.506384251880469,0.751072933654846,0,0,1.11752654125535,0.760431559118708,CIB1;STX4;PPM1F
alpha,2,negative regulation of transport (GO:0051051),2/41,2,41,0.50943717518236,0.751072933654846,0,0,1.18112561270891,0.796608682133388,SNX3;ERBB3
alpha,2,intraciliary transport involved in cilium assembly (GO:0035735),2/41,2,41,0.50943717518236,0.751072933654846,0,0,1.18112561270891,0.796608682133388,IFT140;HSPB11
alpha,2,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),2/41,2,41,0.50943717518236,0.751072933654846,0,0,1.18112561270891,0.796608682133388,CDC42;HGS
alpha,2,positive regulation of epithelial to mesenchymal transition (GO:0010718),2/41,2,41,0.50943717518236,0.751072933654846,0,0,1.18112561270891,0.796608682133388,BMP2;TGFBR2
alpha,2,regulation of protein dephosphorylation (GO:0035304),2/41,2,41,0.50943717518236,0.751072933654846,0,0,1.18112561270891,0.796608682133388,PPP6R1;ARPP19
alpha,2,positive regulation of mitotic nuclear division (GO:0045840),2/41,2,41,0.50943717518236,0.751072933654846,0,0,1.18112561270891,0.796608682133388,BECN1;RANBP1
alpha,2,response to cAMP (GO:0051591),2/41,2,41,0.50943717518236,0.751072933654846,0,0,1.18112561270891,0.796608682133388,VGF;JUNB
alpha,2,peptidyl-proline modification (GO:0018208),2/41,2,41,0.50943717518236,0.751072933654846,0,0,1.18112561270891,0.796608682133388,FKBP14;PPIL3
alpha,2,negative regulation of ERK1 and ERK2 cascade (GO:0070373),2/41,2,41,0.50943717518236,0.751072933654846,0,0,1.18112561270891,0.796608682133388,PTPN1;PHB
alpha,2,regulation of release of cytochrome c from mitochondria (GO:0090199),2/41,2,41,0.50943717518236,0.751072933654846,0,0,1.18112561270891,0.796608682133388,OPA1;BMF
alpha,2,regulation of intracellular transport (GO:0032386),2/41,2,41,0.50943717518236,0.751072933654846,0,0,1.18112561270891,0.796608682133388,PTPN1;SPAG5
alpha,2,positive regulation of cytokine biosynthetic process (GO:0042108),2/41,2,41,0.50943717518236,0.751072933654846,0,0,1.18112561270891,0.796608682133388,CEBPG;GLMN
alpha,2,regulation of protein sumoylation (GO:0033233),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,PIAS1
alpha,2,positive regulation of protein processing (GO:0010954),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,PHB
alpha,2,regulation of cellular protein catabolic process (GO:1903362),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,VPS35
alpha,2,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,PAXIP1
alpha,2,positive regulation of focal adhesion assembly (GO:0051894),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,PPM1F
alpha,2,sialylation (GO:0097503),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,ST6GALNAC4
alpha,2,DNA catabolic process (GO:0006308),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,ERI2
alpha,2,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,BMP2
alpha,2,positive regulation of nitrogen compound metabolic process (GO:0051173),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,KLF4
alpha,2,2-oxoglutarate metabolic process (GO:0006103),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,GOT2
alpha,2,positive regulation of interleukin-6 secretion (GO:2000778),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,MAVS
alpha,2,preassembly of GPI anchor in ER membrane (GO:0016254),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,PIGW
alpha,2,RNA stabilization (GO:0043489),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,E2F1
alpha,2,positive regulation of dendrite extension (GO:1903861),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,RIMS2
alpha,2,peptidyl-lysine methylation (GO:0018022),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,EHMT1
alpha,2,positive regulation of cellular protein catabolic process (GO:1903364),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,VPS35
alpha,2,negative regulation of phosphoprotein phosphatase activity (GO:0032515),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,BOD1
alpha,2,virion assembly (GO:0019068),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,TBC1D20
alpha,2,heterocycle biosynthetic process (GO:0018130),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,NFS1
alpha,2,serine family amino acid metabolic process (GO:0009069),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,SRR
alpha,2,chaperone-mediated protein complex assembly (GO:0051131),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,HSPA1A
alpha,2,positive regulation by host of viral transcription (GO:0043923),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,RRP1B
alpha,2,positive chemotaxis (GO:0050918),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,MET
alpha,2,purine-containing compound metabolic process (GO:0072521),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,MACROD2
alpha,2,cellular response to inorganic substance (GO:0071241),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,DDX11
alpha,2,nucleobase-containing compound biosynthetic process (GO:0034654),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,ADAL
alpha,2,platelet-derived growth factor receptor signaling pathway (GO:0048008),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,PTPN1
alpha,2,positive regulation of transcription of Notch receptor target (GO:0007221),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,MAML1
alpha,2,mitotic G2 DNA damage checkpoint (GO:0007095),1/17,1,17,0.511932741059746,0.751072933654846,0,0,1.42429853297251,0.953656213772205,TAOK1
alpha,2,O-glycan processing (GO:0016266),3/66,3,66,0.51668077953713,0.756279121295787,0,0,1.1005943209333,0.726755495131911,GALNT1;ST6GALNAC4;B4GALT5
alpha,2,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),3/66,3,66,0.51668077953713,0.756279121295787,0,0,1.1005943209333,0.726755495131911,PAXIP1;PIAS1;BIRC3
alpha,2,cellular response to reactive oxygen species (GO:0034614),3/66,3,66,0.51668077953713,0.756279121295787,0,0,1.1005943209333,0.726755495131911,ZNF580;MAPK1;ROMO1
alpha,2,DNA synthesis involved in DNA repair (GO:0000731),3/66,3,66,0.51668077953713,0.756279121295787,0,0,1.1005943209333,0.726755495131911,RFC5;RAD51D;POLD1
alpha,2,regulation of Ras protein signal transduction (GO:0046578),4/91,4,91,0.521593274854948,0.759353028997311,0,0,1.06431099167177,0.692725074371259,ARHGDIA;MADD;MYO9B;SQSTM1
alpha,2,regulation of JNK cascade (GO:0046328),4/91,4,91,0.521593274854948,0.759353028997311,0,0,1.06431099167177,0.692725074371259,FZD7;TAOK1;HRAS;MAPK8IP3
alpha,2,odontogenesis (GO:0042476),2/42,2,42,0.522393935491806,0.759353028997311,0,0,1.15300357431108,0.748683627376171,BMP2;CEMP1
alpha,2,regulation of phagocytosis (GO:0050764),2/42,2,42,0.522393935491806,0.759353028997311,0,0,1.15300357431108,0.748683627376171,SNX3;CALR
alpha,2,mesenchymal cell differentiation (GO:0048762),2/42,2,42,0.522393935491806,0.759353028997311,0,0,1.15300357431108,0.748683627376171,BMP2;DLG5
alpha,2,regulation of cholesterol metabolic process (GO:0090181),2/42,2,42,0.522393935491806,0.759353028997311,0,0,1.15300357431108,0.748683627376171,ACADVL;FASN
alpha,2,DNA duplex unwinding (GO:0032508),2/42,2,42,0.522393935491806,0.759353028997311,0,0,1.15300357431108,0.748683627376171,RTEL1;DDX11
alpha,2,positive regulation of cell division (GO:0051781),2/42,2,42,0.522393935491806,0.759353028997311,0,0,1.15300357431108,0.748683627376171,CDC42;CDC6
alpha,2,positive regulation of receptor-mediated endocytosis (GO:0048260),2/42,2,42,0.522393935491806,0.759353028997311,0,0,1.15300357431108,0.748683627376171,ATAD1;B2M
alpha,2,negative regulation of cell projection organization (GO:0031345),2/42,2,42,0.522393935491806,0.759353028997311,0,0,1.15300357431108,0.748683627376171,EPHA4;CIB1
alpha,2,positive regulation of viral transcription (GO:0050434),2/42,2,42,0.522393935491806,0.759353028997311,0,0,1.15300357431108,0.748683627376171,RSF1;RRP1B
alpha,2,negative regulation of proteolysis (GO:0045861),2/42,2,42,0.522393935491806,0.759353028997311,0,0,1.15300357431108,0.748683627376171,EPHA4;CHAC1
alpha,2,purine ribonucleotide metabolic process (GO:0009150),3/67,3,67,0.526860684066959,0.759894621253697,0,0,1.08416754002385,0.694755291097172,OPA1;CTNS;HSPA1A
alpha,2,regulation of small GTPase mediated signal transduction (GO:0051056),6/141,6,141,0.528872876855674,0.759894621253697,0,0,1.03034361959714,0.656336288088095,CDC42;DEPDC1B;ARHGDIA;ARHGEF3;MYO9B;SQSTM1
alpha,2,positive regulation of Wnt signaling pathway (GO:0030177),6/141,6,141,0.528872876855674,0.759894621253697,0,0,1.03034361959714,0.656336288088095,DEPDC1B;BMP2;SMURF2;PSMD13;PSME3;PSMD3
alpha,2,regulation of cellular component organization (GO:0051128),6/141,6,141,0.528872876855674,0.759894621253697,0,0,1.03034361959714,0.656336288088095,MAD2L2;PTPN1;RAB4A;NEDD4;PTPN11;CAMSAP2
alpha,2,cellular response to lipopolysaccharide (GO:0071222),4/92,4,92,0.530251775175085,0.759894621253697,0,0,1.0527423939362,0.667863288488421,NFKBIL1;SHPK;CACTIN;MAPK14
alpha,2,glucan catabolic process (GO:0009251),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,PGM2L1
alpha,2,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,ACSL4
alpha,2,regulation of telomerase RNA localization to Cajal body (GO:1904872),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,CCT7
alpha,2,mitotic recombination (GO:0006312),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,RAD51D
alpha,2,regulation of amyloid-beta formation (GO:1902003),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,EPHA4
alpha,2,response to nutrient levels (GO:0031667),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,PRKAA2
alpha,2,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,SMURF2
alpha,2,positive regulation of lipid catabolic process (GO:0050996),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,AKT2
alpha,2,anterior/posterior axis specification (GO:0009948),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,TBX3
alpha,2,positive regulation of metabolic process (GO:0009893),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,FASN
alpha,2,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,NEDD4
alpha,2,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,P4HB
alpha,2,tRNA metabolic process (GO:0006399),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,DARS2
alpha,2,negative regulation of peptidyl-serine phosphorylation (GO:0033137),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,PPM1F
alpha,2,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,PVR
alpha,2,positive regulation of p38MAPK cascade (GO:1900745),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,BMP2
alpha,2,glycogen catabolic process (GO:0005980),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,PGM2L1
alpha,2,acute-phase response (GO:0006953),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,CEBPB
alpha,2,DNA conformation change (GO:0071103),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,HAT1
alpha,2,negative regulation of protein transport (GO:0051224),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,SNX3
alpha,2,regulation of epithelial cell differentiation (GO:0030856),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,CEBPB
alpha,2,regulation of microtubule polymerization or depolymerization (GO:0031110),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,CAMSAP2
alpha,2,glyceraldehyde-3-phosphate metabolic process (GO:0019682),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,SHPK
alpha,2,regulation of dendrite extension (GO:1903859),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,RIMS2
alpha,2,positive regulation of natural killer cell mediated immunity (GO:0002717),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,PVR
alpha,2,DNA ligation (GO:0006266),1/18,1,18,0.532107018689147,0.759894621253697,0,0,1.34517083669626,0.848682602800001,POLD1
alpha,2,cellular response to calcium ion (GO:0071277),2/43,2,43,0.535118724848567,0.762899617901688,0,0,1.12618953769919,0.704168749480216,CPNE1;KCNH1
alpha,2,determination of left/right symmetry (GO:0007368),2/43,2,43,0.535118724848567,0.762899617901688,0,0,1.12618953769919,0.704168749480216,CCDC103;DNAAF1
alpha,2,positive regulation of protein localization to nucleus (GO:1900182),2/43,2,43,0.535118724848567,0.762899617901688,0,0,1.12618953769919,0.704168749480216,CCT7;RBM22
alpha,2,negative regulation of protein serine/threonine kinase activity (GO:0071901),3/68,3,68,0.536920572472408,0.763310982962465,0,0,1.06822389972938,0.6643338966826,PTPN1;PRKAR1B;IPO7
alpha,2,positive regulation of endothelial cell proliferation (GO:0001938),3/68,3,68,0.536920572472408,0.763310982962465,0,0,1.06822389972938,0.6643338966826,BMP2;ZNF580;ARNT
alpha,2,negative regulation of protein binding (GO:0032091),3/68,3,68,0.536920572472408,0.763310982962465,0,0,1.06822389972938,0.6643338966826,HSPA5;DDX11;B2M
alpha,2,extrinsic apoptotic signaling pathway (GO:0097191),3/68,3,68,0.536920572472408,0.763310982962465,0,0,1.06822389972938,0.6643338966826,ERBB3;CIB1;ACVR1B
alpha,2,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),3/68,3,68,0.536920572472408,0.763310982962465,0,0,1.06822389972938,0.6643338966826,CDC6;IPO7;CDC25A
alpha,2,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),4/94,4,94,0.547333272552478,0.767947408291742,0,0,1.03034361959714,0.620985408981448,YWHAE;ARL6IP1;KLF4;PPM1F
alpha,2,membrane depolarization (GO:0051899),2/44,2,44,0.54760858486861,0.767947408291742,0,0,1.1005943209333,0.662771856074006,SCN8A;YWHAH
alpha,2,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),2/44,2,44,0.54760858486861,0.767947408291742,0,0,1.1005943209333,0.662771856074006,BCL3;RPS27L
alpha,2,histone H3 acetylation (GO:0043966),2/44,2,44,0.54760858486861,0.767947408291742,0,0,1.1005943209333,0.662771856074006,TADA2A;SUPT7L
alpha,2,digestive tract development (GO:0048565),2/44,2,44,0.54760858486861,0.767947408291742,0,0,1.1005943209333,0.662771856074006,CCDC103;DNAAF1
alpha,2,protein import into mitochondrial matrix (GO:0030150),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,DNLZ
alpha,2,primary alcohol metabolic process (GO:0034308),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,ALDH3A2
alpha,2,error-free translesion synthesis (GO:0070987),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,RFC5
alpha,2,regulation of sprouting angiogenesis (GO:1903670),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,KLF4
alpha,2,histone methylation (GO:0016571),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,EHMT1
alpha,2,negative regulation of protein localization to plasma membrane (GO:1903077),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,AP2M1
alpha,2,NADP metabolic process (GO:0006739),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,SHPK
alpha,2,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,ERI2
alpha,2,endothelial cell development (GO:0001885),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,MET
alpha,2,acylglycerol biosynthetic process (GO:0046463),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,GNPAT
alpha,2,regulation of heterotypic cell-cell adhesion (GO:0034114),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,KLF4
alpha,2,muscle tissue morphogenesis (GO:0060415),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,BMP2
alpha,2,cyclic nucleotide biosynthetic process (GO:0009190),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,ADCY9
alpha,2,Rac protein signal transduction (GO:0016601),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,CYFIP1
alpha,2,endocardial cushion development (GO:0003197),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,BMP2
alpha,2,osteoclast differentiation (GO:0030316),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,MAPK14
alpha,2,intracellular estrogen receptor signaling pathway (GO:0030520),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,NCOA6
alpha,2,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,ERBB3
alpha,2,cellular polysaccharide biosynthetic process (GO:0033692),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,CSGALNACT1
alpha,2,purine ribonucleotide catabolic process (GO:0009154),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,NUDT4
alpha,2,insulin secretion (GO:0030073),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,RIMS2
alpha,2,fatty-acyl-CoA metabolic process (GO:0035337),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,FASN
alpha,2,negative regulation of protein localization to cell periphery (GO:1904376),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,AP2M1
alpha,2,nucleotide-sugar biosynthetic process (GO:0009226),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,PMM2
alpha,2,aspartate family amino acid catabolic process (GO:0009068),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,GOT2
alpha,2,positive regulation of adherens junction organization (GO:1903393),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,PPM1F
alpha,2,positive regulation of epithelial cell differentiation (GO:0030858),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,VEZF1
alpha,2,mitochondrial calcium ion homeostasis (GO:0051560),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,SLC8B1
alpha,2,regulation of cAMP biosynthetic process (GO:0030817),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,GPR176
alpha,2,triglyceride biosynthetic process (GO:0019432),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,GNPAT
alpha,2,regulation of catenin import into nucleus (GO:0035412),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,FZD7
alpha,2,activin receptor signaling pathway (GO:0032924),1/19,1,19,0.551448357024721,0.767947408291742,0,0,1.27437237160698,0.758515465282897,ACVR1B
alpha,2,negative regulation of cell cycle G2/M phase transition (GO:1902750),3/70,3,70,0.556668169406366,0.774788699361399,0,0,1.03770321687997,0.60787197790802,PSMD13;PSME3;PSMD3
alpha,2,adherens junction organization (GO:0034332),2/45,2,45,0.559861196219761,0.776661131389569,0,0,1.07613666935701,0.624230712800171,TBCD;PVR
alpha,2,negative regulation of immune system process (GO:0002683),2/45,2,45,0.559861196219761,0.776661131389569,0,0,1.07613666935701,0.624230712800171,NFKBIL1;CACTIN
alpha,2,positive regulation of transport (GO:0051050),2/45,2,45,0.559861196219761,0.776661131389569,0,0,1.07613666935701,0.624230712800171,SPAG5;AKT2
alpha,2,regulation of steroid biosynthetic process (GO:0050810),2/45,2,45,0.559861196219761,0.776661131389569,0,0,1.07613666935701,0.624230712800171,BMP2;FASN
alpha,2,positive regulation of viral process (GO:0048524),2/45,2,45,0.559861196219761,0.776661131389569,0,0,1.07613666935701,0.624230712800171,TBC1D20;RSF1
alpha,2,myeloid cell differentiation (GO:0030099),2/45,2,45,0.559861196219761,0.776661131389569,0,0,1.07613666935701,0.624230712800171,DYRK3;NCOA6
alpha,2,regulation of cytoskeleton organization (GO:0051493),4/96,4,96,0.564085480562445,0.776913731453434,0,0,1.0088781275222,0.577632644963073,CDC42;TAOK1;MAPK1;PFDN2
alpha,2,positive regulation of endothelial cell migration (GO:0010595),3/71,3,71,0.566350501226093,0.776913731453434,0,0,1.02308767861406,0.581668450354268,ZNF580;CALR;MET
alpha,2,regulation of Notch signaling pathway (GO:0008593),3/71,3,71,0.566350501226093,0.776913731453434,0,0,1.02308767861406,0.581668450354268,YTHDF2;MAML1;CHAC1
alpha,2,stress-activated protein kinase signaling cascade (GO:0031098),3/71,3,71,0.566350501226093,0.776913731453434,0,0,1.02308767861406,0.581668450354268,TAOK1;MAPK1;MAP2K7
alpha,2,Rab protein signal transduction (GO:0032482),3/71,3,71,0.566350501226093,0.776913731453434,0,0,1.02308767861406,0.581668450354268,RAB3B;RAB4A;RAB3D
alpha,2,negative regulation of developmental process (GO:0051093),3/71,3,71,0.566350501226093,0.776913731453434,0,0,1.02308767861406,0.581668450354268,BMP2;FUZ;CALR
alpha,2,negative regulation of innate immune response (GO:0045824),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,CACTIN
alpha,2,positive regulation of interleukin-2 production (GO:0032743),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,GLMN
alpha,2,proteoglycan metabolic process (GO:0006029),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,CSGALNACT1
alpha,2,ureteric bud morphogenesis (GO:0060675),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,BMP2
alpha,2,positive regulation of dendritic spine development (GO:0060999),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,DLG5
alpha,2,negative regulation of macromolecule biosynthetic process (GO:0010558),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,ASB1
alpha,2,negative regulation of ion transport (GO:0043271),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,NEDD4
alpha,2,cellular polysaccharide catabolic process (GO:0044247),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,PGM2L1
alpha,2,endoplasmic reticulum mannose trimming (GO:1904380),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,MAN1B1
alpha,2,regulation of cholesterol transport (GO:0032374),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,ABCA2
alpha,2,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,CLDN23
alpha,2,"regulation of DNA-templated transcription, elongation (GO:0032784)",1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,THOC5
alpha,2,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,ADCY9
alpha,2,regulation of cell development (GO:0060284),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,YAP1
alpha,2,glial cell development (GO:0021782),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,EIF2B3
alpha,2,branching involved in ureteric bud morphogenesis (GO:0001658),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,BMP2
alpha,2,positive regulation of interferon-alpha production (GO:0032727),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,MAVS
alpha,2,regulation of glycogen biosynthetic process (GO:0005979),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,AKT2
alpha,2,adrenergic receptor signaling pathway (GO:0071875),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,ADCY9
alpha,2,telomere maintenance via telomerase (GO:0007004),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,SMG6
alpha,2,inositol phosphate-mediated signaling (GO:0048016),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,DHX8
alpha,2,negative regulation of interferon-gamma production (GO:0032689),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,RARA
alpha,2,chondroitin sulfate biosynthetic process (GO:0030206),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,CSGALNACT1
alpha,2,entrainment of circadian clock by photoperiod (GO:0043153),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,USP2
alpha,2,dopaminergic neuron differentiation (GO:0071542),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,FOXA1
alpha,2,regulation of transport (GO:0051049),1/20,1,20,0.569991105710647,0.776913731453434,0,0,1.21065375302663,0.680550269118275,SLC2A1
alpha,2,stimulatory C-type lectin receptor signaling pathway (GO:0002223),5/122,5,122,0.570616178852289,0.776913731453434,0,0,0.99233914182511,0.55674045022402,PSMD13;PSME3;PSMD3;UBE2V1;HRAS
alpha,2,positive regulation of protein metabolic process (GO:0051247),4/97,4,97,0.57233290731421,0.776913731453434,0,0,0.998477322083822,0.557184744372785,SMURF2;NEDD4;KLF4;OAZ2
alpha,2,epithelial cell differentiation (GO:0030855),4/97,4,97,0.57233290731421,0.776913731453434,0,0,0.998477322083822,0.557184744372785,ACADVL;AKT2;FZD7;RARA
alpha,2,response to insulin (GO:0032868),3/72,3,72,0.575902042898181,0.776913731453434,0,0,1.0088781275222,0.556716805046125,HDAC5;RPS6KB1;AKT2
alpha,2,positive regulation of neuron projection development (GO:0010976),4/98,4,98,0.580492057470816,0.776913731453434,0,0,0.988288777980926,0.537509670562446,RIMS2;SNX3;ARHGDIA;PLXNA2
alpha,2,cellular response to organonitrogen compound (GO:0071417),4/98,4,98,0.580492057470816,0.776913731453434,0,0,0.988288777980926,0.537509670562446,RRAGC;DHX8;LARS;SSH1
alpha,2,protein complex disassembly (GO:0043241),2/47,2,47,0.583648307736272,0.776913731453434,0,0,1.03034361959714,0.554795415318341,MAP1LC3B;LIX1L
alpha,2,intraciliary transport (GO:0042073),2/47,2,47,0.583648307736272,0.776913731453434,0,0,1.03034361959714,0.554795415318341,IFT140;HSPB11
alpha,2,interleukin-12-mediated signaling pathway (GO:0035722),2/47,2,47,0.583648307736272,0.776913731453434,0,0,1.03034361959714,0.554795415318341,CDC42;P4HB
alpha,2,cartilage development (GO:0051216),2/47,2,47,0.583648307736272,0.776913731453434,0,0,1.03034361959714,0.554795415318341,BMP2;GDF5
alpha,2,cellular response to interleukin-12 (GO:0071349),2/47,2,47,0.583648307736272,0.776913731453434,0,0,1.03034361959714,0.554795415318341,CDC42;P4HB
alpha,2,mitotic spindle assembly (GO:0090307),2/47,2,47,0.583648307736272,0.776913731453434,0,0,1.03034361959714,0.554795415318341,ARHGEF10;BIRC3
alpha,2,regulation of cellular component movement (GO:0051270),2/47,2,47,0.583648307736272,0.776913731453434,0,0,1.03034361959714,0.554795415318341,ERBB3;NRG4
alpha,2,regulation of DNA metabolic process (GO:0051052),2/47,2,47,0.583648307736272,0.776913731453434,0,0,1.03034361959714,0.554795415318341,UBE2V1;SMG6
alpha,2,tumor necrosis factor-mediated signaling pathway (GO:0033209),5/124,5,124,0.58514882700581,0.776913731453434,0,0,0.976333671795673,0.523206532617008,PSMD13;PSME3;PSMD3;TXNDC17;BIRC3
alpha,2,cell-cell junction organization (GO:0045216),3/73,3,73,0.585320749141398,0.776913731453434,0,0,0.995057879199973,0.532948316237936,DSP;CXADR;PVR
alpha,2,negative regulation of cysteine-type endopeptidase activity (GO:2000117),3/73,3,73,0.585320749141398,0.776913731453434,0,0,0.995057879199973,0.532948316237936,YWHAE;ARL6IP1;KLF4
alpha,2,response to metal ion (GO:0010038),3/73,3,73,0.585320749141398,0.776913731453434,0,0,0.995057879199973,0.532948316237936,NEDD4;SLC30A1;SLC25A12
alpha,2,regulation of phosphatase activity (GO:0010921),3/73,3,73,0.585320749141398,0.776913731453434,0,0,0.995057879199973,0.532948316237936,BMP2;PPP6R1;RRP1B
alpha,2,Rho protein signal transduction (GO:0007266),3/73,3,73,0.585320749141398,0.776913731453434,0,0,0.995057879199973,0.532948316237936,CDC42;ARHGEF3;MYO9B
alpha,2,regulation of epithelial cell proliferation (GO:0050678),3/73,3,73,0.585320749141398,0.776913731453434,0,0,0.995057879199973,0.532948316237936,LAMC1;HRAS;GDF5
alpha,2,cobalamin metabolic process (GO:0009235),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,MUT
alpha,2,hyaluronan metabolic process (GO:0030212),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,ABCC5
alpha,2,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,BMP2
alpha,2,positive regulation of transcription from RNA polymerase I promoter (GO:0045943),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,DDX11
alpha,2,positive regulation of cellular component movement (GO:0051272),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,AKT2
alpha,2,mRNA transcription (GO:0009299),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,ARNT
alpha,2,dendritic cell differentiation (GO:0097028),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,TGFBR2
alpha,2,RNA-dependent DNA biosynthetic process (GO:0006278),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,SMG6
alpha,2,viral budding via host ESCRT complex (GO:0039702),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,CHMP1A
alpha,2,mesoderm development (GO:0007498),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,TBX3
alpha,2,cellular protein complex localization (GO:0034629),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,GPN1
alpha,2,establishment of spindle orientation (GO:0051294),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,SPAG5
alpha,2,tetrapyrrole metabolic process (GO:0033013),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,MUT
alpha,2,positive regulation of T cell mediated immunity (GO:0002711),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,B2M
alpha,2,mitochondrial fission (GO:0000266),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,OPA1
alpha,2,positive regulation of translational initiation (GO:0045948),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,RPS6KB1
alpha,2,positive regulation of lamellipodium organization (GO:1902745),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,CDC42
alpha,2,protein O-linked glycosylation via threonine (GO:0018243),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,GALNT1
alpha,2,negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,MET
alpha,2,regulation of macrophage activation (GO:0043030),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,SHPK
alpha,2,vesicle docking (GO:0048278),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,STX4
alpha,2,aromatic amino acid family catabolic process (GO:0009074),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,PAH
alpha,2,mitochondrial ATP synthesis coupled proton transport (GO:0042776),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,ATP5G1
alpha,2,positive regulation of BMP signaling pathway (GO:0030513),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,GDF5
alpha,2,response to nicotine (GO:0035094),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,MAPK1
alpha,2,ventricular septum morphogenesis (GO:0060412),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,TGFBR2
alpha,2,positive regulation of defense response to virus by host (GO:0002230),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,MAVS
alpha,2,limb morphogenesis (GO:0035108),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,TBX3
alpha,2,negative regulation of cAMP biosynthetic process (GO:0030818),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,GPR176
alpha,2,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,IPO7
alpha,2,positive regulation of receptor internalization (GO:0002092),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,ATAD1
alpha,2,embryonic skeletal system development (GO:0048706),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,FUZ
alpha,2,photoperiodism (GO:0009648),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,USP2
alpha,2,ERK1 and ERK2 cascade (GO:0070371),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,MAPK1
alpha,2,"synaptic transmission, glutamatergic (GO:0035249)",1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,UNC13B
alpha,2,negative regulation of cell cycle arrest (GO:0071157),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,CALR
alpha,2,glutamate metabolic process (GO:0006536),1/21,1,21,0.587768199688006,0.776913731453434,0,0,1.15300357431108,0.612732188430319,GOT2
alpha,2,phosphatidylinositol biosynthetic process (GO:0006661),4/99,4,99,0.588561230664199,0.777554438834525,0,0,0.978306063051826,0.518574913674659,RAB4A;MTMR3;PITPNM1;PIGW
alpha,2,innate immune response activating cell surface receptor signaling pathway (GO:0002220),5/125,5,125,0.59231438754749,0.781693817579681,0,0,0.968523002421307,0.507232663451988,PSMD13;PSME3;PSMD3;UBE2V1;HRAS
alpha,2,dephosphorylation (GO:0016311),5/125,5,125,0.59231438754749,0.781693817579681,0,0,0.968523002421307,0.507232663451988,PTPN1;MTMR3;PTPN12;SSH2;SSH1
alpha,2,B cell activation (GO:0042113),3/74,3,74,0.594604813430546,0.782202373768012,0,0,0.981611151102677,0.510298677975417,HDAC5;CEBPG;NHEJ1
alpha,2,transcription-coupled nucleotide-excision repair (GO:0006283),3/74,3,74,0.594604813430546,0.782202373768012,0,0,0.981611151102677,0.510298677975417,RFC5;POLD1;COPS2
alpha,2,lymphocyte differentiation (GO:0030098),3/74,3,74,0.594604813430546,0.782202373768012,0,0,0.981611151102677,0.510298677975417,HDAC5;CEBPG;NHEJ1
alpha,2,regulation of peptide hormone secretion (GO:0090276),3/74,3,74,0.594604813430546,0.782202373768012,0,0,0.981611151102677,0.510298677975417,GIPR;SLC2A1;SLC8B1
alpha,2,response to glucose (GO:0009749),2/48,2,48,0.595180949746556,0.782202373768012,0,0,1.0088781275222,0.523496572285788,UNC13B;EIF2B3
alpha,2,positive regulation of organelle assembly (GO:1902117),2/48,2,48,0.595180949746556,0.782202373768012,0,0,1.0088781275222,0.523496572285788,SPAG5;FUZ
alpha,2,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),2/48,2,48,0.595180949746556,0.782202373768012,0,0,1.0088781275222,0.523496572285788,CXADR;PVR
alpha,2,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),2/48,2,48,0.595180949746556,0.782202373768012,0,0,1.0088781275222,0.523496572285788,BMP2;GDF5
alpha,2,regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),3/75,3,75,0.603752658547766,0.78544484512911,0,0,0.968523002421307,0.488707671315549,USP20;PHB;CAMKMT
alpha,2,mitotic nuclear division (GO:0140014),3/75,3,75,0.603752658547766,0.78544484512911,0,0,0.968523002421307,0.488707671315549,ARHGEF10;SPAG5;BIRC3
alpha,2,cellular response to metal ion (GO:0071248),4/101,4,101,0.604423494487931,0.78544484512911,0,0,0.958933665763671,0.482804091696651,CPNE1;MAPK1;B2M;KCNH1
alpha,2,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,PIAS1
alpha,2,regulation of calcium ion import (GO:0090279),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,SLC30A1
alpha,2,establishment of protein localization to vacuole (GO:0072666),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,TMEM50A
alpha,2,cellular response to nerve growth factor stimulus (GO:1990090),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,CIB1
alpha,2,cellular response to hexose stimulus (GO:0071331),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,UNC13B
alpha,2,outflow tract septum morphogenesis (GO:0003148),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,TGFBR2
alpha,2,hematopoietic progenitor cell differentiation (GO:0002244),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,PRRC2C
alpha,2,regulation of DNA biosynthetic process (GO:2000278),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,SMG6
alpha,2,negative regulation of myeloid cell differentiation (GO:0045638),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,CIB1
alpha,2,negative regulation of actin filament polymerization (GO:0030837),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,PFN1
alpha,2,positive regulation of interleukin-10 production (GO:0032733),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,PRKCZ
alpha,2,protein localization to cell surface (GO:0034394),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,USP4
alpha,2,regulation of cytokine production involved in inflammatory response (GO:1900015),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,MAPK14
alpha,2,purine-containing compound biosynthetic process (GO:0072522),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,ADAL
alpha,2,STAT cascade (GO:0097696),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,PIAS1
alpha,2,protein O-linked glycosylation via serine (GO:0018242),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,GALNT1
alpha,2,urogenital system development (GO:0001655),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,IFT140
alpha,2,viral genome replication (GO:0019079),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,CDC42
alpha,2,positive regulation of phosphatase activity (GO:0010922),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,BMP2
alpha,2,NLS-bearing protein import into nucleus (GO:0006607),1/22,1,22,0.604811216986808,0.78544484512911,0,0,1.1005943209333,0.553421646140906,NUP54
alpha,2,cytoskeleton organization (GO:0007010),5/127,5,127,0.606437602396887,0.785579742377497,0,0,0.953270671674515,0.476781603159876,CDC42;SPTBN4;MAST2;FLNB;MARK1
alpha,2,endosome to lysosome transport (GO:0008333),2/49,2,49,0.606472544967877,0.785579742377497,0,0,0.988288777980926,0.494239086432151,VPS18;HOOK2
alpha,2,regulation of cell cycle arrest (GO:0071156),2/49,2,49,0.606472544967877,0.785579742377497,0,0,0.988288777980926,0.494239086432151,AKT2;CALR
alpha,2,regulation of epithelial cell migration (GO:0010632),2/49,2,49,0.606472544967877,0.785579742377497,0,0,0.988288777980926,0.494239086432151,PFN1;PPM1F
alpha,2,glycoprotein metabolic process (GO:0009100),2/49,2,49,0.606472544967877,0.785579742377497,0,0,0.988288777980926,0.494239086432151,MGAT4A;MAN1B1
alpha,2,negative regulation of phosphorylation (GO:0042326),3/76,3,76,0.61276292653431,0.791000066019581,0,0,0.955779278705237,0.468118861534221,CIB1;CACTIN;TARDBP
alpha,2,regulation of actin cytoskeleton organization (GO:0032956),3/76,3,76,0.61276292653431,0.791000066019581,0,0,0.955779278705237,0.468118861534221,CDC42;ARHGDIA;TAOK1
alpha,2,cAMP-mediated signaling (GO:0019933),3/76,3,76,0.61276292653431,0.791000066019581,0,0,0.955779278705237,0.468118861534221,RIMS2;ADCY9;GPR3
alpha,2,glutathione metabolic process (GO:0006749),2/50,2,50,0.617523309449905,0.791000066019581,0,0,0.968523002421307,0.466865339559743,CTNS;CHAC1
alpha,2,protein autoubiquitination (GO:0051865),2/50,2,50,0.617523309449905,0.791000066019581,0,0,0.968523002421307,0.466865339559743,TRIM37;UBE2A
alpha,2,lipid homeostasis (GO:0055088),2/50,2,50,0.617523309449905,0.791000066019581,0,0,0.968523002421307,0.466865339559743,PRKAA2;POLD1
alpha,2,regulation of natural killer cell mediated cytotoxicity (GO:0042269),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,PVR
alpha,2,regulation of axon extension involved in axon guidance (GO:0048841),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,PLXNA2
alpha,2,cellular response to catecholamine stimulus (GO:0071870),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,MAPK1
alpha,2,chromosome condensation (GO:0030261),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,CHMP1A
alpha,2,negative regulation of viral transcription (GO:0032897),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,TARDBP
alpha,2,protein localization to cilium (GO:0061512),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,IFT140
alpha,2,neuronal action potential (GO:0019228),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,SCN8A
alpha,2,melanosome organization (GO:0032438),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,HPS4
alpha,2,positive regulation of protein oligomerization (GO:0032461),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,BMF
alpha,2,lamellipodium assembly (GO:0030032),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,CYFIP1
alpha,2,glutamine family amino acid metabolic process (GO:0009064),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,GOT2
alpha,2,protein K48-linked deubiquitination (GO:0071108),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,USP20
alpha,2,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,COPS2
alpha,2,negative regulation of signal transduction in absence of ligand (GO:1901099),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,HSPA1A
alpha,2,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,HSPA1A
alpha,2,regulation of dendritic spine morphogenesis (GO:0061001),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,EPHA4
alpha,2,rRNA methylation (GO:0031167),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,METTL16
alpha,2,histone H3-K4 methylation (GO:0051568),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,PAXIP1
alpha,2,response to alkaloid (GO:0043279),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,MAPK1
alpha,2,regulation of cell size (GO:0008361),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,LARS
alpha,2,regulation of microtubule cytoskeleton organization (GO:0070507),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,TAOK1
alpha,2,viral budding (GO:0046755),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,CHMP1A
alpha,2,NAD metabolic process (GO:0019674),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,MDH1B
alpha,2,regulation of chondrocyte differentiation (GO:0032330),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,GDF5
alpha,2,regulation of ion homeostasis (GO:2000021),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,SLC30A1
alpha,2,negative regulation of axon extension (GO:0030517),1/23,1,23,0.621150434889039,0.791000066019581,0,0,1.0527423939362,0.501296957771765,EPHA4
alpha,2,transforming growth factor beta receptor signaling pathway (GO:0007179),3/77,3,77,0.62163446901301,0.791000066019581,0,0,0.943366560799975,0.448479320825739,PRKCZ;GDF5;TGFBR2
alpha,2,positive regulation of JNK cascade (GO:0046330),3/77,3,77,0.62163446901301,0.791000066019581,0,0,0.943366560799975,0.448479320825739,FZD7;TAOK1;HRAS
alpha,2,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),3/77,3,77,0.62163446901301,0.791000066019581,0,0,0.943366560799975,0.448479320825739,PSME3;PEA15;HSPA1A
alpha,2,wound healing (GO:0042060),2/51,2,51,0.628333851775382,0.79831635978716,0,0,0.949532355315007,0.441232153692985,ERBB3;FZD7
alpha,2,negative regulation of viral genome replication (GO:0045071),2/51,2,51,0.628333851775382,0.79831635978716,0,0,0.949532355315007,0.441232153692985,MAVS;BANF1
alpha,2,receptor internalization (GO:0031623),2/51,2,51,0.628333851775382,0.79831635978716,0,0,0.949532355315007,0.441232153692985,NEDD4;AP2M1
alpha,2,positive regulation of cell cycle G1/S phase transition (GO:1902808),1/24,1,24,0.636814883322941,0.807870792625984,0,0,1.0088781275222,0.455282760969259,LSM10
alpha,2,phospholipid dephosphorylation (GO:0046839),1/24,1,24,0.636814883322941,0.807870792625984,0,0,1.0088781275222,0.455282760969259,MTMR3
alpha,2,regulation of androgen receptor signaling pathway (GO:0060765),1/24,1,24,0.636814883322941,0.807870792625984,0,0,1.0088781275222,0.455282760969259,PHB
alpha,2,negative regulation of inflammatory response (GO:0050728),3/79,3,79,0.638957777240405,0.810181756762344,0,0,0.919483863058203,0.411852364385784,VPS35;KLF4;PPARD
alpha,2,regulation of endothelial cell proliferation (GO:0001936),3/80,3,80,0.647408211300229,0.813419744238963,0,0,0.907990314769976,0.394774443765282,BMP2;ZNF580;ARNT
alpha,2,positive regulation of nervous system development (GO:0051962),2/53,2,53,0.649238475152954,0.813419744238963,0,0,0.913700945680479,0.394677856103695,SPEN;DLG5
alpha,2,positive regulation of histone methylation (GO:0031062),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,PAXIP1
alpha,2,positive regulation of neutrophil chemotaxis (GO:0090023),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,DAPK2
alpha,2,dendritic spine organization (GO:0097061),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,CDC42
alpha,2,membrane protein intracellular domain proteolysis (GO:0031293),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,YBX1
alpha,2,positive regulation of immune effector process (GO:0002699),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,PHB
alpha,2,cellular lipid catabolic process (GO:0044242),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,PPARD
alpha,2,negative regulation of protein localization to membrane (GO:1905476),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,AP2M1
alpha,2,negative regulation of cytoskeleton organization (GO:0051494),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,PFN1
alpha,2,regulation of chromosome organization (GO:0033044),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,SMG6
alpha,2,cellular modified amino acid biosynthetic process (GO:0042398),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,CHAC1
alpha,2,negative regulation of developmental growth (GO:0048640),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,EPHA4
alpha,2,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,KEAP1
alpha,2,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,THOC5
alpha,2,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,IPO7
alpha,2,macromolecule modification (GO:0043412),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,ST6GALNAC4
alpha,2,positive regulation of microtubule polymerization or depolymerization (GO:0031112),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,MET
alpha,2,regulation of transmembrane transport (GO:0034762),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,NEDD4
alpha,2,negative regulation of oxidative stress-induced cell death (GO:1903202),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,FBXO7
alpha,2,positive regulation of dephosphorylation (GO:0035306),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,BMP2
alpha,2,DNA replication initiation (GO:0006270),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,ORC6
alpha,2,positive regulation of vascular endothelial growth factor production (GO:0010575),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,ARNT
alpha,2,fatty acid derivative biosynthetic process (GO:1901570),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,FASN
alpha,2,mammary gland development (GO:0030879),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,TBX3
alpha,2,"protein alpha-1,2-demannosylation (GO:0036508)",1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,MAN1B1
alpha,2,transition metal ion homeostasis (GO:0055076),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,B2M
alpha,2,proteoglycan biosynthetic process (GO:0030166),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,CSGALNACT1
alpha,2,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,SGTA
alpha,2,cGMP biosynthetic process (GO:0006182),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,ADCY9
alpha,2,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,UBE2V1
alpha,2,cAMP metabolic process (GO:0046058),1/25,1,25,0.651832396156599,0.813419744238963,0,0,0.968523002421307,0.414496669453622,ADCY9
alpha,2,spindle assembly (GO:0051225),3/81,3,81,0.655717238874254,0.817458663589159,0,0,0.896780557797507,0.378464372041254,ARHGEF10;HAUS8;BIRC3
alpha,2,negative regulation of defense response (GO:0031348),3/81,3,81,0.655717238874254,0.817458663589159,0,0,0.896780557797507,0.378464372041254,VPS35;KLF4;PPARD
alpha,2,regulation of response to external stimulus (GO:0032101),4/108,4,108,0.656916246010844,0.818144578982395,0,0,0.896780557797507,0.376826067670406,SHPK;CASP4;CAMKMT;BIRC3
alpha,2,regulation of protein secretion (GO:0050708),4/108,4,108,0.656916246010844,0.818144578982395,0,0,0.896780557797507,0.376826067670406,UNC13B;GIPR;SLC2A1;SLC8B1
alpha,2,regulation of calcium ion-dependent exocytosis (GO:0017158),2/54,2,54,0.659335453529541,0.820024989573285,0,0,0.896780557797507,0.373529584616729,RIMS2;PREPL
alpha,2,positive regulation of protein import into nucleus (GO:0042307),2/54,2,54,0.659335453529541,0.820024989573285,0,0,0.896780557797507,0.373529584616729,MAVS;RBM22
alpha,2,organophosphate ester transport (GO:0015748),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,PITPNM1
alpha,2,lamellipodium organization (GO:0097581),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,CYFIP1
alpha,2,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,UBE2V1
alpha,2,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,SGTA
alpha,2,inorganic cation import across plasma membrane (GO:0098659),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,SLC9A5
alpha,2,positive regulation of interleukin-12 production (GO:0032735),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,MAPK14
alpha,2,peptide catabolic process (GO:0043171),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,CHAC1
alpha,2,in utero embryonic development (GO:0001701),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,BMP2
alpha,2,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,CSGALNACT1
alpha,2,positive regulation of filopodium assembly (GO:0051491),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,CDC42
alpha,2,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,PVR
alpha,2,monocarboxylic acid catabolic process (GO:0072329),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,PPARD
alpha,2,regulation of glucose metabolic process (GO:0010906),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,AKT2
alpha,2,cellular response to vascular endothelial growth factor stimulus (GO:0035924),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,MAPK14
alpha,2,long-chain fatty-acyl-CoA metabolic process (GO:0035336),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,ACSL4
alpha,2,respiratory tube development (GO:0030323),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,DNAAF1
alpha,2,positive regulation of neutrophil migration (GO:1902624),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,DAPK2
alpha,2,peptide hormone secretion (GO:0030072),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,RIMS2
alpha,2,regulation of nervous system development (GO:0051960),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,YAP1
alpha,2,positive regulation of nitric oxide biosynthetic process (GO:0045429),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,KLF4
alpha,2,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,MAPK1
alpha,2,positive regulation of nitric oxide metabolic process (GO:1904407),1/26,1,26,0.666229660442372,0.820024989573285,0,0,0.931272117712796,0.378209007622264,KLF4
alpha,2,protein targeting to mitochondrion (GO:0006626),2/55,2,55,0.669197948544594,0.822474281788239,0,0,0.880475456746643,0.353665309626456,DNLZ;FBXO7
alpha,2,action potential (GO:0001508),2/55,2,55,0.669197948544594,0.822474281788239,0,0,0.880475456746643,0.353665309626456,SCN8A;YWHAH
alpha,2,membrane fusion (GO:0061025),2/55,2,55,0.669197948544594,0.822474281788239,0,0,0.880475456746643,0.353665309626456,NSFL1C;OPA1
alpha,2,negative regulation of protein kinase activity (GO:0006469),4/110,4,110,0.671021311080043,0.823800551768025,0,0,0.880475456746643,0.351269542008274,PTPN1;DBNDD2;LRRC4;PPM1F
alpha,2,regulation of Wnt signaling pathway (GO:0030111),4/110,4,110,0.671021311080043,0.823800551768025,0,0,0.880475456746643,0.351269542008274,SNX3;DEPDC1B;BMP2;CBY1
alpha,2,positive regulation of protein secretion (GO:0050714),3/83,3,83,0.671910283499931,0.823800551768025,0,0,0.875171387730097,0.34799479629073,UNC13B;GLMN;STX4
alpha,2,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),3/83,3,83,0.671910283499931,0.823800551768025,0,0,0.875171387730097,0.34799479629073,BMP2;ACVR1B;GDF5
alpha,2,positive regulation of cell cycle arrest (GO:0071158),3/83,3,83,0.671910283499931,0.823800551768025,0,0,0.875171387730097,0.34799479629073,PLK3;E2F1;RPL26
alpha,2,positive regulation of protein ubiquitination (GO:0031398),3/84,3,84,0.679794287343465,0.825730076616009,0,0,0.86475268073331,0.333764307499587,PAXIP1;DCUN1D3;BIRC3
alpha,2,negative regulation of neuron death (GO:1901215),3/84,3,84,0.679794287343465,0.825730076616009,0,0,0.86475268073331,0.333764307499587,ERBB3;VPS35;FBXO7
alpha,2,apoptotic cell clearance (GO:0043277),1/27,1,27,0.680032263731741,0.825730076616009,0,0,0.896780557797507,0.345812066427421,RARA
alpha,2,positive regulation of synapse assembly (GO:0051965),1/27,1,27,0.680032263731741,0.825730076616009,0,0,0.896780557797507,0.345812066427421,DLG5
alpha,2,cytoskeleton-dependent intracellular transport (GO:0030705),1/27,1,27,0.680032263731741,0.825730076616009,0,0,0.896780557797507,0.345812066427421,HOOK2
alpha,2,lipid modification (GO:0030258),1/27,1,27,0.680032263731741,0.825730076616009,0,0,0.896780557797507,0.345812066427421,DGKA
alpha,2,nucleotide biosynthetic process (GO:0009165),1/27,1,27,0.680032263731741,0.825730076616009,0,0,0.896780557797507,0.345812066427421,ADCY9
alpha,2,regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),1/27,1,27,0.680032263731741,0.825730076616009,0,0,0.896780557797507,0.345812066427421,PPARD
alpha,2,regulation of p38MAPK cascade (GO:1900744),1/27,1,27,0.680032263731741,0.825730076616009,0,0,0.896780557797507,0.345812066427421,BMP2
alpha,2,regulation of NF-kappaB import into nucleus (GO:0042345),1/27,1,27,0.680032263731741,0.825730076616009,0,0,0.896780557797507,0.345812066427421,BCL3
alpha,2,positive regulation of granulocyte chemotaxis (GO:0071624),1/27,1,27,0.680032263731741,0.825730076616009,0,0,0.896780557797507,0.345812066427421,DAPK2
alpha,2,positive regulation of wound healing (GO:0090303),1/27,1,27,0.680032263731741,0.825730076616009,0,0,0.896780557797507,0.345812066427421,HRAS
alpha,2,tRNA methylation (GO:0030488),1/27,1,27,0.680032263731741,0.825730076616009,0,0,0.896780557797507,0.345812066427421,LCMT2
alpha,2,internal peptidyl-lysine acetylation (GO:0018393),1/27,1,27,0.680032263731741,0.825730076616009,0,0,0.896780557797507,0.345812066427421,KANSL3
alpha,2,regulation of cardiac muscle cell contraction (GO:0086004),1/27,1,27,0.680032263731741,0.825730076616009,0,0,0.896780557797507,0.345812066427421,DSP
alpha,2,regulation of microtubule-based process (GO:0032886),1/27,1,27,0.680032263731741,0.825730076616009,0,0,0.896780557797507,0.345812066427421,TAOK1
alpha,2,fat-soluble vitamin metabolic process (GO:0006775),1/27,1,27,0.680032263731741,0.825730076616009,0,0,0.896780557797507,0.345812066427421,VKORC1
alpha,2,positive regulation of release of cytochrome c from mitochondria (GO:0090200),1/27,1,27,0.680032263731741,0.825730076616009,0,0,0.896780557797507,0.345812066427421,BMF
alpha,2,GPI anchor metabolic process (GO:0006505),1/27,1,27,0.680032263731741,0.825730076616009,0,0,0.896780557797507,0.345812066427421,PIGW
alpha,2,regulation of rhodopsin mediated signaling pathway (GO:0022400),1/27,1,27,0.680032263731741,0.825730076616009,0,0,0.896780557797507,0.345812066427421,CAMKMT
alpha,2,regulation of signal transduction by p53 class mediator (GO:1901796),5/139,5,139,0.684954834471597,0.830205922255309,0,0,0.870973923040744,0.329578603629945,RFC5;PLK3;PRKAA2;EHMT1;MAPK14
alpha,2,positive regulation of supramolecular fiber organization (GO:1902905),3/85,3,85,0.687536842434988,0.830205922255309,0,0,0.854579119783507,0.320159403401997,PFN1;COLGALT1;MET
alpha,2,protein modification process (GO:0036211),3/85,3,85,0.687536842434988,0.830205922255309,0,0,0.854579119783507,0.320159403401997,AKT2;NAGPA;GNMT
alpha,2,cellular defense response (GO:0006968),2/57,2,57,0.688228197186287,0.830205922255309,0,0,0.849581581071322,0.317433256094713,BECN1;VEZF1
alpha,2,cellular iron ion homeostasis (GO:0006879),2/57,2,57,0.688228197186287,0.830205922255309,0,0,0.849581581071322,0.317433256094713,ATP6V0D1;ISCU
alpha,2,neuron differentiation (GO:0030182),5/140,5,140,0.690994568618533,0.830205922255309,0,0,0.86475268073331,0.319632752871967,FOXA1;NIF3L1;FZD7;ID4;POU3F2
alpha,2,phosphatidylinositol metabolic process (GO:0046488),4/113,4,113,0.691419667581556,0.830205922255309,0,0,0.85710000214275,0.316277019755623,RAB4A;MTMR3;PITPNM1;PIGW
alpha,2,regulation of calcium ion transmembrane transporter activity (GO:1901019),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,YWHAE
alpha,2,mRNA polyadenylation (GO:0006378),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,SSU72
alpha,2,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,CALR
alpha,2,telomere maintenance via telomere lengthening (GO:0010833),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,SMG6
alpha,2,response to hexose (GO:0009746),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,EIF2B3
alpha,2,cristae formation (GO:0042407),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,ATP5G1
alpha,2,peptidyl-glutamic acid modification (GO:0018200),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,VKORC1
alpha,2,cardiac muscle cell development (GO:0055013),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,CXADR
alpha,2,regulation of double-strand break repair via homologous recombination (GO:0010569),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,RTEL1
alpha,2,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,HSPA1A
alpha,2,transition metal ion transport (GO:0000041),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,SLC30A1
alpha,2,release of sequestered calcium ion into cytosol (GO:0051209),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,SLC8B1
alpha,2,negative regulation of myeloid leukocyte differentiation (GO:0002762),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,RARA
alpha,2,negative regulation of cell-matrix adhesion (GO:0001953),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,NF2
alpha,2,purine ribonucleoside triphosphate biosynthetic process (GO:0009206),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,ATP5G1
alpha,2,regulation of vascular endothelial growth factor production (GO:0010574),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,ARNT
alpha,2,regulation of blood vessel diameter (GO:0097746),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,DHX8
alpha,2,negative regulation of organelle assembly (GO:1902116),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,TRIM37
alpha,2,muscle fiber development (GO:0048747),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,CXADR
alpha,2,protein localization to chromosome (GO:0034502),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,BOD1
alpha,2,regulation of autophagy of mitochondrion (GO:1903146),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,FBXO7
alpha,2,cellular response to glucose stimulus (GO:0071333),1/28,1,28,0.693264739202887,0.830205922255309,0,0,0.86475268073331,0.316796379878199,UNC13B
alpha,2,positive regulation of cell death (GO:0010942),2/58,2,58,0.697400844669626,0.834305265183672,0,0,0.834933622776989,0.300905847517572,PHB;MARK4
alpha,2,epidermal growth factor receptor signaling pathway (GO:0007173),2/58,2,58,0.697400844669626,0.834305265183672,0,0,0.834933622776989,0.300905847517572,PTPN11;HRAS
alpha,2,positive regulation of canonical Wnt signaling pathway (GO:0090263),4/114,4,114,0.698015826595713,0.834305265183672,0,0,0.849581581071322,0.305436049675824,SMURF2;PSMD13;PSME3;PSMD3
alpha,2,regulation of peptidyl-serine phosphorylation (GO:0033135),3/87,3,87,0.702599091487587,0.834305265183672,0,0,0.834933622776989,0.294705545815549,MAD2L2;SPTBN4;PPM1F
alpha,2,negative regulation of endocytosis (GO:0045806),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,SNX3
alpha,2,RNA polyadenylation (GO:0043631),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,SSU72
alpha,2,cellular response to hydrogen peroxide (GO:0070301),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,ZNF580
alpha,2,hydrogen ion transmembrane transport (GO:1902600),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,ATP6V0D1
alpha,2,negative regulation of homeostatic process (GO:0032845),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,PIM3
alpha,2,acute inflammatory response (GO:0002526),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,CEBPB
alpha,2,regulation of mRNA processing (GO:0050684),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,METTL16
alpha,2,regulation of receptor internalization (GO:0002090),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,ATAD1
alpha,2,chondrocyte differentiation (GO:0002062),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,BMP2
alpha,2,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway (GO:0051482),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,GPR157
alpha,2,organelle fission (GO:0048285),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,OPA1
alpha,2,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,SMURF2
alpha,2,regulation of NIK/NF-kappaB signaling (GO:1901222),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,CPNE1
alpha,2,positive regulation of cell communication (GO:0010647),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,RIMS2
alpha,2,positive regulation of calcium-mediated signaling (GO:0050850),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,CIB1
alpha,2,production of miRNAs involved in gene silencing by miRNA (GO:0035196),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,NCBP1
alpha,2,regulation of lipid biosynthetic process (GO:0046890),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,PRKAA2
alpha,2,cGMP metabolic process (GO:0046068),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,ADCY9
alpha,2,ventricular septum development (GO:0003281),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,TGFBR2
alpha,2,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,UBE2V1
alpha,2,protein K63-linked deubiquitination (GO:0070536),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,USP20
alpha,2,primary neural tube formation (GO:0014020),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,FUZ
alpha,2,positive regulation of fibroblast proliferation (GO:0048146),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,E2F1
alpha,2,transcription elongation from RNA polymerase I promoter (GO:0006362),1/29,1,29,0.705950609001568,0.834305265183672,0,0,0.834933622776989,0.290732239172936,TAF1B
alpha,2,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),5/143,5,143,0.708636740202018,0.837087521681259,0,0,0.846611016102542,0.291583195528207,CXADR;CLDN23;PVR;FGFRL1;TGFBR2
alpha,2,positive regulation of cellular component biogenesis (GO:0044089),3/88,3,88,0.709919833482362,0.838210589907546,0,0,0.825445740699978,0.282800373577382,HGS;DLG5;PFN1
alpha,2,protein O-linked glycosylation (GO:0006493),4/116,4,116,0.710902944989832,0.83897858084434,0,0,0.834933622776989,0.284895519273181,GALNT1;B3GALT6;ST6GALNAC4;B4GALT5
alpha,2,cell junction assembly (GO:0034329),2/60,2,60,0.715074817341595,0.840018338714936,0,0,0.807102502017756,0.27067643432113,CDC42;TBCD
alpha,2,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),2/60,2,60,0.715074817341595,0.840018338714936,0,0,0.807102502017756,0.27067643432113,BMP2;GDF5
alpha,2,sterol metabolic process (GO:0016125),2/60,2,60,0.715074817341595,0.840018338714936,0,0,0.807102502017756,0.27067643432113,LBR;PPARD
alpha,2,cell morphogenesis (GO:0000902),2/60,2,60,0.715074817341595,0.840018338714936,0,0,0.807102502017756,0.27067643432113,CYFIP1;SSH1
alpha,2,dicarboxylic acid metabolic process (GO:0043648),2/60,2,60,0.715074817341595,0.840018338714936,0,0,0.807102502017756,0.27067643432113,GOT2;MDH1B
alpha,2,sphingolipid metabolic process (GO:0006665),4/117,4,117,0.717194083776898,0.840018338714936,0,0,0.82779743796693,0.275167141691088,ALDH3A2;ELOVL4;NEU1;TEX2
alpha,2,dicarboxylic acid transport (GO:0006835),1/30,1,30,0.718112425959319,0.840018338714936,0,0,0.807102502017756,0.267255157445981,SLC25A12
alpha,2,cellular response to cadmium ion (GO:0071276),1/30,1,30,0.718112425959319,0.840018338714936,0,0,0.807102502017756,0.267255157445981,MAPK1
alpha,2,keratan sulfate biosynthetic process (GO:0018146),1/30,1,30,0.718112425959319,0.840018338714936,0,0,0.807102502017756,0.267255157445981,B4GALT5
alpha,2,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),1/30,1,30,0.718112425959319,0.840018338714936,0,0,0.807102502017756,0.267255157445981,BIRC3
alpha,2,tube closure (GO:0060606),1/30,1,30,0.718112425959319,0.840018338714936,0,0,0.807102502017756,0.267255157445981,FUZ
alpha,2,lung development (GO:0030324),1/30,1,30,0.718112425959319,0.840018338714936,0,0,0.807102502017756,0.267255157445981,DNAAF1
alpha,2,regulation of vasoconstriction (GO:0019229),1/30,1,30,0.718112425959319,0.840018338714936,0,0,0.807102502017756,0.267255157445981,DHX8
alpha,2,cortical cytoskeleton organization (GO:0030865),1/30,1,30,0.718112425959319,0.840018338714936,0,0,0.807102502017756,0.267255157445981,CDC42
alpha,2,regulation of neutrophil chemotaxis (GO:0090022),1/30,1,30,0.718112425959319,0.840018338714936,0,0,0.807102502017756,0.267255157445981,DAPK2
alpha,2,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),1/30,1,30,0.718112425959319,0.840018338714936,0,0,0.807102502017756,0.267255157445981,SAMD4B
alpha,2,respiratory system development (GO:0060541),1/30,1,30,0.718112425959319,0.840018338714936,0,0,0.807102502017756,0.267255157445981,DNAAF1
alpha,2,regulation of cellular biosynthetic process (GO:0031326),1/30,1,30,0.718112425959319,0.840018338714936,0,0,0.807102502017756,0.267255157445981,PRKAA2
alpha,2,carbohydrate derivative biosynthetic process (GO:1901137),1/30,1,30,0.718112425959319,0.840018338714936,0,0,0.807102502017756,0.267255157445981,ALG6
alpha,2,neuron development (GO:0048666),5/145,5,145,0.719999356374446,0.84183513063345,0,0,0.834933622776989,0.274279837101792,DBNDD2;NEDD4;TBCD;NCDN;POU3F2
alpha,2,protein localization to cell periphery (GO:1990778),4/118,4,118,0.723383846912299,0.844849067880951,0,0,0.820782205441786,0.265781827154008,SPTBN4;TMED2;TTC7A;PIGW
alpha,2,positive regulation of protein binding (GO:0032092),2/61,2,61,0.723582072411917,0.844849067880951,0,0,0.793871313460088,0.256850157835953,BMP2;B2M
alpha,2,membrane lipid biosynthetic process (GO:0046467),2/61,2,61,0.723582072411917,0.844849067880951,0,0,0.793871313460088,0.256850157835953,ALDH3A2;ELOVL4
alpha,2,plasma membrane bounded cell projection organization (GO:0120036),4/119,4,119,0.729472496816708,0.846589012684853,0,0,0.813884875984292,0.256726647116977,CYFIP1;DBNDD2;NEDD4;NCDN
alpha,2,regulation of defense response to virus by host (GO:0050691),1/31,1,31,0.729771813472193,0.846589012684853,0,0,0.781066937436538,0.246054345066795,MAVS
alpha,2,acylglycerol catabolic process (GO:0046464),1/31,1,31,0.729771813472193,0.846589012684853,0,0,0.781066937436538,0.246054345066795,ABHD6
alpha,2,bile acid and bile salt transport (GO:0015721),1/31,1,31,0.729771813472193,0.846589012684853,0,0,0.781066937436538,0.246054345066795,SLC10A3
alpha,2,negative regulation of secretion by cell (GO:1903531),1/31,1,31,0.729771813472193,0.846589012684853,0,0,0.781066937436538,0.246054345066795,SLC30A1
alpha,2,cyclic purine nucleotide metabolic process (GO:0052652),1/31,1,31,0.729771813472193,0.846589012684853,0,0,0.781066937436538,0.246054345066795,ADCY9
alpha,2,protein palmitoylation (GO:0018345),1/31,1,31,0.729771813472193,0.846589012684853,0,0,0.781066937436538,0.246054345066795,ZDHHC16
alpha,2,regulation of cation transmembrane transport (GO:1904062),1/31,1,31,0.729771813472193,0.846589012684853,0,0,0.781066937436538,0.246054345066795,KCNAB2
alpha,2,MyD88-independent toll-like receptor signaling pathway (GO:0002756),1/31,1,31,0.729771813472193,0.846589012684853,0,0,0.781066937436538,0.246054345066795,BIRC3
alpha,2,phosphatidylinositol 3-kinase signaling (GO:0014065),1/31,1,31,0.729771813472193,0.846589012684853,0,0,0.781066937436538,0.246054345066795,ERBB3
alpha,2,response to estradiol (GO:0032355),1/31,1,31,0.729771813472193,0.846589012684853,0,0,0.781066937436538,0.246054345066795,FOXA1
alpha,2,ATP-dependent chromatin remodeling (GO:0043044),1/31,1,31,0.729771813472193,0.846589012684853,0,0,0.781066937436538,0.246054345066795,SMARCD2
alpha,2,chondroitin sulfate metabolic process (GO:0030204),1/31,1,31,0.729771813472193,0.846589012684853,0,0,0.781066937436538,0.246054345066795,CSGALNACT1
alpha,2,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),1/31,1,31,0.729771813472193,0.846589012684853,0,0,0.781066937436538,0.246054345066795,KLF4
alpha,2,protein tetramerization (GO:0051262),3/91,3,91,0.731049144690377,0.847468058281536,0,0,0.798233243753825,0.250066193832493,SRR;CBY1;GNMT
alpha,2,actin cytoskeleton reorganization (GO:0031532),2/62,2,62,0.731873683956061,0.847468058281536,0,0,0.781066937436538,0.243807969079959,PTPN1;CXADR
alpha,2,potassium ion transport (GO:0006813),2/62,2,62,0.731873683956061,0.847468058281536,0,0,0.781066937436538,0.243807969079959,KCND3;KCNH1
alpha,2,positive regulation of leukocyte chemotaxis (GO:0002690),2/62,2,62,0.731873683956061,0.847468058281536,0,0,0.781066937436538,0.243807969079959,ZNF580;CALR
alpha,2,negative regulation of kinase activity (GO:0033673),3/92,3,92,0.737817587444775,0.851332414078941,0,0,0.789556795452153,0.240071578390579,DBNDD2;LRRC4;PPM1F
alpha,2,regulation of actin filament-based process (GO:0032970),2/63,2,63,0.739952928700723,0.851332414078941,0,0,0.76866904954072,0.231499061970869,CDC42;TAOK1
alpha,2,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),2/63,2,63,0.739952928700723,0.851332414078941,0,0,0.76866904954072,0.231499061970869,OPA1;HSPA1A
alpha,2,cellular protein catabolic process (GO:0044257),2/63,2,63,0.739952928700723,0.851332414078941,0,0,0.76866904954072,0.231499061970869,RNF123;AP2M1
alpha,2,second-messenger-mediated signaling (GO:0019932),2/63,2,63,0.739952928700723,0.851332414078941,0,0,0.76866904954072,0.231499061970869,DHX8;NUDT4
alpha,2,positive regulation of ubiquitin-protein transferase activity (GO:0051443),1/32,1,32,0.740949503926755,0.851332414078941,0,0,0.756658595641646,0.226863500193643,DCUN1D3
alpha,2,regulation of ubiquitin-protein transferase activity (GO:0051438),1/32,1,32,0.740949503926755,0.851332414078941,0,0,0.756658595641646,0.226863500193643,DCUN1D3
alpha,2,organelle transport along microtubule (GO:0072384),1/32,1,32,0.740949503926755,0.851332414078941,0,0,0.756658595641646,0.226863500193643,CDC42
alpha,2,secondary alcohol metabolic process (GO:1902652),1/32,1,32,0.740949503926755,0.851332414078941,0,0,0.756658595641646,0.226863500193643,PPARD
alpha,2,zinc ion homeostasis (GO:0055069),1/32,1,32,0.740949503926755,0.851332414078941,0,0,0.756658595641646,0.226863500193643,SLC30A1
alpha,2,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),1/32,1,32,0.740949503926755,0.851332414078941,0,0,0.756658595641646,0.226863500193643,PEA15
alpha,2,cellular zinc ion homeostasis (GO:0006882),1/32,1,32,0.740949503926755,0.851332414078941,0,0,0.756658595641646,0.226863500193643,SLC30A1
alpha,2,response to cadmium ion (GO:0046686),1/32,1,32,0.740949503926755,0.851332414078941,0,0,0.756658595641646,0.226863500193643,MAPK1
alpha,2,termination of RNA polymerase I transcription (GO:0006363),1/32,1,32,0.740949503926755,0.851332414078941,0,0,0.756658595641646,0.226863500193643,TAF1B
alpha,2,regulation of cytokine secretion (GO:0050707),1/32,1,32,0.740949503926755,0.851332414078941,0,0,0.756658595641646,0.226863500193643,GLMN
alpha,2,positive regulation of bone mineralization (GO:0030501),1/32,1,32,0.740949503926755,0.851332414078941,0,0,0.756658595641646,0.226863500193643,BMP2
alpha,2,proton transport (GO:0015992),1/32,1,32,0.740949503926755,0.851332414078941,0,0,0.756658595641646,0.226863500193643,ATP6V0D1
alpha,2,negative regulation of cell migration (GO:0030336),4/122,4,122,0.747135328857154,0.854303774361565,0,0,0.793871313460088,0.231420590742395,DLG5;FUZ;NF2;CALR
alpha,2,kidney development (GO:0001822),2/64,2,64,0.747823181006733,0.854303774361565,0,0,0.756658595641646,0.219876451256342,PYGO2;CENPF
alpha,2,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193),2/64,2,64,0.747823181006733,0.854303774361565,0,0,0.756658595641646,0.219876451256342,ADCY9;DHX8
alpha,2,regulation of viral genome replication (GO:0045069),2/64,2,64,0.747823181006733,0.854303774361565,0,0,0.756658595641646,0.219876451256342,MAVS;BANF1
alpha,2,negative regulation of dephosphorylation (GO:0035305),2/64,2,64,0.747823181006733,0.854303774361565,0,0,0.756658595641646,0.219876451256342,RRP1B;ARPP19
alpha,2,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",2/64,2,64,0.747823181006733,0.854303774361565,0,0,0.756658595641646,0.219876451256342,SAMD4B;EXOSC1
alpha,2,cellular transition metal ion homeostasis (GO:0046916),3/94,3,94,0.750948772387279,0.854303774361565,0,0,0.772757714697852,0.221331597093014,SLC30A1;ATP6V0D1;ISCU
alpha,2,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),1/33,1,33,0.751665374824867,0.854303774361565,0,0,0.733729547288869,0.20945339669197,YWHAE
alpha,2,dendrite morphogenesis (GO:0048813),1/33,1,33,0.751665374824867,0.854303774361565,0,0,0.733729547288869,0.20945339669197,CDC42
alpha,2,7-methylguanosine mRNA capping (GO:0006370),1/33,1,33,0.751665374824867,0.854303774361565,0,0,0.733729547288869,0.20945339669197,NCBP1
alpha,2,response to zinc ion (GO:0010043),1/33,1,33,0.751665374824867,0.854303774361565,0,0,0.733729547288869,0.20945339669197,SLC30A1
alpha,2,oxoacid metabolic process (GO:0043436),1/33,1,33,0.751665374824867,0.854303774361565,0,0,0.733729547288869,0.20945339669197,PPA2
alpha,2,sister chromatid segregation (GO:0000819),1/33,1,33,0.751665374824867,0.854303774361565,0,0,0.733729547288869,0.20945339669197,SPAG5
alpha,2,microtubule bundle formation (GO:0001578),1/33,1,33,0.751665374824867,0.854303774361565,0,0,0.733729547288869,0.20945339669197,MARK4
alpha,2,7-methylguanosine RNA capping (GO:0009452),1/33,1,33,0.751665374824867,0.854303774361565,0,0,0.733729547288869,0.20945339669197,NCBP1
alpha,2,GPI anchor biosynthetic process (GO:0006506),1/33,1,33,0.751665374824867,0.854303774361565,0,0,0.733729547288869,0.20945339669197,PIGW
alpha,2,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),1/33,1,33,0.751665374824867,0.854303774361565,0,0,0.733729547288869,0.20945339669197,MAVS
alpha,2,regulation of cell-cell adhesion (GO:0022407),1/33,1,33,0.751665374824867,0.854303774361565,0,0,0.733729547288869,0.20945339669197,NF2
alpha,2,substrate adhesion-dependent cell spreading (GO:0034446),1/33,1,33,0.751665374824867,0.854303774361565,0,0,0.733729547288869,0.20945339669197,LAMC1
alpha,2,G2 DNA damage checkpoint (GO:0031572),1/33,1,33,0.751665374824867,0.854303774361565,0,0,0.733729547288869,0.20945339669197,TAOK1
alpha,2,positive regulation of transcription factor import into nucleus (GO:0042993),1/33,1,33,0.751665374824867,0.854303774361565,0,0,0.733729547288869,0.20945339669197,MAVS
alpha,2,regulation of nitric oxide biosynthetic process (GO:0045428),1/33,1,33,0.751665374824867,0.854303774361565,0,0,0.733729547288869,0.20945339669197,KLF4
alpha,2,mismatch repair (GO:0006298),1/33,1,33,0.751665374824867,0.854303774361565,0,0,0.733729547288869,0.20945339669197,POLD1
alpha,2,aminoglycan catabolic process (GO:0006026),1/33,1,33,0.751665374824867,0.854303774361565,0,0,0.733729547288869,0.20945339669197,GPC2
alpha,2,positive regulation of protein polymerization (GO:0032273),2/65,2,65,0.755487898710535,0.857103230116046,0,0,0.745017694170237,0.208896639961197,PFN1;MET
alpha,2,glycerophospholipid metabolic process (GO:0006650),2/65,2,65,0.755487898710535,0.857103230116046,0,0,0.745017694170237,0.208896639961197,CPNE1;PIGW
alpha,2,positive regulation of endocytosis (GO:0045807),2/65,2,65,0.755487898710535,0.857103230116046,0,0,0.745017694170237,0.208896639961197,CALR;B2M
alpha,2,cellular response to decreased oxygen levels (GO:0036294),2/65,2,65,0.755487898710535,0.857103230116046,0,0,0.745017694170237,0.208896639961197,LMNA;P4HB
alpha,2,cellular calcium ion homeostasis (GO:0006874),4/124,4,124,0.758412523829978,0.857478294774422,0,0,0.781066937436538,0.215986733334981,YWHAE;SLC30A1;CALR;SLC8B1
alpha,2,activation of MAPKK activity (GO:0000186),1/34,1,34,0.761938484769818,0.857478294774422,0,0,0.712149266486255,0.193625876087991,TAOK1
alpha,2,positive regulation of cell-cell adhesion (GO:0022409),1/34,1,34,0.761938484769818,0.857478294774422,0,0,0.712149266486255,0.193625876087991,FOXA1
alpha,2,oligosaccharide biosynthetic process (GO:0009312),1/34,1,34,0.761938484769818,0.857478294774422,0,0,0.712149266486255,0.193625876087991,GALNT1
alpha,2,entry into host cell (GO:0030260),1/34,1,34,0.761938484769818,0.857478294774422,0,0,0.712149266486255,0.193625876087991,MET
alpha,2,neural tube closure (GO:0001843),1/34,1,34,0.761938484769818,0.857478294774422,0,0,0.712149266486255,0.193625876087991,FUZ
alpha,2,response to exogenous dsRNA (GO:0043330),1/34,1,34,0.761938484769818,0.857478294774422,0,0,0.712149266486255,0.193625876087991,MAVS
alpha,2,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),1/34,1,34,0.761938484769818,0.857478294774422,0,0,0.712149266486255,0.193625876087991,BMF
alpha,2,embryonic organ morphogenesis (GO:0048562),1/34,1,34,0.761938484769818,0.857478294774422,0,0,0.712149266486255,0.193625876087991,FUZ
alpha,2,transcription initiation from RNA polymerase I promoter (GO:0006361),1/34,1,34,0.761938484769818,0.857478294774422,0,0,0.712149266486255,0.193625876087991,TAF1B
alpha,2,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),1/34,1,34,0.761938484769818,0.857478294774422,0,0,0.712149266486255,0.193625876087991,CDC42
alpha,2,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay (GO:0043928),1/34,1,34,0.761938484769818,0.857478294774422,0,0,0.712149266486255,0.193625876087991,EXOSC1
alpha,2,regulation of DNA recombination (GO:0000018),1/34,1,34,0.761938484769818,0.857478294774422,0,0,0.712149266486255,0.193625876087991,RTEL1
alpha,2,positive regulation of biomineral tissue development (GO:0070169),1/34,1,34,0.761938484769818,0.857478294774422,0,0,0.712149266486255,0.193625876087991,BMP2
alpha,2,transcription from RNA polymerase I promoter (GO:0006360),1/34,1,34,0.761938484769818,0.857478294774422,0,0,0.712149266486255,0.193625876087991,TAF1B
alpha,2,positive regulation of Notch signaling pathway (GO:0045747),1/34,1,34,0.761938484769818,0.857478294774422,0,0,0.712149266486255,0.193625876087991,MAML1
alpha,2,cellular glucose homeostasis (GO:0001678),1/34,1,34,0.761938484769818,0.857478294774422,0,0,0.712149266486255,0.193625876087991,UNC13B
alpha,2,regulation of interleukin-12 production (GO:0032655),1/34,1,34,0.761938484769818,0.857478294774422,0,0,0.712149266486255,0.193625876087991,MAST2
alpha,2,negative regulation of blood vessel morphogenesis (GO:2000181),2/66,2,66,0.762950610899185,0.858234362483383,0,0,0.733729547288869,0.198519319053491,HGS;KLF4
alpha,2,negative regulation of macromolecule metabolic process (GO:0010605),4/125,4,125,0.763903364507972,0.858922998345567,0,0,0.774818401937046,0.208669430750052,CPNE1;KLF4;TARDBP;HRAS
alpha,2,sphingolipid biosynthetic process (GO:0030148),2/67,2,67,0.770214906037563,0.862786827306661,0,0,0.722778360015901,0.188707097195718,ALDH3A2;ELOVL4
alpha,2,epithelial tube morphogenesis (GO:0060562),1/35,1,35,0.77178710642499,0.862786827306661,0,0,0.691802144586648,0.179208949061319,MET
alpha,2,embryonic limb morphogenesis (GO:0030326),1/35,1,35,0.77178710642499,0.862786827306661,0,0,0.691802144586648,0.179208949061319,TBX3
alpha,2,apoptotic mitochondrial changes (GO:0008637),1/35,1,35,0.77178710642499,0.862786827306661,0,0,0.691802144586648,0.179208949061319,VPS35
alpha,2,positive regulation of leukocyte migration (GO:0002687),1/35,1,35,0.77178710642499,0.862786827306661,0,0,0.691802144586648,0.179208949061319,ZNF580
alpha,2,keratan sulfate metabolic process (GO:0042339),1/35,1,35,0.77178710642499,0.862786827306661,0,0,0.691802144586648,0.179208949061319,B4GALT5
alpha,2,regulation of wound healing (GO:0061041),1/35,1,35,0.77178710642499,0.862786827306661,0,0,0.691802144586648,0.179208949061319,HRAS
alpha,2,response to peptide (GO:1901652),1/35,1,35,0.77178710642499,0.862786827306661,0,0,0.691802144586648,0.179208949061319,EIF2B3
alpha,2,ventricular cardiac muscle tissue morphogenesis (GO:0055010),1/35,1,35,0.77178710642499,0.862786827306661,0,0,0.691802144586648,0.179208949061319,DSP
alpha,2,regulation of alcohol biosynthetic process (GO:1902930),1/35,1,35,0.77178710642499,0.862786827306661,0,0,0.691802144586648,0.179208949061319,FASN
alpha,2,positive regulation of cell development (GO:0010720),1/35,1,35,0.77178710642499,0.862786827306661,0,0,0.691802144586648,0.179208949061319,SPEN
alpha,2,positive regulation of chemokine production (GO:0032722),1/35,1,35,0.77178710642499,0.862786827306661,0,0,0.691802144586648,0.179208949061319,MAVS
alpha,2,anterior/posterior pattern specification (GO:0009952),1/35,1,35,0.77178710642499,0.862786827306661,0,0,0.691802144586648,0.179208949061319,BMP2
alpha,2,negative regulation of cell motility (GO:2000146),3/98,3,98,0.775623015098782,0.866690848063415,0,0,0.741216583485694,0.188334744867529,DLG5;FUZ;NF2
alpha,2,regulation of cardiac conduction (GO:1903779),2/68,2,68,0.77728442089306,0.867839731398562,0,0,0.712149266486255,0.179425256757618,CXADR;FXYD2
alpha,2,lipid phosphorylation (GO:0046834),1/36,1,36,0.781228759433092,0.867839731398562,0,0,0.67258541834813,0.166052775239956,DGKA
alpha,2,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",1/36,1,36,0.781228759433092,0.867839731398562,0,0,0.67258541834813,0.166052775239956,EXOSC1
alpha,2,positive regulation of peptide secretion (GO:0002793),1/36,1,36,0.781228759433092,0.867839731398562,0,0,0.67258541834813,0.166052775239956,UNC13B
alpha,2,negative regulation of protein kinase B signaling (GO:0051898),1/36,1,36,0.781228759433092,0.867839731398562,0,0,0.67258541834813,0.166052775239956,CIB1
alpha,2,endothelial cell migration (GO:0043542),1/36,1,36,0.781228759433092,0.867839731398562,0,0,0.67258541834813,0.166052775239956,LGALS8
alpha,2,cholesterol biosynthetic process (GO:0006695),1/36,1,36,0.781228759433092,0.867839731398562,0,0,0.67258541834813,0.166052775239956,LBR
alpha,2,carbohydrate catabolic process (GO:0016052),1/36,1,36,0.781228759433092,0.867839731398562,0,0,0.67258541834813,0.166052775239956,NEU1
alpha,2,flagellated sperm motility (GO:0030317),1/36,1,36,0.781228759433092,0.867839731398562,0,0,0.67258541834813,0.166052775239956,PIH1D3
alpha,2,positive regulation of osteoblast differentiation (GO:0045669),1/36,1,36,0.781228759433092,0.867839731398562,0,0,0.67258541834813,0.166052775239956,BMP2
alpha,2,sulfur compound catabolic process (GO:0044273),1/36,1,36,0.781228759433092,0.867839731398562,0,0,0.67258541834813,0.166052775239956,CHAC1
alpha,2,protein kinase B signaling (GO:0043491),1/36,1,36,0.781228759433092,0.867839731398562,0,0,0.67258541834813,0.166052775239956,PLK3
alpha,2,regulation of insulin secretion (GO:0050796),3/99,3,99,0.781468687551996,0.867839731398562,0,0,0.733729547288869,0.180923176341098,GIPR;SLC2A1;SLC8B1
alpha,2,response to molecule of bacterial origin (GO:0002237),3/99,3,99,0.781468687551996,0.867839731398562,0,0,0.733729547288869,0.180923176341098,SRR;MAPKAPK3;JUNB
alpha,2,protein sumoylation (GO:0016925),2/69,2,69,0.784162830665177,0.868918567195772,0,0,0.701828262624136,0.17064153280822,NUP54;PIAS1
alpha,2,negative regulation of phosphatase activity (GO:0010923),2/69,2,69,0.784162830665177,0.868918567195772,0,0,0.701828262624136,0.17064153280822,BOD1;RRP1B
alpha,2,monocarboxylic acid biosynthetic process (GO:0072330),2/69,2,69,0.784162830665177,0.868918567195772,0,0,0.701828262624136,0.17064153280822,SRR;ELOVL4
alpha,2,regulation of endopeptidase activity (GO:0052548),2/69,2,69,0.784162830665177,0.868918567195772,0,0,0.701828262624136,0.17064153280822,PSME3;BIRC3
alpha,2,cholesterol metabolic process (GO:0008203),2/69,2,69,0.784162830665177,0.868918567195772,0,0,0.701828262624136,0.17064153280822,LBR;PPARD
alpha,2,regulation of potassium ion transport (GO:0043266),1/37,1,37,0.790280241123466,0.869456575255562,0,0,0.654407434068451,0.154026346983537,KCNAB2
alpha,2,protein acylation (GO:0043543),1/37,1,37,0.790280241123466,0.869456575255562,0,0,0.654407434068451,0.154026346983537,ZDHHC16
alpha,2,regulation of receptor-mediated endocytosis (GO:0048259),1/37,1,37,0.790280241123466,0.869456575255562,0,0,0.654407434068451,0.154026346983537,B2M
alpha,2,muscle cell differentiation (GO:0042692),1/37,1,37,0.790280241123466,0.869456575255562,0,0,0.654407434068451,0.154026346983537,GLMN
alpha,2,organic hydroxy compound transport (GO:0015850),1/37,1,37,0.790280241123466,0.869456575255562,0,0,0.654407434068451,0.154026346983537,SLC10A3
alpha,2,carbohydrate biosynthetic process (GO:0016051),1/37,1,37,0.790280241123466,0.869456575255562,0,0,0.654407434068451,0.154026346983537,GALNT1
alpha,2,positive regulation of signaling (GO:0023056),1/37,1,37,0.790280241123466,0.869456575255562,0,0,0.654407434068451,0.154026346983537,RIMS2
alpha,2,sodium ion transmembrane transport (GO:0035725),1/37,1,37,0.790280241123466,0.869456575255562,0,0,0.654407434068451,0.154026346983537,SCN8A
alpha,2,regulation of filopodium assembly (GO:0051489),1/37,1,37,0.790280241123466,0.869456575255562,0,0,0.654407434068451,0.154026346983537,CDC42
alpha,2,regulation of blood circulation (GO:1903522),1/37,1,37,0.790280241123466,0.869456575255562,0,0,0.654407434068451,0.154026346983537,DHX8
alpha,2,vesicle-mediated transport in synapse (GO:0099003),1/37,1,37,0.790280241123466,0.869456575255562,0,0,0.654407434068451,0.154026346983537,UNC13B
alpha,2,cardiac muscle tissue morphogenesis (GO:0055008),1/37,1,37,0.790280241123466,0.869456575255562,0,0,0.654407434068451,0.154026346983537,BMP2
alpha,2,axonal transport (GO:0098930),1/37,1,37,0.790280241123466,0.869456575255562,0,0,0.654407434068451,0.154026346983537,OPA1
alpha,2,regulation of cysteine-type endopeptidase activity (GO:2000116),1/37,1,37,0.790280241123466,0.869456575255562,0,0,0.654407434068451,0.154026346983537,BIRC3
alpha,2,secondary alcohol biosynthetic process (GO:1902653),1/37,1,37,0.790280241123466,0.869456575255562,0,0,0.654407434068451,0.154026346983537,LBR
alpha,2,regulation of endothelial cell migration (GO:0010594),2/70,2,70,0.790853839665448,0.869456575255562,0,0,0.691802144586648,0.162325913159647,ZNF580;CALR
alpha,2,regulation of endocytosis (GO:0030100),2/70,2,70,0.790853839665448,0.869456575255562,0,0,0.691802144586648,0.162325913159647,PTPN1;RAB4A
alpha,2,negative regulation of angiogenesis (GO:0016525),2/70,2,70,0.790853839665448,0.869456575255562,0,0,0.691802144586648,0.162325913159647,HGS;KLF4
alpha,2,cellular response to transforming growth factor beta stimulus (GO:0071560),3/101,3,101,0.792782986812478,0.870818245967365,0,0,0.719200249322753,0.167002437478204,PRKCZ;GDF5;TGFBR2
alpha,2,regulation of lipid metabolic process (GO:0019216),3/101,3,101,0.792782986812478,0.870818245967365,0,0,0.719200249322753,0.167002437478204,CPT2;NCOA6;PPARD
alpha,2,protein localization to plasma membrane (GO:0072659),4/131,4,131,0.794823235517736,0.87267923377263,0,0,0.739330536199471,0.16977656271252,SPTBN4;TMED2;TTC7A;PIGW
alpha,2,phospholipid metabolic process (GO:0006644),2/71,2,71,0.797361172269478,0.873416215674897,0,0,0.682058452409371,0.154450457412644,GNPAT;PCYT2
alpha,2,metal ion transport (GO:0030001),3/102,3,102,0.798254771252762,0.873416215674897,0,0,0.712149266486255,0.160466792667825,KCND3;SCN8A;KCNH1
alpha,2,regulation of kinase activity (GO:0043549),3/102,3,102,0.798254771252762,0.873416215674897,0,0,0.712149266486255,0.160466792667825,EPHA4;ERBB3;MET
alpha,2,base-excision repair (GO:0006284),1/38,1,38,0.798957656448053,0.873416215674897,0,0,0.637186185803492,0.143014738310643,POLD1
alpha,2,regulation of regulated secretory pathway (GO:1903305),1/38,1,38,0.798957656448053,0.873416215674897,0,0,0.637186185803492,0.143014738310643,RAB3D
alpha,2,regulation of peptidyl-threonine phosphorylation (GO:0010799),1/38,1,38,0.798957656448053,0.873416215674897,0,0,0.637186185803492,0.143014738310643,MAPK1
alpha,2,regulation of osteoclast differentiation (GO:0045670),1/38,1,38,0.798957656448053,0.873416215674897,0,0,0.637186185803492,0.143014738310643,CEBPB
alpha,2,regulation of carbohydrate catabolic process (GO:0043470),1/38,1,38,0.798957656448053,0.873416215674897,0,0,0.637186185803492,0.143014738310643,NUP54
alpha,2,negative regulation of Ras protein signal transduction (GO:0046580),1/38,1,38,0.798957656448053,0.873416215674897,0,0,0.637186185803492,0.143014738310643,MET
alpha,2,organic cyclic compound biosynthetic process (GO:1901362),1/38,1,38,0.798957656448053,0.873416215674897,0,0,0.637186185803492,0.143014738310643,NFS1
alpha,2,T cell differentiation (GO:0030217),1/39,1,39,0.807276446123841,0.879840621056321,0,0,0.620848078475197,0.132916812019597,NHEJ1
alpha,2,regulation of cellular amide metabolic process (GO:0034248),1/39,1,39,0.807276446123841,0.879840621056321,0,0,0.620848078475197,0.132916812019597,CYFIP1
alpha,2,positive regulation of innate immune response (GO:0045089),1/39,1,39,0.807276446123841,0.879840621056321,0,0,0.620848078475197,0.132916812019597,MAVS
alpha,2,regulation of ossification (GO:0030278),1/39,1,39,0.807276446123841,0.879840621056321,0,0,0.620848078475197,0.132916812019597,BMP2
alpha,2,regulation of cellular pH (GO:0030641),1/39,1,39,0.807276446123841,0.879840621056321,0,0,0.620848078475197,0.132916812019597,SLC9A5
alpha,2,retina homeostasis (GO:0001895),1/39,1,39,0.807276446123841,0.879840621056321,0,0,0.620848078475197,0.132916812019597,B2M
alpha,2,chemical homeostasis (GO:0048878),1/39,1,39,0.807276446123841,0.879840621056321,0,0,0.620848078475197,0.132916812019597,VGF
alpha,2,monovalent inorganic cation transport (GO:0015672),3/105,3,105,0.813948365370218,0.885852678702072,0,0,0.691802144586648,0.142413246764226,KCND3;SCN8A;KCNH1
alpha,2,clathrin-dependent endocytosis (GO:0072583),1/40,1,40,0.815251414459758,0.885852678702072,0,0,0.605326876513317,0.123643298615604,AP2M1
alpha,2,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),1/40,1,40,0.815251414459758,0.885852678702072,0,0,0.605326876513317,0.123643298615604,ATP5G1
alpha,2,positive regulation of phagocytosis (GO:0050766),1/40,1,40,0.815251414459758,0.885852678702072,0,0,0.605326876513317,0.123643298615604,CALR
alpha,2,alpha-amino acid catabolic process (GO:1901606),1/40,1,40,0.815251414459758,0.885852678702072,0,0,0.605326876513317,0.123643298615604,GOT2
alpha,2,acyl-CoA metabolic process (GO:0006637),1/40,1,40,0.815251414459758,0.885852678702072,0,0,0.605326876513317,0.123643298615604,ACOT2
alpha,2,regulation of coenzyme metabolic process (GO:0051196),1/40,1,40,0.815251414459758,0.885852678702072,0,0,0.605326876513317,0.123643298615604,NUP54
alpha,2,mitotic spindle organization (GO:0007052),2/75,2,75,0.821628510939437,0.889179784452849,0,0,0.645682001614205,0.1268551536673,ARHGEF10;BIRC3
alpha,2,glucose homeostasis (GO:0042593),2/75,2,75,0.821628510939437,0.889179784452849,0,0,0.645682001614205,0.1268551536673,PRKAA2;SLC8B1
alpha,2,negative regulation of TOR signaling (GO:0032007),1/41,1,41,0.822896755318378,0.889179784452849,0,0,0.590562806354456,0.115115180630928,PRKAA2
alpha,2,regulation of cellular localization (GO:0060341),1/41,1,41,0.822896755318378,0.889179784452849,0,0,0.590562806354456,0.115115180630928,SPAG5
alpha,2,sensory organ development (GO:0007423),1/41,1,41,0.822896755318378,0.889179784452849,0,0,0.590562806354456,0.115115180630928,ZDHHC16
alpha,2,positive regulation of mitotic cell cycle phase transition (GO:1901992),1/41,1,41,0.822896755318378,0.889179784452849,0,0,0.590562806354456,0.115115180630928,LSM10
alpha,2,sterol biosynthetic process (GO:0016126),1/41,1,41,0.822896755318378,0.889179784452849,0,0,0.590562806354456,0.115115180630928,LBR
alpha,2,androgen receptor signaling pathway (GO:0030521),1/41,1,41,0.822896755318378,0.889179784452849,0,0,0.590562806354456,0.115115180630928,PIAS1
alpha,2,response to peptide hormone (GO:0043434),1/41,1,41,0.822896755318378,0.889179784452849,0,0,0.590562806354456,0.115115180630928,EIF2B3
alpha,2,negative regulation of cytokine-mediated signaling pathway (GO:0001960),1/41,1,41,0.822896755318378,0.889179784452849,0,0,0.590562806354456,0.115115180630928,CACTIN
alpha,2,neuron migration (GO:0001764),1/41,1,41,0.822896755318378,0.889179784452849,0,0,0.590562806354456,0.115115180630928,MARK1
alpha,2,regulation of cholesterol biosynthetic process (GO:0045540),1/41,1,41,0.822896755318378,0.889179784452849,0,0,0.590562806354456,0.115115180630928,FASN
alpha,2,regulation of viral transcription (GO:0046782),1/41,1,41,0.822896755318378,0.889179784452849,0,0,0.590562806354456,0.115115180630928,RSF1
alpha,2,retinoid metabolic process (GO:0001523),2/76,2,76,0.827273516042843,0.892761577860527,0,0,0.637186185803492,0.120823184540359,E2F1;GPC2
alpha,2,negative regulation of cellular amide metabolic process (GO:0034249),2/76,2,76,0.827273516042843,0.892761577860527,0,0,0.637186185803492,0.120823184540359,SAMD4B;CALR
alpha,2,purine ribonucleotide biosynthetic process (GO:0009152),2/76,2,76,0.827273516042843,0.892761577860527,0,0,0.637186185803492,0.120823184540359,ADCY9;ATP5G1
alpha,2,peptide transport (GO:0015833),1/42,1,42,0.830226077189774,0.895564656404025,0,0,0.57650178715554,0.107262327409445,CENPF
alpha,2,response to interleukin-1 (GO:0070555),2/77,2,77,0.832757213147672,0.897677890564417,0,0,0.628911040533317,0.115098984374936,YTHDC2;CACTIN
alpha,2,"DNA-templated transcription, elongation (GO:0006354)",3/109,3,109,0.833252950757852,0.897677890564417,0,0,0.666414909922918,0.121566088724489,NCBP1;TAF1B;CDK12
alpha,2,negative regulation of hydrolase activity (GO:0051346),3/109,3,109,0.833252950757852,0.897677890564417,0,0,0.666414909922918,0.121566088724489,TMED2;RRP1B;HRAS
alpha,2,cellular response to radiation (GO:0071478),1/43,1,43,0.837252427560139,0.900832176751992,0,0,0.563094768849597,0.10002233676854,MAPK14
alpha,2,negative regulation of protein secretion (GO:0050709),1/43,1,43,0.837252427560139,0.900832176751992,0,0,0.563094768849597,0.10002233676854,RAB11FIP3
alpha,2,glycolipid biosynthetic process (GO:0009247),1/43,1,43,0.837252427560139,0.900832176751992,0,0,0.563094768849597,0.10002233676854,PIGW
alpha,2,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),3/110,3,110,0.837801492736714,0.901038535045626,0,0,0.660356592559982,0.116866006209659,CASP4;RPS27L;PPM1F
alpha,2,inorganic cation transmembrane transport (GO:0098662),4/141,4,141,0.839030725700402,0.901975912283211,0,0,0.68689574639809,0.120555665257386,SCN8A;SLC30A1;ATP6V0D1;SLC39A3
alpha,2,adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189),2/79,2,79,0.843255358216989,0.902688096797617,0,0,0.612989242038802,0.104505747274155,ADCY9;GPR3
alpha,2,positive regulation of interferon-gamma production (GO:0032729),1/44,1,44,0.843988315721166,0.902688096797617,0,0,0.550297160466652,0.0933395489843031,CEBPG
alpha,2,cardiac ventricle morphogenesis (GO:0003208),1/44,1,44,0.843988315721166,0.902688096797617,0,0,0.550297160466652,0.0933395489843031,TGFBR2
alpha,2,male gonad development (GO:0008584),1/44,1,44,0.843988315721166,0.902688096797617,0,0,0.550297160466652,0.0933395489843031,KITLG
alpha,2,eye development (GO:0001654),1/44,1,44,0.843988315721166,0.902688096797617,0,0,0.550297160466652,0.0933395489843031,ZDHHC16
alpha,2,protein transmembrane import into intracellular organelle (GO:0044743),1/44,1,44,0.843988315721166,0.902688096797617,0,0,0.550297160466652,0.0933395489843031,DNLZ
alpha,2,development of primary male sexual characteristics (GO:0046546),1/44,1,44,0.843988315721166,0.902688096797617,0,0,0.550297160466652,0.0933395489843031,KITLG
alpha,2,response to hydrogen peroxide (GO:0042542),1/44,1,44,0.843988315721166,0.902688096797617,0,0,0.550297160466652,0.0933395489843031,ZNF580
alpha,2,positive regulation of interleukin-6 production (GO:0032755),1/44,1,44,0.843988315721166,0.902688096797617,0,0,0.550297160466652,0.0933395489843031,MAVS
alpha,2,regulation of ATP metabolic process (GO:1903578),1/44,1,44,0.843988315721166,0.902688096797617,0,0,0.550297160466652,0.0933395489843031,NUP54
alpha,2,nucleobase-containing compound catabolic process (GO:0034655),1/44,1,44,0.843988315721166,0.902688096797617,0,0,0.550297160466652,0.0933395489843031,ENTPD4
alpha,2,regulation of interferon-gamma production (GO:0032649),1/44,1,44,0.843988315721166,0.902688096797617,0,0,0.550297160466652,0.0933395489843031,RARA
alpha,2,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),2/80,2,80,0.848277069092456,0.906506257733549,0,0,0.605326876513317,0.0996053051666454,CASP4;RPS27L
alpha,2,cell-cell junction assembly (GO:0007043),2/80,2,80,0.848277069092456,0.906506257733549,0,0,0.605326876513317,0.0996053051666454,TBCD;STRN
alpha,2,regulation of focal adhesion assembly (GO:0051893),1/45,1,45,0.850445735017073,0.906519080183034,0,0,0.538068334678504,0.0871642038238358,PPM1F
alpha,2,lymphocyte chemotaxis (GO:0048247),1/45,1,45,0.850445735017073,0.906519080183034,0,0,0.538068334678504,0.0871642038238358,CXCL16
alpha,2,positive regulation of viral life cycle (GO:1903902),1/45,1,45,0.850445735017073,0.906519080183034,0,0,0.538068334678504,0.0871642038238358,P4HB
alpha,2,positive regulation of macroautophagy (GO:0016239),1/45,1,45,0.850445735017073,0.906519080183034,0,0,0.538068334678504,0.0871642038238358,PRKAA2
alpha,2,regulation of intracellular pH (GO:0051453),1/45,1,45,0.850445735017073,0.906519080183034,0,0,0.538068334678504,0.0871642038238358,SLC9A5
alpha,2,inorganic anion transport (GO:0015698),1/45,1,45,0.850445735017073,0.906519080183034,0,0,0.538068334678504,0.0871642038238358,ANO7
alpha,2,regulation of hydrolase activity (GO:0051336),2/81,2,81,0.853151990631064,0.908635692724469,0,0,0.597853705198338,0.0949496689322442,EPHA4;PLXNA2
alpha,2,negative regulation of MAPK cascade (GO:0043409),2/81,2,81,0.853151990631064,0.908635692724469,0,0,0.597853705198338,0.0949496689322442,PTPN1;PHB
alpha,2,positive regulation of kinase activity (GO:0033674),3/114,3,114,0.85493913429564,0.910154705231576,0,0,0.637186185803492,0.099863005312652,EPHA4;ERBB3;MET
alpha,2,positive regulation of blood vessel endothelial cell migration (GO:0043536),1/46,1,46,0.856636184306317,0.910807949755705,0,0,0.526371196968102,0.0814517175049283,CIB1
alpha,2,"regulation of synaptic transmission, glutamatergic (GO:0051966)",1/46,1,46,0.856636184306317,0.910807949755705,0,0,0.526371196968102,0.0814517175049283,ATAD1
alpha,2,protein complex subunit organization (GO:0071822),1/46,1,46,0.856636184306317,0.910807949755705,0,0,0.526371196968102,0.0814517175049283,NUP54
alpha,2,epidermis development (GO:0008544),2/82,2,82,0.857883664004667,0.911749937050051,0,0,0.590562806354456,0.0905254700439641,DSP;ALDH3A2
alpha,2,skeletal system development (GO:0001501),4/147,4,147,0.86151313097073,0.913615575609363,0,0,0.658859185320617,0.0982128320367336,VKORC1;BMP2;IFT140;TBX3
alpha,2,modulation of chemical synaptic transmission (GO:0050804),2/83,2,83,0.862475588420806,0.913615575609363,0,0,0.583447591820065,0.0863201573893015,RIMS2;DHX8
alpha,2,pyruvate metabolic process (GO:0006090),1/47,1,47,0.862570688186394,0.913615575609363,0,0,0.515171809798568,0.0761620607477108,SRR
alpha,2,regulation of generation of precursor metabolites and energy (GO:0043467),1/47,1,47,0.862570688186394,0.913615575609363,0,0,0.515171809798568,0.0761620607477108,NUP54
alpha,2,positive regulation of ion transport (GO:0043270),1/47,1,47,0.862570688186394,0.913615575609363,0,0,0.515171809798568,0.0761620607477108,RAB3B
alpha,2,maturation of SSU-rRNA (GO:0030490),1/47,1,47,0.862570688186394,0.913615575609363,0,0,0.515171809798568,0.0761620607477108,RPS28
alpha,2,regulation of fibroblast proliferation (GO:0048145),1/47,1,47,0.862570688186394,0.913615575609363,0,0,0.515171809798568,0.0761620607477108,E2F1
alpha,2,peptidyl-lysine modification (GO:0018205),3/116,3,116,0.862899405670699,0.913615575609363,0,0,0.626200217082742,0.0923377044916125,NUP54;PIAS1;SIRT3
alpha,2,epithelium development (GO:0060429),3/116,3,116,0.862899405670699,0.913615575609363,0,0,0.626200217082742,0.0923377044916125,BMP2;ACADVL;RARA
alpha,2,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),3/117,3,117,0.866733747533192,0.916981263385046,0,0,0.620848078475197,0.0887958314000986,EPHA4;PTPN1;ERBB3
alpha,2,peptide cross-linking (GO:0018149),1/48,1,48,0.868259816401066,0.916981263385046,0,0,0.504439063761098,0.0712592218827546,DSP
alpha,2,polyol metabolic process (GO:0019751),1/48,1,48,0.868259816401066,0.916981263385046,0,0,0.504439063761098,0.0712592218827546,NUDT4
alpha,2,positive regulation of tumor necrosis factor production (GO:0032760),1/48,1,48,0.868259816401066,0.916981263385046,0,0,0.504439063761098,0.0712592218827546,MAVS
alpha,2,fatty acid biosynthetic process (GO:0006633),1/48,1,48,0.868259816401066,0.916981263385046,0,0,0.504439063761098,0.0712592218827546,ELOVL4
alpha,2,inositol phosphate metabolic process (GO:0043647),1/48,1,48,0.868259816401066,0.916981263385046,0,0,0.504439063761098,0.0712592218827546,NUDT4
alpha,2,regulation of mitotic nuclear division (GO:0007088),2/85,2,85,0.8712539642834,0.919758266187834,0,0,0.569719413189004,0.0785197361103451,CHMP1A;HSPA1A
alpha,2,negative regulation of mitotic cell cycle (GO:0045930),1/49,1,49,0.873713702643164,0.921198143004206,0,0,0.494144388990463,0.0667107418769128,BRINP2
alpha,2,pattern recognition receptor signaling pathway (GO:0002221),1/49,1,49,0.873713702643164,0.921198143004206,0,0,0.494144388990463,0.0667107418769128,MAPKAPK3
alpha,2,amino acid transport (GO:0006865),1/49,1,49,0.873713702643164,0.921198143004206,0,0,0.494144388990463,0.0667107418769128,SLC6A8
alpha,2,regulation of phosphorylation (GO:0042325),3/120,3,120,0.877675228475072,0.923837892223218,0,0,0.605326876513317,0.0789822354768408,FZD7;GLMN;NUP54
alpha,2,protein heterooligomerization (GO:0051291),1/50,1,50,0.878942062871817,0.923837892223218,0,0,0.484261501210654,0.0624873104191624,IKZF4
alpha,2,RNA methylation (GO:0001510),1/50,1,50,0.878942062871817,0.923837892223218,0,0,0.484261501210654,0.0624873104191624,LCMT2
alpha,2,organic hydroxy compound biosynthetic process (GO:1901617),1/50,1,50,0.878942062871817,0.923837892223218,0,0,0.484261501210654,0.0624873104191624,LBR
alpha,2,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/50,1,50,0.878942062871817,0.923837892223218,0,0,0.484261501210654,0.0624873104191624,ROMO1
alpha,2,regulation of megakaryocyte differentiation (GO:0045652),1/50,1,50,0.878942062871817,0.923837892223218,0,0,0.484261501210654,0.0624873104191624,CIB1
alpha,2,gonad development (GO:0008406),1/50,1,50,0.878942062871817,0.923837892223218,0,0,0.484261501210654,0.0624873104191624,KITLG
alpha,2,calcium ion transmembrane transport (GO:0070588),2/87,2,87,0.879514186846926,0.923837892223218,0,0,0.556622415184659,0.0714622940372136,PHB;SLC8B1
alpha,2,toll-like receptor signaling pathway (GO:0002224),2/87,2,87,0.879514186846926,0.923837892223218,0,0,0.556622415184659,0.0714622940372136,MAPKAPK3;BIRC3
alpha,2,calcium ion homeostasis (GO:0055074),2/88,2,88,0.883458230706361,0.926957389808565,0,0,0.550297160466652,0.0681880175063719,SLC30A1;CALR
alpha,2,regulation of ion transport (GO:0043269),1/51,1,51,0.883954211930848,0.926957389808565,0,0,0.474766177657504,0.0585624147292851,NEDD4
alpha,2,regulation of bone mineralization (GO:0030500),1/51,1,51,0.883954211930848,0.926957389808565,0,0,0.474766177657504,0.0585624147292851,BMP2
alpha,2,heart morphogenesis (GO:0003007),1/51,1,51,0.883954211930848,0.926957389808565,0,0,0.474766177657504,0.0585624147292851,BMP2
alpha,2,regulation of cell differentiation (GO:0045595),3/122,3,122,0.884519460582098,0.927164621607669,0,0,0.595403485095066,0.073062416446418,TAF8;KLF4;JUNB
alpha,2,T cell activation (GO:0042110),2/89,2,89,0.887282519210244,0.928906092384335,0,0,0.544114046304105,0.0650715980298249,CXADR;NHEJ1
alpha,2,sulfur compound biosynthetic process (GO:0044272),3/123,3,123,0.887811853971443,0.928906092384335,0,0,0.590562806354456,0.0702742777990767,CSGALNACT1;CHAC1;B4GALT5
alpha,2,peptidyl-tyrosine modification (GO:0018212),1/52,1,52,0.888759080461301,0.928906092384335,0,0,0.465636058856398,0.0549120324089651,EPHA4
alpha,2,response to organonitrogen compound (GO:0010243),1/52,1,52,0.888759080461301,0.928906092384335,0,0,0.465636058856398,0.0549120324089651,RRAGC
alpha,2,carboxylic acid transport (GO:0046942),1/52,1,52,0.888759080461301,0.928906092384335,0,0,0.465636058856398,0.0549120324089651,SLC16A13
alpha,2,positive regulation of actin filament polymerization (GO:0030838),1/52,1,52,0.888759080461301,0.928906092384335,0,0,0.465636058856398,0.0549120324089651,PFN1
alpha,2,positive regulation of developmental growth (GO:0048639),1/52,1,52,0.888759080461301,0.928906092384335,0,0,0.465636058856398,0.0549120324089651,RIMS2
alpha,2,negative regulation of cellular protein metabolic process (GO:0032269),2/90,2,90,0.890990201629544,0.930852232191264,0,0,0.538068334678504,0.0621048418727833,SAMD4B;CALR
alpha,2,chemokine-mediated signaling pathway (GO:0070098),1/53,1,53,0.89336523082682,0.931404345657396,0,0,0.456850472840239,0.0515143627545198,CIB1
alpha,2,positive regulation of ossification (GO:0045778),1/53,1,53,0.89336523082682,0.931404345657396,0,0,0.456850472840239,0.0515143627545198,BMP2
alpha,2,regulation of calcium ion transport (GO:0051924),1/53,1,53,0.89336523082682,0.931404345657396,0,0,0.456850472840239,0.0515143627545198,SLC8B1
alpha,2,triglyceride metabolic process (GO:0006641),1/53,1,53,0.89336523082682,0.931404345657396,0,0,0.456850472840239,0.0515143627545198,GNPAT
alpha,2,positive regulation of secretion by cell (GO:1903532),1/53,1,53,0.89336523082682,0.931404345657396,0,0,0.456850472840239,0.0515143627545198,UNC13B
alpha,2,organic anion transport (GO:0015711),3/125,3,125,0.894145905575552,0.931833047050224,0,0,0.581113801452784,0.0650186799709744,SLC25A16;PITPNM1;SLC52A2
alpha,2,positive regulation of response to external stimulus (GO:0032103),2/91,2,91,0.894584371858657,0.931904909470273,0,0,0.532155495835883,0.0592800242418019,STX4;PPM1F
alpha,2,neutrophil chemotaxis (GO:0030593),1/54,1,54,0.897780871947035,0.93476172757906,0,0,0.448390278898753,0.0483495912176022,CXADR
alpha,2,phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200),2/92,2,92,0.89806806737671,0.93476172757906,0,0,0.526371196968102,0.0565898592967928,DHX8;GPR157
alpha,2,intracellular transport of virus (GO:0075733),1/55,1,55,0.902013873996647,0.937321380395363,0,0,0.440237728373322,0.0453996820016726,NUP54
alpha,2,positive regulation of immune response (GO:0050778),1/55,1,55,0.902013873996647,0.937321380395363,0,0,0.440237728373322,0.0453996820016726,STX4
alpha,2,transport of virus (GO:0046794),1/55,1,55,0.902013873996647,0.937321380395363,0,0,0.440237728373322,0.0453996820016726,NUP54
alpha,2,glycosphingolipid metabolic process (GO:0006687),1/55,1,55,0.902013873996647,0.937321380395363,0,0,0.440237728373322,0.0453996820016726,NEU1
alpha,2,protein lipidation (GO:0006497),3/128,3,128,0.903045815973424,0.938007227300237,0,0,0.567493946731235,0.0578741616261488,WDR45B;PIGW;ZDHHC16
alpha,2,positive regulation of cysteine-type endopeptidase activity (GO:2001056),1/56,1,56,0.906071782515836,0.939602399467491,0,0,0.432376340366655,0.0426481952299251,PPM1F
alpha,2,long-chain fatty acid metabolic process (GO:0001676),1/56,1,56,0.906071782515836,0.939602399467491,0,0,0.432376340366655,0.0426481952299251,ACOT2
alpha,2,regulation of gene silencing by RNA (GO:0060966),1/56,1,56,0.906071782515836,0.939602399467491,0,0,0.432376340366655,0.0426481952299251,NUP54
alpha,2,regulation of posttranscriptional gene silencing (GO:0060147),1/56,1,56,0.906071782515836,0.939602399467491,0,0,0.432376340366655,0.0426481952299251,NUP54
alpha,2,vesicle fusion (GO:0006906),2/95,2,95,0.90788582402585,0.940323633754905,0,0,0.509748948642793,0.0492604321408257,STX4;CALR
alpha,2,skin development (GO:0043588),2/95,2,95,0.90788582402585,0.940323633754905,0,0,0.509748948642793,0.0492604321408257,DSP;MET
alpha,2,axon development (GO:0061564),2/95,2,95,0.90788582402585,0.940323633754905,0,0,0.509748948642793,0.0492604321408257,SPTBN4;CAMSAP2
alpha,2,granulocyte chemotaxis (GO:0071621),1/57,1,57,0.909961831621925,0.941314085049424,0,0,0.424790790535661,0.040080125578138,CXADR
alpha,2,chordate embryonic development (GO:0043009),1/57,1,57,0.909961831621925,0.941314085049424,0,0,0.424790790535661,0.040080125578138,BMP2
alpha,2,glycosaminoglycan catabolic process (GO:0006027),1/57,1,57,0.909961831621925,0.941314085049424,0,0,0.424790790535661,0.040080125578138,GPC2
alpha,2,transcription elongation from RNA polymerase II promoter (GO:0006368),2/96,2,96,0.910956850915692,0.941957022554069,0,0,0.504439063761098,0.0470438596504969,NCBP1;CDK12
alpha,2,cellular metal ion homeostasis (GO:0006875),2/97,2,97,0.913931729178481,0.944645828273823,0,0,0.499238661041911,0.0449311823822914,SLC30A1;CALR
alpha,2,cell morphogenesis involved in neuron differentiation (GO:0048667),2/98,2,98,0.91681315000177,0.944993613856278,0,0,0.494144388990463,0.0429172257520179,SPTBN4;TBCD
alpha,2,phospholipid transport (GO:0015914),1/59,1,59,0.917265807581352,0.944993613856278,0,0,0.410391102720893,0.0354405475552676,PITPNM1
alpha,2,cholesterol homeostasis (GO:0042632),1/59,1,59,0.917265807581352,0.944993613856278,0,0,0.410391102720893,0.0354405475552676,ABCA2
alpha,2,integrin-mediated signaling pathway (GO:0007229),1/59,1,59,0.917265807581352,0.944993613856278,0,0,0.410391102720893,0.0354405475552676,CDC42
alpha,2,neutrophil migration (GO:1990266),1/59,1,59,0.917265807581352,0.944993613856278,0,0,0.410391102720893,0.0354405475552676,CXADR
alpha,2,sterol homeostasis (GO:0055092),1/59,1,59,0.917265807581352,0.944993613856278,0,0,0.410391102720893,0.0354405475552676,ABCA2
alpha,2,sodium ion transport (GO:0006814),1/59,1,59,0.917265807581352,0.944993613856278,0,0,0.410391102720893,0.0354405475552676,SCN8A
alpha,2,post-Golgi vesicle-mediated transport (GO:0006892),1/59,1,59,0.917265807581352,0.944993613856278,0,0,0.410391102720893,0.0354405475552676,STX4
alpha,2,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),3/134,3,134,0.918845564430693,0.946234591055209,0,0,0.542083770011926,0.0458804623021246,CDC42;CYFIP1;MAPK1
alpha,2,keratinocyte differentiation (GO:0030216),1/60,1,60,0.920692758674453,0.9477498519906,0,0,0.403551251008878,0.0333449934386764,DSP
alpha,2,Fc-gamma receptor signaling pathway (GO:0038094),3/135,3,135,0.92123824060795,0.947924456472154,0,0,0.538068334678504,0.0441412968333207,CDC42;CYFIP1;MAPK1
alpha,2,Fc receptor mediated stimulatory signaling pathway (GO:0002431),3/136,3,136,0.923566278124545,0.949932362736584,0,0,0.534111949864692,0.0424686904520372,CDC42;CYFIP1;MAPK1
alpha,2,muscle organ development (GO:0007517),1/61,1,61,0.923977922021197,0.949968332383799,0,0,0.396935656730044,0.0313845518764619,UTRN
alpha,2,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),1/62,1,62,0.927127157201277,0.951991935848819,0,0,0.390533468718269,0.0295495400155832,NF2
alpha,2,protein targeting to membrane (GO:0006612),1/62,1,62,0.927127157201277,0.951991935848819,0,0,0.390533468718269,0.0295495400155832,ARL6IP1
alpha,2,negative regulation of MAP kinase activity (GO:0043407),1/62,1,62,0.927127157201277,0.951991935848819,0,0,0.390533468718269,0.0295495400155832,PTPN1
alpha,2,cellular divalent inorganic cation homeostasis (GO:0072503),2/102,2,102,0.92745606121354,0.951991935848819,0,0,0.474766177657504,0.0357545738866133,SLC30A1;CALR
alpha,2,positive regulation of angiogenesis (GO:0045766),2/104,2,104,0.93228250923892,0.956555725824604,0,0,0.465636058856398,0.032650115816539,RRAS;KLF4
alpha,2,negative regulation of neuron apoptotic process (GO:0043524),1/64,1,64,0.933040081494261,0.956555725824604,0,0,0.378329297820823,0.0262209137623396,ERBB3
alpha,2,positive regulation of cell projection organization (GO:0031346),1/64,1,64,0.933040081494261,0.956555725824604,0,0,0.378329297820823,0.0262209137623396,SNX3
alpha,2,peptide metabolic process (GO:0006518),2/105,2,105,0.934580249165196,0.957745383337921,0,0,0.461201429724432,0.0312038657292429,CTNS;THOP1
alpha,2,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/65,1,65,0.935814319865742,0.958620517750366,0,0,0.372508847085118,0.0247115658020201,PVR
alpha,2,defense response to Gram-positive bacterium (GO:0050830),1/66,1,66,0.938473747130649,0.960954441844701,0,0,0.366864773644435,0.0232960586137531,ROMO1
alpha,2,negative regulation of epithelial cell proliferation (GO:0050680),1/67,1,67,0.941023109204249,0.962798531069454,0,0,0.361389180007951,0.0219679742561307,GDF5
alpha,2,viral life cycle (GO:0019058),2/108,2,108,0.941038215339494,0.962798531069454,0,0,0.448390278898753,0.0272493627515586,TBC1D20;NUP54
alpha,2,epidermal cell differentiation (GO:0009913),1/68,1,68,0.943466955955386,0.964500876740772,0,0,0.356074633243128,0.0207213849955936,DSP
alpha,2,regulation of gene silencing by miRNA (GO:0060964),1/68,1,68,0.943466955955386,0.964500876740772,0,0,0.356074633243128,0.0207213849955936,NUP54
alpha,2,regulation of complement activation (GO:0030449),2/110,2,110,0.945001972335068,0.965678676754069,0,0,0.440237728373322,0.0249034842014158,SUSD4;PHB
alpha,2,response to interferon-gamma (GO:0034341),1/69,1,69,0.945809649456617,0.96572143155044,0,0,0.350914131312068,0.0195508111015825,CXCL16
alpha,2,regulation of actin filament polymerization (GO:0030833),1/69,1,69,0.945809649456617,0.96572143155044,0,0,0.350914131312068,0.0195508111015825,PFN1
alpha,2,regulation of protein kinase activity (GO:0045859),3/148,3,148,0.946980392176246,0.966525515608455,0,0,0.490805575551338,0.0267375619444402,DBNDD2;LRRC4;PPM1F
alpha,2,regulation of osteoblast differentiation (GO:0045667),1/70,1,70,0.948055371794051,0.967231249055257,0,0,0.345901072293324,0.0184511827628515,BMP2
alpha,2,regulated exocytosis (GO:0045055),3/149,3,149,0.948595328616489,0.967390788018918,0,0,0.487511578399987,0.0257274436779878,RIMS2;TEX264;SDF4
alpha,2,interferon-gamma-mediated signaling pathway (GO:0060333),1/71,1,71,0.950208132067102,0.968252488514437,0,0,0.341029226204686,0.0174178058169509,B2M
alpha,2,calcium-mediated signaling (GO:0019722),1/71,1,71,0.950208132067102,0.968252488514437,0,0,0.341029226204686,0.0174178058169509,NUDT4
alpha,2,defense response to Gram-negative bacterium (GO:0050829),1/72,1,72,0.952271773924131,0.969571826336964,0,0,0.336292709174065,0.0164463304144675,ROMO1
alpha,2,organelle membrane fusion (GO:0090174),1/72,1,72,0.952271773924131,0.969571826336964,0,0,0.336292709174065,0.0164463304144675,STX4
alpha,2,regulation of neuron death (GO:1901214),1/73,1,73,0.954249982529691,0.971193888595593,0,0,0.331685959733324,0.015532722698827,VPS35
alpha,2,canonical Wnt signaling pathway (GO:0060070),1/74,1,74,0.956146290421795,0.972339090501519,0,0,0.327203717034226,0.0146732393769614,FZD7
alpha,2,chloride transport (GO:0006821),1/74,1,74,0.956146290421795,0.972339090501519,0,0,0.327203717034226,0.0146732393769614,ANO7
alpha,2,nitrogen compound transport (GO:0071705),1/75,1,75,0.957964084565511,0.973795010590173,0,0,0.322841000807103,0.0138644041094976,SLC52A2
alpha,2,positive regulation of protein serine/threonine kinase activity (GO:0071902),2/119,2,119,0.959901746362796,0.975371556940762,0,0,0.406942437992146,0.0166538536622279,CIB1;HRAS
alpha,2,positive regulation of apoptotic signaling pathway (GO:2001235),1/77,1,77,0.961376985214689,0.976477147286124,0,0,0.314455520266658,0.0123859824007825,BMF
alpha,2,enzyme linked receptor protein signaling pathway (GO:0007167),2/121,2,121,0.962642526624877,0.976975634667179,0,0,0.40021611670302,0.0152374859114478,ERBB3;ACVR1B
alpha,2,actin filament organization (GO:0007015),2/121,2,121,0.962642526624877,0.976975634667179,0,0,0.40021611670302,0.0152374859114478,CDC42;MAD2L2
alpha,2,sensory perception of mechanical stimulus (GO:0050954),1/79,1,79,0.964513083628244,0.977693728661748,0,0,0.306494621019401,0.0110742273380267,SPTBN4
alpha,2,extracellular matrix disassembly (GO:0022617),1/79,1,79,0.964513083628244,0.977693728661748,0,0,0.306494621019401,0.0110742273380267,LAMC1
alpha,2,visual perception (GO:0007601),1/79,1,79,0.964513083628244,0.977693728661748,0,0,0.306494621019401,0.0110742273380267,OPA1
alpha,2,peptidyl-tyrosine phosphorylation (GO:0018108),1/80,1,80,0.965984412328487,0.978398669836323,0,0,0.302663438256659,0.0104744495174712,EPHA4
alpha,2,steroid biosynthetic process (GO:0006694),1/80,1,80,0.965984412328487,0.978398669836323,0,0,0.302663438256659,0.0104744495174712,LBR
alpha,2,cellular response to hormone stimulus (GO:0032870),1/81,1,81,0.96739480442659,0.979433840531457,0,0,0.298926852599169,0.00990900345693926,JUNB
alpha,2,sensory perception of light stimulus (GO:0050953),1/82,1,82,0.968746780821382,0.980015796723436,0,0,0.295281403177228,0.00937578141593079,OPA1
alpha,2,sensory perception of sound (GO:0007605),1/82,1,82,0.968746780821382,0.980015796723436,0,0,0.295281403177228,0.00937578141593079,SPTBN4
alpha,2,regulation of anatomical structure morphogenesis (GO:0022603),1/83,1,83,0.970042757969103,0.980540214668569,0,0,0.291723795910032,0.00887281661533328,MYO19
alpha,2,C-terminal protein amino acid modification (GO:0018410),1/83,1,83,0.970042757969103,0.980540214668569,0,0,0.291723795910032,0.00887281661533328,LCMT2
alpha,2,positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/84,1,84,0.971285052805206,0.981402605438594,0,0,0.28825089357777,0.00839827267012335,MAD2L2
alpha,2,regulation of protein processing (GO:0070613),2/129,2,129,0.971910957777687,0.98164174429929,0,0,0.375396512566398,0.0106954543020432,SUSD4;CHAC1
alpha,2,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/86,1,86,0.973617387811692,0.982971598102917,0,0,0.281547384424799,0.00752769811677434,PRKCZ
alpha,2,divalent metal ion transport (GO:0070838),1/89,1,89,0.976765894244438,0.9851971723665,0,0,0.272057023152053,0.00639559066229174,SLC30A1
alpha,2,positive regulation of protein complex assembly (GO:0031334),1/89,1,89,0.976765894244438,0.9851971723665,0,0,0.272057023152053,0.00639559066229174,UNC13B
alpha,2,adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),2/135,2,135,0.977362707550236,0.9851971723665,0,0,0.358712223119003,0.00821359505731881,ADCY9;GPR3
alpha,2,regulation of neuron apoptotic process (GO:0043523),1/90,1,90,0.977729653727166,0.9851971723665,0,0,0.269034167339252,0.00605920765195808,ERBB3
alpha,2,phagocytosis (GO:0006909),2/136,2,136,0.978165630295684,0.9851971723665,0,0,0.356074633243128,0.00786079873091218,CDC42;RARA
alpha,2,cellular response to organic cyclic compound (GO:0071407),2/136,2,136,0.978165630295684,0.9851971723665,0,0,0.356074633243128,0.00786079873091218,DHX8;SSH1
alpha,2,muscle contraction (GO:0006936),2/138,2,138,0.979689563788333,0.985944564993685,0,0,0.350914131312068,0.00720059274478475,SLC6A8;UTRN
alpha,2,regulation of cytosolic calcium ion concentration (GO:0051480),2/138,2,138,0.979689563788333,0.985944564993685,0,0,0.350914131312068,0.00720059274478475,YWHAE;SLC8B1
alpha,2,proteolysis involved in cellular protein catabolic process (GO:0051603),1/94,1,94,0.981201528902318,0.987072299916891,0,0,0.257585904899284,0.00488831291602857,RNF123
alpha,2,regulation of heart contraction (GO:0008016),1/96,1,96,0.982729087164611,0.988214815721351,0,0,0.252219531880549,0.00439411693414342,FXYD2
alpha,2,protein processing (GO:0016485),1/102,1,102,0.986607118636666,0.99171907261924,0,0,0.237383088828752,0.00320072517840497,DDI2
alpha,2,plasma membrane invagination (GO:0099024),1/104,1,104,0.987695784875577,0.992140443357488,0,0,0.232818029428199,0.00288241262182496,CDC42
alpha,2,positive regulation of vasculature development (GO:1904018),1/105,1,105,0.988206500283112,0.992140443357488,0,0,0.230600714862216,0.00273575341629461,RRAS
alpha,2,"phagocytosis, engulfment (GO:0006911)",1/105,1,105,0.988206500283112,0.992140443357488,0,0,0.230600714862216,0.00273575341629461,CDC42
alpha,2,positive regulation of cellular component organization (GO:0051130),1/107,1,107,0.989165272328515,0.992707845926189,0,0,0.226290421126474,0.00246517407986521,DLG5
alpha,2,regulation of protein activation cascade (GO:2000257),1/109,1,109,0.99004616778766,0.992801763483292,0,0,0.222138303307639,0.00222220556942679,SUSD4
alpha,2,regulation of cytokine production (GO:0001817),1/109,1,109,0.99004616778766,0.992801763483292,0,0,0.222138303307639,0.00222220556942679,MAPK14
alpha,2,regulation of humoral immune response (GO:0002920),1/114,1,114,0.991947910661805,0.994253420037504,0,0,0.212395395267831,0.00171714933295832,SUSD4
alpha,2,regulation of immune effector process (GO:0002697),1/115,1,115,0.992282259410943,0.994253420037504,0,0,0.210548478787241,0.00163126149560021,SUSD4
alpha,2,cellular response to interferon-gamma (GO:0071346),1/117,1,117,0.992909915671342,0.994487214981384,0,0,0.206949359491732,0.00147251472784558,B2M
alpha,2,positive regulation of B cell activation (GO:0050871),1/120,1,120,0.993757068946136,0.994940582724159,0,0,0.201775625504439,0.00126361978086735,PAXIP1
alpha,2,regulation of acute inflammatory response (GO:0002673),1/122,1,122,0.994264864632675,0.99505396373159,0,0,0.198467828365022,0.00114151637508017,SUSD4
alpha,2,platelet degranulation (GO:0002576),1/125,1,125,0.9949502221507,0.99534488705437,0,0,0.193704600484262,0.000980643305420186,TEX264
alpha,2,positive regulation of cytosolic calcium ion concentration (GO:0007204),1/134,1,134,0.996553059930578,0.996553059930578,0,0,0.180694590003975,0.000623919347732198,GPR157
alpha,3,proteasome assembly (GO:0043248),4/11,4,11,0.000195058268095377,0.172394757385702,0,0,12.5608415763856,107.297374574219,PSMD9;PSMD11;ADRM1;PSMG2
alpha,3,modification-dependent protein catabolic process (GO:0019941),13/142,13,142,0.000252309559800936,0.172394757385702,0,0,3.16232455180131,26.1993966191161,PSMD11;SIAH1;ADRM1;KCTD6;BAG6;PSMD9;RNF213;ZNRF3;TOLLIP;ARIH2;RBBP6;STUB1;DTL
alpha,3,positive regulation of protein metabolic process (GO:0051247),10/97,10,97,0.00050260862211575,0.172394757385702,0,0,3.56106333351139,27.0487644106496,FZR1;ROCK2;GBA;AXIN1;IDE;OAZ1;DTL;RILP;VPS28;RAB7A
alpha,3,interleukin-1-mediated signaling pathway (GO:0070498),10/96,10,96,0.00046253800560722,0.172394757385702,0,0,3.59815774323546,27.6294683005974,PSMD9;PSMD11;PSMC3;FBXW11;PSMB3;PELI3;TOLLIP;PSMD1;TAB2;RBX1
alpha,3,positive regulation of catabolic process (GO:0009896),8/63,8,63,0.000448370997942119,0.172394757385702,0,0,4.38632562984895,33.8180861270183,FZR1;AXIN1;IDE;DTL;OAZ1;RILP;VPS28;RAB7A
alpha,3,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),10/94,10,94,0.000390318411870326,0.172394757385702,0,0,3.67471429096388,28.8411704378563,PSMD9;PSMD11;PSMC3;EPAS1;PSMB3;HSF1;HSF4;PSMD1;ATF3;RBX1
alpha,3,macromolecular complex assembly (GO:0065003),11/121,11,121,0.000784944153779814,0.211188226822961,0,0,3.1402103940964,22.452183967324,KMT2A;CAPZA1;HSF1;CAPZA2;DNAJB12;TSPAN4;AXIN1;REPS2;APBA1;WASL;PPARGC1A
alpha,3,negative regulation of cell cycle G2/M phase transition (GO:1902750),8/70,8,70,0.000916025511686826,0.211188226822961,0,0,3.94769306686405,27.6159539797345,PSMD9;FZR1;PSMD11;PSMC3;PSMB3;PSMD1;DTL;RBX1
alpha,3,DNA ligation (GO:0006266),4/18,4,18,0.00153927279025482,0.211188226822961,0,0,7.67606985223566,49.7136456588374,PARP3;XRCC6;LIG1;LIG3
alpha,3,negative regulation of proteasomal protein catabolic process (GO:1901799),5/29,5,29,0.00133417584346007,0.211188226822961,0,0,5.95557143707939,39.4225568667087,BAG6;USP25;BAG5;TLK2;CCAR2
alpha,3,regulation of G2/M transition of mitotic cell cycle (GO:0010389),12/150,12,150,0.00142409461065122,0.211188226822961,0,0,2.76338514680484,18.1118315112548,PSMD9;PSMD11;PSMC3;PSMB3;NDE1;CEP164;CNTRL;PSMD1;TUBG1;DTL;RAB11A;RBX1
alpha,3,positive regulation of viral process (GO:0048524),6/45,6,45,0.00178946096708861,0.230169416891772,0,0,4.60564191134139,29.1345576980294,TSG101;DHX9;VPS4A;NELFA;POLR2L;RAB7A
alpha,3,snRNA metabolic process (GO:0016073),4/18,4,18,0.00153927279025482,0.211188226822961,0,0,7.67606985223566,49.7136456588374,INTS1;INTS10;INTS7;INTS8
alpha,3,regulation of ERAD pathway (GO:1904292),3/8,3,8,0.00121240747733753,0.211188226822961,0,0,12.9533678756477,86.9837726089985,BAG6;USP25;TMEM259
alpha,3,transcription-coupled nucleotide-excision repair (GO:0006283),8/74,8,74,0.00132236313013725,0.211188226822961,0,0,3.73430425243897,24.752219177025,ISY1;COPS5;LIG1;XPA;LIG3;GTF2H1;RBX1;POLR2L
alpha,3,regulation of ubiquitin-protein transferase activity (GO:0051438),5/32,5,32,0.00210660399766405,0.255023001599566,0,0,5.3972366148532,33.2614319293947,BAG5;FEM1B;DCUN1D1;AXIN1;RPS2
alpha,3,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),7/63,7,63,0.00223555898501211,0.255598910619718,0,0,3.83803492611783,23.4245403071842,PSMD9;PSMD11;PSMC3;PSMB3;VPS4A;PSMD1;RBX1
alpha,3,lagging strand elongation (GO:0006273),3/8,3,8,0.00121240747733753,0.211188226822961,0,0,12.9533678756477,86.9837726089985,PARP3;LIG1;LIG3
alpha,3,positive regulation of protein catabolic process (GO:0045732),8/82,8,82,0.00255807651399059,0.277080077146981,0,0,3.36998188634736,20.1137357584626,FZR1;AXIN1;IDE;DTL;OAZ1;RILP;VPS28;RAB7A
alpha,3,nucleotide-excision repair (GO:0006289),9/109,9,109,0.0044054503827967,0.362656675511824,0,0,2.85211769739031,15.4724897502871,ISY1;COPS5;LIG1;PNKP;XPA;LIG3;GTF2H1;RBX1;POLR2L
alpha,3,DNA ligation involved in DNA repair (GO:0051103),3/12,3,12,0.00436826209389749,0.362656675511824,0,0,8.63557858376511,46.9204666593955,PARP3;LIG1;LIG3
alpha,3,regulation of cellular amino acid metabolic process (GO:0006521),6/52,6,52,0.00377304145988843,0.362656675511824,0,0,3.98565165404544,22.2394334375715,PSMD9;PSMD11;PSMC3;PSMB3;PSMD1;OAZ1
alpha,3,vesicle budding from membrane (GO:0006900),3/12,3,12,0.00436826209389749,0.362656675511824,0,0,8.63557858376511,46.9204666593955,VPS4A;WASL;RILP
alpha,3,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),8/89,8,89,0.00425426541875262,0.362656675511824,0,0,3.10492713124139,16.9523841459372,BAG6;BAG5;RFWD2;TLK2;ARIH2;STUB1;CCAR2;RBX1
alpha,3,regulation of cellular amine metabolic process (GO:0033238),6/52,6,52,0.00377304145988843,0.362656675511824,0,0,3.98565165404544,22.2394334375715,PSMD9;PSMD11;PSMC3;PSMB3;PSMD1;OAZ1
alpha,3,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),4/25,4,25,0.00542162929713745,0.387345281920245,0,0,5.52677029360967,28.8351441816996,BAG6;BAG5;TLK2;CCAR2
alpha,3,regulation of protein catabolic process (GO:0042176),8/92,8,92,0.00520216340177341,0.387345281920245,0,0,3.00367950739656,15.7953914578729,FZR1;AXIN1;IDE;DTL;OAZ1;RILP;VPS28;RAB7A
alpha,3,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),7/73,7,73,0.00514310606299705,0.387345281920245,0,0,3.31227671706059,17.456023198855,PSMD9;PSMD11;PSMC3;FBXW11;PSMB3;PSMD1;RBX1
alpha,3,regulation of cell junction assembly (GO:1901888),3/15,3,15,0.0084696490215797,0.387345281920245,0,0,6.90846286701209,32.9621154335528,TJP1;RAP1B;CBFB
alpha,3,regulation of primary metabolic process (GO:0080090),10/140,10,140,0.00764046595834461,0.387345281920245,0,0,2.46730816679003,12.0263920265269,PSMD9;PSMD11;NCOR1;PSMC3;ROCK2;PSMB3;TGS1;PSMD1;GRHL1;OAZ1
alpha,3,regulation of hematopoietic progenitor cell differentiation (GO:1901532),7/78,7,78,0.00737426781580914,0.387345281920245,0,0,3.09995128647978,15.2200126771532,PSMD9;PSMD11;CBFB;KMT2A;PSMC3;PSMB3;PSMD1
alpha,3,mRNA metabolic process (GO:0016071),8/98,8,98,0.00757326938626213,0.387345281920245,0,0,2.81978076204575,13.7693572099632,ALKBH5;SSB;AGO3;HSF1;SNRPF;PPARGC1A;SRSF11;HIPK3
alpha,3,positive regulation of exosomal secretion (GO:1903543),3/15,3,15,0.0084696490215797,0.387345281920245,0,0,6.90846286701209,32.9621154335528,TSG101;VPS4A;RAB7A
alpha,3,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),7/79,7,79,0.00789493996144033,0.387345281920245,0,0,3.06071139677751,14.8185359531008,PSMD9;PSMD11;PSMC3;EPAS1;PSMB3;PSMD1;RBX1
alpha,3,regulation of cellular ketone metabolic process (GO:0010565),6/62,6,62,0.00894666082095908,0.396989380707256,0,0,3.34280461307037,15.766254083042,PSMD9;PSMD11;PSMC3;PSMB3;PSMD1;OAZ1
alpha,3,regulation of histone acetylation (GO:0035065),4/27,4,27,0.00718685070073275,0.387345281920245,0,0,5.11737990149044,25.2568398348554,FLCN;KMT2A;CTBP1;PPARGC1A
alpha,3,negative regulation of ubiquitin protein ligase activity (GO:1904667),7/78,7,78,0.00737426781580914,0.387345281920245,0,0,3.09995128647978,15.2200126771532,RPL5;PSMD9;FZR1;PSMD11;PSMC3;PSMB3;PSMD1
alpha,3,regulation of viral transcription (GO:0046782),5/41,5,41,0.0063352994889932,0.387345281920245,0,0,4.2124773579342,21.3219520242284,PSMC3;DHX9;NELFA;MID2;POLR2L
alpha,3,unsaturated fatty acid biosynthetic process (GO:0006636),3/15,3,15,0.0084696490215797,0.387345281920245,0,0,6.90846286701209,32.9621154335528,FADS3;DEGS1;DECR2
alpha,3,regulation of viral release from host cell (GO:1902186),4/26,4,26,0.00626305512340228,0.387345281920245,0,0,5.31420220539392,26.9594110484401,TSG101;TRIM28;VPS4A;MID2
alpha,3,internal peptidyl-lysine acetylation (GO:0018393),4/27,4,27,0.00718685070073275,0.387345281920245,0,0,5.11737990149044,25.2568398348554,BAG6;NAA50;MORF4L1;TEX30
alpha,3,positive regulation of transferase activity (GO:0051347),10/138,10,138,0.0069272670753911,0.387345281920245,0,0,2.5030662561638,12.445971077011,DDR1;VAC14;DSTYK;PNKP;DCUN1D1;AXIN1;MAPKAPK5;ROR1;RPS2;CCT4
alpha,3,regulation of establishment of cell polarity (GO:2000114),3/15,3,15,0.0084696490215797,0.387345281920245,0,0,6.90846286701209,32.9621154335528,RAP1B;ROCK2;KIF20B
alpha,3,snRNA processing (GO:0016180),4/27,4,27,0.00718685070073275,0.387345281920245,0,0,5.11737990149044,25.2568398348554,INTS1;INTS10;INTS7;INTS8
alpha,3,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),4/31,4,31,0.0117669349966679,0.396989380707256,0,0,4.45707281742715,19.8003757299977,CBFB;CNOT2;AXIN1;KCTD6
alpha,3,regulation of histone modification (GO:0031056),3/14,3,14,0.00692285180321473,0.387345281920245,0,0,7.4019245003701,36.8092337820543,FLCN;ZNHIT1;MTHFR
alpha,3,multivesicular body assembly (GO:0036258),4/31,4,31,0.0117669349966679,0.396989380707256,0,0,4.45707281742715,19.8003757299977,TSG101;VPS4A;RAB11A;VPS28
alpha,3,endoplasmic reticulum membrane organization (GO:0090158),2/6,2,6,0.0116155015857983,0.396989380707256,0,0,11.5141047783535,51.3001120250886,ATL1;RTN4
alpha,3,regulation of energy homeostasis (GO:2000505),3/16,3,16,0.0102029763417755,0.396989380707256,0,0,6.47668393782383,29.6960868072762,FLCN;PASK;PPARGC1A
alpha,3,regulation of establishment or maintenance of cell polarity (GO:0032878),3/17,3,17,0.012126826063099,0.402532387707382,0,0,6.09570252971655,26.8962831475521,RAP1B;ROCK2;KIF20B
alpha,3,regulation of hematopoietic stem cell differentiation (GO:1902036),7/77,7,77,0.00687944001846059,0.387345281920245,0,0,3.1402103940964,15.635792190344,PSMD9;PSMD11;CBFB;KMT2A;PSMC3;PSMB3;PSMD1
alpha,3,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),4/30,4,30,0.0104834816841171,0.396989380707256,0,0,4.60564191134139,20.9923059688925,HSF1;SESN2;HSF4;ATF3
alpha,3,monoubiquitinated protein deubiquitination (GO:0035520),2/6,2,6,0.0116155015857983,0.396989380707256,0,0,11.5141047783535,51.3001120250886,USP1;BAP1
alpha,3,regulation of bicellular tight junction assembly (GO:2000810),3/16,3,16,0.0102029763417755,0.396989380707256,0,0,6.47668393782383,29.6960868072762,TJP1;CBFB;ROCK2
alpha,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress (GO:0061408),2/6,2,6,0.0116155015857983,0.396989380707256,0,0,11.5141047783535,51.3001120250886,HSF1;HSF4
alpha,3,regulation of exosomal secretion (GO:1903541),3/16,3,16,0.0102029763417755,0.396989380707256,0,0,6.47668393782383,29.6960868072762,TSG101;VPS4A;RAB7A
alpha,3,positive regulation of RNA export from nucleus (GO:0046833),2/6,2,6,0.0116155015857983,0.396989380707256,0,0,11.5141047783535,51.3001120250886,KHDRBS1;DHX9
alpha,3,multivesicular body organization (GO:0036257),4/32,4,32,0.013146985471267,0.41991691595669,0,0,4.31778929188256,18.702775424728,TSG101;VPS4A;RAB11A;VPS28
alpha,3,regulation of stem cell differentiation (GO:2000736),7/89,7,89,0.0146909708206422,0.41991691595669,0,0,2.71681123983622,11.4663621612681,PSMD9;PSMD11;CBFB;KMT2A;PSMC3;PSMB3;PSMD1
alpha,3,DNA strand elongation involved in DNA replication (GO:0006271),3/16,3,16,0.0102029763417755,0.396989380707256,0,0,6.47668393782383,29.6960868072762,PARP3;LIG1;LIG3
alpha,3,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),3/18,3,18,0.0142443422955926,0.41991691595669,0,0,5.75705238917674,24.4755065227043,TSG101;VPS4A;VPS28
alpha,3,"DNA-templated transcription, elongation (GO:0006354)",8/109,8,109,0.0139135029481517,0.41991691595669,0,0,2.53521573101361,10.8377822573292,TWISTNB;ADRM1;LEO1;GTF2H1;RTF1;NELFA;CDK13;POLR2L
alpha,3,positive regulation of TOR signaling (GO:0032008),4/33,4,33,0.014625949220902,0.41991691595669,0,0,4.18694719212854,17.6896759678739,FLCN;WDR59;RHEB;RRAGD
alpha,3,phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),2/6,2,6,0.0116155015857983,0.396989380707256,0,0,11.5141047783535,51.3001120250886,GTF2H1;CDK13
alpha,3,positive regulation of ubiquitin-protein transferase activity (GO:0051443),4/32,4,32,0.013146985471267,0.41991691595669,0,0,4.31778929188256,18.702775424728,FZR1;DCUN1D1;AXIN1;RPS2
alpha,3,protein autoubiquitination (GO:0051865),5/50,5,50,0.0144976165940429,0.41991691595669,0,0,3.45423143350605,14.6244249253573,RNF213;RNF13;RNF181;STUB1;RNF187
alpha,3,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),7/88,7,88,0.0138701051008506,0.41991691595669,0,0,2.74768409483435,11.7546460471901,PSMD9;FZR1;PSMD11;PSMC3;PSMB3;AXIN1;PSMD1
alpha,3,cellular response to gamma radiation (GO:0071480),3/18,3,18,0.0142443422955926,0.41991691595669,0,0,5.75705238917674,24.4755065227043,XRCC6;HSF1;TLK2
alpha,3,cellular response to ionizing radiation (GO:0071479),5/47,5,47,0.0112605232782696,0.396989380707256,0,0,3.67471429096388,16.4864299600748,XRCC6;HSF1;TLK2;INTS7;GRB2
alpha,3,viral release from host cell (GO:0019076),2/6,2,6,0.0116155015857983,0.396989380707256,0,0,11.5141047783535,51.3001120250886,VPS4A;RAB7A
alpha,3,malate metabolic process (GO:0006108),2/7,2,7,0.0159519625776665,0.426352454348541,0,0,9.86923266716013,40.8405962171138,FH;MDH2
alpha,3,regulation of TOR signaling (GO:0032006),6/68,6,68,0.0137892319182243,0.41991691595669,0,0,3.04785126485828,13.0565903297441,FLCN;WDR59;RHEB;DGKQ;RRAGD;MAPKAPK5
alpha,3,positive regulation of nucleobase-containing compound transport (GO:0032241),2/6,2,6,0.0116155015857983,0.396989380707256,0,0,11.5141047783535,51.3001120250886,KHDRBS1;DHX9
alpha,3,protein localization to cytoplasmic stress granule (GO:1903608),2/7,2,7,0.0159519625776665,0.426352454348541,0,0,9.86923266716013,40.8405962171138,SSB;DHX9
alpha,3,exit from host cell (GO:0035891),2/7,2,7,0.0159519625776665,0.426352454348541,0,0,9.86923266716013,40.8405962171138,VPS4A;RAB7A
alpha,3,snRNA transcription from RNA polymerase II promoter (GO:0042795),6/71,6,71,0.0167911691516386,0.43096938952568,0,0,2.91906881704736,11.92994870177,INTS1;INTS10;NABP1;INTS7;INTS8;POLR2L
alpha,3,response to misfolded protein (GO:0051788),2/7,2,7,0.0159519625776665,0.426352454348541,0,0,9.86923266716013,40.8405962171138,DNAJB12;STUB1
alpha,3,cellular response to copper ion (GO:0071280),3/21,3,21,0.0217788224055737,0.43096938952568,0,0,4.93461633358006,18.8838748119189,PRNP;HSF1;MT1X
alpha,3,snRNA transcription (GO:0009301),6/71,6,71,0.0167911691516386,0.43096938952568,0,0,2.91906881704736,11.92994870177,INTS1;INTS10;NABP1;INTS7;INTS8;POLR2L
alpha,3,AV node cell action potential (GO:0086016),2/7,2,7,0.0159519625776665,0.426352454348541,0,0,9.86923266716013,40.8405962171138,CACNB2;CACNA1C
alpha,3,cellular response to misfolded protein (GO:0071218),3/21,3,21,0.0217788224055737,0.43096938952568,0,0,4.93461633358006,18.8838748119189,BAG6;DNAJB12;STUB1
alpha,3,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",3/21,3,21,0.0217788224055737,0.43096938952568,0,0,4.93461633358006,18.8838748119189,XPA;GTF2H1;RBX1
alpha,3,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),6/72,6,72,0.0178843767473309,0.43096938952568,0,0,2.87852619458837,11.5826935943157,PSMD9;FZR1;PSMD11;PSMC3;PSMB3;PSMD1
alpha,3,establishment of endothelial barrier (GO:0061028),3/21,3,21,0.0217788224055737,0.43096938952568,0,0,4.93461633358006,18.8838748119189,TJP1;RAP1B;PDE2A
alpha,3,positive regulation of canonical Wnt signaling pathway (GO:0090263),8/114,8,114,0.0178105793964725,0.43096938952568,0,0,2.42402205860073,9.76387031511693,PSMD9;PSMD11;PSMC3;PSMB3;AXIN1;PSMD1;FAM53B;CCAR2
alpha,3,positive regulation of translational initiation (GO:0045948),3/21,3,21,0.0217788224055737,0.43096938952568,0,0,4.93461633358006,18.8838748119189,EIF2B5;KHDRBS1;YTHDF3
alpha,3,ribosome disassembly (GO:0032790),2/8,2,8,0.0208651617964824,0.43096938952568,0,0,8.63557858376511,33.4168774656674,PELO;MRRF
alpha,3,regulation of cytoskeleton organization (GO:0051493),7/96,7,96,0.0214286798612092,0.43096938952568,0,0,2.51871042026482,9.67946729862897,CLIC4;TRAF3IP1;ROCK2;CDK10;TRIM36;RHOF;RHOBTB1
alpha,3,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",6/76,6,76,0.0227438199710897,0.445778871433359,0,0,2.72702481592583,10.3175942735507,PDIA3;PSMD9;PSMD11;PSMC3;PSMB3;PSMD1
alpha,3,positive regulation of kinase activity (GO:0033674),8/114,8,114,0.0178105793964725,0.43096938952568,0,0,2.42402205860073,9.76387031511693,DDR1;VAC14;XRCC6;DSTYK;RPLP1;ROR1;TAB2;IQGAP1
alpha,3,viral budding via host ESCRT complex (GO:0039702),3/21,3,21,0.0217788224055737,0.43096938952568,0,0,4.93461633358006,18.8838748119189,TSG101;VPS4A;VPS28
alpha,3,positive regulation of mRNA 3'-end processing (GO:0031442),2/8,2,8,0.0208651617964824,0.43096938952568,0,0,8.63557858376511,33.4168774656674,HSF1;LEO1
alpha,3,transcription elongation from RNA polymerase II promoter (GO:0006368),7/96,7,96,0.0214286798612092,0.43096938952568,0,0,2.51871042026482,9.67946729862897,ADRM1;LEO1;GTF2H1;NELFA;RTF1;CDK13;POLR2L
alpha,3,protein localization to microtubule cytoskeleton (GO:0072698),2/8,2,8,0.0208651617964824,0.43096938952568,0,0,8.63557858376511,33.4168774656674,KIF20B;MID2
alpha,3,insulin metabolic process (GO:1901142),2/8,2,8,0.0208651617964824,0.43096938952568,0,0,8.63557858376511,33.4168774656674,CPD;IDE
alpha,3,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),6/73,6,73,0.0190253878704867,0.43096938952568,0,0,2.83909432890908,11.2484377543661,PSMD9;FZR1;PSMD11;PSMC3;PSMB3;PSMD1
alpha,3,viral budding (GO:0046755),3/23,3,23,0.0277947515325594,0.446887489484432,0,0,4.50551926109484,16.1428613196763,TSG101;VPS4A;VPS28
alpha,3,anaphase-promoting complex-dependent catabolic process (GO:0031145),6/80,6,80,0.0284204644232644,0.449917813715985,0,0,2.59067357512953,9.22447102337539,PSMD9;FZR1;PSMD11;PSMC3;PSMB3;PSMD1
alpha,3,regulation of ATP biosynthetic process (GO:2001169),2/8,2,8,0.0208651617964824,0.43096938952568,0,0,8.63557858376511,33.4168774656674,FLCN;PPARGC1A
alpha,3,maturation of LSU-rRNA (GO:0000470),3/23,3,23,0.0277947515325594,0.446887489484432,0,0,4.50551926109484,16.1428613196763,BOP1;RPL7A;RPL35
alpha,3,negative regulation of mitotic cell cycle phase transition (GO:1901991),6/80,6,80,0.0284204644232644,0.449917813715985,0,0,2.59067357512953,9.22447102337539,PSMD9;PSMD11;PSMC3;PSMB3;PSMD1;RBX1
alpha,3,histone H3-K4 trimethylation (GO:0080182),2/9,2,9,0.0263181899542443,0.446887489484432,0,0,7.67606985223566,27.9216652897734,KMT2A;BEND3
alpha,3,Rho protein signal transduction (GO:0007266),6/73,6,73,0.0190253878704867,0.43096938952568,0,0,2.83909432890908,11.2484377543661,GNA13;RHOT1;ARHGAP1;TAX1BP3;RHOF;RHOBTB1
alpha,3,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",3/23,3,23,0.0277947515325594,0.446887489484432,0,0,4.50551926109484,16.1428613196763,COPS5;XPA;RBX1
alpha,3,protein localization to microtubule (GO:0035372),2/8,2,8,0.0208651617964824,0.43096938952568,0,0,8.63557858376511,33.4168774656674,KIF20B;MID2
alpha,3,cellular response to leucine (GO:0071233),2/9,2,9,0.0263181899542443,0.446887489484432,0,0,7.67606985223566,27.9216652897734,RRAGD;SESN2
alpha,3,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),6/79,6,79,0.0269220949121852,0.446887489484432,0,0,2.62346691152358,9.48332906752987,PDIA3;PSMD9;PSMD11;PSMC3;PSMB3;PSMD1
alpha,3,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),6/77,6,77,0.0240844736916091,0.446887489484432,0,0,2.69160890922549,10.0294405255691,PSMD9;FZR1;PSMD11;PSMC3;PSMB3;PSMD1
alpha,3,protein K48-linked deubiquitination (GO:0071108),3/23,3,23,0.0277947515325594,0.446887489484432,0,0,4.50551926109484,16.1428613196763,USP25;USP37;BAP1
alpha,3,viral genome replication (GO:0019079),3/22,3,22,0.0246874775736143,0.446887489484432,0,0,4.71031559114461,17.4350407194148,NFIA;ROCK2;CTBP1
alpha,3,peptidyl-amino acid modification (GO:0018193),2/9,2,9,0.0263181899542443,0.446887489484432,0,0,7.67606985223566,27.9216652897734,PDF;TTLL4
alpha,3,desmosome organization (GO:0002934),2/8,2,8,0.0208651617964824,0.43096938952568,0,0,8.63557858376511,33.4168774656674,PERP;PRKCA
alpha,3,positive regulation of translation (GO:0045727),6/79,6,79,0.0269220949121852,0.446887489484432,0,0,2.62346691152358,9.48332906752987,EIF2B5;RPL5;KHDRBS1;YTHDF3;DHX9;PASK
alpha,3,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),3/23,3,23,0.0277947515325594,0.446887489484432,0,0,4.50551926109484,16.1428613196763,AXIN1;LEO1;RTF1
alpha,3,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",3/22,3,22,0.0246874775736143,0.446887489484432,0,0,4.71031559114461,17.4350407194148,XPA;GTF2H1;RBX1
alpha,3,positive regulation of proteasomal protein catabolic process (GO:1901800),6/74,6,74,0.0202150748871356,0.43096938952568,0,0,2.80072818932923,10.9265555842689,BAG6;TMEM259;RFWD2;ARIH2;STUB1;RBX1
alpha,3,phosphate ion transmembrane transport (GO:0035435),2/8,2,8,0.0208651617964824,0.43096938952568,0,0,8.63557858376511,33.4168774656674,SLC20A1;SLC25A10
alpha,3,regulation of amyloid precursor protein catabolic process (GO:1902991),2/8,2,8,0.0208651617964824,0.43096938952568,0,0,8.63557858376511,33.4168774656674,PRNP;ROCK2
alpha,3,endodermal cell fate commitment (GO:0001711),2/8,2,8,0.0208651617964824,0.43096938952568,0,0,8.63557858376511,33.4168774656674,LEO1;RTF1
alpha,3,regulation of protein deacetylation (GO:0090311),2/8,2,8,0.0208651617964824,0.43096938952568,0,0,8.63557858376511,33.4168774656674,ZNHIT1;CCAR2
alpha,3,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",3/22,3,22,0.0246874775736143,0.446887489484432,0,0,4.71031559114461,17.4350407194148,XPA;GTF2H1;RBX1
alpha,3,regulation of cytokinesis (GO:0032465),6/78,6,78,0.0254769927564958,0.446887489484432,0,0,2.65710110269696,9.75150652033726,FLCN;CSPP1;VPS4A;KLHL21;KIF20B;RAB11A
alpha,3,small RNA loading onto RISC (GO:0070922),2/9,2,9,0.0263181899542443,0.446887489484432,0,0,7.67606985223566,27.9216652897734,AGO3;DHX9
alpha,3,poly-N-acetyllactosamine biosynthetic process (GO:0030311),2/9,2,9,0.0263181899542443,0.446887489484432,0,0,7.67606985223566,27.9216652897734,B3GNT9;B3GNT2
alpha,3,homocysteine metabolic process (GO:0050667),2/9,2,9,0.0263181899542443,0.446887489484432,0,0,7.67606985223566,27.9216652897734,MTHFR;BLMH
alpha,3,response to leucine (GO:0043201),2/9,2,9,0.0263181899542443,0.446887489484432,0,0,7.67606985223566,27.9216652897734,RRAGD;SESN2
alpha,3,protein polyglutamylation (GO:0018095),2/9,2,9,0.0263181899542443,0.446887489484432,0,0,7.67606985223566,27.9216652897734,TTLL5;TTLL4
alpha,3,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",2/9,2,9,0.0263181899542443,0.446887489484432,0,0,7.67606985223566,27.9216652897734,BOP1;RPL35
alpha,3,response to light stimulus (GO:0009416),5/59,5,59,0.0277723347245437,0.446887489484432,0,0,2.92731477415767,10.4906615953082,MSH6;CRY2;USP1;DTL;CCAR2
alpha,3,cholesterol efflux (GO:0033344),3/23,3,23,0.0277947515325594,0.446887489484432,0,0,4.50551926109484,16.1428613196763,APOM;ABCA5;ABCG2
alpha,3,ERBB signaling pathway (GO:0038127),6/81,6,81,0.0299727513929535,0.467302442171956,0,0,2.55868995074522,8.97451953422638,REPS2;PLCE1;PRKCA;GRB2;STUB1;IQGAP1
alpha,3,NIK/NF-kappaB signaling (GO:0038061),6/81,6,81,0.0299727513929535,0.467302442171956,0,0,2.55868995074522,8.97451953422638,PSMD9;PSMD11;PSMC3;FBXW11;PSMB3;PSMD1
alpha,3,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),4/41,4,41,0.0302363597880949,0.467867883036837,0,0,3.36998188634736,11.790589704013,TSG101;ITGA1;GRB2;RAB7A
alpha,3,cellular biogenic amine metabolic process (GO:0006576),2/10,2,10,0.0322757850504108,0.480392824706307,0,0,6.90846286701209,23.7197790587393,OAZ1;SRM
alpha,3,regulation of DNA damage checkpoint (GO:2000001),2/10,2,10,0.0322757850504108,0.480392824706307,0,0,6.90846286701209,23.7197790587393,FEM1B;CCAR2
alpha,3,neuron projection fasciculation (GO:0106030),2/10,2,10,0.0322757850504108,0.480392824706307,0,0,6.90846286701209,23.7197790587393,CNTN4;RTN4
alpha,3,cellular response to leucine starvation (GO:1990253),2/10,2,10,0.0322757850504108,0.480392824706307,0,0,6.90846286701209,23.7197790587393,RRAGD;SESN2
alpha,3,poly-N-acetyllactosamine metabolic process (GO:0030309),2/10,2,10,0.0322757850504108,0.480392824706307,0,0,6.90846286701209,23.7197790587393,B3GNT9;B3GNT2
alpha,3,regulation of cholesterol metabolic process (GO:0090181),4/42,4,42,0.0326797839936264,0.480392824706307,0,0,3.28974422238671,11.25421044084,MBTPS1;NFYC;DGKQ;PMVK
alpha,3,DNA duplex unwinding (GO:0032508),4/42,4,42,0.0326797839936264,0.480392824706307,0,0,3.28974422238671,11.25421044084,DHX9;XPA;GTF2H1;RBX1
alpha,3,positive regulation of ubiquitin protein ligase activity (GO:1904668),6/83,6,83,0.033241503453075,0.485184497208712,0,0,2.49703477120919,8.49979669088166,PSMD9;FZR1;PSMD11;PSMC3;PSMB3;PSMD1
alpha,3,regulation of mRNA stability (GO:0043488),8/129,8,129,0.0341020631331492,0.494239760056486,0,0,2.14215902853088,7.23706447970325,PSMD9;PSMD11;YTHDF3;PSMC3;PSMB3;PSMD1;PRKCA;TNPO1
alpha,3,histone mRNA metabolic process (GO:0008334),3/25,3,25,0.0346014110615445,0.494511833087906,0,0,4.14507772020725,13.9434645207232,SSB;PAPD5;SNRPF
alpha,3,cellular modified amino acid biosynthetic process (GO:0042398),3/25,3,25,0.0346014110615445,0.494511833087906,0,0,4.14507772020725,13.9434645207232,PTDSS1;GATM;PLOD3
alpha,3,response to endoplasmic reticulum stress (GO:0034976),7/107,7,107,0.0359110035238967,0.509688587946065,0,0,2.25977757332171,7.51762809847755,PDIA3;BAG6;EIF2B5;MBTPS1;TMEM259;DNAJB12;ATF3
alpha,3,response to copper ion (GO:0046688),3/26,3,26,0.0382977241446441,0.524035420616417,0,0,3.98565165404544,13.002649686616,PRNP;HSF1;MT1X
alpha,3,negative regulation of locomotion (GO:0040013),3/26,3,26,0.0382977241446441,0.524035420616417,0,0,3.98565165404544,13.002649686616,FRMD5;TRIM28;MID2
alpha,3,peptidyl-tyrosine dephosphorylation (GO:0035335),3/26,3,26,0.0382977241446441,0.524035420616417,0,0,3.98565165404544,13.002649686616,PTPN9;DUSP18;DUSP14
alpha,3,regulation of histone deacetylation (GO:0031063),2/11,2,11,0.0387042681893563,0.524035420616417,0,0,6.28042078819281,20.42270620755,ZNHIT1;CTBP1
alpha,3,regulation of non-canonical Wnt signaling pathway (GO:2000050),2/11,2,11,0.0387042681893563,0.524035420616417,0,0,6.28042078819281,20.42270620755,RNF213;ZNRF3
alpha,3,internal protein amino acid acetylation (GO:0006475),2/11,2,11,0.0387042681893563,0.524035420616417,0,0,6.28042078819281,20.42270620755,BAG6;MDH2
alpha,3,histone mRNA catabolic process (GO:0071044),2/11,2,11,0.0387042681893563,0.524035420616417,0,0,6.28042078819281,20.42270620755,SSB;PAPD5
alpha,3,cellular response to hypoxia (GO:0071456),8/133,8,133,0.0397453691542199,0.53290273321175,0,0,2.07773319308634,6.70123379730834,PSMD9;PSMD11;PSMC3;EPAS1;PSMB3;PSMD1;STUB1;RBX1
alpha,3,inorganic anion transmembrane transport (GO:0098661),5/65,5,65,0.0398770752743486,0.53290273321175,0,0,2.65710110269696,8.56105666197323,CLCN6;CLIC4;SLC20A1;SLC25A10;SLC12A6
alpha,3,cholesterol transport (GO:0030301),4/45,4,45,0.0406842452458466,0.536719081512515,0,0,3.07042794089426,9.83124730353705,APOM;ABCA5;VPS4A;ABCG2
alpha,3,regulation of steroid biosynthetic process (GO:0050810),4/45,4,45,0.0406842452458466,0.536719081512515,0,0,3.07042794089426,9.83124730353705,MBTPS1;NFYC;DGKQ;PMVK
alpha,3,response to gamma radiation (GO:0010332),3/27,3,27,0.0421865890532662,0.538595895961298,0,0,3.83803492611783,12.1498864071924,XRCC6;HSF1;TLK2
alpha,3,macroautophagy (GO:0016236),7/111,7,111,0.0424720448610533,0.538595895961298,0,0,2.17834414725606,6.88119134019784,TSG101;VPS33A;VPS4A;ATG4B;PGAM5;WIPI2;VPS28
alpha,3,negative regulation of translation (GO:0017148),6/89,6,89,0.0443983619333183,0.538595895961298,0,0,2.32869534843104,7.25284439335919,ZNF540;ILF3;YTHDF3;DAPK1;CNOT2;PAIP2
alpha,3,axonal fasciculation (GO:0007413),2/12,2,12,0.0455714817544802,0.538595895961298,0,0,5.75705238917674,17.7805017744794,CNTN4;RTN4
alpha,3,signal transduction involved in G2 DNA damage checkpoint (GO:0072425),2/12,2,12,0.0455714817544802,0.538595895961298,0,0,5.75705238917674,17.7805017744794,FZR1;DTL
alpha,3,regulation of inclusion body assembly (GO:0090083),2/12,2,12,0.0455714817544802,0.538595895961298,0,0,5.75705238917674,17.7805017744794,BAG5;DNAJA4
alpha,3,negative regulation of ERAD pathway (GO:1904293),2/12,2,12,0.0455714817544802,0.538595895961298,0,0,5.75705238917674,17.7805017744794,USP25;UBE2J1
alpha,3,carbohydrate derivative transport (GO:1901264),2/12,2,12,0.0455714817544802,0.538595895961298,0,0,5.75705238917674,17.7805017744794,SLC25A19;SLC29A1
alpha,3,cellular response to arsenic-containing substance (GO:0071243),2/12,2,12,0.0455714817544802,0.538595895961298,0,0,5.75705238917674,17.7805017744794,HSF1;ATF3
alpha,3,regulation of actomyosin structure organization (GO:0110020),2/12,2,12,0.0455714817544802,0.538595895961298,0,0,5.75705238917674,17.7805017744794,AKAP13;ROCK2
alpha,3,"alternative mRNA splicing, via spliceosome (GO:0000380)",2/12,2,12,0.0455714817544802,0.538595895961298,0,0,5.75705238917674,17.7805017744794,DHX9;CDK13
alpha,3,polyamine metabolic process (GO:0006595),2/12,2,12,0.0455714817544802,0.538595895961298,0,0,5.75705238917674,17.7805017744794,OAZ1;SRM
alpha,3,prostanoid metabolic process (GO:0006692),2/12,2,12,0.0455714817544802,0.538595895961298,0,0,5.75705238917674,17.7805017744794,PTGR2;CES2
alpha,3,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),3/28,3,28,0.0462654411697103,0.538595895961298,0,0,3.70096225018505,11.3743893694105,CBFB;AXIN1;KCTD6
alpha,3,peptidyl-glutamic acid modification (GO:0018200),3/28,3,28,0.0462654411697103,0.538595895961298,0,0,3.70096225018505,11.3743893694105,AGBL5;TTLL5;TTLL4
alpha,3,phagosome acidification (GO:0090383),3/28,3,28,0.0462654411697103,0.538595895961298,0,0,3.70096225018505,11.3743893694105,ATP6V1A;ATP6V0E1;RAB7A
alpha,3,microtubule polymerization (GO:0046785),3/28,3,28,0.0462654411697103,0.538595895961298,0,0,3.70096225018505,11.3743893694105,NDE1;ZNF207;TUBG1
alpha,3,protein targeting to vacuole (GO:0006623),3/28,3,28,0.0462654411697103,0.538595895961298,0,0,3.70096225018505,11.3743893694105,VPS4A;VPS13A;RAB7A
alpha,3,cellular response to topologically incorrect protein (GO:0035967),3/28,3,28,0.0462654411697103,0.538595895961298,0,0,3.70096225018505,11.3743893694105,HSF1;DNAJB12;STUB1
alpha,3,negative regulation of cellular protein metabolic process (GO:0032269),6/90,6,90,0.046459254761712,0.538595895961298,0,0,2.3028209556707,7.06777108162715,BAG6;ZNF540;RGP1;ILF3;DAPK1;CNOT2
alpha,3,protein complex disassembly (GO:0043241),4/47,4,47,0.0465840959577799,0.538595895961298,0,0,2.9397714327711,9.01479758810085,TSG101;VPS33A;VPS4A;AXIN1
alpha,3,regulation of DNA metabolic process (GO:0051052),4/47,4,47,0.0465840959577799,0.538595895961298,0,0,2.9397714327711,9.01479758810085,USP37;SMG1;USP1;RBBP6
alpha,3,regulation of cell cycle process (GO:0010564),6/91,6,91,0.0485785764040841,0.550187942622338,0,0,2.27751523088311,6.88851030004861,FLCN;KLHL21;TXLNG;KIF20B;CDK13;RAB11A
alpha,3,histone H4 acetylation (GO:0043967),4/48,4,48,0.0497027931750778,0.550187942622338,0,0,2.87852619458837,8.64045522957099,MORF4L1;KMT2A;EP400;BEND3
alpha,3,regulation of TORC1 signaling (GO:1903432),3/29,3,29,0.0505313673718577,0.550187942622338,0,0,3.57334286224763,10.6670037500432,DGKQ;SESN2;RRAGD
alpha,3,transcription elongation from RNA polymerase I promoter (GO:0006362),3/29,3,29,0.0505313673718577,0.550187942622338,0,0,3.57334286224763,10.6670037500432,TWISTNB;GTF2H1;POLR2L
alpha,3,protein-DNA complex assembly (GO:0065004),6/92,6,92,0.0507565722577301,0.550187942622338,0,0,2.25275963054742,6.71483254523453,BRD2;XPA;GTF2H1;ANP32B;RBX1;NAP1L4
alpha,3,regulation of small GTPase mediated signal transduction (GO:0051056),8/141,8,141,0.0528222920480786,0.550187942622338,0,0,1.9598476218474,5.76356296278022,GNA13;AKAP13;FGD4;RHOT1;ARHGAP1;PLCE1;RHOF;RHOBTB1
alpha,3,positive regulation of Wnt signaling pathway (GO:0030177),8/141,8,141,0.0528222920480786,0.550187942622338,0,0,1.9598476218474,5.76356296278022,PSMD9;PSMD11;PSMC3;PSMB3;AXIN1;PSMD1;FAM53B;CCAR2
alpha,3,signal transduction involved in DNA damage checkpoint (GO:0072422),2/13,2,13,0.0528467298047009,0.550187942622338,0,0,5.31420220539392,15.6256646499365,FZR1;DTL
alpha,3,atrial cardiac muscle cell action potential (GO:0086014),2/13,2,13,0.0528467298047009,0.550187942622338,0,0,5.31420220539392,15.6256646499365,CACNB2;CACNA1C
alpha,3,regulation of viral life cycle (GO:1903900),2/13,2,13,0.0528467298047009,0.550187942622338,0,0,5.31420220539392,15.6256646499365,TSG101;VPS4A
alpha,3,regulation of DNA-templated transcription in response to stress (GO:0043620),2/13,2,13,0.0528467298047009,0.550187942622338,0,0,5.31420220539392,15.6256646499365,HSF1;HSF4
alpha,3,phosphate ion transport (GO:0006817),2/13,2,13,0.0528467298047009,0.550187942622338,0,0,5.31420220539392,15.6256646499365,SLC20A1;SLC25A10
alpha,3,negative regulation of viral release from host cell (GO:1902187),2/13,2,13,0.0528467298047009,0.550187942622338,0,0,5.31420220539392,15.6256646499365,TRIM28;MID2
alpha,3,protein neddylation (GO:0045116),2/13,2,13,0.0528467298047009,0.550187942622338,0,0,5.31420220539392,15.6256646499365,DCUN1D1;RBX1
alpha,3,positive regulation of ERAD pathway (GO:1904294),2/13,2,13,0.0528467298047009,0.550187942622338,0,0,5.31420220539392,15.6256646499365,BAG6;TMEM259
alpha,3,nucleotide metabolic process (GO:0009117),2/13,2,13,0.0528467298047009,0.550187942622338,0,0,5.31420220539392,15.6256646499365,PNKP;PDE8A
alpha,3,diacylglycerol metabolic process (GO:0046339),2/13,2,13,0.0528467298047009,0.550187942622338,0,0,5.31420220539392,15.6256646499365,DGKQ;PLCE1
alpha,3,negative regulation of ubiquitin-protein transferase activity (GO:0051444),2/13,2,13,0.0528467298047009,0.550187942622338,0,0,5.31420220539392,15.6256646499365,RPL5;BAG5
alpha,3,ribonucleoprotein complex disassembly (GO:0032988),2/13,2,13,0.0528467298047009,0.550187942622338,0,0,5.31420220539392,15.6256646499365,PELO;MRRF
alpha,3,cytoplasmic microtubule organization (GO:0031122),4/49,4,49,0.0529335338383008,0.550187942622338,0,0,2.81978076204575,8.28654113275434,VPS4A;AXIN1;WDR73;RAB11A
alpha,3,regulation of macroautophagy (GO:0016241),7/117,7,117,0.0536884149417625,0.555229939447976,0,0,2.06663419098652,6.04399163360347,ATP6V1A;ATP6V0E1;RHEB;SESN2;RRAGD;GBA;QSOX1
alpha,3,double-strand break repair (GO:0006302),8/142,8,142,0.0546296485087132,0.562139083154659,0,0,1.94604587803157,5.6575027962332,DCLRE1A;MORF4L1;XRCC6;PARP3;EME2;NABP1;LIG3;ZSWIM7
alpha,3,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",3/30,3,30,0.0549811379014964,0.562941202991441,0,0,3.45423143350605,10.0199139889984,XPA;GTF2H1;RBX1
alpha,3,histone acetylation (GO:0016573),5/72,5,72,0.0574978295770439,0.583119841898079,0,0,2.39877182882364,6.85091172130456,NAA50;MORF4L1;TEX30;EP400;BEND3
alpha,3,cellular response to fibroblast growth factor stimulus (GO:0044344),6/95,6,95,0.0576444906133637,0.583119841898079,0,0,2.18161985274066,6.22516630041047,FIBP;DSTYK;HNRNPH1;GRB2;FGF22;POLR2L
alpha,3,cytosolic transport (GO:0016482),7/119,7,119,0.0578019668353781,0.583119841898079,0,0,2.03190084323885,5.7924057209977,SPAG9;RGP1;SNX1;DENND2A;VPS13A;RILP;RAB7A
alpha,3,activation of JUN kinase activity (GO:0007257),3/31,3,31,0.0596112364098083,0.584556258568137,0,0,3.34280461307037,9.4264121421178,SPAG9;AXIN1;MAP4K5
alpha,3,cell-cell junction organization (GO:0045216),5/73,5,73,0.0603266880385911,0.584556258568137,0,0,2.36591194075757,6.64343503314024,TJP1;FLCN;CADM1;PERP;CTNNA1
alpha,3,regulation of neuron death (GO:1901214),5/73,5,73,0.0603266880385911,0.584556258568137,0,0,2.36591194075757,6.64343503314024,PRNP;GBA;RRAS2;DHCR24;PPARGC1A
alpha,3,establishment or maintenance of actin cytoskeleton polarity (GO:0030950),2/14,2,14,0.0605007206389763,0.584556258568137,0,0,4.93461633358006,13.8420922902948,RHOF;RHOBTB1
alpha,3,endoplasmic reticulum tubular network organization (GO:0071786),2/14,2,14,0.0605007206389763,0.584556258568137,0,0,4.93461633358006,13.8420922902948,ATL1;RTN4
alpha,3,regulation of defense response to virus (GO:0050688),2/14,2,14,0.0605007206389763,0.584556258568137,0,0,4.93461633358006,13.8420922902948,DHX9;TRAF3IP1
alpha,3,regulation of transferase activity (GO:0051338),2/14,2,14,0.0605007206389763,0.584556258568137,0,0,4.93461633358006,13.8420922902948,BAG5;FEM1B
alpha,3,negative regulation of T cell receptor signaling pathway (GO:0050860),2/14,2,14,0.0605007206389763,0.584556258568137,0,0,4.93461633358006,13.8420922902948,PRNP;PHPT1
alpha,3,response to ATP (GO:0033198),2/14,2,14,0.0605007206389763,0.584556258568137,0,0,4.93461633358006,13.8420922902948,P2RX4;DGKQ
alpha,3,negative regulation of growth (GO:0045926),7/121,7,121,0.062105217839717,0.595873138171431,0,0,1.99831570533408,5.55317001176729,ST7L;FLCN;GNG4;SESN2;MT1X;CCAR2;RTN4
alpha,3,peptidyl-serine phosphorylation (GO:0018105),8/146,8,146,0.062251081004304,0.595873138171431,0,0,1.89272955260605,5.25531384438377,SMG1;ROCK2;DGKQ;TLK2;PRKCA;MAPKAPK5;TOP1;HIPK3
alpha,3,regulation of telomere maintenance via telomerase (GO:0032210),4/52,4,52,0.0632920866211094,0.603032936417792,0,0,2.65710110269696,7.3335856822942,PAPD5;PNKP;MAPKAPK5;CCT4
alpha,3,stimulatory C-type lectin receptor signaling pathway (GO:0002223),7/122,7,122,0.0643282547141164,0.605351662319276,0,0,1.98193606840511,5.43794962170605,PSMD9;PSMD11;PSMC3;FBXW11;PSMB3;PSMD1;TAB2
alpha,3,positive regulation of protein dephosphorylation (GO:0035307),3/32,3,32,0.0644178882642961,0.605351662319276,0,0,3.23834196891192,8.8807121643883,PPP1R7;GBA;ITGA1
alpha,3,termination of RNA polymerase I transcription (GO:0006363),3/32,3,32,0.0644178882642961,0.605351662319276,0,0,3.23834196891192,8.8807121643883,TWISTNB;GTF2H1;POLR2L
alpha,3,cellular response to organonitrogen compound (GO:0071417),6/98,6,98,0.0650656802760473,0.605905746643011,0,0,2.11483557153431,5.77848800566366,RAP1B;P2RX4;SESN2;RRAGD;PDE2A;CTNNA1
alpha,3,protein localization to organelle (GO:0033365),6/98,6,98,0.0650656802760473,0.605905746643011,0,0,2.11483557153431,5.77848800566366,SSB;DHX9;TOLLIP;XPA;RAB11A;GET4
alpha,3,regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),5/75,5,75,0.0662175492209906,0.610338485237544,0,0,2.3028209556707,6.25172079953415,GRK4;GNG4;DGKQ;NMT1;PLCE1
alpha,3,negative regulation of canonical Wnt signaling pathway (GO:0090090),8/149,8,149,0.0683822892021938,0.610338485237544,0,0,1.85462090389586,4.97528285087545,PSMD9;PSMD11;ZNRF3;PSMC3;PSMB3;AXIN1;PSMD1;RBX1
alpha,3,selective autophagy (GO:0061912),2/15,2,15,0.0685055114402104,0.610338485237544,0,0,4.60564191134139,12.3469940263417,WDFY3;RAB7A
alpha,3,positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),2/15,2,15,0.0685055114402104,0.610338485237544,0,0,4.60564191134139,12.3469940263417,LEO1;RTF1
alpha,3,negative regulation of interleukin-2 production (GO:0032703),2/15,2,15,0.0685055114402104,0.610338485237544,0,0,4.60564191134139,12.3469940263417,PRNP;HDAC7
alpha,3,positive regulation of viral release from host cell (GO:1902188),2/15,2,15,0.0685055114402104,0.610338485237544,0,0,4.60564191134139,12.3469940263417,TSG101;VPS4A
alpha,3,negative regulation of DNA-dependent DNA replication (GO:2000104),2/15,2,15,0.0685055114402104,0.610338485237544,0,0,4.60564191134139,12.3469940263417,GMNN;LIG3
alpha,3,regulation of RNA export from nucleus (GO:0046831),2/15,2,15,0.0685055114402104,0.610338485237544,0,0,4.60564191134139,12.3469940263417,KHDRBS1;DHX9
alpha,3,negative regulation of cellular amide metabolic process (GO:0034249),5/76,5,76,0.0692790818213847,0.610338485237544,0,0,2.27252067993819,6.0667490863815,ZNF540;PRNP;ILF3;DAPK1;CNOT2
alpha,3,regulation of actin cytoskeleton organization (GO:0032956),5/76,5,76,0.0692790818213847,0.610338485237544,0,0,2.27252067993819,6.0667490863815,ROCK2;CDK10;RHOF;PHPT1;RHOBTB1
alpha,3,phagosome maturation (GO:0090382),3/33,3,33,0.0693970872427528,0.610338485237544,0,0,3.1402103940964,8.37779991494957,ATP6V1A;ATP6V0E1;RAB7A
alpha,3,positive regulation of telomere maintenance via telomerase (GO:0032212),3/33,3,33,0.0693970872427528,0.610338485237544,0,0,3.1402103940964,8.37779991494957,PNKP;MAPKAPK5;CCT4
alpha,3,global genome nucleotide-excision repair (GO:0070911),3/33,3,33,0.0693970872427528,0.610338485237544,0,0,3.1402103940964,8.37779991494957,XPA;GTF2H1;RBX1
alpha,3,innate immune response activating cell surface receptor signaling pathway (GO:0002220),7/125,7,125,0.0712837656318273,0.624263785831066,0,0,1.93436960276339,5.10883776978223,PSMD9;PSMD11;PSMC3;FBXW11;PSMB3;PSMD1;TAB2
alpha,3,intracellular pH reduction (GO:0051452),3/34,3,34,0.0745446205824976,0.63656775584556,0,0,3.04785126485828,7.9133111822394,ATP6V1A;ATP6V0E1;RAB7A
alpha,3,platelet aggregation (GO:0070527),3/34,3,34,0.0745446205824976,0.63656775584556,0,0,3.04785126485828,7.9133111822394,FIBP;STXBP1;ACTG1
alpha,3,transcription initiation from RNA polymerase I promoter (GO:0006361),3/34,3,34,0.0745446205824976,0.63656775584556,0,0,3.04785126485828,7.9133111822394,TWISTNB;GTF2H1;POLR2L
alpha,3,transcription from RNA polymerase I promoter (GO:0006360),3/34,3,34,0.0745446205824976,0.63656775584556,0,0,3.04785126485828,7.9133111822394,TWISTNB;GTF2H1;POLR2L
alpha,3,positive regulation of nucleocytoplasmic transport (GO:0046824),3/34,3,34,0.0745446205824976,0.63656775584556,0,0,3.04785126485828,7.9133111822394,KHDRBS1;DHX9;ANP32B
alpha,3,positive regulation of locomotion (GO:0040017),3/34,3,34,0.0745446205824976,0.63656775584556,0,0,3.04785126485828,7.9133111822394,TSG101;VPS4A;PHPT1
alpha,3,ERAD pathway (GO:0036503),5/78,5,78,0.0756327109158926,0.637602049514212,0,0,2.21425091891413,5.71690006045958,BAG6;PSMC3;DNAJB12;GET4;UBE2J1
alpha,3,protein transport along microtubule (GO:0098840),2/16,2,16,0.076834454946319,0.637602049514212,0,0,4.31778929188256,11.0798882008648,ICK;TRAF3IP1
alpha,3,histone H2A acetylation (GO:0043968),2/16,2,16,0.076834454946319,0.637602049514212,0,0,4.31778929188256,11.0798882008648,MORF4L1;EP400
alpha,3,regulation of steroid metabolic process (GO:0019218),2/16,2,16,0.076834454946319,0.637602049514212,0,0,4.31778929188256,11.0798882008648,DGKQ;STUB1
alpha,3,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),2/16,2,16,0.076834454946319,0.637602049514212,0,0,4.31778929188256,11.0798882008648,DTL;RAB11A
alpha,3,regulation of stem cell proliferation (GO:0072091),2/16,2,16,0.076834454946319,0.637602049514212,0,0,4.31778929188256,11.0798882008648,AGO3;EPCAM
alpha,3,positive regulation of response to endoplasmic reticulum stress (GO:1905898),2/16,2,16,0.076834454946319,0.637602049514212,0,0,4.31778929188256,11.0798882008648,BAG6;TMEM259
alpha,3,fibroblast growth factor receptor signaling pathway (GO:0008543),5/79,5,79,0.0789239710296039,0.644485641371975,0,0,2.18622242626965,5.55140963674164,FIBP;HNRNPH1;GRB2;FGF22;POLR2L
alpha,3,positive regulation of exocytosis (GO:0045921),3/35,3,35,0.0798560925898219,0.644485641371975,0,0,2.96076980014804,7.48343184839601,TSG101;VPS4A;RAB7A
alpha,3,positive regulation of muscle cell differentiation (GO:0051149),3/35,3,35,0.0798560925898219,0.644485641371975,0,0,2.96076980014804,7.48343184839601,SPAG9;BOC;CTNNA1
alpha,3,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),3/35,3,35,0.0798560925898219,0.644485641371975,0,0,2.96076980014804,7.48343184839601,PNKP;MAPKAPK5;CCT4
alpha,3,regulation of alcohol biosynthetic process (GO:1902930),3/35,3,35,0.0798560925898219,0.644485641371975,0,0,2.96076980014804,7.48343184839601,MBTPS1;NFYC;PMVK
alpha,3,endoplasmic reticulum organization (GO:0007029),3/35,3,35,0.0798560925898219,0.644485641371975,0,0,2.96076980014804,7.48343184839601,ATL1;RTN4;GET4
alpha,3,cellular macromolecular complex assembly (GO:0034622),3/35,3,35,0.0798560925898219,0.644485641371975,0,0,2.96076980014804,7.48343184839601,HSF1;AXIN1;DNAJB12
alpha,3,protein import into nucleus (GO:0006606),6/104,6,104,0.0815070466918366,0.646293849852108,0,0,1.99282582702272,4.99614547627832,PDIA3;NCKIPSD;TGS1;FAM53B;HEATR3;TNPO1
alpha,3,chromosome organization (GO:0051276),4/57,4,57,0.08272312623923,0.646293849852108,0,0,2.42402205860073,6.04128370368443,MSH6;COPS5;XPA;RBX1
alpha,3,autophagosome organization (GO:1905037),4/57,4,57,0.08272312623923,0.646293849852108,0,0,2.42402205860073,6.04128370368443,ATG4B;WIPI2;EMC6;RAB7A
alpha,3,lipid phosphorylation (GO:0046834),3/36,3,36,0.0853269468211514,0.646293849852108,0,0,2.87852619458837,7.08481568195485,DGKE;SMG1;DGKQ
alpha,3,positive regulation of telomerase activity (GO:0051973),3/36,3,36,0.0853269468211514,0.646293849852108,0,0,2.87852619458837,7.08481568195485,PNKP;MAPKAPK5;CCT4
alpha,3,high-density lipoprotein particle remodeling (GO:0034375),2/17,2,17,0.085462148117535,0.646293849852108,0,0,4.0638016864777,9.99565869406059,APOM;ABCA5
alpha,3,positive regulation of cell cycle G2/M phase transition (GO:1902751),2/17,2,17,0.085462148117535,0.646293849852108,0,0,4.0638016864777,9.99565869406059,DTL;RAB11A
alpha,3,reverse cholesterol transport (GO:0043691),2/17,2,17,0.085462148117535,0.646293849852108,0,0,4.0638016864777,9.99565869406059,APOM;ABCA5
alpha,3,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),2/17,2,17,0.085462148117535,0.646293849852108,0,0,4.0638016864777,9.99565869406059,PRNP;PHPT1
alpha,3,microtubule nucleation (GO:0007020),2/17,2,17,0.085462148117535,0.646293849852108,0,0,4.0638016864777,9.99565869406059,NDE1;TUBG1
alpha,3,N-terminal protein amino acid modification (GO:0031365),2/17,2,17,0.085462148117535,0.646293849852108,0,0,4.0638016864777,9.99565869406059,NAA50;PDF
alpha,3,negative regulation of phosphoprotein phosphatase activity (GO:0032515),2/17,2,17,0.085462148117535,0.646293849852108,0,0,4.0638016864777,9.99565869406059,ROCK2;CRY2
alpha,3,peptidyl-lysine trimethylation (GO:0018023),2/17,2,17,0.085462148117535,0.646293849852108,0,0,4.0638016864777,9.99565869406059,KMT2A;BEND3
alpha,3,response to purine-containing compound (GO:0014074),2/17,2,17,0.085462148117535,0.646293849852108,0,0,4.0638016864777,9.99565869406059,P2RX4;DGKQ
alpha,3,nucleotide catabolic process (GO:0009166),2/17,2,17,0.085462148117535,0.646293849852108,0,0,4.0638016864777,9.99565869406059,SAMHD1;DNPH1
alpha,3,positive regulation of telomere capping (GO:1904355),2/17,2,17,0.085462148117535,0.646293849852108,0,0,4.0638016864777,9.99565869406059,PNKP;MAPKAPK5
alpha,3,membrane depolarization during cardiac muscle cell action potential (GO:0086012),2/17,2,17,0.085462148117535,0.646293849852108,0,0,4.0638016864777,9.99565869406059,CACNB2;CACNA1C
alpha,3,spindle assembly (GO:0051225),5/81,5,81,0.0857328576334428,0.646293849852108,0,0,2.13224162562102,5.23789233011623,NCOR1;STARD9;ZNF207;TUBG1;RAB11A
alpha,3,epidermal growth factor receptor signaling pathway (GO:0007173),4/58,4,58,0.0869236455858347,0.652879060641051,0,0,2.38222857483176,5.81912973050031,REPS2;PLCE1;GRB2;IQGAP1
alpha,3,RNA splicing (GO:0008380),6/107,6,107,0.0905194935364668,0.653370299493796,0,0,1.93695220570432,4.65292732221803,DBR1;PDCD7;SNRPF;PPARGC1A;CCAR2;SRSF11
alpha,3,histone exchange (GO:0043486),3/37,3,37,0.0909524868382525,0.653370299493796,0,0,2.80072818932923,6.7145162623592,ZNHIT1;CENPN;ANP32B
alpha,3,regulation of muscle cell differentiation (GO:0051147),3/37,3,37,0.0909524868382525,0.653370299493796,0,0,2.80072818932923,6.7145162623592,SPAG9;BOC;CTNNA1
alpha,3,transferrin transport (GO:0033572),3/37,3,37,0.0909524868382525,0.653370299493796,0,0,2.80072818932923,6.7145162623592,ATP6V1A;ATP6V0E1;ARHGAP1
alpha,3,regulation of response to DNA damage stimulus (GO:2001020),3/37,3,37,0.0909524868382525,0.653370299493796,0,0,2.80072818932923,6.7145162623592,SMG1;FEM1B;USP1
alpha,3,ferric iron transport (GO:0015682),3/37,3,37,0.0909524868382525,0.653370299493796,0,0,2.80072818932923,6.7145162623592,ATP6V1A;ATP6V0E1;ARHGAP1
alpha,3,autophagosome assembly (GO:0000045),4/59,4,59,0.091225561997381,0.653370299493796,0,0,2.34185181932613,5.6073771519929,ATG4B;WIPI2;EMC6;RAB7A
alpha,3,mitotic sister chromatid segregation (GO:0000070),5/83,5,83,0.0928395528780782,0.653370299493796,0,0,2.08086230934099,4.94596523635635,NAA50;VPS4A;ZNF207;TUBG1;RAB11A
alpha,3,"retrograde transport, endosome to Golgi (GO:0042147)",5/83,5,83,0.0928395528780782,0.653370299493796,0,0,2.08086230934099,4.94596523635635,SPAG9;RGP1;SNX1;DENND2A;RAB7A
alpha,3,viral life cycle (GO:0019058),6/108,6,108,0.0936392330793085,0.653370299493796,0,0,1.91901746305891,4.54482023889859,TSG101;NFIA;CTBP1;VPS4A;VPS28;RAB7A
alpha,3,regulation of viral process (GO:0050792),2/18,2,18,0.0943643825355684,0.653370299493796,0,0,3.83803492611783,9.06003293293515,TSG101;RAB7A
alpha,3,regulation of amyloid-beta formation (GO:1902003),2/18,2,18,0.0943643825355684,0.653370299493796,0,0,3.83803492611783,9.06003293293515,PRNP;ROCK2
alpha,3,response to organophosphorus (GO:0046683),2/18,2,18,0.0943643825355684,0.653370299493796,0,0,3.83803492611783,9.06003293293515,P2RX4;DGKQ
alpha,3,cell junction assembly (GO:0034329),4/60,4,60,0.0956272471831543,0.653370299493796,0,0,2.3028209556707,5.40540584261831,TJP1;FLCN;CAPZA1;ACTG1
alpha,3,dicarboxylic acid metabolic process (GO:0043648),4/60,4,60,0.0956272471831543,0.653370299493796,0,0,2.3028209556707,5.40540584261831,FH;MDH2;DLST;MTHFR
alpha,3,protein monoubiquitination (GO:0006513),3/38,3,38,0.0967278957529798,0.653370299493796,0,0,2.72702481592583,6.36993029954846,LEO1;DTL;RBX1
alpha,3,spliceosomal snRNP assembly (GO:0000387),3/38,3,38,0.0967278957529798,0.653370299493796,0,0,2.72702481592583,6.36993029954846,PRMT7;TGS1;SNRPF
alpha,3,base-excision repair (GO:0006284),3/38,3,38,0.0967278957529798,0.653370299493796,0,0,2.72702481592583,6.36993029954846,LIG1;XPA;LIG3
alpha,3,regulation of DNA repair (GO:0006282),3/38,3,38,0.0967278957529798,0.653370299493796,0,0,2.72702481592583,6.36993029954846,TRIM28;DHX9;USP1
alpha,3,protein K63-linked ubiquitination (GO:0070534),3/38,3,38,0.0967278957529798,0.653370299493796,0,0,2.72702481592583,6.36993029954846,PELI3;ARIH2;STUB1
alpha,3,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",3/38,3,38,0.0967278957529798,0.653370299493796,0,0,2.72702481592583,6.36993029954846,XPA;GTF2H1;RBX1
alpha,3,positive regulation of multi-organism process (GO:0043902),3/38,3,38,0.0967278957529798,0.653370299493796,0,0,2.72702481592583,6.36993029954846,TSG101;PRKCA;RAB7A
alpha,3,homotypic cell-cell adhesion (GO:0034109),3/39,3,39,0.102648254586994,0.653370299493796,0,0,2.65710110269696,6.04875020379462,FIBP;STXBP1;ACTG1
alpha,3,protein ADP-ribosylation (GO:0006471),2/19,2,19,0.103518096841414,0.653370299493796,0,0,3.6360330879011,8.24655515990058,ARF4;PARP3
alpha,3,protein targeting to lysosome (GO:0006622),2/19,2,19,0.103518096841414,0.653370299493796,0,0,3.6360330879011,8.24655515990058,VPS4A;RAB7A
alpha,3,sulfur compound transport (GO:0072348),2/19,2,19,0.103518096841414,0.653370299493796,0,0,3.6360330879011,8.24655515990058,SLC25A19;SLC25A10
alpha,3,endothelial cell development (GO:0001885),2/19,2,19,0.103518096841414,0.653370299493796,0,0,3.6360330879011,8.24655515990058,RAP1B;PDE2A
alpha,3,cellular polysaccharide biosynthetic process (GO:0033692),2/19,2,19,0.103518096841414,0.653370299493796,0,0,3.6360330879011,8.24655515990058,B3GNT9;B3GNT2
alpha,3,purine ribonucleotide catabolic process (GO:0009154),2/19,2,19,0.103518096841414,0.653370299493796,0,0,3.6360330879011,8.24655515990058,PDE2A;NUDT18
alpha,3,positive regulation of phospholipase activity (GO:0010518),2/19,2,19,0.103518096841414,0.653370299493796,0,0,3.6360330879011,8.24655515990058,GNA13;ARF4
alpha,3,regulation of DNA replication (GO:0006275),4/62,4,62,0.104723004391429,0.653370299493796,0,0,2.22853640871358,5.02855082296354,USP37;DHX9;GMNN;RBBP6
alpha,3,positive regulation of cellular amide metabolic process (GO:0034250),4/62,4,62,0.104723004391429,0.653370299493796,0,0,2.22853640871358,5.02855082296354,RPL5;YTHDF3;ROCK2;PASK
alpha,3,ERBB2 signaling pathway (GO:0038128),3/40,3,40,0.108708559219521,0.653370299493796,0,0,2.59067357512953,5.7489242131736,PRKCA;GRB2;STUB1
alpha,3,cellular response to amino acid starvation (GO:0034198),3/40,3,40,0.108708559219521,0.653370299493796,0,0,2.59067357512953,5.7489242131736,WDR59;SESN2;RRAGD
alpha,3,regulation of actin filament-based process (GO:0032970),4/63,4,63,0.109413428145468,0.653370299493796,0,0,2.19316281492447,4.85263953278305,ROCK2;CDK10;RHOF;RHOBTB1
alpha,3,regulation of translational initiation (GO:0006446),4/63,4,63,0.109413428145468,0.653370299493796,0,0,2.19316281492447,4.85263953278305,EIF2B5;KHDRBS1;YTHDF3;PAIP2
alpha,3,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",6/113,6,113,0.110087790174294,0.653370299493796,0,0,1.83410518593241,4.046911163286,RPL5;RPL7A;SMG1;RPLP1;RPL35;RPS2
alpha,3,regulation of gluconeogenesis (GO:0006111),2/20,2,20,0.112901330679752,0.653370299493796,0,0,3.45423143350605,7.53451130065136,DGKQ;PPARGC1A
alpha,3,regulation of epidermal cell differentiation (GO:0045604),2/20,2,20,0.112901330679752,0.653370299493796,0,0,3.45423143350605,7.53451130065136,CBFB;ROCK2
alpha,3,mitochondrial respiratory chain complex IV assembly (GO:0033617),2/20,2,20,0.112901330679752,0.653370299493796,0,0,3.45423143350605,7.53451130065136,COA4;SCO2
alpha,3,autophagy of nucleus (GO:0044804),2/20,2,20,0.112901330679752,0.653370299493796,0,0,3.45423143350605,7.53451130065136,ATG4B;WIPI2
alpha,3,regulation of cell development (GO:0060284),2/20,2,20,0.112901330679752,0.653370299493796,0,0,3.45423143350605,7.53451130065136,AKAP13;RHEB
alpha,3,regulation of response to cytokine stimulus (GO:0060759),2/20,2,20,0.112901330679752,0.653370299493796,0,0,3.45423143350605,7.53451130065136,CBFB;DHX9
alpha,3,organelle disassembly (GO:1903008),2/20,2,20,0.112901330679752,0.653370299493796,0,0,3.45423143350605,7.53451130065136,PELO;MRRF
alpha,3,melanosome localization (GO:0032400),2/20,2,20,0.112901330679752,0.653370299493796,0,0,3.45423143350605,7.53451130065136,VPS33A;RAB11A
alpha,3,vesicle cytoskeletal trafficking (GO:0099518),2/20,2,20,0.112901330679752,0.653370299493796,0,0,3.45423143350605,7.53451130065136,NDE1;WASL
alpha,3,viral transcription (GO:0019083),6/114,6,114,0.113544278005825,0.653370299493796,0,0,1.81801654395055,3.95520844204495,RPL5;RPL7A;DHX9;RPLP1;RPL35;RPS2
alpha,3,ribosomal large subunit biogenesis (GO:0042273),4/64,4,64,0.114196333781388,0.653370299493796,0,0,2.15889464594128,4.68444750813045,RPL5;RPL7A;BOP1;HEATR3
alpha,3,negative regulation of TOR signaling (GO:0032007),3/41,3,41,0.114903736622084,0.653370299493796,0,0,2.52748641476052,5.46862270696688,FLCN;SESN2;MAPKAPK5
alpha,3,"nucleotide-excision repair, DNA incision (GO:0033683)",3/41,3,41,0.114903736622084,0.653370299493796,0,0,2.52748641476052,5.46862270696688,XPA;GTF2H1;RBX1
alpha,3,response to cAMP (GO:0051591),3/41,3,41,0.114903736622084,0.653370299493796,0,0,2.52748641476052,5.46862270696688,RAP1B;DGKQ;PDE2A
alpha,3,regulation of cholesterol biosynthetic process (GO:0045540),3/41,3,41,0.114903736622084,0.653370299493796,0,0,2.52748641476052,5.46862270696688,MBTPS1;NFYC;PMVK
alpha,3,positive regulation of protein complex assembly (GO:0031334),5/89,5,89,0.115887039113662,0.653370299493796,0,0,1.94057945702587,4.18221917500543,XPA;GTF2H1;STUB1;IDE;RBX1
alpha,3,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",5/89,5,89,0.115887039113662,0.653370299493796,0,0,1.94057945702587,4.18221917500543,PSMD9;PSMD11;PSMC3;PSMB3;PSMD1
alpha,3,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),5/90,5,90,0.119971028181324,0.653370299493796,0,0,1.91901746305891,4.06928612007628,RPL5;RPL7A;RPLP1;RPL35;RPS2
alpha,3,regulation of establishment of planar polarity (GO:0090175),5/90,5,90,0.119971028181324,0.653370299493796,0,0,1.91901746305891,4.06928612007628,PSMD9;PSMD11;PSMC3;PSMB3;PSMD1
alpha,3,protein O-linked glycosylation (GO:0006493),6/116,6,116,0.120619852159852,0.653370299493796,0,0,1.78667143112382,3.77900910600082,GALNT11;B3GNT9;PLOD3;B3GNT2;XXYLT1;ST3GAL3
alpha,3,negative regulation of cell growth (GO:0030308),6/116,6,116,0.120619852159852,0.653370299493796,0,0,1.78667143112382,3.77900910600082,ST7L;FLCN;GNG4;SESN2;CCAR2;RTN4
alpha,3,negative regulation of cell projection organization (GO:0031345),3/42,3,42,0.121228659634818,0.653370299493796,0,0,2.46730816679003,5.20620964141796,PRNP;BAG5;PTPN9
alpha,3,positive regulation of viral transcription (GO:0050434),3/42,3,42,0.121228659634818,0.653370299493796,0,0,2.46730816679003,5.20620964141796,DHX9;NELFA;POLR2L
alpha,3,regulation of cellular metabolic process (GO:0031323),3/42,3,42,0.121228659634818,0.653370299493796,0,0,2.46730816679003,5.20620964141796,ARF4;GBA;STUB1
alpha,3,gluconeogenesis (GO:0006094),3/42,3,42,0.121228659634818,0.653370299493796,0,0,2.46730816679003,5.20620964141796,MDH2;SLC25A10;PPARGC1A
alpha,3,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),2/21,2,21,0.122493180556398,0.653370299493796,0,0,3.28974422238671,6.90747567883638,SESN2;SMAD5
alpha,3,mRNA transcription (GO:0009299),2/21,2,21,0.122493180556398,0.653370299493796,0,0,3.28974422238671,6.90747567883638,HSF1;HIPK3
alpha,3,cortical actin cytoskeleton organization (GO:0030866),2/21,2,21,0.122493180556398,0.653370299493796,0,0,3.28974422238671,6.90747567883638,ROCK2;WASL
alpha,3,negative regulation of macroautophagy (GO:0016242),2/21,2,21,0.122493180556398,0.653370299493796,0,0,3.28974422238671,6.90747567883638,FEZ1;QSOX1
alpha,3,regulation of cardiac muscle hypertrophy (GO:0010611),2/21,2,21,0.122493180556398,0.653370299493796,0,0,3.28974422238671,6.90747567883638,P2RX4;PRKCA
alpha,3,regulation of nuclear division (GO:0051783),2/21,2,21,0.122493180556398,0.653370299493796,0,0,3.28974422238671,6.90747567883638,CDK13;KIF20B
alpha,3,regulation of interleukin-2 production (GO:0032663),2/21,2,21,0.122493180556398,0.653370299493796,0,0,3.28974422238671,6.90747567883638,PRNP;HDAC7
alpha,3,mitochondrial respiratory chain complex IV biogenesis (GO:0097034),2/21,2,21,0.122493180556398,0.653370299493796,0,0,3.28974422238671,6.90747567883638,COA4;SCO2
alpha,3,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),2/21,2,21,0.122493180556398,0.653370299493796,0,0,3.28974422238671,6.90747567883638,HEXIM1;NR2F2
alpha,3,O-glycan processing (GO:0016266),4/66,4,66,0.124031567719069,0.653370299493796,0,0,2.09347359606427,4.36953821614506,GALNT11;B3GNT2;XXYLT1;ST3GAL3
alpha,3,regulation of myeloid cell differentiation (GO:0045637),4/66,4,66,0.124031567719069,0.653370299493796,0,0,2.09347359606427,4.36953821614506,CBFB;KMT2A;AGO3;LEO1
alpha,3,regulation of cell division (GO:0051302),4/66,4,66,0.124031567719069,0.653370299493796,0,0,2.09347359606427,4.36953821614506,FLCN;CSPP1;KLHL21;RAB11A
alpha,3,regulation of protein modification process (GO:0031399),3/43,3,43,0.127678161023263,0.653370299493796,0,0,2.40992890709724,4.960218215201,FLCN;SESN2;CCAR2
alpha,3,regulation of telomerase activity (GO:0051972),3/43,3,43,0.127678161023263,0.653370299493796,0,0,2.40992890709724,4.960218215201,PNKP;MAPKAPK5;CCT4
alpha,3,positive regulation of cellular protein metabolic process (GO:0032270),5/92,5,92,0.128338145191791,0.653370299493796,0,0,1.87729969212285,3.85425910314713,RPL5;YTHDF3;FBXW11;PERP;PASK
alpha,3,JNK cascade (GO:0007254),4/67,4,67,0.129079742887838,0.653370299493796,0,0,2.06222772149615,4.22205017128373,SPAG9;AXIN1;TAB2;MAP4K5
alpha,3,positive regulation of cellular protein localization (GO:1903829),4/67,4,67,0.129079742887838,0.653370299493796,0,0,2.06222772149615,4.22205017128373,SESN2;KIF20B;OAZ1;RTN4
alpha,3,regulation of calcium ion transport into cytosol (GO:0010522),2/22,2,22,0.132273757213965,0.653370299493796,0,0,3.1402103940964,6.35227378146616,PRNP;P2RX4
alpha,3,establishment of protein localization to vacuole (GO:0072666),2/22,2,22,0.132273757213965,0.653370299493796,0,0,3.1402103940964,6.35227378146616,VPS13A;VPS28
alpha,3,protein homotrimerization (GO:0070207),2/22,2,22,0.132273757213965,0.653370299493796,0,0,3.1402103940964,6.35227378146616,HSF1;ASIC1
alpha,3,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),2/22,2,22,0.132273757213965,0.653370299493796,0,0,3.1402103940964,6.35227378146616,GBA;AXIN1
alpha,3,early endosome to late endosome transport (GO:0045022),2/22,2,22,0.132273757213965,0.653370299493796,0,0,3.1402103940964,6.35227378146616,RILP;RAB7A
alpha,3,protein complex localization (GO:0031503),2/22,2,22,0.132273757213965,0.653370299493796,0,0,3.1402103940964,6.35227378146616,ICK;TRAF3IP1
alpha,3,NLS-bearing protein import into nucleus (GO:0006607),2/22,2,22,0.132273757213965,0.653370299493796,0,0,3.1402103940964,6.35227378146616,NCKIPSD;TNPO1
alpha,3,negative regulation of protein serine/threonine kinase activity (GO:0071901),4/68,4,68,0.134212102571328,0.653370299493796,0,0,2.03190084323885,4.08073529496285,HEXIM1;PRKAR2A;GBA;NR2F2
alpha,3,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),4/68,4,68,0.134212102571328,0.653370299493796,0,0,2.03190084323885,4.08073529496285,HEXIM1;SERTAD1;GTF2H1;NR2F2
alpha,3,insulin receptor signaling pathway (GO:0008286),4/68,4,68,0.134212102571328,0.653370299493796,0,0,2.03190084323885,4.08073529496285,ATP6V1A;ATP6V0E1;GRB2;IDE
alpha,3,positive regulation of autophagy (GO:0010508),4/68,4,68,0.134212102571328,0.653370299493796,0,0,2.03190084323885,4.08073529496285,FLCN;DAPK1;SESN2;MID2
alpha,3,negative regulation of ERBB signaling pathway (GO:1901185),3/44,3,44,0.134247046502855,0.653370299493796,0,0,2.3551577955723,4.72933006550613,TSG101;ITGA1;GRB2
alpha,3,eye development (GO:0001654),3/44,3,44,0.134247046502855,0.653370299493796,0,0,2.3551577955723,4.72933006550613,SCO2;CACNA1C;HIPK1
alpha,3,negative regulation of DNA metabolic process (GO:0051053),3/44,3,44,0.134247046502855,0.653370299493796,0,0,2.3551577955723,4.72933006550613,MSH6;KMT2A;GMNN
alpha,3,cotranslational protein targeting to membrane (GO:0006613),5/94,5,94,0.136963463016575,0.653370299493796,0,0,1.83735714548194,3.65274148758437,RPL5;RPL7A;RPLP1;RPL35;RPS2
alpha,3,proteolysis involved in cellular protein catabolic process (GO:0051603),5/94,5,94,0.136963463016575,0.653370299493796,0,0,1.83735714548194,3.65274148758437,BAG6;PSMB3;VPS4A;STUB1;IDE
alpha,3,hexose biosynthetic process (GO:0019319),3/45,3,45,0.14093010675018,0.653370299493796,0,0,2.3028209556707,4.51235741694757,MDH2;SLC25A10;PPARGC1A
alpha,3,unsaturated fatty acid metabolic process (GO:0033559),3/45,3,45,0.14093010675018,0.653370299493796,0,0,2.3028209556707,4.51235741694757,FADS3;DEGS1;DECR2
alpha,3,positive regulation of intracellular transport (GO:0032388),3/45,3,45,0.14093010675018,0.653370299493796,0,0,2.3028209556707,4.51235741694757,GAB2;KIF20B;OAZ1
alpha,3,inorganic anion transport (GO:0015698),3/45,3,45,0.14093010675018,0.653370299493796,0,0,2.3028209556707,4.51235741694757,CLCN6;CLIC4;SLC25A10
alpha,3,respiratory electron transport chain (GO:0022904),5/95,5,95,0.141370074063391,0.653370299493796,0,0,1.81801654395055,3.55672064031601,COX4I1;NDUFB4;NDUFB3;PMPCB;PPARGC1A
alpha,3,"nucleotide-excision repair, DNA gap filling (GO:0006297)",2/23,2,23,0.142224144503154,0.653370299493796,0,0,3.00367950739656,5.85822928124422,LIG1;LIG3
alpha,3,regulation of telomere capping (GO:1904353),2/23,2,23,0.142224144503154,0.653370299493796,0,0,3.00367950739656,5.85822928124422,PNKP;MAPKAPK5
alpha,3,vesicle-mediated transport between endosomal compartments (GO:0098927),2/23,2,23,0.142224144503154,0.653370299493796,0,0,3.00367950739656,5.85822928124422,RILP;RAB7A
alpha,3,positive regulation of ATP metabolic process (GO:1903580),2/23,2,23,0.142224144503154,0.653370299493796,0,0,3.00367950739656,5.85822928124422,BEND3;PPARGC1A
alpha,3,cellular nitrogen compound biosynthetic process (GO:0044271),2/23,2,23,0.142224144503154,0.653370299493796,0,0,3.00367950739656,5.85822928124422,GCH1;GBA
alpha,3,histone H3-K4 methylation (GO:0051568),2/23,2,23,0.142224144503154,0.653370299493796,0,0,3.00367950739656,5.85822928124422,KMT2A;BEND3
alpha,3,autophagosome maturation (GO:0097352),2/23,2,23,0.142224144503154,0.653370299493796,0,0,3.00367950739656,5.85822928124422,TSG101;VPS33A
alpha,3,regulation of monooxygenase activity (GO:0032768),2/23,2,23,0.142224144503154,0.653370299493796,0,0,3.00367950739656,5.85822928124422,POR;WASL
alpha,3,positive regulation of monooxygenase activity (GO:0032770),2/23,2,23,0.142224144503154,0.653370299493796,0,0,3.00367950739656,5.85822928124422,POR;GCH1
alpha,3,regulation of microtubule cytoskeleton organization (GO:0070507),2/23,2,23,0.142224144503154,0.653370299493796,0,0,3.00367950739656,5.85822928124422,TRAF3IP1;TRIM36
alpha,3,positive regulation of blood vessel endothelial cell migration (GO:0043536),3/46,3,46,0.147722128818635,0.653370299493796,0,0,2.25275963054742,4.30822770427469,P2RX4;PRKCA;HDAC7
alpha,3,nucleus organization (GO:0006997),3/46,3,46,0.147722128818635,0.653370299493796,0,0,2.25275963054742,4.30822770427469,VPS4A;WDR73;LEMD2
alpha,3,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),4/71,4,71,0.150092103902961,0.653370299493796,0,0,1.94604587803157,3.69068797062052,RFWD2;ARIH2;STUB1;RBX1
alpha,3,ciliary basal body-plasma membrane docking (GO:0097711),5/97,5,97,0.150365177028475,0.653370299493796,0,0,1.78053166675569,3.37355274823257,NDE1;CEP164;CNTRL;TUBG1;RAB11A
alpha,3,intraciliary transport (GO:0042073),3/47,3,47,0.15461790644383,0.653370299493796,0,0,2.20482857457833,4.11597029035461,ICK;TRAF3IP1;TNPO1
alpha,3,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),3/47,3,47,0.15461790644383,0.653370299493796,0,0,2.20482857457833,4.11597029035461,RPL5;BAG5;VPS28
alpha,3,RNA secondary structure unwinding (GO:0010501),3/47,3,47,0.15461790644383,0.653370299493796,0,0,2.20482857457833,4.11597029035461,EIF4A1;AGO3;DHX9
alpha,3,aminoglycan biosynthetic process (GO:0006023),3/47,3,47,0.15461790644383,0.653370299493796,0,0,2.20482857457833,4.11597029035461,B3GNT9;B3GNT2;B4GALT7
alpha,3,negative regulation of autophagy (GO:0010507),3/47,3,47,0.15461790644383,0.653370299493796,0,0,2.20482857457833,4.11597029035461,TLK2;QSOX1;TAB2
alpha,3,protein targeting to ER (GO:0045047),5/98,5,98,0.154951172764865,0.653370299493796,0,0,1.76236297627859,3.28618171039191,RPL5;RPL7A;RPLP1;RPL35;RPS2
alpha,3,mitochondrial respiratory chain complex assembly (GO:0033108),5/98,5,98,0.154951172764865,0.653370299493796,0,0,1.76236297627859,3.28618171039191,COA4;SCO2;NDUFB4;NDUFB3;TTC19
alpha,3,dephosphorylation (GO:0016311),6/125,6,125,0.15501706597053,0.653370299493796,0,0,1.6580310880829,3.09093482294401,FBXW11;PNKP;PTPN9;DUSP18;PHPT1;STYXL1
alpha,3,recombinational repair (GO:0000725),4/72,4,72,0.15553882765825,0.653370299493796,0,0,1.91901746305891,3.57102261174467,MORF4L1;NABP1;LIG3;ZSWIM7
alpha,3,regulation of cation channel activity (GO:2001257),4/72,4,72,0.15553882765825,0.653370299493796,0,0,1.91901746305891,3.57102261174467,CACNB2;JSRP1;DAPK1;KCNIP2
alpha,3,protein dephosphorylation (GO:0006470),6/126,6,126,0.159083029754181,0.653370299493796,0,0,1.64487211119335,3.02381612525519,FBXW11;PTPN9;DUSP18;PHPT1;STYXL1;DUSP14
alpha,3,response to UV (GO:0009411),5/99,5,99,0.159594422877828,0.653370299493796,0,0,1.74456133005356,3.20147858368052,MSH6;XPA;USP1;DTL;CCAR2
alpha,3,lysosomal transport (GO:0007041),4/73,4,73,0.161058373600926,0.653370299493796,0,0,1.89272955260605,3.45610222776172,VPS33A;VPS4A;RILP;RAB7A
alpha,3,fatty acid biosynthetic process (GO:0006633),3/48,3,48,0.161612249777496,0.653370299493796,0,0,2.15889464594128,3.93470494967505,FADS3;DEGS1;DECR2
alpha,3,cellular response to heat (GO:0034605),3/48,3,48,0.161612249777496,0.653370299493796,0,0,2.15889464594128,3.93470494967505,HSF1;HSF4;STUB1
alpha,3,regulation of protein localization to early endosome (GO:1902965),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,ROCK2
alpha,3,polyamine biosynthetic process (GO:0006596),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,SRM
alpha,3,neuron projection maintenance (GO:1990535),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,PRNP
alpha,3,succinyl-CoA metabolic process (GO:0006104),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,DLST
alpha,3,regulation of endothelial cell development (GO:1901550),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,ROCK2
alpha,3,negative regulation of translation in response to stress (GO:0032055),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,SESN2
alpha,3,SCF complex assembly (GO:0010265),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,RBX1
alpha,3,protein retention in ER lumen (GO:0006621),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,PDIA3
alpha,3,embryonic skeletal joint development (GO:0072498),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,AXIN1
alpha,3,positive regulation of aspartic-type peptidase activity (GO:1905247),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,ROCK2
alpha,3,positive regulation of icosanoid secretion (GO:0032305),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,P2RX4
alpha,3,regulation of superoxide metabolic process (GO:0090322),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,GCH1
alpha,3,positive regulation of protein localization to early endosome (GO:1902966),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,ROCK2
alpha,3,"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,RHOT1
alpha,3,positive regulation of ATP biosynthetic process (GO:2001171),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,PPARGC1A
alpha,3,mRNA 3'-splice site recognition (GO:0000389),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,ISY1
alpha,3,astral microtubule organization (GO:0030953),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,RAB11A
alpha,3,establishment of endothelial intestinal barrier (GO:0090557),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,TJP1
alpha,3,negative regulation of lymphocyte migration (GO:2000402),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,WASL
alpha,3,5S class rRNA transcription from RNA polymerase III type 1 promoter (GO:0042791),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,GTF3C2
alpha,3,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,ATF3
alpha,3,negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,CRY2
alpha,3,phagosome-lysosome fusion (GO:0090385),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,RAB7A
alpha,3,retinal ganglion cell axon guidance (GO:0031290),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,ALCAM
alpha,3,iron ion import across plasma membrane (GO:0098711),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,ARHGAP1
alpha,3,azole transport (GO:0045117),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,SLC25A19
alpha,3,centromeric sister chromatid cohesion (GO:0070601),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,NAA50
alpha,3,regulation of cellular response to oxidative stress (GO:1900407),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,GCH1
alpha,3,regulation of glial cell apoptotic process (GO:0034350),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,PRKCA
alpha,3,negative regulation of cAMP-mediated signaling (GO:0043951),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,PDE2A
alpha,3,embryonic skeletal joint morphogenesis (GO:0060272),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,AXIN1
alpha,3,forebrain regionalization (GO:0021871),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,AXIN1
alpha,3,regulation of interferon-alpha secretion (GO:1902739),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,DHX9
alpha,3,positive regulation of action potential (GO:0045760),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,GBA
alpha,3,definitive hemopoiesis (GO:0060216),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,HIPK1
alpha,3,white fat cell differentiation (GO:0050872),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,CTBP1
alpha,3,positive regulation of helicase activity (GO:0051096),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,MSH6
alpha,3,positive regulation of protein localization to endosome (GO:1905668),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,ROCK2
alpha,3,regulation of cell cycle checkpoint (GO:1901976),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,FEM1B
alpha,3,glycosyl compound catabolic process (GO:1901658),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,GBA2
alpha,3,regulation of cortisol biosynthetic process (GO:2000064),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,DGKQ
alpha,3,aggrephagy (GO:0035973),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,WDFY3
alpha,3,polyphosphate metabolic process (GO:0006797),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,MINPP1
alpha,3,positive regulation of clathrin-dependent endocytosis (GO:2000370),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,WASL
alpha,3,positive regulation of interferon-alpha secretion (GO:1902741),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,DHX9
alpha,3,regulation of anion channel activity (GO:0010359),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,PRNP
alpha,3,regulation of lysosomal protein catabolic process (GO:1905165),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,GBA
alpha,3,regulation of extracellular exosome assembly (GO:1903551),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,TSG101
alpha,3,astrocyte differentiation (GO:0048708),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,EIF2B5
alpha,3,insulin secretion involved in cellular response to glucose stimulus (GO:0035773),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,PTPRN
alpha,3,regulation of sarcomere organization (GO:0060297),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,AKAP13
alpha,3,negative regulation of glycogen biosynthetic process (GO:0045719),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,PASK
alpha,3,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,ROCK2
alpha,3,dendritic spine maintenance (GO:0097062),1/6,1,6,0.161621680507855,0.653370299493796,0,0,5.75705238917674,10.4922105949078,PRNP
alpha,3,dendritic spine organization (GO:0097061),2/25,2,25,0.16256331677984,0.653370299493796,0,0,2.76338514680484,5.02020783801279,PRNP;WASL
alpha,3,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",2/25,2,25,0.16256331677984,0.653370299493796,0,0,2.76338514680484,5.02020783801279,LEO1;RTF1
alpha,3,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),2/25,2,25,0.16256331677984,0.653370299493796,0,0,2.76338514680484,5.02020783801279,HEXIM1;NR2F2
alpha,3,negative regulation of oxidative stress-induced cell death (GO:1903202),2/25,2,25,0.16256331677984,0.653370299493796,0,0,2.76338514680484,5.02020783801279,BAG5;PDE8A
alpha,3,positive regulation of dephosphorylation (GO:0035306),2/25,2,25,0.16256331677984,0.653370299493796,0,0,2.76338514680484,5.02020783801279,PPP1R7;GBA
alpha,3,cAMP metabolic process (GO:0046058),2/25,2,25,0.16256331677984,0.653370299493796,0,0,2.76338514680484,5.02020783801279,ADORA2A;PDE2A
alpha,3,G2/M transition of mitotic cell cycle (GO:0000086),6/127,6,127,0.163194936132044,0.653370299493796,0,0,1.63192036228632,2.95836133252205,KHDRBS1;FBXW11;NDE1;CEP164;CNTRL;TUBG1
alpha,3,small GTPase mediated signal transduction (GO:0007264),5/100,5,100,0.164293615316866,0.653370299493796,0,0,1.72711571675302,3.11934389396114,TRIM28;ARHGAP1;PLCE1;MAPKAPK5;GRB2
alpha,3,non-canonical Wnt signaling pathway (GO:0035567),6/128,6,128,0.167351945464873,0.653370299493796,0,0,1.61917098445596,2.89452109175219,PSMD9;PSMD11;AGO3;PSMC3;PSMB3;PSMD1
alpha,3,cell cycle G2/M phase transition (GO:0044839),6/128,6,128,0.167351945464873,0.653370299493796,0,0,1.61917098445596,2.89452109175219,KHDRBS1;FBXW11;NDE1;CEP164;CNTRL;TUBG1
alpha,3,endosome to lysosome transport (GO:0008333),3/49,3,49,0.168699994424815,0.653370299493796,0,0,2.11483557153431,3.76363185466457,VPS33A;RILP;RAB7A
alpha,3,interstrand cross-link repair (GO:0036297),3/49,3,49,0.168699994424815,0.653370299493796,0,0,2.11483557153431,3.76363185466457,DCLRE1A;XPA;USP1
alpha,3,regulation of mitochondrion organization (GO:0010821),3/49,3,49,0.168699994424815,0.653370299493796,0,0,2.11483557153431,3.76363185466457,FLCN;RHOT1;PPARGC1A
alpha,3,cellular response to metal ion (GO:0071248),5/101,5,101,0.169047415362979,0.653370299493796,0,0,1.71001556114161,3.03968268802797,PRNP;CLIC4;HSF1;MT1X;IQGAP1
alpha,3,positive regulation of epithelial cell migration (GO:0010634),4/75,4,75,0.172306453956128,0.653370299493796,0,0,1.84225676453656,3.23957292524062,ROCK2;PRKCA;RTN4;RAB11A
alpha,3,mitotic nuclear division (GO:0140014),4/75,4,75,0.172306453956128,0.653370299493796,0,0,1.84225676453656,3.23957292524062,NDE1;ZNF207;TUBG1;RAB11A
alpha,3,organophosphate ester transport (GO:0015748),2/26,2,26,0.172918787087645,0.653370299493796,0,0,2.65710110269696,4.66303502990563,PRELID2;SLC25A19
alpha,3,respiratory chain complex IV assembly (GO:0008535),2/26,2,26,0.172918787087645,0.653370299493796,0,0,2.65710110269696,4.66303502990563,COA4;SCO2
alpha,3,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058),2/26,2,26,0.172918787087645,0.653370299493796,0,0,2.65710110269696,4.66303502990563,RPL5;AXIN1
alpha,3,misfolded or incompletely synthesized protein catabolic process (GO:0006515),2/26,2,26,0.172918787087645,0.653370299493796,0,0,2.65710110269696,4.66303502990563,BAG6;STUB1
alpha,3,prostaglandin metabolic process (GO:0006693),2/26,2,26,0.172918787087645,0.653370299493796,0,0,2.65710110269696,4.66303502990563,PTGR2;CES2
alpha,3,regulation of glucose metabolic process (GO:0010906),2/26,2,26,0.172918787087645,0.653370299493796,0,0,2.65710110269696,4.66303502990563,DGKQ;PASK
alpha,3,negative regulation of cellular protein localization (GO:1903828),2/26,2,26,0.172918787087645,0.653370299493796,0,0,2.65710110269696,4.66303502990563,FLCN;TAX1BP3
alpha,3,cellular response to epidermal growth factor stimulus (GO:0071364),2/26,2,26,0.172918787087645,0.653370299493796,0,0,2.65710110269696,4.66303502990563,IQGAP1;PDE8A
alpha,3,ncRNA 3'-end processing (GO:0043628),2/26,2,26,0.172918787087645,0.653370299493796,0,0,2.65710110269696,4.66303502990563,SSB;INTS7
alpha,3,protein depolymerization (GO:0051261),2/26,2,26,0.172918787087645,0.653370299493796,0,0,2.65710110269696,4.66303502990563,VPS4A;MICAL3
alpha,3,signal transduction in response to DNA damage (GO:0042770),2/26,2,26,0.172918787087645,0.653370299493796,0,0,2.65710110269696,4.66303502990563,SESN2;GRB2
alpha,3,regulation of protein ubiquitination (GO:0031396),5/102,5,102,0.173854467283835,0.653370299493796,0,0,1.69325070269904,2.96240428843084,BAG5;FEM1B;AXIN1;STUB1;VPS28
alpha,3,regulation of kinase activity (GO:0043549),5/102,5,102,0.173854467283835,0.653370299493796,0,0,1.69325070269904,2.96240428843084,DDR1;VAC14;DSTYK;PLCE1;ROR1
alpha,3,intrinsic apoptotic signaling pathway (GO:0097193),5/102,5,102,0.173854467283835,0.653370299493796,0,0,1.69325070269904,2.96240428843084,MSH6;BAG6;DIABLO;APOPT1;ZNF346
alpha,3,non-recombinational repair (GO:0000726),3/50,3,50,0.175876009506577,0.653370299493796,0,0,2.07253886010363,3.60202284695252,DCLRE1A;XRCC6;LIG3
alpha,3,regulation of megakaryocyte differentiation (GO:0045652),3/50,3,50,0.175876009506577,0.653370299493796,0,0,2.07253886010363,3.60202284695252,CBFB;KMT2A;AGO3
alpha,3,positive regulation of response to DNA damage stimulus (GO:2001022),3/50,3,50,0.175876009506577,0.653370299493796,0,0,2.07253886010363,3.60202284695252,TRIM28;DHX9;CCAR2
alpha,3,cAMP-mediated signaling (GO:0019933),4/76,4,76,0.178030198183197,0.653370299493796,0,0,1.81801654395055,3.13753675186775,GNA13;ADORA2A;DGKQ;PDE2A
alpha,3,protein glycosylation (GO:0006486),6/131,6,131,0.180084943461535,0.653370299493796,0,0,1.58209073290353,2.71222027652716,ARF4;PARP3;B3GNT9;PLOD3;B3GNT2;B4GALT7
alpha,3,regulation of cellular protein metabolic process (GO:0032268),3/51,3,51,0.183135205488638,0.653370299493796,0,0,2.03190084323885,3.44921379890858,GBA;NOLC1;MAPKAPK5
alpha,3,positive regulation of JUN kinase activity (GO:0043507),3/51,3,51,0.183135205488638,0.653370299493796,0,0,2.03190084323885,3.44921379890858,SPAG9;AXIN1;MAP4K5
alpha,3,negative regulation of protein ubiquitination (GO:0031397),3/51,3,51,0.183135205488638,0.653370299493796,0,0,2.03190084323885,3.44921379890858,RPL5;BAG5;VPS28
alpha,3,receptor internalization (GO:0031623),3/51,3,51,0.183135205488638,0.653370299493796,0,0,2.03190084323885,3.44921379890858,SNX1;GRK4;GRB2
alpha,3,double-strand break repair via nonhomologous end joining (GO:0006303),3/51,3,51,0.183135205488638,0.653370299493796,0,0,2.03190084323885,3.44921379890858,DCLRE1A;XRCC6;LIG3
alpha,3,cytoskeleton-dependent intracellular transport (GO:0030705),2/27,2,27,0.183377366685156,0.653370299493796,0,0,2.55868995074522,4.34007327152499,TUBA1C;KIF1B
alpha,3,lipid modification (GO:0030258),2/27,2,27,0.183377366685156,0.653370299493796,0,0,2.55868995074522,4.34007327152499,DGKE;DGKQ
alpha,3,negative regulation of catalytic activity (GO:0043086),2/27,2,27,0.183377366685156,0.653370299493796,0,0,2.55868995074522,4.34007327152499,PHPT1;CCAR2
alpha,3,regulation of microtubule-based process (GO:0032886),2/27,2,27,0.183377366685156,0.653370299493796,0,0,2.55868995074522,4.34007327152499,TRAF3IP1;TRIM36
alpha,3,regulation of T cell receptor signaling pathway (GO:0050856),2/27,2,27,0.183377366685156,0.653370299493796,0,0,2.55868995074522,4.34007327152499,PRNP;PHPT1
alpha,3,regulation of rhodopsin mediated signaling pathway (GO:0022400),2/27,2,27,0.183377366685156,0.653370299493796,0,0,2.55868995074522,4.34007327152499,GRK4;NMT1
alpha,3,snRNA 3'-end processing (GO:0034472),2/27,2,27,0.183377366685156,0.653370299493796,0,0,2.55868995074522,4.34007327152499,INTS1;INTS7
alpha,3,double-strand break repair via homologous recombination (GO:0000724),4/77,4,77,0.183817191190228,0.653370299493796,0,0,1.79440593948366,3.03938907904351,MORF4L1;NABP1;LIG3;ZSWIM7
alpha,3,hemopoiesis (GO:0030097),4/77,4,77,0.183817191190228,0.653370299493796,0,0,1.79440593948366,3.03938907904351,FLCN;KMT2A;HIPK1;CDK13
alpha,3,membrane raft polarization (GO:0001766),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,MARVELD1
alpha,3,intracellular sterol transport (GO:0032366),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,VPS4A
alpha,3,cellular divalent inorganic anion homeostasis (GO:0072501),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,GPCPD1
alpha,3,negative regulation of muscle hypertrophy (GO:0014741),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,P2RX4
alpha,3,smooth muscle cell migration (GO:0014909),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,DDR1
alpha,3,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,NCOR1
alpha,3,coenzyme A biosynthetic process (GO:0015937),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,DCAKD
alpha,3,regulation of hormone biosynthetic process (GO:0046885),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,DGKQ
alpha,3,negative regulation of leukocyte migration (GO:0002686),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,WASL
alpha,3,regulation of myosin-light-chain-phosphatase activity (GO:0035507),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,ROCK2
alpha,3,regulation of chromatin assembly or disassembly (GO:0001672),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,TLK2
alpha,3,tRNA transcription from RNA polymerase III promoter (GO:0042797),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,GTF3C2
alpha,3,cellular trivalent inorganic anion homeostasis (GO:0072502),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,GPCPD1
alpha,3,negative regulation of glial cell apoptotic process (GO:0034351),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,PRKCA
alpha,3,brown fat cell differentiation (GO:0050873),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,PPARGC1A
alpha,3,regulation of endocytic recycling (GO:2001135),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,ARHGAP1
alpha,3,regulation of dendritic spine maintenance (GO:1902950),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,PRNP
alpha,3,regulation of extracellular matrix organization (GO:1903053),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,DDR1
alpha,3,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,AXIN1
alpha,3,ribonucleoside bisphosphate biosynthetic process (GO:0034030),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,DCAKD
alpha,3,positive regulation of mast cell degranulation (GO:0043306),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,GAB2
alpha,3,regulation of lymphocyte migration (GO:2000401),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,WASL
alpha,3,glycoside catabolic process (GO:0016139),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,GBA2
alpha,3,melanocyte differentiation (GO:0030318),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,HPS6
alpha,3,vesicle transport along actin filament (GO:0030050),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,WASL
alpha,3,ribosomal protein import into nucleus (GO:0006610),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,TNPO1
alpha,3,negative regulation of cytokinesis (GO:0032466),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,VPS4A
alpha,3,pteridine-containing compound biosynthetic process (GO:0042559),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,GCH1
alpha,3,miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,AGO3
alpha,3,translational readthrough (GO:0006451),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,EEFSEC
alpha,3,membrane raft distribution (GO:0031580),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,MARVELD1
alpha,3,tRNA 3'-end processing (GO:0042780),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,SSB
alpha,3,regulation of interleukin-18 production (GO:0032661),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,DHX9
alpha,3,establishment of protein localization to peroxisome (GO:0072663),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,ZFAND6
alpha,3,morphogenesis of a polarized epithelium (GO:0001738),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,TRAF3IP1
alpha,3,regulation of histone H3-K9 acetylation (GO:2000615),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,KMT2A
alpha,3,regulation of high voltage-gated calcium channel activity (GO:1901841),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,CACNB2
alpha,3,protein deglutamylation (GO:0035608),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,AGBL5
alpha,3,positive regulation of triglyceride catabolic process (GO:0010898),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,PNPLA2
alpha,3,tRNA transcription (GO:0009304),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,GTF3C2
alpha,3,protection from non-homologous end joining at telomere (GO:0031848),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,DCLRE1A
alpha,3,regulation of glucocorticoid receptor signaling pathway (GO:2000322),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,CRY2
alpha,3,thiamine-containing compound metabolic process (GO:0042723),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,SLC25A19
alpha,3,"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,NOP14
alpha,3,negative regulation of glycogen metabolic process (GO:0070874),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,PASK
alpha,3,regulation of anion transport (GO:0044070),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,NCOR1
alpha,3,epithelial cell differentiation involved in kidney development (GO:0035850),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,MTSS1
alpha,3,tetrahydrofolate interconversion (GO:0035999),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,MTHFR
alpha,3,G-quadruplex DNA unwinding (GO:0044806),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,DHX9
alpha,3,purine nucleoside bisphosphate biosynthetic process (GO:0034033),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,DCAKD
alpha,3,positive regulation of isomerase activity (GO:0010912),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,DHX9
alpha,3,cleavage furrow formation (GO:0036089),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,SPIRE1
alpha,3,response to increased oxygen levels (GO:0036296),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,ATP6V1A
alpha,3,spermidine metabolic process (GO:0008216),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,SRM
alpha,3,regulation of protein heterodimerization activity (GO:0043497),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,HSF1
alpha,3,regulation of transcription involved in cell fate commitment (GO:0060850),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,NR2F2
alpha,3,long-chain fatty acid catabolic process (GO:0042758),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,AIG1
alpha,3,selenocysteine incorporation (GO:0001514),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,EEFSEC
alpha,3,cellular phosphate ion homeostasis (GO:0030643),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,GPCPD1
alpha,3,cAMP catabolic process (GO:0006198),1/7,1,7,0.185899982322593,0.653370299493796,0,0,4.93461633358006,8.30272133898686,PDE2A
alpha,3,response to ionizing radiation (GO:0010212),4/78,4,78,0.189665002055657,0.653370299493796,0,0,1.77140073513131,2.94494647725147,RFWD2;NABP1;INTS7;GRB2
alpha,3,negative regulation of neuron projection development (GO:0010977),3/52,3,52,0.190472541052192,0.653370299493796,0,0,1.99282582702272,3.30459792001409,BAG5;PTPN9;RTN4
alpha,3,regulation of calcium ion transmembrane transporter activity (GO:1901019),2/28,2,28,0.193924441147705,0.653370299493796,0,0,2.46730816679003,4.04709270763726,CACNB2;JSRP1
alpha,3,regulation of protein localization to nucleus (GO:1900180),2/28,2,28,0.193924441147705,0.653370299493796,0,0,2.46730816679003,4.04709270763726,FLCN;SESN2
alpha,3,phosphatidylserine metabolic process (GO:0006658),2/28,2,28,0.193924441147705,0.653370299493796,0,0,2.46730816679003,4.04709270763726,PTDSS1;LPCAT4
alpha,3,negative regulation of organelle assembly (GO:1902116),2/28,2,28,0.193924441147705,0.653370299493796,0,0,2.46730816679003,4.04709270763726,FEZ1;CDK10
alpha,3,protein localization to chromosome (GO:0034502),2/28,2,28,0.193924441147705,0.653370299493796,0,0,2.46730816679003,4.04709270763726,PARP3;LEMD2
alpha,3,positive regulation of proteolysis (GO:0045862),3/53,3,53,0.197883029486556,0.653370299493796,0,0,1.9552253397204,3.16761987100216,FBXW11;PERP;GBA
alpha,3,"DNA-templated transcription, termination (GO:0006353)",5/107,5,107,0.198639783625161,0.653370299493796,0,0,1.61412683808694,2.60885223809037,TWISTNB;GTF2H1;SNRPF;SRSF11;POLR2L
alpha,3,nucleosome organization (GO:0034728),4/80,4,80,0.201533314337694,0.653370299493796,0,0,1.72711571675302,2.76649495606298,BRD2;ZNHIT1;ANP32B;NAP1L4
alpha,3,cell-cell junction assembly (GO:0007043),4/80,4,80,0.201533314337694,0.653370299493796,0,0,1.72711571675302,2.76649495606298,TJP1;FLCN;CTNNA1;PRKCA
alpha,3,neuron projection extension (GO:1990138),2/29,2,29,0.204546153164245,0.653370299493796,0,0,2.38222857483176,3.78050536863375,ALCAM;IQGAP1
alpha,3,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),2/29,2,29,0.204546153164245,0.653370299493796,0,0,2.38222857483176,3.78050536863375,CNOT2;CRY2
alpha,3,aerobic respiration (GO:0009060),2/29,2,29,0.204546153164245,0.653370299493796,0,0,2.38222857483176,3.78050536863375,MDH2;PMPCB
alpha,3,negative regulation of JNK cascade (GO:0046329),2/29,2,29,0.204546153164245,0.653370299493796,0,0,2.38222857483176,3.78050536863375,NCOR1;HIPK3
alpha,3,cardiac muscle cell action potential involved in contraction (GO:0086002),2/29,2,29,0.204546153164245,0.653370299493796,0,0,2.38222857483176,3.78050536863375,CACNA1C;SNTA1
alpha,3,calcium ion import (GO:0070509),2/29,2,29,0.204546153164245,0.653370299493796,0,0,2.38222857483176,3.78050536863375,CACNB2;CACNA1C
alpha,3,regulation of DNA methylation (GO:0044030),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,KMT2A
alpha,3,positive regulation of macrophage differentiation (GO:0045651),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,PRKCA
alpha,3,neuron projection extension involved in neuron projection guidance (GO:1902284),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,ALCAM
alpha,3,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,CACNB2
alpha,3,stress-induced premature senescence (GO:0090400),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,MAPKAPK5
alpha,3,sulfur amino acid catabolic process (GO:0000098),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,BLMH
alpha,3,negative regulation of protein homooligomerization (GO:0032463),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,GBA
alpha,3,positive regulation of protein localization to Cajal body (GO:1904871),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,CCT4
alpha,3,glomerular visceral epithelial cell development (GO:0072015),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,IQGAP1
alpha,3,establishment of integrated proviral latency (GO:0075713),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,XRCC6
alpha,3,"peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)",1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,PRMT7
alpha,3,regulation of histone H4 acetylation (GO:0090239),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,CTBP1
alpha,3,positive regulation of chromatin binding (GO:0035563),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,GMNN
alpha,3,negative regulation of activated T cell proliferation (GO:0046007),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,PRNP
alpha,3,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly (GO:0045899),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,PSMC3
alpha,3,axon extension involved in axon guidance (GO:0048846),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,ALCAM
alpha,3,plasma membrane to endosome transport (GO:0048227),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,RAB11A
alpha,3,regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,SESN2
alpha,3,regulation of striated muscle cell differentiation (GO:0051153),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,AKAP13
alpha,3,"negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,UBE2J1
alpha,3,peptidyl-lysine hydroxylation (GO:0017185),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,PLOD3
alpha,3,genetic imprinting (GO:0071514),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,PRMT7
alpha,3,diol biosynthetic process (GO:0034312),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,GBA
alpha,3,protein localization to endosome (GO:0036010),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,TOLLIP
alpha,3,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,ROCK2
alpha,3,regulation of type B pancreatic cell development (GO:2000074),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,RHEB
alpha,3,sphingosine biosynthetic process (GO:0046512),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,GBA
alpha,3,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,VPS28
alpha,3,regulation of nitrogen compound metabolic process (GO:0051171),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,ROCK2
alpha,3,alpha-amino acid biosynthetic process (GO:1901607),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,GATM
alpha,3,ketone body biosynthetic process (GO:0046951),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,BDH1
alpha,3,cGMP-mediated signaling (GO:0019934),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,PDE2A
alpha,3,regulation of lipid transport (GO:0032368),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,NCOR1
alpha,3,regulation of cytoplasmic mRNA processing body assembly (GO:0010603),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,CNOT2
alpha,3,negative regulation of exocytosis (GO:0045920),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,RAB7A
alpha,3,glomerular epithelial cell development (GO:0072310),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,IQGAP1
alpha,3,response to hydroperoxide (GO:0033194),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,DAPK1
alpha,3,positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,RHOT1
alpha,3,peroxisomal transport (GO:0043574),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,ZFAND6
alpha,3,negative regulation of cAMP-dependent protein kinase activity (GO:2000480),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,PRKAR2A
alpha,3,negative regulation of vascular permeability (GO:0043116),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,PDE2A
alpha,3,negative regulation of cilium assembly (GO:1902018),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,CDK10
alpha,3,nucleotide phosphorylation (GO:0046939),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,PNKP
alpha,3,regulation of protein localization to Cajal body (GO:1904869),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,CCT4
alpha,3,positive regulation of chromatin silencing (GO:0031937),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,TRIM28
alpha,3,acylglycerol acyl-chain remodeling (GO:0036155),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,PNPLA2
alpha,3,positive regulation of TORC1 signaling (GO:1904263),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,RRAGD
alpha,3,peptidyl-lysine acetylation (GO:0018394),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,BAG6
alpha,3,nose development (GO:0043584),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,AXIN1
alpha,3,cellular monovalent inorganic anion homeostasis (GO:0030320),1/8,1,8,0.209476396735162,0.653370299493796,0,0,4.31778929188256,6.74932733469657,GPCPD1
alpha,3,negative regulation of cellular component organization (GO:0051129),3/55,3,55,0.212903826316217,0.653370299493796,0,0,1.88412623645784,2.91458263755171,TRAF3IP1;DNAJA4;WASL
alpha,3,protein catabolic process (GO:0030163),4/82,4,82,0.213615571034535,0.653370299493796,0,0,1.68499094317368,2.6009137309091,BAG6;PSMB3;SIAH1;IDE
alpha,3,regulation of cell motility (GO:2000145),5/110,5,110,0.21405957317615,0.653370299493796,0,0,1.5701051970482,2.42031861104226,FRMD5;ROCK2;RHOF;PHPT1;RHOBTB1
alpha,3,cellular response to cadmium ion (GO:0071276),2/30,2,30,0.215229370961012,0.653370299493796,0,0,2.3028209556707,3.53725038076342,HSF1;MT1X
alpha,3,keratan sulfate biosynthetic process (GO:0018146),2/30,2,30,0.215229370961012,0.653370299493796,0,0,2.3028209556707,3.53725038076342,B3GNT2;ST3GAL3
alpha,3,determination of bilateral symmetry (GO:0009855),2/30,2,30,0.215229370961012,0.653370299493796,0,0,2.3028209556707,3.53725038076342,GALNT11;AXIN1
alpha,3,cardiac muscle cell action potential (GO:0086001),2/30,2,30,0.215229370961012,0.653370299493796,0,0,2.3028209556707,3.53725038076342,KCNIP2;CACNA1C
alpha,3,positive regulation of histone modification (GO:0031058),2/30,2,30,0.215229370961012,0.653370299493796,0,0,2.3028209556707,3.53725038076342,CTBP1;PPARGC1A
alpha,3,lysosome localization (GO:0032418),2/30,2,30,0.215229370961012,0.653370299493796,0,0,2.3028209556707,3.53725038076342,VPS33A;HPS6
alpha,3,regulation of keratinocyte differentiation (GO:0045616),2/30,2,30,0.215229370961012,0.653370299493796,0,0,2.3028209556707,3.53725038076342,CBFB;ROCK2
alpha,3,coenzyme biosynthetic process (GO:0009108),2/30,2,30,0.215229370961012,0.653370299493796,0,0,2.3028209556707,3.53725038076342,GCH1;DCAKD
alpha,3,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),2/30,2,30,0.215229370961012,0.653370299493796,0,0,2.3028209556707,3.53725038076342,EIF4A1;CNOT2
alpha,3,viral gene expression (GO:0019080),5/111,5,111,0.219282188777407,0.653370299493796,0,0,1.5559601051829,2.36100739918463,RPL5;RPL7A;RPLP1;RPL35;RPS2
alpha,3,cellular response to insulin stimulus (GO:0032869),5/111,5,111,0.219282188777407,0.653370299493796,0,0,1.5559601051829,2.36100739918463,ATP6V1A;ATP6V0E1;PKM;GRB2;IDE
alpha,3,regulation of cellular catabolic process (GO:0031329),3/56,3,56,0.220504484781082,0.653370299493796,0,0,1.85048112509252,2.79762628637832,DRAM1;DAPK1;RRAGD
alpha,3,positive regulation of cysteine-type endopeptidase activity (GO:2001056),3/56,3,56,0.220504484781082,0.653370299493796,0,0,1.85048112509252,2.79762628637832,DAPK1;PERP;APOPT1
alpha,3,positive regulation of DNA biosynthetic process (GO:2000573),3/56,3,56,0.220504484781082,0.653370299493796,0,0,1.85048112509252,2.79762628637832,PNKP;MAPKAPK5;CCT4
alpha,3,positive regulation of protein ubiquitination (GO:0031398),4/84,4,84,0.22589221053288,0.653370299493796,0,0,1.64487211119335,2.44707186122026,AXIN1;DCUN1D1;STUB1;RPS2
alpha,3,ribosomal large subunit assembly (GO:0000027),2/31,2,31,0.225961658107163,0.653370299493796,0,0,2.22853640871358,3.31470265417765,RPL5;BOP1
alpha,3,smoothened signaling pathway (GO:0007224),2/31,2,31,0.225961658107163,0.653370299493796,0,0,2.22853640871358,3.31470265417765,DISP2;TMEM231
alpha,3,hippo signaling (GO:0035329),2/31,2,31,0.225961658107163,0.653370299493796,0,0,2.22853640871358,3.31470265417765,TJP1;SAV1
alpha,3,cellular response to cAMP (GO:0071320),2/31,2,31,0.225961658107163,0.653370299493796,0,0,2.22853640871358,3.31470265417765,RAP1B;PDE2A
alpha,3,negative regulation of transferase activity (GO:0051348),2/31,2,31,0.225961658107163,0.653370299493796,0,0,2.22853640871358,3.31470265417765,BAG5;PHPT1
alpha,3,regulation of cation transmembrane transport (GO:1904062),2/31,2,31,0.225961658107163,0.653370299493796,0,0,2.22853640871358,3.31470265417765,KCNIP2;SNTA1
alpha,3,protein localization to lysosome (GO:0061462),2/31,2,31,0.225961658107163,0.653370299493796,0,0,2.22853640871358,3.31470265417765,VPS4A;RAB7A
alpha,3,ATP-dependent chromatin remodeling (GO:0043044),2/31,2,31,0.225961658107163,0.653370299493796,0,0,2.22853640871358,3.31470265417765,ZNHIT1;ANP32B
alpha,3,nuclear envelope organization (GO:0006998),2/31,2,31,0.225961658107163,0.653370299493796,0,0,2.22853640871358,3.31470265417765,VPS4A;LEMD2
alpha,3,positive regulation of protein transport (GO:0051222),3/57,3,57,0.228159005577994,0.653370299493796,0,0,1.81801654395055,2.68650577257918,KIF20B;OAZ1;VPS28
alpha,3,negative regulation of cellular catabolic process (GO:0031330),3/57,3,57,0.228159005577994,0.653370299493796,0,0,1.81801654395055,2.68650577257918,RGP1;TLK2;TAB2
alpha,3,protein modification process (GO:0036211),4/85,4,85,0.232097332273275,0.653370299493796,0,0,1.62552067459108,2.37423299341362,USP25;B4GALT7;BAP1;PIGH
alpha,3,regulation of cell cycle G2/M phase transition (GO:1902749),4/85,4,85,0.232097332273275,0.653370299493796,0,0,1.62552067459108,2.37423299341362,NDE1;CEP164;CNTRL;TUBG1
alpha,3,negative regulation of interleukin-17 production (GO:0032700),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,PRNP
alpha,3,negative regulation of circadian rhythm (GO:0042754),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,CRY2
alpha,3,negative regulation of NIK/NF-kappaB signaling (GO:1901223),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,HDAC7
alpha,3,RNA destabilization (GO:0050779),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,YTHDF3
alpha,3,negative regulation of response to reactive oxygen species (GO:1901032),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,PDE8A
alpha,3,ATF6-mediated unfolded protein response (GO:0036500),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,MBTPS1
alpha,3,neuronal ion channel clustering (GO:0045161),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,KCNIP2
alpha,3,galactose catabolic process (GO:0019388),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,GALE
alpha,3,regulation of SNARE complex assembly (GO:0035542),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,STXBP1
alpha,3,potassium ion export (GO:0071435),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,KCNIP2
alpha,3,regulation of endothelial cell differentiation (GO:0045601),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,ZEB1
alpha,3,embryonic forelimb morphogenesis (GO:0035115),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,CACNA1C
alpha,3,mitochondrial respiratory chain complex III assembly (GO:0034551),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,TTC19
alpha,3,phagolysosome assembly (GO:0001845),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,RAB7A
alpha,3,somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,MSH6
alpha,3,peptidyl-arginine omega-N-methylation (GO:0035247),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,PRMT7
alpha,3,maintenance of protein localization in endoplasmic reticulum (GO:0035437),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,PDIA3
alpha,3,central nervous system neuron development (GO:0021954),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,GBA2
alpha,3,regulation of endoplasmic reticulum unfolded protein response (GO:1900101),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,COPS5
alpha,3,sphingoid biosynthetic process (GO:0046520),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,GBA
alpha,3,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,UBE2J1
alpha,3,establishment of viral latency (GO:0019043),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,XRCC6
alpha,3,heterochromatin organization (GO:0070828),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,MTHFR
alpha,3,respiratory chain complex III assembly (GO:0017062),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,TTC19
alpha,3,cellular response to oxygen levels (GO:0071453),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,ATP6V1A
alpha,3,early endosome to Golgi transport (GO:0034498),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,SNX1
alpha,3,regulation of protein ADP-ribosylation (GO:0010835),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,PNKP
alpha,3,positive regulation of establishment of protein localization to telomere (GO:1904851),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,CCT4
alpha,3,peptidyl-arginine methylation (GO:0018216),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,PRMT7
alpha,3,Notch signaling involved in heart development (GO:0061314),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,GALNT11
alpha,3,regulation of methylation-dependent chromatin silencing (GO:0090308),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,TRIM28
alpha,3,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,GAB2
alpha,3,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,EPCAM
alpha,3,protein modification by small protein conjugation or removal (GO:0070647),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,ZNF862
alpha,3,hexose catabolic process (GO:0019320),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,GALE
alpha,3,regulation of helicase activity (GO:0051095),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,MSH6
alpha,3,regulation of homotypic cell-cell adhesion (GO:0034110),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,PRKCA
alpha,3,negative regulation of amyloid-beta formation (GO:1902430),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,PRNP
alpha,3,neuron projection organization (GO:0106027),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,PRNP
alpha,3,mitochondrial fragmentation involved in apoptotic process (GO:0043653),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,CCAR2
alpha,3,lipoprotein biosynthetic process (GO:0042158),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,WIPI2
alpha,3,sphingosine metabolic process (GO:0006670),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,GBA
alpha,3,DNA topological change (GO:0006265),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,TOP1
alpha,3,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,AXIN1
alpha,3,negative regulation of peptidyl-lysine acetylation (GO:2000757),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,CTBP1
alpha,3,cyclic nucleotide catabolic process (GO:0009214),1/9,1,9,0.232371180845578,0.653370299493796,0,0,3.83803492611783,5.60130212390101,PDE2A
alpha,3,chloride transmembrane transport (GO:1902476),3/58,3,58,0.23586275320411,0.653370299493796,0,0,1.78667143112382,2.58085616820555,CLCN6;CLIC4;SLC12A6
alpha,3,cellular respiration (GO:0045333),3/58,3,58,0.23586275320411,0.653370299493796,0,0,1.78667143112382,2.58085616820555,MDH2;PMPCB;PPARGC1A
alpha,3,regulation of dendritic spine development (GO:0060998),2/32,2,32,0.2367312443859,0.653370299493796,0,0,2.15889464594128,3.11059967882771,FOXO6;LZTS3
alpha,3,alpha-amino acid metabolic process (GO:1901605),2/32,2,32,0.2367312443859,0.653370299493796,0,0,2.15889464594128,3.11059967882771,GATM;MTHFR
alpha,3,organelle transport along microtubule (GO:0072384),2/32,2,32,0.2367312443859,0.653370299493796,0,0,2.15889464594128,3.11059967882771,RHOT1;NDE1
alpha,3,renal water homeostasis (GO:0003091),2/32,2,32,0.2367312443859,0.653370299493796,0,0,2.15889464594128,3.11059967882771,PRKAR2A;RAB11A
alpha,3,response to cadmium ion (GO:0046686),2/32,2,32,0.2367312443859,0.653370299493796,0,0,2.15889464594128,3.11059967882771,HSF1;MT1X
alpha,3,lysosome organization (GO:0007040),2/32,2,32,0.2367312443859,0.653370299493796,0,0,2.15889464594128,3.11059967882771,MBTPS1;VPS33A
alpha,3,protein destabilization (GO:0031648),2/32,2,32,0.2367312443859,0.653370299493796,0,0,2.15889464594128,3.11059967882771,PRNP;FBXW11
alpha,3,mitochondrial ATP synthesis coupled electron transport (GO:0042775),4/86,4,86,0.238343757543015,0.653370299493796,0,0,1.60661927139816,2.30395836923323,COX4I1;NDUFB4;NDUFB3;PMPCB
alpha,3,regulation of type I interferon production (GO:0032479),4/86,4,86,0.238343757543015,0.653370299493796,0,0,1.60661927139816,2.30395836923323,XRCC6;TRAF3IP1;DHX9;POLR2L
alpha,3,receptor metabolic process (GO:0043112),3/59,3,59,0.243611174671579,0.653370299493796,0,0,1.7563888644946,2.48034051315095,SNX1;GRK4;GRB2
alpha,3,ubiquitin-dependent ERAD pathway (GO:0030433),3/59,3,59,0.243611174671579,0.653370299493796,0,0,1.7563888644946,2.48034051315095,BAG6;PSMC3;UBE2J1
alpha,3,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),3/59,3,59,0.243611174671579,0.653370299493796,0,0,1.7563888644946,2.48034051315095,TSG101;ITGA1;GRB2
alpha,3,cellular protein complex assembly (GO:0043623),6/145,6,145,0.244038173648376,0.653370299493796,0,0,1.42933714489905,2.01598087053389,PSMD11;ADRM1;PSMG2;RTN4;CCT6B;RBX1
alpha,3,7-methylguanosine mRNA capping (GO:0006370),2/33,2,33,0.247526997667333,0.653370299493796,0,0,2.09347359606427,2.9229824073652,GTF2H1;POLR2L
alpha,3,cellular response to amino acid stimulus (GO:0071230),2/33,2,33,0.247526997667333,0.653370299493796,0,0,2.09347359606427,2.9229824073652,SESN2;RRAGD
alpha,3,cellular response to glucagon stimulus (GO:0071377),2/33,2,33,0.247526997667333,0.653370299493796,0,0,2.09347359606427,2.9229824073652,GNG4;PRKAR2A
alpha,3,oxoacid metabolic process (GO:0043436),2/33,2,33,0.247526997667333,0.653370299493796,0,0,2.09347359606427,2.9229824073652,MINPP1;PPA1
alpha,3,sister chromatid segregation (GO:0000819),2/33,2,33,0.247526997667333,0.653370299493796,0,0,2.09347359606427,2.9229824073652,ZNF207;TUBG1
alpha,3,ceramide biosynthetic process (GO:0046513),2/33,2,33,0.247526997667333,0.653370299493796,0,0,2.09347359606427,2.9229824073652,GBA;DEGS1
alpha,3,protein trimerization (GO:0070206),2/33,2,33,0.247526997667333,0.653370299493796,0,0,2.09347359606427,2.9229824073652,HSF1;ASIC1
alpha,3,cyclic-nucleotide-mediated signaling (GO:0019935),2/33,2,33,0.247526997667333,0.653370299493796,0,0,2.09347359606427,2.9229824073652,DGKQ;PDE2A
alpha,3,7-methylguanosine RNA capping (GO:0009452),2/33,2,33,0.247526997667333,0.653370299493796,0,0,2.09347359606427,2.9229824073652,GTF2H1;POLR2L
alpha,3,endodermal cell differentiation (GO:0035987),2/33,2,33,0.247526997667333,0.653370299493796,0,0,2.09347359606427,2.9229824073652,LEO1;RTF1
alpha,3,G2 DNA damage checkpoint (GO:0031572),2/33,2,33,0.247526997667333,0.653370299493796,0,0,2.09347359606427,2.9229824073652,FZR1;DTL
alpha,3,positive regulation of telomere maintenance (GO:0032206),2/33,2,33,0.247526997667333,0.653370299493796,0,0,2.09347359606427,2.9229824073652,PNKP;MAPKAPK5
alpha,3,mismatch repair (GO:0006298),2/33,2,33,0.247526997667333,0.653370299493796,0,0,2.09347359606427,2.9229824073652,MSH6;LIG1
alpha,3,positive regulation of cellular component biogenesis (GO:0044089),4/88,4,88,0.250950899975654,0.653370299493796,0,0,1.5701051970482,2.17066725798847,TSG101;VPS4A;PRKCA;RAB7A
alpha,3,renal system development (GO:0072001),3/60,3,60,0.2513998028195,0.653370299493796,0,0,1.72711571675302,2.38464726624534,BAG6;TRAF3IP1;KCTD11
alpha,3,protein deglycosylation (GO:0006517),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,ENGASE
alpha,3,regulation of chromatin organization (GO:1902275),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,TLK2
alpha,3,negative regulation of cellular protein catabolic process (GO:1903363),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,RGP1
alpha,3,epithelial cell apoptotic process (GO:1904019),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,HIPK1
alpha,3,regulation of mammary gland epithelial cell proliferation (GO:0033599),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,RTN4
alpha,3,chloride ion homeostasis (GO:0055064),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,SLC12A6
alpha,3,protein K11-linked deubiquitination (GO:0035871),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,USP37
alpha,3,positive regulation of amyloid-beta formation (GO:1902004),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,ROCK2
alpha,3,pyroptosis (GO:0070269),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,DHX9
alpha,3,galactose metabolic process (GO:0006012),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,GALE
alpha,3,regulation of triglyceride catabolic process (GO:0010896),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,PNPLA2
alpha,3,positive regulation of bone remodeling (GO:0046852),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,PRKCA
alpha,3,aspartate family amino acid metabolic process (GO:0009066),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,MTHFR
alpha,3,ESCRT III complex disassembly (GO:1904903),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,VPS4A
alpha,3,negative regulation of inclusion body assembly (GO:0090084),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,DNAJA4
alpha,3,cellular copper ion homeostasis (GO:0006878),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,PRNP
alpha,3,astrocyte development (GO:0014002),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,EIF2B5
alpha,3,creatine metabolic process (GO:0006600),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,GATM
alpha,3,nuclear pore complex assembly (GO:0051292),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,RTN4
alpha,3,negative regulation of gene silencing by miRNA (GO:0060965),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,NCOR1
alpha,3,DNA dealkylation involved in DNA repair (GO:0006307),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,ALKBH5
alpha,3,telomere maintenance in response to DNA damage (GO:0043247),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,DCLRE1A
alpha,3,glycerolipid metabolic process (GO:0046486),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,DGKQ
alpha,3,actin filament depolymerization (GO:0030042),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,MICAL3
alpha,3,negative regulation of autophagosome assembly (GO:1902902),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,FEZ1
alpha,3,Rap protein signal transduction (GO:0032486),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,RAP1B
alpha,3,endosomal vesicle fusion (GO:0034058),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,VPS4A
alpha,3,regulation of establishment of protein localization to telomere (GO:0070203),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,CCT4
alpha,3,cellular response to ATP (GO:0071318),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,P2RX4
alpha,3,regulation of cytoplasmic translation (GO:2000765),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,DHX9
alpha,3,mitochondrial respiratory chain complex III biogenesis (GO:0097033),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,TTC19
alpha,3,positive regulation of circadian rhythm (GO:0042753),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,FBXW11
alpha,3,DNA dealkylation (GO:0035510),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,ALKBH5
alpha,3,IRES-dependent viral translational initiation (GO:0075522),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,SSB
alpha,3,protein deneddylation (GO:0000338),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,COPS5
alpha,3,negative regulation of protein maturation (GO:1903318),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,PRNP
alpha,3,intraciliary retrograde transport (GO:0035721),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,ICK
alpha,3,regulation of gene expression by genetic imprinting (GO:0006349),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,PRMT7
alpha,3,positive regulation of bone resorption (GO:0045780),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,PRKCA
alpha,3,actin filament-based transport (GO:0099515),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,WASL
alpha,3,negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,CNOT2
alpha,3,coenzyme A metabolic process (GO:0015936),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,DCAKD
alpha,3,ESCRT complex disassembly (GO:1904896),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,VPS4A
alpha,3,UV protection (GO:0009650),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,XPA
alpha,3,regulation of mRNA 3'-end processing (GO:0031440),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,LEO1
alpha,3,regulation of lysosomal lumen pH (GO:0035751),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,VPS33A
alpha,3,histone H2B ubiquitination (GO:0033523),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,LEO1
alpha,3,forelimb morphogenesis (GO:0035136),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,CACNA1C
alpha,3,ketone body metabolic process (GO:1902224),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,BDH1
alpha,3,intracellular cholesterol transport (GO:0032367),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,VPS4A
alpha,3,thyroid hormone generation (GO:0006590),1/10,1,10,0.254604008246492,0.653370299493796,0,0,3.45423143350605,4.7255469764203,DIDO1
alpha,3,activation of MAPK activity (GO:0000187),5/118,5,118,0.256845612061987,0.653370299493796,0,0,1.46365738707883,1.9895203680726,SPAG9;AXIN1;PLCE1;TAB2;MAP4K5
alpha,3,protein acetylation (GO:0006473),2/34,2,34,0.258338397087298,0.653370299493796,0,0,2.03190084323885,2.75014718451846,NAA50;MDH2
alpha,3,stem cell differentiation (GO:0048863),2/34,2,34,0.258338397087298,0.653370299493796,0,0,2.03190084323885,2.75014718451846,PSMD11;EPCAM
alpha,3,positive regulation of calcium ion transport (GO:0051928),2/34,2,34,0.258338397087298,0.653370299493796,0,0,2.03190084323885,2.75014718451846,CACNB2;P2RX4
alpha,3,cellular response to glucose starvation (GO:0042149),2/34,2,34,0.258338397087298,0.653370299493796,0,0,2.03190084323885,2.75014718451846,NUAK2;SESN2
alpha,3,regulation of intracellular protein transport (GO:0033157),2/34,2,34,0.258338397087298,0.653370299493796,0,0,2.03190084323885,2.75014718451846,KIF20B;OAZ1
alpha,3,regulation of protein kinase activity (GO:0045859),6/148,6,148,0.25854687501237,0.653370299493796,0,0,1.40036409466461,1.89424207646285,XRCC6;PRKRIP1;RPLP1;PLCE1;TAB2;IQGAP1
alpha,3,nucleosome assembly (GO:0006334),3/61,3,61,0.259224258847887,0.653370299493796,0,0,1.69880234434724,2.29348802794406,BRD2;ANP32B;NAP1L4
alpha,3,peptidyl-threonine modification (GO:0018210),4/90,4,90,0.263694558862882,0.653370299493796,0,0,1.53521397044713,2.04638467802904,GALNT11;ROCK2;CDK10;HIPK3
alpha,3,negative regulation of viral life cycle (GO:1903901),3/62,3,62,0.267080254904843,0.653370299493796,0,0,1.67140230653518,2.2065954965387,ILF3;TRIM28;MID2
alpha,3,keratan sulfate metabolic process (GO:0042339),2/35,2,35,0.269155506955903,0.653370299493796,0,0,1.97384653343203,2.5906064123142,B3GNT2;ST3GAL3
alpha,3,response to amino acid (GO:0043200),2/35,2,35,0.269155506955903,0.653370299493796,0,0,1.97384653343203,2.5906064123142,SESN2;RRAGD
alpha,3,response to peptide (GO:1901652),2/35,2,35,0.269155506955903,0.653370299493796,0,0,1.97384653343203,2.5906064123142,EIF2B5;PRNP
alpha,3,positive regulation of cytokinesis (GO:0032467),2/35,2,35,0.269155506955903,0.653370299493796,0,0,1.97384653343203,2.5906064123142,CSPP1;KIF20B
alpha,3,response to glucagon (GO:0033762),2/35,2,35,0.269155506955903,0.653370299493796,0,0,1.97384653343203,2.5906064123142,GNG4;PRKAR2A
alpha,3,protein tetramerization (GO:0051262),4/91,4,91,0.270111699173441,0.653370299493796,0,0,1.5183434872554,1.98738970926289,XRCC6;KCNC1;UXS1;SAMHD1
alpha,3,positive regulation of type I interferon production (GO:0032481),3/63,3,63,0.274963596142837,0.653370299493796,0,0,1.64487211119335,2.12372163457632,XRCC6;DHX9;POLR2L
alpha,3,establishment of protein localization to organelle (GO:0072594),3/63,3,63,0.274963596142837,0.653370299493796,0,0,1.64487211119335,2.12372163457632,PDIA3;HEATR3;RAB11A
alpha,3,positive regulation of posttranscriptional gene silencing (GO:0060148),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,DHX9
alpha,3,isotype switching (GO:0045190),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,MSH6
alpha,3,regulation of stem cell population maintenance (GO:2000036),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,CNOT2
alpha,3,negative regulation of defense response to virus (GO:0050687),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,TRAF3IP1
alpha,3,nitric oxide biosynthetic process (GO:0006809),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,GCH1
alpha,3,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,CCT4
alpha,3,negative regulation of protein localization to nucleus (GO:1900181),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,FLCN
alpha,3,immune response-regulating cell surface receptor signaling pathway (GO:0002768),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,BAG6
alpha,3,regulation of hydrogen peroxide-induced cell death (GO:1903205),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,PDE8A
alpha,3,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000059),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,RPL5
alpha,3,embryonic eye morphogenesis (GO:0048048),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,AXIN1
alpha,3,UV-damage excision repair (GO:0070914),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,XPA
alpha,3,negative regulation of JUN kinase activity (GO:0043508),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,HIPK3
alpha,3,protein localization to pre-autophagosomal structure (GO:0034497),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,WIPI2
alpha,3,positive regulation of leukocyte degranulation (GO:0043302),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,GAB2
alpha,3,chromatin silencing at rDNA (GO:0000183),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,BEND3
alpha,3,positive regulation of tumor necrosis factor secretion (GO:1904469),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,DHX9
alpha,3,muscle cell migration (GO:0014812),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,DDR1
alpha,3,positive regulation of protein deacetylation (GO:0090312),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,CTBP1
alpha,3,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,NOP14
alpha,3,regulation of ventricular cardiac muscle cell action potential (GO:0098911),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,CACNA1C
alpha,3,positive regulation of histone deacetylation (GO:0031065),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,CTBP1
alpha,3,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,ATF3
alpha,3,relaxation of cardiac muscle (GO:0055119),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,P2RX4
alpha,3,regulation of hemopoiesis (GO:1903706),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,CBFB
alpha,3,negative regulation of amyloid precursor protein catabolic process (GO:1902992),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,PRNP
alpha,3,T cell proliferation (GO:0042098),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,CTPS1
alpha,3,regulation of short-term neuronal synaptic plasticity (GO:0048172),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,PPFIA3
alpha,3,negative regulation of histone acetylation (GO:0035067),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,CTBP1
alpha,3,synaptonemal complex assembly (GO:0007130),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,BAG6
alpha,3,regulation of chromatin binding (GO:0035561),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,GMNN
alpha,3,negative regulation of cell division (GO:0051782),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,VPS4A
alpha,3,negative regulation of protein localization to cell surface (GO:2000009),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,TAX1BP3
alpha,3,response to sterol (GO:0036314),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,PMVK
alpha,3,relaxation of muscle (GO:0090075),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,P2RX4
alpha,3,regulation of RNA polymerase II transcriptional preinitiation complex assembly (GO:0045898),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,PSMC3
alpha,3,protein kinase C signaling (GO:0070528),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,DGKQ
alpha,3,methionine metabolic process (GO:0006555),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,MTHFR
alpha,3,phosphate ion homeostasis (GO:0055062),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,GPCPD1
alpha,3,negative regulation of cardiac muscle hypertrophy (GO:0010614),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,P2RX4
alpha,3,angiotensin maturation (GO:0002003),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,KCTD11
alpha,3,establishment of synaptic vesicle localization (GO:0097480),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,TMEM230
alpha,3,cellular response to increased oxygen levels (GO:0036295),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,ATP6V1A
alpha,3,positive regulation of fatty acid oxidation (GO:0046321),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,PPARGC1A
alpha,3,magnesium ion transport (GO:0015693),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,NIPA1
alpha,3,"regulation of synaptic transmission, GABAergic (GO:0032228)",1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,STXBP1
alpha,3,positive regulation of glucose metabolic process (GO:0010907),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,PPARGC1A
alpha,3,"negative regulation of translation, ncRNA-mediated (GO:0040033)",1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,AGO3
alpha,3,embryonic hemopoiesis (GO:0035162),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,KMT2A
alpha,3,aspartate family amino acid biosynthetic process (GO:0009067),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,PLOD3
alpha,3,carbohydrate derivative catabolic process (GO:1901136),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,SAMHD1
alpha,3,miRNA mediated inhibition of translation (GO:0035278),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,AGO3
alpha,3,regulation of mRNA polyadenylation (GO:1900363),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,HSF1
alpha,3,response to corticosteroid (GO:0031960),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,PDCD7
alpha,3,urate metabolic process (GO:0046415),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,ABCG2
alpha,3,cardiac muscle cell membrane repolarization (GO:0099622),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,KCNIP2
alpha,3,synaptonemal complex organization (GO:0070193),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,BAG6
alpha,3,positive regulation of interferon-gamma biosynthetic process (GO:0045078),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,CD276
alpha,3,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),1/11,1,11,0.276193985786479,0.653370299493796,0,0,3.1402103940964,4.04035739706027,UAP1
alpha,3,regulation of cyclin-dependent protein kinase activity (GO:1904029),2/36,2,36,0.279968951862955,0.653370299493796,0,0,1.91901746305891,2.44305616611965,SERTAD1;GTF2H1
alpha,3,regulation of heart rate by cardiac conduction (GO:0086091),2/36,2,36,0.279968951862955,0.653370299493796,0,0,1.91901746305891,2.44305616611965,CACNB2;CACNA1C
alpha,3,anatomical structure homeostasis (GO:0060249),2/36,2,36,0.279968951862955,0.653370299493796,0,0,1.91901746305891,2.44305616611965,PARP3;XRCC6
alpha,3,cholesterol biosynthetic process (GO:0006695),2/36,2,36,0.279968951862955,0.653370299493796,0,0,1.91901746305891,2.44305616611965,PMVK;DHCR24
alpha,3,regulation of sodium ion transport (GO:0002028),2/36,2,36,0.279968951862955,0.653370299493796,0,0,1.91901746305891,2.44305616611965,P2RX4;SNTA1
alpha,3,regulation of phosphoprotein phosphatase activity (GO:0043666),2/36,2,36,0.279968951862955,0.653370299493796,0,0,1.91901746305891,2.44305616611965,ITGA1;CRY2
alpha,3,actin filament bundle organization (GO:0061572),2/36,2,36,0.279968951862955,0.653370299493796,0,0,1.91901746305891,2.44305616611965,RHOF;RHOBTB1
alpha,3,negative regulation of protein modification process (GO:0031400),3/64,3,64,0.282870182554722,0.653370299493796,0,0,1.61917098445596,2.04463601922037,PRNP;TRAF3IP1;SNTA1
alpha,3,kidney development (GO:0001822),3/64,3,64,0.282870182554722,0.653370299493796,0,0,1.61917098445596,2.04463601922037,BAG6;TRAF3IP1;KCTD11
alpha,3,regulation of proteolysis (GO:0030162),3/64,3,64,0.282870182554722,0.653370299493796,0,0,1.61917098445596,2.04463601922037,BAG6;FBXW11;PERP
alpha,3,cellular transition metal ion homeostasis (GO:0046916),4/94,4,94,0.289516647759522,0.653370299493796,0,0,1.46988571638555,1.82198578386537,ATP6V1A;PRNP;MT1X;ABCG2
alpha,3,tumor necrosis factor-mediated signaling pathway (GO:0033209),5/124,5,124,0.290171514447361,0.653370299493796,0,0,1.39283525544599,1.72333152501263,PSMD9;PSMD11;PSMC3;PSMB3;PSMD1
alpha,3,actin polymerization or depolymerization (GO:0008154),2/37,2,37,0.290769892575733,0.653370299493796,0,0,1.86715212621948,2.30634938482663,MICAL3;WASL
alpha,3,regulation of nitric-oxide synthase activity (GO:0050999),2/37,2,37,0.290769892575733,0.653370299493796,0,0,1.86715212621948,2.30634938482663,GCH1;WASL
alpha,3,histone deacetylation (GO:0016575),2/37,2,37,0.290769892575733,0.653370299493796,0,0,1.86715212621948,2.30634938482663,ELK4;MORF4L1
alpha,3,acylglycerol metabolic process (GO:0006639),2/37,2,37,0.290769892575733,0.653370299493796,0,0,1.86715212621948,2.30634938482663,DGKQ;PNPLA2
alpha,3,regulation of ubiquitin protein ligase activity (GO:1904666),2/37,2,37,0.290769892575733,0.653370299493796,0,0,1.86715212621948,2.30634938482663,RPL5;FZR1
alpha,3,secondary alcohol biosynthetic process (GO:1902653),2/37,2,37,0.290769892575733,0.653370299493796,0,0,1.86715212621948,2.30634938482663,PMVK;DHCR24
alpha,3,glucose metabolic process (GO:0006006),3/65,3,65,0.290796010507065,0.653370299493796,0,0,1.59426066161817,1.96912435622715,MDH2;SLC25A10;PPARGC1A
alpha,3,negative regulation of neuron differentiation (GO:0045665),3/65,3,65,0.290796010507065,0.653370299493796,0,0,1.59426066161817,1.96912435622715,BAG5;PTPN9;CNTN4
alpha,3,positive regulation of cell adhesion (GO:0045785),3/65,3,65,0.290796010507065,0.653370299493796,0,0,1.59426066161817,1.96912435622715,FLCN;FRMD5;PRKCA
alpha,3,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,UBE2J1
alpha,3,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,HSF1
alpha,3,histone H3-K9 demethylation (GO:0033169),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,KDM3B
alpha,3,peptidyl-arginine modification (GO:0018195),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,PRMT7
alpha,3,negative regulation of protein oligomerization (GO:0032460),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,GBA
alpha,3,regulation of DNA-dependent DNA replication (GO:0090329),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,GMNN
alpha,3,ribose phosphate metabolic process (GO:0019693),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,PGD
alpha,3,regulation of IRE1-mediated unfolded protein response (GO:1903894),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,COPS5
alpha,3,positive regulation of establishment of protein localization (GO:1904951),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,CCT4
alpha,3,pentose-phosphate shunt (GO:0006098),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,PGD
alpha,3,mitochondrial outer membrane permeabilization (GO:0097345),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,RHOT1
alpha,3,amino sugar biosynthetic process (GO:0046349),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,UAP1
alpha,3,viral RNA genome replication (GO:0039694),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,ROCK2
alpha,3,UDP-N-acetylglucosamine metabolic process (GO:0006047),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,UAP1
alpha,3,protein insertion into membrane (GO:0051205),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,GET4
alpha,3,entry of bacterium into host cell (GO:0035635),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,GRB2
alpha,3,oligodendrocyte development (GO:0014003),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,EIF2B5
alpha,3,histone arginine methylation (GO:0034969),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,PRMT7
alpha,3,mitochondrion transport along microtubule (GO:0047497),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,RHOT1
alpha,3,lysine catabolic process (GO:0006554),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,DLST
alpha,3,regulation of histone methylation (GO:0031060),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,MTHFR
alpha,3,positive regulation of amyloid precursor protein catabolic process (GO:1902993),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,ROCK2
alpha,3,cellular glucan metabolic process (GO:0006073),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,PHKB
alpha,3,somatic hypermutation of immunoglobulin genes (GO:0016446),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,MSH6
alpha,3,nitric oxide metabolic process (GO:0046209),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,GCH1
alpha,3,histone H3 deacetylation (GO:0070932),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,ELK4
alpha,3,regulation of protein localization to cell periphery (GO:1904375),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,VPS4A
alpha,3,regulation of establishment of endothelial barrier (GO:1903140),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,ROCK2
alpha,3,tRNA 5'-leader removal (GO:0001682),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,SSB
alpha,3,cellular response to fluid shear stress (GO:0071498),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,MTSS1
alpha,3,lysine metabolic process (GO:0006553),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,DLST
alpha,3,activation of cysteine-type endopeptidase activity (GO:0097202),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,PERP
alpha,3,negative regulation of histone modification (GO:0031057),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,CTBP1
alpha,3,"regulation of protein import into nucleus, translocation (GO:0033158)",1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,PDE2A
alpha,3,regulation of sequestering of triglyceride (GO:0010889),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,PNPLA2
alpha,3,negative regulation of epithelial cell differentiation (GO:0030857),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,ZEB1
alpha,3,negative regulation of ATP metabolic process (GO:1903579),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,FLCN
alpha,3,aromatic compound biosynthetic process (GO:0019438),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,GCH1
alpha,3,regulation of angiotensin levels in blood (GO:0002002),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,KCTD11
alpha,3,protein hydroxylation (GO:0018126),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,PLOD3
alpha,3,peptidyl-methionine modification (GO:0018206),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,PDF
alpha,3,skeletal muscle cell differentiation (GO:0035914),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,LEMD2
alpha,3,PERK-mediated unfolded protein response (GO:0036499),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,ATF3
alpha,3,regulation of antigen receptor-mediated signaling pathway (GO:0050854),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,CBFB
alpha,3,endosome transport via multivesicular body sorting pathway (GO:0032509),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,RILP
alpha,3,membrane repolarization during action potential (GO:0086011),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,KCNIP2
alpha,3,positive regulation of neuron migration (GO:2001224),1/12,1,12,0.297159669740618,0.653370299493796,0,0,2.87852619458837,3.49305030536809,KIF20B
alpha,3,chromatin assembly (GO:0031497),3/66,3,66,0.298737173899038,0.656137784294792,0,0,1.5701051970482,1.89698713960365,BRD2;ANP32B;NAP1L4
alpha,3,myelination (GO:0042552),2/38,2,38,0.301550003025368,0.660054818324103,0,0,1.81801654395055,2.17947355522665,EIF2B5;MARVELD1
alpha,3,regulation of peptidyl-threonine phosphorylation (GO:0010799),2/38,2,38,0.301550003025368,0.660054818324103,0,0,1.81801654395055,2.17947355522665,DGKQ;AXIN1
alpha,3,actin filament bundle assembly (GO:0051017),2/38,2,38,0.301550003025368,0.660054818324103,0,0,1.81801654395055,2.17947355522665,RHOF;RHOBTB1
alpha,3,mitochondrion disassembly (GO:0061726),2/39,2,39,0.312301448164408,0.660054818324103,0,0,1.77140073513131,2.06153204483417,ATG4B;WIPI2
alpha,3,regulation of cellular amide metabolic process (GO:0034248),2/39,2,39,0.312301448164408,0.660054818324103,0,0,1.77140073513131,2.06153204483417,NOLC1;MAPKAPK5
alpha,3,positive regulation of DNA repair (GO:0045739),2/39,2,39,0.312301448164408,0.660054818324103,0,0,1.77140073513131,2.06153204483417,TRIM28;DHX9
alpha,3,chemical homeostasis (GO:0048878),2/39,2,39,0.312301448164408,0.660054818324103,0,0,1.77140073513131,2.06153204483417,EIF5A2;PNPLA2
alpha,3,protein lipidation (GO:0006497),5/128,5,128,0.312800406448312,0.660054818324103,0,0,1.3493091537133,1.56815356612241,ATG4B;CNTN4;WIPI2;RECK;PIGH
alpha,3,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),4/98,4,98,0.31566429382429,0.660054818324103,0,0,1.40989038102288,1.62571074888658,CAPZA1;CAPZA2;RILP;RAB7A
alpha,3,response to tumor necrosis factor (GO:0034612),4/98,4,98,0.31566429382429,0.660054818324103,0,0,1.40989038102288,1.62571074888658,GCH1;DHX9;ZFAND6;GBA
alpha,3,negative regulation of cell motility (GO:2000146),4/98,4,98,0.31566429382429,0.660054818324103,0,0,1.40989038102288,1.62571074888658,FLCN;FRMD5;CLIC4;RECK
alpha,3,antigen processing and presentation of exogenous peptide antigen (GO:0002478),4/98,4,98,0.31566429382429,0.660054818324103,0,0,1.40989038102288,1.62571074888658,CAPZA1;CAPZA2;RILP;RAB7A
alpha,3,positive regulation of histone H3-K4 methylation (GO:0051571),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,KMT2A
alpha,3,negative regulation of macrophage derived foam cell differentiation (GO:0010745),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,ABCA5
alpha,3,regulation of granulocyte chemotaxis (GO:0071622),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,KIF20B
alpha,3,cellular response to exogenous dsRNA (GO:0071360),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,DHX9
alpha,3,glycerolipid catabolic process (GO:0046503),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,GPCPD1
alpha,3,regulation of NMDA receptor activity (GO:2000310),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,DAPK1
alpha,3,muscle cell development (GO:0055001),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,AXIN1
alpha,3,viral translation (GO:0019081),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,SSB
alpha,3,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,TSG101
alpha,3,regulation of biomineral tissue development (GO:0070167),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,TXLNG
alpha,3,multivesicular body sorting pathway (GO:0071985),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,RILP
alpha,3,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,NCOR1
alpha,3,positive regulation of actin nucleation (GO:0051127),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,WASL
alpha,3,regulation of axon guidance (GO:1902667),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,ZSWIM8
alpha,3,positive regulation of endothelial cell chemotaxis (GO:2001028),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,P2RX4
alpha,3,positive regulation of protein complex disassembly (GO:0043243),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,GBA
alpha,3,regulation of macrophage differentiation (GO:0045649),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,PRKCA
alpha,3,catecholamine biosynthetic process (GO:0042423),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,GCH1
alpha,3,cardiocyte differentiation (GO:0035051),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,AKAP13
alpha,3,copper ion homeostasis (GO:0055070),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,PRNP
alpha,3,cellular response to interleukin-15 (GO:0071350),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,GRB2
alpha,3,tetrahydrofolate metabolic process (GO:0046653),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,MTHFR
alpha,3,synaptic vesicle localization (GO:0097479),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,TMEM230
alpha,3,B cell activation involved in immune response (GO:0002312),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,MSH6
alpha,3,ER-associated misfolded protein catabolic process (GO:0071712),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,BAG6
alpha,3,sensory perception of taste (GO:0050909),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,ASIC1
alpha,3,establishment of chromosome localization (GO:0051303),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,NDE1
alpha,3,membrane repolarization (GO:0086009),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,KCNIP2
alpha,3,regulation of endothelial cell chemotaxis (GO:2001026),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,P2RX4
alpha,3,regulation of neurotransmitter transport (GO:0051588),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,CPLX2
alpha,3,RNA interference (GO:0016246),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,DHX9
alpha,3,regulation of cAMP-dependent protein kinase activity (GO:2000479),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,PRKAR2A
alpha,3,regulation of fatty acid oxidation (GO:0046320),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,PPARGC1A
alpha,3,interleukin-15-mediated signaling pathway (GO:0035723),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,GRB2
alpha,3,glomerular visceral epithelial cell differentiation (GO:0072112),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,IQGAP1
alpha,3,high-density lipoprotein particle assembly (GO:0034380),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,APOM
alpha,3,protein kinase C-activating G-protein coupled receptor signaling pathway (GO:0007205),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,PLCE1
alpha,3,detection of calcium ion (GO:0005513),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,KCNIP2
alpha,3,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,TSEN54
alpha,3,pre-miRNA processing (GO:0031054),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,AGO3
alpha,3,regulation of cellular carbohydrate metabolic process (GO:0010675),1/13,1,13,0.317519081701099,0.660054818324103,0,0,2.65710110269696,3.04827251922236,PASK
alpha,3,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),4/99,4,99,0.322235655941859,0.666719624988525,0,0,1.39564906404285,1.58053369670283,CAPZA1;CAPZA2;RILP;RAB7A
alpha,3,histone modification (GO:0016570),4/99,4,99,0.322235655941859,0.666719624988525,0,0,1.39564906404285,1.58053369670283,NAA50;MORF4L1;PRMT7;TEX30
alpha,3,peptidyl-threonine phosphorylation (GO:0018107),3/69,3,69,0.322615099633608,0.666719624988525,0,0,1.50183975369828,1.69902426722321,ROCK2;CDK10;HIPK3
alpha,3,signal transduction by p53 class mediator (GO:0072331),2/40,2,40,0.323016862333984,0.666719624988525,0,0,1.72711571675302,1.95172841408249,SESN2;ZNF346
alpha,3,negative regulation of protein catabolic process (GO:0042177),2/40,2,40,0.323016862333984,0.666719624988525,0,0,1.72711571675302,1.95172841408249,RGP1;RILP
alpha,3,regulation of endothelial cell migration (GO:0010594),3/70,3,70,0.330580526515301,0.666719624988525,0,0,1.48038490007402,1.63864544602898,ROCK2;PRKCA;NR2F2
alpha,3,regulation of innate immune response (GO:0045088),3/70,3,70,0.330580526515301,0.666719624988525,0,0,1.48038490007402,1.63864544602898,DHX9;TRAFD1;SAMHD1
alpha,3,intraciliary transport involved in cilium assembly (GO:0035735),2/41,2,41,0.333689328998821,0.666719624988525,0,0,1.68499094317368,1.84935316831212,TRAF3IP1;TNPO1
alpha,3,regulation of protein dephosphorylation (GO:0035304),2/41,2,41,0.333689328998821,0.666719624988525,0,0,1.68499094317368,1.84935316831212,PPP1R7;GBA
alpha,3,sensory organ development (GO:0007423),2/41,2,41,0.333689328998821,0.666719624988525,0,0,1.68499094317368,1.84935316831212,SCO2;HIPK1
alpha,3,autophagy of mitochondrion (GO:0000422),2/41,2,41,0.333689328998821,0.666719624988525,0,0,1.68499094317368,1.84935316831212,ATG4B;WIPI2
alpha,3,positive regulation of mitotic cell cycle phase transition (GO:1901992),2/41,2,41,0.333689328998821,0.666719624988525,0,0,1.68499094317368,1.84935316831212,DTL;RAB11A
alpha,3,sterol biosynthetic process (GO:0016126),2/41,2,41,0.333689328998821,0.666719624988525,0,0,1.68499094317368,1.84935316831212,PMVK;DHCR24
alpha,3,phosphatidic acid biosynthetic process (GO:0006654),2/41,2,41,0.333689328998821,0.666719624988525,0,0,1.68499094317368,1.84935316831212,LPCAT4;DGKQ
alpha,3,neuron cell-cell adhesion (GO:0007158),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,CNTN4
alpha,3,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,PDE8A
alpha,3,acetyl-CoA metabolic process (GO:0006084),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,PMVK
alpha,3,positive regulation of myoblast differentiation (GO:0045663),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,BOC
alpha,3,establishment of mitotic spindle orientation (GO:0000132),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,NDE1
alpha,3,stem cell development (GO:0048864),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,NOLC1
alpha,3,regulation of nucleocytoplasmic transport (GO:0046822),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,KHDRBS1
alpha,3,pore complex assembly (GO:0046931),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,RTN4
alpha,3,regulation of platelet aggregation (GO:0090330),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,PRKCA
alpha,3,positive regulation of response to cytokine stimulus (GO:0060760),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,DHX9
alpha,3,regulation of extracellular matrix disassembly (GO:0010715),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,DDR1
alpha,3,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,PMPCB
alpha,3,negative regulation of Rho protein signal transduction (GO:0035024),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,FLCN
alpha,3,regulation of calcineurin-NFAT signaling cascade (GO:0070884),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,PRNP
alpha,3,negative regulation of hemopoiesis (GO:1903707),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,LEO1
alpha,3,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,CACNA1C
alpha,3,cell surface receptor signaling pathway involved in heart development (GO:0061311),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,GALNT11
alpha,3,oligodendrocyte differentiation (GO:0048709),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,EIF2B5
alpha,3,copper ion transport (GO:0006825),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,SLC31A2
alpha,3,purine-containing compound salvage (GO:0043101),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,APRT
alpha,3,amyloid-beta metabolic process (GO:0050435),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,IDE
alpha,3,smooth muscle contraction (GO:0006939),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,ROCK2
alpha,3,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,SNTA1
alpha,3,cAMP biosynthetic process (GO:0006171),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,ADORA2A
alpha,3,metallo-sulfur cluster assembly (GO:0031163),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,FAM96B
alpha,3,necroptotic process (GO:0070266),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,PGAM5
alpha,3,epiboly involved in wound healing (GO:0090505),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,DDR1
alpha,3,glycoside metabolic process (GO:0016137),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,GBA2
alpha,3,cellular response to nitrogen compound (GO:1901699),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,HSF1
alpha,3,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,TSEN54
alpha,3,purine nucleotide catabolic process (GO:0006195),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,DNPH1
alpha,3,positive regulation of purine nucleotide metabolic process (GO:1900544),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,BEND3
alpha,3,positive regulation of muscle hypertrophy (GO:0014742),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,PRKCA
alpha,3,histone H4-K16 acetylation (GO:0043984),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,KMT2A
alpha,3,regulation of interferon-gamma biosynthetic process (GO:0045072),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,CD276
alpha,3,positive regulation of transporter activity (GO:0032411),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,KMT2A
alpha,3,purine-containing compound catabolic process (GO:0072523),1/14,1,14,0.337289723862532,0.666719624988525,0,0,2.46730816679003,2.68150259868541,DNPH1
alpha,3,positive regulation of endothelial cell migration (GO:0010595),3/71,3,71,0.338543249811958,0.666719624988525,0,0,1.45953440852368,1.58082671790914,P2RX4;ROCK2;PRKCA
alpha,3,cytoskeleton-dependent cytokinesis (GO:0061640),3/71,3,71,0.338543249811958,0.666719624988525,0,0,1.45953440852368,1.58082671790914,VPS4A;TRIM36;SPIRE1
alpha,3,phospholipid metabolic process (GO:0006644),3/71,3,71,0.338543249811958,0.666719624988525,0,0,1.45953440852368,1.58082671790914,DGKE;LPCAT4;PLCE1
alpha,3,calcium-mediated signaling (GO:0019722),3/71,3,71,0.338543249811958,0.666719624988525,0,0,1.45953440852368,1.58082671790914,PRNP;PLCE1;CACNA1C
alpha,3,phosphatidic acid metabolic process (GO:0046473),2/42,2,42,0.344312360912465,0.666957751593133,0,0,1.64487211119335,1.75377252686331,LPCAT4;DGKQ
alpha,3,regulation of calcium-mediated signaling (GO:0050848),2/42,2,42,0.344312360912465,0.666957751593133,0,0,1.64487211119335,1.75377252686331,JSRP1;P2RX4
alpha,3,peptide transport (GO:0015833),2/42,2,42,0.344312360912465,0.666957751593133,0,0,1.64487211119335,1.75377252686331,RILP;RAB7A
alpha,3,positive regulation of cell division (GO:0051781),2/42,2,42,0.344312360912465,0.666957751593133,0,0,1.64487211119335,1.75377252686331,CSPP1;KIF20B
alpha,3,telomere organization (GO:0032200),2/42,2,42,0.344312360912465,0.666957751593133,0,0,1.64487211119335,1.75377252686331,PARP3;XRCC6
alpha,3,regulation of protein localization (GO:0032880),2/42,2,42,0.344312360912465,0.666957751593133,0,0,1.64487211119335,1.75377252686331,VPS4A;TMEM231
alpha,3,negative regulation of proteolysis (GO:0045861),2/42,2,42,0.344312360912465,0.666957751593133,0,0,1.64487211119335,1.75377252686331,BAG6;PRNP
alpha,3,nuclear import (GO:0051170),3/72,3,72,0.346499962473271,0.666957751593133,0,0,1.43926309729419,1.52543547589872,PDIA3;HEATR3;SNRPF
alpha,3,negative regulation of cell cycle (GO:0045786),3/73,3,73,0.35444745761458,0.666957751593133,0,0,1.41954716445454,1.47234744760967,HEXIM1;GMNN;NR2F2
alpha,3,cellular response to calcium ion (GO:0071277),2/43,2,43,0.354879881057824,0.666957751593133,0,0,1.60661927139816,1.66441886168111,CLIC4;IQGAP1
alpha,3,determination of left/right symmetry (GO:0007368),2/43,2,43,0.354879881057824,0.666957751593133,0,0,1.60661927139816,1.66441886168111,GALNT11;AXIN1
alpha,3,cellular response to radiation (GO:0071478),2/43,2,43,0.354879881057824,0.666957751593133,0,0,1.60661927139816,1.66441886168111,INTS7;GRB2
alpha,3,positive regulation of protein localization to nucleus (GO:1900182),2/43,2,43,0.354879881057824,0.666957751593133,0,0,1.60661927139816,1.66441886168111,SESN2;CCT4
alpha,3,ceramide metabolic process (GO:0006672),2/43,2,43,0.354879881057824,0.666957751593133,0,0,1.60661927139816,1.66441886168111,GBA;DEGS1
alpha,3,translesion synthesis (GO:0019985),2/43,2,43,0.354879881057824,0.666957751593133,0,0,1.60661927139816,1.66441886168111,USP43;DTL
alpha,3,positive regulation of peptidyl-lysine acetylation (GO:2000758),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,PPARGC1A
alpha,3,membrane repolarization during cardiac muscle cell action potential (GO:0086013),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,KCNIP2
alpha,3,regulation of mast cell degranulation (GO:0043304),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,GAB2
alpha,3,regulation of mRNA metabolic process (GO:1903311),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,DHX9
alpha,3,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,DECR2
alpha,3,nuclear pore organization (GO:0006999),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,RTN4
alpha,3,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,DGKQ
alpha,3,regulation of protein homooligomerization (GO:0032462),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,GBA
alpha,3,mitotic sister chromatid cohesion (GO:0007064),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,NAA50
alpha,3,response to X-ray (GO:0010165),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,XRCC6
alpha,3,negative regulation of TORC1 signaling (GO:1904262),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,SESN2
alpha,3,positive regulation of CREB transcription factor activity (GO:0032793),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,CRTC3
alpha,3,transport along microtubule (GO:0010970),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,APBA1
alpha,3,negative regulation of insulin secretion (GO:0046676),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,PSMD9
alpha,3,regulation of tumor necrosis factor secretion (GO:1904467),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,DHX9
alpha,3,cardiac muscle cell differentiation (GO:0055007),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,AKAP13
alpha,3,glycerophospholipid catabolic process (GO:0046475),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,GPCPD1
alpha,3,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,CCT4
alpha,3,regulation of clathrin-dependent endocytosis (GO:2000369),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,WASL
alpha,3,regulation of cell-substrate junction assembly (GO:0090109),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,ROCK2
alpha,3,intra-S DNA damage checkpoint (GO:0031573),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,EME2
alpha,3,positive regulation of phosphoprotein phosphatase activity (GO:0032516),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,ITGA1
alpha,3,negative regulation of cellular component movement (GO:0051271),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,FRMD5
alpha,3,cellular biogenic amine biosynthetic process (GO:0042401),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,SRM
alpha,3,response to cholesterol (GO:0070723),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,PMVK
alpha,3,neural crest cell differentiation (GO:0014033),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,NOLC1
alpha,3,N-terminal protein amino acid acetylation (GO:0006474),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,NAA50
alpha,3,mesenchymal cell development (GO:0014031),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,NOLC1
alpha,3,negative regulation of viral entry into host cell (GO:0046597),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,MID2
alpha,3,cofactor transport (GO:0051181),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,SLC25A19
alpha,3,filopodium assembly (GO:0046847),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,FGD4
alpha,3,negative regulation of RNA metabolic process (GO:0051253),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,NCOR1
alpha,3,monovalent inorganic anion homeostasis (GO:0055083),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,SLC12A6
alpha,3,regulation of protein complex disassembly (GO:0043244),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,GBA
alpha,3,negative regulation of protein processing (GO:0010955),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,PRNP
alpha,3,protein targeting to peroxisome (GO:0006625),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,ZFAND6
alpha,3,positive regulation of protein export from nucleus (GO:0046827),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,ANP32B
alpha,3,cytoplasmic sequestering of protein (GO:0051220),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,GET4
alpha,3,sulfate transport (GO:0008272),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,SLC25A10
alpha,3,nucleobase-containing small molecule catabolic process (GO:0034656),1/15,1,15,0.35648859414599,0.666957751593133,0,0,2.3028209556707,2.37525166061024,NUDT18
alpha,3,cellular response to organic cyclic compound (GO:0071407),5/136,5,136,0.358636360795371,0.669227034015901,0,0,1.26993802702428,1.30225328459589,RAP1B;P2RX4;ROCK2;PDE2A;CTNNA1
alpha,3,regulation of cellular response to stress (GO:0080135),4/105,4,105,0.361793789035415,0.669227034015901,0,0,1.31589768895468,1.33784801120286,SMG1;BAG5;HSF1;CCAR2
alpha,3,protein N-linked glycosylation (GO:0006487),3/74,3,74,0.362382628410169,0.669227034015901,0,0,1.40036409466461,1.42144607311686,B4GALT7;UBE2J1;ST3GAL3
alpha,3,regulation of peptide hormone secretion (GO:0090276),3/74,3,74,0.362382628410169,0.669227034015901,0,0,1.40036409466461,1.42144607311686,PRKCA;CACNA1C;PASK
alpha,3,nucleic acid phosphodiester bond hydrolysis (GO:0090305),3/74,3,74,0.362382628410169,0.669227034015901,0,0,1.40036409466461,1.42144607311686,XPA;GTF2H1;RBX1
alpha,3,chloride transport (GO:0006821),3/74,3,74,0.362382628410169,0.669227034015901,0,0,1.40036409466461,1.42144607311686,CLCN6;CLIC4;SLC12A6
alpha,3,mitotic metaphase plate congression (GO:0007080),2/44,2,44,0.365386204499573,0.669227034015901,0,0,1.5701051970482,1.5807825251495,VPS4A;RAB11A
alpha,3,negative regulation of protein metabolic process (GO:0051248),2/44,2,44,0.365386204499573,0.669227034015901,0,0,1.5701051970482,1.5807825251495,PRNP;RILP
alpha,3,membrane depolarization (GO:0051899),2/44,2,44,0.365386204499573,0.669227034015901,0,0,1.5701051970482,1.5807825251495,P2RX4;CACNA1C
alpha,3,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),2/44,2,44,0.365386204499573,0.669227034015901,0,0,1.5701051970482,1.5807825251495,BAG6;ZNF346
alpha,3,response to unfolded protein (GO:0006986),2/44,2,44,0.365386204499573,0.669227034015901,0,0,1.5701051970482,1.5807825251495,DNAJB5;HSF1
alpha,3,substantia nigra development (GO:0021762),2/44,2,44,0.365386204499573,0.669227034015901,0,0,1.5701051970482,1.5807825251495,ZNF148;INA
alpha,3,mitotic spindle organization (GO:0007052),3/75,3,75,0.370302467279325,0.669227034015901,0,0,1.38169257340242,1.37262193874215,ZNF207;TUBG1;RAB11A
alpha,3,"regulation of gene expression, epigenetic (GO:0040029)",3/75,3,75,0.370302467279325,0.669227034015901,0,0,1.38169257340242,1.37262193874215,PRMT7;TWISTNB;POLR2L
alpha,3,positive regulation of cellular catabolic process (GO:0031331),4/107,4,107,0.374982359687848,0.669227034015901,0,0,1.29130147046955,1.26660700201841,FLCN;DAPK1;MID2;PNPLA2
alpha,3,peptidyl-threonine dephosphorylation (GO:0035970),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,DUSP18
alpha,3,regulation of actin nucleation (GO:0051125),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,WASL
alpha,3,Notch receptor processing (GO:0007220),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,GALNT11
alpha,3,cellular response to dsRNA (GO:0071359),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,DHX9
alpha,3,DNA alkylation (GO:0006305),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,BEND3
alpha,3,glucose 6-phosphate metabolic process (GO:0051156),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,PGD
alpha,3,stabilization of membrane potential (GO:0030322),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,KCNK12
alpha,3,neuromuscular process (GO:0050905),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,GCH1
alpha,3,regulation of histone H3-K4 methylation (GO:0051569),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,KMT2A
alpha,3,positive regulation of mRNA processing (GO:0050685),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,LEO1
alpha,3,ventricular cardiac muscle cell action potential (GO:0086005),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,SNTA1
alpha,3,heme biosynthetic process (GO:0006783),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,NFE2L1
alpha,3,positive regulation of cardiac muscle hypertrophy (GO:0010613),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,PRKCA
alpha,3,DNA methylation or demethylation (GO:0044728),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,BEND3
alpha,3,negative regulation of translational initiation (GO:0045947),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,PAIP2
alpha,3,cellular response to pH (GO:0071467),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,ASIC1
alpha,3,neuron apoptotic process (GO:0051402),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,SIAH1
alpha,3,dendritic spine morphogenesis (GO:0060997),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,WASL
alpha,3,pyrimidine-containing compound metabolic process (GO:0072527),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,SLC25A19
alpha,3,negative regulation of DNA recombination (GO:0045910),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,MSH6
alpha,3,negative regulation of DNA replication (GO:0008156),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,GMNN
alpha,3,rRNA transcription (GO:0009303),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,GTF3C2
alpha,3,positive regulation of triglyceride metabolic process (GO:0090208),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,PNPLA2
alpha,3,positive regulation of nitric-oxide synthase activity (GO:0051000),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,GCH1
alpha,3,negative regulation of peptide hormone secretion (GO:0090278),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,PSMD9
alpha,3,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,HDAC7
alpha,3,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,CDK10
alpha,3,activation of protein kinase A activity (GO:0034199),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,PRKAR2A
alpha,3,protein localization to chromatin (GO:0071168),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,LEMD2
alpha,3,mitochondrial fusion (GO:0008053),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,CHCHD6
alpha,3,myoblast differentiation (GO:0045445),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,EPAS1
alpha,3,negative regulation of lipid storage (GO:0010888),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,PNPLA2
alpha,3,programmed necrotic cell death (GO:0097300),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,PGAM5
alpha,3,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),1/16,1,16,0.375132200411954,0.669227034015901,0,0,2.15889464594128,2.11674607233487,CCAR2
alpha,3,adherens junction organization (GO:0034332),2/45,2,45,0.375826020700354,0.669227034015901,0,0,1.53521397044713,1.50240484141897,CADM1;CTNNA1
alpha,3,amide biosynthetic process (GO:0043604),2/45,2,45,0.375826020700354,0.669227034015901,0,0,1.53521397044713,1.50240484141897,GBA;DEGS1
alpha,3,positive regulation of viral life cycle (GO:1903902),2/45,2,45,0.375826020700354,0.669227034015901,0,0,1.53521397044713,1.50240484141897,TSG101;VPS4A
alpha,3,protein N-linked glycosylation via asparagine (GO:0018279),2/45,2,45,0.375826020700354,0.669227034015901,0,0,1.53521397044713,1.50240484141897,UBE2J1;ST3GAL3
alpha,3,metaphase plate congression (GO:0051310),2/45,2,45,0.375826020700354,0.669227034015901,0,0,1.53521397044713,1.50240484141897,VPS4A;RAB11A
alpha,3,posttranscriptional regulation of gene expression (GO:0010608),2/45,2,45,0.375826020700354,0.669227034015901,0,0,1.53521397044713,1.50240484141897,NOLC1;MAPKAPK5
alpha,3,regulation of signal transduction by p53 class mediator (GO:1901796),5/139,5,139,0.375911783927299,0.669227034015901,0,0,1.24252929262807,1.21569162949491,HEXIM1;RPL5;BOP1;MAPKAPK5;HIPK1
alpha,3,negative regulation of phosphorylation (GO:0042326),3/76,3,76,0.378204065526211,0.672145049095805,0,0,1.36351240796291,1.32577225680784,PRNP;TRAF3IP1;PRKRIP1
alpha,3,C-terminal protein lipidation (GO:0006501),3/76,3,76,0.378204065526211,0.672145049095805,0,0,1.36351240796291,1.32577225680784,ATG4B;CNTN4;RECK
alpha,3,cellular response to starvation (GO:0009267),4/108,4,108,0.381568722001026,0.676031110207952,0,0,1.27934497537261,1.23260322161258,NUAK2;WDR59;SESN2;RRAGD
alpha,3,peptidyl-asparagine modification (GO:0018196),2/46,2,46,0.386194376954759,0.676031110207952,0,0,1.50183975369828,1.42887207182463,UBE2J1;ST3GAL3
alpha,3,peptidyl-tyrosine autophosphorylation (GO:0038083),2/46,2,46,0.386194376954759,0.676031110207952,0,0,1.50183975369828,1.42887207182463,DDR1;GRB2
alpha,3,regulation of cellular protein catabolic process (GO:1903362),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,RGP1
alpha,3,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,PSMC3
alpha,3,negative regulation of immune effector process (GO:0002698),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,TRAF3IP1
alpha,3,sialylation (GO:0097503),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,ST3GAL3
alpha,3,positive regulation of nitrogen compound metabolic process (GO:0051173),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,GBA
alpha,3,2-oxoglutarate metabolic process (GO:0006103),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,DLST
alpha,3,positive regulation of interleukin-6 secretion (GO:2000778),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,DHX9
alpha,3,preassembly of GPI anchor in ER membrane (GO:0016254),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,PIGH
alpha,3,positive regulation of fatty acid metabolic process (GO:0045923),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,PPARGC1A
alpha,3,positive regulation of response to biotic stimulus (GO:0002833),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,PRKCA
alpha,3,pigment granule transport (GO:0051904),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,RAB11A
alpha,3,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,PELI3
alpha,3,positive regulation of stem cell proliferation (GO:2000648),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,EPCAM
alpha,3,spindle assembly checkpoint (GO:0071173),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,ZNF207
alpha,3,negative regulation of intracellular transport (GO:0032387),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,ARHGAP1
alpha,3,positive regulation of cellular protein catabolic process (GO:1903364),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,GBA
alpha,3,rRNA catabolic process (GO:0016075),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,PELO
alpha,3,regulation of protein localization to membrane (GO:1905475),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,VPS4A
alpha,3,phospholipid catabolic process (GO:0009395),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,GPCPD1
alpha,3,positive regulation of signal transduction by p53 class mediator (GO:1901798),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,HEXIM1
alpha,3,long-term memory (GO:0007616),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,PRNP
alpha,3,macrophage activation (GO:0042116),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,CRTC3
alpha,3,regulation of transcription from RNA polymerase I promoter (GO:0006356),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,POLR2L
alpha,3,virion assembly (GO:0019068),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,TSG101
alpha,3,regulation of synaptic vesicle exocytosis (GO:2000300),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,STXBP1
alpha,3,heterocycle biosynthetic process (GO:0018130),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,GCH1
alpha,3,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,CACNA1C
alpha,3,chaperone-mediated protein complex assembly (GO:0051131),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,CCT6B
alpha,3,synaptic vesicle transport (GO:0048489),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,TMEM230
alpha,3,regulation of B cell receptor signaling pathway (GO:0050855),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,CBFB
alpha,3,purine-containing compound metabolic process (GO:0072521),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,ABCG2
alpha,3,melanosome transport (GO:0032402),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,RAB11A
alpha,3,nucleobase-containing compound biosynthetic process (GO:0034654),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,APRT
alpha,3,mitotic spindle assembly checkpoint (GO:0007094),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,ZNF207
alpha,3,mitotic spindle checkpoint (GO:0071174),1/17,1,17,0.393236574963659,0.676031110207952,0,0,2.03190084323885,1.8964622093012,ZNF207
alpha,3,water-soluble vitamin metabolic process (GO:0006767),3/78,3,78,0.393941394870154,0.676031110207952,0,0,1.32855055134848,1.23761541747319,ABCD4;SLC25A19;MTHFR
alpha,3,circulatory system development (GO:0072359),4/110,4,110,0.394716792266353,0.676031110207952,0,0,1.25608415763856,1.16763919339227,AKAP13;PLCE1;TAB2;CACNA1C
alpha,3,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),4/110,4,110,0.394716792266353,0.676031110207952,0,0,1.25608415763856,1.16763919339227,DAPK1;DIABLO;APOPT1;ANP32B
alpha,3,interleukin-12-mediated signaling pathway (GO:0035722),2/47,2,47,0.396486661817783,0.676031110207952,0,0,1.46988571638555,1.35981020582353,RAP1B;CAPZA1
alpha,3,protein methylation (GO:0006479),2/47,2,47,0.396486661817783,0.676031110207952,0,0,1.46988571638555,1.35981020582353,PRMT7;RPS2
alpha,3,cellular response to interleukin-12 (GO:0071349),2/47,2,47,0.396486661817783,0.676031110207952,0,0,1.46988571638555,1.35981020582353,RAP1B;CAPZA1
alpha,3,positive regulation of ion transport (GO:0043270),2/47,2,47,0.396486661817783,0.676031110207952,0,0,1.46988571638555,1.35981020582353,CACNB2;P2RX4
alpha,3,regulation of fibroblast proliferation (GO:0048145),2/47,2,47,0.396486661817783,0.676031110207952,0,0,1.46988571638555,1.35981020582353,DHX9;B4GALT7
alpha,3,mitotic spindle assembly (GO:0090307),2/47,2,47,0.396486661817783,0.676031110207952,0,0,1.46988571638555,1.35981020582353,ZNF207;RAB11A
alpha,3,regulation of cellular component movement (GO:0051270),2/47,2,47,0.396486661817783,0.676031110207952,0,0,1.46988571638555,1.35981020582353,ROCK2;ZSWIM8
alpha,3,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",2/47,2,47,0.396486661817783,0.676031110207952,0,0,1.46988571638555,1.35981020582353,NDUFB4;NDUFB3
alpha,3,positive regulation of macromolecule biosynthetic process (GO:0010557),5/143,5,143,0.398929887643637,0.676911111405616,0,0,1.20777322849862,1.10990687793551,RPL5;YTHDF3;DHX9;GBA;PASK
alpha,3,negative regulation of cytokine production (GO:0001818),4/111,4,111,0.401275093367588,0.676911111405616,0,0,1.24476808414632,1.13660778105223,PRNP;TRAF3IP1;GBA;HDAC7
alpha,3,regulation of cellular response to heat (GO:1900034),3/79,3,79,0.40177179544621,0.676911111405616,0,0,1.31173345576179,1.19613173026802,BAG5;HSF1;CCAR2
alpha,3,polyol metabolic process (GO:0019751),2/48,2,48,0.40669858984529,0.676911111405616,0,0,1.43926309729419,1.29488044528543,MINPP1;PLCE1
alpha,3,regulation of organelle assembly (GO:1902115),2/48,2,48,0.40669858984529,0.676911111405616,0,0,1.43926309729419,1.29488044528543,AKAP13;TSG101
alpha,3,postreplication repair (GO:0006301),2/48,2,48,0.40669858984529,0.676911111405616,0,0,1.43926309729419,1.29488044528543,USP43;DTL
alpha,3,"positive regulation of gene expression, epigenetic (GO:0045815)",2/48,2,48,0.40669858984529,0.676911111405616,0,0,1.43926309729419,1.29488044528543,TWISTNB;POLR2L
alpha,3,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),2/48,2,48,0.40669858984529,0.676911111405616,0,0,1.43926309729419,1.29488044528543,ALCAM;CADM1
alpha,3,inositol phosphate metabolic process (GO:0043647),2/48,2,48,0.40669858984529,0.676911111405616,0,0,1.43926309729419,1.29488044528543,MINPP1;PLCE1
alpha,3,response to calcium ion (GO:0051592),3/80,3,80,0.409573292413959,0.676911111405616,0,0,1.29533678756477,1.15626866768161,CLIC4;KCNIP2;IQGAP1
alpha,3,glucan catabolic process (GO:0009251),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,PHKB
alpha,3,regulation of adherens junction organization (GO:1903391),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,ROCK2
alpha,3,porphyrin-containing compound biosynthetic process (GO:0006779),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,NFE2L1
alpha,3,establishment of melanosome localization (GO:0032401),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,RAB11A
alpha,3,regulation of telomerase RNA localization to Cajal body (GO:1904872),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,CCT4
alpha,3,iron-sulfur cluster assembly (GO:0016226),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,FAM96B
alpha,3,regulation of spindle organization (GO:0090224),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,PARP3
alpha,3,nuclear envelope reassembly (GO:0031468),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,VPS4A
alpha,3,cardiac muscle cell contraction (GO:0086003),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,CACNA1C
alpha,3,calcium-mediated signaling using intracellular calcium source (GO:0035584),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,PRNP
alpha,3,positive regulation of lipid catabolic process (GO:0050996),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,PNPLA2
alpha,3,negative regulation of fibroblast proliferation (GO:0048147),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,B4GALT7
alpha,3,establishment of mitotic spindle localization (GO:0040001),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,NDE1
alpha,3,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,PRKCA
alpha,3,establishment or maintenance of apical/basal cell polarity (GO:0035088),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,CLIC4
alpha,3,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,BAG5
alpha,3,negative regulation of protein dephosphorylation (GO:0035308),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,CRY2
alpha,3,skeletal muscle contraction (GO:0003009),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,JSRP1
alpha,3,regulation of cardiac muscle cell membrane repolarization (GO:0099623),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,SNTA1
alpha,3,tRNA metabolic process (GO:0006399),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,SSB
alpha,3,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,CADM1
alpha,3,glycogen catabolic process (GO:0005980),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,PHKB
alpha,3,phosphatidylglycerol acyl-chain remodeling (GO:0036148),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,LPCAT4
alpha,3,regulation of cAMP-mediated signaling (GO:0043949),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,PDE2A
alpha,3,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,BAG5
alpha,3,DNA conformation change (GO:0071103),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,TOP1
alpha,3,regulation of epithelial cell differentiation (GO:0030856),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,RHEB
alpha,3,DNA methylation (GO:0006306),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,BEND3
alpha,3,glyceraldehyde-3-phosphate metabolic process (GO:0019682),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,PGD
alpha,3,mRNA destabilization (GO:0061157),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,YTHDF3
alpha,3,positive regulation of natural killer cell mediated immunity (GO:0002717),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,CADM1
alpha,3,negative regulation of calcium-mediated signaling (GO:0050849),1/18,1,18,0.410817287728675,0.676911111405616,0,0,1.91901746305891,1.7071708285063,PRNP
alpha,3,protein K48-linked ubiquitination (GO:0070936),2/49,2,49,0.416826186594293,0.683692941462275,0,0,1.40989038102288,1.23377528151299,ARIH2;RNF187
alpha,3,regulation of epithelial cell migration (GO:0010632),2/49,2,49,0.416826186594293,0.683692941462275,0,0,1.40989038102288,1.23377528151299,RTN4;RAB11A
alpha,3,glycoprotein metabolic process (GO:0009100),2/49,2,49,0.416826186594293,0.683692941462275,0,0,1.40989038102288,1.23377528151299,B4GALT7;ENGASE
alpha,3,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),2/49,2,49,0.416826186594293,0.683692941462275,0,0,1.40989038102288,1.23377528151299,MSH6;BAG6
alpha,3,regulation of protein serine/threonine kinase activity (GO:0071900),3/81,3,81,0.417343458077468,0.683692941462275,0,0,1.27934497537261,1.11795017682527,TSG101;SERTAD1;GTF2H1
alpha,3,negative regulation of defense response (GO:0031348),3/81,3,81,0.417343458077468,0.683692941462275,0,0,1.27934497537261,1.11795017682527,TRAF3IP1;GBA;TRAFD1
alpha,3,negative regulation of cell death (GO:0060548),3/82,3,82,0.42507995758864,0.683692941462275,0,0,1.26374320738026,1.08110450176962,GBA;PDE8A;PPARGC1A
alpha,3,RNA methylation (GO:0001510),2/50,2,50,0.426865774004167,0.683692941462275,0,0,1.38169257340242,1.17621507670496,METTL2B;TGS1
alpha,3,regulation of reactive oxygen species metabolic process (GO:2000377),2/50,2,50,0.426865774004167,0.683692941462275,0,0,1.38169257340242,1.17621507670496,ARF4;GRB2
alpha,3,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,FLCN
alpha,3,negative regulation of smoothened signaling pathway (GO:0045879),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,KCTD6
alpha,3,histone methylation (GO:0016571),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,PRMT7
alpha,3,negative regulation of cell junction assembly (GO:1901889),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,ROCK2
alpha,3,organelle fusion (GO:0048284),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,CHCHD6
alpha,3,NADP metabolic process (GO:0006739),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,PGD
alpha,3,negative regulation of double-strand break repair (GO:2000780),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,HSF1
alpha,3,posttranscriptional gene silencing by RNA (GO:0035194),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,AGO3
alpha,3,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,RPL5
alpha,3,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,NOP14
alpha,3,vesicle transport along microtubule (GO:0047496),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,NDE1
alpha,3,production of small RNA involved in gene silencing by RNA (GO:0070918),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,AGO3
alpha,3,acylglycerol biosynthetic process (GO:0046463),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,PLCE1
alpha,3,morphogenesis of an epithelium (GO:0002009),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,TRAF3IP1
alpha,3,cellular response to zinc ion (GO:0071294),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,MT1X
alpha,3,positive regulation of oxidoreductase activity (GO:0051353),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,POR
alpha,3,osteoclast differentiation (GO:0030316),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,GAB2
alpha,3,regulation of transcription factor import into nucleus (GO:0042990),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,TRIM28
alpha,3,folic acid metabolic process (GO:0046655),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,MTHFR
alpha,3,striated muscle cell differentiation (GO:0051146),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,AKAP13
alpha,3,insulin secretion (GO:0030073),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,PTPRN
alpha,3,regulation of neuron migration (GO:2001222),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,KIF20B
alpha,3,nucleotide-sugar biosynthetic process (GO:0009226),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,UAP1
alpha,3,regulation of platelet activation (GO:0010543),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,PRKCA
alpha,3,calcium ion transport into cytosol (GO:0060402),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,CACNA1C
alpha,3,aspartate family amino acid catabolic process (GO:0009068),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,DLST
alpha,3,telomere capping (GO:0016233),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,DCLRE1A
alpha,3,protein heterotetramerization (GO:0051290),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,XRCC6
alpha,3,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,FLCN
alpha,3,positive regulation of neuron apoptotic process (GO:0043525),1/19,1,19,0.427889459962784,0.683692941462275,0,0,1.81801654395055,1.54329676915382,PRNP
alpha,3,positive regulation of DNA metabolic process (GO:0051054),3/83,3,83,0.432780547910074,0.689310237397346,0,0,1.24851738560459,1.04566389564245,PARP3;TRIM28;DHX9
alpha,3,ephrin receptor signaling pathway (GO:0048013),3/83,3,83,0.432780547910074,0.689310237397346,0,0,1.24851738560459,1.04566389564245,ROCK2;WASL;ACTG1
alpha,3,C-terminal protein amino acid modification (GO:0018410),3/83,3,83,0.432780547910074,0.689310237397346,0,0,1.24851738560459,1.04566389564245,ATG4B;CNTN4;RECK
alpha,3,blood circulation (GO:0008015),2/51,2,51,0.436813957015971,0.689310237397346,0,0,1.35460056215923,1.12194507390908,ADORA2A;MTHFR
alpha,3,regulation of blood vessel endothelial cell migration (GO:0043535),2/51,2,51,0.436813957015971,0.689310237397346,0,0,1.35460056215923,1.12194507390908,P2RX4;PRKCA
alpha,3,positive regulation of homeostatic process (GO:0032846),3/84,3,84,0.440443076211673,0.689310237397346,0,0,1.23365408339502,1.01156435647098,P2RX4;PRKCA;PPARGC1A
alpha,3,protein maturation (GO:0051604),3/84,3,84,0.440443076211673,0.689310237397346,0,0,1.23365408339502,1.01156435647098,CPD;PMPCB;STUB1
alpha,3,vacuolar acidification (GO:0007035),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,ATP6V0E1
alpha,3,negative regulation of innate immune response (GO:0045824),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,TRAFD1
alpha,3,Golgi to endosome transport (GO:0006895),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,VPS13A
alpha,3,mesoderm formation (GO:0001707),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,AXIN1
alpha,3,proteoglycan metabolic process (GO:0006029),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,B4GALT7
alpha,3,negative regulation of phosphate metabolic process (GO:0045936),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,PRKRIP1
alpha,3,positive regulation of dendritic spine development (GO:0060999),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,FOXO6
alpha,3,regulation of regulatory T cell differentiation (GO:0045589),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,CBFB
alpha,3,"wound healing, spreading of cells (GO:0044319)",1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,DDR1
alpha,3,synapsis (GO:0007129),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,BAG6
alpha,3,cellular polysaccharide catabolic process (GO:0044247),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,PHKB
alpha,3,neuromuscular junction development (GO:0007528),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,CACNB2
alpha,3,"regulation of DNA-templated transcription, elongation (GO:0032784)",1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,CCAR2
alpha,3,purine nucleotide metabolic process (GO:0006163),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,DNPH1
alpha,3,regulation of calcium ion transmembrane transport (GO:1903169),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,PRNP
alpha,3,axon extension (GO:0048675),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,ALCAM
alpha,3,Arp2/3 complex-mediated actin nucleation (GO:0034314),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,ARPC5L
alpha,3,negative regulation of response to biotic stimulus (GO:0002832),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,TRAF3IP1
alpha,3,positive regulation of gene silencing by miRNA (GO:2000637),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,DHX9
alpha,3,glial cell development (GO:0021782),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,EIF2B5
alpha,3,negative regulation of telomere maintenance via telomerase (GO:0032211),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,PAPD5
alpha,3,positive regulation of interferon-alpha production (GO:0032727),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,DHX9
alpha,3,regulation of glycogen biosynthetic process (GO:0005979),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,PASK
alpha,3,adrenergic receptor signaling pathway (GO:0071875),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,AKAP13
alpha,3,inositol phosphate-mediated signaling (GO:0048016),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,PLCE1
alpha,3,eye morphogenesis (GO:0048592),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,AXIN1
alpha,3,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,DSTYK
alpha,3,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,CDK10
alpha,3,negative regulation of interferon-gamma production (GO:0032689),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,PRNP
alpha,3,immune response-activating cell surface receptor signaling pathway (GO:0002429),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,BAG6
alpha,3,entrainment of circadian clock by photoperiod (GO:0043153),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,CRY2
alpha,3,regulation of transport (GO:0051049),1/20,1,20,0.444467776980699,0.689310237397346,0,0,1.72711571675302,1.40047965351941,RAB11A
alpha,3,telomere maintenance (GO:0000723),2/52,2,52,0.446667610039376,0.691792485906355,0,0,1.32855055134848,1.07073277890138,PARP3;XRCC6
alpha,3,protein localization to cell periphery (GO:1990778),4/118,4,118,0.446740628653812,0.691792485906355,0,0,1.17092590966307,0.943505285998468,CACNB2;ROCK2;STXBP1;RAB11A
alpha,3,regulation of calcium ion transport (GO:0051924),2/53,2,53,0.45642386431571,0.70003386896031,0,0,1.3034835598136,1.02236565868585,CACNB2;P2RX4
alpha,3,plasma membrane bounded cell projection morphogenesis (GO:0120039),2/53,2,53,0.45642386431571,0.70003386896031,0,0,1.3034835598136,1.02236565868585,SNX1;KIF20B
alpha,3,positive regulation of mitotic cell cycle (GO:0045931),2/53,2,53,0.45642386431571,0.70003386896031,0,0,1.3034835598136,1.02236565868585,HSF1;PRKCA
alpha,3,regulation of phosphorylation (GO:0042325),4/120,4,120,0.45954424355842,0.70003386896031,0,0,1.15141047783535,0.895244738645775,FLCN;KCTD20;PRKRIP1;SESN2
alpha,3,RNA export from nucleus (GO:0006405),4/120,4,120,0.45954424355842,0.70003386896031,0,0,1.15141047783535,0.895244738645775,ALKBH5;SMG1;SSB;SRSF11
alpha,3,cobalamin metabolic process (GO:0009235),1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,ABCD4
alpha,3,positive regulation of cellular component movement (GO:0051272),1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,PHPT1
alpha,3,regulation of interleukin-17 production (GO:0032660),1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,PRNP
alpha,3,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,COX4I1
alpha,3,energy reserve metabolic process (GO:0006112),1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,PHKB
alpha,3,histone lysine demethylation (GO:0070076),1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,KDM3B
alpha,3,cellular protein complex localization (GO:0034629),1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,KLHL21
alpha,3,establishment of spindle orientation (GO:0051294),1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,NDE1
alpha,3,histone ubiquitination (GO:0016574),1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,LEO1
alpha,3,tetrapyrrole metabolic process (GO:0033013),1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,ABCD4
alpha,3,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,BAG6
alpha,3,dopamine metabolic process (GO:0042417),1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,GCH1
alpha,3,positive regulation of histone acetylation (GO:0035066),1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,PPARGC1A
alpha,3,protein O-linked glycosylation via threonine (GO:0018243),1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,GALNT11
alpha,3,negative regulation of protein tyrosine kinase activity (GO:0061099),1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,TSG101
alpha,3,negative regulation of viral process (GO:0048525),1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,MID2
alpha,3,mitochondrial calcium ion transmembrane transport (GO:0006851),1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,PMPCB
alpha,3,lipid catabolic process (GO:0016042),1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,CES2
alpha,3,photoperiodism (GO:0009648),1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,CRY2
alpha,3,phosphatidylserine acyl-chain remodeling (GO:0036150),1/21,1,21,0.460566500763974,0.70003386896031,0,0,1.64487211119335,1.27526609721519,LPCAT4
alpha,3,calcium ion transmembrane transport (GO:0070588),3/87,3,87,0.463182086691639,0.703489840894017,0,0,1.19111428741588,0.916723276060605,P2RX4;PMPCB;CACNA1C
alpha,3,sensory perception (GO:0007600),2/55,2,55,0.47563391315407,0.710158358116935,0,0,1.25608415763856,0.933404692309154,P2RX4;ADORA2A
alpha,3,intracellular transport of virus (GO:0075733),2/55,2,55,0.47563391315407,0.710158358116935,0,0,1.25608415763856,0.933404692309154,TSG101;VPS28
alpha,3,membrane fusion (GO:0061025),2/55,2,55,0.47563391315407,0.710158358116935,0,0,1.25608415763856,0.933404692309154,RABIF;CHCHD6
alpha,3,transport of virus (GO:0046794),2/55,2,55,0.47563391315407,0.710158358116935,0,0,1.25608415763856,0.933404692309154,TSG101;VPS28
alpha,3,glycosphingolipid metabolic process (GO:0006687),2/55,2,55,0.47563391315407,0.710158358116935,0,0,1.25608415763856,0.933404692309154,GBA;GBA2
alpha,3,regulation of calcium ion import (GO:0090279),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,PRNP
alpha,3,positive regulation of protein targeting to membrane (GO:0090314),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,PRNP
alpha,3,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,CACNA1C
alpha,3,negative regulation of response to endoplasmic reticulum stress (GO:1903573),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,USP25
alpha,3,regulation of transcription from RNA polymerase III promoter (GO:0006359),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,ZNF76
alpha,3,sulfur amino acid metabolic process (GO:0000096),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,MTHFR
alpha,3,negative regulation of myeloid cell differentiation (GO:0045638),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,LEO1
alpha,3,cytosolic calcium ion transport (GO:0060401),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,CACNA1C
alpha,3,histone lysine methylation (GO:0034968),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,KMT2A
alpha,3,embryonic skeletal system morphogenesis (GO:0048704),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,AXIN1
alpha,3,triglyceride catabolic process (GO:0019433),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,PNPLA2
alpha,3,phosphatidylglycerol metabolic process (GO:0046471),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,LPCAT4
alpha,3,purine-containing compound biosynthetic process (GO:0072522),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,APRT
alpha,3,protein O-linked glycosylation via serine (GO:0018242),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,GALNT11
alpha,3,beta-catenin destruction complex disassembly (GO:1904886),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,AXIN1
alpha,3,negative regulation of protein import into nucleus (GO:0042308),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,PDE2A
alpha,3,cellular response to unfolded protein (GO:0034620),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,HSF1
alpha,3,regulation of bone resorption (GO:0045124),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,PRKCA
alpha,3,negative regulation of lyase activity (GO:0051350),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,PHPT1
alpha,3,positive regulation of phosphatase activity (GO:0010922),1/22,1,22,0.476199482119228,0.710158358116935,0,0,1.5701051970482,1.16488998658791,ITGA1
alpha,3,regulation of axonogenesis (GO:0050770),2/56,2,56,0.485083146975671,0.722328853572335,0,0,1.23365408339502,0.892468499475781,ZSWIM8;RTN4
alpha,3,fat cell differentiation (GO:0045444),2/56,2,56,0.485083146975671,0.722328853572335,0,0,1.23365408339502,0.892468499475781,CTBP1;PPARGC1A
alpha,3,mitochondrial translational termination (GO:0070126),3/90,3,90,0.485509409365335,0.722328853572335,0,0,1.15141047783535,0.831959252349422,MRPS34;MRPL14;MRRF
alpha,3,regulation of natural killer cell mediated cytotoxicity (GO:0042269),1/23,1,23,0.491380172498187,0.722328853572335,0,0,1.50183975369828,1.06711296645737,CADM1
alpha,3,regulation of protein oligomerization (GO:0032459),1/23,1,23,0.491380172498187,0.722328853572335,0,0,1.50183975369828,1.06711296645737,IDE
alpha,3,negative regulation of viral transcription (GO:0032897),1/23,1,23,0.491380172498187,0.722328853572335,0,0,1.50183975369828,1.06711296645737,MID2
alpha,3,microtubule polymerization or depolymerization (GO:0031109),1/23,1,23,0.491380172498187,0.722328853572335,0,0,1.50183975369828,1.06711296645737,ZNF207
alpha,3,positive regulation of ERBB signaling pathway (GO:1901186),1/23,1,23,0.491380172498187,0.722328853572335,0,0,1.50183975369828,1.06711296645737,RTN4
alpha,3,glycolytic process (GO:0006096),1/23,1,23,0.491380172498187,0.722328853572335,0,0,1.50183975369828,1.06711296645737,PKM
alpha,3,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),1/23,1,23,0.491380172498187,0.722328853572335,0,0,1.50183975369828,1.06711296645737,GBA
alpha,3,positive regulation of protein oligomerization (GO:0032461),1/23,1,23,0.491380172498187,0.722328853572335,0,0,1.50183975369828,1.06711296645737,IDE
alpha,3,TOR signaling (GO:0031929),1/23,1,23,0.491380172498187,0.722328853572335,0,0,1.50183975369828,1.06711296645737,FLCN
alpha,3,regulation of smooth muscle contraction (GO:0006940),1/23,1,23,0.491380172498187,0.722328853572335,0,0,1.50183975369828,1.06711296645737,PLCE1
alpha,3,folic acid-containing compound metabolic process (GO:0006760),1/23,1,23,0.491380172498187,0.722328853572335,0,0,1.50183975369828,1.06711296645737,MTHFR
alpha,3,regulation of dendritic spine morphogenesis (GO:0061001),1/23,1,23,0.491380172498187,0.722328853572335,0,0,1.50183975369828,1.06711296645737,LZTS3
alpha,3,protein localization to Golgi apparatus (GO:0034067),1/23,1,23,0.491380172498187,0.722328853572335,0,0,1.50183975369828,1.06711296645737,VPS13A
alpha,3,negative regulation of axonogenesis (GO:0050771),1/23,1,23,0.491380172498187,0.722328853572335,0,0,1.50183975369828,1.06711296645737,RTN4
alpha,3,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),1/23,1,23,0.491380172498187,0.722328853572335,0,0,1.50183975369828,1.06711296645737,CACNA1C
alpha,3,cellular response to amyloid-beta (GO:1904646),1/23,1,23,0.491380172498187,0.722328853572335,0,0,1.50183975369828,1.06711296645737,PRNP
alpha,3,negative regulation of axon extension (GO:0030517),1/23,1,23,0.491380172498187,0.722328853572335,0,0,1.50183975369828,1.06711296645737,RTN4
alpha,3,positive regulation of response to external stimulus (GO:0032103),3/91,3,91,0.492852509768979,0.722676403401434,0,0,1.13875761544155,0.805722619740328,DHX9;PDE2A;PRKCA
alpha,3,regulation of JNK cascade (GO:0046328),3/91,3,91,0.492852509768979,0.722676403401434,0,0,1.13875761544155,0.805722619740328,NCOR1;COPS5;AXIN1
alpha,3,ribosome assembly (GO:0042255),2/57,2,57,0.49442583867309,0.722676403401434,0,0,1.21201102930037,0.853689799734586,RPL5;BOP1
alpha,3,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),2/57,2,57,0.49442583867309,0.722676403401434,0,0,1.21201102930037,0.853689799734586,PELI3;HIPK1
alpha,3,cellular defense response (GO:0006968),2/57,2,57,0.49442583867309,0.722676403401434,0,0,1.21201102930037,0.853689799734586,ADORA2A;ZNF148
alpha,3,organonitrogen compound catabolic process (GO:1901565),2/57,2,57,0.49442583867309,0.722676403401434,0,0,1.21201102930037,0.853689799734586,SIAH1;IDE
alpha,3,protein import (GO:0017038),2/57,2,57,0.49442583867309,0.722676403401434,0,0,1.21201102930037,0.853689799734586,PDIA3;HEATR3
alpha,3,cellular iron ion homeostasis (GO:0006879),2/57,2,57,0.49442583867309,0.722676403401434,0,0,1.21201102930037,0.853689799734586,ATP6V1A;ABCG2
alpha,3,cytoskeleton organization (GO:0007010),4/127,4,127,0.503484229859823,0.734088352318881,0,0,1.08794690819088,0.746552310768941,NCKIPSD;FGD4;MICAL3;PLCE1
alpha,3,regulation of Rho protein signal transduction (GO:0035023),2/58,2,58,0.503660230065238,0.734088352318881,0,0,1.19111428741588,0.81692976588147,AKAP13;FLCN
alpha,3,tRNA modification (GO:0006400),2/58,2,58,0.503660230065238,0.734088352318881,0,0,1.19111428741588,0.81692976588147,METTL2B;SSB
alpha,3,I-kappaB kinase/NF-kappaB signaling (GO:0007249),2/58,2,58,0.503660230065238,0.734088352318881,0,0,1.19111428741588,0.81692976588147,ROCK2;TAB2
alpha,3,post-Golgi vesicle-mediated transport (GO:0006892),2/59,2,59,0.512784753671456,0.739622329096786,0,0,1.17092590966307,0.782060367492275,RABIF;VPS13A
alpha,3,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),3/94,3,94,0.514563004405134,0.739622329096786,0,0,1.10241428728916,0.732485143494414,DAPK1;APOPT1;DHCR24
alpha,3,positive regulation of mitochondrion organization (GO:0010822),4/129,4,129,0.515751777801367,0.739622329096786,0,0,1.07107951426544,0.70919353605137,ARIH2;APOPT1;PPARGC1A;BAP1
alpha,3,positive regulation of NF-kappaB transcription factor activity (GO:0051092),4/129,4,129,0.515751777801367,0.739622329096786,0,0,1.07107951426544,0.70919353605137,DHX9;ROR1;TAB2;MID2
alpha,3,positive regulation of histone methylation (GO:0031062),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,KMT2A
alpha,3,membrane protein intracellular domain proteolysis (GO:0031293),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,MBTPS1
alpha,3,histone monoubiquitination (GO:0010390),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,LEO1
alpha,3,regulation of chromosome organization (GO:0033044),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,SMG1
alpha,3,response to glucocorticoid (GO:0051384),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,PDCD7
alpha,3,positive regulation of purine nucleotide biosynthetic process (GO:1900373),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,PPARGC1A
alpha,3,negative regulation of developmental growth (GO:0048640),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,RTN4
alpha,3,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,PSMB3
alpha,3,regulation of actin filament bundle assembly (GO:0032231),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,ROCK2
alpha,3,ATP generation from ADP (GO:0006757),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,PKM
alpha,3,camera-type eye development (GO:0043010),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,CACNA1C
alpha,3,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,BAG6
alpha,3,macromolecule modification (GO:0043412),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,ST3GAL3
alpha,3,receptor catabolic process (GO:0032801),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,ZNRF3
alpha,3,regulation of epidermal growth factor-activated receptor activity (GO:0007176),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,TSG101
alpha,3,neuromuscular synaptic transmission (GO:0007274),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,KIF1B
alpha,3,positive regulation of endopeptidase activity (GO:0010950),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,ROCK2
alpha,3,sensory perception of pain (GO:0019233),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,P2RX4
alpha,3,DNA geometric change (GO:0032392),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,DHX9
alpha,3,regulation of chemotaxis (GO:0050920),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,ZSWIM8
alpha,3,cellular senescence (GO:0090398),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,MAPKAPK5
alpha,3,chaperone mediated protein folding requiring cofactor (GO:0051085),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,DNAJB12
alpha,3,regulation of neuronal synaptic plasticity (GO:0048168),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,PPFIA3
alpha,3,negative regulation of interleukin-6 production (GO:0032715),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,GBA
alpha,3,mRNA splice site selection (GO:0006376),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,ISY1
alpha,3,fatty acid derivative biosynthetic process (GO:1901570),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,BDH1
alpha,3,actin nucleation (GO:0045010),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,ARPC5L
alpha,3,regulation of cardiac muscle cell action potential (GO:0098901),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,CACNA1C
alpha,3,negative regulation of T cell proliferation (GO:0042130),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,PRNP
alpha,3,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,CCAR2
alpha,3,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,TAB2
alpha,3,organic cation transport (GO:0015695),1/25,1,25,0.520436557983835,0.739622329096786,0,0,1.38169257340242,0.902365851515592,SLC25A19
alpha,3,axon development (GO:0061564),3/95,3,95,0.521689123115751,0.739622329096786,0,0,1.09080992637033,0.709771931383996,ATL1;CNTN4;RTN4
alpha,3,regulation of protein metabolic process (GO:0051246),2/60,2,60,0.521798023067849,0.739622329096786,0,0,1.15141047783535,0.748963379349027,ROCK2;GBA
alpha,3,regulation of extrinsic apoptotic signaling pathway (GO:2001236),2/60,2,60,0.521798023067849,0.739622329096786,0,0,1.15141047783535,0.748963379349027,FEM1B;PELI3
alpha,3,regulation of macromolecule metabolic process (GO:0060255),4/130,4,130,0.521832663677616,0.739622329096786,0,0,1.06284044107878,0.691280255251441,ICK;EIF4A1;ROCK2;CDK10
alpha,3,protein localization to plasma membrane (GO:0072659),4/131,4,131,0.52787706644445,0.74251592399023,0,0,1.05472715526902,0.673856584623005,CACNB2;ROCK2;STXBP1;RAB11A
alpha,3,positive regulation of protein localization to membrane (GO:1905477),3/96,3,96,0.528757845243796,0.74251592399023,0,0,1.07944732297064,0.687850508841979,PRNP;NMT1;PTPN9
alpha,3,glycolytic process through glucose-6-phosphate (GO:0061620),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,PKM
alpha,3,canonical glycolysis (GO:0061621),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,PKM
alpha,3,regulation of voltage-gated calcium channel activity (GO:1901385),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,CACNB2
alpha,3,glucose catabolic process to pyruvate (GO:0061718),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,PKM
alpha,3,regulation of telomere maintenance (GO:0032204),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,SMG1
alpha,3,"protein import into nucleus, translocation (GO:0000060)",1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,TNPO1
alpha,3,glial cell differentiation (GO:0010001),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,EIF2B5
alpha,3,lamellipodium organization (GO:0097581),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,SNX1
alpha,3,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,TAB2
alpha,3,cyclic nucleotide metabolic process (GO:0009187),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,PDE8A
alpha,3,potassium ion homeostasis (GO:0055075),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,SLC12A6
alpha,3,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,JSRP1
alpha,3,peptide catabolic process (GO:0043171),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,IDE
alpha,3,in utero embryonic development (GO:0001701),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,FLCN
alpha,3,response to amyloid-beta (GO:1904645),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,PRNP
alpha,3,positive regulation of filopodium assembly (GO:0051491),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,WASL
alpha,3,"RNA splicing, via transesterification reactions (GO:0000375)",1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,DBR1
alpha,3,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,CADM1
alpha,3,response to alcohol (GO:0097305),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,PMVK
alpha,3,respiratory tube development (GO:0030323),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,BAG6
alpha,3,peptide hormone secretion (GO:0030072),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,PTPRN
alpha,3,positive regulation of Rho protein signal transduction (GO:0035025),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,AKAP13
alpha,3,regulation of nervous system development (GO:0051960),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,RTN4
alpha,3,positive regulation of calcium ion transmembrane transport (GO:1904427),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,CACNB2
alpha,3,positive regulation of nitric oxide biosynthetic process (GO:0045429),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,P2RX4
alpha,3,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,AXIN1
alpha,3,positive regulation of nitric oxide metabolic process (GO:1904407),1/26,1,26,0.534337261141658,0.74251592399023,0,0,1.32855055134848,0.83263991525171,P2RX4
alpha,3,translational termination (GO:0006415),3/97,3,97,0.535768052180373,0.742999091231272,0,0,1.06831900005342,0.666688691885156,MRPS34;MRPL14;MRRF
alpha,3,protein localization to nucleus (GO:0034504),3/97,3,97,0.535768052180373,0.742999091231272,0,0,1.06831900005342,0.666688691885156,PDIA3;XPA;HEATR3
alpha,3,regulation of cell death (GO:0010941),3/97,3,97,0.535768052180373,0.742999091231272,0,0,1.06831900005342,0.666688691885156,RRAS2;DHCR24;PDE8A
alpha,3,potassium ion transport (GO:0006813),2/62,2,62,0.539486104413905,0.746144087959554,0,0,1.11426820435679,0.68765753081623,KCNC1;KCNIP2
alpha,3,regulation of vesicle fusion (GO:0031338),2/62,2,62,0.539486104413905,0.746144087959554,0,0,1.11426820435679,0.68765753081623,TBC1D2;STXBP1
alpha,3,glycosaminoglycan metabolic process (GO:0030203),2/62,2,62,0.539486104413905,0.746144087959554,0,0,1.11426820435679,0.68765753081623,NAGLU;B4GALT7
alpha,3,negative regulation of MAP kinase activity (GO:0043407),2/62,2,62,0.539486104413905,0.746144087959554,0,0,1.11426820435679,0.68765753081623,GBA;HIPK3
alpha,3,cell morphogenesis involved in neuron differentiation (GO:0048667),3/98,3,98,0.54271869331195,0.749077793539605,0,0,1.05741778576716,0.646255845920205,ATL1;CNTN4;RTN4
alpha,3,protein targeting (GO:0006605),4/134,4,134,0.545782819527555,0.749077793539605,0,0,1.03111386074807,0.624374653984309,ZFAND6;TOMM34;VPS13A;ATG4B
alpha,3,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),4/134,4,134,0.545782819527555,0.749077793539605,0,0,1.03111386074807,0.624374653984309,NCKIPSD;GRB2;WASL;ACTG1
alpha,3,monovalent inorganic cation homeostasis (GO:0055067),1/27,1,27,0.547835710688104,0.749077793539605,0,0,1.27934497537261,0.769884008183892,SLC12A6
alpha,3,positive regulation of interferon-beta production (GO:0032728),1/27,1,27,0.547835710688104,0.749077793539605,0,0,1.27934497537261,0.769884008183892,DHX9
alpha,3,tRNA methylation (GO:0030488),1/27,1,27,0.547835710688104,0.749077793539605,0,0,1.27934497537261,0.769884008183892,METTL2B
alpha,3,regulation of supramolecular fiber organization (GO:1902903),1/27,1,27,0.547835710688104,0.749077793539605,0,0,1.27934497537261,0.769884008183892,AKAP13
alpha,3,regulation of cardiac muscle cell contraction (GO:0086004),1/27,1,27,0.547835710688104,0.749077793539605,0,0,1.27934497537261,0.769884008183892,CACNA1C
alpha,3,regulation of muscle contraction (GO:0006937),1/27,1,27,0.547835710688104,0.749077793539605,0,0,1.27934497537261,0.769884008183892,PLCE1
alpha,3,regulation of viral entry into host cell (GO:0046596),1/27,1,27,0.547835710688104,0.749077793539605,0,0,1.27934497537261,0.769884008183892,MID2
alpha,3,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),1/27,1,27,0.547835710688104,0.749077793539605,0,0,1.27934497537261,0.769884008183892,LPCAT4
alpha,3,positive regulation of release of cytochrome c from mitochondria (GO:0090200),1/27,1,27,0.547835710688104,0.749077793539605,0,0,1.27934497537261,0.769884008183892,APOPT1
alpha,3,GPI anchor metabolic process (GO:0006505),1/27,1,27,0.547835710688104,0.749077793539605,0,0,1.27934497537261,0.769884008183892,PIGH
alpha,3,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),1/27,1,27,0.547835710688104,0.749077793539605,0,0,1.27934497537261,0.769884008183892,PAPD5
alpha,3,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),2/63,2,63,0.548158968450265,0.749077793539605,0,0,1.09658140746224,0.659253716795502,BAG5;CCAR2
alpha,3,cellular protein catabolic process (GO:0044257),2/63,2,63,0.548158968450265,0.749077793539605,0,0,1.09658140746224,0.659253716795502,IDE;RAB7A
alpha,3,stress-activated MAPK cascade (GO:0051403),2/63,2,63,0.548158968450265,0.749077793539605,0,0,1.09658140746224,0.659253716795502,FBXW11;TAB2
alpha,3,tRNA processing (GO:0008033),2/63,2,63,0.548158968450265,0.749077793539605,0,0,1.09658140746224,0.659253716795502,SSB;TSEN54
alpha,3,regulation of insulin secretion (GO:0050796),3/99,3,99,0.549608784255732,0.750560635698936,0,0,1.04673679803213,0.626522798140647,PSMD9;PRKCA;CACNA1C
alpha,3,Fc-gamma receptor signaling pathway (GO:0038094),4/135,4,135,0.551672908591809,0.752879871274498,0,0,1.02347598029809,0.608763477500326,NCKIPSD;GRB2;WASL;ACTG1
alpha,3,glycosaminoglycan biosynthetic process (GO:0006024),3/100,3,100,0.556437405325256,0.755017514208364,0,0,1.03626943005181,0.607461755225593,B3GNT2;B4GALT7;ST3GAL3
alpha,3,oligosaccharide metabolic process (GO:0009311),2/64,2,64,0.556716665959441,0.755017514208364,0,0,1.07944732297064,0.632231052659891,GALNT11;ST3GAL3
alpha,3,iron ion homeostasis (GO:0055072),2/64,2,64,0.556716665959441,0.755017514208364,0,0,1.07944732297064,0.632231052659891,ATP6V1A;ABCG2
alpha,3,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",2/64,2,64,0.556716665959441,0.755017514208364,0,0,1.07944732297064,0.632231052659891,EIF4A1;CNOT2
alpha,3,Fc receptor mediated stimulatory signaling pathway (GO:0002431),4/136,4,136,0.557522497618859,0.755017514208364,0,0,1.01595042161943,0.593571494451686,NCKIPSD;GRB2;WASL;ACTG1
alpha,3,phosphatidylcholine acyl-chain remodeling (GO:0036151),1/28,1,28,0.560943527320014,0.755017514208364,0,0,1.23365408339502,0.713218656353484,LPCAT4
alpha,3,mRNA polyadenylation (GO:0006378),1/28,1,28,0.560943527320014,0.755017514208364,0,0,1.23365408339502,0.713218656353484,LEO1
alpha,3,phosphatidylinositol phosphorylation (GO:0046854),1/28,1,28,0.560943527320014,0.755017514208364,0,0,1.23365408339502,0.713218656353484,SMG1
alpha,3,regulation of cilium assembly (GO:1902017),1/28,1,28,0.560943527320014,0.755017514208364,0,0,1.23365408339502,0.713218656353484,CDK10
alpha,3,response to hexose (GO:0009746),1/28,1,28,0.560943527320014,0.755017514208364,0,0,1.23365408339502,0.713218656353484,EIF2B5
alpha,3,negative regulation of synaptic transmission (GO:0050805),1/28,1,28,0.560943527320014,0.755017514208364,0,0,1.23365408339502,0.713218656353484,STXBP1
alpha,3,cristae formation (GO:0042407),1/28,1,28,0.560943527320014,0.755017514208364,0,0,1.23365408339502,0.713218656353484,CHCHD6
alpha,3,modulation by host of viral transcription (GO:0043921),1/28,1,28,0.560943527320014,0.755017514208364,0,0,1.23365408339502,0.713218656353484,PSMC3
alpha,3,transition metal ion transport (GO:0000041),1/28,1,28,0.560943527320014,0.755017514208364,0,0,1.23365408339502,0.713218656353484,SLC31A2
alpha,3,transcription from RNA polymerase III promoter (GO:0006383),1/28,1,28,0.560943527320014,0.755017514208364,0,0,1.23365408339502,0.713218656353484,GTF3C2
alpha,3,negative regulation of osteoblast differentiation (GO:0045668),1/28,1,28,0.560943527320014,0.755017514208364,0,0,1.23365408339502,0.713218656353484,HDAC7
alpha,3,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),1/28,1,28,0.560943527320014,0.755017514208364,0,0,1.23365408339502,0.713218656353484,DIABLO
alpha,3,regulation of neurotransmitter secretion (GO:0046928),1/28,1,28,0.560943527320014,0.755017514208364,0,0,1.23365408339502,0.713218656353484,CPLX2
alpha,3,regulation of protein targeting to membrane (GO:0090313),1/28,1,28,0.560943527320014,0.755017514208364,0,0,1.23365408339502,0.713218656353484,PRNP
alpha,3,regulation of protein localization to cell surface (GO:2000008),1/28,1,28,0.560943527320014,0.755017514208364,0,0,1.23365408339502,0.713218656353484,TAX1BP3
alpha,3,cellular response to glucose stimulus (GO:0071333),1/28,1,28,0.560943527320014,0.755017514208364,0,0,1.23365408339502,0.713218656353484,PTPRN
alpha,3,regulation of lipid metabolic process (GO:0019216),3/101,3,101,0.563203699622909,0.755836728005873,0,0,1.02600933668496,0.589046227083731,NCOR1;TGS1;GRHL1
alpha,3,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),3/101,3,101,0.563203699622909,0.755836728005873,0,0,1.02600933668496,0.589046227083731,ALKBH5;SMG1;SRSF11
alpha,3,NADH dehydrogenase complex assembly (GO:0010257),2/65,2,65,0.565158586222602,0.755836728005873,0,0,1.06284044107878,0.606508732446007,NDUFB4;NDUFB3
alpha,3,mitochondrial respiratory chain complex I biogenesis (GO:0097031),2/65,2,65,0.565158586222602,0.755836728005873,0,0,1.06284044107878,0.606508732446007,NDUFB4;NDUFB3
alpha,3,mitochondrial respiratory chain complex I assembly (GO:0032981),2/65,2,65,0.565158586222602,0.755836728005873,0,0,1.06284044107878,0.606508732446007,NDUFB4;NDUFB3
alpha,3,glycerophospholipid metabolic process (GO:0006650),2/65,2,65,0.565158586222602,0.755836728005873,0,0,1.06284044107878,0.606508732446007,GPCPD1;PIGH
alpha,3,cellular response to decreased oxygen levels (GO:0036294),2/65,2,65,0.565158586222602,0.755836728005873,0,0,1.06284044107878,0.606508732446007,EPAS1;STUB1
alpha,3,muscle contraction (GO:0006936),4/138,4,138,0.569097404897469,0.755836728005873,0,0,1.00122650246552,0.564395057340173,ROCK2;KCNIP2;ITGA1;SNTA1
alpha,3,metal ion transport (GO:0030001),3/102,3,102,0.569906871527383,0.755836728005873,0,0,1.01595042161943,0.571250954777342,KCNC1;KCNIP2;ASIC1
alpha,3,glycolipid metabolic process (GO:0006664),2/66,2,66,0.57348424995824,0.755836728005873,0,0,1.04673679803213,0.582011624859435,GBA;GBA2
alpha,3,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),2/66,2,66,0.57348424995824,0.755836728005873,0,0,1.04673679803213,0.582011624859435,AXIN1;STUB1
alpha,3,DNA synthesis involved in DNA repair (GO:0000731),2/66,2,66,0.57348424995824,0.755836728005873,0,0,1.04673679803213,0.582011624859435,USP43;DTL
alpha,3,RNA polyadenylation (GO:0043631),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,LEO1
alpha,3,cellular response to ketone (GO:1901655),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,ROCK2
alpha,3,hydrogen ion transmembrane transport (GO:1902600),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,ATP6V0E1
alpha,3,cellular response to alcohol (GO:0097306),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,CTNNA1
alpha,3,negative regulation of homeostatic process (GO:0032845),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,FLCN
alpha,3,negative regulation of response to DNA damage stimulus (GO:2001021),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,CCAR2
alpha,3,regulation of mRNA processing (GO:0050684),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,DHX9
alpha,3,positive regulation of phosphate metabolic process (GO:0045937),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,KCTD20
alpha,3,positive regulation of sprouting angiogenesis (GO:1903672),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,HDAC7
alpha,3,positive regulation of protein tyrosine kinase activity (GO:0061098),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,PRNP
alpha,3,organelle fission (GO:0048285),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,TUBG1
alpha,3,lytic vacuole organization (GO:0080171),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,MBTPS1
alpha,3,protein K11-linked ubiquitination (GO:0070979),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,FZR1
alpha,3,regulation of NIK/NF-kappaB signaling (GO:1901222),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,HDAC7
alpha,3,positive regulation of calcium-mediated signaling (GO:0050850),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,P2RX4
alpha,3,production of miRNAs involved in gene silencing by miRNA (GO:0035196),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,AGO3
alpha,3,cGMP metabolic process (GO:0046068),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,PDE2A
alpha,3,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,PDIA3
alpha,3,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,TAB2
alpha,3,protein K63-linked deubiquitination (GO:0070536),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,USP25
alpha,3,positive regulation of fibroblast proliferation (GO:0048146),1/29,1,29,0.573671996669181,0.755836728005873,0,0,1.19111428741588,0.661899208346932,DHX9
alpha,3,response to cytokine (GO:0034097),4/139,4,139,0.574821419841347,0.756866591192253,0,0,0.994023434102459,0.550386660813757,GCH1;TRAFD1;PTPN9;PRKCA
alpha,3,cellular response to growth factor stimulus (GO:0071363),4/140,4,140,0.580502326976102,0.762077294696725,0,0,0.986923266716013,0.536749537902915,DSTYK;PDE2A;IQGAP1;PDE8A
alpha,3,negative regulation of epithelial cell proliferation (GO:0050680),2/67,2,67,0.581693302434313,0.762077294696725,0,0,1.03111386074807,0.558669803223744,NR2F2;MTSS1
alpha,3,sphingolipid biosynthetic process (GO:0030148),2/67,2,67,0.581693302434313,0.762077294696725,0,0,1.03111386074807,0.558669803223744,GBA;DEGS1
alpha,3,regulation of striated muscle contraction (GO:0006942),1/30,1,30,0.58603207869045,0.762077294696725,0,0,1.15141047783535,0.615291593679707,P2RX4
alpha,3,dicarboxylic acid transport (GO:0006835),1/30,1,30,0.58603207869045,0.762077294696725,0,0,1.15141047783535,0.615291593679707,SLC25A10
alpha,3,regulation of macrophage derived foam cell differentiation (GO:0010743),1/30,1,30,0.58603207869045,0.762077294696725,0,0,1.15141047783535,0.615291593679707,ABCA5
alpha,3,lung development (GO:0030324),1/30,1,30,0.58603207869045,0.762077294696725,0,0,1.15141047783535,0.615291593679707,BAG6
alpha,3,vacuolar transport (GO:0007034),1/30,1,30,0.58603207869045,0.762077294696725,0,0,1.15141047783535,0.615291593679707,VPS13A
alpha,3,cortical cytoskeleton organization (GO:0030865),1/30,1,30,0.58603207869045,0.762077294696725,0,0,1.15141047783535,0.615291593679707,ROCK2
alpha,3,protein alkylation (GO:0008213),1/30,1,30,0.58603207869045,0.762077294696725,0,0,1.15141047783535,0.615291593679707,RPS2
alpha,3,regulation of neutrophil chemotaxis (GO:0090022),1/30,1,30,0.58603207869045,0.762077294696725,0,0,1.15141047783535,0.615291593679707,KIF20B
alpha,3,regulation of chromosome segregation (GO:0051983),1/30,1,30,0.58603207869045,0.762077294696725,0,0,1.15141047783535,0.615291593679707,ZNF207
alpha,3,B cell proliferation (GO:0042100),1/30,1,30,0.58603207869045,0.762077294696725,0,0,1.15141047783535,0.615291593679707,CTPS1
alpha,3,regulation of activated T cell proliferation (GO:0046006),1/30,1,30,0.58603207869045,0.762077294696725,0,0,1.15141047783535,0.615291593679707,PRNP
alpha,3,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),1/30,1,30,0.58603207869045,0.762077294696725,0,0,1.15141047783535,0.615291593679707,TAB2
alpha,3,respiratory system development (GO:0060541),1/30,1,30,0.58603207869045,0.762077294696725,0,0,1.15141047783535,0.615291593679707,BAG6
alpha,3,regulation of myoblast differentiation (GO:0045661),1/30,1,30,0.58603207869045,0.762077294696725,0,0,1.15141047783535,0.615291593679707,BOC
alpha,3,regulation of cellular component organization (GO:0051128),4/141,4,141,0.586139554430063,0.762077294696725,0,0,0.979923810923701,0.523472722856637,RAP1B;BAG5;PLCE1;BAP1
alpha,3,inorganic cation transmembrane transport (GO:0098662),4/141,4,141,0.586139554430063,0.762077294696725,0,0,0.979923810923701,0.523472722856637,ATP6V0E1;P2RX4;CACNA1C;ASIC1
alpha,3,monovalent inorganic cation transport (GO:0015672),3/105,3,105,0.58963058028713,0.762077294696725,0,0,0.986923266716013,0.521351170287076,KCNC1;KCNIP2;ASIC1
alpha,3,mRNA transport (GO:0051028),3/105,3,105,0.58963058028713,0.762077294696725,0,0,0.986923266716013,0.521351170287076,ALKBH5;SMG1;SRSF11
alpha,3,regulation of gene silencing by miRNA (GO:0060964),2/68,2,68,0.5897855067196,0.762077294696725,0,0,1.01595042161943,0.536418120608375,DHX9;POLR2L
alpha,3,extrinsic apoptotic signaling pathway (GO:0097191),2/68,2,68,0.5897855067196,0.762077294696725,0,0,1.01595042161943,0.536418120608375,DIABLO;HIPK1
alpha,3,regulation of protein localization to plasma membrane (GO:1903076),2/68,2,68,0.5897855067196,0.762077294696725,0,0,1.01595042161943,0.536418120608375,VPS4A;PTPN9
alpha,3,translational elongation (GO:0006414),3/106,3,106,0.596074472934071,0.762077294696725,0,0,0.977612669860201,0.505806691891284,EEFSEC;MRPS34;MRPL14
alpha,3,mRNA export from nucleus (GO:0006406),3/106,3,106,0.596074472934071,0.762077294696725,0,0,0.977612669860201,0.505806691891284,ALKBH5;SMG1;SRSF11
alpha,3,protein sumoylation (GO:0016925),2/69,2,69,0.597760737068234,0.762077294696725,0,0,1.00122650246552,0.515195825217921,TRIM28;TOP1
alpha,3,response to interferon-gamma (GO:0034341),2/69,2,69,0.597760737068234,0.762077294696725,0,0,1.00122650246552,0.515195825217921,GCH1;DAPK1
alpha,3,termination of RNA polymerase II transcription (GO:0006369),2/69,2,69,0.597760737068234,0.762077294696725,0,0,1.00122650246552,0.515195825217921,SNRPF;SRSF11
alpha,3,cholesterol metabolic process (GO:0008203),2/69,2,69,0.597760737068234,0.762077294696725,0,0,1.00122650246552,0.515195825217921,PMVK;DHCR24
alpha,3,regulation of actin cytoskeleton reorganization (GO:2000249),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,PHPT1
alpha,3,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,NMT1
alpha,3,negative regulation of stress-activated MAPK cascade (GO:0032873),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,NCOR1
alpha,3,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,HDAC7
alpha,3,regulation of defense response to virus by host (GO:0050691),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,DHX9
alpha,3,negative regulation of endothelial cell proliferation (GO:0001937),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,NR2F2
alpha,3,beta-catenin-TCF complex assembly (GO:1904837),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,LEO1
alpha,3,replication fork processing (GO:0031297),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,EME2
alpha,3,acylglycerol catabolic process (GO:0046464),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,PNPLA2
alpha,3,cellular response to drug (GO:0035690),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,PDE2A
alpha,3,cyclic purine nucleotide metabolic process (GO:0052652),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,ADORA2A
alpha,3,negative regulation of DNA biosynthetic process (GO:2000279),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,PAPD5
alpha,3,'de novo' posttranslational protein folding (GO:0051084),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,DNAJB12
alpha,3,regulation of ARF protein signal transduction (GO:0032012),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,ACAP1
alpha,3,aminoglycan metabolic process (GO:0006022),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,B4GALT7
alpha,3,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,NMT1
alpha,3,CENP-A containing nucleosome assembly (GO:0034080),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,CENPN
alpha,3,CENP-A containing chromatin organization (GO:0061641),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,CENPN
alpha,3,bile acid metabolic process (GO:0008206),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,GBA2
alpha,3,regulation of sodium ion transmembrane transport (GO:1902305),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,SNTA1
alpha,3,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,RTN4
alpha,3,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),1/31,1,31,0.598034417364048,0.762077294696725,0,0,1.11426820435679,0.572853053169758,P2RX4
alpha,3,positive regulation of neurogenesis (GO:0050769),2/70,2,70,0.605618972726486,0.769779559243315,0,0,0.986923266716013,0.494946211242081,ZEB1;KIF20B
alpha,3,mitochondrial translation (GO:0032543),3/108,3,108,0.608763075490564,0.769779559243315,0,0,0.959508731529457,0.476229251171305,MRPS34;MRPL14;MRRF
alpha,3,positive regulation of epithelial cell proliferation (GO:0050679),3/108,3,108,0.608763075490564,0.769779559243315,0,0,0.959508731529457,0.476229251171305,PTPRN;PRKCA;RTN4
alpha,3,negative regulation of cell-cell adhesion (GO:0022408),1/32,1,32,0.609689349643636,0.769779559243315,0,0,1.07944732297064,0.534116703813092,EPCAM
alpha,3,regulation of protein tyrosine kinase activity (GO:0061097),1/32,1,32,0.609689349643636,0.769779559243315,0,0,1.07944732297064,0.534116703813092,PRNP
alpha,3,regulation of protein export from nucleus (GO:0046825),1/32,1,32,0.609689349643636,0.769779559243315,0,0,1.07944732297064,0.534116703813092,ANP32B
alpha,3,zinc ion homeostasis (GO:0055069),1/32,1,32,0.609689349643636,0.769779559243315,0,0,1.07944732297064,0.534116703813092,MT1X
alpha,3,anterograde axonal transport (GO:0008089),1/32,1,32,0.609689349643636,0.769779559243315,0,0,1.07944732297064,0.534116703813092,KIF1B
alpha,3,cofactor biosynthetic process (GO:0051188),1/32,1,32,0.609689349643636,0.769779559243315,0,0,1.07944732297064,0.534116703813092,FAM96B
alpha,3,cellular zinc ion homeostasis (GO:0006882),1/32,1,32,0.609689349643636,0.769779559243315,0,0,1.07944732297064,0.534116703813092,MT1X
alpha,3,positive regulation of insulin secretion (GO:0032024),1/32,1,32,0.609689349643636,0.769779559243315,0,0,1.07944732297064,0.534116703813092,PSMD9
alpha,3,nucleobase-containing small molecule interconversion (GO:0015949),1/32,1,32,0.609689349643636,0.769779559243315,0,0,1.07944732297064,0.534116703813092,CTPS1
alpha,3,regulation of cytokine secretion (GO:0050707),1/32,1,32,0.609689349643636,0.769779559243315,0,0,1.07944732297064,0.534116703813092,CADM1
alpha,3,gene silencing by miRNA (GO:0035195),1/32,1,32,0.609689349643636,0.769779559243315,0,0,1.07944732297064,0.534116703813092,AGO3
alpha,3,proton transport (GO:0015992),1/32,1,32,0.609689349643636,0.769779559243315,0,0,1.07944732297064,0.534116703813092,ATP6V0E1
alpha,3,stress-activated protein kinase signaling cascade (GO:0031098),2/71,2,71,0.613360292170494,0.772518654398333,0,0,0.973022939015787,0.475616301430234,FBXW11;MAP4K5
alpha,3,vascular endothelial growth factor receptor signaling pathway (GO:0048010),2/71,2,71,0.613360292170494,0.772518654398333,0,0,0.973022939015787,0.475616301430234,ROCK2;ACTG1
alpha,3,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),2/71,2,71,0.613360292170494,0.772518654398333,0,0,0.973022939015787,0.475616301430234,ARIH2;RBX1
alpha,3,Rab protein signal transduction (GO:0032482),2/71,2,71,0.613360292170494,0.772518654398333,0,0,0.973022939015787,0.475616301430234,RAB11A;RAB7A
alpha,3,dendrite morphogenesis (GO:0048813),1/33,1,33,0.62100691417264,0.773378799913547,0,0,1.04673679803213,0.498679084290829,WASL
alpha,3,protein deacetylation (GO:0006476),1/33,1,33,0.62100691417264,0.773378799913547,0,0,1.04673679803213,0.498679084290829,MORF4L1
alpha,3,positive regulation of calcium ion transport into cytosol (GO:0010524),1/33,1,33,0.62100691417264,0.773378799913547,0,0,1.04673679803213,0.498679084290829,P2RX4
alpha,3,response to zinc ion (GO:0010043),1/33,1,33,0.62100691417264,0.773378799913547,0,0,1.04673679803213,0.498679084290829,MT1X
alpha,3,regulation of glutamate receptor signaling pathway (GO:1900449),1/33,1,33,0.62100691417264,0.773378799913547,0,0,1.04673679803213,0.498679084290829,DAPK1
alpha,3,positive regulation of dendrite development (GO:1900006),1/33,1,33,0.62100691417264,0.773378799913547,0,0,1.04673679803213,0.498679084290829,FOXO6
alpha,3,central nervous system neuron differentiation (GO:0021953),1/33,1,33,0.62100691417264,0.773378799913547,0,0,1.04673679803213,0.498679084290829,GBA2
alpha,3,chromatin remodeling at centromere (GO:0031055),1/33,1,33,0.62100691417264,0.773378799913547,0,0,1.04673679803213,0.498679084290829,CENPN
alpha,3,microtubule bundle formation (GO:0001578),1/33,1,33,0.62100691417264,0.773378799913547,0,0,1.04673679803213,0.498679084290829,ZNF207
alpha,3,negative regulation of BMP signaling pathway (GO:0030514),1/33,1,33,0.62100691417264,0.773378799913547,0,0,1.04673679803213,0.498679084290829,LEMD2
alpha,3,regulation of potassium ion transmembrane transport (GO:1901379),1/33,1,33,0.62100691417264,0.773378799913547,0,0,1.04673679803213,0.498679084290829,KCNIP2
alpha,3,negative regulation of receptor activity (GO:2000272),1/33,1,33,0.62100691417264,0.773378799913547,0,0,1.04673679803213,0.498679084290829,TSG101
alpha,3,GPI anchor biosynthetic process (GO:0006506),1/33,1,33,0.62100691417264,0.773378799913547,0,0,1.04673679803213,0.498679084290829,PIGH
alpha,3,negative regulation of fat cell differentiation (GO:0045599),1/33,1,33,0.62100691417264,0.773378799913547,0,0,1.04673679803213,0.498679084290829,AXIN1
alpha,3,positive regulation of transcription factor import into nucleus (GO:0042993),1/33,1,33,0.62100691417264,0.773378799913547,0,0,1.04673679803213,0.498679084290829,TRIM28
alpha,3,regulation of nitric oxide biosynthetic process (GO:0045428),1/33,1,33,0.62100691417264,0.773378799913547,0,0,1.04673679803213,0.498679084290829,P2RX4
alpha,3,aminoglycan catabolic process (GO:0006026),1/33,1,33,0.62100691417264,0.773378799913547,0,0,1.04673679803213,0.498679084290829,NAGLU
alpha,3,positive regulation of myeloid leukocyte differentiation (GO:0002763),1/33,1,33,0.62100691417264,0.773378799913547,0,0,1.04673679803213,0.498679084290829,PRKCA
alpha,3,regulation of Wnt signaling pathway (GO:0030111),3/110,3,110,0.621183263487412,0.773378799913547,0,0,0.942063118228921,0.448543693169521,CBFB;AXIN1;TAX1BP3
alpha,3,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),3/111,3,111,0.627291819055013,0.776971050294195,0,0,0.933576063109742,0.435367059220156,NMT1;ARIH2;BAP1
alpha,3,cellular response to peptide hormone stimulus (GO:0071375),3/111,3,111,0.627291819055013,0.776971050294195,0,0,0.933576063109742,0.435367059220156,PKM;GNG4;PRKAR2A
alpha,3,glycoprotein biosynthetic process (GO:0009101),2/73,2,73,0.628492957075057,0.776971050294195,0,0,0.946364776303026,0.439520625491604,B3GNT9;B3GNT2
alpha,3,glycogen metabolic process (GO:0005977),1/34,1,34,0.631996860151838,0.776971050294195,0,0,1.01595042161943,0.466190036535407,PHKB
alpha,3,negative regulation of neurogenesis (GO:0050768),1/34,1,34,0.631996860151838,0.776971050294195,0,0,1.01595042161943,0.466190036535407,CNTN4
alpha,3,regulation of T cell differentiation (GO:0045580),1/34,1,34,0.631996860151838,0.776971050294195,0,0,1.01595042161943,0.466190036535407,CBFB
alpha,3,oligosaccharide biosynthetic process (GO:0009312),1/34,1,34,0.631996860151838,0.776971050294195,0,0,1.01595042161943,0.466190036535407,GALNT11
alpha,3,entry into host cell (GO:0030260),1/34,1,34,0.631996860151838,0.776971050294195,0,0,1.01595042161943,0.466190036535407,GRB2
alpha,3,negative regulation of mitochondrion organization (GO:0010823),1/34,1,34,0.631996860151838,0.776971050294195,0,0,1.01595042161943,0.466190036535407,FLCN
alpha,3,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),1/34,1,34,0.631996860151838,0.776971050294195,0,0,1.01595042161943,0.466190036535407,SSB
alpha,3,response to exogenous dsRNA (GO:0043330),1/34,1,34,0.631996860151838,0.776971050294195,0,0,1.01595042161943,0.466190036535407,DHX9
alpha,3,tRNA export from nucleus (GO:0006409),1/34,1,34,0.631996860151838,0.776971050294195,0,0,1.01595042161943,0.466190036535407,SSB
alpha,3,regulation of autophagosome assembly (GO:2000785),1/34,1,34,0.631996860151838,0.776971050294195,0,0,1.01595042161943,0.466190036535407,FEZ1
alpha,3,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),1/34,1,34,0.631996860151838,0.776971050294195,0,0,1.01595042161943,0.466190036535407,SIAH1
alpha,3,embryonic organ morphogenesis (GO:0048562),1/34,1,34,0.631996860151838,0.776971050294195,0,0,1.01595042161943,0.466190036535407,AXIN1
alpha,3,mRNA stabilization (GO:0048255),1/34,1,34,0.631996860151838,0.776971050294195,0,0,1.01595042161943,0.466190036535407,DHX9
alpha,3,regulation of DNA recombination (GO:0000018),1/34,1,34,0.631996860151838,0.776971050294195,0,0,1.01595042161943,0.466190036535407,MSH6
alpha,3,negative regulation of multi-organism process (GO:0043901),1/34,1,34,0.631996860151838,0.776971050294195,0,0,1.01595042161943,0.466190036535407,TRAF3IP1
alpha,3,cellular glucose homeostasis (GO:0001678),1/34,1,34,0.631996860151838,0.776971050294195,0,0,1.01595042161943,0.466190036535407,PPARGC1A
alpha,3,regulation of neurotransmitter receptor activity (GO:0099601),1/34,1,34,0.631996860151838,0.776971050294195,0,0,1.01595042161943,0.466190036535407,DAPK1
alpha,3,positive regulation of organelle organization (GO:0010638),1/34,1,34,0.631996860151838,0.776971050294195,0,0,1.01595042161943,0.466190036535407,PPARGC1A
alpha,3,heart development (GO:0007507),4/150,4,150,0.634829466743661,0.779887445523393,0,0,0.921128382268279,0.418559698299453,AKAP13;PLCE1;TAB2;CACNA1C
alpha,3,positive regulation of inflammatory response (GO:0050729),2/74,2,74,0.635884904561833,0.779887445523393,0,0,0.933576063109742,0.422665079296749,DHX9;PDE2A
alpha,3,regulation of protein complex assembly (GO:0043254),2/74,2,74,0.635884904561833,0.779887445523393,0,0,0.933576063109742,0.422665079296749,TRAF3IP1;STXBP1
alpha,3,positive regulation of cytokine secretion (GO:0050715),2/74,2,74,0.635884904561833,0.779887445523393,0,0,0.933576063109742,0.422665079296749,CADM1;DHX9
alpha,3,epithelial tube morphogenesis (GO:0060562),1/35,1,35,0.642668655420231,0.783210416975664,0,0,0.986923266716013,0.436344434197868,MTSS1
alpha,3,embryonic limb morphogenesis (GO:0030326),1/35,1,35,0.642668655420231,0.783210416975664,0,0,0.986923266716013,0.436344434197868,CACNA1C
alpha,3,apoptotic mitochondrial changes (GO:0008637),1/35,1,35,0.642668655420231,0.783210416975664,0,0,0.986923266716013,0.436344434197868,CCAR2
alpha,3,regulation of JUN kinase activity (GO:0043506),1/35,1,35,0.642668655420231,0.783210416975664,0,0,0.986923266716013,0.436344434197868,HIPK3
alpha,3,bone development (GO:0060348),1/35,1,35,0.642668655420231,0.783210416975664,0,0,0.986923266716013,0.436344434197868,AKAP13
alpha,3,regulation of axon extension (GO:0030516),1/35,1,35,0.642668655420231,0.783210416975664,0,0,0.986923266716013,0.436344434197868,RTN4
alpha,3,negative regulation of endothelial cell migration (GO:0010596),1/35,1,35,0.642668655420231,0.783210416975664,0,0,0.986923266716013,0.436344434197868,NR2F2
alpha,3,anterior/posterior pattern specification (GO:0009952),1/35,1,35,0.642668655420231,0.783210416975664,0,0,0.986923266716013,0.436344434197868,AXIN1
alpha,3,macromolecule catabolic process (GO:0009057),1/35,1,35,0.642668655420231,0.783210416975664,0,0,0.986923266716013,0.436344434197868,SIAH1
alpha,3,positive regulation of defense response (GO:0031349),2/75,2,75,0.643161129586429,0.783210416975664,0,0,0.921128382268279,0.406549218929593,DHX9;PDE2A
alpha,3,glucose homeostasis (GO:0042593),2/75,2,75,0.643161129586429,0.783210416975664,0,0,0.921128382268279,0.406549218929593,CRY2;PPARGC1A
alpha,3,mRNA 3'-end processing (GO:0031124),2/75,2,75,0.643161129586429,0.783210416975664,0,0,0.921128382268279,0.406549218929593,LEO1;SRSF11
alpha,3,regulation of organelle organization (GO:0033043),3/114,3,114,0.645208188132295,0.78523858733073,0,0,0.909008271975275,0.398311282581587,CLIC4;TBC1D2;RHOT1
alpha,3,purine ribonucleotide biosynthetic process (GO:0009152),2/76,2,76,0.65032212507512,0.787310378570762,0,0,0.909008271975275,0.391134862113947,ADORA2A;DCAKD
alpha,3,negative regulation of protein kinase B signaling (GO:0051898),1/36,1,36,0.653031494762046,0.787310378570762,0,0,0.959508731529457,0.408875378998992,FLCN
alpha,3,positive regulation of DNA replication (GO:0045740),1/36,1,36,0.653031494762046,0.787310378570762,0,0,0.959508731529457,0.408875378998992,DHX9
alpha,3,negative regulation of protein complex assembly (GO:0031333),1/36,1,36,0.653031494762046,0.787310378570762,0,0,0.959508731529457,0.408875378998992,TRAF3IP1
alpha,3,negative regulation of epithelial cell migration (GO:0010633),1/36,1,36,0.653031494762046,0.787310378570762,0,0,0.959508731529457,0.408875378998992,NR2F2
alpha,3,apical junction assembly (GO:0043297),1/36,1,36,0.653031494762046,0.787310378570762,0,0,0.959508731529457,0.408875378998992,CTNNA1
alpha,3,regulation of mitotic spindle organization (GO:0060236),1/36,1,36,0.653031494762046,0.787310378570762,0,0,0.959508731529457,0.408875378998992,PARP3
alpha,3,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",1/36,1,36,0.653031494762046,0.787310378570762,0,0,0.959508731529457,0.408875378998992,NOP14
alpha,3,tRNA transport (GO:0051031),1/36,1,36,0.653031494762046,0.787310378570762,0,0,0.959508731529457,0.408875378998992,SSB
alpha,3,positive regulation of ATPase activity (GO:0032781),1/36,1,36,0.653031494762046,0.787310378570762,0,0,0.959508731529457,0.408875378998992,DHX9
alpha,3,membrane protein proteolysis (GO:0033619),1/36,1,36,0.653031494762046,0.787310378570762,0,0,0.959508731529457,0.408875378998992,MBTPS1
alpha,3,carboxylic acid transmembrane transport (GO:1905039),1/36,1,36,0.653031494762046,0.787310378570762,0,0,0.959508731529457,0.408875378998992,SLC25A10
alpha,3,regulation of cardiac muscle contraction (GO:0055117),1/36,1,36,0.653031494762046,0.787310378570762,0,0,0.959508731529457,0.408875378998992,P2RX4
alpha,3,carbohydrate catabolic process (GO:0016052),1/36,1,36,0.653031494762046,0.787310378570762,0,0,0.959508731529457,0.408875378998992,PKM
alpha,3,neural crest cell development (GO:0014032),1/36,1,36,0.653031494762046,0.787310378570762,0,0,0.959508731529457,0.408875378998992,NOLC1
alpha,3,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),1/36,1,36,0.653031494762046,0.787310378570762,0,0,0.959508731529457,0.408875378998992,EME2
alpha,3,peptidyl-lysine modification (GO:0018205),3/116,3,116,0.656809584788999,0.787903051497121,0,0,0.893335715561908,0.375523608886991,TRIM28;PLOD3;TOP1
alpha,3,cellular response to oxidative stress (GO:0034599),3/116,3,116,0.656809584788999,0.787903051497121,0,0,0.893335715561908,0.375523608886991,DAPK1;SESN2;PPARGC1A
alpha,3,nucleic acid-templated transcription (GO:0097659),2/77,2,77,0.657368452493938,0.787903051497121,0,0,0.89720296974183,0.376386162617954,GTF3C2;POLR2L
alpha,3,positive regulation of apoptotic signaling pathway (GO:2001235),2/77,2,77,0.657368452493938,0.787903051497121,0,0,0.89720296974183,0.376386162617954,SIAH1;APOPT1
alpha,3,sphingolipid metabolic process (GO:0006665),3/117,3,117,0.662507108074873,0.787903051497121,0,0,0.885700367565653,0.364664091058587,GBA;DEGS1;GBA2
alpha,3,chromatin remodeling (GO:0006338),3/117,3,117,0.662507108074873,0.787903051497121,0,0,0.885700367565653,0.364664091058587,MORF4L1;ANP32B;TOP1
alpha,3,regulation of potassium ion transport (GO:0043266),1/37,1,37,0.663094307673962,0.787903051497121,0,0,0.933576063109742,0.383548574018431,KCNIP2
alpha,3,muscle cell differentiation (GO:0042692),1/37,1,37,0.663094307673962,0.787903051497121,0,0,0.933576063109742,0.383548574018431,AXIN1
alpha,3,carbohydrate biosynthetic process (GO:0016051),1/37,1,37,0.663094307673962,0.787903051497121,0,0,0.933576063109742,0.383548574018431,GALNT11
alpha,3,regulation of smoothened signaling pathway (GO:0008589),1/37,1,37,0.663094307673962,0.787903051497121,0,0,0.933576063109742,0.383548574018431,KCTD6
alpha,3,lymphocyte proliferation (GO:0046651),1/37,1,37,0.663094307673962,0.787903051497121,0,0,0.933576063109742,0.383548574018431,CTPS1
alpha,3,natural killer cell activation (GO:0030101),1/37,1,37,0.663094307673962,0.787903051497121,0,0,0.933576063109742,0.383548574018431,BAG6
alpha,3,sodium ion transmembrane transport (GO:0035725),1/37,1,37,0.663094307673962,0.787903051497121,0,0,0.933576063109742,0.383548574018431,ASIC1
alpha,3,regulation of filopodium assembly (GO:0051489),1/37,1,37,0.663094307673962,0.787903051497121,0,0,0.933576063109742,0.383548574018431,WASL
alpha,3,organophosphate biosynthetic process (GO:0090407),1/37,1,37,0.663094307673962,0.787903051497121,0,0,0.933576063109742,0.383548574018431,DGKE
alpha,3,mRNA catabolic process (GO:0006402),1/37,1,37,0.663094307673962,0.787903051497121,0,0,0.933576063109742,0.383548574018431,AGO3
alpha,3,regulation of blood circulation (GO:1903522),1/37,1,37,0.663094307673962,0.787903051497121,0,0,0.933576063109742,0.383548574018431,KCNIP2
alpha,3,vesicle-mediated transport in synapse (GO:0099003),1/37,1,37,0.663094307673962,0.787903051497121,0,0,0.933576063109742,0.383548574018431,TMEM230
alpha,3,zymogen activation (GO:0031638),1/37,1,37,0.663094307673962,0.787903051497121,0,0,0.933576063109742,0.383548574018431,PERP
alpha,3,endosome organization (GO:0007032),1/37,1,37,0.663094307673962,0.787903051497121,0,0,0.933576063109742,0.383548574018431,RILP
alpha,3,centromere complex assembly (GO:0034508),1/37,1,37,0.663094307673962,0.787903051497121,0,0,0.933576063109742,0.383548574018431,CENPN
alpha,3,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",1/37,1,37,0.663094307673962,0.787903051497121,0,0,0.933576063109742,0.383548574018431,AGO3
alpha,3,axonal transport (GO:0098930),1/37,1,37,0.663094307673962,0.787903051497121,0,0,0.933576063109742,0.383548574018431,KIF1B
alpha,3,inner mitochondrial membrane organization (GO:0007007),1/37,1,37,0.663094307673962,0.787903051497121,0,0,0.933576063109742,0.383548574018431,CHCHD6
alpha,3,cardiac muscle tissue development (GO:0048738),1/37,1,37,0.663094307673962,0.787903051497121,0,0,0.933576063109742,0.383548574018431,AKAP13
alpha,3,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),2/78,2,78,0.664300737076682,0.788881083037399,0,0,0.885700367565653,0.362269443122641,STUB1;LEMD2
alpha,3,adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189),2/79,2,79,0.671119664213817,0.794924079207641,0,0,0.87448897050786,0.348753040625475,GNA13;ADORA2A
alpha,3,negative regulation of cell communication (GO:0010648),2/79,2,79,0.671119664213817,0.794924079207641,0,0,0.87448897050786,0.348753040625475,DDR1;ROR1
alpha,3,epithelial to mesenchymal transition (GO:0001837),1/38,1,38,0.672865765782172,0.794924079207641,0,0,0.909008271975275,0.360157645415495,TRIM28
alpha,3,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),1/38,1,38,0.672865765782172,0.794924079207641,0,0,0.909008271975275,0.360157645415495,NMT1
alpha,3,phospholipid biosynthetic process (GO:0008654),1/38,1,38,0.672865765782172,0.794924079207641,0,0,0.909008271975275,0.360157645415495,DGKE
alpha,3,negative regulation of G0 to G1 transition (GO:0070317),1/38,1,38,0.672865765782172,0.794924079207641,0,0,0.909008271975275,0.360157645415495,PHC3
alpha,3,negative regulation of Ras protein signal transduction (GO:0046580),1/38,1,38,0.672865765782172,0.794924079207641,0,0,0.909008271975275,0.360157645415495,FLCN
alpha,3,regulation of metal ion transport (GO:0010959),1/38,1,38,0.672865765782172,0.794924079207641,0,0,0.909008271975275,0.360157645415495,P2RX4
alpha,3,organic cyclic compound biosynthetic process (GO:1901362),1/38,1,38,0.672865765782172,0.794924079207641,0,0,0.909008271975275,0.360157645415495,GCH1
alpha,3,calcium ion transport (GO:0006816),3/119,3,119,0.673695646019088,0.795447871203261,0,0,0.870814647102364,0.343951612161232,CACNB2;P2RX4;CACNA1C
alpha,3,peptidyl-tyrosine phosphorylation (GO:0018108),2/80,2,80,0.677825974992844,0.798492190346465,0,0,0.863557858376511,0.335807165837665,DDR1;GRB2
alpha,3,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),2/80,2,80,0.677825974992844,0.798492190346465,0,0,0.863557858376511,0.335807165837665,DIABLO;ANP32B
alpha,3,regulation of endothelial cell proliferation (GO:0001936),2/80,2,80,0.677825974992844,0.798492190346465,0,0,0.863557858376511,0.335807165837665,PRKCA;NR2F2
alpha,3,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),2/80,2,80,0.677825974992844,0.798492190346465,0,0,0.863557858376511,0.335807165837665,FLCN;STUB1
alpha,3,potassium ion import (GO:0010107),1/39,1,39,0.682354290934916,0.800618660629451,0,0,0.885700367565653,0.338520231922041,SLC12A6
alpha,3,positive regulation of neuron death (GO:1901216),1/39,1,39,0.682354290934916,0.800618660629451,0,0,0.885700367565653,0.338520231922041,PRNP
alpha,3,membrane depolarization during action potential (GO:0086010),1/39,1,39,0.682354290934916,0.800618660629451,0,0,0.885700367565653,0.338520231922041,CACNA1C
alpha,3,DNA damage checkpoint (GO:0000077),1/39,1,39,0.682354290934916,0.800618660629451,0,0,0.885700367565653,0.338520231922041,INTS7
alpha,3,positive regulation of innate immune response (GO:0045089),1/39,1,39,0.682354290934916,0.800618660629451,0,0,0.885700367565653,0.338520231922041,DHX9
alpha,3,regulation of ossification (GO:0030278),1/39,1,39,0.682354290934916,0.800618660629451,0,0,0.885700367565653,0.338520231922041,TXLNG
alpha,3,retina homeostasis (GO:0001895),1/39,1,39,0.682354290934916,0.800618660629451,0,0,0.885700367565653,0.338520231922041,ACTG1
alpha,3,nucleic acid metabolic process (GO:0090304),2/81,2,81,0.684420462577546,0.801436514270948,0,0,0.852896650248406,0.323403773083903,HNRNPH1;POLR2L
alpha,3,regulation of hydrolase activity (GO:0051336),2/81,2,81,0.684420462577546,0.801436514270948,0,0,0.852896650248406,0.323403773083903,FGD4;ARHGAP1
alpha,3,negative regulation of MAPK cascade (GO:0043409),2/81,2,81,0.684420462577546,0.801436514270948,0,0,0.852896650248406,0.323403773083903,FLCN;GBA
alpha,3,actin filament organization (GO:0007015),3/121,3,121,0.684609034056524,0.801436514270948,0,0,0.856421016571747,0.324504223751705,WASL;RHOF;RHOBTB1
alpha,3,negative regulation of cell migration (GO:0030336),3/122,3,122,0.689962742856033,0.801829335441622,0,0,0.849401172173618,0.315227791310187,FLCN;CLIC4;RECK
alpha,3,positive regulation of protein targeting to mitochondrion (GO:1903955),2/82,2,82,0.690903968586516,0.801829335441622,0,0,0.84249547158684,0.31151644081175,ARIH2;BAP1
alpha,3,BMP signaling pathway (GO:0030509),2/82,2,82,0.690903968586516,0.801829335441622,0,0,0.84249547158684,0.31151644081175,BMP8B;SMAD5
alpha,3,negative regulation of cell cycle process (GO:0010948),2/82,2,82,0.690903968586516,0.801829335441622,0,0,0.84249547158684,0.31151644081175,VPS4A;PHC3
alpha,3,positive regulation of binding (GO:0051099),2/82,2,82,0.690903968586516,0.801829335441622,0,0,0.84249547158684,0.31151644081175,DHX9;GMNN
alpha,3,skeletal muscle tissue development (GO:0007519),1/40,1,40,0.691568061423168,0.801829335441622,0,0,0.863557858376511,0.318474703753175,LEMD2
alpha,3,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),1/40,1,40,0.691568061423168,0.801829335441622,0,0,0.863557858376511,0.318474703753175,FEM1B
alpha,3,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",1/40,1,40,0.691568061423168,0.801829335441622,0,0,0.863557858376511,0.318474703753175,CELF6
alpha,3,positive regulation of peptide hormone secretion (GO:0090277),1/40,1,40,0.691568061423168,0.801829335441622,0,0,0.863557858376511,0.318474703753175,PSMD9
alpha,3,positive regulation of reactive oxygen species metabolic process (GO:2000379),1/40,1,40,0.691568061423168,0.801829335441622,0,0,0.863557858376511,0.318474703753175,GRB2
alpha,3,regulation of G0 to G1 transition (GO:0070316),1/40,1,40,0.691568061423168,0.801829335441622,0,0,0.863557858376511,0.318474703753175,PHC3
alpha,3,inositol lipid-mediated signaling (GO:0048017),1/40,1,40,0.691568061423168,0.801829335441622,0,0,0.863557858376511,0.318474703753175,GAB2
alpha,3,regulation of RNA metabolic process (GO:0051252),1/40,1,40,0.691568061423168,0.801829335441622,0,0,0.863557858376511,0.318474703753175,HNRNPH1
alpha,3,DNA replication-independent nucleosome assembly (GO:0006336),1/40,1,40,0.691568061423168,0.801829335441622,0,0,0.863557858376511,0.318474703753175,CENPN
alpha,3,mitotic DNA damage checkpoint (GO:0044773),1/40,1,40,0.691568061423168,0.801829335441622,0,0,0.863557858376511,0.318474703753175,EME2
alpha,3,alpha-amino acid catabolic process (GO:1901606),1/40,1,40,0.691568061423168,0.801829335441622,0,0,0.863557858376511,0.318474703753175,BLMH
alpha,3,acyl-CoA metabolic process (GO:0006637),1/40,1,40,0.691568061423168,0.801829335441622,0,0,0.863557858376511,0.318474703753175,DLST
alpha,3,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",2/83,2,83,0.697277379757634,0.805396598370881,0,0,0.832344923736397,0.300120261388001,CNOT2;SESN2
alpha,3,positive regulation of cell cycle (GO:0045787),2/83,2,83,0.697277379757634,0.805396598370881,0,0,0.832344923736397,0.300120261388001,HSF1;PRKCA
alpha,3,positive regulation of protein secretion (GO:0050714),2/83,2,83,0.697277379757634,0.805396598370881,0,0,0.832344923736397,0.300120261388001,PSMD9;CADM1
alpha,3,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),2/83,2,83,0.697277379757634,0.805396598370881,0,0,0.832344923736397,0.300120261388001,FLCN;BMP8B
alpha,3,negative regulation of transport (GO:0051051),1/41,1,41,0.700515019963012,0.805396598370881,0,0,0.84249547158684,0.29987739303297,RAB7A
alpha,3,regulation of cellular localization (GO:0060341),1/41,1,41,0.700515019963012,0.805396598370881,0,0,0.84249547158684,0.29987739303297,CPLX2
alpha,3,positive regulation of Ras protein signal transduction (GO:0046579),1/41,1,41,0.700515019963012,0.805396598370881,0,0,0.84249547158684,0.29987739303297,AKAP13
alpha,3,tRNA aminoacylation (GO:0043039),1/41,1,41,0.700515019963012,0.805396598370881,0,0,0.84249547158684,0.29987739303297,PPA1
alpha,3,androgen receptor signaling pathway (GO:0030521),1/41,1,41,0.700515019963012,0.805396598370881,0,0,0.84249547158684,0.29987739303297,PPARGC1A
alpha,3,response to peptide hormone (GO:0043434),1/41,1,41,0.700515019963012,0.805396598370881,0,0,0.84249547158684,0.29987739303297,EIF2B5
alpha,3,negative regulation of ERK1 and ERK2 cascade (GO:0070373),1/41,1,41,0.700515019963012,0.805396598370881,0,0,0.84249547158684,0.29987739303297,FLCN
alpha,3,regulation of release of cytochrome c from mitochondria (GO:0090199),1/41,1,41,0.700515019963012,0.805396598370881,0,0,0.84249547158684,0.29987739303297,APOPT1
alpha,3,negative regulation of catabolic process (GO:0009895),1/41,1,41,0.700515019963012,0.805396598370881,0,0,0.84249547158684,0.29987739303297,RILP
alpha,3,negative regulation of cytokine-mediated signaling pathway (GO:0001960),1/41,1,41,0.700515019963012,0.805396598370881,0,0,0.84249547158684,0.29987739303297,PELI3
alpha,3,positive regulation of cytokine biosynthetic process (GO:0042108),1/41,1,41,0.700515019963012,0.805396598370881,0,0,0.84249547158684,0.29987739303297,CD276
alpha,3,negative regulation of signaling (GO:0023057),2/84,2,84,0.703541624366791,0.807522957583299,0,0,0.822436055596677,0.289191739974185,DDR1;ROR1
alpha,3,establishment of protein localization to membrane (GO:0090150),2/84,2,84,0.703541624366791,0.807522957583299,0,0,0.822436055596677,0.289191739974185,ATG4B;RAB11A
alpha,3,negative regulation of neuron death (GO:1901215),2/84,2,84,0.703541624366791,0.807522957583299,0,0,0.822436055596677,0.289191739974185,GBA;PPARGC1A
alpha,3,platelet degranulation (GO:0002576),3/125,3,125,0.705613600952255,0.808998769225483,0,0,0.829015544041451,0.289067356476141,STXBP1;QSOX1;NHLRC2
alpha,3,negative regulation of macromolecule metabolic process (GO:0010605),3/125,3,125,0.705613600952255,0.808998769225483,0,0,0.829015544041451,0.289067356476141,FLCN;DGKQ;ZNF148
alpha,3,mesenchymal cell differentiation (GO:0048762),1/42,1,42,0.709202879905459,0.810520423631109,0,0,0.822436055596677,0.282600250028728,TRIM28
alpha,3,regulation of stress-activated MAPK cascade (GO:0032872),1/42,1,42,0.709202879905459,0.810520423631109,0,0,0.822436055596677,0.282600250028728,COPS5
alpha,3,positive regulation of receptor-mediated endocytosis (GO:0048260),1/42,1,42,0.709202879905459,0.810520423631109,0,0,0.822436055596677,0.282600250028728,WASL
alpha,3,cellular response to peptide (GO:1901653),1/42,1,42,0.709202879905459,0.810520423631109,0,0,0.822436055596677,0.282600250028728,PRNP
alpha,3,activation of GTPase activity (GO:0090630),2/85,2,85,0.709697669282439,0.810520423631109,0,0,0.81276033729554,0.278708700636006,TBC1D2;TAX1BP3
alpha,3,regulation of mitotic nuclear division (GO:0007088),2/85,2,85,0.709697669282439,0.810520423631109,0,0,0.81276033729554,0.278708700636006,KIF20B;CDK13
alpha,3,regulation of neuron differentiation (GO:0045664),2/85,2,85,0.709697669282439,0.810520423631109,0,0,0.81276033729554,0.278708700636006,ZEB1;CNTN4
alpha,3,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),2/86,2,86,0.715746517055674,0.816975225790669,0,0,0.80330963569908,0.268650199752748,PRNP;DGKQ
alpha,3,regulation of interleukin-6 production (GO:0032675),1/43,1,43,0.717639131837283,0.817322265257957,0,0,0.80330963569908,0.266528849402352,GBA
alpha,3,negative regulation of protein secretion (GO:0050709),1/43,1,43,0.717639131837283,0.817322265257957,0,0,0.80330963569908,0.266528849402352,PSMD9
alpha,3,glycolipid biosynthetic process (GO:0009247),1/43,1,43,0.717639131837283,0.817322265257957,0,0,0.80330963569908,0.266528849402352,PIGH
alpha,3,regulation of ion transmembrane transporter activity (GO:0032412),1/43,1,43,0.717639131837283,0.817322265257957,0,0,0.80330963569908,0.266528849402352,KCNIP2
alpha,3,vesicle organization (GO:0016050),3/128,3,128,0.720653300755537,0.819394747488893,0,0,0.809585492227979,0.26521787258401,SNX1;VPS4A;WASL
alpha,3,positive regulation of protein kinase B signaling (GO:0051897),3/128,3,128,0.720653300755537,0.819394747488893,0,0,0.809585492227979,0.26521787258401,GRB2;RTN4;FGF22
alpha,3,negative regulation of response to stimulus (GO:0048585),3/128,3,128,0.720653300755537,0.819394747488893,0,0,0.809585492227979,0.26521787258401,DDR1;NCOR1;ROR1
alpha,3,toll-like receptor signaling pathway (GO:0002224),2/87,2,87,0.721689202678338,0.820119480459426,0,0,0.794076191610585,0.258996446486358,TAB2;CNPY3
alpha,3,positive regulation of interferon-gamma production (GO:0032729),1/44,1,44,0.725831050496007,0.821650331089539,0,0,0.785052598524101,0.25156068774893,CD276
alpha,3,RNA catabolic process (GO:0006401),1/44,1,44,0.725831050496007,0.821650331089539,0,0,0.785052598524101,0.25156068774893,AGO3
alpha,3,positive regulation of interleukin-6 production (GO:0032755),1/44,1,44,0.725831050496007,0.821650331089539,0,0,0.785052598524101,0.25156068774893,DHX9
alpha,3,regulation of ATP metabolic process (GO:1903578),1/44,1,44,0.725831050496007,0.821650331089539,0,0,0.785052598524101,0.25156068774893,BEND3
alpha,3,positive regulation of protein localization to plasma membrane (GO:1903078),1/44,1,44,0.725831050496007,0.821650331089539,0,0,0.785052598524101,0.25156068774893,PTPN9
alpha,3,nucleobase-containing compound catabolic process (GO:0034655),1/44,1,44,0.725831050496007,0.821650331089539,0,0,0.785052598524101,0.25156068774893,NUDT18
alpha,3,regulation of interferon-gamma production (GO:0032649),1/44,1,44,0.725831050496007,0.821650331089539,0,0,0.785052598524101,0.25156068774893,PRNP
alpha,3,mitochondrial translational elongation (GO:0070125),2/88,2,88,0.727526791278064,0.822213144673396,0,0,0.785052598524101,0.249728728305473,MRPS34;MRPL14
alpha,3,cellular response to BMP stimulus (GO:0071773),2/88,2,88,0.727526791278064,0.822213144673396,0,0,0.785052598524101,0.249728728305473,BMP8B;SMAD5
alpha,3,regulation of MAP kinase activity (GO:0043405),2/88,2,88,0.727526791278064,0.822213144673396,0,0,0.785052598524101,0.249728728305473,TSG101;GBA
alpha,3,T cell activation (GO:0042110),2/89,2,89,0.733260375335126,0.822511422102079,0,0,0.776231782810347,0.240829342673335,CTPS1;CD276
alpha,3,divalent metal ion transport (GO:0070838),2/89,2,89,0.733260375335126,0.822511422102079,0,0,0.776231782810347,0.240829342673335,NIPA1;CACNA1C
alpha,3,regulation of protein targeting to mitochondrion (GO:1903214),2/89,2,89,0.733260375335126,0.822511422102079,0,0,0.776231782810347,0.240829342673335,ARIH2;BAP1
alpha,3,ribosomal small subunit biogenesis (GO:0042274),1/45,1,45,0.733785700184362,0.822511422102079,0,0,0.767606985223566,0.237603726423638,NOP14
alpha,3,regulation of focal adhesion assembly (GO:0051893),1/45,1,45,0.733785700184362,0.822511422102079,0,0,0.767606985223566,0.237603726423638,ROCK2
alpha,3,sprouting angiogenesis (GO:0002040),1/45,1,45,0.733785700184362,0.822511422102079,0,0,0.767606985223566,0.237603726423638,RNF213
alpha,3,regulation of dendrite morphogenesis (GO:0048814),1/45,1,45,0.733785700184362,0.822511422102079,0,0,0.767606985223566,0.237603726423638,LZTS3
alpha,3,positive regulation of macroautophagy (GO:0016239),1/45,1,45,0.733785700184362,0.822511422102079,0,0,0.767606985223566,0.237603726423638,SESN2
alpha,3,regulation of smooth muscle cell proliferation (GO:0048660),1/45,1,45,0.733785700184362,0.822511422102079,0,0,0.767606985223566,0.237603726423638,XRCC6
alpha,3,negative regulation of type I interferon production (GO:0032480),1/45,1,45,0.733785700184362,0.822511422102079,0,0,0.767606985223566,0.237603726423638,TRAF3IP1
alpha,3,positive regulation of transport (GO:0051050),1/45,1,45,0.733785700184362,0.822511422102079,0,0,0.767606985223566,0.237603726423638,KMT2A
alpha,3,microtubule cytoskeleton organization involved in mitosis (GO:1902850),1/45,1,45,0.733785700184362,0.822511422102079,0,0,0.767606985223566,0.237603726423638,TUBG1
alpha,3,regulation of intracellular pH (GO:0051453),1/45,1,45,0.733785700184362,0.822511422102079,0,0,0.767606985223566,0.237603726423638,VPS33A
alpha,3,mitotic nuclear envelope disassembly (GO:0007077),1/45,1,45,0.733785700184362,0.822511422102079,0,0,0.767606985223566,0.237603726423638,PRKCA
alpha,3,negative regulation of immune response (GO:0050777),1/45,1,45,0.733785700184362,0.822511422102079,0,0,0.767606985223566,0.237603726423638,TRAFD1
alpha,3,regulation of neuron apoptotic process (GO:0043523),2/90,2,90,0.738891072145291,0.827783247945023,0,0,0.767606985223566,0.232281533594106,PRNP;PPARGC1A
alpha,3,protein polymerization (GO:0051258),1/46,1,46,0.741509941792718,0.828462247670692,0,0,0.75091987684914,0.224575136905258,ZNF207
alpha,3,nicotinamide nucleotide metabolic process (GO:0046496),1/46,1,46,0.741509941792718,0.828462247670692,0,0,0.75091987684914,0.224575136905258,PKM
alpha,3,mitochondrial gene expression (GO:0140053),1/46,1,46,0.741509941792718,0.828462247670692,0,0,0.75091987684914,0.224575136905258,MRPS34
alpha,3,metal ion homeostasis (GO:0055065),1/46,1,46,0.741509941792718,0.828462247670692,0,0,0.75091987684914,0.224575136905258,SLC12A6
alpha,3,negative regulation of ossification (GO:0030279),1/46,1,46,0.741509941792718,0.828462247670692,0,0,0.75091987684914,0.224575136905258,HDAC7
alpha,3,cell-matrix adhesion (GO:0007160),2/91,2,91,0.744420021589684,0.830361194813859,0,0,0.759171743627702,0.224069432555017,DDR1;ITGA1
alpha,3,regulation of cytokine-mediated signaling pathway (GO:0001959),2/91,2,91,0.744420021589684,0.830361194813859,0,0,0.759171743627702,0.224069432555017,CBFB;HIPK1
alpha,3,regulation of Ras protein signal transduction (GO:0046578),2/91,2,91,0.744420021589684,0.830361194813859,0,0,0.759171743627702,0.224069432555017,ACAP1;PLCE1
alpha,3,positive regulation of cytosolic calcium ion concentration (GO:0007204),3/134,3,134,0.748929654949893,0.832323693755967,0,0,0.773335395561055,0.223579165184846,P2RX4;PLCE1;CACNA1C
alpha,3,nucleocytoplasmic transport (GO:0006913),1/47,1,47,0.749010437724028,0.832323693755967,0,0,0.734942858192776,0.212400220494556,SNRPF
alpha,3,positive regulation of protein localization to cell periphery (GO:1904377),1/47,1,47,0.749010437724028,0.832323693755967,0,0,0.734942858192776,0.212400220494556,PTPN9
alpha,3,nuclear envelope disassembly (GO:0051081),1/47,1,47,0.749010437724028,0.832323693755967,0,0,0.734942858192776,0.212400220494556,PRKCA
alpha,3,tRNA aminoacylation for protein translation (GO:0006418),1/47,1,47,0.749010437724028,0.832323693755967,0,0,0.734942858192776,0.212400220494556,PPA1
alpha,3,pyruvate metabolic process (GO:0006090),1/47,1,47,0.749010437724028,0.832323693755967,0,0,0.734942858192776,0.212400220494556,PKM
alpha,3,maturation of SSU-rRNA (GO:0030490),1/47,1,47,0.749010437724028,0.832323693755967,0,0,0.734942858192776,0.212400220494556,NOP14
alpha,3,lipid transport (GO:0006869),2/92,2,92,0.749848383847167,0.832355973008344,0,0,0.75091987684914,0.216178003873451,PRELID2;ABCA5
alpha,3,cellular response to acid chemical (GO:0071229),2/92,2,92,0.749848383847167,0.832355973008344,0,0,0.75091987684914,0.216178003873451,SESN2;RRAGD
alpha,3,response to glucose (GO:0009749),1/48,1,48,0.756293658274122,0.837252473764466,0,0,0.719631548647093,0.20101147190137,EIF2B5
alpha,3,regulation of intrinsic apoptotic signaling pathway (GO:2001242),1/48,1,48,0.756293658274122,0.837252473764466,0,0,0.719631548647093,0.20101147190137,SIAH1
alpha,3,positive regulation of tumor necrosis factor production (GO:0032760),1/48,1,48,0.756293658274122,0.837252473764466,0,0,0.719631548647093,0.20101147190137,DHX9
alpha,3,positive regulation of organelle assembly (GO:1902117),1/48,1,48,0.756293658274122,0.837252473764466,0,0,0.719631548647093,0.20101147190137,CNOT2
alpha,3,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),1/48,1,48,0.756293658274122,0.837252473764466,0,0,0.719631548647093,0.20101147190137,BMP8B
alpha,3,mitochondrial transport (GO:0006839),3/136,3,136,0.757831328836709,0.838503696099972,0,0,0.761962816214569,0.211288051984845,SLC25A19;TOMM34;SLC25A10
alpha,3,pattern recognition receptor signaling pathway (GO:0002221),1/49,1,49,0.763365887137462,0.843267308496456,0,0,0.704945190511438,0.190347767161075,CNPY3
alpha,3,positive regulation of chemotaxis (GO:0050921),1/49,1,49,0.763365887137462,0.843267308496456,0,0,0.704945190511438,0.190347767161075,P2RX4
alpha,3,cellular response to mechanical stimulus (GO:0071260),1/49,1,49,0.763365887137462,0.843267308496456,0,0,0.704945190511438,0.190347767161075,PDE2A
alpha,3,vesicle fusion (GO:0006906),2/95,2,95,0.765541810405269,0.844764099632195,0,0,0.72720661758022,0.194288844250315,VPS4A;RAB7A
alpha,3,skin development (GO:0043588),2/95,2,95,0.765541810405269,0.844764099632195,0,0,0.72720661758022,0.194288844250315,CLIC4;DHCR24
alpha,3,protein heterooligomerization (GO:0051291),1/50,1,50,0.770233226063206,0.846828369349155,0,0,0.690846286701209,0.180353657344005,XRCC6
alpha,3,organic hydroxy compound biosynthetic process (GO:1901617),1/50,1,50,0.770233226063206,0.846828369349155,0,0,0.690846286701209,0.180353657344005,PMVK
alpha,3,cilium movement (GO:0003341),1/50,1,50,0.770233226063206,0.846828369349155,0,0,0.690846286701209,0.180353657344005,DNAH9
alpha,3,establishment of protein localization to mitochondrion (GO:0072655),1/50,1,50,0.770233226063206,0.846828369349155,0,0,0.690846286701209,0.180353657344005,TOMM34
alpha,3,lipid homeostasis (GO:0055088),1/50,1,50,0.770233226063206,0.846828369349155,0,0,0.690846286701209,0.180353657344005,PNPLA2
alpha,3,regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/50,1,50,0.770233226063206,0.846828369349155,0,0,0.690846286701209,0.180353657344005,JSRP1
alpha,3,regulation of heart contraction (GO:0008016),2/96,2,96,0.770579759942851,0.846828369349155,0,0,0.719631548647093,0.18754469808365,P2RX4;KCNIP2
alpha,3,regulation of vesicle-mediated transport (GO:0060627),3/139,3,139,0.770704341978118,0.846828369349155,0,0,0.745517575576844,0.19417038983344,TBC1D2;CPLX2;RAB11A
alpha,3,epithelial cell differentiation (GO:0030855),2/97,2,97,0.775523157111117,0.85091191869698,0,0,0.712212666702277,0.181056877968112,TOLLIP;DNPH1
alpha,3,regulation of bone mineralization (GO:0030500),1/51,1,51,0.776901601181548,0.85091191869698,0,0,0.677300281079617,0.170978750408021,TXLNG
alpha,3,fatty acid oxidation (GO:0019395),1/51,1,51,0.776901601181548,0.85091191869698,0,0,0.677300281079617,0.170978750408021,PPARGC1A
alpha,3,myeloid leukocyte differentiation (GO:0002573),1/51,1,51,0.776901601181548,0.85091191869698,0,0,0.677300281079617,0.170978750408021,GAB2
alpha,3,negative regulation of viral genome replication (GO:0045071),1/51,1,51,0.776901601181548,0.85091191869698,0,0,0.677300281079617,0.170978750408021,ILF3
alpha,3,fatty acid beta-oxidation (GO:0006635),1/51,1,51,0.776901601181548,0.85091191869698,0,0,0.677300281079617,0.170978750408021,DECR2
alpha,3,regulation of exocytosis (GO:0017157),1/52,1,52,0.783376767128108,0.856181299389084,0,0,0.66427527567424,0.162177171948723,CPLX2
alpha,3,response to organonitrogen compound (GO:0010243),1/52,1,52,0.783376767128108,0.856181299389084,0,0,0.66427527567424,0.162177171948723,DNAJB12
alpha,3,carboxylic acid transport (GO:0046942),1/52,1,52,0.783376767128108,0.856181299389084,0,0,0.66427527567424,0.162177171948723,SLC25A10
alpha,3,positive regulation of actin filament polymerization (GO:0030838),1/52,1,52,0.783376767128108,0.856181299389084,0,0,0.66427527567424,0.162177171948723,WASL
alpha,3,phosphatidylinositol biosynthetic process (GO:0006661),2/99,2,99,0.785131265673919,0.857643388936797,0,0,0.697824532021423,0.168806795247813,VAC14;PIGH
alpha,3,regulation of cell-matrix adhesion (GO:0001952),1/53,1,53,0.789664312572587,0.861370043410677,0,0,0.651741779906801,0.153907090702699,ROCK2
alpha,3,triglyceride metabolic process (GO:0006641),1/53,1,53,0.789664312572587,0.861370043410677,0,0,0.651741779906801,0.153907090702699,PNPLA2
alpha,3,steroid metabolic process (GO:0008202),2/100,2,100,0.789798480036903,0.861370043410677,0,0,0.690846286701209,0.163024148271207,DHCR24;GBA2
alpha,3,cellular response to transforming growth factor beta stimulus (GO:0071560),2/101,2,101,0.794376145061698,0.86513152144525,0,0,0.684006224456643,0.157456998633392,PDE2A;SMAD5
alpha,3,neuron development (GO:0048666),3/145,3,145,0.794771861822647,0.86513152144525,0,0,0.714668572449527,0.164159493851223,CNTN4;GBA2;RAB11A
alpha,3,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),3/145,3,145,0.794771861822647,0.86513152144525,0,0,0.714668572449527,0.164159493851223,BMP8B;STUB1;SMAD5
alpha,3,negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),1/54,1,54,0.79576966476961,0.86513152144525,0,0,0.639672487686305,0.146130301848307,STUB1
alpha,3,positive regulation of protein import into nucleus (GO:0042307),1/54,1,54,0.79576966476961,0.86513152144525,0,0,0.639672487686305,0.146130301848307,TRIM28
alpha,3,embryonic organ development (GO:0048568),1/54,1,54,0.79576966476961,0.86513152144525,0,0,0.639672487686305,0.146130301848307,KMT2A
alpha,3,protein processing (GO:0016485),2/102,2,102,0.798865523164271,0.867908825802254,0,0,0.677300281079617,0.1520963485446,CPD;PMPCB
alpha,3,protein targeting to mitochondrion (GO:0006626),1/55,1,55,0.801698094193433,0.867908825802254,0,0,0.628042078819281,0.138811859408197,TOMM34
alpha,3,RNA modification (GO:0009451),1/55,1,55,0.801698094193433,0.867908825802254,0,0,0.628042078819281,0.138811859408197,SSB
alpha,3,cellular response to nutrient levels (GO:0031669),1/55,1,55,0.801698094193433,0.867908825802254,0,0,0.628042078819281,0.138811859408197,RRAGD
alpha,3,action potential (GO:0001508),1/55,1,55,0.801698094193433,0.867908825802254,0,0,0.628042078819281,0.138811859408197,CACNA1C
alpha,3,cytoplasmic translation (GO:0002181),1/55,1,55,0.801698094193433,0.867908825802254,0,0,0.628042078819281,0.138811859408197,RPLP1
alpha,3,positive regulation of immune response (GO:0050778),1/55,1,55,0.801698094193433,0.867908825802254,0,0,0.628042078819281,0.138811859408197,DHX9
alpha,3,positive regulation of response to stimulus (GO:0048584),1/55,1,55,0.801698094193433,0.867908825802254,0,0,0.628042078819281,0.138811859408197,DHX9
alpha,3,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),1/56,1,56,0.807454719098156,0.870617525023273,0,0,0.616827041697508,0.131919751343358,STUB1
alpha,3,long-chain fatty acid metabolic process (GO:0001676),1/56,1,56,0.807454719098156,0.870617525023273,0,0,0.616827041697508,0.131919751343358,AIG1
alpha,3,regulation of RNA splicing (GO:0043484),1/56,1,56,0.807454719098156,0.870617525023273,0,0,0.616827041697508,0.131919751343358,HNRNPH1
alpha,3,regulation of gene silencing by RNA (GO:0060966),1/56,1,56,0.807454719098156,0.870617525023273,0,0,0.616827041697508,0.131919751343358,POLR2L
alpha,3,regulation of posttranscriptional gene silencing (GO:0060147),1/56,1,56,0.807454719098156,0.870617525023273,0,0,0.616827041697508,0.131919751343358,POLR2L
alpha,3,negative regulation of cellular response to growth factor stimulus (GO:0090288),1/56,1,56,0.807454719098156,0.870617525023273,0,0,0.616827041697508,0.131919751343358,LEMD2
alpha,3,Notch signaling pathway (GO:0007219),1/56,1,56,0.807454719098156,0.870617525023273,0,0,0.616827041697508,0.131919751343358,GALNT11
alpha,3,positive regulation of angiogenesis (GO:0045766),2/104,2,104,0.807584477779119,0.870617525023273,0,0,0.66427527567424,0.141960683481144,PRKCA;HIPK1
alpha,3,regulated exocytosis (GO:0045055),3/149,3,149,0.809618952202989,0.872353823892017,0,0,0.695482838960949,0.146880113628886,STXBP1;QSOX1;NHLRC2
alpha,3,peptide metabolic process (GO:0006518),2/105,2,105,0.811816584856266,0.872390824713401,0,0,0.657948844477342,0.137169731099094,CPD;IDE
alpha,3,positive regulation of vasculature development (GO:1904018),2/105,2,105,0.811816584856266,0.872390824713401,0,0,0.657948844477342,0.137169731099094,PRKCA;HIPK1
alpha,3,regulation of secretion by cell (GO:1903530),1/57,1,57,0.813044510107047,0.872390824713401,0,0,0.606005514650183,0.125424611673966,CPLX2
alpha,3,DNA-dependent DNA replication (GO:0006261),1/57,1,57,0.813044510107047,0.872390824713401,0,0,0.606005514650183,0.125424611673966,PNKP
alpha,3,chordate embryonic development (GO:0043009),1/57,1,57,0.813044510107047,0.872390824713401,0,0,0.606005514650183,0.125424611673966,FLCN
alpha,3,regulation of BMP signaling pathway (GO:0030510),1/57,1,57,0.813044510107047,0.872390824713401,0,0,0.606005514650183,0.125424611673966,LEMD2
alpha,3,phosphatidylinositol-mediated signaling (GO:0048015),1/57,1,57,0.813044510107047,0.872390824713401,0,0,0.606005514650183,0.125424611673966,GAB2
alpha,3,glycosaminoglycan catabolic process (GO:0006027),1/57,1,57,0.813044510107047,0.872390824713401,0,0,0.606005514650183,0.125424611673966,NAGLU
alpha,3,positive regulation of cell death (GO:0010942),1/58,1,58,0.818472293971214,0.877299990100395,0,0,0.595557143707939,0.119299465489929,PRNP
alpha,3,protein homotetramerization (GO:0051289),1/58,1,58,0.818472293971214,0.877299990100395,0,0,0.595557143707939,0.119299465489929,SAMHD1
alpha,3,phospholipid transport (GO:0015914),1/59,1,59,0.823742758303335,0.879580002377346,0,0,0.585462954831533,0.113519501383509,PRELID2
alpha,3,cholesterol homeostasis (GO:0042632),1/59,1,59,0.823742758303335,0.879580002377346,0,0,0.585462954831533,0.113519501383509,APOM
alpha,3,sterol homeostasis (GO:0055092),1/59,1,59,0.823742758303335,0.879580002377346,0,0,0.585462954831533,0.113519501383509,APOM
alpha,3,sodium ion transport (GO:0006814),1/59,1,59,0.823742758303335,0.879580002377346,0,0,0.585462954831533,0.113519501383509,ASIC1
alpha,3,regulation of response to external stimulus (GO:0032101),2/108,2,108,0.824018583373918,0.879580002377346,0,0,0.639672487686305,0.123816411877901,GRK4;NMT1
alpha,3,positive regulation of cell cycle process (GO:0090068),2/108,2,108,0.824018583373918,0.879580002377346,0,0,0.639672487686305,0.123816411877901,CSPP1;KIF20B
alpha,3,negative regulation of response to external stimulus (GO:0032102),2/108,2,108,0.824018583373918,0.879580002377346,0,0,0.639672487686305,0.123816411877901,TRAF3IP1;GBA
alpha,3,regulation of protein secretion (GO:0050708),2/108,2,108,0.824018583373918,0.879580002377346,0,0,0.639672487686305,0.123816411877901,PRKCA;CACNA1C
alpha,3,mitotic cytokinesis (GO:0000281),1/60,1,60,0.828860455103171,0.882916571740335,0,0,0.575705238917674,0.108061869432218,TRIM36
alpha,3,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),1/60,1,60,0.828860455103171,0.882916571740335,0,0,0.575705238917674,0.108061869432218,BMP8B
alpha,3,sterol metabolic process (GO:0016125),1/60,1,60,0.828860455103171,0.882916571740335,0,0,0.575705238917674,0.108061869432218,PMVK
alpha,3,keratinocyte differentiation (GO:0030216),1/60,1,60,0.828860455103171,0.882916571740335,0,0,0.575705238917674,0.108061869432218,CLIC4
alpha,3,Wnt signaling pathway (GO:0016055),2/110,2,110,0.831753885634296,0.885460133609916,0,0,0.628042078819281,0.115697090568188,AXIN1;RBX1
alpha,3,"regulation of mRNA splicing, via spliceosome (GO:0048024)",1/61,1,61,0.833829805119542,0.885460133609916,0,0,0.566267448115745,0.1029055001833,CELF6
alpha,3,regulation of stress fiber assembly (GO:0051492),1/61,1,61,0.833829805119542,0.885460133609916,0,0,0.566267448115745,0.1029055001833,ROCK2
alpha,3,response to reactive oxygen species (GO:0000302),1/61,1,61,0.833829805119542,0.885460133609916,0,0,0.566267448115745,0.1029055001833,PTPRN
alpha,3,muscle organ development (GO:0007517),1/61,1,61,0.833829805119542,0.885460133609916,0,0,0.566267448115745,0.1029055001833,ZBTB42
alpha,3,membrane lipid biosynthetic process (GO:0046467),1/61,1,61,0.833829805119542,0.885460133609916,0,0,0.566267448115745,0.1029055001833,DEGS1
alpha,3,positive regulation of T cell proliferation (GO:0042102),1/62,1,62,0.838655101154139,0.888749844580442,0,0,0.557134102178394,0.0980309433850092,CD276
alpha,3,RNA 3'-end processing (GO:0031123),1/62,1,62,0.838655101154139,0.888749844580442,0,0,0.557134102178394,0.0980309433850092,SRSF11
alpha,3,protein targeting to membrane (GO:0006612),1/62,1,62,0.838655101154139,0.888749844580442,0,0,0.557134102178394,0.0980309433850092,ATG4B
alpha,3,striated muscle contraction (GO:0006941),1/62,1,62,0.838655101154139,0.888749844580442,0,0,0.557134102178394,0.0980309433850092,JSRP1
alpha,3,regulation of protein binding (GO:0043393),2/112,2,112,0.83918134403618,0.888849822967812,0,0,0.616827041697508,0.10814733086599,PRMT7;HSF1
alpha,3,phosphatidylinositol metabolic process (GO:0046488),2/113,2,113,0.842782721307437,0.890048601991093,0,0,0.611368395310804,0.104572178945032,VAC14;SMG1
alpha,3,diterpenoid metabolic process (GO:0016101),1/63,1,63,0.843340512090686,0.890048601991093,0,0,0.548290703731118,0.0934202229374203,APOM
alpha,3,cellular amide metabolic process (GO:0043603),1/63,1,63,0.843340512090686,0.890048601991093,0,0,0.548290703731118,0.0934202229374203,CPD
alpha,3,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",1/63,1,63,0.843340512090686,0.890048601991093,0,0,0.548290703731118,0.0934202229374203,CNOT2
alpha,3,negative regulation of peptidase activity (GO:0010466),1/63,1,63,0.843340512090686,0.890048601991093,0,0,0.548290703731118,0.0934202229374203,RECK
alpha,3,second-messenger-mediated signaling (GO:0019932),1/63,1,63,0.843340512090686,0.890048601991093,0,0,0.548290703731118,0.0934202229374203,PLCE1
alpha,3,regulation of T cell proliferation (GO:0042129),1/63,1,63,0.843340512090686,0.890048601991093,0,0,0.548290703731118,0.0934202229374203,CD276
alpha,3,vesicle coating (GO:0006901),1/64,1,64,0.847890086335324,0.891649360080785,0,0,0.53972366148532,0.089056707017279,CD59
alpha,3,COPII vesicle coating (GO:0048208),1/64,1,64,0.847890086335324,0.891649360080785,0,0,0.53972366148532,0.089056707017279,CD59
alpha,3,carbohydrate homeostasis (GO:0033500),1/64,1,64,0.847890086335324,0.891649360080785,0,0,0.53972366148532,0.089056707017279,CRY2
alpha,3,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",1/64,1,64,0.847890086335324,0.891649360080785,0,0,0.53972366148532,0.089056707017279,CD59
alpha,3,regulation of viral genome replication (GO:0045069),1/64,1,64,0.847890086335324,0.891649360080785,0,0,0.53972366148532,0.089056707017279,ILF3
alpha,3,negative regulation of neuron apoptotic process (GO:0043524),1/64,1,64,0.847890086335324,0.891649360080785,0,0,0.53972366148532,0.089056707017279,PPARGC1A
alpha,3,signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),1/64,1,64,0.847890086335324,0.891649360080785,0,0,0.53972366148532,0.089056707017279,CNOT2
alpha,3,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/65,1,65,0.852307755454837,0.895379969742754,0,0,0.531420220539392,0.0849249911267656,CADM1
alpha,3,positive regulation of endocytosis (GO:0045807),1/65,1,65,0.852307755454837,0.895379969742754,0,0,0.531420220539392,0.0849249911267656,VPS28
alpha,3,epithelium development (GO:0060429),2/116,2,116,0.853152094429175,0.895809699150634,0,0,0.595557143707939,0.0945848621733422,TOLLIP;DNPH1
alpha,3,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),2/117,2,117,0.856467651886659,0.896226395588318,0,0,0.590466911710435,0.0914861932436363,PRNP;DGKQ
alpha,3,cellular response to interferon-gamma (GO:0071346),2/117,2,117,0.856467651886659,0.896226395588318,0,0,0.590466911710435,0.0914861932436363,DAPK1;NCAM1
alpha,3,cellular response to type I interferon (GO:0071357),1/66,1,66,0.856597337279991,0.896226395588318,0,0,0.523368399016067,0.0810107930502308,SAMHD1
alpha,3,negative regulation of blood vessel morphogenesis (GO:2000181),1/66,1,66,0.856597337279991,0.896226395588318,0,0,0.523368399016067,0.0810107930502308,ROCK2
alpha,3,negative regulation of apoptotic signaling pathway (GO:2001234),1/66,1,66,0.856597337279991,0.896226395588318,0,0,0.523368399016067,0.0810107930502308,PELI3
alpha,3,type I interferon signaling pathway (GO:0060337),1/66,1,66,0.856597337279991,0.896226395588318,0,0,0.523368399016067,0.0810107930502308,SAMHD1
alpha,3,fatty acid catabolic process (GO:0009062),1/66,1,66,0.856597337279991,0.896226395588318,0,0,0.523368399016067,0.0810107930502308,AIG1
alpha,3,intracellular steroid hormone receptor signaling pathway (GO:0030518),1/67,1,67,0.860762539354985,0.900126679874268,0,0,0.515556930374037,0.0773008578500675,PPARGC1A
alpha,3,plasma membrane bounded cell projection organization (GO:0120036),2/119,2,119,0.862894551487816,0.90189791110306,0,0,0.580543098068243,0.0856085012844902,CNTN4;RAB11A
alpha,3,epidermal cell differentiation (GO:0009913),1/68,1,68,0.864806962100864,0.902521667344614,0,0,0.507975210809713,0.0737828721714058,CLIC4
alpha,3,positive regulation of endothelial cell proliferation (GO:0001938),1/68,1,68,0.864806962100864,0.902521667344614,0,0,0.507975210809713,0.0737828721714058,PRKCA
alpha,3,cellular response to UV (GO:0034644),1/68,1,68,0.864806962100864,0.902521667344614,0,0,0.507975210809713,0.0737828721714058,XPA
alpha,3,regulation of neuron projection development (GO:0010975),2/120,2,120,0.866008236245295,0.90283655373649,0,0,0.575705238917674,0.0828214506557673,BAG5;PTPN9
alpha,3,brain development (GO:0007420),2/120,2,120,0.866008236245295,0.90283655373649,0,0,0.575705238917674,0.0828214506557673,BAG6;CNTN4
alpha,3,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),1/69,1,69,0.86873410188734,0.90283655373649,0,0,0.50061325123276,0.0704453867269296,DHCR24
alpha,3,negative regulation of phosphatase activity (GO:0010923),1/69,1,69,0.86873410188734,0.90283655373649,0,0,0.50061325123276,0.0704453867269296,CRY2
alpha,3,regulation of endopeptidase activity (GO:0052548),1/69,1,69,0.86873410188734,0.90283655373649,0,0,0.50061325123276,0.0704453867269296,RECK
alpha,3,COPII-coated vesicle budding (GO:0090114),1/69,1,69,0.86873410188734,0.90283655373649,0,0,0.50061325123276,0.0704453867269296,CD59
alpha,3,positive regulation of T cell activation (GO:0050870),1/69,1,69,0.86873410188734,0.90283655373649,0,0,0.50061325123276,0.0704453867269296,CD276
alpha,3,enzyme linked receptor protein signaling pathway (GO:0007167),2/121,2,121,0.869056954787165,0.90283655373649,0,0,0.570947344381164,0.0801305272743274,GRB2;MTSS1
alpha,3,DNA replication (GO:0006260),2/121,2,121,0.869056954787165,0.90283655373649,0,0,0.570947344381164,0.0801305272743274,PNKP;TOP1
alpha,3,regulation of cell differentiation (GO:0045595),2/122,2,122,0.872041850768942,0.904635997220125,0,0,0.566267448115745,0.0775321284429075,CBFB;ANP32B
alpha,3,negative regulation of angiogenesis (GO:0016525),1/70,1,70,0.87254735397568,0.904635997220125,0,0,0.493461633358006,0.0672777461044671,ROCK2
alpha,3,regulation of osteoblast differentiation (GO:0045667),1/70,1,70,0.87254735397568,0.904635997220125,0,0,0.493461633358006,0.0672777461044671,HDAC7
alpha,3,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),1/70,1,70,0.87254735397568,0.904635997220125,0,0,0.493461633358006,0.0672777461044671,WASL
alpha,3,sulfur compound biosynthetic process (GO:0044272),2/123,2,123,0.874964056228212,0.906647829256112,0,0,0.56166364772456,0.0750228018953901,B3GNT2;ST3GAL3
alpha,3,regulation of Notch signaling pathway (GO:0008593),1/71,1,71,0.876250015738779,0.906647829256112,0,0,0.486511469507894,0.0642700248956778,GALNT11
alpha,3,interferon-gamma-mediated signaling pathway (GO:0060333),1/71,1,71,0.876250015738779,0.906647829256112,0,0,0.486511469507894,0.0642700248956778,NCAM1
alpha,3,negative regulation of developmental process (GO:0051093),1/71,1,71,0.876250015738779,0.906647829256112,0,0,0.486511469507894,0.0642700248956778,ANP32B
alpha,3,actomyosin structure organization (GO:0031032),1/72,1,72,0.87984528898358,0.908085057536715,0,0,0.479754365764728,0.061412970130072,FRMD5
alpha,3,phosphatidylcholine metabolic process (GO:0046470),1/72,1,72,0.87984528898358,0.908085057536715,0,0,0.479754365764728,0.061412970130072,LPCAT4
alpha,3,positive regulation of lymphocyte proliferation (GO:0050671),1/72,1,72,0.87984528898358,0.908085057536715,0,0,0.479754365764728,0.061412970130072,CD276
alpha,3,positive regulation of growth (GO:0045927),1/72,1,72,0.87984528898358,0.908085057536715,0,0,0.479754365764728,0.061412970130072,DNPH1
alpha,3,response to insulin (GO:0032868),1/72,1,72,0.87984528898358,0.908085057536715,0,0,0.479754365764728,0.061412970130072,PKM
alpha,3,organic anion transport (GO:0015711),2/125,2,125,0.880624864228479,0.908434070467273,0,0,0.552677029360967,0.0702582662552115,PRELID2;SLC25A19
alpha,3,lipid biosynthetic process (GO:0008610),1/73,1,73,0.883336282992053,0.908529010144501,0,0,0.473182388151513,0.0586979484890185,DGKE
alpha,3,negative regulation of cysteine-type endopeptidase activity (GO:2000117),1/73,1,73,0.883336282992053,0.908529010144501,0,0,0.473182388151513,0.0586979484890185,DHCR24
alpha,3,response to metal ion (GO:0010038),1/73,1,73,0.883336282992053,0.908529010144501,0,0,0.473182388151513,0.0586979484890185,MT1X
alpha,3,regulation of fat cell differentiation (GO:0045598),1/73,1,73,0.883336282992053,0.908529010144501,0,0,0.473182388151513,0.0586979484890185,AXIN1
alpha,3,regulation of epithelial cell proliferation (GO:0050678),1/73,1,73,0.883336282992053,0.908529010144501,0,0,0.473182388151513,0.0586979484890185,MTSS1
alpha,3,"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",2/126,2,126,0.883365670213385,0.908529010144501,0,0,0.548290703731118,0.0679968426961043,GNA13;ADORA2A
alpha,3,B cell activation (GO:0042113),1/74,1,74,0.886726017361313,0.911074460174529,0,0,0.466788031554871,0.0561168983060325,CTPS1
alpha,3,canonical Wnt signaling pathway (GO:0060070),1/74,1,74,0.886726017361313,0.911074460174529,0,0,0.466788031554871,0.0561168983060325,AXIN1
alpha,3,regulation of protein processing (GO:0070613),2/129,2,129,0.891242651851355,0.915258172410223,0,0,0.53553975713272,0.0616612722039781,PRNP;CD59
alpha,3,retinoid metabolic process (GO:0001523),1/76,1,76,0.893213351047284,0.916367435919895,0,0,0.454504135987637,0.0513270664915473,APOM
alpha,3,regulation of defense response (GO:0031347),1/76,1,76,0.893213351047284,0.916367435919895,0,0,0.454504135987637,0.0513270664915473,SAMHD1
alpha,3,transforming growth factor beta receptor signaling pathway (GO:0007179),1/77,1,77,0.896316562983151,0.917721137621555,0,0,0.448601484870915,0.0491046459433212,SMAD5
alpha,3,positive regulation of JNK cascade (GO:0046330),1/77,1,77,0.896316562983151,0.917721137621555,0,0,0.448601484870915,0.0491046459433212,AXIN1
alpha,3,response to interleukin-1 (GO:0070555),1/77,1,77,0.896316562983151,0.917721137621555,0,0,0.448601484870915,0.0491046459433212,PRKCA
alpha,3,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1/77,1,77,0.896316562983151,0.917721137621555,0,0,0.448601484870915,0.0491046459433212,PELI3
alpha,3,sensory perception of mechanical stimulus (GO:0050954),1/79,1,79,0.902255504784429,0.922883612746697,0,0,0.43724448525393,0.0449738896410852,ROR1
alpha,3,negative regulation of inflammatory response (GO:0050728),1/79,1,79,0.902255504784429,0.922883612746697,0,0,0.43724448525393,0.0449738896410852,GBA
alpha,3,cation transport (GO:0006812),1/80,1,80,0.905096374511606,0.924859887888869,0,0,0.431778929188256,0.0430543392827929,P2RX4
alpha,3,steroid biosynthetic process (GO:0006694),1/80,1,80,0.905096374511606,0.924859887888869,0,0,0.431778929188256,0.0430543392827929,PMVK
alpha,3,adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),2/135,2,135,0.905535798880501,0.924859887888869,0,0,0.511737990149044,0.0507789765284323,GNA13;ADORA2A
alpha,3,RNA transport (GO:0050658),1/81,1,81,0.907854813017813,0.925849953018166,0,0,0.426448325124203,0.0412251053213484,SRSF11
alpha,3,"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",1/81,1,81,0.907854813017813,0.925849953018166,0,0,0.426448325124203,0.0412251053213484,ARF4
alpha,3,positive regulation of stress-activated MAPK cascade (GO:0032874),1/81,1,81,0.907854813017813,0.925849953018166,0,0,0.426448325124203,0.0412251053213484,AXIN1
alpha,3,epidermis development (GO:0008544),1/82,1,82,0.910533208094197,0.927662050622702,0,0,0.42124773579342,0.0394814053279978,GRHL1
alpha,3,sensory perception of sound (GO:0007605),1/82,1,82,0.910533208094197,0.927662050622702,0,0,0.42124773579342,0.0394814053279978,ROR1
alpha,3,regulation of cytosolic calcium ion concentration (GO:0051480),2/138,2,138,0.912005802293481,0.928473084014241,0,0,0.50061325123276,0.046110949294956,PLCE1;CACNA1C
alpha,3,regulation of anatomical structure morphogenesis (GO:0022603),1/83,1,83,0.913133878544618,0.928473084014241,0,0,0.416172461868198,0.0378187457695218,AKAP13
alpha,3,modulation of chemical synaptic transmission (GO:0050804),1/83,1,83,0.913133878544618,0.928473084014241,0,0,0.416172461868198,0.0378187457695218,CPLX2
alpha,3,positive regulation of cell cycle arrest (GO:0071158),1/83,1,83,0.913133878544618,0.928473084014241,0,0,0.416172461868198,0.0378187457695218,CNOT2
alpha,3,negative regulation of endopeptidase activity (GO:0010951),1/84,1,84,0.915659076087364,0.930121608384894,0,0,0.411218027798339,0.0362329020744228,RECK
alpha,3,positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/84,1,84,0.915659076087364,0.930121608384894,0,0,0.411218027798339,0.0362329020744228,AXIN1
alpha,3,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),2/143,2,143,0.921874473260154,0.935973194854167,0,0,0.483109291399447,0.0392991102735276,ALCAM;CADM1
alpha,3,regulation of peptidyl-serine phosphorylation (GO:0033135),1/87,1,87,0.922803382493749,0.936454320104603,0,0,0.397038095805293,0.0318976782091151,AXIN1
alpha,3,organic substance transport (GO:0071702),1/88,1,88,0.925047930757806,0.938269414243255,0,0,0.392526299262051,0.03058161633565,ABCA5
alpha,3,skeletal system development (GO:0001501),2/147,2,147,0.929009411005859,0.941823333916284,0,0,0.469963460340959,0.0346064220345775,AKAP13;BMP8B
alpha,3,negative regulation of kinase activity (GO:0033673),1/92,1,92,0.933393188922203,0.945336212008806,0,0,0.37545993842457,0.0258799814354511,PRKRIP1
alpha,3,phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200),1/92,1,92,0.933393188922203,0.945336212008806,0,0,0.37545993842457,0.0258799814354511,PLCE1
alpha,3,positive regulation of cellular metabolic process (GO:0031325),1/93,1,93,0.93533030763168,0.945901608405895,0,0,0.371422734785596,0.0248316682022632,GRB2
alpha,3,nuclear export (GO:0051168),1/93,1,93,0.93533030763168,0.945901608405895,0,0,0.371422734785596,0.0248316682022632,SRSF11
alpha,3,cell cycle G1/S phase transition (GO:0044843),1/93,1,93,0.93533030763168,0.945901608405895,0,0,0.371422734785596,0.0248316682022632,USP37
alpha,3,positive regulation of neuron differentiation (GO:0045666),1/99,1,99,0.945827322247884,0.955109239051102,0,0,0.348912266010712,0.0194327597960319,ZEB1
alpha,3,positive regulation of cell growth (GO:0030307),1/99,1,99,0.945827322247884,0.955109239051102,0,0,0.348912266010712,0.0194327597960319,DNPH1
alpha,3,response to molecule of bacterial origin (GO:0002237),1/99,1,99,0.945827322247884,0.955109239051102,0,0,0.348912266010712,0.0194327597960319,GCH1
alpha,3,cellular divalent inorganic cation homeostasis (GO:0072503),1/102,1,102,0.950419436727755,0.959275723779166,0,0,0.338650140539808,0.017220996132765,MT1X
alpha,3,plasma membrane invagination (GO:0099024),1/104,1,104,0.953262833189699,0.961673975835491,0,0,0.33213763783712,0.0158976410822669,SPIRE1
alpha,3,G1/S transition of mitotic cell cycle (GO:0000082),1/106,1,106,0.955943420885989,0.963905712975681,0,0,0.3258708899534,0.014682618325604,USP37
alpha,3,fatty acid metabolic process (GO:0006631),1/107,1,107,0.957225591061591,0.964253679101691,0,0,0.322825367617387,0.0141126944527047,PPARGC1A
alpha,3,positive regulation of cellular component organization (GO:0051130),1/107,1,107,0.957225591061591,0.964253679101691,0,0,0.322825367617387,0.0141126944527047,GBA
alpha,3,regulation of protein activation cascade (GO:2000257),1/109,1,109,0.959679248915586,0.965307866211278,0,0,0.316901966376701,0.0130424699536617,CD59
alpha,3,monocarboxylic acid metabolic process (GO:0032787),1/109,1,109,0.959679248915586,0.965307866211278,0,0,0.316901966376701,0.0130424699536617,GBA2
alpha,3,regulation of cytokine production (GO:0001817),1/109,1,109,0.959679248915586,0.965307866211278,0,0,0.316901966376701,0.0130424699536617,CD276
alpha,3,negative regulation of protein kinase activity (GO:0006469),1/110,1,110,0.960852866788053,0.965544531176667,0,0,0.31402103940964,0.0125401117953593,PRKRIP1
alpha,3,regulation of complement activation (GO:0030449),1/110,1,110,0.960852866788053,0.965544531176667,0,0,0.31402103940964,0.0125401117953593,CD59
alpha,3,positive regulation of developmental process (GO:0051094),1/114,1,114,0.965216035638052,0.968982732362494,0,0,0.303002757325092,0.0107273070845187,RTN4
alpha,3,regulation of humoral immune response (GO:0002920),1/114,1,114,0.965216035638052,0.968982732362494,0,0,0.303002757325092,0.0107273070845187,CD59
alpha,3,regulation of immune effector process (GO:0002697),1/115,1,115,0.966228738273967,0.969526447278315,0,0,0.300367950739656,0.0103190459401512,CD59
alpha,3,regulation of acute inflammatory response (GO:0002673),1/122,1,122,0.972539573814047,0.974908155338192,0,0,0.283133724057873,0.00788372022128414,CD59
alpha,3,Golgi organization (GO:0007030),1/122,1,122,0.972539573814047,0.974908155338192,0,0,0.283133724057873,0.00788372022128414,BAG5
alpha,3,negative regulation of multicellular organismal process (GO:0051241),1/126,1,126,0.97560187356124,0.977501779838867,0,0,0.274145351865559,0.0067715799607261,FLCN
alpha,3,cellular response to organic substance (GO:0071310),1/134,1,134,0.980741365958693,0.98217310517907,0,0,0.257778465187018,0.00501288826336675,PTPN9
alpha,3,phagocytosis (GO:0006909),1/136,1,136,0.981847490530338,0.98280259509311,0,0,0.253987605404856,0.00465287200235144,ADORA2A
alpha,3,response to lipid (GO:0033993),1/141,1,141,0.984343157500808,0.984343157500808,0,0,0.244980952730925,0.00386597225028044,GCH1
alpha,3,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),1/141,1,141,0.984343157500808,0.984343157500808,0,0,0.244980952730925,0.00386597225028044,PRNP
alpha,4,viral life cycle (GO:0019058),23/108,23,108,1.72815448801564e-06,0.00607446302537499,0,0,2.99105285060341,39.686654603908,NUP214;VCP;HSP90AB1;PDCD6IP;NUP188;CTBP2;NUP155;CD81;IST1;NUP153;VPS37A;DEK;HTATSF1;UBB;ZNF639;HYAL2;NUP62;KPNA4;KPNA2;EPS15;PPID;RAN;KPNA1
alpha,4,actin polymerization or depolymerization (GO:0008154),11/37,11,37,3.48174092852652e-05,0.0373252233965048,0,0,4.17552383844519,42.8633933055093,COBLL1;MICAL1;CFL1;MICALL2;TWF1;DSTN;COBL;RAC1;CORO7;WASF1;CAP2
alpha,4,cellular protein complex assembly (GO:0043623),25/145,25,145,3.17695165127962e-05,0.0373252233965048,0,0,2.42154203796978,25.079918946522,HIP1;HSP90AB1;ZFYVE9;CLTC;PIK3C2A;CLU;TOMM20;POGZ;FCHO2;LONP1;EIF4H;EPS15;EIF4B;SKP1;CCT2;SMAD4;SMAD3;CENPW;DNAAF3;GPX4;HIP1R;NUP153;PILRB;NDUFAF7;PTGES3L
alpha,4,positive regulation of canonical Wnt signaling pathway (GO:0090263),21/114,21,114,4.91526928176219e-05,0.0373252233965048,0,0,2.58722649319929,25.6667846229652,USP47;VCP;PSMD12;DDX3X;TNKS;DAPK3;GSKIP;NRARP;AXIN2;TMEM198;PSMA5;PSMD6;PSMA3;PSMD7;UBB;PSMA1;TNKS2;PSMF1;TBL1X;ZBED3;RNF220
alpha,4,positive regulation of Wnt signaling pathway (GO:0030177),24/141,24,141,5.61365902328311e-05,0.0373252233965048,0,0,2.3906287353574,23.3988112018465,USP47;KANK1;VCP;PSMD12;DDX3X;TNKS;DAPK3;GSKIP;NRARP;AXIN2;TMEM198;PSMA5;PSMD6;PSMA3;PSMD7;UBB;PSMA1;TNKS2;PSMF1;TBL1X;ATP6V0C;ZBED3;RNF220;DACT1
alpha,4,regulation of anatomical structure morphogenesis (GO:0022603),17/83,17,83,6.371304135961e-05,0.0373252233965048,0,0,2.87667524028699,27.791908395179,PHLDB1;TNFAIP3;ETS1;CAMSAP1;LFNG;ARC;CAPZB;HEY1;CFL1;HEY2;NF1;CTNNB1;QRICH1;KIAA1958;PHLDB2;CLASP2;BCL9L
alpha,4,regulation of type I interferon production (GO:0032479),17/86,17,86,0.000101578820267242,0.0396721725821506,0,0,2.77632610399791,25.527417626452,PRKDC;TNFAIP3;GPATCH3;DDX41;RELA;NFKB2;HERC5;TBK1;RNF216;UBB;POLR3B;TRAF3;POLR3D;POLR1C;CTNNB1;STAT6;POLR2H
alpha,4,positive regulation of mitotic cell cycle phase transition (GO:1901992),11/41,11,41,9.87960526268107e-05,0.0396721725821506,0,0,3.76815565908468,34.7516381128268,RB1;ANKRD17;MECP2;DDX3X;LSM11;CUL3;RDX;NSMCE2;CDC7;ANAPC11;BRD4
alpha,4,negative regulation of supramolecular fiber organization (GO:1902904),13/55,13,55,9.87284468813192e-05,0.0396721725821506,0,0,3.3197139938713,30.6181784184505,KANK1;PLEKHH2;SMAD4;HIP1R;TWF1;CLU;CAMSAP1;TTBK2;LIMA1;STMN1;SLIT2;ANAPC2;CLASP2
alpha,4,modulation by virus of host morphology or physiology (GO:0019048),7/18,7,18,0.000144522963056986,0.0461816559223005,0,0,5.46192259675406,48.2947136735616,RRAGA;SMAD3;HYAL2;KPNA4;KPNA2;HIPK2;KPNA1
alpha,4,RNA transport (GO:0050658),16/81,16,81,0.000162373438660336,0.04756188640759,0,0,2.77430989041476,24.2075508355125,NUP214;NXT1;NUP188;NUP155;NCBP2;ALYREF;EIF4A3;NUP153;CKAP5;CDC40;THOC7;NXF1;NUP62;SRSF2;EIF4E;SRSF9
alpha,4,regulation of adherens junction organization (GO:1903391),7/18,7,18,0.000144522963056986,0.0461816559223005,0,0,5.46192259675406,48.2947136735616,LDB1;RDX;DAPK3;PTPN23;RHOA;ADD1;CORO1C
alpha,4,clathrin coat assembly (GO:0048268),6/14,6,14,0.000235136775581163,0.048617986245164,0,0,6.01926163723917,50.2929967258063,HIP1;CLTC;FCHO2;HIP1R;PIK3C2A;EPS15
alpha,4,mitotic nuclear division (GO:0140014),15/75,15,75,0.000223091949174259,0.048617986245164,0,0,2.80898876404494,23.617771189192,TUBGCP2;BCCIP;SPICE1;INO80;RHOA;NSL1;GOLGA2;DSN1;SPAST;UBE2S;NUP62;TUBGCP4;BIRC2;RAN;CLASP2
alpha,4,cellular response to osmotic stress (GO:0071470),6/14,6,14,0.000235136775581163,0.048617986245164,0,0,6.01926163723917,50.2929967258063,DDX3X;CAB39;STK39;PKD2;MYLK;SERPINB6
alpha,4,positive regulation of neuron apoptotic process (GO:0043525),7/19,7,19,0.000214804486557656,0.048617986245164,0,0,5.17445298639858,43.7023034882129,TFAP2A;FBXW7;DDIT3;NF1;CTNNB1;CDK5R1;ATF4
alpha,4,mitotic spindle organization (GO:0007052),15/75,15,75,0.000223091949174259,0.048617986245164,0,0,2.80898876404494,23.617771189192,TNKS;TUBGCP2;BCCIP;SPICE1;WDR62;RHOA;MECP2;GOLGA2;SPAST;STMN1;SBDS;TUBGCP4;BIRC2;RAN;CLASP2
alpha,4,peptidyl-serine phosphorylation (GO:0018105),23/146,23,146,0.000261893463287118,0.0507428927409789,0,0,2.21255964291211,18.2482466530904,CAB39;PRKDC;TNKS;PRKCE;DAPK3;STK39;LMTK2;DCLK2;CDC7;TGFBR1;TTBK2;CAMKK2;HIPK2;ERN1;IKBKB;LATS1;TBK1;AKT3;MAPKAPK2;PKN2;SGK1;PAK2;CDK5R1
alpha,4,nuclear export (GO:0051168),17/93,17,93,0.000274285906707994,0.0507428927409789,0,0,2.56735532197656,21.0557527165328,NUP214;NXT1;NUP188;NUP155;NCBP2;ALYREF;EIF4A3;NUP153;CDC40;THOC7;NXF1;XPO4;NUP62;SRSF2;EIF4E;RAN;SRSF9
alpha,4,positive regulation of type I interferon production (GO:0032481),13/63,13,63,0.000418195912738207,0.07349793166374,0,0,2.89816301052256,22.5464346081311,SETD2;DDX3X;PRKDC;DDX41;RELA;NFKB2;TBK1;POLR3B;POLR3D;POLR1C;CTNNB1;STAT6;POLR2H
alpha,4,postreplication repair (GO:0006301),11/48,11,48,0.000445750352995271,0.0746101186084941,0,0,3.2186329588015,24.8341721097819,VCP;UBB;POLN;MSH2;PAPD7;USP10;RFC2;ZBTB1;REV1;SPRTN;POLI
alpha,4,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),14/73,14,73,0.000560164963765309,0.0894990839834119,0,0,2.69355086963214,20.1673675066325,FBXW4;PSMD12;FBXW7;PSMA5;FBXL20;PSMD6;PSMA3;PSMD7;PSMA1;UBB;FBXL3;PSMF1;FBXL5;SKP1
alpha,4,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),4/7,4,7,0.000752083010231505,0.09791006596162,0,0,8.02568218298555,57.726034142539,RB1;CUL3;NSMCE2;ANAPC11
alpha,4,translesion synthesis (GO:0019985),10/43,10,43,0.000710281867307187,0.09791006596162,0,0,3.26626600470342,23.6799342517107,VCP;UBB;POLN;PAPD7;USP10;RFC2;ZBTB1;REV1;SPRTN;POLI
alpha,4,regulation of response to biotic stimulus (GO:0002831),4/7,4,7,0.000752083010231505,0.09791006596162,0,0,8.02568218298555,57.726034142539,HERC5;TRAF3;CD55;FOXP1
alpha,4,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),17/101,17,101,0.000741607877438568,0.09791006596162,0,0,2.36400044498832,17.0366181814341,NUP214;NXT1;NUP188;NUP155;NCBP2;ALYREF;EIF4A3;NUP153;CDC40;THOC7;NXF1;NUP62;SRSF2;BUD13;EIF4E;AGFG1;SRSF9
alpha,4,RNA export from nucleus (GO:0006405),19/120,19,120,0.000812767953042828,0.0985130812050186,0,0,2.22378277153558,15.8223587646999,NUP214;NPM1;NXT1;NUP188;NUP155;NCBP2;ALYREF;EIF4A3;NUP153;CDC40;THOC7;NXF1;NUP62;SRSF2;BUD13;EIF4E;RAN;AGFG1;SRSF9
alpha,4,positive regulation of ubiquitin protein ligase activity (GO:1904668),15/83,15,83,0.00069659159293558,0.09791006596162,0,0,2.53824285907676,18.4512774184801,PSMD12;ANAPC10;ANAPC11;GOLGA2;PSMA5;PSMD6;PSMA3;PSMD7;PSMA1;UBB;UBE2S;GORASP1;PSMF1;SKP1;ANAPC2
alpha,4,regulation of phosphorylation (GO:0042325),19/120,19,120,0.000812767953042828,0.0985130812050186,0,0,2.22378277153558,15.8223587646999,NUP214;BARD1;ANKLE2;CDKN2B;NUP188;NUP155;LDB1;PGAM1;ECD;FN1;HSPB1;NUP153;CORO1C;IKBKB;SDCBP;SRPX2;NUP62;RAD17;SLC25A33
alpha,4,regulation of G2/M transition of mitotic cell cycle (GO:0010389),22/150,22,150,0.000953685576750468,0.11174016007593,0,0,2.05992509363296,14.3271426544115,USP47;PSMD12;ODF2;SSNA1;HAUS3;CDC7;HMMR;TUBB4B;CKAP5;TUBA4A;HAUS2;MECP2;PSMA5;PSMD6;PSMA3;PSMD7;UBB;PSMA1;PSMF1;SKP1;PAFAH1B1;BRD4
alpha,4,alpha-linolenic acid metabolic process (GO:0036109),5/13,5,13,0.00144114754069469,0.116572268997694,0,0,5.4019014693172,35.3409441415992,FADS2;SCP2;ELOVL5;ACSL1;FADS1
alpha,4,transport of virus (GO:0046794),11/55,11,55,0.00149239035701173,0.116572268997694,0,0,2.80898876404494,18.2791465675133,NUP214;NUP188;UBB;NUP155;NUP62;KPNA4;VPS37A;NUP153;KPNA2;RAN;KPNA1
alpha,4,anaphase-promoting complex-dependent catabolic process (GO:0031145),14/80,14,80,0.00143420842061983,0.116572268997694,0,0,2.45786516853933,16.0919927797137,PSMD12;CUL3;ANAPC10;ANAPC11;PSMA5;PSMD6;PSMA3;PSMD7;PTTG1;PSMA1;UBB;UBE2S;PSMF1;ANAPC2
alpha,4,positive regulation of extracellular matrix assembly (GO:1901203),4/8,4,8,0.00141935904110989,0.116572268997694,0,0,7.02247191011236,46.0502098930579,PHLDB1;SMAD3;PHLDB2;CLASP2
alpha,4,regulation of catenin import into nucleus (GO:0035412),6/19,6,19,0.00155958417021863,0.116636986347202,0,0,4.43524541691307,28.6664815973047,KANK1;SLC9A3R1;GNAQ;AXIN2;ANAPC2;DACT1
alpha,4,intracellular transport of virus (GO:0075733),11/55,11,55,0.00149239035701173,0.116572268997694,0,0,2.80898876404494,18.2791465675133,NUP214;NUP188;UBB;NUP155;NUP62;KPNA4;VPS37A;NUP153;KPNA2;RAN;KPNA1
alpha,4,actin filament polymerization (GO:0030041),6/18,6,18,0.0011349156585532,0.116572268997694,0,0,4.68164794007491,31.7471766875217,COBLL1;MICALL2;COBL;CORO7;RAC1;WASF1
alpha,4,mRNA transport (GO:0051028),17/105,17,105,0.00116173470843451,0.116572268997694,0,0,2.27394328517924,15.3669470565027,NUP214;NXT1;NUP188;NUP155;NCBP2;ALYREF;EIF4A3;NUP153;CDC40;THOC7;NXF1;NUP62;SRSF2;BUD13;EIF4E;AGFG1;SRSF9
alpha,4,positive regulation of mitotic sister chromatid separation (GO:1901970),4/8,4,8,0.00141935904110989,0.116572268997694,0,0,7.02247191011236,46.0502098930579,RB1;CUL3;NSMCE2;ANAPC11
alpha,4,positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),6/19,6,19,0.00155958417021863,0.116636986347202,0,0,4.43524541691307,28.6664815973047,JUN;SMAD3;SRF;FOS;RELA;GNL3
alpha,4,positive regulation of neuron death (GO:1901216),9/39,9,39,0.00137979450046781,0.116572268997694,0,0,3.24114088159032,21.3455727212817,TFAP2A;DDIT3;NF1;CTNNB1;FOS;CLU;MAP3K5;CDK5R1;ATF4
alpha,4,negative regulation of cytoskeleton organization (GO:0051494),7/25,7,25,0.00140441810433518,0.116572268997694,0,0,3.93258426966292,25.8297334596635,KANK1;LIMA1;PLEKHH2;SMAD4;HIP1R;TWF1;SLIT2
alpha,4,mRNA export from nucleus (GO:0006406),17/106,17,106,0.00129374765484331,0.116572268997694,0,0,2.25249099003604,14.9795428677885,NUP214;NXT1;NUP188;NUP155;NCBP2;ALYREF;EIF4A3;NUP153;CDC40;THOC7;NXF1;NUP62;SRSF2;BUD13;EIF4E;AGFG1;SRSF9
alpha,4,stress-activated protein kinase signaling cascade (GO:0031098),13/71,13,71,0.00136604722316798,0.116572268997694,0,0,2.57160943187213,16.9619087918161,MAP4K2;MAP2K1;STK39;IKBKB;PAK1;UBB;TNIK;PAK2;MAP3K4;MAP4K3;MAP3K5;SKP1;MAP4K4
alpha,4,protein polymerization (GO:0051258),10/46,10,46,0.00124259121624612,0.116572268997694,0,0,3.05324865657059,20.4279323070663,GPX4;MAP7D3;UBE2S;COBLL1;MICALL2;COBL;RAC1;CORO7;WASF1;CKAP5
alpha,4,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),13/71,13,71,0.00136604722316798,0.116572268997694,0,0,2.57160943187213,16.9619087918161,KLHL18;ANKIB1;CUL5;CUL3;FBXO45;BTBD9;ANAPC11;RNF144A;ABTB2;BTBD3;TRIP12;ARIH1;ANAPC2
alpha,4,protein targeting (GO:0006605),20/134,20,134,0.00127867946644435,0.116572268997694,0,0,2.09626027167533,13.9651337422973,ATG3;NLGN1;VPS13C;TIMM9;SRP14;MFF;TOMM20;ZDHHC2;GABARAP;RABGEF1;SDCBP;SPCS3;ZDHHC18;ZDHHC9;LAMP2;VPS41;KIF13B;MFN2;AP4S1;AP1S3
alpha,4,regulation of protein import into nucleus (GO:0042306),7/26,7,26,0.00180504448827944,0.126894627526044,0,0,3.78133102852204,23.8873110856653,HYAL2;GNAQ;ZC3H12A;TXN;CABP1;IPO5;DACT1
alpha,4,Rho protein signal transduction (GO:0007266),13/73,13,73,0.00177712903563935,0.126894627526044,0,0,2.50115437894413,15.8392006956461,RTKN;ARHGAP29;RHOA;RND1;RHOB;PAK1;CDC42EP4;CFL1;GNA12;RAC1;PAK2;CTNNAL1;RHOQ
alpha,4,protein depolymerization (GO:0051261),7/26,7,26,0.00180504448827944,0.126894627526044,0,0,3.78133102852204,23.8873110856653,MICAL1;NCKAP5L;STMN1;CFL1;TWF1;DSTN;CKAP5
alpha,4,activation of MAPKK activity (GO:0000186),8/34,8,34,0.00221265589638723,0.143648556776742,0,0,3.30469266358229,20.2034425707883,MAP3K15;RAP1A;PLCG1;TNIK;CRK;MAP3K4;TGFBR1;MAP3K5
alpha,4,Notch signaling involved in heart development (GO:0061314),4/9,4,9,0.00241117065428955,0.143648556776742,0,0,6.24219725343321,37.6257359597341,DLL4;HEY1;HEY2;SNAI1
alpha,4,regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),7/27,7,27,0.00228891165889258,0.143648556776742,0,0,3.64128173116937,22.1378234642047,JUN;SMAD3;SRF;NFATC3;FOS;RELA;GNL3
alpha,4,negative regulation of protein depolymerization (GO:1901880),6/20,6,20,0.00209501977680686,0.143648556776742,0,0,4.21348314606742,25.9895742372865,LIMA1;PLEKHH2;CAMSAP1;TTBK2;ANAPC2;CLASP2
alpha,4,DNA replication (GO:0006260),18/121,18,121,0.00226497854655225,0.143648556776742,0,0,2.08933048565326,12.724419613315,BARD1;ACHE;TIPIN;SET;POLN;RFC2;REV1;CDC7;RECQL4;KIN;KAT5;ORC1;ORC2;RAD17;MCM4;ATRIP;RAD9A;POLG
alpha,4,regulation of DNA recombination (GO:0000018),8/34,8,34,0.00221265589638723,0.143648556776742,0,0,3.30469266358229,20.2034425707883,SETD2;PPP4R2;MSH2;FIGNL1;ALYREF;TERF2IP;KPNA2;KPNA1
alpha,4,somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),4/9,4,9,0.00241117065428955,0.143648556776742,0,0,6.24219725343321,37.6257359597341,EXOSC6;MSH2;LIG4;EXOSC3
alpha,4,DNA synthesis involved in DNA repair (GO:0000731),12/66,12,66,0.00219252981793526,0.143648556776742,0,0,2.55362614913177,15.6350848668027,BARD1;VCP;KAT5;PAPD7;UBB;POLN;RFC2;USP10;REV1;ZBTB1;SPRTN;POLI
alpha,4,regulation of cell differentiation (GO:0045595),18/122,18,122,0.00248433515342599,0.145540634404873,0,0,2.07220482593479,12.4285669073736,TFAP2A;PHLDB1;DLX2;JUN;HSP90AB1;PLEKHB2;SRF;TGFBR1;CDK9;PURB;HEY1;HEY2;PHLDB2;SKIL;FADS1;BIRC2;ANAPC2;CLASP2
alpha,4,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),4/9,4,9,0.00241117065428955,0.143648556776742,0,0,6.24219725343321,37.6257359597341,RB1;CUL3;NSMCE2;ANAPC11
alpha,4,embryonic limb morphogenesis (GO:0030326),8/35,8,35,0.00269199964385429,0.155120963084391,0,0,3.21027287319422,18.9966966276002,FBXW4;TFAP2A;RARG;MBNL1;PTCH1;CTNNB1;ECE1;GLI3
alpha,4,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),7/28,7,28,0.0028668908125263,0.159954304857618,0,0,3.51123595505618,20.556626323846,MOAP1;DDX3X;BAG3;BLOC1S2;FADD;GABARAP;DEDD2
alpha,4,microtubule polymerization (GO:0046785),7/28,7,28,0.0028668908125263,0.159954304857618,0,0,3.51123595505618,20.556626323846,GOLGA2;MAP7D3;TUBGCP2;RANBP9;TUBGCP4;CKAP5;CLASP2
alpha,4,actin filament bundle organization (GO:0061572),8/36,8,36,0.00324868354781609,0.178423791727712,0,0,3.1210986267166,17.8823515196966,LIMA1;DPYSL3;FSCN1;BAIAP2;ADD1;RHOA;RND1;RHOB
alpha,4,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),14/88,14,88,0.00359969289757683,0.186823851372108,0,0,2.2344228804903,12.5728891738102,PSMD12;FBXW7;CLU;ANAPC10;ANAPC11;PSMA5;PSMD6;PSMA3;PSMD7;PSMA1;UBB;PSMF1;SKP1;ANAPC2
alpha,4,nuclear transport (GO:0051169),6/22,6,22,0.00356699724992709,0.186823851372108,0,0,3.83043922369765,21.5884747583584,NPM1;SET;NXT1;RSRC1;HMGA1;PSIP1
alpha,4,regulation of cell morphogenesis (GO:0022604),7/29,7,29,0.00355031031763319,0.186823851372108,0,0,3.39015885315769,19.1229377476179,ARC;CAPZB;CFL1;QRICH1;KIAA1958;CAMSAP1;BCL9L
alpha,4,contractile actin filament bundle assembly (GO:0030038),4/10,4,10,0.00379321563868437,0.186823851372108,0,0,5.61797752808989,31.3176470007993,ITGB5;CUL3;ARRB1;RHOA
alpha,4,stress fiber assembly (GO:0043149),4/10,4,10,0.00379321563868437,0.186823851372108,0,0,5.61797752808989,31.3176470007993,ITGB5;CUL3;ARRB1;RHOA
alpha,4,negative regulation of mitotic cell cycle phase transition (GO:1901991),13/80,13,80,0.00409258507984419,0.186823851372108,0,0,2.28230337078652,12.5494241531634,RB1;USP47;PSMD12;PKD2;PSMA5;PSMD6;PSMA3;PSMD7;PSMA1;UBB;PSMF1;DACT1;SKP1
alpha,4,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",5/16,5,16,0.00408649460700075,0.186823851372108,0,0,4.38904494382023,24.1400445080759,FOSL1;JUN;SRF;SUB1;CTNNB1
alpha,4,actin filament depolymerization (GO:0030042),4/10,4,10,0.00379321563868437,0.186823851372108,0,0,5.61797752808989,31.3176470007993,MICAL1;CFL1;DSTN;TWF1
alpha,4,microtubule cytoskeleton organization involved in mitosis (GO:1902850),9/45,9,45,0.00392705793912209,0.186823851372108,0,0,2.80898876404494,15.561417835543,MECP2;SETD2;TNKS;STMN1;BCCIP;SBDS;WDR62;RAN;CLASP2
alpha,4,linoleic acid metabolic process (GO:0043651),5/16,5,16,0.00408649460700075,0.186823851372108,0,0,4.38904494382023,24.1400445080759,FADS2;ELOVL5;ACSL1;ALOXE3;FADS1
alpha,4,protein K11-linked deubiquitination (GO:0035871),4/10,4,10,0.00379321563868437,0.186823851372108,0,0,5.61797752808989,31.3176470007993,OTUD7A;TNFAIP3;USP30;OTUD3
alpha,4,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",14/89,14,89,0.00399839130596414,0.186823851372108,0,0,2.20931700542861,12.1995462081343,PSMD12;RYK;CLTC;ARRB2;RHOA;PSMA5;PSMD6;PSMA3;PSMD7;PARD6A;PSMA1;UBB;RAC1;PSMF1
alpha,4,heme biosynthetic process (GO:0006783),5/16,5,16,0.00408649460700075,0.186823851372108,0,0,4.38904494382023,24.1400445080759,SLC25A38;ALAS1;COX15;UROS;HMBS
alpha,4,negative regulation of Notch signaling pathway (GO:0045746),7/30,7,30,0.00435087361645245,0.192336676614388,0,0,3.27715355805243,17.8191246997845,DLL4;LFNG;HEY1;UBB;FBXW7;NRARP;ARRB1
alpha,4,peptidyl-threonine modification (GO:0018210),14/90,14,90,0.0044322249803031,0.192336676614388,0,0,2.18476903870162,11.8389435008903,MAP2K1;GALNT16;TNKS;GALNT2;DAPK3;STK39;LMTK2;DCLK2;GALNT10;TGFBR1;CAMKK2;HIPK2;TBK1;CDK5R1
alpha,4,positive regulation of protein import into nucleus (GO:0042307),10/54,10,54,0.00434738247330971,0.192336676614388,0,0,2.60091552226384,14.1442502737919,KANK1;SMAD4;SMAD3;BAG3;HYAL2;ZC3H12A;TGFBR1;BMP6;IPO5;DACT1
alpha,4,regulation of establishment of planar polarity (GO:0090175),14/90,14,90,0.0044322249803031,0.192336676614388,0,0,2.18476903870162,11.8389435008903,PSMD12;CLTC;ARRB2;RHOA;PSMA5;PSMD6;PSMA3;PSMD7;PARD6A;PSMA1;UBB;RAC1;PSMF1;DACT1
alpha,4,regulation of signal transduction by p53 class mediator (GO:1901796),19/139,19,139,0.00457391840171102,0.193593215979423,0,0,1.91981246463503,10.3427689191962,BARD1;MEAF6;PHF20;RFC2;PAK1IP1;TAF9;HIPK2;KAT5;UBB;TP53INP1;RAD17;TAF4B;TAF6;TAF5;TAF4;ATRIP;TAF3;RAD9A;CDK5R1
alpha,4,actin filament bundle assembly (GO:0051017),8/38,8,38,0.00462640971330628,0.193593215979423,0,0,2.95683027794205,15.8958431448364,LIMA1;DPYSL3;FSCN1;BAIAP2;ADD1;RHOA;RND1;RHOB
alpha,4,regulation of mRNA stability (GO:0043488),18/129,18,129,0.00457133396021823,0.193593215979423,0,0,1.95975960282205,10.5590871864139,NUP214;PSMD12;NPM1;SET;CIRBP;HSPB1;AXIN2;YWHAZ;PSMA5;EXOSC6;PSMD6;PSMA3;PSMD7;UBB;PSMA1;MAPKAPK2;PSMF1;EXOSC3
alpha,4,RNA secondary structure unwinding (GO:0010501),9/47,9,47,0.00531443459919612,0.209890310294094,0,0,2.68945732727707,14.0855719162554,DDX3X;DDX1;EIF4A3;DDX56;AGO2;DDX42;DDX54;DDX51;DDX41
alpha,4,vesicle coating (GO:0006901),11/64,11,64,0.0051613997445619,0.20853241496707,0,0,2.41397471910112,12.7133124445757,GOLGA2;NAPA;ANKRD28;SEC24B;SEC24A;SAR1B;GORASP1;CUL3;TRAPPC10;KLHL12;TRAPPC9
alpha,4,microtubule nucleation (GO:0007020),5/17,5,17,0.0054538785274694,0.21066354971489,0,0,4.13086582947786,21.5277109509168,GOLGA2;TUBGCP2;RANBP9;TUBGCP4;CLASP2
alpha,4,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",11/64,11,64,0.0051613997445619,0.20853241496707,0,0,2.41397471910112,12.7133124445757,GOLGA2;NAPA;ANKRD28;SEC24B;SEC24A;SAR1B;GORASP1;CUL3;TRAPPC10;KLHL12;TRAPPC9
alpha,4,chaperone-mediated protein complex assembly (GO:0051131),5/17,5,17,0.0054538785274694,0.21066354971489,0,0,4.13086582947786,21.5277109509168,CCT2;HSP90AB1;PTGES3L;LONP1;CLU
alpha,4,macroautophagy (GO:0016236),16/111,16,111,0.00528825731363993,0.209890310294094,0,0,2.02449640651888,10.6129497270975,ATG3;VCP;VPS37A;STAM;TOMM20;ATG13;DYNLL2;GABARAP;MAP1LC3A;UBB;C6ORF106;TBC1D5;LAMP2;PLAA;MFN2;VDAC1
alpha,4,isotype switching (GO:0045190),4/11,4,11,0.00562731984235323,0.211475944880793,0,0,5.10725229826354,26.4561899871991,EXOSC6;MSH2;LIG4;EXOSC3
alpha,4,modification-dependent protein catabolic process (GO:0019941),19/142,19,142,0.005773190871469,0.211475944880793,0,0,1.8792530463681,9.68666684528765,FBXW4;RNF20;UBE2H;RNF11;UBE2I;CUL3;AMFR;UBR3;FBXO45;ARRB1;UBE2G1;FBXO21;FBXO22;FBXL14;UBE2S;LONP1;TRIP12;PSMF1;ARIH1
alpha,4,positive regulation of cell cycle G1/S phase transition (GO:1902808),6/24,6,24,0.00569351121792098,0.211475944880793,0,0,3.51123595505618,18.147570700184,ANKRD17;DDX3X;LSM11;STXBP4;RDX;FAM83D
alpha,4,COPII vesicle coating (GO:0048208),11/64,11,64,0.0051613997445619,0.20853241496707,0,0,2.41397471910112,12.7133124445757,GOLGA2;NAPA;ANKRD28;SEC24B;SEC24A;SAR1B;GORASP1;CUL3;TRAPPC10;KLHL12;TRAPPC9
alpha,4,glutathione biosynthetic process (GO:0006750),4/11,4,11,0.00562731984235323,0.211475944880793,0,0,5.10725229826354,26.4561899871991,GCLC;CHAC2;HAGH;GCLM
alpha,4,regulation of organelle assembly (GO:1902115),9/48,9,48,0.00613671305201733,0.211475944880793,0,0,2.63342696629214,13.4132707524041,ATG3;NPM1;KIF9;PDCD6IP;RDX;SPICE1;TBC1D12;STAM;RNF4
alpha,4,N-terminal peptidyl-methionine acetylation (GO:0017196),3/6,3,6,0.00611688742541541,0.211475944880793,0,0,7.02247191011236,35.791445944188,NAA30;NAA25;NAA16
alpha,4,regulation of extracellular exosome assembly (GO:1903551),3/6,3,6,0.00611688742541541,0.211475944880793,0,0,7.02247191011236,35.791445944188,SDCBP;PDCD6IP;STAM
alpha,4,ribosomal small subunit export from nucleus (GO:0000056),3/6,3,6,0.00611688742541541,0.211475944880793,0,0,7.02247191011236,35.791445944188,LTV1;NPM1;RAN
alpha,4,"regulation of wound healing, spreading of epidermal cells (GO:1903689)",3/6,3,6,0.00611688742541541,0.211475944880793,0,0,7.02247191011236,35.791445944188,PHLDB2;RREB1;CLASP2
alpha,4,regulation of nuclear cell cycle DNA replication (GO:0033262),3/6,3,6,0.00611688742541541,0.211475944880793,0,0,7.02247191011236,35.791445944188,TIPIN;CDC7;INO80
alpha,4,negative regulation of membrane potential (GO:0045837),3/6,3,6,0.00611688742541541,0.211475944880793,0,0,7.02247191011236,35.791445944188,HEBP2;PRELID1;BNIP3
alpha,4,activation of GTPase activity (GO:0090630),13/85,13,85,0.00690959888295374,0.235798447316334,0,0,2.14805023132849,10.686214142702,GRTP1;TBC1D9;FOXJ1;RASGRP1;CORO1C;TBC1D1;TBC1D5;TBC1D30;TBC1D7;SGSM2;RUNDC1;TBC1D12;ANAPC2
alpha,4,porphyrin-containing compound biosynthetic process (GO:0006779),5/18,5,18,0.00711502290972845,0.238183862168528,0,0,3.90137328339576,19.2944242646919,SLC25A38;ALAS1;COX15;UROS;HMBS
alpha,4,positive regulation of p38MAPK cascade (GO:1900745),5/18,5,18,0.00711502290972845,0.238183862168528,0,0,3.90137328339576,19.2944242646919,GADD45B;KARS;ZC3H12A;MAP3K4;GADD45G
alpha,4,positive regulation of epithelial to mesenchymal transition (GO:0010718),8/41,8,41,0.00748126606303831,0.241613746293335,0,0,2.74047684297068,13.4156021966404,SDCBP;SMAD4;SMAD3;SNAI1;CTNNB1;AXIN2;TGFBR1;BCL9L
alpha,4,substrate adhesion-dependent cell spreading (GO:0034446),7/33,7,33,0.00757623414866962,0.241613746293335,0,0,2.9792305073204,14.546805038553,MICALL2;FN1;TYRO3;PARVA;RADIL;RAC1;BVES
alpha,4,androgen receptor signaling pathway (GO:0030521),8/41,8,41,0.00748126606303831,0.241613746293335,0,0,2.74047684297068,13.4156021966404,RB1;NCOA1;MED13;KAT5;NCOA4;CTNNB1;RNF4;RAN
alpha,4,positive regulation of apoptotic signaling pathway (GO:2001235),12/77,12,77,0.00797359731721959,0.241613746293335,0,0,2.18882241354151,10.575557122652,SLC9A3R1;MOAP1;TRIM39;HYAL2;BNIP3;PPIF;HIP1R;FADD;MFF;PAK2;TGFBR1;DEDD2
alpha,4,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),12/77,12,77,0.00797359731721959,0.241613746293335,0,0,2.18882241354151,10.575557122652,PSMA5;PSMD6;PSMA3;PSMD12;PSMD7;PSMA1;UBB;PSMF1;ANAPC10;SKP1;ANAPC2;ANAPC11
alpha,4,Golgi localization (GO:0051645),4/12,4,12,0.00797006345576632,0.241613746293335,0,0,4.68164794007491,22.6220169680902,SLC9A3R1;ARHGAP21;YWHAZ;ARCN1
alpha,4,positive regulation of SMAD protein import into nucleus (GO:0060391),4/12,4,12,0.00797006345576632,0.241613746293335,0,0,4.68164794007491,22.6220169680902,SMAD4;SMAD3;TGFBR1;BMP6
alpha,4,regulation of sister chromatid cohesion (GO:0007063),4/12,4,12,0.00797006345576632,0.241613746293335,0,0,4.68164794007491,22.6220169680902,RB1;CTNNB1;AXIN2;CTCF
alpha,4,ribosomal subunit export from nucleus (GO:0000054),4/12,4,12,0.00797006345576632,0.241613746293335,0,0,4.68164794007491,22.6220169680902,LTV1;NPM1;ABCE1;RAN
alpha,4,nonribosomal peptide biosynthetic process (GO:0019184),4/12,4,12,0.00797006345576632,0.241613746293335,0,0,4.68164794007491,22.6220169680902,GCLC;CHAC2;HAGH;GCLM
alpha,4,establishment of apical/basal cell polarity (GO:0035089),4/12,4,12,0.00797006345576632,0.241613746293335,0,0,4.68164794007491,22.6220169680902,SLC9A3R1;FSCN1;FOXJ1;RHOA
alpha,4,fatty acid beta-oxidation (GO:0006635),9/51,9,51,0.0091972657612992,0.246781596572265,0,0,2.47851949768672,11.6214037647684,HADHB;HADHA;ABCD3;SCP2;ACOX3;ACAD10;ACADS;CRAT;ACAT1
alpha,4,peptidyl-threonine phosphorylation (GO:0018107),11/69,11,69,0.009157606607424,0.246781596572265,0,0,2.23904901481843,10.5082386093885,MAP2K1;TBK1;TNKS;DAPK3;STK39;LMTK2;DCLK2;TGFBR1;CAMKK2;HIPK2;CDK5R1
alpha,4,peptide catabolic process (GO:0043171),6/26,6,26,0.00862084518307374,0.246781596572265,0,0,3.24114088159032,15.4069970290597,RNPEPL1;XPNPEP1;ECE1;CHAC2;TPP1;LTA4H
alpha,4,positive regulation of receptor-mediated endocytosis (GO:0048260),8/42,8,42,0.00867815885559875,0.246781596572265,0,0,2.67522739432852,12.6991596742092,VTN;HIP1;ANXA2;TBC1D5;HIP1R;ARRB1;ARRB2;CLU
alpha,4,regulation of actin filament polymerization (GO:0030833),11/69,11,69,0.009157606607424,0.246781596572265,0,0,2.23904901481843,10.5082386093885,LATS1;KANK1;FCHSD2;PRKCE;RASA1;CDC42EP4;HIP1R;TWF1;RAC1;SLIT2;BAIAP2
alpha,4,cellular response to vascular endothelial growth factor stimulus (GO:0035924),6/26,6,26,0.00862084518307374,0.246781596572265,0,0,3.24114088159032,15.4069970290597,DLL4;ERN1;NR4A1;EGR3;MAPKAPK2;HSPB1
alpha,4,non-canonical Wnt signaling pathway (GO:0035567),17/128,17,128,0.00936533371187078,0.249387484827468,0,0,1.8653441011236,8.71253788472559,PSMD12;RYK;CLTC;ARRB2;RHOA;PSMA5;PSMD6;PSMA3;PSMD7;PARD6A;UBB;PSMA1;GNB1;AGO2;CTNNB1;PSMF1;RAC1
alpha,4,COPII-coated vesicle budding (GO:0090114),11/69,11,69,0.009157606607424,0.246781596572265,0,0,2.23904901481843,10.5082386093885,GOLGA2;NAPA;ANKRD28;SEC24B;SEC24A;SAR1B;GORASP1;CUL3;TRAPPC10;KLHL12;TRAPPC9
alpha,4,positive regulation of filopodium assembly (GO:0051491),6/26,6,26,0.00862084518307374,0.246781596572265,0,0,3.24114088159032,15.4069970290597,NLGN1;RALA;DPYSL3;FSCN1;AGRN;RHOQ
alpha,4,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),5/19,5,19,0.00909911338636696,0.246781596572265,0,0,3.69603784742756,17.3698192647676,SDCBP;SMAD4;CDKN2B;HSP90AB1;HIPK2
alpha,4,regulation of epithelial to mesenchymal transition (GO:0010717),11/69,11,69,0.009157606607424,0.246781596572265,0,0,2.23904901481843,10.5082386093885,SDCBP;PHLDB1;SMAD4;SMAD3;SNAI1;CTNNB1;AXIN2;PHLDB2;TGFBR1;CLASP2;BCL9L
alpha,4,protein heterotetramerization (GO:0051290),5/19,5,19,0.00909911338636696,0.246781596572265,0,0,3.69603784742756,17.3698192647676,CPSF6;ANXA2;GPRIN1;FARSB;S100A10
alpha,4,chromatin disassembly (GO:0031498),5/19,5,19,0.00909911338636696,0.246781596572265,0,0,3.69603784742756,17.3698192647676,SMARCD1;SMARCC1;PBRM1;SET;HMGA1
alpha,4,positive regulation of nucleocytoplasmic transport (GO:0046824),7/34,7,34,0.00896679448374412,0.246781596572265,0,0,2.8916060806345,13.6316875351784,CPSF6;XPO4;BAG3;NCBP2;HYAL2;ZC3H12A;IPO5
alpha,4,nucleosome disassembly (GO:0006337),5/19,5,19,0.00909911338636696,0.246781596572265,0,0,3.69603784742756,17.3698192647676,SMARCD1;SMARCC1;PBRM1;SET;HMGA1
alpha,4,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),5/19,5,19,0.00909911338636696,0.246781596572265,0,0,3.69603784742756,17.3698192647676,SDCBP;SMAD4;CDKN2B;HSP90AB1;HIPK2
alpha,4,negative regulation of cell cycle G2/M phase transition (GO:1902750),11/70,11,70,0.0101852637917583,0.257562605957054,0,0,2.20706260032103,10.1233841544437,PSMA5;USP47;PSMD6;PSMA3;PSMD12;PSMD7;PSMA1;UBB;PSMF1;ATF5;SKP1
alpha,4,dorsal aorta development (GO:0035907),3/7,3,7,0.0101405056247594,0.257562605957054,0,0,6.01926163723917,27.6357388705112,DLL4;HEY1;HEY2
alpha,4,response to UV (GO:0009411),14/99,14,99,0.0103002771728406,0.258591604623842,0,0,1.98615367154693,9.08781390275469,USP47;NPM1;REV1;CIRBP;ZBTB1;INO80;TRIAP1;RELA;MSH2;PAPD7;SPRTN;MAP3K4;MAP4K3;ATF4
alpha,4,rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),3/7,3,7,0.0101405056247594,0.257562605957054,0,0,6.01926163723917,27.6357388705112,NPM1;ABCE1;RAN
alpha,4,regulation of stress fiber assembly (GO:0051492),10/61,10,61,0.0104466594186588,0.258591604623842,0,0,2.30244980659422,10.5025626831212,PAK1;STMN1;TESK1;PPFIA1;RAC1;PHLDB2;RHOA;TGFBR1;S100A10;CLASP2
alpha,4,store-operated calcium entry (GO:0002115),3/7,3,7,0.0101405056247594,0.257562605957054,0,0,6.01926163723917,27.6357388705112,STIM2;ORAI2;ORAI1
alpha,4,cytoskeleton-dependent intracellular transport (GO:0030705),6/27,6,27,0.0104299730694067,0.258591604623842,0,0,3.1210986267166,14.2417964794156,TUBA1B;KIF5B;KIF13A;KIF13B;KIF1A;DYNLL2
alpha,4,dorsal aorta morphogenesis (GO:0035912),3/7,3,7,0.0101405056247594,0.257562605957054,0,0,6.01926163723917,27.6357388705112,DLL4;HEY1;HEY2
alpha,4,pri-miRNA transcription from RNA polymerase II promoter (GO:0061614),3/7,3,7,0.0101405056247594,0.257562605957054,0,0,6.01926163723917,27.6357388705112,FOSL1;ETS1;RELA
alpha,4,modulation by symbiont of host cellular process (GO:0044068),3/7,3,7,0.0101405056247594,0.257562605957054,0,0,6.01926163723917,27.6357388705112,KPNA4;KPNA2;KPNA1
alpha,4,modulation by virus of host process (GO:0019054),4/13,4,13,0.0108718120680669,0.265377912633716,0,0,4.32152117545376,19.540111876182,ZC3H12A;KPNA4;KPNA2;KPNA1
alpha,4,B cell activation involved in immune response (GO:0002312),4/13,4,13,0.0108718120680669,0.265377912633716,0,0,4.32152117545376,19.540111876182,EXOSC6;MSH2;LIG4;EXOSC3
alpha,4,cytoskeleton-dependent cytokinesis (GO:0061640),11/71,11,71,0.0112991954671761,0.272965263543538,0,0,2.17597721158411,9.75495752637463,RTKN;ALKBH4;PDCD6IP;SPAST;IST1;RASA1;ARL3;STMN1;SNX9;RHOA;RHOB
alpha,4,error-prone translesion synthesis (GO:0042276),5/20,5,20,0.011433816825849,0.272965263543538,0,0,3.51123595505618,15.6993677190918,UBB;PAPD7;RFC2;REV1;POLI
alpha,4,regulation of ATP metabolic process (GO:1903578),8/44,8,44,0.0114932742544647,0.272965263543538,0,0,2.55362614913177,11.4044771760489,NUP214;NUP188;NUP155;PGAM1;NUP62;ECD;NUP153;SLC25A33
alpha,4,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),5/20,5,20,0.011433816825849,0.272965263543538,0,0,3.51123595505618,15.6993677190918,KANK1;CAPZB;TBC1D30;TBC1D7;SLIT2
alpha,4,NIK/NF-kappaB signaling (GO:0038061),12/81,12,81,0.0118310098864606,0.275403971860325,0,0,2.08073241781107,9.23227473589397,PSMA5;PSMD6;PSMA3;PSMD12;PSMD7;PSMA1;UBB;PSMF1;BIRC2;RELA;SKP1;NFKB2
alpha,4,plasma membrane bounded cell projection morphogenesis (GO:0120039),9/53,9,53,0.011800064784523,0.275403971860325,0,0,2.38499046003816,10.5885235095945,PAK1;UBB;DTNBP1;RAC1;TNIK;SGK1;ZNF335;NBL1;MAP4K4
alpha,4,regulation of vesicle fusion (GO:0031338),10/62,10,62,0.0116830731427725,0.275403971860325,0,0,2.26531351939108,10.079771259177,TBC1D1;ANXA2;TBC1D5;GRTP1;TBC1D30;SGSM2;VPS41;RUNDC1;TBC1D9;TBC1D12
alpha,4,tRNA transport (GO:0051031),7/36,7,36,0.0122943855761041,0.281736538035672,0,0,2.73096129837703,12.01244071718,NUP214;NUP188;NUP155;NUP62;NUP153;TOMM20;RAN
alpha,4,positive regulation of growth (GO:0045927),11/72,11,72,0.0125038122143854,0.281736538035672,0,0,2.14575530586767,9.40210259523455,SUPV3L1;USP47;SDCBP;DDX3X;ZNF639;SPHK1;TAF9;ADNP2;INO80;SLC25A33;TGFBR1
alpha,4,positive regulation of RNA metabolic process (GO:0051254),7/36,7,36,0.0122943855761041,0.281736538035672,0,0,2.73096129837703,12.01244071718,UTP15;SUPV3L1;ERN1;MAP2K1;POLR2A;RIOK1;RELA
alpha,4,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),11/72,11,72,0.0125038122143854,0.281736538035672,0,0,2.14575530586767,9.40210259523455,PSMA5;PSMD6;PSMA3;PSMD12;PSMD7;PSMA1;UBB;PSMF1;ANAPC10;ANAPC2;ANAPC11
alpha,4,protein localization to chromosome (GO:0034502),6/28,6,28,0.0124926361132458,0.281736538035672,0,0,3.00963081861958,13.1900559366219,RB1;ACD;TNKS2;TNKS;TERF2IP;CTCF
alpha,4,regulation of focal adhesion assembly (GO:0051893),8/45,8,45,0.0131292157300859,0.288432458070325,0,0,2.49687890137328,10.8187648529211,LDB1;DAPK3;RAC1;PHLDB2;RHOA;CORO1C;S100A10;CLASP2
alpha,4,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),10/63,10,63,0.0130268680510046,0.288432458070325,0,0,2.22935616194043,9.67705832264092,PSMA5;USP47;PSMD6;PSMA3;PSMD12;PSMD7;PSMA1;UBB;PSMF1;SKP1
alpha,4,unsaturated fatty acid metabolic process (GO:0033559),8/45,8,45,0.0131292157300859,0.288432458070325,0,0,2.49687890137328,10.8187648529211,FADS2;SCP2;ELOVL5;ACSL1;SCD;DAGLB;ALOXE3;FADS1
alpha,4,regulation of translational initiation (GO:0006446),10/63,10,63,0.0130268680510046,0.288432458070325,0,0,2.22935616194043,9.67705832264092,CTIF;NPM1;DDX3X;EIF5;NCBP2;DDX1;AGO2;EIF4H;HSPB1;EIF4B
alpha,4,regulation of phosphate metabolic process (GO:0019220),4/14,4,14,0.0143760830020081,0.290413400873899,0,0,4.01284109149278,17.0232317651142,BARD1;IKBKB;SRPX2;RAD17
alpha,4,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",10/64,10,64,0.0144834383959598,0.290520593893498,0,0,2.19452247191011,9.29325285711202,TTC37;EXOSC6;ZCCHC11;CNOT7;LSM6;CNOT11;EIF4A3;EXOSC3;EIF4E;EIF4B
alpha,4,cell migration involved in sprouting angiogenesis (GO:0002042),4/14,4,14,0.0143760830020081,0.290413400873899,0,0,4.01284109149278,17.0232317651142,NR4A1;EGR3;SRF;SLIT2
alpha,4,glycosphingolipid metabolic process (GO:0006687),9/55,9,55,0.0149162364272348,0.290520593893498,0,0,2.29826353421859,9.66489905411403,CTSA;SMPD2;UGT8;ASAH1;HEXB;PSAP;ARSK;ESYT2;CLN6
alpha,4,tumor necrosis factor-mediated signaling pathway (GO:0033209),16/124,16,124,0.0148837417182646,0.290520593893498,0,0,1.81225081551287,7.62501961150245,PSMD12;RELA;IKBKB;PSMA5;PSMD6;PSMA3;PSMD7;KARS;UBB;PSMA1;TRAF3;CDIP1;TNFSF9;PSMF1;RELT;BIRC2
alpha,4,regulation of defense response to virus (GO:0050688),4/14,4,14,0.0143760830020081,0.290413400873899,0,0,4.01284109149278,17.0232317651142,HERC5;RNF216;TRAF3;TNFAIP3
alpha,4,SMAD protein complex assembly (GO:0007183),3/8,3,8,0.0153732092359006,0.290520593893498,0,0,5.26685393258427,21.9897943005693,SMAD4;SMAD3;ZFYVE9
alpha,4,cellular response to hydrogen peroxide (GO:0070301),6/29,6,29,0.0148254212045254,0.290520593893498,0,0,2.90585044556374,12.2377332121162,NET1;PPIF;TNFAIP3;RELA;MAP3K5;RHOB
alpha,4,cell surface receptor signaling pathway involved in heart development (GO:0061311),4/14,4,14,0.0143760830020081,0.290413400873899,0,0,4.01284109149278,17.0232317651142,DLL4;HEY1;HEY2;SNAI1
alpha,4,regulation of filopodium assembly (GO:0051489),7/37,7,37,0.0142552432064068,0.290413400873899,0,0,2.65715153355603,11.2945693400516,NLGN1;RALA;CAPZB;DPYSL3;FSCN1;AGRN;RHOQ
alpha,4,establishment of integrated proviral latency (GO:0075713),3/8,3,8,0.0153732092359006,0.290520593893498,0,0,5.26685393258427,21.9897943005693,HMGA1;PSIP1;LIG4
alpha,4,protein K11-linked ubiquitination (GO:0070979),6/29,6,29,0.0148254212045254,0.290520593893498,0,0,2.90585044556374,12.2377332121162,UBE2H;UBE2S;RNF4;ANAPC10;ANAPC11;ANAPC2
alpha,4,regulation of fibroblast migration (GO:0010762),4/14,4,14,0.0143760830020081,0.290413400873899,0,0,4.01284109149278,17.0232317651142,PRKCE;HYAL2;GNA12;CORO1C
alpha,4,transferrin transport (GO:0033572),7/37,7,37,0.0142552432064068,0.290413400873899,0,0,2.65715153355603,11.2945693400516,ATP6V0B;TFRC;CLTC;LMTK2;ATP6V1E2;ATP6V0C;ATP6V1C1
alpha,4,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),11/73,11,73,0.0138035323953629,0.290413400873899,0,0,2.11636139756811,9.06401766927996,PSMA5;PSMD6;PSMA3;PSMD12;PSMD7;PSMA1;UBB;PSMF1;ANAPC10;ANAPC2;ANAPC11
alpha,4,barbed-end actin filament capping (GO:0051016),3/8,3,8,0.0153732092359006,0.290520593893498,0,0,5.26685393258427,21.9897943005693,CAPZB;TWF1;ADD1
alpha,4,negative regulation of homeostatic process (GO:0032845),6/29,6,29,0.0148254212045254,0.290520593893498,0,0,2.90585044556374,12.2377332121162,LDB1;TSC22D3;TNFAIP3;TERF2IP;TMBIM6;FADD
alpha,4,glutamate receptor signaling pathway (GO:0007215),7/37,7,37,0.0142552432064068,0.290413400873899,0,0,2.65715153355603,11.2945693400516,GRM4;HOMER1;GPRIN1;GNAQ;GRIK4;DAGLB;CDK5R1
alpha,4,nose development (GO:0043584),3/8,3,8,0.0153732092359006,0.290520593893498,0,0,5.26685393258427,21.9897943005693,SMCHD1;CHD7;GLI3
alpha,4,ferric iron transport (GO:0015682),7/37,7,37,0.0142552432064068,0.290413400873899,0,0,2.65715153355603,11.2945693400516,ATP6V0B;TFRC;CLTC;LMTK2;ATP6V1E2;ATP6V0C;ATP6V1C1
alpha,4,phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),3/8,3,8,0.0153732092359006,0.290520593893498,0,0,5.26685393258427,21.9897943005693,PIK3CA;PIK3CB;PIK3C2A
alpha,4,regulation of receptor-mediated endocytosis (GO:0048259),7/37,7,37,0.0142552432064068,0.290413400873899,0,0,2.65715153355603,11.2945693400516,VTN;HIP1;TNK2;HIP1R;PIK3CB;RAC1;CLU
alpha,4,protein K6-linked ubiquitination (GO:0085020),3/8,3,8,0.0153732092359006,0.290520593893498,0,0,5.26685393258427,21.9897943005693,BARD1;UBE2S;RNF4
alpha,4,hepaticobiliary system development (GO:0061008),5/21,5,21,0.0141449318201117,0.290413400873899,0,0,3.34403424291065,14.2402317225458,PHF2;RARG;NF1;COBL;PKD2
alpha,4,ephrin receptor signaling pathway (GO:0048013),12/83,12,83,0.0142302351824632,0.290413400873899,0,0,2.03059428726141,8.63487140880263,SDCBP;PAK1;RASA1;GPRIN1;ARHGEF28;RAC1;ANKS1A;CRK;ACTB;GIT1;RHOA;CDK5R1
alpha,4,protein-DNA complex disassembly (GO:0032986),5/21,5,21,0.0141449318201117,0.290413400873899,0,0,3.34403424291065,14.2402317225458,SMARCD1;SMARCC1;PBRM1;SET;HMGA1
alpha,4,negative regulation of Ras protein signal transduction (GO:0046580),7/38,7,38,0.0164294995629315,0.301273710213139,0,0,2.58722649319929,10.630077484826,KANK1;CUL3;RASA1;STMN1;NF1;MFN2;RASAL2
alpha,4,regulation of carbohydrate catabolic process (GO:0043470),7/38,7,38,0.0164294995629315,0.301273710213139,0,0,2.58722649319929,10.630077484826,NUP214;NUP188;NUP155;PGAM1;NUP62;ECD;NUP153
alpha,4,"regulation of gene expression, epigenetic (GO:0040029)",11/75,11,75,0.0167059066847294,0.301273710213139,0,0,2.05992509363296,8.42919891617551,CREBZF;PHF1;DNMT3A;POLR1C;CTCF;POLR2H;DEK;BMI1;PPM1D;ZNF335;ACTB
alpha,4,regulation of posttranscriptional gene silencing (GO:0060147),9/56,9,56,0.0166836119078778,0.301273710213139,0,0,2.25722311396469,9.23955539684033,NUP214;NUP188;POLR2A;NUP155;NUP62;AGO2;NUP153;POLR2H;RAN
alpha,4,protein import (GO:0017038),9/57,9,57,0.0185992589235423,0.301273710213139,0,0,2.21762270845653,8.8364138273441,NUP214;NXT1;NUP188;NUP155;LAMP2;NUP62;NUP153;CLU;RAN
alpha,4,regulation of G1/S transition of mitotic cell cycle (GO:2000045),8/47,8,47,0.0169012764844179,0.301273710213139,0,0,2.3906287353574,9.75464051705264,RB1;ANKRD17;DDX3X;LSM11;RDX;INO80;PKD2;DACT1
alpha,4,epithelial to mesenchymal transition (GO:0001837),7/38,7,38,0.0164294995629315,0.301273710213139,0,0,2.58722649319929,10.630077484826,HEY1;HEY2;SNAI1;CTNNB1;FAM83D;HNRNPAB;TGFBR1
alpha,4,regulation of gene silencing by RNA (GO:0060966),9/56,9,56,0.0166836119078778,0.301273710213139,0,0,2.25722311396469,9.23955539684033,NUP214;NUP188;POLR2A;NUP155;NUP62;AGO2;NUP153;POLR2H;RAN
alpha,4,DNA-dependent DNA replication (GO:0006261),9/57,9,57,0.0185992589235423,0.301273710213139,0,0,2.21762270845653,8.8364138273441,PURA;ORC1;POLN;RFC2;ORC2;HMGA1;CDC7;LRWD1;POLG
alpha,4,regulation of generation of precursor metabolites and energy (GO:0043467),8/47,8,47,0.0169012764844179,0.301273710213139,0,0,2.3906287353574,9.75464051705264,NUP214;NUP188;NUP155;PGAM1;NUP62;ECD;NUP153;SLC25A33
alpha,4,T cell differentiation (GO:0030217),7/39,7,39,0.0188281521130276,0.301915750278526,0,0,2.52088735234803,10.0139781528128,DLL4;LFNG;JAG2;CHD7;LIG4;FADD;GLI3
alpha,4,negative regulation of protein polymerization (GO:0032272),5/22,5,22,0.0172560951904172,0.301273710213139,0,0,3.19203268641471,12.9583435059505,KANK1;STMN1;HIP1R;TWF1;SLIT2
alpha,4,regulation of macroautophagy (GO:0016241),15/117,15,117,0.0189824696476684,0.301915750278526,0,0,1.80063382310573,7.13814350302873,SCOC;ATP6V0B;EXOC8;BNIP3;ATG13;ERN1;RRAGA;UCHL1;TBK1;PIK3CA;TBC1D12;ATP6V1E2;ATP6V0C;ATP6V1C1;CDK5R1
alpha,4,"protein localization to chromosome, telomeric region (GO:0070198)",4/15,4,15,0.0185191870249731,0.301273710213139,0,0,3.74531835205993,14.9398799545592,ACD;TNKS2;TNKS;TERF2IP
alpha,4,chromosome organization (GO:0051276),9/57,9,57,0.0185992589235423,0.301273710213139,0,0,2.21762270845653,8.8364138273441,LATS1;CENPW;LDB1;MSH2;UBB;NUP155;LIG4;AXIN2;GEM
alpha,4,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),6/30,6,30,0.0174440627292485,0.301273710213139,0,0,2.80898876404494,11.3729099240794,IKBKB;TBK1;UBB;TRAF3;FADD;BIRC2
alpha,4,mitochondrion disassembly (GO:0061726),7/39,7,39,0.0188281521130276,0.301915750278526,0,0,2.52088735234803,10.0139781528128,ATG3;MAP1LC3A;BNIP3;USP30;ATG13;GABARAP;ATG2B
alpha,4,negative regulation of protein import into nucleus (GO:0042308),5/22,5,22,0.0172560951904172,0.301273710213139,0,0,3.19203268641471,12.9583435059505,SLC9A3R1;NF1;AXIN2;CABP1;ANAPC2
alpha,4,sphingolipid metabolic process (GO:0006665),15/117,15,117,0.0189824696476684,0.301915750278526,0,0,1.80063382310573,7.13814350302873,CTSA;ASAH1;SGMS1;ELOVL5;HEXB;SPHK1;SGPP1;UGT8;SMPD2;ARV1;PRKD3;ARSK;PSAP;ESYT2;ALOXE3
alpha,4,negative regulation of apoptotic signaling pathway (GO:2001234),10/66,10,66,0.0177562776187868,0.301273710213139,0,0,2.12802179094314,8.57809022157535,PRELID1;DDX3X;PPIF;TMBIM6;TRIAP1;ZMYND11;CLU;SH3RF1;TGFBR1;RELA
alpha,4,negative regulation of adherens junction organization (GO:1903392),4/15,4,15,0.0185191870249731,0.301273710213139,0,0,3.74531835205993,14.9398799545592,RDX;PHLDB2;CORO1C;CLASP2
alpha,4,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),6/30,6,30,0.0174440627292485,0.301273710213139,0,0,2.80898876404494,11.3729099240794,ZCCHC11;CNOT7;CNOT11;EIF4A3;EIF4E;EIF4B
alpha,4,GTP metabolic process (GO:0046039),5/22,5,22,0.0172560951904172,0.301273710213139,0,0,3.19203268641471,12.9583435059505,MOCS3;IMPDH1;IMPDH2;RHOQ;RAN
alpha,4,cellular response to reactive oxygen species (GO:0034614),10/66,10,66,0.0177562776187868,0.301273710213139,0,0,2.12802179094314,8.57809022157535,NET1;JUN;PPIF;TNFAIP3;FOS;PKD2;RELA;MAP3K5;RHOB;CAMKK2
alpha,4,positive regulation of response to wounding (GO:1903036),4/15,4,15,0.0185191870249731,0.301273710213139,0,0,3.74531835205993,14.9398799545592,KANK1;VTN;PRKCE;MYLK
alpha,4,regulation of RNA export from nucleus (GO:0046831),4/15,4,15,0.0185191870249731,0.301273710213139,0,0,3.74531835205993,14.9398799545592,SETD2;CPSF6;NCBP2;NUP153
alpha,4,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),10/66,10,66,0.0177562776187868,0.301273710213139,0,0,2.12802179094314,8.57809022157535,PIAS4;UBB;FBXW7;SPHK1;CUL3;ZC3H12A;TBC1D7;SPRTN;ARRB2;GNL3
alpha,4,vasculature development (GO:0001944),4/15,4,15,0.0185191870249731,0.301273710213139,0,0,3.74531835205993,14.9398799545592,ERRFI1;PIK3CA;FBXW7;ACVR2B
alpha,4,glycolipid metabolic process (GO:0006664),10/66,10,66,0.0177562776187868,0.301273710213139,0,0,2.12802179094314,8.57809022157535,CTSA;SMPD2;UGT8;ASAH1;HEXB;FUCA1;PSAP;ARSK;ESYT2;ST3GAL2
alpha,4,negative regulation of release of cytochrome c from mitochondria (GO:0090201),4/15,4,15,0.0185191870249731,0.301273710213139,0,0,3.74531835205993,14.9398799545592,PRELID1;PPIF;TRIAP1;CLU
alpha,4,intra-S DNA damage checkpoint (GO:0031573),4/15,4,15,0.0185191870249731,0.301273710213139,0,0,3.74531835205993,14.9398799545592,MUS81;TIPIN;MSH2;RAD9A
alpha,4,purine ribonucleotide metabolic process (GO:0009150),10/67,10,67,0.0195830657356755,0.310065207481529,0,0,2.09626027167533,8.24478047811628,HINT1;PODXL2;NDUFAF7;ENTPD5;FIGNL1;ABHD14B;NT5C2;RHOQ;RAN;ACAT1
alpha,4,regulation of cell-substrate junction assembly (GO:0090109),4/15,4,15,0.0185191870249731,0.301273710213139,0,0,3.74531835205993,14.9398799545592,LDB1;DAPK3;RHOA;CORO1C
alpha,4,regulation of actin cytoskeleton organization (GO:0032956),11/76,11,76,0.0183173026808277,0.301273710213139,0,0,2.03282081608516,8.13109861134478,DAPK3;RDX;FSCN1;HIP1R;TWF1;BAIAP2;CRK;RHOA;RHOQ;RND1;RHOB
alpha,4,transcription elongation from RNA polymerase II promoter (GO:0006368),13/96,13,96,0.0184057468459076,0.301273710213139,0,0,1.90191947565543,7.59834391812175,SETD2;PBRM1;NCBP2;TAF9;GTF2E2;CDK9;POLR2A;TAF4B;TAF6;POLR2H;TAF5;TAF4;TAF3
alpha,4,regulation of mitotic metaphase/anaphase transition (GO:0030071),4/15,4,15,0.0185191870249731,0.301273710213139,0,0,3.74531835205993,14.9398799545592,RB1;CUL3;NSMCE2;ANAPC11
alpha,4,transforming growth factor beta receptor signaling pathway (GO:0007179),11/77,11,77,0.0200412556531032,0.313939694172879,0,0,2.00642054574639,7.84502878689383,JUN;SMAD4;PARD6A;SMAD3;ITGB5;UBB;ZFYVE9;ARRB2;FOS;RHOA;TGFBR1
alpha,4,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),6/31,6,31,0.0203633052525327,0.313939694172879,0,0,2.7183762232693,10.5854134468411,HSP90AB1;SMAD3;GPRIN1;PKD2;CLU;ASS1
alpha,4,response to ionizing radiation (GO:0010212),11/78,11,78,0.0218819985981096,0.313939694172879,0,0,1.98069720541631,7.57040488726736,NET1;KAT5;MSH2;EEF1D;FIGNL1;SWI5;LIG4;INO80;INIP;RHOB;RAD9A
alpha,4,phosphatidylinositol 3-kinase signaling (GO:0014065),6/31,6,31,0.0203633052525327,0.313939694172879,0,0,2.7183762232693,10.5854134468411,PIK3CA;TYRO3;NF1;PIK3CB;PIK3C2A;IGF1R
alpha,4,negative regulation of ubiquitin protein ligase activity (GO:1904667),11/78,11,78,0.0218819985981096,0.313939694172879,0,0,1.98069720541631,7.57040488726736,PSMA5;PSMD6;PSMA3;PSMD12;PSMD7;PSMA1;UBB;PSMF1;ANAPC10;ANAPC2;ANAPC11
alpha,4,negative regulation of mRNA 3'-end processing (GO:0031441),3/9,3,9,0.0218542445286722,0.313939694172879,0,0,4.68164794007491,17.8996260238809,CDK9;BARD1;RNF20
alpha,4,MyD88-independent toll-like receptor signaling pathway (GO:0002756),6/31,6,31,0.0203633052525327,0.313939694172879,0,0,2.7183762232693,10.5854134468411,IKBKB;TBK1;UBB;TRAF3;FADD;BIRC2
alpha,4,establishment of Golgi localization (GO:0051683),3/9,3,9,0.0218542445286722,0.313939694172879,0,0,4.68164794007491,17.8996260238809,ARHGAP21;SLC9A3R1;YWHAZ
alpha,4,regulation of microtubule cytoskeleton organization (GO:0070507),5/23,5,23,0.0207885433982023,0.313939694172879,0,0,3.05324865657059,11.8263105831193,PHLDB1;STMN1;ATF5;PHLDB2;CLASP2
alpha,4,positive regulation of cell death (GO:0010942),9/58,9,58,0.0206695550242437,0.313939694172879,0,0,2.1793878341728,8.4540490357896,HEBP2;RARG;FAF1;BNIP3;ZC3H12A;AXIN2;FOS;CLU;MAP3K5
alpha,4,positive regulation of protein sumoylation (GO:0033235),3/9,3,9,0.0218542445286722,0.313939694172879,0,0,4.68164794007491,17.8996260238809,PIAS4;UBE2I;GNL3
alpha,4,hyaluronan catabolic process (GO:0030214),4/16,4,16,0.0233300938366004,0.315404922444809,0,0,3.51123595505618,13.1952639424639,TMEM2;HEXB;HYAL2;HMMR
alpha,4,regulation of cell size (GO:0008361),5/23,5,23,0.0207885433982023,0.313939694172879,0,0,3.05324865657059,11.8263105831193,SLC9A3R1;RARG;RDX;RAC1;RHOA
alpha,4,mitochondrial fragmentation involved in apoptotic process (GO:0043653),3/9,3,9,0.0218542445286722,0.313939694172879,0,0,4.68164794007491,17.8996260238809,ATG3;BNIP3;MFF
alpha,4,positive regulation of mitochondrion organization (GO:0010822),16/129,16,129,0.0209864279865751,0.313939694172879,0,0,1.74200853584183,6.73091078572482,MOAP1;FBXW7;STARD7;BNIP3;HIP1R;MIEF2;PLD6;MFF;ATG13;CAMKK2;CYB5R1;PPIF;FAM20B;MICALL2;DPH6;ZBED3
alpha,4,mitochondrial fusion (GO:0008053),4/16,4,16,0.0233300938366004,0.315404922444809,0,0,3.51123595505618,13.1952639424639,MFN2;PLD6;USP30;MFF
alpha,4,regulation of oxidative phosphorylation (GO:0002082),3/9,3,9,0.0218542445286722,0.313939694172879,0,0,4.68164794007491,17.8996260238809,VCP;PPIF;SLC25A33
alpha,4,aorta morphogenesis (GO:0035909),4/16,4,16,0.0233300938366004,0.315404922444809,0,0,3.51123595505618,13.1952639424639,DLL4;HEY1;HEY2;MYLK
alpha,4,positive regulation of ubiquitin-protein transferase activity (GO:0051443),6/32,6,32,0.0235967818507234,0.317788077414915,0,0,2.63342696629214,9.86651581418425,GOLGA2;FBXW7;UBE2S;GORASP1;BMI1;ANAPC10
alpha,4,establishment of viral latency (GO:0019043),3/9,3,9,0.0218542445286722,0.313939694172879,0,0,4.68164794007491,17.8996260238809,HMGA1;PSIP1;LIG4
alpha,4,artery development (GO:0060840),4/16,4,16,0.0233300938366004,0.315404922444809,0,0,3.51123595505618,13.1952639424639,NF1;PKD2;ACVR2B;TGFBR1
alpha,4,"DNA-templated transcription, elongation (GO:0006354)",14/109,14,109,0.0225805075503294,0.315404922444809,0,0,1.80393773837749,6.83812949657124,SETD2;PBRM1;NCBP2;TAF9;GTF2E2;CDK9;POLR2A;POLR1C;TAF4B;TAF6;POLR2H;TAF5;TAF4;TAF3
alpha,4,small nucleolar ribonucleoprotein complex assembly (GO:0000491),3/9,3,9,0.0218542445286722,0.313939694172879,0,0,4.68164794007491,17.8996260238809,SHQ1;NUFIP1;TAF9
alpha,4,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),4/16,4,16,0.0233300938366004,0.315404922444809,0,0,3.51123595505618,13.1952639424639,ANKRD17;DDX3X;LSM11;RDX
alpha,4,insulin receptor signaling pathway (GO:0008286),10/68,10,68,0.0215436250522047,0.313939694172879,0,0,2.06543291473893,7.92646093737508,ATP6V0B;PIK3CA;PIK3C2A;SOS1;BAIAP2;ATP6V1E2;ATP6V0C;RHOQ;ATP6V1C1;IGF1R
alpha,4,G-protein coupled acetylcholine receptor signaling pathway (GO:0007213),4/16,4,16,0.0233300938366004,0.315404922444809,0,0,3.51123595505618,13.1952639424639,GNAQ;GNB1;AGRN;CDK5R1
alpha,4,negative regulation of catenin import into nucleus (GO:0035414),3/9,3,9,0.0218542445286722,0.313939694172879,0,0,4.68164794007491,17.8996260238809,SLC9A3R1;AXIN2;ANAPC2
alpha,4,regulation of coenzyme metabolic process (GO:0051196),7/40,7,40,0.0214616884343929,0.313939694172879,0,0,2.45786516853933,9.44185430711019,NUP214;NUP188;NUP155;PGAM1;NUP62;ECD;NUP153
alpha,4,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),10/68,10,68,0.0215436250522047,0.313939694172879,0,0,2.06543291473893,7.92646093737508,HERC5;LATS1;CDKN2B;CCNE2;BCCIP;CKS2;CCNYL1;MAPRE3;IPO5;CDK5R1
alpha,4,mRNA transcription from RNA polymerase II promoter (GO:0042789),4/16,4,16,0.0233300938366004,0.315404922444809,0,0,3.51123595505618,13.1952639424639,SRF;DDIT3;ZBTB1;ATF4
alpha,4,post-Golgi vesicle-mediated transport (GO:0006892),9/59,9,59,0.022900695849162,0.315404922444809,0,0,2.14244905732241,8.09114736291083,DOPEY1;ARFGEF2;VPS13C;ARL3;VPS54;EXOC6;EXOC5;CORO7;EPS15
alpha,4,purine ribonucleoside monophosphate metabolic process (GO:0009167),7/40,7,40,0.0214616884343929,0.313939694172879,0,0,2.45786516853933,9.44185430711019,ATIC;IMPDH1;NDUFAF7;FIGNL1;ENTPD5;IMPDH2;NT5C2
alpha,4,regulation of SMAD protein import into nucleus (GO:0060390),4/16,4,16,0.0233300938366004,0.315404922444809,0,0,3.51123595505618,13.1952639424639,SMAD4;SMAD3;TGFBR1;BMP6
alpha,4,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),9/59,9,59,0.022900695849162,0.315404922444809,0,0,2.14244905732241,8.09114736291083,ZFYVE28;ERRFI1;HIP1;UBB;SH3KBP1;NUP62;HIP1R;STAM;EPS15
alpha,4,plasma membrane bounded cell projection organization (GO:0120036),15/119,15,119,0.0218234038645472,0.313939694172879,0,0,1.77037106977623,6.77126625192072,RB1;NLGN1;RYK;DTNBP1;CAMSAP1;LIMA1;FLRT3;GPRIN1;BLOC1S2;STMN1;MICALL2;RAC1;NPTXR;NPTX2;CDK5R1
alpha,4,miRNA metabolic process (GO:0010586),4/16,4,16,0.0233300938366004,0.315404922444809,0,0,3.51123595505618,13.1952639424639,ZCCHC11;AGO2;DROSHA;RAN
alpha,4,autophagy of mitochondrion (GO:0000422),7/41,7,41,0.0243400146432546,0.322849628192604,0,0,2.39791723759934,8.90978183360894,ATG3;MAP1LC3A;BNIP3;USP30;ATG13;GABARAP;ATG2B
alpha,4,cardiac ventricle development (GO:0003231),4/16,4,16,0.0233300938366004,0.315404922444809,0,0,3.51123595505618,13.1952639424639,DLL4;TMEM65;HEY1;HEY2
alpha,4,positive regulation of cell growth (GO:0030307),13/99,13,99,0.0232135958971357,0.315404922444809,0,0,1.84428555215072,6.94007814731914,USP47;CDKL5;DDX3X;SPHK1;TAF9;INO80;TGFBR1;SUPV3L1;SDCBP;ZNF639;ADNP2;PLAA;SLC25A33
alpha,4,regulation of release of cytochrome c from mitochondria (GO:0090199),7/41,7,41,0.0243400146432546,0.322849628192604,0,0,2.39791723759934,8.90978183360894,MOAP1;PRELID1;BNIP3;PPIF;TRIAP1;MFF;CLU
alpha,4,regulation of RIG-I signaling pathway (GO:0039535),4/16,4,16,0.0233300938366004,0.315404922444809,0,0,3.51123595505618,13.1952639424639,ANKRD17;SEC14L1;GPATCH3;BIRC2
alpha,4,double-strand break repair (GO:0006302),17/142,17,142,0.0242415119224696,0.322849628192604,0,0,1.68143693622409,6.25442204993654,GEN1;PIAS4;BARD1;VCP;AP5Z1;POLN;PRKDC;DDX1;NSMCE2;LIG4;INO80;PRPF19;RECQL4;KAT5;MSH2;PAPD7;SWI5
alpha,4,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),7/41,7,41,0.0243400146432546,0.322849628192604,0,0,2.39791723759934,8.90978183360894,ZFYVE28;ERRFI1;ZGPAT;UBB;SH3KBP1;STAM;EPS15
alpha,4,actin filament organization (GO:0007015),15/121,15,121,0.0249734711995233,0.330006583707986,0,0,1.74110873804439,6.4245888131792,HIP1;TMOD3;HIP1R;DSTN;COBL;BAIAP2;RHOA;RND1;RHOB;COBLL1;DPYSL3;RAC1;WHAMM;RHOQ;CAP2
alpha,4,regulation of neuron apoptotic process (GO:0043523),12/90,12,90,0.0255979493182266,0.336991729788639,0,0,1.87265917602996,6.86375100273774,TFAP2A;GRM4;SET;MSH2;RASA1;DDIT3;TYRO3;NF1;LIG4;CTNNB1;ATF4;CDK5R1
alpha,4,cellular response to insulin stimulus (GO:0032869),14/111,14,111,0.0259879463243191,0.34084937063426,0,0,1.77143435570402,6.46595231288075,ATP6V0B;GOT1;PRKDC;PDE3B;PIK3C2A;BAIAP2;IGF1R;CPEB1;SOS1;ATP6V1E2;ATP6V0C;SLC25A33;ATP6V1C1;RHOQ
alpha,4,regulation of cellular amino acid metabolic process (GO:0006521),8/52,8,52,0.0296277577008452,0.342570948416022,0,0,2.16076058772688,7.6038107106975,PSMA5;PSMD6;PSMA3;PSMD12;PSMD7;PSMA1;ODC1;PSMF1
alpha,4,regulation of cellular amine metabolic process (GO:0033238),8/52,8,52,0.0296277577008452,0.342570948416022,0,0,2.16076058772688,7.6038107106975,PSMA5;PSMD6;PSMA3;PSMD12;PSMD7;PSMA1;ODC1;PSMF1
alpha,4,"regulation of DNA-templated transcription, initiation (GO:2000142)",3/10,3,10,0.0295947014444803,0.342570948416022,0,0,4.21348314606742,14.8321345741412,FOSL1;JUN;CTNNB1
alpha,4,aspartate family amino acid metabolic process (GO:0009066),3/10,3,10,0.0295947014444803,0.342570948416022,0,0,4.21348314606742,14.8321345741412,GOT1;NIT2;ASS1
alpha,4,sister chromatid segregation (GO:0000819),6/33,6,33,0.0271569085702068,0.342570948416022,0,0,2.55362614913177,9.20869204714931,RB1;LATS1;DSN1;INO80;NSL1;RAN
alpha,4,endothelial tube morphogenesis (GO:0061154),3/10,3,10,0.0295947014444803,0.342570948416022,0,0,4.21348314606742,14.8321345741412,CTNNB1;RHOA;RHOB
alpha,4,cellular response to transforming growth factor beta stimulus (GO:0071560),13/101,13,101,0.0268991546741336,0.342570948416022,0,0,1.80776504616754,6.53626452178769,SMAD4;JUN;SMAD3;ITGB5;ZFYVE9;ARRB2;FOS;NR3C1;RHOA;TGFBR1;PARD6A;UBB;HYAL2
alpha,4,regulation of nitric oxide biosynthetic process (GO:0045428),6/33,6,33,0.0271569085702068,0.342570948416022,0,0,2.55362614913177,9.20869204714931,HSP90AB1;SMAD3;ZC3H12A;PKD2;CLU;ASS1
alpha,4,regulation of neuroblast proliferation (GO:1902692),3/10,3,10,0.0295947014444803,0.342570948416022,0,0,4.21348314606742,14.8321345741412,NF1;CTNNB1;ZNF335
alpha,4,regulation of protein ubiquitination (GO:0031396),13/102,13,102,0.0288948415042917,0.342570948416022,0,0,1.79004185944041,6.34407338179405,HSP90AB1;FBXW7;CUL3;SPHK1;TNFAIP3;ARRB1;ARRB2;TGFBR1;LATS1;UBB;TBC1D7;SPRTN;CRY1
alpha,4,positive regulation of cell cycle G2/M phase transition (GO:1902751),4/17,4,17,0.028830477249896,0.342570948416022,0,0,3.30469266358229,11.7195050017699,MECP2;NPM1;CDC7;BRD4
alpha,4,actin cytoskeleton reorganization (GO:0031532),9/62,9,62,0.03061779970397,0.346050051316574,0,0,2.03878216745198,7.10754887305341,RALA;PAK1;MICALL2;DTNBP1;PARVA;RAC1;TNIK;WHAMM;RHOA
alpha,4,snRNA transcription from RNA polymerase II promoter (GO:0042795),10/71,10,71,0.0282771693894348,0.342570948416022,0,0,1.9781611014401,7.05353009826454,CDK9;POLR2A;NCBP2;TAF9;INTS2;TAF6;POLR2H;TAF5;ELL2;GTF2E2
alpha,4,DNA duplex unwinding (GO:0032508),7/42,7,42,0.0274723898285552,0.342570948416022,0,0,2.34082397003745,8.41426447775243,RECQL4;SUPV3L1;PURA;UBB;DDX1;HMGA1;CHD1L
alpha,4,telomere maintenance via recombination (GO:0000722),3/10,3,10,0.0295947014444803,0.342570948416022,0,0,4.21348314606742,14.8321345741412,SNRNP40;NSMCE2;SMC6
alpha,4,positive regulation of microtubule polymerization (GO:0031116),5/25,5,25,0.0291891738295928,0.342570948416022,0,0,2.80898876404494,9.92684662279952,MECP2;PAK1;CLIP1;RAC1;CDK5R1
alpha,4,regulation of JNK cascade (GO:0046328),12/91,12,91,0.0276467181837491,0.342570948416022,0,0,1.8520805037659,6.64572462542935,MAP4K2;SDCBP;GADD45B;WNT16;ZMYND11;RASGRP1;IGF1R;MAP3K5;DACT1;MAP4K4;HIPK2;GADD45G
alpha,4,protein targeting to membrane (GO:0006612),9/62,9,62,0.03061779970397,0.346050051316574,0,0,2.03878216745198,7.10754887305341,RABGEF1;ATG3;SDCBP;TRAM1;ZDHHC18;ZDHHC9;SRP14;SEC62;ZDHHC2
alpha,4,viral entry into host cell (GO:0046718),4/17,4,17,0.028830477249896,0.342570948416022,0,0,3.30469266358229,11.7195050017699,CD81;ZNF639;HYAL2;EPS15
alpha,4,positive regulation of protein binding (GO:0032092),9/61,9,61,0.0278692078608187,0.342570948416022,0,0,2.07220482593479,7.41897581158039,VTN;EPB41;AMFR;HIP1R;SPPL3;ADD1;RAN;DACT1;HIPK2
alpha,4,snRNA transcription (GO:0009301),10/71,10,71,0.0282771693894348,0.342570948416022,0,0,1.9781611014401,7.05353009826454,CDK9;POLR2A;NCBP2;TAF9;INTS2;TAF6;POLR2H;TAF5;ELL2;GTF2E2
alpha,4,tRNA export from nucleus (GO:0006409),6/34,6,34,0.031054795239873,0.346532080216361,0,0,2.47851949768672,8.60542476815906,NUP214;NUP188;NUP155;NUP62;NUP153;RAN
alpha,4,gluconeogenesis (GO:0006094),7/42,7,42,0.0274723898285552,0.342570948416022,0,0,2.34082397003745,8.41426447775243,TPI1;GOT1;PGAM1;CRY1;SLC37A4;PGM1;ATF4
alpha,4,cytochrome complex assembly (GO:0017004),3/10,3,10,0.0295947014444803,0.342570948416022,0,0,4.21348314606742,14.8321345741412,SURF1;COX15;COX11
alpha,4,DNA replication initiation (GO:0006270),5/25,5,25,0.0291891738295928,0.342570948416022,0,0,2.80898876404494,9.92684662279952,PURA;ORC1;ORC2;CDC7;LRWD1
alpha,4,regulation of Ras protein signal transduction (GO:0046578),12/91,12,91,0.0276467181837491,0.342570948416022,0,0,1.8520805037659,6.64572462542935,ACAP3;DENND4B;RASA1;NUP62;RDX;NF1;MFN2;RASAL2;ASAP2;RASGRP1;GIT1;AGFG1
alpha,4,spindle assembly (GO:0051225),11/81,11,81,0.0281459747199422,0.342570948416022,0,0,1.90733804966015,6.80986617672775,GOLGA2;TNKS;TUBGCP2;BCCIP;SPICE1;HAUS3;INO80;TUBGCP4;RHOA;HAUS2;BIRC2
alpha,4,regulation of protein binding (GO:0043393),14/112,14,112,0.0278276867564069,0.342570948416022,0,0,1.75561797752809,6.2881387419274,EPB41;AMFR;HIP1R;SPPL3;ACTB;ADD1;HIPK2;GOLGA2;VTN;XIRP1;TMBIM6;CRK;RAN;DACT1
alpha,4,RNA 3'-end processing (GO:0031123),9/62,9,62,0.03061779970397,0.346050051316574,0,0,2.03878216745198,7.10754887305341,SUPV3L1;ZCCHC11;NCBP2;ALYREF;EIF4A3;SRSF2;CDC40;THOC7;SRSF9
alpha,4,cellular response to radiation (GO:0071478),7/43,7,43,0.0308673668709124,0.346532080216361,0,0,2.2863862032924,7.9521786615392,NET1;EEF1D;FIGNL1;SWI5;INO80;RHOB;RAD9A
alpha,4,regulation of early endosome to late endosome transport (GO:2000641),4/17,4,17,0.028830477249896,0.342570948416022,0,0,3.30469266358229,11.7195050017699,MAP2K1;RDX;DNAJC13;PTPN23
alpha,4,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),6/34,6,34,0.031054795239873,0.346532080216361,0,0,2.47851949768672,8.60542476815906,NUP214;NUP188;NUP155;NUP62;NUP153;RAN
alpha,4,vascular endothelial growth factor receptor signaling pathway (GO:0048010),10/71,10,71,0.0282771693894348,0.342570948416022,0,0,1.9781611014401,7.05353009826454,PIK3CA;MAPKAPK2;HSPB1;PIK3CB;RAC1;BAIAP2;CRK;PAK2;ACTB;RHOA
alpha,4,cardiovascular system development (GO:0072358),3/10,3,10,0.0295947014444803,0.342570948416022,0,0,4.21348314606742,14.8321345741412,PIK3CA;FBXW7;HSPG2
alpha,4,cellular senescence (GO:0090398),5/25,5,25,0.0291891738295928,0.342570948416022,0,0,2.80898876404494,9.92684662279952,MAP2K1;SRF;NSMCE2;HMGA1;SMC6
alpha,4,regulation of protein serine/threonine kinase activity (GO:0071900),11/81,11,81,0.0281459747199422,0.342570948416022,0,0,1.90733804966015,6.80986617672775,HERC5;MAP2K1;CDKN2B;DDX3X;CCNE2;CAB39;TESK1;BCCIP;CALM2;RHOA;CDK5R1
alpha,4,regulation of cellular ketone metabolic process (GO:0010565),9/62,9,62,0.03061779970397,0.346050051316574,0,0,2.03878216745198,7.10754887305341,PSMA5;PSMD6;PSMA3;PSMD12;PSMD7;PSMA1;ODC1;SIRT5;PSMF1
alpha,4,negative regulation of stress fiber assembly (GO:0051497),4/17,4,17,0.028830477249896,0.342570948416022,0,0,3.30469266358229,11.7195050017699,STMN1;PPFIA1;PHLDB2;CLASP2
alpha,4,entry into host cell (GO:0030260),6/34,6,34,0.031054795239873,0.346532080216361,0,0,2.47851949768672,8.60542476815906,UBB;CD81;ZNF639;HYAL2;CTNNB1;EPS15
alpha,4,protein catabolic process (GO:0030163),11/82,11,82,0.0304943418197149,0.346050051316574,0,0,1.88407782954234,6.57583505644524,PSMA5;LRSAM1;PSMA3;VCP;PSMA1;LAMP2;DENND3;UBE2G1;TPP1;PRPF19;CLN6
alpha,4,actin filament capping (GO:0051693),3/10,3,10,0.0295947014444803,0.342570948416022,0,0,4.21348314606742,14.8321345741412,CAPZB;TWF1;ADD1
alpha,4,positive regulation of stress-activated MAPK cascade (GO:0032874),11/81,11,81,0.0281459747199422,0.342570948416022,0,0,1.90733804966015,6.80986617672775,MAP4K2;SDCBP;KARS;GADD45B;ZC3H12A;WNT16;RASGRP1;MAP3K4;MAP3K5;HIPK2;GADD45G
alpha,4,glycosaminoglycan metabolic process (GO:0030203),9/62,9,62,0.03061779970397,0.346050051316574,0,0,2.03878216745198,7.10754887305341,NDST2;NDST1;HGSNAT;UGDH;HYAL2;FUCA1;AGRN;HSPG2;CLN6
alpha,4,histone H2A monoubiquitination (GO:0035518),4/17,4,17,0.028830477249896,0.342570948416022,0,0,3.30469266358229,11.7195050017699,RYBP;BCOR;BMI1;SKP1
alpha,4,positive regulation of binding (GO:0051099),11/82,11,82,0.0304943418197149,0.346050051316574,0,0,1.88407782954234,6.57583505644524,VTN;EPB41;AMFR;STMN1;HIP1R;TXN;SPPL3;ADD1;RAN;DACT1;HIPK2
alpha,4,positive regulation of receptor recycling (GO:0001921),3/10,3,10,0.0295947014444803,0.342570948416022,0,0,4.21348314606742,14.8321345741412,ANXA2;ECE1;BVES
alpha,4,regulation of protein sumoylation (GO:0033233),4/17,4,17,0.028830477249896,0.342570948416022,0,0,3.30469266358229,11.7195050017699,PIAS4;CTNNB1;RNF4;GNL3
alpha,4,regulation of cell-matrix adhesion (GO:0001952),8/53,8,53,0.032797128770177,0.364816163377127,0,0,2.11999152003392,7.24488934686935,LDB1;ADAM15;RASA1;DAPK3;NF1;PIK3CB;RHOA;CORO1C
alpha,4,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),11/83,11,83,0.0329791381857055,0.365683503857271,0,0,1.86137809665629,6.35079887467075,SDCBP;SMAD4;CDKN2B;HSP90AB1;FOXD1;SMAD3;BMP8A;ACVR2B;TGFBR1;BMP6;HIPK2
alpha,4,protein import into nucleus (GO:0006606),13/104,13,104,0.0332060617022389,0.367041845545188,0,0,1.75561797752809,5.97791930887098,NUP214;NXT1;NUP188;NUP155;ZFYVE9;NUP153;IPO5;NUP62;CTNNB1;KPNA4;KPNA2;RAN;KPNA1
alpha,4,positive regulation of nitric oxide metabolic process (GO:1904407),5/26,5,26,0.0340864016144151,0.369795375539102,0,0,2.7009507346586,9.12612563165064,HSP90AB1;SMAD3;PKD2;CLU;ASS1
alpha,4,positive regulation of nitric oxide biosynthetic process (GO:0045429),5/26,5,26,0.0340864016144151,0.369795375539102,0,0,2.7009507346586,9.12612563165064,HSP90AB1;SMAD3;PKD2;CLU;ASS1
alpha,4,regulation of lamellipodium assembly (GO:0010591),5/26,5,26,0.0340864016144151,0.369795375539102,0,0,2.7009507346586,9.12612563165064,CAPZB;FSCN1;TWF1;SLIT2;RAC1
alpha,4,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058),5/26,5,26,0.0340864016144151,0.369795375539102,0,0,2.7009507346586,9.12612563165064,LATS1;TRIM39;FBXW7;CLU;HIPK2
alpha,4,ncRNA metabolic process (GO:0034660),6/35,6,35,0.0353001725410597,0.371497324795882,0,0,2.40770465489567,8.05104516983816,ZCCHC11;MEPCE;AGO2;DROSHA;PLD6;RAN
alpha,4,"negative regulation of gene expression, epigenetic (GO:0045814)",5/26,5,26,0.0340864016144151,0.369795375539102,0,0,2.7009507346586,9.12612563165064,CREBZF;PHF1;DNMT3A;PPM1D;BMI1
alpha,4,branching morphogenesis of an epithelial tube (GO:0048754),7/44,7,44,0.0345327398769459,0.371497324795882,0,0,2.2344228804903,7.52072649419732,DLL4;PAK1;CTNNB1;NRARP;SLIT2;PKD2;RASIP1
alpha,4,regulation of double-strand break repair (GO:2000779),6/35,6,35,0.0353001725410597,0.371497324795882,0,0,2.40770465489567,8.05104516983816,SETD2;PPP4R2;FIGNL1;TERF2IP;TRIP12;DEK
alpha,4,negative regulation of wound healing (GO:0061045),5/26,5,26,0.0340864016144151,0.369795375539102,0,0,2.7009507346586,9.12612563165064,VTN;SERPINE2;CRK;PHLDB2;CLASP2
alpha,4,regulation of interferon-beta production (GO:0032648),6/35,6,35,0.0353001725410597,0.371497324795882,0,0,2.40770465489567,8.05104516983816,DDX3X;TBK1;RNF216;POLR3B;TRAF3;POLR3D
alpha,4,blood vessel endothelial cell migration (GO:0043534),4/18,4,18,0.0350349022682817,0.371497324795882,0,0,3.1210986267166,10.4600827300524,NR4A1;EGR3;SRF;SLIT2
alpha,4,regulation of wound healing (GO:0061041),6/35,6,35,0.0353001725410597,0.371497324795882,0,0,2.40770465489567,8.05104516983816,KANK1;VTN;PRKCE;TNFAIP3;CRK;MYLK
alpha,4,negative regulation of microtubule depolymerization (GO:0007026),4/18,4,18,0.0350349022682817,0.371497324795882,0,0,3.1210986267166,10.4600827300524,CAMSAP1;TTBK2;ANAPC2;CLASP2
alpha,4,epithelial tube morphogenesis (GO:0060562),6/35,6,35,0.0353001725410597,0.371497324795882,0,0,2.40770465489567,8.05104516983816,PAK1;CTNNB1;SLIT2;PKD2;RASIP1;RHOB
alpha,4,regulation of mitochondrial membrane permeability (GO:0046902),4/18,4,18,0.0350349022682817,0.371497324795882,0,0,3.1210986267166,10.4600827300524,HEBP2;BNIP3;PPIF;SPG7
alpha,4,mitotic recombination (GO:0006312),4/18,4,18,0.0350349022682817,0.371497324795882,0,0,3.1210986267166,10.4600827300524,GEN1;SNRNP40;NSMCE2;SMC6
alpha,4,cytoskeleton organization (GO:0007010),15/127,15,127,0.0364579773907746,0.382536688144993,0,0,1.65885163231001,5.49344474810232,RTKN;SH3KBP1;CAMSAP1;FMNL3;ARHGAP10;ARC;STRIP2;CAPZB;PALLD;MICAL1;CFL1;QRICH1;TNIK;KIAA1958;RHOQ
alpha,4,regulation of proteolysis (GO:0030162),9/64,9,64,0.0366695489699278,0.383611501872905,0,0,1.9750702247191,6.52920412791627,ABTB2;DNAJC1;SERPINE2;IST1;TRAF3;BTBD3;FADD;BTBD9;CLN6
alpha,4,regulation of lamellipodium morphogenesis (GO:2000392),3/11,3,11,0.0385824851604634,0.388588639939911,0,0,3.83043922369765,12.4679144195902,KANK1;RREB1;CORO1C
alpha,4,hepatocyte growth factor receptor signaling pathway (GO:0048012),3/11,3,11,0.0385824851604634,0.388588639939911,0,0,3.83043922369765,12.4679144195902,PAK1;STMN1;RAC1
alpha,4,spinal cord development (GO:0021510),3/11,3,11,0.0385824851604634,0.388588639939911,0,0,3.83043922369765,12.4679144195902,NF1;SOX12;PKD2
alpha,4,oxidative phosphorylation (GO:0006119),3/11,3,11,0.0385824851604634,0.388588639939911,0,0,3.83043922369765,12.4679144195902,SURF1;ATP5C1;UQCRH
alpha,4,glycerol metabolic process (GO:0006071),3/11,3,11,0.0385824851604634,0.388588639939911,0,0,3.83043922369765,12.4679144195902,COQ2;TPI1;GOT1
alpha,4,negative regulation of nucleocytoplasmic transport (GO:0046823),3/11,3,11,0.0385824851604634,0.388588639939911,0,0,3.83043922369765,12.4679144195902,BARD1;NUP153;CABP1
alpha,4,T cell differentiation in thymus (GO:0033077),3/11,3,11,0.0385824851604634,0.388588639939911,0,0,3.83043922369765,12.4679144195902,LIG4;FADD;GLI3
alpha,4,apical junction assembly (GO:0043297),6/36,6,36,0.0399013350747578,0.392866086240262,0,0,2.34082397003745,7.54060275076279,OCLN;PARD6A;PDCD6IP;MICALL2;PKN2;RHOA
alpha,4,regulation of centrosome cycle (GO:0046605),5/27,5,27,0.039462869329205,0.392866086240262,0,0,2.60091552226384,8.40718650163922,GEN1;NPM1;PDCD6IP;CTNNB1;ATF5
alpha,4,positive regulation of extracellular matrix organization (GO:1903055),3/11,3,11,0.0385824851604634,0.388588639939911,0,0,3.83043922369765,12.4679144195902,SMAD3;FSCN1;CLASP2
alpha,4,regulation of microtubule polymerization (GO:0031113),6/36,6,36,0.0399013350747578,0.392866086240262,0,0,2.34082397003745,7.54060275076279,PAK1;CLIP1;STMN1;RAC1;CAMSAP1;CDK5R1
alpha,4,positive regulation of wound healing (GO:0090303),5/27,5,27,0.039462869329205,0.392866086240262,0,0,2.60091552226384,8.40718650163922,KANK1;VTN;PRKCE;RREB1;MYLK
alpha,4,regulation of cytoskeleton organization (GO:0051493),12/96,12,96,0.0396990526898787,0.392866086240262,0,0,1.75561797752809,5.66437491799436,PHLDB1;KATNBL1;STMN1;FSCN1;HIP1R;BAIAP2;PHLDB2;CRK;RHOA;RHOQ;RND1;RHOB
alpha,4,positive regulation of cell cycle phase transition (GO:1901989),3/11,3,11,0.0385824851604634,0.388588639939911,0,0,3.83043922369765,12.4679144195902,NPM1;STXBP4;FAM83D
alpha,4,negative regulation of protein kinase B signaling (GO:0051898),6/36,6,36,0.0399013350747578,0.392866086240262,0,0,2.34082397003745,7.54060275076279,PHLPP2;SLC9A3R1;HYAL2;DDIT3;ARRB2;OTUD3
alpha,4,cell morphogenesis involved in differentiation (GO:0000904),8/55,8,55,0.039810568063411,0.392866086240262,0,0,2.04290091930541,6.58554213014701,RB1;TYRO3;MICALL2;FN1;PARVA;RADIL;RAC1;BVES
alpha,4,regulation of p38MAPK cascade (GO:1900744),5/27,5,27,0.039462869329205,0.392866086240262,0,0,2.60091552226384,8.40718650163922,GADD45B;KARS;ZC3H12A;MAP3K4;GADD45G
alpha,4,negative regulation of type I interferon production (GO:0032480),7/45,7,45,0.0384754984774543,0.388588639939911,0,0,2.18476903870162,7.11739560057212,HERC5;TBK1;RNF216;UBB;TRAF3;TNFAIP3;GPATCH3
alpha,4,regulation of dendrite morphogenesis (GO:0048814),7/45,7,45,0.0384754984774543,0.388588639939911,0,0,2.18476903870162,7.11739560057212,ARC;CDKL5;GORASP1;CFL1;SARM1;TNIK;CDK5R1
alpha,4,regulation of cell cycle G2/M phase transition (GO:1902749),11/85,11,85,0.03837194755687,0.388588639939911,0,0,1.81758096497026,5.92609299504871,NPM1;ODF2;SSNA1;HAUS3;HMMR;ATF5;TUBB4B;CKAP5;TUBA4A;HAUS2;PAFAH1B1
alpha,4,hexose biosynthetic process (GO:0019319),7/45,7,45,0.0384754984774543,0.388588639939911,0,0,2.18476903870162,7.11739560057212,TPI1;GOT1;PGAM1;CRY1;SLC37A4;PGM1;ATF4
alpha,4,RNA splicing (GO:0008380),13/107,13,107,0.0405121174753757,0.397765622698172,0,0,1.7063950435787,5.47096555511189,MBNL1;NCBP2;EIF4A3;WDR62;CDC40;SNRNP40;LSM6;RSRC1;SRSF2;DHX15;DHX16;RP9;PPIG
alpha,4,regulation of primary metabolic process (GO:0080090),16/140,16,140,0.0408709438211431,0.399059354253661,0,0,1.60513643659711,5.13216033454609,NCOA1;PSMD12;ALAS1;ACSL1;CHD9;TXNRD1;ODC1;PSMA5;PSMD6;PSMA3;PSMD7;PSMA1;PSAP;PSMF1;TBL1X;FADS1
alpha,4,cellular response to growth factor stimulus (GO:0071363),16/140,16,140,0.0408709438211431,0.399059354253661,0,0,1.60513643659711,5.13216033454609,STAT5B;SMAD4;SMAD3;EGR3;HSPB1;NR3C1;BMP6;TGFBR1;ERN1;DLL4;NR4A1;RAP1A;HYAL2;MAPKAPK2;CTNNB1;PLCG1
alpha,4,negative regulation of protein localization to plasma membrane (GO:1903077),4/19,4,19,0.041951122044578,0.400701614094271,0,0,2.95683027794205,9.37684831235255,CLTC;PPFIA1;PPP2R5A;RHOQ
alpha,4,negative regulation of cell junction assembly (GO:1901889),4/19,4,19,0.041951122044578,0.400701614094271,0,0,2.95683027794205,9.37684831235255,IKBKB;PHLDB2;CORO1C;CLASP2
alpha,4,mitochondrial membrane organization (GO:0007006),4/19,4,19,0.041951122044578,0.400701614094271,0,0,2.95683027794205,9.37684831235255,BNIP3;PPIF;MFN2;SPG7
alpha,4,positive regulation of adherens junction organization (GO:1903393),4/19,4,19,0.041951122044578,0.400701614094271,0,0,2.95683027794205,9.37684831235255,PTPN23;RAC1;ADD1;S100A10
alpha,4,positive regulation of blood vessel endothelial cell migration (GO:0043536),7/46,7,46,0.042701789060563,0.403485990720105,0,0,2.13727405959941,6.7399246546043,SRPX2;NOS3;AKT3;HSPB1;PLCG1;PIK3C2A;ETS1
alpha,4,purine ribonucleotide biosynthetic process (GO:0009152),10/76,10,76,0.042608743086816,0.403485990720105,0,0,1.84801892371378,5.83178557433708,SLC35B2;GUCY1B3;SURF1;ACOT7;IMPDH1;IMPDH2;ATP5C1;ADCY3;ATP5F1;ACAT1
alpha,4,negative regulation of protein localization to cell periphery (GO:1904376),4/19,4,19,0.041951122044578,0.400701614094271,0,0,2.95683027794205,9.37684831235255,CLTC;PPFIA1;PPP2R5A;RHOQ
alpha,4,regulation of cell death (GO:0010941),12/97,12,97,0.0424919136470959,0.403485990720105,0,0,1.73751882312058,5.48785153761498,JUN;TBK1;UBB;FAF1;BNIP3;ZC3H12A;SARM1;ADNP2;CTNNB1;AXIN2;WNT16;CLU
alpha,4,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",10/76,10,76,0.042608743086816,0.403485990720105,0,0,1.84801892371378,5.83178557433708,IKBKB;PSMA5;PSMD6;PSMA3;PSMD12;PSMD7;ITGB5;PSMA1;HLA-B;PSMF1
alpha,4,acetylcholine receptor signaling pathway (GO:0095500),4/19,4,19,0.041951122044578,0.400701614094271,0,0,2.95683027794205,9.37684831235255,GNAQ;GNB1;AGRN;CDK5R1
alpha,4,organelle fusion (GO:0048284),4/19,4,19,0.041951122044578,0.400701614094271,0,0,2.95683027794205,9.37684831235255,MFN2;PLD6;USP30;MFF
alpha,4,error-free translesion synthesis (GO:0070987),4/19,4,19,0.041951122044578,0.400701614094271,0,0,2.95683027794205,9.37684831235255,VCP;UBB;RFC2;SPRTN
alpha,4,regulation of cellular component organization (GO:0051128),16/141,16,141,0.0431845423752532,0.406953529353927,0,0,1.59375249023827,5.00800488190443,HIP1;CISH;HIP1R;CAMSAP1;SOCS2;NET1;LATS1;ARC;RAP1A;CAPZB;CFL1;QRICH1;ANKRA2;SGK1;KIAA1958;BCL9L
alpha,4,regulation of ubiquitin protein ligase activity (GO:1904666),6/37,6,37,0.0448650999134108,0.421483558409801,0,0,2.27755845733374,7.06975798190626,GOLGA2;UBE2S;GORASP1;ANAPC10;ANAPC11;ANAPC2
alpha,4,negative regulation of microtubule polymerization or depolymerization (GO:0031111),5/28,5,28,0.0453259701504708,0.421483558409801,0,0,2.50802568218299,7.75951825405709,STMN1;CAMSAP1;TTBK2;CLASP2;ANAPC2
alpha,4,purine ribonucleoside triphosphate biosynthetic process (GO:0009206),5/28,5,28,0.0453259701504708,0.421483558409801,0,0,2.50802568218299,7.75951825405709,SURF1;IMPDH1;IMPDH2;ATP5C1;ATP5F1
alpha,4,negative regulation of cell-matrix adhesion (GO:0001953),5/28,5,28,0.0453259701504708,0.421483558409801,0,0,2.50802568218299,7.75951825405709,ADAM15;RASA1;PHLDB2;CORO1C;CLASP2
alpha,4,positive regulation of JNK cascade (GO:0046330),10/77,10,77,0.0459770274350104,0.423060867628433,0,0,1.82401867795126,5.61727238221085,MAP4K2;SDCBP;PAK1;GADD45B;WNT16;RASGRP1;MAP3K4;MAP3K5;HIPK2;GADD45G
alpha,4,negative regulation of small GTPase mediated signal transduction (GO:0051058),5/28,5,28,0.0453259701504708,0.421483558409801,0,0,2.50802568218299,7.75951825405709,RASA1;NF1;MFN2;RASAL2;SLIT2
alpha,4,nucleic acid-templated transcription (GO:0097659),10/77,10,77,0.0459770274350104,0.423060867628433,0,0,1.82401867795126,5.61727238221085,CREBZF;NCOA1;LDB1;POLR2A;NUP62;MED20;POLR2H;NR3C1;PWP1;BPTF
alpha,4,regulation of hematopoietic stem cell differentiation (GO:1902036),10/77,10,77,0.0459770274350104,0.423060867628433,0,0,1.82401867795126,5.61727238221085,PSMA5;PSMD6;PSMA3;PSMD12;PSMD7;LDB1;PSMA1;UBB;TCF12;PSMF1
alpha,4,generation of neurons (GO:0048699),15/131,15,131,0.0459764516781035,0.423060867628433,0,0,1.60819967407153,4.95265342269396,RB1;UNC119B;MAP2K1;CDKL5;LDB1;RYK;DCLK2;WNT16;TUBB3;ADNP2;CTNNB1;KIAA0319;MDGA1;PAFAH1B1;CDK5R1
alpha,4,cellular response to ionizing radiation (GO:0071479),7/47,7,47,0.0472168829133891,0.425308347091499,0,0,2.09180014343772,6.38627370622798,NET1;EEF1D;FIGNL1;SWI5;INO80;RHOB;RAD9A
alpha,4,regulation of DNA metabolic process (GO:0051052),7/47,7,47,0.0472168829133891,0.425308347091499,0,0,2.09180014343772,6.38627370622798,ANKRD17;CDK9;ESCO1;ALYREF;TERF2IP;KPNA2;KPNA1
alpha,4,negative regulation of protein kinase activity (GO:0006469),13/110,13,110,0.0488832353413842,0.425308347091499,0,0,1.65985699693565,5.00998086042975,RB1;NPM1;CISH;TESK1;HSPB1;IGF1R;CORO1C;SOCS2;FLRT3;GNAQ;HYAL2;NF1;PAK2
alpha,4,mitochondrial outer membrane permeabilization (GO:0097345),3/12,3,12,0.0487866407265243,0.425308347091499,0,0,3.51123595505618,10.604981598332,MOAP1;BLOC1S2;BNIP3
alpha,4,icosanoid metabolic process (GO:0006690),7/47,7,47,0.0472168829133891,0.425308347091499,0,0,2.09180014343772,6.38627370622798,GPX4;MAPKAPK2;TBXAS1;LTA4H;DAGLB;ALOXE3;FADS1
alpha,4,regulation of vasculogenesis (GO:2001212),3/12,3,12,0.0487866407265243,0.425308347091499,0,0,3.51123595505618,10.604981598332,RAP1A;HEY1;HEY2
alpha,4,"regulation of DNA-templated transcription, elongation (GO:0032784)",4/20,4,20,0.0495804575748524,0.426100998473365,0,0,2.80898876404494,8.43864753763162,LDB1;ALYREF;HTATSF1;ZMYND11
alpha,4,mitotic spindle assembly (GO:0090307),7/47,7,47,0.0472168829133891,0.425308347091499,0,0,2.09180014343772,6.38627370622798,GOLGA2;TUBGCP2;BCCIP;SPICE1;TUBGCP4;RHOA;BIRC2
alpha,4,regulation of catabolic process (GO:0009894),3/12,3,12,0.0487866407265243,0.425308347091499,0,0,3.51123595505618,10.604981598332,FAF1;ODC1;FAM83D
alpha,4,glycosaminoglycan catabolic process (GO:0006027),8/57,8,57,0.04775744411632,0.425308347091499,0,0,1.9712201852947,5.99570338356437,HGSNAT;TMEM2;HEXB;HYAL2;FUCA1;HMMR;AGRN;HSPG2
alpha,4,negative regulation of actin filament bundle assembly (GO:0032232),4/20,4,20,0.0495804575748524,0.426100998473365,0,0,2.80898876404494,8.43864753763162,STMN1;PPFIA1;PHLDB2;CLASP2
alpha,4,pyruvate metabolic process (GO:0006090),7/47,7,47,0.0472168829133891,0.425308347091499,0,0,2.09180014343772,6.38627370622798,SLC16A1;TPI1;PGAM1;DLAT;HAGH;SLC16A3;PGM1
alpha,4,peptidyl-methionine modification (GO:0018206),3/12,3,12,0.0487866407265243,0.425308347091499,0,0,3.51123595505618,10.604981598332,NAA30;NAA25;NAA16
alpha,4,phosphatidylinositol-mediated signaling (GO:0048015),8/57,8,57,0.04775744411632,0.425308347091499,0,0,1.9712201852947,5.99570338356437,PIK3CA;PITPNM2;TYRO3;NF1;PIK3CB;PIK3C2A;RHOA;IGF1R
alpha,4,positive regulation of stress fiber assembly (GO:0051496),6/38,6,38,0.0501967800686672,0.42825650956642,0,0,2.21762270845653,6.63469336871688,PAK1;TESK1;RAC1;RHOA;TGFBR1;S100A10
alpha,4,Golgi to endosome transport (GO:0006895),4/20,4,20,0.0495804575748524,0.426100998473365,0,0,2.80898876404494,8.43864753763162,DOPEY1;VPS13C;CORO7;EPS15
alpha,4,intraciliary transport (GO:0042073),7/47,7,47,0.0472168829133891,0.425308347091499,0,0,2.09180014343772,6.38627370622798,IFT74;IFT81;IFT172;TTC21A;IFT46;DYNLL2;WDR35
alpha,4,regulation of blood vessel size (GO:0050880),3/12,3,12,0.0487866407265243,0.425308347091499,0,0,3.51123595505618,10.604981598332,GCLC;NOS3;GCLM
alpha,4,regulation of sodium ion transmembrane transporter activity (GO:2000649),6/38,6,38,0.0501967800686672,0.42825650956642,0,0,2.21762270845653,6.63469336871688,SLC9A3R1;FXYD6-FXYD2;PRKCE;SLMAP;STK39;FXYD6
alpha,4,vacuolar acidification (GO:0007035),4/20,4,20,0.0495804575748524,0.426100998473365,0,0,2.80898876404494,8.43864753763162,ATP6V0B;DMXL1;ATP6V0C;CLN6
alpha,4,intracellular steroid hormone receptor signaling pathway (GO:0030518),9/67,9,67,0.0472013664579348,0.425308347091499,0,0,1.8866342445078,5.76052153443472,RB1;NCOA1;MED13;KAT5;NCOA4;DDX54;CTNNB1;RNF4;RAN
alpha,4,positive regulation of DNA-dependent DNA replication (GO:2000105),3/12,3,12,0.0487866407265243,0.425308347091499,0,0,3.51123595505618,10.604981598332,CDC7;INO80;BMP6
alpha,4,regulation of hematopoietic progenitor cell differentiation (GO:1901532),10/78,10,78,0.0495204166648659,0.426100998473365,0,0,1.80063382310573,5.41157129892103,PSMA5;PSMD6;PSMA3;PSMD12;PSMD7;LDB1;PSMA1;UBB;TCF12;PSMF1
alpha,4,positive regulation of receptor activity (GO:2000273),6/38,6,38,0.0501967800686672,0.42825650956642,0,0,2.21762270845653,6.63469336871688,ARC;ANXA2;FBXW7;BUD31;PKD2;CALM2
alpha,4,purine nucleoside monophosphate biosynthetic process (GO:0009127),3/12,3,12,0.0487866407265243,0.425308347091499,0,0,3.51123595505618,10.604981598332,ATIC;IMPDH1;IMPDH2
alpha,4,polyamine metabolic process (GO:0006595),3/12,3,12,0.0487866407265243,0.425308347091499,0,0,3.51123595505618,10.604981598332,ODC1;AMD1;PAOX
alpha,4,exit from mitosis (GO:0010458),3/12,3,12,0.0487866407265243,0.425308347091499,0,0,3.51123595505618,10.604981598332,SPAST;UBE2S;CLASP2
alpha,4,regulation of gene silencing by miRNA (GO:0060964),9/68,9,68,0.0511152622115655,0.432514537889267,0,0,1.85888962326504,5.52772830811161,NUP214;NUP188;POLR2A;NUP155;NUP62;AGO2;NUP153;POLR2H;RAN
alpha,4,negative regulation of proteasomal protein catabolic process (GO:1901799),5/29,5,29,0.0516802577278783,0.432514537889267,0,0,2.42154203796978,7.17425279088938,SDCBP;HSP90AB1;RYBP;TAF9;PSMF1
alpha,4,regulation of rRNA processing (GO:2000232),3/12,3,12,0.0487866407265243,0.425308347091499,0,0,3.51123595505618,10.604981598332,UTP15;SHQ1;RIOK1
alpha,4,cellular response to UV (GO:0034644),9/68,9,68,0.0511152622115655,0.432514537889267,0,0,1.85888962326504,5.52772830811161,USP47;NPM1;PAPD7;HYAL2;ZBTB1;TRIAP1;INO80;PPID;ATF4
alpha,4,cellular response to hypoxia (GO:0071456),15/133,15,133,0.0513392650190659,0.432514537889267,0,0,1.5840162203261,4.70341844363987,PSMD12;BNIP3;HP1BP3;HILPDA;RORA;HIGD1A;HIPK2;PSMA5;PSMD6;CPEB1;PSMA3;PSMD7;UBB;PSMA1;PSMF1
alpha,4,carboxylic acid catabolic process (GO:0046395),5/29,5,29,0.0516802577278783,0.432514537889267,0,0,2.42154203796978,7.17425279088938,ABHD10;TMEM2;HEXB;HYAL2;HMMR
alpha,4,cellular response to arsenic-containing substance (GO:0071243),3/12,3,12,0.0487866407265243,0.425308347091499,0,0,3.51123595505618,10.604981598332,DDX3X;ZC3H12A;PPIF
alpha,4,negative regulation of protein binding (GO:0032091),9/68,9,68,0.0511152622115655,0.432514537889267,0,0,1.85888962326504,5.52772830811161,GOLGA2;ADAM15;XIRP1;TMBIM6;ARRB2;PTPRF;ACTB;DACT1;TTBK2
alpha,4,regulation of glycolytic process (GO:0006110),8/58,8,58,0.0520915098362498,0.433890182640801,0,0,1.93723363037582,5.72404746706548,NUP214;NUP188;NUP155;ENTPD5;PGAM1;NUP62;ECD;NUP153
alpha,4,regulation of vasculature development (GO:1901342),5/29,5,29,0.0516802577278783,0.432514537889267,0,0,2.42154203796978,7.17425279088938,HEY1;HEY2;NF1;CTNNB1;ETS1
alpha,4,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),7/48,7,48,0.052025151283066,0.433890182640801,0,0,2.04822097378277,6.05459854626192,USP10;FAF1;ZC3H12A;OTUD7A;TNFAIP3;RORA;ZMYND11
alpha,4,vesicle budding from membrane (GO:0006900),3/12,3,12,0.0487866407265243,0.425308347091499,0,0,3.51123595505618,10.604981598332,GOLPH3;ANXA2;S100A10
alpha,4,hydrogen ion transmembrane transport (GO:1902600),5/29,5,29,0.0516802577278783,0.432514537889267,0,0,2.42154203796978,7.17425279088938,ATP6V0B;COX15;UCP2;ATP6V0C;ATP6V1C1
alpha,4,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),10/79,10,79,0.0532416851492126,0.442422040897121,0,0,1.77784098990186,5.21425407839836,IKBKB;PSMA5;PSMD6;PSMA3;PSMD12;PSMD7;ITGB5;PSMA1;HLA-B;PSMF1
alpha,4,neuron development (GO:0048666),16/145,16,145,0.0533726960480251,0.442464685398133,0,0,1.54978690430066,4.54158229173433,RB1;NLGN1;RYK;ARL3;SRF;DTNBP1;CAMSAP1;FLRT3;GPRIN1;BLOC1S2;STMN1;MICALL2;NPTXR;NPTX2;SKIL;CDK5R1
alpha,4,positive regulation of protein acetylation (GO:1901985),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,KAT5;TERF2IP
alpha,4,cellular response to monoamine stimulus (GO:0071868),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,NR4A3;GNB1
alpha,4,cellular response to chemokine (GO:1990869),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,ZC3H12A;RHOA
alpha,4,polyamine biosynthetic process (GO:0006596),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,AMD1;PAOX
alpha,4,positive regulation of nucleobase-containing compound transport (GO:0032241),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,CPSF6;NCBP2
alpha,4,neuron remodeling (GO:0016322),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,ANKS1A;RND1
alpha,4,positive regulation of protein localization to centrosome (GO:1904781),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,PARD6A;NUP62
alpha,4,negative regulation of mononuclear cell migration (GO:0071676),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,SLIT2;NBL1
alpha,4,response to catecholamine (GO:0071869),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,NR4A3;GNB1
alpha,4,morphogenesis of an endothelium (GO:0003159),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,CTNNB1;RHOB
alpha,4,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),4/21,4,21,0.0579182372891111,0.451555981326568,0,0,2.67522739432852,7.62098171458571,SMAD4;CHD6;RELA;ATF4
alpha,4,positive regulation of phospholipid transport (GO:2001140),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,PRELID1;TRIAP1
alpha,4,limb morphogenesis (GO:0035108),4/21,4,21,0.0579182372891111,0.451555981326568,0,0,2.67522739432852,7.62098171458571,FBXW4;MBNL1;PTCH1;GLI3
alpha,4,SREBP signaling pathway (GO:0032933),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,ERLIN1;SCAP
alpha,4,regulation of Notch signaling pathway (GO:0008593),9/71,9,71,0.0641084718092415,0.460820610244344,0,0,1.78034499129609,4.89092594249493,LFNG;DLL4;JAG2;HEY1;UBB;ZMIZ1;FBXW7;NRARP;ARRB1
alpha,4,ventricular septum morphogenesis (GO:0060412),4/21,4,21,0.0579182372891111,0.451555981326568,0,0,2.67522739432852,7.62098171458571,SMAD4;HEY1;HEY2;TGFBR1
alpha,4,regulation of tooth mineralization (GO:0070170),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,TFAP2A;BCOR
alpha,4,nucleosome organization (GO:0034728),10/80,10,80,0.0571433055953128,0.451555981326568,0,0,1.75561797752809,5.0249175439647,SMARCD1;SETD2;SMARCC1;PBRM1;NPM1;SET;HIST1H2BJ;HIST1H2BK;HMGA1;CTCF
alpha,4,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),5/30,5,30,0.0585275031452613,0.451555981326568,0,0,2.34082397003745,6.64386352057564,HIP1;UBB;FBXW7;NUP62;HIP1R
alpha,4,negative regulation of protein tyrosine kinase activity (GO:0061099),4/21,4,21,0.0579182372891111,0.451555981326568,0,0,2.67522739432852,7.62098171458571,ZFYVE28;ERRFI1;ZGPAT;HYAL2
alpha,4,autophagosome assembly (GO:0000045),8/59,8,59,0.0566704644913766,0.451555981326568,0,0,1.90439916206437,5.46658181757703,ATG3;MAP1LC3A;TP53INP2;TP53INP1;MFN2;ATG13;GABARAP;ATG2B
alpha,4,regulation of transforming growth factor beta2 production (GO:0032909),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,SMAD4;SMAD3
alpha,4,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),10/80,10,80,0.0571433055953128,0.451555981326568,0,0,1.75561797752809,5.0249175439647,SDCBP;SMAD4;CDKN2B;HSP90AB1;SMAD3;UBB;SKIL;TGFBR1;BCL9L;HIPK2
alpha,4,regulation of embryonic development (GO:0045995),5/30,5,30,0.0585275031452613,0.451555981326568,0,0,2.34082397003745,6.64386352057564,LFNG;PHLDB1;TRIP12;PHLDB2;CLASP2
alpha,4,positive regulation of RNA export from nucleus (GO:0046833),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,CPSF6;NCBP2
alpha,4,positive regulation of lamellipodium organization (GO:1902745),4/21,4,21,0.0579182372891111,0.451555981326568,0,0,2.67522739432852,7.62098171458571,FSCN1;RAC1;RREB1;CORO1C
alpha,4,regulation of epithelial cell migration (GO:0010632),7/49,7,49,0.0571300472123309,0.451555981326568,0,0,2.00642054574639,5.7432284908595,CAPN7;PRKCE;PTPN23;PLCG1;RREB1;CORO1C;CLASP2
alpha,4,interphase microtubule nucleation by interphase microtubule organizing center (GO:0051415),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,TUBGCP2;TUBGCP4
alpha,4,zinc II ion transport (GO:0006829),4/21,4,21,0.0579182372891111,0.451555981326568,0,0,2.67522739432852,7.62098171458571,SLC30A5;SLC30A4;SLC39A13;SLC39A7
alpha,4,protein K48-linked ubiquitination (GO:0070936),7/49,7,49,0.0571300472123309,0.451555981326568,0,0,2.00642054574639,5.7432284908595,ZNRF1;UBE2H;RNF216;AMFR;TNFAIP3;UBE2G1;RNF4
alpha,4,mRNA cleavage involved in mRNA processing (GO:0098787),3/13,3,13,0.0601611035141232,0.451555981326568,0,0,3.24114088159032,9.10996950039335,ERN1;CPSF6;NCBP2
alpha,4,regulation of protein K63-linked ubiquitination (GO:1900044),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,PLAA;BIRC2
alpha,4,mRNA transcription (GO:0009299),4/21,4,21,0.0579182372891111,0.451555981326568,0,0,2.67522739432852,7.62098171458571,SRF;DDIT3;ZBTB1;ATF4
alpha,4,cytoplasmic microtubule organization (GO:0031122),7/49,7,49,0.0571300472123309,0.451555981326568,0,0,2.00642054574639,5.7432284908595,SPAST;TUBGCP2;KATNA1;FIGNL1;CRIPT;TUBGCP4;CAMSAP1
alpha,4,renal absorption (GO:0070293),3/13,3,13,0.0601611035141232,0.451555981326568,0,0,3.24114088159032,9.10996950039335,SLC9A3R1;HYAL2;SGK1
alpha,4,spinal cord dorsal/ventral patterning (GO:0021513),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,DLL4;FOXN4
alpha,4,hyaluronan metabolic process (GO:0030212),4/21,4,21,0.0579182372891111,0.451555981326568,0,0,2.67522739432852,7.62098171458571,TMEM2;HEXB;HYAL2;HMMR
alpha,4,pre-miRNA processing (GO:0031054),3/13,3,13,0.0601611035141232,0.451555981326568,0,0,3.24114088159032,9.10996950039335,ZCCHC11;AGO2;DROSHA
alpha,4,negative regulation of cell size (GO:0045792),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,RDX;RHOA
alpha,4,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),3/13,3,13,0.0601611035141232,0.451555981326568,0,0,3.24114088159032,9.10996950039335,SRF;SUB1;HEY2
alpha,4,membrane raft assembly (GO:0001765),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,ANXA2;S100A10
alpha,4,negative regulation of canonical Wnt signaling pathway (GO:0090090),16/149,16,149,0.0651211587905706,0.467144639079297,0,0,1.50818188673554,4.11960751489432,PSMD12;CUL3;KLHL12;AXIN2;GLI3;LATS1;PSMA5;PSMD6;PSMA3;PSMD7;UBB;PSMA1;DDIT3;PSMF1;ANAPC2;DACT1
alpha,4,nucleus localization (GO:0051647),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,SLC9A3R1;PAFAH1B1
alpha,4,regulation of necrotic cell death (GO:0010939),3/13,3,13,0.0601611035141232,0.451555981326568,0,0,3.24114088159032,9.10996950039335,HEBP2;UBB;BIRC2
alpha,4,spermine metabolic process (GO:0008215),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,AMD1;PAOX
alpha,4,establishment of chromosome localization (GO:0051303),3/13,3,13,0.0601611035141232,0.451555981326568,0,0,3.24114088159032,9.10996950039335,SPICE1;FAM83D;GEM
alpha,4,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),5/31,5,31,0.0658667782156586,0.469618104316511,0,0,2.26531351939108,6.16192707679491,DLL4;SRPX2;AKT3;PIK3C2A;RHOA
alpha,4,cardiolipin acyl-chain remodeling (GO:0035965),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,HADHB;HADHA
alpha,4,neuron fate commitment (GO:0048663),3/13,3,13,0.0601611035141232,0.451555981326568,0,0,3.24114088159032,9.10996950039335,DLL4;FOXN4;TGFBR1
alpha,4,response to estradiol (GO:0032355),5/31,5,31,0.0658667782156586,0.469618104316511,0,0,2.26531351939108,6.16192707679491,SOCS2;STAT5B;KAT5;CTNNB1;STRN3
alpha,4,protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,OTUD7A;TNFAIP3
alpha,4,response to UV-B (GO:0010224),3/13,3,13,0.0601611035141232,0.451555981326568,0,0,3.24114088159032,9.10996950039335,MSH2;HYAL2;RELA
alpha,4,fatty-acyl-CoA biosynthetic process (GO:0046949),5/31,5,31,0.0658667782156586,0.469618104316511,0,0,2.26531351939108,6.16192707679491,ELOVL5;ACSL1;SCD;ACSL3;ACAT1
alpha,4,Golgi to plasma membrane transport (GO:0006893),6/40,6,40,0.0619775563670243,0.451555981326568,0,0,2.10674157303371,5.85881240214811,ARFRP1;ARFGEF2;GOLPH3;KIF13A;EXOC6;EXOC5
alpha,4,viral release from host cell (GO:0019076),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,IST1;PPID
alpha,4,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),3/13,3,13,0.0601611035141232,0.451555981326568,0,0,3.24114088159032,9.10996950039335,ZFYVE28;ERRFI1;ZGPAT
alpha,4,cellular response to hormone stimulus (GO:0032870),10/81,10,81,0.0612274392972543,0.451555981326568,0,0,1.73394368150922,4.84318184806217,NCOA1;SOCS2;STAT5B;JUN;NR4A3;AVPR1B;RDX;ATP1A1;SLIT2;NR3C1
alpha,4,regulation of extrinsic apoptotic signaling pathway (GO:2001236),8/60,8,60,0.0614968985076237,0.451555981326568,0,0,1.87265917602996,5.22241298916046,HYAL2;FADD;ZMYND11;PAK2;SH3RF1;TGFBR1;RELA;DEDD2
alpha,4,NLS-bearing protein import into nucleus (GO:0006607),4/22,4,22,0.0669542774682853,0.471631834270587,0,0,2.55362614913177,6.90435474564905,KPNA4;KPNA2;IPO5;KPNA1
alpha,4,regulation of plasma membrane bounded cell projection assembly (GO:0120032),6/40,6,40,0.0619775563670243,0.451555981326568,0,0,2.10674157303371,5.85881240214811,ATG3;CAPZB;RDX;FSCN1;TWF1;RAC1
alpha,4,cellular response to iron ion (GO:0071281),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,TFAP2A;BMP6
alpha,4,embryonic appendage morphogenesis (GO:0035113),3/13,3,13,0.0601611035141232,0.451555981326568,0,0,3.24114088159032,9.10996950039335,FBXW4;MBNL1;PTCH1
alpha,4,ncRNA catabolic process (GO:0034661),4/22,4,22,0.0669542774682853,0.471631834270587,0,0,2.55362614913177,6.90435474564905,EXOSC6;ZCCHC11;EXOSC3;DEDD2
alpha,4,mitotic cytokinesis (GO:0000281),8/60,8,60,0.0614968985076237,0.451555981326568,0,0,1.87265917602996,5.22241298916046,RTKN;PDCD6IP;SPAST;RASA1;ARL3;STMN1;SNX9;RHOB
alpha,4,inositol lipid-mediated signaling (GO:0048017),6/40,6,40,0.0619775563670243,0.451555981326568,0,0,2.10674157303371,5.85881240214811,PIK3CA;PITPNM2;PIK3CB;PIK3C2A;RHOA;IGF1R
alpha,4,response to chemokine (GO:1990868),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,ZC3H12A;RHOA
alpha,4,mitochondrial genome maintenance (GO:0000002),3/13,3,13,0.0601611035141232,0.451555981326568,0,0,3.24114088159032,9.10996950039335,AKT3;LONP1;SLC25A33
alpha,4,positive regulation of developmental process (GO:0051094),13/114,13,114,0.0617977413810085,0.451555981326568,0,0,1.60161640055194,4.45872141871797,DLX2;JUN;HSP90AB1;FOXD1;TFRC;SRF;BNIP3;MIEF2;PLD6;MFF;CORO1C;AGO2;RREB1
alpha,4,viral genome replication (GO:0019079),4/22,4,22,0.0669542774682853,0.471631834270587,0,0,2.55362614913177,6.90435474564905,VCP;CTBP2;DEK;HTATSF1
alpha,4,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),6/40,6,40,0.0619775563670243,0.451555981326568,0,0,2.10674157303371,5.85881240214811,SURF1;ATIC;IMPDH1;IMPDH2;ATP5C1;ATP5F1
alpha,4,smooth muscle tissue development (GO:0048745),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,NF1;MYLK
alpha,4,protein complex localization (GO:0031503),4/22,4,22,0.0669542774682853,0.471631834270587,0,0,2.55362614913177,6.90435474564905,IFT74;MIOS;IFT81;IFT46
alpha,4,protein repair (GO:0030091),2/6,2,6,0.0626911291286957,0.451555981326568,0,0,4.68164794007491,12.9659893377982,PCMT1;TXN
alpha,4,regulation of microtubule depolymerization (GO:0031114),4/22,4,22,0.0669542774682853,0.471631834270587,0,0,2.55362614913177,6.90435474564905,CAMSAP1;TTBK2;ANAPC2;CLASP2
alpha,4,negative regulation of actin filament polymerization (GO:0030837),4/22,4,22,0.0669542774682853,0.471631834270587,0,0,2.55362614913177,6.90435474564905,KANK1;HIP1R;TWF1;SLIT2
alpha,4,regulation of protein dephosphorylation (GO:0035304),6/41,6,41,0.0684297111916994,0.477242926267507,0,0,2.05535763222801,5.51236264973785,PPP1R2;ANKLE2;TIPRL;PPP2R5A;SPPL3;CALM2
alpha,4,intraciliary transport involved in cilium assembly (GO:0035735),6/41,6,41,0.0684297111916994,0.477242926267507,0,0,2.05535763222801,5.51236264973785,IFT74;IFT81;IFT172;IFT46;DYNLL2;WDR35
alpha,4,peptidyl-proline modification (GO:0018208),6/41,6,41,0.0684297111916994,0.477242926267507,0,0,2.05535763222801,5.51236264973785,NTMT1;PPIF;PPIG;PPIL4;PPID;PPIL6
alpha,4,regulation of blood vessel endothelial cell migration (GO:0043535),7/51,7,51,0.0682388794853522,0.477242926267507,0,0,1.92773738708967,5.17547520735712,MECP2;NOS3;AKT3;NF1;HSPB1;PLCG1;ETS1
alpha,4,tRNA aminoacylation (GO:0043039),6/41,6,41,0.0684297111916994,0.477242926267507,0,0,2.05535763222801,5.51236264973785,AIMP2;VARS;KARS;GATC;GARS;FARSB
alpha,4,proteolysis involved in cellular protein catabolic process (GO:0051603),11/94,11,94,0.0701909053766895,0.487590973120679,0,0,1.64355725555821,4.36616988752073,PSMA5;CTSA;PSMA3;VCP;PDCD6IP;PSMA1;OTUD7A;LONP1;TNFAIP3;CTSV;PRPF19
alpha,4,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),11/94,11,94,0.0701909053766895,0.487590973120679,0,0,1.64355725555821,4.36616988752073,PSMA5;PSMD6;PSMA3;PSMD12;PSMD7;PSMA1;UBB;BAG3;PSMF1;HIGD1A;ATF4
alpha,4,negative regulation of Rho protein signal transduction (GO:0035024),3/14,3,14,0.0726479405027988,0.491072136283342,0,0,3.00963081861958,7.89164397343745,KANK1;CUL3;STMN1
alpha,4,chromatin remodeling (GO:0006338),13/117,13,117,0.0728550524282409,0.491526889223161,0,0,1.5605493133583,4.08752090338968,RB1;KDM6B;SMARCD1;SMARCC1;PBRM1;NPM1;ZBTB1;CHD1L;INO80;DEK;ACTB;BPTF;KDM6A
alpha,4,ribonucleoside monophosphate biosynthetic process (GO:0009156),3/14,3,14,0.0726479405027988,0.491072136283342,0,0,3.00963081861958,7.89164397343745,ATIC;IMPDH1;IMPDH2
alpha,4,histone H4-K16 acetylation (GO:0043984),3/14,3,14,0.0726479405027988,0.491072136283342,0,0,3.00963081861958,7.89164397343745,KANSL1;PHF20;MSL2
alpha,4,regulation of gastrulation (GO:0010470),3/14,3,14,0.0726479405027988,0.491072136283342,0,0,3.00963081861958,7.89164397343745,PHLDB1;PHLDB2;CLASP2
alpha,4,positive regulation of protein dephosphorylation (GO:0035307),5/32,5,32,0.073694561346556,0.493402634539322,0,0,2.19452247191011,5.72293336769977,ANKLE2;HSP90AB1;PPP2R5A;SPPL3;CALM2
alpha,4,positive regulation of vascular smooth muscle cell proliferation (GO:1904707),3/14,3,14,0.0726479405027988,0.491072136283342,0,0,3.00963081861958,7.89164397343745,ERN1;JUN;MFN2
alpha,4,proton transport (GO:0015992),5/32,5,32,0.073694561346556,0.493402634539322,0,0,2.19452247191011,5.72293336769977,ATP6V0B;COX15;UCP2;ATP6V0C;ATP6V1C1
alpha,4,neuron differentiation (GO:0030182),15/140,15,140,0.0734813879942682,0.493402634539322,0,0,1.50481540930979,3.92865639455941,RB1;UNC119B;MAP2K1;LDB1;RYK;SRF;DCLK2;FOXN4;WNT16;TGFBR1;TUBB3;ADNP2;CTNNB1;SKIL;CDK5R1
alpha,4,DNA modification (GO:0006304),3/14,3,14,0.0726479405027988,0.491072136283342,0,0,3.00963081861958,7.89164397343745,EXOSC6;EXOSC3;UNG
alpha,4,liver development (GO:0001889),5/32,5,32,0.073694561346556,0.493402634539322,0,0,2.19452247191011,5.72293336769977,PHF2;RARG;NF1;COBL;PKD2
alpha,4,cellular protein complex disassembly (GO:0043624),3/14,3,14,0.0726479405027988,0.491072136283342,0,0,3.00963081861958,7.89164397343745,NAPA;APEH;ABCE1
alpha,4,regulation of tumor necrosis factor production (GO:0032680),8/62,8,62,0.0718994466715442,0.491072136283342,0,0,1.81225081551287,4.77072618718886,ARFGEF2;ZC3H12A;MAPKAPK2;TNFAIP3;FADD;CLU;RASGRP1;FOXP1
alpha,4,positive regulation of mitochondrial fission (GO:0090141),3/14,3,14,0.0726479405027988,0.491072136283342,0,0,3.00963081861958,7.89164397343745,BNIP3;MIEF2;MFF
alpha,4,telomere maintenance (GO:0000723),7/52,7,52,0.0742450578287559,0.494165082687071,0,0,1.89066551426102,4.91645647504443,RECQL4;ACD;SNRNP40;PRKDC;NSMCE2;TERF2IP;SMC6
alpha,4,positive regulation of protein ubiquitination (GO:0031398),10/84,10,84,0.0745916923706695,0.494165082687071,0,0,1.67201712145532,4.34009854918595,UBB;FBXW7;SPHK1;CUL3;TBC1D7;SPRTN;ARRB2;BMI1;CLU;BIRC2
alpha,4,thymus development (GO:0048538),3/14,3,14,0.0726479405027988,0.491072136283342,0,0,3.00963081861958,7.89164397343745,ZBTB1;FADD;TGFBR1
alpha,4,establishment of protein localization to membrane (GO:0090150),10/84,10,84,0.0745916923706695,0.494165082687071,0,0,1.67201712145532,4.34009854918595,RABGEF1;ATG3;SDCBP;ARFRP1;ZDHHC18;GOLPH3;ZDHHC9;KIF13A;BRAF;ZDHHC2
alpha,4,positive regulation of protein import (GO:1904591),3/15,3,15,0.0861801410205333,0.494165082687071,0,0,2.80898876404494,6.88571772597488,HYAL2;ZC3H12A;IPO5
alpha,4,negative regulation of focal adhesion assembly (GO:0051895),3/14,3,14,0.0726479405027988,0.491072136283342,0,0,3.00963081861958,7.89164397343745,PHLDB2;CORO1C;CLASP2
alpha,4,regulation of cell junction assembly (GO:1901888),3/15,3,15,0.0861801410205333,0.494165082687071,0,0,2.80898876404494,6.88571772597488,OCLN;RAP1A;SNAI1
alpha,4,establishment or maintenance of actin cytoskeleton polarity (GO:0030950),3/14,3,14,0.0726479405027988,0.491072136283342,0,0,3.00963081861958,7.89164397343745,RHOA;RHOB;RND1
alpha,4,histone H4-K5 acetylation (GO:0043981),3/15,3,15,0.0861801410205333,0.494165082687071,0,0,2.80898876404494,6.88571772597488,MEAF6;KANSL1;PHF20
alpha,4,nuclear body organization (GO:0030575),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,ETS1;HIPK2
alpha,4,positive regulation of neural precursor cell proliferation (GO:2000179),3/14,3,14,0.0726479405027988,0.491072136283342,0,0,3.00963081861958,7.89164397343745,DLL4;CTNNB1;ZNF335
alpha,4,regulation of substrate adhesion-dependent cell spreading (GO:1900024),6/42,6,42,0.0752559360841941,0.494165082687071,0,0,2.00642054574639,5.19033004338806,KANK1;RAC1;RREB1;CRK;CORO1C;S100A10
alpha,4,embryonic cranial skeleton morphogenesis (GO:0048701),3/15,3,15,0.0861801410205333,0.494165082687071,0,0,2.80898876404494,6.88571772597488,TFAP2A;EIF4A3;TGFBR1
alpha,4,positive regulation of extracellular matrix disassembly (GO:0090091),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,FSCN1;CLASP2
alpha,4,branching involved in blood vessel morphogenesis (GO:0001569),3/14,3,14,0.0726479405027988,0.491072136283342,0,0,3.00963081861958,7.89164397343745,DLL4;CTNNB1;NRARP
alpha,4,mesenchymal cell differentiation (GO:0048762),6/42,6,42,0.0752559360841941,0.494165082687071,0,0,2.00642054574639,5.19033004338806,HEY2;SNAI1;CTNNB1;FAM83D;HNRNPAB;TGFBR1
alpha,4,negative regulation of mRNA processing (GO:0050686),3/15,3,15,0.0861801410205333,0.494165082687071,0,0,2.80898876404494,6.88571772597488,BARD1;TMBIM6;SRSF9
alpha,4,glycoside catabolic process (GO:0016139),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,ABHD10;FUCA1
alpha,4,glutamine family amino acid metabolic process (GO:0009064),4/23,4,23,0.0766733875702028,0.494165082687071,0,0,2.44259892525647,6.27308402200817,GCLC;GOT1;GCLM;NIT2
alpha,4,mRNA 3'-end processing (GO:0031124),9/75,9,75,0.0844197443641466,0.494165082687071,0,0,1.68539325842697,4.16621455074543,LSM11;CPSF6;NCBP2;ALYREF;EIF4A3;SRSF2;CDC40;THOC7;SRSF9
alpha,4,positive regulation of exosomal secretion (GO:1903543),3/15,3,15,0.0861801410205333,0.494165082687071,0,0,2.80898876404494,6.88571772597488,SDCBP;PDCD6IP;STAM
alpha,4,bone cell development (GO:0098751),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,ANXA2;FOXP1
alpha,4,microtubule polymerization or depolymerization (GO:0031109),4/23,4,23,0.0766733875702028,0.494165082687071,0,0,2.44259892525647,6.27308402200817,MAP7D3;NCKAP5L;STMN1;CKAP5
alpha,4,inorganic cation transmembrane transport (GO:0098662),15/141,15,141,0.0770881568738522,0.494165082687071,0,0,1.49414295959837,3.82919797028852,SLC12A2;ATP6V0B;COX15;SLC30A5;SLC30A4;ATP2A2;CACNA1D;SLC39A13;PKD2;TMCO1;UCP2;TRPM7;SLC39A7;ATP6V0C;ATP6V1C1
alpha,4,positive regulation of epithelial cell migration (GO:0010634),9/75,9,75,0.0844197443641466,0.494165082687071,0,0,1.68539325842697,4.16621455074543,CAPN7;PRKCE;ZC3H12A;PLCG1;ETS1;RREB1;RHOB;FOXP1;CLASP2
alpha,4,microtubule depolymerization (GO:0007019),3/15,3,15,0.0861801410205333,0.494165082687071,0,0,2.80898876404494,6.88571772597488,NCKAP5L;STMN1;CKAP5
alpha,4,oxaloacetate metabolic process (GO:0006107),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,STAT5B;NIT2
alpha,4,autophagosome maturation (GO:0097352),4/23,4,23,0.0766733875702028,0.494165082687071,0,0,2.44259892525647,6.27308402200817,VCP;MAP1LC3A;LAMP2;GABARAP
alpha,4,N-terminal protein amino acid acetylation (GO:0006474),3/15,3,15,0.0861801410205333,0.494165082687071,0,0,2.80898876404494,6.88571772597488,NAA30;NAA25;NAA16
alpha,4,regulation of mitochondrial fusion (GO:0010635),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,BNIP3;PLD6
alpha,4,regulation of dendritic spine morphogenesis (GO:0061001),4/23,4,23,0.0766733875702028,0.494165082687071,0,0,2.44259892525647,6.27308402200817,NLGN1;ARC;CFL1;CDK5R1
alpha,4,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),3/15,3,15,0.0861801410205333,0.494165082687071,0,0,2.80898876404494,6.88571772597488,ACOX3;ACAD10;ACADS
alpha,4,regulation of actin filament-based process (GO:0032970),8/63,8,63,0.0774776058124703,0.494165082687071,0,0,1.78348492955235,4.56173772362667,FSCN1;HIP1R;BAIAP2;CRK;RHOA;RHOQ;RND1;RHOB
alpha,4,mitochondrial DNA metabolic process (GO:0032042),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,LONP1;POLG
alpha,4,apoptotic nuclear changes (GO:0030262),4/23,4,23,0.0766733875702028,0.494165082687071,0,0,2.44259892525647,6.27308402200817,ENDOG;BLCAP;DEDD2;KPNA1
alpha,4,regulation of clathrin-dependent endocytosis (GO:2000369),3/15,3,15,0.0861801410205333,0.494165082687071,0,0,2.80898876404494,6.88571772597488,TNK2;HIP1R;PIK3CB
alpha,4,positive regulation of lipid transport (GO:0032370),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,PRELID1;TRIAP1
alpha,4,brain development (GO:0007420),13/120,13,120,0.0851215685897111,0.494165082687071,0,0,1.52153558052434,3.74856890595899,DLX2;RARG;PTCH1;ROGDI;FOXJ1;HSPG2;GPRIN1;NF1;ZNF335;MDGA1;BPTF;PAFAH1B1;CDK5R1
alpha,4,membrane assembly (GO:0071709),4/23,4,23,0.0766733875702028,0.494165082687071,0,0,2.44259892525647,6.27308402200817,NLGN1;ANXA2;STX2;S100A10
alpha,4,regulation of centriole replication (GO:0046599),3/15,3,15,0.0861801410205333,0.494165082687071,0,0,2.80898876404494,6.88571772597488,NPM1;NUP62;SPICE1
alpha,4,coenzyme A biosynthetic process (GO:0015937),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,ACOT7;ACAT1
alpha,4,zinc II ion transmembrane transport (GO:0071577),4/23,4,23,0.0766733875702028,0.494165082687071,0,0,2.44259892525647,6.27308402200817,SLC30A5;SLC30A4;SLC39A13;SLC39A7
alpha,4,unsaturated fatty acid biosynthetic process (GO:0006636),3/15,3,15,0.0861801410205333,0.494165082687071,0,0,2.80898876404494,6.88571772597488,SCD;ALOXE3;FADS1
alpha,4,regulation of cyclic nucleotide metabolic process (GO:0030799),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,PKD2;CALM2
alpha,4,G-protein coupled glutamate receptor signaling pathway (GO:0007216),3/15,3,15,0.0861801410205333,0.494165082687071,0,0,2.80898876404494,6.88571772597488,GRM4;HOMER1;DAGLB
alpha,4,positive regulation of ERBB signaling pathway (GO:1901186),4/23,4,23,0.0766733875702028,0.494165082687071,0,0,2.44259892525647,6.27308402200817,HIP1;UBB;NUP62;HIP1R
alpha,4,long-chain fatty acid import (GO:0044539),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,ACSL1;ACSL3
alpha,4,positive regulation of cellular catabolic process (GO:0031331),12/107,12,107,0.0781148681074326,0.494165082687071,0,0,1.57513388638034,4.0159217697585,SUPV3L1;CNOT7;ENTPD5;BNIP3;ZC3H12A;RDX;TP53INP1;SNX9;ABHD5;PIK3CB;MTDH;DACT1
alpha,4,mitotic sister chromatid cohesion (GO:0007064),3/15,3,15,0.0861801410205333,0.494165082687071,0,0,2.80898876404494,6.88571772597488,RB1;POGZ;PDS5A
alpha,4,"nucleotide-excision repair, DNA gap filling (GO:0006297)",4/23,4,23,0.0766733875702028,0.494165082687071,0,0,2.44259892525647,6.27308402200817,UBB;PAPD7;RFC2;LIG4
alpha,4,negative regulation of dendrite development (GO:2000171),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,GORASP1;KIAA0319
alpha,4,phosphatidylethanolamine biosynthetic process (GO:0006646),3/15,3,15,0.0861801410205333,0.494165082687071,0,0,2.80898876404494,6.88571772597488,CHKA;CEPT1;LPIN2
alpha,4,spermidine metabolic process (GO:0008216),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,AMD1;PAOX
alpha,4,histone H4-K8 acetylation (GO:0043982),3/15,3,15,0.0861801410205333,0.494165082687071,0,0,2.80898876404494,6.88571772597488,MEAF6;KANSL1;PHF20
alpha,4,regulation of protein localization to centrosome (GO:1904779),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,PARD6A;NUP62
alpha,4,maintenance of protein location in nucleus (GO:0051457),3/15,3,15,0.0861801410205333,0.494165082687071,0,0,2.80898876404494,6.88571772597488,ARL2BP;TAF3;SKP1
alpha,4,interleukin-1-mediated signaling pathway (GO:0070498),11/96,11,96,0.0790402919301084,0.494165082687071,0,0,1.60931647940075,4.08411938979369,IKBKB;PSMA5;PSMD6;PSMA3;PSMD12;PSMD7;PSMA1;UBB;PSMF1;RELA;SKP1
alpha,4,negative regulation of RIG-I signaling pathway (GO:0039536),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,SEC14L1;GPATCH3
alpha,4,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),3/15,3,15,0.0861801410205333,0.494165082687071,0,0,2.80898876404494,6.88571772597488,SCP2;ACOX3;CRAT
alpha,4,regulation of protein complex assembly (GO:0043254),9/74,9,74,0.0790188725185075,0.494165082687071,0,0,1.7081688430003,4.33544963970064,LATS1;NAPA;KIF9;VCP;DDX3X;FAF1;VPS41;ANKRA2;RNF4
alpha,4,cleavage furrow formation (GO:0036089),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,SNX9;RHOA
alpha,4,nucleic acid phosphodiester bond hydrolysis (GO:0090305),9/74,9,74,0.0790188725185075,0.494165082687071,0,0,1.7081688430003,4.33544963970064,MUS81;ENDOG;PAPD7;UBB;RFC2;DDX1;ZC3H12A;CHD1L;PNRC2
alpha,4,regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,NSD1;DDIT3
alpha,4,purine nucleoside bisphosphate biosynthetic process (GO:0034033),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,ACOT7;ACAT1
alpha,4,adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,GNAL;GNB1
alpha,4,negative regulation of transporter activity (GO:0032410),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,PPIF;CTTNBP2NL
alpha,4,positive regulation of neuroblast proliferation (GO:0002052),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,CTNNB1;ZNF335
alpha,4,pericardium morphogenesis (GO:0003344),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,DLL4;FLRT3
alpha,4,positive regulation of calcium ion transport (GO:0051928),5/34,5,34,0.0907893620870771,0.511417640602686,0,0,2.06543291473893,4.95541382573879,STIM2;GPRIN1;ORAI1;CACNA1D;MYLK
alpha,4,glucose metabolic process (GO:0006006),8/65,8,65,0.0893880686466757,0.511271514933911,0,0,1.7286084701815,4.17418853247589,TPI1;GOT1;PGAM1;HECTD4;CRY1;SLC37A4;PGM1;ATF4
alpha,4,gland development (GO:0048732),9/76,9,76,0.0900361501405663,0.511271514933911,0,0,1.6632170313424,4.00426821955093,PHF2;SLC9A3R1;RARG;ZBTB1;NF1;COBL;FADD;PKD2;TGFBR1
alpha,4,protection from non-homologous end joining at telomere (GO:0031848),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,ACD;TERF2IP
alpha,4,intracellular pH reduction (GO:0051452),5/34,5,34,0.0907893620870771,0.511417640602686,0,0,2.06543291473893,4.95541382573879,ATP6V0B;DMXL1;ATP6V1E2;ATP6V0C;ATP6V1C1
alpha,4,negative regulation of phosphorylation (GO:0042326),9/76,9,76,0.0900361501405663,0.511271514933911,0,0,1.6632170313424,4.00426821955093,ANKLE2;CDKN2B;PRKDC;ZC3H12A;PPIF;TERF2IP;SLIT2;CORO1C;ZBED3
alpha,4,modification by symbiont of host morphology or physiology (GO:0044003),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,RRAGA;HIPK2
alpha,4,negative regulation of ERBB signaling pathway (GO:1901185),6/44,6,44,0.090020619776564,0.511271514933911,0,0,1.91521961184883,4.61130591087479,ZFYVE28;ERRFI1;UBB;SH3KBP1;STAM;EPS15
alpha,4,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay (GO:0043928),5/34,5,34,0.0907893620870771,0.511417640602686,0,0,2.06543291473893,4.95541382573879,EXOSC6;TTC37;LSM6;CNOT7;EXOSC3
alpha,4,protein localization to cytoplasmic stress granule (GO:1903608),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,DDX3X;DDX1
alpha,4,regulation of multicellular organismal development (GO:2000026),6/44,6,44,0.090020619776564,0.511271514933911,0,0,1.91521961184883,4.61130591087479,PHLDB1;TRIP12;PHLDB2;TGFBR1;CLASP2;FOXP1
alpha,4,regulation of cell-substrate adhesion (GO:0010810),5/34,5,34,0.0907893620870771,0.511417640602686,0,0,2.06543291473893,4.95541382573879,NF1;PIK3CB;RAC1;RHOA;CORO1C
alpha,4,lysosomal lumen acidification (GO:0007042),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,ATP6V0C;CLN6
alpha,4,negative regulation of mitochondrion organization (GO:0010823),5/34,5,34,0.0907893620870771,0.511417640602686,0,0,2.06543291473893,4.95541382573879,PRELID1;BNIP3;PPIF;TRIAP1;CLU
alpha,4,response to hydrogen peroxide (GO:0042542),6/44,6,44,0.090020619776564,0.511271514933911,0,0,1.91521961184883,4.61130591087479,NET1;PPIF;TNFAIP3;RELA;MAP3K5;RHOB
alpha,4,regulation of calcium ion transport (GO:0051924),7/53,7,53,0.0805523551139381,0.494165082687071,0,0,1.85499258002968,4.67244422384753,HOMER1;STIM2;ORAI1;CTNNB1;CACNA1D;PKD2;MYLK
alpha,4,negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,NPM1;CORO1C
alpha,4,phosphatidylcholine biosynthetic process (GO:0006656),5/33,5,33,0.0820048622714522,0.494165082687071,0,0,2.12802179094314,5.32213299600464,ACHE;CHKA;STARD7;CEPT1;LPIN2
alpha,4,positive regulation of protein deubiquitination (GO:1903003),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,VCP;ZC3H12A
alpha,4,aminoglycan catabolic process (GO:0006026),5/33,5,33,0.0820048622714522,0.494165082687071,0,0,2.12802179094314,5.32213299600464,HGSNAT;HYAL2;FUCA1;AGRN;HSPG2
alpha,4,box C/D snoRNP assembly (GO:0000492),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,NUFIP1;TAF9
alpha,4,positive regulation of transcription factor import into nucleus (GO:0042993),5/33,5,33,0.0820048622714522,0.494165082687071,0,0,2.12802179094314,5.32213299600464,SMAD3;BAG3;SPHK1;SPPL3;RHOA
alpha,4,formation of translation preinitiation complex (GO:0001731),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,EIF4H;EIF4B
alpha,4,regulation of ion transmembrane transporter activity (GO:0032412),6/43,6,43,0.0824540869559634,0.494165082687071,0,0,1.95975960282205,4.89060686367214,FXYD6-FXYD2;HOMER1;STK39;PPIF;CACNA1D;FXYD6
alpha,4,positive regulation of telomere maintenance via telomerase (GO:0032212),5/33,5,33,0.0820048622714522,0.494165082687071,0,0,2.12802179094314,5.32213299600464,CCT2;ACD;TNKS2;TNKS;MAP3K4
alpha,4,activation of MAPKKK activity (GO:0000185),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,GADD45B;GADD45G
alpha,4,purine ribonucleoside triphosphate metabolic process (GO:0009205),5/33,5,33,0.0820048622714522,0.494165082687071,0,0,2.12802179094314,5.32213299600464,NDUFAF7;FIGNL1;ENTPD5;RHOQ;RAN
alpha,4,negative regulation of dendrite morphogenesis (GO:0050774),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,NLGN1;GORASP1
alpha,4,protein localization to plasma membrane (GO:0072659),14/131,14,131,0.0830331156825984,0.494165082687071,0,0,1.50098636246676,3.73522822849643,PTCH1;RDX;ATP1B3;IKBKB;SLC9A3R1;ARFRP1;GOLPH3;PACS1;SLMAP;KIF13A;FCHO2;TNIK;S100A10;CLASP2
alpha,4,mitochondrial transmembrane transport (GO:1990542),5/33,5,33,0.0820048622714522,0.494165082687071,0,0,2.12802179094314,5.32213299600464,MCUR1;TIMM9;UCP2;MICU1;SLC25A33
alpha,4,exit from host cell (GO:0035891),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,IST1;PPID
alpha,4,negative regulation of receptor activity (GO:2000272),5/33,5,33,0.0820048622714522,0.494165082687071,0,0,2.12802179094314,5.32213299600464,ZFYVE28;ERRFI1;ZGPAT;PKD2;CALM2
alpha,4,cellular response to sterol depletion (GO:0071501),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,ERLIN1;SCAP
alpha,4,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,LDB1;NUP155
alpha,4,ribonucleoside bisphosphate biosynthetic process (GO:0034030),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,ACOT7;ACAT1
alpha,4,positive regulation of lamellipodium morphogenesis (GO:2000394),2/7,2,7,0.0837114045832144,0.494165082687071,0,0,4.01284109149278,9.95337100840351,RREB1;CORO1C
alpha,4,RNA modification (GO:0009451),7/55,7,55,0.0940646498063002,0.525511475312953,0,0,1.78753830439224,4.22533472536151,NOP56;WDR4;TSR3;MEPCE;NAT10;PUS7;TARBP1
alpha,4,negative regulation of cell migration (GO:0030336),13/122,13,122,0.0939794364573415,0.525511475312953,0,0,1.49659237428624,3.53896098067868,RNF20;KANK1;PTPN23;CORO1C;RHOB;ADAM15;HYAL2;DPYSL3;TP53INP1;NF1;SLIT2;PHLDB2;CLASP2
alpha,4,stimulatory C-type lectin receptor signaling pathway (GO:0002223),13/122,13,122,0.0939794364573415,0.525511475312953,0,0,1.49659237428624,3.53896098067868,PSMD12;RELA;IKBKB;PSMA5;PSMD6;PSMA3;PAK1;PSMD7;UBB;PSMA1;PSMF1;PAK2;SKP1
alpha,4,Notch signaling pathway (GO:0007219),7/56,7,56,0.101264593932292,0.525511475312953,0,0,1.75561797752809,4.02039755228131,DLL4;JAG2;HEY1;UBB;HEY2;SNAI1;NRARP
alpha,4,regulation of histone H3-K4 methylation (GO:0051569),3/16,3,16,0.100684009031558,0.525511475312953,0,0,2.63342696629214,6.04573812315251,SMAD4;CTNNB1;BCOR
alpha,4,DNA recombination (GO:0006310),7/56,7,56,0.101264593932292,0.525511475312953,0,0,1.75561797752809,4.02039755228131,GEN1;SUPV3L1;RECQL4;BARD1;ENDOG;KAT5;LIG4
alpha,4,negative regulation of steroid biosynthetic process (GO:0010894),3/16,3,16,0.100684009031558,0.525511475312953,0,0,2.63342696629214,6.04573812315251,ERLIN1;SNAI1;SCAP
alpha,4,positive regulation of DNA biosynthetic process (GO:2000573),7/56,7,56,0.101264593932292,0.525511475312953,0,0,1.75561797752809,4.02039755228131,CCT2;ACD;HSP90AB1;TNKS2;RFC2;TNKS;MAP3K4
alpha,4,DNA alkylation (GO:0006305),3/16,3,16,0.100684009031558,0.525511475312953,0,0,2.63342696629214,6.04573812315251,DNMT3A;FOS;PPM1D
alpha,4,long-chain fatty acid metabolic process (GO:0001676),7/56,7,56,0.101264593932292,0.525511475312953,0,0,1.75561797752809,4.02039755228131,FADS2;SCP2;ACSL1;ELOVL5;DAGLB;ALOXE3;FADS1
alpha,4,neural tube development (GO:0021915),3/16,3,16,0.100684009031558,0.525511475312953,0,0,2.63342696629214,6.04573812315251,PTCH1;PKD2;DACT1
alpha,4,endothelial cell migration (GO:0043542),5/36,5,36,0.109736962412435,0.525511475312953,0,0,1.95068664169788,4.31037185469712,NR4A1;EGR3;PIK3CA;NOS3;RHOA
alpha,4,regulation of cytokinesis (GO:0032465),9/78,9,78,0.101912782255269,0.525511475312953,0,0,1.62057044079516,3.7007960902321,SETD2;SPAST;PRKCE;CUL3;KIF13A;PKN2;CALM2;GIT1;RHOA
alpha,4,regulation of cellular catabolic process (GO:0031329),7/56,7,56,0.101264593932292,0.525511475312953,0,0,1.75561797752809,4.02039755228131,RRAGA;USP10;DAPK3;PSAP;HSPB1;TYSND1;DRAM2
alpha,4,axon extension involved in axon guidance (GO:0048846),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,SLIT2;SEMA3F
alpha,4,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),5/36,5,36,0.109736962412435,0.525511475312953,0,0,1.95068664169788,4.31037185469712,MUS81;CDK9;TIPIN;ALYREF;BHLHE40
alpha,4,mesenchyme development (GO:0060485),3/16,3,16,0.100684009031558,0.525511475312953,0,0,2.63342696629214,6.04573812315251,CRELD1;PKD2;TGFBR1
alpha,4,microvillus organization (GO:0032528),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,SLC9A3R1;TNIK
alpha,4,positive regulation of telomerase activity (GO:0051973),5/36,5,36,0.109736962412435,0.525511475312953,0,0,1.95068664169788,4.31037185469712,CCT2;ACD;HSP90AB1;TNKS;MAP3K4
alpha,4,cardiac epithelial to mesenchymal transition (GO:0060317),3/16,3,16,0.100684009031558,0.525511475312953,0,0,2.63342696629214,6.04573812315251,HEY1;HEY2;TGFBR1
alpha,4,cellular response to light stimulus (GO:0071482),8/67,8,67,0.102297256882261,0.525511475312953,0,0,1.67700821734027,3.82336478421805,USP47;NPM1;PAPD7;GNB1;ZBTB1;TRIAP1;INO80;ATF4
alpha,4,histone monoubiquitination (GO:0010390),4/25,4,25,0.0980781258085269,0.525511475312953,0,0,2.24719101123596,5.21795711411365,RNF20;RYBP;BCOR;SKP1
alpha,4,positive regulation of behavior (GO:0048520),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,NLGN1;NR4A3
alpha,4,fatty acid catabolic process (GO:0009062),8/66,8,66,0.0957186406355684,0.525511475312953,0,0,1.70241743275451,3.99445389429676,HADHB;HADHA;ACBD5;ABCD3;ACAD10;ACADS;LPIN2;ACAT1
alpha,4,regulation of mitochondrial membrane potential (GO:0051881),5/36,5,36,0.109736962412435,0.525511475312953,0,0,1.95068664169788,4.31037185469712,HEBP2;VCP;PRELID1;UBB;SLC25A33
alpha,4,double-strand break repair via homologous recombination (GO:0000724),9/77,9,77,0.0958675071481373,0.525511475312953,0,0,1.64161681015614,3.84924368376045,MUS81;GEN1;RECQL4;AP5Z1;POLN;NSMCE2;SWI5;CDC7;INO80
alpha,4,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),3/16,3,16,0.100684009031558,0.525511475312953,0,0,2.63342696629214,6.04573812315251,SRPX2;AKT3;PIK3C2A
alpha,4,microtubule nucleation by microtubule organizing center (GO:0051418),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,TUBGCP2;TUBGCP4
alpha,4,regulation of cell cycle G1/S phase transition (GO:1902806),4/25,4,25,0.0980781258085269,0.525511475312953,0,0,2.24719101123596,5.21795711411365,STXBP4;FBXW7;INO80;FAM83D
alpha,4,negative regulation of epithelial cell migration (GO:0010633),5/36,5,36,0.109736962412435,0.525511475312953,0,0,1.95068664169788,4.31037185469712,DLL4;KRIT1;PTPN23;SLIT2;CORO1C
alpha,4,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),3/16,3,16,0.100684009031558,0.525511475312953,0,0,2.63342696629214,6.04573812315251,MECP2;CDC7;BRD4
alpha,4,neuron projection extension involved in neuron projection guidance (GO:1902284),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,SLIT2;SEMA3F
alpha,4,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),4/25,4,25,0.0980781258085269,0.525511475312953,0,0,2.24719101123596,5.21795711411365,TAF9;SNAI1;TRIAP1;CLU
alpha,4,negative regulation of cell-substrate adhesion (GO:0010812),5/36,5,36,0.109736962412435,0.525511475312953,0,0,1.95068664169788,4.31037185469712,KANK1;ADAM15;RASA1;RHOA;CORO1C
alpha,4,negative regulation of DNA replication (GO:0008156),3/16,3,16,0.100684009031558,0.525511475312953,0,0,2.63342696629214,6.04573812315251,CDAN1;RAD17;PDS5A
alpha,4,succinate metabolic process (GO:0006105),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,STAT5B;SDHA
alpha,4,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),4/25,4,25,0.0980781258085269,0.525511475312953,0,0,2.24719101123596,5.21795711411365,SDCBP;HSP90AB1;RYBP;TAF9
alpha,4,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",5/36,5,36,0.109736962412435,0.525511475312953,0,0,1.95068664169788,4.31037185469712,EXOSC6;TTC37;LSM6;CNOT7;EXOSC3
alpha,4,negative regulation of translational initiation (GO:0045947),3/16,3,16,0.100684009031558,0.525511475312953,0,0,2.63342696629214,6.04573812315251,EIF2AK1;AGO2;ATF4
alpha,4,regulation of receptor binding (GO:1900120),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,ADAM15;PTPRF
alpha,4,regulation of cyclin-dependent protein kinase activity (GO:1904029),5/36,5,36,0.109736962412435,0.525511475312953,0,0,1.95068664169788,4.31037185469712,HERC5;CDKN2B;CCNE2;BCCIP;CDK5R1
alpha,4,small GTPase mediated signal transduction (GO:0007264),11/100,11,100,0.0987433843650436,0.525511475312953,0,0,1.54494382022472,3.57690162687989,RB1;BRAP;JUN;ARL3;TNK2;MAPKAPK2;GNB1;NF1;KRIT1;SOS1;RREB1
alpha,4,negative regulation of interleukin-6 production (GO:0032715),4/25,4,25,0.0980781258085269,0.525511475312953,0,0,2.24719101123596,5.21795711411365,ZC3H12A;TNFAIP3;FOXJ1;ARRB1
alpha,4,cellular response to peptide hormone stimulus (GO:0071375),12/111,12,111,0.096483144529179,0.525511475312953,0,0,1.51837230488916,3.55054198904472,NR4A1;CPEB1;NR4A3;GOT1;GNG5;PRKDC;GNB1;PDE3B;ADCY3;SLC25A33;RHOQ;RELA
alpha,4,negative regulation of transcription regulatory region DNA binding (GO:2000678),3/16,3,16,0.100684009031558,0.525511475312953,0,0,2.63342696629214,6.04573812315251,HEY1;DDIT3;HEY2
alpha,4,potassium ion homeostasis (GO:0055075),4/26,4,26,0.109712991384958,0.525511475312953,0,0,2.16076058772688,4.77503779652525,SLC12A2;ATP1B3;ATP1A1;SLC12A7
alpha,4,viral mRNA export from host cell nucleus (GO:0046784),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,ALYREF;THOC7
alpha,4,positive regulation of dephosphorylation (GO:0035306),4/25,4,25,0.0980781258085269,0.525511475312953,0,0,2.24719101123596,5.21795711411365,ANKLE2;PPP2R5A;SPPL3;CALM2
alpha,4,DNA methylation or demethylation (GO:0044728),3/16,3,16,0.100684009031558,0.525511475312953,0,0,2.63342696629214,6.04573812315251,DNMT3A;FOS;PPM1D
alpha,4,long-chain fatty-acyl-CoA metabolic process (GO:0035336),4/26,4,26,0.109712991384958,0.525511475312953,0,0,2.16076058772688,4.77503779652525,ACOT7;ELOVL5;ACSL1;ACSL3
alpha,4,U4 snRNA 3'-end processing (GO:0034475),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,EXOSC6;EXOSC3
alpha,4,positive regulation of microtubule polymerization or depolymerization (GO:0031112),4/25,4,25,0.0980781258085269,0.525511475312953,0,0,2.24719101123596,5.21795711411365,PAK1;CLIP1;RAC1;CDK5R1
alpha,4,regulation of bicellular tight junction assembly (GO:2000810),3/16,3,16,0.100684009031558,0.525511475312953,0,0,2.63342696629214,6.04573812315251,IKBKB;OCLN;SNAI1
alpha,4,regulation of potassium ion transmembrane transporter activity (GO:1901016),4/26,4,26,0.109712991384958,0.525511475312953,0,0,2.16076058772688,4.77503779652525,CAB39;STK39;CACNA1D;ATP1B3
alpha,4,snoRNA 3'-end processing (GO:0031126),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,EXOSC6;EXOSC3
alpha,4,regulation of epidermal growth factor-activated receptor activity (GO:0007176),4/25,4,25,0.0980781258085269,0.525511475312953,0,0,2.24719101123596,5.21795711411365,ZFYVE28;ERRFI1;ZGPAT;FBXW7
alpha,4,regulation of apoptotic signaling pathway (GO:2001233),4/26,4,26,0.109712991384958,0.525511475312953,0,0,2.16076058772688,4.77503779652525,SGMS1;TRIM39;TMBIM6;TGFBR1
alpha,4,sympathetic nervous system development (GO:0048485),3/16,3,16,0.100684009031558,0.525511475312953,0,0,2.63342696629214,6.04573812315251,NF1;CTNNB1;SEMA3F
alpha,4,negative regulation of cilium assembly (GO:1902018),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,TBC1D30;TBC1D7
alpha,4,cellular modified amino acid biosynthetic process (GO:0042398),4/25,4,25,0.0980781258085269,0.525511475312953,0,0,2.24719101123596,5.21795711411365,GCLC;CHAC2;HAGH;GCLM
alpha,4,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),7/57,7,57,0.108755598068014,0.525511475312953,0,0,1.72481766213286,3.82677038659449,IKBKB;HIST1H2BJ;UBB;SPHK1;TNFAIP3;RBCK1;BIRC2
alpha,4,in utero embryonic development (GO:0001701),4/26,4,26,0.109712991384958,0.525511475312953,0,0,2.16076058772688,4.77503779652525,MBNL1;CHD7;LIG4;TGFBR1
alpha,4,regulation of exosomal secretion (GO:1903541),3/16,3,16,0.100684009031558,0.525511475312953,0,0,2.63342696629214,6.04573812315251,SDCBP;PDCD6IP;STAM
alpha,4,actin filament network formation (GO:0051639),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,COBLL1;COBL
alpha,4,innate immune response activating cell surface receptor signaling pathway (GO:0002220),13/125,13,125,0.10828969872873,0.525511475312953,0,0,1.46067415730337,3.24699867601275,PSMD12;RELA;IKBKB;PSMA5;PSMD6;PSMA3;PAK1;PSMD7;UBB;PSMA1;PSMF1;PAK2;SKP1
alpha,4,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),9/79,9,79,0.108170497081755,0.525511475312953,0,0,1.60005689091168,3.55860112,PSMA5;PSMD6;PSMA3;PSMD12;PSMD7;PSMA1;UBB;PSMF1;HIGD1A
alpha,4,positive regulation of autophagy (GO:0010508),8/68,8,68,0.109121525513652,0.525511475312953,0,0,1.65234633179114,3.66043143562063,SCOC;TBK1;BNIP3;ZC3H12A;TP53INP1;PIK3CB;MTDH;CAMKK2
alpha,4,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),4/25,4,25,0.0980781258085269,0.525511475312953,0,0,2.24719101123596,5.21795711411365,RB1;PRKDC;PKD2;DACT1
alpha,4,ATP metabolic process (GO:0046034),7/57,7,57,0.108755598068014,0.525511475312953,0,0,1.72481766213286,3.82677038659449,SURF1;NDUFAF7;ENTPD5;FIGNL1;ATP5C1;ATP5F1;UQCRH
alpha,4,respiratory chain complex IV assembly (GO:0008535),4/26,4,26,0.109712991384958,0.525511475312953,0,0,2.16076058772688,4.77503779652525,SURF1;COX15;COX11;PET117
alpha,4,monocyte activation (GO:0042117),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,HYAL2;FOXP1
alpha,4,protein transport along microtubule (GO:0098840),3/16,3,16,0.100684009031558,0.525511475312953,0,0,2.63342696629214,6.04573812315251,IFT74;IFT81;IFT46
alpha,4,response to amino acid (GO:0043200),5/35,5,35,0.100037565536518,0.525511475312953,0,0,2.00642054574639,4.61920045780434,RRAGA;CPEB1;GPRIN1;TMBIM6;IPO5
alpha,4,extrinsic apoptotic signaling pathway (GO:0097191),8/68,8,68,0.109121525513652,0.525511475312953,0,0,1.65234633179114,3.66043143562063,MOAP1;DDX3X;SMAD3;BAG3;BLOC1S2;FADD;GABARAP;DEDD2
alpha,4,autophagosome organization (GO:1905037),7/57,7,57,0.108755598068014,0.525511475312953,0,0,1.72481766213286,3.82677038659449,ATG3;MAP1LC3A;TP53INP2;TP53INP1;ATG13;GABARAP;ATG2B
alpha,4,negative regulation of protein localization to membrane (GO:1905476),4/25,4,25,0.0980781258085269,0.525511475312953,0,0,2.24719101123596,5.21795711411365,CLTC;PPFIA1;PPP2R5A;RHOQ
alpha,4,organophosphate ester transport (GO:0015748),4/26,4,26,0.109712991384958,0.525511475312953,0,0,2.16076058772688,4.77503779652525,PRELID1;SCP2;STARD7;TRIAP1
alpha,4,sprouting angiogenesis (GO:0002040),6/45,6,45,0.097950642564261,0.525511475312953,0,0,1.87265917602996,4.35073328555792,NR4A1;EGR3;SRF;NRARP;PARVA;SLIT2
alpha,4,positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,BLOC1S2;BNIP3
alpha,4,regulation of systemic arterial blood pressure by hormone (GO:0001990),3/16,3,16,0.100684009031558,0.525511475312953,0,0,2.63342696629214,6.04573812315251,AVPR1B;NOS3;ECE1
alpha,4,positive regulation of cytokinesis (GO:0032467),5/35,5,35,0.100037565536518,0.525511475312953,0,0,2.00642054574639,4.61920045780434,SPAST;CUL3;PRKCE;PKN2;RHOA
alpha,4,regulation of organelle organization (GO:0033043),12/114,12,114,0.111836058225258,0.534835026750722,0,0,1.47841513897102,3.23879545518149,TBC1D1;GOLPH3;GRTP1;TBC1D5;STMN1;TBC1D30;RDX;SGSM2;RUNDC1;TBC1D9;TBC1D12;MFF
alpha,4,chordate embryonic development (GO:0043009),7/57,7,57,0.108755598068014,0.525511475312953,0,0,1.72481766213286,3.82677038659449,MBNL1;PTCH1;CHD7;LIG4;PKD2;TGFBR1;DACT1
alpha,4,regulation of centrosome duplication (GO:0010824),4/26,4,26,0.109712991384958,0.525511475312953,0,0,2.16076058772688,4.77503779652525,GEN1;NPM1;PDCD6IP;SPICE1
alpha,4,intrinsic apoptotic signaling pathway (GO:0097193),11/102,11,102,0.109596425835157,0.525511475312953,0,0,1.51465080414188,3.34881797696681,MOAP1;HINT1;DDX3X;CUL5;DDIT3;CUL3;BNIP3;GSKIP;MAP3K5;ATF4;HIPK2
alpha,4,positive regulation of actin filament bundle assembly (GO:0032233),6/45,6,45,0.097950642564261,0.525511475312953,0,0,1.87265917602996,4.35073328555792,PAK1;TESK1;RAC1;RHOA;TGFBR1;S100A10
alpha,4,membrane lipid catabolic process (GO:0046466),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,SMPD2;FUCA1
alpha,4,peptidyl-threonine dephosphorylation (GO:0035970),3/16,3,16,0.100684009031558,0.525511475312953,0,0,2.63342696629214,6.04573812315251,DUSP5;PPM1D;PPM1G
alpha,4,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),5/35,5,35,0.100037565536518,0.525511475312953,0,0,2.00642054574639,4.61920045780434,CCT2;ACD;TNKS2;TNKS;MAP3K4
alpha,4,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),10/89,10,89,0.100622066190414,0.525511475312953,0,0,1.57808357530615,3.62388539884502,RNF144A;SDCBP;VCP;HSP90AB1;ANKIB1;RYBP;TAF9;GNA12;ARIH1;CLU
alpha,4,ventricular trabecula myocardium morphogenesis (GO:0003222),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,DLL4;TGFBR1
alpha,4,carboxylic acid biosynthetic process (GO:0046394),6/45,6,45,0.097950642564261,0.525511475312953,0,0,1.87265917602996,4.35073328555792,NANP;UGDH;SLC35D1;GOT1;UROS;FADS1
alpha,4,apoptotic mitochondrial changes (GO:0008637),5/35,5,35,0.100037565536518,0.525511475312953,0,0,2.00642054574639,4.61920045780434,ATG3;BNIP3;PPIF;MFF;CLU
alpha,4,regulation of stem cell differentiation (GO:2000736),10/89,10,89,0.100622066190414,0.525511475312953,0,0,1.57808357530615,3.62388539884502,PSMA5;PSMD6;PSMA3;PSMD12;PSMD7;LDB1;PSMA1;UBB;TCF12;PSMF1
alpha,4,negative regulation of mRNA polyadenylation (GO:1900364),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,CDK9;RNF20
alpha,4,regulation of smooth muscle cell proliferation (GO:0048660),6/45,6,45,0.097950642564261,0.525511475312953,0,0,1.87265917602996,4.35073328555792,NR4A3;PRKDC;TNFAIP3;MFN2;CTNNB1;FOXP1
alpha,4,kinetochore assembly (GO:0051382),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,CENPW;POGZ
alpha,4,protein sumoylation (GO:0016925),8/69,8,69,0.116188467590209,0.536665523757666,0,0,1.62839928350432,3.50519733870898,NUP214;PIAS4;SENP5;UBE2I;NUP188;NUP155;NUP62;NUP153
alpha,4,protein localization to microtubule cytoskeleton (GO:0072698),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,CRIPT;FAM83D
alpha,4,termination of RNA polymerase II transcription (GO:0006369),8/69,8,69,0.116188467590209,0.536665523757666,0,0,1.62839928350432,3.50519733870898,LSM11;NCBP2;ALYREF;EIF4A3;SRSF2;CDC40;THOC7;SRSF9
alpha,4,I-kappaB kinase/NF-kappaB signaling (GO:0007249),7/58,7,58,0.116533024931488,0.537550633378188,0,0,1.69507942657885,3.64370980055915,IKBKB;TBK1;UBB;RBCK1;BIRC2;RELA;NFKB2
alpha,4,mitochondrial transport (GO:0006839),14/136,14,136,0.104704161472343,0.525511475312953,0,0,1.44580304031725,3.26262287401819,TIMM9;BNIP3;ATP5C1;SPG7;ATP5F1;MFF;TOMM20;SLC25A38;SLC25A28;UCP2;PPIF;SLC25A51;MFN2;SLC25A33
alpha,4,lung epithelium development (GO:0060428),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,ERRFI1;FOXJ1
alpha,4,N-terminal protein amino acid modification (GO:0031365),3/17,3,17,0.116081204176352,0.536665523757666,0,0,2.47851949768672,5.33740572566999,NAA30;NTMT1;NAA16
alpha,4,positive regulation of catenin import into nucleus (GO:0035413),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,KANK1;DACT1
alpha,4,DNA catabolic process (GO:0006308),3/17,3,17,0.116081204176352,0.536665523757666,0,0,2.47851949768672,5.33740572566999,MUS81;TATDN3;ENDOG
alpha,4,regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,CHD6;ATF4
alpha,4,detection of mechanical stimulus (GO:0050982),3/17,3,17,0.116081204176352,0.536665523757666,0,0,2.47851949768672,5.33740572566999,DENND5B;DENND5A;PKD2
alpha,4,desensitization of G-protein coupled receptor protein signaling pathway (GO:0002029),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,ARRB1;ARRB2
alpha,4,positive regulation of telomere capping (GO:1904355),3/17,3,17,0.116081204176352,0.536665523757666,0,0,2.47851949768672,5.33740572566999,TNKS2;TNKS;MAP3K4
alpha,4,regulation of lamellipodium organization (GO:1902743),3/17,3,17,0.116081204176352,0.536665523757666,0,0,2.47851949768672,5.33740572566999,CAPZB;TWF1;RAC1
alpha,4,regulation of cytoplasmic transport (GO:1903649),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,MAP2K1;DNAJC13
alpha,4,virion assembly (GO:0019068),3/17,3,17,0.116081204176352,0.536665523757666,0,0,2.47851949768672,5.33740572566999,LRSAM1;PDCD6IP;UBB
alpha,4,positive regulation of early endosome to late endosome transport (GO:2000643),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,RDX;PTPN23
alpha,4,regulation of receptor recycling (GO:0001919),3/17,3,17,0.116081204176352,0.536665523757666,0,0,2.47851949768672,5.33740572566999,ANXA2;ECE1;BVES
alpha,4,microvillus assembly (GO:0030033),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,SLC9A3R1;TNIK
alpha,4,rRNA catabolic process (GO:0016075),3/17,3,17,0.116081204176352,0.536665523757666,0,0,2.47851949768672,5.33740572566999,EXOSC6;EXOSC3;DEDD2
alpha,4,negative regulation of potassium ion transmembrane transporter activity (GO:1901017),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,CAB39;STK39
alpha,4,DNA replication checkpoint (GO:0000076),3/17,3,17,0.116081204176352,0.536665523757666,0,0,2.47851949768672,5.33740572566999,TIPIN;RAD17;RAD9A
alpha,4,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),6/47,6,47,0.114875211113971,0.536665523757666,0,0,1.79297155151805,3.87982702702021,CRY1;TNFAIP3;CTNNB1;ARRB1;ARRB2;RNF4
alpha,4,translocation of molecules into host (GO:0044417),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,ALYREF;THOC7
alpha,4,positive regulation of cellular protein catabolic process (GO:1903364),3/17,3,17,0.116081204176352,0.536665523757666,0,0,2.47851949768672,5.33740572566999,CD81;RDX;DACT1
alpha,4,interleukin-12-mediated signaling pathway (GO:0035722),6/47,6,47,0.114875211113971,0.536665523757666,0,0,1.79297155151805,3.87982702702021,RALA;ANXA2;RPLP0;CFL1;PAK2;LMNB1
alpha,4,ribosomal large subunit export from nucleus (GO:0000055),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,NPM1;RAN
alpha,4,negative regulation of reactive oxygen species metabolic process (GO:2000378),3/17,3,17,0.116081204176352,0.536665523757666,0,0,2.47851949768672,5.33740572566999,TFAP2A;SIRT5;AATF
alpha,4,negative regulation of autophagy (GO:0010507),6/47,6,47,0.114875211113971,0.536665523757666,0,0,1.79297155151805,3.87982702702021,GOLGA2;CTSA;RRAGA;PIK3CA;WDR6;RASIP1
alpha,4,positive regulation of mitochondrial calcium ion concentration (GO:0051561),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,MCUR1;MICU1
alpha,4,positive regulation of response to biotic stimulus (GO:0002833),3/17,3,17,0.116081204176352,0.536665523757666,0,0,2.47851949768672,5.33740572566999,ANKRD17;LRSAM1;BMP6
alpha,4,regulation of fibroblast proliferation (GO:0048145),6/47,6,47,0.114875211113971,0.536665523757666,0,0,1.79297155151805,3.87982702702021,SPHK1;FN1;NF1;LIG4;CTNNB1;BMI1
alpha,4,phosphate ion transmembrane transport (GO:0035435),2/8,2,8,0.106490824540329,0.525511475312953,0,0,3.51123595505618,7.86410271100799,SLC20A2;SLC37A4
alpha,4,histone H2A ubiquitination (GO:0033522),3/17,3,17,0.116081204176352,0.536665523757666,0,0,2.47851949768672,5.33740572566999,RYBP;BCOR;SKP1
alpha,4,maturation of SSU-rRNA (GO:0030490),6/47,6,47,0.114875211113971,0.536665523757666,0,0,1.79297155151805,3.87982702702021,LSM6;TSR3;NAT10;TSR1;NOC4L;RIOK1
alpha,4,negative regulation of telomere maintenance (GO:0032205),3/17,3,17,0.116081204176352,0.536665523757666,0,0,2.47851949768672,5.33740572566999,TNKS2;TNKS;TERF2IP
alpha,4,cellular response to interleukin-12 (GO:0071349),6/47,6,47,0.114875211113971,0.536665523757666,0,0,1.79297155151805,3.87982702702021,RALA;ANXA2;RPLP0;CFL1;PAK2;LMNB1
alpha,4,positive regulation of fatty acid metabolic process (GO:0045923),3/17,3,17,0.116081204176352,0.536665523757666,0,0,2.47851949768672,5.33740572566999,LPGAT1;NR4A3;ELOVL5
alpha,4,protein complex disassembly (GO:0043241),6/47,6,47,0.114875211113971,0.536665523757666,0,0,1.79297155151805,3.87982702702021,VCP;FRAT1;MAP1LC3A;LAMP2;CTNNB1;GABARAP
alpha,4,ureteric bud development (GO:0001657),3/17,3,17,0.116081204176352,0.536665523757666,0,0,2.47851949768672,5.33740572566999,FOXJ1;SLIT2;PKD2
alpha,4,positive regulation of cholesterol transport (GO:0032376),3/17,3,17,0.116081204176352,0.536665523757666,0,0,2.47851949768672,5.33740572566999,SCP2;PTCH1;LIPG
alpha,4,positive regulation of signaling (GO:0023056),5/37,5,37,0.119873195427408,0.548638387926224,0,0,1.89796538111145,4.02619344002012,ANXA2;HOMER1;ECE1;PTPN23;BVES
alpha,4,regulation of cell morphogenesis involved in differentiation (GO:0010769),5/37,5,37,0.119873195427408,0.548638387926224,0,0,1.89796538111145,4.02619344002012,PAK1;KIF13B;SARM1;TNIK;CORO1C
alpha,4,epithelial cell migration (GO:0010631),5/37,5,37,0.119873195427408,0.548638387926224,0,0,1.89796538111145,4.02619344002012,NUP188;PIK3CA;NOS3;PKN2;RHOA
alpha,4,endoderm formation (GO:0001706),5/37,5,37,0.119873195427408,0.548638387926224,0,0,1.89796538111145,4.02619344002012,VTN;DUSP5;SETD2;ITGB5;FN1
alpha,4,carbohydrate biosynthetic process (GO:0016051),5/37,5,37,0.119873195427408,0.548638387926224,0,0,1.89796538111145,4.02619344002012,GALNT16;GALNT2;GLT8D2;GALNT10;ST3GAL2
alpha,4,muscle cell differentiation (GO:0042692),5/37,5,37,0.119873195427408,0.548638387926224,0,0,1.89796538111145,4.02619344002012,RB1;MBNL1;HEY2;RORA;BVES
alpha,4,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),4/27,4,27,0.121930409970155,0.553727895407097,0,0,2.08073241781107,4.37849522903725,ACD;TNKS2;TNKS;NAT10
alpha,4,nucleic acid metabolic process (GO:0090304),9/81,9,81,0.121315148928437,0.553727895407097,0,0,1.5605493133583,3.29176589062779,POLR2A;NCBP2;DDX1;DDX54;HNRNPR;POLR2H;KPNA2;RAN;POLG
alpha,4,RNA biosynthetic process (GO:0032774),4/27,4,27,0.121930409970155,0.553727895407097,0,0,2.08073241781107,4.37849522903725,POLR2A;TAF6;TAF5;TAF4
alpha,4,positive regulation of release of cytochrome c from mitochondria (GO:0090200),4/27,4,27,0.121930409970155,0.553727895407097,0,0,2.08073241781107,4.37849522903725,MOAP1;BNIP3;PPIF;MFF
alpha,4,positive regulation of interferon-beta production (GO:0032728),4/27,4,27,0.121930409970155,0.553727895407097,0,0,2.08073241781107,4.37849522903725,DDX3X;TBK1;POLR3B;POLR3D
alpha,4,regulation of transcription regulatory region DNA binding (GO:2000677),4/27,4,27,0.121930409970155,0.553727895407097,0,0,2.08073241781107,4.37849522903725,RB1;HEY1;NSD1;HEY2
alpha,4,fatty acid biosynthetic process (GO:0006633),6/48,6,48,0.123853794519074,0.555556765678571,0,0,1.75561797752809,3.66687760795946,ABCD3;ACOT7;ELOVL5;SCD;LIAS;FADS1
alpha,4,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),8/70,8,70,0.123494533790017,0.555556765678571,0,0,1.60513643659711,3.35723657255734,NLGN1;RALA;CDC42EP4;DPYSL3;FSCN1;RAC1;AGRN;RHOQ
alpha,4,"positive regulation of gene expression, epigenetic (GO:0045815)",6/48,6,48,0.123853794519074,0.555556765678571,0,0,1.75561797752809,3.66687760795946,SMARCD1;POLR1C;HMGA1;POLR2H;DEK;ACTB
alpha,4,regulation of innate immune response (GO:0045088),8/70,8,70,0.123494533790017,0.555556765678571,0,0,1.60513643659711,3.35723657255734,HSP90AB1;POLR3B;POLR3D;OTUD7A;TYRO3;TNFAIP3;ABCE1;BIRC2
alpha,4,maintenance of protein localization in organelle (GO:0072595),3/18,3,18,0.132290473079079,0.555556765678571,0,0,2.34082397003745,4.73491390552049,ARL2BP;TAF3;SKP1
alpha,4,polyol metabolic process (GO:0019751),6/48,6,48,0.123853794519074,0.555556765678571,0,0,1.75561797752809,3.66687760795946,INPP4A;ITPKC;INPP1;PLCG1;PLCD3;SLC5A3
alpha,4,glucan biosynthetic process (GO:0009250),3/18,3,18,0.132290473079079,0.555556765678571,0,0,2.34082397003745,4.73491390552049,UBB;GYG1;PGM1
alpha,4,positive regulation of neurogenesis (GO:0050769),8/70,8,70,0.123494533790017,0.555556765678571,0,0,1.60513643659711,3.35723657255734,ZNF609;TCF12;LIG4;PLAA;CTNNB1;ZNF335;NBL1;RHOA
alpha,4,mitochondrion morphogenesis (GO:0070584),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,SUPV3L1;MFF
alpha,4,glyceraldehyde-3-phosphate metabolic process (GO:0019682),3/18,3,18,0.132290473079079,0.555556765678571,0,0,2.34082397003745,4.73491390552049,TPI1;PGLS;RBKS
alpha,4,regulation of endothelial cell migration (GO:0010594),8/70,8,70,0.123494533790017,0.555556765678571,0,0,1.60513643659711,3.35723657255734,DLL4;ZC3H12A;KRIT1;NF1;SLIT2;ETS1;RHOB;FOXP1
alpha,4,negative regulation of developmental process (GO:0051093),8/71,8,71,0.13103562327937,0.555556765678571,0,0,1.58252888115208,3.21615138363329,KANK1;ANXA2;FBXW7;SFMBT1;DDIT3;BNIP3;FOXJ1;SKIL
alpha,4,regulation of protein metabolic process (GO:0051246),7/60,7,60,0.132924694522192,0.556889512807514,0,0,1.63857677902622,3.3066029082424,ABTB2;TRAF3;FAF1;BTBD3;ODC1;FAM83D;BTBD9
alpha,4,ionotropic glutamate receptor signaling pathway (GO:0035235),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,GPRIN1;CDK5R1
alpha,4,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),7/59,7,59,0.124591449343463,0.555556765678571,0,0,1.66634926680632,3.47053111284703,CDKL5;RAC1;SLIT2;CRK;RREB1;RHOA;S100A10
alpha,4,G1/S transition of mitotic cell cycle (GO:0000082),11/106,11,106,0.133271913723625,0.557016381377575,0,0,1.45749417002332,2.93738095071032,RB1;LATS1;CCNE2;CUL5;ORC1;CUL3;ORC2;MCM4;CDC7;EIF4E;BRD4
alpha,4,establishment of epithelial cell polarity (GO:0090162),3/18,3,18,0.132290473079079,0.555556765678571,0,0,2.34082397003745,4.73491390552049,SLC9A3R1;GOLPH3;RHOA
alpha,4,cellular macromolecule catabolic process (GO:0044265),6/49,6,49,0.133164088017893,0.557016381377575,0,0,1.71978903921119,3.46739251324632,TATDN3;SUPV3L1;RNASEH1;PABPC4;DENND3;UBE2G1
alpha,4,positive regulation of endothelial cell migration (GO:0010595),8/71,8,71,0.13103562327937,0.555556765678571,0,0,1.58252888115208,3.21615138363329,NOS3;AKT3;ZC3H12A;HSPB1;PLCG1;ETS1;RHOB;FOXP1
alpha,4,cell cycle G1/S phase transition (GO:0044843),10/93,10,93,0.124808134856183,0.555556765678571,0,0,1.51020901292739,3.14271119069205,RB1;LATS1;CCNE2;CUL5;ORC1;CUL3;ORC2;MCM4;CDC7;EIF4E
alpha,4,dicarboxylic acid metabolic process (GO:0043648),7/60,7,60,0.132924694522192,0.556889512807514,0,0,1.63857677902622,3.3066029082424,STAT5B;GCLC;GOT1;SDHA;GCLM;NIT2;ASS1
alpha,4,regulation of interferon-gamma secretion (GO:1902713),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,ZC3H12A;RASGRP1
alpha,4,regulation of microtubule polymerization or depolymerization (GO:0031110),3/18,3,18,0.132290473079079,0.555556765678571,0,0,2.34082397003745,4.73491390552049,STMN1;CAMSAP1;CLASP2
alpha,4,long-chain fatty acid biosynthetic process (GO:0042759),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,ACOT7;ALOXE3
alpha,4,DNA methylation (GO:0006306),3/18,3,18,0.132290473079079,0.555556765678571,0,0,2.34082397003745,4.73491390552049,DNMT3A;FOS;PPM1D
alpha,4,actin crosslink formation (GO:0051764),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,DPYSL3;BAIAP2
alpha,4,glycogen biosynthetic process (GO:0005978),3/18,3,18,0.132290473079079,0.555556765678571,0,0,2.34082397003745,4.73491390552049,UBB;GYG1;PGM1
alpha,4,regulation of organ growth (GO:0046620),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,LATS1;WWC3
alpha,4,endocytic recycling (GO:0032456),4/28,4,28,0.134697822036773,0.558988009987316,0,0,2.00642054574639,4.02231413460789,MICALL2;LMTK2;PTPN23;EPS15
alpha,4,positive regulation of cell cycle (GO:0045787),9/83,9,83,0.135281031263711,0.559426852814052,0,0,1.52294571544605,3.04650205786739,ANKRD17;CDK9;HSP90AB1;SPHK1;CKS2;CCNYL1;MAPRE3;PKN2;EIF4E
alpha,4,heart trabecula morphogenesis (GO:0061384),3/18,3,18,0.132290473079079,0.555556765678571,0,0,2.34082397003745,4.73491390552049,DLL4;HEY1;TGFBR1
alpha,4,negative regulation of leukocyte chemotaxis (GO:0002689),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,SLIT2;NBL1
alpha,4,negative regulation of organelle assembly (GO:1902116),4/28,4,28,0.134697822036773,0.558988009987316,0,0,2.00642054574639,4.02231413460789,SMAD4;TBC1D30;FEZ2;TBC1D7
alpha,4,mitotic sister chromatid segregation (GO:0000070),9/83,9,83,0.135281031263711,0.559426852814052,0,0,1.52294571544605,3.04650205786739,DSN1;PAPD7;CUL3;POGZ;NUP62;INO80;PDS5A;NSL1;RAN
alpha,4,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),3/18,3,18,0.132290473079079,0.555556765678571,0,0,2.34082397003745,4.73491390552049,PLAA;VPS37A;PTPN23
alpha,4,Golgi inheritance (GO:0048313),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,GOLGA2;YWHAZ
alpha,4,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),4/28,4,28,0.134697822036773,0.558988009987316,0,0,2.00642054574639,4.02231413460789,RAC1;RREB1;CRK;S100A10
alpha,4,negative regulation of NF-kappaB transcription factor activity (GO:0032088),9/83,9,83,0.135281031263711,0.559426852814052,0,0,1.52294571544605,3.04650205786739,LRRC14;BRMS1;TRAF3;ZC3H12A;TNFAIP3;FOXJ1;ARRB1;ARRB2;RBCK1
alpha,4,regulation of spindle organization (GO:0090224),3/18,3,18,0.132290473079079,0.555556765678571,0,0,2.34082397003745,4.73491390552049,CLTC;NUP62;RNF4
alpha,4,activation of MAPK activity (GO:0000187),12/118,12,118,0.134379609293922,0.558988009987316,0,0,1.42829937154828,2.86672049938054,ERN1;DUSP5;MAP4K2;MAP2K1;GRM4;KARS;UBB;CD81;MAPKAPK2;STK39;PIK3CB;MAP3K5
alpha,4,establishment of epithelial cell apical/basal polarity (GO:0045198),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,SLC9A3R1;RHOA
alpha,4,phagosome acidification (GO:0090383),4/28,4,28,0.134697822036773,0.558988009987316,0,0,2.00642054574639,4.02231413460789,ATP6V0B;ATP6V1E2;ATP6V0C;ATP6V1C1
alpha,4,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),3/18,3,18,0.132290473079079,0.555556765678571,0,0,2.34082397003745,4.73491390552049,ELOVL5;ACSL1;ACSL3
alpha,4,negative regulation of potassium ion transmembrane transport (GO:1901380),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,CAB39;STK39
alpha,4,regulation of double-strand break repair via homologous recombination (GO:0010569),4/28,4,28,0.134697822036773,0.558988009987316,0,0,2.00642054574639,4.02231413460789,SETD2;PPP4R2;FIGNL1;TERF2IP
alpha,4,positive regulation of protein homooligomerization (GO:0032464),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,MIEF2;CLU
alpha,4,negative regulation of chromatin silencing (GO:0031936),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,PHF2;HMGA1
alpha,4,endothelial cell chemotaxis (GO:0035767),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,NR4A1;EGR3
alpha,4,positive regulation of rRNA processing (GO:2000234),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,UTP15;RIOK1
alpha,4,negative regulation of alcohol biosynthetic process (GO:1902931),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,ERLIN1;SCAP
alpha,4,negative regulation of protein sumoylation (GO:0033234),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,CTNNB1;RNF4
alpha,4,positive regulation of ribosome biogenesis (GO:0090070),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,UTP15;RIOK1
alpha,4,glycine transport (GO:0015816),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,SLC25A38;SLC6A9
alpha,4,positive regulation of vasculature development (GO:1904018),11/105,11,105,0.127110441030912,0.555556765678571,0,0,1.47137506688068,3.03500381434285,RAP1A;NOS3;SPHK1;ZC3H12A;AGO2;HSPB1;PLCG1;ETS1;MTDH;RHOB;HIPK2
alpha,4,production of siRNA involved in RNA interference (GO:0030422),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,AGO2;DROSHA
alpha,4,"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,EXOSC6;EXOSC3
alpha,4,receptor recycling (GO:0001881),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,ARFGEF2;LMTK2
alpha,4,negative regulation of histone methylation (GO:0031061),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,PHF1;BCOR
alpha,4,cellular response to fibroblast growth factor stimulus (GO:0044344),10/95,10,95,0.137989924402557,0.569958383401864,0,0,1.47841513897102,2.9281114844265,DLL4;KL;NR4A1;EGR3;POLR2A;UBB;NCBP2;FLRT3;HYAL2;POLR2H
alpha,4,mitochondrial calcium uptake (GO:0036444),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,MCUR1;MICU1
alpha,4,heterochromatin organization (GO:0070828),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,HP1BP3;SNAI1
alpha,4,regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,HIP1;HIP1R
alpha,4,regulation of cell communication (GO:0010646),8/72,8,72,0.138807104494107,0.571989416526127,0,0,1.5605493133583,3.08156998611626,SAMD5;SOCS2;NLGN1;NUP62;GRIK4;BTBD9;CRK;BIRC2
alpha,4,nuclear migration (GO:0007097),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,SLC9A3R1;PAFAH1B1
alpha,4,actomyosin structure organization (GO:0031032),8/72,8,72,0.138807104494107,0.571989416526127,0,0,1.5605493133583,3.08156998611626,ALKBH4;ITGB5;EPB41;EPB41L1;TMOD3;CUL3;ARRB1;RHOA
alpha,4,sphingomyelin metabolic process (GO:0006684),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,SMPD2;SGMS1
alpha,4,regulation of microvillus organization (GO:0032530),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,CDHR2;FSCN1
alpha,4,negative regulation of T cell apoptotic process (GO:0070233),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,TSC22D3;FADD
alpha,4,"DNA-templated transcription, termination (GO:0006353)",11/107,11,107,0.139591993305816,0.574550183220073,0,0,1.44387272918198,2.84303080610853,LSM11;POLR2A;NCBP2;ALYREF;EIF4A3;POLR1C;SRSF2;POLR2H;CDC40;THOC7;SRSF9
alpha,4,negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,SRF;NFATC3
alpha,4,neuron maturation (GO:0042551),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,ANKS1A;RND1
alpha,4,protein peptidyl-prolyl isomerization (GO:0000413),5/38,5,38,0.130430232200954,0.555556765678571,0,0,1.84801892371378,3.76426081891066,PPIF;PPIG;PPIL4;PPID;PPIL6
alpha,4,regulation of protein acetylation (GO:1901983),2/9,2,9,0.130672721870205,0.555556765678571,0,0,3.1210986267166,6.35162106145469,KAT5;TERF2IP
alpha,4,base-excision repair (GO:0006284),5/38,5,38,0.130430232200954,0.555556765678571,0,0,1.84801892371378,3.76426081891066,RECQL4;USP47;HMGA1;UNG;POLG
alpha,4,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),14/141,14,141,0.1294857536101,0.555556765678571,0,0,1.39453342895848,2.85068350115326,RB1;LRRC14;PTCH1;TNFAIP3;FOXJ1;ARRB1;ARRB2;BRMS1;TRAF3;DDIT3;ZC3H12A;BHLHE40;RBCK1;TAF3
alpha,4,positive regulation of multi-organism process (GO:0043902),5/38,5,38,0.130430232200954,0.555556765678571,0,0,1.84801892371378,3.76426081891066,ANKRD17;LRSAM1;AGO2;LHFPL2;BMP6
alpha,4,cytosolic transport (GO:0016482),12/119,12,119,0.140377647806643,0.577108107649533,0,0,1.41629685582098,2.7807841616293,DOPEY1;ARFRP1;HEATR5B;TBC1D5;VPS13C;CLTC;LMTK2;VPS54;DENND5A;CORO7;PTPN23;EPS15
alpha,4,negative regulation of G0 to G1 transition (GO:0070317),5/38,5,38,0.130430232200954,0.555556765678571,0,0,1.84801892371378,3.76426081891066,RYBP;MGA;CDC7;BMI1;YAF2
alpha,4,protein K63-linked ubiquitination (GO:0070534),5/38,5,38,0.130430232200954,0.555556765678571,0,0,1.84801892371378,3.76426081891066,HECTD1;UBE2S;UBE2G1;PRPF19;RNF4
alpha,4,positive regulation of smooth muscle cell proliferation (GO:0048661),5/38,5,38,0.130430232200954,0.555556765678571,0,0,1.84801892371378,3.76426081891066,ERN1;JUN;NR4A3;MFN2;FOXP1
alpha,4,regulation of dendrite development (GO:0050773),5/38,5,38,0.130430232200954,0.555556765678571,0,0,1.84801892371378,3.76426081891066,CDKL5;SARM1;COBL;TNIK;KIAA0319
alpha,4,DNA damage checkpoint (GO:0000077),5/39,5,39,0.141390538913461,0.580593159206559,0,0,1.80063382310573,3.52245289154228,TIPRL;RAD17;PRPF19;ATRIP;RAD9A
alpha,4,protein heterooligomerization (GO:0051291),6/50,6,50,0.142795453761897,0.584314342227087,0,0,1.68539325842697,3.28035179660347,CPSF6;ANXA2;GPRIN1;TMCC1;S100A10;FARSB
alpha,4,non-recombinational repair (GO:0000726),6/50,6,50,0.142795453761897,0.584314342227087,0,0,1.68539325842697,3.28035179660347,PIAS4;BARD1;KAT5;PRKDC;LIG4;PRPF19
alpha,4,regulation of reactive oxygen species metabolic process (GO:2000377),6/50,6,50,0.142795453761897,0.584314342227087,0,0,1.68539325842697,3.28035179660347,TFAP2A;ZC3H12A;SIRT5;RAC1;AATF;SLC25A33
alpha,4,regulation of transforming growth factor beta production (GO:0071634),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,SMAD4;SMAD3
alpha,4,cellular biogenic amine metabolic process (GO:0006576),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,ODC1;AMD1
alpha,4,regulation of cellular respiration (GO:0043457),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,VCP;PRELID1
alpha,4,negative regulation of sodium ion transmembrane transport (GO:1902306),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,PRKCE;STK39
alpha,4,membrane raft organization (GO:0031579),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,ANXA2;S100A10
alpha,4,activin receptor signaling pathway (GO:0032924),3/19,3,19,0.149229108691095,0.588761520217205,0,0,2.21762270845653,4.21852271978693,SMAD3;ACVR2B;TGFBR1
alpha,4,smooth muscle cell differentiation (GO:0051145),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,HEY1;HEY2
alpha,4,innate immune response in mucosa (GO:0002227),3/19,3,19,0.149229108691095,0.588761520217205,0,0,2.21762270845653,4.21852271978693,HIST1H2BJ;HIST1H2BK;RPL39
alpha,4,pulmonary valve development (GO:0003177),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,HEY1;HEY2
alpha,4,telomere capping (GO:0016233),3/19,3,19,0.149229108691095,0.588761520217205,0,0,2.21762270845653,4.21852271978693,ACD;PRKDC;TERF2IP
alpha,4,regulation of lysosomal lumen pH (GO:0035751),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,ATP6V0C;CLN6
alpha,4,regulation of receptor internalization (GO:0002090),4/29,4,29,0.147980637124661,0.588761520217205,0,0,1.93723363037582,3.7014216273069,SDCBP;TBC1D5;ARRB1;ARRB2
alpha,4,positive regulation of vacuole organization (GO:0044090),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,LRSAM1;ANXA2
alpha,4,interleukin-7-mediated signaling pathway (GO:0038111),3/19,3,19,0.149229108691095,0.588761520217205,0,0,2.21762270845653,4.21852271978693,SOCS2;STAT5B;CISH
alpha,4,bicellular tight junction assembly (GO:0070830),4/29,4,29,0.147980637124661,0.588761520217205,0,0,1.93723363037582,3.7014216273069,OCLN;PARD6A;PDCD6IP;MICALL2
alpha,4,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,RYK;CTNNB1
alpha,4,nucleotide-sugar biosynthetic process (GO:0009226),3/19,3,19,0.149229108691095,0.588761520217205,0,0,2.21762270845653,4.21852271978693,UGDH;SLC35D1;NANS
alpha,4,positive regulation of fibroblast proliferation (GO:0048146),4/29,4,29,0.147980637124661,0.588761520217205,0,0,1.93723363037582,3.7014216273069,SPHK1;FN1;LIG4;BMI1
alpha,4,negative regulation of homotypic cell-cell adhesion (GO:0034111),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,SERPINE2;RDX
alpha,4,cellular response to interleukin-7 (GO:0098761),3/19,3,19,0.149229108691095,0.588761520217205,0,0,2.21762270845653,4.21852271978693,SOCS2;STAT5B;CISH
alpha,4,protein export from nucleus (GO:0006611),4/29,4,29,0.147980637124661,0.588761520217205,0,0,1.93723363037582,3.7014216273069,NUP214;XPO4;NUP62;RAN
alpha,4,chaperone-mediated protein transport (GO:0072321),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,TIMM9;CLU
alpha,4,regulation of transcription factor import into nucleus (GO:0042990),3/19,3,19,0.149229108691095,0.588761520217205,0,0,2.21762270845653,4.21852271978693,SMAD3;BAG3;NF1
alpha,4,positive regulation of lipid localization (GO:1905954),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,ZC3H12A;HILPDA
alpha,4,calcium ion import (GO:0070509),4/29,4,29,0.147980637124661,0.588761520217205,0,0,1.93723363037582,3.7014216273069,MCUR1;ATP2A2;CACNA1D;MICU1
alpha,4,regulation of mitochondrial fission (GO:0090140),3/19,3,19,0.149229108691095,0.588761520217205,0,0,2.21762270845653,4.21852271978693,BNIP3;MIEF2;MFF
alpha,4,negative regulation of cell cycle (GO:0045786),8/73,8,73,0.146803837652389,0.588761520217205,0,0,1.53917192550408,2.95314456071598,LATS1;SLC9A3R1;NR4A1;SMAD3;HECA;TAF6;IPO5;RHOB
alpha,4,regulation of mRNA 3'-end processing (GO:0031440),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,BARD1;NCBP2
alpha,4,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),4/29,4,29,0.147980637124661,0.588761520217205,0,0,1.93723363037582,3.7014216273069,IKBKB;UBB;TNFAIP3;RELA
alpha,4,vesicle transport along microtubule (GO:0047496),3/19,3,19,0.149229108691095,0.588761520217205,0,0,2.21762270845653,4.21852271978693,KIF5B;KIF13A;PAFAH1B1
alpha,4,negative regulation of protein autophosphorylation (GO:0031953),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,ERRFI1;TESK1
alpha,4,ventricular septum development (GO:0003281),4/29,4,29,0.147980637124661,0.588761520217205,0,0,1.93723363037582,3.7014216273069,SMAD4;HEY1;HEY2;TGFBR1
alpha,4,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),3/19,3,19,0.149229108691095,0.588761520217205,0,0,2.21762270845653,4.21852271978693,TRIM39;PSMF1;HIPK2
alpha,4,negative regulation of embryonic development (GO:0045992),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,LFNG;CTNNB1
alpha,4,regulation of defense response to virus by virus (GO:0050690),4/29,4,29,0.147980637124661,0.588761520217205,0,0,1.93723363037582,3.7014216273069,PACS1;AP1S3;RAC1;PAK2
alpha,4,protein targeting to lysosome (GO:0006622),3/19,3,19,0.149229108691095,0.588761520217205,0,0,2.21762270845653,4.21852271978693,NCOA4;LAMP2;CLU
alpha,4,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,PRKCE;STK39
alpha,4,dopamine receptor signaling pathway (GO:0007212),4/29,4,29,0.147980637124661,0.588761520217205,0,0,1.93723363037582,3.7014216273069,GNAL;GNAQ;GNB1;ARRB2
alpha,4,tRNA wobble base modification (GO:0002097),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,MOCS3;NAT10
alpha,4,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),4/29,4,29,0.147980637124661,0.588761520217205,0,0,1.93723363037582,3.7014216273069,SEC24B;SEC24A;SAR1B;HLA-B
alpha,4,coenzyme A metabolic process (GO:0015936),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,ACOT7;ACAT1
alpha,4,establishment of protein localization to organelle (GO:0072594),7/63,7,63,0.159501146783911,0.598981336480179,0,0,1.5605493133583,2.86470687720865,NUP214;NXT1;NUP188;NUP155;NUP62;NUP153;RAN
alpha,4,production of miRNAs involved in gene silencing by miRNA (GO:0035196),4/29,4,29,0.147980637124661,0.588761520217205,0,0,1.93723363037582,3.7014216273069,ZCCHC11;SMAD3;AGO2;DROSHA
alpha,4,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,JUN;BAG3
alpha,4,cellular protein catabolic process (GO:0044257),7/63,7,63,0.159501146783911,0.598981336480179,0,0,1.5605493133583,2.86470687720865,CTSA;BNIP3;CLTC;LONP1;DENND3;UBE2G1;CTSV
alpha,4,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),14/145,14,145,0.15149952614042,0.588761520217205,0,0,1.35606354126308,2.55912620549502,SMAD4;JUN;SMAD3;ITGB5;ZFYVE9;BMP8A;ARRB2;FOS;ACVR2B;BMP6;RHOA;TGFBR1;PARD6A;UBB
alpha,4,positive regulation of JUN kinase activity (GO:0043507),6/51,6,51,0.152736332961454,0.588761520217205,0,0,1.65234633179114,3.10482841735102,ERN1;MAP4K2;PAK1;TNIK;MAP3K4;MAP3K5
alpha,4,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),4/29,4,29,0.147980637124661,0.588761520217205,0,0,1.93723363037582,3.7014216273069,HYAL2;FADD;PAK2;DEDD2
alpha,4,protein localization to nucleus (GO:0034504),10/97,10,97,0.151870909052771,0.588761520217205,0,0,1.44793235260049,2.72895343670821,NUP214;NXT1;NUP188;NUP155;ARL2BP;NUP62;NUP153;TAF3;RAN;SKP1
alpha,4,regulation of cell motility (GO:2000145),11/110,11,110,0.15948021351721,0.598981336480179,0,0,1.40449438202247,2.57842053038779,SERPINE2;LDB1;DAPK3;PKN2;RAC1;SGK1;CRK;RHOA;TTBK2;RND1;RHOB
alpha,4,polarized epithelial cell differentiation (GO:0030859),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,SLC9A3R1;RHOA
alpha,4,fatty acid oxidation (GO:0019395),6/51,6,51,0.152736332961454,0.588761520217205,0,0,1.65234633179114,3.10482841735102,HADHB;HADHA;ABCD3;ACAD10;ACADS;ACAT1
alpha,4,translational termination (GO:0006415),10/97,10,97,0.151870909052771,0.588761520217205,0,0,1.44793235260049,2.72895343670821,MRPL2;MRPS16;MRPS27;MRPL37;APEH;ABCE1;MRPS6;MRPL43;DAP3;C12ORF65
alpha,4,circulatory system development (GO:0072359),11/110,11,110,0.15948021351721,0.598981336480179,0,0,1.40449438202247,2.57842053038779,RARG;FLRT3;TCF25;SRF;NF1;ECE1;BCOR;PKD2;BVES;HSPG2;TGFBR1
alpha,4,regulation of podosome assembly (GO:0071801),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,KIF9;FSCN1
alpha,4,double-strand break repair via nonhomologous end joining (GO:0006303),6/51,6,51,0.152736332961454,0.588761520217205,0,0,1.65234633179114,3.10482841735102,PIAS4;BARD1;KAT5;PRKDC;LIG4;PRPF19
alpha,4,Wnt signaling pathway (GO:0016055),11/110,11,110,0.15948021351721,0.598981336480179,0,0,1.40449438202247,2.57842053038779,RARG;DDX3X;UBB;TNKS2;TNKS;RYK;CTNNB1;KLHL12;AXIN2;WNT16;SKP1
alpha,4,intraciliary retrograde transport (GO:0035721),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,TTC21A;WDR35
alpha,4,neurogenesis (GO:0022008),6/51,6,51,0.152736332961454,0.588761520217205,0,0,1.65234633179114,3.10482841735102,ABTB2;RYK;BTBD3;ROGDI;WDR62;DAGLB
alpha,4,positive regulation of circadian rhythm (GO:0042753),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,NLGN1;RORA
alpha,4,negative regulation of protein ubiquitination (GO:0031397),6/51,6,51,0.152736332961454,0.588761520217205,0,0,1.65234633179114,3.10482841735102,TRIM39;CRY1;TNFAIP3;ARRB1;ARRB2;HIPK2
alpha,4,sympathetic ganglion development (GO:0061549),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,CTNNB1;SEMA3F
alpha,4,regulation of G0 to G1 transition (GO:0070316),5/40,5,40,0.152735254062341,0.588761520217205,0,0,1.75561797752809,3.29889259481588,RYBP;MGA;CDC7;BMI1;YAF2
alpha,4,positive regulation of reproductive process (GO:2000243),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,AGO2;LHFPL2
alpha,4,central nervous system projection neuron axonogenesis (GO:0021952),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,SLIT2;PAFAH1B1
alpha,4,virion attachment to host cell (GO:0019062),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,HSP90AB1;CD81
alpha,4,coenzyme biosynthetic process (GO:0009108),4/30,4,30,0.161742661889228,0.604814315468762,0,0,1.87265917602996,3.41151444498334,MOCS3;ACOT7;LIAS;ACAT1
alpha,4,primary miRNA processing (GO:0031053),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,SMAD3;DROSHA
alpha,4,lysosome localization (GO:0032418),4/30,4,30,0.161742661889228,0.604814315468762,0,0,1.87265917602996,3.41151444498334,NR4A3;BLOC1S2;MAP6D1;ARL8B
alpha,4,telomere maintenance in response to DNA damage (GO:0043247),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,ACD;TERF2IP
alpha,4,cortical cytoskeleton organization (GO:0030865),4/30,4,30,0.161742661889228,0.604814315468762,0,0,1.87265917602996,3.41151444498334,IKBKB;NLGN1;RTKN;RHOQ
alpha,4,positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,PAK1;BUD31
alpha,4,vacuolar transport (GO:0007034),4/30,4,30,0.161742661889228,0.604814315468762,0,0,1.87265917602996,3.41151444498334,HGSNAT;VPS13C;VPS41;VPS54
alpha,4,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,RNASEH1;ZC3H12A
alpha,4,regulation of amyloid-beta clearance (GO:1900221),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,SRF;CLU
alpha,4,chloride ion homeostasis (GO:0055064),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,SLC12A2;SLC12A7
alpha,4,regulation of telomere maintenance via telomerase (GO:0032210),6/52,6,52,0.162974327701096,0.60877232929793,0,0,1.62057044079516,2.93997826709036,CCT2;ACD;TNKS2;TNKS;NAT10;MAP3K4
alpha,4,positive regulation of cytoplasmic transport (GO:1903651),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,RDX;PTPN23
alpha,4,negative regulation of oxidative stress-induced neuron death (GO:1903204),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,NR4A3;ATF4
alpha,4,regulation of sequestering of zinc ion (GO:0061088),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,SLC30A5;SLC30A4
alpha,4,ganglion development (GO:0061548),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,CTNNB1;SEMA3F
alpha,4,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),2/10,2,10,0.155942240489962,0.588761520217205,0,0,2.80898876404494,5.2198584088841,SEC14L1;GPATCH3
alpha,4,regulation of cholesterol biosynthetic process (GO:0045540),5/41,5,41,0.164444360184973,0.612960685100932,0,0,1.71279802685667,3.09191388385346,IDI1;SCD;ERLIN1;SCAP;RAN
alpha,4,neuron migration (GO:0001764),5/41,5,41,0.164444360184973,0.612960685100932,0,0,1.71279802685667,3.09191388385346,CDKL5;KIAA0319;MDGA1;PAFAH1B1;CDK5R1
alpha,4,autophagy of nucleus (GO:0044804),3/20,3,20,0.166814170838652,0.614624539305934,0,0,2.10674157303371,3.77291046825817,ATG3;ATG13;ATG2B
alpha,4,cell projection assembly (GO:0030031),3/20,3,20,0.166814170838652,0.614624539305934,0,0,2.10674157303371,3.77291046825817,PARVA;RAC1;RHOQ
alpha,4,mitochondrial RNA metabolic process (GO:0000959),3/20,3,20,0.166814170838652,0.614624539305934,0,0,2.10674157303371,3.77291046825817,SUPV3L1;ELAC2;SLC25A33
alpha,4,calcium ion transmembrane transport (GO:0070588),9/87,9,87,0.165562559848349,0.614624539305934,0,0,1.45292522278187,2.61294965681662,MCUR1;GPRIN1;ATP2A2;CACNA1D;TRPM7;SPG7;PKD2;MICU1;TMCO1
alpha,4,entrainment of circadian clock by photoperiod (GO:0043153),3/20,3,20,0.166814170838652,0.614624539305934,0,0,2.10674157303371,3.77291046825817,BHLHE40;CRY1;FBXL3
alpha,4,regulation of toll-like receptor signaling pathway (GO:0034121),3/20,3,20,0.166814170838652,0.614624539305934,0,0,2.10674157303371,3.77291046825817,LRRC14;TYRO3;BIRC2
alpha,4,organelle disassembly (GO:1903008),3/20,3,20,0.166814170838652,0.614624539305934,0,0,2.10674157303371,3.77291046825817,GOLGA2;KIF9;KIF5B
alpha,4,excitatory postsynaptic potential (GO:0060079),3/20,3,20,0.166814170838652,0.614624539305934,0,0,2.10674157303371,3.77291046825817,MPP2;GPRIN1;ARRB2
alpha,4,negative regulation of cytokine production (GO:0001818),11/111,11,111,0.1664098921415,0.614624539305934,0,0,1.39184127948173,2.49599078200712,HERC5;TBK1;KAT5;RNF216;UBB;TRAF3;ZC3H12A;TNFAIP3;ARRB1;GPATCH3;RAC1
alpha,4,phosphatidylethanolamine metabolic process (GO:0046337),3/20,3,20,0.166814170838652,0.614624539305934,0,0,2.10674157303371,3.77291046825817,CHKA;CEPT1;LPIN2
alpha,4,negative regulation of innate immune response (GO:0045824),3/20,3,20,0.166814170838652,0.614624539305934,0,0,2.10674157303371,3.77291046825817,CNOT7;TYRO3;TNFAIP3
alpha,4,iron ion homeostasis (GO:0055072),7/64,7,64,0.16885828378728,0.621504573311297,0,0,1.53616573033708,2.73237103081492,SMAD4;SLC25A28;TFRC;UBB;FBXL5;BMP6;SKP1
alpha,4,cellular response to organic cyclic compound (GO:0071407),13/136,13,136,0.17099373166815,0.628706032231744,0,0,1.3425313945803,2.37108279709351,ADCY3;RORA;ATP1A1;NR3C1;PKD2;ACTB;RELA;RAP1A;NR4A3;KAT5;ZC3H12A;GNB1;CTNNB1
alpha,4,regulation of defense response (GO:0031347),8/76,8,76,0.172087042801874,0.632064739235723,0,0,1.47841513897102,2.6016482368032,HERC5;TRAF3;OTUD7A;TNFAIP3;BIRC2;RELA;FOXP1;BRD4
alpha,4,positive regulation of secretion by cell (GO:1903532),6/53,6,53,0.173496283687725,0.634730178362879,0,0,1.58999364002544,2.78503142806644,ACHE;GOLPH3;DTNBP1;PPID;BMP6;CLASP2
alpha,4,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,GSKIP;MAP3K5
alpha,4,cellular response to sterol (GO:0036315),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,PTCH1;RORA
alpha,4,Golgi ribbon formation (GO:0090161),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,GOLGA2;GOLPH3
alpha,4,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),4/31,4,31,0.175946500008584,0.634730178362879,0,0,1.81225081551287,3.14892226781149,CKS2;CCNYL1;MAPRE3;PKD2
alpha,4,positive regulation of cell division (GO:0051781),5/42,5,42,0.176496852429642,0.634730178362879,0,0,1.67201712145532,2.90003383498465,SPAST;CUL3;PRKCE;PKN2;RHOA
alpha,4,protein localization to pre-autophagosomal structure (GO:0034497),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,MFN2;ATG13
alpha,4,replication fork processing (GO:0031297),4/31,4,31,0.175946500008584,0.634730178362879,0,0,1.81225081551287,3.14892226781149,MUS81;CDK9;ALYREF;BHLHE40
alpha,4,positive regulation of viral transcription (GO:0050434),5/42,5,42,0.176496852429642,0.634730178362879,0,0,1.67201712145532,2.90003383498465,CDK9;JUN;POLR2A;ZNF639;POLR2H
alpha,4,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000059),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,TRIM39;HIPK2
alpha,4,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),4/31,4,31,0.175946500008584,0.634730178362879,0,0,1.81225081551287,3.14892226781149,KANK1;GORASP1;RHOA;CORO1C
alpha,4,regulation of cholesterol metabolic process (GO:0090181),5/42,5,42,0.176496852429642,0.634730178362879,0,0,1.67201712145532,2.90003383498465,IDI1;ARV1;SCD;SCAP;RAN
alpha,4,regulation of lipid kinase activity (GO:0043550),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,RB1;PPP2R5A
alpha,4,regulation of protein polymerization (GO:0032271),4/31,4,31,0.175946500008584,0.634730178362879,0,0,1.81225081551287,3.14892226781149,LATS1;FCHSD2;RASA1;CAMSAP1
alpha,4,negative regulation of ion transmembrane transporter activity (GO:0032413),3/21,3,21,0.184963497941176,0.638024234801996,0,0,2.00642054574639,3.3860288559345,CAB39;PRKCE;STK39
alpha,4,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,CCT2;GNL3
alpha,4,artery morphogenesis (GO:0048844),4/31,4,31,0.175946500008584,0.634730178362879,0,0,1.81225081551287,3.14892226781149,HEY2;NF1;PKD2;TGFBR1
alpha,4,regulation of ruffle assembly (GO:1900027),3/21,3,21,0.184963497941176,0.638024234801996,0,0,2.00642054574639,3.3860288559345,KANK1;NLGN1;RDX
alpha,4,negative regulation of morphogenesis of an epithelium (GO:1905331),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,PHLDB2;CLASP2
alpha,4,regulation of ARF protein signal transduction (GO:0032012),4/31,4,31,0.175946500008584,0.634730178362879,0,0,1.81225081551287,3.14892226781149,ACAP3;ASAP2;GIT1;AGFG1
alpha,4,glutamate metabolic process (GO:0006536),3/21,3,21,0.184963497941176,0.638024234801996,0,0,2.00642054574639,3.3860288559345,GCLC;GOT1;GCLM
alpha,4,regulation of mRNA polyadenylation (GO:1900363),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,CDK9;RNF20
alpha,4,regulation of cation transmembrane transport (GO:1904062),4/31,4,31,0.175946500008584,0.634730178362879,0,0,1.81225081551287,3.14892226781149,HOMER1;SLMAP;PPIF;CACNA1D
alpha,4,photoperiodism (GO:0009648),3/21,3,21,0.184963497941176,0.638024234801996,0,0,2.00642054574639,3.3860288559345,BHLHE40;CRY1;FBXL3
alpha,4,midbrain dopaminergic neuron differentiation (GO:1904948),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,RYK;CTNNB1
alpha,4,protein palmitoylation (GO:0018345),4/31,4,31,0.175946500008584,0.634730178362879,0,0,1.81225081551287,3.14892226781149,ZDHHC18;ZDHHC9;ABHD17C;ZDHHC2
alpha,4,positive regulation of receptor internalization (GO:0002092),3/21,3,21,0.184963497941176,0.638024234801996,0,0,2.00642054574639,3.3860288559345,TBC1D5;ARRB1;ARRB2
alpha,4,epithelial cell-cell adhesion (GO:0090136),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,ITGB5;BVES
alpha,4,positive regulation of transferase activity (GO:0051347),13/138,13,138,0.184022979854367,0.638024234801996,0,0,1.32307441784726,2.23956097363621,CCT2;ACD;UBE2I;HSP90AB1;FBXW7;TNKS;RFC2;RYK;LMTK2;BMI1;IGF1R;TYRO3;MAP3K4
alpha,4,multivesicular body assembly (GO:0036258),4/31,4,31,0.175946500008584,0.634730178362879,0,0,1.81225081551287,3.14892226781149,PDCD6IP;IST1;VPS37A;STAM
alpha,4,mitochondrial calcium ion transmembrane transport (GO:0006851),3/21,3,21,0.184963497941176,0.638024234801996,0,0,2.00642054574639,3.3860288559345,MCUR1;SPG7;MICU1
alpha,4,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,PKD2;CALM2
alpha,4,beta-catenin-TCF complex assembly (GO:1904837),4/31,4,31,0.175946500008584,0.634730178362879,0,0,1.81225081551287,3.14892226781149,KAT5;CTNNB1;AXIN2;BCL9L
alpha,4,protein O-linked glycosylation via threonine (GO:0018243),3/21,3,21,0.184963497941176,0.638024234801996,0,0,2.00642054574639,3.3860288559345,GALNT16;GALNT2;GALNT10
alpha,4,cyclooxygenase pathway (GO:0019371),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,PTGES2;TBXAS1
alpha,4,smoothened signaling pathway (GO:0007224),4/31,4,31,0.175946500008584,0.634730178362879,0,0,1.81225081551287,3.14892226781149,KIAA0586;PTCH1;GLI3;TTBK2
alpha,4,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),3/21,3,21,0.184963497941176,0.638024234801996,0,0,2.00642054574639,3.3860288559345,MSH2;CDIP1;HIPK2
alpha,4,carbohydrate phosphorylation (GO:0046835),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,GNPTG;RBKS
alpha,4,positive regulation of protein polymerization (GO:0032273),7/65,7,65,0.178449518191436,0.634730178362879,0,0,1.51253241140882,2.60677327206025,CLIP1;PAK1;PRKCE;CDC42EP4;RAC1;BAIAP2;CDK5R1
alpha,4,histone lysine demethylation (GO:0070076),3/21,3,21,0.184963497941176,0.638024234801996,0,0,2.00642054574639,3.3860288559345,KDM6B;KDM5B;JMJD1C
alpha,4,negative regulation of T cell differentiation (GO:0045581),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,FOXJ1;GLI3
alpha,4,positive regulation of transcription from RNA polymerase I promoter (GO:0045943),3/21,3,21,0.184963497941176,0.638024234801996,0,0,2.00642054574639,3.3860288559345,UTP15;NCL;ATF4
alpha,4,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,TAF9;TRIAP1
alpha,4,arginine metabolic process (GO:0006525),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,NOS3;ASS1
alpha,4,negative regulation of potassium ion transport (GO:0043267),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,CAB39;STK39
alpha,4,cell part morphogenesis (GO:0032990),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,SUPV3L1;MFF
alpha,4,positive regulation of fatty acid biosynthetic process (GO:0045723),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,LPGAT1;ELOVL5
alpha,4,icosanoid biosynthetic process (GO:0046456),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,LTA4H;FADS1
alpha,4,negative regulation of receptor binding (GO:1900121),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,ADAM15;PTPRF
alpha,4,response to sterol (GO:0036314),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,RORA;TGFBR1
alpha,4,cellular response to calcium ion (GO:0071277),5/43,5,43,0.188870902629581,0.649562321925097,0,0,1.63313300235171,2.72192897860709,NLGN1;PPIF;BRAF;PKD2;ADD1
alpha,4,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,CNOT7;AGO2
alpha,4,regulation of vesicle-mediated transport (GO:0060627),13/139,13,139,0.190710758528222,0.649562321925097,0,0,1.31355589685555,2.17655864277091,MAP2K1;RALA;HIP1;GRTP1;HIP1R;TBC1D9;DNAJC13;TBC1D1;TBC1D5;TBC1D30;SGSM2;RUNDC1;TBC1D12
alpha,4,ceramide metabolic process (GO:0006672),5/43,5,43,0.188870902629581,0.649562321925097,0,0,1.63313300235171,2.72192897860709,SMPD2;ASAH1;SGMS1;ALOXE3;CLN6
alpha,4,sphingolipid catabolic process (GO:0030149),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,SMPD2;SPHK1
alpha,4,response to cytokine (GO:0034097),13/139,13,139,0.190710758528222,0.649562321925097,0,0,1.31355589685555,2.17655864277091,JUN;SETD2;SMAD3;SRF;TAF9;PTPN23;RELA;NFKB2;CDK9;TBK1;DPYSL3;MAPKAPK2;MAP4K3
alpha,4,regulation of telomerase activity (GO:0051972),5/43,5,43,0.188870902629581,0.649562321925097,0,0,1.63313300235171,2.72192897860709,CCT2;ACD;HSP90AB1;TNKS;MAP3K4
alpha,4,negative regulation of toll-like receptor signaling pathway (GO:0034122),4/32,4,32,0.190553922665042,0.649562321925097,0,0,1.75561797752809,2.91049871113021,LRRC14;SARM1;TYRO3;TNFAIP3
alpha,4,stress granule assembly (GO:0034063),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,DDX3X;CIRBP
alpha,4,positive regulation of bone mineralization (GO:0030501),4/32,4,32,0.190553922665042,0.649562321925097,0,0,1.75561797752809,2.91049871113021,TFAP2A;KL;ACVR2B;BMP6
alpha,4,regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,PPIL4;BRD4
alpha,4,positive regulation of viral genome replication (GO:0045070),4/32,4,32,0.190553922665042,0.649562321925097,0,0,1.75561797752809,2.91049871113021,DDX3X;CNOT7;PKN2;PPID
alpha,4,lymphocyte mediated immunity (GO:0002449),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,MSH2;GNL1
alpha,4,multivesicular body organization (GO:0036257),4/32,4,32,0.190553922665042,0.649562321925097,0,0,1.75561797752809,2.91049871113021,PDCD6IP;IST1;VPS37A;STAM
alpha,4,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,DDIT3;ATF4
alpha,4,anterograde axonal transport (GO:0008089),4/32,4,32,0.190553922665042,0.649562321925097,0,0,1.75561797752809,2.91049871113021,SPAST;BLOC1S2;DTNBP1;HSPB1
alpha,4,regulation of actin filament depolymerization (GO:0030834),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,LIMA1;PLEKHH2
alpha,4,regulation of protein export from nucleus (GO:0046825),4/32,4,32,0.190553922665042,0.649562321925097,0,0,1.75561797752809,2.91049871113021,BARD1;SETD2;XPO4;BAG3
alpha,4,calcineurin-NFAT signaling cascade (GO:0033173),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,NFAT5;NFATC3
alpha,4,organelle transport along microtubule (GO:0072384),4/32,4,32,0.190553922665042,0.649562321925097,0,0,1.75561797752809,2.91049871113021,ARHGAP21;UBB;KIF5B;PAFAH1B1
alpha,4,regulation of lipid metabolic process (GO:0019216),10/101,10,101,0.181622028283025,0.634730178362879,0,0,1.39058849705195,2.37210412595026,RB1;NCOA1;ALAS1;ACSL1;CHD9;TXNRD1;PSAP;RORA;TBL1X;FADS1
alpha,4,T-helper cell differentiation (GO:0042093),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,RORA;FOXP1
alpha,4,regulation of dendritic spine development (GO:0060998),4/32,4,32,0.190553922665042,0.649562321925097,0,0,1.75561797752809,2.91049871113021,NLGN1;ARC;CFL1;CDK5R1
alpha,4,cellular response to metal ion (GO:0071248),10/101,10,101,0.181622028283025,0.634730178362879,0,0,1.39058849705195,2.37210412595026,TFAP2A;JUN;NLGN1;BNIP3;PPIF;BRAF;FOS;PKD2;BMP6;ADD1
alpha,4,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),2/11,2,11,0.182022196241759,0.634730178362879,0,0,2.55362614913177,4.35042554129018,CNOT7;AGO2
alpha,4,G2/M transition of mitotic cell cycle (GO:0000086),12/127,12,127,0.193264245411072,0.657622287144163,0,0,1.32708130584801,2.18131940099578,LATS1;CDKN2B;UBB;ODF2;SSNA1;HAUS3;TUBB4B;CKAP5;TUBA4A;HAUS2;SKP1;PAFAH1B1
alpha,4,membrane fusion (GO:0061025),6/55,6,55,0.195336177458178,0.663388080932847,0,0,1.53217568947906,2.50209379644505,NAPA;VPS41;MFN2;USP30;PLD6;MFF
alpha,4,cytoplasmic translation (GO:0002181),6/55,6,55,0.195336177458178,0.663388080932847,0,0,1.53217568947906,2.50209379644505,MRPL2;RPLP0;EIF4H;RPL9;RPL39;EIF4B
alpha,4,pre-mRNA cleavage required for polyadenylation (GO:0098789),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,CPSF6;NCBP2
alpha,4,regulation of histone methylation (GO:0031060),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,NSD1;ZNF335
alpha,4,entry of bacterium into host cell (GO:0035635),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,UBB;CTNNB1
alpha,4,iron ion transport (GO:0006826),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,SLC25A28;TFRC
alpha,4,pentose-phosphate shunt (GO:0006098),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,PGLS;RBKS
alpha,4,positive regulation of lyase activity (GO:0051349),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,NOS3;NF1
alpha,4,rRNA 3'-end processing (GO:0031125),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,EXOSC6;EXOSC3
alpha,4,microtubule anchoring (GO:0034453),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,BCCIP;CLASP2
alpha,4,calcineurin-mediated signaling (GO:0097720),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,NFAT5;NFATC3
alpha,4,sphingolipid biosynthetic process (GO:0030148),7/67,7,67,0.198294623988629,0.664377391243435,0,0,1.46738219017273,2.37422637100446,SMPD2;SGMS1;ELOVL5;PRKD3;SPHK1;ALOXE3;SGPP1
alpha,4,positive regulation of neuron migration (GO:2001224),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,ZNF609;PLAA
alpha,4,protein tetramerization (GO:0051262),9/91,9,91,0.198729247190955,0.664377391243435,0,0,1.38906037782442,2.24446035435532,GOLGA2;CPSF6;ANXA2;GPRIN1;PKD2;CUTC;IGF1R;S100A10;FARSB
alpha,4,DNA deamination (GO:0045006),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,EXOSC6;EXOSC3
alpha,4,positive regulation of mRNA metabolic process (GO:1903313),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,CNOT7;ZC3H12A
alpha,4,regulation of cellular response to heat (GO:1900034),8/79,8,79,0.19916899523975,0.664377391243435,0,0,1.42227279192149,2.29498164177584,NUP214;HSP90AB1;NUP188;NUP155;BAG3;NUP62;MAPKAPK2;NUP153
alpha,4,plasma membrane tubulation (GO:0097320),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,SNX9;WHAMM
alpha,4,positive regulation of cyclase activity (GO:0031281),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,NOS3;NF1
alpha,4,PERK-mediated unfolded protein response (GO:0036499),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,DDIT3;ATF4
alpha,4,positive regulation of peptidase activity (GO:0010952),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,PRELID1;KARS
alpha,4,regulation of mononuclear cell migration (GO:0071675),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,KARS;SLIT2
alpha,4,kinetochore organization (GO:0051383),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,CENPW;POGZ
alpha,4,cell cycle G2/M phase transition (GO:0044839),12/128,12,128,0.200448093819425,0.664377391243435,0,0,1.31671348314607,2.11622184354633,LATS1;CDKN2B;UBB;ODF2;SSNA1;HAUS3;TUBB4B;CKAP5;TUBA4A;HAUS2;SKP1;PAFAH1B1
alpha,4,cytoplasmic translational initiation (GO:0002183),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,EIF4H;EIF4B
alpha,4,cellular response to fluid shear stress (GO:0071498),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,PKD2;ASS1
alpha,4,cargo loading into COPII-coated vesicle (GO:0090110),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,SEC24B;SEC24A
alpha,4,positive regulation of angiogenesis (GO:0045766),10/104,10,104,0.205546124155115,0.664377391243435,0,0,1.3504753673293,2.13656658084925,NOS3;SPHK1;ZC3H12A;AGO2;HSPB1;PLCG1;ETS1;MTDH;RHOB;HIPK2
alpha,4,negative regulation by host of viral transcription (GO:0043922),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,JUN;ZNF639
alpha,4,ceramide biosynthetic process (GO:0046513),4/33,4,33,0.205526209063495,0.664377391243435,0,0,1.70241743275451,2.69353373366744,SMPD2;SGMS1;B4GALT6;ALOXE3
alpha,4,nucleobase-containing compound catabolic process (GO:0034655),5/44,5,44,0.201544017486199,0.664377391243435,0,0,1.59601634320735,2.55641514362375,TATDN3;SUPV3L1;RNASEH1;ENTPD5;PABPC4
alpha,4,regulation of establishment of endothelial barrier (GO:1903140),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,IKBKB;ADD1
alpha,4,7-methylguanosine mRNA capping (GO:0006370),4/33,4,33,0.205526209063495,0.664377391243435,0,0,1.70241743275451,2.69353373366744,POLR2A;NCBP2;FAM103A1;POLR2H
alpha,4,substantia nigra development (GO:0021762),5/44,5,44,0.201544017486199,0.664377391243435,0,0,1.59601634320735,2.55641514362375,SUDS3;ATP5F1;CALM2;ACTB;RHOA
alpha,4,somatic hypermutation of immunoglobulin genes (GO:0016446),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,MSH2;PMS2
alpha,4,protein deacetylation (GO:0006476),4/33,4,33,0.205526209063495,0.664377391243435,0,0,1.70241743275451,2.69353373366744,BRMS1;SIRT5;SUDS3;TBL1X
alpha,4,protein O-linked glycosylation via serine (GO:0018242),3/22,3,22,0.203596536409783,0.664377391243435,0,0,1.91521961184883,3.04829227436843,GALNT16;GALNT2;GALNT10
alpha,4,negative regulation of DNA metabolic process (GO:0051053),5/44,5,44,0.201544017486199,0.664377391243435,0,0,1.59601634320735,2.55641514362375,CDAN1;MSH2;RAD17;TERF2IP;PDS5A
alpha,4,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,KANK1;CORO1C
alpha,4,mismatch repair (GO:0006298),4/33,4,33,0.205526209063495,0.664377391243435,0,0,1.70241743275451,2.69353373366744,SETD2;MSH2;PMS2;MLH3
alpha,4,STAT cascade (GO:0097696),3/22,3,22,0.203596536409783,0.664377391243435,0,0,1.91521961184883,3.04829227436843,SOCS2;STAT5B;PKD2
alpha,4,response to axon injury (GO:0048678),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,FLRT3;DPYSL3
alpha,4,positive regulation of telomere maintenance (GO:0032206),4/33,4,33,0.205526209063495,0.664377391243435,0,0,1.70241743275451,2.69353373366744,TNKS2;TNKS;MAP3K4;GNL3
alpha,4,rRNA modification (GO:0000154),3/22,3,22,0.203596536409783,0.664377391243435,0,0,1.91521961184883,3.04829227436843,NOP56;TSR3;NAT10
alpha,4,fat cell differentiation (GO:0045444),6/56,6,56,0.20662476862032,0.664377391243435,0,0,1.50481540930979,2.37286944619749,NR4A1;NR4A3;CTBP2;BBS9;ATF5;ALOXE3
alpha,4,mitochondrion transport along microtubule (GO:0047497),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,SPAST;UBB
alpha,4,positive regulation of T cell differentiation (GO:0045582),4/33,4,33,0.205526209063495,0.664377391243435,0,0,1.70241743275451,2.69353373366744,ZMIZ1;ZBTB1;TNFSF9;GLI3
alpha,4,embryonic skeletal system morphogenesis (GO:0048704),3/22,3,22,0.203596536409783,0.664377391243435,0,0,1.91521961184883,3.04829227436843,TFAP2A;EIF4A3;TGFBR1
alpha,4,regulation of small GTPase mediated signal transduction (GO:0051056),13/141,13,141,0.204419192115077,0.664377391243435,0,0,1.29492389831859,2.05579855887358,ARHGEF12;FAM13B;ARHGAP29;RHOA;RHOB;NET1;ARHGAP21;ARHGAP10;NUP62;RAC1;SLIT2;SOS1;RHOQ
alpha,4,regulation of protein catabolic process (GO:0042176),9/92,9,92,0.207430293541722,0.664377391243435,0,0,1.37396189545677,2.16118700757192,CTSA;BARD1;VCP;FAF1;ODC1;TNFAIP3;FAM83D;DACT1;ANAPC2
alpha,4,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,TAF9;TRIAP1
alpha,4,ribosomal small subunit biogenesis (GO:0042274),5/45,5,45,0.214493190573618,0.680454480926234,0,0,1.5605493133583,2.40243022268337,LTV1;NPM1;LSM6;TSR3;RIOK1
alpha,4,endodermal cell differentiation (GO:0035987),4/33,4,33,0.205526209063495,0.664377391243435,0,0,1.70241743275451,2.69353373366744,VTN;SETD2;ITGB5;FN1
alpha,4,cytosolic calcium ion transport (GO:0060401),3/22,3,22,0.203596536409783,0.664377391243435,0,0,1.91521961184883,3.04829227436843,MCUR1;ATP2A2;MICU1
alpha,4,negative regulation of kinase activity (GO:0033673),9/92,9,92,0.207430293541722,0.664377391243435,0,0,1.37396189545677,2.16118700757192,RB1;SOCS2;CISH;FLRT3;GNAQ;NF1;HSPB1;PPP2R5A;PAK2
alpha,4,ribose phosphate metabolic process (GO:0019693),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,PGLS;RBKS
alpha,4,metaphase plate congression (GO:0051310),5/45,5,45,0.214493190573618,0.680454480926234,0,0,1.5605493133583,2.40243022268337,CUL3;NUP62;SPICE1;FAM83D;GEM
alpha,4,positive regulation of TOR signaling (GO:0032008),4/33,4,33,0.205526209063495,0.664377391243435,0,0,1.70241743275451,2.69353373366744,RRAGA;GOLPH3;MIOS;PIK3CA
alpha,4,"DNA catabolic process, endonucleolytic (GO:0000737)",3/22,3,22,0.203596536409783,0.664377391243435,0,0,1.91521961184883,3.04829227436843,MUS81;ENDOG;KPNA1
alpha,4,positive regulation of cellular protein metabolic process (GO:0032270),9/92,9,92,0.207430293541722,0.664377391243435,0,0,1.37396189545677,2.16118700757192,NPM1;DDX3X;IST1;EIF4A3;RDX;CIRBP;FADD;CLN6;DACT1
alpha,4,regulation of DNA-dependent DNA replication (GO:0090329),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,TIPIN;BMP6
alpha,4,mitotic nuclear envelope disassembly (GO:0007077),5/45,5,45,0.214493190573618,0.680454480926234,0,0,1.5605493133583,2.40243022268337,NUP214;NUP188;NUP155;NUP62;NUP153
alpha,4,phagosome maturation (GO:0090382),4/33,4,33,0.205526209063495,0.664377391243435,0,0,1.70241743275451,2.69353373366744,ATP6V0B;ATP6V1E2;ATP6V0C;ATP6V1C1
alpha,4,negative regulation of cell cycle G1/S phase transition (GO:1902807),3/22,3,22,0.203596536409783,0.664377391243435,0,0,1.91521961184883,3.04829227436843,RB1;PKD2;DACT1
alpha,4,peptidyl-lysine modification (GO:0018205),11/116,11,116,0.203163642398935,0.664377391243435,0,0,1.33184812088338,2.12262429162367,NUP214;PIAS4;UBE2I;SENP5;NUP188;ESCO1;NUP155;NUP62;SIRT5;NUP153;LIAS
alpha,4,positive regulation of transport (GO:0051050),5/45,5,45,0.214493190573618,0.680454480926234,0,0,1.5605493133583,2.40243022268337,NR4A3;ANXA2;BRAF;ACSL3;SGK1
alpha,4,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,PKD2;CALM2
alpha,4,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),4/33,4,33,0.205526209063495,0.664377391243435,0,0,1.70241743275451,2.69353373366744,ARFGEF2;FADD;CLU;RASGRP1
alpha,4,peptidyl-L-cysteine S-palmitoylation (GO:0018230),3/22,3,22,0.203596536409783,0.664377391243435,0,0,1.91521961184883,3.04829227436843,ZDHHC18;ZDHHC9;ZDHHC2
alpha,4,pulmonary valve morphogenesis (GO:0003184),2/12,2,12,0.208669314347867,0.664377391243435,0,0,2.34082397003745,3.66808171362967,HEY1;HEY2
alpha,4,regulation of protein localization to plasma membrane (GO:1903076),7/68,7,68,0.20852760334369,0.664377391243435,0,0,1.44580304031725,2.26656208579382,CNPY4;KIF5B;PRKCE;CLTC;PPFIA1;PPP2R5A;RHOQ
alpha,4,7-methylguanosine RNA capping (GO:0009452),4/33,4,33,0.205526209063495,0.664377391243435,0,0,1.70241743275451,2.69353373366744,POLR2A;NCBP2;FAM103A1;POLR2H
alpha,4,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),3/22,3,22,0.203596536409783,0.664377391243435,0,0,1.91521961184883,3.04829227436843,ZDHHC18;ZDHHC9;ZDHHC2
alpha,4,regulation of TOR signaling (GO:0032006),7/68,7,68,0.20852760334369,0.664377391243435,0,0,1.44580304031725,2.26656208579382,RRAGA;GOLPH3;MIOS;PIK3CA;TBC1D7;GNA12;FAM83D
alpha,4,microtubule bundle formation (GO:0001578),4/33,4,33,0.205526209063495,0.664377391243435,0,0,1.70241743275451,2.69353373366744,CLIP1;SPAST;NCKAP5L;RSPH9
alpha,4,cellular iron ion homeostasis (GO:0006879),6/57,6,57,0.218138789486544,0.690772833374056,0,0,1.47841513897102,2.25107003215142,SMAD4;TFRC;UBB;FBXL5;BMP6;SKP1
alpha,4,organonitrogen compound catabolic process (GO:1901565),6/57,6,57,0.218138789486544,0.690772833374056,0,0,1.47841513897102,2.25107003215142,SMPD2;LRSAM1;RNPEPL1;TPP1;LTA4H;CLN6
alpha,4,protein glycosylation (GO:0006486),12/131,12,131,0.222687199828902,0.690860995056124,0,0,1.28655973925723,1.93239623925466,GOLGA2;DPM1;B3GALNT2;RPN2;TNKS2;TNKS;GALNT2;ENTPD5;MOGS;DOLK;GALNT10;ST3GAL2
alpha,4,protein localization to cell periphery (GO:1990778),11/118,11,118,0.218776696325951,0.690860995056124,0,0,1.30927442391925,1.98970921363535,IKBKB;SLC9A3R1;PACS1;PTCH1;SLMAP;RDX;FCHO2;ATP1B3;TNIK;S100A10;CLASP2
alpha,4,positive regulation of mRNA catabolic process (GO:0061014),3/23,3,23,0.222635011273079,0.690860995056124,0,0,1.83194919394235,2.75199359274778,CNOT7;ZC3H12A;AGO2
alpha,4,positive regulation of protein oligomerization (GO:0032461),3/23,3,23,0.222635011273079,0.690860995056124,0,0,1.83194919394235,2.75199359274778,MIEF2;SNX9;CLU
alpha,4,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),3/23,3,23,0.222635011273079,0.690860995056124,0,0,1.83194919394235,2.75199359274778,CDK9;ZMYND11;BRD4
alpha,4,melanosome organization (GO:0032438),3/23,3,23,0.222635011273079,0.690860995056124,0,0,1.83194919394235,2.75199359274778,BLOC1S2;KIF13A;DTNBP1
alpha,4,cellular response to catecholamine stimulus (GO:0071870),3/23,3,23,0.222635011273079,0.690860995056124,0,0,1.83194919394235,2.75199359274778,NR4A3;GNB1;ATF4
alpha,4,viral budding (GO:0046755),3/23,3,23,0.222635011273079,0.690860995056124,0,0,1.83194919394235,2.75199359274778,LRSAM1;PDCD6IP;VPS37A
alpha,4,negative regulation of transcription factor import into nucleus (GO:0042992),3/23,3,23,0.222635011273079,0.690860995056124,0,0,1.83194919394235,2.75199359274778,ZC3H12A;NF1;PKD2
alpha,4,positive regulation of adenylate cyclase activity (GO:0045762),4/34,4,34,0.220824456877025,0.690860995056124,0,0,1.65234633179114,2.49568275920616,GNAL;NF1;ADCY3;CAP2
alpha,4,histone H3-K4 methylation (GO:0051568),3/23,3,23,0.222635011273079,0.690860995056124,0,0,1.83194919394235,2.75199359274778,SETD1B;ZNF335;KDM6A
alpha,4,positive regulation of biomineral tissue development (GO:0070169),4/34,4,34,0.220824456877025,0.690860995056124,0,0,1.65234633179114,2.49568275920616,TFAP2A;KL;ACVR2B;BMP6
alpha,4,protein localization to Golgi apparatus (GO:0034067),3/23,3,23,0.222635011273079,0.690860995056124,0,0,1.83194919394235,2.75199359274778,ARFRP1;GOLPH3;VPS13C
alpha,4,platelet aggregation (GO:0070527),4/34,4,34,0.220824456877025,0.690860995056124,0,0,1.65234633179114,2.49568275920616,TYRO3;HSPB1;PIK3CB;ACTB
alpha,4,regulation of smooth muscle contraction (GO:0006940),3/23,3,23,0.222635011273079,0.690860995056124,0,0,1.83194919394235,2.75199359274778,SPHK1;SRF;DAPK3
alpha,4,oligosaccharide biosynthetic process (GO:0009312),4/34,4,34,0.220824456877025,0.690860995056124,0,0,1.65234633179114,2.49568275920616,GALNT16;GALNT2;GALNT10;ST3GAL2
alpha,4,metanephros development (GO:0001656),3/23,3,23,0.222635011273079,0.690860995056124,0,0,1.83194919394235,2.75199359274778,FOXD1;NF1;PKD2
alpha,4,protein K48-linked deubiquitination (GO:0071108),3/23,3,23,0.222635011273079,0.690860995056124,0,0,1.83194919394235,2.75199359274778,OTUD7A;TNFAIP3;OTUD3
alpha,4,lamellipodium assembly (GO:0030032),3/23,3,23,0.222635011273079,0.690860995056124,0,0,1.83194919394235,2.75199359274778,GOLPH3;WHAMM;RAC1
alpha,4,cellular transition metal ion homeostasis (GO:0046916),9/94,9,94,0.22527975456916,0.69828777540617,0,0,1.34472866363854,2.00420013434576,SMAD4;TFRC;UBB;SLC30A5;SLC39A13;SLC39A7;FBXL5;BMP6;SKP1
alpha,4,regulation of telomere capping (GO:1904353),3/23,3,23,0.222635011273079,0.690860995056124,0,0,1.83194919394235,2.75199359274778,TNKS2;TNKS;MAP3K4
alpha,4,translational elongation (GO:0006414),10/106,10,106,0.222191116540357,0.690860995056124,0,0,1.3249947000212,1.99308005901813,MRPL2;MRPS16;MRPS27;EEF1D;MRPL37;GTPBP2;MRPS6;MRPL43;DAP3;C12ORF65
alpha,4,glycolytic process (GO:0006096),3/23,3,23,0.222635011273079,0.690860995056124,0,0,1.83194919394235,2.75199359274778,TPI1;PGAM1;PGM1
alpha,4,protein localization to cilium (GO:0061512),3/23,3,23,0.222635011273079,0.690860995056124,0,0,1.83194919394235,2.75199359274778,TTC21A;BBS9;WDR35
alpha,4,positive regulation of protein targeting to mitochondrion (GO:1903955),8/82,8,82,0.227844138810002,0.703754084285726,0,0,1.37023842148534,2.02671072280132,CYB5R1;FBXW7;STARD7;FAM20B;MICALL2;DPH6;ATG13;ZBED3
alpha,4,negative regulation of cell cycle process (GO:0010948),8/82,8,82,0.227844138810002,0.703754084285726,0,0,1.37023842148534,2.02671072280132,CDK9;HSP90AB1;RYBP;FBXW7;MGA;CDC7;BMI1;YAF2
alpha,4,metal ion homeostasis (GO:0055065),5/46,5,46,0.227695047021841,0.703754084285726,0,0,1.5266243282853,2.25901938562343,SLC12A2;GPRIN1;COX11;SLC12A7;LETM2
alpha,4,mitochondrial gene expression (GO:0140053),5/46,5,46,0.227695047021841,0.703754084285726,0,0,1.5266243282853,2.25901938562343,MRPL2;MRPS16;GATC;MRPS6;SLC25A33
alpha,4,positive regulation of exocytosis (GO:0045921),4/35,4,35,0.236409863119777,0.706015861398486,0,0,1.60513643659711,2.31490894407008,SDCBP;PDCD6IP;STAM;CLASP2
alpha,4,negative regulation of cellular metabolic process (GO:0031324),4/35,4,35,0.236409863119777,0.706015861398486,0,0,1.60513643659711,2.31490894407008,TFAP2A;SDCBP;SIRT5;AATF
alpha,4,tRNA modification (GO:0006400),6/58,6,58,0.229862532036763,0.706015861398486,0,0,1.45292522278187,2.1361979400546,MOCS3;OSGEPL1;WDR4;NAT10;PUSL1;TARBP1
alpha,4,response to glucagon (GO:0033762),4/35,4,35,0.236409863119777,0.706015861398486,0,0,1.60513643659711,2.31490894407008,GNG5;GNB1;CRY1;ADCY3
alpha,4,cellular respiration (GO:0045333),6/58,6,58,0.229862532036763,0.706015861398486,0,0,1.45292522278187,2.1361979400546,SURF1;NR4A3;COX15;SDHA;COQ10A;UQCRH
alpha,4,positive regulation of actin nucleation (GO:0051127),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,WHAMM;WASF1
alpha,4,negative regulation of endothelial cell migration (GO:0010596),4/35,4,35,0.236409863119777,0.706015861398486,0,0,1.60513643659711,2.31490894407008,DLL4;MECP2;KRIT1;SLIT2
alpha,4,sodium ion export (GO:0071436),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,ATP1B3;ATP1A1
alpha,4,regulation of alcohol biosynthetic process (GO:1902930),4/35,4,35,0.236409863119777,0.706015861398486,0,0,1.60513643659711,2.31490894407008,IDI1;SCD;SCAP;RAN
alpha,4,regulation of DNA-templated transcription in response to stress (GO:0043620),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,DDIT3;RELA
alpha,4,positive regulation of cellular component organization (GO:0051130),10/107,10,107,0.230706490200485,0.706015861398486,0,0,1.31261157198362,1.92508792076584,VCP;NLGN1;SRPX2;FAF1;BNIP3;PTPN23;TGFBR1;ADD1;IGF1R;ANAPC2
alpha,4,bone development (GO:0060348),4/35,4,35,0.236409863119777,0.706015861398486,0,0,1.60513643659711,2.31490894407008,TFAP2A;RARG;SBDS;DYM
alpha,4,"retrograde transport, endosome to Golgi (GO:0042147)",8/83,8,83,0.237717537045989,0.708716830124386,0,0,1.35372952484094,1.94486547891257,ARFRP1;HEATR5B;TBC1D5;TRAPPC10;CLTC;SGSM2;VPS54;DENND5A
alpha,4,"Notch receptor processing, ligand-dependent (GO:0035333)",2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,JAG2;DLL4
alpha,4,negative regulation of DNA binding (GO:0043392),4/35,4,35,0.236409863119777,0.706015861398486,0,0,1.60513643659711,2.31490894407008,JUN;HEY1;TNKS;HEY2
alpha,4,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",8/83,8,83,0.237717537045989,0.708716830124386,0,0,1.35372952484094,1.94486547891257,NPM1;CNOT7;KAT5;UBB;USP10;CNOT11;TRIAP1;HIPK2
alpha,4,sodium ion export from cell (GO:0036376),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,ATP1B3;ATP1A1
alpha,4,regulation of interleukin-1 beta production (GO:0032651),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,HSPB1;FOXP1
alpha,4,response to iron ion (GO:0010039),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,TFAP2A;BMP6
alpha,4,cellular response to nitrogen levels (GO:0043562),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,MAP1LC3A;GABARAP
alpha,4,endothelial cell differentiation (GO:0045446),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,KDM6B;ACVR2B
alpha,4,regulation of protein secretion (GO:0050708),10/108,10,108,0.239343026668253,0.712354562861058,0,0,1.30045776113192,1.85946928061641,ACHE;DNAJC1;GOLPH3;RAP1A;ARL2BP;CACNA2D2;CACNA1D;SERGEF;PPID;BMP6
alpha,4,regulation of fatty acid oxidation (GO:0046320),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,NR4A3;TYSND1
alpha,4,positive regulation of cell cycle process (GO:0090068),10/108,10,108,0.239343026668253,0.712354562861058,0,0,1.30045776113192,1.85946928061641,GEN1;SPAST;PRKCE;CUL3;NUP62;CDC7;PKN2;INO80;PKD2;RHOA
alpha,4,diacylglycerol metabolic process (GO:0046339),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,DAGLB;DGKZ
alpha,4,RNA interference (GO:0016246),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,AGO2;DROSHA
alpha,4,tRNA aminoacylation for protein translation (GO:0006418),5/47,5,47,0.241125980237948,0.713432508869012,0,0,1.49414295959837,2.125322350131,AIMP2;VARS;KARS;GARS;FARSB
alpha,4,positive regulation of lamellipodium assembly (GO:0010592),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,FSCN1;RAC1
alpha,4,nuclear envelope disassembly (GO:0051081),5/47,5,47,0.241125980237948,0.713432508869012,0,0,1.49414295959837,2.125322350131,NUP214;NUP188;NUP155;NUP62;NUP153
alpha,4,receptor metabolic process (GO:0043112),6/59,6,59,0.241780013296393,0.714165333392286,0,0,1.42829937154828,2.02779518503313,ARFGEF2;TFRC;CD81;CLTC;LMTK2;ARRB2
alpha,4,cranial nerve development (GO:0021545),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,TFAP2A;CHD7
alpha,4,ammonium transport (GO:0015696),3/24,3,24,0.242003458965962,0.714225153875194,0,0,1.75561797752809,2.49087650926935,SLC12A2;SEC14L1;RHCE
alpha,4,protein methylation (GO:0006479),5/47,5,47,0.241125980237948,0.713432508869012,0,0,1.49414295959837,2.125322350131,PCMT1;KIN;VCP;NTMT1;NSD1
alpha,4,phospholipid transport (GO:0015914),6/59,6,59,0.241780013296393,0.714165333392286,0,0,1.42829937154828,2.02779518503313,PRELID1;ATP8B3;SCP2;STARD7;TRIAP1;ATP9B
alpha,4,motile cilium assembly (GO:0044458),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,DNAAF3;RSPH9
alpha,4,nucleocytoplasmic transport (GO:0006913),5/47,5,47,0.241125980237948,0.713432508869012,0,0,1.49414295959837,2.125322350131,NPM1;SET;NXT1;RSRC1;NCBP2
alpha,4,protein localization to endoplasmic reticulum (GO:0070972),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,BCAP29;UBAC2
alpha,4,aminoglycan biosynthetic process (GO:0006023),5/47,5,47,0.241125980237948,0.713432508869012,0,0,1.49414295959837,2.125322350131,NDST2;NDST1;UGDH;AGRN;HSPG2
alpha,4,membrane repolarization (GO:0086009),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,ATP1B3;ATP1A1
alpha,4,regulation of cellular component movement (GO:0051270),5/47,5,47,0.241125980237948,0.713432508869012,0,0,1.49414295959837,2.125322350131,DAPK3;PKN2;ETS1;RHOA;TGFBR1
alpha,4,positive regulation of muscle contraction (GO:0045933),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,SPHK1;SRF
alpha,4,positive regulation of ion transport (GO:0043270),5/47,5,47,0.241125980237948,0.713432508869012,0,0,1.49414295959837,2.125322350131,STIM2;KIF5B;ORAI1;CACNA1D;MYLK
alpha,4,macromolecular complex assembly (GO:0065003),11/121,11,121,0.243066217629829,0.716759861551046,0,0,1.27681307456588,1.8059517010072,SLC9A3R1;OCLN;SLC7A6;TUBGCP2;FANCA;HMGA1;RANBP9;TUBGCP4;WASF1;PPID;MPHOSPH6
alpha,4,synaptic vesicle localization (GO:0097479),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,NLGN1;KIF5B
alpha,4,phosphate ion transport (GO:0006817),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,SLC20A2;SLC37A4
alpha,4,cardiolipin metabolic process (GO:0032048),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,HADHB;HADHA
alpha,4,cellular potassium ion homeostasis (GO:0030007),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,ATP1B3;ATP1A1
alpha,4,positive regulation of protein complex disassembly (GO:0043243),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,BNIP3;IGF1R
alpha,4,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,MAP2K1;ZC3H12A
alpha,4,tricarboxylic acid metabolic process (GO:0072350),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,STAT5B;ASS1
alpha,4,cellular response to nitrogen starvation (GO:0006995),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,MAP1LC3A;GABARAP
alpha,4,negative regulation of hemostasis (GO:1900047),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,VTN;SERPINE2
alpha,4,positive regulation of histone H3-K4 methylation (GO:0051571),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,SMAD4;CTNNB1
alpha,4,DNA-templated transcriptional preinitiation complex assembly (GO:0070897),2/13,2,13,0.235670811489853,0.706015861398486,0,0,2.16076058772688,3.12298901092677,TAF6;BDP1
alpha,4,cellular response to organic substance (GO:0071310),12/134,12,134,0.245879508322264,0.72444800649854,0,0,1.2577561630052,1.7645233103439,SOCS2;CDK9;NCOA1;STAT5B;JUN;TBK1;SMAD3;AVPR1B;DPYSL3;CTNNB1;PTPN23;SLIT2
alpha,4,protein maturation (GO:0051604),8/84,8,84,0.247733724664921,0.72929986783685,0,0,1.33761369716426,1.86650722378728,CPM;ISCA1;PTCH1;TYSND1;ECE1;PCSK7;LIAS;RHBDL2
alpha,4,acyl-CoA biosynthetic process (GO:0071616),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,SCD;ACAT1
alpha,4,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,KAT5;HIPK2
alpha,4,neurotransmitter biosynthetic process (GO:0042136),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,ACHE;DAGLB
alpha,4,lipid particle organization (GO:0034389),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,HILPDA;PPID
alpha,4,ubiquinone metabolic process (GO:0006743),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,COQ2;COQ10A
alpha,4,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,CNOT7;AGO2
alpha,4,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,NR4A3;TXN
alpha,4,neuron cell-cell adhesion (GO:0007158),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,NLGN1;CDK5R1
alpha,4,negative regulation of cation transmembrane transport (GO:1904063),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,CAB39;STK39
alpha,4,nuclear import (GO:0051170),7/72,7,72,0.25126936400193,0.730345565616909,0,0,1.36548064918851,1.88604249833594,NUP214;NXT1;NUP188;NUP155;NUP62;NUP153;RAN
alpha,4,positive regulation of smooth muscle contraction (GO:0045987),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,SPHK1;SRF
alpha,4,recombinational repair (GO:0000725),7/72,7,72,0.25126936400193,0.730345565616909,0,0,1.36548064918851,1.88604249833594,GEN1;RECQL4;AP5Z1;POLN;NSMCE2;SWI5;INO80
alpha,4,establishment of protein localization to chromosome (GO:0070199),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,ACD;LRWD1
alpha,4,lipid phosphorylation (GO:0046834),4/36,4,36,0.252243976000917,0.730345565616909,0,0,1.5605493133583,2.1494358631403,PIK3CA;PIK3CB;PIK3C2A;DGKZ
alpha,4,regulation of mRNA catabolic process (GO:0061013),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,CNOT7;ZC3H12A
alpha,4,regulation of phosphoprotein phosphatase activity (GO:0043666),4/36,4,36,0.252243976000917,0.730345565616909,0,0,1.5605493133583,2.1494358631403,PPP1R2;HSP90AB1;TIPRL;CALM2
alpha,4,positive regulation of transporter activity (GO:0032411),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,STK39;SGK1
alpha,4,membrane lipid biosynthetic process (GO:0046467),6/61,6,61,0.266131322058738,0.737156498846702,0,0,1.38146988395653,1.82874203362876,SGMS1;ELOVL5;PRKD3;SPHK1;ST3GAL2;SGPP1
alpha,4,positive regulation of peptide secretion (GO:0002793),4/36,4,36,0.252243976000917,0.730345565616909,0,0,1.5605493133583,2.1494358631403,ACHE;GOLPH3;BMP6;PPID
alpha,4,regulation of protein modification by small protein conjugation or removal (GO:1903320),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,HSP90AB1;TGFBR1
alpha,4,response to reactive oxygen species (GO:0000302),6/61,6,61,0.266131322058738,0.737156498846702,0,0,1.38146988395653,1.82874203362876,JUN;HYAL2;TXNRD1;FOS;PKD2;CAMKK2
alpha,4,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),10/111,10,111,0.265921455121547,0.737156498846702,0,0,1.2653102540743,1.67597213192447,CYB5R1;FBXW7;STARD7;FAM20B;MICALL2;DPH6;ATG13;DYNLL2;YWHAZ;ZBED3
alpha,4,purine nucleotide catabolic process (GO:0006195),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,HINT1;NT5C2
alpha,4,cell chemotaxis (GO:0060326),6/61,6,61,0.266131322058738,0.737156498846702,0,0,1.38146988395653,1.82874203362876,NR4A1;EGR3;PIK3CA;PARVA;PIK3CB;ARRB2
alpha,4,ciliary basal body-plasma membrane docking (GO:0097711),9/97,9,97,0.253070249132519,0.730345565616909,0,0,1.30313911734044,1.7906280374968,ODF2;SSNA1;HAUS3;TUBB4B;CKAP5;TUBA4A;HAUS2;TTBK2;PAFAH1B1
alpha,4,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,ERN1;DDX1
alpha,4,regulation of histone modification (GO:0031056),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,CDK9;ZNF335
alpha,4,glycoside metabolic process (GO:0016137),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,AKR7A2;FUCA1
alpha,4,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,MSH2;GNL1
alpha,4,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),5/48,5,48,0.25476228085787,0.730345565616909,0,0,1.46301498127341,2.00056238376648,SDCBP;SMAD4;BMP8A;TGFBR1;BMP6
alpha,4,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,DLL4;RHOA
alpha,4,inositol phosphate metabolic process (GO:0043647),5/48,5,48,0.25476228085787,0.730345565616909,0,0,1.46301498127341,2.00056238376648,INPP4A;ITPKC;INPP1;PLCG1;PLCD3
alpha,4,endosome to lysosome transport (GO:0008333),5/49,5,49,0.268580256856155,0.74102009642809,0,0,1.43315753267599,1.88403677694449,VCP;KIF13A;VPS41;DENND3;RHOB
alpha,4,quinone biosynthetic process (GO:1901663),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,COQ2;COQ10A
alpha,4,protein acylation (GO:0043543),4/37,4,37,0.268288918761378,0.74102009642809,0,0,1.51837230488916,1.99770850907317,ZDHHC18;ZDHHC9;ABHD17C;ZDHHC2
alpha,4,positive regulation of organelle assembly (GO:1902117),5/48,5,48,0.25476228085787,0.730345565616909,0,0,1.46301498127341,2.00056238376648,SDCBP;LRSAM1;PDCD6IP;NUP62;FSCN1
alpha,4,interstrand cross-link repair (GO:0036297),5/49,5,49,0.268580256856155,0.74102009642809,0,0,1.43315753267599,1.88403677694449,MUS81;UBB;POLN;FANCA;ATRIP
alpha,4,response to ethanol (GO:0045471),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,GPRIN1;ADH6
alpha,4,axonal transport (GO:0098930),4/37,4,37,0.268288918761378,0.74102009642809,0,0,1.51837230488916,1.99770850907317,SPAST;BLOC1S2;DTNBP1;PAFAH1B1
alpha,4,positive regulation of tumor necrosis factor production (GO:0032760),5/48,5,48,0.25476228085787,0.730345565616909,0,0,1.46301498127341,2.00056238376648,ARFGEF2;HSPB1;FADD;CLU;RASGRP1
alpha,4,regulation of protein kinase activity (GO:0045859),13/148,13,148,0.255573503562072,0.730345565616909,0,0,1.23367749772244,1.68303863612073,RB1;CISH;HSPB1;CAMKK2;SOCS2;SLC9A3R1;RAP1A;FLRT3;GNAQ;NF1;SNX9;MAPRE3;PAK2
alpha,4,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031657),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,CDKN2B;PKD2
alpha,4,plasma membrane organization (GO:0007009),4/37,4,37,0.268288918761378,0.74102009642809,0,0,1.51837230488916,1.99770850907317,ARV1;SNX9;WHAMM;STX2
alpha,4,negative regulation of cellular biosynthetic process (GO:0031327),5/48,5,48,0.25476228085787,0.730345565616909,0,0,1.46301498127341,2.00056238376648,FBXW7;CLTC;ZC3H12A;ERLIN1;SNAI1
alpha,4,smooth muscle contraction (GO:0006939),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,PIK3C2A;MYLK
alpha,4,neuromuscular process controlling balance (GO:0050885),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,TPP1;PAFAH1B1
alpha,4,cardiac left ventricle morphogenesis (GO:0003214),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,SMAD4;HEY2
alpha,4,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,TAF9;TRIAP1
alpha,4,regulation of calcineurin-NFAT signaling cascade (GO:0070884),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,RCAN2;SPPL3
alpha,4,regulation of secretion (GO:0051046),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,ACSL3;SGK1
alpha,4,regulation of extracellular matrix disassembly (GO:0010715),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,FSCN1;CLASP2
alpha,4,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),9/98,9,98,0.262576331621272,0.730345565616909,0,0,1.28984177940839,1.72479377849543,DCTN6;SEC24B;SEC24A;CAPZB;SAR1B;CLTC;AP1S3;CTSV;DYNLL2
alpha,4,negative regulation of receptor-mediated endocytosis (GO:0048261),2/14,2,14,0.262841291751178,0.730345565616909,0,0,2.00642054574639,2.68098892932031,SDCBP;RAC1
alpha,4,mRNA metabolic process (GO:0016071),9/98,9,98,0.262576331621272,0.730345565616909,0,0,1.28984177940839,1.72479377849543,ERN1;KIN;LSM11;CPSF6;NCBP2;SRSF2;DHX15;HNRNPR;SRSF9
alpha,4,antigen processing and presentation of exogenous peptide antigen (GO:0002478),9/98,9,98,0.262576331621272,0.730345565616909,0,0,1.28984177940839,1.72479377849543,DCTN6;SEC24B;SEC24A;CAPZB;SAR1B;CLTC;AP1S3;CTSV;DYNLL2
alpha,4,ATP generation from ADP (GO:0006757),3/25,3,25,0.261629641134337,0.730345565616909,0,0,1.68539325842697,2.25981802033047,TPI1;PGAM1;PGM1
alpha,4,positive regulation of supramolecular fiber organization (GO:1902905),8/85,8,85,0.257883598352439,0.730345565616909,0,0,1.32187706543291,1.79146988108995,CLIP1;PAK1;PRKCE;CDC42EP4;RAC1;BAIAP2;CLU;CDK5R1
alpha,4,negative regulation of cell motility (GO:2000146),9/98,9,98,0.262576331621272,0.730345565616909,0,0,1.28984177940839,1.72479377849543,RNF20;KANK1;ADAM15;DPYSL3;TP53INP1;NF1;SLIT2;CRK;RHOB
alpha,4,Golgi to plasma membrane protein transport (GO:0043001),3/25,3,25,0.261629641134337,0.730345565616909,0,0,1.68539325842697,2.25981802033047,ARFRP1;GOLPH3;KIF13A
alpha,4,regulation of neuron death (GO:1901214),7/73,7,73,0.262349040649053,0.730345565616909,0,0,1.34677543481607,1.80209252718787,GRM4;TBK1;UBB;SARM1;FOS;CLU;MAP3K5
alpha,4,cellular response to organonitrogen compound (GO:0071417),9/98,9,98,0.262576331621272,0.730345565616909,0,0,1.28984177940839,1.72479377849543,RRAGA;CPEB1;RAP1A;CTNNB1;SLIT2;PKD2;ACTB;RELA;IPO5
alpha,4,response to glucocorticoid (GO:0051384),3/25,3,25,0.261629641134337,0.730345565616909,0,0,1.68539325842697,2.25981802033047,GOT1;SLIT2;NR3C1
alpha,4,lysosomal transport (GO:0007041),7/73,7,73,0.262349040649053,0.730345565616909,0,0,1.34677543481607,1.80209252718787,HGSNAT;KIF13A;NCOA4;VPS41;VPS54;DENND3;RHOB
alpha,4,membrane protein intracellular domain proteolysis (GO:0031293),3/25,3,25,0.261629641134337,0.730345565616909,0,0,1.68539325842697,2.25981802033047,DLL4;JAG2;RELA
alpha,4,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),9/99,9,99,0.272191455326372,0.747073959670108,0,0,1.27681307456588,1.66145247754983,DCTN6;SEC24B;SEC24A;CAPZB;SAR1B;CLTC;AP1S3;CTSV;DYNLL2
alpha,4,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),3/25,3,25,0.261629641134337,0.730345565616909,0,0,1.68539325842697,2.25981802033047,IKBKB;UBB;TNFAIP3
alpha,4,transition metal ion homeostasis (GO:0055076),3/25,3,25,0.261629641134337,0.730345565616909,0,0,1.68539325842697,2.25981802033047,SLC25A28;FBXL5;CUTC
alpha,4,sulfur compound biosynthetic process (GO:0044272),11/123,11,123,0.259784353879312,0.730345565616909,0,0,1.25605188636156,1.69303660854525,SLC35B2;NDST1;GCLC;CHPF;CHSY1;CHAC2;HAGH;LIAS;GCLM;B4GALT6;ST3GAL2
alpha,4,positive regulation of histone methylation (GO:0031062),3/25,3,25,0.261629641134337,0.730345565616909,0,0,1.68539325842697,2.25981802033047,SMAD4;PHF1;CTNNB1
alpha,4,cellular lipid catabolic process (GO:0044242),3/25,3,25,0.261629641134337,0.730345565616909,0,0,1.68539325842697,2.25981802033047,ACBD5;LIPG;LPIN2
alpha,4,regulation of chromosome organization (GO:0033044),3/25,3,25,0.261629641134337,0.730345565616909,0,0,1.68539325842697,2.25981802033047,RB1;LIG4;TERF2IP
alpha,4,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),3/25,3,25,0.261629641134337,0.730345565616909,0,0,1.68539325842697,2.25981802033047,PSMA5;PSMA3;PSMA1
alpha,4,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",3/25,3,25,0.261629641134337,0.730345565616909,0,0,1.68539325842697,2.25981802033047,CDK9;ALYREF;BRD4
alpha,4,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),3/25,3,25,0.261629641134337,0.730345565616909,0,0,1.68539325842697,2.25981802033047,DDIT3;MAP3K5;ATF4
alpha,4,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),3/25,3,25,0.261629641134337,0.730345565616909,0,0,1.68539325842697,2.25981802033047,LATS1;CDKN2B;IPO5
alpha,4,DNA geometric change (GO:0032392),3/25,3,25,0.261629641134337,0.730345565616909,0,0,1.68539325842697,2.25981802033047,RECQL4;SUPV3L1;DDX1
alpha,4,negative regulation of oxidative stress-induced cell death (GO:1903202),3/25,3,25,0.261629641134337,0.730345565616909,0,0,1.68539325842697,2.25981802033047,HSPB1;TXN;ATF4
alpha,4,mucosal immune response (GO:0002385),3/25,3,25,0.261629641134337,0.730345565616909,0,0,1.68539325842697,2.25981802033047,HIST1H2BJ;HIST1H2BK;RPL39
alpha,4,limb development (GO:0060173),3/25,3,25,0.261629641134337,0.730345565616909,0,0,1.68539325842697,2.25981802033047,PTCH1;CHD7;GLI3
alpha,4,fatty acid derivative biosynthetic process (GO:1901570),3/25,3,25,0.261629641134337,0.730345565616909,0,0,1.68539325842697,2.25981802033047,SCD;FADS1;ACAT1
alpha,4,regulation of cardiac muscle cell action potential (GO:0098901),3/25,3,25,0.261629641134337,0.730345565616909,0,0,1.68539325842697,2.25981802033047,SLMAP;ATP2A2;DSG2
alpha,4,negative regulation of macromolecule metabolic process (GO:0010605),11/125,11,125,0.276876320885863,0.747073959670108,0,0,1.23595505617978,1.58719416207897,RB1;MECP2;DLL4;SDCBP;MAP2K1;CNOT7;STC2;ZC3H12A;HEY2;ANXA7;DIP2A
alpha,4,regulation of DNA replication (GO:0006275),6/62,6,62,0.278532453863053,0.747073959670108,0,0,1.35918811163465,1.73734237333828,ANKRD17;CDAN1;ESCO1;RAD17;PDS5A;IGF1R
alpha,4,positive regulation of cellular amide metabolic process (GO:0034250),6/62,6,62,0.278532453863053,0.747073959670108,0,0,1.35918811163465,1.73734237333828,SMPD2;NPM1;DDX3X;EIF4A3;CIRBP;CLU
alpha,4,canonical glycolysis (GO:0061621),3/26,3,26,0.281444855682782,0.747073959670108,0,0,1.62057044079516,2.05458958267154,TPI1;PGAM1;PFKP
alpha,4,lamellipodium organization (GO:0097581),3/26,3,26,0.281444855682782,0.747073959670108,0,0,1.62057044079516,2.05458958267154,GOLPH3;WHAMM;RAC1
alpha,4,response to alcohol (GO:0097305),3/26,3,26,0.281444855682782,0.747073959670108,0,0,1.62057044079516,2.05458958267154,GPRIN1;TGFBR1;ADH6
alpha,4,positive regulation of glucose transport (GO:0010828),3/26,3,26,0.281444855682782,0.747073959670108,0,0,1.62057044079516,2.05458958267154,NR4A3;BRAF;RHOQ
alpha,4,ncRNA 3'-end processing (GO:0043628),3/26,3,26,0.281444855682782,0.747073959670108,0,0,1.62057044079516,2.05458958267154,EXOSC6;ELAC2;INTS2
alpha,4,negative regulation of insulin receptor signaling pathway (GO:0046627),3/26,3,26,0.281444855682782,0.747073959670108,0,0,1.62057044079516,2.05458958267154,SOCS2;KANK1;CISH
alpha,4,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),3/26,3,26,0.281444855682782,0.747073959670108,0,0,1.62057044079516,2.05458958267154,SLC35B2;PODXL2;ABHD14B
alpha,4,regulation of vascular smooth muscle cell proliferation (GO:1904705),3/26,3,26,0.281444855682782,0.747073959670108,0,0,1.62057044079516,2.05458958267154,ERN1;JUN;MFN2
alpha,4,positive regulation of embryonic development (GO:0040019),3/26,3,26,0.281444855682782,0.747073959670108,0,0,1.62057044079516,2.05458958267154,PHLDB1;PHLDB2;CLASP2
alpha,4,regulation of cellular protein localization (GO:1903827),3/26,3,26,0.281444855682782,0.747073959670108,0,0,1.62057044079516,2.05458958267154,SETD2;CTNNB1;RAB11FIP5
alpha,4,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),3/26,3,26,0.281444855682782,0.747073959670108,0,0,1.62057044079516,2.05458958267154,CAB39;SPHK1;CALM2
alpha,4,signal transduction in response to DNA damage (GO:0042770),3/26,3,26,0.281444855682782,0.747073959670108,0,0,1.62057044079516,2.05458958267154,USP10;TRIAP1;PRPF19
alpha,4,glycolytic process through glucose-6-phosphate (GO:0061620),3/26,3,26,0.281444855682782,0.747073959670108,0,0,1.62057044079516,2.05458958267154,TPI1;PGAM1;PFKP
alpha,4,glucose catabolic process to pyruvate (GO:0061718),3/26,3,26,0.281444855682782,0.747073959670108,0,0,1.62057044079516,2.05458958267154,TPI1;PGAM1;PFKP
alpha,4,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",3/26,3,26,0.281444855682782,0.747073959670108,0,0,1.62057044079516,2.05458958267154,IKBKB;UBB;TNFAIP3
alpha,4,misfolded or incompletely synthesized protein catabolic process (GO:0006515),3/26,3,26,0.281444855682782,0.747073959670108,0,0,1.62057044079516,2.05458958267154,VCP;CUL3;LONP1
alpha,4,glycosaminoglycan biosynthetic process (GO:0006024),9/100,9,100,0.281908109397622,0.747073959670108,0,0,1.26404494382022,1.60050098723465,NDST2;NDST1;UGDH;CHPF;CHSY1;B4GALT6;AGRN;HSPG2;ST3GAL2
alpha,4,protein autoubiquitination (GO:0051865),5/50,5,50,0.28255634521302,0.747073959670108,0,0,1.40449438202247,1.77510856208157,LRSAM1;RNF11;AMFR;RNF4;RNF220
alpha,4,regulation of DNA repair (GO:0006282),4/38,4,38,0.284507586862244,0.747073959670108,0,0,1.47841513897102,1.85836096750031,CDK9;TRIP12;AXIN2;DEK
alpha,4,phospholipid biosynthetic process (GO:0008654),4/38,4,38,0.284507586862244,0.747073959670108,0,0,1.47841513897102,1.85836096750031,IDI1;SGMS1;DOLK;FADS1
alpha,4,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",4/38,4,38,0.284507586862244,0.747073959670108,0,0,1.47841513897102,1.85836096750031,UBB;PAPD7;RFC2;CHD1L
alpha,4,positive regulation of cellular component biogenesis (GO:0044089),8/88,8,88,0.289042364970882,0.747073959670108,0,0,1.27681307456588,1.58475741830753,SDCBP;NLGN1;VCP;PDCD6IP;SRPX2;SMAD3;FAF1;STAM
alpha,4,pseudouridine synthesis (GO:0001522),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,PUS7;PUSL1
alpha,4,ubiquinone biosynthetic process (GO:0006744),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,COQ2;COQ10A
alpha,4,apoptotic DNA fragmentation (GO:0006309),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,ENDOG;KPNA1
alpha,4,vitamin D metabolic process (GO:0042359),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,PIAS4;UBE2I
alpha,4,regulation of protein homooligomerization (GO:0032462),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,MIEF2;CLU
alpha,4,substrate-dependent cell migration (GO:0006929),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,SDCBP;ANKS1A
alpha,4,lipoxygenase pathway (GO:0019372),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,GPX4;ALOXE3
alpha,4,negative regulation of insulin secretion (GO:0046676),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,MIDN;BMP8A
alpha,4,anterograde synaptic vesicle transport (GO:0048490),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,BLOC1S2;DTNBP1
alpha,4,regulation of establishment of cell polarity (GO:2000114),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,KANK1;KRIT1
alpha,4,positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,CDK9;BRD4
alpha,4,sodium ion import (GO:0097369),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,SLC9A7;SLC9A8
alpha,4,negative regulation of coagulation (GO:0050819),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,VTN;SERPINE2
alpha,4,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,CCT2;SHQ1
alpha,4,negative regulation of interleukin-2 production (GO:0032703),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,KAT5;TNFAIP3
alpha,4,positive regulation of phosphoprotein phosphatase activity (GO:0032516),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,HSP90AB1;CALM2
alpha,4,response to cholesterol (GO:0070723),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,PTCH1;TGFBR1
alpha,4,mesenchymal cell development (GO:0014031),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,HEY2;KLHL12
alpha,4,sodium ion import across plasma membrane (GO:0098719),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,SLC9A7;SLC9A8
alpha,4,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,KAT5;HIPK2
alpha,4,regulation of macrophage chemotaxis (GO:0010758),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,KARS;MTUS1
alpha,4,negative regulation of platelet activation (GO:0010544),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,SERPINE2;NOS3
alpha,4,negative regulation of DNA-dependent DNA replication (GO:2000104),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,TIPIN;FBXW7
alpha,4,positive regulation of NF-kappaB import into nucleus (GO:0042346),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,SPHK1;RHOA
alpha,4,negative regulation of RNA metabolic process (GO:0051253),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,SHQ1;ZC3H12A
alpha,4,monovalent inorganic anion homeostasis (GO:0055083),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,SLC12A2;SLC12A7
alpha,4,regulation of protein complex disassembly (GO:0043244),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,BNIP3;IGF1R
alpha,4,negative regulation of protein processing (GO:0010955),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,SERPINE2;CD55
alpha,4,synaptic vesicle transport along microtubule (GO:0099517),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,BLOC1S2;DTNBP1
alpha,4,positive regulation of protein export from nucleus (GO:0046827),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,XPO4;BAG3
alpha,4,cytoplasmic sequestering of protein (GO:0051220),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,LATS1;PKD2
alpha,4,cellular sodium ion homeostasis (GO:0006883),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,ATP1B3;ATP1A1
alpha,4,establishment of protein localization to endoplasmic reticulum (GO:0072599),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,SPCS3;SRP14
alpha,4,atrioventricular valve morphogenesis (GO:0003181),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,HEY1;HEY2
alpha,4,myeloid cell development (GO:0061515),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,ANXA2;FOXP1
alpha,4,positive regulation of alpha-beta T cell activation (GO:0046635),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,GLI3;CD55
alpha,4,heparan sulfate proteoglycan biosynthetic process (GO:0015012),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,NDST1;HS6ST3
alpha,4,embryonic axis specification (GO:0000578),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,PTCH1;COBL
alpha,4,response to X-ray (GO:0010165),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,MSH2;LIG4
alpha,4,"phototransduction, visible light (GO:0007603)",2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,GNAQ;GNB1
alpha,4,transport along microtubule (GO:0010970),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,ARHGAP21;DYNLL2
alpha,4,"protein localization to chromosome, centromeric region (GO:0071459)",2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,RB1;CTCF
alpha,4,positive regulation of cytokine production involved in immune response (GO:0002720),2/15,2,15,0.290019929936617,0.747073959670108,0,0,1.87265917602996,2.31798807948245,KARS;RAET1G
alpha,4,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),6/63,6,63,0.291062064066843,0.747073959670108,0,0,1.33761369716426,1.65090791328394,DDX3X;PPIF;SNAI1;HSPB1;TMBIM6;CLU
alpha,4,cellular amide metabolic process (GO:0043603),6/63,6,63,0.291062064066843,0.747073959670108,0,0,1.33761369716426,1.65090791328394,MIPEP;CPM;SMPD2;STAT5B;ASAH1;NIT2
alpha,4,stress-activated MAPK cascade (GO:0051403),6/63,6,63,0.291062064066843,0.747073959670108,0,0,1.33761369716426,1.65090791328394,IKBKB;MAP4K2;UBB;MAP4K3;MAP3K5;SKP1
alpha,4,negative regulation of cellular amide metabolic process (GO:0034249),7/76,7,76,0.29634214794665,0.747073959670108,0,0,1.29361324659965,1.57334493436556,CTSA;DDX3X;CNOT7;NCL;EIF4A3;DAPK3;CLU
alpha,4,wound healing (GO:0042060),5/51,5,51,0.296667214839309,0.747073959670108,0,0,1.37695527649262,1.67319929658628,PAK1;SMAD3;SRF;NF1;TGFBR1
alpha,4,receptor internalization (GO:0031623),5/51,5,51,0.296667214839309,0.747073959670108,0,0,1.37695527649262,1.67319929658628,TFRC;CD81;CLTC;ARRB1;ARRB2
alpha,4,regulation of bone mineralization (GO:0030500),5/51,5,51,0.296667214839309,0.747073959670108,0,0,1.37695527649262,1.67319929658628,TFAP2A;KL;BCOR;ACVR2B;BMP6
alpha,4,regulation of protein targeting to mitochondrion (GO:1903214),8/89,8,89,0.299633561849944,0.747073959670108,0,0,1.26246686024492,1.52151876204648,CYB5R1;FBXW7;STARD7;FAM20B;MICALL2;DPH6;ATG13;ZBED3
alpha,4,positive regulation of protein complex assembly (GO:0031334),8/89,8,89,0.299633561849944,0.747073959670108,0,0,1.26246686024492,1.52151876204648,FOSL1;VCP;JUN;FAF1;FSCN1;CTNNB1;SNX9;CHD1L
alpha,4,potassium ion import (GO:0010107),4/39,4,39,0.30086381939271,0.747073959670108,0,0,1.44050705848459,1.73018948988202,SLC12A2;ATP1B3;ATP1A1;SLC12A7
alpha,4,homotypic cell-cell adhesion (GO:0034109),4/39,4,39,0.30086381939271,0.747073959670108,0,0,1.44050705848459,1.73018948988202,TYRO3;HSPB1;PIK3CB;ACTB
alpha,4,positive regulation of innate immune response (GO:0045089),4/39,4,39,0.30086381939271,0.747073959670108,0,0,1.44050705848459,1.73018948988202,ANKRD17;POLR3B;POLR3D;FADD
alpha,4,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),3/27,3,27,0.301384159840605,0.747073959670108,0,0,1.5605493133583,1.87167532684799,CKS2;CCNYL1;MAPRE3
alpha,4,positive regulation of synapse assembly (GO:0051965),3/27,3,27,0.301384159840605,0.747073959670108,0,0,1.5605493133583,1.87167532684799,NLGN1;SRPX2;AGRN
alpha,4,response to growth factor (GO:0070848),3/27,3,27,0.301384159840605,0.747073959670108,0,0,1.5605493133583,1.87167532684799,STAT5B;TBC1D7;CTNNB1
alpha,4,regulation of NF-kappaB import into nucleus (GO:0042345),3/27,3,27,0.301384159840605,0.747073959670108,0,0,1.5605493133583,1.87167532684799,SPHK1;ZC3H12A;RHOA
alpha,4,negative chemotaxis (GO:0050919),3/27,3,27,0.301384159840605,0.747073959670108,0,0,1.5605493133583,1.87167532684799,SEMA3F;SLIT2;RHOA
alpha,4,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),3/27,3,27,0.301384159840605,0.747073959670108,0,0,1.5605493133583,1.87167532684799,RB1;ORC1;BRD4
alpha,4,negative regulation of cellular response to insulin stimulus (GO:1900077),3/27,3,27,0.301384159840605,0.747073959670108,0,0,1.5605493133583,1.87167532684799,SOCS2;KANK1;CISH
alpha,4,regulation of microtubule-based process (GO:0032886),3/27,3,27,0.301384159840605,0.747073959670108,0,0,1.5605493133583,1.87167532684799,PHLDB1;PHLDB2;CLASP2
alpha,4,snRNA 3'-end processing (GO:0034472),3/27,3,27,0.301384159840605,0.747073959670108,0,0,1.5605493133583,1.87167532684799,EXOSC6;INTS2;EXOSC3
alpha,4,sodium ion homeostasis (GO:0055078),3/27,3,27,0.301384159840605,0.747073959670108,0,0,1.5605493133583,1.87167532684799,SLC12A2;ATP1B3;ATP1A1
alpha,4,monovalent inorganic cation homeostasis (GO:0055067),3/27,3,27,0.301384159840605,0.747073959670108,0,0,1.5605493133583,1.87167532684799,SLC12A2;SLC9A7;SLC12A7
alpha,4,negative regulation of response to stimulus (GO:0048585),11/128,11,128,0.303124596605349,0.747073959670108,0,0,1.20698735955056,1.44067380934595,BRAP;RYK;VPS13C;AKT3;ZC3H12A;TYRO3;LMTK2;BRAF;SLIT2;CLU;IGF1R
alpha,4,signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),6/64,6,64,0.303703833087911,0.747073959670108,0,0,1.31671348314607,1.56913046749435,NPM1;CNOT7;UBB;PRKDC;CNOT11;TRIAP1
alpha,4,negative regulation of protein modification process (GO:0031400),6/64,6,64,0.303703833087911,0.747073959670108,0,0,1.31671348314607,1.56913046749435,PRKDC;ZC3H12A;TERF2IP;SLIT2;CORO1C;ZBED3
alpha,4,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),7/77,7,77,0.307883952234614,0.747073959670108,0,0,1.27681307456588,1.50412710095307,NOS3;TNFAIP3;FADD;ZMYND11;SH3RF1;TGFBR1;RELA
alpha,4,mitochondrial translational termination (GO:0070126),8/90,8,90,0.310311378697968,0.747073959670108,0,0,1.24843945068664,1.46089767566779,MRPL2;MRPS16;MRPS27;MRPL37;MRPS6;MRPL43;DAP3;C12ORF65
alpha,4,negative regulation of neuron projection development (GO:0010977),5/52,5,52,0.310889860692102,0.747073959670108,0,0,1.3504753673293,1.57778275606614,KANK1;DPYSL3;DENND5A;KIAA0319;RHOA
alpha,4,positive regulation of actin filament polymerization (GO:0030838),5/52,5,52,0.310889860692102,0.747073959670108,0,0,1.3504753673293,1.57778275606614,PRKCE;CDC42EP4;RAC1;WHAMM;BAIAP2
alpha,4,cellular response to oxidative stress (GO:0034599),10/116,10,116,0.312083147862346,0.747073959670108,0,0,1.21077101898489,1.40992544933959,JUN;TXNRD1;ZC3H12A;LONP1;ADNP2;TXN;FOS;PKD2;WNT16;CAMKK2
alpha,4,epithelium development (GO:0060429),10/116,10,116,0.312083147862346,0.747073959670108,0,0,1.21077101898489,1.40992544933959,ERRFI1;RARG;PTCH1;CDHR2;ANXA7;FOXJ1;VDAC1;TPP1;PKD2;DACT1
alpha,4,cellular response to decreased oxygen levels (GO:0036294),6/65,6,65,0.316441558335979,0.747073959670108,0,0,1.29645635263613,1.49172433568079,CPEB1;BNIP3;HP1BP3;HILPDA;RORA;HIPK2
alpha,4,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,CNOT7;AGO2
alpha,4,Notch receptor processing (GO:0007220),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,JAG2;DLL4
alpha,4,embryonic digit morphogenesis (GO:0042733),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,ECE1;GLI3
alpha,4,glucose 6-phosphate metabolic process (GO:0051156),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,PGLS;RBKS
alpha,4,cytoplasmic sequestering of transcription factor (GO:0042994),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,FAF1;PKD2
alpha,4,regulation of water loss via skin (GO:0033561),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,STMN1;ALOXE3
alpha,4,neuromuscular process (GO:0050905),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,TPP1;PAFAH1B1
alpha,4,leukocyte adhesion to vascular endothelial cell (GO:0061756),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,GOLPH3;PODXL2
alpha,4,positive regulation of lymphocyte differentiation (GO:0045621),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,ZMIZ1;ZBTB1
alpha,4,regulation of energy homeostasis (GO:2000505),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,NR4A3;BMP8A
alpha,4,neuron apoptotic process (GO:0051402),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,BNIP3;LIG4
alpha,4,negative regulation of DNA recombination (GO:0045910),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,MSH2;TERF2IP
alpha,4,regulation of steroid metabolic process (GO:0019218),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,ARV1;RORA
alpha,4,bone morphogenesis (GO:0060349),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,TFAP2A;RARG
alpha,4,negative regulation of peptide hormone secretion (GO:0090278),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,MIDN;BMP8A
alpha,4,regulation of necroptotic process (GO:0060544),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,UBB;BIRC2
alpha,4,ruffle organization (GO:0031529),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,LIMA1;RAC1
alpha,4,myoblast differentiation (GO:0045445),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,RB1;MBNL1
alpha,4,regulation of glucose transport (GO:0010827),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,NR4A3;BRAF
alpha,4,positive regulation of response to endoplasmic reticulum stress (GO:1905898),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,ERN1;DDIT3
alpha,4,regulation of interferon-alpha production (GO:0032647),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,SETD2;TBK1
alpha,4,programmed necrotic cell death (GO:0097300),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,PPIF;TRPM7
alpha,4,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,SNAI1;CLU
alpha,4,negative regulation of NF-kappaB import into nucleus (GO:0042347),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,FAF1;ZC3H12A
alpha,4,lipopolysaccharide-mediated signaling pathway (GO:0031663),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,PRKCE;MTDH
alpha,4,establishment of skin barrier (GO:0061436),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,STMN1;ALOXE3
alpha,4,leukocyte tethering or rolling (GO:0050901),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,GOLPH3;PODXL2
alpha,4,regulation of reactive oxygen species biosynthetic process (GO:1903426),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,GPRIN1;SLC25A33
alpha,4,guanosine-containing compound metabolic process (GO:1901068),2/16,2,16,0.317067916289979,0.747073959670108,0,0,1.75561797752809,2.0165717715606,RHOQ;RAN
alpha,4,regulation of proteasomal protein catabolic process (GO:0061136),4/40,4,40,0.317322546776743,0.747073959670108,0,0,1.40449438202247,1.61212995040219,UBB;FBXW7;GNA12;PSMF1
alpha,4,ERBB2 signaling pathway (GO:0038128),4/40,4,40,0.317322546776743,0.747073959670108,0,0,1.40449438202247,1.61212995040219,CUL5;UBB;PIK3CA;SOS1
alpha,4,mitotic DNA damage checkpoint (GO:0044773),4/40,4,40,0.317322546776743,0.747073959670108,0,0,1.40449438202247,1.61212995040219,MUS81;TIPIN;MSH2;RAD9A
alpha,4,cellular response to amino acid starvation (GO:0034198),4/40,4,40,0.317322546776743,0.747073959670108,0,0,1.40449438202247,1.61212995040219,RRAGA;MIOS;MAP3K5;ATF4
alpha,4,regulation of type I interferon-mediated signaling pathway (GO:0060338),4/40,4,40,0.317322546776743,0.747073959670108,0,0,1.40449438202247,1.61212995040219,HSP90AB1;CNOT7;FADD;ABCE1
alpha,4,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),7/78,7,78,0.319510851592345,0.747073959670108,0,0,1.26044367617401,1.43812091078259,SMAD3;UBB;NBL1;SKIL;TGFBR1;BCL9L;HIPK2
alpha,4,regulation of cell cycle process (GO:0010564),8/91,8,91,0.321066281463713,0.747073959670108,0,0,1.23472033584393,1.40277527207858,SETD2;TIPIN;KIF13A;DAPK3;ATF5;SLC25A33;CALM2;GIT1
alpha,4,regulation of cytokine-mediated signaling pathway (GO:0001959),8/91,8,91,0.321066281463713,0.747073959670108,0,0,1.23472033584393,1.40277527207858,IKBKB;HSP90AB1;UBB;SPHK1;TNFAIP3;RBCK1;ABCE1;BIRC2
alpha,4,phosphatidylinositol phosphorylation (GO:0046854),3/28,3,28,0.321386517899914,0.747073959670108,0,0,1.50481540930979,1.70813218488964,PIK3CA;PIK3CB;PIK3C2A
alpha,4,protein targeting to vacuole (GO:0006623),3/28,3,28,0.321386517899914,0.747073959670108,0,0,1.50481540930979,1.70813218488964,VPS13C;NCOA4;VPS41
alpha,4,cargo loading into vesicle (GO:0035459),3/28,3,28,0.321386517899914,0.747073959670108,0,0,1.50481540930979,1.70813218488964,SEC24B;SEC24A;KIF13A
alpha,4,regulation of autophagy of mitochondrion (GO:1903146),3/28,3,28,0.321386517899914,0.747073959670108,0,0,1.50481540930979,1.70813218488964,FBXW7;VDAC1;CAMKK2
alpha,4,regulation of protein localization to cell surface (GO:2000008),3/28,3,28,0.321386517899914,0.747073959670108,0,0,1.50481540930979,1.70813218488964,HSP90AB1;CTNNB1;RAB11FIP5
alpha,4,cellular response to glucose stimulus (GO:0071333),3/28,3,28,0.321386517899914,0.747073959670108,0,0,1.50481540930979,1.70813218488964,ERN1;IGF1R;RAB11FIP5
alpha,4,regulation of cilium assembly (GO:1902017),3/28,3,28,0.321386517899914,0.747073959670108,0,0,1.50481540930979,1.70813218488964,ATG3;TBC1D30;TBC1D7
alpha,4,positive regulation of nervous system development (GO:0051962),5/53,5,53,0.325201689541698,0.747073959670108,0,0,1.3249947000212,1.4883794068387,NLGN1;SRPX2;LIG4;ZNF335;ANAPC2
alpha,4,positive regulation of cell-substrate adhesion (GO:0010811),5/53,5,53,0.325201689541698,0.747073959670108,0,0,1.3249947000212,1.4883794068387,FN1;RAC1;CRK;RREB1;S100A10
alpha,4,positive regulation of mitotic cell cycle (GO:0045931),5/53,5,53,0.325201689541698,0.747073959670108,0,0,1.3249947000212,1.4883794068387,GEN1;SPHK1;NUP62;PKN2;EIF4E
alpha,4,positive regulation of proteolysis (GO:0045862),5/53,5,53,0.325201689541698,0.747073959670108,0,0,1.3249947000212,1.4883794068387,IST1;ZC3H12A;SNX9;FADD;CLN6
alpha,4,negative regulation of blood vessel morphogenesis (GO:2000181),6/66,6,66,0.329259207479041,0.747073959670108,0,0,1.27681307456588,1.41842437913851,MECP2;PDE3B;KRIT1;CTNNB1;HSPG2;GTF2I
alpha,4,regulation of cellular response to stress (GO:0080135),9/105,9,105,0.331746950297259,0.747073959670108,0,0,1.20385232744783,1.32830995014363,NUP214;NPM1;HSP90AB1;NUP188;NUP155;BAG3;MAPKAPK2;NUP62;NUP153
alpha,4,peptide metabolic process (GO:0006518),9/105,9,105,0.331746950297259,0.747073959670108,0,0,1.20385232744783,1.32830995014363,MIPEP;CPM;SPCS3;RNPEPL1;LAMP2;TPP1;LTA4H;APEH;SPPL3
alpha,4,"nucleotide-excision repair, DNA incision (GO:0033683)",4/41,4,41,0.333849915693223,0.747073959670108,0,0,1.37023842148534,1.50323888902056,UBB;PAPD7;RFC2;CHD1L
alpha,4,cognition (GO:0050890),4/41,4,41,0.333849915693223,0.747073959670108,0,0,1.37023842148534,1.50323888902056,CHD7;NF1;RP9;SOBP
alpha,4,sensory organ development (GO:0007423),4/41,4,41,0.333849915693223,0.747073959670108,0,0,1.37023842148534,1.50323888902056,SMCHD1;CHD7;ECE1;HIPK2
alpha,4,embryonic organ development (GO:0048568),5/54,5,54,0.339580596911736,0.747073959670108,0,0,1.30045776113192,1.40455155183842,RARG;HEY1;HEY2;COBL;GLI3
alpha,4,negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),5/54,5,54,0.339580596911736,0.747073959670108,0,0,1.30045776113192,1.40455155183842,SMAD3;UBB;SKIL;TGFBR1;BCL9L
alpha,4,calcium ion transport (GO:0006816),10/119,10,119,0.340621713233542,0.747073959670108,0,0,1.18024737985082,1.2711060839791,MCUR1;STIM2;ORAI2;ORAI1;ATP2A2;CACNA1D;TRPM7;PKD2;MICU1;TMCO1
alpha,4,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),3/29,3,29,0.341394885431523,0.747073959670108,0,0,1.45292522278187,1.5614811844663,CRY1;STRN3;FOXP1
alpha,4,cellular response to ketone (GO:1901655),3/29,3,29,0.341394885431523,0.747073959670108,0,0,1.45292522278187,1.5614811844663,GNB1;ADCY3;NR3C1
alpha,4,cellular response to alcohol (GO:0097306),3/29,3,29,0.341394885431523,0.747073959670108,0,0,1.45292522278187,1.5614811844663,PTCH1;GNB1;CTNNB1
alpha,4,positive regulation of sprouting angiogenesis (GO:1903672),3/29,3,29,0.341394885431523,0.747073959670108,0,0,1.45292522278187,1.5614811844663,SRPX2;AKT3;PIK3C2A
alpha,4,positive regulation of calcium-mediated signaling (GO:0050850),3/29,3,29,0.341394885431523,0.747073959670108,0,0,1.45292522278187,1.5614811844663,PKD2;SPPL3;CALM2
alpha,4,regulation of fatty acid biosynthetic process (GO:0042304),3/29,3,29,0.341394885431523,0.747073959670108,0,0,1.45292522278187,1.5614811844663,LPGAT1;ELOVL5;ERLIN1
alpha,4,regulation of actin polymerization or depolymerization (GO:0008064),3/29,3,29,0.341394885431523,0.747073959670108,0,0,1.45292522278187,1.5614811844663,LATS1;FCHSD2;RASA1
alpha,4,neuron projection extension (GO:1990138),3/29,3,29,0.341394885431523,0.747073959670108,0,0,1.45292522278187,1.5614811844663,FLRT3;CTNNB1;SEMA3F
alpha,4,RNA phosphodiester bond hydrolysis (GO:0090501),3/29,3,29,0.341394885431523,0.747073959670108,0,0,1.45292522278187,1.5614811844663,ERN1;RNASEH1;ZC3H12A
alpha,4,JNK cascade (GO:0007254),6/67,6,67,0.342140967492127,0.747073959670108,0,0,1.2577561630052,1.34898428793628,ERN1;MAP4K2;UBB;TNIK;MAP4K3;MAP3K5
alpha,4,positive regulation of cellular metabolic process (GO:0031325),8/93,8,93,0.342769325753644,0.747073959670108,0,0,1.20816721034191,1.29358170560308,PRELID1;ANXA2;TBC1D5;ZC3H12A;ECE1;ARRB1;ARRB2;BVES
alpha,4,regulation of endothelial cell proliferation (GO:0001936),7/80,7,80,0.342971661870349,0.747073959670108,0,0,1.22893258426966,1.31508991850098,NR4A1;EGR3;AKT3;KRIT1;NF1;NRARP;TGFBR1
alpha,4,response to calcium ion (GO:0051592),7/80,7,80,0.342971661870349,0.747073959670108,0,0,1.22893258426966,1.31508991850098,NLGN1;HOMER1;PPIF;BRAF;PKD2;CALM2;ADD1
alpha,4,cell-cell junction assembly (GO:0007043),7/80,7,80,0.342971661870349,0.747073959670108,0,0,1.22893258426966,1.31508991850098,OCLN;PDCD6IP;PARD6A;FSCN1;MICALL2;PKN2;RHOA
alpha,4,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,SRF;SUB1
alpha,4,reverse cholesterol transport (GO:0043691),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,LIPG;CLU
alpha,4,RNA stabilization (GO:0043489),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,CIRBP;AXIN2
alpha,4,negative regulation of B cell activation (GO:0050869),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,TNFAIP3;FOXJ1
alpha,4,"mRNA cis splicing, via spliceosome (GO:0045292)",2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,NCBP2;PSIP1
alpha,4,negative regulation of lipid biosynthetic process (GO:0051055),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,FBXW7;ERLIN1
alpha,4,negative regulation of cell development (GO:0010721),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,SMAD4;FBXW7
alpha,4,cardiac atrium morphogenesis (GO:0003209),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,DLL4;HEY2
alpha,4,positive regulation of stem cell proliferation (GO:2000648),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,CTNNB1;ZNF335
alpha,4,maturation of 5.8S rRNA (GO:0000460),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,WDR37;MPHOSPH6
alpha,4,negative regulation of phosphoprotein phosphatase activity (GO:0032515),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,IKBKB;TIPRL
alpha,4,peptidyl-lysine trimethylation (GO:0018023),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,SETD2;ZNF335
alpha,4,pharyngeal system development (GO:0060037),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,PTCH1;TGFBR1
alpha,4,embryo development ending in birth or egg hatching (GO:0009792),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,UBR3;RAI2
alpha,4,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,PKD2;CALM2
alpha,4,long-term memory (GO:0007616),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,ARC;SGK1
alpha,4,macrophage activation (GO:0042116),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,CLU;FOXP1
alpha,4,regulation of transcription from RNA polymerase I promoter (GO:0006356),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,UTP15;ATF4
alpha,4,regulation of synaptic vesicle exocytosis (GO:2000300),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,NAPA;NLGN1
alpha,4,heterocycle biosynthetic process (GO:0018130),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,MOCS3;LIAS
alpha,4,nucleotide catabolic process (GO:0009166),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,VCP;NT5C2
alpha,4,positive regulation by host of viral transcription (GO:0043923),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,JUN;ZNF639
alpha,4,regulation of establishment or maintenance of cell polarity (GO:0032878),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,KANK1;KRIT1
alpha,4,mesonephric tubule development (GO:0072164),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,SLIT2;PKD2
alpha,4,cellular monovalent inorganic cation homeostasis (GO:0030004),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,ATP1B3;ATP1A1
alpha,4,regulation of cellular protein catabolic process (GO:1903362),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,RDX;DACT1
alpha,4,positive regulation of focal adhesion assembly (GO:0051894),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,RAC1;S100A10
alpha,4,negative regulation of axon guidance (GO:1902668),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,SEMA3F;SLIT2
alpha,4,regulation of telomere maintenance via telomere lengthening (GO:1904356),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,TNKS2;TNKS
alpha,4,2-oxoglutarate metabolic process (GO:0006103),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,STAT5B;GOT1
alpha,4,preassembly of GPI anchor in ER membrane (GO:0016254),2/17,2,17,0.343866140455066,0.747073959670108,0,0,1.65234633179114,1.76388437528461,PIGF;PIGX
alpha,4,odontogenesis (GO:0042476),4/42,4,42,0.350413392852214,0.747073959670108,0,0,1.33761369716426,1.40267750005368,TUFT1;ROGDI;AXIN2;BCOR
alpha,4,response to endoplasmic reticulum stress (GO:0034976),9/107,9,107,0.352124664748608,0.747073959670108,0,0,1.18135041478526,1.23305812818967,ERN1;VCP;JUN;DDIT3;AMFR;ATP2A2;MAP3K5;ATF4;TMCO1
alpha,4,protein targeting to mitochondrion (GO:0006626),5/55,5,55,0.354005035991729,0.747073959670108,0,0,1.27681307456588,1.32589905513817,MIPEP;TIMM9;MFN2;MFF;TOMM20
alpha,4,cellular response to nutrient levels (GO:0031669),5/55,5,55,0.354005035991729,0.747073959670108,0,0,1.27681307456588,1.32589905513817,RRAGA;CDKN2B;MAP1LC3A;LAMP2;FADS1
alpha,4,ERBB signaling pathway (GO:0038127),7/81,7,81,0.354781718857442,0.747073959670108,0,0,1.21376057705646,1.25776249922853,PIK3CA;CUL5;UBB;PLCG1;PIK3C2A;SOS1;EPS15
alpha,4,negative regulation of MAPK cascade (GO:0043409),7/81,7,81,0.354781718857442,0.747073959670108,0,0,1.21376057705646,1.25776249922853,SLC9A3R1;UCHL1;SMAD4;HYAL2;NF1;RANBP9;IGF1R
alpha,4,negative regulation of protein serine/threonine kinase activity (GO:0071901),6/68,6,68,0.355071290501995,0.747073959670108,0,0,1.23925974884336,1.28317501406875,LATS1;UCHL1;HYAL2;TESK1;NF1;IPO5
alpha,4,regulation of cardiac conduction (GO:1903779),6/68,6,68,0.355071290501995,0.747073959670108,0,0,1.23925974884336,1.28317501406875,TMEM65;ATP2A2;ATP1B3;FXYD6;ATP1A1;CALM2
alpha,4,regulation of protein localization to early endosome (GO:1902965),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,RDX
alpha,4,macropinocytosis (GO:0044351),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,MAPKAPK2
alpha,4,hindlimb morphogenesis (GO:0035137),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,RARG
alpha,4,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,FBXW7
alpha,4,regulation of histone H3-K27 methylation (GO:0061085),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,PHF1
alpha,4,arginine biosynthetic process (GO:0006526),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,ASS1
alpha,4,negative regulation of chromosome organization (GO:2001251),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,TERF2IP
alpha,4,nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,EXOSC3
alpha,4,negative regulation of transforming growth factor beta production (GO:0071635),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,HSP90AB1
alpha,4,determination of liver left/right asymmetry (GO:0071910),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,PKD2
alpha,4,vascular smooth muscle cell differentiation (GO:0035886),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,HEY2
alpha,4,positive regulation of ATP biosynthetic process (GO:2001171),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,VCP
alpha,4,negative regulation of oligodendrocyte differentiation (GO:0048715),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,NF1
alpha,4,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,CNOT7
alpha,4,negative regulation of necroptotic process (GO:0060546),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,BIRC2
alpha,4,ventricular cardiac muscle cell development (GO:0055015),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,HEY2
alpha,4,regulation of digestive system process (GO:0044058),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,SGK1
alpha,4,response to lipoteichoic acid (GO:0070391),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,RELA
alpha,4,nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,EXOSC3
alpha,4,bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,DSG2
alpha,4,response to DNA damage checkpoint signaling (GO:0072423),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,MUS81
alpha,4,muscle tissue development (GO:0060537),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,NF1
alpha,4,negative regulation of muscle cell apoptotic process (GO:0010656),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,ZC3H12A
alpha,4,histone H4-K12 acetylation (GO:0043983),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,MEAF6
alpha,4,vascular smooth muscle cell development (GO:0097084),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,HEY2
alpha,4,rRNA transport (GO:0051029),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,NPM1
alpha,4,iron ion import (GO:0097286),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,TFRC
alpha,4,protein localization to endoplasmic reticulum exit site (GO:0070973),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,BCAP29
alpha,4,negative regulation of neural precursor cell proliferation (GO:2000178),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,NF1
alpha,4,positive regulation of vesicle fusion (GO:0031340),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,ANXA2
alpha,4,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,TGFBR1
alpha,4,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,SLC35B2
alpha,4,phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,CDK9
alpha,4,transcription initiation from RNA polymerase III promoter (GO:0006384),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,BDP1
alpha,4,platelet dense granule organization (GO:0060155),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,BLOC1S2
alpha,4,regulation of ribonucleoprotein complex localization (GO:2000197),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,SETD2
alpha,4,pyrimidine-containing compound transmembrane transport (GO:0072531),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,SLC25A33
alpha,4,negative regulation of dendritic spine development (GO:0061000),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,NLGN1
alpha,4,rescue of stalled ribosome (GO:0072344),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,C12ORF65
alpha,4,glandular epithelial cell development (GO:0002068),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,BMP6
alpha,4,regulation of glucokinase activity (GO:0033131),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,MIDN
alpha,4,citrate metabolic process (GO:0006101),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,STAT5B
alpha,4,citrulline metabolic process (GO:0000052),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,ASS1
alpha,4,ammonium transmembrane transport (GO:0072488),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,RHCE
alpha,4,negative regulation of complement activation (GO:0045916),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,CD55
alpha,4,blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,NRARP
alpha,4,negative regulation of cAMP-mediated signaling (GO:0043951),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,PDE3B
alpha,4,photoreceptor cell differentiation (GO:0046530),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,ARL3
alpha,4,embryonic skeletal joint morphogenesis (GO:0060272),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,CTNNB1
alpha,4,deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,PNRC2
alpha,4,regulation of protein localization to cell cortex (GO:1904776),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,EPB41
alpha,4,lymphoid progenitor cell differentiation (GO:0002320),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,LIG4
alpha,4,regulation of chemokine-mediated signaling pathway (GO:0070099),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,SLIT2
alpha,4,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,NR4A3
alpha,4,regulation of interleukin-12 secretion (GO:2001182),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,FOXP1
alpha,4,Golgi disassembly (GO:0090166),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,GOLGA2
alpha,4,response to UV-A (GO:0070141),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,PPID
alpha,4,trigeminal nerve development (GO:0021559),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,TFAP2A
alpha,4,acetyl-CoA biosynthetic process (GO:0006085),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,ACAT1
alpha,4,negative regulation of amino acid transport (GO:0051956),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,STK39
alpha,4,type B pancreatic cell development (GO:0003323),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,BMP6
alpha,4,regulation of hyaluronan biosynthetic process (GO:1900125),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,CLTC
alpha,4,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway (GO:0007196),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,GRM4
alpha,4,positive regulation of microtubule motor activity (GO:2000576),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,DYNLL2
alpha,4,regulation of glial cell differentiation (GO:0045685),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,NF1
alpha,4,mRNA 5'-splice site recognition (GO:0000395),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,PSIP1
alpha,4,white fat cell differentiation (GO:0050872),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,CTBP2
alpha,4,positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,MFN2
alpha,4,regulation of cellular carbohydrate catabolic process (GO:0043471),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,PGAM1
alpha,4,response to heparin (GO:0071503),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,SLIT2
alpha,4,positive regulation of helicase activity (GO:0051096),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,MSH2
alpha,4,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,MOAP1
alpha,4,regulation of keratinocyte apoptotic process (GO:1902172),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,PIAS4
alpha,4,bile acid secretion (GO:0032782),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,SLC9A3R1
alpha,4,positive regulation of histone phosphorylation (GO:0033129),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,CDK9
alpha,4,gland morphogenesis (GO:0022612),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,SLC9A3R1
alpha,4,negative regulation of cytoplasmic translation (GO:2000766),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,CPEB1
alpha,4,positive regulation of protein localization to endosome (GO:1905668),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,RDX
alpha,4,plus-end-directed organelle transport along microtubule (GO:0072386),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,KIF13A
alpha,4,negative regulation of erythrocyte differentiation (GO:0045647),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,LDB1
alpha,4,NADH metabolic process (GO:0006734),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,VCP
alpha,4,regulation of aldosterone biosynthetic process (GO:0032347),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,BMP6
alpha,4,negative regulation of T cell differentiation in thymus (GO:0033085),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,FOXJ1
alpha,4,"heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,HS6ST3
alpha,4,ventricular compact myocardium morphogenesis (GO:0003223),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,TGFBR1
alpha,4,regulation of cell cycle checkpoint (GO:1901976),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,CRY1
alpha,4,glycosyl compound catabolic process (GO:1901658),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,FUCA1
alpha,4,positive regulation of clathrin-dependent endocytosis (GO:2000370),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,NLGN1
alpha,4,heart trabecula formation (GO:0060347),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,HEY1
alpha,4,positive regulation of kidney development (GO:0090184),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,FOXD1
alpha,4,negative regulation of DNA repair (GO:0045738),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,TRIP12
alpha,4,regulation of biosynthetic process (GO:0009889),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,SLC25A33
alpha,4,monoubiquitinated protein deubiquitination (GO:0035520),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,USP47
alpha,4,maintenance of protein location in extracellular region (GO:0071694),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,NBL1
alpha,4,endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,VCP
alpha,4,mitochondrial RNA processing (GO:0000963),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,ELAC2
alpha,4,positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,PAK1
alpha,4,positive regulation of trophoblast cell migration (GO:1901165),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,AGO2
alpha,4,protein localization to nucleolus (GO:1902570),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,RAN
alpha,4,negative regulation of cell cycle phase transition (GO:1901988),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,ATF5
alpha,4,tRNA catabolic process (GO:0016078),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,EXOSC3
alpha,4,insulin secretion involved in cellular response to glucose stimulus (GO:0035773),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,RAB11FIP5
alpha,4,peptidyl-serine autophosphorylation (GO:0036289),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,ERN1
alpha,4,regulation of mRNA export from nucleus (GO:0010793),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,SETD2
alpha,4,negative regulation of interleukin-6 secretion (GO:1900165),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,ZC3H12A
alpha,4,regulation of NFAT protein import into nucleus (GO:0051532),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,SPPL3
alpha,4,regulation of DNA-directed DNA polymerase activity (GO:1900262),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,RFC2
alpha,4,L-amino acid import (GO:0043092),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,SLC25A38
alpha,4,single strand break repair (GO:0000012),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,LIG4
alpha,4,establishment of protein localization to telomere (GO:0070200),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,ACD
alpha,4,regulation of osteoclast development (GO:2001204),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,FBXW7
alpha,4,regulation of microtubule nucleation (GO:0010968),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,MECP2
alpha,4,dendritic spine maintenance (GO:0097062),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,IGF1R
alpha,4,cellular response to lipoteichoic acid (GO:0071223),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,RELA
alpha,4,positive regulation of DNA-directed DNA polymerase activity (GO:1900264),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,RFC2
alpha,4,positive regulation of protein glycosylation (GO:0060050),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,GOLGA2
alpha,4,positive regulation of interferon-gamma secretion (GO:1902715),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,RASGRP1
alpha,4,embryonic camera-type eye morphogenesis (GO:0048596),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,TFAP2A
alpha,4,granzyme-mediated apoptotic signaling pathway (GO:0008626),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,BNIP3
alpha,4,positive regulation of adaptive immune response (GO:0002821),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,FADD
alpha,4,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,PTPRF
alpha,4,regulation of endothelial cell development (GO:1901550),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,IKBKB
alpha,4,protein localization to nuclear envelope (GO:0090435),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,NUP155
alpha,4,regulation of hydrogen peroxide metabolic process (GO:0010310),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,RAC1
alpha,4,negative regulation of translation in response to stress (GO:0032055),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,ATF4
alpha,4,SCF complex assembly (GO:0010265),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,SKP1
alpha,4,regulation of translational initiation in response to stress (GO:0043558),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,ATF4
alpha,4,regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,UBB
alpha,4,positive regulation of protein localization to early endosome (GO:1902966),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,RDX
alpha,4,"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,UBB
alpha,4,negative regulation of cellular response to hypoxia (GO:1900038),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,TMBIM6
alpha,4,activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,PILRB
alpha,4,"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,NDST1
alpha,4,snRNA modification (GO:0040031),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,MEPCE
alpha,4,positive regulation of receptor binding (GO:1900122),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,ANXA2
alpha,4,negative regulation of bone resorption (GO:0045779),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,TNFAIP3
alpha,4,positive regulation of podosome assembly (GO:0071803),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,FSCN1
alpha,4,regulation of adiponectin secretion (GO:0070163),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,RAB11FIP5
alpha,4,ceramide transport (GO:0035627),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,PSAP
alpha,4,negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,CRY1
alpha,4,nucleobase metabolic process (GO:0009112),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,UCK2
alpha,4,positive regulation of fibroblast migration (GO:0010763),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,PRKCE
alpha,4,positive regulation of cGMP biosynthetic process (GO:0030828),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,NOS3
alpha,4,retinal ganglion cell axon guidance (GO:0031290),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,SLIT2
alpha,4,ear development (GO:0043583),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,ECE1
alpha,4,positive regulation of mitochondrial membrane potential (GO:0010918),1/6,1,6,0.358039043358236,0.747073959670108,0,0,2.34082397003745,2.40429128948533,VCP
alpha,4,protein alkylation (GO:0008213),3/30,3,30,0.361356239446307,0.747073959670108,0,0,1.40449438202247,1.42962218308755,PCMT1;KIN;VCP
alpha,4,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),3/30,3,30,0.361356239446307,0.747073959670108,0,0,1.40449438202247,1.42962218308755,DDIT3;CHD6;ATF4
alpha,4,carbohydrate derivative biosynthetic process (GO:1901137),3/30,3,30,0.361356239446307,0.747073959670108,0,0,1.40449438202247,1.42962218308755,GOLPH3;TPI1;ST3GAL2
alpha,4,mitochondrial translation (GO:0032543),9/108,9,108,0.362377538876178,0.747073959670108,0,0,1.17041198501873,1.18804855518793,MRPL2;MRPS16;MRPS27;GATC;MRPL37;MRPS6;MRPL43;DAP3;C12ORF65
alpha,4,regulation of response to external stimulus (GO:0032101),9/108,9,108,0.362377538876178,0.747073959670108,0,0,1.17041198501873,1.18804855518793,HERC5;TRAF3;OTUD7A;TNFAIP3;BIRC2;RELA;CD55;FOXP1;BRD4
alpha,4,cellular response to starvation (GO:0009267),9/108,9,108,0.362377538876178,0.747073959670108,0,0,1.17041198501873,1.18804855518793,RRAGA;MAP1LC3A;MIOS;LAMP2;ZC3H12A;FADS1;GABARAP;MAP3K5;ATF4
alpha,4,positive regulation of epithelial cell proliferation (GO:0050679),9/108,9,108,0.362377538876178,0.747073959670108,0,0,1.17041198501873,1.18804855518793,NR4A1;EGR3;NR4A3;STXBP4;AKT3;NRARP;RREB1;BMP6;TGFBR1
alpha,4,positive regulation of protein catabolic process (GO:0045732),7/82,7,82,0.366629223790682,0.747073959670108,0,0,1.19895861879967,1.20304015091259,BARD1;VCP;RDX;TNFAIP3;SNX9;DACT1;ANAPC2
alpha,4,positive regulation of protein localization to nucleus (GO:1900182),4/43,4,43,0.366981849729372,0.747073959670108,0,0,1.30650640188137,1.30969805059945,CCT2;HYAL2;ZC3H12A;IPO5
alpha,4,negative regulation of protein secretion (GO:0050709),4/43,4,43,0.366981849729372,0.747073959670108,0,0,1.30650640188137,1.30969805059945,MIDN;BMP8A;SERGEF;RAB11FIP5
alpha,4,regulation of interleukin-6 production (GO:0032675),4/43,4,43,0.366981849729372,0.747073959670108,0,0,1.30650640188137,1.30969805059945,ZC3H12A;MAPKAPK2;TNFAIP3;ARRB1
alpha,4,regulation of protein modification process (GO:0031399),4/43,4,43,0.366981849729372,0.747073959670108,0,0,1.30650640188137,1.30969805059945,CDK9;FN1;HSPB1;CORO1C
alpha,4,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),6/69,6,69,0.368034935302403,0.747073959670108,0,0,1.22129946262824,1.22078335665863,USP47;DDX3X;TRIAP1;PAK2;SH3RF1;BIRC2
alpha,4,regulation of endopeptidase activity (GO:0052548),6/69,6,69,0.368034935302403,0.747073959670108,0,0,1.22129946262824,1.22078335665863,VTN;PSMA3;PRELID1;SERPINE2;BIRC2;SERPINB6
alpha,4,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),5/56,5,56,0.36845407860354,0.747073959670108,0,0,1.25401284109149,1.25205556807387,SMAD3;UBB;SKIL;TGFBR1;BCL9L
alpha,4,Golgi organization (GO:0007030),10/122,10,122,0.369580267410205,0.747073959670108,0,0,1.15122490329711,1.14591468235576,GOLGA2;ARHGAP21;GOLPH3;ATP8B3;GORASP2;GORASP1;DYM;YWHAZ;TMED4;CLASP2
alpha,4,glucan catabolic process (GO:0009251),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,GYG1;PGM1
alpha,4,regulation of multicellular organism growth (GO:0040014),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,STAT5B;PTCH1
alpha,4,regulation of telomerase RNA localization to Cajal body (GO:1904872),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,CCT2;SHQ1
alpha,4,nuclear envelope reassembly (GO:0031468),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,ANKLE2;SPAST
alpha,4,regulation of lipid catabolic process (GO:0050994),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,PDE3B;TYSND1
alpha,4,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,BMP6;CD55
alpha,4,establishment or maintenance of apical/basal cell polarity (GO:0035088),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,FSCN1;FOXJ1
alpha,4,negative regulation of RNA splicing (GO:0033119),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,TMBIM6;SRSF9
alpha,4,anion homeostasis (GO:0055081),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,LIPG;PQLC2
alpha,4,prostaglandin biosynthetic process (GO:0001516),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,PTGES2;TBXAS1
alpha,4,glycogen catabolic process (GO:0005980),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,GYG1;PGM1
alpha,4,regulation of smooth muscle cell migration (GO:0014910),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,VTN;SLIT2
alpha,4,snRNA metabolic process (GO:0016073),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,MEPCE;INTS2
alpha,4,positive regulation of natural killer cell mediated immunity (GO:0002717),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,RAET1G;RASGRP1
alpha,4,negative regulation of calcium-mediated signaling (GO:0050849),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,PKD2;CALM2
alpha,4,membrane lipid metabolic process (GO:0006643),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,ARV1;ALOXE3
alpha,4,receptor localization to synapse (GO:0097120),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,NLGN1;KIF5B
alpha,4,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,SMAD4;SMAD3
alpha,4,cardiac muscle cell contraction (GO:0086003),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,CACNA1D;ATP1A1
alpha,4,negative regulation of osteoclast differentiation (GO:0045671),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,FBXW7;TCTA
alpha,4,release of cytochrome c from mitochondria (GO:0001836),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,MFF;CLU
alpha,4,endoplasmic reticulum calcium ion homeostasis (GO:0032469),2/18,2,18,0.370313093222065,0.747073959670108,0,0,1.5605493133583,1.5502597273252,ATP2A2;TMCO1
alpha,4,nucleotide-excision repair (GO:0006289),9/109,9,109,0.37266296746985,0.747073959670108,0,0,1.15967426038553,1.14469224338418,UBE2I;UBB;PAPD7;POLR2A;RFC2;LIG4;CHD1L;POLR2H;PRPF19
alpha,4,Fc receptor mediated stimulatory signaling pathway (GO:0002431),11/136,11,136,0.375677766856324,0.747073959670108,0,0,1.13598810310641,1.11215905555817,PAK1;NR4A3;HSP90AB1;PIK3CA;PRKCE;PLCG1;PIK3CB;RAC1;BAIAP2;CRK;ACTB
alpha,4,heart development (GO:0007507),12/150,12,150,0.380922613799749,0.747073959670108,0,0,1.12359550561798,1.08444835715982,RARG;FLRT3;TCF25;SRF;CHD7;NF1;ECE1;CRELD1;BCOR;PKD2;BVES;TGFBR1
alpha,4,negative regulation of angiogenesis (GO:0016525),6/70,6,70,0.381017005565352,0.747073959670108,0,0,1.20385232744783,1.16161067915936,MECP2;PDE3B;KRIT1;CTNNB1;HSPG2;GTF2I
alpha,4,regulation of defense response to virus by host (GO:0050691),3/31,3,31,0.381221563755154,0.747073959670108,0,0,1.35918811163465,1.31076641090157,RNF216;ZC3H12A;TNFAIP3
alpha,4,activation of JUN kinase activity (GO:0007257),3/31,3,31,0.381221563755154,0.747073959670108,0,0,1.35918811163465,1.31076641090157,ERN1;MAP4K2;MAP3K5
alpha,4,positive regulation of cation channel activity (GO:2001259),3/31,3,31,0.381221563755154,0.747073959670108,0,0,1.35918811163465,1.31076641090157,ARC;PKD2;CALM2
alpha,4,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),3/31,3,31,0.381221563755154,0.747073959670108,0,0,1.35918811163465,1.31076641090157,LATS1;PAK1;STRN3
alpha,4,aminoglycan metabolic process (GO:0006022),3/31,3,31,0.381221563755154,0.747073959670108,0,0,1.35918811163465,1.31076641090157,AGRN;HSPG2;CLN6
alpha,4,ATP-dependent chromatin remodeling (GO:0043044),3/31,3,31,0.381221563755154,0.747073959670108,0,0,1.35918811163465,1.31076641090157,SMARCC1;PBRM1;ACTB
alpha,4,regulation of blood coagulation (GO:0030193),3/31,3,31,0.381221563755154,0.747073959670108,0,0,1.35918811163465,1.31076641090157,VTN;TEC;SERPINE2
alpha,4,regulation of sodium ion transmembrane transport (GO:1902305),3/31,3,31,0.381221563755154,0.747073959670108,0,0,1.35918811163465,1.31076641090157,FXYD6-FXYD2;SLMAP;FXYD6
alpha,4,chondroitin sulfate metabolic process (GO:0030204),3/31,3,31,0.381221563755154,0.747073959670108,0,0,1.35918811163465,1.31076641090157,CHPF;CHSY1;HEXB
alpha,4,negative regulation of endothelial cell proliferation (GO:0001937),3/31,3,31,0.381221563755154,0.747073959670108,0,0,1.35918811163465,1.31076641090157,DLL4;KRIT1;NF1
alpha,4,regulation of BMP signaling pathway (GO:0030510),5/57,5,57,0.382907468192564,0.747073959670108,0,0,1.23201261580919,1.1826851917003,SMAD4;FOXD1;NBL1;SKIL;HIPK2
alpha,4,positive regulation of protein transport (GO:0051222),5/57,5,57,0.382907468192564,0.747073959670108,0,0,1.23201261580919,1.1826851917003,ACHE;GOLPH3;ACSL3;PPID;BMP6
alpha,4,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),4/44,4,44,0.383525628808663,0.747073959670108,0,0,1.27681307456588,1.22363231831205,HINT1;MSH2;CDIP1;HIPK2
alpha,4,positive regulation of protein localization to plasma membrane (GO:1903078),4/44,4,44,0.383525628808663,0.747073959670108,0,0,1.27681307456588,1.22363231831205,CNPY4;KIF5B;PRKCE;ACSL3
alpha,4,histone H3 acetylation (GO:0043966),4/44,4,44,0.383525628808663,0.747073959670108,0,0,1.27681307456588,1.22363231831205,MEAF6;LDB1;TAF9;TAF5L
alpha,4,RNA catabolic process (GO:0006401),4/44,4,44,0.383525628808663,0.747073959670108,0,0,1.27681307456588,1.22363231831205,ERN1;SUPV3L1;RNASEH1;PABPC4
alpha,4,positive regulation of protein metabolic process (GO:0051247),8/97,8,97,0.386685831856475,0.747073959670108,0,0,1.15834588208039,1.1005939066745,BARD1;VCP;LDB1;SCAP;TNFAIP3;CLU;ANAPC2;DACT1
alpha,4,viral gene expression (GO:0019080),9/111,9,111,0.393301561228507,0.747073959670108,0,0,1.13877922866687,1.06268444046937,NUP214;NUP188;NUP155;RPL12;RPLP0;NUP62;NUP153;RPL9;RPL39
alpha,4,negative regulation of smoothened signaling pathway (GO:0045879),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,PTCH1;GLI3
alpha,4,positive regulation of chromosome organization (GO:2001252),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,LIG4;GNL3
alpha,4,negative regulation of lymphocyte activation (GO:0051250),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,TNFAIP3;FOXJ1
alpha,4,protein ADP-ribosylation (GO:0006471),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,TNKS2;TNKS
alpha,4,posttranscriptional gene silencing by RNA (GO:0035194),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,CNOT7;AGO2
alpha,4,sulfur compound transport (GO:0072348),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,SLC35B2;SLC9A3R1
alpha,4,endothelial cell development (GO:0001885),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,RAP1A;RDX
alpha,4,muscle tissue morphogenesis (GO:0060415),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,HEY2;MYLK
alpha,4,cyclic nucleotide biosynthetic process (GO:0009190),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,GUCY1B3;ADCY3
alpha,4,Rac protein signal transduction (GO:0016601),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,RAC1;WASF1
alpha,4,purine ribonucleoside bisphosphate metabolic process (GO:0034035),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,PODXL2;ABHD14B
alpha,4,endocardial cushion development (GO:0003197),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,HEY1;CRELD1
alpha,4,negative regulation of lipid metabolic process (GO:0045833),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,PDE3B;PPP2R5A
alpha,4,positive regulation of lipid storage (GO:0010884),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,HILPDA;ZC3H12A
alpha,4,osteoclast differentiation (GO:0030316),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,ANXA2;FOXP1
alpha,4,leukotriene metabolic process (GO:0006691),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,MAPKAPK2;LTA4H
alpha,4,purine ribonucleotide catabolic process (GO:0009154),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,HINT1;PDE3B
alpha,4,striated muscle cell differentiation (GO:0051146),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,KDM6B;BVES
alpha,4,positive regulation of excitatory postsynaptic potential (GO:2000463),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,NLGN1;GPRIN1
alpha,4,regulation of neuron migration (GO:2001222),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,ZNF609;PLAA
alpha,4,macromolecule biosynthetic process (GO:0009059),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,GALNT2;GLT8D2
alpha,4,regulation of platelet activation (GO:0010543),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,TEC;NOS3
alpha,4,DNA double-strand break processing (GO:0000729),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,BARD1;KAT5
alpha,4,mitochondrial calcium ion homeostasis (GO:0051560),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,MCUR1;MICU1
alpha,4,regulation of cAMP biosynthetic process (GO:0030817),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,CALM2;CAP2
alpha,4,positive regulation of transcription regulatory region DNA binding (GO:2000679),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,RB1;CTNNB1
alpha,4,histone methylation (GO:0016571),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,NTMT1;NSD1
alpha,4,NADP metabolic process (GO:0006739),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,PGLS;RBKS
alpha,4,positive regulation of activated T cell proliferation (GO:0042104),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,TNFSF9;FADD
alpha,4,production of small RNA involved in gene silencing by RNA (GO:0070918),2/19,2,19,0.396322966716718,0.747073959670108,0,0,1.47841513897102,1.36831139504619,AGO2;DROSHA
alpha,4,regulation of neurogenesis (GO:0050767),5/58,5,58,0.397345665754226,0.747073959670108,0,0,1.21077101898489,1.11747951682315,NLGN1;LIG4;CTNNB1;ZNF335;CDK5R1
alpha,4,regulation of Rho protein signal transduction (GO:0035023),5/58,5,58,0.397345665754226,0.747073959670108,0,0,1.21077101898489,1.11747951682315,KANK1;CUL3;STMN1;ARRB1;RAC1
alpha,4,epidermal growth factor receptor signaling pathway (GO:0007173),5/58,5,58,0.397345665754226,0.747073959670108,0,0,1.21077101898489,1.11747951682315,PIK3CA;PLCG1;PIK3C2A;SOS1;EPS15
alpha,4,protein localization to organelle (GO:0033365),8/98,8,98,0.397717784614447,0.747073959670108,0,0,1.14652602614079,1.05711145276299,FAM83H;ARFRP1;DDX3X;DDX1;TTC21A;BBS9;WDR35;UBAC2
alpha,4,amide biosynthetic process (GO:0043604),4/45,4,45,0.400016593710426,0.747073959670108,0,0,1.24843945068664,1.14388170843763,SMPD2;SGMS1;ALOXE3;ASS1
alpha,4,positive regulation of macroautophagy (GO:0016239),4/45,4,45,0.400016593710426,0.747073959670108,0,0,1.24843945068664,1.14388170843763,SCOC;LRSAM1;TBK1;BNIP3
alpha,4,protein N-linked glycosylation via asparagine (GO:0018279),4/45,4,45,0.400016593710426,0.747073959670108,0,0,1.24843945068664,1.14388170843763,DPM1;VCP;RPN2;ST3GAL2
alpha,4,regulation of steroid biosynthetic process (GO:0050810),4/45,4,45,0.400016593710426,0.747073959670108,0,0,1.24843945068664,1.14388170843763,IDI1;SCD;SCAP;RAN
alpha,4,positive regulation of viral process (GO:0048524),4/45,4,45,0.400016593710426,0.747073959670108,0,0,1.24843945068664,1.14388170843763,CDK9;POLR2A;CFL1;POLR2H
alpha,4,myeloid cell differentiation (GO:0030099),4/45,4,45,0.400016593710426,0.747073959670108,0,0,1.24843945068664,1.14388170843763,SLC25A38;CDKN2B;SNRK;HIPK2
alpha,4,positive regulation of viral life cycle (GO:1903902),4/45,4,45,0.400016593710426,0.747073959670108,0,0,1.24843945068664,1.14388170843763,DDX3X;CNOT7;PKN2;PPID
alpha,4,negative regulation of immune system process (GO:0002683),4/45,4,45,0.400016593710426,0.747073959670108,0,0,1.24843945068664,1.14388170843763,LRRC14;TSC22D3;TYRO3;FADD
alpha,4,skeletal system morphogenesis (GO:0048705),3/32,3,32,0.400945796841592,0.747073959670108,0,0,1.31671348314607,1.20338267747052,TFAP2A;RARG;TGFBR1
alpha,4,zinc ion homeostasis (GO:0055069),3/32,3,32,0.400945796841592,0.747073959670108,0,0,1.31671348314607,1.20338267747052,SLC30A5;SLC39A13;SLC39A7
alpha,4,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),3/32,3,32,0.400945796841592,0.747073959670108,0,0,1.31671348314607,1.20338267747052,NOS3;TNFAIP3;FADD
alpha,4,regulation of protein autophosphorylation (GO:0031952),3/32,3,32,0.400945796841592,0.747073959670108,0,0,1.31671348314607,1.20338267747052,ERRFI1;TESK1;CALM2
alpha,4,cellular zinc ion homeostasis (GO:0006882),3/32,3,32,0.400945796841592,0.747073959670108,0,0,1.31671348314607,1.20338267747052,SLC30A5;SLC39A13;SLC39A7
alpha,4,nucleobase-containing small molecule interconversion (GO:0015949),3/32,3,32,0.400945796841592,0.747073959670108,0,0,1.31671348314607,1.20338267747052,TXNRD1;CMPK1;TXN
alpha,4,gene silencing by miRNA (GO:0035195),3/32,3,32,0.400945796841592,0.747073959670108,0,0,1.31671348314607,1.20338267747052,CNOT7;AGO2;RAN
alpha,4,vesicle-mediated transport to the plasma membrane (GO:0098876),3/32,3,32,0.400945796841592,0.747073959670108,0,0,1.31671348314607,1.20338267747052,ARFGEF2;EXOC6;EXOC5
alpha,4,negative regulation of blood vessel endothelial cell migration (GO:0043537),3/32,3,32,0.400945796841592,0.747073959670108,0,0,1.31671348314607,1.20338267747052,DLL4;MECP2;RHOA
alpha,4,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),3/32,3,32,0.400945796841592,0.747073959670108,0,0,1.31671348314607,1.20338267747052,PLCG1;PKD2;CALM2
alpha,4,protein modification process (GO:0036211),7/85,7,85,0.402282412512867,0.747073959670108,0,0,1.1566424322538,1.05323966098413,ATG3;UBE2I;PPP4R2;RPN2;PRKDC;UBE2S;FBXO22
alpha,4,adherens junction assembly (GO:0034333),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,CTNNB1
alpha,4,ATP hydrolysis coupled proton transport (GO:0015991),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ATP1A1
alpha,4,regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,CALM2
alpha,4,intracellular sterol transport (GO:0032366),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ARV1
alpha,4,replication fork protection (GO:0048478),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,TIPIN
alpha,4,tRNA pseudouridine synthesis (GO:0031119),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,PUSL1
alpha,4,smooth muscle cell migration (GO:0014909),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,PARVA
alpha,4,bleb assembly (GO:0032060),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,MYLK
alpha,4,regulation of myosin-light-chain-phosphatase activity (GO:0035507),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,IKBKB
alpha,4,dolichyl diphosphate biosynthetic process (GO:0006489),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,DOLK
alpha,4,response to misfolded protein (GO:0051788),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,CLU
alpha,4,purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SLC35B2
alpha,4,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SPPL3
alpha,4,regulation of DNA endoreduplication (GO:0032875),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,FBXW7
alpha,4,positive regulation of activin receptor signaling pathway (GO:0032927),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ACVR2B
alpha,4,cytoplasmic sequestering of NF-kappaB (GO:0007253),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,FAF1
alpha,4,death-inducing signaling complex assembly (GO:0071550),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,FADD
alpha,4,negative regulation of cardiac muscle cell differentiation (GO:2000726),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SMAD4
alpha,4,miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,AGO2
alpha,4,valine metabolic process (GO:0006573),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,STAT5B
alpha,4,protein import into mitochondrial inner membrane (GO:0045039),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,TIMM9
alpha,4,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SRF
alpha,4,molybdopterin cofactor metabolic process (GO:0043545),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,MOCS3
alpha,4,lymphatic endothelial cell differentiation (GO:0060836),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ACVR2B
alpha,4,tRNA 3'-end processing (GO:0042780),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ELAC2
alpha,4,central nervous system neuron axonogenesis (GO:0021955),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SLIT2
alpha,4,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031659),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,PKD2
alpha,4,regulation of isotype switching (GO:0045191),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,TFRC
alpha,4,"fatty acid elongation, saturated fatty acid (GO:0019367)",1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ELOVL5
alpha,4,retinoic acid receptor signaling pathway (GO:0048384),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,RARG
alpha,4,"fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ELOVL5
alpha,4,phosphorylated carbohydrate dephosphorylation (GO:0046838),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,INPP1
alpha,4,negative regulation of cell adhesion mediated by integrin (GO:0033629),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,PDE3B
alpha,4,positive regulation of phospholipid biosynthetic process (GO:0071073),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ACSL3
alpha,4,regulation of smooth muscle cell differentiation (GO:0051150),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SRF
alpha,4,chromatin-mediated maintenance of transcription (GO:0048096),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SMARCD1
alpha,4,response to type I interferon (GO:0034340),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SETD2
alpha,4,adenine nucleotide transport (GO:0051503),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SLC35B2
alpha,4,positive regulation of lymphocyte apoptotic process (GO:0070230),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,PRELID1
alpha,4,negative regulation of nitrogen compound metabolic process (GO:0051172),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,CLTC
alpha,4,positive regulation of macrophage migration (GO:1905523),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,KARS
alpha,4,regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SCAP
alpha,4,regulation of histone H3-K9 acetylation (GO:2000615),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SMAD4
alpha,4,regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,CACNA1D
alpha,4,regulation of interleukin-23 production (GO:0032667),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,RAC1
alpha,4,inositol phosphate dephosphorylation (GO:0046855),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,INPP1
alpha,4,positive regulation of urine volume (GO:0035810),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,HYAL2
alpha,4,cellular lipid biosynthetic process (GO:0097384),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ACAT1
alpha,4,regulation of vitamin D biosynthetic process (GO:0060556),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SNAI1
alpha,4,peroxisome proliferator activated receptor signaling pathway (GO:0035357),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ALOXE3
alpha,4,negative regulation of nitric oxide metabolic process (GO:1904406),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ZC3H12A
alpha,4,positive regulation of triglyceride catabolic process (GO:0010898),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ABHD5
alpha,4,negative regulation of macrophage activation (GO:0043031),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ZC3H12A
alpha,4,regulation of alpha-beta T cell differentiation (GO:0046637),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,GLI3
alpha,4,negative regulation of cardiocyte differentiation (GO:1905208),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,HEY2
alpha,4,positive regulation of RIG-I signaling pathway (GO:1900246),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ANKRD17
alpha,4,negative regulation of receptor internalization (GO:0002091),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SDCBP
alpha,4,negative regulation of alpha-beta T cell activation (GO:0046636),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,GLI3
alpha,4,regulation of glucocorticoid receptor signaling pathway (GO:2000322),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,CRY1
alpha,4,purine ribonucleotide transport (GO:0015868),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SLC35B2
alpha,4,auditory receptor cell differentiation (GO:0042491),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,JAG2
alpha,4,negative regulation of B cell apoptotic process (GO:0002903),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,FOXP1
alpha,4,regulation of toll-like receptor 3 signaling pathway (GO:0034139),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,TNFAIP3
alpha,4,positive regulation of mRNA binding (GO:1902416),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,CDK9
alpha,4,V(D)J recombination (GO:0033151),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,LIG4
alpha,4,activation of signaling protein activity involved in unfolded protein response (GO:0006987),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ERN1
alpha,4,regulation of establishment of protein localization (GO:0070201),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,KIAA0586
alpha,4,positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,HSPB1
alpha,4,regulation of growth hormone secretion (GO:0060123),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,CHD7
alpha,4,positive regulation of ceramide biosynthetic process (GO:2000304),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SMPD2
alpha,4,vascular smooth muscle contraction (GO:0014829),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,PIK3C2A
alpha,4,regulation of NADP metabolic process (GO:1902031),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,PGAM1
alpha,4,positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,GEN1
alpha,4,cell differentiation in spinal cord (GO:0021515),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,MDGA1
alpha,4,"fatty acid elongation, monounsaturated fatty acid (GO:0034625)",1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ELOVL5
alpha,4,negative regulation of nitric oxide biosynthetic process (GO:0045019),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ZC3H12A
alpha,4,molybdopterin cofactor biosynthetic process (GO:0032324),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,MOCS3
alpha,4,alditol metabolic process (GO:0019400),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,COQ2
alpha,4,SA node cell action potential (GO:0086015),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,CACNA1D
alpha,4,regulation of protein deubiquitination (GO:0090085),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ZC3H12A
alpha,4,regulation of microtubule binding (GO:1904526),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,TTBK2
alpha,4,protein maturation by iron-sulfur cluster transfer (GO:0097428),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ISCA1
alpha,4,positive regulation of macrophage chemotaxis (GO:0010759),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,KARS
alpha,4,positive regulation of type I interferon-mediated signaling pathway (GO:0060340),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,FADD
alpha,4,positive regulation of myeloid cell apoptotic process (GO:0033034),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,PIK3CB
alpha,4,outer mitochondrial membrane organization (GO:0007008),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,TOMM20
alpha,4,sensory organ morphogenesis (GO:0090596),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,GLI3
alpha,4,"regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,DACT1
alpha,4,excitatory chemical synaptic transmission (GO:0098976),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,GPRIN1
alpha,4,negative regulation of necrotic cell death (GO:0060547),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,BIRC2
alpha,4,regulation of transcription involved in cell fate commitment (GO:0060850),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,RORA
alpha,4,metanephric nephron tubule development (GO:0072234),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,PKD2
alpha,4,cellular response to cholesterol (GO:0071397),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,PTCH1
alpha,4,marginal zone B cell differentiation (GO:0002315),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,LFNG
alpha,4,ER overload response (GO:0006983),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,TMCO1
alpha,4,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,CD55
alpha,4,membrane invagination (GO:0010324),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,FCHO2
alpha,4,microglial cell activation (GO:0001774),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,CLU
alpha,4,cAMP catabolic process (GO:0006198),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,PDE3B
alpha,4,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031658),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,CDKN2B
alpha,4,"substrate-dependent cell migration, cell extension (GO:0006930)",1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SDCBP
alpha,4,histone H3-K4 demethylation (GO:0034720),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,KDM5B
alpha,4,positive regulation of keratinocyte proliferation (GO:0010838),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,STXBP4
alpha,4,cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,DSG2
alpha,4,cardiac atrium development (GO:0003230),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,DLL4
alpha,4,negative regulation of muscle hypertrophy (GO:0014741),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SMAD4
alpha,4,venous blood vessel development (GO:0060841),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ACVR2B
alpha,4,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ZC3H12A
alpha,4,regulation of hormone biosynthetic process (GO:0046885),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,STC2
alpha,4,"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,EXOSC3
alpha,4,ATP hydrolysis coupled cation transmembrane transport (GO:0099132),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ATP1A1
alpha,4,negative regulation of leukocyte migration (GO:0002686),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SLIT2
alpha,4,positive regulation of sphingolipid biosynthetic process (GO:0090154),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SMPD2
alpha,4,positive regulation of glutamate receptor signaling pathway (GO:1900451),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ARC
alpha,4,negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SARM1
alpha,4,exonucleolytic trimming involved in rRNA processing (GO:0000459),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,EXOSC3
alpha,4,tachykinin receptor signaling pathway (GO:0007217),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,GRK5
alpha,4,"fatty acid elongation, unsaturated fatty acid (GO:0019368)",1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ELOVL5
alpha,4,regulation of MDA-5 signaling pathway (GO:0039533),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ANKRD17
alpha,4,regulation of cardiac muscle cell membrane potential (GO:0086036),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ATP2A2
alpha,4,cellular response to laminar fluid shear stress (GO:0071499),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ASS1
alpha,4,positive regulation of cellular senescence (GO:2000774),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,HMGA1
alpha,4,regulation of low-density lipoprotein particle clearance (GO:0010988),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ANXA2
alpha,4,nucleoside diphosphate metabolic process (GO:0009132),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,CMPK1
alpha,4,ribosomal protein import into nucleus (GO:0006610),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,IPO5
alpha,4,positive regulation of histone H4 acetylation (GO:0090240),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,ARRB1
alpha,4,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,SEC62
alpha,4,nucleic acid transport (GO:0050657),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,CKAP5
alpha,4,nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,RELA
alpha,4,dolichyl diphosphate metabolic process (GO:0046465),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,DOLK
alpha,4,retrograde axonal transport (GO:0008090),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,PAFAH1B1
alpha,4,positive regulation of autophagy of mitochondrion (GO:1903599),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,CAMKK2
alpha,4,cellular response to leptin stimulus (GO:0044320),1/7,1,7,0.403760304885243,0.747073959670108,0,0,2.00642054574639,1.81969077414805,NR4A3
alpha,4,response to insulin (GO:0032868),6/72,6,72,0.406978764195876,0.747073959670108,0,0,1.17041198501873,1.05219366962042,CPEB1;GOT1;PRKDC;PDE3B;SLC25A33;RHOQ
alpha,4,protein dephosphorylation (GO:0006470),10/126,10,126,0.408549235726708,0.747073959670108,0,0,1.11467808097022,0.997796107377218,PHLPP2;DUSP5;PPP4R2;UBLCP1;PPP2R2B;PPP2R5A;PPM1D;PTPRF;CTTNBP2NL;PPM1G
alpha,4,negative regulation of multicellular organismal process (GO:0051241),10/126,10,126,0.408549235726708,0.747073959670108,0,0,1.11467808097022,0.997796107377218,CHSY1;FBXW7;SFMBT1;DDIT3;PTCH1;SRF;WWC3;PTPN23;CORO1C;RAB11FIP5
alpha,4,phosphatidylinositol biosynthetic process (GO:0006661),8/99,8,99,0.408753063258462,0.747073959670108,0,0,1.13494495516967,1.01537176550726,DPM1;INPP4A;PIK3CA;SACM1L;PITPNM2;PIK3CB;PIK3C2A;PIGF
alpha,4,peptidyl-asparagine modification (GO:0018196),4/46,4,46,0.416428164505628,0.747073959670108,0,0,1.22129946262824,1.06990877677917,DPM1;VCP;RPN2;ST3GAL2
alpha,4,negative regulation of ossification (GO:0030279),4/46,4,46,0.416428164505628,0.747073959670108,0,0,1.22129946262824,1.06990877677917,CHSY1;PTCH1;AXIN2;BCOR
alpha,4,hexose metabolic process (GO:0019318),4/46,4,46,0.416428164505628,0.747073959670108,0,0,1.22129946262824,1.06990877677917,HECTD4;FUCA1;SLC37A4;PGM1
alpha,4,cell-cell junction organization (GO:0045216),6/73,6,73,0.419930675786264,0.747073959670108,0,0,1.15437894412806,1.00161494418192,SDK1;OCLN;PARD6A;SMAD3;FSCN1;DSG2
alpha,4,glycoprotein biosynthetic process (GO:0009101),6/73,6,73,0.419930675786264,0.747073959670108,0,0,1.15437894412806,1.00161494418192,GOLGA2;B3GALNT2;GOLPH3;FAM20B;DOLK;ST3GAL2
alpha,4,dendrite morphogenesis (GO:0048813),3/33,3,33,0.420487749317196,0.747073959670108,0,0,1.27681307456588,1.10615415424291,ARC;BTBD3;MAP6D1
alpha,4,cellular response to amino acid stimulus (GO:0071230),3/33,3,33,0.420487749317196,0.747073959670108,0,0,1.27681307456588,1.10615415424291,RRAGA;CPEB1;IPO5
alpha,4,cellular response to glucagon stimulus (GO:0071377),3/33,3,33,0.420487749317196,0.747073959670108,0,0,1.27681307456588,1.10615415424291,GNG5;GNB1;ADCY3
alpha,4,central nervous system neuron differentiation (GO:0021953),3/33,3,33,0.420487749317196,0.747073959670108,0,0,1.27681307456588,1.10615415424291,RYK;CTNNB1;MDGA1
alpha,4,negative regulation of BMP signaling pathway (GO:0030514),3/33,3,33,0.420487749317196,0.747073959670108,0,0,1.27681307456588,1.10615415424291,SKIL;NBL1;HIPK2
alpha,4,regulation of potassium ion transmembrane transport (GO:1901379),3/33,3,33,0.420487749317196,0.747073959670108,0,0,1.27681307456588,1.10615415424291,CAB39;STK39;CACNA1D
alpha,4,ATP biosynthetic process (GO:0006754),3/33,3,33,0.420487749317196,0.747073959670108,0,0,1.27681307456588,1.10615415424291,SURF1;ATP5C1;ATP5F1
alpha,4,GPI anchor biosynthetic process (GO:0006506),3/33,3,33,0.420487749317196,0.747073959670108,0,0,1.27681307456588,1.10615415424291,DPM1;PIGF;PIGX
alpha,4,activation of adenylate cyclase activity (GO:0007190),3/33,3,33,0.420487749317196,0.747073959670108,0,0,1.27681307456588,1.10615415424291,GNAL;ADCY3;CAP2
alpha,4,regulation of erythrocyte differentiation (GO:0045646),3/33,3,33,0.420487749317196,0.747073959670108,0,0,1.27681307456588,1.10615415424291,STAT5B;LDB1;ETS1
alpha,4,vasculogenesis (GO:0001570),3/33,3,33,0.420487749317196,0.747073959670108,0,0,1.27681307456588,1.10615415424291,RASA1;HEY2;RASIP1
alpha,4,global genome nucleotide-excision repair (GO:0070911),3/33,3,33,0.420487749317196,0.747073959670108,0,0,1.27681307456588,1.10615415424291,UBE2I;UBB;CHD1L
alpha,4,positive regulation of dendrite development (GO:1900006),3/33,3,33,0.420487749317196,0.747073959670108,0,0,1.27681307456588,1.10615415424291,NLGN1;CDKL5;COBL
alpha,4,regulation of vacuole organization (GO:0044088),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,ANXA2;TBC1D12
alpha,4,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,DDIT3;TMBIM6
alpha,4,negative regulation of phosphate metabolic process (GO:0045936),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,ANKLE2;CDKN2B
alpha,4,regulation of epidermal cell differentiation (GO:0045604),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,ERRFI1;CTSV
alpha,4,cellular polysaccharide catabolic process (GO:0044247),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,GYG1;PGM1
alpha,4,endoplasmic reticulum mannose trimming (GO:1904380),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,UBB;AMFR
alpha,4,regulation of anoikis (GO:2000209),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,BRMS1;PIK3CA
alpha,4,positive regulation of gene silencing by miRNA (GO:2000637),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,MAP2K1;AGO2
alpha,4,branching involved in ureteric bud morphogenesis (GO:0001658),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,FOXD1;PKD2
alpha,4,negative regulation of telomere maintenance via telomerase (GO:0032211),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,ACD;NAT10
alpha,4,growth hormone receptor signaling pathway (GO:0060396),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,SOCS2;STAT5B
alpha,4,positive regulation of interferon-alpha production (GO:0032727),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,SETD2;TBK1
alpha,4,dorsal/ventral pattern formation (GO:0009953),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,PTCH1;NBL1
alpha,4,telomere maintenance via telomerase (GO:0007004),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,HSP90AB1;TERF2IP
alpha,4,inositol phosphate-mediated signaling (GO:0048016),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,NFAT5;NFATC3
alpha,4,vesicle cytoskeletal trafficking (GO:0099518),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,KIF5B;PAFAH1B1
alpha,4,heparan sulfate proteoglycan metabolic process (GO:0030201),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,NDST1;HS6ST3
alpha,4,eye morphogenesis (GO:0048592),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,RARG;NF1
alpha,4,chondroitin sulfate biosynthetic process (GO:0030206),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,CHPF;CHSY1
alpha,4,cellular response to steroid hormone stimulus (GO:0071383),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,ATP1A1;NR3C1
alpha,4,dopaminergic neuron differentiation (GO:0071542),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,RYK;CTNNB1
alpha,4,positive regulation of cAMP biosynthetic process (GO:0030819),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,NF1;CALM2
alpha,4,mesoderm formation (GO:0001707),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,KDM6B;SNAI1
alpha,4,negative regulation of intracellular protein transport (GO:0090317),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,BARD1;CABP1
alpha,4,regulation of cholesterol transport (GO:0032374),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,ARV1;LIPG
alpha,4,mitochondrial respiratory chain complex IV assembly (GO:0033617),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,SURF1;PET117
alpha,4,axon extension (GO:0048675),2/20,2,20,0.421823935760667,0.747073959670108,0,0,1.40449438202247,1.21231357561982,SEMA3F;SLIT2
alpha,4,response to lipid (GO:0033993),11/141,11,141,0.421975500834852,0.747073959670108,0,0,1.09570483703881,0.945382922620928,SOCS2;STAT5B;JUN;RARG;NOS3;MAPKAPK2;CTNNB1;LIAS;RELT;FOXP1;STRN3
alpha,4,viral transcription (GO:0019083),9/114,9,114,0.424319146229457,0.747073959670108,0,0,1.10881135422827,0.950550048253174,NUP214;NUP188;NUP155;RPL12;RPLP0;NUP62;NUP153;RPL9;RPL39
alpha,4,regulation of peptidyl-serine phosphorylation (GO:0033135),7/87,7,87,0.42603356458505,0.747073959670108,0,0,1.13005295105256,0.964203154458147,LATS1;PAK1;TBK1;NSD1;TERF2IP;BRAF;TXN
alpha,4,renal system development (GO:0072001),5/60,5,60,0.426102142134853,0.747073959670108,0,0,1.17041198501873,0.998450598295242,TFAP2A;HYAL2;ARL3;PTCH1;TGFBR1
alpha,4,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),5/60,5,60,0.426102142134853,0.747073959670108,0,0,1.17041198501873,0.998450598295242,SDCBP;SMAD4;BMP8A;TGFBR1;BMP6
alpha,4,protein lipidation (GO:0006497),10/128,10,128,0.428075869104453,0.747073959670108,0,0,1.09726123595506,0.930976600736319,DPM1;CPM;ZDHHC18;ZDHHC9;RAET1G;ABHD17C;ULBP2;ZDHHC2;PIGF;MDGA1
alpha,4,positive regulation of protein localization to cell periphery (GO:1904377),4/47,4,47,0.432735338859256,0.747073959670108,0,0,1.1953143676787,1.00122993606,CNPY4;EPB41;KIF5B;PRKCE
alpha,4,transcription-coupled nucleotide-excision repair (GO:0006283),6/74,6,74,0.432845510541291,0.747073959670108,0,0,1.13877922866687,0.953584577018009,PAPD7;POLR2A;UBB;RFC2;POLR2H;PRPF19
alpha,4,positive regulation of proteasomal protein catabolic process (GO:1901800),6/74,6,74,0.432845510541291,0.747073959670108,0,0,1.13877922866687,0.953584577018009,RNF144A;VCP;ANKIB1;FBXW7;ARIH1;CLU
alpha,4,protein N-linked glycosylation (GO:0006487),6/74,6,74,0.432845510541291,0.747073959670108,0,0,1.13877922866687,0.953584577018009,DPM1;VCP;RPN2;ENTPD5;MOGS;ST3GAL2
alpha,4,positive regulation of NF-kappaB transcription factor activity (GO:0051092),10/129,10,129,0.437828834140433,0.747073959670108,0,0,1.08875533490114,0.899232682930028,IKBKB;NPM1;UBB;SPHK1;TERF2IP;RBCK1;CLU;RELA;MTDH;NFKB2
alpha,4,mitochondrial translational elongation (GO:0070125),7/88,7,88,0.437872306371349,0.747073959670108,0,0,1.11721144024515,0.922624432382009,MRPL2;MRPS16;MRPS27;MRPL37;MRPS6;MRPL43;DAP3
alpha,4,glycogen metabolic process (GO:0005977),3/34,3,34,0.439809996450409,0.747073959670108,0,0,1.23925974884336,1.01794341323039,UBB;GYG1;PGM1
alpha,4,protein acetylation (GO:0006473),3/34,3,34,0.439809996450409,0.747073959670108,0,0,1.23925974884336,1.01794341323039,NAA30;ESCO1;NAA16
alpha,4,"chemical synaptic transmission, postsynaptic (GO:0099565)",3/34,3,34,0.439809996450409,0.747073959670108,0,0,1.23925974884336,1.01794341323039,MPP2;GPRIN1;ARRB2
alpha,4,regulation of T cell differentiation (GO:0045580),3/34,3,34,0.439809996450409,0.747073959670108,0,0,1.23925974884336,1.01794341323039,PRELID1;ZMIZ1;ZBTB1
alpha,4,regulation of autophagosome assembly (GO:2000785),3/34,3,34,0.439809996450409,0.747073959670108,0,0,1.23925974884336,1.01794341323039,LRSAM1;FEZ2;TBC1D12
alpha,4,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),3/34,3,34,0.439809996450409,0.747073959670108,0,0,1.23925974884336,1.01794341323039,SLC9A3R1;UBB;DDIT3
alpha,4,mRNA stabilization (GO:0048255),3/34,3,34,0.439809996450409,0.747073959670108,0,0,1.23925974884336,1.01794341323039,MAPKAPK2;CIRBP;AXIN2
alpha,4,regulation of postsynaptic membrane potential (GO:0060078),3/34,3,34,0.439809996450409,0.747073959670108,0,0,1.23925974884336,1.01794341323039,MPP2;GPRIN1;ARRB2
alpha,4,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),3/34,3,34,0.439809996450409,0.747073959670108,0,0,1.23925974884336,1.01794341323039,SLC9A3R1;PDCD6IP;RHOA
alpha,4,positive regulation of Notch signaling pathway (GO:0045747),3/34,3,34,0.439809996450409,0.747073959670108,0,0,1.23925974884336,1.01794341323039,DLL4;JAG2;ZMIZ1
alpha,4,positive regulation of organelle organization (GO:0010638),3/34,3,34,0.439809996450409,0.747073959670108,0,0,1.23925974884336,1.01794341323039,ANXA2;KATNBL1;LIG4
alpha,4,muscle organ development (GO:0007517),5/61,5,61,0.44038524615828,0.747073959670108,0,0,1.15122490329711,0.944125731831117,COPRS;ACHE;EGR3;TCF12;BVES
alpha,4,protein processing (GO:0016485),8/102,8,102,0.441793699607887,0.747073959670108,0,0,1.1015642211941,0.899881305167905,CPM;SPCS3;PTCH1;TYSND1;ECE1;PCSK7;RHBDL2;SPPL3
alpha,4,regulation of kinase activity (GO:0043549),8/102,8,102,0.441793699607887,0.747073959670108,0,0,1.1015642211941,0.899881305167905,RB1;SLC9A3R1;LDB1;RYK;TYRO3;LMTK2;IGF1R;CAMKK2
alpha,4,protein insertion into mitochondrial membrane (GO:0051204),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,MOAP1
alpha,4,regulation of DNA methylation (GO:0044030),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,MECP2
alpha,4,positive regulation of macrophage differentiation (GO:0045651),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,FADD
alpha,4,cell migration involved in heart development (GO:0060973),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,FLRT3
alpha,4,lipoprotein transport (GO:0042953),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,UNC119B
alpha,4,aminoglycoside antibiotic metabolic process (GO:0030647),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,AKR7A2
alpha,4,mast cell activation involved in immune response (GO:0002279),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,NR4A3
alpha,4,stress-induced premature senescence (GO:0090400),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,WNT16
alpha,4,positive regulation of isotype switching (GO:0045830),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,TFRC
alpha,4,DNA recombinase assembly (GO:0000730),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,SWI5
alpha,4,cellular response to forskolin (GO:1904322),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,ADCY3
alpha,4,negative regulation of protein homooligomerization (GO:0032463),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,CLU
alpha,4,T-helper 17 cell differentiation (GO:0072539),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,RORA
alpha,4,organophosphate catabolic process (GO:0046434),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,LIPG
alpha,4,lagging strand elongation (GO:0006273),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,LIG4
alpha,4,DNA repair complex assembly (GO:0090735),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,SWI5
alpha,4,regulation of T cell mediated immunity (GO:0002709),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,ZBTB1
alpha,4,transepithelial transport (GO:0070633),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,SLC12A2
alpha,4,protein localization to microtubule (GO:0035372),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,CRIPT
alpha,4,regulation of ATP biosynthetic process (GO:2001169),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,VCP
alpha,4,sequestering of extracellular ligand from receptor (GO:0035581),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,NBL1
alpha,4,cellular response to UV-B (GO:0071493),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,HYAL2
alpha,4,response to forskolin (GO:1904321),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,ADCY3
alpha,4,positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,CALM2
alpha,4,positive regulation of spindle checkpoint (GO:0090232),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,GEN1
alpha,4,bundle of His cell to Purkinje myocyte communication (GO:0086069),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,DSG2
alpha,4,insulin metabolic process (GO:1901142),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,ERN1
alpha,4,nodal signaling pathway (GO:0038092),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,SMAD3
alpha,4,central nervous system myelination (GO:0022010),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,CLU
alpha,4,"negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,UBAC2
alpha,4,negative regulation of calcium ion transmembrane transport (GO:1903170),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,SESTD1
alpha,4,glycosyl compound metabolic process (GO:1901657),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,KL
alpha,4,regulation of toll-like receptor 2 signaling pathway (GO:0034135),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,TNFAIP3
alpha,4,isoprenoid biosynthetic process (GO:0008299),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,IDI1
alpha,4,regulation of store-operated calcium entry (GO:2001256),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,HOMER1
alpha,4,positive regulation of protein localization to cell surface (GO:2000010),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,HSP90AB1
alpha,4,genetic imprinting (GO:0071514),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,DNMT3A
alpha,4,negative regulation of hippo signaling (GO:0035331),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,WWC3
alpha,4,positive regulation of tumor necrosis factor biosynthetic process (GO:0042535),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,HSPB1
alpha,4,angiogenesis involved in wound healing (GO:0060055),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,SRF
alpha,4,diol biosynthetic process (GO:0034312),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,SPHK1
alpha,4,B cell mediated immunity (GO:0019724),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,MSH2
alpha,4,sphingosine biosynthetic process (GO:0046512),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,SPHK1
alpha,4,double-strand break repair via synthesis-dependent strand annealing (GO:0045003),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,SWI5
alpha,4,heterochromatin assembly (GO:0031507),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,HMGA1
alpha,4,inositol phosphate catabolic process (GO:0071545),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,INPP1
alpha,4,positive regulation of mRNA 3'-end processing (GO:0031442),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,NCBP2
alpha,4,membrane fusion involved in viral entry into host cell (GO:0039663),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,HYAL2
alpha,4,positive regulation of vasculogenesis (GO:2001214),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,RAP1A
alpha,4,establishment of protein localization to chromatin (GO:0071169),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,LRWD1
alpha,4,phospholipid homeostasis (GO:0055091),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,LIPG
alpha,4,ketone body biosynthetic process (GO:0046951),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,ACAT1
alpha,4,cGMP-mediated signaling (GO:0019934),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,GUCY1B3
alpha,4,polyol transport (GO:0015791),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,SLC5A3
alpha,4,peripheral nervous system axon ensheathment (GO:0032292),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,NF1
alpha,4,pyrimidine nucleobase metabolic process (GO:0006206),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,UCK2
alpha,4,glomerular epithelial cell development (GO:0072310),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,FOXJ1
alpha,4,response to hydroperoxide (GO:0033194),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,STX2
alpha,4,short-chain fatty acid catabolic process (GO:0019626),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,ACADS
alpha,4,peptidyl-diphthamide metabolic process (GO:0017182),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,DPH6
alpha,4,mast cell degranulation (GO:0043303),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,NR4A3
alpha,4,negative regulation of bone remodeling (GO:0046851),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,TNFAIP3
alpha,4,fusion of virus membrane with host plasma membrane (GO:0019064),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,HYAL2
alpha,4,negative regulation of vascular permeability (GO:0043116),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,SLIT2
alpha,4,nucleotide phosphorylation (GO:0046939),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,CMPK1
alpha,4,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,MAP2K1
alpha,4,regulation of protein localization to Cajal body (GO:1904869),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,CCT2
alpha,4,acid secretion (GO:0046717),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,SLC9A3R1
alpha,4,bone resorption (GO:0045453),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,TPP1
alpha,4,regulation of amyloid fibril formation (GO:1905906),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,CLU
alpha,4,positive regulation of TORC1 signaling (GO:1904263),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,RRAGA
alpha,4,peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,DPH6
alpha,4,osteoblast development (GO:0002076),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,ACHE
alpha,4,peptidyl-lysine acetylation (GO:0018394),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,ESCO1
alpha,4,mammary gland epithelial cell differentiation (GO:0060644),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,LATS1
alpha,4,regulation of dopamine receptor signaling pathway (GO:0060159),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,DTNBP1
alpha,4,peptidyl-lysine monomethylation (GO:0018026),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,SETD2
alpha,4,aldehyde biosynthetic process (GO:0046184),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,TPI1
alpha,4,depyrimidination (GO:0045008),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,UNG
alpha,4,lipoprotein localization (GO:0044872),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,UNC119B
alpha,4,response to leptin (GO:0044321),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,NR4A3
alpha,4,telomeric D-loop disassembly (GO:0061820),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,RECQL4
alpha,4,arginine catabolic process (GO:0006527),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,NOS3
alpha,4,tRNA aminoacylation for mitochondrial protein translation (GO:0070127),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,GARS
alpha,4,kidney mesenchyme development (GO:0072074),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,PKD2
alpha,4,regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,ATP2A2
alpha,4,exocyst localization (GO:0051601),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,EXOC8
alpha,4,regulation of stress-activated protein kinase signaling cascade (GO:0070302),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,MAP2K1
alpha,4,positive regulation of smooth muscle cell apoptotic process (GO:0034393),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,MFN2
alpha,4,histone H2A-K119 monoubiquitination (GO:0036353),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,BMI1
alpha,4,positive regulation of cell aging (GO:0090343),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,HMGA1
alpha,4,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,SESTD1
alpha,4,cellular response to prostaglandin E stimulus (GO:0071380),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,GNB1
alpha,4,mRNA cleavage (GO:0006379),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,ERN1
alpha,4,regulation of chaperone-mediated autophagy (GO:1904714),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,CTSA
alpha,4,negative regulation of glial cell differentiation (GO:0045686),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,NF1
alpha,4,nucleoside diphosphate phosphorylation (GO:0006165),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,CMPK1
alpha,4,positive regulation of membrane potential (GO:0045838),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,VCP
alpha,4,myelin maintenance (GO:0043217),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,CLU
alpha,4,protein lipoylation (GO:0009249),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,LIAS
alpha,4,cellular response to angiotensin (GO:1904385),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,RELA
alpha,4,positive regulation of protein localization to Cajal body (GO:1904871),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,CCT2
alpha,4,aorta development (GO:0035904),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,PKD2
alpha,4,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,ARRB2
alpha,4,negative regulation of anion transmembrane transport (GO:1903960),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,STK39
alpha,4,development of primary female sexual characteristics (GO:0046545),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,LHFPL2
alpha,4,negative regulation of platelet aggregation (GO:0090331),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,SERPINE2
alpha,4,regulation of histone H4 acetylation (GO:0090239),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,ARRB1
alpha,4,positive regulation of alpha-beta T cell differentiation (GO:0046638),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,GLI3
alpha,4,daunorubicin metabolic process (GO:0044597),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,AKR7A2
alpha,4,positive regulation of DNA recombination (GO:0045911),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,TFRC
alpha,4,"nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,PNRC2
alpha,4,coronary vasculature morphogenesis (GO:0060977),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,TGFBR1
alpha,4,regulation of protein deacetylation (GO:0090311),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,BRMS1
alpha,4,cellular cation homeostasis (GO:0030003),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,LETM2
alpha,4,desmosome organization (GO:0002934),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,DSG2
alpha,4,regulation of muscle organ development (GO:0048634),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,SFMBT1
alpha,4,negative regulation of execution phase of apoptosis (GO:1900118),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,PAK2
alpha,4,DNA damage induced protein phosphorylation (GO:0006975),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,CRY1
alpha,4,regulation of endodeoxyribonuclease activity (GO:0032071),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,NPM1
alpha,4,regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,SARM1
alpha,4,spleen development (GO:0048536),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,FADD
alpha,4,excitatory synapse assembly (GO:1904861),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,NLGN1
alpha,4,protein desumoylation (GO:0016926),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,SENP5
alpha,4,Schwann cell development (GO:0014044),1/8,1,8,0.446227358230753,0.747073959670108,0,0,1.75561797752809,1.4166549947924,NF1
alpha,4,positive regulation of cellular component movement (GO:0051272),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,ETS1;TGFBR1
alpha,4,viral budding via host ESCRT complex (GO:0039702),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,PDCD6IP;VPS37A
alpha,4,cortical actin cytoskeleton organization (GO:0030866),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,IKBKB;RHOQ
alpha,4,positive regulation of T cell mediated immunity (GO:0002711),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,ZBTB1;FADD
alpha,4,regulation of cardiac muscle hypertrophy (GO:0010611),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,SMAD4;NR4A3
alpha,4,phospholipid translocation (GO:0045332),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,ATP8B3;ATP9B
alpha,4,positive regulation of histone acetylation (GO:0035066),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,SMAD4;ARRB1
alpha,4,negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,STMN1;CRY1
alpha,4,regulation of macrophage activation (GO:0043030),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,KARS;ZC3H12A
alpha,4,establishment of endothelial barrier (GO:0061028),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,RAP1A;RDX
alpha,4,mitochondrial ATP synthesis coupled proton transport (GO:0042776),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,ATP5C1;ATP5F1
alpha,4,positive regulation of BMP signaling pathway (GO:0030513),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,SMAD4;FOXD1
alpha,4,regulation of interleukin-2 production (GO:0032663),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,KAT5;TNFAIP3
alpha,4,cellular response to misfolded protein (GO:0071218),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,VCP;CUL3
alpha,4,mitochondrial respiratory chain complex IV biogenesis (GO:0097034),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,SURF1;PET117
alpha,4,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,LATS1;IPO5
alpha,4,long-term synaptic potentiation (GO:0060291),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,MPP2;ARC
alpha,4,ERK1 and ERK2 cascade (GO:0070371),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,MAP2K1;KARS
alpha,4,"synaptic transmission, glutamatergic (GO:0035249)",2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,NAPA;GRIK4
alpha,4,negative regulation of cell cycle arrest (GO:0071157),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,CDK9;HSP90AB1
alpha,4,RNA-dependent DNA biosynthetic process (GO:0006278),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,HSP90AB1;TERF2IP
alpha,4,positive regulation of leukocyte cell-cell adhesion (GO:1903039),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,NR4A3;ETS1
alpha,4,cellular protein complex localization (GO:0034629),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,EXOC8;MIOS
alpha,4,negative regulation of macroautophagy (GO:0016242),2/21,2,21,0.446756604047388,0.747073959670108,0,0,1.33761369716426,1.07777065627214,PIK3CA;FEZ2
alpha,4,regulation of intrinsic apoptotic signaling pathway (GO:2001242),4/48,4,48,0.448914701780647,0.749969190474798,0,0,1.17041198501873,0.937409156191083,SLC9A3R1;DDX3X;SGMS1;PPIF
alpha,4,histone H4 acetylation (GO:0043967),4/48,4,48,0.448914701780647,0.749969190474798,0,0,1.17041198501873,0.937409156191083,MEAF6;KANSL1;PHF20;MSL2
alpha,4,negative regulation of translation (GO:0017148),7/89,7,89,0.449673170761379,0.750879427660925,0,0,1.1046585027143,0.88288090692829,CPEB1;DDX3X;CNOT7;NCL;EIF4A3;DAPK3;AGO2
alpha,4,regulation of JUN kinase activity (GO:0043506),3/35,3,35,0.458878751379583,0.756709184394691,0,0,1.20385232744783,0.937763959107464,PAK1;MAP3K4;MAP3K5
alpha,4,ventricular cardiac muscle tissue morphogenesis (GO:0055010),3/35,3,35,0.458878751379583,0.756709184394691,0,0,1.20385232744783,0.937763959107464,DLL4;SMAD4;TGFBR1
alpha,4,regulation of insulin receptor signaling pathway (GO:0046626),3/35,3,35,0.458878751379583,0.756709184394691,0,0,1.20385232744783,0.937763959107464,SOCS2;KANK1;CISH
alpha,4,cellular macromolecular complex assembly (GO:0034622),3/35,3,35,0.458878751379583,0.756709184394691,0,0,1.20385232744783,0.937763959107464,SHQ1;KIF13A;SNX9
alpha,4,macromolecule catabolic process (GO:0009057),3/35,3,35,0.458878751379583,0.756709184394691,0,0,1.20385232744783,0.937763959107464,LRSAM1;TPP1;CLN6
alpha,4,regulation of interleukin-8 production (GO:0032677),3/35,3,35,0.458878751379583,0.756709184394691,0,0,1.20385232744783,0.937763959107464,DDIT3;ARRB1;FADD
alpha,4,keratan sulfate metabolic process (GO:0042339),3/35,3,35,0.458878751379583,0.756709184394691,0,0,1.20385232744783,0.937763959107464,HEXB;B4GALT6;ST3GAL2
alpha,4,negative regulation of cellular protein metabolic process (GO:0032269),7/90,7,90,0.461426570612917,0.756709184394691,0,0,1.09238451935081,0.844885523680091,DNAJC1;DDX3X;CNOT7;SERPINE2;NCL;EIF4A3;DAPK3
alpha,4,regulation of mitochondrion organization (GO:0010821),4/49,4,49,0.464944423832478,0.756709184394691,0,0,1.14652602614079,0.87805250994902,GOLPH3;FBXW7;VDAC1;MFF
alpha,4,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),4/49,4,49,0.464944423832478,0.756709184394691,0,0,1.14652602614079,0.87805250994902,MOAP1;MSH2;CDIP1;HIPK2
alpha,4,negative regulation of mitotic cell cycle (GO:0045930),4/49,4,49,0.464944423832478,0.756709184394691,0,0,1.14652602614079,0.87805250994902,SLC9A3R1;SMAD3;CTNNB1;HECA
alpha,4,regulation of cell cycle arrest (GO:0071156),4/49,4,49,0.464944423832478,0.756709184394691,0,0,1.14652602614079,0.87805250994902,CDK9;HSP90AB1;PKD2;SLC25A33
alpha,4,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",5/63,5,63,0.46867946855362,0.756709184394691,0,0,1.11467808097022,0.84474337892861,NPM1;CNOT7;UBB;CNOT11;TRIAP1
alpha,4,tRNA processing (GO:0008033),5/63,5,63,0.46867946855362,0.756709184394691,0,0,1.11467808097022,0.84474337892861,KARS;ELAC2;DDX1;WDR4;RPP14
alpha,4,positive regulation of catabolic process (GO:0009896),5/63,5,63,0.46867946855362,0.756709184394691,0,0,1.11467808097022,0.84474337892861,BARD1;VCP;TNFAIP3;DACT1;ANAPC2
alpha,4,establishment of protein localization to vacuole (GO:0072666),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,VPS13C;VPS41
alpha,4,cellular response to nerve growth factor stimulus (GO:1990090),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,RAP1A;WASF1
alpha,4,positive regulation of protein targeting to membrane (GO:0090314),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,MIEF2;MFF
alpha,4,cellular response to hexose stimulus (GO:0071331),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,ERN1;IGF1R
alpha,4,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,ATP2A2;CALM2
alpha,4,early endosome to late endosome transport (GO:0045022),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,LMTK2;PTPN23
alpha,4,negative regulation of response to endoplasmic reticulum stress (GO:1903573),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,TMBIM6;CLU
alpha,4,peripheral nervous system development (GO:0007422),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,UGT8;NF1
alpha,4,histone lysine methylation (GO:0034968),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,SETD1B;KDM6A
alpha,4,positive regulation of erythrocyte differentiation (GO:0045648),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,STAT5B;ETS1
alpha,4,negative regulation of sprouting angiogenesis (GO:1903671),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,DLL4;RHOA
alpha,4,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,UBB;CHD1L
alpha,4,regulation of cytokine production involved in inflammatory response (GO:1900015),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,KARS;ZC3H12A
alpha,4,branched-chain amino acid metabolic process (GO:0009081),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,STAT5B;ACAT1
alpha,4,beta-catenin destruction complex disassembly (GO:1904886),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,FRAT1;CTNNB1
alpha,4,inner ear morphogenesis (GO:0042472),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,TFAP2A;CHD7
alpha,4,positive regulation of RNA splicing (GO:0033120),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,ERN1;POLR2A
alpha,4,regulation of bone resorption (GO:0045124),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,NF1;TNFAIP3
alpha,4,regulation of monocyte chemotaxis (GO:0090025),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,SLIT2;NBL1
alpha,4,positive regulation of phosphatase activity (GO:0010922),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,HSP90AB1;CALM2
alpha,4,regulation of calcium ion transport into cytosol (GO:0010522),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,GPRIN1;TMBIM6
alpha,4,regulation of calcium ion import (GO:0090279),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,CTNNB1;PKD2
alpha,4,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,FBXW7;CLU
alpha,4,lipid translocation (GO:0034204),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,ATP8B3;ATP9B
alpha,4,activation of phospholipase C activity (GO:0007202),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,AVPR1B;GNAQ
alpha,4,outflow tract septum morphogenesis (GO:0003148),2/22,2,22,0.471072600386,0.756709184394691,0,0,1.27681307456588,0.961112175558341,SMAD4;PARVA
alpha,4,positive regulation of protein serine/threonine kinase activity (GO:0071902),9/119,9,119,0.475710181894675,0.756709184394691,0,0,1.06222264186574,0.789174563984989,MAP2K1;DDX3X;CAB39;CKS2;CCNYL1;MAPRE3;RASGRP1;CALM2;RHOA
alpha,4,anatomical structure homeostasis (GO:0060249),3/36,3,36,0.477663722813641,0.756709184394691,0,0,1.17041198501873,0.864756908739657,RECQL4;ACD;TERF2IP
alpha,4,regulation of cardiac muscle contraction (GO:0055117),3/36,3,36,0.477663722813641,0.756709184394691,0,0,1.17041198501873,0.864756908739657,ZC3H12A;ATP2A2;CALM2
alpha,4,carbohydrate catabolic process (GO:0016052),3/36,3,36,0.477663722813641,0.756709184394691,0,0,1.17041198501873,0.864756908739657,TPI1;PGAM1;PGM1
alpha,4,neural crest cell development (GO:0014032),3/36,3,36,0.477663722813641,0.756709184394691,0,0,1.17041198501873,0.864756908739657,KLHL12;SEMA3F;CORO1C
alpha,4,sulfur compound catabolic process (GO:0044273),3/36,3,36,0.477663722813641,0.756709184394691,0,0,1.17041198501873,0.864756908739657,HEXB;CHAC2;ACAT1
alpha,4,protein kinase B signaling (GO:0043491),3/36,3,36,0.477663722813641,0.756709184394691,0,0,1.17041198501873,0.864756908739657,NR4A1;MKRN1;TYRO3
alpha,4,antibacterial humoral response (GO:0019731),3/36,3,36,0.477663722813641,0.756709184394691,0,0,1.17041198501873,0.864756908739657,HIST1H2BJ;HIST1H2BK;RPL39
alpha,4,glutathione metabolic process (GO:0006749),4/50,4,50,0.480804249974777,0.756709184394691,0,0,1.12359550561798,0.822803434177967,GCLC;CHAC2;HAGH;GCLM
alpha,4,establishment of protein localization to mitochondrion (GO:0072655),4/50,4,50,0.480804249974777,0.756709184394691,0,0,1.12359550561798,0.822803434177967,TIMM9;MFN2;MFF;TOMM20
alpha,4,lipid homeostasis (GO:0055088),4/50,4,50,0.480804249974777,0.756709184394691,0,0,1.12359550561798,0.822803434177967,FBXW7;LIPG;ACOX3;ABHD5
alpha,4,negative regulation of neuron apoptotic process (GO:0043524),5/64,5,64,0.482660448750579,0.756709184394691,0,0,1.09726123595506,0.799291034509302,SET;MSH2;RASA1;TYRO3;LIG4
alpha,4,synapse assembly (GO:0007416),5/64,5,64,0.482660448750579,0.756709184394691,0,0,1.09726123595506,0.799291034509302,ACHE;SDK1;NLGN1;FLRT3;RYK
alpha,4,kidney development (GO:0001822),5/64,5,64,0.482660448750579,0.756709184394691,0,0,1.09726123595506,0.799291034509302,TFAP2A;HYAL2;ARL3;NF1;TGFBR1
alpha,4,lipid transport (GO:0006869),7/92,7,92,0.484754328892488,0.756709184394691,0,0,1.06863702979971,0.773814024061415,NCOA1;PRELID1;SCP2;CHKA;STARD7;PSAP;TRIAP1
alpha,4,type B pancreatic cell differentiation (GO:0003309),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,BMP6
alpha,4,negative regulation of circadian rhythm (GO:0042754),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,CRY1
alpha,4,inositol metabolic process (GO:0006020),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,SLC5A3
alpha,4,secretory granule organization (GO:0033363),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,BLOC1S2
alpha,4,negative regulation of cytokine production involved in inflammatory response (GO:1900016),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,ZC3H12A
alpha,4,integrin activation (GO:0033622),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,FN1
alpha,4,ATF6-mediated unfolded protein response (GO:0036500),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,DDIT3
alpha,4,regulation of interleukin-6 biosynthetic process (GO:0045408),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,FOXJ1
alpha,4,galactose catabolic process (GO:0019388),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,PGM1
alpha,4,cellular response to interleukin-4 (GO:0071353),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,STAT6
alpha,4,anoikis (GO:0043276),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,PIK3CA
alpha,4,negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,TNFAIP3
alpha,4,postsynaptic membrane assembly (GO:0097104),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,NLGN1
alpha,4,sarcoplasmic reticulum calcium ion transport (GO:0070296),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,ATP2A2
alpha,4,regulation of interleukin-1 secretion (GO:0050704),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,FOXP1
alpha,4,regulation of SNARE complex assembly (GO:0035542),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,VPS41
alpha,4,vasodilation (GO:0042311),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,NOS3
alpha,4,embryonic forelimb morphogenesis (GO:0035115),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,TFAP2A
alpha,4,mitochondrial respiratory chain complex III assembly (GO:0034551),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,SLC25A33
alpha,4,negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,ARRB2
alpha,4,Cdc42 protein signal transduction (GO:0032488),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,RHOQ
alpha,4,peptidyl-arginine omega-N-methylation (GO:0035247),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,NDUFAF7
alpha,4,positive regulation of leukocyte apoptotic process (GO:2000108),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,PIK3CB
alpha,4,regulation of endoplasmic reticulum unfolded protein response (GO:1900101),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,ERN1
alpha,4,response to dopamine (GO:1903350),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,ATF4
alpha,4,sphingoid biosynthetic process (GO:0046520),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,SPHK1
alpha,4,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,UBAC2
alpha,4,negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,SLC9A3R1
alpha,4,nucleoside phosphate biosynthetic process (GO:1901293),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,CMPK1
alpha,4,cell junction maintenance (GO:0034331),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,PARD6A
alpha,4,respiratory chain complex III assembly (GO:0017062),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,SLC25A33
alpha,4,positive regulation of astrocyte differentiation (GO:0048711),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,SERPINE2
alpha,4,early endosome to Golgi transport (GO:0034498),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,TRAPPC10
alpha,4,positive regulation of autophagosome assembly (GO:2000786),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,LRSAM1
alpha,4,regulation of cytokine secretion involved in immune response (GO:0002739),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,KARS
alpha,4,Golgi vesicle budding (GO:0048194),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,GOLPH3
alpha,4,protein localization to vacuole (GO:0072665),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,CD81
alpha,4,positive regulation of immunoglobulin mediated immune response (GO:0002891),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,TFRC
alpha,4,nucleoside triphosphate biosynthetic process (GO:0009142),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,CMPK1
alpha,4,positive regulation of establishment of protein localization to telomere (GO:1904851),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,CCT2
alpha,4,mitotic DNA replication checkpoint (GO:0033314),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,RAD17
alpha,4,mitochondrial protein processing (GO:0034982),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,MIPEP
alpha,4,pinocytosis (GO:0006907),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,MAPKAPK2
alpha,4,doxorubicin metabolic process (GO:0044598),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,AKR7A2
alpha,4,engulfment of apoptotic cell (GO:0043652),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,RAC1
alpha,4,negative regulation of lymphocyte apoptotic process (GO:0070229),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,FOXP1
alpha,4,cellular response to superoxide (GO:0071451),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,NOS3
alpha,4,toll-like receptor 3 signaling pathway (GO:0034138),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,FADD
alpha,4,peroxisome fission (GO:0016559),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,MFF
alpha,4,postsynaptic density organization (GO:0097106),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,NLGN1
alpha,4,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,DENND6A
alpha,4,protein hexamerization (GO:0034214),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,SPAST
alpha,4,potassium ion import across plasma membrane (GO:1990573),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,ATP1A1
alpha,4,positive regulation of cytokine production involved in inflammatory response (GO:1900017),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,KARS
alpha,4,hexose catabolic process (GO:0019320),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,PGM1
alpha,4,B cell homeostasis (GO:0001782),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,TNFAIP3
alpha,4,regulation of helicase activity (GO:0051095),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,MSH2
alpha,4,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,CALM2
alpha,4,regulation of homotypic cell-cell adhesion (GO:0034110),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,RDX
alpha,4,T cell mediated immunity (GO:0002456),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,GNL1
alpha,4,mast cell mediated immunity (GO:0002448),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,NR4A3
alpha,4,negative regulation of amyloid-beta formation (GO:1902430),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,CLU
alpha,4,negative regulation of transcription by competitive promoter binding (GO:0010944),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,TFAP2A
alpha,4,positive regulation of vascular endothelial cell proliferation (GO:1905564),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,AKT3
alpha,4,axonal transport of mitochondrion (GO:0019896),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,SPAST
alpha,4,cellular response to acidic pH (GO:0071468),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,RAB11FIP5
alpha,4,negative regulation of microtubule polymerization (GO:0031115),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,STMN1
alpha,4,mesodermal cell differentiation (GO:0048333),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,KDM6B
alpha,4,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,HLA-B
alpha,4,tRNA wobble uridine modification (GO:0002098),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,MOCS3
alpha,4,nuclear RNA surveillance (GO:0071027),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,EXOSC6
alpha,4,proton-transporting V-type ATPase complex assembly (GO:0070070),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,DMXL1
alpha,4,sphingosine metabolic process (GO:0006670),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,SPHK1
alpha,4,regulation of nephron tubule epithelial cell differentiation (GO:0072182),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,CTNNB1
alpha,4,negative regulation of peptidyl-lysine acetylation (GO:2000757),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,SET
alpha,4,histone H3-K4 trimethylation (GO:0080182),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,ZNF335
alpha,4,cyclic nucleotide catabolic process (GO:0009214),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,PDE3B
alpha,4,removal of superoxide radicals (GO:0019430),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,NOS3
alpha,4,negative regulation of NIK/NF-kappaB signaling (GO:1901223),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,RELA
alpha,4,positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901838),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,NCL
alpha,4,small RNA loading onto RISC (GO:0070922),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,AGO2
alpha,4,ornithine metabolic process (GO:0006591),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,ODC1
alpha,4,megakaryocyte differentiation (GO:0030219),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,CDKN2B
alpha,4,response to UV-C (GO:0010225),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,MAP3K4
alpha,4,negative regulation of response to reactive oxygen species (GO:1901032),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,TXN
alpha,4,actin filament reorganization (GO:0090527),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,WHAMM
alpha,4,neuronal ion channel clustering (GO:0045161),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,AGRN
alpha,4,microtubule anchoring at centrosome (GO:0034454),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,CEP19
alpha,4,pericardium development (GO:0060039),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,DLL4
alpha,4,regulation of endothelial cell differentiation (GO:0045601),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,APOLD1
alpha,4,positive regulation of mitochondrial translation (GO:0070131),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,MRPS27
alpha,4,mature B cell differentiation involved in immune response (GO:0002313),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,LFNG
alpha,4,positive regulation of synapse maturation (GO:0090129),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,ANAPC2
alpha,4,regulation of morphogenesis of an epithelium (GO:1905330),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,FOXP1
alpha,4,positive regulation of ion transmembrane transport (GO:0034767),1/9,1,9,0.485671669984188,0.756709184394691,0,0,1.5605493133583,1.12706376334312,STK39
alpha,4,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),10/134,10,134,0.48626426341721,0.757296803682541,0,0,1.04813013583767,0.755705025756612,PAK1;HSP90AB1;PIK3CA;PRKCE;PLCG1;PIK3CB;RAC1;BAIAP2;CRK;ACTB
alpha,4,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),2/23,2,23,0.494733311874262,0.762779606226704,0,0,1.22129946262824,0.859472918281926,LATS1;UBB
alpha,4,vesicle-mediated transport between endosomal compartments (GO:0098927),2/23,2,23,0.494733311874262,0.762779606226704,0,0,1.22129946262824,0.859472918281926,LMTK2;PTPN23
alpha,4,peroxisome organization (GO:0007031),2/23,2,23,0.494733311874262,0.762779606226704,0,0,1.22129946262824,0.859472918281926,ABCD3;MFF
alpha,4,positive regulation of ATP metabolic process (GO:1903580),2/23,2,23,0.494733311874262,0.762779606226704,0,0,1.22129946262824,0.859472918281926,VCP;ENTPD5
alpha,4,cellular nitrogen compound biosynthetic process (GO:0044271),2/23,2,23,0.494733311874262,0.762779606226704,0,0,1.22129946262824,0.859472918281926,NOS3;SPHK1
alpha,4,cellular response to interleukin-6 (GO:0071354),2/23,2,23,0.494733311874262,0.762779606226704,0,0,1.22129946262824,0.859472918281926,SMAD4;RELA
alpha,4,positive regulation of ion transmembrane transporter activity (GO:0032414),2/23,2,23,0.494733311874262,0.762779606226704,0,0,1.22129946262824,0.859472918281926,STK39;ATP1B3
alpha,4,positive regulation of cell junction assembly (GO:1901890),2/23,2,23,0.494733311874262,0.762779606226704,0,0,1.22129946262824,0.859472918281926,RAC1;S100A10
alpha,4,regulation of ion homeostasis (GO:2000021),2/23,2,23,0.494733311874262,0.762779606226704,0,0,1.22129946262824,0.859472918281926,SLC30A5;SLC30A4
alpha,4,regulation of natural killer cell mediated cytotoxicity (GO:0042269),2/23,2,23,0.494733311874262,0.762779606226704,0,0,1.22129946262824,0.859472918281926,ARRB2;RASGRP1
alpha,4,mitotic G2/M transition checkpoint (GO:0044818),2/23,2,23,0.494733311874262,0.762779606226704,0,0,1.22129946262824,0.859472918281926,MUS81;RAD17
alpha,4,negative regulation of viral transcription (GO:0032897),2/23,2,23,0.494733311874262,0.762779606226704,0,0,1.22129946262824,0.859472918281926,JUN;ZNF639
alpha,4,Fc-gamma receptor signaling pathway (GO:0038094),10/135,10,135,0.495847922205486,0.762779606226704,0,0,1.04036620890553,0.729802338460128,PAK1;HSP90AB1;PIK3CA;PRKCE;PLCG1;PIK3CB;RAC1;BAIAP2;CRK;ACTB
alpha,4,regulation of smoothened signaling pathway (GO:0008589),3/37,3,37,0.496137961516186,0.762779606226704,0,0,1.13877922866687,0.798171776550793,PTCH1;RORA;GLI3
alpha,4,organophosphate biosynthetic process (GO:0090407),3/37,3,37,0.496137961516186,0.762779606226704,0,0,1.13877922866687,0.798171776550793,MOCS3;TPI1;FADS1
alpha,4,heart looping (GO:0001947),3/37,3,37,0.496137961516186,0.762779606226704,0,0,1.13877922866687,0.798171776550793,SRF;FOXN4;PKD2
alpha,4,histone deacetylation (GO:0016575),3/37,3,37,0.496137961516186,0.762779606226704,0,0,1.13877922866687,0.798171776550793,BRMS1;SUDS3;TBL1X
alpha,4,endosome organization (GO:0007032),3/37,3,37,0.496137961516186,0.762779606226704,0,0,1.13877922866687,0.798171776550793,ARFGEF2;EXOC8;DNAJC13
alpha,4,centromere complex assembly (GO:0034508),3/37,3,37,0.496137961516186,0.762779606226704,0,0,1.13877922866687,0.798171776550793,NPM1;CENPW;POGZ
alpha,4,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",3/37,3,37,0.496137961516186,0.762779606226704,0,0,1.13877922866687,0.798171776550793,GNB1;AGO2;CTNNB1
alpha,4,negative regulation of blood coagulation (GO:0030195),3/37,3,37,0.496137961516186,0.762779606226704,0,0,1.13877922866687,0.798171776550793,VTN;SERPINE2;NOS3
alpha,4,inner mitochondrial membrane organization (GO:0007007),3/37,3,37,0.496137961516186,0.762779606226704,0,0,1.13877922866687,0.798171776550793,TIMM9;ATP5C1;ATP5F1
alpha,4,secondary alcohol biosynthetic process (GO:1902653),3/37,3,37,0.496137961516186,0.762779606226704,0,0,1.13877922866687,0.798171776550793,IDI1;ARV1;ACAT1
alpha,4,regulation of muscle cell differentiation (GO:0051147),3/37,3,37,0.496137961516186,0.762779606226704,0,0,1.13877922866687,0.798171776550793,CDK9;SRF;CTNNB1
alpha,4,fatty acid metabolic process (GO:0006631),8/107,8,107,0.496164583133055,0.762779606226704,0,0,1.05008925758689,0.735952521752383,STAT5B;ACBD5;ACOT7;ABCD3;GPX4;ACSL1;ALOXE3;LPIN2
alpha,4,negative regulation of cell communication (GO:0010648),6/79,6,79,0.496435859463056,0.762779606226704,0,0,1.06670459394112,0.747014282335599,BRAP;RYK;TYRO3;LMTK2;BRAF;IGF1R
alpha,4,extracellular matrix disassembly (GO:0022617),6/79,6,79,0.496435859463056,0.762779606226704,0,0,1.06670459394112,0.747014282335599,KIF9;EXOC8;ADAM15;FN1;CTSV;HSPG2
alpha,4,fibroblast growth factor receptor signaling pathway (GO:0008543),6/79,6,79,0.496435859463056,0.762779606226704,0,0,1.06670459394112,0.747014282335599,KL;POLR2A;UBB;NCBP2;FLRT3;POLR2H
alpha,4,heart morphogenesis (GO:0003007),4/51,4,51,0.496475479857189,0.762779606226704,0,0,1.1015642211941,0.77133860178891,HEY1;CHD7;HEY2;TGFBR1
alpha,4,blood circulation (GO:0008015),4/51,4,51,0.496475479857189,0.762779606226704,0,0,1.1015642211941,0.77133860178891,DLL4;GCLC;NOS3;GCLM
alpha,4,inorganic anion transmembrane transport (GO:0098661),5/65,5,65,0.496512016798492,0.762779606226704,0,0,1.08038029386344,0.756425662026457,SLC12A2;SLC20A2;SLC37A4;SLC12A7;CLCN2
alpha,4,cotranslational protein targeting to membrane (GO:0006613),7/94,7,94,0.507785819482575,0.765282830871989,0,0,1.04590007171886,0.708801809183119,TRAM1;RPL12;RPLP0;SRP14;SEC62;RPL9;RPL39
alpha,4,negative regulation of cell adhesion (GO:0007162),5/66,5,66,0.51022125707046,0.765282830871989,0,0,1.06401089547157,0.715984433468398,CD164;RASA1;PDE3B;RHOA;RND1
alpha,4,chromatin assembly (GO:0031497),5/66,5,66,0.51022125707046,0.765282830871989,0,0,1.06401089547157,0.715984433468398,NPM1;CDAN1;HIST1H2BJ;HIST1H2BK;CTCF
alpha,4,carboxylic acid transport (GO:0046942),4/52,4,52,0.511940940562082,0.765282830871989,0,0,1.08038029386344,0.723364316184841,SLC7A6;SLC16A1;PSAP;SLC16A3
alpha,4,arachidonic acid metabolic process (GO:0019369),4/52,4,52,0.511940940562082,0.765282830871989,0,0,1.08038029386344,0.723364316184841,PTGES2;TBXAS1;DAGLB;ALOXE3
alpha,4,protein monoubiquitination (GO:0006513),3/38,3,38,0.514277698756268,0.765282830871989,0,0,1.10881135422827,0.737350557510064,RNF20;CUL3;KLHL12
alpha,4,positive regulation of axonogenesis (GO:0050772),3/38,3,38,0.514277698756268,0.765282830871989,0,0,1.10881135422827,0.737350557510064,CDKL5;SLIT2;RHOA
alpha,4,regulation of peptidyl-threonine phosphorylation (GO:0010799),3/38,3,38,0.514277698756268,0.765282830871989,0,0,1.10881135422827,0.737350557510064,CAB39;SPHK1;CALM2
alpha,4,response to steroid hormone (GO:0048545),3/38,3,38,0.514277698756268,0.765282830871989,0,0,1.10881135422827,0.737350557510064,CATSPERD;ATP1A1;NR3C1
alpha,4,organic cyclic compound biosynthetic process (GO:1901362),3/38,3,38,0.514277698756268,0.765282830871989,0,0,1.10881135422827,0.737350557510064,MOCS3;SCP2;LIAS
alpha,4,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),3/38,3,38,0.514277698756268,0.765282830871989,0,0,1.10881135422827,0.737350557510064,HIP1R;DYNLL2;YWHAZ
alpha,4,regulation of cytokine production (GO:0001817),8/109,8,109,0.517497602690343,0.765282830871989,0,0,1.03082156478714,0.679054104046772,CD83;TBK1;UBB;TRAF3;MAPKAPK2;HILPDA;DDX41;FOXP1
alpha,4,regulation of androgen receptor signaling pathway (GO:0060765),2/24,2,24,0.517708740934502,0.765282830871989,0,0,1.17041198501873,0.770531918360733,ARRB2;FOXP1
alpha,4,regulation of hydrolase activity (GO:0051336),6/81,6,81,0.521206665272168,0.765282830871989,0,0,1.04036620890553,0.677911616202279,RDX;NF1;BVES;CRK;RASIP1;PAFAH1B1
alpha,4,regulation of chromatin organization (GO:1902275),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,CDK9
alpha,4,negative regulation of cellular protein catabolic process (GO:1903363),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,ANXA2
alpha,4,cellular response to growth hormone stimulus (GO:0071378),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,SOCS2
alpha,4,3'-UTR-mediated mRNA destabilization (GO:0061158),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,ZC3H12A
alpha,4,regulation of mammary gland epithelial cell proliferation (GO:0033599),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,RREB1
alpha,4,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,WASF1
alpha,4,mitotic nuclear envelope reassembly (GO:0007084),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,ANKLE2
alpha,4,positive regulation of amyloid-beta formation (GO:1902004),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,CLU
alpha,4,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,SLC9A3R1
alpha,4,mesoderm morphogenesis (GO:0048332),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,SNAI1
alpha,4,response to laminar fluid shear stress (GO:0034616),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,ASS1
alpha,4,galactose metabolic process (GO:0006012),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,PGM1
alpha,4,nerve growth factor signaling pathway (GO:0038180),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,RAP1A
alpha,4,regulation of respiratory burst (GO:0060263),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,RAC1
alpha,4,hair cell differentiation (GO:0035315),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,CTNNB1
alpha,4,glutamine metabolic process (GO:0006541),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,NIT2
alpha,4,"base-excision repair, AP site formation (GO:0006285)",1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,UNG
alpha,4,neuroepithelial cell differentiation (GO:0060563),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,BCCIP
alpha,4,peptidyl-lysine dimethylation (GO:0018027),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,SETD2
alpha,4,positive regulation of lipase activity (GO:0060193),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,RHOA
alpha,4,creatine metabolic process (GO:0006600),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,STAT5B
alpha,4,neurotransmitter receptor transport (GO:0099637),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,HIP1
alpha,4,mitotic G1 DNA damage checkpoint (GO:0031571),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,PRKDC
alpha,4,nuclear pore complex assembly (GO:0051292),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,NUP153
alpha,4,negative regulation of gene silencing by miRNA (GO:0060965),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,ZC3H12A
alpha,4,positive regulation of fertilization (GO:1905516),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,LHFPL2
alpha,4,regulation of urine volume (GO:0035809),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,HYAL2
alpha,4,regulation of pH (GO:0006885),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,SLC9A7
alpha,4,positive regulation of natural killer cell activation (GO:0032816),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,ZBTB1
alpha,4,glycerolipid metabolic process (GO:0046486),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,DGKZ
alpha,4,positive regulation of T cell apoptotic process (GO:0070234),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,PRELID1
alpha,4,negative regulation of autophagosome assembly (GO:1902902),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,FEZ2
alpha,4,negative regulation of cell activation (GO:0050866),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,NOS3
alpha,4,negative regulation of interleukin-1 beta secretion (GO:0050713),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,ZC3H12A
alpha,4,regulation of histone phosphorylation (GO:0033127),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,CDK9
alpha,4,Rap protein signal transduction (GO:0032486),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,RAP1A
alpha,4,protein localization to synapse (GO:0035418),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,NLGN1
alpha,4,endosomal vesicle fusion (GO:0034058),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,VPS41
alpha,4,regulation of establishment of protein localization to telomere (GO:0070203),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,CCT2
alpha,4,regulation of cytoplasmic translation (GO:2000765),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,CPEB1
alpha,4,motor neuron axon guidance (GO:0008045),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,SLIT2
alpha,4,mitochondrial respiratory chain complex III biogenesis (GO:0097033),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,SLC25A33
alpha,4,regulation of fatty acid beta-oxidation (GO:0031998),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,TYSND1
alpha,4,nuclear mRNA surveillance (GO:0071028),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,EXOSC6
alpha,4,insulin-like growth factor receptor signaling pathway (GO:0048009),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,IGF1R
alpha,4,protein-cofactor linkage (GO:0018065),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,LIAS
alpha,4,ectoderm development (GO:0007398),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,STX2
alpha,4,regulation of DNA damage checkpoint (GO:2000001),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,CRY1
alpha,4,negative regulation of protein maturation (GO:1903318),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,SERPINE2
alpha,4,positive regulation of smooth muscle cell migration (GO:0014911),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,VTN
alpha,4,negative regulation of centrosome duplication (GO:0010826),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,NPM1
alpha,4,maintenance of apical/basal cell polarity (GO:0035090),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,PDCD6IP
alpha,4,regulation of gene expression by genetic imprinting (GO:0006349),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,DNMT3A
alpha,4,negative regulation by host of viral process (GO:0044793),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,ZC3H12A
alpha,4,neuron projection fasciculation (GO:0106030),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,CDK5R1
alpha,4,negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,STRN3
alpha,4,ESCRT complex disassembly (GO:1904896),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,IST1
alpha,4,cilium movement involved in cell motility (GO:0060294),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,RSPH9
alpha,4,regulation of astrocyte differentiation (GO:0048710),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,SERPINE2
alpha,4,protein kinase A signaling (GO:0010737),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,RDX
alpha,4,T cell homeostasis (GO:0043029),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,FADD
alpha,4,very-low-density lipoprotein particle assembly (GO:0034379),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,ACSL3
alpha,4,positive regulation of execution phase of apoptosis (GO:1900119),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,ZC3H12A
alpha,4,dicarboxylic acid biosynthetic process (GO:0043650),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,GOT1
alpha,4,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,ZBTB1
alpha,4,medium-chain fatty acid metabolic process (GO:0051791),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,ACOT7
alpha,4,sequestering of actin monomers (GO:0042989),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,TWF1
alpha,4,quinone metabolic process (GO:1901661),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,AKR7A2
alpha,4,telomeric loop disassembly (GO:0090657),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,RECQL4
alpha,4,regulation of plasminogen activation (GO:0010755),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,SERPINE2
alpha,4,histone H2B ubiquitination (GO:0033523),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,RNF20
alpha,4,maintenance of epithelial cell apical/basal polarity (GO:0045199),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,PDCD6IP
alpha,4,forelimb morphogenesis (GO:0035136),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,TFAP2A
alpha,4,positive regulation of nuclease activity (GO:0032075),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,ERN1
alpha,4,ketone body metabolic process (GO:1902224),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,ACAT1
alpha,4,regulation of T cell apoptotic process (GO:0070232),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,PRELID1
alpha,4,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,FBXW7
alpha,4,regulation of B cell apoptotic process (GO:0002902),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,FOXP1
alpha,4,low-density lipoprotein particle receptor catabolic process (GO:0032802),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,CLTC
alpha,4,regulation of synapse maturation (GO:0090128),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,ANAPC2
alpha,4,adrenal gland development (GO:0030325),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,NF1
alpha,4,peptidyl-serine dephosphorylation (GO:0070262),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,PPP2R2B
alpha,4,vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,DMXL1
alpha,4,cellular response to thyroid hormone stimulus (GO:0097067),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,RDX
alpha,4,regulation of myeloid leukocyte differentiation (GO:0002761),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,FOXP1
alpha,4,negative regulation of cytosolic calcium ion concentration (GO:0051481),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,SMAD3
alpha,4,"energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)",1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,ATP1A1
alpha,4,regulation of cytoplasmic translational elongation (GO:1900247),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,DPH6
alpha,4,presynaptic membrane assembly (GO:0097105),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,NLGN1
alpha,4,N-acetylneuraminate metabolic process (GO:0006054),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,NANP
alpha,4,response to acidic pH (GO:0010447),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,RAB11FIP5
alpha,4,regulation of triglyceride catabolic process (GO:0010896),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,ABHD5
alpha,4,cellular response to dopamine (GO:1903351),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,ATF4
alpha,4,ESCRT III complex disassembly (GO:1904903),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,IST1
alpha,4,negative regulation of inclusion body assembly (GO:0090084),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,SACS
alpha,4,positive regulation of glial cell differentiation (GO:0045687),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,SERPINE2
alpha,4,astrocyte development (GO:0014002),1/10,1,10,0.522308253559574,0.765282830871989,0,0,1.40449438202247,0.912215367036143,NF1
alpha,4,positive regulation of ossification (GO:0045778),4/53,4,53,0.527184953179535,0.772106296010861,0,0,1.05999576001696,0.678613352990384,TFAP2A;KL;ACVR2B;BMP6
alpha,4,positive regulation of protein localization to membrane (GO:1905477),7/96,7,96,0.530457094988168,0.775960052731883,0,0,1.02411048689139,0.649302640049835,CNPY4;KIF5B;PRKCE;MIEF2;MFF;DYNLL2;YWHAZ
alpha,4,regulation of heart contraction (GO:0008016),7/96,7,96,0.530457094988168,0.775960052731883,0,0,1.02411048689139,0.649302640049835,TMEM65;ATP2A2;ATP1B3;FOXN4;FXYD6;ATP1A1;CALM2
alpha,4,regulation of cellular amide metabolic process (GO:0034248),3/39,3,39,0.532062179028365,0.775960052731883,0,0,1.08038029386344,0.681714475580501,CTSA;PGAM1;EIF4E
alpha,4,chemical homeostasis (GO:0048878),3/39,3,39,0.532062179028365,0.775960052731883,0,0,1.08038029386344,0.681714475580501,FBXW7;ABHD5;ACOX3
alpha,4,negative regulation of cell death (GO:0060548),6/82,6,82,0.533410141438374,0.775960052731883,0,0,1.027678816114,0.645859812203292,BNIP3;NUP62;ADNP2;CTNNB1;WNT16;CLU
alpha,4,platelet degranulation (GO:0002576),9/125,9,125,0.535902041737446,0.775960052731883,0,0,1.01123595505618,0.630812925066874,CYB5R1;LAMP2;PSAP;FN1;CDC37L1;LHFPL2;GTPBP2;CLU;TUBA4A
alpha,4,positive regulation of synaptic transmission (GO:0050806),5/68,5,68,0.537165377034587,0.775960052731883,0,0,1.03271645736946,0.641780885659705,MPP2;ARC;NLGN1;GPRIN1;DTNBP1
alpha,4,positive regulation of endothelial cell proliferation (GO:0001938),5/68,5,68,0.537165377034587,0.775960052731883,0,0,1.03271645736946,0.641780885659705,NR4A1;EGR3;AKT3;NRARP;TGFBR1
alpha,4,dendritic spine organization (GO:0097061),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,ARC;IGF1R
alpha,4,positive regulation of purine nucleotide biosynthetic process (GO:1900373),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,VCP;CALM2
alpha,4,receptor clustering (GO:0043113),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,NLGN1;AGRN
alpha,4,macromolecule modification (GO:0043412),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,ZNF335;ST3GAL2
alpha,4,neuromuscular synaptic transmission (GO:0007274),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,DTNA;FCHSD2
alpha,4,positive regulation of endopeptidase activity (GO:0010950),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,PRELID1;GPRIN1
alpha,4,axoneme assembly (GO:0035082),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,DNAAF3;RSPH9
alpha,4,negative regulation of endothelial cell apoptotic process (GO:2000352),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,KRIT1;TNFAIP3
alpha,4,regulation of AMPA receptor activity (GO:2000311),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,NLGN1;ARC
alpha,4,positive regulation of vascular endothelial growth factor production (GO:0010575),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,RORA;ATF4
alpha,4,mRNA splice site selection (GO:0006376),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,PSIP1;SRSF9
alpha,4,"protein alpha-1,2-demannosylation (GO:0036508)",2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,UBB;AMFR
alpha,4,proteoglycan biosynthetic process (GO:0030166),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,NDST1;FAM20B
alpha,4,cGMP biosynthetic process (GO:0006182),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,GUCY1B3;ADCY3
alpha,4,cAMP metabolic process (GO:0046058),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,PDE3B;ADCY3
alpha,4,regulation of cellular senescence (GO:2000772),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,AKT3;HMGA1
alpha,4,organic cation transport (GO:0015695),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,SEC14L1;RHCE
alpha,4,ear morphogenesis (GO:0042471),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,TFAP2A;CHD7
alpha,4,histone mRNA metabolic process (GO:0008334),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,LSM11;NCBP2
alpha,4,negative regulation of developmental growth (GO:0048640),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,PTCH1;WWC3
alpha,4,regulation of actin filament bundle assembly (GO:0032231),2/25,2,25,0.539976475899168,0.775960052731883,0,0,1.12359550561798,0.692392925306076,RDX;RAC1
alpha,4,epithelial cell differentiation (GO:0030855),7/97,7,97,0.54163929876835,0.775960052731883,0,0,1.01355264682034,0.62146487266813,KDM6B;LATS1;RARG;CDHR2;ANXA7;VDAC1;TPP1
alpha,4,negative regulation of binding (GO:0051100),6/83,6,83,0.545480847553408,0.775960052731883,0,0,1.0152971436307,0.615358993046878,GOLGA2;JUN;XIRP1;TMBIM6;ACTB;DACT1
alpha,4,positive regulation of cell cycle arrest (GO:0071158),6/83,6,83,0.545480847553408,0.775960052731883,0,0,1.0152971436307,0.615358993046878,NPM1;CNOT7;UBB;CNOT11;TRIAP1;PKD2
alpha,4,signal transduction by p53 class mediator (GO:0072331),3/40,3,40,0.549473490406643,0.775960052731883,0,0,1.05337078651685,0.630752896158947,HINT1;USP10;TRIAP1
alpha,4,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",3/40,3,40,0.549473490406643,0.775960052731883,0,0,1.05337078651685,0.630752896158947,RBM25;RBM15B;MBNL1
alpha,4,DNA replication-independent nucleosome assembly (GO:0006336),3/40,3,40,0.549473490406643,0.775960052731883,0,0,1.05337078651685,0.630752896158947,NPM1;CENPW;UBN1
alpha,4,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),3/40,3,40,0.549473490406643,0.775960052731883,0,0,1.05337078651685,0.630752896158947,NOS3;TNFAIP3;FADD
alpha,4,clathrin-dependent endocytosis (GO:0072583),3/40,3,40,0.549473490406643,0.775960052731883,0,0,1.05337078651685,0.630752896158947,NLGN1;CLTC;FCHO2
alpha,4,positive regulation of neuron projection development (GO:0010976),7/98,7,98,0.552710178768877,0.775960052731883,0,0,1.00321027287319,0.594824943687797,RAP1A;DPYSL3;PLAA;TWF1;COBL;SLIT2;RHOA
alpha,4,mitochondrial respiratory chain complex assembly (GO:0033108),7/98,7,98,0.552710178768877,0.775960052731883,0,0,1.00321027287319,0.594824943687797,SURF1;NDUFAF6;NDUFAF7;NDUFB2;NDUFAF3;SLC25A33;PET117
alpha,4,protein targeting to ER (GO:0045047),7/98,7,98,0.552710178768877,0.775960052731883,0,0,1.00321027287319,0.594824943687797,SPCS3;RPL12;RPLP0;SRP14;SEC62;RPL9;RPL39
alpha,4,atrial septum morphogenesis (GO:0060413),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,HEY2
alpha,4,L-phenylalanine catabolic process (GO:0006559),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,IL4I1
alpha,4,replicative senescence (GO:0090399),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,WNT16
alpha,4,negative regulation of leukocyte activation (GO:0002695),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,ZC3H12A
alpha,4,nitric oxide biosynthetic process (GO:0006809),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,NOS3
alpha,4,regulation of feeding behavior (GO:0060259),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,NR4A3
alpha,4,positive regulation by host of viral process (GO:0044794),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,CFL1
alpha,4,negative regulation of leukocyte cell-cell adhesion (GO:1903038),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,ASS1
alpha,4,negative regulation of fatty acid biosynthetic process (GO:0045717),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,ERLIN1
alpha,4,positive regulation of cytolysis (GO:0045919),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,RRAGA
alpha,4,modulation by host of viral process (GO:0044788),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,CFL1
alpha,4,positive regulation of protein deacetylation (GO:0090312),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,BRMS1
alpha,4,urea cycle (GO:0000050),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,ASS1
alpha,4,brain morphogenesis (GO:0048854),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,PAFAH1B1
alpha,4,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,TSR1
alpha,4,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,FADD
alpha,4,relaxation of cardiac muscle (GO:0055119),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,ATP1A1
alpha,4,phosphatidylinositol dephosphorylation (GO:0046856),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,SACM1L
alpha,4,regulation of hemopoiesis (GO:1903706),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,PURB
alpha,4,negative regulation of peptide secretion (GO:0002792),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,SERGEF
alpha,4,negative regulation of amyloid precursor protein catabolic process (GO:1902992),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,CLU
alpha,4,positive regulation of chromosome segregation (GO:0051984),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,SMC6
alpha,4,regulation of ceramide biosynthetic process (GO:2000303),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,SMPD2
alpha,4,negative regulation of cellular senescence (GO:2000773),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,AKT3
alpha,4,positive regulation of glycoprotein biosynthetic process (GO:0010560),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,GOLGA2
alpha,4,negative regulation of histone acetylation (GO:0035067),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,SET
alpha,4,transcytosis (GO:0045056),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,CLTC
alpha,4,cellular response to interleukin-2 (GO:0071352),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,STAT5B
alpha,4,relaxation of muscle (GO:0090075),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,ATP1A1
alpha,4,rhodopsin mediated signaling pathway (GO:0016056),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,GNB1
alpha,4,positive regulation of T cell receptor signaling pathway (GO:0050862),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,RELA
alpha,4,protein kinase C signaling (GO:0070528),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,ADAM15
alpha,4,camera-type eye morphogenesis (GO:0048593),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,NF1
alpha,4,metanephric mesenchyme development (GO:0072075),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,PKD2
alpha,4,negative regulation of heart contraction (GO:0045822),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,ZC3H12A
alpha,4,photoreceptor cell development (GO:0042461),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,ARL3
alpha,4,negative regulation of cardiac muscle hypertrophy (GO:0010614),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,SMAD4
alpha,4,modulation by host of viral genome replication (GO:0044827),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,ZC3H12A
alpha,4,negative regulation of chemotaxis (GO:0050922),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,SLIT2
alpha,4,establishment of synaptic vesicle localization (GO:0097480),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,KIF5B
alpha,4,positive regulation of fatty acid oxidation (GO:0046321),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,NR4A3
alpha,4,inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,BIRC2
alpha,4,magnesium ion transport (GO:0015693),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,NIPA2
alpha,4,"regulation of synaptic transmission, GABAergic (GO:0032228)",1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,NLGN1
alpha,4,low-density lipoprotein receptor particle metabolic process (GO:0032799),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,CLTC
alpha,4,response to thyroid hormone (GO:0097066),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,RDX
alpha,4,"negative regulation of translation, ncRNA-mediated (GO:0040033)",1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,AGO2
alpha,4,hemidesmosome assembly (GO:0031581),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,PLEC
alpha,4,aspartate family amino acid biosynthetic process (GO:0009067),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,GOT1
alpha,4,carbohydrate derivative catabolic process (GO:1901136),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,FUCA1
alpha,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,IL4I1
alpha,4,presynaptic membrane organization (GO:0097090),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,NLGN1
alpha,4,miRNA mediated inhibition of translation (GO:0035278),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,AGO2
alpha,4,regulation of chromatin silencing (GO:0031935),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,HMGA1
alpha,4,response to corticosteroid (GO:0031960),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,GOT1
alpha,4,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,DLL4
alpha,4,cardiac muscle cell membrane repolarization (GO:0099622),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,ATP1A1
alpha,4,RNA polymerase II transcriptional preinitiation complex assembly (GO:0051123),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,TAF6
alpha,4,L-phenylalanine metabolic process (GO:0006558),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,IL4I1
alpha,4,regulation of hippo signaling (GO:0035330),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,WWC3
alpha,4,microtubule anchoring at microtubule organizing center (GO:0072393),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,CEP19
alpha,4,endothelium development (GO:0003158),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,KDM6B
alpha,4,regulation of tumor necrosis factor biosynthetic process (GO:0042534),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,HSPB1
alpha,4,cellular response to prostaglandin stimulus (GO:0071379),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,GNB1
alpha,4,postsynapse assembly (GO:0099068),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,NLGN1
alpha,4,carnitine metabolic process (GO:0009437),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,CRAT
alpha,4,morphogenesis of an epithelial sheet (GO:0002011),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,DLL4
alpha,4,regulation of trophoblast cell migration (GO:1901163),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,AGO2
alpha,4,negative regulation of protein localization to nucleus (GO:1900181),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,CABP1
alpha,4,regulation of hydrogen peroxide-induced cell death (GO:1903205),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,TXN
alpha,4,embryonic eye morphogenesis (GO:0048048),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,RARG
alpha,4,UV-damage excision repair (GO:0070914),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,INO80
alpha,4,negative regulation of bone mineralization (GO:0030502),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,BCOR
alpha,4,positive regulation of receptor biosynthetic process (GO:0010870),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,SCAP
alpha,4,cell-substrate junction assembly (GO:0007044),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,PLEC
alpha,4,regulation of non-canonical Wnt signaling pathway (GO:2000050),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,DACT1
alpha,4,regulation of ventricular cardiac muscle cell action potential (GO:0098911),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,DSG2
alpha,4,myeloid cell activation involved in immune response (GO:0002275),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,KARS
alpha,4,somite development (GO:0061053),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,PTCH1
alpha,4,cell-cell junction maintenance (GO:0045217),1/11,1,11,0.556336838247702,0.775960052731883,0,0,1.27681307456588,0.748699366678282,PARD6A
alpha,4,negative regulation of cellular component organization (GO:0051129),4/55,4,55,0.556953148307965,0.775960052731883,0,0,1.02145045965271,0.597828556630257,LRSAM1;DDX3X;RDX;SACS
alpha,4,positive regulation of response to stimulus (GO:0048584),4/55,4,55,0.556953148307965,0.775960052731883,0,0,1.02145045965271,0.597828556630257,MAP2K1;HOMER1;TAF9;HMGA1
alpha,4,negative regulation of signaling (GO:0023057),6/84,6,84,0.557410848690755,0.775960052731883,0,0,1.00321027287319,0.586328953749578,BRAP;RYK;TYRO3;LMTK2;BRAF;IGF1R
alpha,4,negative regulation of neuron death (GO:1901215),6/84,6,84,0.557410848690755,0.775960052731883,0,0,1.00321027287319,0.586328953749578,SET;MSH2;RASA1;TYRO3;LIG4;ATF4
alpha,4,positive regulation of peptidyl-serine phosphorylation (GO:0033138),6/84,6,84,0.557410848690755,0.775960052731883,0,0,1.00321027287319,0.586328953749578,LATS1;PAK1;TBK1;TERF2IP;BRAF;TXN
alpha,4,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",8/113,8,113,0.559167905199374,0.776759341046022,0,0,0.994332305856617,0.578010822158935,CTIF;NCBP2;RPL12;EIF4A3;RPLP0;RPL9;RPL39;PNRC2
alpha,4,heterotypic cell-cell adhesion (GO:0034113),2/26,2,26,0.561520764039244,0.776759341046022,0,0,1.08038029386344,0.623494518040548,PARVA;DSG2
alpha,4,regulation of telomere maintenance (GO:0032204),2/26,2,26,0.561520764039244,0.776759341046022,0,0,1.08038029386344,0.623494518040548,TERF2IP;GNL3
alpha,4,"protein import into nucleus, translocation (GO:0000060)",2/26,2,26,0.561520764039244,0.776759341046022,0,0,1.08038029386344,0.623494518040548,RAN;IPO5
alpha,4,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),2/26,2,26,0.561520764039244,0.776759341046022,0,0,1.08038029386344,0.623494518040548,CHPF;CHSY1
alpha,4,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),2/26,2,26,0.561520764039244,0.776759341046022,0,0,1.08038029386344,0.623494518040548,FADD;RASGRP1
alpha,4,monocarboxylic acid catabolic process (GO:0072329),2/26,2,26,0.561520764039244,0.776759341046022,0,0,1.08038029386344,0.623494518040548,ACBD5;LPIN2
alpha,4,modulation of excitatory postsynaptic potential (GO:0098815),2/26,2,26,0.561520764039244,0.776759341046022,0,0,1.08038029386344,0.623494518040548,NLGN1;GPRIN1
alpha,4,cellular response to epidermal growth factor stimulus (GO:0071364),2/26,2,26,0.561520764039244,0.776759341046022,0,0,1.08038029386344,0.623494518040548,STAT5B;PLCG1
alpha,4,long-chain fatty acid transport (GO:0015909),2/26,2,26,0.561520764039244,0.776759341046022,0,0,1.08038029386344,0.623494518040548,ACSL1;ACSL3
alpha,4,positive regulation of Rho protein signal transduction (GO:0035025),2/26,2,26,0.561520764039244,0.776759341046022,0,0,1.08038029386344,0.623494518040548,ARRB1;RAC1
alpha,4,peptidyl-tyrosine dephosphorylation (GO:0035335),2/26,2,26,0.561520764039244,0.776759341046022,0,0,1.08038029386344,0.623494518040548,DUSP5;PTPRF
alpha,4,signal peptide processing (GO:0006465),2/26,2,26,0.561520764039244,0.776759341046022,0,0,1.08038029386344,0.623494518040548,SPCS3;SPPL3
alpha,4,cyclic nucleotide metabolic process (GO:0009187),2/26,2,26,0.561520764039244,0.776759341046022,0,0,1.08038029386344,0.623494518040548,GUCY1B3;ADCY3
alpha,4,inorganic cation import across plasma membrane (GO:0098659),2/26,2,26,0.561520764039244,0.776759341046022,0,0,1.08038029386344,0.623494518040548,SLC9A7;SLC9A8
alpha,4,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),2/26,2,26,0.561520764039244,0.776759341046022,0,0,1.08038029386344,0.623494518040548,PKD2;CALM2
alpha,4,regulation of insulin secretion (GO:0050796),7/99,7,99,0.563663431625027,0.778497824032208,0,0,0.993076835773465,0.569328922135264,MIDN;RAP1A;ARL2BP;STXBP4;BMP8A;CACNA2D2;CACNA1D
alpha,4,histone modification (GO:0016570),7/99,7,99,0.563663431625027,0.778497824032208,0,0,0.993076835773465,0.569328922135264,BRMS1;KAT5;ATXN7;NTMT1;NSD1;SUDS3;TBL1X
alpha,4,positive regulation of neuron differentiation (GO:0045666),7/99,7,99,0.563663431625027,0.778497824032208,0,0,0.993076835773465,0.569328922135264,DLX2;RAP1A;DPYSL3;TCF12;TWF1;NBL1;RHOA
alpha,4,response to molecule of bacterial origin (GO:0002237),7/99,7,99,0.563663431625027,0.778497824032208,0,0,0.993076835773465,0.569328922135264,JUN;NOS3;MAPKAPK2;TNFAIP3;LIAS;RELT;FOXP1
alpha,4,vesicle organization (GO:0016050),9/128,9,128,0.565044779542019,0.779043358327606,0,0,0.987535112359551,0.563734710361134,ARFGEF2;ANXA2;EXOC8;SNX9;DNAJC13;SNX30;STX2;EPS15;S100A10
alpha,4,ameboidal-type cell migration (GO:0001667),3/41,3,41,0.566496393708495,0.779043358327606,0,0,1.027678816114,0.584014008410351,PKN2;SEMA3F;CORO1C
alpha,4,positive regulation of Ras protein signal transduction (GO:0046579),3/41,3,41,0.566496393708495,0.779043358327606,0,0,1.027678816114,0.584014008410351,ARRB1;RAC1;RASGRP1
alpha,4,response to cAMP (GO:0051591),3/41,3,41,0.566496393708495,0.779043358327606,0,0,1.027678816114,0.584014008410351,JUN;RAP1A;PKD2
alpha,4,sterol biosynthetic process (GO:0016126),3/41,3,41,0.566496393708495,0.779043358327606,0,0,1.027678816114,0.584014008410351,IDI1;ARV1;ACAT1
alpha,4,negative regulation of ERK1 and ERK2 cascade (GO:0070373),3/41,3,41,0.566496393708495,0.779043358327606,0,0,1.027678816114,0.584014008410351,SLC9A3R1;SMAD4;RANBP9
alpha,4,negative regulation of cytokine-mediated signaling pathway (GO:0001960),3/41,3,41,0.566496393708495,0.779043358327606,0,0,1.027678816114,0.584014008410351,CNOT7;HIST1H2BJ;SLIT2
alpha,4,regulation of viral transcription (GO:0046782),3/41,3,41,0.566496393708495,0.779043358327606,0,0,1.027678816114,0.584014008410351,CDK9;POLR2A;POLR2H
alpha,4,determination of heart left/right asymmetry (GO:0061371),3/41,3,41,0.566496393708495,0.779043358327606,0,0,1.027678816114,0.584014008410351,SRF;FOXN4;PKD2
alpha,4,JAK-STAT cascade (GO:0007259),3/41,3,41,0.566496393708495,0.779043358327606,0,0,1.027678816114,0.584014008410351,SOCS2;STAT5B;PKD2
alpha,4,embryonic heart tube morphogenesis (GO:0003143),3/41,3,41,0.566496393708495,0.779043358327606,0,0,1.027678816114,0.584014008410351,SRF;FOXN4;PKD2
alpha,4,positive regulation of kinase activity (GO:0033674),8/114,8,114,0.569345164605483,0.781330618292127,0,0,0.985610092647349,0.55516303232276,RAP1A;RYK;TYRO3;LMTK2;SNX9;MAPRE3;IGF1R;CAMKK2
alpha,4,regulation of axonogenesis (GO:0050770),4/56,4,56,0.571453067917239,0.781330618292127,0,0,1.00321027287319,0.561369301764745,PAK1;KIF13B;SLIT2;RHOA
alpha,4,negative regulation of cellular response to growth factor stimulus (GO:0090288),4/56,4,56,0.571453067917239,0.781330618292127,0,0,1.00321027287319,0.561369301764745,SLIT2;NBL1;SKIL;HIPK2
alpha,4,positive regulation of cysteine-type endopeptidase activity (GO:2001056),4/56,4,56,0.571453067917239,0.781330618292127,0,0,1.00321027287319,0.561369301764745,DDX3X;GPRIN1;FADD;MAP3K5
alpha,4,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),5/71,5,71,0.576240091659072,0.781330618292127,0,0,0.989080550720051,0.545211741708524,RNF144A;VCP;ANKIB1;ARIH1;CLU
alpha,4,phospholipid metabolic process (GO:0006644),5/71,5,71,0.576240091659072,0.781330618292127,0,0,0.989080550720051,0.545211741708524,SMPD2;GPX4;LIPG;PLAA;FADS1
alpha,4,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),6/86,6,86,0.580819683501083,0.781330618292127,0,0,0.979879801411027,0.532383321518413,VTN;TEC;CNOT7;CD81;TNK2;PAK2
alpha,4,bile acid biosynthetic process (GO:0006699),2/27,2,27,0.582331678275687,0.781330618292127,0,0,1.04036620890553,0.562541718304311,OSBPL6;SCP2
alpha,4,nucleotide biosynthetic process (GO:0009165),2/27,2,27,0.582331678275687,0.781330618292127,0,0,1.04036620890553,0.562541718304311,GUCY1B3;ADCY3
alpha,4,response to ketone (GO:1901654),2/27,2,27,0.582331678275687,0.781330618292127,0,0,1.04036620890553,0.562541718304311,CATSPERD;SLIT2
alpha,4,regulation of supramolecular fiber organization (GO:1902903),2/27,2,27,0.582331678275687,0.781330618292127,0,0,1.04036620890553,0.562541718304311,RDX;CAMSAP1
alpha,4,regulation of cardiac muscle cell contraction (GO:0086004),2/27,2,27,0.582331678275687,0.781330618292127,0,0,1.04036620890553,0.562541718304311,ATP2A2;DSG2
alpha,4,regulation of histone acetylation (GO:0035065),2/27,2,27,0.582331678275687,0.781330618292127,0,0,1.04036620890553,0.562541718304311,SET;ARRB1
alpha,4,fat-soluble vitamin metabolic process (GO:0006775),2/27,2,27,0.582331678275687,0.781330618292127,0,0,1.04036620890553,0.562541718304311,PIAS4;UBE2I
alpha,4,strand displacement (GO:0000732),2/27,2,27,0.582331678275687,0.781330618292127,0,0,1.04036620890553,0.562541718304311,BARD1;KAT5
alpha,4,GPI anchor metabolic process (GO:0006505),2/27,2,27,0.582331678275687,0.781330618292127,0,0,1.04036620890553,0.562541718304311,DPM1;PIGF
alpha,4,endocrine system development (GO:0035270),2/27,2,27,0.582331678275687,0.781330618292127,0,0,1.04036620890553,0.562541718304311,NF1;TGFBR1
alpha,4,apoptotic cell clearance (GO:0043277),2/27,2,27,0.582331678275687,0.781330618292127,0,0,1.04036620890553,0.562541718304311,TYRO3;RAC1
alpha,4,negative regulation of cell projection organization (GO:0031345),3/42,3,42,0.583118152027984,0.781330618292127,0,0,1.00321027287319,0.541096961300379,KANK1;DPYSL3;DENND5A
alpha,4,spliceosomal complex assembly (GO:0000245),3/42,3,42,0.583118152027984,0.781330618292127,0,0,1.00321027287319,0.541096961300379,DDX1;PRPF19;SRSF9
alpha,4,negative regulation of STAT cascade (GO:1904893),3/42,3,42,0.583118152027984,0.781330618292127,0,0,1.00321027287319,0.541096961300379,SOCS2;CISH;FLRT3
alpha,4,regulation of protein localization (GO:0032880),3/42,3,42,0.583118152027984,0.781330618292127,0,0,1.00321027287319,0.541096961300379,FBXW7;KIAA0586;TESK1
alpha,4,regulation of stress-activated MAPK cascade (GO:0032872),3/42,3,42,0.583118152027984,0.781330618292127,0,0,1.00321027287319,0.541096961300379,MAP2K1;IGF1R;MAP4K4
alpha,4,telomere organization (GO:0032200),3/42,3,42,0.583118152027984,0.781330618292127,0,0,1.00321027287319,0.541096961300379,RECQL4;ACD;TERF2IP
alpha,4,negative regulation of cellular catabolic process (GO:0031330),4/57,4,57,0.585682915391408,0.781330618292127,0,0,0.985610092647349,0.527278470202278,GOLGA2;RRAGA;WDR6;RASIP1
alpha,4,ribosome assembly (GO:0042255),4/57,4,57,0.585682915391408,0.781330618292127,0,0,0.985610092647349,0.527278470202278,NPM1;DDX3X;RPL12;SBDS
alpha,4,axonal fasciculation (GO:0007413),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,CDK5R1
alpha,4,negative regulation of chondrocyte differentiation (GO:0032331),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,TGFBR1
alpha,4,import across plasma membrane (GO:0098739),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,ATP1A1
alpha,4,regulation of leukocyte cell-cell adhesion (GO:1903037),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,ASS1
alpha,4,fatty acid elongation (GO:0030497),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,ELOVL5
alpha,4,interleukin-2-mediated signaling pathway (GO:0038110),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,STAT5B
alpha,4,positive regulation of establishment of protein localization (GO:1904951),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,CCT2
alpha,4,pyrimidine nucleoside salvage (GO:0043097),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,UCK2
alpha,4,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,ATP1B3
alpha,4,positive regulation of amyloid precursor protein catabolic process (GO:1902993),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,CLU
alpha,4,regulation of bone remodeling (GO:0046850),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,NF1
alpha,4,DNA ligation involved in DNA repair (GO:0051103),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,LIG4
alpha,4,regulation of cell communication by electrical coupling (GO:0010649),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,CALM2
alpha,4,response to prostaglandin E (GO:0034695),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,GNB1
alpha,4,positive regulation of ruffle assembly (GO:1900029),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,NLGN1
alpha,4,nitric oxide metabolic process (GO:0046209),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,NOS3
alpha,4,spliceosomal tri-snRNP complex assembly (GO:0000244),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,PRPF19
alpha,4,tRNA 5'-leader removal (GO:0001682),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,RPP14
alpha,4,positive regulation of pseudopodium assembly (GO:0031274),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,CDC42EP4
alpha,4,vasoconstriction (GO:0042310),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,PIK3C2A
alpha,4,activation of cysteine-type endopeptidase activity (GO:0097202),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,FADD
alpha,4,regulation of pseudopodium assembly (GO:0031272),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,CDC42EP4
alpha,4,negative regulation of histone modification (GO:0031057),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,SET
alpha,4,response to interleukin-6 (GO:0070741),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,RELA
alpha,4,"regulation of protein import into nucleus, translocation (GO:0033158)",1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,TXN
alpha,4,regulation of sequestering of triglyceride (GO:0010889),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,ABHD5
alpha,4,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,ERN1
alpha,4,negative regulation of interleukin-1 secretion (GO:0050711),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,ZC3H12A
alpha,4,negative regulation of ATP metabolic process (GO:1903579),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,PPIF
alpha,4,regulation of angiotensin levels in blood (GO:0002002),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,ECE1
alpha,4,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,SNAI1
alpha,4,establishment of protein localization to mitochondrial membrane (GO:0090151),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,TIMM9
alpha,4,L-serine metabolic process (GO:0006563),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,SERINC3
alpha,4,protein O-linked mannosylation (GO:0035269),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,DPM1
alpha,4,cellular response to fatty acid (GO:0071398),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,ZC3H12A
alpha,4,transcription from mitochondrial promoter (GO:0006390),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,SLC25A33
alpha,4,regulation of vascular endothelial cell proliferation (GO:1905562),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,AKT3
alpha,4,pyrimidine-containing compound salvage (GO:0008655),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,UCK2
alpha,4,prostanoid metabolic process (GO:0006692),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,PLAA
alpha,4,regulation of T cell differentiation in thymus (GO:0033081),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,FOXJ1
alpha,4,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,UNG
alpha,4,endosome transport via multivesicular body sorting pathway (GO:0032509),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,VCP
alpha,4,negative regulation of androgen receptor signaling pathway (GO:0060766),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,FOXP1
alpha,4,keratan sulfate catabolic process (GO:0042340),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,HEXB
alpha,4,membrane repolarization during action potential (GO:0086011),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,ATP1A1
alpha,4,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,VTN
alpha,4,negative regulation of fatty acid metabolic process (GO:0045922),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,ERLIN1
alpha,4,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,RASGRP1
alpha,4,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,UBAC2
alpha,4,cardiac right ventricle morphogenesis (GO:0003215),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,HEY2
alpha,4,regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901836),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,NCL
alpha,4,histone H3-K9 demethylation (GO:0033169),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,JMJD1C
alpha,4,positive regulation of interleukin-1 production (GO:0032732),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,HSPB1
alpha,4,regulation of inclusion body assembly (GO:0090083),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,SACS
alpha,4,negative regulation of protein oligomerization (GO:0032460),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,CLU
alpha,4,negative regulation of ATPase activity (GO:0032780),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,PPIF
alpha,4,regulation of protein glycosylation (GO:0060049),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,GOLGA2
alpha,4,negative regulation of ERAD pathway (GO:1904293),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,UBAC2
alpha,4,cellular modified amino acid catabolic process (GO:0042219),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,CHAC2
alpha,4,amino sugar biosynthetic process (GO:0046349),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,NANP
alpha,4,histone arginine methylation (GO:0034969),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,COPRS
alpha,4,regulation of actomyosin structure organization (GO:0110020),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,RAC1
alpha,4,regulation of cholesterol homeostasis (GO:2000188),1/12,1,12,0.587942954589666,0.781330618292127,0,0,1.17041198501873,0.621635477286793,RORA
alpha,4,phosphatidylcholine metabolic process (GO:0046470),5/72,5,72,0.588871526108257,0.782268864047816,0,0,0.975343320848939,0.516490364758813,ACHE;CHKA;STARD7;CEPT1;LPIN2
alpha,4,toll-like receptor signaling pathway (GO:0002224),6/87,6,87,0.592285314913598,0.786506566649527,0,0,0.968616815187912,0.507329338755893,IKBKB;UBB;TRAF3;MAPKAPK2;FADD;BIRC2
alpha,4,glycolipid biosynthetic process (GO:0009247),3/43,3,43,0.599328363414588,0.79555860929089,0,0,0.979879801411027,0.5016451970193,DPM1;PIGF;ST3GAL2
alpha,4,IRE1-mediated unfolded protein response (GO:0036498),4/58,4,58,0.599633813342732,0.795663591506116,0,0,0.968616815187912,0.495385626866588,ERN1;TPP1;SEC62;ADD1
alpha,4,ATP synthesis coupled proton transport (GO:0015986),2/28,2,28,0.602404368227539,0.796034343729248,0,0,1.00321027287319,0.508453402035522,ATP5C1;ATP5F1
alpha,4,cristae formation (GO:0042407),2/28,2,28,0.602404368227539,0.796034343729248,0,0,1.00321027287319,0.508453402035522,ATP5C1;ATP5F1
alpha,4,modulation by host of viral transcription (GO:0043921),2/28,2,28,0.602404368227539,0.796034343729248,0,0,1.00321027287319,0.508453402035522,JUN;ZNF639
alpha,4,transition metal ion transport (GO:0000041),2/28,2,28,0.602404368227539,0.796034343729248,0,0,1.00321027287319,0.508453402035522,SLC30A5;CUTC
alpha,4,negative regulation of osteoblast differentiation (GO:0045668),2/28,2,28,0.602404368227539,0.796034343729248,0,0,1.00321027287319,0.508453402035522,PTCH1;AXIN2
alpha,4,regulation of protein targeting to membrane (GO:0090313),2/28,2,28,0.602404368227539,0.796034343729248,0,0,1.00321027287319,0.508453402035522,MIEF2;MFF
alpha,4,regulation of vascular endothelial growth factor production (GO:0010574),2/28,2,28,0.602404368227539,0.796034343729248,0,0,1.00321027287319,0.508453402035522,RORA;ATF4
alpha,4,regulation of blood vessel diameter (GO:0097746),2/28,2,28,0.602404368227539,0.796034343729248,0,0,1.00321027287319,0.508453402035522,NOS3;ECE1
alpha,4,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),2/28,2,28,0.602404368227539,0.796034343729248,0,0,1.00321027287319,0.508453402035522,LATS1;ARRB2
alpha,4,telomere maintenance via telomere lengthening (GO:0010833),2/28,2,28,0.602404368227539,0.796034343729248,0,0,1.00321027287319,0.508453402035522,HSP90AB1;TERF2IP
alpha,4,negative regulation of smooth muscle cell proliferation (GO:0048662),2/28,2,28,0.602404368227539,0.796034343729248,0,0,1.00321027287319,0.508453402035522,TNFAIP3;MFN2
alpha,4,ubiquitin-dependent ERAD pathway (GO:0030433),4/59,4,59,0.613298089170324,0.796551316579595,0,0,0.952199581032184,0.465534357272471,VCP;AMFR;ERLIN1;DZIP3
alpha,4,integrin-mediated signaling pathway (GO:0007229),4/59,4,59,0.613298089170324,0.796551316579595,0,0,0.952199581032184,0.465534357272471,TEC;ITGB5;ADAM15;CUL3
alpha,4,sodium ion transport (GO:0006814),4/59,4,59,0.613298089170324,0.796551316579595,0,0,0.952199581032184,0.465534357272471,SLC12A2;TRAPPC10;PKD2;SGK1
alpha,4,response to light stimulus (GO:0009416),4/59,4,59,0.613298089170324,0.796551316579595,0,0,0.952199581032184,0.465534357272471,REV1;CIRBP;SPRTN;MAP4K3
alpha,4,lymphocyte differentiation (GO:0030098),5/74,5,74,0.613500017135163,0.796551316579595,0,0,0.948982690555724,0.463649205607534,LFNG;DLL4;JAG2;MSH2;CHD7
alpha,4,regulation of peptide hormone secretion (GO:0090276),5/74,5,74,0.613500017135163,0.796551316579595,0,0,0.948982690555724,0.463649205607534,RAP1A;ARL2BP;CHD7;CACNA2D2;CACNA1D
alpha,4,cardiac ventricle morphogenesis (GO:0003208),3/44,3,44,0.615118795778899,0.796551316579595,0,0,0.957609805924413,0.465340780734067,DLL4;HEY1;HEY2
alpha,4,development of primary male sexual characteristics (GO:0046546),3/44,3,44,0.615118795778899,0.796551316579595,0,0,0.957609805924413,0.465340780734067,MSH2;NCOA4;LHFPL2
alpha,4,response to unfolded protein (GO:0006986),3/44,3,44,0.615118795778899,0.796551316579595,0,0,0.957609805924413,0.465340780734067,HSP90AB1;DDIT3;HSPB1
alpha,4,regulation of acyl-CoA biosynthetic process (GO:0050812),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,DLAT
alpha,4,signal transduction involved in DNA damage checkpoint (GO:0072422),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,PRPF19
alpha,4,regulation of granulocyte chemotaxis (GO:0071622),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,KARS
alpha,4,regulation of oligodendrocyte differentiation (GO:0048713),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,NF1
alpha,4,very long-chain fatty acid biosynthetic process (GO:0042761),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,ELOVL5
alpha,4,muscle cell development (GO:0055001),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,HEY2
alpha,4,regulation of triglyceride biosynthetic process (GO:0010866),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,FBXW7
alpha,4,myelination in peripheral nervous system (GO:0022011),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,NF1
alpha,4,serine family amino acid biosynthetic process (GO:0009070),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,SERINC3
alpha,4,atrial septum development (GO:0003283),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,HEY2
alpha,4,positive regulation of cholesterol efflux (GO:0010875),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,PTCH1
alpha,4,positive regulation of endothelial cell chemotaxis (GO:2001028),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,HSPB1
alpha,4,regulation of macrophage differentiation (GO:0045649),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,FADD
alpha,4,pathway-restricted SMAD protein phosphorylation (GO:0060389),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,TGFBR1
alpha,4,glutamine family amino acid biosynthetic process (GO:0009084),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,ASS1
alpha,4,regulation of cAMP metabolic process (GO:0030814),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,PKD2
alpha,4,cardiocyte differentiation (GO:0035051),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,KDM6B
alpha,4,poly(A)+ mRNA export from nucleus (GO:0016973),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,NXF1
alpha,4,copper ion homeostasis (GO:0055070),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,CUTC
alpha,4,cellular response to interleukin-15 (GO:0071350),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,STAT5B
alpha,4,phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,GNAQ
alpha,4,regulation of execution phase of apoptosis (GO:1900117),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,ZC3H12A
alpha,4,ER-associated misfolded protein catabolic process (GO:0071712),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,VCP
alpha,4,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,ZC3H12A
alpha,4,regulation of endothelial cell chemotaxis (GO:2001026),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,HSPB1
alpha,4,cellular response to low-density lipoprotein particle stimulus (GO:0071404),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,CD81
alpha,4,dicarboxylic acid catabolic process (GO:0043649),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,GOT1
alpha,4,negative regulation of hormone secretion (GO:0046888),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,RAB11FIP5
alpha,4,mammary gland epithelium development (GO:0061180),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,LATS1
alpha,4,nucleotide metabolic process (GO:0009117),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,REXO2
alpha,4,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,SEMA3F
alpha,4,chondroitin sulfate catabolic process (GO:0030207),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,HEXB
alpha,4,negative regulation of blood pressure (GO:0045776),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,NOS3
alpha,4,positive regulation of alpha-beta T cell proliferation (GO:0046641),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,CD55
alpha,4,regulation of cytolysis (GO:0042268),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,RRAGA
alpha,4,regulation of retinoic acid receptor signaling pathway (GO:0048385),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,CTBP2
alpha,4,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,ATP5F1
alpha,4,interleukin-15-mediated signaling pathway (GO:0035723),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,STAT5B
alpha,4,negative regulation of cartilage development (GO:0061037),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,TGFBR1
alpha,4,amyloid precursor protein metabolic process (GO:0042982),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,ACHE
alpha,4,mitotic DNA integrity checkpoint (GO:0044774),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,RAD17
alpha,4,ribonucleoprotein complex disassembly (GO:0032988),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,KIF5B
alpha,4,protein kinase C-activating G-protein coupled receptor signaling pathway (GO:0007205),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,PRKD3
alpha,4,detection of calcium ion (GO:0005513),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,CALM2
alpha,4,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,DDX1
alpha,4,regulation of cellular carbohydrate metabolic process (GO:0010675),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,RORA
alpha,4,nucleotide-sugar metabolic process (GO:0009225),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,UGDH
alpha,4,regulation of superoxide anion generation (GO:0032928),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,AATF
alpha,4,regulation of NMDA receptor activity (GO:2000310),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,NLGN1
alpha,4,DNA replication-independent nucleosome organization (GO:0034724),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,UBN1
alpha,4,positive regulation of cellular carbohydrate metabolic process (GO:0010676),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,PRKCE
alpha,4,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,SRSF9
alpha,4,chromatin assembly or disassembly (GO:0006333),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,CDAN1
alpha,4,synaptic vesicle cycle (GO:0099504),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,NLGN1
alpha,4,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),1/13,1,13,0.61729894348871,0.796551316579595,0,0,1.08038029386344,0.521177464442029,RASGRP1
alpha,4,negative regulation of endocytosis (GO:0045806),2/29,2,29,0.6217383888618,0.797886249306034,0,0,0.968616815187912,0.460321456222163,LRSAM1;RAC1
alpha,4,negative regulation of response to DNA damage stimulus (GO:2001021),2/29,2,29,0.6217383888618,0.797886249306034,0,0,0.968616815187912,0.460321456222163,SNAI1;CLU
alpha,4,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),2/29,2,29,0.6217383888618,0.797886249306034,0,0,0.968616815187912,0.460321456222163,SMAD4;SMAD3
alpha,4,lytic vacuole organization (GO:0080171),2/29,2,29,0.6217383888618,0.797886249306034,0,0,0.968616815187912,0.460321456222163,TPP1;CLN6
alpha,4,regulation of NIK/NF-kappaB signaling (GO:1901222),2/29,2,29,0.6217383888618,0.797886249306034,0,0,0.968616815187912,0.460321456222163,TERF2IP;RELA
alpha,4,positive regulation of cell communication (GO:0010647),2/29,2,29,0.6217383888618,0.797886249306034,0,0,0.968616815187912,0.460321456222163,HOMER1;PTPN23
alpha,4,negative regulation of JNK cascade (GO:0046329),2/29,2,29,0.6217383888618,0.797886249306034,0,0,0.968616815187912,0.460321456222163,ZMYND11;DACT1
alpha,4,cardiac muscle cell action potential involved in contraction (GO:0086002),2/29,2,29,0.6217383888618,0.797886249306034,0,0,0.968616815187912,0.460321456222163,CACNA1D;ATP1A1
alpha,4,neural crest cell migration (GO:0001755),2/29,2,29,0.6217383888618,0.797886249306034,0,0,0.968616815187912,0.460321456222163,SEMA3F;CORO1C
alpha,4,cGMP metabolic process (GO:0046068),2/29,2,29,0.6217383888618,0.797886249306034,0,0,0.968616815187912,0.460321456222163,GUCY1B3;ADCY3
alpha,4,positive regulation of lipid biosynthetic process (GO:0046889),2/29,2,29,0.6217383888618,0.797886249306034,0,0,0.968616815187912,0.460321456222163,LPGAT1;ELOVL5
alpha,4,regulation of adenylate cyclase activity (GO:0045761),2/29,2,29,0.6217383888618,0.797886249306034,0,0,0.968616815187912,0.460321456222163,NF1;CAP2
alpha,4,protein K63-linked deubiquitination (GO:0070536),2/29,2,29,0.6217383888618,0.797886249306034,0,0,0.968616815187912,0.460321456222163,OTUD7A;TNFAIP3
alpha,4,transcription elongation from RNA polymerase I promoter (GO:0006362),2/29,2,29,0.6217383888618,0.797886249306034,0,0,0.968616815187912,0.460321456222163,POLR1C;POLR2H
alpha,4,aerobic respiration (GO:0009060),2/29,2,29,0.6217383888618,0.797886249306034,0,0,0.968616815187912,0.460321456222163,SURF1;UQCRH
alpha,4,regulated exocytosis (GO:0045055),10/149,10,149,0.623189813866153,0.799457005744353,0,0,0.942613679209713,0.445765901371134,CYB5R1;LAMP2;PSAP;FN1;CDC37L1;LHFPL2;GTPBP2;CLU;TUBA4A;RAB11FIP5
alpha,4,positive regulation of defense response (GO:0031349),5/75,5,75,0.62548497108213,0.802108600274968,0,0,0.936329588014981,0.439352037837809,LRSAM1;POLR3B;HYAL2;POLR3D;ETS1
alpha,4,cell junction assembly (GO:0034329),4/60,4,60,0.62666921832619,0.803041306021348,0,0,0.936329588014981,0.437580936364635,FSCN1;CTNNB1;ACTB;RHOA
alpha,4,cell morphogenesis (GO:0000902),4/60,4,60,0.62666921832619,0.803041306021348,0,0,0.936329588014981,0.437580936364635,CAPZB;RAC1;CLU;CAP2
alpha,4,regulation of neuron projection development (GO:0010975),8/120,8,120,0.6280255022716,0.804486020584794,0,0,0.936329588014981,0.435556652271265,KANK1;PAK1;CDKL5;RAP1A;DPYSL3;KIF13B;TWF1;DENND5A
alpha,4,positive regulation of interleukin-8 production (GO:0032757),3/45,3,45,0.630483226761759,0.806853845630917,0,0,0.936329588014981,0.43189955712094,HYAL2;DDIT3;FADD
alpha,4,cell-matrix adhesion (GO:0007160),6/91,6,91,0.636425883730098,0.806853845630917,0,0,0.926040251882949,0.418465839520344,VTN;ITGB5;ADAM15;PPFIA1;RAC1;WHAMM
alpha,4,"regulation of mRNA splicing, via spliceosome (GO:0048024)",4/61,4,61,0.639741767660128,0.806853845630917,0,0,0.920979922637687,0.411393140617672,RBM25;MBNL1;RBM15B;SRSF9
alpha,4,nucleosome assembly (GO:0006334),4/61,4,61,0.639741767660128,0.806853845630917,0,0,0.920979922637687,0.411393140617672,NPM1;HIST1H2BJ;HIST1H2BK;UBN1
alpha,4,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",2/30,2,30,0.64033709815767,0.806853845630917,0,0,0.936329588014981,0.417378769122824,UBB;CHD1L
alpha,4,collagen fibril organization (GO:0030199),2/30,2,30,0.64033709815767,0.806853845630917,0,0,0.936329588014981,0.417378769122824,NF1;TGFBR1
alpha,4,keratan sulfate biosynthetic process (GO:0018146),2/30,2,30,0.64033709815767,0.806853845630917,0,0,0.936329588014981,0.417378769122824,B4GALT6;ST3GAL2
alpha,4,regulation of vasoconstriction (GO:0019229),2/30,2,30,0.64033709815767,0.806853845630917,0,0,0.936329588014981,0.417378769122824,AVPR1B;ECE1
alpha,4,positive regulation of myeloid cell differentiation (GO:0045639),2/30,2,30,0.64033709815767,0.806853845630917,0,0,0.936329588014981,0.417378769122824,STAT5B;ETS1
alpha,4,positive regulation of histone modification (GO:0031058),2/30,2,30,0.64033709815767,0.806853845630917,0,0,0.936329588014981,0.417378769122824,CDK9;ARRB1
alpha,4,regulation of neutrophil chemotaxis (GO:0090022),2/30,2,30,0.64033709815767,0.806853845630917,0,0,0.936329588014981,0.417378769122824,SLIT2;RAC1
alpha,4,regulation of keratinocyte differentiation (GO:0045616),2/30,2,30,0.64033709815767,0.806853845630917,0,0,0.936329588014981,0.417378769122824,ERRFI1;CTSV
alpha,4,negative regulation of epithelial cell apoptotic process (GO:1904036),2/30,2,30,0.64033709815767,0.806853845630917,0,0,0.936329588014981,0.417378769122824,KRIT1;TNFAIP3
alpha,4,regulation of activated T cell proliferation (GO:0046006),2/30,2,30,0.64033709815767,0.806853845630917,0,0,0.936329588014981,0.417378769122824,TNFSF9;FADD
alpha,4,semaphorin-plexin signaling pathway (GO:0071526),2/30,2,30,0.64033709815767,0.806853845630917,0,0,0.936329588014981,0.417378769122824,SEMA3F;RAC1
alpha,4,respiratory system development (GO:0060541),2/30,2,30,0.64033709815767,0.806853845630917,0,0,0.936329588014981,0.417378769122824,SMCHD1;CHD7
alpha,4,regulation of cellular biosynthetic process (GO:0031326),2/30,2,30,0.64033709815767,0.806853845630917,0,0,0.936329588014981,0.417378769122824,STC2;SIRT5
alpha,4,cellular response to cadmium ion (GO:0071276),2/30,2,30,0.64033709815767,0.806853845630917,0,0,0.936329588014981,0.417378769122824,JUN;FOS
alpha,4,very long-chain fatty acid metabolic process (GO:0000038),2/30,2,30,0.64033709815767,0.806853845630917,0,0,0.936329588014981,0.417378769122824,ABCD3;ELOVL5
alpha,4,lung development (GO:0030324),2/30,2,30,0.64033709815767,0.806853845630917,0,0,0.936329588014981,0.417378769122824,ERRFI1;FOXJ1
alpha,4,cardiac muscle cell action potential (GO:0086001),2/30,2,30,0.64033709815767,0.806853845630917,0,0,0.936329588014981,0.417378769122824,CACNA1D;ATP1A1
alpha,4,nucleoside salvage (GO:0043174),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,UCK2
alpha,4,regulation of Golgi organization (GO:1903358),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,MAP2K1
alpha,4,regulation of lipase activity (GO:0060191),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,RHOA
alpha,4,regulation of platelet aggregation (GO:0090330),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,SERPINE2
alpha,4,positive regulation of T cell mediated cytotoxicity (GO:0001916),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,FADD
alpha,4,positive regulation of response to cytokine stimulus (GO:0060760),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,TAF9
alpha,4,regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,DLAT
alpha,4,regulation of monocyte differentiation (GO:0045655),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,FOXP1
alpha,4,modified amino acid transport (GO:0072337),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,SLC9A3R1
alpha,4,glucuronate metabolic process (GO:0019585),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,ABHD10
alpha,4,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,ATP1A1
alpha,4,copper ion transport (GO:0006825),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,CUTC
alpha,4,regulation of lymphocyte differentiation (GO:0045619),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,PRELID1
alpha,4,regulation of neural precursor cell proliferation (GO:2000177),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,DLL4
alpha,4,negative regulation of biomineral tissue development (GO:0070168),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,BCOR
alpha,4,amyloid-beta metabolic process (GO:0050435),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,APEH
alpha,4,cAMP biosynthetic process (GO:0006171),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,ADCY3
alpha,4,Golgi to vacuole transport (GO:0006896),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,VPS54
alpha,4,metallo-sulfur cluster assembly (GO:0031163),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,ISCA1
alpha,4,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,TMBIM6
alpha,4,necroptotic process (GO:0070266),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,TRPM7
alpha,4,epiboly involved in wound healing (GO:0090505),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,RHOA
alpha,4,regulation of transferase activity (GO:0051338),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,LDB1
alpha,4,negative regulation of smooth muscle cell migration (GO:0014912),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,SLIT2
alpha,4,nucleoside triphosphate metabolic process (GO:0009141),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,CMPK1
alpha,4,positive regulation of heart rate (GO:0010460),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,ATP2A2
alpha,4,positive regulation of muscle hypertrophy (GO:0014742),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,NR4A3
alpha,4,interleukin-6-mediated signaling pathway (GO:0070102),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,SMAD4
alpha,4,positive regulation of calcium ion-dependent exocytosis (GO:0045956),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,NLGN1
alpha,4,regulation of response to interferon-gamma (GO:0060330),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,HSP90AB1
alpha,4,regulation of adaptive immune response (GO:0002819),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,FADD
alpha,4,positive regulation of interleukin-8 secretion (GO:2000484),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,HYAL2
alpha,4,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,GEN1
alpha,4,purine-containing compound catabolic process (GO:0072523),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,NT5C2
alpha,4,positive regulation of blood vessel diameter (GO:0097755),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,NOS3
alpha,4,acetyl-CoA metabolic process (GO:0006084),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,ACAT1
alpha,4,establishment of mitotic spindle orientation (GO:0000132),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,PAFAH1B1
alpha,4,stem cell development (GO:0048864),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,KLHL12
alpha,4,regulation of activin receptor signaling pathway (GO:0032925),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,ACVR2B
alpha,4,regulation of nucleocytoplasmic transport (GO:0046822),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,NUP214
alpha,4,pore complex assembly (GO:0046931),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,NUP153
alpha,4,negative regulation of interleukin-1 beta production (GO:0032691),1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,ZC3H12A
alpha,4,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",1/14,1,14,0.644564892896619,0.806853845630917,0,0,1.00321027287319,0.440589661393838,UQCRH
alpha,4,peptidyl-tyrosine autophosphorylation (GO:0038083),3/46,3,46,0.645417288592927,0.807345825410726,0,0,0.915974596971177,0.401066999556078,TEC;TNK2;IGF1R
alpha,4,nicotinamide nucleotide metabolic process (GO:0046496),3/46,3,46,0.645417288592927,0.807345825410726,0,0,0.915974596971177,0.401066999556078,TPI1;PGAM1;PGM1
alpha,4,protein-DNA complex assembly (GO:0065004),6/92,6,92,0.647007612219956,0.808759515274945,0,0,0.915974596971177,0.398812792324989,NPM1;HIST1H2BJ;UBB;HIST1H2BK;SWI5;CHD1L
alpha,4,cellular response to lipopolysaccharide (GO:0071222),6/92,6,92,0.647007612219956,0.808759515274945,0,0,0.915974596971177,0.398812792324989,PRKCE;ZC3H12A;TNFAIP3;PLAA;RHOA;MTDH
alpha,4,response to interleukin-1 (GO:0070555),5/77,5,77,0.648771332249981,0.810675873749976,0,0,0.912009338975631,0.394603606962049,USP10;HYAL2;ZC3H12A;TAF9;RELA
alpha,4,regulation of actin cytoskeleton reorganization (GO:2000249),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,DAPK3;BAIAP2
alpha,4,negative regulation of cation channel activity (GO:2001258),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,PKD2;CALM2
alpha,4,connective tissue development (GO:0061448),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,HYAL2;SLC39A13
alpha,4,bile acid and bile salt transport (GO:0015721),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,NCOA1;SLC9A3R1
alpha,4,regulation of leukocyte chemotaxis (GO:0002688),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,MTUS1;SLIT2
alpha,4,cyclic purine nucleotide metabolic process (GO:0052652),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,GUCY1B3;ADCY3
alpha,4,negative regulation of DNA biosynthetic process (GO:2000279),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,ACD;NAT10
alpha,4,'de novo' posttranslational protein folding (GO:0051084),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,CCT2;ENTPD5
alpha,4,protein localization to lysosome (GO:0061462),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,CD81;NCOA4
alpha,4,regulation of developmental growth (GO:0048638),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,LATS1;STAT5B
alpha,4,positive regulation of phospholipase C activity (GO:0010863),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,AVPR1B;GNAQ
alpha,4,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,DYNLL2;YWHAZ
alpha,4,positive regulation of B cell proliferation (GO:0030890),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,TFRC;CD81
alpha,4,nuclear envelope organization (GO:0006998),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,SPAST;NUP155
alpha,4,CENP-A containing nucleosome assembly (GO:0034080),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,NPM1;CENPW
alpha,4,CENP-A containing chromatin organization (GO:0061641),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,NPM1;CENPW
alpha,4,bile acid metabolic process (GO:0008206),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,OSBPL6;SCP2
alpha,4,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,DYNLL2;YWHAZ
alpha,4,negative regulation of stress-activated MAPK cascade (GO:0032873),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,ZMYND11;DACT1
alpha,4,cellular response to cAMP (GO:0071320),2/31,2,31,0.658207118959637,0.815891068422464,0,0,0.906125407756434,0.37897392781014,RAP1A;PKD2
alpha,4,positive regulation of cytoskeleton organization (GO:0051495),5/78,5,78,0.66006476218858,0.815891068422464,0,0,0.900316911552867,0.374007242371985,KATNBL1;PRKCE;CDC42EP4;RAC1;BAIAP2
alpha,4,second-messenger-mediated signaling (GO:0019932),4/63,4,63,0.66497450452688,0.815891068422464,0,0,0.891742464776173,0.363836791616343,NOS3;SPHK1;PLCG1;CAMKK2
alpha,4,monocarboxylic acid metabolic process (GO:0032787),7/109,7,109,0.665605037349881,0.815891068422464,0,0,0.901968869188743,0.367154384804348,STAT5B;ACOT7;SLC16A1;DLAT;HAGH;SLC16A3;NIT2
alpha,4,positive regulation of peptidyl-lysine acetylation (GO:2000758),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,ARRB1
alpha,4,regulation of mRNA metabolic process (GO:1903311),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,PTCD2
alpha,4,nuclear pore organization (GO:0006999),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,NUP153
alpha,4,autonomic nervous system development (GO:0048483),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,NF1
alpha,4,endocardial cushion morphogenesis (GO:0003203),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,HEY1
alpha,4,positive regulation of glycolytic process (GO:0045821),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,ENTPD5
alpha,4,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,SLC9A3R1
alpha,4,pyrimidine nucleoside biosynthetic process (GO:0046134),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,UCK2
alpha,4,positive regulation of small GTPase mediated signal transduction (GO:0051057),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,RASGRP1
alpha,4,positive regulation of coenzyme metabolic process (GO:0051197),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,ENTPD5
alpha,4,positive regulation of potassium ion transmembrane transport (GO:1901381),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,ATP1B3
alpha,4,regulation of tumor necrosis factor secretion (GO:1904467),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,ZC3H12A
alpha,4,intracellular lipid transport (GO:0032365),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,ARV1
alpha,4,cardiac muscle cell differentiation (GO:0055007),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,KDM6B
alpha,4,negative regulation of cell aging (GO:0090344),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,AKT3
alpha,4,presynapse assembly (GO:0099054),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,NLGN1
alpha,4,mitochondrion localization (GO:0051646),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,MFN2
alpha,4,mesenchyme morphogenesis (GO:0072132),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,HEY1
alpha,4,nitric oxide mediated signal transduction (GO:0007263),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,NOS3
alpha,4,mitotic chromosome condensation (GO:0007076),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,PAPD7
alpha,4,negative regulation of lipid catabolic process (GO:0050995),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,PDE3B
alpha,4,cellular response to virus (GO:0098586),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,ZC3H12A
alpha,4,negative regulation of cellular component movement (GO:0051271),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,CRK
alpha,4,cellular biogenic amine biosynthetic process (GO:0042401),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,PAOX
alpha,4,neural crest cell differentiation (GO:0014033),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,KLHL12
alpha,4,ganglioside metabolic process (GO:0001573),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,CLN6
alpha,4,regulation of mitotic sister chromatid separation (GO:0010965),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,PTTG1
alpha,4,regulation of exit from mitosis (GO:0007096),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,MAD2L1BP
alpha,4,regulation of mitochondrial translation (GO:0070129),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,MRPS27
alpha,4,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,SNX9
alpha,4,negative regulation of signal transduction by p53 class mediator (GO:1901797),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,SNAI1
alpha,4,negative regulation of axon extension involved in axon guidance (GO:0048843),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,SEMA3F
alpha,4,cofactor transport (GO:0051181),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,SLC48A1
alpha,4,protein O-linked fucosylation (GO:0036066),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,LFNG
alpha,4,JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,STAT5B
alpha,4,regulation of lymphocyte proliferation (GO:0050670),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,ZNF335
alpha,4,toll-like receptor 4 signaling pathway (GO:0034142),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,PRKCE
alpha,4,regulation of T cell mediated cytotoxicity (GO:0001914),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,FADD
alpha,4,regulation of fertilization (GO:0080154),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,LHFPL2
alpha,4,positive regulation of potassium ion transport (GO:0043268),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,KIF5B
alpha,4,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,FADD
alpha,4,regulation of peptide secretion (GO:0002791),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,DNAJC1
alpha,4,negative regulation of anoikis (GO:2000811),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,PIK3CA
alpha,4,endoderm development (GO:0007492),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,DUSP5
alpha,4,inhibition of cysteine-type endopeptidase activity (GO:0097340),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,BIRC2
alpha,4,nucleobase-containing small molecule catabolic process (GO:0034656),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,ENTPD5
alpha,4,cellular response to corticosteroid stimulus (GO:0071384),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,NR3C1
alpha,4,membrane repolarization during cardiac muscle cell action potential (GO:0086013),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,ATP1A1
alpha,4,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,CALM2
alpha,4,positive regulation of vasoconstriction (GO:0045907),1/15,1,15,0.669889508810023,0.815891068422464,0,0,0.936329588014981,0.37513341986937,AVPR1B
alpha,4,positive regulation of translation (GO:0045727),5/79,5,79,0.671120759891999,0.816824609079077,0,0,0.888920494950932,0.354506994177868,NPM1;DDX3X;MRPS27;EIF4A3;CIRBP
alpha,4,sensory perception of mechanical stimulus (GO:0050954),5/79,5,79,0.671120759891999,0.816824609079077,0,0,0.888920494950932,0.354506994177868,TFAP2A;TIMM9;CACNA1D;TBL1X;SERPINB6
alpha,4,dephosphorylation (GO:0016311),8/125,8,125,0.673404048737692,0.817734367378599,0,0,0.898876404494382,0.355424503273486,PHLPP2;DUSP5;PPP4R2;UBLCP1;PPP2R5A;PPM1D;CTTNBP2NL;PPM1G
alpha,4,organic anion transport (GO:0015711),8/125,8,125,0.673404048737692,0.817734367378599,0,0,0.898876404494382,0.355424503273486,SLC35B2;SLC9A3R1;CYB5R1;PRELID1;SCP2;STARD7;CYB5RL;TRIAP1
alpha,4,negative regulation of JAK-STAT cascade (GO:0046426),3/48,3,48,0.673985212898448,0.817734367378599,0,0,0.877808988764045,0.346336997568742,SOCS2;CISH;FLRT3
alpha,4,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),3/48,3,48,0.673985212898448,0.817734367378599,0,0,0.877808988764045,0.346336997568742,CD164;NLGN1;SMAGP
alpha,4,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),7/110,7,110,0.674953531685969,0.817734367378599,0,0,0.893769152196119,0.35135087167802,VCP;SMAD3;DDX3X;HIP1;HIP1R;FADD;MAP3K5
alpha,4,negative regulation of cell-cell adhesion (GO:0022408),2/32,2,32,0.675357857325768,0.817734367378599,0,0,0.877808988764045,0.344551061791698,RDX;ASS1
alpha,4,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),2/32,2,32,0.675357857325768,0.817734367378599,0,0,0.877808988764045,0.344551061791698,ZC3H12A;TNFAIP3
alpha,4,regulation of ubiquitin-protein transferase activity (GO:0051438),2/32,2,32,0.675357857325768,0.817734367378599,0,0,0.877808988764045,0.344551061791698,FBXW7;BMI1
alpha,4,alpha-amino acid metabolic process (GO:1901605),2/32,2,32,0.675357857325768,0.817734367378599,0,0,0.877808988764045,0.344551061791698,STAT5B;ASS1
alpha,4,secondary alcohol metabolic process (GO:1902652),2/32,2,32,0.675357857325768,0.817734367378599,0,0,0.877808988764045,0.344551061791698,FDX1;CLN6
alpha,4,cofactor biosynthetic process (GO:0051188),2/32,2,32,0.675357857325768,0.817734367378599,0,0,0.877808988764045,0.344551061791698,ISCA1;MOCS3
alpha,4,response to cadmium ion (GO:0046686),2/32,2,32,0.675357857325768,0.817734367378599,0,0,0.877808988764045,0.344551061791698,JUN;FOS
alpha,4,lysosome organization (GO:0007040),2/32,2,32,0.675357857325768,0.817734367378599,0,0,0.877808988764045,0.344551061791698,TPP1;CLN6
alpha,4,termination of RNA polymerase I transcription (GO:0006363),2/32,2,32,0.675357857325768,0.817734367378599,0,0,0.877808988764045,0.344551061791698,POLR1C;POLR2H
alpha,4,protein destabilization (GO:0031648),2/32,2,32,0.675357857325768,0.817734367378599,0,0,0.877808988764045,0.344551061791698,CUL3;FBXL3
alpha,4,oligosaccharide metabolic process (GO:0009311),4/64,4,64,0.677128764101173,0.818750466396843,0,0,0.877808988764045,0.342252305191124,GALNT16;GALNT2;GALNT10;ST3GAL2
alpha,4,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193),4/64,4,64,0.677128764101173,0.818750466396843,0,0,0.877808988764045,0.342252305191124,GRM4;GNAL;PSAP;ADCY3
alpha,4,regulation of viral genome replication (GO:0045069),4/64,4,64,0.677128764101173,0.818750466396843,0,0,0.877808988764045,0.342252305191124,DDX3X;CNOT7;PKN2;PPID
alpha,4,ribosomal large subunit biogenesis (GO:0042273),4/64,4,64,0.677128764101173,0.818750466396843,0,0,0.877808988764045,0.342252305191124,NPM1;WDR37;PAK1IP1;RPL12
alpha,4,cation transport (GO:0006812),5/80,5,80,0.681936874672474,0.823865330193,0,0,0.877808988764045,0.336041243463664,SLC12A2;SLC6A9;GPRIN1;PQLC2;RHCE
alpha,4,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),5/80,5,80,0.681936874672474,0.823865330193,0,0,0.877808988764045,0.336041243463664,VCP;HIP1;SMAD3;HIP1R;FADD
alpha,4,"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",8/126,8,126,0.682062051454233,0.823865330193,0,0,0.891742464776173,0.341211557642695,GNAZ;GNAL;GRK5;CNR2;GNAQ;GNA12;DHX15;CACNA1D
alpha,4,NADH dehydrogenase complex assembly (GO:0010257),4/65,4,65,0.688972474232169,0.825377377665147,0,0,0.864304235090752,0.321999964634978,NDUFAF6;NDUFAF7;NDUFB2;NDUFAF3
alpha,4,mitochondrial respiratory chain complex I biogenesis (GO:0097031),4/65,4,65,0.688972474232169,0.825377377665147,0,0,0.864304235090752,0.321999964634978,NDUFAF6;NDUFAF7;NDUFB2;NDUFAF3
alpha,4,mitochondrial respiratory chain complex I assembly (GO:0032981),4/65,4,65,0.688972474232169,0.825377377665147,0,0,0.864304235090752,0.321999964634978,NDUFAF6;NDUFAF7;NDUFB2;NDUFAF3
alpha,4,positive regulation of endocytosis (GO:0045807),4/65,4,65,0.688972474232169,0.825377377665147,0,0,0.864304235090752,0.321999964634978,VTN;HIP1;HIP1R;CLU
alpha,4,negative regulation of neuron differentiation (GO:0045665),4/65,4,65,0.688972474232169,0.825377377665147,0,0,0.864304235090752,0.321999964634978,KANK1;DLX2;DPYSL3;DENND5A
alpha,4,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),2/33,2,33,0.691801073346265,0.825377377665147,0,0,0.851208716377256,0.313633666116307,PKD2;CALM2
alpha,4,cyclic-nucleotide-mediated signaling (GO:0019935),2/33,2,33,0.691801073346265,0.825377377665147,0,0,0.851208716377256,0.313633666116307,GUCY1B3;ADCY3
alpha,4,negative regulation of fat cell differentiation (GO:0045599),2/33,2,33,0.691801073346265,0.825377377665147,0,0,0.851208716377256,0.313633666116307,SMAD3;RORA
alpha,4,positive regulation of calcium ion transport into cytosol (GO:0010524),2/33,2,33,0.691801073346265,0.825377377665147,0,0,0.851208716377256,0.313633666116307,GPRIN1;PLCG1
alpha,4,response to zinc ion (GO:0010043),2/33,2,33,0.691801073346265,0.825377377665147,0,0,0.851208716377256,0.313633666116307,SLC30A5;SLC30A4
alpha,4,oxoacid metabolic process (GO:0043436),2/33,2,33,0.691801073346265,0.825377377665147,0,0,0.851208716377256,0.313633666116307,PODXL2;ABHD14B
alpha,4,chromatin remodeling at centromere (GO:0031055),2/33,2,33,0.691801073346265,0.825377377665147,0,0,0.851208716377256,0.313633666116307,NPM1;CENPW
alpha,4,"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",5/81,5,81,0.692511221007394,0.825377377665147,0,0,0.866971840754612,0.31855218947768,NAPA;GOLPH3;KDELR2;ATP9B;ARCN1
alpha,4,positive regulation of secretion (GO:0051047),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,ACSL3
alpha,4,cellular response to dsRNA (GO:0071359),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,NPM1
alpha,4,positive regulation of dendrite morphogenesis (GO:0050775),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,CDKL5
alpha,4,negative regulation of response to wounding (GO:1903035),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,CRK
alpha,4,regulation of cell cycle phase transition (GO:1901987),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,FBXW7
alpha,4,protein deacylation (GO:0035601),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,SIRT5
alpha,4,positive regulation of cardiac muscle hypertrophy (GO:0010613),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,NR4A3
alpha,4,positive regulation of immune system process (GO:0002684),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,PIK3CB
alpha,4,glutamine family amino acid catabolic process (GO:0009065),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,NOS3
alpha,4,cellular response to pH (GO:0071467),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,RAB11FIP5
alpha,4,dendritic spine morphogenesis (GO:0060997),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,ARC
alpha,4,pyrimidine-containing compound metabolic process (GO:0072527),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,UCK2
alpha,4,regulation of osteoblast proliferation (GO:0033688),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,RHOA
alpha,4,positive regulation of triglyceride metabolic process (GO:0090208),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,ABHD5
alpha,4,positive regulation of cyclic nucleotide metabolic process (GO:0030801),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,CALM2
alpha,4,genitalia development (GO:0048806),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,CHD7
alpha,4,odontogenesis of dentin-containing tooth (GO:0042475),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,ROGDI
alpha,4,activation of protein kinase A activity (GO:0034199),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,ADCY3
alpha,4,protein localization to chromatin (GO:0071168),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,LRWD1
alpha,4,detection of visible light (GO:0009584),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,GNAQ
alpha,4,endoplasmic reticulum to cytosol transport (GO:1903513),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,VCP
alpha,4,negative regulation of lipid storage (GO:0010888),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,ABHD5
alpha,4,positive regulation of epithelial cell apoptotic process (GO:1904037),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,PIAS4
alpha,4,regulation of actin nucleation (GO:0051125),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,WHAMM
alpha,4,postsynaptic membrane organization (GO:0001941),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,NLGN1
alpha,4,C21-steroid hormone biosynthetic process (GO:0006700),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,FDX1
alpha,4,DNA strand elongation involved in DNA replication (GO:0006271),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,LIG4
alpha,4,regulation of dopamine secretion (GO:0014059),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,DTNBP1
alpha,4,histone H2A acetylation (GO:0043968),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,MEAF6
alpha,4,positive regulation of mRNA processing (GO:0050685),1/16,1,16,0.693410923540592,0.825377377665147,0,0,0.877808988764045,0.321394392787435,NCBP2
alpha,4,cellular metal ion homeostasis (GO:0006875),6/97,6,97,0.697029870739521,0.829404196225259,0,0,0.868759411560292,0.313558739417627,STIM2;RMDN3;ATP2A2;ATP1B3;ATP1A1;LETM2
alpha,4,regulation of JAK-STAT cascade (GO:0046425),4/66,4,66,0.70050479969044,0.832411890098681,0,0,0.851208716377256,0.302991199712349,SOCS2;CNOT7;CISH;FLRT3
alpha,4,regulation of cell division (GO:0051302),4/66,4,66,0.70050479969044,0.832411890098681,0,0,0.851208716377256,0.302991199712349,SETD2;KIF13A;CALM2;GIT1
alpha,4,defense response to Gram-positive bacterium (GO:0050830),4/66,4,66,0.70050479969044,0.832411890098681,0,0,0.851208716377256,0.302991199712349,HIST1H2BJ;HIST1H2BK;DROSHA;RPL39
alpha,4,O-glycan processing (GO:0016266),4/66,4,66,0.70050479969044,0.832411890098681,0,0,0.851208716377256,0.302991199712349,GALNT16;GALNT2;GALNT10;ST3GAL2
alpha,4,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),3/50,3,50,0.700819177825933,0.832504025028102,0,0,0.842696629213483,0.299583180434149,HIST1H2BJ;HIST1H2BK;RPL39
alpha,4,sensory perception of sound (GO:0007605),5/82,5,82,0.702842450221499,0.83462540963803,0,0,0.856399013428337,0.301985580746433,TFAP2A;TIMM9;CACNA1D;TBL1X;SERPINB6
alpha,4,cell morphogenesis involved in neuron differentiation (GO:0048667),6/98,6,98,0.706442015941907,0.836648894203838,0,0,0.859894519605595,0.298825515215602,RB1;RYK;BTBD3;MAP6D1;SLIT2;BAIAP2
alpha,4,positive regulation of cell-cell adhesion (GO:0022409),2/34,2,34,0.707550498518671,0.836648894203838,0,0,0.826173165895572,0.285811530084078,PTPN23;DENND6A
alpha,4,positive regulation of cell-matrix adhesion (GO:0001954),2/34,2,34,0.707550498518671,0.836648894203838,0,0,0.826173165895572,0.285811530084078,RAC1;S100A10
alpha,4,intra-Golgi vesicle-mediated transport (GO:0006891),2/34,2,34,0.707550498518671,0.836648894203838,0,0,0.826173165895572,0.285811530084078,NAPA;TRAPPC10
alpha,4,cellular response to glucose starvation (GO:0042149),2/34,2,34,0.707550498518671,0.836648894203838,0,0,0.826173165895572,0.285811530084078,ZC3H12A;ATF4
alpha,4,transcription initiation from RNA polymerase I promoter (GO:0006361),2/34,2,34,0.707550498518671,0.836648894203838,0,0,0.826173165895572,0.285811530084078,POLR1C;POLR2H
alpha,4,transcription from RNA polymerase I promoter (GO:0006360),2/34,2,34,0.707550498518671,0.836648894203838,0,0,0.826173165895572,0.285811530084078,POLR1C;POLR2H
alpha,4,cellular glucose homeostasis (GO:0001678),2/34,2,34,0.707550498518671,0.836648894203838,0,0,0.826173165895572,0.285811530084078,ERN1;IGF1R
alpha,4,negative regulation of epithelial cell proliferation (GO:0050680),4/67,4,67,0.71172565730415,0.836648894203838,0,0,0.838504108670133,0.285144016935497,CDKN2B;FBXW7;KRIT1;NF1
alpha,4,positive regulation of cellular protein localization (GO:1903829),4/67,4,67,0.71172565730415,0.836648894203838,0,0,0.838504108670133,0.285144016935497,HSP90AB1;PARD6A;NUP62;GNL3
alpha,4,modulation of chemical synaptic transmission (GO:0050804),5/83,5,83,0.71292972259302,0.836648894203838,0,0,0.846080953025586,0.286290467386928,NLGN1;GRM4;SLC6A9;GRIK4;BTBD9
alpha,4,positive regulation of protein secretion (GO:0050714),5/83,5,83,0.71292972259302,0.836648894203838,0,0,0.846080953025586,0.286290467386928,ACHE;GOLPH3;PTPN23;PPID;BMP6
alpha,4,high-density lipoprotein particle remodeling (GO:0034375),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,LIPG
alpha,4,cellular glucuronidation (GO:0052695),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,ABHD10
alpha,4,negative regulation of immune effector process (GO:0002698),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,CD55
alpha,4,sialylation (GO:0097503),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,ST3GAL2
alpha,4,regulation of toll-like receptor 4 signaling pathway (GO:0034143),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,TNFAIP3
alpha,4,DNA packaging (GO:0006323),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,CDAN1
alpha,4,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,HIP1R
alpha,4,gastrulation (GO:0007369),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,NR4A3
alpha,4,positive regulation of dendrite extension (GO:1903861),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,PLAA
alpha,4,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,RELA
alpha,4,negative regulation of interleukin-8 production (GO:0032717),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,ARRB1
alpha,4,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,HIST1H2BJ
alpha,4,peptidyl-lysine methylation (GO:0018022),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,SETD2
alpha,4,3'-UTR-mediated mRNA stabilization (GO:0070935),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,MAPKAPK2
alpha,4,regulation of protein localization to membrane (GO:1905475),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,CRIPT
alpha,4,response to purine-containing compound (GO:0014074),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,JUN
alpha,4,phospholipid catabolic process (GO:0009395),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,LIPG
alpha,4,positive regulation of signal transduction by p53 class mediator (GO:1901798),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,UBB
alpha,4,positive regulation of macrophage activation (GO:0043032),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,KARS
alpha,4,neurotrophin signaling pathway (GO:0038179),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,RAP1A
alpha,4,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,CALM2
alpha,4,serine family amino acid metabolic process (GO:0009069),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,GCLC
alpha,4,regulation of T cell migration (GO:2000404),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,RHOA
alpha,4,synaptic vesicle transport (GO:0048489),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,KIF5B
alpha,4,septin ring organization (GO:0031106),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,RTKN
alpha,4,positive regulation of leukocyte activation (GO:0002696),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,KARS
alpha,4,platelet-derived growth factor receptor signaling pathway (GO:0048008),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,PIK3C2A
alpha,4,cellular response to glucocorticoid stimulus (GO:0071385),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,NR3C1
alpha,4,membrane depolarization during cardiac muscle cell action potential (GO:0086012),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,CACNA1D
alpha,4,mitotic G2 DNA damage checkpoint (GO:0007095),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,MUS81
alpha,4,positive regulation of lymphocyte migration (GO:2000403),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,RHOA
alpha,4,positive regulation of nitrogen compound metabolic process (GO:0051173),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,ACSL3
alpha,4,positive regulation of interleukin-6 secretion (GO:2000778),1/17,1,17,0.715257447249654,0.836648894203838,0,0,0.826173165895572,0.276861149217559,HYAL2
alpha,4,positive regulation of DNA binding (GO:0043388),2/35,2,35,0.722621496102249,0.843314817285256,0,0,0.802568218298555,0.260730106290386,RB1;TXN
alpha,4,positive regulation of cell development (GO:0010720),2/35,2,35,0.722621496102249,0.843314817285256,0,0,0.802568218298555,0.260730106290386,LIG4;ZNF335
alpha,4,regulation of interleukin-1 beta secretion (GO:0050706),2/35,2,35,0.722621496102249,0.843314817285256,0,0,0.802568218298555,0.260730106290386,ZC3H12A;FOXP1
alpha,4,anterior/posterior pattern specification (GO:0009952),2/35,2,35,0.722621496102249,0.843314817285256,0,0,0.802568218298555,0.260730106290386,ACVR2B;TGFBR1
alpha,4,positive regulation of homeostatic process (GO:0032846),5/84,5,84,0.722772679279763,0.843314817285256,0,0,0.836008560727662,0.271418973573136,STAT5B;GPRIN1;PIK3CB;ETS1;GNL3
alpha,4,response to organonitrogen compound (GO:0010243),3/52,3,52,0.72593653185492,0.843314817285256,0,0,0.81028522039758,0.259528432637973,VCP;AVPR1B;AMFR
alpha,4,positive regulation of developmental growth (GO:0048639),3/52,3,52,0.72593653185492,0.843314817285256,0,0,0.81028522039758,0.259528432637973,CDKL5;PLAA;AGRN
alpha,4,protein O-linked glycosylation (GO:0006493),7/116,7,116,0.727524330320225,0.843314817285256,0,0,0.847539713289423,0.269609024759788,DPM1;B3GALNT2;LFNG;GALNT16;GALNT2;GALNT10;ST3GAL2
alpha,4,regulation of neuron differentiation (GO:0045664),5/85,5,85,0.732371414805852,0.843314817285256,0,0,0.826173165895572,0.257326087597111,NLGN1;TCF12;NBL1;RHOA;CDK5R1
alpha,4,cellular response to molecule of bacterial origin (GO:0071219),5/85,5,85,0.732371414805852,0.843314817285256,0,0,0.826173165895572,0.257326087597111,ZC3H12A;TNFAIP3;PLAA;RHOA;RELA
alpha,4,cholesterol metabolic process (GO:0008203),4/69,4,69,0.733236081072748,0.843314817285256,0,0,0.814199641752158,0.252636015158113,IDI1;ARV1;FDX1;CLN6
alpha,4,homologous chromosome segregation (GO:0045143),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,PTTG1
alpha,4,regulation of amyloid-beta formation (GO:1902003),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,CLU
alpha,4,anion transmembrane transport (GO:0098656),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,LRRC8B
alpha,4,regulation of keratinocyte proliferation (GO:0010837),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,STXBP4
alpha,4,anterior/posterior axis specification (GO:0009948),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,DDIT3
alpha,4,leukotriene biosynthetic process (GO:0019370),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,LTA4H
alpha,4,protein mannosylation (GO:0035268),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,DPM1
alpha,4,positive regulation of cyclic nucleotide biosynthetic process (GO:0030804),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,CALM2
alpha,4,negative regulation of fibroblast proliferation (GO:0048147),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,NF1
alpha,4,establishment of mitotic spindle localization (GO:0040001),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,PAFAH1B1
alpha,4,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,HSPB1
alpha,4,negative regulation of protein dephosphorylation (GO:0035308),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,TIPRL
alpha,4,regulation of cardiac muscle cell proliferation (GO:0060043),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,TGFBR1
alpha,4,"retrograde protein transport, ER to cytosol (GO:0030970)",1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,VCP
alpha,4,regulation of cholesterol efflux (GO:0010874),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,PTCH1
alpha,4,regulation of cardiac muscle cell membrane repolarization (GO:0099623),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,CACNA1D
alpha,4,tRNA metabolic process (GO:0006399),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,KARS
alpha,4,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,DOLK
alpha,4,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,RASGRP1
alpha,4,positive regulation of actin cytoskeleton reorganization (GO:2000251),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,BAIAP2
alpha,4,phosphatidylglycerol acyl-chain remodeling (GO:0036148),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,LPGAT1
alpha,4,regulation of cAMP-mediated signaling (GO:0043949),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,PDE3B
alpha,4,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,HSPB1
alpha,4,negative regulation of protein transport (GO:0051224),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,SERGEF
alpha,4,regulation of cellular response to growth factor stimulus (GO:0090287),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,SLIT2
alpha,4,regulation of epithelial cell differentiation (GO:0030856),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,APOLD1
alpha,4,positive regulation of carbohydrate metabolic process (GO:0045913),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,ENTPD5
alpha,4,regulation of peptidase activity (GO:0052547),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,PSMA3
alpha,4,cell-substrate adherens junction assembly (GO:0007045),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,WHAMM
alpha,4,regulation of dendrite extension (GO:1903859),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,PLAA
alpha,4,piRNA metabolic process (GO:0034587),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,PLD6
alpha,4,response to organophosphorus (GO:0046683),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,JUN
alpha,4,mRNA destabilization (GO:0061157),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,ZC3H12A
alpha,4,positive regulation of morphogenesis of an epithelium (GO:1905332),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,RREB1
alpha,4,DNA ligation (GO:0006266),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,LIG4
alpha,4,focal adhesion assembly (GO:0048041),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,WHAMM
alpha,4,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,NLGN1
alpha,4,iron-sulfur cluster assembly (GO:0016226),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,ISCA1
alpha,4,glycosphingolipid biosynthetic process (GO:0006688),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,B4GALT6
alpha,4,positive regulation of lipid catabolic process (GO:0050996),1/18,1,18,0.735548266090843,0.843314817285256,0,0,0.780274656679151,0.239652869526224,ABHD5
alpha,4,regulation of heart rate by cardiac conduction (GO:0086091),2/36,2,36,0.737030759231951,0.843314817285256,0,0,0.780274656679151,0.238081813307701,CACNA1D;DSG2
alpha,4,negative regulation of protein complex assembly (GO:0031333),2/36,2,36,0.737030759231951,0.843314817285256,0,0,0.780274656679151,0.238081813307701,DDX3X;DACT1
alpha,4,regulation of mitotic spindle organization (GO:0060236),2/36,2,36,0.737030759231951,0.843314817285256,0,0,0.780274656679151,0.238081813307701,CLTC;NUP62
alpha,4,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",2/36,2,36,0.737030759231951,0.843314817285256,0,0,0.780274656679151,0.238081813307701,TSR1;NOC4L
alpha,4,cholesterol biosynthetic process (GO:0006695),2/36,2,36,0.737030759231951,0.843314817285256,0,0,0.780274656679151,0.238081813307701,IDI1;ARV1
alpha,4,regulation of sodium ion transport (GO:0002028),2/36,2,36,0.737030759231951,0.843314817285256,0,0,0.780274656679151,0.238081813307701,SLMAP;ATP1A1
alpha,4,regulation of synapse assembly (GO:0051963),2/36,2,36,0.737030759231951,0.843314817285256,0,0,0.780274656679151,0.238081813307701,NLGN1;SRPX2
alpha,4,positive regulation of ATPase activity (GO:0032781),2/36,2,36,0.737030759231951,0.843314817285256,0,0,0.780274656679151,0.238081813307701,ATP1B3;DYNLL2
alpha,4,membrane protein proteolysis (GO:0033619),2/36,2,36,0.737030759231951,0.843314817285256,0,0,0.780274656679151,0.238081813307701,SPPL3;RELA
alpha,4,negative regulation of tumor necrosis factor production (GO:0032720),2/36,2,36,0.737030759231951,0.843314817285256,0,0,0.780274656679151,0.238081813307701,ZC3H12A;TNFAIP3
alpha,4,flagellated sperm motility (GO:0030317),2/36,2,36,0.737030759231951,0.843314817285256,0,0,0.780274656679151,0.238081813307701,CATSPERD;ADCY3
alpha,4,positive regulation of osteoblast differentiation (GO:0045669),2/36,2,36,0.737030759231951,0.843314817285256,0,0,0.780274656679151,0.238081813307701,ACVR2B;BMP6
alpha,4,positive regulation of NIK/NF-kappaB signaling (GO:1901224),2/36,2,36,0.737030759231951,0.843314817285256,0,0,0.780274656679151,0.238081813307701,TERF2IP;RELA
alpha,4,regulation of endothelial cell apoptotic process (GO:2000351),2/36,2,36,0.737030759231951,0.843314817285256,0,0,0.780274656679151,0.238081813307701,KRIT1;TNFAIP3
alpha,4,erythrocyte differentiation (GO:0030218),2/36,2,36,0.737030759231951,0.843314817285256,0,0,0.780274656679151,0.238081813307701,SLC25A38;HIPK2
alpha,4,positive regulation of DNA replication (GO:0045740),2/36,2,36,0.737030759231951,0.843314817285256,0,0,0.780274656679151,0.238081813307701,BMP6;IGF1R
alpha,4,regulation of DNA binding (GO:0051101),3/53,3,53,0.737861612590881,0.843990747887063,0,0,0.79499682001272,0.241678229366917,RB1;JUN;TXN
alpha,4,cellular divalent inorganic cation homeostasis (GO:0072503),6/102,6,102,0.742079395003061,0.848539060974548,0,0,0.826173165895572,0.246446662415035,STIM2;SLC30A5;RMDN3;ATP2A2;SLC39A13;SLC39A7
alpha,4,regulation of osteoblast differentiation (GO:0045667),4/70,4,70,0.743528771185229,0.849643573054642,0,0,0.802568218298555,0.237839339387423,PTCH1;AXIN2;ACVR2B;BMP6
alpha,4,response to organic cyclic compound (GO:0014070),4/70,4,70,0.743528771185229,0.849643573054642,0,0,0.802568218298555,0.237839339387423,SOCS2;STAT5B;CTNNB1;STRN3
alpha,4,monocarboxylic acid transport (GO:0015718),3/54,3,54,0.749371499581963,0.85181343623873,0,0,0.780274656679151,0.225125175037387,NCOA1;SLC16A1;SLC16A3
alpha,4,regulation of potassium ion transport (GO:0043266),2/37,2,37,0.750796044029653,0.85181343623873,0,0,0.759186152444579,0.217598878902612,KIF5B;CACNA1D
alpha,4,histone exchange (GO:0043486),2/37,2,37,0.750796044029653,0.85181343623873,0,0,0.759186152444579,0.217598878902612,NPM1;CENPW
alpha,4,natural killer cell activation (GO:0030101),2/37,2,37,0.750796044029653,0.85181343623873,0,0,0.759186152444579,0.217598878902612,ULBP2;ULBP3
alpha,4,sodium ion transmembrane transport (GO:0035725),2/37,2,37,0.750796044029653,0.85181343623873,0,0,0.759186152444579,0.217598878902612,SLC12A2;PKD2
alpha,4,regulation of response to DNA damage stimulus (GO:2001020),2/37,2,37,0.750796044029653,0.85181343623873,0,0,0.759186152444579,0.217598878902612,CDK9;CRY1
alpha,4,mRNA catabolic process (GO:0006402),2/37,2,37,0.750796044029653,0.85181343623873,0,0,0.759186152444579,0.217598878902612,SUPV3L1;ERN1
alpha,4,calcium ion transmembrane import into cytosol (GO:0097553),2/37,2,37,0.750796044029653,0.85181343623873,0,0,0.759186152444579,0.217598878902612,GPRIN1;PKD2
alpha,4,regulation of blood circulation (GO:1903522),2/37,2,37,0.750796044029653,0.85181343623873,0,0,0.759186152444579,0.217598878902612,ECE1;FOXN4
alpha,4,vesicle-mediated transport in synapse (GO:0099003),2/37,2,37,0.750796044029653,0.85181343623873,0,0,0.759186152444579,0.217598878902612,NLGN1;KIF5B
alpha,4,regulation of cysteine-type endopeptidase activity (GO:2000116),2/37,2,37,0.750796044029653,0.85181343623873,0,0,0.759186152444579,0.217598878902612,GPRIN1;BIRC2
alpha,4,organic hydroxy compound transport (GO:0015850),2/37,2,37,0.750796044029653,0.85181343623873,0,0,0.759186152444579,0.217598878902612,NCOA1;SLC16A1
alpha,4,adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),8/135,8,135,0.753372791610578,0.85181343623873,0,0,0.832292967124428,0.235701288815212,GNAZ;GNAL;GRK5;GNAQ;PSAP;GNA12;ADCY3;CACNA1D
alpha,4,calcium-mediated signaling (GO:0019722),4/71,4,71,0.753516143068397,0.85181343623873,0,0,0.791264440576041,0.223931664055288,SPHK1;ATP2A2;PLCG1;CAMKK2
alpha,4,protein import into mitochondrial matrix (GO:0030150),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,TOMM20
alpha,4,primary alcohol metabolic process (GO:0034308),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,GDPD1
alpha,4,regulation of sprouting angiogenesis (GO:1903670),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,TMEM2
alpha,4,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,EXOSC3
alpha,4,intracellular estrogen receptor signaling pathway (GO:0030520),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,DDX54
alpha,4,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,MOAP1
alpha,4,cellular polysaccharide biosynthetic process (GO:0033692),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,NDST1
alpha,4,histone deubiquitination (GO:0016578),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,ATXN7
alpha,4,insulin secretion (GO:0030073),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,RAB11FIP5
alpha,4,fatty-acyl-CoA metabolic process (GO:0035337),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,SCD
alpha,4,positive regulation of immunoglobulin production (GO:0002639),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,TFRC
alpha,4,calcium ion transport into cytosol (GO:0060402),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,GPRIN1
alpha,4,positive regulation of phospholipase activity (GO:0010518),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,PLAA
alpha,4,aspartate family amino acid catabolic process (GO:0009068),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,GOT1
alpha,4,negative regulation of calcium ion transport (GO:0051926),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,TMBIM6
alpha,4,positive regulation of epithelial cell differentiation (GO:0030858),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,FOXJ1
alpha,4,triglyceride biosynthetic process (GO:0019432),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,LPIN2
alpha,4,positive regulation of axon extension (GO:0045773),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,CDKL5
alpha,4,positive regulation of heart contraction (GO:0045823),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,ATP2A2
alpha,4,regulation of long-term synaptic potentiation (GO:1900271),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,ARC
alpha,4,negative regulation of double-strand break repair (GO:2000780),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,TRIP12
alpha,4,protein exit from endoplasmic reticulum (GO:0032527),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,VCP
alpha,4,acylglycerol biosynthetic process (GO:0046463),1/19,1,19,0.754394090188098,0.85181343623873,0,0,0.739207569485512,0.208338543380053,LPIN2
alpha,4,organic substance transport (GO:0071702),5/88,5,88,0.759709469383494,0.857264457426318,0,0,0.798008171603677,0.219307964053937,SLC48A1;SCP2;CHKA;PSAP;RHCE
alpha,4,regulation of MAP kinase activity (GO:0043405),5/88,5,88,0.759709469383494,0.857264457426318,0,0,0.798008171603677,0.219307964053937,UCHL1;HYAL2;NF1;RASGRP1;IGF1R
alpha,4,positive regulation of immune response (GO:0050778),3/55,3,55,0.760472543994284,0.857850125847211,0,0,0.76608784473953,0.209766550438806,POLR3B;POLR3D;FADD
alpha,4,histone acetylation (GO:0016573),4/72,4,72,0.763201108506468,0.860651875649738,0,0,0.780274656679151,0.210856512487152,KAT5;MEAF6;TAF9;TAF5L
alpha,4,spliceosomal snRNP assembly (GO:0000387),2/38,2,38,0.763935934053078,0.860652182114285,0,0,0.739207569485512,0.199047419635713,PRPF19;WDR77
alpha,4,regulation of metal ion transport (GO:0010959),2/38,2,38,0.763935934053078,0.860652182114285,0,0,0.739207569485512,0.199047419635713,ORAI1;ATP1A1
alpha,4,myelination (GO:0042552),2/38,2,38,0.763935934053078,0.860652182114285,0,0,0.739207569485512,0.199047419635713,NF1;SBF2
alpha,4,T cell activation (GO:0042110),5/89,5,89,0.768340386527139,0.863479629046694,0,0,0.789041787653074,0.207930211147461,LFNG;DLL4;JAG2;CHD7;KIF13B
alpha,4,regulation of RNA splicing (GO:0043484),3/56,3,56,0.771171745154122,0.863479629046694,0,0,0.752407704654896,0.195508758425406,ERN1;MBNL1;POLR2A
alpha,4,positive regulation of dendritic spine development (GO:0060999),1/20,1,20,0.771897756465292,0.863479629046694,0,0,0.702247191011236,0.181814029171408,NLGN1
alpha,4,negative regulation of ion transport (GO:0043271),1/20,1,20,0.771897756465292,0.863479629046694,0,0,0.702247191011236,0.181814029171408,PPIF
alpha,4,response to progesterone (GO:0032570),1/20,1,20,0.771897756465292,0.863479629046694,0,0,0.702247191011236,0.181814029171408,CATSPERD
alpha,4,purine nucleotide metabolic process (GO:0006163),1/20,1,20,0.771897756465292,0.863479629046694,0,0,0.702247191011236,0.181814029171408,NT5C2
alpha,4,regulation of cell development (GO:0060284),1/20,1,20,0.771897756465292,0.863479629046694,0,0,0.702247191011236,0.181814029171408,CTNNB1
alpha,4,glial cell development (GO:0021782),1/20,1,20,0.771897756465292,0.863479629046694,0,0,0.702247191011236,0.181814029171408,NF1
alpha,4,striated muscle cell development (GO:0055002),1/20,1,20,0.771897756465292,0.863479629046694,0,0,0.702247191011236,0.181814029171408,TMOD3
alpha,4,regulation of response to cytokine stimulus (GO:0060759),1/20,1,20,0.771897756465292,0.863479629046694,0,0,0.702247191011236,0.181814029171408,TAF9
alpha,4,covalent chromatin modification (GO:0016569),1/20,1,20,0.771897756465292,0.863479629046694,0,0,0.702247191011236,0.181814029171408,ZNF335
alpha,4,positive regulation of T cell migration (GO:2000406),1/20,1,20,0.771897756465292,0.863479629046694,0,0,0.702247191011236,0.181814029171408,RHOA
alpha,4,negative regulation of interferon-gamma production (GO:0032689),1/20,1,20,0.771897756465292,0.863479629046694,0,0,0.702247191011236,0.181814029171408,ZC3H12A
alpha,4,cellular response to estradiol stimulus (GO:0071392),1/20,1,20,0.771897756465292,0.863479629046694,0,0,0.702247191011236,0.181814029171408,KAT5
alpha,4,proteoglycan metabolic process (GO:0006029),1/20,1,20,0.771897756465292,0.863479629046694,0,0,0.702247191011236,0.181814029171408,FAM20B
alpha,4,ureteric bud morphogenesis (GO:0060675),1/20,1,20,0.771897756465292,0.863479629046694,0,0,0.702247191011236,0.181814029171408,PKD2
alpha,4,negative regulation of macromolecule biosynthetic process (GO:0010558),1/20,1,20,0.771897756465292,0.863479629046694,0,0,0.702247191011236,0.181814029171408,CLTC
alpha,4,"wound healing, spreading of cells (GO:0044319)",1/20,1,20,0.771897756465292,0.863479629046694,0,0,0.702247191011236,0.181814029171408,RHOA
alpha,4,embryonic digestive tract development (GO:0048566),1/20,1,20,0.771897756465292,0.863479629046694,0,0,0.702247191011236,0.181814029171408,GLI3
alpha,4,neuromuscular junction development (GO:0007528),1/20,1,20,0.771897756465292,0.863479629046694,0,0,0.702247191011236,0.181814029171408,PDZRN3
alpha,4,Arp2/3 complex-mediated actin nucleation (GO:0034314),1/20,1,20,0.771897756465292,0.863479629046694,0,0,0.702247191011236,0.181814029171408,WHAMM
alpha,4,lipid biosynthetic process (GO:0008610),4/73,4,73,0.772587036515463,0.863479629046694,0,0,0.769585962752039,0.198561342102846,ABCD3;SCP2;ACSL1;FADS1
alpha,4,negative regulation of cysteine-type endopeptidase activity (GO:2000117),4/73,4,73,0.772587036515463,0.863479629046694,0,0,0.769585962752039,0.198561342102846,USP47;DDX3X;TRIAP1;SH3RF1
alpha,4,response to metal ion (GO:0010038),4/73,4,73,0.772587036515463,0.863479629046694,0,0,0.769585962752039,0.198561342102846,HOMER1;SLC30A5;SLC30A4;CALM2
alpha,4,regulation of epithelial cell proliferation (GO:0050678),4/73,4,73,0.772587036515463,0.863479629046694,0,0,0.769585962752039,0.198561342102846,NR4A1;CDKN2B;NR4A3;BMP6
alpha,4,regulation of cellular pH (GO:0030641),2/39,2,39,0.776469632199097,0.867267479243669,0,0,0.720253529242293,0.182222519247614,SLC9A7;SLC9A8
alpha,4,retina homeostasis (GO:0001895),2/39,2,39,0.776469632199097,0.867267479243669,0,0,0.720253529242293,0.182222519247614,HSPB1;ACTB
alpha,4,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),5/90,5,90,0.776733417104426,0.867286518780832,0,0,0.780274656679151,0.197142696640054,RPL12;RPLP0;SRP14;RPL9;RPL39
alpha,4,anion transport (GO:0006820),3/57,3,57,0.781476665541817,0.872253064869362,0,0,0.739207569485512,0.182266401624866,VDAC2;VDAC1;LRRC8B
alpha,4,canonical Wnt signaling pathway (GO:0060070),4/74,4,74,0.781677711049357,0.872253064869362,0,0,0.759186152444579,0.186997234736907,RARG;FRAT1;RYK;CTNNB1
alpha,4,positive regulation of response to external stimulus (GO:0032103),5/91,5,91,0.784890821133053,0.873120661134959,0,0,0.771700209902457,0.186914011167741,ANKRD17;LRSAM1;HYAL2;ETS1;BMP6
alpha,4,mesoderm development (GO:0007498),1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,MEST
alpha,4,ventricular cardiac muscle tissue development (GO:0003229),1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,DSG2
alpha,4,mitochondrial fission (GO:0000266),1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,MFF
alpha,4,positive regulation of translational initiation (GO:0045948),1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,DDX3X
alpha,4,negative regulation of cytokine biosynthetic process (GO:0042036),1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,FOXJ1
alpha,4,branched-chain amino acid catabolic process (GO:0009083),1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,ACAT1
alpha,4,vesicle docking (GO:0048278),1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,STX2
alpha,4,aromatic amino acid family catabolic process (GO:0009074),1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,IL4I1
alpha,4,regulation of nuclear division (GO:0051783),1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,DAPK3
alpha,4,response to nicotine (GO:0035094),1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,RELA
alpha,4,steroid hormone mediated signaling pathway (GO:0043401),1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,MED13
alpha,4,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,CHD1L
alpha,4,positive regulation of defense response to virus by host (GO:0002230),1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,ZC3H12A
alpha,4,meiosis I (GO:0007127),1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,PTTG1
alpha,4,cellular response to alkaloid (GO:0071312),1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,RELA
alpha,4,lipid catabolic process (GO:0016042),1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,CES4A
alpha,4,phosphatidylserine acyl-chain remodeling (GO:0036150),1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,OSBPL10
alpha,4,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,COX15
alpha,4,establishment of spindle orientation (GO:0051294),1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,PAFAH1B1
alpha,4,histone ubiquitination (GO:0016574),1/21,1,21,0.788154787818034,0.873120661134959,0,0,0.66880684858213,0.159216678152213,RNF20
alpha,4,positive regulation of reactive oxygen species metabolic process (GO:2000379),2/40,2,40,0.788416779073218,0.873120661134959,0,0,0.702247191011236,0.166944116217123,GPRIN1;ZC3H12A
alpha,4,regulation of RNA metabolic process (GO:0051252),2/40,2,40,0.788416779073218,0.873120661134959,0,0,0.702247191011236,0.166944116217123,MBNL1;RASA1
alpha,4,DNA biosynthetic process (GO:0071897),2/40,2,40,0.788416779073218,0.873120661134959,0,0,0.702247191011236,0.166944116217123,BARD1;KAT5
alpha,4,regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),4/75,4,75,0.790477289589201,0.875126826112139,0,0,0.749063670411985,0.176118615668706,GRK5;CRY1;DTNBP1;GIT1
alpha,4,chloride transmembrane transport (GO:1902476),3/58,3,58,0.791395351803492,0.875867336772441,0,0,0.726462611390934,0.169961466073649,SLC12A2;SLC12A7;CLCN2
alpha,4,cellular response to acid chemical (GO:0071229),5/92,5,92,0.792815132634313,0.877162477560469,0,0,0.763312164142648,0.177214527790213,RARG;RRAGA;CPEB1;ADNP2;IPO5
alpha,4,C-terminal protein lipidation (GO:0006501),4/76,4,76,0.798990264661196,0.880947739386712,0,0,0.739207569485512,0.165882996521365,CPM;RAET1G;ULBP2;MDGA1
alpha,4,regulation of cellular localization (GO:0060341),2/41,2,41,0.799797293117671,0.880947739386712,0,0,0.685119210742669,0.153053553729905,PARD6A;STXBP4
alpha,4,positive regulation of mitotic nuclear division (GO:0045840),2/41,2,41,0.799797293117671,0.880947739386712,0,0,0.685119210742669,0.153053553729905,NUP62;NSMCE2
alpha,4,negative regulation of cytokine secretion (GO:0050710),2/41,2,41,0.799797293117671,0.880947739386712,0,0,0.685119210742669,0.153053553729905,ZC3H12A;FN1
alpha,4,phosphatidic acid biosynthetic process (GO:0006654),2/41,2,41,0.799797293117671,0.880947739386712,0,0,0.685119210742669,0.153053553729905,ABHD5;PLD6
alpha,4,regulation of ATPase activity (GO:0043462),2/41,2,41,0.799797293117671,0.880947739386712,0,0,0.685119210742669,0.153053553729905,PPIF;ATP1B3
alpha,4,negative regulation of transport (GO:0051051),2/41,2,41,0.799797293117671,0.880947739386712,0,0,0.685119210742669,0.153053553729905,LRSAM1;CTTNBP2NL
alpha,4,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,VTN
alpha,4,positive regulation of protein autophosphorylation (GO:0031954),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,CALM2
alpha,4,acylglycerol homeostasis (GO:0055090),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,RORA
alpha,4,regulation of catecholamine secretion (GO:0050433),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,DTNBP1
alpha,4,sterol transport (GO:0015918),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,ARV1
alpha,4,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,CHD1L
alpha,4,regulation of DNA biosynthetic process (GO:2000278),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,TNKS
alpha,4,sulfur amino acid metabolic process (GO:0000096),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,GCLC
alpha,4,negative regulation of myeloid cell differentiation (GO:0045638),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,LDB1
alpha,4,protein localization to cell surface (GO:0034394),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,CTNNB1
alpha,4,phosphatidylglycerol metabolic process (GO:0046471),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,LPGAT1
alpha,4,regulation of membrane protein ectodomain proteolysis (GO:0051043),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,SNX9
alpha,4,positive regulation of biosynthetic process (GO:0009891),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,GPRIN1
alpha,4,urogenital system development (GO:0001655),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,PTCH1
alpha,4,C21-steroid hormone metabolic process (GO:0008207),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,FDX1
alpha,4,negative regulation of GTPase activity (GO:0034260),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,RDX
alpha,4,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,STXBP4
alpha,4,digestive system development (GO:0055123),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,COBL
alpha,4,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,HSP90AB1
alpha,4,protein homotrimerization (GO:0070207),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,SMAD4
alpha,4,hematopoietic progenitor cell differentiation (GO:0002244),1/22,1,22,0.80325391315346,0.880947739386712,0,0,0.638406537282942,0.139864919144083,ARMC6
alpha,4,hemopoiesis (GO:0030097),4/77,4,77,0.807221426474234,0.88502286776573,0,0,0.729607471180505,0.156250741354145,CD164;SNRK;ARMC6;BMI1
alpha,4,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),5/94,5,94,0.807975850630967,0.885573780781992,0,0,0.747071479799187,0.159292903374263,USP47;DDX3X;TRIAP1;SH3RF1;MAP3K5
alpha,4,sterol metabolic process (GO:0016125),3/60,3,60,0.81010819650198,0.887101114051594,0,0,0.702247191011236,0.147884455272298,ARV1;FDX1;CLN6
alpha,4,negative regulation of proteolysis (GO:0045861),2/42,2,42,0.810631231389394,0.887101114051594,0,0,0.66880684858213,0.14041067201651,DNAJC1;SERPINE2
alpha,4,bicarbonate transport (GO:0015701),2/42,2,42,0.810631231389394,0.887101114051594,0,0,0.66880684858213,0.14041067201651,CYB5R1;CYB5RL
alpha,4,phosphatidic acid metabolic process (GO:0046473),2/42,2,42,0.810631231389394,0.887101114051594,0,0,0.66880684858213,0.14041067201651,ABHD5;PLD6
alpha,4,peptide transport (GO:0015833),2/42,2,42,0.810631231389394,0.887101114051594,0,0,0.66880684858213,0.14041067201651,RAP1A;ZFYVE9
alpha,4,positive regulation of protein kinase B signaling (GO:0051897),7/128,7,128,0.814251318351593,0.888564982768557,0,0,0.768082865168539,0.157830441328865,KL;HIP1;PIK3CA;TXN;PIK3CB;TGFBR1;MTDH
alpha,4,ERAD pathway (GO:0036503),4/78,4,78,0.815175828086177,0.888564982768557,0,0,0.720253529242293,0.1471848523673,VCP;AMFR;ERLIN1;DZIP3
alpha,4,regulation of protein oligomerization (GO:0032459),1/23,1,23,0.817277550296087,0.888564982768557,0,0,0.610649731314118,0.123214779536429,SNX9
alpha,4,chromosome condensation (GO:0030261),1/23,1,23,0.817277550296087,0.888564982768557,0,0,0.610649731314118,0.123214779536429,PAPD7
alpha,4,cellular amino acid catabolic process (GO:0009063),1/23,1,23,0.817277550296087,0.888564982768557,0,0,0.610649731314118,0.123214779536429,ACAT1
alpha,4,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",1/23,1,23,0.817277550296087,0.888564982768557,0,0,0.610649731314118,0.123214779536429,UBB
alpha,4,cellular response to ammonium ion (GO:0071242),1/23,1,23,0.817277550296087,0.888564982768557,0,0,0.610649731314118,0.123214779536429,ATF4
alpha,4,positive regulation of blood circulation (GO:1903524),1/23,1,23,0.817277550296087,0.888564982768557,0,0,0.610649731314118,0.123214779536429,AVPR1B
alpha,4,regulation of interleukin-8 secretion (GO:2000482),1/23,1,23,0.817277550296087,0.888564982768557,0,0,0.610649731314118,0.123214779536429,HYAL2
alpha,4,maturation of LSU-rRNA (GO:0000470),1/23,1,23,0.817277550296087,0.888564982768557,0,0,0.610649731314118,0.123214779536429,WDR37
alpha,4,negative regulation of axonogenesis (GO:0050771),1/23,1,23,0.817277550296087,0.888564982768557,0,0,0.610649731314118,0.123214779536429,RHOA
alpha,4,divalent inorganic cation homeostasis (GO:0072507),1/23,1,23,0.817277550296087,0.888564982768557,0,0,0.610649731314118,0.123214779536429,GPRIN1
alpha,4,regulation of monooxygenase activity (GO:0032768),1/23,1,23,0.817277550296087,0.888564982768557,0,0,0.610649731314118,0.123214779536429,NOS3
alpha,4,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),1/23,1,23,0.817277550296087,0.888564982768557,0,0,0.610649731314118,0.123214779536429,CALM2
alpha,4,cellular response to amyloid-beta (GO:1904646),1/23,1,23,0.817277550296087,0.888564982768557,0,0,0.610649731314118,0.123214779536429,IGF1R
alpha,4,NAD metabolic process (GO:0019674),1/23,1,23,0.817277550296087,0.888564982768557,0,0,0.610649731314118,0.123214779536429,VCP
alpha,4,regulation of chondrocyte differentiation (GO:0032330),1/23,1,23,0.817277550296087,0.888564982768557,0,0,0.610649731314118,0.123214779536429,TGFBR1
alpha,4,negative regulation of axon extension (GO:0030517),1/23,1,23,0.817277550296087,0.888564982768557,0,0,0.610649731314118,0.123214779536429,SEMA3F
alpha,4,regulation of axon extension involved in axon guidance (GO:0048841),1/23,1,23,0.817277550296087,0.888564982768557,0,0,0.610649731314118,0.123214779536429,SEMA3F
alpha,4,cell-cell adhesion mediated by cadherin (GO:0044331),1/23,1,23,0.817277550296087,0.888564982768557,0,0,0.610649731314118,0.123214779536429,CDHR2
alpha,4,TOR signaling (GO:0031929),1/23,1,23,0.817277550296087,0.888564982768557,0,0,0.610649731314118,0.123214779536429,TIPRL
alpha,4,cellular response to retinoic acid (GO:0071300),2/43,2,43,0.820938669541301,0.892269456845292,0,0,0.653253200940685,0.128891347310031,RARG;ADNP2
alpha,4,negative regulation of inflammatory response (GO:0050728),4/79,4,79,0.822858752373878,0.893803620084728,0,0,0.711136395960745,0.138650773957834,ZC3H12A;TYRO3;TNFAIP3;RORA
alpha,4,adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189),4/79,4,79,0.822858752373878,0.893803620084728,0,0,0.711136395960745,0.138650773957834,GNAL;GNAQ;GNB1;ADCY3
alpha,4,phosphatidylinositol metabolic process (GO:0046488),6/113,6,113,0.823714056759826,0.894456258730549,0,0,0.745749229392463,0.144624511131207,INPP4A;PIK3CA;SACM1L;PITPNM2;PIK3CB;PIK3C2A
alpha,4,positive regulation of T cell proliferation (GO:0042102),3/62,3,62,0.827381692609656,0.897884115320451,0,0,0.679594055817325,0.128775701074705,TFRC;TNFSF9;FADD
alpha,4,negative regulation of MAP kinase activity (GO:0043407),3/62,3,62,0.827381692609656,0.897884115320451,0,0,0.679594055817325,0.128775701074705,UCHL1;HYAL2;NF1
alpha,4,phospholipid dephosphorylation (GO:0046839),1/24,1,24,0.830302254472947,0.899306955233189,0,0,0.585205992509363,0.108828114739459,SACM1L
alpha,4,regulation of B cell proliferation (GO:0030888),2/44,2,44,0.830739597053248,0.899306955233189,0,0,0.638406537282942,0.118385402311825,TFRC;CD81
alpha,4,digestive tract development (GO:0048565),2/44,2,44,0.830739597053248,0.899306955233189,0,0,0.638406537282942,0.118385402311825,COBL;GLI3
alpha,4,positive regulation of interferon-gamma production (GO:0032729),2/44,2,44,0.830739597053248,0.899306955233189,0,0,0.638406537282942,0.118385402311825,FADD;RASGRP1
alpha,4,mitotic metaphase plate congression (GO:0007080),2/44,2,44,0.830739597053248,0.899306955233189,0,0,0.638406537282942,0.118385402311825,CUL3;NUP62
alpha,4,male gonad development (GO:0008584),2/44,2,44,0.830739597053248,0.899306955233189,0,0,0.638406537282942,0.118385402311825,MSH2;NCOA4
alpha,4,negative regulation of protein metabolic process (GO:0051248),2/44,2,44,0.830739597053248,0.899306955233189,0,0,0.638406537282942,0.118385402311825,EIF2AK1;CLU
alpha,4,protein transmembrane import into intracellular organelle (GO:0044743),2/44,2,44,0.830739597053248,0.899306955233189,0,0,0.638406537282942,0.118385402311825,TIMM9;TOMM20
alpha,4,negative regulation of peptidase activity (GO:0010466),3/63,3,63,0.835502036891429,0.904051689637119,0,0,0.66880684858213,0.120199634175071,VTN;SERPINE2;SERPINB6
alpha,4,response to tumor necrosis factor (GO:0034612),5/98,5,98,0.835636967178094,0.904051689637119,0,0,0.716578766337996,0.128669607026877,IKBKB;HYAL2;ZC3H12A;RELA;MAP4K3
alpha,4,regulation of immune effector process (GO:0002697),6/115,6,115,0.836093115291622,0.904266861615401,0,0,0.732779677576942,0.131178766613701,HERC5;VTN;CD81;TRAF3;CLU;CD55
alpha,4,regulation of intracellular pH (GO:0051453),2/45,2,45,0.840053827796577,0.907179215812958,0,0,0.624219725343321,0.108794824274437,SLC9A7;SLC9A8
alpha,4,negative regulation of immune response (GO:0050777),2/45,2,45,0.840053827796577,0.907179215812958,0,0,0.624219725343321,0.108794824274437,TYRO3;TNFAIP3
alpha,4,cholesterol transport (GO:0030301),2/45,2,45,0.840053827796577,0.907179215812958,0,0,0.624219725343321,0.108794824274437,LIPG;CLU
alpha,4,negative regulation of cell growth (GO:0030308),6/116,6,116,0.842015039050456,0.907179215812958,0,0,0.726462611390934,0.124920624608386,SMAD4;SMAD3;DDX3X;ADAM15;HYAL2;SLIT2
alpha,4,negative regulation of sequestering of calcium ion (GO:0051283),1/25,1,25,0.842399135252773,0.907179215812958,0,0,0.561797752808989,0.0963490700510931,PKD2
alpha,4,receptor catabolic process (GO:0032801),1/25,1,25,0.842399135252773,0.907179215812958,0,0,0.561797752808989,0.0963490700510931,CLTC
alpha,4,sensory perception of pain (GO:0019233),1/25,1,25,0.842399135252773,0.907179215812958,0,0,0.561797752808989,0.0963490700510931,ALOXE3
alpha,4,regulation of transmembrane transport (GO:0034762),1/25,1,25,0.842399135252773,0.907179215812958,0,0,0.561797752808989,0.0963490700510931,CTTNBP2NL
alpha,4,cilium-dependent cell motility (GO:0060285),1/25,1,25,0.842399135252773,0.907179215812958,0,0,0.561797752808989,0.0963490700510931,RSPH9
alpha,4,regulation of neuronal synaptic plasticity (GO:0048168),1/25,1,25,0.842399135252773,0.907179215812958,0,0,0.561797752808989,0.0963490700510931,ARC
alpha,4,actin nucleation (GO:0045010),1/25,1,25,0.842399135252773,0.907179215812958,0,0,0.561797752808989,0.0963490700510931,WHAMM
alpha,4,positive regulation of neutrophil chemotaxis (GO:0090023),1/25,1,25,0.842399135252773,0.907179215812958,0,0,0.561797752808989,0.0963490700510931,RAC1
alpha,4,positive regulation of immune effector process (GO:0002699),1/25,1,25,0.842399135252773,0.907179215812958,0,0,0.561797752808989,0.0963490700510931,ANKRD17
alpha,4,camera-type eye development (GO:0043010),1/25,1,25,0.842399135252773,0.907179215812958,0,0,0.561797752808989,0.0963490700510931,NF1
alpha,4,positive regulation of cell projection organization (GO:0031346),3/64,3,64,0.843290871134388,0.907861381941002,0,0,0.658356741573034,0.112212520384813,RAP1A;DPYSL3;TWF1
alpha,4,BMP signaling pathway (GO:0030509),4/82,4,82,0.844334291836671,0.908706379609889,0,0,0.685119210742669,0.115926817230819,SMAD4;BMP8A;ACVR2B;BMP6
alpha,4,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),6/117,6,117,0.847762378517861,0.912116547441164,0,0,0.720253529242293,0.118953397053783,VTN;TEC;ARL2BP;CD81;TNK2;PAK2
alpha,4,steroid metabolic process (GO:0008202),5/100,5,100,0.848195636939499,0.912224625051908,0,0,0.702247191011236,0.11562076254228,PIAS4;ARV1;UBE2I;SCP2;FDX1
alpha,4,nucleus organization (GO:0006997),2/46,2,46,0.84890092419482,0.912224625051908,0,0,0.610649731314118,0.100032240194115,NUP155;ATXN7
alpha,4,"regulation of synaptic transmission, glutamatergic (GO:0051966)",2/46,2,46,0.84890092419482,0.912224625051908,0,0,0.610649731314118,0.100032240194115,NLGN1;GRM4
alpha,4,protein complex subunit organization (GO:0071822),2/46,2,46,0.84890092419482,0.912224625051908,0,0,0.610649731314118,0.100032240194115,NF1;TGFBR1
alpha,4,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),3/65,3,65,0.850757875049576,0.912290776945335,0,0,0.648228176318064,0.104771635078225,SDK1;SMAGP;DSG2
alpha,4,glycerophospholipid metabolic process (GO:0006650),3/65,3,65,0.850757875049576,0.912290776945335,0,0,0.648228176318064,0.104771635078225,PIGF;PIGX;PAFAH1B1
alpha,4,C-terminal protein amino acid modification (GO:0018410),4/83,4,83,0.850987674849139,0.912290776945335,0,0,0.676864762420468,0.109217296366686,CPM;RAET1G;ULBP2;MDGA1
alpha,4,regulation of spindle assembly (GO:0090169),1/26,1,26,0.853634243349419,0.912290776945335,0,0,0.54019014693172,0.0854864214620275,RNF4
alpha,4,response to amyloid-beta (GO:1904645),1/26,1,26,0.853634243349419,0.912290776945335,0,0,0.54019014693172,0.0854864214620275,IGF1R
alpha,4,positive regulation of nuclear division (GO:0051785),1/26,1,26,0.853634243349419,0.912290776945335,0,0,0.54019014693172,0.0854864214620275,NUP62
alpha,4,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",1/26,1,26,0.853634243349419,0.912290776945335,0,0,0.54019014693172,0.0854864214620275,SNAI1
alpha,4,"RNA splicing, via transesterification reactions (GO:0000375)",1/26,1,26,0.853634243349419,0.912290776945335,0,0,0.54019014693172,0.0854864214620275,SNRNP40
alpha,4,regulation of glucose metabolic process (GO:0010906),1/26,1,26,0.853634243349419,0.912290776945335,0,0,0.54019014693172,0.0854864214620275,RORA
alpha,4,negative regulation of cellular protein localization (GO:1903828),1/26,1,26,0.853634243349419,0.912290776945335,0,0,0.54019014693172,0.0854864214620275,TTBK2
alpha,4,respiratory tube development (GO:0030323),1/26,1,26,0.853634243349419,0.912290776945335,0,0,0.54019014693172,0.0854864214620275,HECA
alpha,4,positive regulation of neutrophil migration (GO:1902624),1/26,1,26,0.853634243349419,0.912290776945335,0,0,0.54019014693172,0.0854864214620275,RAC1
alpha,4,negative regulation of locomotion (GO:0040013),1/26,1,26,0.853634243349419,0.912290776945335,0,0,0.54019014693172,0.0854864214620275,CRK
alpha,4,regulation of nervous system development (GO:0051960),1/26,1,26,0.853634243349419,0.912290776945335,0,0,0.54019014693172,0.0854864214620275,CTNNB1
alpha,4,positive regulation of calcium ion transmembrane transport (GO:1904427),1/26,1,26,0.853634243349419,0.912290776945335,0,0,0.54019014693172,0.0854864214620275,PLCG1
alpha,4,L-amino acid transport (GO:0015807),1/26,1,26,0.853634243349419,0.912290776945335,0,0,0.54019014693172,0.0854864214620275,SLC6A9
alpha,4,neutral amino acid transport (GO:0015804),1/26,1,26,0.853634243349419,0.912290776945335,0,0,0.54019014693172,0.0854864214620275,SLC6A9
alpha,4,prostaglandin metabolic process (GO:0006693),1/26,1,26,0.853634243349419,0.912290776945335,0,0,0.54019014693172,0.0854864214620275,PLAA
alpha,4,regulation of myeloid cell differentiation (GO:0045637),3/66,3,66,0.857912768147748,0.916584613993719,0,0,0.638406537282942,0.0978376235241757,PURB;NR4A3;KMT2C
alpha,4,response to gamma radiation (GO:0010332),1/27,1,27,0.864068930684151,0.920085516920567,0,0,0.520183104452767,0.0760001729483837,LIG4
alpha,4,positive regulation of granulocyte chemotaxis (GO:0071624),1/27,1,27,0.864068930684151,0.920085516920567,0,0,0.520183104452767,0.0760001729483837,RAC1
alpha,4,tRNA methylation (GO:0030488),1/27,1,27,0.864068930684151,0.920085516920567,0,0,0.520183104452767,0.0760001729483837,TARBP1
alpha,4,positive regulation of cAMP metabolic process (GO:0030816),1/27,1,27,0.864068930684151,0.920085516920567,0,0,0.520183104452767,0.0760001729483837,CALM2
alpha,4,internal peptidyl-lysine acetylation (GO:0018393),1/27,1,27,0.864068930684151,0.920085516920567,0,0,0.520183104452767,0.0760001729483837,KAT5
alpha,4,regulation of muscle contraction (GO:0006937),1/27,1,27,0.864068930684151,0.920085516920567,0,0,0.520183104452767,0.0760001729483837,DAPK3
alpha,4,regulation of T cell receptor signaling pathway (GO:0050856),1/27,1,27,0.864068930684151,0.920085516920567,0,0,0.520183104452767,0.0760001729483837,RELA
alpha,4,cation transmembrane transport (GO:0098655),1/27,1,27,0.864068930684151,0.920085516920567,0,0,0.520183104452767,0.0760001729483837,RHCE
alpha,4,positive regulation of glucose import (GO:0046326),1/27,1,27,0.864068930684151,0.920085516920567,0,0,0.520183104452767,0.0760001729483837,RHOQ
alpha,4,snRNA processing (GO:0016180),1/27,1,27,0.864068930684151,0.920085516920567,0,0,0.520183104452767,0.0760001729483837,INTS2
alpha,4,lipid modification (GO:0030258),1/27,1,27,0.864068930684151,0.920085516920567,0,0,0.520183104452767,0.0760001729483837,DGKZ
alpha,4,response to glucose (GO:0009749),2/48,2,48,0.865270326829384,0.921085765840486,0,0,0.585205992509363,0.0846870928766541,ERN1;IGF1R
alpha,4,negative regulation of growth (GO:0045926),6/121,6,121,0.869066586583618,0.924566904310357,0,0,0.696443495217755,0.0977357686010096,SMAD4;SMAD3;DDX3X;ADAM15;HYAL2;SLIT2
alpha,4,enzyme linked receptor protein signaling pathway (GO:0007167),6/121,6,121,0.869066586583618,0.924566904310357,0,0,0.696443495217755,0.0977357686010096,TEC;TNK2;PILRB;PIK3CB;ACVR2B;PTPRF
alpha,4,mitochondrial ATP synthesis coupled electron transport (GO:0042775),4/86,4,86,0.869516271622104,0.92476541444832,0,0,0.653253200940685,0.0913367073386119,COX15;NDUFB2;SDHA;UQCRH
alpha,4,glycoprotein metabolic process (GO:0009100),2/49,2,49,0.87282996865005,0.925638049135842,0,0,0.573263013070397,0.0779720871565696,GOLPH3;ST3GAL2
alpha,4,pattern recognition receptor signaling pathway (GO:0002221),2/49,2,49,0.87282996865005,0.925638049135842,0,0,0.573263013070397,0.0779720871565696,TRAF3;MAPKAPK2
alpha,4,cellular response to mechanical stimulus (GO:0071260),2/49,2,49,0.87282996865005,0.925638049135842,0,0,0.573263013070397,0.0779720871565696,BNIP3;FADD
alpha,4,mRNA polyadenylation (GO:0006378),1/28,1,28,0.873760184077588,0.925638049135842,0,0,0.501605136436597,0.0676912770392133,CPSF6
alpha,4,positive regulation of lipid kinase activity (GO:0090218),1/28,1,28,0.873760184077588,0.925638049135842,0,0,0.501605136436597,0.0676912770392133,CD81
alpha,4,negative regulation of synaptic transmission (GO:0050805),1/28,1,28,0.873760184077588,0.925638049135842,0,0,0.501605136436597,0.0676912770392133,ACHE
alpha,4,release of sequestered calcium ion into cytosol (GO:0051209),1/28,1,28,0.873760184077588,0.925638049135842,0,0,0.501605136436597,0.0676912770392133,PKD2
alpha,4,negative regulation of myeloid leukocyte differentiation (GO:0002762),1/28,1,28,0.873760184077588,0.925638049135842,0,0,0.501605136436597,0.0676912770392133,TCTA
alpha,4,regulation of protein transport (GO:0051223),1/28,1,28,0.873760184077588,0.925638049135842,0,0,0.501605136436597,0.0676912770392133,DNAJC1
alpha,4,phosphatidylserine metabolic process (GO:0006658),1/28,1,28,0.873760184077588,0.925638049135842,0,0,0.501605136436597,0.0676912770392133,OSBPL10
alpha,4,regulation of neurotransmitter secretion (GO:0046928),1/28,1,28,0.873760184077588,0.925638049135842,0,0,0.501605136436597,0.0676912770392133,DTNBP1
alpha,4,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),1/28,1,28,0.873760184077588,0.925638049135842,0,0,0.501605136436597,0.0676912770392133,HYAL2
alpha,4,cardiac muscle cell development (GO:0055013),1/28,1,28,0.873760184077588,0.925638049135842,0,0,0.501605136436597,0.0676912770392133,HEY2
alpha,4,positive regulation of T cell activation (GO:0050870),3/69,3,69,0.87760184402998,0.9291477354715,0,0,0.610649731314118,0.0797278143649929,TFRC;ZMIZ1;ZBTB1
alpha,4,monocarboxylic acid biosynthetic process (GO:0072330),3/69,3,69,0.87760184402998,0.9291477354715,0,0,0.610649731314118,0.0797278143649929,ABCD3;OSBPL6;SCP2
alpha,4,RNA methylation (GO:0001510),2/50,2,50,0.879997065830893,0.929570008906267,0,0,0.561797752808989,0.0718183740441125,MEPCE;TARBP1
alpha,4,organic hydroxy compound biosynthetic process (GO:1901617),2/50,2,50,0.879997065830893,0.929570008906267,0,0,0.561797752808989,0.0718183740441125,OSBPL6;SCP2
alpha,4,regulation of megakaryocyte differentiation (GO:0045652),2/50,2,50,0.879997065830893,0.929570008906267,0,0,0.561797752808989,0.0718183740441125,NR4A3;KMT2C
alpha,4,gonad development (GO:0008406),2/50,2,50,0.879997065830893,0.929570008906267,0,0,0.561797752808989,0.0718183740441125,MSH2;NCOA4
alpha,4,regulation of release of sequestered calcium ion into cytosol (GO:0051279),2/50,2,50,0.879997065830893,0.929570008906267,0,0,0.561797752808989,0.0718183740441125,PLCG1;CALM2
alpha,4,calcium ion homeostasis (GO:0055074),4/88,4,88,0.880736893633502,0.929570008906267,0,0,0.638406537282942,0.0810752954463784,STIM2;GPRIN1;ATP2A2;RMDN3
alpha,4,cellular response to BMP stimulus (GO:0071773),4/88,4,88,0.880736893633502,0.929570008906267,0,0,0.638406537282942,0.0810752954463784,SMAD4;BMP8A;ACVR2B;BMP6
alpha,4,regulation of TORC1 signaling (GO:1903432),1/29,1,29,0.882760935911556,0.929570008906267,0,0,0.484308407593956,0.060393672894269,RRAGA
alpha,4,cellular amino acid biosynthetic process (GO:0008652),1/29,1,29,0.882760935911556,0.929570008906267,0,0,0.484308407593956,0.060393672894269,GOT1
alpha,4,"synaptic transmission, cholinergic (GO:0007271)",1/29,1,29,0.882760935911556,0.929570008906267,0,0,0.484308407593956,0.060393672894269,ACHE
alpha,4,regulation of mRNA processing (GO:0050684),1/29,1,29,0.882760935911556,0.929570008906267,0,0,0.484308407593956,0.060393672894269,PTCD2
alpha,4,positive regulation of protein tyrosine kinase activity (GO:0061098),1/29,1,29,0.882760935911556,0.929570008906267,0,0,0.484308407593956,0.060393672894269,FBXW7
alpha,4,organelle fission (GO:0048285),1/29,1,29,0.882760935911556,0.929570008906267,0,0,0.484308407593956,0.060393672894269,MFF
alpha,4,positive regulation of phospholipid metabolic process (GO:1903727),1/29,1,29,0.882760935911556,0.929570008906267,0,0,0.484308407593956,0.060393672894269,CD81
alpha,4,triglyceride homeostasis (GO:0070328),1/29,1,29,0.882760935911556,0.929570008906267,0,0,0.484308407593956,0.060393672894269,RORA
alpha,4,primary neural tube formation (GO:0014020),1/29,1,29,0.882760935911556,0.929570008906267,0,0,0.484308407593956,0.060393672894269,COBL
alpha,4,RNA polyadenylation (GO:0043631),1/29,1,29,0.882760935911556,0.929570008906267,0,0,0.484308407593956,0.060393672894269,CPSF6
alpha,4,positive regulation of phosphate metabolic process (GO:0045937),1/29,1,29,0.882760935911556,0.929570008906267,0,0,0.484308407593956,0.060393672894269,SDCBP
alpha,4,regulation of endocytosis (GO:0030100),3/70,3,70,0.883605100613781,0.930180272134603,0,0,0.601926163723917,0.0744853741467113,LRSAM1;HIP1;HIP1R
alpha,4,divalent metal ion transport (GO:0070838),4/89,4,89,0.886026128024161,0.932449652696086,0,0,0.631233430122459,0.0763848244808848,SLC30A5;CACNA1D;NIPA2;PKD2
alpha,4,regulation of ion transport (GO:0043269),2/51,2,51,0.886789145552694,0.932973315359987,0,0,0.550782110597048,0.0661753917890233,SLC30A5;DTNBP1
alpha,4,regulation of striated muscle contraction (GO:0006942),1/30,1,30,0.891120352008824,0.934453471751497,0,0,0.468164794007491,0.0539680643384129,CALM2
alpha,4,synaptic vesicle endocytosis (GO:0048488),1/30,1,30,0.891120352008824,0.934453471751497,0,0,0.468164794007491,0.0539680643384129,NLGN1
alpha,4,superoxide metabolic process (GO:0006801),1/30,1,30,0.891120352008824,0.934453471751497,0,0,0.468164794007491,0.0539680643384129,NOS3
alpha,4,regulation of chromosome segregation (GO:0051983),1/30,1,30,0.891120352008824,0.934453471751497,0,0,0.468164794007491,0.0539680643384129,SMC6
alpha,4,synaptic vesicle recycling (GO:0036465),1/30,1,30,0.891120352008824,0.934453471751497,0,0,0.468164794007491,0.0539680643384129,NLGN1
alpha,4,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),1/30,1,30,0.891120352008824,0.934453471751497,0,0,0.468164794007491,0.0539680643384129,UBB
alpha,4,skeletal muscle organ development (GO:0060538),1/30,1,30,0.891120352008824,0.934453471751497,0,0,0.468164794007491,0.0539680643384129,BVES
alpha,4,amino acid transmembrane transport (GO:0003333),1/30,1,30,0.891120352008824,0.934453471751497,0,0,0.468164794007491,0.0539680643384129,SLC7A6
alpha,4,striated muscle tissue development (GO:0014706),1/30,1,30,0.891120352008824,0.934453471751497,0,0,0.468164794007491,0.0539680643384129,BVES
alpha,4,tube closure (GO:0060606),1/30,1,30,0.891120352008824,0.934453471751497,0,0,0.468164794007491,0.0539680643384129,COBL
alpha,4,determination of bilateral symmetry (GO:0009855),1/30,1,30,0.891120352008824,0.934453471751497,0,0,0.468164794007491,0.0539680643384129,PKD2
alpha,4,coenzyme metabolic process (GO:0006732),2/52,2,52,0.893223231006364,0.93610007662116,0,0,0.54019014693172,0.0609975964858383,ACOT7;ACAT1
alpha,4,regulation of exocytosis (GO:0017157),2/52,2,52,0.893223231006364,0.93610007662116,0,0,0.54019014693172,0.0609975964858383,RALA;CLASP2
alpha,4,positive regulation of lymphocyte proliferation (GO:0050671),3/72,3,72,0.894828775448748,0.936944636789499,0,0,0.585205992509363,0.0650297819274294,TFRC;CD81;ZNF335
alpha,4,defense response to Gram-negative bacterium (GO:0050829),3/72,3,72,0.894828775448748,0.936944636789499,0,0,0.585205992509363,0.0650297819274294,HIST1H2BJ;HIST1H2BK;DROSHA
alpha,4,regulation of cation channel activity (GO:2001257),3/72,3,72,0.894828775448748,0.936944636789499,0,0,0.585205992509363,0.0650297819274294,NLGN1;HOMER1;SLMAP
alpha,4,cellular response to drug (GO:0035690),1/31,1,31,0.898884100007864,0.939232345876231,0,0,0.453062703878217,0.0482970160548011,TFRC
alpha,4,negative regulation of secretion by cell (GO:1903531),1/31,1,31,0.898884100007864,0.939232345876231,0,0,0.453062703878217,0.0482970160548011,SERGEF
alpha,4,activation of protein kinase B activity (GO:0032148),1/31,1,31,0.898884100007864,0.939232345876231,0,0,0.453062703878217,0.0482970160548011,TXN
alpha,4,regulation of cell adhesion mediated by integrin (GO:0033628),1/31,1,31,0.898884100007864,0.939232345876231,0,0,0.453062703878217,0.0482970160548011,PDE3B
alpha,4,ribosomal large subunit assembly (GO:0000027),1/31,1,31,0.898884100007864,0.939232345876231,0,0,0.453062703878217,0.0482970160548011,RPL12
alpha,4,hippo signaling (GO:0035329),1/31,1,31,0.898884100007864,0.939232345876231,0,0,0.453062703878217,0.0482970160548011,LATS1
alpha,4,acylglycerol catabolic process (GO:0046464),1/31,1,31,0.898884100007864,0.939232345876231,0,0,0.453062703878217,0.0482970160548011,DAGLB
alpha,4,regulation of phosphatase activity (GO:0010921),3/73,3,73,0.900067691753662,0.939910260402294,0,0,0.57718947206403,0.0607695698552573,PPP1R2;TIPRL;PCIF1
alpha,4,regulation of fat cell differentiation (GO:0045598),3/73,3,73,0.900067691753662,0.939910260402294,0,0,0.57718947206403,0.0607695698552573,SMAD3;ZC3H12A;RORA
alpha,4,positive regulation of cytokine secretion (GO:0050715),3/74,3,74,0.905070070044141,0.943960435915946,0,0,0.569389614333435,0.0567925786609486,KARS;HYAL2;RASGRP1
alpha,4,chloride transport (GO:0006821),3/74,3,74,0.905070070044141,0.943960435915946,0,0,0.569389614333435,0.0567925786609486,SLC12A2;SLC12A7;CLCN2
alpha,4,positive regulation of inflammatory response (GO:0050729),3/74,3,74,0.905070070044141,0.943960435915946,0,0,0.569389614333435,0.0567925786609486,KARS;HYAL2;ETS1
alpha,4,renal water homeostasis (GO:0003091),1/32,1,32,0.906094597661565,0.943960435915946,0,0,0.438904494382023,0.0432810594977934,ADCY3
alpha,4,positive regulation of interleukin-1 beta production (GO:0032731),1/32,1,32,0.906094597661565,0.943960435915946,0,0,0.438904494382023,0.0432810594977934,HSPB1
alpha,4,regulation of cytokine secretion (GO:0050707),1/32,1,32,0.906094597661565,0.943960435915946,0,0,0.438904494382023,0.0432810594977934,FOXP1
alpha,4,regulation of glucose import (GO:0046324),1/32,1,32,0.906094597661565,0.943960435915946,0,0,0.438904494382023,0.0432810594977934,RHOQ
alpha,4,regulation of protein tyrosine kinase activity (GO:0061097),1/32,1,32,0.906094597661565,0.943960435915946,0,0,0.438904494382023,0.0432810594977934,HYAL2
alpha,4,regulation of macromolecule metabolic process (GO:0060255),6/130,6,130,0.908025219645601,0.945691450979048,0,0,0.648228176318064,0.0625430806999598,DDX3X;RASA1;EIF4A3;ZC3H12A;BMI1;ZNF335
alpha,4,nitrogen compound transport (GO:0071705),3/75,3,75,0.909844753934464,0.947305779052026,0,0,0.561797752808989,0.0530793787062398,SLC48A1;SLC12A2;SLC7A6
alpha,4,sensory perception (GO:0007600),2/55,2,55,0.910539870440292,0.947468219241452,0,0,0.510725229826353,0.0478639382853863,GNAL;ALOXE3
alpha,4,action potential (GO:0001508),2/55,2,55,0.910539870440292,0.947468219241452,0,0,0.510725229826353,0.0478639382853863,GNAQ;CACNA1D
alpha,4,regulation of glutamate receptor signaling pathway (GO:1900449),1/33,1,33,0.912791244145707,0.948687529027842,0,0,0.425604358188628,0.0388355774529293,NLGN1
alpha,4,protein trimerization (GO:0070206),1/33,1,33,0.912791244145707,0.948687529027842,0,0,0.425604358188628,0.0388355774529293,SMAD4
alpha,4,G2 DNA damage checkpoint (GO:0031572),1/33,1,33,0.912791244145707,0.948687529027842,0,0,0.425604358188628,0.0388355774529293,MUS81
alpha,4,positive regulation of myeloid leukocyte differentiation (GO:0002763),1/33,1,33,0.912791244145707,0.948687529027842,0,0,0.425604358188628,0.0388355774529293,FADD
alpha,4,skin development (GO:0043588),4/95,4,95,0.913650054574225,0.948738535252112,0,0,0.591366055588409,0.0534048807211382,ERRFI1;STMN1;WNT16;ALOXE3
alpha,4,respiratory electron transport chain (GO:0022904),4/95,4,95,0.913650054574225,0.948738535252112,0,0,0.591366055588409,0.0534048807211382,COX15;NDUFB2;SDHA;UQCRH
alpha,4,axon development (GO:0061564),4/95,4,95,0.913650054574225,0.948738535252112,0,0,0.591366055588409,0.0534048807211382,RYK;SLIT2;BAIAP2;CDK5R1
alpha,4,cAMP-mediated signaling (GO:0019933),3/76,3,76,0.914400402684314,0.949237275674945,0,0,0.554405677114134,0.0496119489876805,GNAL;GNAQ;ADCY3
alpha,4,axonemal dynein complex assembly (GO:0070286),1/34,1,34,0.919010634646747,0.950933877180841,0,0,0.413086582947786,0.0348882950745748,DNAAF3
alpha,4,negative regulation of neurogenesis (GO:0050768),1/34,1,34,0.919010634646747,0.950933877180841,0,0,0.413086582947786,0.0348882950745748,NF1
alpha,4,neural tube closure (GO:0001843),1/34,1,34,0.919010634646747,0.950933877180841,0,0,0.413086582947786,0.0348882950745748,COBL
alpha,4,embryonic organ morphogenesis (GO:0048562),1/34,1,34,0.919010634646747,0.950933877180841,0,0,0.413086582947786,0.0348882950745748,RARG
alpha,4,carboxylic acid metabolic process (GO:0019752),1/34,1,34,0.919010634646747,0.950933877180841,0,0,0.413086582947786,0.0348882950745748,TBXAS1
alpha,4,negative regulation of multi-organism process (GO:0043901),1/34,1,34,0.919010634646747,0.950933877180841,0,0,0.413086582947786,0.0348882950745748,ANXA2
alpha,4,positive regulation of locomotion (GO:0040017),1/34,1,34,0.919010634646747,0.950933877180841,0,0,0.413086582947786,0.0348882950745748,BVES
alpha,4,regulation of neurotransmitter receptor activity (GO:0099601),1/34,1,34,0.919010634646747,0.950933877180841,0,0,0.413086582947786,0.0348882950745748,NLGN1
alpha,4,regulation of interleukin-12 production (GO:0032655),1/34,1,34,0.919010634646747,0.950933877180841,0,0,0.413086582947786,0.0348882950745748,FOXP1
alpha,4,positive regulation of cytokine-mediated signaling pathway (GO:0001961),1/34,1,34,0.919010634646747,0.950933877180841,0,0,0.413086582947786,0.0348882950745748,FADD
alpha,4,stem cell differentiation (GO:0048863),1/34,1,34,0.919010634646747,0.950933877180841,0,0,0.413086582947786,0.0348882950745748,SETD2
alpha,4,regulation of secretion by cell (GO:1903530),2/57,2,57,0.92058252323812,0.951999873251542,0,0,0.492805046323674,0.0407789433661374,DNAJC1;RALA
alpha,4,cellular defense response (GO:0006968),2/57,2,57,0.92058252323812,0.951999873251542,0,0,0.492805046323674,0.0407789433661374,FOSL1;RELA
alpha,4,positive regulation of muscle cell differentiation (GO:0051149),1/35,1,35,0.924786759946889,0.954804787836843,0,0,0.401284109149278,0.0313772463214024,CTNNB1
alpha,4,response to peptide (GO:1901652),1/35,1,35,0.924786759946889,0.954804787836843,0,0,0.401284109149278,0.0313772463214024,AVPR1B
alpha,4,regulation of axon extension (GO:0030516),1/35,1,35,0.924786759946889,0.954804787836843,0,0,0.401284109149278,0.0313772463214024,CDKL5
alpha,4,endoplasmic reticulum organization (GO:0007029),1/35,1,35,0.924786759946889,0.954804787836843,0,0,0.401284109149278,0.0313772463214024,TMCC1
alpha,4,positive regulation of chemokine production (GO:0032722),1/35,1,35,0.924786759946889,0.954804787836843,0,0,0.401284109149278,0.0313772463214024,DDX3X
alpha,4,protein homotetramerization (GO:0051289),2/58,2,58,0.925196332111604,0.954804787836843,0,0,0.484308407593956,0.0376546459997532,GOLGA2;PKD2
alpha,4,response to retinoic acid (GO:0032526),2/58,2,58,0.925196332111604,0.954804787836843,0,0,0.484308407593956,0.0376546459997532,RARG;ADNP2
alpha,4,carboxylic acid transmembrane transport (GO:1905039),1/36,1,36,0.930151191496091,0.959535068111283,0,0,0.390137328339576,0.0282491161622099,SLC7A6
alpha,4,peptidyl-tyrosine phosphorylation (GO:0018108),3/80,3,80,0.930598875445623,0.959535068111283,0,0,0.526685393258427,0.0378828728884914,TEC;TNK2;IGF1R
alpha,4,steroid biosynthetic process (GO:0006694),3/80,3,80,0.930598875445623,0.959535068111283,0,0,0.526685393258427,0.0378828728884914,OSBPL6;SCP2;FDX1
alpha,4,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),3/81,3,81,0.934182191820913,0.96195299558837,0,0,0.520183104452767,0.0354160391109108,SLC9A3R1;ENTPD5;WNT16
alpha,4,negative regulation of defense response (GO:0031348),3/81,3,81,0.934182191820913,0.96195299558837,0,0,0.520183104452767,0.0354160391109108,TYRO3;TNFAIP3;RORA
alpha,4,zymogen activation (GO:0031638),1/37,1,37,0.935133253463858,0.96195299558837,0,0,0.37959307622229,0.0254578814054047,FADD
alpha,4,acylglycerol metabolic process (GO:0006639),1/37,1,37,0.935133253463858,0.96195299558837,0,0,0.37959307622229,0.0254578814054047,DGKZ
alpha,4,cardiac muscle contraction (GO:0060048),1/37,1,37,0.935133253463858,0.96195299558837,0,0,0.37959307622229,0.0254578814054047,PIK3CA
alpha,4,cardiac muscle tissue development (GO:0048738),1/37,1,37,0.935133253463858,0.96195299558837,0,0,0.37959307622229,0.0254578814054047,KDM6B
alpha,4,spermatid development (GO:0007286),1/37,1,37,0.935133253463858,0.96195299558837,0,0,0.37959307622229,0.0254578814054047,PLD6
alpha,4,regulation of nitric-oxide synthase activity (GO:0050999),1/37,1,37,0.935133253463858,0.96195299558837,0,0,0.37959307622229,0.0254578814054047,NOS3
alpha,4,regulation of osteoclast differentiation (GO:0045670),1/38,1,38,0.939760182905355,0.966429796053927,0,0,0.369603784742756,0.0229636904334226,TCTA
alpha,4,positive regulation of DNA metabolic process (GO:0051054),3/83,3,83,0.940841849620556,0.967100663779998,0,0,0.507648571815351,0.0309565214965821,MECP2;IGF1R;GNL3
alpha,4,striated muscle contraction (GO:0006941),2/62,2,62,0.941237943326137,0.967100663779998,0,0,0.453062703878217,0.0274371643554419,DTNA;PIK3CA
alpha,4,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),2/62,2,62,0.941237943326137,0.967100663779998,0,0,0.453062703878217,0.0274371643554419,CNOT7;ARL2BP
alpha,4,negative regulation of endopeptidase activity (GO:0010951),3/84,3,84,0.943932332598512,0.969147584950785,0,0,0.501605136436597,0.0289430161392737,VTN;SERPINE2;SERPINB6
alpha,4,membrane depolarization during action potential (GO:0086010),1/39,1,39,0.94405727763058,0.969147584950785,0,0,0.360126764621147,0.0207319357610181,CACNA1D
alpha,4,regulation of ossification (GO:0030278),1/39,1,39,0.94405727763058,0.969147584950785,0,0,0.360126764621147,0.0207319357610181,CHSY1
alpha,4,diterpenoid metabolic process (GO:0016101),2/63,2,63,0.944704676313119,0.969529032770982,0,0,0.445871232388086,0.0253624541503317,AGRN;HSPG2
alpha,4,cellular calcium ion homeostasis (GO:0006874),5/124,5,124,0.945881814518161,0.97012775623794,0,0,0.566328379847771,0.0315091799190546,STIM2;RMDN3;ATP2A2;MICU1;TMCO1
alpha,4,positive regulation of macromolecule biosynthetic process (GO:0010557),6/143,6,143,0.946458931071725,0.97012775623794,0,0,0.589298342107331,0.0324277321348306,NPM1;DDX3X;LDB1;EIF4A3;CIRBP;IGF1R
alpha,4,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),6/143,6,143,0.946458931071725,0.97012775623794,0,0,0.589298342107331,0.0324277321348306,CD164;SDK1;NLGN1;FLRT3;SMAGP;DSG2
alpha,4,regulation of mitotic nuclear division (GO:0007088),3/85,3,85,0.946872309246415,0.97012775623794,0,0,0.495703899537343,0.0270609874463309,NUP62;DAPK3;MAD2L1BP
alpha,4,carbohydrate homeostasis (GO:0033500),2/64,2,64,0.947976071414608,0.97012775623794,0,0,0.438904494382023,0.023448919491533,HECTD4;CRY1
alpha,4,negative regulation of protein catabolic process (GO:0042177),1/40,1,40,0.948048034901088,0.97012775623794,0,0,0.351123595505618,0.0187324818412557,CTSA
alpha,4,skeletal muscle tissue development (GO:0007519),1/40,1,40,0.948048034901088,0.97012775623794,0,0,0.351123595505618,0.0187324818412557,BVES
alpha,4,positive regulation of fat cell differentiation (GO:0045600),1/40,1,40,0.948048034901088,0.97012775623794,0,0,0.351123595505618,0.0187324818412557,ZC3H12A
alpha,4,alpha-amino acid catabolic process (GO:1901606),1/40,1,40,0.948048034901088,0.97012775623794,0,0,0.351123595505618,0.0187324818412557,ACAT1
alpha,4,acyl-CoA metabolic process (GO:0006637),1/40,1,40,0.948048034901088,0.97012775623794,0,0,0.351123595505618,0.0187324818412557,ACOT7
alpha,4,negative regulation of TOR signaling (GO:0032007),1/41,1,41,0.951754279038168,0.972504735703244,0,0,0.342559605371335,0.0169390201976507,TBC1D7
alpha,4,response to peptide hormone (GO:0043434),1/41,1,41,0.951754279038168,0.972504735703244,0,0,0.342559605371335,0.0169390201976507,CRY1
alpha,4,negative regulation of catabolic process (GO:0009895),1/41,1,41,0.951754279038168,0.972504735703244,0,0,0.342559605371335,0.0169390201976507,PDE3B
alpha,4,regulation of intracellular transport (GO:0032386),1/41,1,41,0.951754279038168,0.972504735703244,0,0,0.342559605371335,0.0169390201976507,NUP214
alpha,4,positive regulation of cytokine biosynthetic process (GO:0042108),1/41,1,41,0.951754279038168,0.972504735703244,0,0,0.342559605371335,0.0169390201976507,HSPB1
alpha,4,negative regulation of response to external stimulus (GO:0032102),4/108,4,108,0.954002861317059,0.974519051883017,0,0,0.520183104452767,0.0244946984260401,TYRO3;TNFAIP3;RORA;CRK
alpha,4,regulation of calcium-mediated signaling (GO:0050848),1/42,1,42,0.95519628032999,0.974888189709615,0,0,0.334403424291065,0.0153285281160635,RCAN2
alpha,4,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),1/42,1,42,0.95519628032999,0.974888189709615,0,0,0.334403424291065,0.0153285281160635,NLGN1
alpha,4,cellular response to peptide (GO:1901653),1/42,1,42,0.95519628032999,0.974888189709615,0,0,0.334403424291065,0.0153285281160635,IGF1R
alpha,4,regulation of protein activation cascade (GO:2000257),4/109,4,109,0.956241747173354,0.975671913298793,0,0,0.515410782393568,0.0230618102698605,VTN;CD81;CLU;CD55
alpha,4,regulation of protein processing (GO:0070613),5/129,5,129,0.957025660107794,0.976188390968919,0,0,0.54437766745057,0.0239118297724782,VTN;SERPINE2;CD81;CLU;CD55
alpha,4,regulation of complement activation (GO:0030449),4/110,4,110,0.958379641607461,0.977015929412959,0,0,0.510725229826353,0.0217115903518388,VTN;CD81;CLU;CD55
alpha,4,determination of left/right symmetry (GO:0007368),1/43,1,43,0.95839286617806,0.977015929412959,0,0,0.326626600470342,0.0138808123592107,PKD2
alpha,4,epidermal cell differentiation (GO:0009913),2/68,2,68,0.959305745040371,0.977663001976487,0,0,0.413086582947786,0.0171618631825403,CTNNB1;WNT16
alpha,4,membrane depolarization (GO:0051899),1/44,1,44,0.961361523264729,0.978623155017527,0,0,0.319203268641471,0.0125781236883774,CACNA1D
alpha,4,eye development (GO:0001654),1/44,1,44,0.961361523264729,0.978623155017527,0,0,0.319203268641471,0.0125781236883774,HIPK2
alpha,4,positive regulation of interleukin-6 production (GO:0032755),1/44,1,44,0.961361523264729,0.978623155017527,0,0,0.319203268641471,0.0125781236883774,HYAL2
alpha,4,regulation of interferon-gamma production (GO:0032649),1/44,1,44,0.961361523264729,0.978623155017527,0,0,0.319203268641471,0.0125781236883774,FADD
alpha,4,negative regulation of phosphatase activity (GO:0010923),2/69,2,69,0.961744650211429,0.97872971786137,0,0,0.407099820876079,0.0158794577111038,TIPRL;PCIF1
alpha,4,regulation of T cell activation (GO:0050863),1/45,1,45,0.9641184928947,0.979727234034366,0,0,0.312109862671661,0.0114048295832779,PRELID1
alpha,4,positive regulation of intracellular transport (GO:0032388),1/45,1,45,0.9641184928947,0.979727234034366,0,0,0.312109862671661,0.0114048295832779,HIP1R
alpha,4,heart contraction (GO:0060047),1/45,1,45,0.9641184928947,0.979727234034366,0,0,0.312109862671661,0.0114048295832779,PIK3CA
alpha,4,posttranscriptional regulation of gene expression (GO:0010608),1/45,1,45,0.9641184928947,0.979727234034366,0,0,0.312109862671661,0.0114048295832779,EIF4E
alpha,4,adherens junction organization (GO:0034332),1/45,1,45,0.9641184928947,0.979727234034366,0,0,0.312109862671661,0.0114048295832779,CTNNB1
alpha,4,regulation of humoral immune response (GO:0002920),4/114,4,114,0.965999904026217,0.98128320369045,0,0,0.492805046323674,0.0170468875031373,VTN;CD81;CLU;CD55
alpha,4,Rab protein signal transduction (GO:0032482),2/71,2,71,0.96620801364798,0.98128320369045,0,0,0.39563222028802,0.0136003057887183,RAB36;RAB24
alpha,4,cartilage development (GO:0051216),1/47,1,47,0.969056635804929,0.983607876076906,0,0,0.298828591919675,0.00939284637708134,HYAL2
alpha,4,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",1/47,1,47,0.969056635804929,0.983607876076906,0,0,0.298828591919675,0.00939284637708134,NDUFB2
alpha,4,peptide cross-linking (GO:0018149),1/48,1,48,0.971264832623127,0.984995928064135,0,0,0.292602996254682,0.00853116389654953,FN1
alpha,4,cellular response to heat (GO:0034605),1/48,1,48,0.971264832623127,0.984995928064135,0,0,0.292602996254682,0.00853116389654953,BAG3
alpha,4,myofibril assembly (GO:0030239),1/48,1,48,0.971264832623127,0.984995928064135,0,0,0.292602996254682,0.00853116389654953,TMOD3
alpha,4,positive regulation of chemotaxis (GO:0050921),1/49,1,49,0.973315536701297,0.986506375866511,0,0,0.286631506535198,0.00775250996505207,HSPB1
alpha,4,amino acid transport (GO:0006865),1/49,1,49,0.973315536701297,0.986506375866511,0,0,0.286631506535198,0.00775250996505207,SLC7A6
alpha,4,glucose homeostasis (GO:0042593),2/75,2,75,0.973678415140056,0.986589688445459,0,0,0.374531835205993,0.00999033674838791,HECTD4;CRY1
alpha,4,cilium movement (GO:0003341),1/50,1,50,0.975219973311615,0.987643613857924,0,0,0.280898876404494,0.00704837634221479,RSPH9
alpha,4,retinoid metabolic process (GO:0001523),2/76,2,76,0.975280507454013,0.987643613857924,0,0,0.369603784742756,0.00925123795429903,AGRN;HSPG2
alpha,4,myeloid leukocyte differentiation (GO:0002573),1/51,1,51,0.976988568196788,0.988518945656796,0,0,0.275391055298524,0.00641119407696789,FOXP1
alpha,4,negative regulation of viral genome replication (GO:0045071),1/51,1,51,0.976988568196788,0.988518945656796,0,0,0.275391055298524,0.00641119407696789,ZC3H12A
alpha,4,regulation of cellular protein metabolic process (GO:0032268),1/51,1,51,0.976988568196788,0.988518945656796,0,0,0.275391055298524,0.00641119407696789,EIF4E
alpha,4,regulation of acute inflammatory response (GO:0002673),4/122,4,122,0.977500204724358,0.988752005642048,0,0,0.460489961318843,0.0104792676763471,VTN;CD81;CLU;CD55
alpha,4,peptidyl-tyrosine modification (GO:0018212),1/52,1,52,0.978631004351775,0.989611041512224,0,0,0.27009507346586,0.00583422057984952,TEC
alpha,4,visual perception (GO:0007601),2/79,2,79,0.979540756099799,0.990246119554442,0,0,0.355568197980373,0.00735010431557117,ATXN7;DRAM2
alpha,4,B cell differentiation (GO:0030183),1/53,1,53,0.98015627516037,0.990298737335068,0,0,0.26499894000424,0.00531144148326944,MSH2
alpha,4,triglyceride metabolic process (GO:0006641),1/53,1,53,0.98015627516037,0.990298737335068,0,0,0.26499894000424,0.00531144148326944,LPIN2
alpha,4,plasma membrane invagination (GO:0099024),3/104,3,104,0.981554557076739,0.990875404156832,0,0,0.40514261019879,0.0075428160397316,ALKBH4;SNX9;RHOA
alpha,4,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/54,1,54,0.981572733221647,0.990875404156832,0,0,0.260091552226384,0.00483748539918992,WNT16
alpha,4,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),1/54,1,54,0.981572733221647,0.990875404156832,0,0,0.260091552226384,0.00483748539918992,ARL2BP
alpha,4,skeletal system development (GO:0001501),5/147,5,147,0.981935986629348,0.99095750588635,0,0,0.477719177558664,0.00870841907639856,HYAL2;CHD7;DYM;BMP6;TGFBR1
alpha,4,sensory perception of light stimulus (GO:0050953),2/82,2,82,0.983085258201934,0.991832572497072,0,0,0.342559605371335,0.005843871587738,ATXN7;DRAM2
alpha,4,negative regulation of hydrolase activity (GO:0051346),3/109,3,109,0.986167857451572,0.99465710730051,0,0,0.386558086795176,0.00538425086810528,RDX;PCIF1;PPIF
alpha,4,regulation of Wnt signaling pathway (GO:0030111),3/110,3,110,0.986946954363606,0.994918139157514,0,0,0.383043922369765,0.00503280846733492,KANK1;ATP6V0C;DACT1
alpha,4,cholesterol homeostasis (GO:0042632),1/59,1,59,0.98727580921235,0.994918139157514,0,0,0.238049895258046,0.00304842806786469,LIPG
alpha,4,sterol homeostasis (GO:0055092),1/59,1,59,0.98727580921235,0.994918139157514,0,0,0.238049895258046,0.00304842806786469,LIPG
alpha,4,positive regulation of cytosolic calcium ion concentration (GO:0007204),4/134,4,134,0.988113529448914,0.995262958860095,0,0,0.419252054335066,0.00501328168984759,AVPR1B;GPRIN1;SPPL3;CD55
alpha,4,keratinocyte differentiation (GO:0030216),1/60,1,60,0.988184274942171,0.995262958860095,0,0,0.234082397003745,0.00278232339099043,WNT16
alpha,4,positive regulation of leukocyte chemotaxis (GO:0002690),1/62,1,62,0.989811331052984,0.996492278303328,0,0,0.226531351939108,0.00231989142558928,KARS
alpha,4,muscle contraction (GO:0006936),4/138,4,138,0.990434211409868,0.996492278303328,0,0,0.407099820876079,0.00391297615433722,DTNA;ITGB5;TMOD3;MYLK
alpha,4,regulation of cytosolic calcium ion concentration (GO:0051480),4/138,4,138,0.990434211409868,0.996492278303328,0,0,0.407099820876079,0.00391297615433722,SMAD3;AVPR1B;SPPL3;CD55
alpha,4,regulation of T cell proliferation (GO:0042129),1/63,1,63,0.990538839371786,0.996492278303328,0,0,0.222935616194043,0.00211927093980886,TFRC
alpha,4,phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200),2/92,2,92,0.991091926040241,0.996601455583704,0,0,0.305324865657059,0.00273204325413393,HOMER1;GNAQ
alpha,4,negative regulation of dephosphorylation (GO:0035305),1/64,1,64,0.991214420688657,0.996601455583704,0,0,0.219452247191011,0.00193653442232844,PCIF1
alpha,4,positive regulation of JAK-STAT cascade (GO:0046427),1/65,1,65,0.991841778911447,0.996634305055318,0,0,0.216076058772688,0.00177002624964299,ARL2BP
alpha,4,positive regulation of cell adhesion (GO:0045785),1/65,1,65,0.991841778911447,0.996634305055318,0,0,0.216076058772688,0.00177002624964299,RAC1
alpha,4,cellular response to type I interferon (GO:0071357),1/66,1,66,0.99242435401675,0.996634305055318,0,0,0.212802179094314,0.00161825139191074,HLA-B
alpha,4,type I interferon signaling pathway (GO:0060337),1/66,1,66,0.99242435401675,0.996634305055318,0,0,0.212802179094314,0.00161825139191074,HLA-B
alpha,4,vesicle fusion (GO:0006906),2/95,2,95,0.992664780084969,0.996634305055318,0,0,0.295683027794205,0.00217689382818863,VPS41;STX2
alpha,4,regulation of B cell activation (GO:0050864),2/96,2,96,0.99312595431318,0.996812601202406,0,0,0.292602996254682,0.0020183113214294,TNFAIP3;FOXJ1
alpha,4,response to interferon-gamma (GO:0034341),1/69,1,69,0.993934203793365,0.997339059758401,0,0,0.203549910438039,0.00123845218272203,DAPK3
alpha,4,interferon-gamma-mediated signaling pathway (GO:0060333),1/71,1,71,0.994769655339032,0.997892505284446,0,0,0.19781611014401,0.00103736168621131,HLA-B
alpha,4,organelle membrane fusion (GO:0090174),1/72,1,72,0.995143191892158,0.997907282621253,0,0,0.195068664169788,0.000949719243211374,STX2
alpha,4,metal ion transport (GO:0030001),2/102,2,102,0.995352185738297,0.997907282621253,0,0,0.275391055298524,0.00128295024651455,TRAPPC10;SGK1
alpha,4,B cell activation (GO:0042113),1/74,1,74,0.995812145879886,0.998083744729911,0,0,0.189796538111145,0.000796509212856902,MSH2
alpha,4,monovalent inorganic cation transport (GO:0015672),2/105,2,105,0.996182229921953,0.998170050791239,0,0,0.267522739432852,0.0010232949074299,TRAPPC10;SGK1
alpha,4,phagocytosis (GO:0006909),3/136,3,136,0.997224026519541,0.998929168770643,0,0,0.309814937210839,0.000861233984725099,TYRO3;CDC7;CORO1C
alpha,4,epidermis development (GO:0008544),1/82,1,82,0.997684925194894,0.999106128792038,0,0,0.171279802685667,0.00039698525861768,ATP2A2
alpha,4,cellular response to interferon-gamma (GO:0071346),2/117,2,117,0.998272517009844,0.999409825488352,0,0,0.240084509747431,0.000415100549675673,DAPK3;HLA-B
alpha,4,positive regulation of B cell activation (GO:0050871),2/120,2,120,0.998585051810379,0.999438057264659,0,0,0.234082397003745,0.000331449010789534,TFRC;CD81
alpha,4,positive regulation of lymphocyte activation (GO:0051251),1/105,1,105,0.999577611688218,0.999577611688218,0,0,0.133761369716426,5.6511174806395e-05,ZNF335
alpha,4,"phagocytosis, engulfment (GO:0006911)",1/105,1,105,0.999577611688218,0.999577611688218,0,0,0.133761369716426,5.6511174806395e-05,RAC1
alpha,4,B cell receptor signaling pathway (GO:0050853),1/105,1,105,0.999577611688218,0.999577611688218,0,0,0.133761369716426,5.6511174806395e-05,TEC
delta,1,nitric oxide mediated signal transduction (GO:0007263),2/15,2,15,0.000182291841891916,0.0379167031135186,0,0,98.7654320987654,850.360654645463,NOS3;NDNF
delta,1,regulation of nitric-oxide synthase activity (GO:0050999),2/37,2,37,0.00113528335685322,0.0682771067712338,0,0,40.04004004004,271.506426650325,S100A1;NOS3
delta,1,sterol metabolic process (GO:0016125),2/60,2,60,0.00296007920275242,0.0682771067712338,0,0,24.6913580246914,143.766401316482,CYP27A1;NR0B2
delta,1,second-messenger-mediated signaling (GO:0019932),2/63,2,63,0.00325799621012048,0.0682771067712338,0,0,23.5155790711346,134.665324680925,NOS3;NDNF
delta,1,monocarboxylic acid biosynthetic process (GO:0072330),2/69,2,69,0.00389415741682432,0.0682771067712338,0,0,21.4707461084273,119.125667146922,CYP27A1;ACSF3
delta,1,positive regulation of neuron differentiation (GO:0045666),2/99,2,99,0.00785444632891569,0.0682771067712338,0,0,14.9644594089039,72.5278787311834,NDNF;ADRA2B
delta,1,steroid metabolic process (GO:0008202),2/100,2,100,0.00800810651058956,0.0682771067712338,0,0,14.8148148148148,71.5155694301407,CYP27A1;DHRS2
delta,1,negative regulation of catecholamine secretion (GO:0033604),1/6,1,6,0.00807362689081275,0.0682771067712338,0,0,123.456790123457,594.95709491531,ADRA2B
delta,1,inner ear receptor cell differentiation (GO:0060113),1/6,1,6,0.00807362689081275,0.0682771067712338,0,0,123.456790123457,594.95709491531,USH2A
delta,1,ceramide transport (GO:0035627),1/6,1,6,0.00807362689081275,0.0682771067712338,0,0,123.456790123457,594.95709491531,COL4A3BP
delta,1,iron ion import (GO:0097286),1/6,1,6,0.00807362689081275,0.0682771067712338,0,0,123.456790123457,594.95709491531,TFR2
delta,1,positive regulation of cGMP biosynthetic process (GO:0030828),1/6,1,6,0.00807362689081275,0.0682771067712338,0,0,123.456790123457,594.95709491531,NOS3
delta,1,cellular response to iron ion (GO:0071281),1/6,1,6,0.00807362689081275,0.0682771067712338,0,0,123.456790123457,594.95709491531,TFR2
delta,1,positive regulation of angiogenesis (GO:0045766),2/104,2,104,0.00863628207704604,0.0682771067712338,0,0,14.2450142450142,67.6892180047723,S100A1;NOS3
delta,1,positive regulation of cellular component organization (GO:0051130),2/107,2,107,0.00912152317040695,0.0682771067712338,0,0,13.8456213222568,65.0345237042883,CDT1;TFR2
delta,1,positive regulation of membrane depolarization (GO:1904181),1/7,1,7,0.00941312053617665,0.0682771067712338,0,0,105.820105820106,493.719657271002,MLLT11
delta,1,regulation of norepinephrine secretion (GO:0014061),1/7,1,7,0.00941312053617665,0.0682771067712338,0,0,105.820105820106,493.719657271002,ADRA2B
delta,1,positive regulation of chromatin binding (GO:0035563),1/8,1,8,0.0107508728609496,0.0682771067712338,0,0,92.5925925925926,419.700771420121,CDT1
delta,1,arginine catabolic process (GO:0006527),1/8,1,8,0.0107508728609496,0.0682771067712338,0,0,92.5925925925926,419.700771420121,NOS3
delta,1,angiogenesis involved in wound healing (GO:0060055),1/8,1,8,0.0107508728609496,0.0682771067712338,0,0,92.5925925925926,419.700771420121,NDNF
delta,1,microvillus assembly (GO:0030033),1/8,1,8,0.0107508728609496,0.0682771067712338,0,0,92.5925925925926,419.700771420121,FXYD5
delta,1,microvillus organization (GO:0032528),1/8,1,8,0.0107508728609496,0.0682771067712338,0,0,92.5925925925926,419.700771420121,FXYD5
delta,1,negative regulation of double-strand break repair via homologous recombination (GO:2000042),1/8,1,8,0.0107508728609496,0.0682771067712338,0,0,92.5925925925926,419.700771420121,POLK
delta,1,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),1/9,1,9,0.0120868859385031,0.0682771067712338,0,0,82.3045267489712,363.426684844275,CDT1
delta,1,removal of superoxide radicals (GO:0019430),1/9,1,9,0.0120868859385031,0.0682771067712338,0,0,82.3045267489712,363.426684844275,NOS3
delta,1,vasodilation (GO:0042311),1/9,1,9,0.0120868859385031,0.0682771067712338,0,0,82.3045267489712,363.426684844275,NOS3
delta,1,positive regulation of protein maturation (GO:1903319),1/9,1,9,0.0120868859385031,0.0682771067712338,0,0,82.3045267489712,363.426684844275,TFR2
delta,1,cellular response to superoxide (GO:0071451),1/9,1,9,0.0120868859385031,0.0682771067712338,0,0,82.3045267489712,363.426684844275,NOS3
delta,1,regulation of hair cycle (GO:0042634),1/9,1,9,0.0120868859385031,0.0682771067712338,0,0,82.3045267489712,363.426684844275,TRPV3
delta,1,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),1/10,1,10,0.0134211618656948,0.0682771067712338,0,0,74.0740740740741,319.327598074868,ADRA2B
delta,1,hair cell differentiation (GO:0035315),1/10,1,10,0.0134211618656948,0.0682771067712338,0,0,74.0740740740741,319.327598074868,USH2A
delta,1,detection of light stimulus involved in visual perception (GO:0050908),1/10,1,10,0.0134211618656948,0.0682771067712338,0,0,74.0740740740741,319.327598074868,EYS
delta,1,regulation of mitochondrial depolarization (GO:0051900),1/10,1,10,0.0134211618656948,0.0682771067712338,0,0,74.0740740740741,319.327598074868,MLLT11
delta,1,myeloid dendritic cell differentiation (GO:0043011),1/10,1,10,0.0134211618656948,0.0682771067712338,0,0,74.0740740740741,319.327598074868,DHRS2
delta,1,negative regulation of cell activation (GO:0050866),1/10,1,10,0.0134211618656948,0.0682771067712338,0,0,74.0740740740741,319.327598074868,NOS3
delta,1,nitric oxide biosynthetic process (GO:0006809),1/11,1,11,0.014753702756032,0.0682771067712338,0,0,67.3400673400673,283.92331268639,NOS3
delta,1,detection of light stimulus involved in sensory perception (GO:0050962),1/11,1,11,0.014753702756032,0.0682771067712338,0,0,67.3400673400673,283.92331268639,EYS
delta,1,regulation of chromatin binding (GO:0035561),1/11,1,11,0.014753702756032,0.0682771067712338,0,0,67.3400673400673,283.92331268639,CDT1
delta,1,arginine metabolic process (GO:0006525),1/11,1,11,0.014753702756032,0.0682771067712338,0,0,67.3400673400673,283.92331268639,NOS3
delta,1,iron ion transport (GO:0006826),1/12,1,12,0.0160845107297618,0.0682771067712338,0,0,61.7283950617284,254.932008428958,TFR2
delta,1,positive regulation of lyase activity (GO:0051349),1/12,1,12,0.0160845107297618,0.0682771067712338,0,0,61.7283950617284,254.932008428958,NOS3
delta,1,positive regulation of cyclase activity (GO:0031281),1/12,1,12,0.0160845107297618,0.0682771067712338,0,0,61.7283950617284,254.932008428958,NOS3
delta,1,somatic hypermutation of immunoglobulin genes (GO:0016446),1/12,1,12,0.0160845107297618,0.0682771067712338,0,0,61.7283950617284,254.932008428958,POLK
delta,1,positive regulation of DNA-dependent DNA replication (GO:2000105),1/12,1,12,0.0160845107297618,0.0682771067712338,0,0,61.7283950617284,254.932008428958,CDT1
delta,1,kinetochore organization (GO:0051383),1/12,1,12,0.0160845107297618,0.0682771067712338,0,0,61.7283950617284,254.932008428958,CDT1
delta,1,nitric oxide metabolic process (GO:0046209),1/12,1,12,0.0160845107297618,0.0682771067712338,0,0,61.7283950617284,254.932008428958,NOS3
delta,1,regulation of DNA-dependent DNA replication (GO:0090329),1/12,1,12,0.0160845107297618,0.0682771067712338,0,0,61.7283950617284,254.932008428958,CDT1
delta,1,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),1/12,1,12,0.0160845107297618,0.0682771067712338,0,0,61.7283950617284,254.932008428958,CDT1
delta,1,regulation of blood vessel size (GO:0050880),1/12,1,12,0.0160845107297618,0.0682771067712338,0,0,61.7283950617284,254.932008428958,NOS3
delta,1,response to iron ion (GO:0010039),1/13,1,13,0.0174135879176466,0.0683401186201979,0,0,56.980056980057,230.797975083174,TFR2
delta,1,dicarboxylic acid catabolic process (GO:0043649),1/13,1,13,0.0174135879176466,0.0683401186201979,0,0,56.980056980057,230.797975083174,ACSF3
delta,1,negative regulation of blood pressure (GO:0045776),1/13,1,13,0.0174135879176466,0.0683401186201979,0,0,56.980056980057,230.797975083174,NOS3
delta,1,negative regulation of hormone secretion (GO:0046888),1/13,1,13,0.0174135879176466,0.0683401186201979,0,0,56.980056980057,230.797975083174,ADRA2B
delta,1,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),1/14,1,14,0.0187409364492419,0.0696091925257556,0,0,52.9100529100529,210.425663111629,CDT1
delta,1,positive regulation of blood vessel diameter (GO:0097755),1/14,1,14,0.0187409364492419,0.0696091925257556,0,0,52.9100529100529,210.425663111629,NOS3
delta,1,myeloid dendritic cell activation (GO:0001773),1/14,1,14,0.0187409364492419,0.0696091925257556,0,0,52.9100529100529,210.425663111629,DHRS2
delta,1,negative regulation of platelet activation (GO:0010544),1/15,1,15,0.0200665584643781,0.07062245821442,0,0,49.3827160493827,193.02225222176,NOS3
delta,1,intracellular lipid transport (GO:0032365),1/15,1,15,0.0200665584643781,0.07062245821442,0,0,49.3827160493827,193.02225222176,COL4A3BP
delta,1,regulation of systemic arterial blood pressure by hormone (GO:0001990),1/16,1,16,0.0213904560937907,0.07062245821442,0,0,46.2962962962963,178.0004830258,NOS3
delta,1,positive regulation of nitric-oxide synthase activity (GO:0051000),1/16,1,16,0.0213904560937907,0.07062245821442,0,0,46.2962962962963,178.0004830258,S100A1
delta,1,detection of visible light (GO:0009584),1/16,1,16,0.0213904560937907,0.07062245821442,0,0,46.2962962962963,178.0004830258,EYS
delta,1,glutamine family amino acid catabolic process (GO:0009065),1/16,1,16,0.0213904560937907,0.07062245821442,0,0,46.2962962962963,178.0004830258,NOS3
delta,1,negative regulation of DNA recombination (GO:0045910),1/16,1,16,0.0213904560937907,0.07062245821442,0,0,46.2962962962963,178.0004830258,POLK
delta,1,positive regulation of hormone secretion (GO:0046887),1/17,1,17,0.0227126314766075,0.0726804207251441,0,0,43.5729847494553,164.916516624976,TFR2
delta,1,DNA replication checkpoint (GO:0000076),1/17,1,17,0.0227126314766075,0.0726804207251441,0,0,43.5729847494553,164.916516624976,CDT1
delta,1,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),1/18,1,18,0.0240330867565966,0.0757406370510923,0,0,41.1522633744856,153.428962271316,ACSF3
delta,1,regulation of platelet activation (GO:0010543),1/19,1,19,0.0253518240632961,0.0764228899299361,0,0,38.9863547758285,143.271134361559,NOS3
delta,1,negative regulation of double-strand break repair (GO:2000780),1/19,1,19,0.0253518240632961,0.0764228899299361,0,0,38.9863547758285,143.271134361559,POLK
delta,1,regulation of sprouting angiogenesis (GO:1903670),1/19,1,19,0.0253518240632961,0.0764228899299361,0,0,38.9863547758285,143.271134361559,S100A1
delta,1,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),1/20,1,20,0.0266688455361458,0.0781284488946244,0,0,37.037037037037,134.23182328551,ADRA2B
delta,1,adrenergic receptor signaling pathway (GO:0071875),1/20,1,20,0.0266688455361458,0.0781284488946244,0,0,37.037037037037,134.23182328551,ADRA2B
delta,1,phospholipid translocation (GO:0045332),1/21,1,21,0.027984153316514,0.0797356697237659,0,0,35.2733686067019,126.14168895945,ATP11C
delta,1,dendritic cell differentiation (GO:0097028),1/21,1,21,0.027984153316514,0.0797356697237659,0,0,35.2733686067019,126.14168895945,DHRS2
delta,1,C21-steroid hormone metabolic process (GO:0008207),1/22,1,22,0.0292977495261991,0.0812524253526589,0,0,33.6700336700337,118.863453666281,DHRS2
delta,1,lipid translocation (GO:0034204),1/22,1,22,0.0292977495261991,0.0812524253526589,0,0,33.6700336700337,118.863453666281,ATP11C
delta,1,positive regulation of monooxygenase activity (GO:0032770),1/23,1,23,0.0306096363049702,0.0816256968132538,0,0,32.2061191626409,112.284715222899,S100A1
delta,1,regulation of monooxygenase activity (GO:0032768),1/23,1,23,0.0306096363049702,0.0816256968132538,0,0,32.2061191626409,112.284715222899,NOS3
delta,1,cellular nitrogen compound biosynthetic process (GO:0044271),1/23,1,23,0.0306096363049702,0.0816256968132538,0,0,32.2061191626409,112.284715222899,NOS3
delta,1,transition metal ion homeostasis (GO:0055076),1/25,1,25,0.0332282900970065,0.0853269671626834,0,0,29.6296296296296,100.86973791244,TFR2
delta,1,negative regulation of endothelial cell apoptotic process (GO:2000352),1/25,1,25,0.0332282900970065,0.0853269671626834,0,0,29.6296296296296,100.86973791244,NDNF
delta,1,regulation of chromosome organization (GO:0033044),1/25,1,25,0.0332282900970065,0.0853269671626834,0,0,29.6296296296296,100.86973791244,CDT1
delta,1,long-chain fatty-acyl-CoA metabolic process (GO:0035336),1/26,1,26,0.0345350613606547,0.0865456959399539,0,0,28.4900284900285,95.8911737799315,ACSF3
delta,1,negative regulation of cellular protein localization (GO:1903828),1/26,1,26,0.0345350613606547,0.0865456959399539,0,0,28.4900284900285,95.8911737799315,CDT1
delta,1,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1/27,1,27,0.0358401317118484,0.0866831092565636,0,0,27.4348422496571,91.3220031793248,CDT1
delta,1,bile acid biosynthetic process (GO:0006699),1/27,1,27,0.0358401317118484,0.0866831092565636,0,0,27.4348422496571,91.3220031793248,CYP27A1
delta,1,positive regulation of release of cytochrome c from mitochondria (GO:0090200),1/27,1,27,0.0358401317118484,0.0866831092565636,0,0,27.4348422496571,91.3220031793248,MLLT11
delta,1,transition metal ion transport (GO:0000041),1/28,1,28,0.0371435032676452,0.0868072885356203,0,0,26.4550264550265,87.1155132673506,TFR2
delta,1,regulation of blood vessel diameter (GO:0097746),1/28,1,28,0.0371435032676452,0.0868072885356203,0,0,26.4550264550265,87.1155132673506,NOS3
delta,1,regulation of double-strand break repair via homologous recombination (GO:0010569),1/28,1,28,0.0371435032676452,0.0868072885356203,0,0,26.4550264550265,87.1155132673506,POLK
delta,1,positive regulation of sprouting angiogenesis (GO:1903672),1/29,1,29,0.0384451781473962,0.0880106890987409,0,0,25.5427841634738,83.2317240532282,S100A1
delta,1,negative regulation of epithelial cell apoptotic process (GO:1904036),1/30,1,30,0.0397451584744872,0.0880106890987409,0,0,24.6913580246914,79.6362282638003,NDNF
delta,1,superoxide metabolic process (GO:0006801),1/30,1,30,0.0397451584744872,0.0880106890987409,0,0,24.6913580246914,79.6362282638003,NOS3
delta,1,bile acid metabolic process (GO:0008206),1/31,1,31,0.0410434463585474,0.0880106890987409,0,0,23.89486260454,76.2992617932435,CYP27A1
delta,1,regulation of sodium ion transmembrane transport (GO:1902305),1/31,1,31,0.0410434463585474,0.0880106890987409,0,0,23.89486260454,76.2992617932435,FXYD5
delta,1,fatty-acyl-CoA biosynthetic process (GO:0046949),1/31,1,31,0.0410434463585474,0.0880106890987409,0,0,23.89486260454,76.2992617932435,ACSF3
delta,1,chondroitin sulfate metabolic process (GO:0030204),1/31,1,31,0.0410434463585474,0.0880106890987409,0,0,23.89486260454,76.2992617932435,NDNF
delta,1,activation of protein kinase B activity (GO:0032148),1/31,1,31,0.0410434463585474,0.0880106890987409,0,0,23.89486260454,76.2992617932435,ADRA2B
delta,1,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),1/32,1,32,0.0423400439315087,0.088067291377538,0,0,23.1481481481481,73.194953140907,NOS3
delta,1,secondary alcohol metabolic process (GO:1902652),1/32,1,32,0.0423400439315087,0.088067291377538,0,0,23.1481481481481,73.194953140907,NR0B2
delta,1,negative regulation of cell-cell adhesion (GO:0022408),1/32,1,32,0.0423400439315087,0.088067291377538,0,0,23.1481481481481,73.194953140907,FXYD5
delta,1,regulation of cell-substrate adhesion (GO:0010810),1/34,1,34,0.0449281765490304,0.0922721106109135,0,0,21.7864923747277,67.596735097764,NDNF
delta,1,positive regulation of DNA replication (GO:0045740),1/36,1,36,0.0475095732087328,0.0922721106109135,0,0,20.5761316872428,62.6918528191722,CDT1
delta,1,endothelial cell migration (GO:0043542),1/36,1,36,0.0475095732087328,0.0922721106109135,0,0,20.5761316872428,62.6918528191722,NOS3
delta,1,positive regulation of peptide secretion (GO:0002793),1/36,1,36,0.0475095732087328,0.0922721106109135,0,0,20.5761316872428,62.6918528191722,TFR2
delta,1,regulation of endothelial cell apoptotic process (GO:2000351),1/36,1,36,0.0475095732087328,0.0922721106109135,0,0,20.5761316872428,62.6918528191722,NDNF
delta,1,transferrin transport (GO:0033572),1/37,1,37,0.0487977508038485,0.0922721106109135,0,0,20.02002002002,60.4618830284342,TFR2
delta,1,ferric iron transport (GO:0015682),1/37,1,37,0.0487977508038485,0.0922721106109135,0,0,20.02002002002,60.4618830284342,TFR2
delta,1,epithelial cell migration (GO:0010631),1/37,1,37,0.0487977508038485,0.0922721106109135,0,0,20.02002002002,60.4618830284342,NOS3
delta,1,regulation of blood circulation (GO:1903522),1/37,1,37,0.0487977508038485,0.0922721106109135,0,0,20.02002002002,60.4618830284342,S100A1
delta,1,negative regulation of blood coagulation (GO:0030195),1/37,1,37,0.0487977508038485,0.0922721106109135,0,0,20.02002002002,60.4618830284342,NOS3
delta,1,base-excision repair (GO:0006284),1/38,1,38,0.0500842507282724,0.093013608495363,0,0,19.4931773879142,58.3635219694515,POLK
delta,1,regulation of sodium ion transmembrane transporter activity (GO:2000649),1/38,1,38,0.0500842507282724,0.093013608495363,0,0,19.4931773879142,58.3635219694515,FXYD5
delta,1,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),1/40,1,40,0.0526522259283912,0.0960672192377664,0,0,18.5185185185185,54.5193845084009,NOS3
delta,1,positive regulation of peptide hormone secretion (GO:0090277),1/40,1,40,0.0526522259283912,0.0960672192377664,0,0,18.5185185185185,54.5193845084009,TFR2
delta,1,regulation of release of cytochrome c from mitochondria (GO:0090199),1/41,1,41,0.0539337053893905,0.0967087131120106,0,0,18.06684733514,52.7551881590979,MLLT11
delta,1,neuron migration (GO:0001764),1/41,1,41,0.0539337053893905,0.0967087131120106,0,0,18.06684733514,52.7551881590979,NDNF
delta,1,regulation of ion transmembrane transporter activity (GO:0032412),1/43,1,43,0.0564916585091406,0.100429615127361,0,0,17.2265288544358,49.5032263348065,FXYD5
delta,1,substantia nigra development (GO:0021762),1/44,1,44,0.0577681363361376,0.100972876957283,0,0,16.8350168350168,48.0019853497092,S100A1
delta,1,mitotic metaphase plate congression (GO:0007080),1/44,1,44,0.0577681363361376,0.100972876957283,0,0,16.8350168350168,48.0019853497092,CDT1
delta,1,positive regulation of transport (GO:0051050),1/45,1,45,0.059042951121717,0.102341115277643,0,0,16.4609053497942,46.5759689681515,TFR2
delta,1,protein complex subunit organization (GO:0071822),1/46,1,46,0.0603161049564981,0.1028340150078,0,0,16.1030595813205,45.2199054809938,CDT1
delta,1,positive regulation of blood vessel endothelial cell migration (GO:0043536),1/46,1,46,0.0603161049564981,0.1028340150078,0,0,16.1030595813205,45.2199054809938,NOS3
delta,1,peptide cross-linking (GO:0018149),1/48,1,48,0.0628574380669869,0.105438283209139,0,0,15.4320987654321,42.6988580959248,NDNF
delta,1,fatty acid biosynthetic process (GO:0006633),1/48,1,48,0.0628574380669869,0.105438283209139,0,0,15.4320987654321,42.6988580959248,ACSF3
delta,1,negative regulation of mitotic cell cycle (GO:0045930),1/49,1,49,0.0641256214892022,0.10583712022496,0,0,15.1171579743008,41.5254918170636,CDT1
delta,1,pattern recognition receptor signaling pathway (GO:0002221),1/49,1,49,0.0641256214892022,0.10583712022496,0,0,15.1171579743008,41.5254918170636,S100A1
delta,1,organic hydroxy compound biosynthetic process (GO:1901617),1/50,1,50,0.0653921522588676,0.10583712022496,0,0,14.8148148148148,40.4052299816425,CYP27A1
delta,1,double-strand break repair via nonhomologous end joining (GO:0006303),1/51,1,51,0.066657032449374,0.10583712022496,0,0,14.5243282498184,39.3347091474894,POLK
delta,1,myeloid leukocyte differentiation (GO:0002573),1/51,1,51,0.066657032449374,0.10583712022496,0,0,14.5243282498184,39.3347091474894,DHRS2
delta,1,blood circulation (GO:0008015),1/51,1,51,0.066657032449374,0.10583712022496,0,0,14.5243282498184,39.3347091474894,NOS3
delta,1,regulation of blood vessel endothelial cell migration (GO:0043535),1/51,1,51,0.066657032449374,0.10583712022496,0,0,14.5243282498184,39.3347091474894,NOS3
delta,1,regulation of DNA binding (GO:0051101),1/53,1,53,0.0691818493313732,0.108194170382899,0,0,13.9762403913347,37.3307720987078,CDT1
delta,1,positive regulation of cell-substrate adhesion (GO:0010811),1/53,1,53,0.0691818493313732,0.108194170382899,0,0,13.9762403913347,37.3307720987078,NDNF
delta,1,sensory perception (GO:0007600),1/55,1,55,0.0717000886591323,0.111295660008205,0,0,13.4680134680135,35.4917615467783,USH2A
delta,1,chromosome organization (GO:0051276),1/57,1,57,0.0742117668943127,0.112671879664358,0,0,12.9954515919428,33.7989936049452,CDT1
delta,1,DNA-dependent DNA replication (GO:0006261),1/57,1,57,0.0742117668943127,0.112671879664358,0,0,12.9954515919428,33.7989936049452,POLK
delta,1,cellular iron ion homeostasis (GO:0006879),1/57,1,57,0.0742117668943127,0.112671879664358,0,0,12.9954515919428,33.7989936049452,TFR2
delta,1,phospholipid transport (GO:0015914),1/59,1,59,0.076716900477825,0.115631270285417,0,0,12.5549278091651,32.2364500900003,ATP11C
delta,1,membrane lipid biosynthetic process (GO:0046467),1/61,1,61,0.0792155057834974,0.118538310812715,0,0,12.1432908318154,30.7903244593748,COL4A3BP
delta,1,negative regulation of neuron apoptotic process (GO:0043524),1/64,1,64,0.0829512090283501,0.120773689483761,0,0,11.5740740740741,28.8136885076959,NDNF
delta,1,iron ion homeostasis (GO:0055072),1/64,1,64,0.0829512090283501,0.120773689483761,0,0,11.5740740740741,28.8136885076959,TFR2
delta,1,positive regulation of cell projection organization (GO:0031346),1/64,1,64,0.0829512090283501,0.120773689483761,0,0,11.5740740740741,28.8136885076959,NDNF
delta,1,cellular response to decreased oxygen levels (GO:0036294),1/65,1,65,0.0841931969958913,0.120773689483761,0,0,11.3960113960114,28.2010388236043,NDNF
delta,1,positive regulation of endocytosis (GO:0045807),1/65,1,65,0.0841931969958913,0.120773689483761,0,0,11.3960113960114,28.2010388236043,TFR2
delta,1,positive regulation of cell adhesion (GO:0045785),1/65,1,65,0.0841931969958913,0.120773689483761,0,0,11.3960113960114,28.2010388236043,NDNF
delta,1,sphingolipid biosynthetic process (GO:0030148),1/67,1,67,0.0866723154837574,0.122638378371575,0,0,11.0558319513543,27.0383721404093,COL4A3BP
delta,1,positive regulation of cellular protein localization (GO:1903829),1/67,1,67,0.0866723154837574,0.122638378371575,0,0,11.0558319513543,27.0383721404093,CDT1
delta,1,epidermal cell differentiation (GO:0009913),1/68,1,68,0.0879094500534163,0.122719232289333,0,0,10.8932461873638,26.4863613391022,USH2A
delta,1,extrinsic apoptotic signaling pathway (GO:0097191),1/68,1,68,0.0879094500534163,0.122719232289333,0,0,10.8932461873638,26.4863613391022,MLLT11
delta,1,cholesterol metabolic process (GO:0008203),1/69,1,69,0.0891449708907093,0.123614359635117,0,0,10.7353730542136,25.9526714764803,NR0B2
delta,1,positive regulation of neurogenesis (GO:0050769),1/70,1,70,0.0903788799946025,0.123676362097877,0,0,10.5820105820106,25.436451505372,ADRA2B
delta,1,regulation of endocytosis (GO:0030100),1/70,1,70,0.0903788799946025,0.123676362097877,0,0,10.5820105820106,25.436451505372,TFR2
delta,1,positive regulation of endothelial cell migration (GO:0010595),1/71,1,71,0.0916111794054684,0.12454330272116,0,0,10.4329681794471,24.9369010833367,NOS3
delta,1,recombinational repair (GO:0000725),1/72,1,72,0.0928418711410692,0.125396812969756,0,0,10.2880658436214,24.4532669064629,POLK
delta,1,response to metal ion (GO:0010038),1/73,1,73,0.0940709572022729,0.125427942936364,0,0,10.1471334348047,23.9848393467741,TFR2
delta,1,lipid biosynthetic process (GO:0008610),1/73,1,73,0.0940709572022729,0.125427942936364,0,0,10.1471334348047,23.9848393467741,ACSF3
delta,1,regulation of peptide hormone secretion (GO:0090276),1/74,1,74,0.0952984396193822,0.125456173676149,0,0,10.01001001001,23.5309493674658,TFR2
delta,1,regulation of protein complex assembly (GO:0043254),1/74,1,74,0.0952984396193822,0.125456173676149,0,0,10.01001001001,23.5309493674658,CDT1
delta,1,nitrogen compound transport (GO:0071705),1/75,1,75,0.0965243203976376,0.126270809073639,0,0,9.87654320987654,23.0909657041396,COL4A3BP
delta,1,double-strand break repair via homologous recombination (GO:0000724),1/77,1,77,0.0989712850798696,0.127074242571684,0,0,9.62000962000962,22.2503657587146,POLK
delta,1,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1/77,1,77,0.0989712850798696,0.127074242571684,0,0,9.62000962000962,22.2503657587146,NOS3
delta,1,positive regulation of apoptotic signaling pathway (GO:2001235),1/77,1,77,0.0989712850798696,0.127074242571684,0,0,9.62000962000962,22.2503657587146,MLLT11
delta,1,adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189),1/79,1,79,0.1014118672916,0.127840414525168,0,0,9.3764650726676,21.4586512915061,ADRA2B
delta,1,sensory perception of mechanical stimulus (GO:0050954),1/79,1,79,0.1014118672916,0.127840414525168,0,0,9.3764650726676,21.4586512915061,USH2A
delta,1,visual perception (GO:0007601),1/79,1,79,0.1014118672916,0.127840414525168,0,0,9.3764650726676,21.4586512915061,EYS
delta,1,steroid biosynthetic process (GO:0006694),1/80,1,80,0.102629769964322,0.128544989178545,0,0,9.25925925925926,21.0798817845813,CYP27A1
delta,1,sensory perception of sound (GO:0007605),1/82,1,82,0.105060808463234,0.128544989178545,0,0,9.03342366757001,20.354254455586,USH2A
delta,1,positive regulation of binding (GO:0051099),1/82,1,82,0.105060808463234,0.128544989178545,0,0,9.03342366757001,20.354254455586,CDT1
delta,1,sensory perception of light stimulus (GO:0050953),1/82,1,82,0.105060808463234,0.128544989178545,0,0,9.03342366757001,20.354254455586,USH2A
delta,1,negative regulation of cell cycle process (GO:0010948),1/82,1,82,0.105060808463234,0.128544989178545,0,0,9.03342366757001,20.354254455586,CDT1
delta,1,negative regulation of neuron death (GO:1901215),1/84,1,84,0.107485504421298,0.130742601869182,0,0,8.81834215167548,19.6684240132193,NDNF
delta,1,regulation of neuron differentiation (GO:0045664),1/85,1,85,0.108695478928664,0.131445695448617,0,0,8.71459694989107,19.3394778031595,ADRA2B
delta,1,toll-like receptor signaling pathway (GO:0002224),1/87,1,87,0.111110690914868,0.132821975346509,0,0,8.51426138782461,18.7077765781997,S100A1
delta,1,calcium ion transmembrane transport (GO:0070588),1/87,1,87,0.111110690914868,0.132821975346509,0,0,8.51426138782461,18.7077765781997,TRPV3
delta,1,positive regulation of cellular component biogenesis (GO:0044089),1/88,1,88,0.112315932362021,0.13349550817886,0,0,8.41750841750842,18.4043733508922,CDT1
delta,1,positive regulation of protein complex assembly (GO:0031334),1/89,1,89,0.11351960008436,0.134159527372425,0,0,8.32292967124428,18.1088619975165,CDT1
delta,1,regulation of neuron apoptotic process (GO:0043523),1/90,1,90,0.114721696046825,0.134814196484404,0,0,8.23045267489712,17.8209557037899,NDNF
delta,1,cell cycle G1/S phase transition (GO:0044843),1/93,1,93,0.118318573152666,0.138259905706487,0,0,7.96495420151334,17.0001952996884,CDT1
delta,1,cellular transition metal ion homeostasis (GO:0046916),1/94,1,94,0.119514401824505,0.138877070276519,0,0,7.88022064617809,16.7400976951327,TFR2
delta,1,regulation of heart contraction (GO:0008016),1/96,1,96,0.121901375379384,0.14086381154951,0,0,7.71604938271605,16.2387574051606,S100A1
delta,1,positive regulation of protein metabolic process (GO:0051247),1/97,1,97,0.123092524200374,0.141454392451259,0,0,7.63650248186331,15.997090317839,TFR2
delta,1,positive regulation of neuron projection development (GO:0010976),1/98,1,98,0.12428211698541,0.142036705126183,0,0,7.55857898715042,15.7611576765174,NDNF
delta,1,response to molecule of bacterial origin (GO:0002237),1/99,1,99,0.125470155714752,0.142610887369773,0,0,7.48222970445193,15.5307695604911,NOS3
delta,1,small GTPase mediated signal transduction (GO:0007264),1/100,1,100,0.126656642302827,0.143177073907543,0,0,7.40740740740741,15.3057441316745,ARHGEF38
delta,1,cellular response to metal ion (GO:0071248),1/101,1,101,0.12784157869394,0.14373539658562,0,0,7.33406674000733,15.0859072098114,TFR2
delta,1,intrinsic apoptotic signaling pathway (GO:0097193),1/102,1,102,0.129024966890665,0.144285984479883,0,0,7.26216412490922,14.8710918776991,MLLT11
delta,1,positive regulation of vasculature development (GO:1904018),1/105,1,105,0.132565861512571,0.147452936869597,0,0,7.05467372134039,14.2552076827784,NOS3
delta,1,G1/S transition of mitotic cell cycle (GO:0000082),1/106,1,106,0.133743076206254,0.147971063036707,0,0,6.98812019566736,14.0589424264722,CDT1
delta,1,fatty acid metabolic process (GO:0006631),1/107,1,107,0.134918752379403,0.148482013200613,0,0,6.92281066112842,13.8669609965058,ACSF3
delta,1,monocarboxylic acid metabolic process (GO:0032787),1/109,1,109,0.137265496864257,0.150269596567187,0,0,6.79578661230037,13.4953333007715,ACSF3
delta,1,regulation of organelle organization (GO:0033043),1/114,1,114,0.143105568947329,0.155842713827458,0,0,6.49772579597141,12.6327009532401,CDT1
delta,1,cellular response to oxidative stress (GO:0034599),1/116,1,116,0.145430922474545,0.157550166014091,0,0,6.38569604086846,12.311967207725,DHRS2
delta,1,sphingolipid metabolic process (GO:0006665),1/117,1,117,0.146591319333685,0.157984427053919,0,0,6.33111744222855,12.1564210481743,COL4A3BP
delta,1,calcium ion transport (GO:0006816),1/119,1,119,0.148907562786229,0.15965346937905,0,0,6.22471210706505,11.8545256740709,TRPV3
delta,1,regulation of neuron projection development (GO:0010975),1/120,1,120,0.150063413213018,0.160067640760552,0,0,6.17283950617284,11.7080081448645,NDNF
delta,1,DNA replication (GO:0006260),1/121,1,121,0.151217751943812,0.160475981654658,0,0,6.12182430364249,11.5643367927308,POLK
delta,1,negative regulation of macromolecule metabolic process (GO:0010605),1/125,1,125,0.155820028222617,0.164065839757701,0,0,5.92592592592593,11.0166139434444,NR0B2
delta,1,"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",1/126,1,126,0.156966837075877,0.164065839757701,0,0,5.87889476778366,10.886071280199,ADRA2B
delta,1,negative regulation of multicellular organismal process (GO:0051241),1/126,1,126,0.156966837075877,0.164065839757701,0,0,5.87889476778366,10.886071280199,TRPV3
delta,1,positive regulation of mitochondrion organization (GO:0010822),1/129,1,129,0.160398269428878,0.166814200206033,0,0,5.74217628481194,10.508730248089,MLLT11
delta,1,generation of neurons (GO:0048699),1/131,1,131,0.162678414630487,0.168343832055429,0,0,5.65450947130336,10.2684757891765,NDNF
delta,1,cellular response to hypoxia (GO:0071456),1/133,1,133,0.164952596297777,0.169852178366028,0,0,5.56947925368978,10.0367426428499,NDNF
delta,1,adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),1/135,1,135,0.167220829400654,0.171339569041064,0,0,5.48696844993141,9.81311390033246,ADRA2B
delta,1,neuron differentiation (GO:0030182),1/140,1,140,0.172865485401769,0.174830518240222,0,0,5.29100529100529,9.28699221140956,USH2A
delta,1,inorganic cation transmembrane transport (GO:0098662),1/141,1,141,0.173989986902528,0.174830518240222,0,0,5.2534804307854,9.18706345133001,TRPV3
delta,1,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),1/141,1,141,0.173989986902528,0.174830518240222,0,0,5.2534804307854,9.18706345133001,NR0B2
delta,1,response to lipid (GO:0033993),1/141,1,141,0.173989986902528,0.174830518240222,0,0,5.2534804307854,9.18706345133001,NOS3
delta,1,double-strand break repair (GO:0006302),1/142,1,142,0.175113016193367,0.175113016193367,0,0,5.21648408972353,9.08880389505929,POLK
delta,2,peptidyl-lysine modification (GO:0018205),14/116,14,116,0.00354393957613536,0.329586380580589,0,0,2.26010590210513,12.7526843833317,LIPT2;TOP2A;NUP205;NUP107;PLOD2;AAAS;METTL21A;HDAC9;SIRT2;SENP1;BLOC1S1;INCENP;MDM2;TP53BP1
delta,2,response to endoplasmic reticulum stress (GO:0034976),16/107,16,107,0.000173219235903837,0.329586380580589,0,0,2.80023802023172,24.2527284992892,PDIA3;WFS1;ATG10;DNAJB12;ITPR1;PDIA5;HERPUD1;BAG6;ERLEC1;ERP44;DNAJC10;CASP4;TRIB3;CHAC1;UBXN6;NCK1
delta,2,termination of RNA polymerase II transcription (GO:0006369),10/69,10,69,0.0034880334685014,0.329586380580589,0,0,2.71399880584053,15.356937463101,NUDT21;NCBP1;PABPN1;POLDIP3;SARNP;EIF4A3;SRSF5;THOC5;SRSF11;WDR33
delta,2,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",6/26,6,26,0.00209332938851551,0.329586380580589,0,0,4.32152117545376,26.6594618480511,DDX5;MDM2;ATM;PTTG1IP;MIF;ATR
delta,2,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),7/35,7,35,0.00219004897405582,0.329586380580589,0,0,3.74531835205993,22.9356980255476,PKIB;RTEL1;TNKS;ATM;HNRNPA1;CCT5;ATR
delta,2,cell cycle G2/M phase transition (GO:0044839),15/128,15,128,0.00344686976549578,0.329586380580589,0,0,2.19452247191011,12.4435761370846,DYNC1I2;CDKN1A;PPP1R12A;CEP152;DCTN3;HAUS3;CKAP5;DNM2;NEDD1;CCNB1;CNTRL;CEP250;PHLDA1;CLASP1;CEP78
delta,2,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),5/18,5,18,0.00205575577091988,0.329586380580589,0,0,5.20183104452767,32.1843098569924,DLX1;SMAD4;SMAD3;SMURF2;TRIM33
delta,2,IRE1-mediated unfolded protein response (GO:0036498),9/58,9,58,0.00342915087175267,0.329586380580589,0,0,2.90585044556374,16.4919874303795,ACADVL;EXTL2;WFS1;LMNA;SRPRB;HDGF;SEC62;TLN1;PDIA5
delta,2,regulation of fatty acid oxidation (GO:0046320),4/13,4,13,0.00392110718345151,0.343212205233873,0,0,5.76202823393835,31.9295950463944,ACADVL;PRKAG2;LONP2;PPARGC1B
delta,2,G2/M transition of mitotic cell cycle (GO:0000086),15/127,15,127,0.00319656931288477,0.329586380580589,0,0,2.21180217641334,12.7083011899479,DYNC1I2;CDKN1A;PPP1R12A;CEP152;DCTN3;HAUS3;CKAP5;DNM2;NEDD1;CCNB1;CNTRL;CEP250;PHLDA1;CLASP1;CEP78
delta,2,ciliary basal body-plasma membrane docking (GO:0097711),13/97,13,97,0.00192338760333109,0.329586380580589,0,0,2.50974941117418,15.6951377507997,DYNC1I2;CEP152;RAB3IP;DCTN3;SCLT1;HAUS3;RPGRIP1L;CKAP5;NEDD1;CNTRL;CEP250;CLASP1;CEP78
delta,2,"regulation of DNA-templated transcription, elongation (GO:0032784)",5/20,5,20,0.00340343709616941,0.329586380580589,0,0,4.68164794007491,26.6056622066855,SUPT16H;ZNF326;ERCC6;THOC5;ELL3
delta,2,mRNA 3'-end processing (GO:0031124),11/75,11,75,0.00202810297145477,0.329586380580589,0,0,2.74656679151061,17.0305115146802,NUDT21;NCBP1;PABPN1;POLDIP3;SARNP;EIF4A3;LEO1;SRSF5;THOC5;SRSF11;WDR33
delta,2,mRNA transport (GO:0051028),13/105,13,105,0.00389698317447469,0.343212205233873,0,0,2.31853040841805,12.862169326291,NUP205;NUP107;NXT1;NCBP1;POLDIP3;EIF4A3;THOC5;AAAS;WDR33;KIF5C;SARNP;SRSF5;SRSF11
delta,2,positive regulation of microtubule polymerization (GO:0031116),6/25,6,25,0.00168547945712984,0.329586380580589,0,0,4.49438202247191,28.6997987027513,MECP2;CLIP1;PSRC1;MET;CLASP1;HSPA1A
delta,2,"retrograde transport, endosome to Golgi (GO:0042147)",11/83,11,83,0.00454199471965081,0.36182734541685,0,0,2.48183746220838,13.3879967006132,SPAG9;TMEM87A;ARFRP1;SNX1;TBC1D5;STX16;GBF1;VPS54;VPS35;YKT6;RAB9B
delta,2,regulation of lipid metabolic process (GO:0019216),13/101,13,101,0.0027692063283724,0.329586380580589,0,0,2.41035339489005,14.1950400138311,RB1;SLC27A1;ACSL1;CHD9;PRKAG2;HMGCR;GRHL1;LACTB;OPA3;ME1;TRIB3;TNFRSF21;PPARD
delta,2,nucleocytoplasmic transport (GO:0006913),8/47,8,47,0.00315918550317984,0.329586380580589,0,0,3.18750498047653,18.3518719794897,NUP205;NXT1;NCBP1;RSRC1;SNRPD1;AAAS;HNRNPA1;MALT1
delta,2,protein localization to nucleus (GO:0034504),12/97,12,97,0.00547117961819834,0.36182734541685,0,0,2.31669176416078,12.0659354418543,PDIA3;CTDNEP1;IPO11;NUP107;NXT1;ARL2BP;PINX1;LMNA;MDM2;PTTG1IP;GPN1;KPNB1
delta,2,regulation of transforming growth factor beta2 production (GO:0032909),3/6,3,6,0.00268861922300964,0.329586380580589,0,0,9.36329588014981,55.4187969770445,SMAD4;SMAD3;HIF1A
delta,2,progesterone receptor signaling pathway (GO:0050847),3/7,3,7,0.00451871405150316,0.36182734541685,0,0,8.02568218298555,43.3348942816707,NEDD4;UBE3A;PHB
delta,2,regulation of cellular response to heat (GO:1900034),11/79,11,79,0.0030839224174286,0.329586380580589,0,0,2.60750011852273,15.0754000807866,HSPA8;NUP205;NUP107;HSP90AB1;DNAJC7;HSPA1L;ATM;AAAS;IER5;HSPA1A;ATR
delta,2,fatty acid beta-oxidation (GO:0006635),8/51,8,51,0.00530279399332347,0.36182734541685,0,0,2.93750458985092,15.3911182456547,ACADVL;ABCD3;SCP2;ECHDC2;ETFA;HADH;ACAD10;PPARD
delta,2,regulation of cell cycle G2/M phase transition (GO:1902749),11/85,11,85,0.00545216353912392,0.36182734541685,0,0,2.42344128662701,12.6303526027087,DYNC1I2;NEDD1;CDK6;CEP152;CNTRL;DCTN3;CEP250;HAUS3;CKAP5;CLASP1;CEP78
delta,2,pore complex assembly (GO:0046931),4/14,4,14,0.00525983631989287,0.36182734541685,0,0,5.35045478865704,28.0773428068902,NUP205;NUP107;BAD;TMEM170A
delta,2,ATP metabolic process (GO:0046034),9/57,9,57,0.0030379569053448,0.329586380580589,0,0,2.95683027794205,17.1394738619603,ATP5B;HSPA8;BAD;OLA1;PRKAG2;ENPP1;ATP5G2;UQCRH;HSPA1A
delta,2,regulation of response to biotic stimulus (GO:0002831),3/7,3,7,0.00451871405150316,0.36182734541685,0,0,8.02568218298555,43.3348942816707,SCARB2;TRAF3;CD55
delta,2,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",7/40,7,40,0.00481630995123796,0.36182734541685,0,0,3.27715355805243,17.4860629685419,PTBP1;DDX5;MBNL1;RBFOX2;CELF6;MBNL3;HNRNPA1
delta,2,histone deubiquitination (GO:0016578),5/19,5,19,0.00266853854396984,0.329586380580589,0,0,4.92805046323674,29.2047324967287,ENY2;ATXN7;USP3;ATXN7L3;SUPT3H
delta,2,RNA 3'-end processing (GO:0031123),11/62,11,62,0.000395610979506248,0.329586380580589,0,0,3.32245982844026,26.0317359097337,NUDT21;ZCCHC6;NCBP1;PABPN1;POLDIP3;SARNP;EIF4A3;SRSF5;THOC5;SRSF11;WDR33
delta,2,mRNA metabolic process (GO:0016071),14/98,14,98,0.0006926183337493,0.329586380580589,0,0,2.67522739432852,19.4623634441963,DDX5;SF3B2;NCBP1;DIS3;NONO;ELAVL4;HIPK3;WDR33;PTBP1;NUDT21;SRSF5;METTL16;SRSF11;HSPA1A
delta,2,chaperone mediated protein folding requiring cofactor (GO:0051085),6/25,6,25,0.00168547945712984,0.329586380580589,0,0,4.49438202247191,28.6997987027513,HSPA8;HSPA1L;DNAJC7;HSPA6;DNAJB12;HSPA1A
delta,2,regulation of response to interferon-gamma (GO:0060330),4/14,4,14,0.00525983631989287,0.36182734541685,0,0,5.35045478865704,28.0773428068902,HSP90AB1;SOCS1;IFNGR1;CDC37
delta,2,regulation of telomere maintenance via telomerase (GO:0032210),8/52,8,52,0.0059803638754176,0.386903541157452,0,0,2.88101411696917,14.7487002712151,CTC1;PKIB;TNKS;PINX1;ATM;HNRNPA1;CCT5;ATR
delta,2,intrinsic apoptotic signaling pathway (GO:0097193),13/102,13,102,0.00302235165100341,0.329586380580589,0,0,2.38672247925387,13.8470956813246,DDX5;CDKN1A;PPP1R13B;CUL5;BAD;ITPR1;BAG6;DNAJC10;CASP4;CYCS;TRIB3;CHAC1;PDK1
delta,2,regulation of synapse organization (GO:0050807),4/14,4,14,0.00525983631989287,0.36182734541685,0,0,5.35045478865704,28.0773428068902,FXR1;NEDD4;VPS35;CTNNA2
delta,2,DNA replication (GO:0006260),14/121,14,121,0.00518733457780498,0.36182734541685,0,0,2.16671309623301,11.4002374029925,ACHE;MCM7;POLN;RMI1;REV1;DONSON;CDC7;BAZ1A;POLD4;ORC6;REV3L;KAT7;ATM;ATR
delta,2,macroautophagy (GO:0016236),13/111,13,111,0.00625797566968245,0.396249693467552,0,0,2.19320444039545,11.1280967677271,GABARAPL1;PRKAA1;TOMM40;LIX1L;ATG10;PRKAG2;ATG12;HGS;ATG16L1;TBC1D5;RB1CC1;PLAA;UBXN6
delta,2,positive regulation of mRNA 3'-end processing (GO:0031442),3/8,3,8,0.00694436992406387,0.40522440968655,0,0,7.02247191011236,34.9004496528678,NUDT21;NCBP1;LEO1
delta,2,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),6/25,6,25,0.00168547945712984,0.329586380580589,0,0,4.49438202247191,28.6997987027513,BAG6;CASP4;DNAJC10;ITPR1;TRIB3;CHAC1
delta,2,protein K6-linked ubiquitination (GO:0085020),3/8,3,8,0.00694436992406387,0.40522440968655,0,0,7.02247191011236,34.9004496528678,UBE2D4;UBE2T;RNF6
delta,2,synaptic vesicle transport along microtubule (GO:0099517),4/15,4,15,0.00687296753253884,0.40522440968655,0,0,4.99375780274657,24.869709417068,BLOC1S5;BLOC1S1;BLOC1S2;AP3S1
delta,2,RNA transport (GO:0050658),12/81,12,81,0.00118165212815425,0.329586380580589,0,0,2.77430989041476,18.7011838289288,NXT1;NCBP1;KIF5C;POLDIP3;SARNP;EIF4A3;SRSF5;THOC5;HNRNPA1;CKAP5;SRSF11;TGFBR2
delta,2,positive regulation of telomere maintenance via telomerase (GO:0032212),6/33,6,33,0.00732670723006395,0.411401522956044,0,0,3.40483486550902,16.7389481861922,PKIB;TNKS;ATM;HNRNPA1;CCT5;ATR
delta,2,mRNA export from nucleus (GO:0006406),14/106,14,106,0.00151263399802606,0.329586380580589,0,0,2.47332344003957,16.061521958777,NUP205;ENY2;NUP107;NXT1;NCBP1;POLDIP3;EIF4A3;THOC5;AAAS;WDR33;PABPN1;SARNP;SRSF5;SRSF11
delta,2,anterograde synaptic vesicle transport (GO:0048490),4/15,4,15,0.00687296753253884,0.40522440968655,0,0,4.99375780274657,24.869709417068,BLOC1S5;BLOC1S1;BLOC1S2;AP3S1
delta,2,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),12/101,12,101,0.00753942733521243,0.415506217585041,0,0,2.22494159528312,10.8746446770135,NUP205;NUP107;NXT1;NCBP1;POLDIP3;SARNP;EIF4A3;SRSF5;THOC5;AAAS;SRSF11;WDR33
delta,2,microtubule bundle formation (GO:0001578),6/33,6,33,0.00732670723006395,0.411401522956044,0,0,3.40483486550902,16.7389481861922,LRGUK;CLIP1;PSRC1;NCKAP5L;KIF20A;CLASP1
delta,2,RNA splicing (GO:0008380),15/107,15,107,0.000555273253675433,0.329586380580589,0,0,2.62522314396724,19.6788045164787,MBNL1;SF3B2;NCBP1;NONO;EIF4A3;USB1;ZCRB1;PPP2CA;PTBP1;SNRPD1;RSRC1;NOVA1;TARDBP;SMNDC1;SRSF11
delta,2,"regulation of mRNA splicing, via spliceosome (GO:0048024)",10/61,10,61,0.00135824915587633,0.329586380580589,0,0,3.06993307545895,20.2663436913235,PTBP1;MBNL1;DDX5;RBFOX2;NCBP1;CELF6;METTL16;MBNL3;HNRNPA1;PRDX6
delta,2,protein targeting to lysosome (GO:0006622),6/19,6,19,0.000339970668793537,0.329586380580589,0,0,5.91366055588409,47.230344247958,SCARB2;AP4M1;HSPA8;HGS;NEDD4;SORL1
delta,2,response to unfolded protein (GO:0006986),7/44,7,44,0.00823188124135147,0.437465688826107,0,0,2.9792305073204,14.2995339415758,HSPA8;ERP44;HSP90AB1;HSPA1L;HSPA6;HERPUD1;HSPA1A
delta,2,positive regulation of mRNA processing (GO:0050685),5/16,5,16,0.0011457981408208,0.329586380580589,0,0,5.85205992509363,39.6281239384054,NUDT21;NCBP1;LEO1;PRDX6;HSPA1A
delta,2,ERAD pathway (GO:0036503),10/78,10,78,0.00839816131526481,0.438472422354878,0,0,2.40084509747431,11.4754213198236,BAG6;ERLEC1;WFS1;JKAMP;FAF2;DNAJC10;DNAJB12;UBXN4;UBXN6;HERPUD1
delta,2,fatty acid catabolic process (GO:0009062),9/66,9,66,0.00816173297785504,0.437465688826107,0,0,2.55362614913177,12.2785974408001,ALDH3A2;ACADVL;ABCD3;ABHD3;ECHDC2;HADH;AIG1;ACAD10;PPARD
delta,2,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),4/16,4,16,0.00878202959496881,0.450608966803917,0,0,4.68164794007491,22.16782648357,MECP2;CCNB1;CDK4;CDC7
delta,2,intracellular steroid hormone receptor signaling pathway (GO:0030518),9/67,9,67,0.00899375416346426,0.453651057465587,0,0,2.5155123260104,11.8511443679358,RB1;DDX5;RBFOX2;RNF14;NEDD4;CTNNB1;UBE3A;PHB;PPARGC1B
delta,2,regulation of G2/M transition of mitotic cell cycle (GO:0010389),18/150,18,150,0.00109193340297531,0.329586380580589,0,0,2.24719101123595,15.3254053703495,DYNC1I2;PSMD14;CEP152;PINX1;DCTN3;HAUS3;CDC7;CKAP5;MECP2;NEDD1;CCNB1;CDK6;CDK4;PSMB3;CNTRL;CEP250;CLASP1;CEP78
delta,2,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",5/25,5,25,0.00934948970348201,0.456132481271516,0,0,3.74531835205993,17.4997509900323,SUPT16H;LEO1;ERCC6;THOC5;ELL3
delta,2,microtubule cytoskeleton organization involved in mitosis (GO:1902850),7/45,7,45,0.00931002635371647,0.456132481271516,0,0,2.9130253849355,13.6232390757619,MECP2;SETD2;CCNB1;TNKS;TBCE;CLASP1;KPNB1
delta,2,regulation of cellular protein localization (GO:1903827),5/26,5,26,0.0110771509335754,0.457855571921117,0,0,3.60126764621147,16.2160428071414,SETD2;RALB;GBF1;CTNNB1;RAB11FIP5
delta,2,regulation of telomere maintenance via telomere lengthening (GO:1904356),4/17,4,17,0.0110065466563043,0.457855571921117,0,0,4.40625688477638,19.8689800953625,RTEL1;TNKS;PINX1;ATM
delta,2,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),3/9,3,9,0.0100062915377564,0.457855571921117,0,0,6.24219725343321,28.7424546195176,HGS;NEDD4;FAM129B
delta,2,positive regulation of cell cycle G2/M phase transition (GO:1902751),4/17,4,17,0.0110065466563043,0.457855571921117,0,0,4.40625688477638,19.8689800953625,MECP2;CCNB1;CDK4;CDC7
delta,2,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),3/9,3,9,0.0100062915377564,0.457855571921117,0,0,6.24219725343321,28.7424546195176,PPP2CA;SOCS1;PIBF1
delta,2,RNA export from nucleus (GO:0006405),13/120,13,120,0.011790904618913,0.46170700191954,0,0,2.02871410736579,9.00835657249225,NUP205;NUP107;NXT1;NCBP1;POLDIP3;EIF4A3;THOC5;AAAS;WDR33;SARNP;SRSF5;HNRNPA1;SRSF11
delta,2,mitotic G2 DNA damage checkpoint (GO:0007095),4/17,4,17,0.0110065466563043,0.457855571921117,0,0,4.40625688477638,19.8689800953625,TAOK1;DONSON;ATM;CDK5RAP3
delta,2,regulation of phosphorylation (GO:0042325),13/120,13,120,0.011790904618913,0.46170700191954,0,0,2.02871410736579,9.00835657249225,NUP205;CDKN1A;NUP107;MCM7;FZD7;PRKAG2;MIF;AAAS;BTBD10;SIRT2;PPP2CA;SOCS1;KCTD20
delta,2,regulation of transforming growth factor beta production (GO:0071634),3/10,3,10,0.0137333253086874,0.464436092257428,0,0,5.61797752808989,24.0894937955832,SMAD4;SMAD3;HIF1A
delta,2,'de novo' posttranslational protein folding (GO:0051084),7/31,7,31,0.00103161335932787,0.329586380580589,0,0,4.22858523619669,29.0784217334509,CHCHD4;HSPA8;HSPA1L;DNAJC7;HSPA6;DNAJB12;HSPA1A
delta,2,regulation of fibroblast proliferation (GO:0048145),7/47,7,47,0.0117704236000438,0.46170700191954,0,0,2.78906685791697,12.3894962068072,CDKN1A;MED25;CDK6;CDK4;FTH1;CTNNB1;MIF
delta,2,nuclear export (GO:0051168),11/93,11,93,0.0106107694489821,0.457855571921117,0,0,2.21497321896017,10.0690153208949,NXT1;XPO4;NCBP1;POLDIP3;SARNP;EIF4A3;SRSF5;THOC5;HNRNPA1;MALT1;SRSF11
delta,2,positive regulation of blood vessel endothelial cell migration (GO:0043536),7/46,7,46,0.0104878967236427,0.457855571921117,0,0,2.84969874613255,12.9875971574932,ATP5B;SP1;CIB1;PLCG1;ETS1;HDAC9;HIF1A
delta,2,positive regulation of signal transduction by p53 class mediator (GO:1901798),4/17,4,17,0.0110065466563043,0.457855571921117,0,0,4.40625688477638,19.8689800953625,DDX5;ATM;CDK5RAP3;ATR
delta,2,negative regulation of inclusion body assembly (GO:0090084),3/10,3,10,0.0137333253086874,0.464436092257428,0,0,5.61797752808989,24.0894937955832,SACS;SORL1;HSPA1A
delta,2,"DNA-templated transcription, termination (GO:0006353)",12/107,12,107,0.0117373676921549,0.46170700191954,0,0,2.10017851517379,9.33524668013265,NUDT21;NCBP1;PABPN1;POLDIP3;SARNP;EIF4A3;POLR1C;POLR1E;SRSF5;THOC5;SRSF11;WDR33
delta,2,positive regulation of vacuole organization (GO:0044090),3/10,3,10,0.0137333253086874,0.464436092257428,0,0,5.61797752808989,24.0894937955832,RALB;ANXA2;PIP4K2B
delta,2,negative regulation of MAPK cascade (GO:0043409),10/81,10,81,0.0108694990865598,0.457855571921117,0,0,2.31192490867897,10.454049708938,DUSP4;UCHL1;SMAD4;SMPD1;RANBP9;PTPRJ;PHB;SORL1;CDK5RAP3;IGF1R
delta,2,negative regulation of telomere maintenance (GO:0032205),4/17,4,17,0.0110065466563043,0.457855571921117,0,0,4.40625688477638,19.8689800953625,RTEL1;TNKS;PINX1;ATM
delta,2,regulation of mRNA 3'-end processing (GO:0031440),3/10,3,10,0.0137333253086874,0.464436092257428,0,0,5.61797752808989,24.0894937955832,NUDT21;NCBP1;LEO1
delta,2,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),3/10,3,10,0.0137333253086874,0.464436092257428,0,0,5.61797752808989,24.0894937955832,SIRT2;HSPA1A;NCK1
delta,2,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),9/71,9,71,0.0129759708677106,0.464436092257428,0,0,2.37379332172812,10.3133154613904,RNF144A;ABTB1;CUL5;BTBD1;SMURF2;RNF14;NEDD4;UBE3A;RNF7
delta,2,IRES-dependent viral translational initiation (GO:0075522),3/10,3,10,0.0137333253086874,0.464436092257428,0,0,5.61797752808989,24.0894937955832,PTBP1;DENR;EIF3F
delta,2,regulation of muscle cell differentiation (GO:0051147),6/37,6,37,0.0128389493216309,0.464436092257428,0,0,3.03674460977832,13.2258482010382,SPAG9;PTBP1;CDH2;CTNNB1;CTNNA2;HDAC9
delta,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),9/71,9,71,0.0129759708677106,0.464436092257428,0,0,2.37379332172812,10.3133154613904,RNF144A;DET1;RNF14;MDM2;TRIB3;SIRT2;HERPUD1;HSPA1A;NFE2L2
delta,2,cellular response to topologically incorrect protein (GO:0035967),5/28,5,28,0.0151588108946275,0.490354578504471,0,0,3.34403424291065,14.0087390946833,HSPA8;HSPA1L;HSPA6;DNAJB12;HSPA1A
delta,2,modulation by virus of host morphology or physiology (GO:0019048),4/18,4,18,0.0135639216981185,0.464436092257428,0,0,4.16146483562214,17.8957212963278,RRAGA;SMAD3;KPNA2;KPNB1
delta,2,nuclear pore complex assembly (GO:0051292),3/10,3,10,0.0137333253086874,0.464436092257428,0,0,5.61797752808989,24.0894937955832,NUP205;NUP107;TMEM170A
delta,2,regulation of protein localization to cell surface (GO:2000008),5/28,5,28,0.0151588108946275,0.490354578504471,0,0,3.34403424291065,14.0087390946833,HSP90AB1;GBF1;CTNNB1;STX3;RAB11FIP5
delta,2,axonal transport (GO:0098930),6/37,6,37,0.0128389493216309,0.464436092257428,0,0,3.03674460977832,13.2258482010382,FXR1;BLOC1S5;BLOC1S1;BLOC1S2;AP3S1;HIF1A
delta,2,protein localization to chromosome (GO:0034502),5/28,5,28,0.0151588108946275,0.490354578504471,0,0,3.34403424291065,14.0087390946833,RB1;TNKS;PINX1;CTCF;ATR
delta,2,protein targeting to vacuole (GO:0006623),5/28,5,28,0.0151588108946275,0.490354578504471,0,0,3.34403424291065,14.0087390946833,SCARB2;AP4M1;HGS;NEDD4;SORL1
delta,2,DNA damage checkpoint (GO:0000077),6/39,6,39,0.0164691894773742,0.525067964089075,0,0,2.88101411696917,11.8302044023722,TAOK1;H2AFX;DONSON;TP53BP1;STK3;ATR
delta,2,DNA biosynthetic process (GO:0071897),6/40,6,40,0.0185255834104008,0.525067964089075,0,0,2.80898876404494,11.2039399302158,POLD3;POLD4;RMI1;WRNIP1;ATM;TYMS
delta,2,negative regulation of MAP kinase activity (GO:0043407),8/62,8,62,0.0168648840889191,0.525067964089075,0,0,2.41633442068382,9.8647376667144,DUSP4;PPP2CA;UCHL1;SMPD1;PTPRJ;SORL1;CDK5RAP3;HIPK3
delta,2,mitotic DNA damage checkpoint (GO:0044773),6/40,6,40,0.0185255834104008,0.525067964089075,0,0,2.80898876404494,11.2039399302158,MSH2;EME2;RFWD3;TAOK1;DONSON;CDK5RAP3
delta,2,establishment of synaptic vesicle localization (GO:0097480),3/11,3,11,0.0181439165829849,0.525067964089075,0,0,5.10725229826353,20.4771192489581,KIF5C;SPG11;DNM2
delta,2,purine ribonucleoside monophosphate metabolic process (GO:0009167),6/40,6,40,0.0185255834104008,0.525067964089075,0,0,2.80898876404494,11.2039399302158,HSPA8;BAD;OLA1;ENPP1;PFAS;HSPA1A
delta,2,rhodopsin mediated signaling pathway (GO:0016056),3/11,3,11,0.0181439165829849,0.525067964089075,0,0,5.10725229826353,20.4771192489581,GNB1;CNGA1;RNF7
delta,2,negative regulation of protein catabolic process (GO:0042177),6/40,6,40,0.0185255834104008,0.525067964089075,0,0,2.80898876404494,11.2039399302158,SNX3;PHB;FMN2;TIMP1;CDK5RAP3;SIRT2
delta,2,positive regulation of chromosome segregation (GO:0051984),3/11,3,11,0.0181439165829849,0.525067964089075,0,0,5.10725229826353,20.4771192489581,CCNB1;SMC6;SIRT2
delta,2,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),5/30,5,30,0.020138428343534,0.544836025003248,0,0,3.1210986267166,12.1882816207992,CNOT4;ZCCHC6;CNOT6L;CNOT2;EIF4A3
delta,2,organelle disassembly (GO:1903008),4/20,4,20,0.0197358519392781,0.543832364548996,0,0,3.74531835205993,14.7015670481144,RB1CC1;GBF1;DENR;KLC1
delta,2,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),4/21,4,21,0.0233741327036045,0.552074753380372,0,0,3.56696985910469,13.397985760959,CREB3;SMAD4;HIF1A;NFE2L2
delta,2,regulation of primary metabolic process (GO:0080090),14/140,14,140,0.0176733534424342,0.525067964089075,0,0,1.87265917602996,7.55748544750634,SLC27A1;PSMD14;ACSL1;CHD9;CACYBP;HMGCR;GRHL1;LACTB;PSMB3;OPA3;ME1;TRIB3;TNFRSF21;PPARD
delta,2,negative regulation of response to DNA damage stimulus (GO:2001021),5/29,5,29,0.0175320271422711,0.525067964089075,0,0,3.22872271729304,13.0560698316892,RTEL1;MDM2;PTTG1IP;MIF;THOC5
delta,2,negative regulation of fatty acid biosynthetic process (GO:0045717),3/11,3,11,0.0181439165829849,0.525067964089075,0,0,5.10725229826353,20.4771192489581,ACADVL;TRIB3;PIBF1
delta,2,regulation of proteolysis (GO:0030162),8/64,8,64,0.0201245325660131,0.544836025003248,0,0,2.34082397003745,9.14282697209916,CYFIP2;BAG6;ABTB1;BTBD1;TRAF3;BAD;PERP;CLN8
delta,2,regulation of cholesterol biosynthetic process (GO:0045540),6/41,6,41,0.0207507048575443,0.552074753380372,0,0,2.74047684297068,10.6198275249221,PRKAA1;NFYA;SP1;FASN;HMGCR;KPNB1
delta,2,negative regulation of cell cycle arrest (GO:0071157),4/21,4,21,0.0233741327036045,0.552074753380372,0,0,3.56696985910469,13.397985760959,HSP90AB1;CDK4;MDM2;MIF
delta,2,phosphatidylethanolamine metabolic process (GO:0046337),4/20,4,20,0.0197358519392781,0.543832364548996,0,0,3.74531835205993,14.7015670481144,SLC27A1;PCYT2;PNPLA8;ETNK1
delta,2,negative regulation of cell growth (GO:0030308),12/116,12,116,0.0211366579742843,0.552074753380372,0,0,1.93723363037582,7.4714188322065,PPP2CA;SMAD4;CDKN1A;SMAD3;PSRC1;ENPP1;PTPRJ;RNF6;PHB;SMARCA2;DCBLD2;HSPA1A
delta,2,vesicle docking (GO:0048278),4/21,4,21,0.0233741327036045,0.552074753380372,0,0,3.56696985910469,13.397985760959,STX12;STX16;USO1;STX3
delta,2,fatty acid oxidation (GO:0019395),7/51,7,51,0.0180425513872598,0.525067964089075,0,0,2.57031651611956,10.3198782456826,ALDH3A2;ACADVL;ABCD3;ECHDC2;HADH;ACAD10;PPARD
delta,2,mitochondrial outer membrane permeabilization (GO:0097345),3/12,3,12,0.0232474289265268,0.552074753380372,0,0,4.68164794007491,17.610303075229,BNIP3L;BAD;BLOC1S2
delta,2,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),4/20,4,20,0.0197358519392781,0.543832364548996,0,0,3.74531835205993,14.7015670481144,CREB3;HERPUD1;HSPA1A;NCK1
delta,2,regulation of sister chromatid cohesion (GO:0007063),3/12,3,12,0.0232474289265268,0.552074753380372,0,0,4.68164794007491,17.610303075229,RB1;CTNNB1;CTCF
delta,2,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",3/12,3,12,0.0232474289265268,0.552074753380372,0,0,4.68164794007491,17.610303075229,MDM2;MIF;PTTG1IP
delta,2,cellular response to decreased oxygen levels (GO:0036294),8/65,8,65,0.0219119022887687,0.552074753380372,0,0,2.30481129357534,8.80605083558153,BNIP3L;BAD;SUV39H1;LMNA;MDM2;FMN2;HIF1A;SIRT2
delta,2,protein hydroxylation (GO:0018126),3/12,3,12,0.0232474289265268,0.552074753380372,0,0,4.68164794007491,17.610303075229,EGLN3;OGFOD1;PLOD2
delta,2,regulation of protein catabolic process (GO:0042176),10/92,10,92,0.0247919412557025,0.564960278828232,0,0,2.03549910438039,7.52572184494691,SNX3;FZR1;SMURF2;HGS;NEDD4;MDM2;FMN2;PHB;SORL1;SIRT2
delta,2,activation of cysteine-type endopeptidase activity (GO:0097202),3/12,3,12,0.0232474289265268,0.552074753380372,0,0,4.68164794007491,17.610303075229,CYFIP2;BAD;PERP
delta,2,positive regulation of cellular protein metabolic process (GO:0032270),10/92,10,92,0.0247919412557025,0.564960278828232,0,0,2.03549910438039,7.52572184494691,CYFIP2;RPS4X;FXR1;POLDIP3;BAD;PERP;EIF4A3;ATG10;VPS35;PTTG1IP
delta,2,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),5/31,5,31,0.022985732757455,0.552074753380372,0,0,3.02041802585478,11.3956795047153,PPP1R13B;YWHAB;BAD;NMT1;YWHAZ
delta,2,regulation of cholesterol metabolic process (GO:0090181),6/42,6,42,0.0231500310853913,0.552074753380372,0,0,2.67522739432852,10.07426205369,ACADVL;NFYA;SP1;FASN;HMGCR;KPNB1
delta,2,viral translation (GO:0019081),3/13,3,13,0.0290453369155643,0.564960278828232,0,0,4.32152117545376,15.2934197399589,PTBP1;DENR;EIF3F
delta,2,cytosolic transport (GO:0016482),12/119,12,119,0.0252586440582428,0.564960278828232,0,0,1.88839580776131,6.94662797262782,AP4M1;SPAG9;TMEM87A;ARFRP1;SNX1;TBC1D5;STX16;GBF1;VPS54;VPS35;YKT6;RAB9B
delta,2,G2 DNA damage checkpoint (GO:0031572),5/33,5,33,0.0294297939283259,0.565052043423858,0,0,2.83736238792419,10.003823966794,FZR1;TAOK1;DONSON;CDK5RAP3;STK3
delta,2,nucleotide-sugar metabolic process (GO:0009225),3/13,3,13,0.0290453369155643,0.564960278828232,0,0,4.32152117545376,15.2934197399589,EXTL2;SLC35A3;UGP2
delta,2,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),5/31,5,31,0.022985732757455,0.552074753380372,0,0,3.02041802585478,11.3956795047153,PPP1R13B;YWHAB;BAD;NMT1;YWHAZ
delta,2,purine ribonucleoside triphosphate metabolic process (GO:0009205),5/33,5,33,0.0294297939283259,0.565052043423858,0,0,2.83736238792419,10.003823966794,HSPA8;BAD;OLA1;ENPP1;HSPA1A
delta,2,positive regulation of ERAD pathway (GO:1904294),3/13,3,13,0.0290453369155643,0.564960278828232,0,0,4.32152117545376,15.2934197399589,BAG6;HERPUD1;NFE2L2
delta,2,protein localization to lysosome (GO:0061462),5/31,5,31,0.022985732757455,0.552074753380372,0,0,3.02041802585478,11.3956795047153,SCARB2;AP4M1;HGS;NEDD4;SORL1
delta,2,anterograde axonal transport (GO:0008089),5/32,5,32,0.0260808372925459,0.564960278828232,0,0,2.92602996254682,10.6699275446615,FXR1;BLOC1S5;BLOC1S1;BLOC1S2;AP3S1
delta,2,synaptic vesicle localization (GO:0097479),3/13,3,13,0.0290453369155643,0.564960278828232,0,0,4.32152117545376,15.2934197399589,KIF5C;SPG11;DNM2
delta,2,protein import into nucleus (GO:0006606),11/104,11,104,0.0229668314429816,0.552074753380372,0,0,1.98069720541631,7.4745653928585,PDIA3;IPO11;NUP107;NXT1;CTNNB1;PTTG1IP;KPNA2;GDF5;GPN1;KPNB1;IPO5
delta,2,positive regulation of ubiquitin-protein transferase activity (GO:0051443),5/32,5,32,0.0260808372925459,0.564960278828232,0,0,2.92602996254682,10.6699275446615,ARRDC4;FZR1;DCUN1D5;TRIB3;UBE2L3
delta,2,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),4/22,4,22,0.0273927420062002,0.564960278828232,0,0,3.40483486550902,12.2488157676623,HSP90AB1;SOCS1;IFNGR1;CDC37
delta,2,response to UV-B (GO:0010224),3/13,3,13,0.0290453369155643,0.564960278828232,0,0,4.32152117545376,15.2934197399589,MFAP4;CDKN1A;MSH2
delta,2,regulation of epithelial to mesenchymal transition (GO:0010717),8/69,8,69,0.030182772234942,0.573721074932537,0,0,2.17119904467242,7.60024745843728,FOXA1;PPP2CA;SMAD4;SMAD3;CTNNB1;CLASP1;ELL3;TGFBR2
delta,2,positive regulation of cellular metabolic process (GO:0031325),10/93,10,93,0.0265005180095784,0.564960278828232,0,0,2.01361201723652,7.31060166455187,LIPT2;CDKN1A;ANXA2;PAX8;TBC1D5;FASN;RIPK1;HIF1A;SCYL2;TGFBR2
delta,2,G1/S transition of mitotic cell cycle (GO:0000082),11/106,11,106,0.026030025985332,0.564960278828232,0,0,1.94332556003109,7.09023217062646,RB1;NPAT;USP37;CDKN1A;ORC6;CDK6;CUL5;MCM7;CDK4;CDC7;TYMS
delta,2,cellular response to unfolded protein (GO:0034620),4/22,4,22,0.0273927420062002,0.564960278828232,0,0,3.40483486550902,12.2488157676623,HSPA8;HSPA1L;HSPA6;HSPA1A
delta,2,poly(A)+ mRNA export from nucleus (GO:0016973),3/13,3,13,0.0290453369155643,0.564960278828232,0,0,4.32152117545376,15.2934197399589,ENY2;PABPN1;POLDIP3
delta,2,negative regulation of cell death (GO:0060548),9/82,9,82,0.0305177326110165,0.573721074932537,0,0,2.05535763222801,7.17206227849836,DUS2;BNIP3L;WFS1;CTNNB1;VPS35;BTBD10;SORL1;NCK1;HSPA1A
delta,2,positive regulation of DNA biosynthetic process (GO:2000573),7/56,7,56,0.0287824221235694,0.564960278828232,0,0,2.34082397003745,8.30522102319037,PKIB;HSP90AB1;TNKS;ATM;HNRNPA1;CCT5;ATR
delta,2,metaphase plate congression (GO:0051310),6/45,6,45,0.031442291899489,0.573721074932537,0,0,2.49687890137328,8.6382057840489,CCNB1;PSRC1;PINX1;PIBF1;GEM;KPNB1
delta,2,cellular response to interleukin-6 (GO:0071354),4/23,4,23,0.0317980513303826,0.573721074932537,0,0,3.25679856700863,11.2305822178551,SMAD4;PHB;IL6ST;IL6R
delta,2,regulation of DNA biosynthetic process (GO:2000278),4/22,4,22,0.0273927420062002,0.564960278828232,0,0,3.40483486550902,12.2488157676623,TNKS;PINX1;ATM;FAM129B
delta,2,serine family amino acid biosynthetic process (GO:0009070),3/13,3,13,0.0290453369155643,0.564960278828232,0,0,4.32152117545376,15.2934197399589,MTHFD1;PSAT1;SEPHS1
delta,2,negative regulation of protein serine/threonine kinase activity (GO:0071901),8/68,8,68,0.0279411095469843,0.564960278828232,0,0,2.20312844238819,7.88203616251849,PKIB;UCHL1;SMPD1;PRKAR2A;PTPRJ;SORL1;CDK5RAP3;IPO5
delta,2,regulation of RNA splicing (GO:0043484),7/56,7,56,0.0287824221235694,0.564960278828232,0,0,2.34082397003745,8.30522102319037,PTBP1;MBNL1;ESRP2;FASTK;ZNF326;METTL16;MBNL3
delta,2,regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),2/6,2,6,0.0370142628988733,0.573721074932537,0,0,6.24219725343321,20.5771033512132,MDM2;PTTG1IP
delta,2,mitotic nuclear envelope disassembly (GO:0007077),6/45,6,45,0.031442291899489,0.573721074932537,0,0,2.49687890137328,8.6382057840489,CTDNEP1;NUP205;CCNB1;NUP107;LMNA;AAAS
delta,2,RNA catabolic process (GO:0006401),6/44,6,44,0.028491319933259,0.564960278828232,0,0,2.55362614913177,9.0861996982681,ISG20;DIS3;XRN2;METTL16;SKIV2L2;HSPA1A
delta,2,regulation of telomere capping (GO:1904353),4/23,4,23,0.0317980513303826,0.573721074932537,0,0,3.25679856700863,11.2305822178551,PKIB;RTEL1;TNKS;ATM
delta,2,"DNA-templated transcription, elongation (GO:0006354)",11/109,11,109,0.0311632032086149,0.573721074932537,0,0,1.88983953544308,6.55494105586998,SUPT16H;SETD2;GTF2A2;NCBP1;POLR1C;LEO1;TAF4B;POLR1E;SSRP1;GTF2E2;ELL3
delta,2,negative regulation of response to endoplasmic reticulum stress (GO:1903573),4/22,4,22,0.0273927420062002,0.564960278828232,0,0,3.40483486550902,12.2488157676623,CREB3;HERPUD1;HSPA1A;NCK1
delta,2,COPI coating of Golgi vesicle (GO:0048205),2/6,2,6,0.0370142628988733,0.573721074932537,0,0,6.24219725343321,20.5771033512132,GBF1;ARFGAP2
delta,2,regulation of cellular catabolic process (GO:0031329),7/56,7,56,0.0287824221235694,0.564960278828232,0,0,2.34082397003745,8.30522102319037,RRAGA;DRAM1;ITPR1;LONP2;KAT8;PIP4K2B;ATM
delta,2,branching morphogenesis of an epithelial tube (GO:0048754),6/44,6,44,0.028491319933259,0.564960278828232,0,0,2.55362614913177,9.0861996982681,PAX8;CTNNBIP1;CTNNB1;NRARP;MET;TGFBR2
delta,2,nuclear import (GO:0051170),8/72,8,72,0.0376398885183348,0.580395379432975,0,0,2.08073241781107,6.82415923024638,PDIA3;IPO11;NXT1;NUP107;SNRPD1;PTTG1IP;HNRNPA1;KPNB1
delta,2,positive regulation of hormone metabolic process (GO:0032352),2/6,2,6,0.0370142628988733,0.573721074932537,0,0,6.24219725343321,20.5771033512132,PAX8;HIF1A
delta,2,nuclear transport (GO:0051169),4/22,4,22,0.0273927420062002,0.564960278828232,0,0,3.40483486550902,12.2488157676623,NUP205;NXT1;RSRC1;AAAS
delta,2,nuclear envelope disassembly (GO:0051081),6/47,6,47,0.0379242437592993,0.581765718699354,0,0,2.3906287353574,7.82253094519133,CTDNEP1;NUP205;CCNB1;NUP107;LMNA;AAAS
delta,2,nucleic acid metabolic process (GO:0090304),9/81,9,81,0.0284638841143509,0.564960278828232,0,0,2.08073241781107,7.40557473860336,PTBP1;RBFOX2;HNRNPK;NCBP1;IGFBP4;XRN2;ENPP1;KPNA2;HNRNPA1
delta,2,regulation of microtubule nucleation (GO:0010968),2/6,2,6,0.0370142628988733,0.573721074932537,0,0,6.24219725343321,20.5771033512132,MECP2;HSPA1A
delta,2,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),4/22,4,22,0.0273927420062002,0.564960278828232,0,0,3.40483486550902,12.2488157676623,HGS;NEDD4;HIF1A;FAM129B
delta,2,peptidyl-proline hydroxylation (GO:0019511),2/6,2,6,0.0370142628988733,0.573721074932537,0,0,6.24219725343321,20.5771033512132,EGLN3;OGFOD1
delta,2,positive regulation of cell cycle (GO:0045787),9/83,9,83,0.0326726149099155,0.573721074932537,0,0,2.03059428726141,6.94710575973365,FOXA1;CCNB1;HSP90AB1;PSRC1;CCPG1;CDK4;MDM2;PKN2;MIF
delta,2,peptidyl-serine autophosphorylation (GO:0036289),2/6,2,6,0.0370142628988733,0.573721074932537,0,0,6.24219725343321,20.5771033512132,ATM;RIPK1
delta,2,histone modification (GO:0016570),10/99,10,99,0.038547344710925,0.587338296554057,0,0,1.89157492528279,6.15871838315573,ENY2;ATXN7;USP3;NSD1;KAT8;PHB;ATXN7L3;HDAC9;SIRT2;SUPT3H
delta,2,insulin secretion involved in cellular response to glucose stimulus (GO:0035773),2/6,2,6,0.0370142628988733,0.573721074932537,0,0,6.24219725343321,20.5771033512132,PTPRN;RAB11FIP5
delta,2,queuosine biosynthetic process (GO:0008616),2/6,2,6,0.0370142628988733,0.573721074932537,0,0,6.24219725343321,20.5771033512132,PDCL3;TXNDC9
delta,2,ribonucleoside biosynthetic process (GO:0042455),2/6,2,6,0.0370142628988733,0.573721074932537,0,0,6.24219725343321,20.5771033512132,PDCL3;TXNDC9
delta,2,type B pancreatic cell development (GO:0003323),2/6,2,6,0.0370142628988733,0.573721074932537,0,0,6.24219725343321,20.5771033512132,CDK6;NKX6-1
delta,2,nucleus localization (GO:0051647),2/6,2,6,0.0370142628988733,0.573721074932537,0,0,6.24219725343321,20.5771033512132,DCTN4;SYNE2
delta,2,transport along microtubule (GO:0010970),3/15,3,15,0.042697147912618,0.587338296554057,0,0,3.74531835205993,11.8113226763815,HSPA8;DYNC1I2;SPG11
delta,2,regulation of protein metabolic process (GO:0051246),7/60,7,60,0.0399875372968252,0.587338296554057,0,0,2.18476903870162,7.03318105086262,ABTB1;BTBD1;TRAF3;HGS;WFS1;MDM2;VPS35
delta,2,"phototransduction, visible light (GO:0007603)",3/15,3,15,0.042697147912618,0.587338296554057,0,0,3.74531835205993,11.8113226763815,GNB1;CNGA1;RNF7
delta,2,COPI-coated vesicle budding (GO:0035964),2/6,2,6,0.0370142628988733,0.573721074932537,0,0,6.24219725343321,20.5771033512132,GBF1;ARFGAP2
delta,2,dicarboxylic acid metabolic process (GO:0043648),7/60,7,60,0.0399875372968252,0.587338296554057,0,0,2.18476903870162,7.03318105086262,FH;MTHFD1;IDH2;ME1;DLST;ALDH1L2;NIT2
delta,2,lysosomal transport (GO:0007041),8/73,8,73,0.0403772929407864,0.587338296554057,0,0,2.05222923400544,6.58660450043364,SCARB2;AP4M1;HGS;NEDD4;VPS54;VPS35;SORL1;SCYL2
delta,2,"protein localization to chromosome, telomeric region (GO:0070198)",3/15,3,15,0.042697147912618,0.587338296554057,0,0,3.74531835205993,11.8113226763815,TNKS;PINX1;ATR
delta,2,myoblast differentiation (GO:0045445),3/16,3,16,0.0505237244347576,0.587338296554057,0,0,3.51123595505618,10.4821357522145,RB1;MBNL1;DDX5
delta,2,positive regulation of proteasomal protein catabolic process (GO:1901800),8/74,8,74,0.0432439708154647,0.587338296554057,0,0,2.02449640651888,6.35873561784069,RNF144A;BAG6;DET1;RNF14;MDM2;TRIB3;SIRT2;HSPA1A
delta,2,platelet dense granule organization (GO:0060155),2/6,2,6,0.0370142628988733,0.573721074932537,0,0,6.24219725343321,20.5771033512132,BLOC1S1;BLOC1S2
delta,2,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),5/36,5,36,0.0410473318650243,0.587338296554057,0,0,2.60091552226384,8.30479983976814,RTEL1;FANCM;EME2;RFWD3;DONSON
delta,2,neurotransmitter biosynthetic process (GO:0042136),3/14,3,14,0.0355323029570626,0.573721074932537,0,0,4.01284109149278,13.3921069574437,ACHE;PAH;DAGLB
delta,2,endoplasmic reticulum to cytosol transport (GO:1903513),3/16,3,16,0.0505237244347576,0.587338296554057,0,0,3.51123595505618,10.4821357522145,ERLEC1;FAF2;HERPUD1
delta,2,embryonic cranial skeleton morphogenesis (GO:0048701),3/15,3,15,0.042697147912618,0.587338296554057,0,0,3.74531835205993,11.8113226763815,MTHFD1;EIF4A3;TGFBR2
delta,2,queuosine metabolic process (GO:0046116),2/6,2,6,0.0370142628988733,0.573721074932537,0,0,6.24219725343321,20.5771033512132,PDCL3;TXNDC9
delta,2,anatomical structure homeostasis (GO:0060249),5/36,5,36,0.0410473318650243,0.587338296554057,0,0,2.60091552226384,8.30479983976814,DCLRE1B;POLD3;CTC1;POLD4;RTEL1
delta,2,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),5/38,5,38,0.0501335681249256,0.587338296554057,0,0,2.46402523161837,7.37498638084601,PPP1R13B;YWHAB;BAD;NMT1;YWHAZ
delta,2,negative regulation of DNA recombination (GO:0045910),3/16,3,16,0.0505237244347576,0.587338296554057,0,0,3.51123595505618,10.4821357522145,RTEL1;MSH2;TP53BP1
delta,2,positive regulation of microtubule polymerization or depolymerization (GO:0031112),4/25,4,25,0.0417838321086903,0.587338296554057,0,0,2.99625468164794,9.51384511140896,CLIP1;PSRC1;MET;CLASP1
delta,2,postreplication repair (GO:0006301),6/48,6,48,0.0414616452976611,0.587338296554057,0,0,2.34082397003745,7.45081106925445,POLD3;POLD4;POLN;MSH2;REV1;WDR33
delta,2,negative regulation of signal transduction by p53 class mediator (GO:1901797),3/15,3,15,0.042697147912618,0.587338296554057,0,0,3.74531835205993,11.8113226763815,MDM2;MIF;PTTG1IP
delta,2,gliogenesis (GO:0042063),3/14,3,14,0.0355323029570626,0.573721074932537,0,0,4.01284109149278,13.3921069574437,CDK6;CDH2;NFIB
delta,2,myelination (GO:0042552),5/38,5,38,0.0501335681249256,0.587338296554057,0,0,2.46402523161837,7.37498638084601,ARHGEF10;SCN8A;SBF2;SIRT2;TNFRSF21
delta,2,regulation of microtubule polymerization (GO:0031113),5/36,5,36,0.0410473318650243,0.587338296554057,0,0,2.60091552226384,8.30479983976814,CLIP1;PSRC1;MAP2;MET;CLASP1
delta,2,Golgi transport vesicle coating (GO:0048200),2/6,2,6,0.0370142628988733,0.573721074932537,0,0,6.24219725343321,20.5771033512132,GBF1;ARFGAP2
delta,2,peptidyl-threonine dephosphorylation (GO:0035970),3/16,3,16,0.0505237244347576,0.587338296554057,0,0,3.51123595505618,10.4821357522145,DUSP4;PPP2CA;PPM1D
delta,2,negative regulation of cytoskeleton organization (GO:0051494),4/25,4,25,0.0417838321086903,0.587338296554057,0,0,2.99625468164794,9.51384511140896,SMAD4;TWF2;PFN1;CLASP1
delta,2,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",7/63,7,63,0.0500356543327403,0.587338296554057,0,0,2.08073241781107,6.23183404291442,CNOT4;CDKN1A;CCNB1;CNOT6L;CNOT2;MDM2;ATM
delta,2,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),3/15,3,15,0.042697147912618,0.587338296554057,0,0,3.74531835205993,11.8113226763815,ACADVL;ETFA;ACAD10
delta,2,interleukin-6-mediated signaling pathway (GO:0070102),3/14,3,14,0.0355323029570626,0.573721074932537,0,0,4.01284109149278,13.3921069574437,SMAD4;IL6ST;IL6R
delta,2,ribosomal protein import into nucleus (GO:0006610),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,KPNB1;IPO5
delta,2,astral microtubule organization (GO:0030953),2/6,2,6,0.0370142628988733,0.573721074932537,0,0,6.24219725343321,20.5771033512132,KPNB1;CLASP1
delta,2,negative regulation of TORC1 signaling (GO:1904262),3/15,3,15,0.042697147912618,0.587338296554057,0,0,3.74531835205993,11.8113226763815,SESN3;ATM;RNF152
delta,2,regulation of low-density lipoprotein particle clearance (GO:0010988),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,HNRNPK;ANXA2
delta,2,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),3/14,3,14,0.0355323029570626,0.573721074932537,0,0,4.01284109149278,13.3921069574437,CREB3;HERPUD1;HSPA1A
delta,2,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),2/6,2,6,0.0370142628988733,0.573721074932537,0,0,6.24219725343321,20.5771033512132,NONO;HIF1A
delta,2,phosphatidylethanolamine biosynthetic process (GO:0006646),3/15,3,15,0.042697147912618,0.587338296554057,0,0,3.74531835205993,11.8113226763815,SLC27A1;PCYT2;ETNK1
delta,2,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),4/27,4,27,0.0533419393743186,0.605899280831955,0,0,2.77430989041476,8.13159218245415,CTC1;TNKS;PINX1;HNRNPA1
delta,2,signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),7/64,7,64,0.0537089530088677,0.6077484568608,0,0,2.04822097378277,5.98935773076544,CNOT4;CDKN1A;CCNB1;CNOT6L;CNOT2;MDM2;ATM
delta,2,positive regulation of protein ubiquitination (GO:0031398),9/84,9,84,0.0349305537292572,0.573721074932537,0,0,2.00642054574639,6.7303237715651,ARRDC4;DCUN1D5;WFS1;UBE3A;TRIB3;PTTG1IP;CDK5RAP3;MALT1;UBE2L3
delta,2,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,SLC25A5;HSPA1A
delta,2,regulation of cellular response to stress (GO:0080135),10/105,10,105,0.0539193080328423,0.607817654188404,0,0,1.78348492955235,5.20825155284329,HSPA8;NUP205;NUP107;HSP90AB1;DNAJC7;HSPA1L;ATM;AAAS;ATR;HSPA1A
delta,2,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",3/14,3,14,0.0355323029570626,0.573721074932537,0,0,4.01284109149278,13.3921069574437,DDX5;ATM;ATR
delta,2,ubiquitin-dependent ERAD pathway (GO:0030433),7/59,7,59,0.0369560625179591,0.573721074932537,0,0,2.22179902240843,7.32754999061174,BAG6;ERLEC1;WFS1;JKAMP;FAF2;DNAJC10;UBXN4
delta,2,regulation of rhodopsin mediated signaling pathway (GO:0022400),4/27,4,27,0.0533419393743186,0.605899280831955,0,0,2.77430989041476,8.13159218245415,FNTA;CNGA1;NMT1;RNF7
delta,2,nuclear pore organization (GO:0006999),3/15,3,15,0.042697147912618,0.587338296554057,0,0,3.74531835205993,11.8113226763815,NUP205;NUP107;TMEM170A
delta,2,chondroitin sulfate proteoglycan metabolic process (GO:0050654),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,CSGALNACT2;XYLT2
delta,2,regulation of alcohol biosynthetic process (GO:1902930),5/35,5,35,0.0369091569549352,0.573721074932537,0,0,2.67522739432852,8.82636597849371,NFYA;SP1;FASN;HMGCR;KPNB1
delta,2,cellular response to hypoxia (GO:0071456),12/133,12,133,0.0524380966371204,0.605899280831955,0,0,1.68961730168117,4.98119779801901,BNIP3L;EGLN3;PSMD14;PSMB3;BAD;SUV39H1;LMNA;MDM2;FMN2;HIGD1A;HIF1A;SIRT2
delta,2,regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),4/27,4,27,0.0533419393743186,0.605899280831955,0,0,2.77430989041476,8.13159218245415,SMAD3;NFIB;HIF1A;PPARD
delta,2,regulation of androgen receptor signaling pathway (GO:0060765),4/24,4,24,0.0365943315680145,0.573721074932537,0,0,3.1210986267166,10.3241633138579,DDX5;RNF14;RNF6;PHB
delta,2,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),3/14,3,14,0.0355323029570626,0.573721074932537,0,0,4.01284109149278,13.3921069574437,MDM2;MIF;PTTG1IP
delta,2,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031658),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,CDK6;CDK4
delta,2,regulation of epithelial cell migration (GO:0010632),6/49,6,49,0.045200191513818,0.587338296554057,0,0,2.29305205228159,7.10078870699738,CAPN7;PLCG1;PFN1;DOCK1;HIF1A;CLASP1
delta,2,response to gamma radiation (GO:0010332),4/27,4,27,0.0533419393743186,0.605899280831955,0,0,2.77430989041476,8.13159218245415,PRKAA1;MDM2;ATM;ATR
delta,2,positive regulation of DNA binding (GO:0043388),5/35,5,35,0.0369091569549352,0.573721074932537,0,0,2.67522739432852,8.82636597849371,RB1;PINX1;CEBPG;SIRT2;FAM129B
delta,2,membrane invagination (GO:0010324),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,SNX3;HGS
delta,2,protein K48-linked ubiquitination (GO:0070936),6/49,6,49,0.045200191513818,0.587338296554057,0,0,2.29305205228159,7.10078870699738,UBE2D4;UBE2T;TTC3;UBE3A;RNF6;RNF152
delta,2,regulation of blood vessel endothelial cell migration (GO:0043535),6/51,6,51,0.053288545612758,0.605899280831955,0,0,2.20312844238819,6.4596472240171,MECP2;ATP5B;SP1;PLCG1;ETS1;HIF1A
delta,2,branching involved in blood vessel morphogenesis (GO:0001569),3/14,3,14,0.0355323029570626,0.573721074932537,0,0,4.01284109149278,13.3921069574437,CTNNB1;NRARP;TGFBR2
delta,2,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,CD55;TGFBR2
delta,2,interstrand cross-link repair (GO:0036297),6/49,6,49,0.045200191513818,0.587338296554057,0,0,2.29305205228159,7.10078870699738,DCLRE1B;POLN;FANCM;UBE2T;RFWD3;ATR
delta,2,regulation of MAP kinase activity (GO:0043405),9/88,9,88,0.0450296833887437,0.587338296554057,0,0,1.91521961184883,5.93801080658515,UCHL1;HGS;SMPD1;PTPRJ;TRIB3;RASGRP1;SORL1;CDK5RAP3;IGF1R
delta,2,ER overload response (GO:0006983),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,WFS1;ATG10
delta,2,"regulation of gene expression, epigenetic (GO:0040029)",8/75,8,75,0.046241722018878,0.587338296554057,0,0,1.99750312109863,6.14007054066167,AEBP2;POLR1C;SMARCA5;POLR1E;CTCF;SLC50A1;ERCC6;PPM1D
delta,2,neuron fate specification (GO:0048665),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,ASCL1;POU3F2
delta,2,mitotic spindle organization (GO:0007052),8/75,8,75,0.046241722018878,0.587338296554057,0,0,1.99750312109863,6.14007054066167,MECP2;ARHGEF10;CCNB1;TNKS;TBCE;PIBF1;KPNB1;CLASP1
delta,2,malate metabolic process (GO:0006108),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,FH;ME1
delta,2,cellular protein complex assembly (GO:0043623),13/145,13,145,0.0467429028628675,0.587338296554057,0,0,1.67893581299238,5.14273627631317,NUP205;SMAD4;NUP107;SMAD3;HSP90AB1;DNAAF2;TOMM20L;TMEM170A;IMMP2L;LONP1;PSMG2;NCK1;HSPA1A
delta,2,positive regulation of epithelial cell migration (GO:0010634),8/75,8,75,0.046241722018878,0.587338296554057,0,0,1.99750312109863,6.14007054066167,BCAS3;CAPN7;PLCG1;PFN1;ETS1;DOCK1;HIF1A;CLASP1
delta,2,Schwann cell development (GO:0014044),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,ARHGEF10;SIRT2
delta,2,DNA ligation (GO:0006266),3/18,3,18,0.0680772672316318,0.613933173579807,0,0,3.1210986267166,8.38674137349757,TOP2A;POLD3;POLD4
delta,2,regulation of skeletal muscle fiber development (GO:0048742),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,HDAC9;FAM129B
delta,2,positive regulation of phosphate metabolic process (GO:0045937),4/29,4,29,0.0664536106560207,0.613933173579807,0,0,2.58297817383443,7.00310256713246,KCTD20;FZD7;MIF;BTBD10
delta,2,desmosome organization (GO:0002934),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,PERP;PKP2
delta,2,regulation of microtubule polymerization or depolymerization (GO:0031110),3/18,3,18,0.0680772672316318,0.613933173579807,0,0,3.1210986267166,8.38674137349757,MAP2;MAP1A;CLASP1
delta,2,positive regulation of fibroblast proliferation (GO:0048146),4/29,4,29,0.0664536106560207,0.613933173579807,0,0,2.58297817383443,7.00310256713246,CDKN1A;CDK6;CDK4;MIF
delta,2,tetrahydrofolate interconversion (GO:0035999),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,MTHFD1;TYMS
delta,2,regulation of protein serine/threonine kinase activity (GO:0071900),8/81,8,81,0.0670588579453811,0.613933173579807,0,0,1.84953992694317,4.99779824927979,PPP2CA;CDKN1A;RALB;HGS;CDC37;CIB1;TRIB3;CDK5RAP3
delta,2,SMAD protein complex assembly (GO:0007183),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,SMAD4;SMAD3
delta,2,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),3/18,3,18,0.0680772672316318,0.613933173579807,0,0,3.1210986267166,8.38674137349757,NONO;HIF1A;NFE2L2
delta,2,regulation of fatty acid biosynthetic process (GO:0042304),4/29,4,29,0.0664536106560207,0.613933173579807,0,0,2.58297817383443,7.00310256713246,ACADVL;LPGAT1;PRKAG2;TRIB3
delta,2,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,CASP7;CYCS
delta,2,positive regulation of alpha-beta T cell differentiation (GO:0046638),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,GLI3;TGFBR2
delta,2,"retrograde protein transport, ER to cytosol (GO:0030970)",3/18,3,18,0.0680772672316318,0.613933173579807,0,0,3.1210986267166,8.38674137349757,ERLEC1;FAF2;HERPUD1
delta,2,protein K11-linked ubiquitination (GO:0070979),4/29,4,29,0.0664536106560207,0.613933173579807,0,0,2.58297817383443,7.00310256713246,FZR1;UBE2D4;UBE2T;UBE2L3
delta,2,negative regulation of catabolic process (GO:0009895),5/41,5,41,0.0658008016342424,0.613933173579807,0,0,2.28373070247556,6.2143127291355,SNX3;PRKAA1;PHB;FMN2;SIRT2
delta,2,amyloid fibril formation (GO:1990000),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,MDM2;RIPK1
delta,2,regulation of chemokine production (GO:0032642),3/18,3,18,0.0680772672316318,0.613933173579807,0,0,3.1210986267166,8.38674137349757,TLR9;HIF1A;IL6R
delta,2,negative regulation of alpha-beta T cell activation (GO:0046636),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,TWSG1;GLI3
delta,2,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),4/29,4,29,0.0664536106560207,0.613933173579807,0,0,2.58297817383443,7.00310256713246,SMAD4;SMAD3;SMURF2;TRIM33
delta,2,positive regulation of mitotic cell cycle phase transition (GO:1901992),5/41,5,41,0.0658008016342424,0.613933173579807,0,0,2.28373070247556,6.2143127291355,RB1;MECP2;CCNB1;CDK4;CDC7
delta,2,positive regulation of cell aging (GO:0090343),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,ARG2;LMNA
delta,2,regulation of coenzyme metabolic process (GO:0051196),5/40,5,40,0.0603068833759249,0.613933173579807,0,0,2.34082397003745,6.57375709174306,NUP205;NUP107;ME1;PRKAG2;AAAS
delta,2,cellular response to gamma radiation (GO:0071480),3/18,3,18,0.0680772672316318,0.613933173579807,0,0,3.1210986267166,8.38674137349757,MDM2;ATM;ATR
delta,2,regulation of mRNA processing (GO:0050684),4/29,4,29,0.0664536106560207,0.613933173579807,0,0,2.58297817383443,7.00310256713246,CDK11A;PTCD2;PABPN1;METTL16
delta,2,purine ribonucleotide metabolic process (GO:0009150),7/67,7,67,0.0657181010443594,0.613933173579807,0,0,1.95650958689698,5.32636429260524,HSPA8;BAD;OLA1;ENPP1;ABHD14B;SULT6B1;HSPA1A
delta,2,positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,CASP4;HSPA1A
delta,2,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),9/89,9,89,0.0478295367255685,0.587338296554057,0,0,1.89370029036738,5.75706080139799,RNF144A;BAG6;DET1;HSP90AB1;RNF14;MDM2;TRIB3;SIRT2;HSPA1A
delta,2,anion transmembrane transport (GO:0098656),3/18,3,18,0.0680772672316318,0.613933173579807,0,0,3.1210986267166,8.38674137349757,SLC35A2;SLC35A3;LRRC8A
delta,2,positive regulation of extracellular matrix assembly (GO:1901203),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,SMAD3;CLASP1
delta,2,regulation of RNA metabolic process (GO:0051252),5/40,5,40,0.0603068833759249,0.613933173579807,0,0,2.34082397003745,6.57375709174306,MBNL1;ESRP2;FASTK;ZNF326;MBNL3
delta,2,positive regulation of transferase activity (GO:0051347),12/138,12,138,0.0656986312594113,0.613933173579807,0,0,1.62839928350432,4.43360558035934,ARRDC4;ALK;PKIB;HSP90AB1;DCUN1D5;PABPN1;TNKS;TRIB3;MET;SORL1;UBE2L3;IGF1R
delta,2,regulation of TORC1 signaling (GO:1903432),4/29,4,29,0.0664536106560207,0.613933173579807,0,0,2.58297817383443,7.00310256713246,RRAGA;SESN3;ATM;RNF152
delta,2,cell cycle G1/S phase transition (GO:0044843),9/93,9,93,0.0601695991846918,0.613933173579807,0,0,1.81225081551287,5.09349048777327,RB1;USP37;CDKN1A;ORC6;CDK6;MCM7;CUL5;CDK4;CDC7
delta,2,peptidyl-lysine deacetylation (GO:0034983),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,HDAC9;SIRT2
delta,2,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),4/28,4,28,0.0597058006002938,0.613933173579807,0,0,2.67522739432852,7.53966319106358,PPP2CA;SOCS1;SH3BP5;PIBF1
delta,2,depyrimidination (GO:0045008),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,NEIL2;UNG
delta,2,mitochondrial transport (GO:0006839),12/136,12,136,0.060155225272559,0.613933173579807,0,0,1.65234633179114,4.64445963257643,CHCHD4;ATP5B;SLC25A26;SLC25A37;TOMM40;BAD;TIMM9;TOMM20L;VPS35;ATP5G2;SLC25A5;SLC25A11
delta,2,regulation of macroautophagy (GO:0016241),11/117,11,117,0.0482879507984532,0.587338296554057,0,0,1.76061973814783,5.33568702078736,BNIP3L;RRAGA;UCHL1;PRKAA1;SESN3;RB1CC1;NEDD4;PRKAG2;VPS35;ATP6V0C;GAPDH
delta,2,nose development (GO:0043584),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,CHD7;GLI3
delta,2,regulation of cilium assembly (GO:1902017),4/28,4,28,0.0597058006002938,0.613933173579807,0,0,2.67522739432852,7.53966319106358,TCTEX1D2;CDK10;FUZ;EVI5L
delta,2,inositol phosphate dephosphorylation (GO:0046855),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,INPP5A;INPP1
delta,2,extrinsic apoptotic signaling pathway (GO:0097191),7/68,7,68,0.0700531685162431,0.629843593668699,0,0,1.92773738708967,5.12489133759947,SMAD3;BAD;BLOC1S2;CIB1;RIPK1;IL6R;DEDD
delta,2,peptidyl-lysine acetylation (GO:0018394),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,BAG6;BLOC1S1
delta,2,telomere maintenance via telomere lengthening (GO:0010833),4/28,4,28,0.0597058006002938,0.613933173579807,0,0,2.67522739432852,7.53966319106358,DCLRE1B;CTC1;HSP90AB1;PINX1
delta,2,lysosomal lumen acidification (GO:0007042),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,CCDC115;ATP6V0C
delta,2,negative regulation of cilium assembly (GO:1902018),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,CDK10;EVI5L
delta,2,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),4/28,4,28,0.0597058006002938,0.613933173579807,0,0,2.67522739432852,7.53966319106358,DDX5;CBFB;RNF14;RNF6
delta,2,regulation of cellular protein catabolic process (GO:1903362),3/17,3,17,0.0589917014296152,0.613933173579807,0,0,3.30469266358229,9.35346496597626,VPS35;PTTG1IP;CDK5RAP3
delta,2,transcription elongation from RNA polymerase II promoter (GO:0006368),9/96,9,96,0.0706492476821775,0.633289641873977,0,0,1.75561797752809,4.65243647897939,SETD2;SUPT16H;GTF2A2;NCBP1;LEO1;TAF4B;SSRP1;GTF2E2;ELL3
delta,2,positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,NFE2L2;HERPUD1
delta,2,negative regulation of cAMP-dependent protein kinase activity (GO:2000480),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,PKIB;PRKAR2A
delta,2,DNA synthesis involved in DNA repair (GO:0000731),7/66,7,66,0.0615493536980301,0.613933173579807,0,0,1.98615367154693,5.53722945406733,POLD3;POLD4;POLN;RMI1;REV1;WRNIP1;ATM
delta,2,protein autoubiquitination (GO:0051865),6/50,6,50,0.0491419547887476,0.587338296554057,0,0,2.24719101123595,6.77088119705509,CNOT4;RNF11;RNF13;UBE2T;MDM2;UBE3A
delta,2,cellular response to glucose stimulus (GO:0071333),4/28,4,28,0.0597058006002938,0.613933173579807,0,0,2.67522739432852,7.53966319106358,UNC13B;PTPRN;IGF1R;RAB11FIP5
delta,2,positive regulation of binding (GO:0051099),8/82,8,82,0.0710092522940436,0.634605209690912,0,0,1.82698456198045,4.83227385846413,MED25;RALB;NCBP1;CEBPG;TRIB3;MET;SIRT2;STK3
delta,2,positive regulation of telomere capping (GO:1904355),3/17,3,17,0.0589917014296152,0.613933173579807,0,0,3.30469266358229,9.35346496597626,PKIB;RTEL1;TNKS
delta,2,phosphorylated carbohydrate dephosphorylation (GO:0046838),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,INPP5A;INPP1
delta,2,positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,BNIP3L;BLOC1S2
delta,2,negative regulation of organelle assembly (GO:1902116),4/28,4,28,0.0597058006002938,0.613933173579807,0,0,2.67522739432852,7.53966319106358,SMAD4;CDK10;EVI5L;MDM1
delta,2,telomere maintenance (GO:0000723),6/52,6,52,0.0576411124767579,0.613933173579807,0,0,2.16076058772688,6.16577184012001,DCLRE1B;POLD3;CTC1;POLD4;RTEL1;SMC6
delta,2,organic hydroxy compound biosynthetic process (GO:1901617),6/50,6,50,0.0491419547887476,0.587338296554057,0,0,2.24719101123595,6.77088119705509,SCP2;PSAT1;OSBPL2;PRKAG2;HMGCR;CYP46A1
delta,2,synaptic vesicle transport (GO:0048489),3/17,3,17,0.0589917014296152,0.613933173579807,0,0,3.30469266358229,9.35346496597626,KIF5C;SPG11;DNM2
delta,2,peripheral nervous system axon ensheathment (GO:0032292),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,ARHGEF10;SIRT2
delta,2,telomere organization (GO:0032200),5/42,5,42,0.071564423736817,0.637651871379543,0,0,2.22935616194043,5.87916266203637,DCLRE1B;POLD3;CTC1;POLD4;RTEL1
delta,2,negative regulation of cardiac muscle cell differentiation (GO:2000726),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,SMAD4;FZD7
delta,2,peptidyl-glutamic acid modification (GO:0018200),4/28,4,28,0.0597058006002938,0.613933173579807,0,0,2.67522739432852,7.53966319106358,AGBL5;VKORC1L1;TTLL5;PROS1
delta,2,chaperone-mediated protein complex assembly (GO:0051131),3/17,3,17,0.0589917014296152,0.613933173579807,0,0,3.30469266358229,9.35346496597626,HSP90AB1;LONP1;HSPA1A
delta,2,negative regulation of supramolecular fiber organization (GO:1902904),6/55,6,55,0.0719392796993932,0.639078496672818,0,0,2.04290091930541,5.37677804552328,HSPA8;SMAD4;TWF2;CIB1;PFN1;CLASP1
delta,2,regulation of cytoplasmic mRNA processing body assembly (GO:0010603),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,CNOT6L;CNOT2
delta,2,pri-miRNA transcription from RNA polymerase II promoter (GO:0061614),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,DDX5;ETS1
delta,2,phospholipid catabolic process (GO:0009395),3/17,3,17,0.0589917014296152,0.613933173579807,0,0,3.30469266358229,9.35346496597626,SMPD1;LIPG;PRDX6
delta,2,regulation of nitrogen compound metabolic process (GO:0051171),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,NOS1AP;CACYBP
delta,2,modulation by symbiont of host cellular process (GO:0044068),2/7,2,7,0.0500125065091053,0.587338296554057,0,0,5.35045478865704,16.0271919456887,KPNA2;KPNB1
delta,2,negative regulation of stress fiber assembly (GO:0051497),3/17,3,17,0.0589917014296152,0.613933173579807,0,0,3.30469266358229,9.35346496597626,PFN1;MET;CLASP1
delta,2,inositol phosphate catabolic process (GO:0071545),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,INPP5A;INPP1
delta,2,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),10/111,10,111,0.0728750923243305,0.64546510344407,0,0,1.68708033876573,4.41847752374751,PPP1R13B;HSPA1L;YWHAB;BAD;NMT1;DPH6;YWHAZ;BAP1;UBE2L3;ZBED3
delta,2,negative regulation of lipid biosynthetic process (GO:0051055),3/17,3,17,0.0589917014296152,0.613933173579807,0,0,3.30469266358229,9.35346496597626,SLC27A1;ACADVL;TRIB3
delta,2,regulation of type B pancreatic cell development (GO:2000074),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,BAD;NKX6-1
delta,2,negative regulation of growth (GO:0045926),11/121,11,121,0.0588719470430773,0.613933173579807,0,0,1.70241743275451,4.82191110467266,PPP2CA;SMAD4;CDKN1A;SMAD3;PSRC1;ENPP1;PTPRJ;PHB;SMARCA2;DCBLD2;HSPA1A
delta,2,mitochondrial translation (GO:0032543),10/108,10,108,0.0629376428108926,0.613933173579807,0,0,1.73394368150922,4.79541344051755,MRPS9;MRPS27;MRPS14;MRPS34;MRPL15;HARS;HARS2;MRPS6;DAP3;C12ORF65
delta,2,histone H4 deacetylation (GO:0070933),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,HDAC9;SIRT2
delta,2,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),8/80,8,80,0.0632470064568726,0.613933173579807,0,0,1.87265917602996,5.16986419707799,CASP7;EGLN3;SMAD3;BAD;CASP4;CYCS;RIPK1;SENP1
delta,2,coenzyme biosynthetic process (GO:0009108),4/30,4,30,0.0735790294009112,0.649766146875703,0,0,2.49687890137328,6.5153438713225,MAT2A;DCAKD;GPHN;PTS
delta,2,lung epithelium development (GO:0060428),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,ERRFI1;ASCL1
delta,2,positive regulation of protein localization to cell surface (GO:2000010),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,HSP90AB1;STX3
delta,2,regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),2/9,2,9,0.0799006733783964,0.651464120477007,0,0,4.16146483562214,10.5159009508147,NFE2L2;HERPUD1
delta,2,bundle of His cell to Purkinje myocyte communication (GO:0086069),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,PKP2;TNNI3K
delta,2,oligosaccharide catabolic process (GO:0009313),2/9,2,9,0.0799006733783964,0.651464120477007,0,0,4.16146483562214,10.5159009508147,NEU3;MAN2C1
delta,2,replication fork processing (GO:0031297),4/31,4,31,0.0810743384527784,0.652100624960725,0,0,2.41633442068382,6.07077150299969,RTEL1;FANCM;EME2;RFWD3
delta,2,protein sumoylation (GO:0016925),7/69,7,69,0.0745546676951453,0.651464120477007,0,0,1.89979916408837,4.93230157870206,TOP2A;NUP205;NUP107;INCENP;TP53BP1;AAAS;SENP1
delta,2,actin filament reorganization (GO:0090527),2/9,2,9,0.0799006733783964,0.651464120477007,0,0,4.16146483562214,10.5159009508147,NEDD9;WHAMM
delta,2,aminoglycan metabolic process (GO:0006022),4/31,4,31,0.0810743384527784,0.652100624960725,0,0,2.41633442068382,6.07077150299969,XYLT2;XYLT1;GPC2;GPC5
delta,2,cellular response to UV-B (GO:0071493),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,MFAP4;CDKN1A
delta,2,positive regulation of cell cycle arrest (GO:0071158),8/83,8,83,0.075098496001123,0.651464120477007,0,0,1.80497269978792,4.67299263937329,CNOT4;CDKN1A;MED25;CCNB1;CNOT6L;CNOT2;MDM2;ATM
delta,2,peptidyl-threonine phosphorylation (GO:0018107),7/69,7,69,0.0745546676951453,0.651464120477007,0,0,1.89979916408837,4.93230157870206,TNKS;CDK10;OXSR1;CAMKK1;HIPK3;PSKH1;TGFBR2
delta,2,Golgi inheritance (GO:0048313),2/9,2,9,0.0799006733783964,0.651464120477007,0,0,4.16146483562214,10.5159009508147,GBF1;YWHAZ
delta,2,activation of JUN kinase activity (GO:0007257),4/31,4,31,0.0810743384527784,0.652100624960725,0,0,2.41633442068382,6.07077150299969,SPAG9;MAP3K2;TAOK1;RIPK1
delta,2,double-strand break repair (GO:0006302),12/142,12,142,0.0777620842104615,0.651464120477007,0,0,1.58252888115208,4.04193909807102,DCLRE1B;GEN1;MSH2;PSMD14;POLN;EME2;TDP1;RFWD3;H2AFX;CIB1;ATM;TP53BP1
delta,2,cardiolipin biosynthetic process (GO:0032049),2/8,2,8,0.0643685736307615,0.613933173579807,0,0,4.68164794007491,12.842367753166,SLC27A1;CRLS1
delta,2,regulation of nephron tubule epithelial cell differentiation (GO:0072182),2/9,2,9,0.0799006733783964,0.651464120477007,0,0,4.16146483562214,10.5159009508147,PAX8;CTNNB1
delta,2,negative regulation of DNA biosynthetic process (GO:2000279),4/31,4,31,0.0810743384527784,0.652100624960725,0,0,2.41633442068382,6.07077150299969,CTC1;PINX1;HNRNPA1;FAM129B
delta,2,modification-dependent protein catabolic process (GO:0019941),12/142,12,142,0.0777620842104615,0.651464120477007,0,0,1.58252888115208,4.04193909807102,FBXW4;BAG6;RNF11;PSMD14;SMURF2;NEDD4;TTC3;LONP1;MDM2;RNF6;FBXO11;UBE2L3
delta,2,autophagosome organization (GO:1905037),6/57,6,57,0.0825018571825705,0.656485366244197,0,0,1.9712201852947,4.91806519730139,STX12;GABARAPL1;ATG16L2;ATG16L1;RB1CC1;ATG12
delta,2,protein localization to organelle (GO:0033365),9/98,9,98,0.0782282104533292,0.651464120477007,0,0,1.71978903921119,4.38223735783004,CTDNEP1;TUB;ARFRP1;MTCH2;LMNA;GBF1;MDM2;CEP250;SORL1
delta,2,beta-catenin-TCF complex assembly (GO:1904837),4/31,4,31,0.0810743384527784,0.652100624960725,0,0,2.41633442068382,6.07077150299969,PYGO1;PYGO2;LEO1;CTNNB1
delta,2,positive regulation of rRNA processing (GO:2000234),2/9,2,9,0.0799006733783964,0.651464120477007,0,0,4.16146483562214,10.5159009508147,UTP15;DIMT1
delta,2,protein exit from endoplasmic reticulum (GO:0032527),3/19,3,19,0.077753758442853,0.651464120477007,0,0,2.95683027794205,7.55236070073961,ERLEC1;FAF2;HERPUD1
delta,2,negative regulation of cellular response to growth factor stimulus (GO:0090288),6/56,6,56,0.0771181060169373,0.651464120477007,0,0,2.00642054574639,5.14128649255704,DLX1;SMURF2;HGS;NEDD4;TRIM33;FAM129B
delta,2,positive regulation of protein localization to nucleus (GO:1900182),5/43,5,43,0.0775954488254988,0.651464120477007,0,0,2.17751066980228,5.56625403420616,PINX1;KAT7;CDK5RAP3;CCT5;IPO5
delta,2,translesion synthesis (GO:0019985),5/43,5,43,0.0775954488254988,0.651464120477007,0,0,2.17751066980228,5.56625403420616,POLD3;POLD4;POLN;REV3L;REV1
delta,2,purine ribonucleoside bisphosphate metabolic process (GO:0034035),3/19,3,19,0.077753758442853,0.651464120477007,0,0,2.95683027794205,7.55236070073961,ABHD14B;ENPP1;SULT6B1
delta,2,osteoclast differentiation (GO:0030316),3/19,3,19,0.077753758442853,0.651464120477007,0,0,2.95683027794205,7.55236070073961,FARP2;ANXA2;GAB2
delta,2,intracellular estrogen receptor signaling pathway (GO:0030520),3/19,3,19,0.077753758442853,0.651464120477007,0,0,2.95683027794205,7.55236070073961,DDX5;RBFOX2;PPARGC1B
delta,2,positive regulation of transcription regulatory region DNA binding (GO:2000679),3/19,3,19,0.077753758442853,0.651464120477007,0,0,2.95683027794205,7.55236070073961,RB1;CTNNB1;FAM129B
delta,2,negative regulation of double-strand break repair (GO:2000780),3/19,3,19,0.077753758442853,0.651464120477007,0,0,2.95683027794205,7.55236070073961,RNF169;TP53BP1;NUDT16L1
delta,2,secretory granule organization (GO:0033363),2/9,2,9,0.0799006733783964,0.651464120477007,0,0,4.16146483562214,10.5159009508147,BLOC1S1;BLOC1S2
delta,2,regulation of amyloid precursor protein biosynthetic process (GO:0042984),2/9,2,9,0.0799006733783964,0.651464120477007,0,0,4.16146483562214,10.5159009508147,NECAB3;SOAT1
delta,2,negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894),2/9,2,9,0.0799006733783964,0.651464120477007,0,0,4.16146483562214,10.5159009508147,NFIB;PPARD
delta,2,nuclear migration (GO:0007097),2/9,2,9,0.0799006733783964,0.651464120477007,0,0,4.16146483562214,10.5159009508147,DCTN4;SYNE2
delta,2,positive regulation of autophagosome assembly (GO:2000786),2/9,2,9,0.0799006733783964,0.651464120477007,0,0,4.16146483562214,10.5159009508147,RALB;PIP4K2B
delta,2,glycine transport (GO:0015816),2/9,2,9,0.0799006733783964,0.651464120477007,0,0,4.16146483562214,10.5159009508147,SLC6A9;SLC6A17
delta,2,positive regulation of ribosome biogenesis (GO:0090070),2/9,2,9,0.0799006733783964,0.651464120477007,0,0,4.16146483562214,10.5159009508147,UTP15;DIMT1
delta,2,DNA-dependent DNA replication (GO:0006261),6/57,6,57,0.0825018571825705,0.656485366244197,0,0,1.9712201852947,4.91806519730139,POLD4;ORC6;POLN;REV3L;CDC7;BAZ1A
delta,2,protein import (GO:0017038),6/57,6,57,0.0825018571825705,0.656485366244197,0,0,1.9712201852947,4.91806519730139,PDIA3;IPO11;NXT1;NUP107;PTTG1IP;KPNB1
delta,2,negative regulation of cellular catabolic process (GO:0031330),6/57,6,57,0.0825018571825705,0.656485366244197,0,0,1.9712201852947,4.91806519730139,RRAGA;WDR6;TIMP1;MET;CDK5RAP3;SIRT2
delta,2,nucleobase-containing compound catabolic process (GO:0034655),5/44,5,44,0.0838908541623628,0.658291210394831,0,0,2.12802179094314,5.27374591471469,ISG20;DIS3;XRN2;NUDT18;SKIV2L2
delta,2,mitotic metaphase plate congression (GO:0007080),5/44,5,44,0.0838908541623628,0.658291210394831,0,0,2.12802179094314,5.27374591471469,CCNB1;PSRC1;PINX1;PIBF1;KPNB1
delta,2,protein transmembrane import into intracellular organelle (GO:0044743),5/44,5,44,0.0838908541623628,0.658291210394831,0,0,2.12802179094314,5.27374591471469,CHCHD4;TOMM40;TIMM9;PEX5;TOMM20L
delta,2,positive regulation of endothelial cell migration (GO:0010595),7/71,7,71,0.0840560013272969,0.658291210394831,0,0,1.84628369467743,4.57190065375198,BCAS3;ATP5B;SP1;PLCG1;ETS1;MET;HIF1A
delta,2,snRNA transcription (GO:0009301),7/71,7,71,0.0840560013272969,0.658291210394831,0,0,1.84628369467743,4.57190065375198,GTF2A2;SNAPC1;NCBP1;SP1;INTS8;GTF2E2;ELL3
delta,2,snRNA transcription from RNA polymerase II promoter (GO:0042795),7/71,7,71,0.0840560013272969,0.658291210394831,0,0,1.84628369467743,4.57190065375198,GTF2A2;SNAPC1;NCBP1;SP1;INTS8;GTF2E2;ELL3
delta,2,glycosaminoglycan biosynthetic process (GO:0006024),9/100,9,100,0.086283512321232,0.671563104920903,0,0,1.68539325842697,4.12941025261379,CHST12;GLCE;ABCC5;CSGALNACT2;XYLT2;XYLT1;GPC2;GPC5;B4GALT6
delta,2,small GTPase mediated signal transduction (GO:0007264),9/100,9,100,0.086283512321232,0.671563104920903,0,0,1.68539325842697,4.12941025261379,RB1;BRAP;CNKSR2;RASSF1;CDKN1A;DNMBP;GNB1;SAMD3;RASGRP3
delta,2,regulation of regulatory T cell differentiation (GO:0045589),3/20,3,20,0.087992221251721,0.671563104920903,0,0,2.80898876404494,6.82726646988145,SOCS1;CBFB;IRF1
delta,2,negative regulation of actin filament bundle assembly (GO:0032232),3/20,3,20,0.087992221251721,0.671563104920903,0,0,2.80898876404494,6.82726646988145,PFN1;MET;CLASP1
delta,2,regulation of cell development (GO:0060284),3/20,3,20,0.087992221251721,0.671563104920903,0,0,2.80898876404494,6.82726646988145,CTNNB1;ASCL1;HDAC9
delta,2,negative regulation of telomere maintenance via telomerase (GO:0032211),3/20,3,20,0.087992221251721,0.671563104920903,0,0,2.80898876404494,6.82726646988145,CTC1;PINX1;HNRNPA1
delta,2,neuromuscular junction development (GO:0007528),3/20,3,20,0.087992221251721,0.671563104920903,0,0,2.80898876404494,6.82726646988145,UNC13B;NEDD4;GPHN
delta,2,regulation of glycolytic process (GO:0006110),6/58,6,58,0.088089016380202,0.671563104920903,0,0,1.93723363037582,4.70632976753318,NUP205;PRKAA1;NUP107;PRKAG2;AAAS;HIF1A
delta,2,regulation of ubiquitin-protein transferase activity (GO:0051438),4/32,4,32,0.0889305584850511,0.671563104920903,0,0,2.34082397003745,5.66455865060395,ARRDC4;DCUN1D5;TRIB3;UBE2L3
delta,2,renal water homeostasis (GO:0003091),4/32,4,32,0.0889305584850511,0.671563104920903,0,0,2.34082397003745,5.66455865060395,WFS1;PRKAR2A;MYO5B;PRKACB
delta,2,regulation of steroid biosynthetic process (GO:0050810),5/45,5,45,0.0904469284917721,0.671563104920903,0,0,2.08073241781107,4.9999834078157,NFYA;SP1;FASN;HMGCR;KPNB1
delta,2,autophagosome assembly (GO:0000045),6/59,6,59,0.0938776557804858,0.671563104920903,0,0,1.90439916206437,4.50535684382715,STX12;GABARAPL1;ATG16L2;ATG16L1;RB1CC1;ATG12
delta,2,lipid biosynthetic process (GO:0008610),7/73,7,73,0.0942174161068465,0.671563104920903,0,0,1.79570057975476,4.24171453770761,PRKAA1;ABCD3;PCYT2;SCP2;ACSL1;HMGCR;CLN8
delta,2,regulation of protein ubiquitination (GO:0031396),9/102,9,102,0.0948146410409987,0.671563104920903,0,0,1.65234633179114,3.89264943867359,HSP90AB1;WFS1;PINX1;UBE3A;PTTG1IP;CDK5RAP3;MALT1;UBE2L3;HSPA1A
delta,2,ganglion development (GO:0061548),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,CTNNB1;ASCL1
delta,2,negative regulation of cellular protein catabolic process (GO:1903363),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,ANXA2;CDK5RAP3
delta,2,negative regulation of oxidative stress-induced neuron death (GO:1903204),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,NONO;HIF1A
delta,2,establishment of spindle localization (GO:0051293),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,KPNB1;CLASP1
delta,2,mitotic nuclear envelope reassembly (GO:0007084),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,PPP2CA;LMNA
delta,2,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,HGS;PTPRJ
delta,2,"base-excision repair, AP site formation (GO:0006285)",2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,NEIL2;UNG
delta,2,peptidyl-lysine dimethylation (GO:0018027),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,SETD2;SUV39H1
delta,2,DNA dealkylation involved in DNA repair (GO:0006307),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,FTO;ASCC3
delta,2,telomere maintenance in response to DNA damage (GO:0043247),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,DCLRE1B;RTEL1
delta,2,primary miRNA processing (GO:0031053),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,SMAD3;NCBP1
delta,2,negative regulation of B cell proliferation (GO:0030889),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,ATM;TNFRSF21
delta,2,sympathetic ganglion development (GO:0061549),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,CTNNB1;ASCL1
delta,2,myeloid dendritic cell differentiation (GO:0043011),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,BATF3;TGFBR2
delta,2,DNA dealkylation (GO:0035510),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,FTO;ASCC3
delta,2,regulation of DNA damage checkpoint (GO:2000001),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,RFWD3;THOC5
delta,2,negative regulation of embryonic development (GO:0045992),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,CTNNB1;FUZ
delta,2,negative regulation of protein autophosphorylation (GO:0031953),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,ERRFI1;ENPP1
delta,2,chaperone-mediated protein transport (GO:0072321),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,HSPA8;TIMM9
delta,2,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,WFS1;NCK1
delta,2,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,NCBP1;PRDX6
delta,2,regulation of lysosomal lumen pH (GO:0035751),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,CCDC115;ATP6V0C
delta,2,peptidyl-serine dephosphorylation (GO:0070262),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,PPP2CA;NCK1
delta,2,amino sugar metabolic process (GO:0006040),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,EXTL2;SLC35A3
delta,2,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,CCNB1;SIRT2
delta,2,phosphatidylglycerol biosynthetic process (GO:0006655),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,SLC27A1;CRLS1
delta,2,aspartate family amino acid metabolic process (GO:0009066),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,MTHFD1;NIT2
delta,2,mesenchymal to epithelial transition (GO:0060231),2/10,2,10,0.0964425271677593,0.671563104920903,0,0,3.74531835205993,8.75958060469129,PAX8;FZD7
delta,2,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),4/33,4,33,0.0971375657924151,0.671563104920903,0,0,2.26988991033935,5.29253683153965,TLR9;RIPK1;MIF;RASGRP1
delta,2,negative regulation of fat cell differentiation (GO:0045599),4/33,4,33,0.0971375657924151,0.671563104920903,0,0,2.26988991033935,5.29253683153965,SMAD3;ENPP1;TRIB3;SIRT2
delta,2,regulation of erythrocyte differentiation (GO:0045646),4/33,4,33,0.0971375657924151,0.671563104920903,0,0,2.26988991033935,5.29253683153965,CDK6;ETS1;HIF1A;HSPA1A
delta,2,positive regulation of telomere maintenance (GO:0032206),4/33,4,33,0.0971375657924151,0.671563104920903,0,0,2.26988991033935,5.29253683153965,PKIB;RTEL1;TNKS;ATM
delta,2,mismatch repair (GO:0006298),4/33,4,33,0.0971375657924151,0.671563104920903,0,0,2.26988991033935,5.29253683153965,POLD3;POLD4;SETD2;MSH2
delta,2,aminoglycan catabolic process (GO:0006026),4/33,4,33,0.0971375657924151,0.671563104920903,0,0,2.26988991033935,5.29253683153965,GLB1;GPC2;GPC5;CTBS
delta,2,oxoacid metabolic process (GO:0043436),4/33,4,33,0.0971375657924151,0.671563104920903,0,0,2.26988991033935,5.29253683153965,ENPP1;ABHD14B;MIF;SULT6B1
delta,2,nucleus organization (GO:0006997),5/46,5,46,0.0972593071978862,0.671563104920903,0,0,2.03549910438039,4.74347540552963,CTDNEP1;NUP205;ATXN7;PITPNB;TMEM170A
delta,2,hexose metabolic process (GO:0019318),5/46,5,46,0.0972593071978862,0.671563104920903,0,0,2.03549910438039,4.74347540552963,SLC35A2;FPGT;MAN2C1;GDPGP1;PPARD
delta,2,mRNA transcription (GO:0009299),3/21,3,21,0.0987619107792415,0.67257539240051,0,0,2.67522739432852,6.1932671669031,DDX5;HIF1A;HIPK3
delta,2,positive regulation of histone acetylation (GO:0035066),3/21,3,21,0.0987619107792415,0.67257539240051,0,0,2.67522739432852,6.1932671669031,TADA2B;SMAD4;KAT7
delta,2,negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744),3/21,3,21,0.0987619107792415,0.67257539240051,0,0,2.67522739432852,6.1932671669031,YWHAB;RPGRIP1L;MET
delta,2,negative regulation of protein tyrosine kinase activity (GO:0061099),3/21,3,21,0.0987619107792415,0.67257539240051,0,0,2.67522739432852,6.1932671669031,ERRFI1;ZGPAT;SH3BP5
delta,2,non-motile cilium assembly (GO:1905515),3/21,3,21,0.0987619107792415,0.67257539240051,0,0,2.67522739432852,6.1932671669031,CEP250;FUZ;PIBF1
delta,2,limb morphogenesis (GO:0035108),3/21,3,21,0.0987619107792415,0.67257539240051,0,0,2.67522739432852,6.1932671669031,FBXW4;MBNL1;GLI3
delta,2,regulation of peptide hormone secretion (GO:0090276),7/74,7,74,0.0995430024232416,0.67545358728323,0,0,1.77143435570402,4.0869923072101,PAX8;ARL2BP;CHD7;ITPR1;ITPR2;SLC25A5;SLC8B1
delta,2,renal system development (GO:0072001),6/60,6,60,0.0998654497327357,0.67545358728323,0,0,1.87265917602996,4.31447846754342,PYGO1;BAG6;PYGO2;PAX8;WFS1;NPHP3
delta,2,sterol metabolic process (GO:0016125),6/60,6,60,0.0998654497327357,0.67545358728323,0,0,1.87265917602996,4.31447846754342,SOAT1;PRKAG2;HMGCR;CYP46A1;CLN8;PPARD
delta,2,aminoglycan biosynthetic process (GO:0006023),5/47,5,47,0.104323008933545,0.699988605716439,0,0,1.99219061279783,4.50287540424549,B3GNT9;XYLT2;XYLT1;GPC2;GPC5
delta,2,regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),7/75,7,75,0.105029901312325,0.699988605716439,0,0,1.7478152309613,3.93871944188124,FNTA;YWHAB;CNGA1;NMT1;RPGRIP1L;RNF7;PHB
delta,2,regulation of DNA recombination (GO:0000018),4/34,4,34,0.105684207090251,0.699988605716439,0,0,2.20312844238819,4.95109012965307,RTEL1;SETD2;MSH2;KPNA2
delta,2,negative regulation of cellular protein metabolic process (GO:0032269),8/90,8,90,0.107596485520164,0.699988605716439,0,0,1.66458593424886,3.71097344026615,FXR1;BAG6;CNOT2;EIF4A3;TYMS;CLN8;GAPDH;CDK5RAP3
delta,2,peptidyl-threonine modification (GO:0018210),8/90,8,90,0.107596485520164,0.699988605716439,0,0,1.66458593424886,3.71097344026615,TNKS;CDK10;OXSR1;GALNT10;CAMKK1;HIPK3;PSKH1;TGFBR2
delta,2,mitochondrial translational termination (GO:0070126),8/90,8,90,0.107596485520164,0.699988605716439,0,0,1.66458593424886,3.71097344026615,MRPS9;MRPS27;MRPS14;MRPS34;MRPL15;MRPS6;DAP3;C12ORF65
delta,2,negative regulation of cell cycle G1/S phase transition (GO:1902807),3/22,3,22,0.110030734346631,0.699988605716439,0,0,2.55362614913177,5.63584154510808,RB1;CDKN1A;ZNF655
delta,2,negative regulation of myeloid cell differentiation (GO:0045638),3/22,3,22,0.110030734346631,0.699988605716439,0,0,2.55362614913177,5.63584154510808,CDK6;LEO1;CIB1
delta,2,positive regulation of erythrocyte differentiation (GO:0045648),3/22,3,22,0.110030734346631,0.699988605716439,0,0,2.55362614913177,5.63584154510808,ETS1;HIF1A;HSPA1A
delta,2,embryonic skeletal system morphogenesis (GO:0048704),3/22,3,22,0.110030734346631,0.699988605716439,0,0,2.55362614913177,5.63584154510808,EIF4A3;FUZ;TGFBR2
delta,2,phosphatidylglycerol metabolic process (GO:0046471),3/22,3,22,0.110030734346631,0.699988605716439,0,0,2.55362614913177,5.63584154510808,SLC27A1;LPGAT1;CRLS1
delta,2,regulation of microtubule depolymerization (GO:0031114),3/22,3,22,0.110030734346631,0.699988605716439,0,0,2.55362614913177,5.63584154510808,MAP1A;CIB1;CLASP1
delta,2,positive regulation of RNA splicing (GO:0033120),3/22,3,22,0.110030734346631,0.699988605716439,0,0,2.55362614913177,5.63584154510808,NCBP1;PRDX6;HSPA1A
delta,2,NLS-bearing protein import into nucleus (GO:0006607),3/22,3,22,0.110030734346631,0.699988605716439,0,0,2.55362614913177,5.63584154510808,KPNA2;KPNB1;IPO5
delta,2,negative regulation of cellular amide metabolic process (GO:0034249),7/76,7,76,0.11067634013811,0.699988605716439,0,0,1.72481766213286,3.79657410350663,FXR1;ORMDL2;CNOT2;EIF4A3;TYMS;GAPDH;SORL1
delta,2,positive regulation of tumor necrosis factor production (GO:0032760),5/48,5,48,0.111632473339308,0.699988605716439,0,0,1.95068664169788,4.27696491030434,TLR9;RIPK1;MIF;RASGRP1;HAVCR2
delta,2,positive regulation of organelle assembly (GO:1902117),5/48,5,48,0.111632473339308,0.699988605716439,0,0,1.95068664169788,4.27696491030434,RALB;CNOT6L;CNOT2;PIP4K2B;FUZ
delta,2,"positive regulation of gene expression, epigenetic (GO:0045815)",5/48,5,48,0.111632473339308,0.699988605716439,0,0,1.95068664169788,4.27696491030434,POLR1C;SMARCA5;POLR1E;SLC50A1;ERCC6
delta,2,cellular response to heat (GO:0034605),5/48,5,48,0.111632473339308,0.699988605716439,0,0,1.95068664169788,4.27696491030434,HSPA8;HSPA1L;HSPA6;IER5;HSPA1A
delta,2,regulation of tumor necrosis factor production (GO:0032680),6/62,6,62,0.112427295567304,0.699988605716439,0,0,1.81225081551287,3.96058087690954,ARG2;TLR9;RIPK1;MIF;RASGRP1;HAVCR2
delta,2,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),6/62,6,62,0.112427295567304,0.699988605716439,0,0,1.81225081551287,3.96058087690954,PPP2CA;SOCS1;ARL2BP;IL6ST;IL6R;PIBF1
delta,2,regulation of cytokine-mediated signaling pathway (GO:0001959),8/91,8,91,0.112784660898527,0.699988605716439,0,0,1.64629378112524,3.59266565272602,IFNAR2;HSP90AB1;SOCS1;CBFB;IFNGR1;CDC37;RIPK1;RBCK1
delta,2,replicative senescence (GO:0090399),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,ATM;ATR
delta,2,positive regulation of extracellular matrix organization (GO:1903055),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,SMAD3;CLASP1
delta,2,synaptonemal complex assembly (GO:0007130),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,BAG6;STAG3
delta,2,transcytosis (GO:0045056),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,USO1;VPS35
delta,2,negative regulation of cell division (GO:0051782),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,ORC6;ZFYVE19
delta,2,icosanoid biosynthetic process (GO:0046456),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,ALOX5;MGST3
delta,2,negative regulation of T cell differentiation (GO:0045581),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,IRF1;GLI3
delta,2,negative regulation of cardiac muscle hypertrophy (GO:0010614),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,SMAD4;LMNA
delta,2,magnesium ion transport (GO:0015693),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,NIPAL1;NIPA1
delta,2,icosanoid secretion (GO:0032309),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,ABCC4;PNPLA8
delta,2,regulation of cardiac muscle cell differentiation (GO:2000725),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,EFNB2;FZD7
delta,2,embryonic hemopoiesis (GO:0035162),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,THOC5;TGFBR2
delta,2,aspartate family amino acid biosynthetic process (GO:0009067),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,MTHFD1;PLOD2
delta,2,protein carboxylation (GO:0018214),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,VKORC1L1;PROS1
delta,2,peptidyl-glutamic acid carboxylation (GO:0017187),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,VKORC1L1;PROS1
delta,2,synaptonemal complex organization (GO:0070193),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,BAG6;STAG3
delta,2,positive regulation of interferon-gamma biosynthetic process (GO:0045078),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,CEBPG;TLR9
delta,2,regulation of lipid kinase activity (GO:0043550),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,RB1;PIK3R3
delta,2,regulation of trophoblast cell migration (GO:1901163),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,SMURF2;TIMP1
delta,2,regulation of hydrogen peroxide-induced cell death (GO:1903205),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,RIPK1;NFE2L2
delta,2,positive regulation of receptor biosynthetic process (GO:0010870),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,HNRNPK;HIF1A
delta,2,chromatin silencing at rDNA (GO:0000183),2/11,2,11,0.113842232918937,0.699988605716439,0,0,3.40483486550902,7.39850769783966,SUV39H1;SIRT2
delta,2,positive regulation of muscle cell differentiation (GO:0051149),4/35,4,35,0.114558411805245,0.700053046267779,0,0,2.14018191546281,4.63706889095296,SPAG9;CDH2;CTNNB1;CTNNA2
delta,2,positive regulation of cell development (GO:0010720),4/35,4,35,0.114558411805245,0.700053046267779,0,0,2.14018191546281,4.63706889095296,BAD;NUMB;NKX6-1;FAM129B
delta,2,embryonic limb morphogenesis (GO:0030326),4/35,4,35,0.114558411805245,0.700053046267779,0,0,2.14018191546281,4.63706889095296,FBXW4;MBNL1;CTNNB1;GLI3
delta,2,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),6/63,6,63,0.118994839375882,0.719441055649998,0,0,1.78348492955235,3.79646005600177,CREB3;MDM2;PTTG1IP;HERPUD1;HSPA1A;NFE2L2
delta,2,cellular amide metabolic process (GO:0043603),6/63,6,63,0.118994839375882,0.719441055649998,0,0,1.78348492955235,3.79646005600177,PPP2CA;SMPD1;ORMDL2;FASN;CLN8;NIT2
delta,2,establishment of protein localization to organelle (GO:0072594),6/63,6,63,0.118994839375882,0.719441055649998,0,0,1.78348492955235,3.79646005600177,PDIA3;IPO11;NXT1;NUP107;PTTG1IP;KPNB1
delta,2,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),6/63,6,63,0.118994839375882,0.719441055649998,0,0,1.78348492955235,3.79646005600177,PSMD14;PSMB3;ZFYVE19;PINX1;ATM;CDK5RAP3
delta,2,cellular macromolecule catabolic process (GO:0044265),5/49,5,49,0.119181599608686,0.719441055649998,0,0,1.91087671023466,4.06463903914516,ISG20;DIS3;XRN2;RIPK1;SKIV2L2
delta,2,regulation of cell cycle arrest (GO:0071156),5/49,5,49,0.119181599608686,0.719441055649998,0,0,1.91087671023466,4.06463903914516,MED25;HSP90AB1;CDK4;MDM2;MIF
delta,2,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),3/23,3,23,0.121765643621315,0.726201513861789,0,0,2.44259892525647,5.14327561204383,PSMD14;UBE3A;UCHL5
delta,2,apoptotic nuclear changes (GO:0030262),3/23,3,23,0.121765643621315,0.726201513861789,0,0,2.44259892525647,5.14327561204383,TOP2A;KPNB1;CDK5RAP3
delta,2,protein localization to Golgi apparatus (GO:0034067),3/23,3,23,0.121765643621315,0.726201513861789,0,0,2.44259892525647,5.14327561204383,ARFRP1;GBF1;SORL1
delta,2,mitotic G2/M transition checkpoint (GO:0044818),3/23,3,23,0.121765643621315,0.726201513861789,0,0,2.44259892525647,5.14327561204383,TAOK1;DONSON;CDK5RAP3
delta,2,cholesterol efflux (GO:0033344),3/23,3,23,0.121765643621315,0.726201513861789,0,0,2.44259892525647,5.14327561204383,STX12;APOM;SOAT1
delta,2,melanosome organization (GO:0032438),3/23,3,23,0.121765643621315,0.726201513861789,0,0,2.44259892525647,5.14327561204383,BLOC1S5;BLOC1S1;BLOC1S2
delta,2,regulation of response to external stimulus (GO:0032101),9/108,9,108,0.123224953792211,0.729251422303689,0,0,1.5605493133583,3.26739029553355,SCARB2;EFNB2;FNTA;TRAF3;CASP4;NMT1;CNGA1;RNF7;CD55
delta,2,cellular response to starvation (GO:0009267),9/108,9,108,0.123224953792211,0.729251422303689,0,0,1.5605493133583,3.26739029553355,HSPA8;GABARAPL1;RRAGA;CDKN1A;PRKAA1;RALB;SESN3;HNRNPA1;RNF152
delta,2,positive regulation of RNA metabolic process (GO:0051254),4/36,4,36,0.123747301163764,0.729251422303689,0,0,2.08073241781107,4.34771886506203,UTP15;DDX5;DIMT1;HSPA1A
delta,2,negative regulation of protein kinase B signaling (GO:0051898),4/36,4,36,0.123747301163764,0.729251422303689,0,0,2.08073241781107,4.34771886506203,PHLPP2;CIB1;PTPRJ;TRIB3
delta,2,tRNA transport (GO:0051031),4/36,4,36,0.123747301163764,0.729251422303689,0,0,2.08073241781107,4.34771886506203,NUP205;NUP107;TOMM20L;AAAS
delta,2,regulation of sodium ion transport (GO:0002028),4/36,4,36,0.123747301163764,0.729251422303689,0,0,2.08073241781107,4.34771886506203,NEDD4;SLMAP;PKP2;SCN3B
delta,2,regulation of signal transduction by p53 class mediator (GO:1901796),11/139,11,139,0.124485786737797,0.73215355994404,0,0,1.48196049901652,3.08775914851583,SUPT16H;PRKAA1;PPP1R13B;RMI1;MDM2;TAF4B;PRKAG2;ATM;SSRP1;CDK5RAP3;ATR
delta,2,iron ion homeostasis (GO:0055072),6/64,6,64,0.125748554260457,0.733779798978668,0,0,1.75561797752809,3.64022290555322,SLC25A37;SMAD4;CCDC115;FTH1;NEO1;NUBP1
delta,2,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",6/64,6,64,0.125748554260457,0.733779798978668,0,0,1.75561797752809,3.64022290555322,CNOT4;ZCCHC6;CNOT6L;DIS3;CNOT2;EIF4A3
delta,2,negative regulation of protein modification process (GO:0031400),6/64,6,64,0.125748554260457,0.733779798978668,0,0,1.75561797752809,3.64022290555322,YWHAB;DNAJC10;CIB1;TARDBP;CDK5RAP3;ZBED3
delta,2,kidney development (GO:0001822),6/64,6,64,0.125748554260457,0.733779798978668,0,0,1.75561797752809,3.64022290555322,PYGO1;BAG6;PYGO2;PAX8;WFS1;NPHP3
delta,2,regulation of reactive oxygen species metabolic process (GO:2000377),5/50,5,50,0.126963785500286,0.735647840227953,0,0,1.87265917602996,3.86489398263783,CDKN1A;STK17A;RIPK1;SIRT2;TGFBR2
delta,2,positive regulation of response to DNA damage stimulus (GO:2001022),5/50,5,50,0.126963785500286,0.735647840227953,0,0,1.87265917602996,3.86489398263783,DDX5;H2AFX;CEBPG;ATM;ATR
delta,2,non-recombinational repair (GO:0000726),5/50,5,50,0.126963785500286,0.735647840227953,0,0,1.87265917602996,3.86489398263783,DCLRE1B;PSMD14;H2AFX;ATM;TP53BP1
delta,2,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),7/79,7,79,0.128551532840721,0.735647840227953,0,0,1.65931825724174,3.40396765486569,EGLN3;PSMD14;PSMB3;HIGD1A;HIF1A;SIRT2;NFE2L2
delta,2,vesicle budding from membrane (GO:0006900),2/12,2,12,0.131961206059373,0.735647840227953,0,0,3.1210986267166,6.32099654519513,SNX3;ANXA2
delta,2,viral RNA genome replication (GO:0039694),2/12,2,12,0.131961206059373,0.735647840227953,0,0,3.1210986267166,6.32099654519513,ATG16L2;ATG16L1
delta,2,regulation of rRNA processing (GO:2000232),2/12,2,12,0.131961206059373,0.735647840227953,0,0,3.1210986267166,6.32099654519513,UTP15;DIMT1
delta,2,cellular glucan metabolic process (GO:0006073),2/12,2,12,0.131961206059373,0.735647840227953,0,0,3.1210986267166,6.32099654519513,UGP2;PRKAG2
delta,2,histone H3 deacetylation (GO:0070932),2/12,2,12,0.131961206059373,0.735647840227953,0,0,3.1210986267166,6.32099654519513,HDAC9;SIRT2
delta,2,negative regulation by host of viral transcription (GO:0043922),2/12,2,12,0.131961206059373,0.735647840227953,0,0,3.1210986267166,6.32099654519513,ZNF639;TARDBP
delta,2,regulation of skeletal muscle tissue development (GO:0048641),2/12,2,12,0.131961206059373,0.735647840227953,0,0,3.1210986267166,6.32099654519513,DDX5;HDAC9
delta,2,PERK-mediated unfolded protein response (GO:0036499),2/12,2,12,0.131961206059373,0.735647840227953,0,0,3.1210986267166,6.32099654519513,HERPUD1;NFE2L2
delta,2,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),2/12,2,12,0.131961206059373,0.735647840227953,0,0,3.1210986267166,6.32099654519513,NEIL2;UNG
delta,2,positive regulation of neuron migration (GO:2001224),2/12,2,12,0.131961206059373,0.735647840227953,0,0,3.1210986267166,6.32099654519513,ZNF609;PLAA
delta,2,negative regulation of fatty acid metabolic process (GO:0045922),2/12,2,12,0.131961206059373,0.735647840227953,0,0,3.1210986267166,6.32099654519513,ACADVL;TRIB3
delta,2,regulation of catabolic process (GO:0009894),2/12,2,12,0.131961206059373,0.735647840227953,0,0,3.1210986267166,6.32099654519513,HGS;MDM2
delta,2,positive regulation of SMAD protein import into nucleus (GO:0060391),2/12,2,12,0.131961206059373,0.735647840227953,0,0,3.1210986267166,6.32099654519513,SMAD4;SMAD3
delta,2,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),2/12,2,12,0.131961206059373,0.735647840227953,0,0,3.1210986267166,6.32099654519513,TLR9;RASGRP1
delta,2,regulation of mesenchymal cell proliferation (GO:0010464),2/12,2,12,0.131961206059373,0.735647840227953,0,0,3.1210986267166,6.32099654519513,CTNNBIP1;TGFBR2
delta,2,signal transduction involved in G2 DNA damage checkpoint (GO:0072425),2/12,2,12,0.131961206059373,0.735647840227953,0,0,3.1210986267166,6.32099654519513,FZR1;ATM
delta,2,regulation of inclusion body assembly (GO:0090083),2/12,2,12,0.131961206059373,0.735647840227953,0,0,3.1210986267166,6.32099654519513,SACS;HSPA1A
delta,2,entry of bacterium into host cell (GO:0035635),2/12,2,12,0.131961206059373,0.735647840227953,0,0,3.1210986267166,6.32099654519513,CTNNB1;MET
delta,2,pre-mRNA cleavage required for polyadenylation (GO:0098789),2/12,2,12,0.131961206059373,0.735647840227953,0,0,3.1210986267166,6.32099654519513,NUDT21;NCBP1
delta,2,positive regulation of protein polymerization (GO:0032273),6/65,6,65,0.13268435557815,0.735647840227953,0,0,1.7286084701815,3.49141268409729,CLIP1;PSRC1;PFN1;MET;CLASP1;NCK1
delta,2,negative regulation of neuron differentiation (GO:0045665),6/65,6,65,0.13268435557815,0.735647840227953,0,0,1.7286084701815,3.49141268409729,EFNB2;DLX1;CRMP1;CIB1;CBFA2T2;ASCL1
delta,2,mRNA catabolic process (GO:0006402),4/37,4,37,0.133237293643436,0.735647840227953,0,0,2.02449640651888,4.08062269006073,DDX5;DIS3;METTL16;HSPA1A
delta,2,vesicle-mediated transport in synapse (GO:0099003),4/37,4,37,0.133237293643436,0.735647840227953,0,0,2.02449640651888,4.08062269006073,UNC13B;KIF5C;SPG11;DNM2
delta,2,zymogen activation (GO:0031638),4/37,4,37,0.133237293643436,0.735647840227953,0,0,2.02449640651888,4.08062269006073,CYFIP2;BAD;PERP;F11
delta,2,inner mitochondrial membrane organization (GO:0007007),4/37,4,37,0.133237293643436,0.735647840227953,0,0,2.02449640651888,4.08062269006073,ATP5B;TIMM9;IMMT;ATP5G2
delta,2,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),7/80,7,80,0.134813612611669,0.738376052935983,0,0,1.63857677902622,3.28348190843972,SMAD4;HSP90AB1;SMAD3;SMURF2;TRIM33;TGFBR2;HSPA1A
delta,2,myeloid leukocyte differentiation (GO:0002573),5/51,5,51,0.134971966665717,0.738376052935983,0,0,1.83594036865683,3.67681606894851,FARP2;BATF3;GAB2;THOC5;TGFBR2
delta,2,neurogenesis (GO:0022008),5/51,5,51,0.134971966665717,0.738376052935983,0,0,1.83594036865683,3.67681606894851,CDK6;BTBD1;CHAC1;DAGLB;ASCL1
delta,2,double-strand break repair via nonhomologous end joining (GO:0006303),5/51,5,51,0.134971966665717,0.738376052935983,0,0,1.83594036865683,3.67681606894851,DCLRE1B;PSMD14;H2AFX;ATM;TP53BP1
delta,2,positive regulation of JUN kinase activity (GO:0043507),5/51,5,51,0.134971966665717,0.738376052935983,0,0,1.83594036865683,3.67681606894851,MAP3K2;SPAG9;TAOK1;TLR9;RIPK1
delta,2,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),6/66,6,66,0.139797857972166,0.763373257477371,0,0,1.70241743275451,3.34960464996139,WFS1;UBE3A;PTTG1IP;CDK5RAP3;MALT1;UBE2L3
delta,2,positive regulation of protein localization to membrane (GO:1905477),8/96,8,96,0.140688749914474,0.766830988544826,0,0,1.5605493133583,3.06055754685165,PPP1R13B;YWHAB;BAD;NMT1;CIB1;STX3;YWHAZ;PLS1
delta,2,protein K63-linked ubiquitination (GO:0070534),4/38,4,38,0.143014206220446,0.771778693978016,0,0,1.9712201852947,3.83365130979227,UBE2D4;UBE2T;NEDD4;RNF152
delta,2,regulation of carbohydrate catabolic process (GO:0043470),4/38,4,38,0.143014206220446,0.771778693978016,0,0,1.9712201852947,3.83365130979227,NUP205;NUP107;PRKAG2;AAAS
delta,2,cellular lipid catabolic process (GO:0044242),3/25,3,25,0.146498778417588,0.771778693978016,0,0,2.24719101123595,4.31626559327254,LIPG;SIRT2;PPARD
delta,2,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),3/25,3,25,0.146498778417588,0.771778693978016,0,0,2.24719101123595,4.31626559327254,RB1;CDKN1A;ZNF655
delta,2,cellular modified amino acid biosynthetic process (GO:0042398),3/25,3,25,0.146498778417588,0.771778693978016,0,0,2.24719101123595,4.31626559327254,SLC27A1;PLOD2;CHAC1
delta,2,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),3/25,3,25,0.146498778417588,0.771778693978016,0,0,2.24719101123595,4.31626559327254,CDK6;CDK4;IPO5
delta,2,regulation of cardiac muscle cell action potential (GO:0098901),3/25,3,25,0.146498778417588,0.771778693978016,0,0,2.24719101123595,4.31626559327254,SLMAP;NOS1AP;PKP2
delta,2,proteoglycan biosynthetic process (GO:0030166),3/25,3,25,0.146498778417588,0.771778693978016,0,0,2.24719101123595,4.31626559327254,GLCE;CSGALNACT2;XYLT2
delta,2,histone monoubiquitination (GO:0010390),3/25,3,25,0.146498778417588,0.771778693978016,0,0,2.24719101123595,4.31626559327254,LEO1;PCGF1;ATXN7L3
delta,2,translational termination (GO:0006415),8/97,8,97,0.146649156613162,0.771778693978016,0,0,1.54446117610719,2.9649210156277,MRPS9;MRPS27;MRPS14;MRPS34;MRPL15;MRPS6;DAP3;C12ORF65
delta,2,regulation of cell death (GO:0010941),8/97,8,97,0.146649156613162,0.771778693978016,0,0,1.54446117610719,2.9649210156277,DUS2;BNIP3L;RRAS2;CTNNB1;VPS35;PHB;NCK1;HSPA1A
delta,2,positive regulation of cellular protein localization (GO:1903829),6/67,6,67,0.147084393489323,0.771778693978016,0,0,1.67700821734026,3.21440340695841,BCAS3;HSP90AB1;CEP250;KAT7;STX3;CDK5RAP3
delta,2,negative regulation of cell cycle process (GO:0010948),7/82,7,82,0.147776118553905,0.771778693978016,0,0,1.59861149173289,3.05663607403265,HSP90AB1;CBX5;CDK4;ZFYVE19;MDM2;CDC7;MIF
delta,2,positive regulation of histone H3-K4 methylation (GO:0051571),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,SMAD4;CTNNB1
delta,2,regulation of acyl-CoA biosynthetic process (GO:0050812),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,PDHB;PDK1
delta,2,regulation of plasma membrane bounded cell projection organization (GO:0120035),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,TCTEX1D2;VPS35
delta,2,embryonic appendage morphogenesis (GO:0035113),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,FBXW4;MBNL1
delta,2,regulation of cell aging (GO:0090342),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,LMNA;MIF
delta,2,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,ERRFI1;ZGPAT
delta,2,myelination in peripheral nervous system (GO:0022011),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,ARHGEF10;SIRT2
delta,2,alpha-linolenic acid metabolic process (GO:0036109),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,SCP2;ACSL1
delta,2,cardiolipin metabolic process (GO:0032048),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,SLC27A1;CRLS1
delta,2,tetrahydrofolate metabolic process (GO:0046653),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,MTHFD1;TYMS
delta,2,neuron fate commitment (GO:0048663),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,ASCL1;POU3F2
delta,2,protein neddylation (GO:0045116),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,DCUN1D5;RNF7
delta,2,prostanoid biosynthetic process (GO:0046457),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,PNPLA8;MIF
delta,2,regulation of cAMP-dependent protein kinase activity (GO:2000479),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,PKIB;PRKAR2A
delta,2,positive regulation of alpha-beta T cell proliferation (GO:0046641),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,CD55;TGFBR2
delta,2,regulation of cytolysis (GO:0042268),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,RRAGA;BAD
delta,2,high-density lipoprotein particle assembly (GO:0034380),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,APOM;PRKACB
delta,2,ribonucleoprotein complex disassembly (GO:0032988),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,DENR;KLC1
delta,2,modulation by virus of host process (GO:0019054),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,KPNA2;KPNB1
delta,2,positive regulation of sodium ion transport (GO:0010765),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,PKP2;SCN3B
delta,2,mRNA cleavage involved in mRNA processing (GO:0098787),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,NUDT21;NCBP1
delta,2,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),2/13,2,13,0.150673192607939,0.771778693978016,0,0,2.88101411696917,5.452728536406,TLR9;RASGRP1
delta,2,positive regulation of mitotic cell cycle (GO:0045931),5/53,5,53,0.151635982671392,0.775375746443408,0,0,1.76665960002827,3.33240138722333,FOXA1;GEN1;CCNB1;MDM2;PKN2
delta,2,neuron development (GO:0048666),11/145,11,145,0.152870106728103,0.780345519078617,0,0,1.42063799560894,2.66819496730934,RB1;FXR1;ALK;BLOC1S5;BLOC1S1;MAP2;BLOC1S2;NEDD4;STX3;ASCL1;POU3F2
delta,2,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",7/83,7,83,0.154470111679389,0.787162760886751,0,0,1.57935111231443,2.94984038917544,CNOT4;CDKN1A;CCNB1;CNOT6L;CNOT2;MDM2;ATM
delta,2,peptidyl-serine phosphorylation (GO:0018105),11/146,11,146,0.157899438449816,0.78928073174808,0,0,1.41090759837874,2.60424889115759,TNKS;RIPK1;CDC7;ATM;PKN2;STK32C;CAMKK1;HIPK3;PSKH1;ATR;TGFBR2
delta,2,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),8/99,8,99,0.158931875672746,0.78928073174808,0,0,1.51325994022623,2.78330817306143,DCTN6;MARCH1;DYNC1I2;DCTN4;DCTN3;KLC1;KIF15;DNM2
delta,2,canonical glycolysis (GO:0061621),3/26,3,26,0.159429031911593,0.78928073174808,0,0,2.16076058772688,3.96749437503457,ENO3;PFKM;GAPDH
delta,2,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),3/26,3,26,0.159429031911593,0.78928073174808,0,0,2.16076058772688,3.96749437503457,CHST12;CSGALNACT2;XYLT2
delta,2,long-chain fatty acid transport (GO:0015909),3/26,3,26,0.159429031911593,0.78928073174808,0,0,2.16076058772688,3.96749437503457,SLC27A1;ACSL1;PRKAG2
delta,2,negative regulation of insulin receptor signaling pathway (GO:0046627),3/26,3,26,0.159429031911593,0.78928073174808,0,0,2.16076058772688,3.96749437503457,SOCS1;ENPP1;NCK1
delta,2,negative regulation of epithelial to mesenchymal transition (GO:0010719),3/26,3,26,0.159429031911593,0.78928073174808,0,0,2.16076058772688,3.96749437503457,FOXA1;PPP2CA;FUZ
delta,2,protein depolymerization (GO:0051261),3/26,3,26,0.159429031911593,0.78928073174808,0,0,2.16076058772688,3.96749437503457,NCKAP5L;TWF2;CKAP5
delta,2,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),3/26,3,26,0.159429031911593,0.78928073174808,0,0,2.16076058772688,3.96749437503457,ENPP1;ABHD14B;SULT6B1
delta,2,regulation of nervous system development (GO:0051960),3/26,3,26,0.159429031911593,0.78928073174808,0,0,2.16076058772688,3.96749437503457,CTNNB1;ASCL1;SIRT2
delta,2,positive regulation of embryonic development (GO:0040019),3/26,3,26,0.159429031911593,0.78928073174808,0,0,2.16076058772688,3.96749437503457,RBM19;CLASP1;FAM129B
delta,2,positive regulation of nitric oxide biosynthetic process (GO:0045429),3/26,3,26,0.159429031911593,0.78928073174808,0,0,2.16076058772688,3.96749437503457,HSP90AB1;SMAD3;NOS1AP
delta,2,positive regulation of nitric oxide metabolic process (GO:1904407),3/26,3,26,0.159429031911593,0.78928073174808,0,0,2.16076058772688,3.96749437503457,HSP90AB1;SMAD3;NOS1AP
delta,2,glycolytic process through glucose-6-phosphate (GO:0061620),3/26,3,26,0.159429031911593,0.78928073174808,0,0,2.16076058772688,3.96749437503457,ENO3;PFKM;GAPDH
delta,2,glucose catabolic process to pyruvate (GO:0061718),3/26,3,26,0.159429031911593,0.78928073174808,0,0,2.16076058772688,3.96749437503457,ENO3;PFKM;GAPDH
delta,2,peptide catabolic process (GO:0043171),3/26,3,26,0.159429031911593,0.78928073174808,0,0,2.16076058772688,3.96749437503457,XPNPEP1;CPQ;CHAC1
delta,2,prostaglandin metabolic process (GO:0006693),3/26,3,26,0.159429031911593,0.78928073174808,0,0,2.16076058772688,3.96749437503457,PNPLA8;PLAA;MIF
delta,2,negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),5/54,5,54,0.160275730913621,0.78928073174808,0,0,1.73394368150922,3.17460748499658,DLX1;SMAD3;SMURF2;TGFBR2;HSPA1A
delta,2,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),4/40,4,40,0.163369628421594,0.78928073174808,0,0,1.87265917602996,3.39277151012274,ATP5B;PRKAG2;ATP5G2;PFAS
delta,2,cellular response to amino acid starvation (GO:0034198),4/40,4,40,0.163369628421594,0.78928073174808,0,0,1.87265917602996,3.39277151012274,CDKN1A;RRAGA;SESN3;RNF152
delta,2,cellular response to oxidative stress (GO:0034599),9/116,9,116,0.167360607312615,0.78928073174808,0,0,1.45292522278187,2.59725562185035,VKORC1L1;LONP1;CYCS;HIF1A;PRDX6;SIRT2;TXN2;NFE2L2;HSPA1A
delta,2,activation of GTPase activity (GO:0090630),7/85,7,85,0.168266112469246,0.78928073174808,0,0,1.54218990967173,2.74850404273291,SYDE2;BCAS3;ARHGEF10;TBC1D5;EVI5L;RASGRP1;TBC1D22B
delta,2,intracellular transport of virus (GO:0075733),5/55,5,55,0.169109378083777,0.78928073174808,0,0,1.70241743275451,3.02555254649517,NUP205;NUP107;KPNA2;AAAS;KPNB1
delta,2,transport of virus (GO:0046794),5/55,5,55,0.169109378083777,0.78928073174808,0,0,1.70241743275451,3.02555254649517,NUP205;NUP107;KPNA2;AAAS;KPNB1
delta,2,protein targeting to mitochondrion (GO:0006626),5/55,5,55,0.169109378083777,0.78928073174808,0,0,1.70241743275451,3.02555254649517,CHCHD4;IMMP2L;TOMM40;TIMM9;TOMM20L
delta,2,myeloid dendritic cell activation (GO:0001773),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,BATF3;TGFBR2
delta,2,"retrograde transport, endosome to plasma membrane (GO:1990126)",2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,SNX27;VPS35
delta,2,regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,PDHB;PDK1
delta,2,regulation of monocyte differentiation (GO:0045655),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,CDK6;CTNNBIP1
delta,2,negative regulation of hemopoiesis (GO:1903707),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,CDK6;LEO1
delta,2,pancreas development (GO:0031016),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,NPHP3;NKX6-1
delta,2,cardiac left ventricle morphogenesis (GO:0003214),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,SMAD4;TGFBR2
delta,2,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031657),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,CDK6;CDK4
delta,2,quinone biosynthetic process (GO:1901663),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,COQ2;COQ7
delta,2,Golgi to vacuole transport (GO:0006896),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,AP4M1;VPS54
delta,2,metallo-sulfur cluster assembly (GO:0031163),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,ISCA1;NUBP1
delta,2,DNA modification (GO:0006304),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,NEIL2;UNG
delta,2,fatty acid transport (GO:0015908),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,SLC27A1;PPARD
delta,2,regulation of protein modification by small protein conjugation or removal (GO:1903320),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,HSP90AB1;HSPA1A
delta,2,regulation of interferon-gamma biosynthetic process (GO:0045072),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,CEBPG;TLR9
delta,2,regulation of adaptive immune response (GO:0002819),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,IRF1;IL6ST
delta,2,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,GEN1;CCNB1
delta,2,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,MET;NFE2L2
delta,2,ubiquinone metabolic process (GO:0006743),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,COQ2;COQ7
delta,2,regulation of nucleocytoplasmic transport (GO:0046822),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,NEDD4;AAAS
delta,2,regulation of phosphate metabolic process (GO:0019220),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,MCM7;SIRT2
delta,2,endoplasmic reticulum tubular network organization (GO:0071786),2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,ATL2;TMEM170A
delta,2,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",2/14,2,14,0.169863349303485,0.78928073174808,0,0,2.67522739432852,4.7425387715385,CYCS;UQCRH
delta,2,positive regulation of neurogenesis (GO:0050769),6/70,6,70,0.169931669373112,0.78928073174808,0,0,1.60513643659711,2.8448777971066,ZNF609;TCF12;NUMB;PLAA;CTNNB1;ASCL1
delta,2,regulation of innate immune response (GO:0045088),6/70,6,70,0.169931669373112,0.78928073174808,0,0,1.60513643659711,2.8448777971066,IFNAR2;HSP90AB1;IRF1;CDC37;TRAFD1;SAMHD1
delta,2,bile acid biosynthetic process (GO:0006699),3/27,3,27,0.172689922617746,0.78928073174808,0,0,2.08073241781107,3.65430222115039,SCP2;OSBPL2;CYP46A1
delta,2,response to growth factor (GO:0070848),3/27,3,27,0.172689922617746,0.78928073174808,0,0,2.08073241781107,3.65430222115039,TWF2;CTNNB1;CIB1
delta,2,regulation of transcription regulatory region DNA binding (GO:2000677),3/27,3,27,0.172689922617746,0.78928073174808,0,0,2.08073241781107,3.65430222115039,RB1;NSD1;FAM129B
delta,2,regulation of supramolecular fiber organization (GO:1902903),3/27,3,27,0.172689922617746,0.78928073174808,0,0,2.08073241781107,3.65430222115039,HSPA8;MAP2;MAP1A
delta,2,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),3/27,3,27,0.172689922617746,0.78928073174808,0,0,2.08073241781107,3.65430222115039,RB1;NPAT;TYMS
delta,2,negative regulation of cellular response to insulin stimulus (GO:1900077),3/27,3,27,0.172689922617746,0.78928073174808,0,0,2.08073241781107,3.65430222115039,SOCS1;ENPP1;NCK1
delta,2,strand displacement (GO:0000732),3/27,3,27,0.172689922617746,0.78928073174808,0,0,2.08073241781107,3.65430222115039,RTEL1;RMI1;ATM
delta,2,regulation of centrosome cycle (GO:0046605),3/27,3,27,0.172689922617746,0.78928073174808,0,0,2.08073241781107,3.65430222115039,GEN1;CEP250;CTNNB1
delta,2,chromatin remodeling (GO:0006338),9/117,9,117,0.173344703448665,0.78928073174808,0,0,1.44050705848459,2.52444995881148,RB1;FOXA1;TADA2B;SMARCA5;BAZ1A;SSRP1;TOX;SMARCA2;GATAD2B
delta,2,negative regulation of TOR signaling (GO:0032007),4/41,4,41,0.173917612347046,0.78928073174808,0,0,1.82698456198045,3.19571313448218,PRKAA1;SESN3;ATM;RNF152
delta,2,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),4/41,4,41,0.173917612347046,0.78928073174808,0,0,1.82698456198045,3.19571313448218,ERRFI1;ZGPAT;HGS;PTPRJ
delta,2,tRNA aminoacylation (GO:0043039),4/41,4,41,0.173917612347046,0.78928073174808,0,0,1.82698456198045,3.19571313448218,TARSL2;GARS;HARS;HARS2
delta,2,androgen receptor signaling pathway (GO:0030521),4/41,4,41,0.173917612347046,0.78928073174808,0,0,1.82698456198045,3.19571313448218,RB1;DDX5;RNF14;CTNNB1
delta,2,negative regulation of ERK1 and ERK2 cascade (GO:0070373),4/41,4,41,0.173917612347046,0.78928073174808,0,0,1.82698456198045,3.19571313448218,DUSP4;SMAD4;RANBP9;PHB
delta,2,positive regulation of epithelial to mesenchymal transition (GO:0010718),4/41,4,41,0.173917612347046,0.78928073174808,0,0,1.82698456198045,3.19571313448218,SMAD4;SMAD3;CTNNB1;TGFBR2
delta,2,regulation of protein dephosphorylation (GO:0035304),4/41,4,41,0.173917612347046,0.78928073174808,0,0,1.82698456198045,3.19571313448218,PPP1R14C;YWHAB;PPP6R1;SMPD1
delta,2,phospholipid metabolic process (GO:0006644),6/71,6,71,0.17785865553326,0.78928073174808,0,0,1.58252888115208,2.73265724666645,PCYT2;SMPD1;LIPG;PLAA;PIP4K2B;CLN8
delta,2,negative regulation of developmental process (GO:0051093),6/71,6,71,0.17785865553326,0.78928073174808,0,0,1.58252888115208,2.73265724666645,CDK6;ANXA2;NFIB;FUZ;TIMP1;MIF
delta,2,long-chain fatty acid metabolic process (GO:0001676),5/56,5,56,0.178128132069213,0.78928073174808,0,0,1.67201712145532,2.88465112454413,SCP2;ACSL1;PNPLA8;DAGLB;AIG1
delta,2,positive regulation of cysteine-type endopeptidase activity (GO:2001056),5/56,5,56,0.178128132069213,0.78928073174808,0,0,1.67201712145532,2.88465112454413,CYFIP2;BAD;PERP;CYCS;SOX7
delta,2,negative regulation of cell projection organization (GO:0031345),4/42,4,42,0.184691634478187,0.78928073174808,0,0,1.78348492955235,3.01242676170283,EFNB2;CRMP1;CIB1;CBFA2T2
delta,2,regulation of cellular metabolic process (GO:0031323),4/42,4,42,0.184691634478187,0.78928073174808,0,0,1.78348492955235,3.01242676170283,STK17A;FASN;VPS35;CACYBP
delta,2,negative regulation of proteolysis (GO:0045861),4/42,4,42,0.184691634478187,0.78928073174808,0,0,1.78348492955235,3.01242676170283,BAG6;CHAC1;TIMP1;CLN8
delta,2,positive regulation of receptor-mediated endocytosis (GO:0048260),4/42,4,42,0.184691634478187,0.78928073174808,0,0,1.78348492955235,3.01242676170283,HNRNPK;ANXA2;TBC1D5;SCYL2
delta,2,mRNA polyadenylation (GO:0006378),3/28,3,28,0.186248020738523,0.78928073174808,0,0,2.00642054574639,3.37214295482784,NUDT21;LEO1;WDR33
delta,2,cristae formation (GO:0042407),3/28,3,28,0.186248020738523,0.78928073174808,0,0,2.00642054574639,3.37214295482784,ATP5B;IMMT;ATP5G2
delta,2,regulation of double-strand break repair via homologous recombination (GO:0010569),3/28,3,28,0.186248020738523,0.78928073174808,0,0,2.00642054574639,3.37214295482784,RTEL1;SETD2;TP53BP1
delta,2,modulation by host of viral transcription (GO:0043921),3/28,3,28,0.186248020738523,0.78928073174808,0,0,2.00642054574639,3.37214295482784,SP1;ZNF639;TARDBP
delta,2,transcription from RNA polymerase III promoter (GO:0006383),3/28,3,28,0.186248020738523,0.78928073174808,0,0,2.00642054574639,3.37214295482784,GTF3C1;SNAPC1;TROVE2
delta,2,release of sequestered calcium ion into cytosol (GO:0051209),3/28,3,28,0.186248020738523,0.78928073174808,0,0,2.00642054574639,3.37214295482784,ITPR1;ITPR2;SLC8B1
delta,2,microtubule polymerization (GO:0046785),3/28,3,28,0.186248020738523,0.78928073174808,0,0,2.00642054574639,3.37214295482784,RANBP9;CKAP5;CLASP1
delta,2,purine ribonucleoside triphosphate biosynthetic process (GO:0009206),3/28,3,28,0.186248020738523,0.78928073174808,0,0,2.00642054574639,3.37214295482784,ATP5B;PRKAG2;ATP5G2
delta,2,regulation of BMP signaling pathway (GO:0030510),5/57,5,57,0.187322967768677,0.78928073174808,0,0,1.64268348774558,2.75136515454878,DLX1;SMAD4;SMURF2;GDF5;TRIM33
delta,2,regulation of mRNA metabolic process (GO:1903311),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,CDK11A;PTCD2
delta,2,ubiquinone biosynthetic process (GO:0006744),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,COQ2;COQ7
delta,2,histone H4-K8 acetylation (GO:0043982),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,KAT8;KAT7
delta,2,positive regulation of glycolytic process (GO:0045821),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,PRKAA1;HIF1A
delta,2,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,HGS;PTPRJ
delta,2,positive regulation of coenzyme metabolic process (GO:0051197),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,PRKAA1;HIF1A
delta,2,regulation of establishment of cell polarity (GO:2000114),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,RAP1B;BCAS3
delta,2,positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,SUPT16H;LEO1
delta,2,glycerophospholipid catabolic process (GO:0046475),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,PNPLA8;PRDX6
delta,2,negative regulation of cell aging (GO:0090344),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,CDK6;MIF
delta,2,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,CHST12;CSGALNACT2
delta,2,intra-S DNA damage checkpoint (GO:0031573),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,MSH2;EME2
delta,2,positive regulation of phosphoprotein phosphatase activity (GO:0032516),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,PPP1R12A;HSP90AB1
delta,2,microtubule depolymerization (GO:0007019),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,NCKAP5L;CKAP5
delta,2,regulation of protein complex disassembly (GO:0043244),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,OGFOD1;IGF1R
delta,2,negative regulation of protein processing (GO:0010955),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,CHAC1;CD55
delta,2,protein targeting to peroxisome (GO:0006625),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,PEX5;LONP2
delta,2,cytoplasmic sequestering of protein (GO:0051220),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,YWHAB;NFKBIE
delta,2,endoderm development (GO:0007492),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,DUSP4;SOX7
delta,2,histone H4-K5 acetylation (GO:0043981),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,KAT8;KAT7
delta,2,regulation of cell junction assembly (GO:1901888),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,RAP1B;CBFB
delta,2,positive regulation of alpha-beta T cell activation (GO:0046635),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,GLI3;CD55
delta,2,heparan sulfate proteoglycan biosynthetic process (GO:0015012),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,GLCE;XYLT2
delta,2,response to X-ray (GO:0010165),2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,MSH2;ATM
delta,2,"protein localization to chromosome, centromeric region (GO:0071459)",2/15,2,15,0.189427386994074,0.78928073174808,0,0,2.49687890137328,4.15418104864417,RB1;CTCF
delta,2,mitochondrial translational elongation (GO:0070125),7/88,7,88,0.189922775792152,0.78928073174808,0,0,1.4896152536602,2.47445610497296,MRPS9;MRPS27;MRPS14;MRPS34;MRPL15;MRPS6;DAP3
delta,2,regulation of neuron death (GO:1901214),6/73,6,73,0.194144971842116,0.78928073174808,0,0,1.53917192550408,2.52293384863009,EFNB2;EGLN3;RRAS2;VPS35;BTBD10;SORL1
delta,2,regulation of fat cell differentiation (GO:0045598),6/73,6,73,0.194144971842116,0.78928073174808,0,0,1.53917192550408,2.52293384863009,FTO;SMAD3;ENPP1;TRIB3;SIRT2;PPARD
delta,2,regulation of telomerase activity (GO:0051972),4/43,4,43,0.195675860584781,0.78928073174808,0,0,1.74200853584183,2.84173114061419,PKIB;HSP90AB1;TNKS;PINX1
delta,2,ceramide metabolic process (GO:0006672),4/43,4,43,0.195675860584781,0.78928073174808,0,0,1.74200853584183,2.84173114061419,PPP2CA;ORMDL2;SMPD1;CLN8
delta,2,regulation of protein modification process (GO:0031399),4/43,4,43,0.195675860584781,0.78928073174808,0,0,1.74200853584183,2.84173114061419,PPP2CA;SOCS1;PPP1R14C;ATG10
delta,2,I-kappaB kinase/NF-kappaB signaling (GO:0007249),5/58,5,58,0.196684662647326,0.78928073174808,0,0,1.61436135864652,2.62519942197857,IRAK1BP1;NKIRAS2;TLR9;RIPK1;RBCK1
delta,2,regulation of neurogenesis (GO:0050767),5/58,5,58,0.196684662647326,0.78928073174808,0,0,1.61436135864652,2.62519942197857,NUMB;CTNNB1;ASCL1;SORL1;CDK5RAP3
delta,2,regulation of vasculature development (GO:1901342),3/29,3,29,0.200070455531684,0.78928073174808,0,0,1.93723363037582,3.11717492601876,CTNNB1;TSPAN12;ETS1
delta,2,RNA polyadenylation (GO:0043631),3/29,3,29,0.200070455531684,0.78928073174808,0,0,1.93723363037582,3.11717492601876,NUDT21;LEO1;WDR33
delta,2,regulation of cell differentiation (GO:0045595),9/122,9,122,0.204674505271943,0.78928073174808,0,0,1.38146988395653,2.19147311778715,PPP2CA;DLX1;DDX5;CDK6;HSP90AB1;PLEKHB2;CBFB;ELL3;CLASP1
delta,2,translational elongation (GO:0006414),8/106,8,106,0.205436052538855,0.78928073174808,0,0,1.41332768002261,2.23676132193051,MRPS9;MRPS27;MRPS14;MRPS34;MRPL15;MRPS6;DAP3;C12ORF65
delta,2,regulation of B cell proliferation (GO:0030888),4/44,4,44,0.206854362800676,0.78928073174808,0,0,1.70241743275451,2.68256774715968,TLR9;ATM;MIF;TNFRSF21
delta,2,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),4/44,4,44,0.206854362800676,0.78928073174808,0,0,1.70241743275451,2.68256774715968,BAG6;DDX5;PPP1R13B;MSH2
delta,2,negative regulation of DNA metabolic process (GO:0051053),4/44,4,44,0.206854362800676,0.78928073174808,0,0,1.70241743275451,2.68256774715968,RTEL1;MSH2;FAM129B;ATR
delta,2,regulation of ATP metabolic process (GO:1903578),4/44,4,44,0.206854362800676,0.78928073174808,0,0,1.70241743275451,2.68256774715968,NUP205;NUP107;PRKAG2;AAAS
delta,2,negative regulation of protein metabolic process (GO:0051248),4/44,4,44,0.206854362800676,0.78928073174808,0,0,1.70241743275451,2.68256774715968,SNX3;PHB;FMN2;SIRT2
delta,2,protein localization to microtubule organizing center (GO:1905508),2/16,2,16,0.209270772433046,0.78928073174808,0,0,2.34082397003745,3.6613443437567,NEDD1;PIBF1
delta,2,protein transport along microtubule (GO:0098840),2/16,2,16,0.209270772433046,0.78928073174808,0,0,2.34082397003745,3.6613443437567,IFT74;IFT27
delta,2,sympathetic nervous system development (GO:0048485),2/16,2,16,0.209270772433046,0.78928073174808,0,0,2.34082397003745,3.6613443437567,CTNNB1;ASCL1
delta,2,ventricular cardiac muscle cell action potential (GO:0086005),2/16,2,16,0.209270772433046,0.78928073174808,0,0,2.34082397003745,3.6613443437567,PKP2;SCN3B
delta,2,neuron apoptotic process (GO:0051402),2/16,2,16,0.209270772433046,0.78928073174808,0,0,2.34082397003745,3.6613443437567,GAPDH;TNFRSF21
delta,2,regulation of SMAD protein import into nucleus (GO:0060390),2/16,2,16,0.209270772433046,0.78928073174808,0,0,2.34082397003745,3.6613443437567,SMAD4;SMAD3
delta,2,positive regulation of nitric-oxide synthase activity (GO:0051000),2/16,2,16,0.209270772433046,0.78928073174808,0,0,2.34082397003745,3.6613443437567,NOS1AP;HIF1A
delta,2,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),2/16,2,16,0.209270772433046,0.78928073174808,0,0,2.34082397003745,3.6613443437567,CIB1;HDAC9
delta,2,activation of protein kinase A activity (GO:0034199),2/16,2,16,0.209270772433046,0.78928073174808,0,0,2.34082397003745,3.6613443437567,PRKAR2A;PRKACB
delta,2,linoleic acid metabolic process (GO:0043651),2/16,2,16,0.209270772433046,0.78928073174808,0,0,2.34082397003745,3.6613443437567,PNPLA8;ACSL1
delta,2,regulation of glucose transport (GO:0010827),2/16,2,16,0.209270772433046,0.78928073174808,0,0,2.34082397003745,3.6613443437567,PRKAG2;TRIB3
delta,2,positive regulation of response to endoplasmic reticulum stress (GO:1905898),2/16,2,16,0.209270772433046,0.78928073174808,0,0,2.34082397003745,3.6613443437567,BAG6;NCK1
delta,2,regulation of interferon-alpha production (GO:0032647),2/16,2,16,0.209270772433046,0.78928073174808,0,0,2.34082397003745,3.6613443437567,SETD2;HAVCR2
delta,2,histone H2A acetylation (GO:0043968),2/16,2,16,0.209270772433046,0.78928073174808,0,0,2.34082397003745,3.6613443437567,YEATS4;BRD8
delta,2,regulation of histone H3-K4 methylation (GO:0051569),2/16,2,16,0.209270772433046,0.78928073174808,0,0,2.34082397003745,3.6613443437567,SMAD4;CTNNB1
delta,2,regulation of JNK cascade (GO:0046328),7/91,7,91,0.21263512709583,0.78928073174808,0,0,1.44050705848459,2.23016076130191,FZD7;TAOK1;TLR9;RIPK1;RASGRP1;IGF1R;ANKRD6
delta,2,positive regulation of myeloid cell differentiation (GO:0045639),3/30,3,30,0.214125060670563,0.78928073174808,0,0,1.87265917602996,2.88613303182789,ETS1;HIF1A;HSPA1A
delta,2,negative regulation of Notch signaling pathway (GO:0045746),3/30,3,30,0.214125060670563,0.78928073174808,0,0,1.87265917602996,2.88613303182789,NRARP;CHAC1;FAM129B
delta,2,regulation of embryonic development (GO:0045995),3/30,3,30,0.214125060670563,0.78928073174808,0,0,1.87265917602996,2.88613303182789,RBM19;CLASP1;FAM129B
delta,2,lysosome localization (GO:0032418),3/30,3,30,0.214125060670563,0.78928073174808,0,0,1.87265917602996,2.88613303182789,BLOC1S1;BLOC1S2;ARL8B
delta,2,respiratory system development (GO:0060541),3/30,3,30,0.214125060670563,0.78928073174808,0,0,1.87265917602996,2.88613303182789,BAG6;CHD7;NPHP3
delta,2,lung development (GO:0030324),3/30,3,30,0.214125060670563,0.78928073174808,0,0,1.87265917602996,2.88613303182789,BAG6;ERRFI1;NPHP3
delta,2,unsaturated fatty acid metabolic process (GO:0033559),4/45,4,45,0.218211186874231,0.78928073174808,0,0,1.66458593424886,2.53398574780894,SCP2;PNPLA8;ACSL1;DAGLB
delta,2,positive regulation of macroautophagy (GO:0016239),4/45,4,45,0.218211186874231,0.78928073174808,0,0,1.66458593424886,2.53398574780894,BNIP3L;RALB;SESN3;PIP4K2B
delta,2,positive regulation of intracellular transport (GO:0032388),4/45,4,45,0.218211186874231,0.78928073174808,0,0,1.66458593424886,2.53398574780894,BCAS3;NEDD4;GAB2;SORL1
delta,2,cholesterol transport (GO:0030301),4/45,4,45,0.218211186874231,0.78928073174808,0,0,1.66458593424886,2.53398574780894,STX12;APOM;SOAT1;LIPG
delta,2,negative regulation of phosphorylation (GO:0042326),6/76,6,76,0.219563548121586,0.78928073174808,0,0,1.47841513897102,2.24144526210133,CDKN1A;DNAJC10;CIB1;TARDBP;CDK5RAP3;ZBED3
delta,2,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),10/141,10,141,0.221606249054191,0.78928073174808,0,0,1.32812707519856,2.00129243339919,RB1;WFS1;TRAF3;CTNNBIP1;CEBPG;PIM1;TLR9;RBCK1;CDK5RAP3;HAVCR2
delta,2,transforming growth factor beta receptor signaling pathway (GO:0007179),6/77,6,77,0.228274808898717,0.78928073174808,0,0,1.45921494236101,2.15555971637806,TWSG1;SMAD4;SMAD3;FNTA;GDF5;TGFBR2
delta,2,positive regulation of JNK cascade (GO:0046330),6/77,6,77,0.228274808898717,0.78928073174808,0,0,1.45921494236101,2.15555971637806,FZD7;TAOK1;TLR9;RIPK1;RASGRP1;ANKRD6
delta,2,smoothened signaling pathway (GO:0007224),3/31,3,31,0.228380496799985,0.78928073174808,0,0,1.81225081551287,2.67622724789641,KIAA0586;IFT27;GLI3
delta,2,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),3/31,3,31,0.228380496799985,0.78928073174808,0,0,1.81225081551287,2.67622724789641,FOXA1;CBFB;CNOT2
delta,2,nuclear envelope organization (GO:0006998),3/31,3,31,0.228380496799985,0.78928073174808,0,0,1.81225081551287,2.67622724789641,CTDNEP1;TMEM43;TMEM170A
delta,2,bile acid metabolic process (GO:0008206),3/31,3,31,0.228380496799985,0.78928073174808,0,0,1.81225081551287,2.67622724789641,SCP2;OSBPL2;CYP46A1
delta,2,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),3/31,3,31,0.228380496799985,0.78928073174808,0,0,1.81225081551287,2.67622724789641,HSP90AB1;SMAD3;NOS1AP
delta,2,hippo signaling (GO:0035329),3/31,3,31,0.228380496799985,0.78928073174808,0,0,1.81225081551287,2.67622724789641,MOB1A;YWHAB;STK3
delta,2,high-density lipoprotein particle remodeling (GO:0034375),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,APOM;LIPG
delta,2,positive regulation of cholesterol transport (GO:0032376),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,SCP2;LIPG
delta,2,reverse cholesterol transport (GO:0043691),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,APOM;LIPG
delta,2,negative regulation of immune effector process (GO:0002698),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,CD55;HAVCR2
delta,2,positive regulation of fatty acid metabolic process (GO:0045923),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,LPGAT1;PPARGC1B
delta,2,negative regulation of B cell activation (GO:0050869),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,ATM;TNFRSF21
delta,2,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,SLC25A5;HSPA1A
delta,2,positive regulation of dendrite extension (GO:1903861),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,SYT4;PLAA
delta,2,negative regulation of cell development (GO:0010721),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,SMAD4;SORL1
delta,2,regulation of myelination (GO:0031641),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,SIRT2;TNFRSF21
delta,2,peptidyl-lysine methylation (GO:0018022),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,SETD2;METTL21A
delta,2,negative regulation of intracellular transport (GO:0032387),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,SLC25A5;HSPA1A
delta,2,positive regulation of cellular protein catabolic process (GO:1903364),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,VPS35;PTTG1IP
delta,2,peptidyl-lysine trimethylation (GO:0018023),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,SETD2;SUV39H1
delta,2,serine family amino acid metabolic process (GO:0009069),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,SEPSECS;MTHFD1
delta,2,positive regulation by host of viral transcription (GO:0043923),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,SP1;ZNF639
delta,2,positive chemotaxis (GO:0050918),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,PTPRJ;MET
delta,2,regulation of establishment or maintenance of cell polarity (GO:0032878),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,RAP1B;BCAS3
delta,2,nucleobase-containing compound biosynthetic process (GO:0034654),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,AMPD3;TYMS
delta,2,DNA catabolic process (GO:0006308),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,ISG20;XRN2
delta,2,positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,VPS35;PHB
delta,2,microtubule nucleation (GO:0007020),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,RANBP9;CLASP1
delta,2,positive regulation of nitrogen compound metabolic process (GO:0051173),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,PAX8;WFS1
delta,2,2-oxoglutarate metabolic process (GO:0006103),2/17,2,17,0.229307985471193,0.78928073174808,0,0,2.20312844238819,3.24452360496642,IDH2;DLST
delta,2,mitochondrial gene expression (GO:0140053),4/46,4,46,0.229730414411358,0.78928073174808,0,0,1.62839928350432,2.39512908121404,MRPS34;HARS;HARS2;MRPS6
delta,2,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),8/110,8,110,0.234168313141134,0.78928073174808,0,0,1.36193394620361,1.97714012292731,EGLN3;SMAD3;BAD;CASP4;CYCS;RIPK1;SOX7;SENP1
delta,2,negative regulation of protein kinase activity (GO:0006469),8/110,8,110,0.234168313141134,0.78928073174808,0,0,1.36193394620361,1.97714012292731,RB1;CDKN1A;SH3BP5;PRKAG2;TRIB3;SORL1;CDK5RAP3;IGF1R
delta,2,glycosaminoglycan metabolic process (GO:0030203),5/62,5,62,0.235610563503973,0.78928073174808,0,0,1.51020901292739,2.18312038118512,GLB1;XYLT2;XYLT1;GPC2;GPC5
delta,2,regulation of DNA replication (GO:0006275),5/62,5,62,0.235610563503973,0.78928073174808,0,0,1.51020901292739,2.18312038118512,PPP2CA;CTC1;USP37;IGF1R;ATR
delta,2,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),7/94,7,94,0.23628251917351,0.78928073174808,0,0,1.39453342895848,2.0119311346519,EGLN3;PSMD14;PSMB3;HIGD1A;HIF1A;HSPA1A;NFE2L2
delta,2,response to ionizing radiation (GO:0010212),6/78,6,78,0.23709441594584,0.78928073174808,0,0,1.44050705848459,2.07331725390484,CDKN1A;PRKAA1;MSH2;RFWD3;H2AFX;ATM
delta,2,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),6/78,6,78,0.23709441594584,0.78928073174808,0,0,1.44050705848459,2.07331725390484,DLX1;SMAD3;SMURF2;TRIM33;TGFBR2;HSPA1A
delta,2,RNA secondary structure unwinding (GO:0010501),4/47,4,47,0.241396220084562,0.78928073174808,0,0,1.59375249023827,2.26522532273301,DDX28;DDX5;EIF4A3;DDX50
delta,2,cellular response to interleukin-12 (GO:0071349),4/47,4,47,0.241396220084562,0.78928073174808,0,0,1.59375249023827,2.26522532273301,RAP1B;ANXA2;MIF;LMNB1
delta,2,regulation of generation of precursor metabolites and energy (GO:0043467),4/47,4,47,0.241396220084562,0.78928073174808,0,0,1.59375249023827,2.26522532273301,NUP205;NUP107;PRKAG2;AAAS
delta,2,positive regulation of ion transport (GO:0043270),4/47,4,47,0.241396220084562,0.78928073174808,0,0,1.59375249023827,2.26522532273301,RAB3B;WFS1;PKP2;SCN3B
delta,2,maturation of SSU-rRNA (GO:0030490),4/47,4,47,0.241396220084562,0.78928073174808,0,0,1.59375249023827,2.26522532273301,MRPS9;WDR3;NGDN;PWP2
delta,2,mitotic spindle assembly (GO:0090307),4/47,4,47,0.241396220084562,0.78928073174808,0,0,1.59375249023827,2.26522532273301,ARHGEF10;PIBF1;CLASP1;KPNB1
delta,2,negative regulation of autophagy (GO:0010507),4/47,4,47,0.241396220084562,0.78928073174808,0,0,1.59375249023827,2.26522532273301,RRAGA;WDR6;MET;SIRT2
delta,2,cellular response to ionizing radiation (GO:0071479),4/47,4,47,0.241396220084562,0.78928073174808,0,0,1.59375249023827,2.26522532273301,CDKN1A;MDM2;ATM;ATR
delta,2,interleukin-12-mediated signaling pathway (GO:0035722),4/47,4,47,0.241396220084562,0.78928073174808,0,0,1.59375249023827,2.26522532273301,RAP1B;ANXA2;MIF;LMNB1
delta,2,regulation of G1/S transition of mitotic cell cycle (GO:2000045),4/47,4,47,0.241396220084562,0.78928073174808,0,0,1.59375249023827,2.26522532273301,RB1;CDKN1A;ZNF655;TMEM14B
delta,2,tRNA aminoacylation for protein translation (GO:0006418),4/47,4,47,0.241396220084562,0.78928073174808,0,0,1.59375249023827,2.26522532273301,TARSL2;GARS;HARS;HARS2
delta,2,secondary alcohol metabolic process (GO:1902652),3/32,3,32,0.242806353538816,0.78928073174808,0,0,1.75561797752809,2.48506153853865,SOAT1;CLN8;PPARD
delta,2,cofactor biosynthetic process (GO:0051188),3/32,3,32,0.242806353538816,0.78928073174808,0,0,1.75561797752809,2.48506153853865,ISCA1;NUBP1;GPHN
delta,2,nucleobase-containing small molecule interconversion (GO:0015949),3/32,3,32,0.242806353538816,0.78928073174808,0,0,1.75561797752809,2.48506153853865,AK2;CTPS1;TYMS
delta,2,liver development (GO:0001889),3/32,3,32,0.242806353538816,0.78928073174808,0,0,1.75561797752809,2.48506153853865,CEBPG;NPHP3;MET
delta,2,cellular protein catabolic process (GO:0044257),5/63,5,63,0.245663643352431,0.78928073174808,0,0,1.48623744129362,2.08636820359591,BNIP3L;LONP1;MDM2;RIPK1;VLDLR
delta,2,positive regulation of type I interferon production (GO:0032481),5/63,5,63,0.245663643352431,0.78928073174808,0,0,1.48623744129362,2.08636820359591,SETD2;IRF1;POLR1C;TLR9;CTNNB1
delta,2,mitotic recombination (GO:0006312),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,GEN1;SMC6
delta,2,protein localization to centrosome (GO:0071539),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,NEDD1;PIBF1
delta,2,nuclear envelope reassembly (GO:0031468),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,PPP2CA;LMNA
delta,2,regulation of lipid catabolic process (GO:0050994),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,PRKAA1;LONP2
delta,2,leukotriene biosynthetic process (GO:0019370),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,MGST3;ALOX5
delta,2,negative regulation of fibroblast proliferation (GO:0048147),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,MED25;FTH1
delta,2,establishment of mitotic spindle localization (GO:0040001),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,KPNB1;CLASP1
delta,2,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,SCARB2;CD55
delta,2,regulation of dephosphorylation (GO:0035303),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,PPP1R14C;CDK5RAP3
delta,2,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,NEDD4;PLAA
delta,2,anion homeostasis (GO:0055081),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,PRKAA1;LIPG
delta,2,prostaglandin biosynthetic process (GO:0001516),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,PNPLA8;MIF
delta,2,negative regulation of microtubule depolymerization (GO:0007026),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,CIB1;CLASP1
delta,2,phosphatidylglycerol acyl-chain remodeling (GO:0036148),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,LPGAT1;CRLS1
delta,2,positive regulation of carbohydrate metabolic process (GO:0045913),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,PRKAA1;HIF1A
delta,2,regulation of dendrite extension (GO:1903859),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,SYT4;PLAA
delta,2,receptor localization to synapse (GO:0097120),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,KIF5C;GPHN
delta,2,iron-sulfur cluster assembly (GO:0016226),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,ISCA1;NUBP1
delta,2,cardiac muscle cell contraction (GO:0086003),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,PKP2;SCN3B
delta,2,endoplasmic reticulum calcium ion homeostasis (GO:0032469),2/18,2,18,0.249461827441203,0.78928073174808,0,0,2.08073241781107,2.88899161823413,WFS1;HERPUD1
delta,2,regulation of mRNA stability (GO:0043488),9/129,9,129,0.252016785455003,0.78928073174808,0,0,1.30650640188137,1.80070497091791,FXR1;HSPA8;PSMD14;YWHAB;DIS3;PSMB3;METTL16;YWHAZ;HSPA1A
delta,2,polyol metabolic process (GO:0019751),4/48,4,48,0.253192924516987,0.78928073174808,0,0,1.5605493133583,2.14357605079318,INPP5A;INPP1;PLCG1;SLC5A3
delta,2,negative regulation of JAK-STAT cascade (GO:0046426),4/48,4,48,0.253192924516987,0.78928073174808,0,0,1.5605493133583,2.14357605079318,PPP2CA;SOCS1;HGS;PIBF1
delta,2,histone H4 acetylation (GO:0043967),4/48,4,48,0.253192924516987,0.78928073174808,0,0,1.5605493133583,2.14357605079318,KAT8;YEATS4;KAT7;BRD8
delta,2,negative regulation of mitotic cell cycle phase transition (GO:1901991),6/80,6,80,0.255032138208531,0.78928073174808,0,0,1.40449438202247,1.91905296288593,RB1;CDKN1A;PSMD14;PSMB3;PINX1;ZNF655
delta,2,cellular response to amino acid stimulus (GO:0071230),3/33,3,33,0.257373232736004,0.78928073174808,0,0,1.70241743275451,2.31056857363323,RRAGA;SESN3;IPO5
delta,2,cellular response to glucagon stimulus (GO:0071377),3/33,3,33,0.257373232736004,0.78928073174808,0,0,1.70241743275451,2.31056857363323,PRKAR2A;GNB1;PRKACB
delta,2,negative regulation of BMP signaling pathway (GO:0030514),3/33,3,33,0.257373232736004,0.78928073174808,0,0,1.70241743275451,2.31056857363323,DLX1;SMURF2;TRIM33
delta,2,ATP biosynthetic process (GO:0006754),3/33,3,33,0.257373232736004,0.78928073174808,0,0,1.70241743275451,2.31056857363323,ATP5B;PRKAG2;ATP5G2
delta,2,regulation of nitric oxide biosynthetic process (GO:0045428),3/33,3,33,0.257373232736004,0.78928073174808,0,0,1.70241743275451,2.31056857363323,HSP90AB1;SMAD3;NOS1AP
delta,2,protein deacetylation (GO:0006476),3/33,3,33,0.257373232736004,0.78928073174808,0,0,1.70241743275451,2.31056857363323,PHB;HDAC9;SIRT2
delta,2,phosphatidylcholine biosynthetic process (GO:0006656),3/33,3,33,0.257373232736004,0.78928073174808,0,0,1.70241743275451,2.31056857363323,ACHE;SLC27A1;ABHD3
delta,2,ceramide biosynthetic process (GO:0046513),3/33,3,33,0.257373232736004,0.78928073174808,0,0,1.70241743275451,2.31056857363323,SMPD1;CLN8;B4GALT6
delta,2,regulation of macromolecule metabolic process (GO:0060255),9/130,9,130,0.259063134748511,0.78928073174808,0,0,1.29645635263613,1.75110218255877,NPAT;MFAP4;CDK11A;CDK6;CDK4;EIF4A3;CDK10;ASCL1;HIF1A
delta,2,positive regulation of stress-activated MAPK cascade (GO:0032874),6/81,6,81,0.264136881157798,0.78928073174808,0,0,1.38715494520738,1.84670248435405,FZD7;TAOK1;TLR9;RIPK1;RASGRP1;ANKRD6
delta,2,spindle assembly (GO:0051225),6/81,6,81,0.264136881157798,0.78928073174808,0,0,1.38715494520738,1.84670248435405,ARHGEF10;TNKS;HAUS3;PIBF1;KPNB1;CLASP1
delta,2,regulation of organelle organization (GO:0033043),8/114,8,114,0.264192014002512,0.78928073174808,0,0,1.31414679019646,1.74923334574142,SCARB2;CLIC4;TBC1D5;TAOK1;TCTEX1D2;VPS35;EVI5L;TBC1D22B
delta,2,positive regulation of developmental process (GO:0051094),8/114,8,114,0.264192014002512,0.78928073174808,0,0,1.31414679019646,1.74923334574142,DLX1;HSP90AB1;SMURF2;RBM19;LMNA;VPS35;TP53BP1;FAM129B
delta,2,glucose metabolic process (GO:0006006),5/65,5,65,0.266087737352703,0.78928073174808,0,0,1.44050705848459,1.90712933580203,ENO3;SLC25A11;GAPDH;GDPGP1;PPARD
delta,2,positive regulation of neuron projection development (GO:0010976),7/98,7,98,0.269045369829004,0.78928073174808,0,0,1.33761369716426,1.75611992044892,SCARB2;SNX3;SYT4;TWF2;PLAA;VLDLR;CBFA2T2
delta,2,antigen processing and presentation of exogenous peptide antigen (GO:0002478),7/98,7,98,0.269045369829004,0.78928073174808,0,0,1.33761369716426,1.75611992044892,DCTN6;DYNC1I2;DCTN4;DCTN3;KLC1;KIF15;DNM2
delta,2,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),7/98,7,98,0.269045369829004,0.78928073174808,0,0,1.33761369716426,1.75611992044892,DCTN6;DYNC1I2;DCTN4;DCTN3;KLC1;KIF15;DNM2
delta,2,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),2/19,2,19,0.269662777627532,0.78928073174808,0,0,1.9712201852947,2.5834478067197,SMAD4;HSP90AB1
delta,2,protein import into mitochondrial matrix (GO:0030150),2/19,2,19,0.269662777627532,0.78928073174808,0,0,1.9712201852947,2.5834478067197,TOMM40;TOMM20L
delta,2,negative regulation of lymphocyte activation (GO:0051250),2/19,2,19,0.269662777627532,0.78928073174808,0,0,1.9712201852947,2.5834478067197,PIBF1;PAG1
delta,2,protein ADP-ribosylation (GO:0006471),2/19,2,19,0.269662777627532,0.78928073174808,0,0,1.9712201852947,2.5834478067197,TNKS;SIRT2
delta,2,sulfur compound transport (GO:0072348),2/19,2,19,0.269662777627532,0.78928073174808,0,0,1.9712201852947,2.5834478067197,SLC6A6;SLC25A26
delta,2,endothelial cell development (GO:0001885),2/19,2,19,0.269662777627532,0.78928073174808,0,0,1.9712201852947,2.5834478067197,RAP1B;MET
delta,2,leukotriene metabolic process (GO:0006691),2/19,2,19,0.269662777627532,0.78928073174808,0,0,1.9712201852947,2.5834478067197,MGST3;ALOX5
delta,2,cellular polysaccharide biosynthetic process (GO:0033692),2/19,2,19,0.269662777627532,0.78928073174808,0,0,1.9712201852947,2.5834478067197,B3GNT9;CSGALNACT2
delta,2,purine ribonucleotide catabolic process (GO:0009154),2/19,2,19,0.269662777627532,0.78928073174808,0,0,1.9712201852947,2.5834478067197,NUDT18;AMPD3
delta,2,folic acid metabolic process (GO:0046655),2/19,2,19,0.269662777627532,0.78928073174808,0,0,1.9712201852947,2.5834478067197,MTHFD1;ALDH1L2
delta,2,insulin secretion (GO:0030073),2/19,2,19,0.269662777627532,0.78928073174808,0,0,1.9712201852947,2.5834478067197,PTPRN;RAB11FIP5
delta,2,regulation of neuron migration (GO:2001222),2/19,2,19,0.269662777627532,0.78928073174808,0,0,1.9712201852947,2.5834478067197,ZNF609;PLAA
delta,2,positive regulation of immunoglobulin production (GO:0002639),2/19,2,19,0.269662777627532,0.78928073174808,0,0,1.9712201852947,2.5834478067197,TLR9;TP53BP1
delta,2,positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),2/19,2,19,0.269662777627532,0.78928073174808,0,0,1.9712201852947,2.5834478067197,SMAD3;HIF1A
delta,2,telomere capping (GO:0016233),2/19,2,19,0.269662777627532,0.78928073174808,0,0,1.9712201852947,2.5834478067197,DCLRE1B;CTC1
delta,2,positive regulation of epithelial cell differentiation (GO:0030858),2/19,2,19,0.269662777627532,0.78928073174808,0,0,1.9712201852947,2.5834478067197,BAD;NKX6-1
delta,2,protein heterotetramerization (GO:0051290),2/19,2,19,0.269662777627532,0.78928073174808,0,0,1.9712201852947,2.5834478067197,NUDT21;ANXA2
delta,2,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),2/19,2,19,0.269662777627532,0.78928073174808,0,0,1.9712201852947,2.5834478067197,SMAD4;HSP90AB1
delta,2,response to interferon-beta (GO:0035456),2/19,2,19,0.269662777627532,0.78928073174808,0,0,1.9712201852947,2.5834478067197,IFNAR2;IRF1
delta,2,entry into host cell (GO:0030260),3/34,3,34,0.272052815773988,0.78928073174808,0,0,1.65234633179114,2.15095680088587,ZNF639;CTNNB1;MET
delta,2,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),3/34,3,34,0.272052815773988,0.78928073174808,0,0,1.65234633179114,2.15095680088587,NUP205;NUP107;AAAS
delta,2,tRNA export from nucleus (GO:0006409),3/34,3,34,0.272052815773988,0.78928073174808,0,0,1.65234633179114,2.15095680088587,NUP205;NUP107;AAAS
delta,2,positive regulation of cell-matrix adhesion (GO:0001954),3/34,3,34,0.272052815773988,0.78928073174808,0,0,1.65234633179114,2.15095680088587,CDK6;CIB1;PTPRJ
delta,2,cellular response to glucose starvation (GO:0042149),3/34,3,34,0.272052815773988,0.78928073174808,0,0,1.65234633179114,2.15095680088587,PRKAA1;SESN3;HNRNPA1
delta,2,positive regulation of catalytic activity (GO:0043085),3/34,3,34,0.272052815773988,0.78928073174808,0,0,1.65234633179114,2.15095680088587,BCAS3;YWHAB;CIB1
delta,2,positive regulation of nucleocytoplasmic transport (GO:0046824),3/34,3,34,0.272052815773988,0.78928073174808,0,0,1.65234633179114,2.15095680088587,XPO4;NEDD4;IPO5
delta,2,negative regulation of multi-organism process (GO:0043901),3/34,3,34,0.272052815773988,0.78928073174808,0,0,1.65234633179114,2.15095680088587,ANXA2;TIMP1;SIRT2
delta,2,activation of MAPKK activity (GO:0000186),3/34,3,34,0.272052815773988,0.78928073174808,0,0,1.65234633179114,2.15095680088587,TAOK1;PLCG1;STK3
delta,2,positive regulation of cytokine-mediated signaling pathway (GO:0001961),3/34,3,34,0.272052815773988,0.78928073174808,0,0,1.65234633179114,2.15095680088587,CASP4;HIF1A;HSPA1A
delta,2,stem cell differentiation (GO:0048863),3/34,3,34,0.272052815773988,0.78928073174808,0,0,1.65234633179114,2.15095680088587,SETD2;ZNF281;ELL3
delta,2,positive regulation of protein catabolic process (GO:0045732),6/82,6,82,0.273323256697482,0.78928073174808,0,0,1.37023842148534,1.77733638505403,FZR1;SMURF2;NEDD4;VPS35;PTTG1IP;SORL1
delta,2,negative regulation of canonical Wnt signaling pathway (GO:0090090),10/149,10,149,0.273874904059864,0.78928073174808,0,0,1.25681823894628,1.62768498023384,INVS;PSMD14;IGFBP4;PSMB3;NPHP3;FUZ;GLI3;SCYL2;STK3;ANKRD6
delta,2,cellular response to type I interferon (GO:0071357),5/66,5,66,0.276439366314952,0.78928073174808,0,0,1.41868119396209,1.82408888330991,IFNAR2;ISG20;IRF1;SAMHD1;IRF9
delta,2,regulation of cell division (GO:0051302),5/66,5,66,0.276439366314952,0.78928073174808,0,0,1.41868119396209,1.82408888330991,SETD2;ORC6;CIB1;KIF20A;SIRT2
delta,2,type I interferon signaling pathway (GO:0060337),5/66,5,66,0.276439366314952,0.78928073174808,0,0,1.41868119396209,1.82408888330991,IFNAR2;ISG20;IRF1;SAMHD1;IRF9
delta,2,establishment of protein localization to mitochondrion (GO:0072655),4/50,4,50,0.277117324864516,0.78928073174808,0,0,1.49812734082397,1.92256825018955,CHCHD4;TOMM40;TIMM9;TOMM20L
delta,2,protein heterooligomerization (GO:0051291),4/50,4,50,0.277117324864516,0.78928073174808,0,0,1.49812734082397,1.92256825018955,NUDT21;ANXA2;MAT2A;RIPK1
delta,2,regulation of insulin secretion (GO:0050796),7/99,7,99,0.277423569935449,0.78928073174808,0,0,1.32410244769795,1.69777714442444,ARL2BP;STXBP4;BAD;ITPR1;ITPR2;SLC25A5;SLC8B1
delta,2,positive regulation of neuron differentiation (GO:0045666),7/99,7,99,0.277423569935449,0.78928073174808,0,0,1.32410244769795,1.69777714442444,SCARB2;SNX3;DLX1;TCF12;TWF2;CBFA2T2;ASCL1
delta,2,regulation of protein localization to early endosome (GO:1902965),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,SORL1
delta,2,positive regulation of skeletal muscle fiber development (GO:0048743),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,FAM129B
delta,2,protein localization to non-motile cilium (GO:0097499),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,TUB
delta,2,negative regulation of chromosome organization (GO:2001251),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,TOP2A
delta,2,negative regulation of transforming growth factor beta production (GO:0071635),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,HSP90AB1
delta,2,galactosylceramide metabolic process (GO:0006681),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,GALC
delta,2,vitamin K metabolic process (GO:0042373),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,VKORC1L1
delta,2,regulation of extent of cell growth (GO:0061387),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,DNM2
delta,2,determination of liver left/right asymmetry (GO:0071910),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,NPHP3
delta,2,lipoxin biosynthetic process (GO:2001301),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,ALOX5
delta,2,prepulse inhibition (GO:0060134),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,CTNNA2
delta,2,regulation of nuclear cell cycle DNA replication (GO:0033262),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,CDC7
delta,2,purine nucleobase biosynthetic process (GO:0009113),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,MTHFD1
delta,2,chromatin silencing at telomere (GO:0006348),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,SIRT2
delta,2,positive regulation of humoral immune response (GO:0002922),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,PHB
delta,2,bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,PKP2
delta,2,histone H4-K12 acetylation (GO:0043983),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,KAT7
delta,2,positive regulation of cardiac muscle tissue development (GO:0055025),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,EFNB2
delta,2,protein localization to endoplasmic reticulum exit site (GO:0070973),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,GBF1
delta,2,negative regulation of neural precursor cell proliferation (GO:2000178),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,SIRT2
delta,2,positive regulation of vesicle fusion (GO:0031340),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,ANXA2
delta,2,negative regulation of phospholipid metabolic process (GO:1903726),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,SLC27A1
delta,2,peroxisomal membrane transport (GO:0015919),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,PEX5
delta,2,"regulation of wound healing, spreading of epidermal cells (GO:1903689)",1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,CLASP1
delta,2,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,TGFBR2
delta,2,oxygen homeostasis (GO:0032364),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,HIF1A
delta,2,transcription initiation from RNA polymerase III promoter (GO:0006384),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,GTF3C1
delta,2,regulation of ribonucleoprotein complex localization (GO:2000197),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,SETD2
delta,2,membrane raft assembly (GO:0001765),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,ANXA2
delta,2,rescue of stalled ribosome (GO:0072344),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,C12ORF65
delta,2,glandular epithelial cell development (GO:0002068),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,CDK6
delta,2,intermediate filament bundle assembly (GO:0045110),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,PKP2
delta,2,regulation of glucokinase activity (GO:0033131),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,BAD
delta,2,regulation of interleukin-5 secretion (GO:2000662),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,TNFRSF21
delta,2,regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,SCN3B
delta,2,negative regulation of complement activation (GO:0045916),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,CD55
delta,2,blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,NRARP
delta,2,spinal cord dorsal/ventral patterning (GO:0021513),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,ASCL1
delta,2,regulation of protein K63-linked ubiquitination (GO:1900044),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,PLAA
delta,2,embryonic skeletal joint morphogenesis (GO:0060272),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,CTNNB1
delta,2,pronephros development (GO:0048793),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,PAX8
delta,2,signal complex assembly (GO:0007172),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,NCK1
delta,2,regulation of chemokine-mediated signaling pathway (GO:0070099),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,HIF1A
delta,2,pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,TYMS
delta,2,Golgi disassembly (GO:0090166),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,GBF1
delta,2,acetyl-CoA biosynthetic process (GO:0006085),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,PDHB
delta,2,response to lead ion (GO:0010288),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,PPP2CA
delta,2,positive regulation of microtubule motor activity (GO:2000576),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,DYNC1I2
delta,2,macrophage derived foam cell differentiation (GO:0010742),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,SOAT1
delta,2,regulation of response to wounding (GO:1903034),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,TNFRSF12A
delta,2,regulation of glial cell differentiation (GO:0045685),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,TNFRSF21
delta,2,purine ribonucleoside monophosphate catabolic process (GO:0009169),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,AMPD3
delta,2,corticosteroid receptor signaling pathway (GO:0031958),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,NEDD4
delta,2,positive regulation of helicase activity (GO:0051096),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,MSH2
delta,2,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,BAD
delta,2,regulation of mitotic spindle checkpoint (GO:1903504),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,CCNB1
delta,2,protein geranylgeranylation (GO:0018344),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,FNTA
delta,2,positive regulation of protein localization to endosome (GO:1905668),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,SORL1
delta,2,negative regulation of calcium ion-dependent exocytosis (GO:0045955),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,SYT4
delta,2,regulation of cell cycle checkpoint (GO:1901976),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,RFWD3
delta,2,regulation of interleukin-10 secretion (GO:2001179),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,TNFRSF21
delta,2,positive regulation of clathrin-dependent endocytosis (GO:2000370),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,SCYL2
delta,2,mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,PAX8
delta,2,regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,LMNA
delta,2,negative regulation of DNA repair (GO:0045738),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,RNF169
delta,2,monoubiquitinated protein deubiquitination (GO:0035520),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,BAP1
delta,2,morphogenesis of an endothelium (GO:0003159),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,CTNNB1
delta,2,response to catecholamine (GO:0071869),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,GNB1
delta,2,endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,UBXN6
delta,2,positive regulation of oxidative stress-induced cell death (GO:1903209),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,RIPK1
delta,2,mitochondrial RNA processing (GO:0000963),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,ELAC2
delta,2,positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,FOXA1
delta,2,positive regulation of trophoblast cell migration (GO:1901165),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,SMURF2
delta,2,protein localization to nucleolus (GO:1902570),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,PINX1
delta,2,astrocyte differentiation (GO:0048708),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,CDK6
delta,2,nucleoside phosphate catabolic process (GO:1901292),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,ENPP1
delta,2,regulation of mRNA export from nucleus (GO:0010793),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,SETD2
delta,2,regulation of interleukin-13 secretion (GO:2000665),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,TNFRSF21
delta,2,single strand break repair (GO:0000012),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,TDP1
delta,2,snRNA transcription from RNA polymerase III promoter (GO:0042796),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,SNAPC1
delta,2,positive regulation of fibroblast apoptotic process (GO:2000271),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,STK17A
delta,2,regulation of t-circle formation (GO:1904429),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,RTEL1
delta,2,glucocorticoid receptor signaling pathway (GO:0042921),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,NEDD4
delta,2,endoplasmic reticulum membrane organization (GO:0090158),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,ATL2
delta,2,foam cell differentiation (GO:0090077),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,SOAT1
delta,2,positive regulation of protein localization to centrosome (GO:1904781),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,CEP250
delta,2,negative regulation of glycogen biosynthetic process (GO:0045719),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,ENPP1
delta,2,dendritic spine maintenance (GO:0097062),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,IGF1R
delta,2,fructose 6-phosphate metabolic process (GO:0006002),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,PFKM
delta,2,neuron remodeling (GO:0016322),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,FARP2
delta,2,positive regulation of interferon-gamma secretion (GO:1902715),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,RASGRP1
delta,2,positive regulation of adaptive immune response (GO:0002821),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,IL6ST
delta,2,succinyl-CoA metabolic process (GO:0006104),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,DLST
delta,2,positive regulation of RNA binding (GO:1905216),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,NCBP1
delta,2,regulation of protein depolymerization (GO:1901879),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,MAP1A
delta,2,positive regulation of deacetylase activity (GO:0090045),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,FNTA
delta,2,protein retention in ER lumen (GO:0006621),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,PDIA3
delta,2,mitochondrial ribosome assembly (GO:0061668),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,DDX28
delta,2,positive regulation of protein localization to early endosome (GO:1902966),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,SORL1
delta,2,negative regulation of catecholamine secretion (GO:0033604),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,SYT4
delta,2,regulation of T cell tolerance induction (GO:0002664),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,TGFBR2
delta,2,response to gonadotropin (GO:0034698),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,PAX8
delta,2,snRNA modification (GO:0040031),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,METTL16
delta,2,cellular response to monoamine stimulus (GO:0071868),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,GNB1
delta,2,positive regulation of receptor binding (GO:1900122),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,ANXA2
delta,2,5S class rRNA transcription from RNA polymerase III type 1 promoter (GO:0042791),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,GTF3C1
delta,2,regulation of adiponectin secretion (GO:0070163),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,RAB11FIP5
delta,2,negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,PHB
delta,2,inner ear receptor cell development (GO:0060119),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,SLC4A7
delta,2,negative regulation of neurological system process (GO:0031645),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,TNFRSF21
delta,2,positive regulation of mitochondrial membrane potential (GO:0010918),1/6,1,6,0.280582655727579,0.78928073174808,0,0,3.1210986267166,3.96656343508521,BAD
delta,2,positive regulation of DNA metabolic process (GO:0051054),6/83,6,83,0.282584540112407,0.78928073174808,0,0,1.35372952484094,1.71081293641401,MECP2;CTC1;RTEL1;H2AFX;CEBPG;IGF1R
delta,2,negative regulation of T cell activation (GO:0050868),3/35,3,35,0.28681791550268,0.78928073174808,0,0,1.60513643659711,2.00466726375992,PAG1;TNFRSF21;HAVCR2
delta,2,regulation of axon extension (GO:0030516),3/35,3,35,0.28681791550268,0.78928073174808,0,0,1.60513643659711,2.00466726375992,TWF2;RNF6;DNM2
delta,2,regulation of insulin receptor signaling pathway (GO:0046626),3/35,3,35,0.28681791550268,0.78928073174808,0,0,1.60513643659711,2.00466726375992,SOCS1;ENPP1;NCK1
delta,2,positive regulation of chemokine production (GO:0032722),3/35,3,35,0.28681791550268,0.78928073174808,0,0,1.60513643659711,2.00466726375992,TLR9;HIF1A;IL6R
delta,2,response to glucagon (GO:0033762),3/35,3,35,0.28681791550268,0.78928073174808,0,0,1.60513643659711,2.00466726375992,PRKAR2A;GNB1;PRKACB
delta,2,regulation of interferon-beta production (GO:0032648),3/35,3,35,0.28681791550268,0.78928073174808,0,0,1.60513643659711,2.00466726375992,TRAF3;IRF1;TLR9
delta,2,regulation of double-strand break repair (GO:2000779),3/35,3,35,0.28681791550268,0.78928073174808,0,0,1.60513643659711,2.00466726375992,RTEL1;SETD2;RNF169
delta,2,regulation of interleukin-8 production (GO:0032677),3/35,3,35,0.28681791550268,0.78928073174808,0,0,1.60513643659711,2.00466726375992,TLR9;RIPK1;HSPA1A
delta,2,response to amino acid (GO:0043200),3/35,3,35,0.28681791550268,0.78928073174808,0,0,1.60513643659711,2.00466726375992,RRAGA;SESN3;IPO5
delta,2,cellular response to light stimulus (GO:0071482),5/67,5,67,0.28687121820113,0.78928073174808,0,0,1.39750684778355,1.7450973796682,NEDD4;GNB1;CNGA1;RNF7;ATR
delta,2,sphingolipid metabolic process (GO:0006665),8/117,8,117,0.287412824642943,0.78928073174808,0,0,1.28045071865297,1.59651164679796,ALDH3A2;PPP2CA;GALC;NEU3;GLB1;SMPD1;ORMDL2;CLN8
delta,2,protein targeting (GO:0006605),9/134,9,134,0.28783659815577,0.78928073174808,0,0,1.2577561630052,1.56636214243007,AP4M1;TOMM40;CDC37;TIMM9;RAB3IP;AP4E1;LONP2;AP4B1;SORL1
delta,2,receptor internalization (GO:0031623),4/51,4,51,0.289214801359325,0.78928073174808,0,0,1.46875229492546,1.82211296122482,SNX1;NEDD4;SCYL2;DNM2
delta,2,vacuolar acidification (GO:0007035),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,CCDC115;ATP6V0C
delta,2,regulation of vacuole organization (GO:0044088),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,SCARB2;ANXA2
delta,2,Golgi to endosome transport (GO:0006895),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,AP4M1;GBF1
delta,2,regulation of epidermal cell differentiation (GO:0045604),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,ERRFI1;CBFB
delta,2,response to progesterone (GO:0032570),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,CATSPERD;UBE3A
delta,2,negative regulation of protein depolymerization (GO:1901880),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,CIB1;CLASP1
delta,2,positive regulation of gene silencing by miRNA (GO:2000637),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,FXR1;DDX5
delta,2,glial cell development (GO:0021782),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,CDK6;ZNF488
delta,2,branching involved in ureteric bud morphogenesis (GO:0001658),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,PAX8;CTNNBIP1
delta,2,positive regulation of interferon-alpha production (GO:0032727),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,SETD2;TLR9
delta,2,regulation of toll-like receptor signaling pathway (GO:0034121),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,IRF1;TLR9
delta,2,inactivation of MAPK activity (GO:0000188),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,DUSP4;PPP2CA
delta,2,telomere maintenance via telomerase (GO:0007004),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,HSP90AB1;PINX1
delta,2,heparan sulfate proteoglycan metabolic process (GO:0030201),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,GLCE;XYLT2
delta,2,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,CDK10;EVI5L
delta,2,chondroitin sulfate biosynthetic process (GO:0030206),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,CHST12;CSGALNACT2
delta,2,dopaminergic neuron differentiation (GO:0071542),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,FOXA1;CTNNB1
delta,2,ureteric bud morphogenesis (GO:0060675),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,PAX8;CTNNBIP1
delta,2,synapsis (GO:0007129),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,BAG6;STAG3
delta,2,error-prone translesion synthesis (GO:0042276),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,REV1;REV3L
delta,2,Arp2/3 complex-mediated actin nucleation (GO:0034314),2/20,2,20,0.289848394738319,0.78928073174808,0,0,1.87265917602996,2.31909601022743,ACTR3;WHAMM
delta,2,protein maturation (GO:0051604),6/84,6,84,0.291914016839651,0.78928073174808,0,0,1.33761369716426,1.64699837206323,LIPT2;ISCA1;MMP16;DDI2;LONP2;SORL1
delta,2,cellular response to transforming growth factor beta stimulus (GO:0071560),7/101,7,101,0.29437007585683,0.78928073174808,0,0,1.29788259724849,1.58720339537422,DLX1;TWSG1;SMAD4;SMAD3;FNTA;GDF5;TGFBR2
delta,2,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),5/68,5,68,0.29737377185176,0.78928073174808,0,0,1.37695527649262,1.66992377221332,CDKN1A;PSRC1;CDC37;CDK5RAP3;IPO5
delta,2,positive regulation of autophagy (GO:0010508),5/68,5,68,0.29737377185176,0.78928073174808,0,0,1.37695527649262,1.66992377221332,BNIP3L;PRKAA1;SESN3;BAD;RNF152
delta,2,regulation of cardiac conduction (GO:1903779),5/68,5,68,0.29737377185176,0.78928073174808,0,0,1.37695527649262,1.66992377221332,TMEM65;ITPR1;ITPR2;TNNI3K;FPGT-TNNI3K
delta,2,positive regulation of supramolecular fiber organization (GO:1902905),6/85,6,85,0.301304995956038,0.78928073174808,0,0,1.32187706543291,1.58576636040847,CLIP1;PSRC1;PFN1;MET;CLASP1;NCK1
delta,2,negative regulation of neuron projection development (GO:0010977),4/52,4,52,0.301382812357506,0.78928073174808,0,0,1.44050705848459,1.7277067422011,EFNB2;CRMP1;CIB1;CBFA2T2
delta,2,response to organonitrogen compound (GO:0010243),4/52,4,52,0.301382812357506,0.78928073174808,0,0,1.44050705848459,1.7277067422011,ERLEC1;DNAJB12;KAT7;UBXN6
delta,2,regulation of exocytosis (GO:0017157),4/52,4,52,0.301382812357506,0.78928073174808,0,0,1.44050705848459,1.7277067422011,RAB3B;RALB;RAB40C;CLASP1
delta,2,regulation of cyclin-dependent protein kinase activity (GO:1904029),3/36,3,36,0.301642515653172,0.78928073174808,0,0,1.5605493133583,1.87033814881937,CDKN1A;CDC37;CDK5RAP3
delta,2,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",3/36,3,36,0.301642515653172,0.78928073174808,0,0,1.5605493133583,1.87033814881937,MRPS9;NGDN;PWP2
delta,2,positive regulation of ATPase activity (GO:0032781),3/36,3,36,0.301642515653172,0.78928073174808,0,0,1.5605493133583,1.87033814881937,DYNC1I2;DNAJC10;PFN1
delta,2,regulation of phosphoprotein phosphatase activity (GO:0043666),3/36,3,36,0.301642515653172,0.78928073174808,0,0,1.5605493133583,1.87033814881937,HSP90AB1;PPP1R12A;PPP6R1
delta,2,positive regulation of telomerase activity (GO:0051973),3/36,3,36,0.301642515653172,0.78928073174808,0,0,1.5605493133583,1.87033814881937,PKIB;HSP90AB1;TNKS
delta,2,carbohydrate catabolic process (GO:0016052),3/36,3,36,0.301642515653172,0.78928073174808,0,0,1.5605493133583,1.87033814881937,NEU3;MAN2C1;PFKM
delta,2,positive regulation of osteoblast differentiation (GO:0045669),3/36,3,36,0.301642515653172,0.78928073174808,0,0,1.5605493133583,1.87033814881937,CTNNBIP1;IL6ST;IL6R
delta,2,protein kinase B signaling (GO:0043491),3/36,3,36,0.301642515653172,0.78928073174808,0,0,1.5605493133583,1.87033814881937,CDKN1A;MDM2;SIRT2
delta,2,plasma membrane bounded cell projection organization (GO:0120036),8/119,8,119,0.303170170206703,0.78928073174808,0,0,1.25893053850754,1.50248451613274,RB1;BLOC1S5;BLOC1S1;MAP2;BLOC1S2;NEDD4;STX3;CEP78
delta,2,cholesterol metabolic process (GO:0008203),5/69,5,69,0.307937613004654,0.78928073174808,0,0,1.35699940292026,1.59835270002894,SOAT1;HMGCR;CYP46A1;CLN8;PPARD
delta,2,monocarboxylic acid biosynthetic process (GO:0072330),5/69,5,69,0.307937613004654,0.78928073174808,0,0,1.35699940292026,1.59835270002894,ABCD3;SCP2;CHST12;OSBPL2;CYP46A1
delta,2,dendritic cell differentiation (GO:0097028),2/21,2,21,0.309962760122715,0.78928073174808,0,0,1.78348492955235,2.08900145774098,BATF3;TGFBR2
delta,2,energy reserve metabolic process (GO:0006112),2/21,2,21,0.309962760122715,0.78928073174808,0,0,1.78348492955235,2.08900145774098,UGP2;PRKAG2
delta,2,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),2/21,2,21,0.309962760122715,0.78928073174808,0,0,1.78348492955235,2.08900145774098,BAG6;MSH2
delta,2,regulation of cardiac muscle hypertrophy (GO:0010611),2/21,2,21,0.309962760122715,0.78928073174808,0,0,1.78348492955235,2.08900145774098,SMAD4;IL6ST
delta,2,zinc II ion transport (GO:0006829),2/21,2,21,0.309962760122715,0.78928073174808,0,0,1.78348492955235,2.08900145774098,SLC30A7;SLC39A13
delta,2,mitochondrial ATP synthesis coupled proton transport (GO:0042776),2/21,2,21,0.309962760122715,0.78928073174808,0,0,1.78348492955235,2.08900145774098,ATP5B;ATP5G2
delta,2,positive regulation of BMP signaling pathway (GO:0030513),2/21,2,21,0.309962760122715,0.78928073174808,0,0,1.78348492955235,2.08900145774098,SMAD4;GDF5
delta,2,regulation of interleukin-2 production (GO:0032663),2/21,2,21,0.309962760122715,0.78928073174808,0,0,1.78348492955235,2.08900145774098,MALT1;HAVCR2
delta,2,ventricular septum morphogenesis (GO:0060412),2/21,2,21,0.309962760122715,0.78928073174808,0,0,1.78348492955235,2.08900145774098,SMAD4;TGFBR2
delta,2,cellular response to misfolded protein (GO:0071218),2/21,2,21,0.309962760122715,0.78928073174808,0,0,1.78348492955235,2.08900145774098,BAG6;DNAJB12
delta,2,cellular response to alkaloid (GO:0071312),2/21,2,21,0.309962760122715,0.78928073174808,0,0,1.78348492955235,2.08900145774098,CASP7;BAD
delta,2,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),2/21,2,21,0.309962760122715,0.78928073174808,0,0,1.78348492955235,2.08900145774098,CDKN1A;IPO5
delta,2,mitochondrial calcium ion transmembrane transport (GO:0006851),2/21,2,21,0.309962760122715,0.78928073174808,0,0,1.78348492955235,2.08900145774098,PHB;SLC8B1
delta,2,positive regulation of receptor internalization (GO:0002092),2/21,2,21,0.309962760122715,0.78928073174808,0,0,1.78348492955235,2.08900145774098,TBC1D5;SCYL2
delta,2,hepaticobiliary system development (GO:0061008),2/21,2,21,0.309962760122715,0.78928073174808,0,0,1.78348492955235,2.08900145774098,CEBPG;MET
delta,2,RNA-dependent DNA biosynthetic process (GO:0006278),2/21,2,21,0.309962760122715,0.78928073174808,0,0,1.78348492955235,2.08900145774098,HSP90AB1;PINX1
delta,2,histone ubiquitination (GO:0016574),2/21,2,21,0.309962760122715,0.78928073174808,0,0,1.78348492955235,2.08900145774098,LEO1;ATXN7L3
delta,2,regulation of neuron projection development (GO:0010975),8/120,8,120,0.311120161367283,0.78928073174808,0,0,1.24843945068664,1.45764802805124,SCARB2;EFNB2;SNX3;CDH2;TWF2;CRMP1;CIB1;CBFA2T2
delta,2,brain development (GO:0007420),8/120,8,120,0.311120161367283,0.78928073174808,0,0,1.24843945068664,1.45764802805124,BAG6;CDH2;SLC6A17;UBE3A;CTNNA2;CIC;CDK5RAP3;TGFBR2
delta,2,muscle cell differentiation (GO:0042692),3/37,3,37,0.316501798293306,0.78928073174808,0,0,1.51837230488916,1.74677551716164,RB1;DDX5;MBNL1
delta,2,endoderm formation (GO:0001706),3/37,3,37,0.316501798293306,0.78928073174808,0,0,1.51837230488916,1.74677551716164,DUSP4;SETD2;SOX7
delta,2,histone deacetylation (GO:0016575),3/37,3,37,0.316501798293306,0.78928073174808,0,0,1.51837230488916,1.74677551716164,PHB;HDAC9;SIRT2
delta,2,regulation of cell morphogenesis involved in differentiation (GO:0010769),3/37,3,37,0.316501798293306,0.78928073174808,0,0,1.51837230488916,1.74677551716164,FXR1;CDH2;NEDD4
delta,2,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",3/37,3,37,0.316501798293306,0.78928073174808,0,0,1.51837230488916,1.74677551716164,GNAO1;GNB1;CTNNB1
delta,2,spermatid development (GO:0007286),3/37,3,37,0.316501798293306,0.78928073174808,0,0,1.51837230488916,1.74677551716164,KLHL26;CIB1;IQCG
delta,2,regulation of nitric-oxide synthase activity (GO:0050999),3/37,3,37,0.316501798293306,0.78928073174808,0,0,1.51837230488916,1.74677551716164,NOS1AP;HIF1A;DNM2
delta,2,regulation of osteoblast differentiation (GO:0045667),5/70,5,70,0.318553453427528,0.78928073174808,0,0,1.33761369716426,1.5301832388894,DDX5;CDK6;CTNNBIP1;IL6ST;IL6R
delta,2,adherens junction assembly (GO:0034333),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,CTNNB1
delta,2,protein localization to basolateral plasma membrane (GO:1903361),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,AP4M1
delta,2,replication fork protection (GO:0048478),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,DONSON
delta,2,tRNA pseudouridine synthesis (GO:0031119),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,RPUSD3
delta,2,positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,FZD7
delta,2,cellular response to interleukin-18 (GO:0071351),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,ALOX5
delta,2,regulation of myosin-light-chain-phosphatase activity (GO:0035507),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,PPP1R12A
delta,2,response to misfolded protein (GO:0051788),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,DNAJB12
delta,2,tRNA transcription from RNA polymerase III promoter (GO:0042797),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,GTF3C1
delta,2,flavin-containing compound metabolic process (GO:0042726),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,ENPP1
delta,2,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,CIB1
delta,2,regulation of ER to Golgi vesicle-mediated transport (GO:0060628),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,SORL1
delta,2,ribonucleoside bisphosphate biosynthetic process (GO:0034030),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,DCAKD
delta,2,elastic fiber assembly (GO:0048251),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,MFAP4
delta,2,sulfur amino acid biosynthetic process (GO:0000097),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,MTHFD1
delta,2,death-inducing signaling complex assembly (GO:0071550),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,RIPK1
delta,2,negative regulation of cytokinesis (GO:0032466),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,ZFYVE19
delta,2,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,NUP107
delta,2,translational readthrough (GO:0006451),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,SEPSECS
delta,2,protein import into mitochondrial inner membrane (GO:0045039),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,TIMM9
delta,2,molybdopterin cofactor metabolic process (GO:0043545),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,GPHN
delta,2,AMP metabolic process (GO:0046033),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,AMPD3
delta,2,regulation of toll-like receptor 9 signaling pathway (GO:0034163),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,TLR9
delta,2,tRNA 3'-end processing (GO:0042780),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,ELAC2
delta,2,gas homeostasis (GO:0033483),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,HIF1A
delta,2,chitin metabolic process (GO:0006030),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,CTBS
delta,2,regulation of isotype switching (GO:0045191),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,TP53BP1
delta,2,formation of translation preinitiation complex (GO:0001731),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,DENR
delta,2,box C/D snoRNP assembly (GO:0000492),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,NUFIP1
delta,2,regulation of interleukin-18 production (GO:0032661),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,TLR9
delta,2,glycosphingolipid catabolic process (GO:0046479),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,NEU3
delta,2,response to type I interferon (GO:0034340),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,SETD2
delta,2,negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,CDK5RAP3
delta,2,determination of digestive tract left/right asymmetry (GO:0071907),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,NPHP3
delta,2,establishment of protein localization to peroxisome (GO:0072663),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,LONP2
delta,2,carbohydrate transport (GO:0008643),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,SLC50A1
delta,2,morphogenesis of a polarized epithelium (GO:0001738),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,FUZ
delta,2,regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,HNRNPK
delta,2,regulation of histone H3-K9 acetylation (GO:2000615),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,SMAD4
delta,2,regulation of high voltage-gated calcium channel activity (GO:1901841),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,NOS1AP
delta,2,modification by symbiont of host morphology or physiology (GO:0044003),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,RRAGA
delta,2,protein deglutamylation (GO:0035608),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,AGBL5
delta,2,negative regulation of membrane protein ectodomain proteolysis (GO:0051045),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,TIMP1
delta,2,positive regulation of protein kinase A signaling (GO:0010739),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,MIF
delta,2,regulation of alpha-beta T cell differentiation (GO:0046637),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,GLI3
delta,2,negative regulation of cardiocyte differentiation (GO:1905208),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,FZD7
delta,2,tRNA transcription (GO:0009304),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,GTF3C1
delta,2,regulation of meiotic nuclear division (GO:0040020),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,SIRT2
delta,2,"retrograde transport, vesicle recycling within Golgi (GO:0000301)",1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,GOLGA5
delta,2,protection from non-homologous end joining at telomere (GO:0031848),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,DCLRE1B
delta,2,regulation of glucocorticoid receptor signaling pathway (GO:2000322),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,PHB
delta,2,positive regulation of neuroblast proliferation (GO:0002052),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,CTNNB1
delta,2,auditory receptor cell differentiation (GO:0042491),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,SLC4A7
delta,2,regulation of establishment of protein localization (GO:0070201),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,KIAA0586
delta,2,cellular response to histamine (GO:0071420),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,GABRB1
delta,2,regulation of growth hormone secretion (GO:0060123),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,CHD7
delta,2,female gonad development (GO:0008585),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,NUP107
delta,2,mannose metabolic process (GO:0006013),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,MAN2C1
delta,2,regulation of NADP metabolic process (GO:1902031),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,ME1
delta,2,hyaluronan biosynthetic process (GO:0030213),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,ABCC5
delta,2,negative regulation of glycogen metabolic process (GO:0070874),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,ENPP1
delta,2,epithelial cell differentiation involved in kidney development (GO:0035850),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,PAX8
delta,2,positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,GEN1
delta,2,adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,GNB1
delta,2,forebrain neuron differentiation (GO:0021879),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,ASCL1
delta,2,molybdopterin cofactor biosynthetic process (GO:0032324),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,GPHN
delta,2,xenobiotic catabolic process (GO:0042178),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,CRYZ
delta,2,noradrenergic neuron differentiation (GO:0003357),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,ASCL1
delta,2,purine nucleoside bisphosphate biosynthetic process (GO:0034033),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,DCAKD
delta,2,alditol metabolic process (GO:0019400),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,COQ2
delta,2,SA node cell action potential (GO:0086015),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,SCN3B
delta,2,regulation of microtubule binding (GO:1904526),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,PPP2CA
delta,2,protein maturation by iron-sulfur cluster transfer (GO:0097428),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,ISCA1
delta,2,tooth mineralization (GO:0034505),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,FAM20C
delta,2,regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,NSD1
delta,2,cleavage furrow formation (GO:0036089),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,SPIRE1
delta,2,outer mitochondrial membrane organization (GO:0007008),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,TOMM20L
delta,2,response to increased oxygen levels (GO:0036296),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,CCDC115
delta,2,kidney epithelium development (GO:0072073),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,PAX8
delta,2,sensory organ morphogenesis (GO:0090596),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,GLI3
delta,2,"regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,NPHP3
delta,2,regulation of protein localization to centrosome (GO:1904779),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,CEP250
delta,2,negative regulation of cardiac muscle tissue development (GO:0055026),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,FZD7
delta,2,chitin catabolic process (GO:0006032),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,CTBS
delta,2,metanephric nephron tubule development (GO:0072234),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,PAX8
delta,2,long-chain fatty acid catabolic process (GO:0042758),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,AIG1
delta,2,selenocysteine incorporation (GO:0001514),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,SEPSECS
delta,2,long-chain fatty acid import (GO:0044539),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,ACSL1
delta,2,cellular phosphate ion homeostasis (GO:0030643),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,ENPP1
delta,2,leucine metabolic process (GO:0006551),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,HMGCLL1
delta,2,cellular response to gonadotropin stimulus (GO:0071371),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,PAX8
delta,2,inner ear receptor stereocilium organization (GO:0060122),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,CLIC5
delta,2,positive regulation of keratinocyte proliferation (GO:0010838),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,STXBP4
delta,2,cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,PKP2
delta,2,cardiac atrium development (GO:0003230),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,NPHP3
delta,2,purine nucleotide biosynthetic process (GO:0006164),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,MTHFD1
delta,2,regulation of entry of bacterium into host cell (GO:2000535),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,EXOC2
delta,2,cellular divalent inorganic anion homeostasis (GO:0072501),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,ENPP1
delta,2,negative regulation of muscle hypertrophy (GO:0014741),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,SMAD4
delta,2,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,BCDIN3D
delta,2,coenzyme A biosynthetic process (GO:0015937),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,DCAKD
delta,2,regulation of hormone biosynthetic process (GO:0046885),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,HIF1A
delta,2,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,RB1
delta,2,cellular trivalent inorganic anion homeostasis (GO:0072502),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,ENPP1
delta,2,mitochondrial DNA metabolic process (GO:0032042),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,LONP1
delta,2,regulation of endocytic recycling (GO:2001135),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,SORL1
delta,2,regulation of dendritic spine maintenance (GO:1902950),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,VPS35
delta,2,regulation of cardiac muscle cell membrane potential (GO:0086036),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,SLC8B1
delta,2,oxaloacetate metabolic process (GO:0006107),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,NIT2
delta,2,bone cell development (GO:0098751),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,ANXA2
delta,2,positive regulation of mast cell degranulation (GO:0043306),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,GAB2
delta,2,cellular response to laminar fluid shear stress (GO:0071499),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,NFE2L2
delta,2,regulation of lymphocyte migration (GO:2000401),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,SLC8B1
delta,2,positive regulation of epithelial cell differentiation involved in kidney development (GO:2000698),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,PAX8
delta,2,positive regulation of cellular senescence (GO:2000774),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,ARG2
delta,2,protein localization to ciliary membrane (GO:1903441),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,TUB
delta,2,positive regulation of extracellular matrix disassembly (GO:0090091),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,CLASP1
delta,2,riboflavin metabolic process (GO:0006771),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,ENPP1
delta,2,positive regulation of histone H4 acetylation (GO:0090240),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,KAT7
delta,2,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,SEC62
delta,2,nucleic acid transport (GO:0050657),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,CKAP5
delta,2,negative regulation of striated muscle tissue development (GO:0045843),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,SIRT2
delta,2,pteridine-containing compound biosynthetic process (GO:0042559),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,PTS
delta,2,negative regulation of telomere capping (GO:1904354),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,ATM
delta,2,nuclear body organization (GO:0030575),1/7,1,7,0.319011014076749,0.78928073174808,0,0,2.67522739432852,3.0565266182637,ETS1
delta,2,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),4/54,4,54,0.325873545076291,0.78928073174808,0,0,1.38715494520738,1.5553417553149,ARL2BP;IL6ST;IL6R;PIBF1
delta,2,Golgi organization (GO:0007030),8/122,8,122,0.327143212032172,0.78928073174808,0,0,1.22797323018358,1.37208478746885,BCAS3;GOLGA5;GORASP2;STX16;ATL2;GBF1;YWHAZ;CLASP1
delta,2,cytoskeleton-dependent cytokinesis (GO:0061640),5/71,5,71,0.329212148623978,0.78928073174808,0,0,1.31877406762673,1.46522776202078,INCENP;DCTN3;JTB;SPIRE1;KIF20A
delta,2,stress-activated protein kinase signaling cascade (GO:0031098),5/71,5,71,0.329212148623978,0.78928073174808,0,0,1.31877406762673,1.46522776202078,MAP3K2;TAOK1;KAT7;OXSR1;STK3
delta,2,positive regulation of cellular component biogenesis (GO:0044089),6/88,6,88,0.329780653997875,0.78928073174808,0,0,1.27681307456588,1.41640389476181,SMAD3;CLSTN2;HGS;ATM;PFN1;ATR
delta,2,cellular response to hexose stimulus (GO:0071331),2/22,2,22,0.329955960358118,0.78928073174808,0,0,1.70241743275451,1.88763378768738,UNC13B;IGF1R
delta,2,peripheral nervous system development (GO:0007422),2/22,2,22,0.329955960358118,0.78928073174808,0,0,1.70241743275451,1.88763378768738,ALDH3A2;SCN8A
delta,2,negative regulation of actin filament polymerization (GO:0030837),2/22,2,22,0.329955960358118,0.78928073174808,0,0,1.70241743275451,1.88763378768738,TWF2;PFN1
delta,2,positive regulation of interleukin-10 production (GO:0032733),2/22,2,22,0.329955960358118,0.78928073174808,0,0,1.70241743275451,1.88763378768738,TLR9;PIBF1
delta,2,rRNA modification (GO:0000154),2/22,2,22,0.329955960358118,0.78928073174808,0,0,1.70241743275451,1.88763378768738,DIMT1;THUMPD1
delta,2,purine-containing compound biosynthetic process (GO:0072522),2/22,2,22,0.329955960358118,0.78928073174808,0,0,1.70241743275451,1.88763378768738,MTHFD1;AMPD3
delta,2,protein complex localization (GO:0031503),2/22,2,22,0.329955960358118,0.78928073174808,0,0,1.70241743275451,1.88763378768738,IFT74;IFT27
delta,2,inner ear morphogenesis (GO:0042472),2/22,2,22,0.329955960358118,0.78928073174808,0,0,1.70241743275451,1.88763378768738,PAX8;CHD7
delta,2,negative regulation of nervous system development (GO:0051961),2/22,2,22,0.329955960358118,0.78928073174808,0,0,1.70241743275451,1.88763378768738,SORL1;TNFRSF21
delta,2,negative regulation of protein polymerization (GO:0032272),2/22,2,22,0.329955960358118,0.78928073174808,0,0,1.70241743275451,1.88763378768738,TWF2;PFN1
delta,2,protein homotrimerization (GO:0070207),2/22,2,22,0.329955960358118,0.78928073174808,0,0,1.70241743275451,1.88763378768738,SMAD4;MIF
delta,2,outflow tract septum morphogenesis (GO:0003148),2/22,2,22,0.329955960358118,0.78928073174808,0,0,1.70241743275451,1.88763378768738,SMAD4;TGFBR2
delta,2,hematopoietic progenitor cell differentiation (GO:0002244),2/22,2,22,0.329955960358118,0.78928073174808,0,0,1.70241743275451,1.88763378768738,ARMC6;PRRC2C
delta,2,epithelial to mesenchymal transition (GO:0001837),3/38,3,38,0.331372161213028,0.78928073174808,0,0,1.47841513897102,1.63292900813108,DDX5;CTNNB1;HIF1A
delta,2,protein monoubiquitination (GO:0006513),3/38,3,38,0.331372161213028,0.78928073174808,0,0,1.47841513897102,1.63292900813108,UBE2T;LEO1;ATXN7L3
delta,2,regulation of dendrite development (GO:0050773),3/38,3,38,0.331372161213028,0.78928073174808,0,0,1.47841513897102,1.63292900813108,FXR1;NEDD4;VLDLR
delta,2,regulation of sodium ion transmembrane transporter activity (GO:2000649),3/38,3,38,0.331372161213028,0.78928073174808,0,0,1.47841513897102,1.63292900813108,NEDD4;SLMAP;SCN3B
delta,2,response to steroid hormone (GO:0048545),3/38,3,38,0.331372161213028,0.78928073174808,0,0,1.47841513897102,1.63292900813108,CATSPERD;UBE3A;UBE2L3
delta,2,base-excision repair (GO:0006284),3/38,3,38,0.331372161213028,0.78928073174808,0,0,1.47841513897102,1.63292900813108,NEIL2;ERCC6;UNG
delta,2,neuron differentiation (GO:0030182),9/140,9,140,0.33241734330116,0.78928073174808,0,0,1.20385232744783,1.32587966456544,RB1;FOXA1;FXR1;ALK;MYEF2;FZD7;CTNNB1;ASCL1;POU3F2
delta,2,sulfur compound biosynthetic process (GO:0044272),8/123,8,123,0.335208465167228,0.78928073174808,0,0,1.21798970798697,1.33126598655856,MAT2A;CHST12;GLCE;MGST3;CSGALNACT2;XYLT2;CHAC1;B4GALT6
delta,2,negative regulation of cellular component organization (GO:0051129),4/55,4,55,0.338168771829562,0.78928073174808,0,0,1.36193394620361,1.47662265329356,HSPA8;SACS;DNM2;HSPA1A
delta,2,glycosphingolipid metabolic process (GO:0006687),4/55,4,55,0.338168771829562,0.78928073174808,0,0,1.36193394620361,1.47662265329356,GALC;NEU3;GLB1;SMPD1
delta,2,cellular response to nutrient levels (GO:0031669),4/55,4,55,0.338168771829562,0.78928073174808,0,0,1.36193394620361,1.47662265329356,HSPA8;RRAGA;PRKAA1;RALB
delta,2,negative regulation of translation (GO:0017148),6/89,6,89,0.339351636208625,0.78928073174808,0,0,1.26246686024492,1.36437120849378,FXR1;CNOT2;EIF4A3;METTL16;TYMS;GAPDH
delta,2,histone acetylation (GO:0016573),5/72,5,72,0.339904714099297,0.78928073174808,0,0,1.30045776113192,1.40331090472738,KAT8;YEATS4;KAT7;BRD8;SUPT3H
delta,2,organelle membrane fusion (GO:0090174),5/72,5,72,0.339904714099297,0.78928073174808,0,0,1.30045776113192,1.40331090472738,STX12;SYT4;STX16;STX3;YKT6
delta,2,mitochondrion disassembly (GO:0061726),3/39,3,39,0.346231226095208,0.78928073174808,0,0,1.44050705848459,1.527871569597,GABARAPL1;RB1CC1;ATG12
delta,2,fatty acid metabolic process (GO:0006631),7/107,7,107,0.346370986760091,0.78928073174808,0,0,1.22510413385138,1.29891036365906,SCARB2;ABCD3;ACSL1;PNPLA8;FASN;ALOX5;PPARD
delta,2,regulation of establishment of planar polarity (GO:0090175),6/90,6,90,0.348951442616321,0.78928073174808,0,0,1.24843945068664,1.31438514277667,PSMD14;SMURF2;PSMB3;FZD7;NPHP3;PFN1
delta,2,"nucleotide-excision repair, DNA gap filling (GO:0006297)",2/23,2,23,0.34978360635625,0.78928073174808,0,0,1.62839928350432,1.71053669314191,POLD3;POLD4
delta,2,zinc II ion transmembrane transport (GO:0071577),2/23,2,23,0.34978360635625,0.78928073174808,0,0,1.62839928350432,1.71053669314191,SLC30A7;SLC39A13
delta,2,protein K48-linked deubiquitination (GO:0071108),2/23,2,23,0.34978360635625,0.78928073174808,0,0,1.62839928350432,1.71053669314191,USP37;BAP1
delta,2,peroxisome organization (GO:0007031),2/23,2,23,0.34978360635625,0.78928073174808,0,0,1.62839928350432,1.71053669314191,ABCD3;LONP2
delta,2,positive regulation of ATP metabolic process (GO:1903580),2/23,2,23,0.34978360635625,0.78928073174808,0,0,1.62839928350432,1.71053669314191,PRKAA1;HIF1A
delta,2,cellular response to ammonium ion (GO:0071242),2/23,2,23,0.34978360635625,0.78928073174808,0,0,1.62839928350432,1.71053669314191,GABRB1;CASP7
delta,2,folic acid-containing compound metabolic process (GO:0006760),2/23,2,23,0.34978360635625,0.78928073174808,0,0,1.62839928350432,1.71053669314191,MTHFD1;ALDH1L2
delta,2,rRNA methylation (GO:0031167),2/23,2,23,0.34978360635625,0.78928073174808,0,0,1.62839928350432,1.71053669314191,DIMT1;METTL16
delta,2,autophagosome maturation (GO:0097352),2/23,2,23,0.34978360635625,0.78928073174808,0,0,1.62839928350432,1.71053669314191,GABARAPL1;LIX1L
delta,2,regulation of monooxygenase activity (GO:0032768),2/23,2,23,0.34978360635625,0.78928073174808,0,0,1.62839928350432,1.71053669314191,NOS1AP;DNM2
delta,2,cellular response to amyloid-beta (GO:1904646),2/23,2,23,0.34978360635625,0.78928073174808,0,0,1.62839928350432,1.71053669314191,CASP4;IGF1R
delta,2,positive regulation of monooxygenase activity (GO:0032770),2/23,2,23,0.34978360635625,0.78928073174808,0,0,1.62839928350432,1.71053669314191,NOS1AP;HIF1A
delta,2,regulation of microtubule cytoskeleton organization (GO:0070507),2/23,2,23,0.34978360635625,0.78928073174808,0,0,1.62839928350432,1.71053669314191,TAOK1;CLASP1
delta,2,cellular response to catecholamine stimulus (GO:0071870),2/23,2,23,0.34978360635625,0.78928073174808,0,0,1.62839928350432,1.71053669314191,GNB1;SIRT2
delta,2,negative regulation of viral transcription (GO:0032897),2/23,2,23,0.34978360635625,0.78928073174808,0,0,1.62839928350432,1.71053669314191,ZNF639;TARDBP
delta,2,microtubule polymerization or depolymerization (GO:0031109),2/23,2,23,0.34978360635625,0.78928073174808,0,0,1.62839928350432,1.71053669314191,NCKAP5L;CKAP5
delta,2,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),2/23,2,23,0.34978360635625,0.78928073174808,0,0,1.62839928350432,1.71053669314191,SUPT16H;LEO1
delta,2,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),4/56,4,56,0.350479587945739,0.78928073174808,0,0,1.33761369716426,1.40242484104161,SMAD3;SMURF2;TGFBR2;HSPA1A
delta,2,DNA recombination (GO:0006310),4/56,4,56,0.350479587945739,0.78928073174808,0,0,1.33761369716426,1.40242484104161,GEN1;RTEL1;RMI1;ATM
delta,2,response to metal ion (GO:0010038),5/73,5,73,0.350622340153248,0.78928073174808,0,0,1.2826432712534,1.34426862237654,SLC30A7;PPP2CA;NEDD4;HIF1A;GPHN
delta,2,negative regulation of cell cycle (GO:0045786),5/73,5,73,0.350622340153248,0.78928073174808,0,0,1.2826432712534,1.34426862237654,RNF167;PPP1R13B;SMAD3;CDK6;IPO5
delta,2,negative regulation of macromolecule metabolic process (GO:0010605),8/125,8,125,0.351427026877126,0.78928073174808,0,0,1.19850187265918,1.25333716157098,RB1;MECP2;ZNF281;DIP2A;MIF;TARDBP;HIF1A;HAVCR2
delta,2,viral life cycle (GO:0019058),7/108,7,108,0.355155278496572,0.78928073174808,0,0,1.21376057705646,1.2564851689677,NUP205;NUP107;HSP90AB1;ZNF639;KPNA2;AAAS;KPNB1
delta,2,positive regulation of epithelial cell proliferation (GO:0050679),7/108,7,108,0.355155278496572,0.78928073174808,0,0,1.21376057705646,1.2564851689677,PDCL3;STXBP4;BAD;FZD7;PTPRN;NRARP;HIF1A
delta,2,regulation of protein secretion (GO:0050708),7/108,7,108,0.355155278496572,0.78928073174808,0,0,1.21376057705646,1.2564851689677,UNC13B;ACHE;ARL2BP;ITPR1;ITPR2;SLC25A5;SLC8B1
delta,2,protein insertion into mitochondrial membrane (GO:0051204),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,BAD
delta,2,regulation of DNA methylation (GO:0044030),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,MECP2
delta,2,peptidyl-cysteine modification (GO:0018198),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,CHCHD4
delta,2,Golgi to lysosome transport (GO:0090160),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,AP4M1
delta,2,biomineral tissue development (GO:0031214),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,FAM20C
delta,2,positive regulation of macrophage differentiation (GO:0045651),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,RIPK1
delta,2,regulation of brown fat cell differentiation (GO:0090335),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,FTO
delta,2,regulation of fibroblast apoptotic process (GO:2000269),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,STK17A
delta,2,stress-induced premature senescence (GO:0090400),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,CDKN1A
delta,2,interleukin-18-mediated signaling pathway (GO:0035655),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,ALOX5
delta,2,neurotransmitter receptor diffusion trapping (GO:0099628),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,GPHN
delta,2,positive regulation of isotype switching (GO:0045830),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,TP53BP1
delta,2,negative regulation of protein homooligomerization (GO:0032463),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,PEX5
delta,2,endodermal cell fate commitment (GO:0001711),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,LEO1
delta,2,translocation of molecules into host (GO:0044417),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,THOC5
delta,2,positive regulation of steroid biosynthetic process (GO:0010893),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,PRKAA1
delta,2,cytoskeletal anchoring at nuclear membrane (GO:0090286),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,SYNE2
delta,2,organophosphate catabolic process (GO:0046434),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,LIPG
delta,2,negative regulation of glucose import (GO:0046325),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,ENPP1
delta,2,isoprenoid metabolic process (GO:0006720),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,HMGCR
delta,2,glycerolipid biosynthetic process (GO:0045017),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,CRLS1
delta,2,positive regulation of spindle checkpoint (GO:0090232),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,GEN1
delta,2,atrial cardiac muscle cell to AV node cell signaling (GO:0086026),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,SCN3B
delta,2,regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,HIF1A
delta,2,nodal signaling pathway (GO:0038092),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,SMAD3
delta,2,regulation of striated muscle cell differentiation (GO:0051153),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,HDAC9
delta,2,"negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,ERLEC1
delta,2,peptidyl-lysine hydroxylation (GO:0017185),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,PLOD2
delta,2,positive regulation of IRE1-mediated unfolded protein response (GO:1903896),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,HSPA1A
delta,2,isoprenoid biosynthetic process (GO:0008299),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,HMGCR
delta,2,regulation of store-operated calcium entry (GO:2001256),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,SLC8B1
delta,2,positive regulation of metanephros development (GO:0072216),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,PAX8
delta,2,response to hydroxyurea (GO:0072710),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,KAT7
delta,2,cellular response to epinephrine stimulus (GO:0071872),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,SIRT2
delta,2,negative regulation of centriole replication (GO:0046600),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,MDM1
delta,2,negative regulation of establishment of protein localization (GO:1904950),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,SNX3
delta,2,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,SORL1
delta,2,B cell mediated immunity (GO:0019724),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,MSH2
delta,2,positive regulation of regulatory T cell differentiation (GO:0045591),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,SOCS1
delta,2,arachidonate transport (GO:1903963),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,PNPLA8
delta,2,positive regulation of monocyte differentiation (GO:0045657),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,CTNNBIP1
delta,2,fatty acid alpha-oxidation (GO:0001561),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,ALDH3A2
delta,2,phospholipid homeostasis (GO:0055091),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,LIPG
delta,2,alpha-amino acid biosynthetic process (GO:1901607),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,MTHFD1
delta,2,positive regulation of mitotic sister chromatid separation (GO:1901970),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,RB1
delta,2,ketone body biosynthetic process (GO:0046951),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,HMGCLL1
delta,2,polyol transport (GO:0015791),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,SLC5A3
delta,2,actin filament network formation (GO:0051639),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,PLS1
delta,2,peroxisomal transport (GO:0043574),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,LONP2
delta,2,peptidyl-diphthamide metabolic process (GO:0017182),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,DPH6
delta,2,negative regulation of vascular permeability (GO:0043116),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,PTPRJ
delta,2,regulation of ERAD pathway (GO:1904292),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,BAG6
delta,2,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,DDX5
delta,2,regulation of protein localization to Cajal body (GO:1904869),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,CCT5
delta,2,positive regulation of TORC1 signaling (GO:1904263),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,RRAGA
delta,2,peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,DPH6
delta,2,osteoblast development (GO:0002076),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,ACHE
delta,2,regulation of dopamine receptor signaling pathway (GO:0060159),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,VPS35
delta,2,peptidyl-lysine monomethylation (GO:0018026),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,SETD2
delta,2,ribosome disassembly (GO:0032790),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,DENR
delta,2,viral mRNA export from host cell nucleus (GO:0046784),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,THOC5
delta,2,postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,GPHN
delta,2,negative regulation of telomerase activity (GO:0051974),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,PINX1
delta,2,arginine catabolic process (GO:0006527),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,ARG2
delta,2,pantothenate metabolic process (GO:0015939),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,FASN
delta,2,tRNA aminoacylation for mitochondrial protein translation (GO:0070127),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,GARS
delta,2,cellular monovalent inorganic anion homeostasis (GO:0030320),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,ENPP1
delta,2,negative regulation of double-strand break repair via homologous recombination (GO:2000042),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,TP53BP1
delta,2,barbed-end actin filament capping (GO:0051016),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,TWF2
delta,2,histone H2A-K119 monoubiquitination (GO:0036353),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,PCGF1
delta,2,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,NOS1AP
delta,2,4-hydroxyproline metabolic process (GO:0019471),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,EGLN3
delta,2,cellular response to prostaglandin E stimulus (GO:0071380),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,GNB1
delta,2,mRNA cleavage (GO:0006379),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,WDR33
delta,2,response to epinephrine (GO:0071871),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,SIRT2
delta,2,regulation of dopamine uptake involved in synaptic transmission (GO:0051584),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,RAB3B
delta,2,positive regulation of membrane potential (GO:0045838),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,BAD
delta,2,protein lipoylation (GO:0009249),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,LIPT2
delta,2,positive regulation of protein localization to Cajal body (GO:1904871),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,CCT5
delta,2,development of primary female sexual characteristics (GO:0046545),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,NUP107
delta,2,regulation of histone H4 acetylation (GO:0090239),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,KAT7
delta,2,positive regulation of chromatin binding (GO:0035563),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,MED25
delta,2,positive regulation of DNA recombination (GO:0045911),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,TP53BP1
delta,2,regulation of PERK-mediated unfolded protein response (GO:1903897),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,NCK1
delta,2,DNA damage induced protein phosphorylation (GO:0006975),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,ATM
delta,2,arachidonic acid secretion (GO:0050482),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,PNPLA8
delta,2,protein desumoylation (GO:0016926),1/8,1,8,0.355388501526353,0.78928073174808,0,0,2.34082397003745,2.42168473173411,SENP1
delta,2,protein tetramerization (GO:0051262),6/91,6,91,0.35857376884023,0.795761026151026,0,0,1.23472033584393,1.26635494417441,NUDT21;ANXA2;HMGCR;SAMHD1;IGF1R;CRYZ
delta,2,protein dephosphorylation (GO:0006470),8/126,8,126,0.359572642549324,0.796391626234836,0,0,1.1889899530349,1.21614536202099,CTDNEP1;DUSP4;PHLPP2;PPP2CA;PPP1R12A;PTPRJ;PPM1D;NCK1
delta,2,positive regulation of reactive oxygen species metabolic process (GO:2000379),3/40,3,40,0.361057839082536,0.796391626234836,0,0,1.40449438202247,1.43078246406989,CDKN1A;RIPK1;TGFBR2
delta,2,inositol lipid-mediated signaling (GO:0048017),3/40,3,40,0.361057839082536,0.796391626234836,0,0,1.40449438202247,1.43078246406989,PITPNM2;GAB2;IGF1R
delta,2,regulation of type I interferon-mediated signaling pathway (GO:0060338),3/40,3,40,0.361057839082536,0.796391626234836,0,0,1.40449438202247,1.43078246406989,IFNAR2;HSP90AB1;CDC37
delta,2,B cell activation (GO:0042113),5/74,5,74,0.361356405650679,0.796391626234836,0,0,1.2653102540743,1.28794733071718,MSH2;CEBPG;CTPS1;HDAC9;MALT1
delta,2,nucleic acid phosphodiester bond hydrolysis (GO:0090305),5/74,5,74,0.361356405650679,0.796391626234836,0,0,1.2653102540743,1.28794733071718,POLD3;ISG20;POLD4;XRN2;ENPP1
delta,2,phosphatidylinositol-mediated signaling (GO:0048015),4/57,4,57,0.362793292516643,0.796391626234836,0,0,1.31414679019646,1.33244240622108,PITPNM2;GAB2;SIRT2;IGF1R
delta,2,cellular iron ion homeostasis (GO:0006879),4/57,4,57,0.362793292516643,0.796391626234836,0,0,1.31414679019646,1.33244240622108,SMAD4;CCDC115;FTH1;NUBP1
delta,2,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),4/57,4,57,0.362793292516643,0.796391626234836,0,0,1.31414679019646,1.33244240622108,CASP4;RIPK1;RBCK1;HSPA1A
delta,2,regulation of Wnt signaling pathway (GO:0030111),7/110,7,110,0.372781001193282,0.796391626234836,0,0,1.19169220292816,1.17591915552195,SNX3;PPP2CA;CBFB;CTNNBIP1;ANKRD10;SOX7;ATP6V0C
delta,2,cellular respiration (GO:0045333),4/58,4,58,0.375097632577133,0.796391626234836,0,0,1.29148908691722,1.26639407640295,BLOC1S1;CYCS;ETFA;UQCRH
delta,2,tRNA modification (GO:0006400),4/58,4,58,0.375097632577133,0.796391626234836,0,0,1.29148908691722,1.26639407640295,METTL1;RPUSD3;THUMPD1;SEPHS1
delta,2,intraciliary transport involved in cilium assembly (GO:0035735),3/41,3,41,0.375832064072645,0.796391626234836,0,0,1.37023842148534,1.34093295898797,IFT74;IFT27;DYNLRB1
delta,2,autophagy of mitochondrion (GO:0000422),3/41,3,41,0.375832064072645,0.796391626234836,0,0,1.37023842148534,1.34093295898797,GABARAPL1;RB1CC1;ATG12
delta,2,non-canonical Wnt signaling pathway (GO:0035567),8/128,8,128,0.375917536119921,0.796391626234836,0,0,1.17041198501873,1.14511408997675,GNAO1;PSMD14;SMURF2;PSMB3;FZD7;GNB1;CTNNB1;PFN1
delta,2,cellular response to insulin stimulus (GO:0032869),7/111,7,111,0.381613021753912,0.796391626234836,0,0,1.18095623713601,1.1376720840976,ENPP1;PIK3R3;TRIB3;AP3S1;ATP6V0C;HDAC9;IGF1R
delta,2,positive regulation of NF-kappaB transcription factor activity (GO:0051092),8/129,8,129,0.384109319343856,0.796391626234836,0,0,1.16133902389455,1.11120178976097,ALK;TLR9;CIB1;RIPK1;RBCK1;MALT1;NFKBIB;HSPA1A
delta,2,positive regulation of mitochondrion organization (GO:0010822),8/129,8,129,0.384109319343856,0.796391626234836,0,0,1.16133902389455,1.11120178976097,HSPA1L;BAD;VPS35;DPH6;PPARGC1B;BAP1;UBE2L3;ZBED3
delta,2,post-Golgi vesicle-mediated transport (GO:0006892),4/59,4,59,0.387380815023688,0.796391626234836,0,0,1.26959944137625,1.20402088698251,AP4M1;GBF1;VPS54;SORL1
delta,2,positive regulation of histone methylation (GO:0031062),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,SMAD4;CTNNB1
delta,2,negative regulation of sequestering of calcium ion (GO:0051283),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,ITPR1;ITPR2
delta,2,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,PSMB3;NFE2L2
delta,2,receptor catabolic process (GO:0032801),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,NEDD4;VLDLR
delta,2,regulation of epidermal growth factor-activated receptor activity (GO:0007176),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,ERRFI1;ZGPAT
delta,2,DNA geometric change (GO:0032392),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,RTEL1;ASCC3
delta,2,axoneme assembly (GO:0035082),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,LRGUK;DNAAF2
delta,2,regulation of chemotaxis (GO:0050920),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,EFNB2;STX3
delta,2,cellular senescence (GO:0090398),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,CDKN1A;SMC6
delta,2,DNA replication initiation (GO:0006270),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,ORC6;CDC7
delta,2,limb development (GO:0060173),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,CHD7;GLI3
delta,2,positive regulation of vascular endothelial growth factor production (GO:0010575),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,IL6ST;HIF1A
delta,2,fatty acid derivative biosynthetic process (GO:1901570),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,FASN;HMGCLL1
delta,2,actin nucleation (GO:0045010),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,ACTR3;WHAMM
delta,2,transition metal ion homeostasis (GO:0055076),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,SLC25A37;NEO1
delta,2,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,BAG6;HSP90AB1
delta,2,regulation of cell cycle G1/S phase transition (GO:1902806),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,STXBP4;TMEM14B
delta,2,regulation of cellular senescence (GO:2000772),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,ARG2;CDK6
delta,2,ear morphogenesis (GO:0042471),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,PAX8;CHD7
delta,2,histone mRNA metabolic process (GO:0008334),2/25,2,25,0.388789651855729,0.796391626234836,0,0,1.49812734082397,1.41530610089507,NCBP1;ATM
delta,2,type B pancreatic cell differentiation (GO:0003309),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,CDK6
delta,2,negative regulation of circadian rhythm (GO:0042754),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,SUV39H1
delta,2,inositol metabolic process (GO:0006020),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,SLC5A3
delta,2,alanine transport (GO:0032328),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,SLC6A17
delta,2,negative regulation of phagocytosis (GO:0050765),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,SNX3
delta,2,positive regulation of production of molecular mediator of immune response (GO:0002702),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,TLR9
delta,2,positive regulation of voltage-gated potassium channel activity (GO:1903818),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,NOS1AP
delta,2,neuron maturation (GO:0042551),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,FARP2
delta,2,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,RB1
delta,2,regulation of microtubule-based movement (GO:0060632),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,TCTEX1D2
delta,2,regulation of microvillus organization (GO:0032530),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,TWF2
delta,2,sphingomyelin metabolic process (GO:0006684),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,SMPD1
delta,2,somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,MSH2
delta,2,multi-ciliated epithelial cell differentiation (GO:1903251),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,CEP152
delta,2,small nucleolar ribonucleoprotein complex assembly (GO:0000491),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,NUFIP1
delta,2,regulation of integrin activation (GO:0033623),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,FARP2
delta,2,maintenance of protein localization in endoplasmic reticulum (GO:0035437),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,PDIA3
delta,2,ATP synthesis coupled electron transport (GO:0042773),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,COQ7
delta,2,central nervous system neuron development (GO:0021954),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,MAP2
delta,2,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,ERLEC1
delta,2,endosome to pigment granule transport (GO:0043485),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,BLOC1S5
delta,2,epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,NPHP3
delta,2,nicotinamide nucleotide biosynthetic process (GO:0019359),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,ME1
delta,2,response to leucine (GO:0043201),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,SESN3
delta,2,protein polyglutamylation (GO:0018095),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,TTLL5
delta,2,regulation of skeletal muscle cell differentiation (GO:2001014),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,DDX5
delta,2,cellular response to oxygen levels (GO:0071453),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,CCDC115
delta,2,early endosome to Golgi transport (GO:0034498),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,SNX1
delta,2,peptidyl-amino acid modification (GO:0018193),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,MDM2
delta,2,positive regulation of immunoglobulin mediated immune response (GO:0002891),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,TP53BP1
delta,2,regulation of striated muscle tissue development (GO:0016202),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,SIRT2
delta,2,podosome assembly (GO:0071800),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,FARP2
delta,2,positive regulation of establishment of protein localization to telomere (GO:1904851),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,CCT5
delta,2,oogenesis (GO:0048477),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,FMN2
delta,2,mitochondrial protein processing (GO:0034982),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,IMMP2L
delta,2,negative regulation of protein sumoylation (GO:0033234),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,CTNNB1
delta,2,atrioventricular valve development (GO:0003171),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,TGFBR2
delta,2,regulation of natural killer cell activation (GO:0032814),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,PIBF1
delta,2,toll-like receptor 3 signaling pathway (GO:0034138),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,RIPK1
delta,2,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,GAB2
delta,2,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,FOXA1
delta,2,regulation of leukocyte activation (GO:0002694),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,MIF
delta,2,protein modification by small protein conjugation or removal (GO:0070647),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,ATG10
delta,2,protein hexamerization (GO:0034214),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,MAT2A
delta,2,cholesterol catabolic process (GO:0006707),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,CYP46A1
delta,2,cellular response to leucine (GO:0071233),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,SESN3
delta,2,regulation of helicase activity (GO:0051095),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,MSH2
delta,2,endosome to melanosome transport (GO:0035646),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,BLOC1S5
delta,2,dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,DNM2
delta,2,proline transport (GO:0015824),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,SLC6A17
delta,2,negative regulation of amyloid-beta formation (GO:1902430),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,SORL1
delta,2,negative regulation of transcription by competitive promoter binding (GO:0010944),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,PHB
delta,2,positive regulation of vascular endothelial cell proliferation (GO:1905564),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,SP1
delta,2,axonal transport of mitochondrion (GO:0019896),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,HIF1A
delta,2,cellular response to acidic pH (GO:0071468),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,RAB11FIP5
delta,2,mitochondrial fragmentation involved in apoptotic process (GO:0043653),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,VPS35
delta,2,tRNA wobble uridine modification (GO:0002098),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,KIAA1456
delta,2,lipoprotein biosynthetic process (GO:0042158),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,ATG10
delta,2,fatty acid homeostasis (GO:0055089),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,PRKAA1
delta,2,cytoskeletal anchoring at plasma membrane (GO:0007016),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,TLN1
delta,2,DNA topological change (GO:0006265),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,TOP2A
delta,2,regulation of glycoprotein biosynthetic process (GO:0010559),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,NECAB3
delta,2,negative regulation of leukocyte chemotaxis (GO:0002689),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,MIF
delta,2,RNA destabilization (GO:0050779),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,METTL16
delta,2,ornithine metabolic process (GO:0006591),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,ARG2
delta,2,negative regulation of response to reactive oxygen species (GO:1901032),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,NFE2L2
delta,2,poly-N-acetyllactosamine biosynthetic process (GO:0030311),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,B3GNT9
delta,2,actin crosslink formation (GO:0051764),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,PLS1
delta,2,positive regulation of triglyceride biosynthetic process (GO:0010867),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,CTDNEP1
delta,2,sterol catabolic process (GO:0016127),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,CYP46A1
delta,2,regulation of interferon-gamma secretion (GO:1902713),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,RASGRP1
delta,2,positive regulation of mitochondrial translation (GO:0070131),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,MRPS27
delta,2,establishment of Golgi localization (GO:0051683),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,YWHAZ
delta,2,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),1/9,1,9,0.389824472887383,0.796391626234836,0,0,2.08073241781107,1.96017209881328,TLR9
delta,2,regulation of protein binding (GO:0043393),7/112,7,112,0.390451652605308,0.796391626234836,0,0,1.17041198501873,1.10071526956535,PPP2CA;RALB;BTBD1;CTNNBIP1;TRIB3;SORL1;STK3
delta,2,mesenchymal cell differentiation (GO:0048762),3/42,3,42,0.3905351701557,0.796391626234836,0,0,1.33761369716426,1.25767422329955,DDX5;CTNNB1;HIF1A
delta,2,cellular response to peptide (GO:1901653),3/42,3,42,0.3905351701557,0.796391626234836,0,0,1.33761369716426,1.25767422329955,CASP4;MDM2;IGF1R
delta,2,spliceosomal complex assembly (GO:0000245),3/42,3,42,0.3905351701557,0.796391626234836,0,0,1.33761369716426,1.25767422329955,NCBP1;SNRPD1;SRSF5
delta,2,gluconeogenesis (GO:0006094),3/42,3,42,0.3905351701557,0.796391626234836,0,0,1.33761369716426,1.25767422329955,ENO3;SLC25A11;GAPDH
delta,2,double-strand break repair via homologous recombination (GO:0000724),5/77,5,77,0.393574102551854,0.796391626234836,0,0,1.21601245196751,1.13391448067862,GEN1;PSMD14;POLN;RFWD3;CDC7
delta,2,nucleic acid-templated transcription (GO:0097659),5/77,5,77,0.393574102551854,0.796391626234836,0,0,1.21601245196751,1.13391448067862,GTF3C1;PAX8;FUBP3;BAZ1A;NFKBIB
delta,2,regulation of ion transmembrane transporter activity (GO:0032412),3/43,3,43,0.405149614123371,0.796391626234836,0,0,1.30650640188137,1.18042704795519,NEDD4;RIPK1;SCN3B
delta,2,organophosphate ester transport (GO:0015748),2/26,2,26,0.407903031250896,0.796391626234836,0,0,1.44050705848459,1.29173984633869,SCP2;PITPNB
delta,2,"protein import into nucleus, translocation (GO:0000060)",2/26,2,26,0.407903031250896,0.796391626234836,0,0,1.44050705848459,1.29173984633869,KPNB1;IPO5
delta,2,glial cell differentiation (GO:0010001),2/26,2,26,0.407903031250896,0.796391626234836,0,0,1.44050705848459,1.29173984633869,CDH2;NFIB
delta,2,respiratory chain complex IV assembly (GO:0008535),2/26,2,26,0.407903031250896,0.796391626234836,0,0,1.44050705848459,1.29173984633869,COX11;COX14
delta,2,lamellipodium organization (GO:0097581),2/26,2,26,0.407903031250896,0.796391626234836,0,0,1.44050705848459,1.29173984633869,SNX1;WHAMM
delta,2,"negative regulation of gene expression, epigenetic (GO:0045814)",2/26,2,26,0.407903031250896,0.796391626234836,0,0,1.44050705848459,1.29173984633869,AEBP2;PPM1D
delta,2,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058),2/26,2,26,0.407903031250896,0.796391626234836,0,0,1.44050705848459,1.29173984633869,PDCL3;UBE3A
delta,2,in utero embryonic development (GO:0001701),2/26,2,26,0.407903031250896,0.796391626234836,0,0,1.44050705848459,1.29173984633869,MBNL1;CHD7
delta,2,response to amyloid-beta (GO:1904645),2/26,2,26,0.407903031250896,0.796391626234836,0,0,1.44050705848459,1.29173984633869,CASP4;IGF1R
delta,2,regulation of interleukin-10 production (GO:0032653),2/26,2,26,0.407903031250896,0.796391626234836,0,0,1.44050705848459,1.29173984633869,TLR9;PIBF1
delta,2,respiratory tube development (GO:0030323),2/26,2,26,0.407903031250896,0.796391626234836,0,0,1.44050705848459,1.29173984633869,BAG6;NPHP3
delta,2,peptidyl-tyrosine dephosphorylation (GO:0035335),2/26,2,26,0.407903031250896,0.796391626234836,0,0,1.44050705848459,1.29173984633869,DUSP4;PTPRJ
delta,2,L-amino acid transport (GO:0015807),2/26,2,26,0.407903031250896,0.796391626234836,0,0,1.44050705848459,1.29173984633869,SLC6A17;SLC6A9
delta,2,regulation of protein import into nucleus (GO:0042306),2/26,2,26,0.407903031250896,0.796391626234836,0,0,1.44050705848459,1.29173984633869,FZD7;IPO5
delta,2,signal peptide processing (GO:0006465),2/26,2,26,0.407903031250896,0.796391626234836,0,0,1.44050705848459,1.29173984633869,IMMP2L;PROS1
delta,2,neutral amino acid transport (GO:0015804),2/26,2,26,0.407903031250896,0.796391626234836,0,0,1.44050705848459,1.29173984633869,SLC6A17;SLC6A9
delta,2,misfolded or incompletely synthesized protein catabolic process (GO:0006515),2/26,2,26,0.407903031250896,0.796391626234836,0,0,1.44050705848459,1.29173984633869,BAG6;LONP1
delta,2,positive regulation of kinase activity (GO:0033674),7/114,7,114,0.40813070118601,0.796391626234836,0,0,1.14987844142191,1.03048404442403,ALK;CDKN1A;JTB;PRKAG2;MET;CAMKK1;IGF1R
delta,2,positive regulation of protein binding (GO:0032092),4/61,4,61,0.411838886579684,0.796391626234836,0,0,1.22797323018358,1.08936336723084,PPP2CA;RALB;TRIB3;STK3
delta,2,regulation of stress fiber assembly (GO:0051492),4/61,4,61,0.411838886579684,0.796391626234836,0,0,1.22797323018358,1.08936336723084,ARHGEF10;PFN1;MET;CLASP1
delta,2,muscle organ development (GO:0007517),4/61,4,61,0.411838886579684,0.796391626234836,0,0,1.22797323018358,1.08936336723084,COPRS;ACHE;TCF12;CHD2
delta,2,positive regulation of translation (GO:0045727),5/79,5,79,0.414986216670235,0.796391626234836,0,0,1.18522732660124,1.0424192530055,RPS4X;FXR1;MRPS27;POLDIP3;EIF4A3
delta,2,fibroblast growth factor receptor signaling pathway (GO:0008543),5/79,5,79,0.414986216670235,0.796391626234836,0,0,1.18522732660124,1.0424192530055,PTBP1;RBFOX2;NCBP1;ESRP2;HNRNPA1
delta,2,positive regulation of protein metabolic process (GO:0051247),6/97,6,97,0.416441116676781,0.796391626234836,0,0,1.15834588208039,1.01472281234354,FZR1;HNRNPK;SMURF2;WFS1;NEDD4;SORL1
delta,2,positive regulation of protein localization to plasma membrane (GO:1903078),3/44,3,44,0.419659018127357,0.796391626234836,0,0,1.27681307456588,1.10867308356022,CIB1;STX3;PLS1
delta,2,positive regulation of interferon-gamma production (GO:0032729),3/44,3,44,0.419659018127357,0.796391626234836,0,0,1.27681307456588,1.10867308356022,CEBPG;TLR9;RASGRP1
delta,2,negative regulation of ERBB signaling pathway (GO:1901185),3/44,3,44,0.419659018127357,0.796391626234836,0,0,1.27681307456588,1.10867308356022,ERRFI1;HGS;PTPRJ
delta,2,male meiosis I (GO:0007141),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,MYBL1
delta,2,thyroid gland development (GO:0030878),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,PAX8
delta,2,regulation of sequestering of zinc ion (GO:0061088),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,SLC30A7
delta,2,positive regulation of cytoplasmic transport (GO:1903651),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,SORL1
delta,2,protein K11-linked deubiquitination (GO:0035871),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,USP37
delta,2,positive regulation of receptor recycling (GO:0001921),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,ANXA2
delta,2,response to laminar fluid shear stress (GO:0034616),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,NFE2L2
delta,2,galactose metabolic process (GO:0006012),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,SLC35A2
delta,2,hair cell differentiation (GO:0035315),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,CTNNB1
delta,2,regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,TOP2A
delta,2,positive regulation of glucose import in response to insulin stimulus (GO:2001275),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,PIK3R3
delta,2,glutamine metabolic process (GO:0006541),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,NIT2
delta,2,regulation of protein exit from endoplasmic reticulum (GO:0070861),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,SORL1
delta,2,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,LACTB2
delta,2,positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,FOXA1
delta,2,epithelial cell morphogenesis (GO:0003382),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,MET
delta,2,cell differentiation involved in metanephros development (GO:0072202),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,PAX8
delta,2,mitotic G1 DNA damage checkpoint (GO:0031571),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,RFWD3
delta,2,actin filament depolymerization (GO:0030042),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,TWF2
delta,2,negative regulation of reproductive process (GO:2000242),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,TIMP1
delta,2,virion attachment to host cell (GO:0019062),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,HSP90AB1
delta,2,Rap protein signal transduction (GO:0032486),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,RAP1B
delta,2,G1 DNA damage checkpoint (GO:0044783),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,RFWD3
delta,2,protein localization to synapse (GO:0035418),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,KIF5C
delta,2,regulation of establishment of protein localization to telomere (GO:0070203),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,CCT5
delta,2,nucleoside metabolic process (GO:0009116),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,OARD1
delta,2,central nervous system projection neuron axonogenesis (GO:0021952),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,NFIB
delta,2,positive regulation of reproductive process (GO:2000243),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,SMURF2
delta,2,regulation of fatty acid beta-oxidation (GO:0031998),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,LONP2
delta,2,insulin-like growth factor receptor signaling pathway (GO:0048009),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,IGF1R
delta,2,actin filament capping (GO:0051693),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,TWF2
delta,2,protein-cofactor linkage (GO:0018065),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,LIPT2
delta,2,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,SORL1
delta,2,cytochrome complex assembly (GO:0017004),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,COX11
delta,2,negative regulation of protein maturation (GO:1903318),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,CHAC1
delta,2,negative regulation of centrosome duplication (GO:0010826),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,MDM1
delta,2,telomere maintenance via recombination (GO:0000722),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,SMC6
delta,2,actin filament-based transport (GO:0099515),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,SYNE2
delta,2,ceramide catabolic process (GO:0046514),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,NEU3
delta,2,negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,CNOT2
delta,2,coenzyme A metabolic process (GO:0015936),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,DCAKD
delta,2,tRNA wobble base modification (GO:0002097),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,KIAA1456
delta,2,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,NEDD4
delta,2,UV protection (GO:0009650),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,MFAP4
delta,2,mitotic G1/S transition checkpoint (GO:0044819),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,RFWD3
delta,2,cellular response to leucine starvation (GO:1990253),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,SESN3
delta,2,neurotransmitter receptor internalization (GO:0099590),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,DNM2
delta,2,poly-N-acetyllactosamine metabolic process (GO:0030309),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,B3GNT9
delta,2,regulation of immunoglobulin production (GO:0002637),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,TLR9
delta,2,very-low-density lipoprotein particle assembly (GO:0034379),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,SOAT1
delta,2,positive regulation of execution phase of apoptosis (GO:1900119),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,SIRT2
delta,2,dicarboxylic acid biosynthetic process (GO:0043650),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,MTHFD1
delta,2,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,CTNNB1
delta,2,regulation of neuroblast proliferation (GO:1902692),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,CTNNB1
delta,2,endothelial tube morphogenesis (GO:0061154),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,CTNNB1
delta,2,response to histamine (GO:0034776),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,GABRB1
delta,2,medium-chain fatty acid metabolic process (GO:0051791),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,ABHD3
delta,2,sequestering of actin monomers (GO:0042989),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,TWF2
delta,2,regulation of phospholipid metabolic process (GO:1903725),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,PIK3R3
delta,2,telomeric loop disassembly (GO:0090657),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,RTEL1
delta,2,histone H2B ubiquitination (GO:0033523),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,LEO1
delta,2,positive regulation of nuclease activity (GO:0032075),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,HSPA1A
delta,2,ketone body metabolic process (GO:1902224),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,HMGCLL1
delta,2,protein prenylation (GO:0018342),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,FNTA
delta,2,thyroid hormone generation (GO:0006590),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,CPQ
delta,2,negative regulation of glucose transport (GO:0010829),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,ENPP1
delta,2,low-density lipoprotein particle receptor catabolic process (GO:0032802),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,VLDLR
delta,2,protein deglycosylation (GO:0006517),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,MAN2C1
delta,2,membrane raft organization (GO:0031579),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,ANXA2
delta,2,negative regulation of sodium ion transmembrane transport (GO:1902306),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,NEDD4
delta,2,dynamin family protein polymerization involved in membrane fission (GO:0003373),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,DNM2
delta,2,glucosamine-containing compound catabolic process (GO:1901072),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,CTBS
delta,2,negative regulation of cytosolic calcium ion concentration (GO:0051481),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,SMAD3
delta,2,regulation of cytoplasmic translational elongation (GO:1900247),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,DPH6
delta,2,positive regulation of alcohol biosynthetic process (GO:1902932),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,PRKAA1
delta,2,response to acidic pH (GO:0010447),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,RAB11FIP5
delta,2,"regulation of DNA-templated transcription, initiation (GO:2000142)",1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,CTNNB1
delta,2,astrocyte development (GO:0014002),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,CDK6
delta,2,positive regulation of cardiac muscle cell differentiation (GO:2000727),1/10,1,10,0.422422457307045,0.796391626234836,0,0,1.87265917602996,1.61376288769706,EFNB2
delta,2,regulation of vesicle fusion (GO:0031338),4/62,4,62,0.423992560116146,0.796391626234836,0,0,1.20816721034191,1.03665503298298,ANXA2;TBC1D5;EVI5L;TBC1D22B
delta,2,protein targeting to membrane (GO:0006612),4/62,4,62,0.423992560116146,0.796391626234836,0,0,1.20816721034191,1.03665503298298,TRAM1;PEX5;RAB3IP;SEC62
delta,2,positive regulation of cellular amide metabolic process (GO:0034250),4/62,4,62,0.423992560116146,0.796391626234836,0,0,1.20816721034191,1.03665503298298,RPS4X;FXR1;POLDIP3;EIF4A3
delta,2,steroid biosynthetic process (GO:0006694),5/80,5,80,0.425649818490763,0.796391626234836,0,0,1.17041198501873,0.999693695084894,SCP2;OSBPL2;PRKAG2;HMGCR;CYP46A1
delta,2,nucleosome organization (GO:0034728),5/80,5,80,0.425649818490763,0.796391626234836,0,0,1.17041198501873,0.999693695084894,SETD2;SUPT16H;H2AFX;SMARCA5;CTCF
delta,2,cell morphogenesis involved in neuron differentiation (GO:0048667),6/98,6,98,0.426053879805204,0.796391626234836,0,0,1.14652602614079,0.978203923749731,RB1;NTNG1;MAP2;MAP1A;TLR9;CTNNA2
delta,2,cellular response to organonitrogen compound (GO:0071417),6/98,6,98,0.426053879805204,0.796391626234836,0,0,1.14652602614079,0.978203923749731,RAP1B;RRAGA;GABRB1;SESN3;CTNNB1;IPO5
delta,2,positive regulation of interferon-beta production (GO:0032728),2/27,2,27,0.426720073692498,0.796391626234836,0,0,1.38715494520738,1.18133866812768,IRF1;TLR9
delta,2,response to ketone (GO:1901654),2/27,2,27,0.426720073692498,0.796391626234836,0,0,1.38715494520738,1.18133866812768,CATSPERD;UBE3A
delta,2,negative regulation of catalytic activity (GO:0043086),2/27,2,27,0.426720073692498,0.796391626234836,0,0,1.38715494520738,1.18133866812768,PPP1R12A;TIMP1
delta,2,internal peptidyl-lysine acetylation (GO:0018393),2/27,2,27,0.426720073692498,0.796391626234836,0,0,1.38715494520738,1.18133866812768,BAG6;KAT8
delta,2,regulation of microtubule-based process (GO:0032886),2/27,2,27,0.426720073692498,0.796391626234836,0,0,1.38715494520738,1.18133866812768,TAOK1;CLASP1
delta,2,RNA biosynthetic process (GO:0032774),2/27,2,27,0.426720073692498,0.796391626234836,0,0,1.38715494520738,1.18133866812768,SMARCA5;ELL3
delta,2,cytoskeleton-dependent intracellular transport (GO:0030705),2/27,2,27,0.426720073692498,0.796391626234836,0,0,1.38715494520738,1.18133866812768,DYNC1I2;KIF5C
delta,2,amide biosynthetic process (GO:0043604),3/45,3,45,0.434048143925183,0.796391626234836,0,0,1.24843945068664,1.04194734123708,ARG2;SMPD1;CLN8
delta,2,hexose biosynthetic process (GO:0019319),3/45,3,45,0.434048143925183,0.796391626234836,0,0,1.24843945068664,1.04194734123708,ENO3;SLC25A11;GAPDH
delta,2,positive regulation of interleukin-8 production (GO:0032757),3/45,3,45,0.434048143925183,0.796391626234836,0,0,1.24843945068664,1.04194734123708,TLR9;RIPK1;HSPA1A
delta,2,carboxylic acid biosynthetic process (GO:0046394),3/45,3,45,0.434048143925183,0.796391626234836,0,0,1.24843945068664,1.04194734123708,UGP2;ABCC5;PAH
delta,2,inorganic anion transport (GO:0015698),3/45,3,45,0.434048143925183,0.796391626234836,0,0,1.24843945068664,1.04194734123708,CLIC5;CLIC4;ENPP1
delta,2,posttranscriptional regulation of gene expression (GO:0010608),3/45,3,45,0.434048143925183,0.796391626234836,0,0,1.24843945068664,1.04194734123708,CYFIP2;NOLC1;METTL16
delta,2,regulation of focal adhesion assembly (GO:0051893),3/45,3,45,0.434048143925183,0.796391626234836,0,0,1.24843945068664,1.04194734123708,BCAS3;PTPRJ;CLASP1
delta,2,response to UV (GO:0009411),6/99,6,99,0.435642928895409,0.796391626234836,0,0,1.13494495516967,0.943062469181664,MFAP4;MSH2;NEDD4;REV1;ERCC6;ATR
delta,2,positive regulation of cell growth (GO:0030307),6/99,6,99,0.435642928895409,0.796391626234836,0,0,1.13494495516967,0.943062469181664,SYT4;NCBP1;ZNF639;TWF2;PLAA;CIB1
delta,2,diterpenoid metabolic process (GO:0016101),4/63,4,63,0.436082651995947,0.796391626234836,0,0,1.1889899530349,0.986770685216043,ALDH3A2;APOM;GPC2;GPC5
delta,2,tRNA processing (GO:0008033),4/63,4,63,0.436082651995947,0.796391626234836,0,0,1.1889899530349,0.986770685216043,METTL1;ELAC2;RPP40;THUMPD1
delta,2,regulation of translational initiation (GO:0006446),4/63,4,63,0.436082651995947,0.796391626234836,0,0,1.1889899530349,0.986770685216043,EIF5B;EIF5;NCBP1;NCK1
delta,2,positive regulation of catabolic process (GO:0009896),4/63,4,63,0.436082651995947,0.796391626234836,0,0,1.1889899530349,0.986770685216043,FZR1;SMURF2;NEDD4;SORL1
delta,2,"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",5/81,5,81,0.436275666082781,0.796391626234836,0,0,1.15596245433948,0.958848862265386,PITPNB;GBF1;KLC1;KIF15;ARFGAP2
delta,2,ATP synthesis coupled proton transport (GO:0015986),2/28,2,28,0.445217917068554,0.796391626234836,0,0,1.33761369716426,1.0823855208705,ATP5B;ATP5G2
delta,2,regulation of protein localization to nucleus (GO:1900180),2/28,2,28,0.445217917068554,0.796391626234836,0,0,1.33761369716426,1.0823855208705,KAT7;CDK5RAP3
delta,2,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),2/28,2,28,0.445217917068554,0.796391626234836,0,0,1.33761369716426,1.0823855208705,BLOC1S2;DEDD
delta,2,regulation of protein transport (GO:0051223),2/28,2,28,0.445217917068554,0.796391626234836,0,0,1.33761369716426,1.0823855208705,SNX3;HSPA8
delta,2,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),2/28,2,28,0.445217917068554,0.796391626234836,0,0,1.33761369716426,1.0823855208705,CIB1;DOCK1
delta,2,regulation of vascular endothelial growth factor production (GO:0010574),2/28,2,28,0.445217917068554,0.796391626234836,0,0,1.33761369716426,1.0823855208705,IL6ST;HIF1A
delta,2,negative regulation of microtubule polymerization or depolymerization (GO:0031111),2/28,2,28,0.445217917068554,0.796391626234836,0,0,1.33761369716426,1.0823855208705,CIB1;CLASP1
delta,2,protein catabolic process (GO:0030163),5/82,5,82,0.446856987617972,0.796391626234836,0,0,1.14186535123778,0.919791579627461,BAG6;HSPA8;PSMB3;RIPK1;CLN8
delta,2,positive regulation of protein targeting to mitochondrion (GO:1903955),5/82,5,82,0.446856987617972,0.796391626234836,0,0,1.14186535123778,0.919791579627461,HSPA1L;DPH6;BAP1;UBE2L3;ZBED3
delta,2,carbohydrate homeostasis (GO:0033500),4/64,4,64,0.448099761817495,0.796391626234836,0,0,1.17041198501873,0.939535801414924,PRKAA1;BAD;WFS1;SLC8B1
delta,2,negative regulation of neuron apoptotic process (GO:0043524),4/64,4,64,0.448099761817495,0.796391626234836,0,0,1.17041198501873,0.939535801414924,MSH2;WFS1;NONO;HIF1A
delta,2,positive regulation of cell projection organization (GO:0031346),4/64,4,64,0.448099761817495,0.796391626234836,0,0,1.17041198501873,0.939535801414924,SCARB2;SNX3;TWF2;CBFA2T2
delta,2,peptidyl-tyrosine autophosphorylation (GO:0038083),3/46,3,46,0.448302863944277,0.796391626234836,0,0,1.22129946262824,0.979831753036604,ITK;TEC;IGF1R
delta,2,positive regulation of posttranscriptional gene silencing (GO:0060148),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,FXR1
delta,2,L-phenylalanine catabolic process (GO:0006559),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,PAH
delta,2,interleukin-27-mediated signaling pathway (GO:0070106),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,IL6ST
delta,2,negative regulation of leukocyte activation (GO:0002695),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,HAVCR2
delta,2,nitric oxide biosynthetic process (GO:0006809),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,ARG2
delta,2,positive regulation of cell cycle phase transition (GO:1901989),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,STXBP4
delta,2,mononuclear cell differentiation (GO:1903131),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,THOC5
delta,2,immune response-regulating cell surface receptor signaling pathway (GO:0002768),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,BAG6
delta,2,negative regulation of leukocyte cell-cell adhesion (GO:1903038),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,PAG1
delta,2,negative regulation of JUN kinase activity (GO:0043508),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,HIPK3
delta,2,T cell differentiation in thymus (GO:0033077),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,GLI3
delta,2,I-kappaB phosphorylation (GO:0007252),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,TLR9
delta,2,positive regulation of cytolysis (GO:0045919),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,RRAGA
delta,2,positive regulation of protein deacetylation (GO:0090312),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,FNTA
delta,2,urea cycle (GO:0000050),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,ARG2
delta,2,brain morphogenesis (GO:0048854),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,CTNNA2
delta,2,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,RIPK1
delta,2,purine nucleobase metabolic process (GO:0006144),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,MTHFD1
delta,2,regulation of integrin-mediated signaling pathway (GO:2001044),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,TIMP1
delta,2,regulation of hemopoiesis (GO:1903706),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,CBFB
delta,2,rRNA base methylation (GO:0070475),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,METTL16
delta,2,lymphocyte mediated immunity (GO:0002449),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,MSH2
delta,2,negative regulation of amyloid precursor protein catabolic process (GO:1902992),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,SORL1
delta,2,regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,PPIL4
delta,2,stress granule assembly (GO:0034063),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,OGFOD1
delta,2,monocyte differentiation (GO:0030224),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,THOC5
delta,2,T cell proliferation (GO:0042098),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,CTPS1
delta,2,positive regulation of mesenchymal cell proliferation (GO:0002053),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,TGFBR2
delta,2,regulation of ceramide biosynthetic process (GO:2000303),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,ORMDL2
delta,2,sphingolipid catabolic process (GO:0030149),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,SMPD1
delta,2,negative regulation of cellular senescence (GO:2000773),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,CDK6
delta,2,positive regulation of glycoprotein biosynthetic process (GO:0010560),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,SOAT1
delta,2,regulation of chromatin binding (GO:0035561),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,MED25
delta,2,response to sterol (GO:0036314),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,TGFBR2
delta,2,histone mRNA catabolic process (GO:0071044),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,ATM
delta,2,cellular response to interferon-beta (GO:0035458),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,IRF1
delta,2,positive regulation of fatty acid biosynthetic process (GO:0045723),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,LPGAT1
delta,2,methionine metabolic process (GO:0006555),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,MTHFD1
delta,2,phosphate ion homeostasis (GO:0055062),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,ENPP1
delta,2,fatty acid transmembrane transport (GO:1902001),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,PRKAG2
delta,2,protein localization to mitochondrion (GO:0070585),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,MTCH2
delta,2,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,MIF
delta,2,cellular response to increased oxygen levels (GO:0036295),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,CCDC115
delta,2,glycerol metabolic process (GO:0006071),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,COQ2
delta,2,positive regulation of fatty acid oxidation (GO:0046321),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,PPARGC1B
delta,2,low-density lipoprotein receptor particle metabolic process (GO:0032799),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,VLDLR
delta,2,oxidative phosphorylation (GO:0006119),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,UQCRH
delta,2,hemidesmosome assembly (GO:0031581),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,LAMC2
delta,2,carbohydrate derivative catabolic process (GO:1901136),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,SAMHD1
delta,2,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,PAH
delta,2,glutathione biosynthetic process (GO:0006750),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,CHAC1
delta,2,regulation of receptor biosynthetic process (GO:0010869),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,HIF1A
delta,2,midbrain dopaminergic neuron differentiation (GO:1904948),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,CTNNB1
delta,2,"regulation of symbiosis, encompassing mutualism through parasitism (GO:0043903)",1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,EXOC2
delta,2,interleukin-35-mediated signaling pathway (GO:0070757),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,IL6ST
delta,2,regulation of mRNA polyadenylation (GO:1900363),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,NUDT21
delta,2,alcohol catabolic process (GO:0046164),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,CYP46A1
delta,2,RNA polymerase II transcriptional preinitiation complex assembly (GO:0051123),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,GTF2A2
delta,2,hepatocyte growth factor receptor signaling pathway (GO:0048012),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,SIRT2
delta,2,isotype switching (GO:0045190),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,MSH2
delta,2,L-phenylalanine metabolic process (GO:0006558),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,PAH
delta,2,negative regulation of morphogenesis of an epithelium (GO:1905331),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,CLASP1
delta,2,regulation of stem cell population maintenance (GO:2000036),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,CNOT2
delta,2,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,CCT5
delta,2,cellular response to prostaglandin stimulus (GO:0071379),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,GNB1
delta,2,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000059),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,PDCL3
delta,2,positive regulation of leukocyte degranulation (GO:0043302),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,GAB2
delta,2,mesonephros development (GO:0001823),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,PAX8
delta,2,carnitine shuttle (GO:0006853),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,PRKAG2
delta,2,Golgi ribbon formation (GO:0090161),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,STX16
delta,2,proteasome assembly (GO:0043248),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,PSMG2
delta,2,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,PDK1
delta,2,cell-substrate junction assembly (GO:0007044),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,LAMC2
delta,2,positive regulation of tumor necrosis factor secretion (GO:1904469),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,HAVCR2
delta,2,regulation of non-canonical Wnt signaling pathway (GO:2000050),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,NPHP3
delta,2,regulation of ventricular cardiac muscle cell action potential (GO:0098911),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,PKP2
delta,2,somite development (GO:0061053),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,MTHFD1
delta,2,internal protein amino acid acetylation (GO:0006475),1/11,1,11,0.45328046846475,0.796391626234836,0,0,1.70241743275451,1.3470279356499,BAG6
delta,2,negative regulation of NF-kappaB transcription factor activity (GO:0032088),5/83,5,83,0.457387268804155,0.796391626234836,0,0,1.12810793736745,0.882434041351026,TRAF3;TLR9;RBCK1;CDK5RAP3;HAVCR2
delta,2,mitotic sister chromatid segregation (GO:0000070),5/83,5,83,0.457387268804155,0.796391626234836,0,0,1.12810793736745,0.882434041351026,CCNB1;PSRC1;PINX1;PIBF1;KPNB1
delta,2,positive regulation of protein secretion (GO:0050714),5/83,5,83,0.457387268804155,0.796391626234836,0,0,1.12810793736745,0.882434041351026,UNC13B;ACHE;BAD;MIF;GAPDH
delta,2,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),5/83,5,83,0.457387268804155,0.796391626234836,0,0,1.12810793736745,0.882434041351026,TWSG1;SMAD4;HSP90AB1;SMAD3;GDF5
delta,2,positive regulation of JAK-STAT cascade (GO:0046427),4/65,4,65,0.460034971928619,0.796391626234836,0,0,1.15240564678767,0.894788552529001,ARL2BP;IL6ST;IL6R;PIBF1
delta,2,glycerophospholipid metabolic process (GO:0006650),4/65,4,65,0.460034971928619,0.796391626234836,0,0,1.15240564678767,0.894788552529001,ABHD3;PIGP;CRLS1;PRDX6
delta,2,positive regulation of cell adhesion (GO:0045785),4/65,4,65,0.460034971928619,0.796391626234836,0,0,1.15240564678767,0.894788552529001,FRMD5;CIB1;PTPRJ;STX3
delta,2,protein complex disassembly (GO:0043241),3/47,3,47,0.462410129417743,0.796391626234836,0,0,1.1953143676787,0.921949624293169,GABARAPL1;LIX1L;CTNNB1
delta,2,intraciliary transport (GO:0042073),3/47,3,47,0.462410129417743,0.796391626234836,0,0,1.1953143676787,0.921949624293169,IFT74;IFT27;DYNLRB1
delta,2,positive regulation of protein localization to cell periphery (GO:1904377),3/47,3,47,0.462410129417743,0.796391626234836,0,0,1.1953143676787,0.921949624293169,CIB1;STX3;PLS1
delta,2,pyruvate metabolic process (GO:0006090),3/47,3,47,0.462410129417743,0.796391626234836,0,0,1.1953143676787,0.921949624293169,ME1;PDHB;PFKM
delta,2,regulation of cellular component movement (GO:0051270),3/47,3,47,0.462410129417743,0.796391626234836,0,0,1.1953143676787,0.921949624293169,CDK6;PKN2;ETS1
delta,2,icosanoid metabolic process (GO:0006690),3/47,3,47,0.462410129417743,0.796391626234836,0,0,1.1953143676787,0.921949624293169,PNPLA8;ALOX5;DAGLB
delta,2,regulation of DNA metabolic process (GO:0051052),3/47,3,47,0.462410129417743,0.796391626234836,0,0,1.1953143676787,0.921949624293169,PPP2CA;USP37;KPNA2
delta,2,protein methylation (GO:0006479),3/47,3,47,0.462410129417743,0.796391626234836,0,0,1.1953143676787,0.921949624293169,HSPA8;NSD1;METTL21A
delta,2,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),3/47,3,47,0.462410129417743,0.796391626234836,0,0,1.1953143676787,0.921949624293169,PINX1;CTNNB1;HSPA1A
delta,2,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),2/29,2,29,0.463376980910567,0.796391626234836,0,0,1.29148908691722,0.993431928914207,CNOT2;PHB
delta,2,hydrogen ion transmembrane transport (GO:1902600),2/29,2,29,0.463376980910567,0.796391626234836,0,0,1.29148908691722,0.993431928914207,ATP5B;ATP6V0C
delta,2,cellular response to alcohol (GO:0097306),2/29,2,29,0.463376980910567,0.796391626234836,0,0,1.29148908691722,0.993431928914207,GNB1;CTNNB1
delta,2,acute inflammatory response (GO:0002526),2/29,2,29,0.463376980910567,0.796391626234836,0,0,1.29148908691722,0.993431928914207,CTNNBIP1;IL6R
delta,2,positive regulation of sprouting angiogenesis (GO:1903672),2/29,2,29,0.463376980910567,0.796391626234836,0,0,1.29148908691722,0.993431928914207,CIB1;HDAC9
delta,2,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),2/29,2,29,0.463376980910567,0.796391626234836,0,0,1.29148908691722,0.993431928914207,TNFRSF12A;RIPK1
delta,2,cardiac muscle cell action potential involved in contraction (GO:0086002),2/29,2,29,0.463376980910567,0.796391626234836,0,0,1.29148908691722,0.993431928914207,PKP2;SCN3B
delta,2,production of miRNAs involved in gene silencing by miRNA (GO:0035196),2/29,2,29,0.463376980910567,0.796391626234836,0,0,1.29148908691722,0.993431928914207,SMAD3;NCBP1
delta,2,dopamine receptor signaling pathway (GO:0007212),2/29,2,29,0.463376980910567,0.796391626234836,0,0,1.29148908691722,0.993431928914207,GNAO1;GNB1
delta,2,positive regulation of lipid biosynthetic process (GO:0046889),2/29,2,29,0.463376980910567,0.796391626234836,0,0,1.29148908691722,0.993431928914207,CTDNEP1;LPGAT1
delta,2,ventricular septum development (GO:0003281),2/29,2,29,0.463376980910567,0.796391626234836,0,0,1.29148908691722,0.993431928914207,SMAD4;TGFBR2
delta,2,primary neural tube formation (GO:0014020),2/29,2,29,0.463376980910567,0.796391626234836,0,0,1.29148908691722,0.993431928914207,MTHFD1;FUZ
delta,2,transcription elongation from RNA polymerase I promoter (GO:0006362),2/29,2,29,0.463376980910567,0.796391626234836,0,0,1.29148908691722,0.993431928914207,POLR1C;POLR1E
delta,2,RNA phosphodiester bond hydrolysis (GO:0090501),2/29,2,29,0.463376980910567,0.796391626234836,0,0,1.29148908691722,0.993431928914207,LACTB2;WDR33
delta,2,negative regulation of proteasomal protein catabolic process (GO:1901799),2/29,2,29,0.463376980910567,0.796391626234836,0,0,1.29148908691722,0.993431928914207,BAG6;HSP90AB1
delta,2,regulation of receptor internalization (GO:0002090),2/29,2,29,0.463376980910567,0.796391626234836,0,0,1.29148908691722,0.993431928914207,TBC1D5;SCYL2
delta,2,aerobic respiration (GO:0009060),2/29,2,29,0.463376980910567,0.796391626234836,0,0,1.29148908691722,0.993431928914207,BLOC1S1;UQCRH
delta,2,response to cytokine (GO:0034097),8/139,8,139,0.465883530002383,0.796391626234836,0,0,1.07778945383019,0.823236722132737,IFNAR2;SETD2;SMAD3;TRAFD1;RIPK1;TIMP1;IL6ST;IL6R
delta,2,negative regulation of neuron death (GO:1901215),5/84,5,84,0.467860255332672,0.796391626234836,0,0,1.11467808097022,0.846693449450213,MSH2;WFS1;VPS35;BTBD10;SORL1
delta,2,glycolipid metabolic process (GO:0006664),4/66,4,66,0.471879844889599,0.796391626234836,0,0,1.13494495516967,0.852378721729485,GALC;NEU3;GLB1;SMPD1
delta,2,negative regulation of blood vessel morphogenesis (GO:2000181),4/66,4,66,0.471879844889599,0.796391626234836,0,0,1.13494495516967,0.852378721729485,MECP2;HGS;CTNNB1;FAM129B
delta,2,negative regulation of apoptotic signaling pathway (GO:2001234),4/66,4,66,0.471879844889599,0.796391626234836,0,0,1.13494495516967,0.852378721729485,RIPK1;SLC25A5;HERPUD1;HSPA1A
delta,2,cellular response to growth factor stimulus (GO:0071363),8/140,8,140,0.473972386823401,0.796391626234836,0,0,1.07009095773141,0.798936559262515,DLX1;SMAD4;SMAD3;TWF2;CTNNB1;CIB1;PLCG1;SIRT2
delta,2,negative regulation of cellular biosynthetic process (GO:0031327),3/48,3,48,0.476357937096312,0.796391626234836,0,0,1.17041198501873,0.867960836432335,SLC27A1;ACADVL;TRIB3
delta,2,inositol phosphate metabolic process (GO:0043647),3/48,3,48,0.476357937096312,0.796391626234836,0,0,1.17041198501873,0.867960836432335,INPP5A;INPP1;PLCG1
delta,2,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),3/48,3,48,0.476357937096312,0.796391626234836,0,0,1.17041198501873,0.867960836432335,SMAD4;TWSG1;GDF5
delta,2,response to glucose (GO:0009749),3/48,3,48,0.476357937096312,0.796391626234836,0,0,1.17041198501873,0.867960836432335,UNC13B;NKX6-1;IGF1R
delta,2,protein modification process (GO:0036211),5/85,5,85,0.478269954774219,0.796391626234836,0,0,1.1015642211941,0.812491679847006,PLOD2;SEPHS1;FBXO11;BAP1;UBE2L3
delta,2,vacuolar transport (GO:0007034),2/30,2,30,0.481180681557443,0.796391626234836,0,0,1.24843945068664,0.913248991356871,NEDD4;VPS54
delta,2,protein alkylation (GO:0008213),2/30,2,30,0.481180681557443,0.796391626234836,0,0,1.24843945068664,0.913248991356871,HSPA8;METTL21A
delta,2,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),2/30,2,30,0.481180681557443,0.796391626234836,0,0,1.24843945068664,0.913248991356871,HIF1A;NFE2L2
delta,2,negative regulation of lymphocyte proliferation (GO:0050672),2/30,2,30,0.481180681557443,0.796391626234836,0,0,1.24843945068664,0.913248991356871,ATM;TNFRSF21
delta,2,regulation of keratinocyte differentiation (GO:0045616),2/30,2,30,0.481180681557443,0.796391626234836,0,0,1.24843945068664,0.913248991356871,ERRFI1;CBFB
delta,2,negative regulation of epithelial cell apoptotic process (GO:1904036),2/30,2,30,0.481180681557443,0.796391626234836,0,0,1.24843945068664,0.913248991356871,WFS1;NFE2L2
delta,2,semaphorin-plexin signaling pathway (GO:0071526),2/30,2,30,0.481180681557443,0.796391626234836,0,0,1.24843945068664,0.913248991356871,FARP2;MET
delta,2,regulation of cellular biosynthetic process (GO:0031326),2/30,2,30,0.481180681557443,0.796391626234836,0,0,1.24843945068664,0.913248991356871,NOS1AP;PRKAG2
delta,2,very long-chain fatty acid metabolic process (GO:0000038),2/30,2,30,0.481180681557443,0.796391626234836,0,0,1.24843945068664,0.913248991356871,ACADVL;ABCD3
delta,2,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),2/30,2,30,0.481180681557443,0.796391626234836,0,0,1.24843945068664,0.913248991356871,TRAF3;RIPK1
delta,2,tube closure (GO:0060606),2/30,2,30,0.481180681557443,0.796391626234836,0,0,1.24843945068664,0.913248991356871,MTHFD1;FUZ
delta,2,cardiac muscle cell action potential (GO:0086001),2/30,2,30,0.481180681557443,0.796391626234836,0,0,1.24843945068664,0.913248991356871,PKP2;SCN3B
delta,2,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,NUDT16L1
delta,2,negative regulation of chondrocyte differentiation (GO:0032331),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,GDF5
delta,2,regulation of DNA-dependent DNA replication (GO:0090329),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,WRNIP1
delta,2,regulation of leukocyte cell-cell adhesion (GO:1903037),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,PAG1
delta,2,positive regulation of establishment of protein localization (GO:1904951),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,CCT5
delta,2,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,MIF
delta,2,UDP-N-acetylglucosamine metabolic process (GO:0006047),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,SLC35A3
delta,2,oligodendrocyte development (GO:0014003),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,ZNF488
delta,2,cellular response to arsenic-containing substance (GO:0071243),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,HNRNPA1
delta,2,mitochondrion transport along microtubule (GO:0047497),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,HIF1A
delta,2,nonribosomal peptide biosynthetic process (GO:0019184),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,CHAC1
delta,2,protein import into peroxisome matrix (GO:0016558),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,PEX5
delta,2,"alternative mRNA splicing, via spliceosome (GO:0000380)",1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,DDX5
delta,2,exit from mitosis (GO:0010458),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,CLASP1
delta,2,positive regulation of cardiocyte differentiation (GO:1905209),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,EFNB2
delta,2,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,PAX8
delta,2,somatic hypermutation of immunoglobulin genes (GO:0016446),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,MSH2
delta,2,response to prostaglandin E (GO:0034695),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,GNB1
delta,2,positive regulation of ruffle assembly (GO:1900029),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,PFN1
delta,2,plasminogen activation (GO:0031639),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,F11
delta,2,nitric oxide metabolic process (GO:0046209),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,ARG2
delta,2,tRNA 5'-leader removal (GO:0001682),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,RPP40
delta,2,positive regulation of chondrocyte differentiation (GO:0032332),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,GDF5
delta,2,cellular response to fluid shear stress (GO:0071498),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,NFE2L2
delta,2,cytoplasmic translational initiation (GO:0002183),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,DENR
delta,2,lysine metabolic process (GO:0006553),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,DLST
delta,2,response to interleukin-6 (GO:0070741),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,PHB
delta,2,purine nucleoside monophosphate biosynthetic process (GO:0009127),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,PFAS
delta,2,collagen metabolic process (GO:0032963),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,HIF1A
delta,2,positive regulation of DNA-dependent DNA replication (GO:2000105),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,CDC7
delta,2,aromatic compound biosynthetic process (GO:0019438),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,PSAT1
delta,2,establishment of protein localization to mitochondrial membrane (GO:0090151),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,TIMM9
delta,2,L-serine metabolic process (GO:0006563),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,PSAT1
delta,2,regulation of vascular endothelial cell proliferation (GO:1905562),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,SP1
delta,2,regulation of antigen receptor-mediated signaling pathway (GO:0050854),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,CBFB
delta,2,regulation of hormone secretion (GO:0046883),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,SCG5
delta,2,prostanoid metabolic process (GO:0006692),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,PLAA
delta,2,plasma membrane tubulation (GO:0097320),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,WHAMM
delta,2,endosome transport via multivesicular body sorting pathway (GO:0032509),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,UBXN6
delta,2,positive regulation of mRNA metabolic process (GO:1903313),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,NUDT21
delta,2,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,FUZ
delta,2,dermatan sulfate biosynthetic process (GO:0030208),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,CHST12
delta,2,negative regulation of interleukin-12 production (GO:0032695),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,PIBF1
delta,2,negative regulation of androgen receptor signaling pathway (GO:0060766),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,PHB
delta,2,keratan sulfate catabolic process (GO:0042340),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,GLB1
delta,2,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,HIF1A
delta,2,positive regulation of T cell cytokine production (GO:0002726),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,MALT1
delta,2,microtubule anchoring (GO:0034453),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,CLASP1
delta,2,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,ERLEC1
delta,2,negative regulation of protein oligomerization (GO:0032460),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,SORL1
delta,2,negative regulation of ATPase activity (GO:0032780),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,TLR9
delta,2,negative regulation of ERAD pathway (GO:1904293),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,ERLEC1
delta,2,iron ion transport (GO:0006826),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,SLC25A37
delta,2,carbohydrate derivative transport (GO:1901264),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,VLDLR
delta,2,cellular modified amino acid catabolic process (GO:0042219),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,CHAC1
delta,2,Golgi localization (GO:0051645),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,YWHAZ
delta,2,epithelial structure maintenance (GO:0010669),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,TLR9
delta,2,histone arginine methylation (GO:0034969),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,COPRS
delta,2,lysine catabolic process (GO:0006554),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,DLST
delta,2,regulation of histone methylation (GO:0031060),1/12,1,12,0.48249129774913,0.796391626234836,0,0,1.5605493133583,1.13731647022291,NSD1
delta,2,JNK cascade (GO:0007254),4/67,4,67,0.483626419247056,0.797822740398691,0,0,1.11800547822684,0.812166729681288,MAP3K2;SPAG9;TAOK1;RIPK1
delta,2,cytoplasmic microtubule organization (GO:0031122),3/49,3,49,0.490135293568236,0.806687008968996,0,0,1.14652602614079,0.817557689366773,CIB1;KPNB1;CLASP1
delta,2,glycoprotein metabolic process (GO:0009100),3/49,3,49,0.490135293568236,0.806687008968996,0,0,1.14652602614079,0.817557689366773,ERP44;MAN2C1;HIF1A
delta,2,positive regulation of chemotaxis (GO:0050921),3/49,3,49,0.490135293568236,0.806687008968996,0,0,1.14652602614079,0.817557689366773,STX3;IL6R;MET
delta,2,cellular response to mechanical stimulus (GO:0071260),3/49,3,49,0.490135293568236,0.806687008968996,0,0,1.14652602614079,0.817557689366773,MAP3K2;BAD;IRF1
delta,2,positive regulation of endothelial cell proliferation (GO:0001938),4/68,4,68,0.495267204449504,0.806687008968996,0,0,1.1015642211941,0.774022752906063,PDCL3;SP1;NRARP;HIF1A
delta,2,insulin receptor signaling pathway (GO:0008286),4/68,4,68,0.495267204449504,0.806687008968996,0,0,1.1015642211941,0.774022752906063,PIK3R3;AP3S1;ATP6V0C;IGF1R
delta,2,cellular response to UV (GO:0034644),4/68,4,68,0.495267204449504,0.806687008968996,0,0,1.1015642211941,0.774022752906063,MFAP4;CDKN1A;NEDD4;ATR
delta,2,regulation of protein localization to plasma membrane (GO:1903076),4/68,4,68,0.495267204449504,0.806687008968996,0,0,1.1015642211941,0.774022752906063,NUMB;CIB1;STX3;PLS1
delta,2,regulation of gene silencing by miRNA (GO:0060964),4/68,4,68,0.495267204449504,0.806687008968996,0,0,1.1015642211941,0.774022752906063,FXR1;NUP205;NUP107;AAAS
delta,2,positive regulation of macromolecule biosynthetic process (GO:0010557),8/143,8,143,0.498055015175323,0.806687008968996,0,0,1.0476414970797,0.730252990565452,FXR1;CTC1;RPS4X;POLDIP3;EIF4A3;TLR9;HIF1A;IGF1R
delta,2,regulation of leukocyte chemotaxis (GO:0002688),2/31,2,31,0.498615168618787,0.806687008968996,0,0,1.20816721034191,0.840788553745415,IL6R;SLC8B1
delta,2,fatty-acyl-CoA biosynthetic process (GO:0046949),2/31,2,31,0.498615168618787,0.806687008968996,0,0,1.20816721034191,0.840788553745415,ACSL1;FASN
delta,2,MyD88-independent toll-like receptor signaling pathway (GO:0002756),2/31,2,31,0.498615168618787,0.806687008968996,0,0,1.20816721034191,0.840788553745415,TRAF3;RIPK1
delta,2,phosphatidylinositol 3-kinase signaling (GO:0014065),2/31,2,31,0.498615168618787,0.806687008968996,0,0,1.20816721034191,0.840788553745415,SIRT2;IGF1R
delta,2,response to estradiol (GO:0032355),2/31,2,31,0.498615168618787,0.806687008968996,0,0,1.20816721034191,0.840788553745415,FOXA1;CTNNB1
delta,2,ATP-dependent chromatin remodeling (GO:0043044),2/31,2,31,0.498615168618787,0.806687008968996,0,0,1.20816721034191,0.840788553745415,SMARCA5;GATAD2B
delta,2,positive regulation of B cell proliferation (GO:0030890),2/31,2,31,0.498615168618787,0.806687008968996,0,0,1.20816721034191,0.840788553745415,TLR9;MIF
delta,2,regulation of protein polymerization (GO:0032271),2/31,2,31,0.498615168618787,0.806687008968996,0,0,1.20816721034191,0.840788553745415,MAP2;PFN1
delta,2,regulation of sodium ion transmembrane transport (GO:1902305),2/31,2,31,0.498615168618787,0.806687008968996,0,0,1.20816721034191,0.840788553745415,SLMAP;SCN3B
delta,2,chondroitin sulfate metabolic process (GO:0030204),2/31,2,31,0.498615168618787,0.806687008968996,0,0,1.20816721034191,0.840788553745415,CHST12;CSGALNACT2
delta,2,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),2/31,2,31,0.498615168618787,0.806687008968996,0,0,1.20816721034191,0.840788553745415,CIB1;HDAC9
delta,2,RNA methylation (GO:0001510),3/50,3,50,0.50373217859758,0.806687008968996,0,0,1.12359550561798,0.770461285191942,DIMT1;METTL1;BCDIN3D
delta,2,gonad development (GO:0008406),3/50,3,50,0.50373217859758,0.806687008968996,0,0,1.12359550561798,0.770461285191942,NUP107;MSH2;KLHL26
delta,2,lipid homeostasis (GO:0055088),3/50,3,50,0.50373217859758,0.806687008968996,0,0,1.12359550561798,0.770461285191942,PRKAA1;ORMDL2;LIPG
delta,2,organic substance transport (GO:0071702),5/88,5,88,0.509063349367307,0.806687008968996,0,0,1.06401089547157,0.718401868077533,SLC48A1;SLC25A26;SCP2;SLC50A1;CLN8
delta,2,cellular response to BMP stimulus (GO:0071773),5/88,5,88,0.509063349367307,0.806687008968996,0,0,1.06401089547157,0.718401868077533,DLX1;DDX5;SMAD4;SMURF2;GDF5
delta,2,DNA-templated transcriptional preinitiation complex assembly (GO:0070897),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,GTF2A2
delta,2,dermatan sulfate metabolic process (GO:0030205),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,CHST12
delta,2,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,TLR9
delta,2,signal transduction involved in DNA damage checkpoint (GO:0072422),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,FZR1
delta,2,mitochondrial genome maintenance (GO:0000002),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,LONP1
delta,2,atrial cardiac muscle cell action potential (GO:0086014),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,SCN3B
delta,2,regulation of oligodendrocyte differentiation (GO:0048713),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,TNFRSF21
delta,2,cellular response to nitrogen starvation (GO:0006995),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,GABARAPL1
delta,2,regulation of glucose import in response to insulin stimulus (GO:2001273),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,PIK3R3
delta,2,maintenance of gastrointestinal epithelium (GO:0030277),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,TLR9
delta,2,regulation of triglyceride biosynthetic process (GO:0010866),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,CTDNEP1
delta,2,tricarboxylic acid metabolic process (GO:0072350),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,IDH2
delta,2,atrial septum development (GO:0003283),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,NPHP3
delta,2,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,DDX5
delta,2,positive regulation of endothelial cell chemotaxis (GO:2001028),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,MET
delta,2,positive regulation of protein complex disassembly (GO:0043243),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,IGF1R
delta,2,regulation of macrophage differentiation (GO:0045649),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,RIPK1
delta,2,pathway-restricted SMAD protein phosphorylation (GO:0060389),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,TGFBR2
delta,2,catecholamine biosynthetic process (GO:0042423),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,PAH
delta,2,B cell activation involved in immune response (GO:0002312),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,MSH2
delta,2,leukocyte differentiation (GO:0002521),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,BATF3
delta,2,toll-like receptor 9 signaling pathway (GO:0034162),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,TLR9
delta,2,regulation of execution phase of apoptosis (GO:1900117),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,SIRT2
delta,2,ER-associated misfolded protein catabolic process (GO:0071712),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,BAG6
delta,2,establishment of chromosome localization (GO:0051303),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,GEM
delta,2,protein localization to endoplasmic reticulum (GO:0070972),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,GBF1
delta,2,regulation of endothelial cell chemotaxis (GO:2001026),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,MET
delta,2,regulation of necrotic cell death (GO:0010939),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,RIPK1
delta,2,cranial nerve development (GO:0021545),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,CHD7
delta,2,positive regulation of lamellipodium assembly (GO:0010592),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,TWF2
delta,2,negative regulation of hormone secretion (GO:0046888),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,RAB11FIP5
delta,2,regulation of fibrinolysis (GO:0051917),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,F11
delta,2,diacylglycerol metabolic process (GO:0046339),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,DAGLB
delta,2,regulation of T cell cytokine production (GO:0002724),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,MALT1
delta,2,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,ATP5G2
delta,2,negative regulation of cartilage development (GO:0061037),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,GDF5
delta,2,amyloid precursor protein metabolic process (GO:0042982),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,ACHE
delta,2,negative regulation of interleukin-10 production (GO:0032693),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,TNFRSF21
delta,2,mitotic DNA integrity checkpoint (GO:0044774),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,TOP2A
delta,2,cellular response to nitrogen levels (GO:0043562),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,GABARAPL1
delta,2,regulation of cellular carbohydrate metabolic process (GO:0010675),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,PDK1
delta,2,DNA strand elongation (GO:0022616),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,DCLRE1B
delta,2,response to iron ion (GO:0010039),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,HIF1A
delta,2,cellular response to exogenous dsRNA (GO:0071360),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,RALB
delta,2,regulation of lymphocyte activation (GO:0051249),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,PAG1
delta,2,glycerolipid catabolic process (GO:0046503),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,PRDX6
delta,2,DNA replication-independent nucleosome organization (GO:0034724),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,SUPT16H
delta,2,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,PTBP1
delta,2,chromatin assembly or disassembly (GO:0006333),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,SUPT16H
delta,2,regulation of biomineral tissue development (GO:0070167),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,ENPP1
delta,2,positive regulation of skeletal muscle tissue development (GO:0048643),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,FAM129B
delta,2,positive regulation of actin nucleation (GO:0051127),1/13,1,13,0.510142792634291,0.806687008968996,0,0,1.44050705848459,0.969554317048363,WHAMM
delta,2,positive regulation of cellular catabolic process (GO:0031331),6/107,6,107,0.510915251102864,0.807479440935806,0,0,1.05008925758689,0.705189070299997,PRKAA1;BAD;VPS35;PTTG1IP;HIF1A;RNF152
delta,2,negative regulation of multicellular organismal process (GO:0051241),7/126,7,126,0.512509963802282,0.809569879127172,0,0,1.04036620890553,0.695417318552986,FOXA1;PPP2CA;TWSG1;NFIB;FUZ;TIMP1;RAB11FIP5
delta,2,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),8/145,8,145,0.513928626281296,0.809831759619357,0,0,1.03319126953377,0.687765344227031,TWSG1;DDX5;SMAD4;SMAD3;FNTA;SMURF2;GDF5;TGFBR2
delta,2,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),2/32,2,32,0.515669080806009,0.809831759619357,0,0,1.17041198501873,0.775152195106789,ARG2;HAVCR2
delta,2,regulation of protein export from nucleus (GO:0046825),2/32,2,32,0.515669080806009,0.809831759619357,0,0,1.17041198501873,0.775152195106789,SETD2;XPO4
delta,2,positive regulation of viral genome replication (GO:0045070),2/32,2,32,0.515669080806009,0.809831759619357,0,0,1.17041198501873,0.775152195106789,TOP2A;PKN2
delta,2,regulation of protein autophosphorylation (GO:0031952),2/32,2,32,0.515669080806009,0.809831759619357,0,0,1.17041198501873,0.775152195106789,ERRFI1;ENPP1
delta,2,termination of RNA polymerase I transcription (GO:0006363),2/32,2,32,0.515669080806009,0.809831759619357,0,0,1.17041198501873,0.775152195106789,POLR1C;POLR1E
delta,2,regulation of cytokine secretion (GO:0050707),2/32,2,32,0.515669080806009,0.809831759619357,0,0,1.17041198501873,0.775152195106789,MIF;GAPDH
delta,2,proton transport (GO:0015992),2/32,2,32,0.515669080806009,0.809831759619357,0,0,1.17041198501873,0.775152195106789,ATP5B;ATP6V0C
delta,2,vesicle-mediated transport to the plasma membrane (GO:0098876),2/32,2,32,0.515669080806009,0.809831759619357,0,0,1.17041198501873,0.775152195106789,SNX27;VPS35
delta,2,regulation of glucose import (GO:0046324),2/32,2,32,0.515669080806009,0.809831759619357,0,0,1.17041198501873,0.775152195106789,PRKAG2;ENPP1
delta,2,positive regulation of protein dephosphorylation (GO:0035307),2/32,2,32,0.515669080806009,0.809831759619357,0,0,1.17041198501873,0.775152195106789,HSP90AB1;SMPD1
delta,2,wound healing (GO:0042060),3/51,3,51,0.517139507856116,0.810199775103788,0,0,1.1015642211941,0.726418373826757,SMAD3;FZD7;DCBLD2
delta,2,negative regulation of protein ubiquitination (GO:0031397),3/51,3,51,0.517139507856116,0.810199775103788,0,0,1.1015642211941,0.726418373826757,PDCL3;PINX1;HSPA1A
delta,2,regulation of cellular protein metabolic process (GO:0032268),3/51,3,51,0.517139507856116,0.810199775103788,0,0,1.1015642211941,0.726418373826757,CYFIP2;NOLC1;VPS35
delta,2,negative regulation of angiogenesis (GO:0016525),4/70,4,70,0.518203757322733,0.810199775103788,0,0,1.07009095773141,0.703463627780771,MECP2;HGS;CTNNB1;FAM129B
delta,2,negative regulation of cell cycle G2/M phase transition (GO:1902750),4/70,4,70,0.518203757322733,0.810199775103788,0,0,1.07009095773141,0.703463627780771,FZR1;PSMD14;PSMB3;PINX1
delta,2,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),4/70,4,70,0.518203757322733,0.810199775103788,0,0,1.07009095773141,0.703463627780771,BCAS3;TWF2;FUZ;PFN1
delta,2,regulation of protein targeting to mitochondrion (GO:1903214),5/89,5,89,0.519165232219515,0.810199775103788,0,0,1.05205571687077,0.689657324382994,HSPA1L;DPH6;BAP1;UBE2L3;ZBED3
delta,2,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",5/89,5,89,0.519165232219515,0.810199775103788,0,0,1.05205571687077,0.689657324382994,PSMD14;SMURF2;PSMB3;FZD7;PFN1
delta,2,positive regulation of cell cycle process (GO:0090068),6/108,6,108,0.520077598117977,0.810199775103788,0,0,1.04036620890553,0.680167760497266,GEN1;CCNB1;MED25;CDC7;PKN2;SIRT2
delta,2,monocarboxylic acid metabolic process (GO:0032787),6/109,6,109,0.529171811320885,0.810199775103788,0,0,1.03082156478714,0.656058256622472,SCARB2;PNPLA8;FASN;ME1;PDHB;NIT2
delta,2,vesicle organization (GO:0016050),7/128,7,128,0.5293456207452,0.810199775103788,0,0,1.02411048689139,0.651450724459432,SYT4;STX12;SNX1;ANXA2;STX16;STX3;YKT6
delta,2,vascular endothelial growth factor receptor signaling pathway (GO:0048010),4/71,4,71,0.529486832577445,0.810199775103788,0,0,1.05501925410139,0.670830808570377,CYFIP2;SHB;DOCK1;NCK1
delta,2,Rab protein signal transduction (GO:0032482),4/71,4,71,0.529486832577445,0.810199775103788,0,0,1.05501925410139,0.670830808570377,RAB3B;RAB40C;IFT27;RAB9B
delta,2,positive regulation of actin filament polymerization (GO:0030838),3/52,3,52,0.530349094341033,0.810199775103788,0,0,1.08038029386344,0.685198596256394,WHAMM;PFN1;NCK1
delta,2,positive regulation of developmental growth (GO:0048639),3/52,3,52,0.530349094341033,0.810199775103788,0,0,1.08038029386344,0.685198596256394,SYT4;TWF2;PLAA
delta,2,dendrite morphogenesis (GO:0048813),2/33,2,33,0.532333319758337,0.810199775103788,0,0,1.13494495516967,0.715566275038211,MAP2;CTNNA2
delta,2,central nervous system neuron differentiation (GO:0021953),2/33,2,33,0.532333319758337,0.810199775103788,0,0,1.13494495516967,0.715566275038211,MAP2;CTNNB1
delta,2,protein trimerization (GO:0070206),2/33,2,33,0.532333319758337,0.810199775103788,0,0,1.13494495516967,0.715566275038211,SMAD4;MIF
delta,2,regulation of potassium ion transmembrane transport (GO:1901379),2/33,2,33,0.532333319758337,0.810199775103788,0,0,1.13494495516967,0.715566275038211,NEDD4;NOS1AP
delta,2,negative regulation of receptor activity (GO:2000272),2/33,2,33,0.532333319758337,0.810199775103788,0,0,1.13494495516967,0.715566275038211,ERRFI1;ZGPAT
delta,2,mitochondrial transmembrane transport (GO:1990542),2/33,2,33,0.532333319758337,0.810199775103788,0,0,1.13494495516967,0.715566275038211,TIMM9;PRKAG2
delta,2,endodermal cell differentiation (GO:0035987),2/33,2,33,0.532333319758337,0.810199775103788,0,0,1.13494495516967,0.715566275038211,SETD2;LEO1
delta,2,positive regulation of T cell differentiation (GO:0045582),2/33,2,33,0.532333319758337,0.810199775103788,0,0,1.13494495516967,0.715566275038211,SOCS1;GLI3
delta,2,positive regulation of transcription factor import into nucleus (GO:0042993),2/33,2,33,0.532333319758337,0.810199775103788,0,0,1.13494495516967,0.715566275038211,SMAD3;TLR9
delta,2,positive regulation of myeloid leukocyte differentiation (GO:0002763),2/33,2,33,0.532333319758337,0.810199775103788,0,0,1.13494495516967,0.715566275038211,CTNNBIP1;RIPK1
delta,2,sister chromatid segregation (GO:0000819),2/33,2,33,0.532333319758337,0.810199775103788,0,0,1.13494495516967,0.715566275038211,RB1;TOP2A
delta,2,positive regulation of cardiac muscle cell proliferation (GO:0060045),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,PIM1
delta,2,positive regulation of neural precursor cell proliferation (GO:2000179),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,CTNNB1
delta,2,positive regulation of cell adhesion mediated by integrin (GO:0033630),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,CIB1
delta,2,regulation of extracellular matrix disassembly (GO:0010715),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,CLASP1
delta,2,regulation of calcineurin-NFAT signaling cascade (GO:0070884),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,CIB1
delta,2,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,PKP2
delta,2,negative regulation of focal adhesion assembly (GO:0051895),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,BCAS3
delta,2,oligodendrocyte differentiation (GO:0048709),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,ZNF488
delta,2,regulation of lymphocyte differentiation (GO:0045619),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,TLR9
delta,2,positive regulation of mitochondrial fission (GO:0090141),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,VPS35
delta,2,regulation of defense response to virus (GO:0050688),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,TRAF3
delta,2,hydrogen peroxide catabolic process (GO:0042744),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,PRDX6
delta,2,purine-containing compound salvage (GO:0043101),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,AMPD3
delta,2,cell migration involved in sprouting angiogenesis (GO:0002042),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,EFNB2
delta,2,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,NOS1AP
delta,2,monosaccharide transport (GO:0015749),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,SLC50A1
delta,2,regulation of fatty acid metabolic process (GO:0019217),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,PRKAG2
delta,2,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,ALG12
delta,2,necroptotic process (GO:0070266),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,RIPK1
delta,2,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,MSH2
delta,2,regulation of transferase activity (GO:0051338),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,PINX1
delta,2,regulation of gastrulation (GO:0010470),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,CLASP1
delta,2,nucleoside triphosphate metabolic process (GO:0009141),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,ENPP1
delta,2,positive regulation of heart rate (GO:0010460),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,SCN3B
delta,2,positive regulation of muscle hypertrophy (GO:0014742),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,IL6ST
delta,2,histone H4-K16 acetylation (GO:0043984),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,KAT8
delta,2,positive regulation of calcium ion-dependent exocytosis (GO:0045956),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,SYT4
delta,2,negative regulation of T cell receptor signaling pathway (GO:0050860),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,PTPRJ
delta,2,ribonucleoside monophosphate biosynthetic process (GO:0009156),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,PFAS
delta,2,ncRNA transcription (GO:0098781),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,GTF3C1
delta,2,intermediate filament organization (GO:0045109),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,PKP2
delta,2,glucosamine-containing compound metabolic process (GO:1901071),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,EXTL2
delta,2,lipid particle organization (GO:0034389),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,FAF2
delta,2,stem cell development (GO:0048864),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,NOLC1
delta,2,negative regulation of Rho protein signal transduction (GO:0035024),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,MET
delta,2,acyl-CoA biosynthetic process (GO:0071616),1/14,1,14,0.536318119634178,0.810199775103788,0,0,1.33761369716426,0.833370501854796,FASN
delta,2,phosphatidylcholine metabolic process (GO:0046470),4/72,4,72,0.540638715906472,0.810199775103788,0,0,1.04036620890553,0.639829412354328,ACHE;SLC27A1;ABHD3;PNPLA8
delta,2,recombinational repair (GO:0000725),4/72,4,72,0.540638715906472,0.810199775103788,0,0,1.04036620890553,0.639829412354328,GEN1;PSMD14;POLN;RFWD3
delta,2,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),4/72,4,72,0.540638715906472,0.810199775103788,0,0,1.04036620890553,0.639829412354328,FZR1;CCNB1;PSMD14;PSMB3
delta,2,positive regulation of lymphocyte proliferation (GO:0050671),4/72,4,72,0.540638715906472,0.810199775103788,0,0,1.04036620890553,0.639829412354328,TLR9;MIF;IL6ST;NCK1
delta,2,positive regulation of growth (GO:0045927),4/72,4,72,0.540638715906472,0.810199775103788,0,0,1.04036620890553,0.639829412354328,NCBP1;ZNF639;WFS1;CIB1
delta,2,positive regulation of ossification (GO:0045778),3/53,3,53,0.543353610149911,0.810199775103788,0,0,1.05999576001696,0.646592066198295,CTNNBIP1;IL6ST;IL6R
delta,2,regulation of calcium ion transport (GO:0051924),3/53,3,53,0.543353610149911,0.810199775103788,0,0,1.05999576001696,0.646592066198295,WFS1;CTNNB1;SLC8B1
delta,2,regulation of cell-matrix adhesion (GO:0001952),3/53,3,53,0.543353610149911,0.810199775103788,0,0,1.05999576001696,0.646592066198295,CDK6;CIB1;CLASP1
delta,2,B cell differentiation (GO:0030183),3/53,3,53,0.543353610149911,0.810199775103788,0,0,1.05999576001696,0.646592066198295,MSH2;CEBPG;HDAC9
delta,2,positive regulation of cell-substrate adhesion (GO:0010811),3/53,3,53,0.543353610149911,0.810199775103788,0,0,1.05999576001696,0.646592066198295,CDK6;CIB1;DOCK1
delta,2,regulation of DNA binding (GO:0051101),3/53,3,53,0.543353610149911,0.810199775103788,0,0,1.05999576001696,0.646592066198295,RB1;CEBPG;SIRT2
delta,2,positive regulation of secretion by cell (GO:1903532),3/53,3,53,0.543353610149911,0.810199775103788,0,0,1.05999576001696,0.646592066198295,UNC13B;ACHE;CLASP1
delta,2,positive regulation of proteolysis (GO:0045862),3/53,3,53,0.543353610149911,0.810199775103788,0,0,1.05999576001696,0.646592066198295,CYFIP2;BAD;PERP
delta,2,regulated exocytosis (GO:0045055),8/149,8,149,0.545146114027986,0.810199775103788,0,0,1.00545459115703,0.610010729323706,ABCC4;PROS1;DNAJC5;ENDOD1;OLA1;TIMP1;TLN1;RAB11FIP5
delta,2,cellular response to peptide hormone stimulus (GO:0071375),6/111,6,111,0.547141853535531,0.810199775103788,0,0,1.01224820325944,0.610433424571014,PRKAR2A;GNB1;ENPP1;TRIB3;PRKACB;HDAC9
delta,2,glycogen metabolic process (GO:0005977),2/34,2,34,0.548600841576716,0.810199775103788,0,0,1.1015642211941,0.661361716716773,UGP2;PRKAG2
delta,2,negative regulation of neurogenesis (GO:0050768),2/34,2,34,0.548600841576716,0.810199775103788,0,0,1.1015642211941,0.661361716716773,ASCL1;SORL1
delta,2,negative regulation of mitochondrion organization (GO:0010823),2/34,2,34,0.548600841576716,0.810199775103788,0,0,1.1015642211941,0.661361716716773,SLC25A5;HSPA1A
delta,2,neural tube closure (GO:0001843),2/34,2,34,0.548600841576716,0.810199775103788,0,0,1.1015642211941,0.661361716716773,MTHFD1;FUZ
delta,2,platelet aggregation (GO:0070527),2/34,2,34,0.548600841576716,0.810199775103788,0,0,1.1015642211941,0.661361716716773,TLN1;MYL12A
delta,2,regulation of autophagosome assembly (GO:2000785),2/34,2,34,0.548600841576716,0.810199775103788,0,0,1.1015642211941,0.661361716716773,RALB;PIP4K2B
delta,2,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),2/34,2,34,0.548600841576716,0.810199775103788,0,0,1.1015642211941,0.661361716716773,BAD;NCK1
delta,2,transcription initiation from RNA polymerase I promoter (GO:0006361),2/34,2,34,0.548600841576716,0.810199775103788,0,0,1.1015642211941,0.661361716716773,POLR1C;POLR1E
delta,2,transcription from RNA polymerase I promoter (GO:0006360),2/34,2,34,0.548600841576716,0.810199775103788,0,0,1.1015642211941,0.661361716716773,POLR1C;POLR1E
delta,2,cellular glucose homeostasis (GO:0001678),2/34,2,34,0.548600841576716,0.810199775103788,0,0,1.1015642211941,0.661361716716773,UNC13B;IGF1R
delta,2,regulation of intracellular protein transport (GO:0033157),2/34,2,34,0.548600841576716,0.810199775103788,0,0,1.1015642211941,0.661361716716773,BCAS3;TCTEX1D2
delta,2,positive regulation of organelle organization (GO:0010638),2/34,2,34,0.548600841576716,0.810199775103788,0,0,1.1015642211941,0.661361716716773,ANXA2;PPARGC1B
delta,2,regulation of interleukin-12 production (GO:0032655),2/34,2,34,0.548600841576716,0.810199775103788,0,0,1.1015642211941,0.661361716716773,TLR9;PIBF1
delta,2,cellular response to acid chemical (GO:0071229),5/92,5,92,0.548917564361836,0.810199775103788,0,0,1.0177495521902,0.610453310471132,RRAGA;SESN3;FZD7;TWF2;IPO5
delta,2,lipid transport (GO:0006869),5/92,5,92,0.548917564361836,0.810199775103788,0,0,1.0177495521902,0.610453310471132,SCP2;PITPNB;SLC10A3;CLN8;PPARD
delta,2,regulation of phosphatase activity (GO:0010921),4/73,4,73,0.551654151737259,0.810199775103788,0,0,1.02611461700272,0.610367826965317,PPP1R12A;PPP6R1;PCIF1;CDK5RAP3
delta,2,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),4/73,4,73,0.551654151737259,0.810199775103788,0,0,1.02611461700272,0.610367826965317,FBXW4;PSMD14;PSMB3;RNF7
delta,2,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),4/73,4,73,0.551654151737259,0.810199775103788,0,0,1.02611461700272,0.610367826965317,FZR1;CCNB1;PSMD14;PSMB3
delta,2,cell-cell junction organization (GO:0045216),4/73,4,73,0.551654151737259,0.810199775103788,0,0,1.02611461700272,0.610367826965317,SMAD3;CDH2;PERP;TLN1
delta,2,generation of neurons (GO:0048699),7/131,7,131,0.554162169117799,0.810199775103788,0,0,1.00065757497784,0.590686076166595,RB1;CDK6;MYEF2;FZD7;CTNNB1;ASCL1;POU3F2
delta,2,positive regulation of protein import into nucleus (GO:0042307),3/54,3,54,0.556146547566195,0.810199775103788,0,0,1.04036620890553,0.610407245840548,SMAD4;SMAD3;IPO5
delta,2,positive regulation of peptidyl-lysine acetylation (GO:2000758),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,TADA2B
delta,2,myotube differentiation (GO:0014902),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,MYEF2
delta,2,pseudouridine synthesis (GO:0001522),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,RPUSD3
delta,2,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,SLC5A8
delta,2,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,SCP2
delta,2,catecholamine metabolic process (GO:0006584),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,PAH
delta,2,apoptotic DNA fragmentation (GO:0006309),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,KPNB1
delta,2,maintenance of protein location in nucleus (GO:0051457),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,ARL2BP
delta,2,epithelial cilium movement (GO:0003351),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,NPHP3
delta,2,autonomic nervous system development (GO:0048483),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,ASCL1
delta,2,endocardial cushion morphogenesis (GO:0003203),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,TGFBR2
delta,2,positive regulation of mesonephros development (GO:0061213),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,PAX8
delta,2,mitotic sister chromatid cohesion (GO:0007064),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,RB1
delta,2,positive regulation of small GTPase mediated signal transduction (GO:0051057),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,RASGRP1
delta,2,G-protein coupled glutamate receptor signaling pathway (GO:0007216),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,DAGLB
delta,2,regulation of mitotic metaphase/anaphase transition (GO:0030071),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,RB1
delta,2,lipoxygenase pathway (GO:0019372),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,ALOX5
delta,2,positive regulation of potassium ion transmembrane transport (GO:1901381),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,NOS1AP
delta,2,regulation of interleukin-4 production (GO:0032673),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,HAVCR2
delta,2,unsaturated fatty acid biosynthetic process (GO:0006636),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,ALOX5
delta,2,regulation of tumor necrosis factor secretion (GO:1904467),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,HAVCR2
delta,2,intracellular lipid transport (GO:0032365),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,PRKAG2
delta,2,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,CCT5
delta,2,regulation of centriole replication (GO:0046599),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,MDM1
delta,2,N-acetylglucosamine metabolic process (GO:0006044),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,EXTL2
delta,2,negative regulation of interleukin-2 production (GO:0032703),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,HAVCR2
delta,2,regulation of clathrin-dependent endocytosis (GO:2000369),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,SCYL2
delta,2,regulation of cell-substrate junction assembly (GO:0090109),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,CLASP1
delta,2,negative regulation of lipid catabolic process (GO:0050995),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,PRKAA1
delta,2,cellular response to virus (GO:0098586),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,GBF1
delta,2,negative regulation of cellular component movement (GO:0051271),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,FRMD5
delta,2,positive regulation of acute inflammatory response (GO:0002675),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,IL6ST
delta,2,response to cholesterol (GO:0070723),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,TGFBR2
delta,2,neural crest cell differentiation (GO:0014033),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,NOLC1
delta,2,ganglioside metabolic process (GO:0001573),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,NEU3
delta,2,regulation of exit from mitosis (GO:0007096),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,SIRT2
delta,2,mesenchymal cell development (GO:0014031),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,NOLC1
delta,2,regulation of delayed rectifier potassium channel activity (GO:1902259),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,NOS1AP
delta,2,negative regulation of muscle cell differentiation (GO:0051148),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,PTBP1
delta,2,vasculature development (GO:0001944),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,ERRFI1
delta,2,regulation of mitochondrial translation (GO:0070129),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,MRPS27
delta,2,regulation of macrophage chemotaxis (GO:0010758),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,MIF
delta,2,negative regulation of viral entry into host cell (GO:0046597),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,SNX3
delta,2,positive regulation of cellular response to insulin stimulus (GO:1900078),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,PIK3R3
delta,2,cofactor transport (GO:0051181),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,SLC48A1
delta,2,positive regulation of interleukin-4 production (GO:0032753),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,HAVCR2
delta,2,negative regulation of DNA-dependent DNA replication (GO:2000104),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,DONSON
delta,2,positive regulation of NF-kappaB import into nucleus (GO:0042346),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,TLR9
delta,2,negative regulation of RNA metabolic process (GO:0051253),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,PTBP1
delta,2,positive regulation of exosomal secretion (GO:1903543),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,HGS
delta,2,negative regulation of mRNA processing (GO:0050686),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,PTBP1
delta,2,regulation of RNA export from nucleus (GO:0046831),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,SETD2
delta,2,positive regulation of potassium ion transport (GO:0043268),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,NOS1AP
delta,2,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,RIPK1
delta,2,positive regulation of protein export from nucleus (GO:0046827),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,XPO4
delta,2,nucleobase-containing small molecule catabolic process (GO:0034656),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,NUDT18
delta,2,cellular response to corticosteroid stimulus (GO:0071384),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,UBE2L3
delta,2,atrioventricular valve morphogenesis (GO:0003181),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,TGFBR2
delta,2,myeloid cell development (GO:0061515),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,ANXA2
delta,2,regulation of mast cell degranulation (GO:0043304),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,GAB2
delta,2,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,PAX8
delta,2,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,SIRT2
delta,2,selective autophagy (GO:0061912),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,RB1CC1
delta,2,negative regulation of adherens junction organization (GO:1903392),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,BCAS3
delta,2,regulation of B cell differentiation (GO:0045577),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,TLR9
delta,2,positive regulation of protein import (GO:1904591),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,IPO5
delta,2,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,TAOK1
delta,2,positive regulation of cytokine production involved in immune response (GO:0002720),1/15,1,15,0.561096013605143,0.810199775103788,0,0,1.24843945068664,0.721427266987784,MALT1
delta,2,lymphocyte differentiation (GO:0030098),4/74,4,74,0.562528302273381,0.811087319556967,0,0,1.01224820325944,0.582360391756909,MSH2;CHD7;CEBPG;HDAC9
delta,2,positive regulation of cytokine secretion (GO:0050715),4/74,4,74,0.562528302273381,0.811087319556967,0,0,1.01224820325944,0.582360391756909,MIF;GAPDH;RASGRP1;HAVCR2
delta,2,regulation of protein complex assembly (GO:0043254),4/74,4,74,0.562528302273381,0.811087319556967,0,0,1.01224820325944,0.582360391756909,FARP2;HSPA8;RALB;ANKRA2
delta,2,epithelial tube morphogenesis (GO:0060562),2/35,2,35,0.564466463423373,0.81113094888844,0,0,1.07009095773141,0.611957524349556,CTNNB1;MET
delta,2,regulation of JUN kinase activity (GO:0043506),2/35,2,35,0.564466463423373,0.81113094888844,0,0,1.07009095773141,0.611957524349556,TLR9;HIPK3
delta,2,ventricular cardiac muscle tissue morphogenesis (GO:0055010),2/35,2,35,0.564466463423373,0.81113094888844,0,0,1.07009095773141,0.611957524349556,SMAD4;PKP2
delta,2,endoplasmic reticulum organization (GO:0007029),2/35,2,35,0.564466463423373,0.81113094888844,0,0,1.07009095773141,0.611957524349556,ATL2;TMEM170A
delta,2,macromolecule catabolic process (GO:0009057),2/35,2,35,0.564466463423373,0.81113094888844,0,0,1.07009095773141,0.611957524349556,NEDD4;CLN8
delta,2,keratan sulfate metabolic process (GO:0042339),2/35,2,35,0.564466463423373,0.81113094888844,0,0,1.07009095773141,0.611957524349556,GLB1;B4GALT6
delta,2,positive regulation of exocytosis (GO:0045921),2/35,2,35,0.564466463423373,0.81113094888844,0,0,1.07009095773141,0.611957524349556,HGS;CLASP1
delta,2,cellular transition metal ion homeostasis (GO:0046916),5/94,5,94,0.568250273718977,0.815670944411748,0,0,0.996095306398916,0.562986427765165,SMAD4;CCDC115;FTH1;SLC39A13;NUBP1
delta,2,RNA modification (GO:0009451),3/55,3,55,0.568722180663433,0.815670944411748,0,0,1.02145045965271,0.576469073577632,METTL1;BCDIN3D;THUMPD1
delta,2,positive regulation of response to stimulus (GO:0048584),3/55,3,55,0.568722180663433,0.815670944411748,0,0,1.02145045965271,0.576469073577632,ARG2;DDX5;IER5
delta,2,action potential (GO:0001508),3/55,3,55,0.568722180663433,0.815670944411748,0,0,1.02145045965271,0.576469073577632,SCARB2;SCN8A;SCN3B
delta,2,glucose homeostasis (GO:0042593),4/75,4,75,0.57325673583584,0.816341537423287,0,0,0.998751560549313,0.555726948368926,PRKAA1;BAD;WFS1;SLC8B1
delta,2,mitotic nuclear division (GO:0140014),4/75,4,75,0.57325673583584,0.816341537423287,0,0,0.998751560549313,0.555726948368926,ARHGEF10;PIBF1;KPNB1;CLASP1
delta,2,positive regulation of canonical Wnt signaling pathway (GO:0090263),6/114,6,114,0.573502860608427,0.816341537423287,0,0,0.985610092647349,0.547991675972643,PSMD14;SMURF2;TNKS;PSMB3;NRARP;ZBED3
delta,2,vesicle fusion (GO:0006906),5/95,5,95,0.577754959126923,0.816341537423287,0,0,0.985610092647349,0.540711064801425,STX12;SYT4;STX16;STX3;YKT6
delta,2,cellular response to fibroblast growth factor stimulus (GO:0044344),5/95,5,95,0.577754959126923,0.816341537423287,0,0,0.985610092647349,0.540711064801425,PTBP1;RBFOX2;NCBP1;ESRP2;HNRNPA1
delta,2,regulation of heart rate by cardiac conduction (GO:0086091),2/36,2,36,0.579926685274312,0.816341537423287,0,0,1.04036620890553,0.566847261892303,PKP2;SCN3B
delta,2,positive regulation of peptide secretion (GO:0002793),2/36,2,36,0.579926685274312,0.816341537423287,0,0,1.04036620890553,0.566847261892303,UNC13B;ACHE
delta,2,regulation of mitotic spindle organization (GO:0060236),2/36,2,36,0.579926685274312,0.816341537423287,0,0,1.04036620890553,0.566847261892303,PSRC1;HSPA1A
delta,2,regulation of synapse assembly (GO:0051963),2/36,2,36,0.579926685274312,0.816341537423287,0,0,1.04036620890553,0.566847261892303,CLSTN2;VPS35
delta,2,negative regulation of tumor necrosis factor production (GO:0032720),2/36,2,36,0.579926685274312,0.816341537423287,0,0,1.04036620890553,0.566847261892303,ARG2;HAVCR2
delta,2,flagellated sperm motility (GO:0030317),2/36,2,36,0.579926685274312,0.816341537423287,0,0,1.04036620890553,0.566847261892303,CATSPERD;SLC9B2
delta,2,actin filament bundle organization (GO:0061572),2/36,2,36,0.579926685274312,0.816341537423287,0,0,1.04036620890553,0.566847261892303,NEDD9;PLS1
delta,2,sulfur compound catabolic process (GO:0044273),2/36,2,36,0.579926685274312,0.816341537423287,0,0,1.04036620890553,0.566847261892303,GLB1;CHAC1
delta,2,positive regulation of DNA replication (GO:0045740),2/36,2,36,0.579926685274312,0.816341537423287,0,0,1.04036620890553,0.566847261892303,CTC1;IGF1R
delta,2,regulation of gene silencing by RNA (GO:0060966),3/56,3,56,0.581075526921592,0.816341537423287,0,0,1.00321027287319,0.544617311273344,NUP205;NUP107;AAAS
delta,2,regulation of posttranscriptional gene silencing (GO:0060147),3/56,3,56,0.581075526921592,0.816341537423287,0,0,1.00321027287319,0.544617311273344,NUP205;NUP107;AAAS
delta,2,regulation of defense response (GO:0031347),4/76,4,76,0.583835415339465,0.816341537423287,0,0,0.985610092647349,0.530392429452346,TRAF3;IRF1;CASP4;SAMHD1
delta,2,purine ribonucleotide biosynthetic process (GO:0009152),4/76,4,76,0.583835415339465,0.816341537423287,0,0,0.985610092647349,0.530392429452346,ATP5B;DCAKD;PRKAG2;ATP5G2
delta,2,glucose transmembrane transport (GO:1904659),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,PPARD
delta,2,cellular response to dsRNA (GO:0071359),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,RALB
delta,2,embryonic digit morphogenesis (GO:0042733),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,GLI3
delta,2,positive regulation of regulated secretory pathway (GO:1903307),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,SYT4
delta,2,cytoplasmic sequestering of transcription factor (GO:0042994),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,NFKBIE
delta,2,regulation of exosomal secretion (GO:1903541),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,HGS
delta,2,regulation of water loss via skin (GO:0033561),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,MET
delta,2,cardiac ventricle development (GO:0003231),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,TMEM65
delta,2,protein deacylation (GO:0035601),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,SIRT2
delta,2,negative regulation of striated muscle cell differentiation (GO:0051154),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,FZD7
delta,2,regulation of bicellular tight junction assembly (GO:2000810),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,CBFB
delta,2,extracellular matrix assembly (GO:0085029),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,MFAP4
delta,2,regulation of energy homeostasis (GO:2000505),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,PRKAA1
delta,2,positive regulation of cardiac muscle hypertrophy (GO:0010613),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,IL6ST
delta,2,DNA methylation or demethylation (GO:0044728),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,PPM1D
delta,2,cellular response to pH (GO:0071467),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,RAB11FIP5
delta,2,hexose transport (GO:0008645),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,SLC50A1
delta,2,positive regulation of myotube differentiation (GO:0010831),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,FAM129B
delta,2,positive regulation of cilium assembly (GO:0045724),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,FUZ
delta,2,negative regulation of DNA replication (GO:0008156),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,ATR
delta,2,miRNA metabolic process (GO:0010586),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,BCDIN3D
delta,2,rRNA transcription (GO:0009303),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,GTF3C1
delta,2,regulation of steroid metabolic process (GO:0019218),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,ACADVL
delta,2,positive regulation of triglyceride metabolic process (GO:0090208),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,CTDNEP1
delta,2,genitalia development (GO:0048806),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,CHD7
delta,2,mRNA transcription from RNA polymerase II promoter (GO:0042789),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,HIF1A
delta,2,G-protein coupled acetylcholine receptor signaling pathway (GO:0007213),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,GNB1
delta,2,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,CDK10
delta,2,regulation of necroptotic process (GO:0060544),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,RIPK1
delta,2,programmed necrotic cell death (GO:0097300),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,RIPK1
delta,2,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,CTNNB1
delta,2,regulation of actin nucleation (GO:0051125),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,WHAMM
delta,2,postsynaptic membrane organization (GO:0001941),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,GPHN
delta,2,positive regulation of cardiac muscle tissue growth (GO:0055023),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,PIM1
delta,2,DNA alkylation (GO:0006305),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,PPM1D
delta,2,establishment of skin barrier (GO:0061436),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,MET
delta,2,activation of NF-kappaB-inducing kinase activity (GO:0007250),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,MALT1
delta,2,regulation of reactive oxygen species biosynthetic process (GO:1903426),1/16,1,16,0.584551013524538,0.816341537423287,0,0,1.17041198501873,0.628407332252459,NOS1AP
delta,2,regulation of heart contraction (GO:0008016),5/96,5,96,0.587147536289728,0.819198812938693,0,0,0.975343320848939,0.51934998364254,TMEM65;ITPR1;ITPR2;TNNI3K;FPGT-TNNI3K
delta,2,regulation of cytoskeleton organization (GO:0051493),5/96,5,96,0.587147536289728,0.819198812938693,0,0,0.975343320848939,0.51934998364254,CLIC4;TAOK1;TWF2;CDK10;CLASP1
delta,2,chromosome organization (GO:0051276),3/57,3,57,0.593202309460248,0.820026780090059,0,0,0.985610092647349,0.514705081315124,TOP2A;MSH2;GEM
delta,2,organonitrogen compound catabolic process (GO:1901565),3/57,3,57,0.593202309460248,0.820026780090059,0,0,0.985610092647349,0.514705081315124,CPQ;PNPLA8;CLN8
delta,2,positive regulation of protein transport (GO:0051222),3/57,3,57,0.593202309460248,0.820026780090059,0,0,0.985610092647349,0.514705081315124,UNC13B;ACHE;BCAS3
delta,2,glycosaminoglycan catabolic process (GO:0006027),3/57,3,57,0.593202309460248,0.820026780090059,0,0,0.985610092647349,0.514705081315124,GLB1;GPC2;GPC5
delta,2,regulation of secretion by cell (GO:1903530),3/57,3,57,0.593202309460248,0.820026780090059,0,0,0.985610092647349,0.514705081315124,RAB3B;RAB40C;SCG5
delta,2,cellular response to organic cyclic compound (GO:0071407),7/136,7,136,0.594185671564995,0.820026780090059,0,0,0.963868693544834,0.501754793248492,RAP1B;GABRB1;CASP7;BAD;GNB1;CTNNB1;UBE2L3
delta,2,regulation of hematopoietic stem cell differentiation (GO:1902036),4/77,4,77,0.594260685894407,0.820026780090059,0,0,0.972809961574007,0.50628648353571,PSMD14;CBFB;PSMB3;TCF12
delta,2,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),4/77,4,77,0.594260685894407,0.820026780090059,0,0,0.972809961574007,0.50628648353571,FZR1;CCNB1;PSMD14;PSMB3
delta,2,hemopoiesis (GO:0030097),4/77,4,77,0.594260685894407,0.820026780090059,0,0,0.972809961574007,0.50628648353571,ARMC6;KAT8;PRRC2C;TGFBR2
delta,2,regulation of smoothened signaling pathway (GO:0008589),2/37,2,37,0.59497952530166,0.820026780090059,0,0,1.01224820325944,0.525587898862539,FUZ;GLI3
delta,2,natural killer cell activation (GO:0030101),2/37,2,37,0.59497952530166,0.820026780090059,0,0,1.01224820325944,0.525587898862539,BAG6;SNX27
delta,2,sodium ion transmembrane transport (GO:0035725),2/37,2,37,0.59497952530166,0.820026780090059,0,0,1.01224820325944,0.525587898862539,SCN8A;SCN3B
delta,2,organophosphate biosynthetic process (GO:0090407),2/37,2,37,0.59497952530166,0.820026780090059,0,0,1.01224820325944,0.525587898862539,PCYT2;GPHN
delta,2,calcium ion transmembrane import into cytosol (GO:0097553),2/37,2,37,0.59497952530166,0.820026780090059,0,0,1.01224820325944,0.525587898862539,ITPR1;ITPR2
delta,2,heart looping (GO:0001947),2/37,2,37,0.59497952530166,0.820026780090059,0,0,1.01224820325944,0.525587898862539,NPHP3;TGFBR2
delta,2,ferric iron transport (GO:0015682),2/37,2,37,0.59497952530166,0.820026780090059,0,0,1.01224820325944,0.525587898862539,ATP6V0C;DNM2
delta,2,epithelial cell migration (GO:0010631),2/37,2,37,0.59497952530166,0.820026780090059,0,0,1.01224820325944,0.525587898862539,S100A2;PKN2
delta,2,regulation of ubiquitin protein ligase activity (GO:1904666),2/37,2,37,0.59497952530166,0.820026780090059,0,0,1.01224820325944,0.525587898862539,FZR1;CCNB1
delta,2,transferrin transport (GO:0033572),2/37,2,37,0.59497952530166,0.820026780090059,0,0,1.01224820325944,0.525587898862539,ATP6V0C;DNM2
delta,2,positive regulation of signaling (GO:0023056),2/37,2,37,0.59497952530166,0.820026780090059,0,0,1.01224820325944,0.525587898862539,CLSTN2;ANXA2
delta,2,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),6/117,6,117,0.599082844761151,0.820026780090059,0,0,0.960338038989724,0.492034366003575,TEC;ARL2BP;MIF;IL6ST;IL6R;PIBF1
delta,2,water-soluble vitamin metabolic process (GO:0006767),4/78,4,78,0.604529262578582,0.820026780090059,0,0,0.960338038989724,0.483343130888215,MTHFD1;FASN;ENPP1;ALDH1L2
delta,2,negative regulation of ubiquitin protein ligase activity (GO:1904667),4/78,4,78,0.604529262578582,0.820026780090059,0,0,0.960338038989724,0.483343130888215,FZR1;CCNB1;PSMD14;PSMB3
delta,2,regulation of hematopoietic progenitor cell differentiation (GO:1901532),4/78,4,78,0.604529262578582,0.820026780090059,0,0,0.960338038989724,0.483343130888215,PSMD14;CBFB;PSMB3;TCF12
delta,2,regulation of cytokinesis (GO:0032465),4/78,4,78,0.604529262578582,0.820026780090059,0,0,0.960338038989724,0.483343130888215,SETD2;ZFYVE19;PKN2;KIF20A
delta,2,response to retinoic acid (GO:0032526),3/58,3,58,0.605098919733645,0.820026780090059,0,0,0.968616815187912,0.486597569376785,FZD7;TWF2;ASCL1
delta,2,positive regulation of cell death (GO:0010942),3/58,3,58,0.605098919733645,0.820026780090059,0,0,0.968616815187912,0.486597569376785,EFNB2;RIPK1;PHB
delta,2,chloride transmembrane transport (GO:1902476),3/58,3,58,0.605098919733645,0.820026780090059,0,0,0.968616815187912,0.486597569376785,CLIC5;CLIC4;GABRB1
delta,2,regulation of protein sumoylation (GO:0033233),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,CTNNB1
delta,2,regulation of membrane depolarization (GO:0003254),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,SCN3B
delta,2,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,PTPRJ
delta,2,response to interferon-alpha (GO:0035455),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,IFNAR2
delta,2,positive regulation of monocyte chemotaxis (GO:0090026),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,CREB3
delta,2,histone H2A ubiquitination (GO:0033522),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,PCGF1
delta,2,positive regulation of striated muscle cell differentiation (GO:0051155),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,EFNB2
delta,2,gastrulation (GO:0007369),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,NPHP3
delta,2,pigment granule transport (GO:0051904),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,BLOC1S5
delta,2,histone H2A monoubiquitination (GO:0035518),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,PCGF1
delta,2,negative regulation of interleukin-8 production (GO:0032717),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,TLR9
delta,2,negative regulation of reactive oxygen species metabolic process (GO:2000378),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,SIRT2
delta,2,positive regulation of stem cell proliferation (GO:2000648),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,CTNNB1
delta,2,spindle assembly checkpoint (GO:0071173),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,ATM
delta,2,maturation of 5.8S rRNA (GO:0000460),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,SKIV2L2
delta,2,3'-UTR-mediated mRNA stabilization (GO:0070935),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,TARDBP
delta,2,rRNA catabolic process (GO:0016075),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,DIS3
delta,2,regulation of receptor recycling (GO:0001919),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,ANXA2
delta,2,regulation of transcription from RNA polymerase I promoter (GO:0006356),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,UTP15
delta,2,heterocycle biosynthetic process (GO:0018130),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,GPHN
delta,2,nucleotide catabolic process (GO:0009166),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,SAMHD1
delta,2,defense response to fungus (GO:0050832),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,GAPDH
delta,2,regulation of lamellipodium organization (GO:1902743),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,TWF2
delta,2,regulation of B cell receptor signaling pathway (GO:0050855),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,CBFB
delta,2,purine-containing compound metabolic process (GO:0072521),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,OARD1
delta,2,detection of mechanical stimulus (GO:0050982),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,DENND5B
delta,2,melanosome transport (GO:0032402),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,BLOC1S5
delta,2,positive regulation of cartilage development (GO:0061036),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,GDF5
delta,2,regulation of early endosome to late endosome transport (GO:2000641),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,SNX3
delta,2,positive regulation of cation transmembrane transport (GO:1904064),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,NOS1AP
delta,2,platelet-derived growth factor receptor signaling pathway (GO:0048008),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,PTPRJ
delta,2,cellular response to glucocorticoid stimulus (GO:0071385),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,UBE2L3
delta,2,viral entry into host cell (GO:0046718),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,ZNF639
delta,2,mitotic spindle assembly checkpoint (GO:0007094),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,ATM
delta,2,mitotic spindle checkpoint (GO:0071174),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,ATM
delta,2,membrane depolarization during cardiac muscle cell action potential (GO:0086012),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,SCN3B
delta,2,positive regulation of protein processing (GO:0010954),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,PHB
delta,2,positive regulation of focal adhesion assembly (GO:0051894),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,PTPRJ
delta,2,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,IGFBP4
delta,2,preassembly of GPI anchor in ER membrane (GO:0016254),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,PIGP
delta,2,regulation of transposition (GO:0010528),1/17,1,17,0.606753686074701,0.820026780090059,0,0,1.1015642211941,0.550377130734814,MYBL1
delta,2,activation of MAPK activity (GO:0000187),6/118,6,118,0.607424368799965,0.820313457621178,0,0,0.952199581032184,0.474697778823278,ALK;MAP3K2;SPAG9;PRKAA1;TAOK1;RIPK1
delta,2,regulation of DNA repair (GO:0006282),2/38,2,38,0.609624367905303,0.820313457621178,0,0,0.985610092647349,0.487790559639943,CEBPG;H2AFX
delta,2,phospholipid biosynthetic process (GO:0008654),2/38,2,38,0.609624367905303,0.820313457621178,0,0,0.985610092647349,0.487790559639943,PCYT2;CRLS1
delta,2,regulation of peptidyl-threonine phosphorylation (GO:0010799),2/38,2,38,0.609624367905303,0.820313457621178,0,0,0.985610092647349,0.487790559639943,PRKAG2;SIRT2
delta,2,negative regulation of G0 to G1 transition (GO:0070317),2/38,2,38,0.609624367905303,0.820313457621178,0,0,0.985610092647349,0.487790559639943,CBX5;CDC7
delta,2,actin filament bundle assembly (GO:0051017),2/38,2,38,0.609624367905303,0.820313457621178,0,0,0.985610092647349,0.487790559639943,NEDD9;PLS1
delta,2,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",2/38,2,38,0.609624367905303,0.820313457621178,0,0,0.985610092647349,0.487790559639943,POLD3;POLD4
delta,2,organic cyclic compound biosynthetic process (GO:1901362),2/38,2,38,0.609624367905303,0.820313457621178,0,0,0.985610092647349,0.487790559639943,SCP2;GPHN
delta,2,phosphatidylinositol biosynthetic process (GO:0006661),5/99,5,99,0.614624242011863,0.820313457621178,0,0,0.945787462641395,0.460356549108892,SLC27A1;PIGP;PITPNM2;PIK3R3;PIP4K2B
delta,2,negative regulation of cell communication (GO:0010648),4/79,4,79,0.614638217968574,0.820313457621178,0,0,0.948181861280993,0.461500448239882,ALK;BRAP;MET;IGF1R
delta,2,visual perception (GO:0007601),4/79,4,79,0.614638217968574,0.820313457621178,0,0,0.948181861280993,0.461500448239882,ATXN7;WFS1;OPA3;CRYZ
delta,2,positive regulation of protein serine/threonine kinase activity (GO:0071902),6/119,6,119,0.615669707707062,0.820313457621178,0,0,0.944197903880653,0.457978139964562,PPP2CA;PSRC1;RALB;CIB1;RASGRP1;MALT1
delta,2,phospholipid transport (GO:0015914),3/59,3,59,0.616762381027502,0.820313457621178,0,0,0.952199581032184,0.46017087140074,SCP2;PITPNB;ATP10D
delta,2,receptor metabolic process (GO:0043112),3/59,3,59,0.616762381027502,0.820313457621178,0,0,0.952199581032184,0.46017087140074,SNX1;NEDD4;DNM2
delta,2,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),3/59,3,59,0.616762381027502,0.820313457621178,0,0,0.952199581032184,0.46017087140074,ERRFI1;HGS;PTPRJ
delta,2,cholesterol homeostasis (GO:0042632),3/59,3,59,0.616762381027502,0.820313457621178,0,0,0.952199581032184,0.46017087140074,APOM;SOAT1;LIPG
delta,2,integrin-mediated signaling pathway (GO:0007229),3/59,3,59,0.616762381027502,0.820313457621178,0,0,0.952199581032184,0.46017087140074,TEC;NEDD9;DOCK1
delta,2,sterol homeostasis (GO:0055092),3/59,3,59,0.616762381027502,0.820313457621178,0,0,0.952199581032184,0.46017087140074,APOM;SOAT1;LIPG
delta,2,sodium ion transport (GO:0006814),3/59,3,59,0.616762381027502,0.820313457621178,0,0,0.952199581032184,0.46017087140074,SCN8A;SCN3B;SLC9B2
delta,2,regulation of cellular amide metabolic process (GO:0034248),2/39,2,39,0.623861823732436,0.820313457621178,0,0,0.960338038989724,0.453112812311127,CYFIP2;NOLC1
delta,2,membrane depolarization during action potential (GO:0086010),2/39,2,39,0.623861823732436,0.820313457621178,0,0,0.960338038989724,0.453112812311127,SCN8A;SCN3B
delta,2,homotypic cell-cell adhesion (GO:0034109),2/39,2,39,0.623861823732436,0.820313457621178,0,0,0.960338038989724,0.453112812311127,TLN1;MYL12A
delta,2,regulation of ossification (GO:0030278),2/39,2,39,0.623861823732436,0.820313457621178,0,0,0.960338038989724,0.453112812311127,DDX5;ENPP1
delta,2,regulation of cellular pH (GO:0030641),2/39,2,39,0.623861823732436,0.820313457621178,0,0,0.960338038989724,0.453112812311127,SLC4A7;ATP5B
delta,2,positive regulation of DNA repair (GO:0045739),2/39,2,39,0.623861823732436,0.820313457621178,0,0,0.960338038989724,0.453112812311127,CEBPG;H2AFX
delta,2,T cell differentiation (GO:0030217),2/39,2,39,0.623861823732436,0.820313457621178,0,0,0.960338038989724,0.453112812311127,CHD7;GLI3
delta,2,positive regulation of neuron death (GO:1901216),2/39,2,39,0.623861823732436,0.820313457621178,0,0,0.960338038989724,0.453112812311127,EFNB2;CTNNB1
delta,2,cation transport (GO:0006812),4/80,4,80,0.624584968508059,0.820313457621178,0,0,0.936329588014981,0.440700281097336,SLC6A17;SLC6A9;ATP10D;SLC9B2
delta,2,peptidyl-tyrosine phosphorylation (GO:0018108),4/80,4,80,0.624584968508059,0.820313457621178,0,0,0.936329588014981,0.440700281097336,ITK;TEC;PIBF1;IGF1R
delta,2,anaphase-promoting complex-dependent catabolic process (GO:0031145),4/80,4,80,0.624584968508059,0.820313457621178,0,0,0.936329588014981,0.440700281097336,FZR1;CCNB1;PSMD14;PSMB3
delta,2,cell-cell junction assembly (GO:0007043),4/80,4,80,0.624584968508059,0.820313457621178,0,0,0.936329588014981,0.440700281097336,CDH2;PKP2;PKN2;TLN1
delta,2,regulation of adherens junction organization (GO:1903391),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,CLASP1
delta,2,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,ACSL1
delta,2,establishment of melanosome localization (GO:0032401),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,BLOC1S5
delta,2,regulation of telomerase RNA localization to Cajal body (GO:1904872),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,CCT5
delta,2,homologous chromosome segregation (GO:0045143),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,FMN2
delta,2,regulation of amyloid-beta formation (GO:1902003),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,SORL1
delta,2,regulation of spindle organization (GO:0090224),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,PSRC1
delta,2,response to nutrient levels (GO:0031667),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,PRKAA1
delta,2,regulation of keratinocyte proliferation (GO:0010837),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,STXBP4
delta,2,regulation of mitochondrial membrane permeability (GO:0046902),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,BAD
delta,2,establishment or maintenance of apical/basal cell polarity (GO:0035088),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,CLIC4
delta,2,negative regulation of RNA splicing (GO:0033119),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,PTBP1
delta,2,positive regulation of metabolic process (GO:0009893),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,FASN
delta,2,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,NFE2L2
delta,2,negative regulation of protein dephosphorylation (GO:0035308),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,YWHAB
delta,2,regulation of cardiac muscle cell proliferation (GO:0060043),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,PIM1
delta,2,regulation of cardiac muscle cell membrane repolarization (GO:0099623),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,NOS1AP
delta,2,tRNA metabolic process (GO:0006399),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,GTF3C1
delta,2,negative regulation of peptidyl-serine phosphorylation (GO:0033137),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,NCK1
delta,2,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,ALG12
delta,2,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,RASGRP1
delta,2,positive regulation of actin cytoskeleton reorganization (GO:2000251),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,BCAS3
delta,2,glycogen catabolic process (GO:0005980),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,RB1CC1
delta,2,acute-phase response (GO:0006953),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,IL6R
delta,2,glycogen biosynthetic process (GO:0005978),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,UGP2
delta,2,DNA conformation change (GO:0071103),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,TOP2A
delta,2,blood vessel endothelial cell migration (GO:0043534),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,EFNB2
delta,2,negative regulation of protein transport (GO:0051224),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,SNX3
delta,2,DNA methylation (GO:0006306),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,PPM1D
delta,2,establishment of epithelial cell polarity (GO:0090162),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,CLASP1
delta,2,cell-substrate adherens junction assembly (GO:0007045),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,WHAMM
delta,2,regulation of smooth muscle cell migration (GO:0014910),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,SORL1
delta,2,piRNA metabolic process (GO:0034587),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,MYBL1
delta,2,snRNA metabolic process (GO:0016073),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,INTS8
delta,2,response to organophosphorus (GO:0046683),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,TYMS
delta,2,mRNA destabilization (GO:0061157),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,METTL16
delta,2,positive regulation of natural killer cell mediated immunity (GO:0002717),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,RASGRP1
delta,2,positive regulation of morphogenesis of an epithelium (GO:1905332),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,PAX8
delta,2,focal adhesion assembly (GO:0048041),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,WHAMM
delta,2,negative regulation of calcium-mediated signaling (GO:0050849),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,ITPR1
delta,2,glycosphingolipid biosynthetic process (GO:0006688),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,B4GALT6
delta,2,glucan biosynthetic process (GO:0009250),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,UGP2
delta,2,maintenance of protein localization in organelle (GO:0072595),1/18,1,18,0.627770837064052,0.820313457621178,0,0,1.04036620890553,0.484373791347433,ARL2BP
delta,2,mitotic cytokinesis (GO:0000281),3/60,3,60,0.628190312472669,0.820313457621178,0,0,0.936329588014981,0.435310967307357,INCENP;JTB;KIF20A
delta,2,cell junction assembly (GO:0034329),3/60,3,60,0.628190312472669,0.820313457621178,0,0,0.936329588014981,0.435310967307357,CDH2;CTNNB1;TLN1
delta,2,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),3/60,3,60,0.628190312472669,0.820313457621178,0,0,0.936329588014981,0.435310967307357,TWSG1;SMAD4;GDF5
delta,2,enzyme linked receptor protein signaling pathway (GO:0007167),6/121,6,121,0.631864203372398,0.824749065454498,0,0,0.928591326957006,0.426298426970361,ITK;TEC;NEDD9;IL6ST;PAG1;MPZL1
delta,2,positive regulation of Wnt signaling pathway (GO:0030177),7/141,7,141,0.632303812114741,0.824961045529798,0,0,0.929688952638988,0.426155735489323,PSMD14;SMURF2;TNKS;PSMB3;NRARP;ATP6V0C;ZBED3
delta,2,ERBB signaling pathway (GO:0038127),4/81,4,81,0.634367262538776,0.826169377678737,0,0,0.924769963471586,0.420887976889609,CUL5;CDC37;PLCG1;PAG1
delta,2,negative regulation of defense response (GO:0031348),4/81,4,81,0.634367262538776,0.826169377678737,0,0,0.924769963471586,0.420887976889609,TRAFD1;VPS35;SIRT2;PPARD
delta,2,signal transduction by p53 class mediator (GO:0072331),2/40,2,40,0.6376936008974,0.826169377678737,0,0,0.936329588014981,0.421252210085328,DDX5;PPP1R13B
delta,2,regulation of proteasomal protein catabolic process (GO:0061136),2/40,2,40,0.6376936008974,0.826169377678737,0,0,0.936329588014981,0.421252210085328,PSMD14;UCHL5
delta,2,ERBB2 signaling pathway (GO:0038128),2/40,2,40,0.6376936008974,0.826169377678737,0,0,0.936329588014981,0.421252210085328,CUL5;CDC37
delta,2,regulation of G0 to G1 transition (GO:0070316),2/40,2,40,0.6376936008974,0.826169377678737,0,0,0.936329588014981,0.421252210085328,CBX5;CDC7
delta,2,regulation of plasma membrane bounded cell projection assembly (GO:0120032),2/40,2,40,0.6376936008974,0.826169377678737,0,0,0.936329588014981,0.421252210085328,TCTEX1D2;TWF2
delta,2,protein processing (GO:0016485),5/102,5,102,0.640999199590301,0.826169377678737,0,0,0.917970184328413,0.408246191113428,IMMP2L;MMP16;PROS1;DDI2;LONP2
delta,2,BMP signaling pathway (GO:0030509),4/82,4,82,0.6439831665204,0.826169377678737,0,0,0.913492280990226,0.402012142288198,DDX5;SMAD4;SMURF2;GDF5
delta,2,sensory perception of light stimulus (GO:0050953),4/82,4,82,0.6439831665204,0.826169377678737,0,0,0.913492280990226,0.402012142288198,ATXN7;WFS1;OPA3;CRYZ
delta,2,regulation of mitotic spindle assembly (GO:1901673),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,HSPA1A
delta,2,negative regulation of smoothened signaling pathway (GO:0045879),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,GLI3
delta,2,positive regulation of chromosome organization (GO:2001252),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,RTEL1
delta,2,primary alcohol metabolic process (GO:0034308),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,ALDH3A2
delta,2,acetylcholine receptor signaling pathway (GO:0095500),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,GNB1
delta,2,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,PDCL3
delta,2,positive regulation of mononuclear cell migration (GO:0071677),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,CREB3
delta,2,Rac protein signal transduction (GO:0016601),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,FARP2
delta,2,ribosomal small subunit assembly (GO:0000028),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,PWP2
delta,2,positive regulation of toll-like receptor signaling pathway (GO:0034123),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,TLR9
delta,2,negative regulation of lipid metabolic process (GO:0045833),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,PRKAA1
delta,2,regulation of mitochondrial fission (GO:0090140),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,VPS35
delta,2,nucleosome disassembly (GO:0006337),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,SUPT16H
delta,2,regulation of transcription factor import into nucleus (GO:0042990),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,SMAD3
delta,2,chromatin disassembly (GO:0031498),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,SUPT16H
delta,2,gamma-aminobutyric acid signaling pathway (GO:0007214),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,GABRB1
delta,2,striated muscle cell differentiation (GO:0051146),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,MYEF2
delta,2,cellular response to interleukin-7 (GO:0098761),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,SOCS1
delta,2,fatty-acyl-CoA metabolic process (GO:0035337),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,FASN
delta,2,negative regulation of protein localization to cell periphery (GO:1904376),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,NUMB
delta,2,nucleotide-sugar biosynthetic process (GO:0009226),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,UGP2
delta,2,regulation of platelet activation (GO:0010543),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,TEC
delta,2,positive regulation of phospholipase activity (GO:0010518),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,PLAA
delta,2,DNA double-strand break processing (GO:0000729),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,ATM
delta,2,aspartate family amino acid catabolic process (GO:0009068),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,DLST
delta,2,interleukin-7-mediated signaling pathway (GO:0038111),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,SOCS1
delta,2,positive regulation of adherens junction organization (GO:1903393),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,PTPRJ
delta,2,hexose transmembrane transport (GO:0035428),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,PPARD
delta,2,mitochondrial calcium ion homeostasis (GO:0051560),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,SLC8B1
delta,2,mitochondrial membrane organization (GO:0007006),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,BAD
delta,2,regulation of catenin import into nucleus (GO:0035412),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,FZD7
delta,2,activin receptor signaling pathway (GO:0032924),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,SMAD3
delta,2,positive regulation of neuron apoptotic process (GO:0043525),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,CTNNB1
delta,2,positive regulation of axon extension (GO:0045773),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,TWF2
delta,2,regulation of protein kinase A signaling (GO:0010738),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,MIF
delta,2,histone methylation (GO:0016571),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,NSD1
delta,2,negative regulation of cell junction assembly (GO:1901889),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,BCAS3
delta,2,negative regulation of protein localization to plasma membrane (GO:1903077),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,NUMB
delta,2,positive regulation of heart contraction (GO:0045823),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,SCN3B
delta,2,NADP metabolic process (GO:0006739),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,ME1
delta,2,negative regulation of transposition (GO:0010529),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,MYBL1
delta,2,regulation of myotube differentiation (GO:0010830),1/19,1,19,0.647665711735381,0.826169377678737,0,0,0.985610092647349,0.428129896207107,HDAC9
delta,2,regulation of cellular ketone metabolic process (GO:0010565),3/62,3,62,0.650332834545387,0.827033811617807,0,0,0.906125407756434,0.389879479884181,PSMD14;PSMB3;PRKAG2
delta,2,actin cytoskeleton reorganization (GO:0031532),3/62,3,62,0.650332834545387,0.827033811617807,0,0,0.906125407756434,0.389879479884181,FARP2;NEDD9;WHAMM
delta,2,"nucleotide-excision repair, DNA incision (GO:0033683)",2/41,2,41,0.651122385961197,0.827033811617807,0,0,0.913492280990226,0.391940858294114,POLD3;POLD4
delta,2,sensory organ development (GO:0007423),2/41,2,41,0.651122385961197,0.827033811617807,0,0,0.913492280990226,0.391940858294114,PAX8;CHD7
delta,2,sterol biosynthetic process (GO:0016126),2/41,2,41,0.651122385961197,0.827033811617807,0,0,0.913492280990226,0.391940858294114,PRKAG2;HMGCR
delta,2,peptidyl-proline modification (GO:0018208),2/41,2,41,0.651122385961197,0.827033811617807,0,0,0.913492280990226,0.391940858294114,OGFOD1;PPIL4
delta,2,positive regulation of cytokine biosynthetic process (GO:0042108),2/41,2,41,0.651122385961197,0.827033811617807,0,0,0.913492280990226,0.391940858294114,CEBPG;TLR9
delta,2,regulation of ATPase activity (GO:0043462),2/41,2,41,0.651122385961197,0.827033811617807,0,0,0.913492280990226,0.391940858294114,DNAJC10;PFN1
delta,2,determination of heart left/right asymmetry (GO:0061371),2/41,2,41,0.651122385961197,0.827033811617807,0,0,0.913492280990226,0.391940858294114,NPHP3;TGFBR2
delta,2,embryonic heart tube morphogenesis (GO:0003143),2/41,2,41,0.651122385961197,0.827033811617807,0,0,0.913492280990226,0.391940858294114,NPHP3;TGFBR2
delta,2,regulation of anatomical structure morphogenesis (GO:0022603),4/83,4,83,0.653431052405582,0.829258341986786,0,0,0.902486349893958,0.384024418213635,CTNNB1;TSPAN12;ETS1;CLASP1
delta,2,positive regulation of ubiquitin protein ligase activity (GO:1904668),4/83,4,83,0.653431052405582,0.829258341986786,0,0,0.902486349893958,0.384024418213635,FZR1;CCNB1;PSMD14;PSMB3
delta,2,tumor necrosis factor-mediated signaling pathway (GO:0033209),6/124,6,124,0.655390691834927,0.830958775163556,0,0,0.906125407756434,0.382859500801177,PSMD14;TNFRSF12A;TRAF3;PSMB3;RIPK1;TNFRSF21
delta,2,positive regulation of angiogenesis (GO:0045766),5/104,5,104,0.657944904056916,0.830958775163556,0,0,0.900316911552867,0.376903345216503,PDCL3;SP1;PLCG1;ETS1;HIF1A
delta,2,regulation of actin filament-based process (GO:0032970),3/63,3,63,0.661045334323693,0.830958775163556,0,0,0.891742464776173,0.369121506178761,TAOK1;TWF2;CDK10
delta,2,second-messenger-mediated signaling (GO:0019932),3/63,3,63,0.661045334323693,0.830958775163556,0,0,0.891742464776173,0.369121506178761,PPP2CA;INPP5A;PLCG1
delta,2,regulation of T cell proliferation (GO:0042129),3/63,3,63,0.661045334323693,0.830958775163556,0,0,0.891742464776173,0.369121506178761,IL6ST;TNFRSF21;NCK1
delta,2,negative regulation of signaling (GO:0023057),4/84,4,84,0.662709584430617,0.830958775163556,0,0,0.891742464776173,0.366879273491666,ALK;BRAP;MET;IGF1R
delta,2,positive regulation of homeostatic process (GO:0032846),4/84,4,84,0.662709584430617,0.830958775163556,0,0,0.891742464776173,0.366879273491666,RTEL1;ETS1;HIF1A;HSPA1A
delta,2,platelet degranulation (GO:0002576),6/125,6,125,0.663023151875456,0.830958775163556,0,0,0.898876404494382,0.369389096209867,ABCC4;PROS1;ENDOD1;OLA1;TIMP1;TLN1
delta,2,dephosphorylation (GO:0016311),6/125,6,125,0.663023151875456,0.830958775163556,0,0,0.898876404494382,0.369389096209867,CTDNEP1;DUSP4;PHLPP2;PPP2CA;PPP1R12A;PPM1D
delta,2,regulation of phagocytosis (GO:0050764),2/42,2,42,0.664151734743369,0.830958775163556,0,0,0.891742464776173,0.364940823463328,SNX3;TUB
delta,2,regulation of calcium-mediated signaling (GO:0050848),2/42,2,42,0.664151734743369,0.830958775163556,0,0,0.891742464776173,0.364940823463328,TMBIM4;ITPR1
delta,2,regulation of substrate adhesion-dependent cell spreading (GO:1900024),2/42,2,42,0.664151734743369,0.830958775163556,0,0,0.891742464776173,0.364940823463328,CIB1;DOCK1
delta,2,positive regulation of viral transcription (GO:0050434),2/42,2,42,0.664151734743369,0.830958775163556,0,0,0.891742464776173,0.364940823463328,SP1;ZNF639
delta,2,negative regulation of STAT cascade (GO:1904893),2/42,2,42,0.664151734743369,0.830958775163556,0,0,0.891742464776173,0.364940823463328,SOCS1;HGS
delta,2,regulation of protein localization (GO:0032880),2/42,2,42,0.664151734743369,0.830958775163556,0,0,0.891742464776173,0.364940823463328,KIAA0586;DZIP1L
delta,2,DNA duplex unwinding (GO:0032508),2/42,2,42,0.664151734743369,0.830958775163556,0,0,0.891742464776173,0.364940823463328,RTEL1;ASCC3
delta,2,regulation of stress-activated MAPK cascade (GO:0032872),2/42,2,42,0.664151734743369,0.830958775163556,0,0,0.891742464776173,0.364940823463328,TAOK1;IGF1R
delta,2,positive regulation of cell division (GO:0051781),2/42,2,42,0.664151734743369,0.830958775163556,0,0,0.891742464776173,0.364940823463328,PKN2;SIRT2
delta,2,positive regulation of vasculature development (GO:1904018),5/105,5,105,0.666222085720675,0.830958775163556,0,0,0.891742464776173,0.362165330822903,PDCL3;SP1;PLCG1;ETS1;HIF1A
delta,2,negative regulation of innate immune response (GO:0045824),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,TRAFD1
delta,2,hydrogen peroxide metabolic process (GO:0042743),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,PRDX6
delta,2,negative regulation of phosphate metabolic process (GO:0045936),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,CDKN1A
delta,2,negative regulation of ion transport (GO:0043271),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,NEDD4
delta,2,purine nucleotide metabolic process (GO:0006163),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,MTHFD1
delta,2,negative regulation of response to biotic stimulus (GO:0002832),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,SIRT2
delta,2,regulation of response to cytokine stimulus (GO:0060759),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,CBFB
delta,2,regulation of glycogen biosynthetic process (GO:0005979),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,ENPP1
delta,2,melanosome localization (GO:0032400),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,BLOC1S5
delta,2,inositol phosphate-mediated signaling (GO:0048016),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,INPP5A
delta,2,negative regulation of interferon-gamma production (GO:0032689),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,HAVCR2
delta,2,cellular response to steroid hormone stimulus (GO:0071383),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,UBE2L3
delta,2,immune response-activating cell surface receptor signaling pathway (GO:0002429),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,BAG6
delta,2,regulation of transport (GO:0051049),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,TRIB3
delta,2,mitochondrial RNA metabolic process (GO:0000959),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,ELAC2
delta,2,positive regulation of interleukin-2 production (GO:0032743),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,MALT1
delta,2,cell projection assembly (GO:0030031),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,CYFIP2
delta,2,proteoglycan metabolic process (GO:0006029),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,CSGALNACT2
delta,2,embryonic digestive tract development (GO:0048566),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,GLI3
delta,2,regulation of cholesterol transport (GO:0032374),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,LIPG
delta,2,regulation of calcium ion transmembrane transport (GO:1903169),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,NOS1AP
delta,2,mitochondrial respiratory chain complex IV assembly (GO:0033617),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,COX14
delta,2,autophagy of nucleus (GO:0044804),1/20,1,20,0.666498184245769,0.830958775163556,0,0,0.936329588014981,0.379885640149354,ATG12
delta,2,COPII vesicle coating (GO:0048208),3/64,3,64,0.671518057919426,0.835118153099963,0,0,0.877808988764045,0.349556154729332,CNIH1;PPP6R1;USO1
delta,2,oligosaccharide metabolic process (GO:0009311),3/64,3,64,0.671518057919426,0.835118153099963,0,0,0.877808988764045,0.349556154729332,NEU3;MAN2C1;GALNT10
delta,2,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",3/64,3,64,0.671518057919426,0.835118153099963,0,0,0.877808988764045,0.349556154729332,CNIH1;PPP6R1;USO1
delta,2,regulation of viral genome replication (GO:0045069),3/64,3,64,0.671518057919426,0.835118153099963,0,0,0.877808988764045,0.349556154729332,TOP2A;ISG20;PKN2
delta,2,negative regulation of dephosphorylation (GO:0035305),3/64,3,64,0.671518057919426,0.835118153099963,0,0,0.877808988764045,0.349556154729332,PPP1R12A;YWHAB;PCIF1
delta,2,vesicle coating (GO:0006901),3/64,3,64,0.671518057919426,0.835118153099963,0,0,0.877808988764045,0.349556154729332,CNIH1;PPP6R1;USO1
delta,2,cellular response to retinoic acid (GO:0071300),2/43,2,43,0.676785972347641,0.840161309139654,0,0,0.871004267920913,0.340040238081717,FZD7;TWF2
delta,2,regulation of interleukin-6 production (GO:0032675),2/43,2,43,0.676785972347641,0.840161309139654,0,0,0.871004267920913,0.340040238081717,TLR9;IL6R
delta,2,regulation of type I interferon production (GO:0032479),4/86,4,86,0.680754628552946,0.840161309139654,0,0,0.871004267920913,0.334947607573371,TRAF3;IRF1;POLR1C;CTNNB1
delta,2,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),4/86,4,86,0.680754628552946,0.840161309139654,0,0,0.871004267920913,0.334947607573371,PDCL3;TEC;MIF;IL6R
delta,2,inorganic anion transmembrane transport (GO:0098661),3/65,3,65,0.681751100861213,0.840161309139654,0,0,0.864304235090752,0.331106864736233,CLIC5;CLIC4;GABRB1
delta,2,hyaluronan metabolic process (GO:0030212),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,ABCC5
delta,2,positive regulation of transcription from RNA polymerase I promoter (GO:0045943),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,UTP15
delta,2,positive regulation of cellular component movement (GO:0051272),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,ETS1
delta,2,ventricular cardiac muscle tissue development (GO:0003229),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,PKP2
delta,2,positive regulation of T cell mediated immunity (GO:0002711),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,MALT1
delta,2,mitochondrial fission (GO:0000266),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,DNM2
delta,2,phospholipid translocation (GO:0045332),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,ATP10D
delta,2,positive regulation of lamellipodium organization (GO:1902745),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,TWF2
delta,2,protein O-linked glycosylation via threonine (GO:0018243),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,GALNT10
delta,2,regulation of macrophage activation (GO:0043030),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,MIF
delta,2,establishment of endothelial barrier (GO:0061028),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,RAP1B
delta,2,branched-chain amino acid catabolic process (GO:0009083),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,HMGCLL1
delta,2,aromatic amino acid family catabolic process (GO:0009074),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,PAH
delta,2,response to nicotine (GO:0035094),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,BAD
delta,2,meiosis I (GO:0007127),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,MYBL1
delta,2,protein-DNA complex disassembly (GO:0032986),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,SUPT16H
delta,2,mitochondrial respiratory chain complex IV biogenesis (GO:0097034),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,COX14
delta,2,lipid catabolic process (GO:0016042),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,SIRT2
delta,2,embryonic skeletal system development (GO:0048706),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,FUZ
delta,2,"synaptic transmission, glutamatergic (GO:0035249)",1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,UNC13B
delta,2,positive regulation of leukocyte cell-cell adhesion (GO:1903039),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,ETS1
delta,2,regulation of ruffle assembly (GO:1900027),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,PFN1
delta,2,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,CYCS
delta,2,cellular protein complex localization (GO:0034629),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,GPN1
delta,2,establishment of spindle orientation (GO:0051294),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,CLASP1
delta,2,negative regulation of ion transmembrane transporter activity (GO:0032413),1/21,1,21,0.684324937283105,0.840161309139654,0,0,0.891742464776173,0.338257909447826,NEDD4
delta,2,cardiac ventricle morphogenesis (GO:0003208),2/44,2,44,0.68903010065522,0.843502089489895,0,0,0.851208716377256,0.31704998422676,PKP2;TGFBR2
delta,2,membrane depolarization (GO:0051899),2/44,2,44,0.68903010065522,0.843502089489895,0,0,0.851208716377256,0.31704998422676,SCN8A;SCN3B
delta,2,development of primary male sexual characteristics (GO:0046546),2/44,2,44,0.68903010065522,0.843502089489895,0,0,0.851208716377256,0.31704998422676,MSH2;KLHL26
delta,2,positive regulation of interleukin-6 production (GO:0032755),2/44,2,44,0.68903010065522,0.843502089489895,0,0,0.851208716377256,0.31704998422676,TLR9;IL6R
delta,2,histone H3 acetylation (GO:0043966),2/44,2,44,0.68903010065522,0.843502089489895,0,0,0.851208716377256,0.31704998422676,KAT7;SUPT3H
delta,2,regulation of multicellular organismal development (GO:2000026),2/44,2,44,0.68903010065522,0.843502089489895,0,0,0.851208716377256,0.31704998422676,CLASP1;ELL3
delta,2,male gonad development (GO:0008584),2/44,2,44,0.68903010065522,0.843502089489895,0,0,0.851208716377256,0.31704998422676,MSH2;KLHL26
delta,2,regulation of myeloid cell differentiation (GO:0045637),3/66,3,66,0.691744960462606,0.845208708164858,0,0,0.851208716377256,0.313702711561171,CDK6;CBFB;LEO1
delta,2,chromatin assembly (GO:0031497),3/66,3,66,0.691744960462606,0.845208708164858,0,0,0.851208716377256,0.313702711561171,H2AFX;SMARCA5;CTCF
delta,2,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),4/88,4,88,0.698112971976729,0.845208708164858,0,0,0.851208716377256,0.305902569243015,FZR1;CCNB1;PSMD14;PSMB3
delta,2,regulation of dendrite morphogenesis (GO:0048814),2/45,2,45,0.700889713977659,0.845208708164858,0,0,0.832292967124428,0.295800858121297,FXR1;NEDD4
delta,2,regulation of smooth muscle cell proliferation (GO:0048660),2/45,2,45,0.700889713977659,0.845208708164858,0,0,0.832292967124428,0.295800858121297,CTNNB1;IL6R
delta,2,negative regulation of type I interferon production (GO:0032480),2/45,2,45,0.700889713977659,0.845208708164858,0,0,0.832292967124428,0.295800858121297,TRAF3;HAVCR2
delta,2,regulation of intracellular pH (GO:0051453),2/45,2,45,0.700889713977659,0.845208708164858,0,0,0.832292967124428,0.295800858121297,SLC4A7;ATP5B
delta,2,negative regulation of immune response (GO:0050777),2/45,2,45,0.700889713977659,0.845208708164858,0,0,0.832292967124428,0.295800858121297,TRAFD1;HAVCR2
delta,2,positive regulation of actin filament bundle assembly (GO:0032233),2/45,2,45,0.700889713977659,0.845208708164858,0,0,0.832292967124428,0.295800858121297,ARHGEF10;PFN1
delta,2,ribosomal small subunit biogenesis (GO:0042274),2/45,2,45,0.700889713977659,0.845208708164858,0,0,0.832292967124428,0.295800858121297,WDR3;PWP2
delta,2,sprouting angiogenesis (GO:0002040),2/45,2,45,0.700889713977659,0.845208708164858,0,0,0.832292967124428,0.295800858121297,EFNB2;NRARP
delta,2,adherens junction organization (GO:0034332),2/45,2,45,0.700889713977659,0.845208708164858,0,0,0.832292967124428,0.295800858121297,CDH2;CTNNB1
delta,2,positive regulation of viral life cycle (GO:1903902),2/45,2,45,0.700889713977659,0.845208708164858,0,0,0.832292967124428,0.295800858121297,TOP2A;PKN2
delta,2,GTP metabolic process (GO:0046039),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,GPHN
delta,2,NAD biosynthetic process (GO:0009435),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,SLC5A8
delta,2,glutathione derivative biosynthetic process (GO:1901687),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,MGST3
delta,2,cellular response to nerve growth factor stimulus (GO:1990090),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,CIB1
delta,2,regulation of catecholamine secretion (GO:0050433),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,SYT4
delta,2,positive regulation of protein targeting to membrane (GO:0090314),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,CIB1
delta,2,sulfur amino acid metabolic process (GO:0000096),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,MTHFD1
delta,2,"DNA catabolic process, endonucleolytic (GO:0000737)",1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,KPNB1
delta,2,protein localization to cell surface (GO:0034394),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,CTNNB1
delta,2,STAT cascade (GO:0097696),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,IFNAR2
delta,2,protein O-linked glycosylation via serine (GO:0018242),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,GALNT10
delta,2,beta-catenin destruction complex disassembly (GO:1904886),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,CTNNB1
delta,2,regulation of membrane protein ectodomain proteolysis (GO:0051043),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,TIMP1
delta,2,urogenital system development (GO:0001655),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,PAX8
delta,2,negative regulation of GTPase activity (GO:0034260),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,BCAS3
delta,2,ncRNA catabolic process (GO:0034661),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,DIS3
delta,2,regulation of monocyte chemotaxis (GO:0090025),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,CREB3
delta,2,glutathione derivative metabolic process (GO:1901685),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,MGST3
delta,2,positive regulation of phosphatase activity (GO:0010922),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,HSP90AB1
delta,2,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,STXBP4
delta,2,glucose transport (GO:0015758),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,PPARD
delta,2,regulation of calcium ion import (GO:0090279),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,CTNNB1
delta,2,lipid translocation (GO:0034204),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,ATP10D
delta,2,activation of phospholipase C activity (GO:0007202),1/22,1,22,0.701199632057664,0.845208708164858,0,0,0.851208716377256,0.302147302236604,ITK
delta,2,negative regulation of epithelial cell proliferation (GO:0050680),3/67,3,67,0.701500507112634,0.845208708164858,0,0,0.838504108670133,0.297277927672588,CDK6;NFIB;GDF5
delta,2,sphingolipid biosynthetic process (GO:0030148),3/67,3,67,0.701500507112634,0.845208708164858,0,0,0.838504108670133,0.297277927672588,ALDH3A2;SMPD1;CLN8
delta,2,Wnt signaling pathway (GO:0016055),5/110,5,110,0.705612854370576,0.849475669339334,0,0,0.851208716377256,0.296806738857781,SNX3;TNKS;FZD7;CTNNB1;VPS35
delta,2,circulatory system development (GO:0072359),5/110,5,110,0.705612854370576,0.849475669339334,0,0,0.851208716377256,0.296806738857781,MTHFD1;PKP2;CACYBP;HDAC9;TGFBR2
delta,2,T cell activation (GO:0042110),4/89,4,89,0.706534033813563,0.84956679187119,0,0,0.841644573496612,0.292373779067845,ITK;CHD7;CTPS1;NCK1
delta,2,regulation of stem cell differentiation (GO:2000736),4/89,4,89,0.706534033813563,0.84956679187119,0,0,0.841644573496612,0.292373779067845,PSMD14;CBFB;PSMB3;TCF12
delta,2,protein glycosylation (GO:0006486),6/131,6,131,0.706544962997714,0.84956679187119,0,0,0.857706492838151,0.297940163812657,B3GNT9;TNKS;MGAT5;ALG12;GALNT10;SIRT2
delta,2,negative regulation of protein binding (GO:0032091),3/68,3,68,0.711018957226903,0.853040389251983,0,0,0.826173165895572,0.28177146957035,RALB;CTNNBIP1;SORL1
delta,2,metal ion homeostasis (GO:0055065),2/46,2,46,0.712370921721487,0.853040389251983,0,0,0.814199641752158,0.27614113804543,WFS1;COX11
delta,2,nicotinamide nucleotide metabolic process (GO:0046496),2/46,2,46,0.712370921721487,0.853040389251983,0,0,0.814199641752158,0.27614113804543,PDHB;PFKM
delta,2,viral gene expression (GO:0019080),5/111,5,111,0.713087894264974,0.853040389251983,0,0,0.843540169382866,0.285243607906941,RPS4X;NUP205;NUP107;RPLP2;AAAS
delta,2,negative regulation of cytokine production (GO:0001818),5/111,5,111,0.713087894264974,0.853040389251983,0,0,0.843540169382866,0.285243607906941,TWSG1;TRAF3;TLR9;PIBF1;HAVCR2
delta,2,regulation of neuron apoptotic process (GO:0043523),4/90,4,90,0.714783152372519,0.853040389251983,0,0,0.832292967124428,0.279464057996603,EGLN3;MSH2;WFS1;CTNNB1
delta,2,regulation of protein oligomerization (GO:0032459),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,SORL1
delta,2,chromosome condensation (GO:0030261),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,TOP2A
delta,2,protein localization to cilium (GO:0061512),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,TUB
delta,2,glycolytic process (GO:0006096),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,PFKM
delta,2,lamellipodium assembly (GO:0030032),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,WHAMM
delta,2,metanephros development (GO:0001656),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,PAX8
delta,2,membrane assembly (GO:0071709),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,ANXA2
delta,2,cellular nitrogen compound biosynthetic process (GO:0044271),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,ARG2
delta,2,negative regulation of signal transduction in absence of ligand (GO:1901099),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,HSPA1A
delta,2,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,HSPA1A
delta,2,negative regulation of axonogenesis (GO:0050771),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,RNF6
delta,2,divalent inorganic cation homeostasis (GO:0072507),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,WFS1
delta,2,negative regulation of transcription factor import into nucleus (GO:0042992),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,NFKBIE
delta,2,positive regulation of cell junction assembly (GO:1901890),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,PTPRJ
delta,2,regulation of chondrocyte differentiation (GO:0032330),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,GDF5
delta,2,regulation of ion homeostasis (GO:2000021),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,SLC30A7
delta,2,negative regulation of axon extension (GO:0030517),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,RNF6
delta,2,regulation of natural killer cell mediated cytotoxicity (GO:0042269),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,RASGRP1
delta,2,neuronal action potential (GO:0019228),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,SCN8A
delta,2,cell-cell adhesion mediated by cadherin (GO:0044331),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,CDH2
delta,2,glutamine family amino acid metabolic process (GO:0009064),1/23,1,23,0.717173069189671,0.853040389251983,0,0,0.814199641752158,0.270670972062301,NIT2
delta,2,COPII-coated vesicle budding (GO:0090114),3/69,3,69,0.720301846358566,0.856077593755228,0,0,0.814199641752158,0.267126627398842,CNIH1;PPP6R1;USO1
delta,2,regulation of actin filament polymerization (GO:0030833),3/69,3,69,0.720301846358566,0.856077593755228,0,0,0.814199641752158,0.267126627398842,TWF2;PFN1;NCK1
delta,2,cartilage development (GO:0051216),2/47,2,47,0.723480277341276,0.859511898350355,0,0,0.796876245119133,0.25793449147303,NFIB;GDF5
delta,2,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),6/134,6,134,0.726816631098062,0.86313100325133,0,0,0.838504108670133,0.267550779882926,CYFIP2;ACTR3;HSP90AB1;PLCG1;DOCK1;NCK1
delta,2,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",5/113,5,113,0.727632955958854,0.86375575466037,0,0,0.828610254880514,0.263463706293145,RPS4X;PPP2CA;NCBP1;EIF4A3;RPLP2
delta,2,positive regulation of cell cycle G1/S phase transition (GO:1902808),1/24,1,24,0.732293340817903,0.868941380492058,0,0,0.780274656679151,0.243113378958263,STXBP4
delta,2,Fc-gamma receptor signaling pathway (GO:0038094),6/135,6,135,0.73335109267898,0.869849681870325,0,0,0.832292967124428,0.258119609910574,CYFIP2;ACTR3;HSP90AB1;PLCG1;DOCK1;NCK1
delta,2,regulation of intrinsic apoptotic signaling pathway (GO:2001242),2/48,2,48,0.73422471387307,0.870192253479194,0,0,0.780274656679151,0.241058167549192,BAD;HERPUD1
delta,2,fatty acid biosynthetic process (GO:0006633),2/48,2,48,0.73422471387307,0.870192253479194,0,0,0.780274656679151,0.241058167549192,ABCD3;ABHD3
delta,2,viral transcription (GO:0019083),5/114,5,114,0.734703136350932,0.870412632874352,0,0,0.821341743872791,0.253210425683758,RPS4X;NUP205;NUP107;RPLP2;AAAS
delta,2,regulation of Notch signaling pathway (GO:0008593),3/71,3,71,0.738168530896301,0.873822413662446,0,0,0.791264440576041,0.240214526668866,NRARP;CHAC1;FAM129B
delta,2,interferon-gamma-mediated signaling pathway (GO:0060333),3/71,3,71,0.738168530896301,0.873822413662446,0,0,0.791264440576041,0.240214526668866,IFNGR1;IRF1;IRF9
delta,2,Fc receptor mediated stimulatory signaling pathway (GO:0002431),6/136,6,136,0.739774105447571,0.874251832176169,0,0,0.826173165895572,0.249017186297766,CYFIP2;ACTR3;HSP90AB1;PLCG1;DOCK1;NCK1
delta,2,regulation of mitochondrion organization (GO:0010821),2/49,2,49,0.744611484590621,0.874251832176169,0,0,0.764350684093862,0.225401432258144,VPS35;PPARGC1B
delta,2,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),2/49,2,49,0.744611484590621,0.874251832176169,0,0,0.764350684093862,0.225401432258144,BAG6;MSH2
delta,2,pattern recognition receptor signaling pathway (GO:0002221),2/49,2,49,0.744611484590621,0.874251832176169,0,0,0.764350684093862,0.225401432258144,TRAF3;TLR9
delta,2,amino acid transport (GO:0006865),2/49,2,49,0.744611484590621,0.874251832176169,0,0,0.764350684093862,0.225401432258144,SLC6A6;SLC6A17
delta,2,negative regulation of mitotic cell cycle (GO:0045930),2/49,2,49,0.744611484590621,0.874251832176169,0,0,0.764350684093862,0.225401432258144,SMAD3;CTNNB1
delta,2,endosome to lysosome transport (GO:0008333),2/49,2,49,0.744611484590621,0.874251832176169,0,0,0.764350684093862,0.225401432258144,UBXN6;SCYL2
delta,2,cotranslational protein targeting to membrane (GO:0006613),4/94,4,94,0.746070171648209,0.874251832176169,0,0,0.796876245119133,0.233433436393745,RPS4X;TRAM1;RPLP2;SEC62
delta,2,proteolysis involved in cellular protein catabolic process (GO:0051603),4/94,4,94,0.746070171648209,0.874251832176169,0,0,0.796876245119133,0.233433436393745,BAG6;PSMB3;LONP1;MDM2
delta,2,dendritic spine organization (GO:0097061),1/25,1,25,0.746605975558231,0.874251832176169,0,0,0.749063670411985,0.218889669542543,IGF1R
delta,2,negative regulation of protein localization to membrane (GO:1905476),1/25,1,25,0.746605975558231,0.874251832176169,0,0,0.749063670411985,0.218889669542543,NUMB
delta,2,regulation of chromosome organization (GO:0033044),1/25,1,25,0.746605975558231,0.874251832176169,0,0,0.749063670411985,0.218889669542543,RB1
delta,2,regulation of transmembrane transport (GO:0034762),1/25,1,25,0.746605975558231,0.874251832176169,0,0,0.749063670411985,0.218889669542543,NEDD4
delta,2,negative regulation of oxidative stress-induced cell death (GO:1903202),1/25,1,25,0.746605975558231,0.874251832176169,0,0,0.749063670411985,0.218889669542543,NFE2L2
delta,2,negative regulation of endothelial cell apoptotic process (GO:2000352),1/25,1,25,0.746605975558231,0.874251832176169,0,0,0.749063670411985,0.218889669542543,NFE2L2
delta,2,cilium-dependent cell motility (GO:0060285),1/25,1,25,0.746605975558231,0.874251832176169,0,0,0.749063670411985,0.218889669542543,DNAAF2
delta,2,positive regulation of dephosphorylation (GO:0035306),1/25,1,25,0.746605975558231,0.874251832176169,0,0,0.749063670411985,0.218889669542543,SMPD1
delta,2,negative regulation of interleukin-6 production (GO:0032715),1/25,1,25,0.746605975558231,0.874251832176169,0,0,0.749063670411985,0.218889669542543,TLR9
delta,2,mRNA splice site selection (GO:0006376),1/25,1,25,0.746605975558231,0.874251832176169,0,0,0.749063670411985,0.218889669542543,SRSF5
delta,2,negative regulation of T cell proliferation (GO:0042130),1/25,1,25,0.746605975558231,0.874251832176169,0,0,0.749063670411985,0.218889669542543,TNFRSF21
delta,2,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),1/25,1,25,0.746605975558231,0.874251832176169,0,0,0.749063670411985,0.218889669542543,MIF
delta,2,positive regulation of immune effector process (GO:0002699),1/25,1,25,0.746605975558231,0.874251832176169,0,0,0.749063670411985,0.218889669542543,PHB
delta,2,response to glucocorticoid (GO:0051384),1/25,1,25,0.746605975558231,0.874251832176169,0,0,0.749063670411985,0.218889669542543,UBE2L3
delta,2,Golgi to plasma membrane protein transport (GO:0043001),1/25,1,25,0.746605975558231,0.874251832176169,0,0,0.749063670411985,0.218889669542543,ARFRP1
delta,2,negative regulation of developmental growth (GO:0048640),1/25,1,25,0.746605975558231,0.874251832176169,0,0,0.749063670411985,0.218889669542543,RNF6
delta,2,regulation of actin filament bundle assembly (GO:0032231),1/25,1,25,0.746605975558231,0.874251832176169,0,0,0.749063670411985,0.218889669542543,PFN1
delta,2,ATP generation from ADP (GO:0006757),1/25,1,25,0.746605975558231,0.874251832176169,0,0,0.749063670411985,0.218889669542543,PFKM
delta,2,response to insulin (GO:0032868),3/72,3,72,0.746756773317145,0.874251832176169,0,0,0.780274656679151,0.227852490271914,ENPP1;TRIB3;HDAC9
delta,2,axon development (GO:0061564),4/95,4,95,0.753468633633055,0.88058331047195,0,0,0.788488074117879,0.223195654912424,NTNG1;MAP1A;TLR9;CTNNA2
delta,2,regulation of megakaryocyte differentiation (GO:0045652),2/50,2,50,0.75464810901599,0.88058331047195,0,0,0.749063670411985,0.210864209105648,CBFB;CIB1
delta,2,regulation of epithelial cell proliferation (GO:0050678),3/73,3,73,0.755118303666202,0.88058331047195,0,0,0.769585962752039,0.216161958142723,CDK6;BAD;GDF5
delta,2,heterotypic cell-cell adhesion (GO:0034113),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,PKP2
delta,2,negative regulation of wound healing (GO:0061045),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,CLASP1
delta,2,regulation of centrosome duplication (GO:0010824),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,GEN1
delta,2,regulation of spindle assembly (GO:0090169),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,HSPA1A
delta,2,regulation of telomere maintenance (GO:0032204),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,RTEL1
delta,2,positive regulation of nuclear division (GO:0051785),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,SIRT2
delta,2,positive regulation of filopodium assembly (GO:0051491),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,BCAS3
delta,2,"RNA splicing, via transesterification reactions (GO:0000375)",1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,SMNDC1
delta,2,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,RASGRP1
delta,2,response to alcohol (GO:0097305),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,TGFBR2
delta,2,monocarboxylic acid catabolic process (GO:0072329),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,PPARD
delta,2,regulation of lamellipodium assembly (GO:0010591),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,TWF2
delta,2,regulation of glucose metabolic process (GO:0010906),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,PDK1
delta,2,cellular response to epidermal growth factor stimulus (GO:0071364),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,PLCG1
delta,2,female gamete generation (GO:0007292),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,FMN2
delta,2,regulation of potassium ion transmembrane transporter activity (GO:1901016),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,NEDD4
delta,2,ncRNA 3'-end processing (GO:0043628),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,ELAC2
delta,2,long-chain fatty-acyl-CoA metabolic process (GO:0035336),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,ACSL1
delta,2,peptide hormone secretion (GO:0030072),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,PTPRN
delta,2,negative regulation of locomotion (GO:0040013),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,FRMD5
delta,2,positive regulation of calcium ion transmembrane transport (GO:1904427),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,PLCG1
delta,2,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,PRKAG2
delta,2,regulation of voltage-gated calcium channel activity (GO:1901385),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,NOS1AP
delta,2,positive regulation of interleukin-12 production (GO:0032735),1/26,1,26,0.760154074127164,0.88058331047195,0,0,0.720253529242293,0.197518105109364,TLR9
delta,2,protein localization to cell periphery (GO:1990778),5/118,5,118,0.761642537875115,0.881964277321534,0,0,0.793499650860154,0.216052453312313,AP4M1;RAB40C;SLMAP;PKP2;SCN3B
delta,2,transcription-coupled nucleotide-excision repair (GO:0006283),3/74,3,74,0.763255898727756,0.882459034426497,0,0,0.759186152444579,0.205103187794072,POLD3;POLD4;ERCC6
delta,2,canonical Wnt signaling pathway (GO:0060070),3/74,3,74,0.763255898727756,0.882459034426497,0,0,0.759186152444579,0.205103187794072,FZD7;CTNNB1;SCYL2
delta,2,chloride transport (GO:0006821),3/74,3,74,0.763255898727756,0.882459034426497,0,0,0.759186152444579,0.205103187794072,CLIC5;CLIC4;GABRB1
delta,2,positive regulation of inflammatory response (GO:0050729),3/74,3,74,0.763255898727756,0.882459034426497,0,0,0.759186152444579,0.205103187794072,TLR9;IL6ST;ETS1
delta,2,regulation of cellular component organization (GO:0051128),6/141,6,141,0.77022384620358,0.886614274416342,0,0,0.796876245119133,0.208043746136653,RAP1B;HSPA8;CDK11A;NEDD4;ANKRA2;BAP1
delta,2,inorganic cation transmembrane transport (GO:0098662),6/141,6,141,0.77022384620358,0.886614274416342,0,0,0.796876245119133,0.208043746136653,SLC30A7;ATP5B;SCN8A;SLC39A13;SCN3B;ATP6V0C
delta,2,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),1/27,1,27,0.772978439393483,0.886614274416342,0,0,0.69357747260369,0.178599058746571,PSRC1
delta,2,positive regulation of synapse assembly (GO:0051965),1/27,1,27,0.772978439393483,0.886614274416342,0,0,0.69357747260369,0.178599058746571,CLSTN2
delta,2,nucleotide biosynthetic process (GO:0009165),1/27,1,27,0.772978439393483,0.886614274416342,0,0,0.69357747260369,0.178599058746571,MTHFD1
delta,2,regulation of NF-kappaB import into nucleus (GO:0042345),1/27,1,27,0.772978439393483,0.886614274416342,0,0,0.69357747260369,0.178599058746571,TLR9
delta,2,tRNA methylation (GO:0030488),1/27,1,27,0.772978439393483,0.886614274416342,0,0,0.69357747260369,0.178599058746571,METTL1
delta,2,regulation of cardiac muscle cell contraction (GO:0086004),1/27,1,27,0.772978439393483,0.886614274416342,0,0,0.69357747260369,0.178599058746571,PKP2
delta,2,regulation of histone acetylation (GO:0035065),1/27,1,27,0.772978439393483,0.886614274416342,0,0,0.69357747260369,0.178599058746571,TADA2B
delta,2,regulation of viral entry into host cell (GO:0046596),1/27,1,27,0.772978439393483,0.886614274416342,0,0,0.69357747260369,0.178599058746571,SNX3
delta,2,fat-soluble vitamin metabolic process (GO:0006775),1/27,1,27,0.772978439393483,0.886614274416342,0,0,0.69357747260369,0.178599058746571,VKORC1L1
delta,2,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),1/27,1,27,0.772978439393483,0.886614274416342,0,0,0.69357747260369,0.178599058746571,PNPLA8
delta,2,positive regulation of release of cytochrome c from mitochondria (GO:0090200),1/27,1,27,0.772978439393483,0.886614274416342,0,0,0.69357747260369,0.178599058746571,BAD
delta,2,GPI anchor metabolic process (GO:0006505),1/27,1,27,0.772978439393483,0.886614274416342,0,0,0.69357747260369,0.178599058746571,PIGP
delta,2,regulation of T cell receptor signaling pathway (GO:0050856),1/27,1,27,0.772978439393483,0.886614274416342,0,0,0.69357747260369,0.178599058746571,PTPRJ
delta,2,endocrine system development (GO:0035270),1/27,1,27,0.772978439393483,0.886614274416342,0,0,0.69357747260369,0.178599058746571,PAX8
delta,2,cation transmembrane transport (GO:0098655),1/27,1,27,0.772978439393483,0.886614274416342,0,0,0.69357747260369,0.178599058746571,SLC9B2
delta,2,snRNA 3'-end processing (GO:0034472),1/27,1,27,0.772978439393483,0.886614274416342,0,0,0.69357747260369,0.178599058746571,USB1
delta,2,positive regulation of glucose import (GO:0046326),1/27,1,27,0.772978439393483,0.886614274416342,0,0,0.69357747260369,0.178599058746571,PIK3R3
delta,2,snRNA processing (GO:0016180),1/27,1,27,0.772978439393483,0.886614274416342,0,0,0.69357747260369,0.178599058746571,INTS8
delta,2,regulation of cellular amine metabolic process (GO:0033238),2/52,2,52,0.773702039872056,0.886614274416342,0,0,0.720253529242293,0.184794325060995,PSMD14;PSMB3
delta,2,regulation of cellular amino acid metabolic process (GO:0006521),2/52,2,52,0.773702039872056,0.886614274416342,0,0,0.720253529242293,0.184794325060995,PSMD14;PSMB3
delta,2,arachidonic acid metabolic process (GO:0019369),2/52,2,52,0.773702039872056,0.886614274416342,0,0,0.720253529242293,0.184794325060995,PNPLA8;DAGLB
delta,2,response to tumor necrosis factor (GO:0034612),4/98,4,98,0.77466685622746,0.887036769577884,0,0,0.764350684093862,0.195155702039789,CIB1;RIPK1;TNFRSF21;NFE2L2
delta,2,negative regulation of cell motility (GO:2000146),4/98,4,98,0.77466685622746,0.887036769577884,0,0,0.764350684093862,0.195155702039789,FRMD5;CLIC4;FUZ;PTPRJ
delta,2,retinoid metabolic process (GO:0001523),3/76,3,76,0.778871294138237,0.890480588304031,0,0,0.739207569485512,0.184734969024503,APOM;GPC2;GPC5
delta,2,regulation of actin cytoskeleton organization (GO:0032956),3/76,3,76,0.778871294138237,0.890480588304031,0,0,0.739207569485512,0.184734969024503,TAOK1;TWF2;CDK10
delta,2,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",3/76,3,76,0.778871294138237,0.890480588304031,0,0,0.739207569485512,0.184734969024503,PDIA3;PSMD14;PSMB3
delta,2,gland development (GO:0048732),3/76,3,76,0.778871294138237,0.890480588304031,0,0,0.739207569485512,0.184734969024503,PAX8;CEBPG;MET
delta,2,plasma membrane bounded cell projection morphogenesis (GO:0120039),2/53,2,53,0.782735298029511,0.893161418574234,0,0,0.706663840011307,0.173104869911609,SNX1;DNM2
delta,2,positive regulation of nervous system development (GO:0051962),2/53,2,53,0.782735298029511,0.893161418574234,0,0,0.706663840011307,0.173104869911609,CLSTN2;NUMB
delta,2,phosphatidylinositol phosphorylation (GO:0046854),1/28,1,28,0.785117698585415,0.893161418574234,0,0,0.668806848582129,0.161798848271181,PIK3R3
delta,2,negative regulation of synaptic transmission (GO:0050805),1/28,1,28,0.785117698585415,0.893161418574234,0,0,0.668806848582129,0.161798848271181,ACHE
delta,2,phagosome acidification (GO:0090383),1/28,1,28,0.785117698585415,0.893161418574234,0,0,0.668806848582129,0.161798848271181,ATP6V0C
delta,2,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),1/28,1,28,0.785117698585415,0.893161418574234,0,0,0.668806848582129,0.161798848271181,HSPA1A
delta,2,negative regulation of myeloid leukocyte differentiation (GO:0002762),1/28,1,28,0.785117698585415,0.893161418574234,0,0,0.668806848582129,0.161798848271181,CDK6
delta,2,negative regulation of cell-matrix adhesion (GO:0001953),1/28,1,28,0.785117698585415,0.893161418574234,0,0,0.668806848582129,0.161798848271181,BCAS3
delta,2,negative regulation of osteoblast differentiation (GO:0045668),1/28,1,28,0.785117698585415,0.893161418574234,0,0,0.668806848582129,0.161798848271181,CDK6
delta,2,phosphatidylserine metabolic process (GO:0006658),1/28,1,28,0.785117698585415,0.893161418574234,0,0,0.668806848582129,0.161798848271181,SLC27A1
delta,2,regulation of protein targeting to membrane (GO:0090313),1/28,1,28,0.785117698585415,0.893161418574234,0,0,0.668806848582129,0.161798848271181,CIB1
delta,2,phosphatidylcholine acyl-chain remodeling (GO:0036151),1/28,1,28,0.785117698585415,0.893161418574234,0,0,0.668806848582129,0.161798848271181,PNPLA8
delta,2,endocytic recycling (GO:0032456),1/28,1,28,0.785117698585415,0.893161418574234,0,0,0.668806848582129,0.161798848271181,DENND1B
delta,2,positive regulation of apoptotic signaling pathway (GO:2001235),3/77,3,77,0.786355497134029,0.894012062395539,0,0,0.729607471180505,0.175358457882347,TNFRSF12A;BAD;RIPK1
delta,2,negative regulation of cell migration (GO:0030336),5/122,5,122,0.786466256502527,0.894012062395539,0,0,0.767483268864739,0.18435367223117,CLIC4;FUZ;PTPRJ;TIMP1;CLASP1
delta,2,monocarboxylic acid transport (GO:0015718),2/54,2,54,0.791450236272532,0.898990802727883,0,0,0.69357747260369,0.162219638173961,SLC10A3;PPARD
delta,2,embryonic organ development (GO:0048568),2/54,2,54,0.791450236272532,0.898990802727883,0,0,0.69357747260369,0.162219638173961,GLI3;TGFBR2
delta,2,positive regulation of cytoskeleton organization (GO:0051495),3/78,3,78,0.793628535501225,0.899016554783309,0,0,0.720253529242293,0.166479232659982,BCAS3;PFN1;NCK1
delta,2,negative regulation of endocytosis (GO:0045806),1/29,1,29,0.796608419006581,0.899016554783309,0,0,0.645744543458608,0.146837168807533,SNX3
delta,2,cellular response to ketone (GO:1901655),1/29,1,29,0.796608419006581,0.899016554783309,0,0,0.645744543458608,0.146837168807533,GNB1
delta,2,cellular amino acid biosynthetic process (GO:0008652),1/29,1,29,0.796608419006581,0.899016554783309,0,0,0.645744543458608,0.146837168807533,PAH
delta,2,"synaptic transmission, cholinergic (GO:0007271)",1/29,1,29,0.796608419006581,0.899016554783309,0,0,0.645744543458608,0.146837168807533,ACHE
delta,2,chondrocyte differentiation (GO:0002062),1/29,1,29,0.796608419006581,0.899016554783309,0,0,0.645744543458608,0.146837168807533,NFIB
delta,2,organelle fission (GO:0048285),1/29,1,29,0.796608419006581,0.899016554783309,0,0,0.645744543458608,0.146837168807533,DNM2
delta,2,positive regulation of cell communication (GO:0010647),1/29,1,29,0.796608419006581,0.899016554783309,0,0,0.645744543458608,0.146837168807533,CLSTN2
delta,2,negative regulation of JNK cascade (GO:0046329),1/29,1,29,0.796608419006581,0.899016554783309,0,0,0.645744543458608,0.146837168807533,HIPK3
delta,2,positive regulation of calcium-mediated signaling (GO:0050850),1/29,1,29,0.796608419006581,0.899016554783309,0,0,0.645744543458608,0.146837168807533,CIB1
delta,2,regulation of lipid biosynthetic process (GO:0046890),1/29,1,29,0.796608419006581,0.899016554783309,0,0,0.645744543458608,0.146837168807533,PRKAG2
delta,2,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),1/29,1,29,0.796608419006581,0.899016554783309,0,0,0.645744543458608,0.146837168807533,PDIA3
delta,2,protein K63-linked deubiquitination (GO:0070536),1/29,1,29,0.796608419006581,0.899016554783309,0,0,0.645744543458608,0.146837168807533,PSMD14
delta,2,protein export from nucleus (GO:0006611),1/29,1,29,0.796608419006581,0.899016554783309,0,0,0.645744543458608,0.146837168807533,XPO4
delta,2,regulation of actin polymerization or depolymerization (GO:0008064),1/29,1,29,0.796608419006581,0.899016554783309,0,0,0.645744543458608,0.146837168807533,PFN1
delta,2,neuron projection extension (GO:1990138),1/29,1,29,0.796608419006581,0.899016554783309,0,0,0.645744543458608,0.146837168807533,CTNNB1
delta,2,cellular response to hydrogen peroxide (GO:0070301),1/29,1,29,0.796608419006581,0.899016554783309,0,0,0.645744543458608,0.146837168807533,NFE2L2
delta,2,cytoplasmic translation (GO:0002181),2/55,2,55,0.799855054777567,0.901575914237925,0,0,0.680966973101805,0.152076778520672,RPLP2;RPL26L1
delta,2,membrane fusion (GO:0061025),2/55,2,55,0.799855054777567,0.901575914237925,0,0,0.680966973101805,0.152076778520672,USO1;DNM2
delta,2,regulation of kinase activity (GO:0043549),4/102,4,102,0.800663009438801,0.901575914237925,0,0,0.73437614746273,0.16326293071098,RB1;ALK;MET;IGF1R
delta,2,extracellular matrix disassembly (GO:0022617),3/79,3,79,0.800693931898802,0.901575914237925,0,0,0.711136395960745,0.158068917954473,MMP16;LAMC2;TIMP1
delta,2,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),3/79,3,79,0.800693931898802,0.901575914237925,0,0,0.711136395960745,0.158068917954473,PDIA3;PSMD14;PSMB3
delta,2,sensory perception of mechanical stimulus (GO:0050954),3/79,3,79,0.800693931898802,0.901575914237925,0,0,0.711136395960745,0.158068917954473,CLIC5;WFS1;TIMM9
delta,2,regulation of striated muscle contraction (GO:0006942),1/30,1,30,0.807485217938786,0.905984539376115,0,0,0.624219725343321,0.133477234713509,TNNI3K
delta,2,synaptic vesicle endocytosis (GO:0048488),1/30,1,30,0.807485217938786,0.905984539376115,0,0,0.624219725343321,0.133477234713509,DNM2
delta,2,keratan sulfate biosynthetic process (GO:0018146),1/30,1,30,0.807485217938786,0.905984539376115,0,0,0.624219725343321,0.133477234713509,B4GALT6
delta,2,positive regulation of histone modification (GO:0031058),1/30,1,30,0.807485217938786,0.905984539376115,0,0,0.624219725343321,0.133477234713509,TADA2B
delta,2,regulation of chromosome segregation (GO:0051983),1/30,1,30,0.807485217938786,0.905984539376115,0,0,0.624219725343321,0.133477234713509,SMC6
delta,2,B cell proliferation (GO:0042100),1/30,1,30,0.807485217938786,0.905984539376115,0,0,0.624219725343321,0.133477234713509,CTPS1
delta,2,amino acid transmembrane transport (GO:0003333),1/30,1,30,0.807485217938786,0.905984539376115,0,0,0.624219725343321,0.133477234713509,SLC6A6
delta,2,determination of bilateral symmetry (GO:0009855),1/30,1,30,0.807485217938786,0.905984539376115,0,0,0.624219725343321,0.133477234713509,NPHP3
delta,2,regulation of endothelial cell proliferation (GO:0001936),3/80,3,80,0.807555308999305,0.905984539376115,0,0,0.702247191011236,0.150100935473423,PDCL3;NRARP;HIF1A
delta,2,regulation of axonogenesis (GO:0050770),2/56,2,56,0.807957986392544,0.905984539376115,0,0,0.668806848582129,0.142619862795523,CDH2;DNM2
delta,2,Notch signaling pathway (GO:0007219),2/56,2,56,0.807957986392544,0.905984539376115,0,0,0.668806848582129,0.142619862795523,NRARP;ASCL1
delta,2,regulation of protein kinase activity (GO:0045859),6/148,6,148,0.808273224769452,0.905996654204855,0,0,0.759186152444579,0.161596665770986,RB1;CDKN1A;JTB;PRKAG2;TRIB3;CAMKK1
delta,2,NIK/NF-kappaB signaling (GO:0038061),3/81,3,81,0.81421637665031,0.909460335881588,0,0,0.69357747260369,0.142550374061921,PSMD14;PSMB3;MALT1
delta,2,cytoskeleton organization (GO:0007010),5/127,5,127,0.81461420540186,0.909460335881588,0,0,0.737267392137781,0.151169781931174,ARHGAP10;PALLD;NEDD9;TLN1;SYNE2
delta,2,chordate embryonic development (GO:0043009),2/57,2,57,0.815767269806673,0.909460335881588,0,0,0.657073395098232,0.133797341000054,MBNL1;CHD7
delta,2,regulation of actin cytoskeleton reorganization (GO:2000249),1/31,1,31,0.817780866538686,0.909460335881588,0,0,0.604083605170956,0.121517982110156,BCAS3
delta,2,connective tissue development (GO:0061448),1/31,1,31,0.817780866538686,0.909460335881588,0,0,0.604083605170956,0.121517982110156,SLC39A13
delta,2,bile acid and bile salt transport (GO:0015721),1/31,1,31,0.817780866538686,0.909460335881588,0,0,0.604083605170956,0.121517982110156,SLC10A3
delta,2,negative regulation of secretion by cell (GO:1903531),1/31,1,31,0.817780866538686,0.909460335881588,0,0,0.604083605170956,0.121517982110156,SYT4
delta,2,multivesicular body assembly (GO:0036258),1/31,1,31,0.817780866538686,0.909460335881588,0,0,0.604083605170956,0.121517982110156,HGS
delta,2,regulation of cell adhesion mediated by integrin (GO:0033628),1/31,1,31,0.817780866538686,0.909460335881588,0,0,0.604083605170956,0.121517982110156,CIB1
delta,2,regulation of cation transmembrane transport (GO:1904062),1/31,1,31,0.817780866538686,0.909460335881588,0,0,0.604083605170956,0.121517982110156,SLMAP
delta,2,regulation of ARF protein signal transduction (GO:0032012),1/31,1,31,0.817780866538686,0.909460335881588,0,0,0.604083605170956,0.121517982110156,ARFGAP2
delta,2,regulation of developmental growth (GO:0048638),1/31,1,31,0.817780866538686,0.909460335881588,0,0,0.604083605170956,0.121517982110156,DNM2
delta,2,positive regulation of phospholipase C activity (GO:0010863),1/31,1,31,0.817780866538686,0.909460335881588,0,0,0.604083605170956,0.121517982110156,ITK
delta,2,regulation of blood coagulation (GO:0030193),1/31,1,31,0.817780866538686,0.909460335881588,0,0,0.604083605170956,0.121517982110156,TEC
delta,2,CENP-A containing nucleosome assembly (GO:0034080),1/31,1,31,0.817780866538686,0.909460335881588,0,0,0.604083605170956,0.121517982110156,SMARCA5
delta,2,CENP-A containing chromatin organization (GO:0061641),1/31,1,31,0.817780866538686,0.909460335881588,0,0,0.604083605170956,0.121517982110156,SMARCA5
delta,2,ribosomal large subunit assembly (GO:0000027),1/31,1,31,0.817780866538686,0.909460335881588,0,0,0.604083605170956,0.121517982110156,DDX28
delta,2,acylglycerol catabolic process (GO:0046464),1/31,1,31,0.817780866538686,0.909460335881588,0,0,0.604083605170956,0.121517982110156,DAGLB
delta,2,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),1/31,1,31,0.817780866538686,0.909460335881588,0,0,0.604083605170956,0.121517982110156,PSRC1
delta,2,cellular response to cAMP (GO:0071320),1/31,1,31,0.817780866538686,0.909460335881588,0,0,0.604083605170956,0.121517982110156,RAP1B
delta,2,negative regulation of transferase activity (GO:0051348),1/31,1,31,0.817780866538686,0.909460335881588,0,0,0.604083605170956,0.121517982110156,PINX1
delta,2,heart development (GO:0007507),6/150,6,150,0.818192515864011,0.909578232055022,0,0,0.749063670411985,0.150305333784813,MTHFD1;CHD7;PKP2;CACYBP;HDAC9;TGFBR2
delta,2,peptide metabolic process (GO:0006518),4/105,4,105,0.818524036348824,0.909606994837229,0,0,0.713393971820938,0.142858937943784,HSPA8;IMMP2L;CPQ;PROS1
delta,2,negative regulation of response to stimulus (GO:0048585),5/128,5,128,0.81987185203986,0.910764700138344,0,0,0.731507490636704,0.145282675661786,BRAP;ALK;CDK6;MET;IGF1R
delta,2,epidermis development (GO:0008544),3/82,3,82,0.820680917804741,0.910983368663525,0,0,0.685119210742669,0.135393872114341,ALDH3A2;LAMC2;GRHL1
delta,2,sensory perception of sound (GO:0007605),3/82,3,82,0.820680917804741,0.910983368663525,0,0,0.685119210742669,0.135393872114341,CLIC5;WFS1;TIMM9
delta,2,protein homotetramerization (GO:0051289),2/58,2,58,0.82329112546165,0.912455921280706,0,0,0.645744543458608,0.125562058610214,SAMHD1;CRYZ
delta,2,epidermal growth factor receptor signaling pathway (GO:0007173),2/58,2,58,0.82329112546165,0.912455921280706,0,0,0.645744543458608,0.125562058610214,PLCG1;PAG1
delta,2,modulation of chemical synaptic transmission (GO:0050804),3/83,3,83,0.826952776572011,0.912455921280706,0,0,0.676864762420468,0.128609508378434,CLSTN2;CDH2;SLC6A9
delta,2,ephrin receptor signaling pathway (GO:0048013),3/83,3,83,0.826952776572011,0.912455921280706,0,0,0.676864762420468,0.128609508378434,ACTR3;EFNB2;MYL12A
delta,2,negative regulation of binding (GO:0051100),3/83,3,83,0.826952776572011,0.912455921280706,0,0,0.676864762420468,0.128609508378434,RALB;CTNNBIP1;SORL1
delta,2,regulation of dendritic spine development (GO:0060998),1/32,1,32,0.827526388285156,0.912455921280706,0,0,0.585205992509363,0.110787852921943,FXR1
delta,2,alpha-amino acid metabolic process (GO:1901605),1/32,1,32,0.827526388285156,0.912455921280706,0,0,0.585205992509363,0.110787852921943,MTHFD1
delta,2,skeletal system morphogenesis (GO:0048705),1/32,1,32,0.827526388285156,0.912455921280706,0,0,0.585205992509363,0.110787852921943,FUZ
delta,2,zinc ion homeostasis (GO:0055069),1/32,1,32,0.827526388285156,0.912455921280706,0,0,0.585205992509363,0.110787852921943,SLC39A13
delta,2,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),1/32,1,32,0.827526388285156,0.912455921280706,0,0,0.585205992509363,0.110787852921943,RIPK1
delta,2,multivesicular body organization (GO:0036257),1/32,1,32,0.827526388285156,0.912455921280706,0,0,0.585205992509363,0.110787852921943,HGS
delta,2,cellular zinc ion homeostasis (GO:0006882),1/32,1,32,0.827526388285156,0.912455921280706,0,0,0.585205992509363,0.110787852921943,SLC39A13
delta,2,positive regulation of insulin secretion (GO:0032024),1/32,1,32,0.827526388285156,0.912455921280706,0,0,0.585205992509363,0.110787852921943,BAD
delta,2,protein destabilization (GO:0031648),1/32,1,32,0.827526388285156,0.912455921280706,0,0,0.585205992509363,0.110787852921943,MDM2
delta,2,negative regulation of toll-like receptor signaling pathway (GO:0034122),1/32,1,32,0.827526388285156,0.912455921280706,0,0,0.585205992509363,0.110787852921943,TLR9
delta,2,negative regulation of blood vessel endothelial cell migration (GO:0043537),1/32,1,32,0.827526388285156,0.912455921280706,0,0,0.585205992509363,0.110787852921943,MECP2
delta,2,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),1/32,1,32,0.827526388285156,0.912455921280706,0,0,0.585205992509363,0.110787852921943,PLCG1
delta,2,regulation of protein tyrosine kinase activity (GO:0061097),1/32,1,32,0.827526388285156,0.912455921280706,0,0,0.585205992509363,0.110787852921943,SH3BP5
delta,2,positive regulation of cellular component organization (GO:0051130),4/107,4,107,0.829683924523682,0.914496059030547,0,0,0.70005950505793,0.130708435399476,CLSTN2;ATM;IGF1R;ATR
delta,2,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),2/59,2,59,0.830537734109324,0.914759547264747,0,0,0.634799720688123,0.117870828127567,CIB1;DOCK1
delta,2,response to light stimulus (GO:0009416),2/59,2,59,0.830537734109324,0.914759547264747,0,0,0.634799720688123,0.117870828127567,REV1;ERCC6
delta,2,negative regulation of endopeptidase activity (GO:0010951),3/84,3,84,0.833035846532339,0.916852513986916,0,0,0.668806848582129,0.122176701905539,TIMP1;GAPDH;SORL1
delta,2,protein localization to plasma membrane (GO:0072659),5/131,5,131,0.834926555204657,0.916852513986916,0,0,0.714755410698459,0.128950107097903,ARFRP1;RAB40C;SLMAP;PKP2;SCN3B
delta,2,negative regulation of response to external stimulus (GO:0032102),4/108,4,108,0.835046435646071,0.916852513986916,0,0,0.69357747260369,0.125029785077935,VPS35;CTNNA2;SIRT2;PPARD
delta,2,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),1/33,1,33,0.836751151877844,0.916852513986916,0,0,0.567472477584837,0.101139803814739,TLR9
delta,2,7-methylguanosine RNA capping (GO:0009452),1/33,1,33,0.836751151877844,0.916852513986916,0,0,0.567472477584837,0.101139803814739,NCBP1
delta,2,GPI anchor biosynthetic process (GO:0006506),1/33,1,33,0.836751151877844,0.916852513986916,0,0,0.567472477584837,0.101139803814739,PIGP
delta,2,phagosome maturation (GO:0090382),1/33,1,33,0.836751151877844,0.916852513986916,0,0,0.567472477584837,0.101139803814739,ATP6V0C
delta,2,positive regulation of TOR signaling (GO:0032008),1/33,1,33,0.836751151877844,0.916852513986916,0,0,0.567472477584837,0.101139803814739,RRAGA
delta,2,vasculogenesis (GO:0001570),1/33,1,33,0.836751151877844,0.916852513986916,0,0,0.567472477584837,0.101139803814739,TGFBR2
delta,2,7-methylguanosine mRNA capping (GO:0006370),1/33,1,33,0.836751151877844,0.916852513986916,0,0,0.567472477584837,0.101139803814739,NCBP1
delta,2,positive regulation of calcium ion transport into cytosol (GO:0010524),1/33,1,33,0.836751151877844,0.916852513986916,0,0,0.567472477584837,0.101139803814739,PLCG1
delta,2,response to zinc ion (GO:0010043),1/33,1,33,0.836751151877844,0.916852513986916,0,0,0.567472477584837,0.101139803814739,SLC30A7
delta,2,positive regulation of dendrite development (GO:1900006),1/33,1,33,0.836751151877844,0.916852513986916,0,0,0.567472477584837,0.101139803814739,VLDLR
delta,2,chromatin remodeling at centromere (GO:0031055),1/33,1,33,0.836751151877844,0.916852513986916,0,0,0.567472477584837,0.101139803814739,SMARCA5
delta,2,regulation of extrinsic apoptotic signaling pathway (GO:2001236),2/60,2,60,0.837515217354403,0.917014454321818,0,0,0.624219725343321,0.110684048359914,TNFRSF12A;RIPK1
delta,2,cell morphogenesis (GO:0000902),2/60,2,60,0.837515217354403,0.917014454321818,0,0,0.624219725343321,0.110684048359914,CYFIP2;CDH2
delta,2,regulation of neuron differentiation (GO:0045664),3/85,3,85,0.838934059878348,0.917892559631604,0,0,0.660938532716457,0.116076119836313,TCF12;ASCL1;CDK5RAP3
delta,2,cellular response to molecule of bacterial origin (GO:0071219),3/85,3,85,0.838934059878348,0.917892559631604,0,0,0.660938532716457,0.116076119836313,PABPN1;PLAA;SIRT2
delta,2,nucleosome assembly (GO:0006334),2/61,2,61,0.844231621012902,0.918640849933963,0,0,0.613986615091791,0.103965364742521,H2AFX;SMARCA5
delta,2,mitochondrial ATP synthesis coupled electron transport (GO:0042775),3/86,3,86,0.844651377494266,0.918640849933963,0,0,0.653253200940685,0.110289592218776,CYCS;COQ7;UQCRH
delta,2,regulation of cell motility (GO:2000145),4/110,4,110,0.845348415052883,0.918640849933963,0,0,0.680966973101805,0.114406817229414,FRMD5;CDK6;LMNA;PKN2
delta,2,axonemal dynein complex assembly (GO:0070286),1/34,1,34,0.845482959667044,0.918640849933963,0,0,0.550782110597048,0.0924472708722029,DNAAF2
delta,2,positive regulation of cell-cell adhesion (GO:0022409),1/34,1,34,0.845482959667044,0.918640849933963,0,0,0.550782110597048,0.0924472708722029,FOXA1
delta,2,protein acetylation (GO:0006473),1/34,1,34,0.845482959667044,0.918640849933963,0,0,0.550782110597048,0.0924472708722029,BLOC1S1
delta,2,regulation of T cell differentiation (GO:0045580),1/34,1,34,0.845482959667044,0.918640849933963,0,0,0.550782110597048,0.0924472708722029,CBFB
delta,2,oligosaccharide biosynthetic process (GO:0009312),1/34,1,34,0.845482959667044,0.918640849933963,0,0,0.550782110597048,0.0924472708722029,GALNT10
delta,2,regulation of cell-substrate adhesion (GO:0010810),1/34,1,34,0.845482959667044,0.918640849933963,0,0,0.550782110597048,0.0924472708722029,FZD7
delta,2,response to exogenous dsRNA (GO:0043330),1/34,1,34,0.845482959667044,0.918640849933963,0,0,0.550782110597048,0.0924472708722029,RALB
delta,2,intra-Golgi vesicle-mediated transport (GO:0006891),1/34,1,34,0.845482959667044,0.918640849933963,0,0,0.550782110597048,0.0924472708722029,GOLGA5
delta,2,embryonic organ morphogenesis (GO:0048562),1/34,1,34,0.845482959667044,0.918640849933963,0,0,0.550782110597048,0.0924472708722029,FUZ
delta,2,mRNA stabilization (GO:0048255),1/34,1,34,0.845482959667044,0.918640849933963,0,0,0.550782110597048,0.0924472708722029,TARDBP
delta,2,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay (GO:0043928),1/34,1,34,0.845482959667044,0.918640849933963,0,0,0.550782110597048,0.0924472708722029,DIS3
delta,2,carboxylic acid metabolic process (GO:0019752),1/34,1,34,0.845482959667044,0.918640849933963,0,0,0.550782110597048,0.0924472708722029,MIF
delta,2,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),1/34,1,34,0.845482959667044,0.918640849933963,0,0,0.550782110597048,0.0924472708722029,PIK3R3
delta,2,positive regulation of locomotion (GO:0040017),1/34,1,34,0.845482959667044,0.918640849933963,0,0,0.550782110597048,0.0924472708722029,STX3
delta,2,intracellular pH reduction (GO:0051452),1/34,1,34,0.845482959667044,0.918640849933963,0,0,0.550782110597048,0.0924472708722029,ATP6V0C
delta,2,positive regulation of calcium ion transport (GO:0051928),1/34,1,34,0.845482959667044,0.918640849933963,0,0,0.550782110597048,0.0924472708722029,WFS1
delta,2,toll-like receptor signaling pathway (GO:0002224),3/87,3,87,0.850191779134744,0.922233915629833,0,0,0.645744543458608,0.104800033859772,TRAF3;TLR9;RIPK1
delta,2,regulation of peptidyl-serine phosphorylation (GO:0033135),3/87,3,87,0.850191779134744,0.922233915629833,0,0,0.645744543458608,0.104800033859772,NSD1;MIF;NCK1
delta,2,positive regulation of T cell proliferation (GO:0042102),2/62,2,62,0.850694899786198,0.922233915629833,0,0,0.604083605170956,0.0976813666379636,IL6ST;NCK1
delta,2,positive regulation of leukocyte chemotaxis (GO:0002690),2/62,2,62,0.850694899786198,0.922233915629833,0,0,0.604083605170956,0.0976813666379636,CREB3;IL6R
delta,2,negative regulation of viral life cycle (GO:1903901),2/62,2,62,0.850694899786198,0.922233915629833,0,0,0.604083605170956,0.0976813666379636,SNX3;ISG20
delta,2,apoptotic mitochondrial changes (GO:0008637),1/35,1,35,0.853748130900602,0.922233915629833,0,0,0.535045478865704,0.084600886774428,VPS35
delta,2,positive regulation of leukocyte migration (GO:0002687),1/35,1,35,0.853748130900602,0.922233915629833,0,0,0.535045478865704,0.084600886774428,IL6R
delta,2,negative regulation of DNA binding (GO:0043392),1/35,1,35,0.853748130900602,0.922233915629833,0,0,0.535045478865704,0.084600886774428,TNKS
delta,2,regulation of wound healing (GO:0061041),1/35,1,35,0.853748130900602,0.922233915629833,0,0,0.535045478865704,0.084600886774428,TNFRSF12A
delta,2,response to peptide (GO:1901652),1/35,1,35,0.853748130900602,0.922233915629833,0,0,0.535045478865704,0.084600886774428,KAT7
delta,2,positive regulation of cytokinesis (GO:0032467),1/35,1,35,0.853748130900602,0.922233915629833,0,0,0.535045478865704,0.084600886774428,PKN2
delta,2,negative regulation of endothelial cell migration (GO:0010596),1/35,1,35,0.853748130900602,0.922233915629833,0,0,0.535045478865704,0.084600886774428,MECP2
delta,2,anterior/posterior pattern specification (GO:0009952),1/35,1,35,0.853748130900602,0.922233915629833,0,0,0.535045478865704,0.084600886774428,CTNNBIP1
delta,2,cellular macromolecular complex assembly (GO:0034622),1/35,1,35,0.853748130900602,0.922233915629833,0,0,0.535045478865704,0.084600886774428,DNAJB12
delta,2,negative regulation of cellular metabolic process (GO:0031324),1/35,1,35,0.853748130900602,0.922233915629833,0,0,0.535045478865704,0.084600886774428,SIRT2
delta,2,ncRNA metabolic process (GO:0034660),1/35,1,35,0.853748130900602,0.922233915629833,0,0,0.535045478865704,0.084600886774428,BCDIN3D
delta,2,negative regulation of peptidase activity (GO:0010466),2/63,2,63,0.856912904169735,0.924310391106953,0,0,0.594494976517448,0.0918013163836912,TIMP1;GAPDH
delta,2,phosphatidylinositol metabolic process (GO:0046488),4/113,4,113,0.859780294463024,0.924310391106953,0,0,0.662888203904412,0.100148085199446,SLC27A1;PITPNM2;PIK3R3;PIP4K2B
delta,2,divalent metal ion transport (GO:0070838),3/89,3,89,0.860757798054122,0.924310391106953,0,0,0.631233430122459,0.094648476960337,NIPAL1;NIPA1;ITPR1
delta,2,positive regulation of protein complex assembly (GO:0031334),3/89,3,89,0.860757798054122,0.924310391106953,0,0,0.631233430122459,0.094648476960337,UNC13B;MED25;CTNNB1
delta,2,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",1/36,1,36,0.861571580957892,0.924310391106953,0,0,0.520183104452767,0.0775057936517386,DIS3
delta,2,negative regulation of cell-substrate adhesion (GO:0010812),1/36,1,36,0.861571580957892,0.924310391106953,0,0,0.520183104452767,0.0775057936517386,FZD7
delta,2,negative regulation of protein complex assembly (GO:0031333),1/36,1,36,0.861571580957892,0.924310391106953,0,0,0.520183104452767,0.0775057936517386,SORL1
delta,2,cholesterol biosynthetic process (GO:0006695),1/36,1,36,0.861571580957892,0.924310391106953,0,0,0.520183104452767,0.0775057936517386,HMGCR
delta,2,regulation of mitochondrial membrane potential (GO:0051881),1/36,1,36,0.861571580957892,0.924310391106953,0,0,0.520183104452767,0.0775057936517386,BAD
delta,2,regulation of ion transmembrane transport (GO:0034765),1/36,1,36,0.861571580957892,0.924310391106953,0,0,0.520183104452767,0.0775057936517386,NEDD4
delta,2,carboxylic acid transmembrane transport (GO:1905039),1/36,1,36,0.861571580957892,0.924310391106953,0,0,0.520183104452767,0.0775057936517386,SLC6A6
delta,2,regulation of cardiac muscle contraction (GO:0055117),1/36,1,36,0.861571580957892,0.924310391106953,0,0,0.520183104452767,0.0775057936517386,TNNI3K
delta,2,neural crest cell development (GO:0014032),1/36,1,36,0.861571580957892,0.924310391106953,0,0,0.520183104452767,0.0775057936517386,NOLC1
delta,2,lipid phosphorylation (GO:0046834),1/36,1,36,0.861571580957892,0.924310391106953,0,0,0.520183104452767,0.0775057936517386,PIK3R3
delta,2,positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/36,1,36,0.861571580957892,0.924310391106953,0,0,0.520183104452767,0.0775057936517386,MALT1
delta,2,regulation of endothelial cell apoptotic process (GO:2000351),1/36,1,36,0.861571580957892,0.924310391106953,0,0,0.520183104452767,0.0775057936517386,NFE2L2
delta,2,erythrocyte differentiation (GO:0030218),1/36,1,36,0.861571580957892,0.924310391106953,0,0,0.520183104452767,0.0775057936517386,CEBPG
delta,2,endothelial cell migration (GO:0043542),1/36,1,36,0.861571580957892,0.924310391106953,0,0,0.520183104452767,0.0775057936517386,S100A2
delta,2,apical junction assembly (GO:0043297),1/36,1,36,0.861571580957892,0.924310391106953,0,0,0.520183104452767,0.0775057936517386,PKN2
delta,2,synapse assembly (GO:0007416),2/64,2,64,0.862893368924847,0.92539483456589,0,0,0.585205992509363,0.0862969066810556,ACHE;CDH2
delta,2,positive regulation of endocytosis (GO:0045807),2/65,2,65,0.868643902965324,0.92624471441342,0,0,0.576202823393835,0.0811420430102059,TUB;HNRNPK
delta,2,regulation of receptor-mediated endocytosis (GO:0048259),1/37,1,37,0.868976896049149,0.92624471441342,0,0,0.50612410162972,0.0710794315695391,HNRNPK
delta,2,histone exchange (GO:0043486),1/37,1,37,0.868976896049149,0.92624471441342,0,0,0.50612410162972,0.0710794315695391,SMARCA5
delta,2,carbohydrate biosynthetic process (GO:0016051),1/37,1,37,0.868976896049149,0.92624471441342,0,0,0.50612410162972,0.0710794315695391,GALNT10
delta,2,lymphocyte proliferation (GO:0046651),1/37,1,37,0.868976896049149,0.92624471441342,0,0,0.50612410162972,0.0710794315695391,CTPS1
delta,2,regulation of response to DNA damage stimulus (GO:2001020),1/37,1,37,0.868976896049149,0.92624471441342,0,0,0.50612410162972,0.0710794315695391,RFWD3
delta,2,plasma membrane organization (GO:0007009),1/37,1,37,0.868976896049149,0.92624471441342,0,0,0.50612410162972,0.0710794315695391,WHAMM
delta,2,endosome organization (GO:0007032),1/37,1,37,0.868976896049149,0.92624471441342,0,0,0.50612410162972,0.0710794315695391,SNX3
delta,2,centromere complex assembly (GO:0034508),1/37,1,37,0.868976896049149,0.92624471441342,0,0,0.50612410162972,0.0710794315695391,SMARCA5
delta,2,cardiac muscle contraction (GO:0060048),1/37,1,37,0.868976896049149,0.92624471441342,0,0,0.50612410162972,0.0710794315695391,SCN3B
delta,2,cardiac muscle tissue morphogenesis (GO:0055008),1/37,1,37,0.868976896049149,0.92624471441342,0,0,0.50612410162972,0.0710794315695391,PKP2
delta,2,negative regulation of blood coagulation (GO:0030195),1/37,1,37,0.868976896049149,0.92624471441342,0,0,0.50612410162972,0.0710794315695391,F11
delta,2,glutamate receptor signaling pathway (GO:0007215),1/37,1,37,0.868976896049149,0.92624471441342,0,0,0.50612410162972,0.0710794315695391,DAGLB
delta,2,secondary alcohol biosynthetic process (GO:1902653),1/37,1,37,0.868976896049149,0.92624471441342,0,0,0.50612410162972,0.0710794315695391,HMGCR
delta,2,actin polymerization or depolymerization (GO:0008154),1/37,1,37,0.868976896049149,0.92624471441342,0,0,0.50612410162972,0.0710794315695391,TWF2
delta,2,organic hydroxy compound transport (GO:0015850),1/37,1,37,0.868976896049149,0.92624471441342,0,0,0.50612410162972,0.0710794315695391,SLC10A3
delta,2,regulation of filopodium assembly (GO:0051489),1/37,1,37,0.868976896049149,0.92624471441342,0,0,0.50612410162972,0.0710794315695391,BCAS3
delta,2,regulation of vesicle-mediated transport (GO:0060627),5/139,5,139,0.87008803344004,0.92709702381581,0,0,0.673618408643871,0.0937413336233525,RAB3B;RAB40C;TBC1D5;EVI5L;TBC1D22B
delta,2,positive regulation of response to external stimulus (GO:0032103),3/91,3,91,0.870664021621443,0.927378714511601,0,0,0.617360167921966,0.0855038370246153,TLR9;STX3;ETS1
delta,2,epithelium development (GO:0060429),4/116,4,116,0.873046553224389,0.929057568934981,0,0,0.645744543458608,0.0876704113342727,ERRFI1;ACADVL;MTHFD1;PAX8
delta,2,regulation of JAK-STAT cascade (GO:0046425),2/66,2,66,0.874171980788059,0.929057568934981,0,0,0.567472477584837,0.0763126480121945,SOCS1;HGS
delta,2,negative regulation of kinase activity (GO:0033673),3/92,3,92,0.875379634029447,0.929057568934981,0,0,0.610649731314118,0.0812760254369629,RB1;PRKAG2;TRIB3
delta,2,spliceosomal snRNP assembly (GO:0000387),1/38,1,38,0.875986404042861,0.929057568934981,0,0,0.492805046323674,0.0652497085872297,SNRPD1
delta,2,positive regulation of receptor activity (GO:2000273),1/38,1,38,0.875986404042861,0.929057568934981,0,0,0.492805046323674,0.0652497085872297,ANXA2
delta,2,positive regulation of smooth muscle cell proliferation (GO:0048661),1/38,1,38,0.875986404042861,0.929057568934981,0,0,0.492805046323674,0.0652497085872297,IL6R
delta,2,positive regulation of axonogenesis (GO:0050772),1/38,1,38,0.875986404042861,0.929057568934981,0,0,0.492805046323674,0.0652497085872297,TWF2
delta,2,positive regulation of stress fiber assembly (GO:0051496),1/38,1,38,0.875986404042861,0.929057568934981,0,0,0.492805046323674,0.0652497085872297,ARHGEF10
delta,2,negative regulation of Ras protein signal transduction (GO:0046580),1/38,1,38,0.875986404042861,0.929057568934981,0,0,0.492805046323674,0.0652497085872297,MET
delta,2,positive regulation of multi-organism process (GO:0043902),1/38,1,38,0.875986404042861,0.929057568934981,0,0,0.492805046323674,0.0652497085872297,SMURF2
delta,2,protein peptidyl-prolyl isomerization (GO:0000413),1/38,1,38,0.875986404042861,0.929057568934981,0,0,0.492805046323674,0.0652497085872297,PPIL4
delta,2,regulation of regulated secretory pathway (GO:1903305),1/38,1,38,0.875986404042861,0.929057568934981,0,0,0.492805046323674,0.0652497085872297,SYT4
delta,2,cellular response to interferon-gamma (GO:0071346),4/117,4,117,0.877221363942838,0.930007423887508,0,0,0.640225359326483,0.0838669022919923,IFNGR1;IRF1;GAPDH;IRF9
delta,2,response to lipid (GO:0033993),5/141,5,141,0.87781950729167,0.930007423887508,0,0,0.664063537599278,0.0865369611394641,FOXA1;CTNNB1;ASCL1;TNFRSF21;PPARD
delta,2,regulation of small GTPase mediated signal transduction (GO:0051056),5/141,5,141,0.87781950729167,0.930007423887508,0,0,0.664063537599278,0.0865369611394641,SYDE2;ARHGAP10;ARHGEF26;MCF2L;ARHGEF3
delta,2,positive regulation of innate immune response (GO:0045089),1/39,1,39,0.882621241615505,0.934761855888876,0,0,0.480169019494862,0.0599534789898102,TLR9
delta,2,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),3/94,3,94,0.884355515651133,0.935515171450864,0,0,0.59765718383935,0.0734497550596513,BAD;CYCS;SOX7
delta,2,positive regulation of synaptic transmission (GO:0050806),2/68,2,68,0.884589950424305,0.935515171450864,0,0,0.550782110597048,0.0675430018726232,UNC13B;CLSTN2
delta,2,regulation of TOR signaling (GO:0032006),2/68,2,68,0.884589950424305,0.935515171450864,0,0,0.550782110597048,0.0675430018726232,RRAGA;PRKAA1
delta,2,epidermal cell differentiation (GO:0009913),2/68,2,68,0.884589950424305,0.935515171450864,0,0,0.550782110597048,0.0675430018726232,CLIC4;CTNNB1
delta,2,skin development (GO:0043588),3/95,3,95,0.888623554704802,0.936375776102785,0,0,0.591366055588409,0.0698294388963689,ERRFI1;CLIC4;MET
delta,2,respiratory electron transport chain (GO:0022904),3/95,3,95,0.888623554704802,0.936375776102785,0,0,0.591366055588409,0.0698294388963689,CYCS;ETFA;UQCRH
delta,2,positive regulation of phagocytosis (GO:0050766),1/40,1,40,0.888901417833755,0.936375776102785,0,0,0.468164794007491,0.0551352718598986,TUB
delta,2,positive regulation of peptide hormone secretion (GO:0090277),1/40,1,40,0.888901417833755,0.936375776102785,0,0,0.468164794007491,0.0551352718598986,BAD
delta,2,positive regulation of fat cell differentiation (GO:0045600),1/40,1,40,0.888901417833755,0.936375776102785,0,0,0.468164794007491,0.0551352718598986,PPARD
delta,2,Golgi to plasma membrane transport (GO:0006893),1/40,1,40,0.888901417833755,0.936375776102785,0,0,0.468164794007491,0.0551352718598986,ARFRP1
delta,2,DNA replication-independent nucleosome assembly (GO:0006336),1/40,1,40,0.888901417833755,0.936375776102785,0,0,0.468164794007491,0.0551352718598986,SMARCA5
delta,2,alpha-amino acid catabolic process (GO:1901606),1/40,1,40,0.888901417833755,0.936375776102785,0,0,0.468164794007491,0.0551352718598986,HMGCLL1
delta,2,acyl-CoA metabolic process (GO:0006637),1/40,1,40,0.888901417833755,0.936375776102785,0,0,0.468164794007491,0.0551352718598986,DLST
delta,2,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),1/40,1,40,0.888901417833755,0.936375776102785,0,0,0.468164794007491,0.0551352718598986,RIPK1
delta,2,negative regulation of phosphatase activity (GO:0010923),2/69,2,69,0.889494058818069,0.936375776102785,0,0,0.542799761168105,0.0635631825089563,PPP1R12A;PCIF1
delta,2,regulation of endopeptidase activity (GO:0052548),2/69,2,69,0.889494058818069,0.936375776102785,0,0,0.542799761168105,0.0635631825089563,TIMP1;GAPDH
delta,2,positive regulation of T cell activation (GO:0050870),2/69,2,69,0.889494058818069,0.936375776102785,0,0,0.542799761168105,0.0635631825089563,IL6ST;NCK1
delta,2,macromolecular complex assembly (GO:0065003),4/121,4,121,0.892751608658437,0.937367589267051,0,0,0.619060884638004,0.0702305324514961,DET1;DNAJB12;MDM2;RANBP9
delta,2,regulation of endothelial cell migration (GO:0010594),2/70,2,70,0.894204134516326,0.937367589267051,0,0,0.535045478865704,0.0598294229474115,BCAS3;ETS1
delta,2,response to organic cyclic compound (GO:0014070),2/70,2,70,0.894204134516326,0.937367589267051,0,0,0.535045478865704,0.0598294229474115,FOXA1;CTNNB1
delta,2,regulation of cellular localization (GO:0060341),1/41,1,41,0.894845874028123,0.937367589267051,0,0,0.456746140495113,0.0507462242288082,STXBP4
delta,2,cognition (GO:0050890),1/41,1,41,0.894845874028123,0.937367589267051,0,0,0.456746140495113,0.0507462242288082,CHD7
delta,2,ameboidal-type cell migration (GO:0001667),1/41,1,41,0.894845874028123,0.937367589267051,0,0,0.456746140495113,0.0507462242288082,PKN2
delta,2,positive regulation of Ras protein signal transduction (GO:0046579),1/41,1,41,0.894845874028123,0.937367589267051,0,0,0.456746140495113,0.0507462242288082,RASGRP1
delta,2,response to cAMP (GO:0051591),1/41,1,41,0.894845874028123,0.937367589267051,0,0,0.456746140495113,0.0507462242288082,RAP1B
delta,2,negative regulation of cytokine secretion (GO:0050710),1/41,1,41,0.894845874028123,0.937367589267051,0,0,0.456746140495113,0.0507462242288082,TNFRSF21
delta,2,phosphatidic acid biosynthetic process (GO:0006654),1/41,1,41,0.894845874028123,0.937367589267051,0,0,0.456746140495113,0.0507462242288082,SLC27A1
delta,2,regulation of release of cytochrome c from mitochondria (GO:0090199),1/41,1,41,0.894845874028123,0.937367589267051,0,0,0.456746140495113,0.0507462242288082,BAD
delta,2,regulation of intracellular transport (GO:0032386),1/41,1,41,0.894845874028123,0.937367589267051,0,0,0.456746140495113,0.0507462242288082,AAAS
delta,2,JAK-STAT cascade (GO:0007259),1/41,1,41,0.894845874028123,0.937367589267051,0,0,0.456746140495113,0.0507462242288082,IFNAR2
delta,2,negative regulation of transport (GO:0051051),1/41,1,41,0.894845874028123,0.937367589267051,0,0,0.456746140495113,0.0507462242288082,SNX3
delta,2,stimulatory C-type lectin receptor signaling pathway (GO:0002223),4/122,4,122,0.896354492354395,0.938617512050204,0,0,0.613986615091791,0.0671819889870496,PSMD14;PSMB3;PRKACB;MALT1
delta,2,epithelial cell differentiation (GO:0030855),3/97,3,97,0.896738967815442,0.938689823502904,0,0,0.579172941040195,0.0631243281904466,ACADVL;FZD7;ASCL1
delta,2,calcium-mediated signaling (GO:0019722),2/71,2,71,0.898726891521693,0.940079741514998,0,0,0.527509627050694,0.0563254112334611,PRKAA1;PLCG1
delta,2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),1/42,1,42,0.900472540679544,0.940079741514998,0,0,0.445871232388086,0.0467431818469482,CDH2
delta,2,monocyte chemotaxis (GO:0002548),1/42,1,42,0.900472540679544,0.940079741514998,0,0,0.445871232388086,0.0467431818469482,IL6R
delta,2,bicarbonate transport (GO:0015701),1/42,1,42,0.900472540679544,0.940079741514998,0,0,0.445871232388086,0.0467431818469482,SLC4A7
delta,2,phosphatidic acid metabolic process (GO:0046473),1/42,1,42,0.900472540679544,0.940079741514998,0,0,0.445871232388086,0.0467431818469482,SLC27A1
delta,2,peptide transport (GO:0015833),1/42,1,42,0.900472540679544,0.940079741514998,0,0,0.445871232388086,0.0467431818469482,ARRDC4
delta,2,mitochondrial respiratory chain complex assembly (GO:0033108),3/98,3,98,0.900593865275289,0.940079741514998,0,0,0.573263013070397,0.0600211436353148,IMMP2L;NDUFAF3;COX14
delta,2,protein targeting to ER (GO:0045047),3/98,3,98,0.900593865275289,0.940079741514998,0,0,0.573263013070397,0.0600211436353148,RPS4X;RPLP2;SEC62
delta,2,defense response to Gram-negative bacterium (GO:0050829),2/72,2,72,0.903068880870159,0.942332745255818,0,0,0.520183104452767,0.0530360218689798,TLR9;IL6R
delta,2,response to molecule of bacterial origin (GO:0002237),3/99,3,99,0.904318490840329,0.943196645944745,0,0,0.567472477584837,0.057072788424185,TLR9;SIRT2;TNFRSF21
delta,2,determination of left/right symmetry (GO:0007368),1/43,1,43,0.905798391838065,0.943196645944745,0,0,0.435502133960456,0.0430879380135418,NPHP3
delta,2,cellular response to radiation (GO:0071478),1/43,1,43,0.905798391838065,0.943196645944745,0,0,0.435502133960456,0.0430879380135418,CDKN1A
delta,2,negative regulation of protein secretion (GO:0050709),1/43,1,43,0.905798391838065,0.943196645944745,0,0,0.435502133960456,0.0430879380135418,RAB11FIP5
delta,2,glycolipid biosynthetic process (GO:0009247),1/43,1,43,0.905798391838065,0.943196645944745,0,0,0.435502133960456,0.0430879380135418,PIGP
delta,2,cellular response to calcium ion (GO:0071277),1/43,1,43,0.905798391838065,0.943196645944745,0,0,0.435502133960456,0.0430879380135418,CLIC4
delta,2,innate immune response activating cell surface receptor signaling pathway (GO:0002220),4/125,4,125,0.906531689526487,0.943300107703086,0,0,0.599250936329588,0.0588040696859946,PSMD14;PSMB3;PRKACB;MALT1
delta,2,organic anion transport (GO:0015711),4/125,4,125,0.906531689526487,0.943300107703086,0,0,0.599250936329588,0.0588040696859946,SLC4A7;SLC6A6;SCP2;PITPNB
delta,2,glycoprotein biosynthetic process (GO:0009101),2/73,2,73,0.907236488695464,0.943703526863929,0,0,0.51305730850136,0.0499472195332934,B3GNT9;CSGALNACT2
delta,2,response to hydrogen peroxide (GO:0042542),1/44,1,44,0.91083949542713,0.946128564883469,0,0,0.425604358188628,0.0397465876260453,NFE2L2
delta,2,substantia nigra development (GO:0021762),1/44,1,44,0.91083949542713,0.946128564883469,0,0,0.425604358188628,0.0397465876260453,SIRT2
delta,2,digestive tract development (GO:0048565),1/44,1,44,0.91083949542713,0.946128564883469,0,0,0.425604358188628,0.0397465876260453,GLI3
delta,2,regulation of interferon-gamma production (GO:0032649),1/44,1,44,0.91083949542713,0.946128564883469,0,0,0.425604358188628,0.0397465876260453,HAVCR2
delta,2,protein N-linked glycosylation (GO:0006487),2/74,2,74,0.911235935506962,0.94621009911679,0,0,0.50612410162972,0.0470459712846904,MGAT5;ALG12
delta,2,metal ion transport (GO:0030001),3/102,3,102,0.914746805673705,0.947985722788858,0,0,0.550782110597048,0.049079074195864,SCN8A;SCN3B;SLC9B2
delta,2,positive regulation of defense response (GO:0031349),2/75,2,75,0.915073275351104,0.947985722788858,0,0,0.499375780274657,0.044320167072211,TLR9;ETS1
delta,2,nitrogen compound transport (GO:0071705),2/75,2,75,0.915073275351104,0.947985722788858,0,0,0.499375780274657,0.044320167072211,SLC48A1;SLC6A6
delta,2,regulation of T cell activation (GO:0050863),1/45,1,45,0.915611061959796,0.947985722788858,0,0,0.416146483562214,0.0366889759989823,PAG1
delta,2,positive regulation of transport (GO:0051050),1/45,1,45,0.915611061959796,0.947985722788858,0,0,0.416146483562214,0.0366889759989823,ANXA2
delta,2,heart contraction (GO:0060047),1/45,1,45,0.915611061959796,0.947985722788858,0,0,0.416146483562214,0.0366889759989823,SCN3B
delta,2,myeloid cell differentiation (GO:0030099),1/45,1,45,0.915611061959796,0.947985722788858,0,0,0.416146483562214,0.0366889759989823,KAT8
delta,2,negative regulation of immune system process (GO:0002683),1/45,1,45,0.915611061959796,0.947985722788858,0,0,0.416146483562214,0.0366889759989823,TLR9
delta,2,protein lipidation (GO:0006497),4/128,4,128,0.915812820234532,0.947985722788858,0,0,0.585205992509363,0.0514649344050568,NTNG1;PIGP;ATG10;ATG12
delta,2,C-terminal protein lipidation (GO:0006501),2/76,2,76,0.918754396116841,0.950699959264158,0,0,0.492805046323674,0.0417585470024934,NTNG1;ATG12
delta,2,"regulation of synaptic transmission, glutamatergic (GO:0051966)",1/46,1,46,0.920127490286036,0.950798406628904,0,0,0.407099820876079,0.0338882275451911,CDH2
delta,2,protein complex subunit organization (GO:0071822),1/46,1,46,0.920127490286036,0.950798406628904,0,0,0.407099820876079,0.0338882275451911,NUP205
delta,2,negative regulation of ossification (GO:0030279),1/46,1,46,0.920127490286036,0.950798406628904,0,0,0.407099820876079,0.0338882275451911,CDK6
delta,2,protein polymerization (GO:0051258),1/46,1,46,0.920127490286036,0.950798406628904,0,0,0.407099820876079,0.0338882275451911,CKAP5
delta,2,plasma membrane invagination (GO:0099024),3/104,3,104,0.921112769302816,0.951486151143763,0,0,0.54019014693172,0.0443889412178654,SCARB2;SPIRE1;DOCK1
delta,2,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),2/77,2,77,0.922285019565516,0.952366487934412,0,0,0.486404980787003,0.0393506354137594,RIPK1;HSPA1A
delta,2,monovalent inorganic cation transport (GO:0015672),3/105,3,105,0.924130073887335,0.953940721432088,0,0,0.535045478865704,0.0422163962774988,SCN8A;SCN3B;SLC9B2
delta,2,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),1/48,1,48,0.928448725321273,0.957734283035047,0,0,0.390137328339576,0.0289638431831092,RIPK1
delta,2,regulation of organelle assembly (GO:1902115),1/48,1,48,0.928448725321273,0.957734283035047,0,0,0.390137328339576,0.0289638431831092,TCTEX1D2
delta,2,negative regulation of inflammatory response (GO:0050728),2/79,2,79,0.928916838821391,0.957885139408336,0,0,0.474090930640497,0.0349575978059262,VPS35;PPARD
delta,2,cellular response to organic substance (GO:0071310),4/134,4,134,0.931940761684928,0.960428424398642,0,0,0.559002739113422,0.0394018820171568,SMAD3;TWF2;CTNNB1;CIB1
delta,2,response to calcium ion (GO:0051592),2/80,2,80,0.932028659161048,0.960428424398642,0,0,0.468164794007491,0.032954922563916,CLIC4;NEDD4
delta,2,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),2/81,2,81,0.935011234975759,0.961425453751783,0,0,0.462384981735793,0.0310707605071381,NEDD4;PIP4K2B
delta,2,regulation of hydrolase activity (GO:0051336),2/81,2,81,0.935011234975759,0.961425453751783,0,0,0.462384981735793,0.0310707605071381,SYDE2;CDK5RAP3
delta,2,cellular response to hormone stimulus (GO:0032870),2/81,2,81,0.935011234975759,0.961425453751783,0,0,0.462384981735793,0.0310707605071381,PAX8;UBE2L3
delta,2,nucleotide-excision repair (GO:0006289),3/109,3,109,0.935170343066203,0.961425453751783,0,0,0.515410782393568,0.0345462226520955,POLD3;POLD4;ERCC6
delta,2,regulation of cytokine production (GO:0001817),3/109,3,109,0.935170343066203,0.961425453751783,0,0,0.515410782393568,0.0345462226520955,TWSG1;TRAF3;ERMAP
delta,2,negative regulation of hydrolase activity (GO:0051346),3/109,3,109,0.935170343066203,0.961425453751783,0,0,0.515410782393568,0.0345462226520955,BCAS3;PPP1R12A;PCIF1
delta,2,glutathione metabolic process (GO:0006749),1/50,1,50,0.935903743117915,0.961425453751783,0,0,0.374531835205993,0.0248099799033811,CHAC1
delta,2,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/50,1,50,0.935903743117915,0.961425453751783,0,0,0.374531835205993,0.0248099799033811,GAPDH
delta,2,regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/50,1,50,0.935903743117915,0.961425453751783,0,0,0.374531835205993,0.0248099799033811,PLCG1
delta,2,regulation of complement activation (GO:0030449),3/110,3,110,0.937688703917901,0.962926702159998,0,0,0.510725229826353,0.0328586604767208,PROS1;PHB;CD55
delta,2,negative regulation of viral genome replication (GO:0045071),1/51,1,51,0.939334952774333,0.963287670384705,0,0,0.367188073731365,0.0229797867227785,ISG20
delta,2,heart morphogenesis (GO:0003007),1/51,1,51,0.939334952774333,0.963287670384705,0,0,0.367188073731365,0.0229797867227785,CHD7
delta,2,regulation of ion transport (GO:0043269),1/51,1,51,0.939334952774333,0.963287670384705,0,0,0.367188073731365,0.0229797867227785,NEDD4
delta,2,regulation of bone mineralization (GO:0030500),1/51,1,51,0.939334952774333,0.963287670384705,0,0,0.367188073731365,0.0229797867227785,ENPP1
delta,2,C-terminal protein amino acid modification (GO:0018410),2/83,2,83,0.940608149825195,0.964261058863169,0,0,0.451243174946979,0.0276290081731206,NTNG1;ATG12
delta,2,muscle contraction (GO:0006936),4/138,4,138,0.941082637980876,0.964415265368832,0,0,0.542799761168105,0.0329611485272999,GNAO1;PABPN1;TLN1;MYL12A
delta,2,carboxylic acid transport (GO:0046942),1/52,1,52,0.942582638308753,0.964955600827949,0,0,0.360126764621147,0.0212949019016288,SLC6A6
delta,2,coenzyme metabolic process (GO:0006732),1/52,1,52,0.942582638308753,0.964955600827949,0,0,0.360126764621147,0.0212949019016288,FASN
delta,2,peptidyl-tyrosine modification (GO:0018212),1/52,1,52,0.942582638308753,0.964955600827949,0,0,0.360126764621147,0.0212949019016288,TEC
delta,2,establishment of protein localization to membrane (GO:0090150),2/84,2,84,0.943231851061883,0.965288166698818,0,0,0.445871232388086,0.0260581242997869,ARFRP1;RAB3IP
delta,2,chemokine-mediated signaling pathway (GO:0070098),1/53,1,53,0.945656607194725,0.967194924871471,0,0,0.353331920005653,0.0197426932151297,CIB1
delta,2,regulation of mitotic nuclear division (GO:0007088),2/85,2,85,0.945745037424725,0.967194924871471,0,0,0.440625688477638,0.024579097916148,SIRT2;HSPA1A
delta,2,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/54,1,54,0.948566143022696,0.96908096176984,0,0,0.346788736301845,0.0183117484037739,NEDD4
delta,2,neutrophil chemotaxis (GO:0030593),1/54,1,54,0.948566143022696,0.96908096176984,0,0,0.346788736301845,0.0183117484037739,GBF1
delta,2,regulation of calcium ion-dependent exocytosis (GO:0017158),1/54,1,54,0.948566143022696,0.96908096176984,0,0,0.346788736301845,0.0183117484037739,SYT4
delta,2,regulation of immune effector process (GO:0002697),3/115,3,115,0.948976306663381,0.969167291911539,0,0,0.488519785051295,0.0255844881870466,TRAF3;PROS1;CD55
delta,2,calcium ion transmembrane transport (GO:0070588),2/87,2,87,0.950456949599452,0.970346443227434,0,0,0.430496362305739,0.0218745578597425,PHB;SLC8B1
delta,2,cell morphogenesis involved in differentiation (GO:0000904),1/55,1,55,0.951320033855986,0.970561680066991,0,0,0.340483486550902,0.0169917431189005,RB1
delta,2,positive regulation of immune response (GO:0050778),1/55,1,55,0.951320033855986,0.970561680066991,0,0,0.340483486550902,0.0169917431189005,IL6ST
delta,2,granulocyte chemotaxis (GO:0071621),1/57,1,57,0.956393711450193,0.974401809406291,0,0,0.328536697549116,0.0146480119092619,GBF1
delta,2,ribosome assembly (GO:0042255),1/57,1,57,0.956393711450193,0.974401809406291,0,0,0.328536697549116,0.0146480119092619,PWP2
delta,2,anion transport (GO:0006820),1/57,1,57,0.956393711450193,0.974401809406291,0,0,0.328536697549116,0.0146480119092619,LRRC8A
delta,2,cellular defense response (GO:0006968),1/57,1,57,0.956393711450193,0.974401809406291,0,0,0.328536697549116,0.0146480119092619,ITK
delta,2,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),2/90,2,90,0.956799008213057,0.974481125407959,0,0,0.416146483562214,0.0183778328559834,RPS4X;RPLP2
delta,2,positive regulation of B cell activation (GO:0050871),3/120,3,120,0.958334792055539,0.975117637791011,0,0,0.468164794007491,0.0199242005032977,TLR9;MIF;TP53BP1
delta,2,regulation of Rho protein signal transduction (GO:0035023),1/58,1,58,0.95872882675719,0.975117637791011,0,0,0.322872271729304,0.0136081011110945,MET
delta,2,regulation of cell cycle process (GO:0010564),2/91,2,91,0.958734612962532,0.975117637791011,0,0,0.41157344528131,0.0173441064702237,SETD2;KIF20A
delta,2,regulation of Ras protein signal transduction (GO:0046578),2/91,2,91,0.958734612962532,0.975117637791011,0,0,0.41157344528131,0.0173441064702237,RASGRP1;ARFGAP2
delta,2,actin filament organization (GO:0007015),3/121,3,121,0.960002150652962,0.976000926059672,0,0,0.464295663478503,0.0189524348868339,NEDD9;WHAMM;PLS1
delta,2,protein-DNA complex assembly (GO:0065004),2/92,2,92,0.960586932939778,0.976000926059672,0,0,0.407099820876079,0.0163698065718584,H2AFX;SMARCA5
delta,2,cellular response to lipopolysaccharide (GO:0071222),2/92,2,92,0.960586932939778,0.976000926059672,0,0,0.407099820876079,0.0163698065718584,PABPN1;PLAA
delta,2,neutrophil migration (GO:1990266),1/59,1,59,0.960939000468101,0.976025414809921,0,0,0.317399860344061,0.0126465902004949,GBF1
delta,2,regulation of acute inflammatory response (GO:0002673),3/122,3,122,0.961606703096087,0.976370367933795,0,0,0.460489961318843,0.0180280643082007,PROS1;IL6ST;CD55
delta,2,keratinocyte differentiation (GO:0030216),1/60,1,60,0.963030911537599,0.977482944316472,0,0,0.31210986267166,0.0117571062705598,CLIC4
delta,2,cellular calcium ion homeostasis (GO:0006874),3/124,3,124,0.964635923000626,0.978491443323443,0,0,0.453062703878217,0.0163123100292208,WFS1;SLC8B1;HERPUD1
delta,2,response to reactive oxygen species (GO:0000302),1/61,1,61,0.965010882444323,0.978491443323443,0,0,0.306993307545896,0.010933843114865,PTPRN
delta,2,membrane lipid biosynthetic process (GO:0046467),1/61,1,61,0.965010882444323,0.978491443323443,0,0,0.306993307545896,0.010933843114865,ALDH3A2
delta,2,striated muscle contraction (GO:0006941),1/62,1,62,0.966884897820961,0.980057716592363,0,0,0.302041802585478,0.0101715056144449,SCN3B
delta,2,interleukin-1-mediated signaling pathway (GO:0070498),2/96,2,96,0.967228853574603,0.980072546216554,0,0,0.390137328339576,0.0129994335440624,PSMD14;PSMB3
delta,2,ribosomal large subunit biogenesis (GO:0042273),1/64,1,64,0.970337419370805,0.982824620779001,0,0,0.292602996254682,0.0088106896508634,RPL26L1
delta,2,regulation of protein processing (GO:0070613),3/129,3,129,0.971252910595592,0.982824620779001,0,0,0.435502133960456,0.012702891974807,PROS1;CHAC1;CD55
delta,2,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/65,1,65,0.971926363895363,0.982824620779001,0,0,0.288101411696917,0.00820375531568003,CDH2
delta,2,NADH dehydrogenase complex assembly (GO:0010257),1/65,1,65,0.971926363895363,0.982824620779001,0,0,0.288101411696917,0.00820375531568003,NDUFAF3
delta,2,mitochondrial respiratory chain complex I biogenesis (GO:0097031),1/65,1,65,0.971926363895363,0.982824620779001,0,0,0.288101411696917,0.00820375531568003,NDUFAF3
delta,2,mitochondrial respiratory chain complex I assembly (GO:0032981),1/65,1,65,0.971926363895363,0.982824620779001,0,0,0.288101411696917,0.00820375531568003,NDUFAF3
delta,2,steroid metabolic process (GO:0008202),2/100,2,100,0.972786323406393,0.983009316846395,0,0,0.374531835205993,0.0103336430215077,SCP2;CYP46A1
delta,2,cellular response to reactive oxygen species (GO:0034614),1/66,1,66,0.97343026100347,0.983009316846395,0,0,0.283736238792419,0.00764075988061982,NFE2L2
delta,2,negative regulation of cell adhesion (GO:0007162),1/66,1,66,0.97343026100347,0.983009316846395,0,0,0.283736238792419,0.00764075988061982,FZD7
delta,2,O-glycan processing (GO:0016266),1/66,1,66,0.97343026100347,0.983009316846395,0,0,0.283736238792419,0.00764075988061982,GALNT10
delta,2,response to interferon-gamma (GO:0034341),1/69,1,69,0.977475945929198,0.986759977980086,0,0,0.271399880584053,0.00618292220877656,GAPDH
delta,2,"phagocytosis, engulfment (GO:0006911)",2/105,2,105,0.978463261226126,0.986862520889076,0,0,0.356696985910469,0.00776602063992591,SCARB2;DOCK1
delta,2,B cell receptor signaling pathway (GO:0050853),2/105,2,105,0.978463261226126,0.986862520889076,0,0,0.356696985910469,0.00776602063992591,ITK;TEC
delta,2,phagocytosis (GO:0006909),3/136,3,136,0.97857234514236,0.986862520889076,0,0,0.413086582947786,0.00894768677288098,SCARB2;CDC7;DOCK1
delta,2,neuropeptide signaling pathway (GO:0007218),1/71,1,71,0.979824978945967,0.987542747228088,0,0,0.263754813525347,0.00537567024830171,GPR19
delta,2,regulation of cytosolic calcium ion concentration (GO:0051480),3/138,3,138,0.980313163631496,0.987542747228088,0,0,0.407099820876079,0.00809444863957003,SMAD3;SLC8B1;CD55
delta,2,actomyosin structure organization (GO:0031032),1/72,1,72,0.980906035217146,0.987542747228088,0,0,0.260091552226384,0.00501420326061754,FRMD5
delta,2,regulation of cation channel activity (GO:2001257),1/72,1,72,0.980906035217146,0.987542747228088,0,0,0.260091552226384,0.00501420326061754,SLMAP
delta,2,regulation of cell communication (GO:0010646),1/72,1,72,0.980906035217146,0.987542747228088,0,0,0.260091552226384,0.00501420326061754,SCG5
delta,2,Rho protein signal transduction (GO:0007266),1/73,1,73,0.981929207913462,0.988138393727826,0,0,0.25652865425068,0.00467807268160106,ARHGEF3
delta,2,regulation of protein activation cascade (GO:2000257),2/109,2,109,0.982161750217375,0.988138393727826,0,0,0.343607188262379,0.00618467824716868,PROS1;CD55
delta,2,response to interleukin-1 (GO:0070555),1/77,1,77,0.985502563916614,0.991164457659967,0,0,0.243202490393502,0.00355161991155855,HIF1A
delta,2,regulation of humoral immune response (GO:0002920),2/114,2,114,0.985925331466588,0.991254657582624,0,0,0.328536697549116,0.00465689466547706,PROS1;CD55
delta,2,adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189),1/79,1,79,0.987014991769843,0.991869664473703,0,0,0.237045465320248,0.00309819618692923,GNB1
delta,2,protein O-linked glycosylation (GO:0006493),2/116,2,116,0.987203610944593,0.991869664473703,0,0,0.322872271729304,0.00415826167949501,B3GNT9;GALNT10
delta,2,positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/84,1,84,0.990141669872189,0.994485862146349,0,0,0.222935616194043,0.00220867781577875,MIF
delta,2,"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",2/126,2,126,0.992077276864015,0.995772428903899,0,0,0.297247488258724,0.002364388165622,GNAO1;PRKACB
delta,2,calcium ion homeostasis (GO:0055074),1/88,1,88,0.992091818447601,0.995772428903899,0,0,0.212802179094314,0.00168956781188805,WFS1
delta,2,positive regulation of protein kinase B signaling (GO:0051897),2/128,2,128,0.992806185777092,0.996153475681937,0,0,0.292602996254682,0.00211253934733928,PTPRJ;MET
delta,2,cell-matrix adhesion (GO:0007160),1/91,1,91,0.993296934394172,0.996309968573325,0,0,0.205786722640655,0.00138404577715757,WHAMM
delta,2,adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),2/135,2,135,0.994876076648612,0.997257213729651,0,0,0.277430989041476,0.0014251895302672,GNAO1;PRKACB
delta,2,regulation of B cell activation (GO:0050864),1/96,1,96,0.994911514638217,0.997257213729651,0,0,0.195068664169788,0.000995138067629282,TLR9
delta,2,cellular response to metal ion (GO:0071248),1/101,1,101,0.996137294922844,0.997820525567131,0,0,0.185411799606927,0.000717577889530139,CLIC4
delta,2,cellular divalent inorganic cation homeostasis (GO:0072503),1/102,1,102,0.996344462565231,0.997820525567131,0,0,0.183594036865683,0.000672364551559859,SLC39A13
delta,2,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),2/143,2,143,0.996532248681721,0.997820525567131,0,0,0.261910374269925,0.000909818471067519,CDH2;TGFBR2
delta,2,positive regulation of lymphocyte activation (GO:0051251),1/105,1,105,0.9969016568664,0.997820525567131,0,0,0.178348492955235,0.000553442649581236,TLR9
delta,2,skeletal system development (GO:0001501),2/147,2,147,0.997149947256938,0.997820525567131,0,0,0.254783561364621,0.000727183336318725,IGFBP4;CHD7
delta,2,calcium ion transport (GO:0006816),1/119,1,119,0.998567796604159,0.998903449645034,0,0,0.157366317313442,0.000225542123725487,ITPR1
delta,2,positive regulation of cytosolic calcium ion concentration (GO:0007204),1/134,1,134,0.999372896102536,0.999372896102536,0,0,0.139750684778355,8.76656897194818e-05,CD55
delta,3,spermine metabolic process (GO:0008215),3/6,3,6,0.000384664097217415,0.109189651595858,0,0,18.2481751824818,143.487957650804,AMD1;SAT1;PAOX
delta,3,actin polymerization or depolymerization (GO:0008154),7/37,7,37,5.62426437934891e-05,0.109189651595858,0,0,6.90471493391202,67.5684031535363,COBLL1;DSTN;ANG;EVL;JAK2;WASF3;CAP2
delta,3,negative regulation of translation in response to stress (GO:0032055),3/6,3,6,0.000384664097217415,0.109189651595858,0,0,18.2481751824818,143.487957650804,RBM4;SESN2;EIF2AK3
delta,3,positive regulation of autophagy (GO:0010508),8/68,8,68,0.00052633642035974,0.13072880840685,0,0,4.293688278231,32.4155000740201,SH3GLB1;SCOC;PLK2;SESN2;PIM2;FBXO7;TRIM65;SVIP
delta,3,spermidine metabolic process (GO:0008216),3/7,3,7,0.000659460883414943,0.145594308371721,0,0,15.6412930135558,114.558204901764,AMD1;SAT1;PAOX
delta,3,polyamine biosynthetic process (GO:0006596),3/6,3,6,0.000384664097217415,0.109189651595858,0,0,18.2481751824818,143.487957650804,AMD1;SAT1;PAOX
delta,3,"alternative mRNA splicing, via spliceosome (GO:0000380)",4/12,4,12,0.000231604622900018,0.109189651595858,0,0,12.1654501216545,101.830642965407,HNRNPM;SFPQ;SRSF1;SLU7
delta,3,regulation of translational initiation (GO:0006446),8/63,8,63,0.000310734700471818,0.109189651595858,0,0,4.63445718920171,37.4305228269596,EIF2B5;RBM4;KHDRBS1;AGO2;NCK2;EIF2AK3;EIF4EBP2;EIF4B
delta,3,negative regulation of translational initiation (GO:0045947),4/16,4,16,0.000780411324051546,0.155067730089042,0,0,9.12408759124088,65.2891372148459,RBM4;AGO2;EIF2AK3;EIF4EBP2
delta,3,mRNA 3'-end processing (GO:0031124),9/75,9,75,0.000205107840767286,0.109189651595858,0,0,4.37956204379562,37.1911299180422,APP;CPSF7;LSM11;FIP1L1;SRSF1;SRSF2;TUT1;PAF1;SLU7
delta,3,actin filament polymerization (GO:0030041),4/18,4,18,0.00125626776614793,0.226927641030539,0,0,8.110300081103,54.1736418819918,COBLL1;ANG;JAK2;WASF3
delta,3,protein deglycosylation (GO:0006517),3/10,3,10,0.00212609809933241,0.324965917182577,0,0,10.9489051094891,67.3737247165993,MGEA5;NGLY1;MAN2B1
delta,3,double-strand break repair (GO:0006302),11/142,11,142,0.00186435696195671,0.308706440283999,0,0,2.82718207052534,17.7683843570557,SETX;SFPQ;PAXIP1;RAD21L1;NSMCE2;NABP2;RBBP8;SMC5;AP5S1;ORAOV1;APTX
delta,3,positive regulation of cell cycle G1/S phase transition (GO:1902808),4/24,4,24,0.00383068152426083,0.362455437557442,0,0,6.08272506082725,33.8486164717059,ANKRD17;LSM11;UBE2E2;PAF1
delta,3,polyamine metabolic process (GO:0006595),3/12,3,12,0.00374174568140196,0.362455437557442,0,0,9.12408759124088,50.9872538021988,AMD1;SAT1;PAOX
delta,3,lipid phosphorylation (GO:0046834),5/36,5,36,0.00283275241214016,0.362455437557442,0,0,5.06893755068938,29.7369548671181,DGKE;SMG1;EFR3A;PI4KA;PIK3C2B
delta,3,carbohydrate biosynthetic process (GO:0016051),5/37,5,37,0.00320278465056259,0.362455437557442,0,0,4.93193923850858,28.3277502677206,GALNT7;GALNT11;GLT8D1;GLT8D2;ST6GALNAC5
delta,3,pre-mRNA cleavage required for polyadenylation (GO:0098789),3/12,3,12,0.00374174568140196,0.362455437557442,0,0,9.12408759124088,50.9872538021988,CPSF7;FIP1L1;TUT1
delta,3,negative regulation of translation (GO:0017148),8/89,8,89,0.00305292743294752,0.362455437557442,0,0,3.28057081932256,18.9999322057202,RBM4;AGO2;EIF2AK3;EIF4EBP2;EIF4E2;PUM1;CPEB3;CPEB2
delta,3,recombinational repair (GO:0000725),7/72,7,72,0.00353261970922376,0.362455437557442,0,0,3.54825628548256,20.0324457076888,SFPQ;NSMCE2;RBBP8;NABP2;SMC5;AP5S1;ORAOV1
delta,3,regulation of histone methylation (GO:0031060),3/12,3,12,0.00374174568140196,0.362455437557442,0,0,9.12408759124088,50.9872538021988,PAF1;ZNF335;PRDM10
delta,3,mRNA cleavage involved in mRNA processing (GO:0098787),3/13,3,13,0.00476607981726618,0.430463663495814,0,0,8.42223469960696,45.0272135307906,CPSF7;FIP1L1;TUT1
delta,3,double-strand break repair via homologous recombination (GO:0000724),7/77,7,77,0.00513249155013973,0.443402639570767,0,0,3.3178500331785,17.4922496861861,SFPQ;NSMCE2;RBBP8;NABP2;SMC5;AP5S1;ORAOV1
delta,3,mRNA polyadenylation (GO:0006378),4/28,4,28,0.00677143724906542,0.51635172461927,0,0,5.21376433785193,26.0429714172559,APP;FIP1L1;TUT1;PAF1
delta,3,phosphatidylinositol phosphorylation (GO:0046854),4/28,4,28,0.00677143724906542,0.51635172461927,0,0,5.21376433785193,26.0429714172559,SMG1;EFR3A;PI4KA;PIK3C2B
delta,3,"protein localization to chromosome, telomeric region (GO:0070198)",3/15,3,15,0.00728001534228905,0.51635172461927,0,0,7.2992700729927,35.9315497030546,TNKS2;NABP2;TERF2IP
delta,3,transport along microtubule (GO:0010970),3/15,3,15,0.00728001534228905,0.51635172461927,0,0,7.2992700729927,35.9315497030546,APP;COPG2;DYNC1I1
delta,3,RNA polyadenylation (GO:0043631),4/29,4,29,0.00768776965566333,0.51635172461927,0,0,5.03397936068462,24.5060386071243,APP;FIP1L1;TUT1;PAF1
delta,3,ephrin receptor signaling pathway (GO:0048013),7/83,7,83,0.00770770553659361,0.51635172461927,0,0,3.0780054524668,14.9761424326308,ACTR2;EPHA6;ARPC2;CHN1;NCK2;ARHGEF7;ACTB
delta,3,protein dephosphorylation (GO:0006470),9/126,9,126,0.00791513138726088,0.51635172461927,0,0,2.60688216892596,12.6146480344282,PPP3CA;DUSP5;PPP3CB;SDHAF2;FBXW11;DUSP18;DUSP16;DUSP14;CTTNBP2NL
delta,3,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",6/64,6,64,0.00805581452601779,0.51635172461927,0,0,3.42153284671533,16.4964455300539,EIF4A1;PDE12;CNOT11;EXOSC8;EIF4B;EXOSC1
delta,3,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),3/16,3,16,0.00877992877619851,0.545178702447076,0,0,6.84306569343066,32.4038799047785,ANKRD17;LSM11;UBE2E2
delta,3,"DNA-templated transcription, termination (GO:0006353)",8/107,8,107,0.0092163358864405,0.554935133525978,0,0,2.72869909270755,12.7888061387036,SETX;CPSF7;TAF1D;LSM11;FIP1L1;SRSF1;SRSF2;SLU7
delta,3,positive regulation of telomere capping (GO:1904355),3/17,3,17,0.0104473675852519,0.576648085165266,0,0,6.4405324173465,29.3778783041375,TNKS2;NABP2;MAP3K4
delta,3,negative regulation of cytoplasmic translation (GO:2000766),2/6,2,6,0.0104475747689731,0.576648085165266,0,0,12.1654501216545,55.4913066548667,CPEB3;CPEB2
delta,3,positive regulation of oxidative stress-induced cell death (GO:1903209),2/6,2,6,0.0104475747689731,0.576648085165266,0,0,12.1654501216545,55.4913066548667,SFPQ;SOD1
delta,3,termination of RNA polymerase II transcription (GO:0006369),6/69,6,69,0.011495070376955,0.617316347000261,0,0,3.17359568390987,14.1727610231311,CPSF7;LSM11;FIP1L1;SRSF1;SRSF2;SLU7
delta,3,stress-activated protein kinase signaling cascade (GO:0031098),6/71,6,71,0.0131235012358734,0.622566189906432,0,0,3.08419862239128,13.3649141623645,STK10;FBXW11;MAP3K4;NFKB1;MAP3K5;MAP4K4
delta,3,cellular response to glucose starvation (GO:0042149),4/34,4,34,0.0134854288809962,0.622566189906432,0,0,4.293688278231,18.48924653755,SH3GLB1;SESN2;PIK3R4;EIF2AK3
delta,3,acylglycerol biosynthetic process (GO:0046463),3/19,3,19,0.0142971930442591,0.622566189906432,0,0,5.76258163657318,24.4776722143395,DGAT1;ANG;LPIN2
delta,3,negative regulation of cell adhesion mediated by integrin (GO:0033629),2/7,2,7,0.0143628338966265,0.622566189906432,0,0,10.4275286757039,44.2451656753972,ACER2;PDE3B
delta,3,positive regulation of RIG-I signaling pathway (GO:1900246),2/7,2,7,0.0143628338966265,0.622566189906432,0,0,10.4275286757039,44.2451656753972,ANKRD17;PUM1
delta,3,positive regulation of neuroblast proliferation (GO:0002052),2/7,2,7,0.0143628338966265,0.622566189906432,0,0,10.4275286757039,44.2451656753972,FZD3;ZNF335
delta,3,store-operated calcium entry (GO:0002115),2/7,2,7,0.0143628338966265,0.622566189906432,0,0,10.4275286757039,44.2451656753972,STIM2;ORAI1
delta,3,ER overload response (GO:0006983),2/7,2,7,0.0143628338966265,0.622566189906432,0,0,10.4275286757039,44.2451656753972,EIF2AK3;TMCO1
delta,3,Arp2/3 complex-mediated actin nucleation (GO:0034314),3/20,3,20,0.0164841298950234,0.622566189906432,0,0,5.47445255474453,22.4745831321333,ACTR2;ARPC2;ARPC5L
delta,3,protein acylation (GO:0043543),4/37,4,37,0.0180136329999524,0.622566189906432,0,0,3.94555139080687,15.8478059533397,ING5;KAT6A;ZDHHC16;ZDHHC2
delta,3,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",4/37,4,37,0.0180136329999524,0.622566189906432,0,0,3.94555139080687,15.8478059533397,PPP3CA;PPP3CB;FZD3;AGO2
delta,3,mRNA metabolic process (GO:0016071),7/98,7,98,0.0181564283010709,0.622566189906432,0,0,2.60688216892596,10.450288333184,SFPQ;LSM11;SF3B3;SRSF1;SRSF2;RNASE4;DXO
delta,3,positive regulation of extracellular matrix assembly (GO:1901203),2/8,2,8,0.0188058951963248,0.622566189906432,0,0,9.12408759124088,36.2553365331001,PHLDB1;DAG1
delta,3,myelin maintenance (GO:0043217),2/8,2,8,0.0188058951963248,0.622566189906432,0,0,9.12408759124088,36.2553365331001,CLU;SOD1
delta,3,positive regulation of mRNA 3'-end processing (GO:0031442),2/8,2,8,0.0188058951963248,0.622566189906432,0,0,9.12408759124088,36.2553365331001,PAF1;CPEB3
delta,3,regulation of amyloid fibril formation (GO:1905906),2/8,2,8,0.0188058951963248,0.622566189906432,0,0,9.12408759124088,36.2553365331001,APP;CLU
delta,3,phosphatidylserine acyl-chain remodeling (GO:0036150),3/21,3,21,0.0188477787819008,0.622566189906432,0,0,5.21376433785193,20.7057362280257,OSBPL8;LPCAT4;OSBPL10
delta,3,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),7/101,7,101,0.0210675156718155,0.622566189906432,0,0,2.5294500252945,9.76373519007922,RANBP2;POM121;SMG1;FIP1L1;SRSF1;SRSF2;SLU7
delta,3,positive regulation of cell death (GO:0010942),5/58,5,58,0.0211134195896941,0.622566189906432,0,0,3.14623710042789,12.1376996009015,ACER2;HEBP2;ZNF746;CLU;MAP3K5
delta,3,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),3/22,3,22,0.0213889695142631,0.622566189906432,0,0,4.97677504976775,19.1351025204028,FBXW7;TMTC3;CLU
delta,3,negative regulation of response to endoplasmic reticulum stress (GO:1903573),3/22,3,22,0.0213889695142631,0.622566189906432,0,0,4.97677504976775,19.1351025204028,USP25;NCK2;CLU
delta,3,chemical homeostasis (GO:0048878),4/39,4,39,0.0214987139355972,0.622566189906432,0,0,3.74321542204754,14.3730569439887,FBXW7;EIF5A2;IRS2;ABHD5
delta,3,dephosphorylation (GO:0016311),8/125,8,125,0.0218260247778174,0.622566189906432,0,0,2.33576642335766,8.9334942459532,PPP3CA;DUSP5;PPP3CB;SDHAF2;FBXW11;DUSP18;DUSP16;CTTNBP2NL
delta,3,cellular response to amino acid starvation (GO:0034198),4/40,4,40,0.0233851457043715,0.622566189906432,0,0,3.64963503649635,13.7067673618508,SH3GLB1;SESN2;EIF2AK3;MAP3K5
delta,3,NIK/NF-kappaB signaling (GO:0038061),6/81,6,81,0.0237181423694174,0.622566189906432,0,0,2.70343336036767,10.1149365311383,PSMA3;PSMA1;IRAK1;FBXW11;REL;NFKB1
delta,3,negative regulation of circadian rhythm (GO:0042754),2/9,2,9,0.0237450037241628,0.622566189906432,0,0,8.110300081103,30.3356296848434,SFPQ;CRY1
delta,3,RNA destabilization (GO:0050779),2/9,2,9,0.0237450037241628,0.622566189906432,0,0,8.110300081103,30.3356296848434,DXO;PUM1
delta,3,response to UV-C (GO:0010225),2/9,2,9,0.0237450037241628,0.622566189906432,0,0,8.110300081103,30.3356296848434,ERCC5;MAP3K4
delta,3,endosome to pigment granule transport (GO:0043485),2/9,2,9,0.0237450037241628,0.622566189906432,0,0,8.110300081103,30.3356296848434,AP1G1;BLOC1S3
delta,3,mitotic DNA replication checkpoint (GO:0033314),2/9,2,9,0.0237450037241628,0.622566189906432,0,0,8.110300081103,30.3356296848434,CLSPN;ORAOV1
delta,3,mitochondrial protein processing (GO:0034982),2/9,2,9,0.0237450037241628,0.622566189906432,0,0,8.110300081103,30.3356296848434,IMMP1L;OMA1
delta,3,negative regulation of alcohol biosynthetic process (GO:1902931),2/9,2,9,0.0237450037241628,0.622566189906432,0,0,8.110300081103,30.3356296848434,NFKB1;SOD1
delta,3,endosome to melanosome transport (GO:0035646),2/9,2,9,0.0237450037241628,0.622566189906432,0,0,8.110300081103,30.3356296848434,AP1G1;BLOC1S3
delta,3,nuclear RNA surveillance (GO:0071027),2/9,2,9,0.0237450037241628,0.622566189906432,0,0,8.110300081103,30.3356296848434,EXOSC8;DXO
delta,3,melanosome organization (GO:0032438),3/23,3,23,0.0241080241174141,0.622566189906432,0,0,4.76039352586481,17.7334681512441,TRAPPC6A;AP1G1;BLOC1S3
delta,3,regulation of telomere capping (GO:1904353),3/23,3,23,0.0241080241174141,0.622566189906432,0,0,4.76039352586481,17.7334681512441,TNKS2;NABP2;MAP3K4
delta,3,regulation of microtubule cytoskeleton organization (GO:0070507),3/23,3,23,0.0241080241174141,0.622566189906432,0,0,4.76039352586481,17.7334681512441,PHLDB1;TRAF3IP1;STMN1
delta,3,positive regulation of mitotic cell cycle phase transition (GO:1901992),4/41,4,41,0.0253689493851964,0.622566189906432,0,0,3.56061954780132,13.0825327325171,ANKRD17;LSM11;NSMCE2;UBE2E2
delta,3,mRNA transport (GO:0051028),7/105,7,105,0.0254326994042286,0.622566189906432,0,0,2.4330900243309,8.93362422092238,RANBP2;POM121;SMG1;FIP1L1;SRSF1;SRSF2;SLU7
delta,3,mRNA export from nucleus (GO:0006406),7/106,7,106,0.0266136994153282,0.622566189906432,0,0,2.41013634485608,8.73994775550533,RANBP2;POM121;SMG1;FIP1L1;SRSF1;SRSF2;SLU7
delta,3,RNA 3'-end processing (GO:0031123),5/62,5,62,0.0273058228229074,0.622566189906432,0,0,2.94325406169061,10.5976433638979,CPSF7;FIP1L1;SRSF1;SRSF2;SLU7
delta,3,positive regulation of cellular catabolic process (GO:0031331),7/107,7,107,0.0278315163389,0.622566189906432,0,0,2.38761170611911,8.55143718334482,SH3GLB1;PLK2;IRS2;PIM2;ABHD5;TRIM65;SVIP
delta,3,response to endoplasmic reticulum stress (GO:0034976),7/107,7,107,0.0278315163389,0.622566189906432,0,0,2.38761170611911,8.55143718334482,EIF2B5;CEBPB;UBA5;TMTC3;EIF2AK3;MAP3K5;TMCO1
delta,3,cellular response to growth hormone stimulus (GO:0071378),2/10,2,10,0.0291497429453724,0.622566189906432,0,0,7.2992700729927,25.8051765296722,SOCS2;JAK2
delta,3,regulation of cytoplasmic translational elongation (GO:1900247),2/10,2,10,0.0291497429453724,0.622566189906432,0,0,7.2992700729927,25.8051765296722,CPEB3;CPEB2
delta,3,positive regulation of amyloid-beta formation (GO:1902004),2/10,2,10,0.0291497429453724,0.622566189906432,0,0,7.2992700729927,25.8051765296722,APP;CLU
delta,3,negative regulation of inclusion body assembly (GO:0090084),2/10,2,10,0.0291497429453724,0.622566189906432,0,0,7.2992700729927,25.8051765296722,DNAJB2;DNAJA4
delta,3,astrocyte development (GO:0014002),2/10,2,10,0.0291497429453724,0.622566189906432,0,0,7.2992700729927,25.8051765296722,EIF2B5;APP
delta,3,positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),2/10,2,10,0.0291497429453724,0.622566189906432,0,0,7.2992700729927,25.8051765296722,WBP2;BUD31
delta,3,glycoprotein catabolic process (GO:0006516),2/10,2,10,0.0291497429453724,0.622566189906432,0,0,7.2992700729927,25.8051765296722,MGEA5;NGLY1
delta,3,regulation of cytoplasmic translation (GO:2000765),2/10,2,10,0.0291497429453724,0.622566189906432,0,0,7.2992700729927,25.8051765296722,CPEB3;CPEB2
delta,3,nuclear mRNA surveillance (GO:0071028),2/10,2,10,0.0291497429453724,0.622566189906432,0,0,7.2992700729927,25.8051765296722,EXOSC8;DXO
delta,3,telomere maintenance via recombination (GO:0000722),2/10,2,10,0.0291497429453724,0.622566189906432,0,0,7.2992700729927,25.8051765296722,NSMCE2;SMC5
delta,3,regulation of neuroblast proliferation (GO:1902692),2/10,2,10,0.0291497429453724,0.622566189906432,0,0,7.2992700729927,25.8051765296722,FZD3;ZNF335
delta,3,macromolecule modification (GO:0043412),3/25,3,25,0.0300786885913525,0.622566189906432,0,0,4.37956204379562,15.3457155250197,ZNF335;PRDM10;ST6GALNAC5
delta,3,regulation of epidermal growth factor-activated receptor activity (GO:0007176),3/25,3,25,0.0300786885913525,0.622566189906432,0,0,4.37956204379562,15.3457155250197,APP;FBXW7;NCK2
delta,3,cellular senescence (GO:0090398),3/25,3,25,0.0300786885913525,0.622566189906432,0,0,4.37956204379562,15.3457155250197,KAT6A;NSMCE2;SMC5
delta,3,mRNA splice site selection (GO:0006376),3/25,3,25,0.0300786885913525,0.622566189906432,0,0,4.37956204379562,15.3457155250197,SETX;SRSF1;SLU7
delta,3,actin nucleation (GO:0045010),3/25,3,25,0.0300786885913525,0.622566189906432,0,0,4.37956204379562,15.3457155250197,ACTR2;ARPC2;ARPC5L
delta,3,response to hydrogen peroxide (GO:0042542),4/44,4,44,0.0319129506007064,0.637863193382131,0,0,3.3178500331785,11.4291419264535,SETX;APTX;MAP3K5;SOD1
delta,3,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058),3/26,3,26,0.0333287189688374,0.637863193382131,0,0,4.21111734980348,14.3234242932881,TRIM39;FBXW7;CLU
delta,3,"RNA splicing, via transesterification reactions (GO:0000375)",3/26,3,26,0.0333287189688374,0.637863193382131,0,0,4.21111734980348,14.3234242932881,SF3B3;WDR83;SLU7
delta,3,peptidyl-tyrosine dephosphorylation (GO:0035335),3/26,3,26,0.0333287189688374,0.637863193382131,0,0,4.21111734980348,14.3234242932881,DUSP5;DUSP18;DUSP14
delta,3,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),6/88,6,88,0.0338366076540067,0.637863193382131,0,0,2.48838752488388,8.42620768721006,PSMA3;PSMA1;FBXW7;BUB3;CLU;ANAPC10
delta,3,positive regulation of macroautophagy (GO:0016239),4/45,4,45,0.0342939103781496,0.637863193382131,0,0,3.2441200324412,10.9417274308774,SH3GLB1;SCOC;SESN2;SMCR8
delta,3,regulation of cell division (GO:0051302),5/66,5,66,0.0345457302721386,0.637863193382131,0,0,2.76487502764875,9.3051076021069,SH3GLB1;KLHL9;PIK3R4;KLHL21;MYO19
delta,3,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),2/11,2,11,0.0349909854447168,0.637863193382131,0,0,6.635700066357,22.2472780981357,AGO2;CPEB3
delta,3,calcineurin-NFAT signaling cascade (GO:0033173),2/11,2,11,0.0349909854447168,0.637863193382131,0,0,6.635700066357,22.2472780981357,PPP3CA;PPP3CB
delta,3,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),2/11,2,11,0.0349909854447168,0.637863193382131,0,0,6.635700066357,22.2472780981357,AGO2;CPEB3
delta,3,"negative regulation of translation, ncRNA-mediated (GO:0040033)",2/11,2,11,0.0349909854447168,0.637863193382131,0,0,6.635700066357,22.2472780981357,RBM4;AGO2
delta,3,carbohydrate derivative catabolic process (GO:1901136),2/11,2,11,0.0349909854447168,0.637863193382131,0,0,6.635700066357,22.2472780981357,MGEA5;NGLY1
delta,3,miRNA mediated inhibition of translation (GO:0035278),2/11,2,11,0.0349909854447168,0.637863193382131,0,0,6.635700066357,22.2472780981357,RBM4;AGO2
delta,3,sphingolipid biosynthetic process (GO:0030148),5/67,5,67,0.0365240449360411,0.642918867157385,0,0,2.72360823619131,9.01455624227411,ACER2;CERS6;VAPA;SGMS2;ST6GALNAC5
delta,3,protein polymerization (GO:0051258),4/46,4,46,0.0367753946822172,0.642918867157385,0,0,3.17359568390987,10.4821525871183,COBLL1;ANG;JAK2;WASF3
delta,3,regulation of G1/S transition of mitotic cell cycle (GO:2000045),4/47,4,47,0.0393576343201888,0.642918867157385,0,0,3.10607237148626,10.0483469863585,ANKRD17;RBL2;LSM11;UBE2E2
delta,3,response to hexose (GO:0009746),3/28,3,28,0.0403513725384491,0.642918867157385,0,0,3.91032325338895,12.5526454732349,EIF2B5;SLC30A8;IRS2
delta,3,phosphatidylserine metabolic process (GO:0006658),3/28,3,28,0.0403513725384491,0.642918867157385,0,0,3.91032325338895,12.5526454732349,OSBPL8;LPCAT4;OSBPL10
delta,3,regulation of inclusion body assembly (GO:0090083),2/12,2,12,0.0412408453435459,0.642918867157385,0,0,6.08272506082725,19.3937112037551,DNAJB2;DNAJA4
delta,3,negative regulation of ERAD pathway (GO:1904293),2/12,2,12,0.0412408453435459,0.642918867157385,0,0,6.08272506082725,19.3937112037551,USP25;SVIP
delta,3,mitochondrial outer membrane permeabilization (GO:0097345),2/12,2,12,0.0412408453435459,0.642918867157385,0,0,6.08272506082725,19.3937112037551,MOAP1;RHOT1
delta,3,response to axon injury (GO:0048678),2/12,2,12,0.0412408453435459,0.642918867157385,0,0,6.08272506082725,19.3937112037551,MTR;SOD1
delta,3,positive regulation of amyloid precursor protein catabolic process (GO:1902993),2/12,2,12,0.0412408453435459,0.642918867157385,0,0,6.08272506082725,19.3937112037551,APP;CLU
delta,3,cytoplasmic translational initiation (GO:0002183),2/12,2,12,0.0412408453435459,0.642918867157385,0,0,6.08272506082725,19.3937112037551,RBM4;EIF4B
delta,3,regulation of sequestering of triglyceride (GO:0010889),2/12,2,12,0.0412408453435459,0.642918867157385,0,0,6.08272506082725,19.3937112037551,OSBPL8;ABHD5
delta,3,calcineurin-mediated signaling (GO:0097720),2/12,2,12,0.0412408453435459,0.642918867157385,0,0,6.08272506082725,19.3937112037551,PPP3CA;PPP3CB
delta,3,nuclear export (GO:0051168),6/93,6,93,0.0425509095790393,0.642918867157385,0,0,2.35460324935248,7.43360971857913,RANBP2;POM121;ATXN1;SRSF1;SRSF2;SLU7
delta,3,proteolysis involved in cellular protein catabolic process (GO:0051603),6/94,6,94,0.0444477096503595,0.642918867157385,0,0,2.32955427861469,7.25293177071563,PSMA3;PDCD6IP;PSMA1;NGLY1;OMA1;RNF41
delta,3,regulation of mitochondrion organization (GO:0010821),4/49,4,49,0.0448246736885959,0.642918867157385,0,0,2.97929390734396,9.25069727153826,RHOT1;FBXW7;MARCH5;MYO19
delta,3,RNA export from nucleus (GO:0006405),7/120,7,120,0.0471929898741217,0.642918867157385,0,0,2.12895377128954,6.50078145354555,RANBP2;POM121;SMG1;FIP1L1;SRSF1;SRSF2;SLU7
delta,3,placenta development (GO:0001890),2/13,2,13,0.047872632346713,0.642918867157385,0,0,5.61482313307131,17.0646338439259,ANG;SOD1
delta,3,positive regulation of protein complex disassembly (GO:0043243),2/13,2,13,0.047872632346713,0.642918867157385,0,0,5.61482313307131,17.0646338439259,SETX;SMCR8
delta,3,toll-like receptor 9 signaling pathway (GO:0034162),2/13,2,13,0.047872632346713,0.642918867157385,0,0,5.61482313307131,17.0646338439259,IRAK1;PIK3R4
delta,3,diacylglycerol metabolic process (GO:0046339),2/13,2,13,0.047872632346713,0.642918867157385,0,0,5.61482313307131,17.0646338439259,DGAT1;ANG
delta,3,mitotic DNA integrity checkpoint (GO:0044774),2/13,2,13,0.047872632346713,0.642918867157385,0,0,5.61482313307131,17.0646338439259,CLSPN;ORAOV1
delta,3,regulation of macrophage derived foam cell differentiation (GO:0010743),3/30,3,30,0.0480578451804588,0.642918867157385,0,0,3.64963503649635,11.0779192909041,PRKCH;ABCA5;NFKB1
delta,3,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),3/30,3,30,0.0480578451804588,0.642918867157385,0,0,3.64963503649635,11.0779192909041,EIF4A1;CNOT11;EIF4B
delta,3,lysosomal transport (GO:0007041),5/73,5,73,0.0498394110503787,0.642918867157385,0,0,2.4997500249975,7.4966233911083,AP3M1;AP1G1;VPS33A;TGFBRAP1;HOOK3
delta,3,regulation of cellular protein metabolic process (GO:0032268),4/51,4,51,0.0506944044799384,0.642918867157385,0,0,2.862458852154,8.53567980467413,APP;CYFIP1;PM20D2;NFKB1
delta,3,cellular response to drug (GO:0035690),3/31,3,31,0.0521615560257645,0.642918867157385,0,0,3.53190487402873,10.4311615141031,ACER2;PPP3CA;PPP3CB
delta,3,response to estradiol (GO:0032355),3/31,3,31,0.0521615560257645,0.642918867157385,0,0,3.53190487402873,10.4311615141031,SOCS2;NRIP1;CCDC62
delta,3,regulated exocytosis (GO:0045055),8/149,8,149,0.0529715178697871,0.642918867157385,0,0,1.95953559006515,5.75711734397434,APP;PPP3CB;TEX264;APLP2;PSAP;RAB11FIP2;CLU;SOD1
delta,3,ncRNA transcription (GO:0098781),2/14,2,14,0.054860807343667,0.642918867157385,0,0,5.21376433785193,15.1353288693701,SPIN1;ANG
delta,3,positive regulation of neural precursor cell proliferation (GO:2000179),2/14,2,14,0.054860807343667,0.642918867157385,0,0,5.21376433785193,15.1353288693701,FZD3;ZNF335
delta,3,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",2/14,2,14,0.054860807343667,0.642918867157385,0,0,5.21376433785193,15.1353288693701,AGO2;CPEB3
delta,3,regulation of nucleocytoplasmic transport (GO:0046822),2/14,2,14,0.054860807343667,0.642918867157385,0,0,5.21376433785193,15.1353288693701,KHDRBS1;RBM4
delta,3,cellular protein complex disassembly (GO:0043624),2/14,2,14,0.054860807343667,0.642918867157385,0,0,5.21376433785193,15.1353288693701,ABCE1;MTRF1L
delta,3,regulation of gastrulation (GO:0010470),2/14,2,14,0.054860807343667,0.642918867157385,0,0,5.21376433785193,15.1353288693701,PHLDB1;DAG1
delta,3,regulation of histone modification (GO:0031056),2/14,2,14,0.054860807343667,0.642918867157385,0,0,5.21376433785193,15.1353288693701,ZNF335;PRDM10
delta,3,positive regulation of ubiquitin-protein transferase activity (GO:0051443),3/32,3,32,0.0564285582054752,0.642918867157385,0,0,3.42153284671533,9.83615384626953,FBXW7;DCUN1D1;ANAPC10
delta,3,organelle transport along microtubule (GO:0072384),3/32,3,32,0.0564285582054752,0.642918867157385,0,0,3.42153284671533,9.83615384626953,RHOT1;COPG2;DYNC1I1
delta,3,anterograde axonal transport (GO:0008089),3/32,3,32,0.0564285582054752,0.642918867157385,0,0,3.42153284671533,9.83615384626953,AP3M1;BLOC1S3;SOD1
delta,3,positive regulation of insulin secretion (GO:0032024),3/32,3,32,0.0564285582054752,0.642918867157385,0,0,3.42153284671533,9.83615384626953,PPP3CB;SLC30A8;IRS2
delta,3,nucleobase-containing small molecule interconversion (GO:0015949),3/32,3,32,0.0564285582054752,0.642918867157385,0,0,3.42153284671533,9.83615384626953,DTYMK;TXNRD1;GSR
delta,3,gene silencing by miRNA (GO:0035195),3/32,3,32,0.0564285582054752,0.642918867157385,0,0,3.42153284671533,9.83615384626953,RBM4;AGO2;PUM1
delta,3,negative regulation of macromolecule metabolic process (GO:0010605),7/125,7,125,0.0564737109510379,0.642918867157385,0,0,2.04379562043796,5.87382782309443,RBL2;APP;PTRH2;REL;ZNF503;SMCR8;NFKB1
delta,3,negative regulation of cellular amide metabolic process (GO:0034249),5/76,5,76,0.0574358169674014,0.642918867157385,0,0,2.40107568190549,6.86008255204974,RBM4;EIF2AK3;EIF4E2;CPEB3;CLU
delta,3,regulation of lipid metabolic process (GO:0019216),6/101,6,101,0.059193044435017,0.642918867157385,0,0,2.168100021681,6.12911303746488,NCOA1;RBL2;TXNRD1;PSAP;IRS2;FDFT1
delta,3,nucleic acid-templated transcription (GO:0097659),5/77,5,77,0.0601074169443866,0.642918867157385,0,0,2.36989288084179,6.66324304436207,NCOA1;MEF2A;ZNF219;BAZ2A;ILF2
delta,3,positive regulation of telomere maintenance (GO:0032206),3/33,3,33,0.0608558015249023,0.642918867157385,0,0,3.3178500331785,9.287485476714,TNKS2;NABP2;MAP3K4
delta,3,vitamin D metabolic process (GO:0042359),2/15,2,15,0.0621809395909642,0.642918867157385,0,0,4.8661800486618,13.5168212342718,UBE2I;CYP2R1
delta,3,phosphatidylethanolamine biosynthetic process (GO:0006646),2/15,2,15,0.0621809395909642,0.642918867157385,0,0,4.8661800486618,13.5168212342718,CEPT1;LPIN2
delta,3,anterograde synaptic vesicle transport (GO:0048490),2/15,2,15,0.0621809395909642,0.642918867157385,0,0,4.8661800486618,13.5168212342718,AP3M1;BLOC1S3
delta,3,regulation of centriole replication (GO:0046599),2/15,2,15,0.0621809395909642,0.642918867157385,0,0,4.8661800486618,13.5168212342718,PLK4;PLK2
delta,3,cellular biogenic amine biosynthetic process (GO:0042401),2/15,2,15,0.0621809395909642,0.642918867157385,0,0,4.8661800486618,13.5168212342718,SAT1;PAOX
delta,3,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),2/15,2,15,0.0621809395909642,0.642918867157385,0,0,4.8661800486618,13.5168212342718,GCDH;ACAD11
delta,3,synaptic vesicle transport along microtubule (GO:0099517),2/15,2,15,0.0621809395909642,0.642918867157385,0,0,4.8661800486618,13.5168212342718,AP3M1;BLOC1S3
delta,3,regulation of peptide secretion (GO:0002791),2/15,2,15,0.0621809395909642,0.642918867157385,0,0,4.8661800486618,13.5168212342718,LLGL1;STXBP5L
delta,3,regulation of cell junction assembly (GO:1901888),2/15,2,15,0.0621809395909642,0.642918867157385,0,0,4.8661800486618,13.5168212342718,TJP1;PRKCH
delta,3,regulation of cytokinesis (GO:0032465),5/78,5,78,0.0628486020992533,0.642918867157385,0,0,2.33950963877971,6.47348536882552,SH3GLB1;KLHL9;PIK3R4;KLHL21;MYO19
delta,3,negative regulation of cellular component organization (GO:0051129),4/55,4,55,0.063630253802193,0.642918867157385,0,0,2.6542800265428,7.31165556211372,DNAJB2;TRAF3IP1;DNAJA4;SVIP
delta,3,cytoplasmic translation (GO:0002181),4/55,4,55,0.063630253802193,0.642918867157385,0,0,2.6542800265428,7.31165556211372,MRPL2;RPL22L1;EIF4B;ZC3H15
delta,3,positive regulation of mitochondrion organization (GO:0010822),7/129,7,129,0.064659333191204,0.642918867157385,0,0,1.98042211282748,5.42362918999089,SH3GLB1;MOAP1;HHAT;FBXW7;ARIH2;FBXO7;MARCH5
delta,3,positive regulation of NF-kappaB transcription factor activity (GO:0051092),7/129,7,129,0.064659333191204,0.642918867157385,0,0,1.98042211282748,5.42362918999089,APP;PRKCH;IRAK1;TERF2IP;RHEBL1;CLU;NFKB1
delta,3,oligosaccharide biosynthetic process (GO:0009312),3/34,3,34,0.0654400360274604,0.642918867157385,0,0,3.22026620867325,8.78044558655835,GALNT7;GALNT11;ST6GALNAC5
delta,3,protein import into nucleus (GO:0006606),6/104,6,104,0.0663061446514666,0.642918867157385,0,0,2.10555867490174,5.71337599643915,RANBP2;POM121;ZFYVE9;DAG1;JAK2;GPN3
delta,3,regulation of gene silencing by RNA (GO:0060966),4/56,4,56,0.0671099310837003,0.642918867157385,0,0,2.60688216892596,7.04229207958296,RANBP2;POM121;AGO2;PUM1
delta,3,regulation of posttranscriptional gene silencing (GO:0060147),4/56,4,56,0.0671099310837003,0.642918867157385,0,0,2.60688216892596,7.04229207958296,RANBP2;POM121;AGO2;PUM1
delta,3,anaphase-promoting complex-dependent catabolic process (GO:0031145),5/80,5,80,0.0685390135880066,0.642918867157385,0,0,2.28102189781022,6.11394195805285,PSMA3;PTTG1;PSMA1;BUB3;ANAPC10
delta,3,peptidyl-threonine dephosphorylation (GO:0035970),2/16,2,16,0.0698096652675608,0.642918867157385,0,0,4.56204379562044,12.1440821529109,DUSP5;DUSP18
delta,3,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",2/16,2,16,0.0698096652675608,0.642918867157385,0,0,4.56204379562044,12.1440821529109,AGO2;CPEB3
delta,3,protein transport along microtubule (GO:0098840),2/16,2,16,0.0698096652675608,0.642918867157385,0,0,4.56204379562044,12.1440821529109,TTC30B;TRAF3IP1
delta,3,regulation of RIG-I signaling pathway (GO:0039535),2/16,2,16,0.0698096652675608,0.642918867157385,0,0,4.56204379562044,12.1440821529109,ANKRD17;PUM1
delta,3,regulation of cell cycle phase transition (GO:1901987),2/16,2,16,0.0698096652675608,0.642918867157385,0,0,4.56204379562044,12.1440821529109,FBXW7;NEK10
delta,3,negative regulation of steroid biosynthetic process (GO:0010894),2/16,2,16,0.0698096652675608,0.642918867157385,0,0,4.56204379562044,12.1440821529109,NFKB1;SOD1
delta,3,regulation of bicellular tight junction assembly (GO:2000810),2/16,2,16,0.0698096652675608,0.642918867157385,0,0,4.56204379562044,12.1440821529109,TJP1;PRKCH
delta,3,positive regulation of macrophage derived foam cell differentiation (GO:0010744),2/16,2,16,0.0698096652675608,0.642918867157385,0,0,4.56204379562044,12.1440821529109,PRKCH;NFKB1
delta,3,pyrimidine-containing compound metabolic process (GO:0072527),2/16,2,16,0.0698096652675608,0.642918867157385,0,0,4.56204379562044,12.1440821529109,UCK2;ERH
delta,3,rRNA transcription (GO:0009303),2/16,2,16,0.0698096652675608,0.642918867157385,0,0,4.56204379562044,12.1440821529109,SPIN1;ANG
delta,3,negative regulation of lipid storage (GO:0010888),2/16,2,16,0.0698096652675608,0.642918867157385,0,0,4.56204379562044,12.1440821529109,OSBPL8;ABHD5
delta,3,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",2/16,2,16,0.0698096652675608,0.642918867157385,0,0,4.56204379562044,12.1440821529109,SETX;PAXIP1
delta,3,positive regulation of muscle cell differentiation (GO:0051149),3/35,3,35,0.0701778318203192,0.642918867157385,0,0,3.12825860271116,8.31091596618338,MEF2A;RBM4;CTNNA1
delta,3,regulation of JUN kinase activity (GO:0043506),3/35,3,35,0.0701778318203192,0.642918867157385,0,0,3.12825860271116,8.31091596618338,AIDA;MAP3K4;MAP3K5
delta,3,G1/S transition of mitotic cell cycle (GO:0000082),6/106,6,106,0.0713135041922642,0.642918867157385,0,0,2.06583115273378,5.45517746154399,RANBP2;KLF11;WEE1;DBF4;PLK2;PIM2
delta,3,RNA transport (GO:0050658),5/81,5,81,0.0714877573402817,0.642918867157385,0,0,2.25286113363972,5.94356373333574,RANBP2;POM121;SRSF1;SRSF2;SLU7
delta,3,RNA splicing (GO:0008380),6/107,6,107,0.0738965943069394,0.642918867157385,0,0,2.04652431953066,5.33137704600526,SFPQ;SF3B3;SRSF2;WDR83;WDR62;SLU7
delta,3,protein catabolic process (GO:0030163),5/82,5,82,0.0745051230750728,0.642918867157385,0,0,2.22538721737582,5.77908000234232,MGEA5;PSMA3;PSMA1;NGLY1;RNF41
delta,3,positive regulation of NIK/NF-kappaB signaling (GO:1901224),3/36,3,36,0.0750655977731524,0.642918867157385,0,0,3.04136253041363,7.8752825752509,APP;IRAK1;TERF2IP
delta,3,apical junction assembly (GO:0043297),3/36,3,36,0.0750655977731524,0.642918867157385,0,0,3.04136253041363,7.8752825752509,PDCD6IP;CTNNA1;MPP5
delta,3,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",5/83,5,83,0.0775907486165201,0.642918867157385,0,0,2.19857532319057,5.62023365965916,RBL2;PAXIP1;CNOT11;PLK2;SESN2
delta,3,reverse cholesterol transport (GO:0043691),2/17,2,17,0.0777246475927077,0.642918867157385,0,0,4.293688278231,10.9685824691935,ABCA5;CLU
delta,3,positive regulation of nitrogen compound metabolic process (GO:0051173),2/17,2,17,0.0777246475927077,0.642918867157385,0,0,4.293688278231,10.9685824691935,APP;NFKB1
delta,3,negative regulation of telomere maintenance (GO:0032205),2/17,2,17,0.0777246475927077,0.642918867157385,0,0,4.293688278231,10.9685824691935,TNKS2;TERF2IP
delta,3,DNA packaging (GO:0006323),2/17,2,17,0.0777246475927077,0.642918867157385,0,0,4.293688278231,10.9685824691935,KAT6A;GATAD1
delta,3,positive regulation of response to biotic stimulus (GO:0002833),2/17,2,17,0.0777246475927077,0.642918867157385,0,0,4.293688278231,10.9685824691935,ANKRD17;PUM1
delta,3,negative regulation of cell development (GO:0010721),2/17,2,17,0.0777246475927077,0.642918867157385,0,0,4.293688278231,10.9685824691935,FBXW7;HOOK3
delta,3,positive regulation of stem cell proliferation (GO:2000648),2/17,2,17,0.0777246475927077,0.642918867157385,0,0,4.293688278231,10.9685824691935,FZD3;ZNF335
delta,3,DNA replication checkpoint (GO:0000076),2/17,2,17,0.0777246475927077,0.642918867157385,0,0,4.293688278231,10.9685824691935,CLSPN;ORAOV1
delta,3,positive regulation of macrophage activation (GO:0043032),2/17,2,17,0.0777246475927077,0.642918867157385,0,0,4.293688278231,10.9685824691935,APP;KARS
delta,3,regulation of establishment or maintenance of cell polarity (GO:0032878),2/17,2,17,0.0777246475927077,0.642918867157385,0,0,4.293688278231,10.9685824691935,RUFY3;LLGL1
delta,3,regulation of muscle cell differentiation (GO:0051147),3/37,3,37,0.0800995991708792,0.642918867157385,0,0,2.95916354310515,7.47036228751988,MEF2A;RBM4;CTNNA1
delta,3,axonal transport (GO:0098930),3/37,3,37,0.0800995991708792,0.642918867157385,0,0,2.95916354310515,7.47036228751988,AP3M1;BLOC1S3;SOD1
delta,3,activation of GTPase activity (GO:0090630),5/85,5,85,0.0839650991252819,0.642918867157385,0,0,2.1468441391155,5.31849302937116,ARHGAP42;TBC1D2;RALGAPA1;TBC1D10A;TBC1D15
delta,3,protein modification process (GO:0036211),5/85,5,85,0.0839650991252819,0.642918867157385,0,0,2.1468441391155,5.31849302937116,USP25;SLC35A1;UBE2I;MAN2B1;RABGGTB
delta,3,positive regulation of multi-organism process (GO:0043902),3/38,3,38,0.0852759743121517,0.642918867157385,0,0,2.88129081828659,7.09334188977646,ANKRD17;AGO2;PUM1
delta,3,regulation of multicellular organism growth (GO:0040014),2/18,2,18,0.0859045382124656,0.642918867157385,0,0,4.0551500405515,9.95344128160287,APP;SOD1
delta,3,mitotic recombination (GO:0006312),2/18,2,18,0.0859045382124656,0.642918867157385,0,0,4.0551500405515,9.95344128160287,NSMCE2;SMC5
delta,3,regulation of amyloid-beta formation (GO:1902003),2/18,2,18,0.0859045382124656,0.642918867157385,0,0,4.0551500405515,9.95344128160287,APP;CLU
delta,3,negative regulation of osteoclast differentiation (GO:0045671),2/18,2,18,0.0859045382124656,0.642918867157385,0,0,4.0551500405515,9.95344128160287,MAFB;FBXW7
delta,3,positive regulation of lipid catabolic process (GO:0050996),2/18,2,18,0.0859045382124656,0.642918867157385,0,0,4.0551500405515,9.95344128160287,IRS2;ABHD5
delta,3,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),2/18,2,18,0.0859045382124656,0.642918867157385,0,0,4.0551500405515,9.95344128160287,SFPQ;SOD1
delta,3,positive regulation of p38MAPK cascade (GO:1900745),2/18,2,18,0.0859045382124656,0.642918867157385,0,0,4.0551500405515,9.95344128160287,KARS;MAP3K4
delta,3,DNA conformation change (GO:0071103),2/18,2,18,0.0859045382124656,0.642918867157385,0,0,4.0551500405515,9.95344128160287,KAT6A;TOP3A
delta,3,regulation of epithelial cell differentiation (GO:0030856),2/18,2,18,0.0859045382124656,0.642918867157385,0,0,4.0551500405515,9.95344128160287,CEBPB;RHEB
delta,3,snRNA metabolic process (GO:0016073),2/18,2,18,0.0859045382124656,0.642918867157385,0,0,4.0551500405515,9.95344128160287,INTS10;TUT1
delta,3,mRNA destabilization (GO:0061157),2/18,2,18,0.0859045382124656,0.642918867157385,0,0,4.0551500405515,9.95344128160287,PUM1;CPEB3
delta,3,membrane lipid biosynthetic process (GO:0046467),4/61,4,61,0.085937902232622,0.642918867157385,0,0,2.39320330262056,5.87323276440623,ACER2;CERS6;VAPA;SGMS2
delta,3,phosphatidylinositol metabolic process (GO:0046488),6/113,6,113,0.0904977639443796,0.642918867157385,0,0,1.93785931141399,4.65557160980249,EFR3A;SMG1;PIK3R4;PI4KA;PIGW;PIK3C2B
delta,3,positive regulation of neuron death (GO:1901216),3/39,3,39,0.0905907502259977,0.642918867157385,0,0,2.80741156653565,6.74172702352893,ZNF746;CLU;MAP3K5
delta,3,regulation of primary metabolic process (GO:0080090),7/140,7,140,0.0906883073789944,0.642918867157385,0,0,1.82481751824818,4.38015847720379,NCOA1;PSMA3;PSMA1;TXNRD1;PSAP;IRS2;FDFT1
delta,3,regulation of organelle organization (GO:0033043),6/114,6,114,0.0934464024970138,0.642918867157385,0,0,1.92086054552439,4.55314491428301,TBC1D2;RHOT1;STMN1;SURF4;TBC1D10A;TBC1D15
delta,3,stress-activated MAPK cascade (GO:0051403),4/63,4,63,0.0941147602330101,0.642918867157385,0,0,2.31722859460086,5.47616820253774,IRAK1;FBXW11;NFKB1;MAP3K5
delta,3,protein targeting to lysosome (GO:0006622),2/19,2,19,0.0943289399646157,0.642918867157385,0,0,3.84172109104879,9.07017765618447,AP3M1;CLU
delta,3,production of small RNA involved in gene silencing by RNA (GO:0070918),2/19,2,19,0.0943289399646157,0.642918867157385,0,0,3.84172109104879,9.07017765618447,AGO2;PUM1
delta,3,morphogenesis of an epithelium (GO:0002009),2/19,2,19,0.0943289399646157,0.642918867157385,0,0,3.84172109104879,9.07017765618447,TRAF3IP1;MPP5
delta,3,regulation of mitochondrial fission (GO:0090140),2/19,2,19,0.0943289399646157,0.642918867157385,0,0,3.84172109104879,9.07017765618447,MYO19;MARCH5
delta,3,cellular response to interleukin-7 (GO:0098761),2/19,2,19,0.0943289399646157,0.642918867157385,0,0,3.84172109104879,9.07017765618447,SOCS2;IRS2
delta,3,insulin secretion (GO:0030073),2/19,2,19,0.0943289399646157,0.642918867157385,0,0,3.84172109104879,9.07017765618447,SLC30A8;RAB11FIP2
delta,3,macromolecule biosynthetic process (GO:0009059),2/19,2,19,0.0943289399646157,0.642918867157385,0,0,3.84172109104879,9.07017765618447,GLT8D1;GLT8D2
delta,3,interleukin-7-mediated signaling pathway (GO:0038111),2/19,2,19,0.0943289399646157,0.642918867157385,0,0,3.84172109104879,9.07017765618447,SOCS2;IRS2
delta,3,triglyceride biosynthetic process (GO:0019432),2/19,2,19,0.0943289399646157,0.642918867157385,0,0,3.84172109104879,9.07017765618447,DGAT1;LPIN2
delta,3,inositol lipid-mediated signaling (GO:0048017),3/40,3,40,0.0960398573604793,0.642918867157385,0,0,2.73722627737226,6.41329925047361,PI4KA;IRS2;PIK3C2B
delta,3,oligosaccharide metabolic process (GO:0009311),4/64,4,64,0.098336268217373,0.642918867157385,0,0,2.28102189781022,5.29051634461097,GALNT7;GALNT11;MAN2B1;ST6GALNAC5
delta,3,cellular response to oxidative stress (GO:0034599),6/116,6,116,0.099496965951524,0.642918867157385,0,0,1.88774226025673,4.35620713862072,SETX;TXNRD1;SESN2;GSR;CPEB2;SOD1
delta,3,negative regulation of cellular protein metabolic process (GO:0032269),5/90,5,90,0.101061508550698,0.642918867157385,0,0,2.02757502027575,4.64725456600153,RBM4;EIF2AK3;EIF4E2;CPEB3;NFKB1
delta,3,intraciliary transport involved in cilium assembly (GO:0035735),3/41,3,41,0.101619143484493,0.642918867157385,0,0,2.67046466085099,6.10607977958955,TTC30B;TRAF3IP1;IFT140
delta,3,sensory organ development (GO:0007423),3/41,3,41,0.101619143484493,0.642918867157385,0,0,2.67046466085099,6.10607977958955,MAFB;BLOC1S3;ZDHHC16
delta,3,positive regulation of mitotic nuclear division (GO:0045840),3/41,3,41,0.101619143484493,0.642918867157385,0,0,2.67046466085099,6.10607977958955,RANBP2;NSMCE2;SMC5
delta,3,regulation of macroautophagy (GO:0016241),6/117,6,117,0.102598202095413,0.642918867157385,0,0,1.87160771102377,4.26152885988307,SH3GLB1;SCOC;RHEB;SESN2;ATP6V1H;SMCR8
delta,3,phosphatidylethanolamine metabolic process (GO:0046337),2/20,2,20,0.102978370970984,0.642918867157385,0,0,3.64963503649635,8.29648285903862,CEPT1;LPIN2
delta,3,axon extension (GO:0048675),2/20,2,20,0.102978370970984,0.642918867157385,0,0,3.64963503649635,8.29648285903862,CYFIP1;PPP3CB
delta,3,positive regulation of gene silencing by miRNA (GO:2000637),2/20,2,20,0.102978370970984,0.642918867157385,0,0,3.64963503649635,8.29648285903862,AGO2;PUM1
delta,3,glial cell development (GO:0021782),2/20,2,20,0.102978370970984,0.642918867157385,0,0,3.64963503649635,8.29648285903862,EIF2B5;APP
delta,3,growth hormone receptor signaling pathway (GO:0060396),2/20,2,20,0.102978370970984,0.642918867157385,0,0,3.64963503649635,8.29648285903862,SOCS2;JAK2
delta,3,covalent chromatin modification (GO:0016569),2/20,2,20,0.102978370970984,0.642918867157385,0,0,3.64963503649635,8.29648285903862,ZNF335;PRDM10
delta,3,melanosome localization (GO:0032400),2/20,2,20,0.102978370970984,0.642918867157385,0,0,3.64963503649635,8.29648285903862,VPS33A;BLOC1S3
delta,3,inositol phosphate-mediated signaling (GO:0048016),2/20,2,20,0.102978370970984,0.642918867157385,0,0,3.64963503649635,8.29648285903862,PPP3CA;PPP3CB
delta,3,cellular response to estradiol stimulus (GO:0071392),2/20,2,20,0.102978370970984,0.642918867157385,0,0,3.64963503649635,8.29648285903862,NRIP1;CCDC62
delta,3,entrainment of circadian clock by photoperiod (GO:0043153),2/20,2,20,0.102978370970984,0.642918867157385,0,0,3.64963503649635,8.29648285903862,RBM4;CRY1
delta,3,regulation of transport (GO:0051049),2/20,2,20,0.102978370970984,0.642918867157385,0,0,3.64963503649635,8.29648285903862,SLC30A8;SLC2A1
delta,3,regulation of cell cycle process (GO:0010564),5/91,5,91,0.104674839910333,0.642918867157385,0,0,2.0052939760969,4.52574094905639,SH3GLB1;KLHL9;PIK3R4;KLHL21;MYO19
delta,3,regulation of JNK cascade (GO:0046328),5/91,5,91,0.104674839910333,0.642918867157385,0,0,2.0052939760969,4.52574094905639,APP;AIDA;MAPK8IP3;MAP3K5;MAP4K4
delta,3,activation of MAPK activity (GO:0000187),6/118,6,118,0.105749574357479,0.642918867157385,0,0,1.85574662872696,4.1692715935647,DUSP5;KARS;IRAK1;MAPK8IP3;MAP3K5;SOD1
delta,3,plasma membrane bounded cell projection organization (GO:0120036),6/119,6,119,0.108950677696448,0.642918867157385,0,0,1.84015211924186,4.07935962220251,APP;CYFIP1;VAPA;STMN1;BLOC1S3;FAM161B
delta,3,calcium ion transport (GO:0006816),6/119,6,119,0.108950677696448,0.642918867157385,0,0,1.84015211924186,4.07935962220251,MCUR1;STIM2;TRPC1;ORAI1;NALCN;TMCO1
delta,3,positive regulation of cellular protein localization (GO:1903829),4/67,4,67,0.11151508563165,0.642918867157385,0,0,2.17888658895305,4.7795955988429,RUFY3;SESN2;EIF2AK3;CEP290
delta,3,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),2/21,2,21,0.111834229905631,0.642918867157385,0,0,3.47584289190129,7.61465969492781,SESN2;SMAD5
delta,3,cellular protein complex localization (GO:0034629),2/21,2,21,0.111834229905631,0.642918867157385,0,0,3.47584289190129,7.61465969492781,KLHL21;GPN3
delta,3,positive regulation of translational initiation (GO:0045948),2/21,2,21,0.111834229905631,0.642918867157385,0,0,3.47584289190129,7.61465969492781,EIF2B5;KHDRBS1
delta,3,positive regulation of histone acetylation (GO:0035066),2/21,2,21,0.111834229905631,0.642918867157385,0,0,3.47584289190129,7.61465969492781,PAXIP1;WBP2
delta,3,positive regulation of lamellipodium organization (GO:1902745),2/21,2,21,0.111834229905631,0.642918867157385,0,0,3.47584289190129,7.61465969492781,ARPC2;ARHGEF7
delta,3,protein O-linked glycosylation via threonine (GO:0018243),2/21,2,21,0.111834229905631,0.642918867157385,0,0,3.47584289190129,7.61465969492781,GALNT7;GALNT11
delta,3,negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744),2/21,2,21,0.111834229905631,0.642918867157385,0,0,3.47584289190129,7.61465969492781,STMN1;CRY1
delta,3,photoperiodism (GO:0009648),2/21,2,21,0.111834229905631,0.642918867157385,0,0,3.47584289190129,7.61465969492781,RBM4;CRY1
delta,3,cell cycle G1/S phase transition (GO:0044843),5/93,5,93,0.112089876001382,0.642918867157385,0,0,1.9621693744604,4.29411793656565,RANBP2;WEE1;DBF4;PLK2;PIM2
delta,3,macromolecular complex assembly (GO:0065003),6/121,6,121,0.115500341214052,0.642918867157385,0,0,1.80973638173373,3.90628303334216,SF3B3;TUBGCP2;SLC2A1;LLGL1;MDN1;WASF3
delta,3,DNA replication (GO:0006260),6/121,6,121,0.115500341214052,0.642918867157385,0,0,1.80973638173373,3.90628303334216,ING5;DBF4;TOP3A;RBBP8;CLSPN;PTMS
delta,3,regulation of gene silencing by miRNA (GO:0060964),4/68,4,68,0.116074114933766,0.642918867157385,0,0,2.1468441391155,4.62328546598674,RANBP2;POM121;AGO2;PUM1
delta,3,negative regulation of protein metabolic process (GO:0051248),3/44,3,44,0.119095581146426,0.642918867157385,0,0,2.48838752488388,5.29486290317095,SF3B3;CLU;NFKB1
delta,3,histone H3 acetylation (GO:0043966),3/44,3,44,0.119095581146426,0.642918867157385,0,0,2.48838752488388,5.29486290317095,ING5;KAT6A;ELP4
delta,3,sulfur amino acid metabolic process (GO:0000096),2/22,2,22,0.120878762563456,0.642918867157385,0,0,3.3178500331785,7.010508287892,MTR;PCYOX1
delta,3,negative regulation of myeloid cell differentiation (GO:0045638),2/22,2,22,0.120878762563456,0.642918867157385,0,0,3.3178500331785,7.010508287892,MAFB;PAF1
delta,3,rRNA modification (GO:0000154),2/22,2,22,0.120878762563456,0.642918867157385,0,0,3.3178500331785,7.010508287892,NOP56;NOP58
delta,3,STAT cascade (GO:0097696),2/22,2,22,0.120878762563456,0.642918867157385,0,0,3.3178500331785,7.010508287892,SOCS2;JAK2
delta,3,protein O-linked glycosylation via serine (GO:0018242),2/22,2,22,0.120878762563456,0.642918867157385,0,0,3.3178500331785,7.010508287892,GALNT7;GALNT11
delta,3,protein complex localization (GO:0031503),2/22,2,22,0.120878762563456,0.642918867157385,0,0,3.3178500331785,7.010508287892,TTC30B;TRAF3IP1
delta,3,negative regulation of nervous system development (GO:0051961),2/22,2,22,0.120878762563456,0.642918867157385,0,0,3.3178500331785,7.010508287892,EIF2AK3;HOOK3
delta,3,NLS-bearing protein import into nucleus (GO:0006607),2/22,2,22,0.120878762563456,0.642918867157385,0,0,3.3178500331785,7.010508287892,RANBP2;DAG1
delta,3,interleukin-1-mediated signaling pathway (GO:0070498),5/96,5,96,0.123671254403362,0.642918867157385,0,0,1.90085158150852,3.97302389014904,PSMA3;PSMA1;IRAK1;FBXW11;NFKB1
delta,3,amide biosynthetic process (GO:0043604),3/45,3,45,0.125152846617094,0.642918867157385,0,0,2.4330900243309,5.05649517207069,CERS6;ST20-MTHFS;SGMS2
delta,3,microtubule cytoskeleton organization involved in mitosis (GO:1902850),3/45,3,45,0.125152846617094,0.642918867157385,0,0,2.4330900243309,5.05649517207069,PLK2;STMN1;WDR62
delta,3,posttranscriptional regulation of gene expression (GO:0010608),3/45,3,45,0.125152846617094,0.642918867157385,0,0,2.4330900243309,5.05649517207069,APP;CYFIP1;PUM1
delta,3,positive regulation of protein metabolic process (GO:0051247),5/97,5,97,0.127650610694878,0.642918867157385,0,0,1.88125517345173,3.87248542247486,APP;PLK2;WWP1;CLU;RNF41
delta,3,translational termination (GO:0006415),5/97,5,97,0.127650610694878,0.642918867157385,0,0,1.88125517345173,3.87248542247486,MRPL2;MRPS23;MRPL14;ABCE1;MTRF1L
delta,3,platelet degranulation (GO:0002576),6/125,6,125,0.129176096571231,0.642918867157385,0,0,1.75182481751825,3.58524738535862,APP;TEX264;APLP2;PSAP;CLU;SOD1
delta,3,mitotic G2/M transition checkpoint (GO:0044818),2/23,2,23,0.130095029461747,0.642918867157385,0,0,3.17359568390987,6.47251697783021,CLSPN;ORAOV1
delta,3,positive regulation of protein oligomerization (GO:0032461),2/23,2,23,0.130095029461747,0.642918867157385,0,0,3.17359568390987,6.47251697783021,SH3GLB1;CLU
delta,3,TOR signaling (GO:0031929),2/23,2,23,0.130095029461747,0.642918867157385,0,0,3.17359568390987,6.47251697783021,EIF4EBP2;RHEBL1
delta,3,lamellipodium assembly (GO:0030032),2/23,2,23,0.130095029461747,0.642918867157385,0,0,3.17359568390987,6.47251697783021,CYFIP1;ARHGEF7
delta,3,positive regulation of mRNA catabolic process (GO:0061014),2/23,2,23,0.130095029461747,0.642918867157385,0,0,3.17359568390987,6.47251697783021,AGO2;CPEB3
delta,3,vesicle-mediated transport between endosomal compartments (GO:0098927),2/23,2,23,0.130095029461747,0.642918867157385,0,0,3.17359568390987,6.47251697783021,MYO1D;HOOK3
delta,3,cellular response to interleukin-6 (GO:0071354),2/23,2,23,0.130095029461747,0.642918867157385,0,0,3.17359568390987,6.47251697783021,JAK2;NFKB1
delta,3,histone H3-K4 methylation (GO:0051568),2/23,2,23,0.130095029461747,0.642918867157385,0,0,3.17359568390987,6.47251697783021,PAXIP1;ZNF335
delta,3,autophagosome maturation (GO:0097352),2/23,2,23,0.130095029461747,0.642918867157385,0,0,3.17359568390987,6.47251697783021,VPS33A;SNAP29
delta,3,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),4/71,4,71,0.130225633980785,0.642918867157385,0,0,2.05613241492752,4.19139855456657,BTBD3;ARIH2;WWP1;FBXO7
delta,3,hexose metabolic process (GO:0019318),3/46,3,46,0.13131871846662,0.642918867157385,0,0,2.3801967629324,4.83210396363571,IRS2;MAN2B1;OMA1
delta,3,phosphatidylcholine metabolic process (GO:0046470),4/72,4,72,0.135094980902449,0.642918867157385,0,0,2.02757502027575,4.05875341785733,LPCAT4;DBI;CEPT1;LPIN2
delta,3,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),4/72,4,72,0.135094980902449,0.642918867157385,0,0,2.02757502027575,4.05875341785733,PSMA3;PSMA1;BUB3;ANAPC10
delta,3,G2/M transition of mitotic cell cycle (GO:0000086),6/127,6,127,0.136293772885414,0.642918867157385,0,0,1.72423702511639,3.43630546839038,PLK4;KHDRBS1;WEE1;FBXW11;CEP290;SDCCAG8
delta,3,intraciliary transport (GO:0042073),3/47,3,47,0.137588795323401,0.642918867157385,0,0,2.32955427861469,4.62063779966033,TTC30B;TRAF3IP1;IFT140
delta,3,interleukin-12-mediated signaling pathway (GO:0035722),3/47,3,47,0.137588795323401,0.642918867157385,0,0,2.32955427861469,4.62063779966033,HNRNPF;JAK2;SOD1
delta,3,cellular response to interleukin-12 (GO:0071349),3/47,3,47,0.137588795323401,0.642918867157385,0,0,2.32955427861469,4.62063779966033,HNRNPF;JAK2;SOD1
delta,3,regulation of DNA metabolic process (GO:0051052),3/47,3,47,0.137588795323401,0.642918867157385,0,0,2.32955427861469,4.62063779966033,ANKRD17;SMG1;TERF2IP
delta,3,non-canonical Wnt signaling pathway (GO:0035567),6/128,6,128,0.139920563040542,0.642918867157385,0,0,1.71076642335766,3.36453083530273,PPP3CA;FZD3;PPP3CB;PSMA3;PSMA1;AGO2
delta,3,cell cycle G2/M phase transition (GO:0044839),6/128,6,128,0.139920563040542,0.642918867157385,0,0,1.71076642335766,3.36453083530273,PLK4;KHDRBS1;WEE1;FBXW11;CEP290;SDCCAG8
delta,3,response to metal ion (GO:0010038),4/73,4,73,0.140037334673485,0.642918867157385,0,0,1.999800019998,3.93129930144073,PPP3CA;SLC30A8;HOMER1;TRPC1
delta,3,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),4/73,4,73,0.140037334673485,0.642918867157385,0,0,1.999800019998,3.93129930144073,PSMA3;PSMA1;FBXW7;FBXW11
delta,3,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),4/73,4,73,0.140037334673485,0.642918867157385,0,0,1.999800019998,3.93129930144073,PSMA3;PSMA1;BUB3;ANAPC10
delta,3,regulation of mRNA stability (GO:0043488),6/129,6,129,0.143591843617306,0.642918867157385,0,0,1.69750466813784,3.29448382838828,PSMA3;PSMA1;PDE12;EXOSC8;PUM1;EXOSC1
delta,3,response to glucose (GO:0009749),3/48,3,48,0.143958668872149,0.642918867157385,0,0,2.28102189781022,4.4211428885172,EIF2B5;SLC30A8;IRS2
delta,3,regulation of organelle assembly (GO:1902115),3/48,3,48,0.143958668872149,0.642918867157385,0,0,2.28102189781022,4.4211428885172,PDCD6IP;IFT140;PLK2
delta,3,positive regulation of organelle assembly (GO:1902117),3/48,3,48,0.143958668872149,0.642918867157385,0,0,2.28102189781022,4.4211428885172,PLK4;SH3GLB1;PDCD6IP
delta,3,"positive regulation of gene expression, epigenetic (GO:0045815)",3/48,3,48,0.143958668872149,0.642918867157385,0,0,2.28102189781022,4.4211428885172,TAF1D;WBP2;ACTB
delta,3,positive regulation of proteasomal protein catabolic process (GO:1901800),4/74,4,74,0.145050796846081,0.642918867157385,0,0,1.97277569540343,3.80878136680596,FBXW7;ARIH2;TMTC3;CLU
delta,3,positive regulation of histone methylation (GO:0031062),2/25,2,25,0.148978896072447,0.642918867157385,0,0,2.91970802919708,5.55897991289294,PAXIP1;PAF1
delta,3,positive regulation of immune effector process (GO:0002699),2/25,2,25,0.148978896072447,0.642918867157385,0,0,2.91970802919708,5.55897991289294,ANKRD17;PUM1
delta,3,regulation of chromosome organization (GO:0033044),2/25,2,25,0.148978896072447,0.642918867157385,0,0,2.91970802919708,5.55897991289294,SMG1;TERF2IP
delta,3,cellular modified amino acid biosynthetic process (GO:0042398),2/25,2,25,0.148978896072447,0.642918867157385,0,0,2.91970802919708,5.55897991289294,ST20-MTHFS;GCLM
delta,3,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),2/25,2,25,0.148978896072447,0.642918867157385,0,0,2.91970802919708,5.55897991289294,PSMA3;PSMA1
delta,3,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),2/25,2,25,0.148978896072447,0.642918867157385,0,0,2.91970802919708,5.55897991289294,CEBPB;MAP3K5
delta,3,receptor catabolic process (GO:0032801),2/25,2,25,0.148978896072447,0.642918867157385,0,0,2.91970802919708,5.55897991289294,SH3GLB1;PIK3R4
delta,3,regulation of cell cycle G1/S phase transition (GO:1902806),2/25,2,25,0.148978896072447,0.642918867157385,0,0,2.91970802919708,5.55897991289294,FBXW7;PAF1
delta,3,mitotic spindle organization (GO:0007052),4/75,4,75,0.150133439696586,0.642918867157385,0,0,1.94647201946472,3.6909601603239,TUBGCP2;PLK2;STMN1;WDR62
delta,3,"regulation of gene expression, epigenetic (GO:0040029)",4/75,4,75,0.150133439696586,0.642918867157385,0,0,1.94647201946472,3.6909601603239,TAF1D;WBP2;ZNF335;ACTB
delta,3,endosome to lysosome transport (GO:0008333),3/49,3,49,0.150423932046557,0.642918867157385,0,0,2.23447043050797,4.23275232565563,VPS33A;TGFBRAP1;HOOK3
delta,3,cytoplasmic microtubule organization (GO:0031122),3/49,3,49,0.150423932046557,0.642918867157385,0,0,2.23447043050797,4.23275232565563,TUBGCP2;KATNA1;HOOK3
delta,3,glycoprotein metabolic process (GO:0009100),3/49,3,49,0.150423932046557,0.642918867157385,0,0,2.23447043050797,4.23275232565563,MGEA5;NGLY1;MAN2B1
delta,3,protein glycosylation (GO:0006486),6/131,6,131,0.151065338439237,0.642918867157385,0,0,1.67158856633421,3.1593739859498,GALNT7;MGEA5;TNKS2;ALG5;DAG1;FUT4
delta,3,positive regulation of nucleobase-containing compound transport (GO:0032241),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,KHDRBS1
delta,3,negative regulation of membrane potential (GO:0045837),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,HEBP2
delta,3,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,FBXW7
delta,3,neuron projection maintenance (GO:1990535),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,APP
delta,3,negative regulation of chromosome organization (GO:2001251),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,TERF2IP
delta,3,nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,EXOSC8
delta,3,regulation of translational initiation in response to stress (GO:0043558),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,EIF2AK3
delta,3,mitochondrial ribosome assembly (GO:0061668),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,FASTKD2
delta,3,"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,RHOT1
delta,3,mRNA 3'-splice site recognition (GO:0000389),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,SLU7
delta,3,ventricular cardiac muscle cell development (GO:0055015),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,MEF2A
delta,3,establishment of endothelial intestinal barrier (GO:0090557),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,TJP1
delta,3,nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,EXOSC8
delta,3,ceramide transport (GO:0035627),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,PSAP
delta,3,negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,CRY1
delta,3,nucleobase metabolic process (GO:0009112),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,UCK2
delta,3,positive regulation of fibroblast migration (GO:0010763),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,ARHGEF7
delta,3,negative regulation of neurological system process (GO:0031645),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,EIF2AK3
delta,3,negative regulation of sterol transport (GO:0032372),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,NFKB1
delta,3,positive regulation of protein acetylation (GO:1901985),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,TERF2IP
delta,3,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,SLC35B2
delta,3,platelet dense granule organization (GO:0060155),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,BLOC1S3
delta,3,regulation of glial cell apoptotic process (GO:0034350),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,PRKCH
delta,3,negative regulation of cAMP-mediated signaling (GO:0043951),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,PDE3B
delta,3,pronephros development (GO:0048793),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,CEP290
delta,3,signal complex assembly (GO:0007172),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,NCK2
delta,3,pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,DTYMK
delta,3,interphase microtubule nucleation by interphase microtubule organizing center (GO:0051415),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,TUBGCP2
delta,3,positive regulation of RNA export from nucleus (GO:0046833),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,KHDRBS1
delta,3,regulation of hyaluronan biosynthetic process (GO:1900125),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,NFKB1
delta,3,positive regulation of microtubule motor activity (GO:2000576),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,DYNC1I1
delta,3,mRNA 5'-splice site recognition (GO:0000395),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,SRSF1
delta,3,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,MOAP1
delta,3,protein geranylgeranylation (GO:0018344),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,RABGGTB
delta,3,folic acid-containing compound biosynthetic process (GO:0009396),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,ST20-MTHFS
delta,3,negative regulation of erythrocyte differentiation (GO:0045647),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,MAFB
delta,3,NADH metabolic process (GO:0006734),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,MDH1B
delta,3,positive regulation of microglial cell activation (GO:1903980),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,APP
delta,3,regulation of cell cycle checkpoint (GO:1901976),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,CRY1
delta,3,positive regulation of autophagosome maturation (GO:1901098),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,SMCR8
delta,3,epithelial tube formation (GO:0072175),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,CEP290
delta,3,positive regulation of centrosome cycle (GO:0046607),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,RANBP2
delta,3,positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,WBP2
delta,3,positive regulation of trophoblast cell migration (GO:1901165),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,AGO2
delta,3,regulation of extracellular exosome assembly (GO:1903551),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,PDCD6IP
delta,3,cellular response to cold (GO:0070417),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,EIF2AK3
delta,3,astrocyte differentiation (GO:0048708),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,EIF2B5
delta,3,tRNA catabolic process (GO:0016078),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,EXOSC8
delta,3,insulin secretion involved in cellular response to glucose stimulus (GO:0035773),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,RAB11FIP2
delta,3,chondrocyte development (GO:0002063),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,EIF2AK3
delta,3,astrocyte activation (GO:0048143),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,APP
delta,3,single strand break repair (GO:0000012),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,APTX
delta,3,establishment of protein localization to telomere (GO:0070200),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,NABP2
delta,3,regulation of osteoclast development (GO:2001204),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,FBXW7
delta,3,neuron remodeling (GO:0016322),1/6,1,6,0.153559170901949,0.642918867157385,0,0,6.08272506082725,11.3970152557416,APP
delta,3,negative regulation of phosphorylation (GO:0042326),4/76,4,76,0.155283309268535,0.642918867157385,0,0,1.92086054552439,3.57761050466251,TRAF3IP1;PDE12;TERF2IP;IRS2
delta,3,glutathione metabolic process (GO:0006749),3/50,3,50,0.156980186594798,0.642918867157385,0,0,2.18978102189781,4.05467667510406,GSR;GCLM;SOD1
delta,3,lipid homeostasis (GO:0055088),3/50,3,50,0.156980186594798,0.642918867157385,0,0,2.18978102189781,4.05467667510406,FBXW7;IRS2;ABHD5
delta,3,signal peptide processing (GO:0006465),2/26,2,26,0.158616415499068,0.642918867157385,0,0,2.80741156653565,5.1691927923111,IMMP1L;SPCS1
delta,3,regulation of centrosome duplication (GO:0010824),2/26,2,26,0.158616415499068,0.642918867157385,0,0,2.80741156653565,5.1691927923111,PDCD6IP;PLK2
delta,3,regulation of telomere maintenance (GO:0032204),2/26,2,26,0.158616415499068,0.642918867157385,0,0,2.80741156653565,5.1691927923111,SMG1;TERF2IP
delta,3,lamellipodium organization (GO:0097581),2/26,2,26,0.158616415499068,0.642918867157385,0,0,2.80741156653565,5.1691927923111,CYFIP1;ARHGEF7
delta,3,misfolded or incompletely synthesized protein catabolic process (GO:0006515),2/26,2,26,0.158616415499068,0.642918867157385,0,0,2.80741156653565,5.1691927923111,NGLY1;OMA1
delta,3,modulation of excitatory postsynaptic potential (GO:0098815),2/26,2,26,0.158616415499068,0.642918867157385,0,0,2.80741156653565,5.1691927923111,APP;CBLN1
delta,3,protein depolymerization (GO:0051261),2/26,2,26,0.158616415499068,0.642918867157385,0,0,2.80741156653565,5.1691927923111,STMN1;DSTN
delta,3,positive regulation of embryonic development (GO:0040019),2/26,2,26,0.158616415499068,0.642918867157385,0,0,2.80741156653565,5.1691927923111,PHLDB1;DAG1
delta,3,signal transduction in response to DNA damage (GO:0042770),2/26,2,26,0.158616415499068,0.642918867157385,0,0,2.80741156653565,5.1691927923111,PAXIP1;SESN2
delta,3,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),4/77,4,77,0.160498428213629,0.642918867157385,0,0,1.89591430467343,3.46852048444691,PSMA3;PSMA1;BUB3;ANAPC10
delta,3,peptide metabolic process (GO:0006518),5/105,5,105,0.161486787117675,0.642918867157385,0,0,1.73792144595064,3.16880770451717,IMMP1L;SPCS1;RNPEP;GSR;SOD1
delta,3,positive regulation of JUN kinase activity (GO:0043507),3/51,3,51,0.163623050273411,0.642918867157385,0,0,2.1468441391155,3.88619572916783,MAPK8IP3;MAP3K4;MAP3K5
delta,3,negative regulation of ubiquitin protein ligase activity (GO:1904667),4/78,4,78,0.165776798659568,0.642918867157385,0,0,1.87160771102377,3.36349051428249,PSMA3;PSMA1;BUB3;ANAPC10
delta,3,positive regulation of glucose import (GO:0046326),2/27,2,27,0.16836545153866,0.642918867157385,0,0,2.70343336036767,4.81648649731106,OSBPL8;IRS2
delta,3,cytoskeleton-dependent intracellular transport (GO:0030705),2/27,2,27,0.16836545153866,0.642918867157385,0,0,2.70343336036767,4.81648649731106,HOOK3;DYNC1I1
delta,3,snRNA processing (GO:0016180),2/27,2,27,0.16836545153866,0.642918867157385,0,0,2.70343336036767,4.81648649731106,INTS10;TUT1
delta,3,regulation of p38MAPK cascade (GO:1900744),2/27,2,27,0.16836545153866,0.642918867157385,0,0,2.70343336036767,4.81648649731106,KARS;MAP3K4
delta,3,regulation of microtubule-based process (GO:0032886),2/27,2,27,0.16836545153866,0.642918867157385,0,0,2.70343336036767,4.81648649731106,PHLDB1;TRAF3IP1
delta,3,fat-soluble vitamin metabolic process (GO:0006775),2/27,2,27,0.16836545153866,0.642918867157385,0,0,2.70343336036767,4.81648649731106,UBE2I;CYP2R1
delta,3,strand displacement (GO:0000732),2/27,2,27,0.16836545153866,0.642918867157385,0,0,2.70343336036767,4.81648649731106,TOP3A;RBBP8
delta,3,telomere maintenance (GO:0000723),3/52,3,52,0.170348163287752,0.642918867157385,0,0,2.10555867490174,3.72665128493424,NSMCE2;TERF2IP;SMC5
delta,3,cellular response to organic cyclic compound (GO:0071407),6/136,6,136,0.170481556224893,0.642918867157385,0,0,1.61013310433663,2.84853182064822,PDE12;NRIP1;CTNNA1;ACTB;NFKB1;CCDC62
delta,3,cellular response to starvation (GO:0009267),5/108,5,108,0.175023023144062,0.642918867157385,0,0,1.68964585022979,2.94477857679234,SH3GLB1;SESN2;PIK3R4;EIF2AK3;MAP3K5
delta,3,regulation of protein secretion (GO:0050708),5/108,5,108,0.175023023144062,0.642918867157385,0,0,1.68964585022979,2.94477857679234,PPP3CB;SLC2A1;ANG;LLGL1;STXBP5L
delta,3,response to calcium ion (GO:0051592),4/80,4,80,0.176515216307475,0.642918867157385,0,0,1.82481751824818,3.16486896888864,MEF2A;PPP3CA;HOMER1;TRPC1
delta,3,cell-cell junction assembly (GO:0007043),4/80,4,80,0.176515216307475,0.642918867157385,0,0,1.82481751824818,3.16486896888864,TJP1;PDCD6IP;CTNNA1;MPP5
delta,3,ATP hydrolysis coupled proton transport (GO:0015991),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,ATP6V1H
delta,3,inner ear receptor stereocilium organization (GO:0060122),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,SOD1
delta,3,axon regeneration (GO:0031103),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,MTR
delta,3,tRNA pseudouridine synthesis (GO:0031119),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,RPUSD4
delta,3,"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,EXOSC8
delta,3,ATP hydrolysis coupled cation transmembrane transport (GO:0099132),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,ATP6V1H
delta,3,progesterone receptor signaling pathway (GO:0050847),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,WBP2
delta,3,positive regulation of lamellipodium morphogenesis (GO:2000394),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,ARHGEF7
delta,3,cellular response to interferon-alpha (GO:0035457),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,PDE12
delta,3,response to misfolded protein (GO:0051788),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,CLU
delta,3,purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,SLC35B2
delta,3,rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,ABCE1
delta,3,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,NSMCE2
delta,3,exonucleolytic trimming involved in rRNA processing (GO:0000459),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,EXOSC8
delta,3,negative regulation of glial cell apoptotic process (GO:0034351),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,PRKCH
delta,3,regulation of mitochondrial fusion (GO:0010635),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,OMA1
delta,3,regulation of MDA-5 signaling pathway (GO:0039533),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,ANKRD17
delta,3,regulation of DNA endoreduplication (GO:0032875),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,FBXW7
delta,3,oxaloacetate metabolic process (GO:0006107),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,MDH1B
delta,3,sulfur amino acid biosynthetic process (GO:0000097),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,MTR
delta,3,regulation of lymphocyte migration (GO:2000401),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,STK10
delta,3,retrograde axonal transport (GO:0008090),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,SOD1
delta,3,pteridine-containing compound biosynthetic process (GO:0042559),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,ST20-MTHFS
delta,3,miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,AGO2
delta,3,positive regulation of autophagy of mitochondrion (GO:1903599),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,FBXO7
delta,3,terpenoid metabolic process (GO:0006721),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,FDFT1
delta,3,regulation of isotype switching (GO:0045191),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,PAXIP1
delta,3,formation of translation preinitiation complex (GO:0001731),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,EIF4B
delta,3,box C/D snoRNP assembly (GO:0000492),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,PIH1D2
delta,3,phosphorylated carbohydrate dephosphorylation (GO:0046838),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,IMPA2
delta,3,adenine nucleotide transport (GO:0051503),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,SLC35B2
delta,3,morphogenesis of a polarized epithelium (GO:0001738),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,TRAF3IP1
delta,3,positive regulation of macrophage migration (GO:1905523),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,KARS
delta,3,inositol phosphate dephosphorylation (GO:0046855),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,IMPA2
delta,3,modification by symbiont of host morphology or physiology (GO:0044003),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,DAG1
delta,3,regulation of vitamin D biosynthetic process (GO:0060556),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,NFKB1
delta,3,positive regulation of triglyceride catabolic process (GO:0010898),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,ABHD5
delta,3,"retrograde transport, vesicle recycling within Golgi (GO:0000301)",1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,COG4
delta,3,positive regulation of fatty acid beta-oxidation (GO:0032000),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,IRS2
delta,3,protection from non-homologous end joining at telomere (GO:0031848),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,TERF2IP
delta,3,regulation of glucocorticoid receptor signaling pathway (GO:2000322),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,CRY1
delta,3,purine ribonucleotide transport (GO:0015868),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,SLC35B2
delta,3,negative regulation of B cell apoptotic process (GO:0002903),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,IRS2
delta,3,regulation of establishment of protein localization (GO:0070201),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,CEP290
delta,3,negative regulation of transporter activity (GO:0032410),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,CTTNBP2NL
delta,3,mannose metabolic process (GO:0006013),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,MAN2B1
delta,3,adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,GNAL
delta,3,tetrahydrofolate interconversion (GO:0035999),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,ST20-MTHFS
delta,3,regulation of calcidiol 1-monooxygenase activity (GO:0060558),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,NFKB1
delta,3,negative regulation of glycoprotein biosynthetic process (GO:0010561),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,ITM2C
delta,3,positive regulation of macrophage chemotaxis (GO:0010759),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,KARS
delta,3,regulation of microglial cell activation (GO:1903978),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,APP
delta,3,long term synaptic depression (GO:0060292),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,PLK2
delta,3,regulation of transcription involved in cell fate commitment (GO:0060850),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,CEBPB
delta,3,malate metabolic process (GO:0006108),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,MDH1B
delta,3,microglial cell activation (GO:0001774),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,CLU
delta,3,cAMP catabolic process (GO:0006198),1/7,1,7,0.176758576672315,0.642918867157385,0,0,5.21376433785193,9.03529953633872,PDE3B
delta,3,regulation of calcium ion transport (GO:0051924),3/53,3,53,0.177151194570287,0.642918867157385,0,0,2.06583115273378,3.57544078864486,HOMER1;STIM2;ORAI1
delta,3,regulation of cell-matrix adhesion (GO:0001952),3/53,3,53,0.177151194570287,0.642918867157385,0,0,2.06583115273378,3.57544078864486,ACER2;ADAM15;UTRN
delta,3,positive regulation of cell-substrate adhesion (GO:0010811),3/53,3,53,0.177151194570287,0.642918867157385,0,0,2.06583115273378,3.57544078864486,JAK2;UTRN;ARHGEF7
delta,3,phosphatidylcholine acyl-chain remodeling (GO:0036151),2/28,2,28,0.178212692155992,0.642918867157385,0,0,2.60688216892596,4.49629182028629,LPCAT4;DBI
delta,3,negative regulation of synaptic transmission (GO:0050805),2/28,2,28,0.178212692155992,0.642918867157385,0,0,2.60688216892596,4.49629182028629,PLK2;CBLN1
delta,3,regulation of protein localization to nucleus (GO:1900180),2/28,2,28,0.178212692155992,0.642918867157385,0,0,2.60688216892596,4.49629182028629,SESN2;EIF2AK3
delta,3,transition metal ion transport (GO:0000041),2/28,2,28,0.178212692155992,0.642918867157385,0,0,2.60688216892596,4.49629182028629,SLC30A8;TRPC1
delta,3,negative regulation of cell-matrix adhesion (GO:0001953),2/28,2,28,0.178212692155992,0.642918867157385,0,0,2.60688216892596,4.49629182028629,ACER2;ADAM15
delta,3,regulation of protein transport (GO:0051223),2/28,2,28,0.178212692155992,0.642918867157385,0,0,2.60688216892596,4.49629182028629,LLGL1;STXBP5L
delta,3,protein targeting to vacuole (GO:0006623),2/28,2,28,0.178212692155992,0.642918867157385,0,0,2.60688216892596,4.49629182028629,AP3M1;PIK3R4
delta,3,protein localization to chromosome (GO:0034502),2/28,2,28,0.178212692155992,0.642918867157385,0,0,2.60688216892596,4.49629182028629,TNKS2;TERF2IP
delta,3,regulation of autophagy of mitochondrion (GO:1903146),2/28,2,28,0.178212692155992,0.642918867157385,0,0,2.60688216892596,4.49629182028629,FBXW7;FBXO7
delta,3,nucleotide-excision repair (GO:0006289),5/109,5,109,0.17962888996456,0.642918867157385,0,0,1.67414451215429,2.8742755621551,UBE2I;RBBP8;ERCC5;ORAOV1;RNF111
delta,3,nucleic acid metabolic process (GO:0090304),4/81,4,81,0.181971189394723,0.642918867157385,0,0,1.80228890691178,3.07093251232786,HNRNPM;PDE12;HNRNPF;DXO
delta,3,positive regulation of stress-activated MAPK cascade (GO:0032874),4/81,4,81,0.181971189394723,0.642918867157385,0,0,1.80228890691178,3.07093251232786,APP;KARS;MAP3K4;MAP3K5
delta,3,regulation of vesicle-mediated transport (GO:0060627),6/139,6,139,0.182605122317198,0.642918867157385,0,0,1.57538203014231,2.67882569830529,TBC1D2;SLC30A8;TBC1D10A;LLGL1;TBC1D15;STXBP5L
delta,3,positive regulation of protein targeting to mitochondrion (GO:1903955),4/82,4,82,0.187482270825981,0.642918867157385,0,0,1.78030977390066,2.98036495217572,SH3GLB1;HHAT;FBXW7;ARIH2
delta,3,neuron projection extension (GO:1990138),2/29,2,29,0.188145468605806,0.642918867157385,0,0,2.51698968034231,4.20473155342916,CYFIP1;PPP3CB
delta,3,regulation of TORC1 signaling (GO:1903432),2/29,2,29,0.188145468605806,0.642918867157385,0,0,2.51698968034231,4.20473155342916,SESN2;SMCR8
delta,3,cellular response to hydrogen peroxide (GO:0070301),2/29,2,29,0.188145468605806,0.642918867157385,0,0,2.51698968034231,4.20473155342916,SETX;MAP3K5
delta,3,negative regulation of homeostatic process (GO:0032845),2/29,2,29,0.188145468605806,0.642918867157385,0,0,2.51698968034231,4.20473155342916,MAFB;TERF2IP
delta,3,RNA phosphodiester bond hydrolysis (GO:0090501),2/29,2,29,0.188145468605806,0.642918867157385,0,0,2.51698968034231,4.20473155342916,PDE12;RNASE4
delta,3,positive regulation of phosphate metabolic process (GO:0045937),2/29,2,29,0.188145468605806,0.642918867157385,0,0,2.51698968034231,4.20473155342916,APP;ANG
delta,3,protein K11-linked ubiquitination (GO:0070979),2/29,2,29,0.188145468605806,0.642918867157385,0,0,2.51698968034231,4.20473155342916,UBE2E2;ANAPC10
delta,3,regulation of NIK/NF-kappaB signaling (GO:1901222),2/29,2,29,0.188145468605806,0.642918867157385,0,0,2.51698968034231,4.20473155342916,APP;TERF2IP
delta,3,production of miRNAs involved in gene silencing by miRNA (GO:0035196),2/29,2,29,0.188145468605806,0.642918867157385,0,0,2.51698968034231,4.20473155342916,AGO2;PUM1
delta,3,regulation of defense response to virus by virus (GO:0050690),2/29,2,29,0.188145468605806,0.642918867157385,0,0,2.51698968034231,4.20473155342916,AP1G1;ATP6V1H
delta,3,calcium ion import (GO:0070509),2/29,2,29,0.188145468605806,0.642918867157385,0,0,2.51698968034231,4.20473155342916,MCUR1;NALCN
delta,3,bicellular tight junction assembly (GO:0070830),2/29,2,29,0.188145468605806,0.642918867157385,0,0,2.51698968034231,4.20473155342916,PDCD6IP;MPP5
delta,3,cellular response to peptide hormone stimulus (GO:0071375),5/111,5,111,0.188974241518086,0.642918867157385,0,0,1.64397974616953,2.73910791325488,PRKAR1B;PDE3B;IRS2;CPEB2;NFKB1
delta,3,regulation of anatomical structure morphogenesis (GO:0022603),4/83,4,83,0.193046399557452,0.642918867157385,0,0,1.75886025855246,2.89301680899984,PHLDB1;DAG1;MARCH5;MYO19
delta,3,positive regulation of ubiquitin protein ligase activity (GO:1904668),4/83,4,83,0.193046399557452,0.642918867157385,0,0,1.75886025855246,2.89301680899984,PSMA3;PSMA1;BUB3;ANAPC10
delta,3,modification-dependent protein catabolic process (GO:0019941),6/142,6,142,0.19505922180417,0.642918867157385,0,0,1.54209931119564,2.52048740356717,RANBP2;UBE2I;ARIH2;UBR3;FBXO7;PCYOX1
delta,3,regulation of cellular catabolic process (GO:0031329),3/56,3,56,0.197985031342588,0.642918867157385,0,0,1.95516162669447,3.16650909233296,PSAP;SMCR8;DRAM2
delta,3,regulation of axonogenesis (GO:0050770),3/56,3,56,0.197985031342588,0.642918867157385,0,0,1.95516162669447,3.16650909233296,RUFY3;CHN1;ZSWIM8
delta,3,positive regulation of histone modification (GO:0031058),2/30,2,30,0.198151730356796,0.642918867157385,0,0,2.4330900243309,3.93849690224735,PAXIP1;PAF1
delta,3,regulation of embryonic development (GO:0045995),2/30,2,30,0.198151730356796,0.642918867157385,0,0,2.4330900243309,3.93849690224735,PHLDB1;DAG1
delta,3,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),2/30,2,30,0.198151730356796,0.642918867157385,0,0,2.4330900243309,3.93849690224735,CEBPB;SESN2
delta,3,regulation of chromosome segregation (GO:0051983),2/30,2,30,0.198151730356796,0.642918867157385,0,0,2.4330900243309,3.93849690224735,SMC5;PUM1
delta,3,positive regulation of protein ubiquitination (GO:0031398),4/84,4,84,0.198661509194113,0.642918867157385,0,0,1.73792144595064,2.80874671768194,PAXIP1;FBXW7;DCUN1D1;CLU
delta,3,positive regulation of macromolecule biosynthetic process (GO:0010557),6/143,6,143,0.199280370764255,0.642918867157385,0,0,1.53131539992854,2.47007689374325,DBF4;IRS2;CPEB3;JAK2;SVIP;NFKB1
delta,3,protein insertion into mitochondrial membrane (GO:0051204),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,MOAP1
delta,3,Golgi to lysosome transport (GO:0090160),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,AP1G1
delta,3,phosphate ion transmembrane transport (GO:0035435),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,SLC20A1
delta,3,cellular response to nitric oxide (GO:0071732),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,MTR
delta,3,late endosome to vacuole transport (GO:0045324),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,PIK3R4
delta,3,positive regulation of mitochondrial calcium ion concentration (GO:0051561),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,MCUR1
delta,3,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,SESTD1
delta,3,positive regulation of isotype switching (GO:0045830),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,PAXIP1
delta,3,microtubule nucleation by microtubule organizing center (GO:0051418),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,TUBGCP2
delta,3,mRNA cleavage (GO:0006379),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,RNASE4
delta,3,sulfur amino acid catabolic process (GO:0000098),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,PCYOX1
delta,3,cellular response to angiotensin (GO:1904385),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,NFKB1
delta,3,negative regulation of protein homooligomerization (GO:0032463),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,CLU
delta,3,phenol-containing compound biosynthetic process (GO:0046189),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,TRPC1
delta,3,negative regulation of anion transmembrane transport (GO:1903960),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,IRS2
delta,3,endodermal cell fate commitment (GO:0001711),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,PAF1
delta,3,amyloid fibril formation (GO:1990000),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,APP
delta,3,SMAD protein complex assembly (GO:0007183),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,ZFYVE9
delta,3,positive regulation of DNA recombination (GO:0045911),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,PAXIP1
delta,3,negative regulation of monooxygenase activity (GO:0032769),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,NFKB1
delta,3,negative regulation of execution phase of apoptosis (GO:1900118),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,FZD3
delta,3,DNA damage induced protein phosphorylation (GO:0006975),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,CRY1
delta,3,regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,SESN2
delta,3,central nervous system myelination (GO:0022010),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,CLU
delta,3,"negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,SVIP
delta,3,negative regulation of calcium ion transmembrane transport (GO:1903170),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,SESTD1
delta,3,regulation of store-operated calcium entry (GO:2001256),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,HOMER1
delta,3,negative regulation of hippo signaling (GO:0035331),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,MARK3
delta,3,angiogenesis involved in wound healing (GO:0060055),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,ADIPOR2
delta,3,diol biosynthetic process (GO:0034312),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,ACER2
delta,3,regulation of type B pancreatic cell development (GO:2000074),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,RHEB
delta,3,sphingosine biosynthetic process (GO:0046512),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,ACER2
delta,3,inositol phosphate catabolic process (GO:0071545),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,IMPA2
delta,3,positive regulation of mitotic sister chromatid separation (GO:1901970),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,NSMCE2
delta,3,pyrimidine nucleobase metabolic process (GO:0006206),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,UCK2
delta,3,positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,RHOT1
delta,3,actin filament network formation (GO:0051639),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,COBLL1
delta,3,negative regulation of cAMP-dependent protein kinase activity (GO:2000480),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,PRKAR1B
delta,3,regulation of ERAD pathway (GO:1904292),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,USP25
delta,3,acylglycerol acyl-chain remodeling (GO:0036155),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,DGAT1
delta,3,regulation of long term synaptic depression (GO:1900452),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,CBLN1
delta,3,U4 snRNA 3'-end processing (GO:0034475),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,EXOSC8
delta,3,phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,PIK3C2B
delta,3,regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,ASXL2
delta,3,regulation of receptor binding (GO:1900120),1/8,1,8,0.199323257785763,0.642918867157385,0,0,4.56204379562044,7.35778905658024,ADAM15
delta,3,regulation of cell cycle G2/M phase transition (GO:1902749),4/85,4,85,0.204325530280645,0.642918867157385,0,0,1.7174753112924,2.72742090219498,PLK4;NEK10;CEP290;SDCCAG8
delta,3,positive regulation of protein transport (GO:0051222),3/57,3,57,0.205057185192499,0.642918867157385,0,0,1.92086054552439,3.04353896770095,RUFY3;ANG;CEP290
delta,3,protein import (GO:0017038),3/57,3,57,0.205057185192499,0.642918867157385,0,0,1.92086054552439,3.04353896770095,RANBP2;POM121;CLU
delta,3,phosphatidylinositol-mediated signaling (GO:0048015),3/57,3,57,0.205057185192499,0.642918867157385,0,0,1.92086054552439,3.04353896770095,PI4KA;IRS2;PIK3C2B
delta,3,cellular protein complex assembly (GO:0043623),6/145,6,145,0.207822496874046,0.642918867157385,0,0,1.51019380820539,2.37262161192613,IMMP1L;ZFYVE9;COG4;NCK2;CLU;EIF4B
delta,3,ribosomal large subunit assembly (GO:0000027),2/31,2,31,0.208220020804835,0.642918867157385,0,0,2.35460324935248,3.69474915473975,FASTKD2;MDN1
delta,3,activation of protein kinase B activity (GO:0032148),2/31,2,31,0.208220020804835,0.642918867157385,0,0,2.35460324935248,3.69474915473975,OSBPL8;ANG
delta,3,protein palmitoylation (GO:0018345),2/31,2,31,0.208220020804835,0.642918867157385,0,0,2.35460324935248,3.69474915473975,ZDHHC16;ZDHHC2
delta,3,activation of JUN kinase activity (GO:0007257),2/31,2,31,0.208220020804835,0.642918867157385,0,0,2.35460324935248,3.69474915473975,MAPK8IP3;MAP3K5
delta,3,regulation of cell adhesion mediated by integrin (GO:0033628),2/31,2,31,0.208220020804835,0.642918867157385,0,0,2.35460324935248,3.69474915473975,ACER2;PDE3B
delta,3,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),2/31,2,31,0.208220020804835,0.642918867157385,0,0,2.35460324935248,3.69474915473975,WBP2;UBA5
delta,3,regulation of developmental growth (GO:0048638),2/31,2,31,0.208220020804835,0.642918867157385,0,0,2.35460324935248,3.69474915473975,APP;SOD1
delta,3,regulation of type I interferon production (GO:0032479),4/86,4,86,0.210036392418754,0.642918867157385,0,0,1.69750466813784,2.64891269062424,IRAK1;TRAF3IP1;POLR3E;NFKB1
delta,3,protein O-linked glycosylation (GO:0006493),5/116,5,116,0.213060582427885,0.642918867157385,0,0,1.57311855021394,2.43232244080299,GALNT7;GALNT11;MGEA5;SLC35C1;DAG1
delta,3,calcium ion transmembrane transport (GO:0070588),4/87,4,87,0.215792026334798,0.642918867157385,0,0,1.67799312022821,2.57310206589439,MCUR1;TRPC1;NALCN;TMCO1
delta,3,sphingolipid metabolic process (GO:0006665),5/117,5,117,0.217991939145218,0.642918867157385,0,0,1.55967309251981,2.37584564426161,ACER2;CERS6;VAPA;PSAP;SGMS2
delta,3,regulation of ubiquitin-protein transferase activity (GO:0051438),2/32,2,32,0.218339453799558,0.642918867157385,0,0,2.28102189781022,3.47104082969474,FBXW7;DCUN1D1
delta,3,regulation of protein tyrosine kinase activity (GO:0061097),2/32,2,32,0.218339453799558,0.642918867157385,0,0,2.28102189781022,3.47104082969474,APP;NCK2
delta,3,renal water homeostasis (GO:0003091),2/32,2,32,0.218339453799558,0.642918867157385,0,0,2.28102189781022,3.47104082969474,PRKAR1B;RAB11FIP2
delta,3,positive regulation of viral genome replication (GO:0045070),2/32,2,32,0.218339453799558,0.642918867157385,0,0,2.28102189781022,3.47104082969474,VAPA;PDE12
delta,3,lysosome organization (GO:0007040),2/32,2,32,0.218339453799558,0.642918867157385,0,0,2.28102189781022,3.47104082969474,VPS33A;HOOK3
delta,3,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),3/59,3,59,0.219368060932295,0.642918867157385,0,0,1.85574662872696,2.81517564581245,APP;NCK2;ARHGEF7
delta,3,inositol metabolic process (GO:0006020),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,IMPA2
delta,3,secretory granule organization (GO:0033363),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,BLOC1S3
delta,3,removal of superoxide radicals (GO:0019430),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,SOD1
delta,3,small RNA loading onto RISC (GO:0070922),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,AGO2
delta,3,L-fucose metabolic process (GO:0042354),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,FUT4
delta,3,manganese ion transport (GO:0006828),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,TRPC1
delta,3,regulation of protein acetylation (GO:1901983),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,TERF2IP
delta,3,positive regulation of protein sumoylation (GO:0033235),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,UBE2I
delta,3,regulation of organ growth (GO:0046620),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,SOD1
delta,3,neuron maturation (GO:0042551),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,APP
delta,3,microtubule anchoring at centrosome (GO:0034454),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,HOOK3
delta,3,regulation of amyloid precursor protein biosynthetic process (GO:0042984),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,ITM2C
delta,3,short-chain fatty acid metabolic process (GO:0046459),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,OXSM
delta,3,oligosaccharide catabolic process (GO:0009313),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,MAN2B1
delta,3,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,NSMCE2
delta,3,cellular response to reactive nitrogen species (GO:1902170),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,MTR
delta,3,vasodilation (GO:0042311),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,SOD1
delta,3,regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,SVIP
delta,3,regulation of endothelial cell differentiation (GO:0045601),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,ZEB1
delta,3,sphingomyelin metabolic process (GO:0006684),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,SGMS2
delta,3,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,JAK2
delta,3,ionotropic glutamate receptor signaling pathway (GO:0035235),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,APP
delta,3,L-fucose catabolic process (GO:0042355),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,FUT4
delta,3,positive regulation of long-term synaptic potentiation (GO:1900273),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,APP
delta,3,nuclear migration (GO:0007097),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,HOOK3
delta,3,multi-ciliated epithelial cell differentiation (GO:1903251),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,PLK4
delta,3,small nucleolar ribonucleoprotein complex assembly (GO:0000491),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,PIH1D2
delta,3,sphingoid biosynthetic process (GO:0046520),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,ACER2
delta,3,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,SVIP
delta,3,L-ascorbic acid metabolic process (GO:0019852),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,SLC2A1
delta,3,response to leucine (GO:0043201),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,SESN2
delta,3,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,RPL35
delta,3,mitochondrial calcium uptake (GO:0036444),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,MCUR1
delta,3,positive regulation of astrocyte differentiation (GO:0048711),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,APP
delta,3,tyrosine phosphorylation of STAT protein (GO:0007260),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,JAK2
delta,3,positive regulation of autophagosome assembly (GO:2000786),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,SH3GLB1
delta,3,regulation of cytokine secretion involved in immune response (GO:0002739),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,KARS
delta,3,Golgi vesicle budding (GO:0048194),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,VAPA
delta,3,protein localization to vacuole (GO:0072665),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,SH3GLB1
delta,3,"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,EXOSC8
delta,3,positive regulation of immunoglobulin mediated immune response (GO:0002891),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,PAXIP1
delta,3,production of siRNA involved in RNA interference (GO:0030422),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,AGO2
delta,3,interleukin-23-mediated signaling pathway (GO:0038155),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,JAK2
delta,3,Notch signaling involved in heart development (GO:0061314),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,GALNT11
delta,3,positive regulation of cell activation (GO:0050867),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,APP
delta,3,negative regulation of lymphocyte apoptotic process (GO:0070229),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,IRS2
delta,3,cellular response to superoxide (GO:0071451),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,SOD1
delta,3,negative regulation of interferon-beta production (GO:0032688),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,REL
delta,3,fucose catabolic process (GO:0019317),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,FUT4
delta,3,positive regulation of cytokine production involved in inflammatory response (GO:1900017),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,KARS
delta,3,regulation of oxidative phosphorylation (GO:0002082),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,PDE12
delta,3,cellular response to leucine (GO:0071233),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,SESN2
delta,3,negative regulation of amyloid-beta formation (GO:1902430),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,CLU
delta,3,positive regulation of protein homooligomerization (GO:0032464),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,CLU
delta,3,negative regulation of microtubule polymerization (GO:0031115),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,STMN1
delta,3,mesodermal cell differentiation (GO:0048333),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,ITGA2
delta,3,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,HLA-A
delta,3,neuron projection organization (GO:0106027),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,APP
delta,3,cytoskeletal anchoring at plasma membrane (GO:0007016),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,DAG1
delta,3,sphingosine metabolic process (GO:0006670),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,ACER2
delta,3,DNA topological change (GO:0006265),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,TOP3A
delta,3,histone H3-K4 trimethylation (GO:0080182),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,ZNF335
delta,3,cyclic nucleotide catabolic process (GO:0009214),1/9,1,9,0.221270548700286,0.642918867157385,0,0,4.0551500405515,6.11666311405207,PDE3B
delta,3,regulation of protein metabolic process (GO:0051246),3/60,3,60,0.226598731600664,0.642918867157385,0,0,1.82481751824818,2.70907760571105,APP;PM20D2;BTBD3
delta,3,cell junction assembly (GO:0034329),3/60,3,60,0.226598731600664,0.642918867157385,0,0,1.82481751824818,2.70907760571105,TJP1;VMP1;ACTB
delta,3,cell morphogenesis (GO:0000902),3/60,3,60,0.226598731600664,0.642918867157385,0,0,1.82481751824818,2.70907760571105,CYFIP1;CLU;CAP2
delta,3,divalent metal ion transport (GO:0070838),4/89,4,89,0.227429349969979,0.642918867157385,0,0,1.64028540966128,2.42912431461355,SLC30A8;TRPC1;NIPA2;NALCN
delta,3,regulation of protein targeting to mitochondrion (GO:1903214),4/89,4,89,0.227429349969979,0.642918867157385,0,0,1.64028540966128,2.42912431461355,SH3GLB1;HHAT;FBXW7;ARIH2
delta,3,cytosolic transport (GO:0016482),5/119,5,119,0.227958755526079,0.642918867157385,0,0,1.53346009936821,2.26735963198022,DOPEY1;MYO1D;AP1G1;HOOK3;TBC1D10A
delta,3,dendrite morphogenesis (GO:0048813),2/33,2,33,0.228499691231451,0.642918867157385,0,0,2.211900022119,3.26525197950336,MEF2A;BTBD3
delta,3,cellular response to amino acid stimulus (GO:0071230),2/33,2,33,0.228499691231451,0.642918867157385,0,0,2.211900022119,3.26525197950336,SESN2;CPEB3
delta,3,phosphatidylcholine biosynthetic process (GO:0006656),2/33,2,33,0.228499691231451,0.642918867157385,0,0,2.211900022119,3.26525197950336,CEPT1;LPIN2
delta,3,ceramide biosynthetic process (GO:0046513),2/33,2,33,0.228499691231451,0.642918867157385,0,0,2.211900022119,3.26525197950336,CERS6;SGMS2
delta,3,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),2/33,2,33,0.228499691231451,0.642918867157385,0,0,2.211900022119,3.26525197950336,JAK2;CLU
delta,3,positive regulation of TOR signaling (GO:0032008),2/33,2,33,0.228499691231451,0.642918867157385,0,0,2.211900022119,3.26525197950336,RHEB;SMCR8
delta,3,activation of adenylate cyclase activity (GO:0007190),2/33,2,33,0.228499691231451,0.642918867157385,0,0,2.211900022119,3.26525197950336,GNAL;CAP2
delta,3,G2 DNA damage checkpoint (GO:0031572),2/33,2,33,0.228499691231451,0.642918867157385,0,0,2.211900022119,3.26525197950336,RBBP8;CLSPN
delta,3,positive regulation of telomere maintenance via telomerase (GO:0032212),2/33,2,33,0.228499691231451,0.642918867157385,0,0,2.211900022119,3.26525197950336,TNKS2;MAP3K4
delta,3,global genome nucleotide-excision repair (GO:0070911),2/33,2,33,0.228499691231451,0.642918867157385,0,0,2.211900022119,3.26525197950336,UBE2I;RNF111
delta,3,regulation of neuron projection development (GO:0010975),5/120,5,120,0.232991698025915,0.642918867157385,0,0,1.52068126520681,2.21525616916255,SETX;RUFY3;CHN1;FBXO7;ITM2C
delta,3,regulation of phosphorylation (GO:0042325),5/120,5,120,0.232991698025915,0.642918867157385,0,0,1.52068126520681,2.21525616916255,RANBP2;APP;POM121;SESN2;ANG
delta,3,mitochondrial translational termination (GO:0070126),4/90,4,90,0.233306924397482,0.642918867157385,0,0,1.6220600162206,2.36074682914187,MRPL2;MRPS23;MRPL14;MTRF1L
delta,3,response to reactive oxygen species (GO:0000302),3/61,3,61,0.233874292450328,0.642918867157385,0,0,1.79490247696542,2.6079421797148,TXNRD1;APTX;SOD1
delta,3,actin filament organization (GO:0007015),5/121,5,121,0.238055980850234,0.642918867157385,0,0,1.50811365144477,2.16451924249353,RUFY3;COBLL1;DSTN;EVL;CAP2
delta,3,positive regulation of adenylate cyclase activity (GO:0045762),2/34,2,34,0.238690921133429,0.642918867157385,0,0,2.1468441391155,3.07553838770357,GNAL;CAP2
delta,3,activation of MAPKK activity (GO:0000186),2/34,2,34,0.238690921133429,0.642918867157385,0,0,2.1468441391155,3.07553838770357,MAP3K4;MAP3K5
delta,3,protein acetylation (GO:0006473),2/34,2,34,0.238690921133429,0.642918867157385,0,0,2.1468441391155,3.07553838770357,ING5;KAT6A
delta,3,negative regulation of mitochondrion organization (GO:0010823),2/34,2,34,0.238690921133429,0.642918867157385,0,0,2.1468441391155,3.07553838770357,OMA1;CLU
delta,3,positive regulation of calcium ion transport (GO:0051928),2/34,2,34,0.238690921133429,0.642918867157385,0,0,2.1468441391155,3.07553838770357,STIM2;ORAI1
delta,3,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),2/34,2,34,0.238690921133429,0.642918867157385,0,0,2.1468441391155,3.07553838770357,RANBP2;POM121
delta,3,tRNA export from nucleus (GO:0006409),2/34,2,34,0.238690921133429,0.642918867157385,0,0,2.1468441391155,3.07553838770357,RANBP2;POM121
delta,3,intra-Golgi vesicle-mediated transport (GO:0006891),2/34,2,34,0.238690921133429,0.642918867157385,0,0,2.1468441391155,3.07553838770357,COG4;COPG2
delta,3,regulation of autophagosome assembly (GO:2000785),2/34,2,34,0.238690921133429,0.642918867157385,0,0,2.1468441391155,3.07553838770357,SH3GLB1;SMCR8
delta,3,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),2/34,2,34,0.238690921133429,0.642918867157385,0,0,2.1468441391155,3.07553838770357,SFPQ;SOD1
delta,3,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay (GO:0043928),2/34,2,34,0.238690921133429,0.642918867157385,0,0,2.1468441391155,3.07553838770357,EXOSC8;EXOSC1
delta,3,regulation of intracellular protein transport (GO:0033157),2/34,2,34,0.238690921133429,0.642918867157385,0,0,2.1468441391155,3.07553838770357,RUFY3;CEP290
delta,3,positive regulation of organelle organization (GO:0010638),2/34,2,34,0.238690921133429,0.642918867157385,0,0,2.1468441391155,3.07553838770357,SURF4;SMCR8
delta,3,regulation of vesicle fusion (GO:0031338),3/62,3,62,0.241190875830787,0.642918867157385,0,0,1.76595243701436,2.51147864917915,TBC1D2;TBC1D10A;TBC1D15
delta,3,positive regulation of cellular amide metabolic process (GO:0034250),3/62,3,62,0.241190875830787,0.642918867157385,0,0,1.76595243701436,2.51147864917915,APP;CPEB3;CLU
delta,3,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,FBXW7
delta,3,regulation of B cell apoptotic process (GO:0002902),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,IRS2
delta,3,ganglion development (GO:0061548),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,FZD3
delta,3,negative regulation of cholesterol transport (GO:0032375),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,NFKB1
delta,3,regulation of myeloid leukocyte differentiation (GO:0002761),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,CEBPB
delta,3,3'-UTR-mediated mRNA destabilization (GO:0061158),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,CPEB3
delta,3,regulation of sequestering of zinc ion (GO:0061088),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,SLC30A8
delta,3,neuron projection regeneration (GO:0031102),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,MTR
delta,3,negative regulation of oxidative stress-induced neuron death (GO:1903204),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,FBXO7
delta,3,chloride ion homeostasis (GO:0055064),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,SLC12A1
delta,3,"energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)",1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,ATP6V1H
delta,3,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,CYFIP1
delta,3,establishment of spindle localization (GO:0051293),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,LLGL1
delta,3,cellular biogenic amine metabolic process (GO:0006576),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,AMD1
delta,3,regulation of triglyceride catabolic process (GO:0010896),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,ABHD5
delta,3,positive regulation of glucose import in response to insulin stimulus (GO:2001275),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,OSBPL8
delta,3,regulation of protein exit from endoplasmic reticulum (GO:0070861),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,TMEM30B
delta,3,cellular copper ion homeostasis (GO:0006878),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,APP
delta,3,regulation of amyloid-beta clearance (GO:1900221),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,CLU
delta,3,"regulation of DNA-templated transcription, initiation (GO:2000142)",1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,SETX
delta,3,positive regulation of natural killer cell activation (GO:0032816),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,AP1G1
delta,3,telomere maintenance in response to DNA damage (GO:0043247),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,TERF2IP
delta,3,actin filament depolymerization (GO:0030042),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,DSTN
delta,3,negative regulation of autophagosome assembly (GO:1902902),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,SMCR8
delta,3,Rap protein signal transduction (GO:0032486),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,PLK2
delta,3,endosomal vesicle fusion (GO:0034058),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,TGFBRAP1
delta,3,nucleoside metabolic process (GO:0009116),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,ERH
delta,3,motor neuron axon guidance (GO:0008045),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,CHN1
delta,3,positive regulation of reproductive process (GO:2000243),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,AGO2
delta,3,sympathetic ganglion development (GO:0061549),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,FZD3
delta,3,regulation of fatty acid beta-oxidation (GO:0031998),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,IRS2
delta,3,insulin-like growth factor receptor signaling pathway (GO:0048009),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,EIF2AK3
delta,3,DNA replication-dependent nucleosome assembly (GO:0006335),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,ASF1B
delta,3,positive regulation of circadian rhythm (GO:0042753),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,FBXW11
delta,3,cardiovascular system development (GO:0072358),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,FBXW7
delta,3,protein-cofactor linkage (GO:0018065),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,SDHAF2
delta,3,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,TMEM30B
delta,3,regulation of DNA damage checkpoint (GO:2000001),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,CRY1
delta,3,intraciliary retrograde transport (GO:0035721),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,IFT140
delta,3,maintenance of apical/basal cell polarity (GO:0035090),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,PDCD6IP
delta,3,negative regulation by host of viral process (GO:0044793),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,VAPA
delta,3,actin filament-based transport (GO:0099515),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,MYO19
delta,3,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,PPP3CB
delta,3,negative regulation of embryonic development (GO:0045992),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,FZD3
delta,3,UV protection (GO:0009650),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,ERCC5
delta,3,regulation of mRNA 3'-end processing (GO:0031440),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,PAF1
delta,3,positive regulation of lipid localization (GO:1905954),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,NFKB1
delta,3,chaperone-mediated protein transport (GO:0072321),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,CLU
delta,3,cellular response to leucine starvation (GO:1990253),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,SESN2
delta,3,DNA replication-dependent nucleosome organization (GO:0034723),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,ASF1B
delta,3,very-low-density lipoprotein particle assembly (GO:0034379),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,DGAT1
delta,3,medium-chain fatty acid metabolic process (GO:0051791),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,OXSM
delta,3,positive regulation of vacuole organization (GO:0044090),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,SH3GLB1
delta,3,sequestering of actin monomers (GO:0042989),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,PFN4
delta,3,regulation of lysosomal lumen pH (GO:0035751),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,VPS33A
delta,3,histone H2B ubiquitination (GO:0033523),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,PAF1
delta,3,maintenance of epithelial cell apical/basal polarity (GO:0045199),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,PDCD6IP
delta,3,smooth muscle cell differentiation (GO:0051145),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,MKL1
delta,3,protein prenylation (GO:0018342),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,RABGGTB
delta,3,thyroid hormone generation (GO:0006590),1/10,1,10,0.242617311507676,0.642918867157385,0,0,3.64963503649635,5.16886834592563,DIDO1
delta,3,Golgi organization (GO:0007030),5/122,5,122,0.243150340123681,0.642918867157385,0,0,1.49575206413785,2.11510611360366,VMP1;COG4;SURF4;ARHGEF7;TMED5
delta,3,lipid transport (GO:0006869),4/92,4,92,0.245169672087008,0.642918867157385,0,0,1.58679784195494,2.23072797366127,NCOA1;OSBPL8;ABCA5;PSAP
delta,3,regulation of protein catabolic process (GO:0042176),4/92,4,92,0.245169672087008,0.642918867157385,0,0,1.58679784195494,2.23072797366127,SF3B3;PLK2;WWP1;RNF41
delta,3,negative regulation of kinase activity (GO:0033673),4/92,4,92,0.245169672087008,0.642918867157385,0,0,1.58679784195494,2.23072797366127,SOCS2;LRRC4;IRS2;SMCR8
delta,3,positive regulation of type I interferon production (GO:0032481),3/63,3,63,0.248544682053651,0.642918867157385,0,0,1.73792144595064,2.41941717509882,IRAK1;POLR3E;NFKB1
delta,3,positive regulation of catabolic process (GO:0009896),3/63,3,63,0.248544682053651,0.642918867157385,0,0,1.73792144595064,2.41941717509882,PLK2;WWP1;RNF41
delta,3,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",3/63,3,63,0.248544682053651,0.642918867157385,0,0,1.73792144595064,2.41941717509882,RBL2;CNOT11;PLK2
delta,3,response to amino acid (GO:0043200),2/35,2,35,0.248903836760428,0.642918867157385,0,0,2.08550573514077,2.9002891655063,SESN2;CPEB3
delta,3,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),2/35,2,35,0.248903836760428,0.642918867157385,0,0,2.08550573514077,2.9002891655063,TNKS2;MAP3K4
delta,3,endoplasmic reticulum organization (GO:0007029),2/35,2,35,0.248903836760428,0.642918867157385,0,0,2.08550573514077,2.9002891655063,VMP1;EIF2AK3
delta,3,response to glucagon (GO:0033762),2/35,2,35,0.248903836760428,0.642918867157385,0,0,2.08550573514077,2.9002891655063,PRKAR1B;CRY1
delta,3,macromolecule catabolic process (GO:0009057),2/35,2,35,0.248903836760428,0.642918867157385,0,0,2.08550573514077,2.9002891655063,SH3GLB1;PIK3R4
delta,3,regulation of proteolysis (GO:0030162),3/64,3,64,0.255931981344453,0.642918867157385,0,0,1.71076642335766,2.33150701587546,FBXW11;BTBD3;TBC1D10A
delta,3,signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),3/64,3,64,0.255931981344453,0.642918867157385,0,0,1.71076642335766,2.33150701587546,RBL2;CNOT11;PLK2
delta,3,positive regulation of RNA metabolic process (GO:0051254),2/36,2,36,0.259129616310789,0.642918867157385,0,0,2.02757502027575,2.73809183574426,SETX;NFKB1
delta,3,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",2/36,2,36,0.259129616310789,0.642918867157385,0,0,2.02757502027575,2.73809183574426,EXOSC8;EXOSC1
delta,3,negative regulation of cell-substrate adhesion (GO:0010812),2/36,2,36,0.259129616310789,0.642918867157385,0,0,2.02757502027575,2.73809183574426,ACER2;ADAM15
delta,3,negative regulation of protein kinase B signaling (GO:0051898),2/36,2,36,0.259129616310789,0.642918867157385,0,0,2.02757502027575,2.73809183574426,DAG1;PPP2R5C
delta,3,negative regulation of protein complex assembly (GO:0031333),2/36,2,36,0.259129616310789,0.642918867157385,0,0,2.02757502027575,2.73809183574426,TRAF3IP1;SVIP
delta,3,tRNA transport (GO:0051031),2/36,2,36,0.259129616310789,0.642918867157385,0,0,2.02757502027575,2.73809183574426,RANBP2;POM121
delta,3,regulation of mitochondrial membrane potential (GO:0051881),2/36,2,36,0.259129616310789,0.642918867157385,0,0,2.02757502027575,2.73809183574426,HEBP2;SOD1
delta,3,positive regulation of ATPase activity (GO:0032781),2/36,2,36,0.259129616310789,0.642918867157385,0,0,2.02757502027575,2.73809183574426,DNAJB2;DYNC1I1
delta,3,membrane protein proteolysis (GO:0033619),2/36,2,36,0.259129616310789,0.642918867157385,0,0,2.02757502027575,2.73809183574426,DAG1;NFKB1
delta,3,protein kinase B signaling (GO:0043491),2/36,2,36,0.259129616310789,0.642918867157385,0,0,2.02757502027575,2.73809183574426,SETX;MKRN1
delta,3,glucose metabolic process (GO:0006006),3/65,3,65,0.26334911607078,0.642918867157385,0,0,1.68444693992139,2.24751491780883,CRY1;IRS2;OMA1
delta,3,positive regulation of posttranscriptional gene silencing (GO:0060148),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,PUM1
delta,3,negative regulation of defense response to virus (GO:0050687),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,TRAF3IP1
delta,3,regulation of hippo signaling (GO:0035330),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,MARK3
delta,3,interleukin-27-mediated signaling pathway (GO:0070106),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,JAK2
delta,3,microtubule anchoring at microtubule organizing center (GO:0072393),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,HOOK3
delta,3,positive regulation of cell cycle phase transition (GO:1901989),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,PAF1
delta,3,regulation of lipid kinase activity (GO:0043550),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,RBL2
delta,3,morphogenesis of an epithelial sheet (GO:0002011),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,MPP5
delta,3,regulation of trophoblast cell migration (GO:1901163),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,AGO2
delta,3,positive regulation by host of viral process (GO:0044794),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,VAPA
delta,3,positive regulation of superoxide anion generation (GO:0032930),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,SOD1
delta,3,regulation of lamellipodium morphogenesis (GO:2000392),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,ARHGEF7
delta,3,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000059),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,TRIM39
delta,3,negative regulation of JUN kinase activity (GO:0043508),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,AIDA
delta,3,positive regulation of leukocyte degranulation (GO:0043302),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,AP1G1
delta,3,Golgi ribbon formation (GO:0090161),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,TMED5
delta,3,chromatin silencing at rDNA (GO:0000183),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,BAZ2A
delta,3,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,MAP3K5
delta,3,cell-substrate junction assembly (GO:0007044),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,CD151
delta,3,regulation of mitotic centrosome separation (GO:0046602),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,RANBP2
delta,3,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,JAK2
delta,3,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,CEBPB
delta,3,myeloid cell activation involved in immune response (GO:0002275),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,KARS
delta,3,calcium ion regulated exocytosis (GO:0017156),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,PPP3CB
delta,3,mitochondrion distribution (GO:0048311),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,MEF2A
delta,3,negative regulation of amyloid precursor protein catabolic process (GO:1902992),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,CLU
delta,3,T cell proliferation (GO:0042098),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,PPP3CB
delta,3,positive regulation of chromosome segregation (GO:0051984),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,SMC5
delta,3,negative regulation of receptor binding (GO:1900121),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,ADAM15
delta,3,protein kinase C signaling (GO:0070528),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,ADAM15
delta,3,methionine metabolic process (GO:0006555),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,MTR
delta,3,protein localization to mitochondrion (GO:0070585),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,MARCH5
delta,3,response to nitric oxide (GO:0071731),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,MTR
delta,3,photoreceptor cell development (GO:0042461),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,CEP290
delta,3,heart process (GO:0003015),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,SOD1
delta,3,modulation by host of viral genome replication (GO:0044827),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,VAPA
delta,3,establishment of synaptic vesicle localization (GO:0097480),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,TMEM230
delta,3,positive regulation of fatty acid oxidation (GO:0046321),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,IRS2
delta,3,magnesium ion transport (GO:0015693),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,NIPA2
delta,3,positive regulation of glucose metabolic process (GO:0010907),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,IRS2
delta,3,hemidesmosome assembly (GO:0031581),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,CD151
delta,3,aspartate family amino acid biosynthetic process (GO:0009067),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,MTR
delta,3,glutathione biosynthetic process (GO:0006750),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,GCLM
delta,3,regulation of autophagosome maturation (GO:1901096),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,SMCR8
delta,3,interleukin-35-mediated signaling pathway (GO:0070757),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,JAK2
delta,3,regulation of mRNA polyadenylation (GO:1900363),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,CPEB3
delta,3,hepatocyte growth factor receptor signaling pathway (GO:0048012),1/11,1,11,0.263379948598949,0.642918867157385,0,0,3.3178500331785,4.42653489668003,STMN1
delta,3,sodium ion transmembrane transport (GO:0035725),2/37,2,37,0.26935990349095,0.649150187902973,0,0,1.97277569540343,2.58770341767526,SLC12A1;NALCN
delta,3,regulation of response to DNA damage stimulus (GO:2001020),2/37,2,37,0.26935990349095,0.649150187902973,0,0,1.97277569540343,2.58770341767526,SMG1;CRY1
delta,3,mRNA catabolic process (GO:0006402),2/37,2,37,0.26935990349095,0.649150187902973,0,0,1.97277569540343,2.58770341767526,PDE12;DXO
delta,3,histone deacetylation (GO:0016575),2/37,2,37,0.26935990349095,0.649150187902973,0,0,1.97277569540343,2.58770341767526,SFPQ;BAZ2A
delta,3,regulation of cell morphogenesis involved in differentiation (GO:0010769),2/37,2,37,0.26935990349095,0.649150187902973,0,0,1.97277569540343,2.58770341767526,RUFY3;CHN1
delta,3,acylglycerol metabolic process (GO:0006639),2/37,2,37,0.26935990349095,0.649150187902973,0,0,1.97277569540343,2.58770341767526,ABHD12;DGAT1
delta,3,glutamate receptor signaling pathway (GO:0007215),2/37,2,37,0.26935990349095,0.649150187902973,0,0,1.97277569540343,2.58770341767526,APP;HOMER1
delta,3,cellular response to reactive oxygen species (GO:0034614),3/66,3,66,0.270792502239738,0.649150187902973,0,0,1.65892501658925,2.16722366584754,SETX;MTR;MAP3K5
delta,3,negative regulation of cell adhesion (GO:0007162),3/66,3,66,0.270792502239738,0.649150187902973,0,0,1.65892501658925,2.16722366584754,ACER2;CD164;PDE3B
delta,3,protein localization to nucleus (GO:0034504),4/97,4,97,0.27536013661127,0.649150187902973,0,0,1.50500413876138,1.94096689051131,RANBP2;POM121;PAF1;GPN3
delta,3,intracellular steroid hormone receptor signaling pathway (GO:0030518),3/67,3,67,0.278258630993204,0.649150187902973,0,0,1.63416494171478,2.0904307720842,NCOA1;WBP2;NRIP1
delta,3,JNK cascade (GO:0007254),3/67,3,67,0.278258630993204,0.649150187902973,0,0,1.63416494171478,2.0904307720842,IRAK1;MAPK8IP3;MAP3K5
delta,3,positive regulation of receptor activity (GO:2000273),2/38,2,38,0.279586788609905,0.649150187902973,0,0,1.92086054552439,2.44802635569801,FBXW7;BUD31
delta,3,phospholipid biosynthetic process (GO:0008654),2/38,2,38,0.279586788609905,0.649150187902973,0,0,1.92086054552439,2.44802635569801,DGKE;SGMS2
delta,3,protein K63-linked ubiquitination (GO:0070534),2/38,2,38,0.279586788609905,0.649150187902973,0,0,1.92086054552439,2.44802635569801,ARIH2;UBE2E2
delta,3,regulation of osteoclast differentiation (GO:0045670),2/38,2,38,0.279586788609905,0.649150187902973,0,0,1.92086054552439,2.44802635569801,CEBPB;MAFB
delta,3,regulation of carbohydrate catabolic process (GO:0043470),2/38,2,38,0.279586788609905,0.649150187902973,0,0,1.92086054552439,2.44802635569801,RANBP2;POM121
delta,3,negative regulation of Ras protein signal transduction (GO:0046580),2/38,2,38,0.279586788609905,0.649150187902973,0,0,1.92086054552439,2.44802635569801,STMN1;RASAL2
delta,3,cell morphogenesis involved in neuron differentiation (GO:0048667),4/98,4,98,0.281473849079389,0.649150187902973,0,0,1.48964695367198,1.88844888156169,MEF2A;APP;BTBD3;LLGL1
delta,3,cellular response to organonitrogen compound (GO:0071417),4/98,4,98,0.281473849079389,0.649150187902973,0,0,1.48964695367198,1.88844888156169,SESN2;CTNNA1;CPEB3;ACTB
delta,3,protein localization to organelle (GO:0033365),4/98,4,98,0.281473849079389,0.649150187902973,0,0,1.48964695367198,1.88844888156169,VAPA;IFT140;PAF1;MARCH5
delta,3,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,SVIP
delta,3,rRNA 3'-end processing (GO:0031125),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,EXOSC8
delta,3,negative regulation of protein oligomerization (GO:0032460),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,CLU
delta,3,ribose phosphate metabolic process (GO:0019693),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,PGD
delta,3,pentose-phosphate shunt (GO:0006098),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,PGD
delta,3,pyrimidine nucleoside salvage (GO:0043097),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,UCK2
delta,3,cellular modified amino acid catabolic process (GO:0042219),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,PCYOX1
delta,3,viral RNA genome replication (GO:0039694),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,PI4KA
delta,3,cell differentiation in hindbrain (GO:0021533),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,CBLN1
delta,3,regulation of long-term neuronal synaptic plasticity (GO:0048169),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,APP
delta,3,Golgi localization (GO:0051645),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,HOOK3
delta,3,oligodendrocyte development (GO:0014003),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,EIF2B5
delta,3,cellular response to arsenic-containing substance (GO:0071243),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,CPEB2
delta,3,mitochondrion transport along microtubule (GO:0047497),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,RHOT1
delta,3,lysine catabolic process (GO:0006554),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,GCDH
delta,3,nonribosomal peptide biosynthetic process (GO:0019184),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,GCLM
delta,3,positive regulation of keratinocyte differentiation (GO:0045618),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,PRKCH
delta,3,eye photoreceptor cell development (GO:0042462),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,CEP290
delta,3,histone H3 deacetylation (GO:0070932),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,SFPQ
delta,3,lysine metabolic process (GO:0006553),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,GCDH
delta,3,activation of cysteine-type endopeptidase activity (GO:0097202),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,TBC1D10A
delta,3,regulation of mononuclear cell migration (GO:0071675),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,KARS
delta,3,positive regulation of peptidase activity (GO:0010952),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,KARS
delta,3,response to interleukin-6 (GO:0070741),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,NFKB1
delta,3,negative regulation of epithelial cell differentiation (GO:0030857),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,ZEB1
delta,3,ribosomal subunit export from nucleus (GO:0000054),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,ABCE1
delta,3,negative regulation of ATP metabolic process (GO:1903579),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,PDE12
delta,3,regulation of blood vessel size (GO:0050880),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,GCLM
delta,3,PERK-mediated unfolded protein response (GO:0036499),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,EIF2AK3
delta,3,pyrimidine-containing compound salvage (GO:0008655),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,UCK2
delta,3,regulation of T cell differentiation in thymus (GO:0033081),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,SOD1
delta,3,microtubule anchoring (GO:0034453),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,DAG1
delta,3,eye photoreceptor cell differentiation (GO:0001754),1/12,1,12,0.283574415249009,0.649150187902973,0,0,3.04136253041363,3.83297050671338,CEP290
delta,3,regulation of macromolecule metabolic process (GO:0060255),5/130,5,130,0.284836556083145,0.649235616845069,0,0,1.40370578326783,1.76282952084203,APP;EIF4A1;TOB2;ZNF335;PRDM10
delta,3,negative regulation of protein binding (GO:0032091),3/68,3,68,0.285744069918488,0.649235616845069,0,0,1.61013310433663,2.01694728834333,DNAJB2;ADAM15;ACTB
delta,3,extrinsic apoptotic signaling pathway (GO:0097191),3/68,3,68,0.285744069918488,0.649235616845069,0,0,1.61013310433663,2.01694728834333,MOAP1;JAK2;RNF41
delta,3,phosphatidylinositol biosynthetic process (GO:0006661),4/99,4,99,0.28760823720679,0.649235616845069,0,0,1.474600014746,1.83758167419229,PIK3R4;PI4KA;PIGW;PIK3C2B
delta,3,regulation of insulin secretion (GO:0050796),4/99,4,99,0.28760823720679,0.649235616845069,0,0,1.474600014746,1.83758167419229,PPP3CB;SLC30A8;SLC2A1;IRS2
delta,3,regulation of cellular amide metabolic process (GO:0034248),2/39,2,39,0.289802790580954,0.649235616845069,0,0,1.87160771102377,2.31808837695687,APP;CYFIP1
delta,3,DNA damage checkpoint (GO:0000077),2/39,2,39,0.289802790580954,0.649235616845069,0,0,1.87160771102377,2.31808837695687,RBBP8;CLSPN
delta,3,positive regulation of innate immune response (GO:0045089),2/39,2,39,0.289802790580954,0.649235616845069,0,0,1.87160771102377,2.31808837695687,ANKRD17;PUM1
delta,3,retina homeostasis (GO:0001895),2/39,2,39,0.289802790580954,0.649235616845069,0,0,1.87160771102377,2.31808837695687,ACTB;SOD1
delta,3,regulation of epithelial to mesenchymal transition (GO:0010717),3/69,3,69,0.293245464063601,0.649235616845069,0,0,1.58679784195494,1.94659673021578,PHLDB1;SDHAF2;DAG1
delta,3,protein sumoylation (GO:0016925),3/69,3,69,0.293245464063601,0.649235616845069,0,0,1.58679784195494,1.94659673021578,RANBP2;POM121;UBE2I
delta,3,signal transduction by p53 class mediator (GO:0072331),2/40,2,40,0.300000839293066,0.649235616845069,0,0,1.82481751824818,2.19702555964653,PAXIP1;SESN2
delta,3,regulation of proteasomal protein catabolic process (GO:0061136),2/40,2,40,0.300000839293066,0.649235616845069,0,0,1.82481751824818,2.19702555964653,FBXW7;TMTC3
delta,3,positive regulation of peptide hormone secretion (GO:0090277),2/40,2,40,0.300000839293066,0.649235616845069,0,0,1.82481751824818,2.19702555964653,SLC30A8;IRS2
delta,3,positive regulation of fat cell differentiation (GO:0045600),2/40,2,40,0.300000839293066,0.649235616845069,0,0,1.82481751824818,2.19702555964653,CEBPB;ASXL2
delta,3,positive regulation of reactive oxygen species metabolic process (GO:2000379),2/40,2,40,0.300000839293066,0.649235616845069,0,0,1.82481751824818,2.19702555964653,RNF41;SOD1
delta,3,mitotic DNA damage checkpoint (GO:0044773),2/40,2,40,0.300000839293066,0.649235616845069,0,0,1.82481751824818,2.19702555964653,CLSPN;ORAOV1
delta,3,acyl-CoA metabolic process (GO:0006637),2/40,2,40,0.300000839293066,0.649235616845069,0,0,1.82481751824818,2.19702555964653,OXSM;DBI
delta,3,DNA biosynthetic process (GO:0071897),2/40,2,40,0.300000839293066,0.649235616845069,0,0,1.82481751824818,2.19702555964653,TOP3A;RBBP8
delta,3,regulation of coenzyme metabolic process (GO:0051196),2/40,2,40,0.300000839293066,0.649235616845069,0,0,1.82481751824818,2.19702555964653,RANBP2;POM121
delta,3,positive regulation of neurogenesis (GO:0050769),3/70,3,70,0.300759536799757,0.649235616845069,0,0,1.56412930135558,1.87921409995733,FZD3;ZEB1;ZNF335
delta,3,modulation by virus of host process (GO:0019054),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,VAPA
delta,3,positive regulation of histone H3-K4 methylation (GO:0051571),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,PAXIP1
delta,3,negative regulation of macrophage derived foam cell differentiation (GO:0010745),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,ABCA5
delta,3,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,JAK2
delta,3,regulation of granulocyte chemotaxis (GO:0071622),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,KARS
delta,3,regulation of plasma membrane bounded cell projection organization (GO:0120035),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,FBXO7
delta,3,mitochondrial genome maintenance (GO:0000002),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,MEF2A
delta,3,regulation of superoxide anion generation (GO:0032928),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,SOD1
delta,3,glycerolipid catabolic process (GO:0046503),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,ABHD12
delta,3,regulation of NMDA receptor activity (GO:2000310),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,APP
delta,3,regulation of cell aging (GO:0090342),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,MARCH5
delta,3,DNA replication-independent nucleosome organization (GO:0034724),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,ASF1B
delta,3,positive regulation of cellular carbohydrate metabolic process (GO:0010676),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,IRS2
delta,3,chromatin assembly or disassembly (GO:0006333),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,GATAD1
delta,3,regulation of glucose import in response to insulin stimulus (GO:2001273),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,OSBPL8
delta,3,positive regulation of glycogen biosynthetic process (GO:0045725),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,IRS2
delta,3,regulation of triglyceride biosynthetic process (GO:0010866),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,FBXW7
delta,3,myelination in peripheral nervous system (GO:0022011),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,SOD1
delta,3,positive regulation of actin nucleation (GO:0051127),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,CYFIP1
delta,3,regulation of axon guidance (GO:1902667),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,ZSWIM8
delta,3,copper ion homeostasis (GO:0055070),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,APP
delta,3,phosphate ion transport (GO:0006817),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,SLC20A1
delta,3,tetrahydrofolate metabolic process (GO:0046653),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,ST20-MTHFS
delta,3,synaptic vesicle localization (GO:0097479),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,TMEM230
delta,3,regulation of execution phase of apoptosis (GO:1900117),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,FZD3
delta,3,protein neddylation (GO:0045116),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,DCUN1D1
delta,3,protein localization to endoplasmic reticulum (GO:0070972),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,VAPA
delta,3,regulation of necrotic cell death (GO:0010939),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,HEBP2
delta,3,dicarboxylic acid catabolic process (GO:0043649),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,PM20D2
delta,3,motile cilium assembly (GO:0044458),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,SPATA6
delta,3,positive regulation of lamellipodium assembly (GO:0010592),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,ARPC2
delta,3,RNA interference (GO:0016246),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,AGO2
delta,3,mammary gland epithelium development (GO:0061180),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,JAK2
delta,3,regulation of cAMP-dependent protein kinase activity (GO:2000479),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,PRKAR1B
delta,3,negative regulation of blood pressure (GO:0045776),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,RNPEP
delta,3,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,PAXIP1
delta,3,regulation of leukocyte migration (GO:0002685),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,STK10
delta,3,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,TSEN54
delta,3,pre-miRNA processing (GO:0031054),1/13,1,13,0.303216231722307,0.649235616845069,0,0,2.80741156653565,3.35010974717202,AGO2
delta,3,regulation of protein ubiquitination (GO:0031396),4/102,4,102,0.306116551764821,0.653569726975324,0,0,1.431229426077,1.69427416835393,DNAJB2;PAXIP1;FBXW7;CRY1
delta,3,regulation of kinase activity (GO:0043549),4/102,4,102,0.306116551764821,0.653569726975324,0,0,1.431229426077,1.69427416835393,RBL2;EPHA6;IRS2;SOD1
delta,3,regulation of Notch signaling pathway (GO:0008593),3/71,3,71,0.308283090668706,0.653569726975324,0,0,1.54209931119564,1.81464499732403,GALNT11;FBXW7;LLGL1
delta,3,vascular endothelial growth factor receptor signaling pathway (GO:0048010),3/71,3,71,0.308283090668706,0.653569726975324,0,0,1.54209931119564,1.81464499732403,CYFIP1;NCK2;ACTB
delta,3,phospholipid metabolic process (GO:0006644),3/71,3,71,0.308283090668706,0.653569726975324,0,0,1.54209931119564,1.81464499732403,DGKE;LPCAT4;FDFT1
delta,3,interferon-gamma-mediated signaling pathway (GO:0060333),3/71,3,71,0.308283090668706,0.653569726975324,0,0,1.54209931119564,1.81464499732403,NCAM1;HLA-A;JAK2
delta,3,negative regulation of developmental process (GO:0051093),3/71,3,71,0.308283090668706,0.653569726975324,0,0,1.54209931119564,1.81464499732403,FBXW7;OMA1;MARCH5
delta,3,cognition (GO:0050890),2/41,2,41,0.310174258952054,0.653569726975324,0,0,1.78030977390066,2.08406803237422,CYFIP1;TTC8
delta,3,androgen receptor signaling pathway (GO:0030521),2/41,2,41,0.310174258952054,0.653569726975324,0,0,1.78030977390066,2.08406803237422,NCOA1;NRIP1
delta,3,response to peptide hormone (GO:0043434),2/41,2,41,0.310174258952054,0.653569726975324,0,0,1.78030977390066,2.08406803237422,EIF2B5;CRY1
delta,3,phosphatidic acid biosynthetic process (GO:0006654),2/41,2,41,0.310174258952054,0.653569726975324,0,0,1.78030977390066,2.08406803237422,LPCAT4;ABHD5
delta,3,regulation of release of cytochrome c from mitochondria (GO:0090199),2/41,2,41,0.310174258952054,0.653569726975324,0,0,1.78030977390066,2.08406803237422,MOAP1;CLU
delta,3,negative regulation of catabolic process (GO:0009895),2/41,2,41,0.310174258952054,0.653569726975324,0,0,1.78030977390066,2.08406803237422,SF3B3;PDE3B
delta,3,regulation of cholesterol biosynthetic process (GO:0045540),2/41,2,41,0.310174258952054,0.653569726975324,0,0,1.78030977390066,2.08406803237422,FDFT1;SOD1
delta,3,JAK-STAT cascade (GO:0007259),2/41,2,41,0.310174258952054,0.653569726975324,0,0,1.78030977390066,2.08406803237422,SOCS2;JAK2
delta,3,positive regulation of lymphocyte proliferation (GO:0050671),3/72,3,72,0.315813007695506,0.655527966929197,0,0,1.52068126520681,1.75274481196181,NCK2;IRS2;ZNF335
delta,3,histone acetylation (GO:0016573),3/72,3,72,0.315813007695506,0.655527966929197,0,0,1.52068126520681,1.75274481196181,ING5;KAT6A;ELP4
delta,3,response to insulin (GO:0032868),3/72,3,72,0.315813007695506,0.655527966929197,0,0,1.52068126520681,1.75274481196181,PDE3B;IRS2;CPEB2
delta,3,phosphatidic acid metabolic process (GO:0046473),2/42,2,42,0.320316751642283,0.655527966929197,0,0,1.73792144595064,1.97852784825094,LPCAT4;ABHD5
delta,3,peptide transport (GO:0015833),2/42,2,42,0.320316751642283,0.655527966929197,0,0,1.73792144595064,1.97852784825094,ZFYVE9;CEP290
delta,3,regulation of stress-activated MAPK cascade (GO:0032872),2/42,2,42,0.320316751642283,0.655527966929197,0,0,1.73792144595064,1.97852784825094,MAPK8IP3;MAP4K4
delta,3,spliceosomal complex assembly (GO:0000245),2/42,2,42,0.320316751642283,0.655527966929197,0,0,1.73792144595064,1.97852784825094,SETX;SRSF1
delta,3,negative regulation of STAT cascade (GO:1904893),2/42,2,42,0.320316751642283,0.655527966929197,0,0,1.73792144595064,1.97852784825094,SOCS2;LRRC4
delta,3,regulation of cellular metabolic process (GO:0031323),2/42,2,42,0.320316751642283,0.655527966929197,0,0,1.73792144595064,1.97852784825094,PM20D2;RNF41
delta,3,regulation of protein localization (GO:0032880),2/42,2,42,0.320316751642283,0.655527966929197,0,0,1.73792144595064,1.97852784825094,FBXW7;CEP290
delta,3,regulation of fibroblast migration (GO:0010762),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,ARHGEF7
delta,3,nucleoside salvage (GO:0043174),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,UCK2
delta,3,glucosamine-containing compound metabolic process (GO:1901071),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,MGEA5
delta,3,ubiquinone metabolic process (GO:0006743),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,COQ6
delta,3,negative regulation of Rho protein signal transduction (GO:0035024),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,STMN1
delta,3,negative regulation of hemopoiesis (GO:1903707),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,PAF1
delta,3,cell surface receptor signaling pathway involved in heart development (GO:0061311),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,GALNT11
delta,3,thymus development (GO:0048538),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,SOD1
delta,3,oligodendrocyte differentiation (GO:0048709),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,EIF2B5
delta,3,positive regulation of mitochondrial fission (GO:0090141),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,MARCH5
delta,3,regulation of defense response to virus (GO:0050688),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,TRAF3IP1
delta,3,positive regulation of glycogen metabolic process (GO:0070875),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,IRS2
delta,3,response to ethanol (GO:0045471),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,SOD1
delta,3,quinone biosynthetic process (GO:1901663),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,COQ6
delta,3,regulation of fatty acid metabolic process (GO:0019217),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,ADIPOR2
delta,3,Golgi to vacuole transport (GO:0006896),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,AP1G1
delta,3,epiboly involved in wound healing (GO:0090505),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,CD151
delta,3,cellular response to nitrogen compound (GO:1901699),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,PDE12
delta,3,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,TSEN54
delta,3,positive regulation of muscle hypertrophy (GO:0014742),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,MEF2A
delta,3,interleukin-6-mediated signaling pathway (GO:0070102),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,JAK2
delta,3,regulation of protein modification by small protein conjugation or removal (GO:1903320),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,DNAJB2
delta,3,regulation of response to interferon-gamma (GO:0060330),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,JAK2
delta,3,establishment of protein localization to chromosome (GO:0070199),1/14,1,14,0.322320495062821,0.655527966929197,0,0,2.60688216892596,2.95153519855173,NABP2
delta,3,cell-cell junction organization (GO:0045216),3/73,3,73,0.323346249896764,0.656270682885465,0,0,1.4998500149985,1.69337798542606,TJP1;CTNNA1;ANG
delta,3,regulation of neuron death (GO:1901214),3/73,3,73,0.323346249896764,0.656270682885465,0,0,1.4998500149985,1.69337798542606,ZNF746;CLU;MAP3K5
delta,3,positive regulation of transferase activity (GO:0051347),5/138,5,138,0.327727070054452,0.656368272319085,0,0,1.32233153496245,1.47515883909975,EPHA6;UBE2I;FBXW7;DCUN1D1;MAP3K4
delta,3,positive regulation of protein localization to nucleus (GO:1900182),2/43,2,43,0.330422381929197,0.656368272319085,0,0,1.69750466813784,1.87978865678703,SESN2;EIF2AK3
delta,3,glycolipid biosynthetic process (GO:0009247),2/43,2,43,0.330422381929197,0.656368272319085,0,0,1.69750466813784,1.87978865678703,PIGW;ST6GALNAC5
delta,3,regulation of ion transmembrane transporter activity (GO:0032412),2/43,2,43,0.330422381929197,0.656368272319085,0,0,1.69750466813784,1.87978865678703,HOMER1;UTRN
delta,3,ceramide metabolic process (GO:0006672),2/43,2,43,0.330422381929197,0.656368272319085,0,0,1.69750466813784,1.87978865678703,CERS6;SGMS2
delta,3,nucleic acid phosphodiester bond hydrolysis (GO:0090305),3/74,3,74,0.330879859542009,0.656368272319085,0,0,1.47958177155257,1.63641733813449,PDE12;DXO;ERCC5
delta,3,eye development (GO:0001654),2/44,2,44,0.340485561532272,0.656368272319085,0,0,1.65892501658925,1.78729687792762,BLOC1S3;ZDHHC16
delta,3,response to unfolded protein (GO:0006986),2/44,2,44,0.340485561532272,0.656368272319085,0,0,1.65892501658925,1.78729687792762,DNAJB2;HSPA4L
delta,3,regulation of ATP metabolic process (GO:1903578),2/44,2,44,0.340485561532272,0.656368272319085,0,0,1.65892501658925,1.78729687792762,RANBP2;POM121
delta,3,regulation of multicellular organismal development (GO:2000026),2/44,2,44,0.340485561532272,0.656368272319085,0,0,1.65892501658925,1.78729687792762,PHLDB1;DAG1
delta,3,positive regulation of peptidyl-lysine acetylation (GO:2000758),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,PAXIP1
delta,3,myeloid cell development (GO:0061515),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,APP
delta,3,pseudouridine synthesis (GO:0001522),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,RPUSD4
delta,3,ubiquinone biosynthetic process (GO:0006744),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,COQ6
delta,3,heparan sulfate proteoglycan biosynthetic process (GO:0015012),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,EXTL3
delta,3,regulation of protein homooligomerization (GO:0032462),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,CLU
delta,3,pyrimidine nucleoside biosynthetic process (GO:0046134),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,UCK2
delta,3,substrate-dependent cell migration (GO:0006929),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,ITGA2
delta,3,negative regulation of TORC1 signaling (GO:1904262),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,SESN2
delta,3,G-protein coupled glutamate receptor signaling pathway (GO:0007216),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,HOMER1
delta,3,regulation of mitotic metaphase/anaphase transition (GO:0030071),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,NSMCE2
delta,3,positive regulation of cytokine production involved in immune response (GO:0002720),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,KARS
delta,3,regulation of interleukin-4 production (GO:0032673),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,CEBPB
delta,3,regulation of establishment of cell polarity (GO:2000114),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,RUFY3
delta,3,positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,PAF1
delta,3,glycerophospholipid catabolic process (GO:0046475),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,ABHD12
delta,3,negative regulation of cell aging (GO:0090344),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,MARCH5
delta,3,N-acetylglucosamine metabolic process (GO:0006044),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,MGEA5
delta,3,mitochondrion localization (GO:0051646),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,MEF2A
delta,3,pyrimidine nucleoside metabolic process (GO:0006213),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,ERH
delta,3,intra-S DNA damage checkpoint (GO:0031573),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,ORAOV1
delta,3,negative regulation of lipid catabolic process (GO:0050995),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,PDE3B
delta,3,negative regulation of release of cytochrome c from mitochondria (GO:0090201),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,CLU
delta,3,regulation of mitotic sister chromatid separation (GO:0010965),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,PTTG1
delta,3,positive regulation of viral release from host cell (GO:1902188),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,VAPA
delta,3,vasculature development (GO:0001944),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,FBXW7
delta,3,regulation of macrophage chemotaxis (GO:0010758),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,KARS
delta,3,positive regulation of cellular response to insulin stimulus (GO:1900078),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,OSBPL8
delta,3,positive regulation of interleukin-4 production (GO:0032753),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,CEBPB
delta,3,negative regulation of DNA-dependent DNA replication (GO:2000104),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,FBXW7
delta,3,positive regulation of NF-kappaB import into nucleus (GO:0042346),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,APP
delta,3,microtubule depolymerization (GO:0007019),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,STMN1
delta,3,monovalent inorganic anion homeostasis (GO:0055083),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,SLC12A1
delta,3,protein O-linked fucosylation (GO:0036066),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,SLC35C1
delta,3,positive regulation of exosomal secretion (GO:1903543),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,PDCD6IP
delta,3,JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,JAK2
delta,3,regulation of RNA export from nucleus (GO:0046831),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,KHDRBS1
delta,3,regulation of lymphocyte proliferation (GO:0050670),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,ZNF335
delta,3,toll-like receptor 4 signaling pathway (GO:0034142),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,IRAK1
delta,3,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,JAK2
delta,3,negative regulation of anoikis (GO:2000811),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,PTRH2
delta,3,endoderm development (GO:0007492),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,DUSP5
delta,3,establishment of protein localization to endoplasmic reticulum (GO:0072599),1/15,1,15,0.340901890806892,0.656368272319085,0,0,2.4330900243309,2.61839550690723,SPCS1
delta,3,viral life cycle (GO:0019058),4/108,4,108,0.343442100740993,0.659766379761116,0,0,1.35171668018383,1.44462927591485,RANBP2;POM121;PDCD6IP;WWP1
delta,3,mitochondrial translation (GO:0032543),4/108,4,108,0.343442100740993,0.659766379761116,0,0,1.35171668018383,1.44462927591485,MRPL2;MRPS23;MRPL14;MTRF1L
delta,3,positive regulation of Wnt signaling pathway (GO:0030177),5/141,5,141,0.343994951903632,0.659766379761116,0,0,1.29419682145261,1.38107404930263,PSMA3;PSMA1;TNKS2;SPIN1;NFKB1
delta,3,inorganic cation transmembrane transport (GO:0098662),5/141,5,141,0.343994951903632,0.659766379761116,0,0,1.29419682145261,1.38107404930263,SLC30A8;TRPC1;SLC12A1;NALCN;TMCO1
delta,3,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",3/76,3,76,0.34593675174167,0.660963314619986,0,0,1.4406454091433,1.52924412082486,PSMA3;PSMA1;HLA-A
delta,3,"DNA-templated transcription, elongation (GO:0006354)",4/109,4,109,0.349682602860998,0.660963314619986,0,0,1.33931560972343,1.40725826679641,TAF1D;PAF1;NELFA;ELP4
delta,3,cholesterol transport (GO:0030301),2/45,2,45,0.350501035056587,0.660963314619986,0,0,1.6220600162206,1.7005541272117,ABCA5;CLU
delta,3,adherens junction organization (GO:0034332),2/45,2,45,0.350501035056587,0.660963314619986,0,0,1.6220600162206,1.7005541272117,CTNNA1;ANG
delta,3,positive regulation of intracellular transport (GO:0032388),2/45,2,45,0.350501035056587,0.660963314619986,0,0,1.6220600162206,1.7005541272117,RUFY3;CEP290
delta,3,negative regulation of type I interferon production (GO:0032480),2/45,2,45,0.350501035056587,0.660963314619986,0,0,1.6220600162206,1.7005541272117,TRAF3IP1;REL
delta,3,protein N-linked glycosylation via asparagine (GO:0018279),2/45,2,45,0.350501035056587,0.660963314619986,0,0,1.6220600162206,1.7005541272117,ALG5;ST6GALNAC5
delta,3,mitotic nuclear envelope disassembly (GO:0007077),2/45,2,45,0.350501035056587,0.660963314619986,0,0,1.6220600162206,1.7005541272117,RANBP2;POM121
delta,3,myeloid cell differentiation (GO:0030099),2/45,2,45,0.350501035056587,0.660963314619986,0,0,1.6220600162206,1.7005541272117,KAT6A;JAK2
delta,3,transforming growth factor beta receptor signaling pathway (GO:0007179),3/77,3,77,0.353454520265321,0.660963314619986,0,0,1.42193572850507,1.47881380813251,ZFYVE9;TGFBRAP1;SMAD5
delta,3,positive regulation of JNK cascade (GO:0046330),3/77,3,77,0.353454520265321,0.660963314619986,0,0,1.42193572850507,1.47881380813251,APP;MAP3K4;MAP3K5
delta,3,hemopoiesis (GO:0030097),3/77,3,77,0.353454520265321,0.660963314619986,0,0,1.42193572850507,1.47881380813251,CD164;ZNF160;KAT6A
delta,3,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),4/110,4,110,0.355924220885304,0.660963314619986,0,0,1.3271400132714,1.37098531316564,ACER2;EIF2AK3;JAK2;MAP3K5
delta,3,protein localization to microtubule organizing center (GO:1905508),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,HOOK3
delta,3,lipopolysaccharide-mediated signaling pathway (GO:0031663),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,IRAK1
delta,3,Notch receptor processing (GO:0007220),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,GALNT11
delta,3,glucose transmembrane transport (GO:1904659),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,SLC2A1
delta,3,cellular response to dsRNA (GO:0071359),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,PDE12
delta,3,DNA alkylation (GO:0006305),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,BAZ2A
delta,3,establishment of skin barrier (GO:0061436),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,STMN1
delta,3,glucose 6-phosphate metabolic process (GO:0051156),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,PGD
delta,3,hyaluronan catabolic process (GO:0030214),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,TMEM2
delta,3,activation of NF-kappaB-inducing kinase activity (GO:0007250),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,IRAK1
delta,3,regulation of exosomal secretion (GO:1903541),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,PDCD6IP
delta,3,regulation of water loss via skin (GO:0033561),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,STMN1
delta,3,sympathetic nervous system development (GO:0048485),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,FZD3
delta,3,regulation of histone H3-K4 methylation (GO:0051569),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,PAXIP1
delta,3,positive regulation of mRNA processing (GO:0050685),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,PAF1
delta,3,guanosine-containing compound metabolic process (GO:1901068),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,RAB23
delta,3,positive regulation of cardiac muscle hypertrophy (GO:0010613),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,MEF2A
delta,3,DNA methylation or demethylation (GO:0044728),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,BAZ2A
delta,3,neuron apoptotic process (GO:0051402),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,APP
delta,3,negative regulation of DNA recombination (GO:0045910),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,TERF2IP
delta,3,miRNA metabolic process (GO:0010586),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,AGO2
delta,3,positive regulation of triglyceride metabolic process (GO:0090208),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,ABHD5
delta,3,regulation of protein homodimerization activity (GO:0043496),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,AIDA
delta,3,activation of protein kinase A activity (GO:0034199),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,PRKAR1B
delta,3,ruffle organization (GO:0031529),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,CYFIP1
delta,3,regulation of glucose transport (GO:0010827),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,SLC2A1
delta,3,mesenchyme development (GO:0060485),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,CRELD1
delta,3,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),1/16,1,16,0.358974703797025,0.660963314619986,0,0,2.28102189781022,2.33691458927332,CLU
delta,3,peptidyl-asparagine modification (GO:0018196),2/46,2,46,0.360463865769065,0.660963314619986,0,0,1.58679784195494,1.61911069649503,ALG5;ST6GALNAC5
delta,3,metal ion homeostasis (GO:0055065),2/46,2,46,0.360463865769065,0.660963314619986,0,0,1.58679784195494,1.61911069649503,SLC12A1;CNNM4
delta,3,macroautophagy (GO:0016236),4/111,4,111,0.362165340303939,0.660963314619986,0,0,1.31518379693562,1.33577224996352,VMP1;VPS33A;PIK3R4;SNAP29
delta,3,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),4/111,4,111,0.362165340303939,0.660963314619986,0,0,1.31518379693562,1.33577224996352,SH3GLB1;HHAT;FBXW7;ARIH2
delta,3,cellular response to insulin stimulus (GO:0032869),4/111,4,111,0.362165340303939,0.660963314619986,0,0,1.31518379693562,1.33577224996352,PDE3B;ATP6V1H;IRS2;CPEB2
delta,3,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),5/145,5,145,0.365760656805535,0.660963314619986,0,0,1.25849484017116,1.26576403555139,IRAK1;ZFYVE9;TGFBRAP1;SMAD5;RNF111
delta,3,regulation of protein binding (GO:0043393),4/112,4,112,0.368404376516272,0.660963314619986,0,0,1.30344108446298,1.30158250114326,DNAJB2;APP;AIDA;ACTB
delta,3,positive regulation of translation (GO:0045727),3/79,3,79,0.368455516374914,0.660963314619986,0,0,1.38593735563153,1.38376876564715,EIF2B5;KHDRBS1;CPEB3
delta,3,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),3/79,3,79,0.368455516374914,0.660963314619986,0,0,1.38593735563153,1.38376876564715,PSMA3;PSMA1;HLA-A
delta,3,fibroblast growth factor receptor signaling pathway (GO:0008543),3/79,3,79,0.368455516374914,0.660963314619986,0,0,1.38593735563153,1.38376876564715,SETX;HNRNPM;HNRNPF
delta,3,protein complex disassembly (GO:0043241),2/47,2,47,0.370369422414666,0.660963314619986,0,0,1.55303618574313,1.54255992000926,VPS33A;SNAP29
delta,3,nuclear envelope disassembly (GO:0051081),2/47,2,47,0.370369422414666,0.660963314619986,0,0,1.55303618574313,1.54255992000926,RANBP2;POM121
delta,3,RNA secondary structure unwinding (GO:0010501),2/47,2,47,0.370369422414666,0.660963314619986,0,0,1.55303618574313,1.54255992000926,EIF4A1;AGO2
delta,3,regulation of generation of precursor metabolites and energy (GO:0043467),2/47,2,47,0.370369422414666,0.660963314619986,0,0,1.55303618574313,1.54255992000926,RANBP2;POM121
delta,3,positive regulation of ion transport (GO:0043270),2/47,2,47,0.370369422414666,0.660963314619986,0,0,1.55303618574313,1.54255992000926,STIM2;ORAI1
delta,3,peptidyl-serine phosphorylation (GO:0018105),5/146,5,146,0.371208131746531,0.660963314619986,0,0,1.24987501249875,1.23861660292132,SMG1;PRKCH;PLK2;EIF2AK3;CLSPN
delta,3,negative regulation of mitotic cell cycle phase transition (GO:1901991),3/80,3,80,0.375933708190536,0.660963314619986,0,0,1.36861313868613,1.33897234371381,RBL2;PSMA3;PSMA1
delta,3,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),3/80,3,80,0.375933708190536,0.660963314619986,0,0,1.36861313868613,1.33897234371381,ACER2;EIF2AK3;JAK2
delta,3,cardiac myofibril assembly (GO:0055003),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,MEF2A
delta,3,high-density lipoprotein particle remodeling (GO:0034375),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,ABCA5
delta,3,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,PAXIP1
delta,3,negative regulation of immune effector process (GO:0002698),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,TRAF3IP1
delta,3,sialylation (GO:0097503),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,ST6GALNAC5
delta,3,regulation of telomere maintenance via telomere lengthening (GO:1904356),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,TNKS2
delta,3,response to interferon-alpha (GO:0035455),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,PDE12
delta,3,positive regulation of lymphocyte migration (GO:2000403),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,APP
delta,3,positive regulation of epidermal cell differentiation (GO:0045606),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,PRKCH
delta,3,microtubule nucleation (GO:0007020),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,TUBGCP2
delta,3,preassembly of GPI anchor in ER membrane (GO:0016254),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,PIGW
delta,3,"mRNA cis splicing, via spliceosome (GO:0045292)",1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,SRSF1
delta,3,negative regulation of lipid biosynthetic process (GO:0051055),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,FBXW7
delta,3,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,PRKCH
delta,3,pigment granule transport (GO:0051904),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,BLOC1S3
delta,3,regulation of myelination (GO:0031641),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,EIF2AK3
delta,3,spindle assembly checkpoint (GO:0071173),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,BUB3
delta,3,negative regulation of stress fiber assembly (GO:0051497),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,STMN1
delta,3,peptidyl-lysine trimethylation (GO:0018023),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,ZNF335
delta,3,rRNA catabolic process (GO:0016075),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,EXOSC8
delta,3,embryo development ending in birth or egg hatching (GO:0009792),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,UBR3
delta,3,phospholipid catabolic process (GO:0009395),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,ABHD12
delta,3,long-term memory (GO:0007616),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,CPEB3
delta,3,macrophage activation (GO:0042116),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,CLU
delta,3,regulation of transcription from RNA polymerase I promoter (GO:0006356),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,EIF2AK3
delta,3,virion assembly (GO:0019068),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,PDCD6IP
delta,3,chaperone-mediated protein complex assembly (GO:0051131),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,CLU
delta,3,regulation of T cell migration (GO:2000404),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,APP
delta,3,synaptic vesicle transport (GO:0048489),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,TMEM230
delta,3,regulation of B cell receptor signaling pathway (GO:0050855),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,PRKCH
delta,3,melanosome transport (GO:0032402),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,BLOC1S3
delta,3,positive regulation of leukocyte activation (GO:0002696),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,KARS
delta,3,cellular response to inorganic substance (GO:0071241),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,MTR
delta,3,viral entry into host cell (GO:0046718),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,WWP1
delta,3,mitotic spindle assembly checkpoint (GO:0007094),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,BUB3
delta,3,mitotic spindle checkpoint (GO:0071174),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,BUB3
delta,3,mitotic G2 DNA damage checkpoint (GO:0007095),1/17,1,17,0.376552829466444,0.660963314619986,0,0,2.1468441391155,2.09681606757791,CLSPN
delta,3,polyol metabolic process (GO:0019751),2/48,2,48,0.380213365960975,0.663267933585061,0,0,1.52068126520681,1.47053329450562,ITPKC;IMPA2
delta,3,negative regulation of cellular biosynthetic process (GO:0031327),2/48,2,48,0.380213365960975,0.663267933585061,0,0,1.52068126520681,1.47053329450562,FBXW7;NFKB1
delta,3,positive regulation of tumor necrosis factor production (GO:0032760),2/48,2,48,0.380213365960975,0.663267933585061,0,0,1.52068126520681,1.47053329450562,JAK2;CLU
delta,3,negative regulation of JAK-STAT cascade (GO:0046426),2/48,2,48,0.380213365960975,0.663267933585061,0,0,1.52068126520681,1.47053329450562,SOCS2;LRRC4
delta,3,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),2/48,2,48,0.380213365960975,0.663267933585061,0,0,1.52068126520681,1.47053329450562,CD164;CBLN1
delta,3,inositol phosphate metabolic process (GO:0043647),2/48,2,48,0.380213365960975,0.663267933585061,0,0,1.52068126520681,1.47053329450562,ITPKC;IMPA2
delta,3,cellular response to heat (GO:0034605),2/48,2,48,0.380213365960975,0.663267933585061,0,0,1.52068126520681,1.47053329450562,HSPA4L;SLU7
delta,3,positive regulation of developmental process (GO:0051094),4/114,4,114,0.380870011182967,0.663267933585061,0,0,1.28057369701626,1.23613412737528,PAXIP1;AGO2;ARHGEF7;MARCH5
delta,3,positive regulation of canonical Wnt signaling pathway (GO:0090263),4/114,4,114,0.380870011182967,0.663267933585061,0,0,1.28057369701626,1.23613412737528,PSMA3;PSMA1;TNKS2;NFKB1
delta,3,regulation of protein kinase activity (GO:0045859),5/148,5,148,0.382102830075578,0.664832157057945,0,0,1.23298480962715,1.18621216946243,SOCS2;LRRC4;SMCR8;MAPRE3;SOD1
delta,3,"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",3/81,3,81,0.383393803232098,0.665912139005401,0,0,1.35171668018383,1.29588079368991,COG4;SURF4;COPG2
delta,3,regulation of hydrolase activity (GO:0051336),3/81,3,81,0.383393803232098,0.665912139005401,0,0,1.35171668018383,1.29588079368991,CHN1;TBC1D15;SOD1
delta,3,protein K48-linked ubiquitination (GO:0070936),2/49,2,49,0.389991637350886,0.666821927709201,0,0,1.48964695367198,1.40269623533201,ARIH2;UBE2E2
delta,3,cellular macromolecule catabolic process (GO:0044265),2/49,2,49,0.389991637350886,0.666821927709201,0,0,1.48964695367198,1.40269623533201,MGEA5;NGLY1
delta,3,positive regulation of protein catabolic process (GO:0045732),3/82,3,82,0.390833479771824,0.666821927709201,0,0,1.33523233042549,1.25441564800674,PLK2;WWP1;RNF41
delta,3,regulation of G2/M transition of mitotic cell cycle (GO:0010389),5/150,5,150,0.392990257311833,0.666821927709201,0,0,1.21654501216545,1.13621710215973,PLK4;PSMA3;PSMA1;CEP290;SDCCAG8
delta,3,establishment of melanosome localization (GO:0032401),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,BLOC1S3
delta,3,membrane protein ectodomain proteolysis (GO:0006509),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,DAG1
delta,3,homologous chromosome segregation (GO:0045143),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,PTTG1
delta,3,protein localization to centrosome (GO:0071539),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,HOOK3
delta,3,anion transmembrane transport (GO:0098656),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,SLC35B1
delta,3,glycosphingolipid biosynthetic process (GO:0006688),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,ST6GALNAC5
delta,3,regulation of lipid catabolic process (GO:0050994),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,PDE3B
delta,3,release of cytochrome c from mitochondria (GO:0001836),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,CLU
delta,3,endoplasmic reticulum calcium ion homeostasis (GO:0032469),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,TMCO1
delta,3,regulation of mitochondrial membrane permeability (GO:0046902),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,HEBP2
delta,3,modulation by virus of host morphology or physiology (GO:0019048),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,DAG1
delta,3,tRNA metabolic process (GO:0006399),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,KARS
delta,3,negative regulation of peptidyl-serine phosphorylation (GO:0033137),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,NCK2
delta,3,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,AP1G1
delta,3,acute-phase response (GO:0006953),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,CEBPB
delta,3,phosphatidylglycerol acyl-chain remodeling (GO:0036148),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,LPCAT4
delta,3,regulation of cAMP-mediated signaling (GO:0043949),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,PDE3B
delta,3,DNA methylation (GO:0006306),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,BAZ2A
delta,3,regulation of microtubule polymerization or depolymerization (GO:0031110),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,STMN1
delta,3,positive regulation of carbohydrate metabolic process (GO:0045913),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,NFKB1
delta,3,regulation of peptidase activity (GO:0052547),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,PSMA3
delta,3,glyceraldehyde-3-phosphate metabolic process (GO:0019682),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,PGD
delta,3,cell-substrate adherens junction assembly (GO:0007045),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,ARHGEF7
delta,3,positive regulation of natural killer cell mediated immunity (GO:0002717),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,AP1G1
delta,3,focal adhesion assembly (GO:0048041),1/18,1,18,0.393649784198738,0.666821927709201,0,0,2.02757502027575,1.89029529107408,ARHGEF7
delta,3,positive regulation of cell cycle (GO:0045787),3/83,3,83,0.398250493270782,0.671518787796875,0,0,1.31914519391434,1.21450280309155,ANKRD17;APP;MAPRE3
delta,3,positive regulation of protein secretion (GO:0050714),3/83,3,83,0.398250493270782,0.671518787796875,0,0,1.31914519391434,1.21450280309155,SLC30A8;IRS2;ANG
delta,3,negative regulation of binding (GO:0051100),3/83,3,83,0.398250493270782,0.671518787796875,0,0,1.31914519391434,1.21450280309155,DNAJB2;JAK2;ACTB
delta,3,positive regulation of cell cycle arrest (GO:0071158),3/83,3,83,0.398250493270782,0.671518787796875,0,0,1.31914519391434,1.21450280309155,RBL2;CNOT11;PLK2
delta,3,cellular response to interferon-gamma (GO:0071346),4/117,4,117,0.39951496899804,0.671518787796875,0,0,1.24773847401585,1.14480509719384,PDE12;NCAM1;HLA-A;JAK2
delta,3,protein autoubiquitination (GO:0051865),2/50,2,50,0.399700445164534,0.671518787796875,0,0,1.45985401459854,1.33874437885961,MARCH5;RNF41
delta,3,fatty acid oxidation (GO:0019395),2/51,2,51,0.409336254444912,0.671518787796875,0,0,1.431229426077,1.27840034736303,ACAD11;ADIPOR2
delta,3,blood circulation (GO:0008015),2/51,2,51,0.409336254444912,0.671518787796875,0,0,1.431229426077,1.27840034736303,GCLM;SOD1
delta,3,negative regulation of protein ubiquitination (GO:0031397),2/51,2,51,0.409336254444912,0.671518787796875,0,0,1.431229426077,1.27840034736303,TRIM39;CRY1
delta,3,neurogenesis (GO:0022008),2/51,2,51,0.409336254444912,0.671518787796875,0,0,1.431229426077,1.27840034736303,BTBD3;WDR62
delta,3,fatty acid beta-oxidation (GO:0006635),2/51,2,51,0.409336254444912,0.671518787796875,0,0,1.431229426077,1.27840034736303,GCDH;ACAD11
delta,3,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,RNF111
delta,3,protein ADP-ribosylation (GO:0006471),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,TNKS2
delta,3,regulation of sprouting angiogenesis (GO:1903670),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,TMEM2
delta,3,NADP metabolic process (GO:0006739),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,PGD
delta,3,regulation of long-term synaptic potentiation (GO:1900271),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,APP
delta,3,posttranscriptional gene silencing by RNA (GO:0035194),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,AGO2
delta,3,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,TRIM39
delta,3,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,EXOSC8
delta,3,vesicle transport along microtubule (GO:0047496),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,DYNC1I1
delta,3,sulfur compound transport (GO:0072348),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,SLC35B2
delta,3,Rac protein signal transduction (GO:0016601),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,CYFIP1
delta,3,endocardial cushion development (GO:0003197),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,CRELD1
delta,3,negative regulation of lipid metabolic process (GO:0045833),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,PDE3B
delta,3,positive regulation of lipid storage (GO:0010884),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,NFKB1
delta,3,regulation of transcription factor import into nucleus (GO:0042990),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,RAB23
delta,3,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,MOAP1
delta,3,purine ribonucleotide catabolic process (GO:0009154),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,PDE3B
delta,3,folic acid metabolic process (GO:0046655),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,PM20D2
delta,3,fatty-acyl-CoA metabolic process (GO:0035337),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,DGAT1
delta,3,positive regulation of immunoglobulin production (GO:0002639),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,PAXIP1
delta,3,DNA double-strand break processing (GO:0000729),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,RBBP8
delta,3,aspartate family amino acid catabolic process (GO:0009068),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,GCDH
delta,3,telomere capping (GO:0016233),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,TERF2IP
delta,3,hexose transmembrane transport (GO:0035428),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,SLC2A1
delta,3,protein heterotetramerization (GO:0051290),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,CPSF7
delta,3,mitochondrial calcium ion homeostasis (GO:0051560),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,MCUR1
delta,3,regulation of cAMP biosynthetic process (GO:0030817),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,CAP2
delta,3,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,RNF111
delta,3,positive regulation of neuron apoptotic process (GO:0043525),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,FBXW7
delta,3,positive regulation of axon extension (GO:0045773),1/19,1,19,0.4102787158457,0.671518787796875,0,0,1.92086054552439,1.71133030252393,RUFY3
delta,3,positive regulation of supramolecular fiber organization (GO:1902905),3/85,3,85,0.413007934915977,0.6754294375951,0,0,1.2881064834693,1.13905771575876,APP;NCK2;CLU
delta,3,negative regulation of neuron projection development (GO:0010977),2/52,2,52,0.418895775105203,0.679519603537465,0,0,1.40370578326783,1.22141091629454,RUFY3;ITM2C
delta,3,regulation of exocytosis (GO:0017157),2/52,2,52,0.418895775105203,0.679519603537465,0,0,1.40370578326783,1.22141091629454,LLGL1;STXBP5L
delta,3,carboxylic acid transport (GO:0046942),2/52,2,52,0.418895775105203,0.679519603537465,0,0,1.40370578326783,1.22141091629454,PSAP;SLC16A13
delta,3,regulation of cellular amine metabolic process (GO:0033238),2/52,2,52,0.418895775105203,0.679519603537465,0,0,1.40370578326783,1.22141091629454,PSMA3;PSMA1
delta,3,regulation of telomere maintenance via telomerase (GO:0032210),2/52,2,52,0.418895775105203,0.679519603537465,0,0,1.40370578326783,1.22141091629454,TNKS2;MAP3K4
delta,3,regulation of cellular amino acid metabolic process (GO:0006521),2/52,2,52,0.418895775105203,0.679519603537465,0,0,1.40370578326783,1.22141091629454,PSMA3;PSMA1
delta,3,coenzyme metabolic process (GO:0006732),2/52,2,52,0.418895775105203,0.679519603537465,0,0,1.40370578326783,1.22141091629454,OXSM;DBI
delta,3,negative regulation of growth (GO:0045926),4/121,4,121,0.424215611463286,0.679519603537465,0,0,1.20649092115582,1.03458217457845,DNAJB2;ING5;ADAM15;SESN2
delta,3,vacuolar acidification (GO:0007035),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,ATP6V1H
delta,3,Golgi to endosome transport (GO:0006895),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,DOPEY1
delta,3,cell projection assembly (GO:0030031),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,CYFIP1
delta,3,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,EIF2AK3
delta,3,mesoderm formation (GO:0001707),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,ITGA2
delta,3,hydrogen peroxide metabolic process (GO:0042743),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,SOD1
delta,3,positive regulation of dendritic spine development (GO:0060999),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,CPEB3
delta,3,negative regulation of actin filament bundle assembly (GO:0032232),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,STMN1
delta,3,"wound healing, spreading of cells (GO:0044319)",1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,CD151
delta,3,response to progesterone (GO:0032570),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,WBP2
delta,3,regulation of cholesterol transport (GO:0032374),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,NFKB1
delta,3,mitochondrial respiratory chain complex IV assembly (GO:0033617),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,CHCHD5
delta,3,negative regulation of response to biotic stimulus (GO:0002832),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,TRAF3IP1
delta,3,regulation of anoikis (GO:2000209),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,PTRH2
delta,3,regulation of cell development (GO:0060284),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,RHEB
delta,3,regulation of response to cytokine stimulus (GO:0060759),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,IRAK1
delta,3,regulation of glycogen biosynthetic process (GO:0005979),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,IRS2
delta,3,positive regulation of T cell migration (GO:2000406),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,APP
delta,3,inactivation of MAPK activity (GO:0000188),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,DUSP16
delta,3,dorsal/ventral pattern formation (GO:0009953),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,AIDA
delta,3,telomere maintenance via telomerase (GO:0007004),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,TERF2IP
delta,3,vesicle cytoskeletal trafficking (GO:0099518),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,DYNC1I1
delta,3,heparan sulfate proteoglycan metabolic process (GO:0030201),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,EXTL3
delta,3,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),1/20,1,20,0.426452413493316,0.679519603537465,0,0,1.82481751824818,1.55520892834692,EVL
delta,3,regulation of peptidyl-serine phosphorylation (GO:0033135),3/87,3,87,0.427649687738621,0.680402091037342,0,0,1.25849484017116,1.0690295810916,APP;NCK2;TERF2IP
delta,3,positive regulation of proteolysis (GO:0045862),2/53,2,53,0.428375951629449,0.680402091037342,0,0,1.37722076848919,1.16754452183299,FBXW11;TBC1D10A
delta,3,plasma membrane bounded cell projection morphogenesis (GO:0120039),2/53,2,53,0.428375951629449,0.680402091037342,0,0,1.37722076848919,1.16754452183299,ZNF335;MAP4K4
delta,3,triglyceride metabolic process (GO:0006641),2/53,2,53,0.428375951629449,0.680402091037342,0,0,1.37722076848919,1.16754452183299,DGAT1;LPIN2
delta,3,stimulatory C-type lectin receptor signaling pathway (GO:0002223),4/122,4,122,0.43035341523401,0.682451904285696,0,0,1.19660165131028,1.00891290172665,PSMA3;PSMA1;FBXW11;NFKB1
delta,3,negative regulation of cell migration (GO:0030336),4/122,4,122,0.43035341523401,0.682451904285696,0,0,1.19660165131028,1.00891290172665,ADAM15;DAG1;EVL;RNF41
delta,3,mitochondrial translational elongation (GO:0070125),3/88,3,88,0.434922367173339,0.684355882279939,0,0,1.24419376244194,1.03590046046198,MRPL2;MRPS23;MRPL14
delta,3,monocarboxylic acid transport (GO:0015718),2/54,2,54,0.437773952345364,0.684355882279939,0,0,1.35171668018383,1.11658906780474,NCOA1;SLC16A13
delta,3,T cell activation (GO:0042110),3/89,3,89,0.442160493087497,0.684355882279939,0,0,1.23021405724596,1.00395598656466,PPP3CA;PPP3CB;NCK2
delta,3,positive regulation of protein complex assembly (GO:0031334),3/89,3,89,0.442160493087497,0.684355882279939,0,0,1.23021405724596,1.00395598656466,SH3GLB1;SETX;ERCC5
delta,3,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",3/89,3,89,0.442160493087497,0.684355882279939,0,0,1.23021405724596,1.00395598656466,PSMA3;FZD3;PSMA1
delta,3,cobalamin metabolic process (GO:0009235),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,MTR
delta,3,hyaluronan metabolic process (GO:0030212),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,TMEM2
delta,3,positive regulation of transcription from RNA polymerase I promoter (GO:0045943),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,EIF2AK3
delta,3,RNA-dependent DNA biosynthetic process (GO:0006278),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,TERF2IP
delta,3,viral budding via host ESCRT complex (GO:0039702),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,PDCD6IP
delta,3,regulation of ruffle assembly (GO:1900027),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,EVL
delta,3,cortical actin cytoskeleton organization (GO:0030866),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,LLGL1
delta,3,mesoderm development (GO:0007498),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,JAK2
delta,3,establishment of spindle orientation (GO:0051294),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,LLGL1
delta,3,histone ubiquitination (GO:0016574),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,PAF1
delta,3,tetrapyrrole metabolic process (GO:0033013),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,MTR
delta,3,negative regulation of macroautophagy (GO:0016242),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,SMCR8
delta,3,regulation of cardiac muscle hypertrophy (GO:0010611),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,MEF2A
delta,3,zinc II ion transport (GO:0006829),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,SLC30A8
delta,3,regulation of macrophage activation (GO:0043030),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,KARS
delta,3,establishment of endothelial barrier (GO:0061028),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,TJP1
delta,3,response to nicotine (GO:0035094),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,NFKB1
delta,3,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,ERCC5
delta,3,meiosis I (GO:0007127),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,PTTG1
delta,3,cellular response to alkaloid (GO:0071312),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,NFKB1
delta,3,mitochondrial respiratory chain complex IV biogenesis (GO:0097034),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,CHCHD5
delta,3,long-term synaptic potentiation (GO:0060291),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,PLK2
delta,3,mitochondrial calcium ion transmembrane transport (GO:0006851),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,MCUR1
delta,3,ERK1 and ERK2 cascade (GO:0070371),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,KARS
delta,3,glutamate metabolic process (GO:0006536),1/21,1,21,0.442183317478214,0.684355882279939,0,0,1.73792144595064,1.41819731918965,GCLM
delta,3,tumor necrosis factor-mediated signaling pathway (GO:0033209),4/124,4,124,0.442575394428647,0.684355882279939,0,0,1.17730162467624,0.959670880807712,PSMA3;KARS;PSMA1;JAK2
delta,3,cellular calcium ion homeostasis (GO:0006874),4/124,4,124,0.442575394428647,0.684355882279939,0,0,1.17730162467624,0.959670880807712,STIM2;TRPC1;ATP13A3;TMCO1
delta,3,sensory perception (GO:0007600),2/55,2,55,0.447087159818839,0.685018667435226,0,0,1.3271400132714,1.0683499866852,TTC8;GNAL
delta,3,protein targeting to mitochondrion (GO:0006626),2/55,2,55,0.447087159818839,0.685018667435226,0,0,1.3271400132714,1.0683499866852,IMMP1L;FBXO7
delta,3,RNA modification (GO:0009451),2/55,2,55,0.447087159818839,0.685018667435226,0,0,1.3271400132714,1.0683499866852,NOP56;NOP58
delta,3,intracellular transport of virus (GO:0075733),2/55,2,55,0.447087159818839,0.685018667435226,0,0,1.3271400132714,1.0683499866852,RANBP2;POM121
delta,3,positive regulation of response to stimulus (GO:0048584),2/55,2,55,0.447087159818839,0.685018667435226,0,0,1.3271400132714,1.0683499866852,PPP3CB;HOMER1
delta,3,membrane fusion (GO:0061025),2/55,2,55,0.447087159818839,0.685018667435226,0,0,1.3271400132714,1.0683499866852,VAPA;SNAP29
delta,3,transport of virus (GO:0046794),2/55,2,55,0.447087159818839,0.685018667435226,0,0,1.3271400132714,1.0683499866852,RANBP2;POM121
delta,3,negative regulation of supramolecular fiber organization (GO:1902904),2/55,2,55,0.447087159818839,0.685018667435226,0,0,1.3271400132714,1.0683499866852,STMN1;CLU
delta,3,glycosphingolipid metabolic process (GO:0006687),2/55,2,55,0.447087159818839,0.685018667435226,0,0,1.3271400132714,1.0683499866852,PSAP;ST6GALNAC5
delta,3,innate immune response activating cell surface receptor signaling pathway (GO:0002220),4/125,4,125,0.448657182583282,0.685018667435226,0,0,1.16788321167883,0.936053951581971,PSMA3;PSMA1;FBXW11;NFKB1
delta,3,regulation of establishment of planar polarity (GO:0090175),3/90,3,90,0.449362337632008,0.685018667435226,0,0,1.21654501216545,0.973145655273847,PSMA3;FZD3;PSMA1
delta,3,positive regulation of cysteine-type endopeptidase activity (GO:2001056),2/56,2,56,0.456313161000464,0.685018667435226,0,0,1.30344108446298,1.02264852528308,TBC1D10A;MAP3K5
delta,3,regulation of RNA splicing (GO:0043484),2/56,2,56,0.456313161000464,0.685018667435226,0,0,1.30344108446298,1.02264852528308,SETX;HNRNPF
delta,3,positive regulation of DNA biosynthetic process (GO:2000573),2/56,2,56,0.456313161000464,0.685018667435226,0,0,1.30344108446298,1.02264852528308,TNKS2;MAP3K4
delta,3,DNA recombination (GO:0006310),2/56,2,56,0.456313161000464,0.685018667435226,0,0,1.30344108446298,1.02264852528308,TOP3A;RBBP8
delta,3,cell-matrix adhesion (GO:0007160),3/91,3,91,0.456526242633701,0.685018667435226,0,0,1.20317638565814,0.943421545677769,ADAM15;ITGA2;ARHGEF7
delta,3,regulation of cytokine-mediated signaling pathway (GO:0001959),3/91,3,91,0.456526242633701,0.685018667435226,0,0,1.20317638565814,0.943421545677769,IRAK1;JAK2;ABCE1
delta,3,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,JAK2
delta,3,positive regulation of protein autophosphorylation (GO:0031954),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,NEK10
delta,3,GTP metabolic process (GO:0046039),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,RAB23
delta,3,establishment of protein localization to vacuole (GO:0072666),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,PIK3R4
delta,3,negative regulation of protein polymerization (GO:0032272),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,STMN1
delta,3,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,ZDHHC2
delta,3,peptidyl-L-cysteine S-palmitoylation (GO:0018230),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,ZDHHC2
delta,3,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,ERCC5
delta,3,early endosome to late endosome transport (GO:0045022),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,HOOK3
delta,3,activation of phospholipase C activity (GO:0007202),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,ANG
delta,3,negative regulation of cell cycle G1/S phase transition (GO:1902807),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,RBL2
delta,3,negative regulation of actin filament polymerization (GO:0030837),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,PFN4
delta,3,cytosolic calcium ion transport (GO:0060401),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,MCUR1
delta,3,histone lysine methylation (GO:0034968),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,PAXIP1
delta,3,phosphatidylglycerol metabolic process (GO:0046471),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,LPCAT4
delta,3,regulation of cytokine production involved in inflammatory response (GO:1900015),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,KARS
delta,3,urogenital system development (GO:0001655),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,IFT140
delta,3,negative regulation of protein import into nucleus (GO:0042308),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,RAB23
delta,3,cellular response to unfolded protein (GO:0034620),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,HSPA4L
delta,3,viral genome replication (GO:0019079),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,PI4KA
delta,3,negative regulation of GTPase activity (GO:0034260),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,CPEB2
delta,3,positive regulation of RNA splicing (GO:0033120),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,SETX
delta,3,ncRNA catabolic process (GO:0034661),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,EXOSC8
delta,3,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,PPP3CB
delta,3,glucose transport (GO:0015758),1/22,1,22,0.457483528780345,0.685018667435226,0,0,1.65892501658925,1.29730324747941,SLC2A1
delta,3,positive regulation of cellular protein metabolic process (GO:0032270),3/92,3,92,0.463650618564055,0.692687051944945,0,0,1.1900983814662,0.914738163620595,FBXW11;CPEB3;TBC1D10A
delta,3,cellular response to acid chemical (GO:0071229),3/92,3,92,0.463650618564055,0.692687051944945,0,0,1.1900983814662,0.914738163620595,SETX;SESN2;CPEB3
delta,3,cellular response to lipopolysaccharide (GO:0071222),3/92,3,92,0.463650618564055,0.692687051944945,0,0,1.1900983814662,0.914738163620595,IRAK1;PAF1;NFKB1
delta,3,regulation of secretion by cell (GO:1903530),2/57,2,57,0.465449738255392,0.694852464247531,0,0,1.28057369701626,0.979320222521731,LLGL1;STXBP5L
delta,3,regulation of natural killer cell mediated cytotoxicity (GO:0042269),1/23,1,23,0.472364818229497,0.695251032460749,0,0,1.58679784195494,1.19010420813655,AP1G1
delta,3,exogenous drug catabolic process (GO:0042738),1/23,1,23,0.472364818229497,0.695251032460749,0,0,1.58679784195494,1.19010420813655,CYP2R1
delta,3,regulation of protein oligomerization (GO:0032459),1/23,1,23,0.472364818229497,0.695251032460749,0,0,1.58679784195494,1.19010420813655,SH3GLB1
delta,3,cholesterol efflux (GO:0033344),1/23,1,23,0.472364818229497,0.695251032460749,0,0,1.58679784195494,1.19010420813655,ABCA5
delta,3,protein localization to cilium (GO:0061512),1/23,1,23,0.472364818229497,0.695251032460749,0,0,1.58679784195494,1.19010420813655,IFT140
delta,3,microtubule polymerization or depolymerization (GO:0031109),1/23,1,23,0.472364818229497,0.695251032460749,0,0,1.58679784195494,1.19010420813655,STMN1
delta,3,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),1/23,1,23,0.472364818229497,0.695251032460749,0,0,1.58679784195494,1.19010420813655,PAF1
delta,3,zinc II ion transmembrane transport (GO:0071577),1/23,1,23,0.472364818229497,0.695251032460749,0,0,1.58679784195494,1.19010420813655,SLC30A8
delta,3,glutamine family amino acid metabolic process (GO:0009064),1/23,1,23,0.472364818229497,0.695251032460749,0,0,1.58679784195494,1.19010420813655,GCLM
delta,3,protein K48-linked deubiquitination (GO:0071108),1/23,1,23,0.472364818229497,0.695251032460749,0,0,1.58679784195494,1.19010420813655,USP25
delta,3,cellular nitrogen compound biosynthetic process (GO:0044271),1/23,1,23,0.472364818229497,0.695251032460749,0,0,1.58679784195494,1.19010420813655,ACER2
delta,3,folic acid-containing compound metabolic process (GO:0006760),1/23,1,23,0.472364818229497,0.695251032460749,0,0,1.58679784195494,1.19010420813655,ST20-MTHFS
delta,3,maturation of LSU-rRNA (GO:0000470),1/23,1,23,0.472364818229497,0.695251032460749,0,0,1.58679784195494,1.19010420813655,RPL35
delta,3,negative regulation of axonogenesis (GO:0050771),1/23,1,23,0.472364818229497,0.695251032460749,0,0,1.58679784195494,1.19010420813655,RUFY3
delta,3,negative regulation of transcription factor import into nucleus (GO:0042992),1/23,1,23,0.472364818229497,0.695251032460749,0,0,1.58679784195494,1.19010420813655,RAB23
delta,3,cellular response to amyloid-beta (GO:1904646),1/23,1,23,0.472364818229497,0.695251032460749,0,0,1.58679784195494,1.19010420813655,APP
delta,3,viral budding (GO:0046755),1/23,1,23,0.472364818229497,0.695251032460749,0,0,1.58679784195494,1.19010420813655,PDCD6IP
delta,3,NAD metabolic process (GO:0019674),1/23,1,23,0.472364818229497,0.695251032460749,0,0,1.58679784195494,1.19010420813655,MDH1B
delta,3,regulation of ion homeostasis (GO:2000021),1/23,1,23,0.472364818229497,0.695251032460749,0,0,1.58679784195494,1.19010420813655,SLC30A8
delta,3,regulation of glycolytic process (GO:0006110),2/58,2,58,0.47449486025611,0.695295934608326,0,0,1.25849484017116,0.938213557646979,RANBP2;POM121
delta,3,IRE1-mediated unfolded protein response (GO:0036498),2/58,2,58,0.47449486025611,0.695295934608326,0,0,1.25849484017116,0.938213557646979,KLHDC3;EXTL3
delta,3,I-kappaB kinase/NF-kappaB signaling (GO:0007249),2/58,2,58,0.47449486025611,0.695295934608326,0,0,1.25849484017116,0.938213557646979,REL;NFKB1
delta,3,regulation of neurogenesis (GO:0050767),2/58,2,58,0.47449486025611,0.695295934608326,0,0,1.25849484017116,0.938213557646979,HOOK3;ZNF335
delta,3,cellular respiration (GO:0045333),2/58,2,58,0.47449486025611,0.695295934608326,0,0,1.25849484017116,0.938213557646979,CHCHD5;FASTKD2
delta,3,response to retinoic acid (GO:0032526),2/58,2,58,0.47449486025611,0.695295934608326,0,0,1.25849484017116,0.938213557646979,ACER2;SETX
delta,3,cellular transition metal ion homeostasis (GO:0046916),3/94,3,94,0.477774761253888,0.699586183206688,0,0,1.16477713930735,0.860322878138632,APP;SLC30A8;SOD1
delta,3,phospholipid transport (GO:0015914),2/59,2,59,0.483446673806732,0.705292614430233,0,0,1.23716441915131,0.899188744518997,OSBPL8;TMEM30B
delta,3,receptor metabolic process (GO:0043112),2/59,2,59,0.483446673806732,0.705292614430233,0,0,1.23716441915131,0.899188744518997,SH3GLB1;PIK3R4
delta,3,integrin-mediated signaling pathway (GO:0007229),2/59,2,59,0.483446673806732,0.705292614430233,0,0,1.23716441915131,0.899188744518997,ADAM15;ITGA2
delta,3,sodium ion transport (GO:0006814),2/59,2,59,0.483446673806732,0.705292614430233,0,0,1.23716441915131,0.899188744518997,SLC12A1;NALCN
delta,3,post-Golgi vesicle-mediated transport (GO:0006892),2/59,2,59,0.483446673806732,0.705292614430233,0,0,1.23716441915131,0.899188744518997,DOPEY1;LLGL1
delta,3,cellular response to fibroblast growth factor stimulus (GO:0044344),3/95,3,95,0.484771681412513,0.706188659066469,0,0,1.15251632731464,0.834510863074666,SETX;HNRNPM;HNRNPF
delta,3,axon development (GO:0061564),3/95,3,95,0.484771681412513,0.706188659066469,0,0,1.15251632731464,0.834510863074666,APP;MTR;LLGL1
delta,3,transcription elongation from RNA polymerase II promoter (GO:0006368),3/96,3,96,0.491723376957085,0.712679868730958,0,0,1.14051094890511,0.809579108763973,PAF1;NELFA;ELP4
delta,3,regulation of cytoskeleton organization (GO:0051493),3/96,3,96,0.491723376957085,0.712679868730958,0,0,1.14051094890511,0.809579108763973,PHLDB1;TRAF3IP1;STMN1
delta,3,renal system development (GO:0072001),2/60,2,60,0.492303495288964,0.712679868730958,0,0,1.21654501216545,0.86211665733156,TRAF3IP1;IFT140
delta,3,mitotic cytokinesis (GO:0000281),2/60,2,60,0.492303495288964,0.712679868730958,0,0,1.21654501216545,0.86211665733156,PDCD6IP;STMN1
delta,3,dicarboxylic acid metabolic process (GO:0043648),2/60,2,60,0.492303495288964,0.712679868730958,0,0,1.21654501216545,0.86211665733156,GCLM;MDH1B
delta,3,regulation of cell death (GO:0010941),3/97,3,97,0.498628583542413,0.712679868730958,0,0,1.12875310407104,0.785492266461433,ACER2;PDE12;CLU
delta,3,ciliary basal body-plasma membrane docking (GO:0097711),3/97,3,97,0.498628583542413,0.712679868730958,0,0,1.12875310407104,0.785492266461433,PLK4;CEP290;SDCCAG8
delta,3,membrane protein intracellular domain proteolysis (GO:0031293),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,NFKB1
delta,3,cellular lipid catabolic process (GO:0044242),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,LPIN2
delta,3,histone monoubiquitination (GO:0010390),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,PAF1
delta,3,histone mRNA metabolic process (GO:0008334),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,LSM11
delta,3,response to dsRNA (GO:0043331),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,PDE12
delta,3,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,RBL2
delta,3,drug catabolic process (GO:0042737),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,CYP2R1
delta,3,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,PAF1
delta,3,regulation of transmembrane transport (GO:0034762),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,CTTNBP2NL
delta,3,regulation of chemotaxis (GO:0050920),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,ZSWIM8
delta,3,negative regulation of oxidative stress-induced cell death (GO:1903202),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,FBXO7
delta,3,cilium-dependent cell motility (GO:0060285),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,SPATA4
delta,3,DNA replication initiation (GO:0006270),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,PURA
delta,3,limb development (GO:0060173),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,INTU
delta,3,positive regulation of vascular endothelial growth factor production (GO:0010575),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,EIF2AK3
delta,3,chaperone mediated protein folding requiring cofactor (GO:0051085),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,HSPA4L
delta,3,regulation of neuronal synaptic plasticity (GO:0048168),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,APP
delta,3,mammary gland development (GO:0030879),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,JAK2
delta,3,proteoglycan biosynthetic process (GO:0030166),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,EXTL3
delta,3,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,SVIP
delta,3,negative regulation of T cell proliferation (GO:0042130),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,CEBPB
delta,3,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,CLU
delta,3,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,IRAK1
delta,3,cAMP metabolic process (GO:0046058),1/25,1,25,0.500916118044351,0.712679868730958,0,0,1.45985401459854,1.00922134447923,PDE3B
delta,3,regulation of stress fiber assembly (GO:0051492),2/61,2,61,0.501063803028258,0.712679868730958,0,0,1.19660165131028,0.826877868435993,STMN1;EVL
delta,3,muscle organ development (GO:0007517),2/61,2,61,0.501063803028258,0.712679868730958,0,0,1.19660165131028,0.826877868435993,MEF2A;UTRN
delta,3,protein targeting (GO:0006605),4/134,4,134,0.502320816722827,0.713446363708547,0,0,1.08944329447652,0.750099451221412,SPCS1;PIK3R4;ZDHHC2;FBXO7
delta,3,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),4/134,4,134,0.502320816722827,0.713446363708547,0,0,1.08944329447652,0.750099451221412,CYFIP1;ACTR2;ARPC2;ACTB
delta,3,negative regulation of cell motility (GO:2000146),3/98,3,98,0.50548609815511,0.714054674049609,0,0,1.11723521525398,0.762216678917708,ADAM15;DAG1;RNF41
delta,3,mitochondrial respiratory chain complex assembly (GO:0033108),3/98,3,98,0.50548609815511,0.714054674049609,0,0,1.11723521525398,0.762216678917708,CHCHD5;IMMP1L;SDHAF2
delta,3,Fc-gamma receptor signaling pathway (GO:0038094),4/135,4,135,0.508146128346662,0.714054674049609,0,0,1.08137334414707,0.732074851086766,CYFIP1;ACTR2;ARPC2;ACTB
delta,3,regulation of cellular ketone metabolic process (GO:0010565),2/62,2,62,0.509726229593391,0.714054674049609,0,0,1.17730162467624,0.793361787277894,PSMA3;PSMA1
delta,3,regulation of tumor necrosis factor production (GO:0032680),2/62,2,62,0.509726229593391,0.714054674049609,0,0,1.17730162467624,0.793361787277894,JAK2;CLU
delta,3,negative regulation of MAP kinase activity (GO:0043407),2/62,2,62,0.509726229593391,0.714054674049609,0,0,1.17730162467624,0.793361787277894,AIDA;DUSP16
delta,3,regulation of DNA replication (GO:0006275),2/62,2,62,0.509726229593391,0.714054674049609,0,0,1.17730162467624,0.793361787277894,ANKRD17;DBF4
delta,3,Fc receptor mediated stimulatory signaling pathway (GO:0002431),4/136,4,136,0.513940682507965,0.714054674049609,0,0,1.07342206955775,0.714520635323627,CYFIP1;ACTR2;ARPC2;ACTB
delta,3,organophosphate ester transport (GO:0015748),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,OSBPL8
delta,3,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,PIK3R4
delta,3,glial cell differentiation (GO:0010001),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,EIF2B5
delta,3,respiratory chain complex IV assembly (GO:0008535),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,CHCHD5
delta,3,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,IRAK1
delta,3,potassium ion homeostasis (GO:0055075),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,SLC12A1
delta,3,peptide catabolic process (GO:0043171),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,RNPEP
delta,3,response to amyloid-beta (GO:1904645),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,APP
delta,3,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,AP1G1
delta,3,response to alcohol (GO:0097305),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,SOD1
delta,3,monocarboxylic acid catabolic process (GO:0072329),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,LPIN2
delta,3,regulation of lamellipodium assembly (GO:0010591),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,ARPC2
delta,3,positive regulation of glucose transport (GO:0010828),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,IRS2
delta,3,regulation of glucose metabolic process (GO:0010906),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,IRS2
delta,3,female gamete generation (GO:0007292),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,TOB2
delta,3,regulation of apoptotic signaling pathway (GO:2001233),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,TRIM39
delta,3,negative regulation of insulin receptor signaling pathway (GO:0046627),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,SOCS2
delta,3,long-chain fatty-acyl-CoA metabolic process (GO:0035336),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,DGAT1
delta,3,peptide hormone secretion (GO:0030072),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,SLC30A8
delta,3,negative regulation of epithelial to mesenchymal transition (GO:0010719),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,SDHAF2
delta,3,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,SLC35B2
delta,3,positive regulation of calcium ion transmembrane transport (GO:1904427),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,TRPC1
delta,3,positive regulation of nitric oxide biosynthetic process (GO:0045429),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,CLU
delta,3,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,APP
delta,3,positive regulation of nitric oxide metabolic process (GO:1904407),1/26,1,26,0.514608099264741,0.714054674049609,0,0,1.40370578326783,0.93255143220981,CLU
delta,3,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),2/63,2,63,0.518289554587952,0.71715971097929,0,0,1.15861429730043,0.76146588715784,PSMA3;PSMA1
delta,3,tRNA processing (GO:0008033),2/63,2,63,0.518289554587952,0.71715971097929,0,0,1.15861429730043,0.76146588715784,KARS;TSEN54
delta,3,establishment of protein localization to organelle (GO:0072594),2/63,2,63,0.518289554587952,0.71715971097929,0,0,1.15861429730043,0.76146588715784,RANBP2;POM121
delta,3,regulation of T cell proliferation (GO:0042129),2/63,2,63,0.518289554587952,0.71715971097929,0,0,1.15861429730043,0.76146588715784,CEBPB;NCK2
delta,3,steroid metabolic process (GO:0008202),3/100,3,100,0.519053538812236,0.717717036617893,0,0,1.09489051094891,0.717972529382042,UBE2I;CYP2R1;FDFT1
delta,3,cellular response to transforming growth factor beta stimulus (GO:0071560),3/101,3,101,0.52576135417023,0.718484388730756,0,0,1.0840500108405,0.696944281809534,ZFYVE9;TGFBRAP1;SMAD5
delta,3,negative regulation of protein modification process (GO:0031400),2/64,2,64,0.526752697523261,0.718484388730756,0,0,1.14051094890511,0.731095010540188,TRAF3IP1;TERF2IP
delta,3,kidney development (GO:0001822),2/64,2,64,0.526752697523261,0.718484388730756,0,0,1.14051094890511,0.731095010540188,TRAF3IP1;CEP290
delta,3,carbohydrate homeostasis (GO:0033500),2/64,2,64,0.526752697523261,0.718484388730756,0,0,1.14051094890511,0.731095010540188,CRY1;ADIPOR2
delta,3,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193),2/64,2,64,0.526752697523261,0.718484388730756,0,0,1.14051094890511,0.731095010540188,GNAL;PSAP
delta,3,ribosomal large subunit biogenesis (GO:0042273),2/64,2,64,0.526752697523261,0.718484388730756,0,0,1.14051094890511,0.731095010540188,YAE1D1;MDN1
delta,3,sodium ion homeostasis (GO:0055078),1/27,1,27,0.527925117034174,0.718484388730756,0,0,1.35171668018383,0.86347773605398,SLC12A1
delta,3,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),1/27,1,27,0.527925117034174,0.718484388730756,0,0,1.35171668018383,0.86347773605398,MAPRE3
delta,3,monovalent inorganic cation homeostasis (GO:0055067),1/27,1,27,0.527925117034174,0.718484388730756,0,0,1.35171668018383,0.86347773605398,SLC12A1
delta,3,lipid modification (GO:0030258),1/27,1,27,0.527925117034174,0.718484388730756,0,0,1.35171668018383,0.86347773605398,DGKE
delta,3,regulation of centrosome cycle (GO:0046605),1/27,1,27,0.527925117034174,0.718484388730756,0,0,1.35171668018383,0.86347773605398,PDCD6IP
delta,3,regulation of NF-kappaB import into nucleus (GO:0042345),1/27,1,27,0.527925117034174,0.718484388730756,0,0,1.35171668018383,0.86347773605398,APP
delta,3,response to ketone (GO:1901654),1/27,1,27,0.527925117034174,0.718484388730756,0,0,1.35171668018383,0.86347773605398,WBP2
delta,3,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1/27,1,27,0.527925117034174,0.718484388730756,0,0,1.35171668018383,0.86347773605398,KLF11
delta,3,internal peptidyl-lysine acetylation (GO:0018393),1/27,1,27,0.527925117034174,0.718484388730756,0,0,1.35171668018383,0.86347773605398,KAT6A
delta,3,negative regulation of cellular response to insulin stimulus (GO:1900077),1/27,1,27,0.527925117034174,0.718484388730756,0,0,1.35171668018383,0.86347773605398,SOCS2
delta,3,regulation of histone acetylation (GO:0035065),1/27,1,27,0.527925117034174,0.718484388730756,0,0,1.35171668018383,0.86347773605398,PAXIP1
delta,3,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),1/27,1,27,0.527925117034174,0.718484388730756,0,0,1.35171668018383,0.86347773605398,LPCAT4
delta,3,positive regulation of release of cytochrome c from mitochondria (GO:0090200),1/27,1,27,0.527925117034174,0.718484388730756,0,0,1.35171668018383,0.86347773605398,MOAP1
delta,3,GPI anchor metabolic process (GO:0006505),1/27,1,27,0.527925117034174,0.718484388730756,0,0,1.35171668018383,0.86347773605398,PIGW
delta,3,snRNA 3'-end processing (GO:0034472),1/27,1,27,0.527925117034174,0.718484388730756,0,0,1.35171668018383,0.86347773605398,EXOSC8
delta,3,RNA biosynthetic process (GO:0032774),1/27,1,27,0.527925117034174,0.718484388730756,0,0,1.35171668018383,0.86347773605398,SETX
delta,3,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),1/27,1,27,0.527925117034174,0.718484388730756,0,0,1.35171668018383,0.86347773605398,TNKS2
delta,3,regulation of signal transduction by p53 class mediator (GO:1901796),4/139,4,139,0.531131857378423,0.722197778694806,0,0,1.05025468676154,0.664543369832666,ING5;KAT6A;TOP3A;RBBP8
delta,3,protein processing (GO:0016485),3/102,3,102,0.532417253708135,0.722197778694806,0,0,1.07342206955775,0.676607756086903,IMMP1L;SPCS1;OMA1
delta,3,cellular divalent inorganic cation homeostasis (GO:0072503),3/102,3,102,0.532417253708135,0.722197778694806,0,0,1.07342206955775,0.676607756086903,SLC30A8;STIM2;ATP13A3
delta,3,intrinsic apoptotic signaling pathway (GO:0097193),3/102,3,102,0.532417253708135,0.722197778694806,0,0,1.07342206955775,0.676607756086903,MOAP1;CEBPB;MAP3K5
delta,3,inorganic anion transmembrane transport (GO:0098661),2/65,2,65,0.535114711333061,0.722197778694806,0,0,1.12296462661426,0.702160742687038,SLC20A1;SLC12A1
delta,3,glycerophospholipid metabolic process (GO:0006650),2/65,2,65,0.535114711333061,0.722197778694806,0,0,1.12296462661426,0.702160742687038,ABHD12;PIGW
delta,3,positive regulation of endocytosis (GO:0045807),2/65,2,65,0.535114711333061,0.722197778694806,0,0,1.12296462661426,0.702160742687038,CD151;CLU
delta,3,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),1/28,1,28,0.540877421674765,0.722197778694806,0,0,1.30344108446298,0.80104614588001,UBA5
delta,3,telomere maintenance via telomere lengthening (GO:0010833),1/28,1,28,0.540877421674765,0.722197778694806,0,0,1.30344108446298,0.80104614588001,TERF2IP
delta,3,regulation of cilium assembly (GO:1902017),1/28,1,28,0.540877421674765,0.722197778694806,0,0,1.30344108446298,0.80104614588001,IFT140
delta,3,positive regulation of lipid kinase activity (GO:0090218),1/28,1,28,0.540877421674765,0.722197778694806,0,0,1.30344108446298,0.80104614588001,PIK3R4
delta,3,negative regulation of smooth muscle cell proliferation (GO:0048662),1/28,1,28,0.540877421674765,0.722197778694806,0,0,1.30344108446298,0.80104614588001,ANG
delta,3,negative regulation of microtubule polymerization or depolymerization (GO:0031111),1/28,1,28,0.540877421674765,0.722197778694806,0,0,1.30344108446298,0.80104614588001,STMN1
delta,3,negative regulation of small GTPase mediated signal transduction (GO:0051058),1/28,1,28,0.540877421674765,0.722197778694806,0,0,1.30344108446298,0.80104614588001,RASAL2
delta,3,regulation of double-strand break repair via homologous recombination (GO:0010569),1/28,1,28,0.540877421674765,0.722197778694806,0,0,1.30344108446298,0.80104614588001,TERF2IP
delta,3,phagosome acidification (GO:0090383),1/28,1,28,0.540877421674765,0.722197778694806,0,0,1.30344108446298,0.80104614588001,ATP6V1H
delta,3,negative regulation of myeloid leukocyte differentiation (GO:0002762),1/28,1,28,0.540877421674765,0.722197778694806,0,0,1.30344108446298,0.80104614588001,MAFB
delta,3,microtubule polymerization (GO:0046785),1/28,1,28,0.540877421674765,0.722197778694806,0,0,1.30344108446298,0.80104614588001,TUBGCP2
delta,3,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),1/28,1,28,0.540877421674765,0.722197778694806,0,0,1.30344108446298,0.80104614588001,MOAP1
delta,3,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),1/28,1,28,0.540877421674765,0.722197778694806,0,0,1.30344108446298,0.80104614588001,ARHGEF7
delta,3,regulation of vascular endothelial growth factor production (GO:0010574),1/28,1,28,0.540877421674765,0.722197778694806,0,0,1.30344108446298,0.80104614588001,EIF2AK3
delta,3,negative regulation of organelle assembly (GO:1902116),1/28,1,28,0.540877421674765,0.722197778694806,0,0,1.30344108446298,0.80104614588001,SMCR8
delta,3,cellular response to topologically incorrect protein (GO:0035967),1/28,1,28,0.540877421674765,0.722197778694806,0,0,1.30344108446298,0.80104614588001,HSPA4L
delta,3,cellular response to glucose stimulus (GO:0071333),1/28,1,28,0.540877421674765,0.722197778694806,0,0,1.30344108446298,0.80104614588001,RAB11FIP2
delta,3,response to lipid (GO:0033993),4/141,4,141,0.542424795681715,0.722197778694806,0,0,1.03535745716209,0.633334191280649,SOCS2;ACER2;IRAK1;JAK2
delta,3,regulation of small GTPase mediated signal transduction (GO:0051056),4/141,4,141,0.542424795681715,0.722197778694806,0,0,1.03535745716209,0.633334191280649,ARHGAP20;RHOT1;CHN1;ARHGEF7
delta,3,O-glycan processing (GO:0016266),2/66,2,66,0.54337477561587,0.722197778694806,0,0,1.1059500110595,0.674580847841766,GALNT7;GALNT11
delta,3,glycolipid metabolic process (GO:0006664),2/66,2,66,0.54337477561587,0.722197778694806,0,0,1.1059500110595,0.674580847841766,PSAP;PIGW
delta,3,cellular response to type I interferon (GO:0071357),2/66,2,66,0.54337477561587,0.722197778694806,0,0,1.1059500110595,0.674580847841766,IRAK1;HLA-A
delta,3,chromatin assembly (GO:0031497),2/66,2,66,0.54337477561587,0.722197778694806,0,0,1.1059500110595,0.674580847841766,GATAD1;PAF1
delta,3,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),2/66,2,66,0.54337477561587,0.722197778694806,0,0,1.1059500110595,0.674580847841766,PAXIP1;FBXW7
delta,3,regulation of JAK-STAT cascade (GO:0046425),2/66,2,66,0.54337477561587,0.722197778694806,0,0,1.1059500110595,0.674580847841766,SOCS2;LRRC4
delta,3,DNA synthesis involved in DNA repair (GO:0000731),2/66,2,66,0.54337477561587,0.722197778694806,0,0,1.1059500110595,0.674580847841766,TOP3A;RBBP8
delta,3,type I interferon signaling pathway (GO:0060337),2/66,2,66,0.54337477561587,0.722197778694806,0,0,1.1059500110595,0.674580847841766,IRAK1;HLA-A
delta,3,fatty acid catabolic process (GO:0009062),2/66,2,66,0.54337477561587,0.722197778694806,0,0,1.1059500110595,0.674580847841766,ACAD11;LPIN2
delta,3,regulation of cellular response to stress (GO:0080135),3/105,3,105,0.552064571187717,0.724476148170297,0,0,1.04275286757039,0.619489325085453,RANBP2;POM121;SMG1
delta,3,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,CRY1
delta,3,cellular response to alcohol (GO:0097306),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,CTNNA1
delta,3,carboxylic acid catabolic process (GO:0046395),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,TMEM2
delta,3,negative regulation of proteasomal protein catabolic process (GO:1901799),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,USP25
delta,3,acute inflammatory response (GO:0002526),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,CEBPB
delta,3,negative regulation of response to DNA damage stimulus (GO:2001021),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,CLU
delta,3,aerobic respiration (GO:0009060),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,CHCHD5
delta,3,chondrocyte differentiation (GO:0002062),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,EIF2AK3
delta,3,positive regulation of protein tyrosine kinase activity (GO:0061098),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,FBXW7
delta,3,lytic vacuole organization (GO:0080171),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,HOOK3
delta,3,positive regulation of phospholipid metabolic process (GO:1903727),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,PIK3R4
delta,3,positive regulation of cell communication (GO:0010647),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,HOMER1
delta,3,negative regulation of JNK cascade (GO:0046329),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,AIDA
delta,3,regulation of lipid biosynthetic process (GO:0046890),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,ADIPOR2
delta,3,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,HLA-A
delta,3,dopamine receptor signaling pathway (GO:0007212),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,GNAL
delta,3,regulation of fatty acid biosynthetic process (GO:0042304),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,ADIPOR2
delta,3,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,IRAK1
delta,3,regulation of adenylate cyclase activity (GO:0045761),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,CAP2
delta,3,protein K63-linked deubiquitination (GO:0070536),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,USP25
delta,3,protein export from nucleus (GO:0006611),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,DUSP16
delta,3,transcription elongation from RNA polymerase I promoter (GO:0006362),1/29,1,29,0.553474983856321,0.724476148170297,0,0,1.25849484017116,0.744448432091246,TAF1D
delta,3,translational elongation (GO:0006414),3/106,3,106,0.558504184550231,0.730070991026023,0,0,1.03291557636689,0.601666266375858,MRPL2;MRPS23;MRPL14
delta,3,positive regulation of synaptic transmission (GO:0050806),2/68,2,68,0.559586371078325,0.730070991026023,0,0,1.07342206955775,0.623183116405948,APP;PLK2
delta,3,regulation of TOR signaling (GO:0032006),2/68,2,68,0.559586371078325,0.730070991026023,0,0,1.07342206955775,0.623183116405948,RHEB;SMCR8
delta,3,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),2/68,2,68,0.559586371078325,0.730070991026023,0,0,1.07342206955775,0.623183116405948,SERTAD1;MAPRE3
delta,3,insulin receptor signaling pathway (GO:0008286),2/68,2,68,0.559586371078325,0.730070991026023,0,0,1.07342206955775,0.623183116405948,ATP6V1H;IRS2
delta,3,neuron development (GO:0048666),4/145,4,145,0.564583593243408,0.73088462067556,0,0,1.00679587213692,0.575551797296768,APP;VAPA;STMN1;BLOC1S3
delta,3,positive regulation of cellular component organization (GO:0051130),3/107,3,107,0.564887829560385,0.73088462067556,0,0,1.02326215976533,0.584413772389587,SH3GLB1;CD151;SURF4
delta,3,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",1/30,1,30,0.565727502062914,0.73088462067556,0,0,1.21654501216545,0.692996060619699,ERCC5
delta,3,superoxide metabolic process (GO:0006801),1/30,1,30,0.565727502062914,0.73088462067556,0,0,1.21654501216545,0.692996060619699,SOD1
delta,3,determination of bilateral symmetry (GO:0009855),1/30,1,30,0.565727502062914,0.73088462067556,0,0,1.21654501216545,0.692996060619699,GALNT11
delta,3,vacuolar transport (GO:0007034),1/30,1,30,0.565727502062914,0.73088462067556,0,0,1.21654501216545,0.692996060619699,PIK3R4
delta,3,cortical cytoskeleton organization (GO:0030865),1/30,1,30,0.565727502062914,0.73088462067556,0,0,1.21654501216545,0.692996060619699,LLGL1
delta,3,negative regulation of Notch signaling pathway (GO:0045746),1/30,1,30,0.565727502062914,0.73088462067556,0,0,1.21654501216545,0.692996060619699,FBXW7
delta,3,lysosome localization (GO:0032418),1/30,1,30,0.565727502062914,0.73088462067556,0,0,1.21654501216545,0.692996060619699,VPS33A
delta,3,negative regulation of lymphocyte proliferation (GO:0050672),1/30,1,30,0.565727502062914,0.73088462067556,0,0,1.21654501216545,0.692996060619699,CEBPB
delta,3,regulation of keratinocyte differentiation (GO:0045616),1/30,1,30,0.565727502062914,0.73088462067556,0,0,1.21654501216545,0.692996060619699,PRKCH
delta,3,coenzyme biosynthetic process (GO:0009108),1/30,1,30,0.565727502062914,0.73088462067556,0,0,1.21654501216545,0.692996060619699,ST20-MTHFS
delta,3,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),1/30,1,30,0.565727502062914,0.73088462067556,0,0,1.21654501216545,0.692996060619699,FBXW7
delta,3,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),1/30,1,30,0.565727502062914,0.73088462067556,0,0,1.21654501216545,0.692996060619699,IRAK1
delta,3,regulation of cellular biosynthetic process (GO:0031326),1/30,1,30,0.565727502062914,0.73088462067556,0,0,1.21654501216545,0.692996060619699,ADIPOR2
delta,3,COPII-coated vesicle budding (GO:0090114),2/69,2,69,0.567536840864274,0.73274574580722,0,0,1.05786522796996,0.599227349953603,TRAPPC6A;VAPA
delta,3,negative regulation of cell cycle G2/M phase transition (GO:1902750),2/70,2,70,0.575383226985933,0.736700541124444,0,0,1.04275286757039,0.576349299760609,PSMA3;PSMA1
delta,3,negative regulation of stress-activated MAPK cascade (GO:0032873),1/31,1,31,0.577644410202257,0.736700541124444,0,0,1.17730162467624,0.646099372368648,AIDA
delta,3,hippo signaling (GO:0035329),1/31,1,31,0.577644410202257,0.736700541124444,0,0,1.17730162467624,0.646099372368648,TJP1
delta,3,acylglycerol catabolic process (GO:0046464),1/31,1,31,0.577644410202257,0.736700541124444,0,0,1.17730162467624,0.646099372368648,ABHD12
delta,3,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),1/31,1,31,0.577644410202257,0.736700541124444,0,0,1.17730162467624,0.646099372368648,MAPRE3
delta,3,bile acid and bile salt transport (GO:0015721),1/31,1,31,0.577644410202257,0.736700541124444,0,0,1.17730162467624,0.646099372368648,NCOA1
delta,3,negative regulation of transferase activity (GO:0051348),1/31,1,31,0.577644410202257,0.736700541124444,0,0,1.17730162467624,0.646099372368648,IRS2
delta,3,multivesicular body assembly (GO:0036258),1/31,1,31,0.577644410202257,0.736700541124444,0,0,1.17730162467624,0.646099372368648,PDCD6IP
delta,3,regulation of cation transmembrane transport (GO:1904062),1/31,1,31,0.577644410202257,0.736700541124444,0,0,1.17730162467624,0.646099372368648,HOMER1
delta,3,'de novo' posttranslational protein folding (GO:0051084),1/31,1,31,0.577644410202257,0.736700541124444,0,0,1.17730162467624,0.646099372368648,HSPA4L
delta,3,regulation of ARF protein signal transduction (GO:0032012),1/31,1,31,0.577644410202257,0.736700541124444,0,0,1.17730162467624,0.646099372368648,APLP2
delta,3,protein localization to lysosome (GO:0061462),1/31,1,31,0.577644410202257,0.736700541124444,0,0,1.17730162467624,0.646099372368648,AP3M1
delta,3,positive regulation of phospholipase C activity (GO:0010863),1/31,1,31,0.577644410202257,0.736700541124444,0,0,1.17730162467624,0.646099372368648,ANG
delta,3,phosphatidylinositol 3-kinase signaling (GO:0014065),1/31,1,31,0.577644410202257,0.736700541124444,0,0,1.17730162467624,0.646099372368648,PIK3C2B
delta,3,ATP-dependent chromatin remodeling (GO:0043044),1/31,1,31,0.577644410202257,0.736700541124444,0,0,1.17730162467624,0.646099372368648,ACTB
delta,3,positive regulation of B cell proliferation (GO:0030890),1/31,1,31,0.577644410202257,0.736700541124444,0,0,1.17730162467624,0.646099372368648,IRS2
delta,3,regulation of sodium ion transmembrane transport (GO:1902305),1/31,1,31,0.577644410202257,0.736700541124444,0,0,1.17730162467624,0.646099372368648,UTRN
delta,3,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),1/31,1,31,0.577644410202257,0.736700541124444,0,0,1.17730162467624,0.646099372368648,RUFY3
delta,3,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),1/31,1,31,0.577644410202257,0.736700541124444,0,0,1.17730162467624,0.646099372368648,CLU
delta,3,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),2/71,2,71,0.583125254687248,0.741786095431218,0,0,1.02806620746376,0.554490871407347,ARIH2;CLU
delta,3,cytoskeleton-dependent cytokinesis (GO:0061640),2/71,2,71,0.583125254687248,0.741786095431218,0,0,1.02806620746376,0.554490871407347,PDCD6IP;STMN1
delta,3,snRNA transcription (GO:0009301),2/71,2,71,0.583125254687248,0.741786095431218,0,0,1.02806620746376,0.554490871407347,INTS10;NABP2
delta,3,snRNA transcription from RNA polymerase II promoter (GO:0042795),2/71,2,71,0.583125254687248,0.741786095431218,0,0,1.02806620746376,0.554490871407347,INTS10;NABP2
delta,3,negative regulation of protein kinase activity (GO:0006469),3/110,3,110,0.583696592783191,0.742037831004607,0,0,0.99535500995355,0.535873222359044,SOCS2;LRRC4;SMCR8
delta,3,regulation of dendritic spine development (GO:0060998),1/32,1,32,0.589234884610392,0.74337124807673,0,0,1.14051094890511,0.603250900328121,CPEB3
delta,3,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),1/32,1,32,0.589234884610392,0.74337124807673,0,0,1.14051094890511,0.603250900328121,TRPC1
delta,3,regulation of glucose import (GO:0046324),1/32,1,32,0.589234884610392,0.74337124807673,0,0,1.14051094890511,0.603250900328121,IRS2
delta,3,skeletal system morphogenesis (GO:0048705),1/32,1,32,0.589234884610392,0.74337124807673,0,0,1.14051094890511,0.603250900328121,IFT140
delta,3,zinc ion homeostasis (GO:0055069),1/32,1,32,0.589234884610392,0.74337124807673,0,0,1.14051094890511,0.603250900328121,SLC30A8
delta,3,multivesicular body organization (GO:0036257),1/32,1,32,0.589234884610392,0.74337124807673,0,0,1.14051094890511,0.603250900328121,PDCD6IP
delta,3,regulation of protein autophosphorylation (GO:0031952),1/32,1,32,0.589234884610392,0.74337124807673,0,0,1.14051094890511,0.603250900328121,NEK10
delta,3,cellular zinc ion homeostasis (GO:0006882),1/32,1,32,0.589234884610392,0.74337124807673,0,0,1.14051094890511,0.603250900328121,SLC30A8
delta,3,termination of RNA polymerase I transcription (GO:0006363),1/32,1,32,0.589234884610392,0.74337124807673,0,0,1.14051094890511,0.603250900328121,TAF1D
delta,3,liver development (GO:0001889),1/32,1,32,0.589234884610392,0.74337124807673,0,0,1.14051094890511,0.603250900328121,CEBPB
delta,3,protein destabilization (GO:0031648),1/32,1,32,0.589234884610392,0.74337124807673,0,0,1.14051094890511,0.603250900328121,FBXW11
delta,3,vesicle-mediated transport to the plasma membrane (GO:0098876),1/32,1,32,0.589234884610392,0.74337124807673,0,0,1.14051094890511,0.603250900328121,LLGL1
delta,3,viral gene expression (GO:0019080),3/111,3,111,0.589850234576821,0.743410746488015,0,0,0.986387847701716,0.520700941019359,RANBP2;POM121;RPL35
delta,3,regulation of cell communication (GO:0010646),2/72,2,72,0.590762742176434,0.743410746488015,0,0,1.01378751013788,0.533597722685899,SOCS2;EIF4EBP2
delta,3,nuclear import (GO:0051170),2/72,2,72,0.590762742176434,0.743410746488015,0,0,1.01378751013788,0.533597722685899,RANBP2;POM121
delta,3,regulation of cation channel activity (GO:2001257),2/72,2,72,0.590762742176434,0.743410746488015,0,0,1.01378751013788,0.533597722685899,APP;HOMER1
delta,3,lipid biosynthetic process (GO:0008610),2/73,2,73,0.598295595728266,0.746222076515453,0,0,0.999900009999,0.513618978025378,DGKE;FDFT1
delta,3,glycoprotein biosynthetic process (GO:0009101),2/73,2,73,0.598295595728266,0.746222076515453,0,0,0.999900009999,0.513618978025378,ALG5;FUT4
delta,3,regulation of fat cell differentiation (GO:0045598),2/73,2,73,0.598295595728266,0.746222076515453,0,0,0.999900009999,0.513618978025378,CEBPB;ASXL2
delta,3,protein deacetylation (GO:0006476),1/33,1,33,0.600507851206949,0.746222076515453,0,0,1.1059500110595,0.564011903448383,BAZ2A
delta,3,7-methylguanosine mRNA capping (GO:0006370),1/33,1,33,0.600507851206949,0.746222076515453,0,0,1.1059500110595,0.564011903448383,RNMT
delta,3,positive regulation of calcium ion transport into cytosol (GO:0010524),1/33,1,33,0.600507851206949,0.746222076515453,0,0,1.1059500110595,0.564011903448383,TRPC1
delta,3,response to zinc ion (GO:0010043),1/33,1,33,0.600507851206949,0.746222076515453,0,0,1.1059500110595,0.564011903448383,SLC30A8
delta,3,regulation of glutamate receptor signaling pathway (GO:1900449),1/33,1,33,0.600507851206949,0.746222076515453,0,0,1.1059500110595,0.564011903448383,APP
delta,3,cellular response to glucagon stimulus (GO:0071377),1/33,1,33,0.600507851206949,0.746222076515453,0,0,1.1059500110595,0.564011903448383,PRKAR1B
delta,3,positive regulation of dendrite development (GO:1900006),1/33,1,33,0.600507851206949,0.746222076515453,0,0,1.1059500110595,0.564011903448383,CPEB3
delta,3,central nervous system neuron differentiation (GO:0021953),1/33,1,33,0.600507851206949,0.746222076515453,0,0,1.1059500110595,0.564011903448383,CBLN1
delta,3,7-methylguanosine RNA capping (GO:0009452),1/33,1,33,0.600507851206949,0.746222076515453,0,0,1.1059500110595,0.564011903448383,RNMT
delta,3,GPI anchor biosynthetic process (GO:0006506),1/33,1,33,0.600507851206949,0.746222076515453,0,0,1.1059500110595,0.564011903448383,PIGW
delta,3,phagosome maturation (GO:0090382),1/33,1,33,0.600507851206949,0.746222076515453,0,0,1.1059500110595,0.564011903448383,ATP6V1H
delta,3,mitochondrial transmembrane transport (GO:1990542),1/33,1,33,0.600507851206949,0.746222076515453,0,0,1.1059500110595,0.564011903448383,MCUR1
delta,3,endodermal cell differentiation (GO:0035987),1/33,1,33,0.600507851206949,0.746222076515453,0,0,1.1059500110595,0.564011903448383,PAF1
delta,3,purine ribonucleoside triphosphate metabolic process (GO:0009205),1/33,1,33,0.600507851206949,0.746222076515453,0,0,1.1059500110595,0.564011903448383,RAB23
delta,3,positive regulation of transcription factor import into nucleus (GO:0042993),1/33,1,33,0.600507851206949,0.746222076515453,0,0,1.1059500110595,0.564011903448383,APP
delta,3,regulation of erythrocyte differentiation (GO:0045646),1/33,1,33,0.600507851206949,0.746222076515453,0,0,1.1059500110595,0.564011903448383,MAFB
delta,3,regulation of nitric oxide biosynthetic process (GO:0045428),1/33,1,33,0.600507851206949,0.746222076515453,0,0,1.1059500110595,0.564011903448383,CLU
delta,3,protein N-linked glycosylation (GO:0006487),2/74,2,74,0.605723805160007,0.749072039787273,0,0,0.986387847701716,0.494506967714435,ALG5;ST6GALNAC5
delta,3,regulation of peptide hormone secretion (GO:0090276),2/74,2,74,0.605723805160007,0.749072039787273,0,0,0.986387847701716,0.494506967714435,PPP3CB;SLC2A1
delta,3,regulation of protein complex assembly (GO:0043254),2/74,2,74,0.605723805160007,0.749072039787273,0,0,0.986387847701716,0.494506967714435,TRAF3IP1;SVIP
delta,3,chloride transport (GO:0006821),2/74,2,74,0.605723805160007,0.749072039787273,0,0,0.986387847701716,0.494506967714435,SLC12A1;ANO10
delta,3,viral transcription (GO:0019083),3/114,3,114,0.607956624685292,0.749072039787273,0,0,0.960430272762197,0.477959796906451,RANBP2;POM121;RPL35
delta,3,intracellular pH reduction (GO:0051452),1/34,1,34,0.611471992216888,0.749072039787273,0,0,1.07342206955775,0.528001424082312,ATP6V1H
delta,3,negative regulation of neurogenesis (GO:0050768),1/34,1,34,0.611471992216888,0.749072039787273,0,0,1.07342206955775,0.528001424082312,HOOK3
delta,3,regulation of T cell differentiation (GO:0045580),1/34,1,34,0.611471992216888,0.749072039787273,0,0,1.07342206955775,0.528001424082312,SOD1
delta,3,entry into host cell (GO:0030260),1/34,1,34,0.611471992216888,0.749072039787273,0,0,1.07342206955775,0.528001424082312,WWP1
delta,3,stem cell differentiation (GO:0048863),1/34,1,34,0.611471992216888,0.749072039787273,0,0,1.07342206955775,0.528001424082312,PUM1
delta,3,regulation of cell-substrate adhesion (GO:0010810),1/34,1,34,0.611471992216888,0.749072039787273,0,0,1.07342206955775,0.528001424082312,JAK2
delta,3,positive regulation of cell-matrix adhesion (GO:0001954),1/34,1,34,0.611471992216888,0.749072039787273,0,0,1.07342206955775,0.528001424082312,UTRN
delta,3,platelet aggregation (GO:0070527),1/34,1,34,0.611471992216888,0.749072039787273,0,0,1.07342206955775,0.528001424082312,ACTB
delta,3,transcription initiation from RNA polymerase I promoter (GO:0006361),1/34,1,34,0.611471992216888,0.749072039787273,0,0,1.07342206955775,0.528001424082312,TAF1D
delta,3,positive regulation of catalytic activity (GO:0043085),1/34,1,34,0.611471992216888,0.749072039787273,0,0,1.07342206955775,0.528001424082312,SOD1
delta,3,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),1/34,1,34,0.611471992216888,0.749072039787273,0,0,1.07342206955775,0.528001424082312,PDCD6IP
delta,3,carboxylic acid metabolic process (GO:0019752),1/34,1,34,0.611471992216888,0.749072039787273,0,0,1.07342206955775,0.528001424082312,SLC2A1
delta,3,regulation of DNA recombination (GO:0000018),1/34,1,34,0.611471992216888,0.749072039787273,0,0,1.07342206955775,0.528001424082312,TERF2IP
delta,3,transcription from RNA polymerase I promoter (GO:0006360),1/34,1,34,0.611471992216888,0.749072039787273,0,0,1.07342206955775,0.528001424082312,TAF1D
delta,3,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),1/34,1,34,0.611471992216888,0.749072039787273,0,0,1.07342206955775,0.528001424082312,PIK3R4
delta,3,positive regulation of nucleocytoplasmic transport (GO:0046824),1/34,1,34,0.611471992216888,0.749072039787273,0,0,1.07342206955775,0.528001424082312,KHDRBS1
delta,3,negative regulation of multi-organism process (GO:0043901),1/34,1,34,0.611471992216888,0.749072039787273,0,0,1.07342206955775,0.528001424082312,TRAF3IP1
delta,3,regulation of neurotransmitter receptor activity (GO:0099601),1/34,1,34,0.611471992216888,0.749072039787273,0,0,1.07342206955775,0.528001424082312,APP
delta,3,glucose homeostasis (GO:0042593),2/75,2,75,0.613047439193211,0.7505392863074,0,0,0.97323600973236,0.476216990239018,CRY1;ADIPOR2
delta,3,peptidyl-lysine modification (GO:0018205),3/116,3,116,0.619728259258058,0.754690928737622,0,0,0.943871130128366,0.451617973074562,RANBP2;POM121;UBE2I
delta,3,negative regulation of cell growth (GO:0030308),3/116,3,116,0.619728259258058,0.754690928737622,0,0,0.943871130128366,0.451617973074562,DNAJB2;ADAM15;SESN2
delta,3,regulation of double-strand break repair (GO:2000779),1/35,1,35,0.622135753030813,0.754690928737622,0,0,1.04275286757039,0.494887338472834,TERF2IP
delta,3,apoptotic mitochondrial changes (GO:0008637),1/35,1,35,0.622135753030813,0.754690928737622,0,0,1.04275286757039,0.494887338472834,CLU
delta,3,negative regulation of DNA binding (GO:0043392),1/35,1,35,0.622135753030813,0.754690928737622,0,0,1.04275286757039,0.494887338472834,JAK2
delta,3,negative regulation of cellular metabolic process (GO:0031324),1/35,1,35,0.622135753030813,0.754690928737622,0,0,1.04275286757039,0.494887338472834,NFKB1
delta,3,ncRNA metabolic process (GO:0034660),1/35,1,35,0.622135753030813,0.754690928737622,0,0,1.04275286757039,0.494887338472834,AGO2
delta,3,positive regulation of exocytosis (GO:0045921),1/35,1,35,0.622135753030813,0.754690928737622,0,0,1.04275286757039,0.494887338472834,PDCD6IP
delta,3,response to peptide (GO:1901652),1/35,1,35,0.622135753030813,0.754690928737622,0,0,1.04275286757039,0.494887338472834,EIF2B5
delta,3,regulation of alcohol biosynthetic process (GO:1902930),1/35,1,35,0.622135753030813,0.754690928737622,0,0,1.04275286757039,0.494887338472834,FDFT1
delta,3,negative regulation of T cell activation (GO:0050868),1/35,1,35,0.622135753030813,0.754690928737622,0,0,1.04275286757039,0.494887338472834,CEBPB
delta,3,regulation of axon extension (GO:0030516),1/35,1,35,0.622135753030813,0.754690928737622,0,0,1.04275286757039,0.494887338472834,RUFY3
delta,3,regulation of insulin receptor signaling pathway (GO:0046626),1/35,1,35,0.622135753030813,0.754690928737622,0,0,1.04275286757039,0.494887338472834,SOCS2
delta,3,positive regulation of cell development (GO:0010720),1/35,1,35,0.622135753030813,0.754690928737622,0,0,1.04275286757039,0.494887338472834,ZNF335
delta,3,regulation of interferon-beta production (GO:0032648),1/35,1,35,0.622135753030813,0.754690928737622,0,0,1.04275286757039,0.494887338472834,REL
delta,3,regulation of hematopoietic stem cell differentiation (GO:1902036),2/77,2,77,0.627381625657804,0.759663187191991,0,0,0.947957152336714,0.441937880502245,PSMA3;PSMA1
delta,3,positive regulation of apoptotic signaling pathway (GO:2001235),2/77,2,77,0.627381625657804,0.759663187191991,0,0,0.947957152336714,0.441937880502245,MOAP1;TRIM39
delta,3,response to interleukin-1 (GO:0070555),2/77,2,77,0.627381625657804,0.759663187191991,0,0,0.947957152336714,0.441937880502245,IRAK1;NFKB1
delta,3,regulation of cyclin-dependent protein kinase activity (GO:1904029),1/36,1,36,0.632507348353035,0.761230830513313,0,0,1.01378751013788,0.46437899482815,SERTAD1
delta,3,positive regulation of peptide secretion (GO:0002793),1/36,1,36,0.632507348353035,0.761230830513313,0,0,1.01378751013788,0.46437899482815,ANG
delta,3,regulation of microtubule polymerization (GO:0031113),1/36,1,36,0.632507348353035,0.761230830513313,0,0,1.01378751013788,0.46437899482815,STMN1
delta,3,anatomical structure homeostasis (GO:0060249),1/36,1,36,0.632507348353035,0.761230830513313,0,0,1.01378751013788,0.46437899482815,TERF2IP
delta,3,erythrocyte differentiation (GO:0030218),1/36,1,36,0.632507348353035,0.761230830513313,0,0,1.01378751013788,0.46437899482815,JAK2
delta,3,positive regulation of DNA replication (GO:0045740),1/36,1,36,0.632507348353035,0.761230830513313,0,0,1.01378751013788,0.46437899482815,DBF4
delta,3,negative regulation of epithelial cell migration (GO:0010633),1/36,1,36,0.632507348353035,0.761230830513313,0,0,1.01378751013788,0.46437899482815,EVL
delta,3,cholesterol biosynthetic process (GO:0006695),1/36,1,36,0.632507348353035,0.761230830513313,0,0,1.01378751013788,0.46437899482815,FDFT1
delta,3,positive regulation of telomerase activity (GO:0051973),1/36,1,36,0.632507348353035,0.761230830513313,0,0,1.01378751013788,0.46437899482815,MAP3K4
delta,3,carbohydrate catabolic process (GO:0016052),1/36,1,36,0.632507348353035,0.761230830513313,0,0,1.01378751013788,0.46437899482815,MAN2B1
delta,3,water-soluble vitamin metabolic process (GO:0006767),2/78,2,78,0.634392672483032,0.762115018273147,0,0,0.935803855511885,0.42587231802235,SLC2A1;MTR
delta,3,response to ionizing radiation (GO:0010212),2/78,2,78,0.634392672483032,0.762115018273147,0,0,0.935803855511885,0.42587231802235,PAXIP1;NABP2
delta,3,regulation of hematopoietic progenitor cell differentiation (GO:1901532),2/78,2,78,0.634392672483032,0.762115018273147,0,0,0.935803855511885,0.42587231802235,PSMA3;PSMA1
delta,3,positive regulation of protein serine/threonine kinase activity (GO:0071902),3/119,3,119,0.636930828587307,0.76274540345475,0,0,0.920076059620929,0.415040991214295,IRAK1;NEK10;MAPRE3
delta,3,regulation of cellular response to heat (GO:1900034),2/79,2,79,0.641300125266768,0.76274540345475,0,0,0.923958237087684,0.410475577469078,RANBP2;POM121
delta,3,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),2/79,2,79,0.641300125266768,0.76274540345475,0,0,0.923958237087684,0.410475577469078,PSMA3;PSMA1
delta,3,visual perception (GO:0007601),2/79,2,79,0.641300125266768,0.76274540345475,0,0,0.923958237087684,0.410475577469078,RABGGTB;DRAM2
delta,3,regulation of receptor-mediated endocytosis (GO:0048259),1/37,1,37,0.642594768688099,0.76274540345475,0,0,0.986387847701716,0.436221121706597,CLU
delta,3,muscle cell differentiation (GO:0042692),1/37,1,37,0.642594768688099,0.76274540345475,0,0,0.986387847701716,0.436221121706597,MKL1
delta,3,organic hydroxy compound transport (GO:0015850),1/37,1,37,0.642594768688099,0.76274540345475,0,0,0.986387847701716,0.436221121706597,NCOA1
delta,3,regulation of smoothened signaling pathway (GO:0008589),1/37,1,37,0.642594768688099,0.76274540345475,0,0,0.986387847701716,0.436221121706597,INTU
delta,3,transferrin transport (GO:0033572),1/37,1,37,0.642594768688099,0.76274540345475,0,0,0.986387847701716,0.436221121706597,ATP6V1H
delta,3,lymphocyte proliferation (GO:0046651),1/37,1,37,0.642594768688099,0.76274540345475,0,0,0.986387847701716,0.436221121706597,PPP3CB
delta,3,positive regulation of signaling (GO:0023056),1/37,1,37,0.642594768688099,0.76274540345475,0,0,0.986387847701716,0.436221121706597,HOMER1
delta,3,natural killer cell activation (GO:0030101),1/37,1,37,0.642594768688099,0.76274540345475,0,0,0.986387847701716,0.436221121706597,ULBP3
delta,3,endoderm formation (GO:0001706),1/37,1,37,0.642594768688099,0.76274540345475,0,0,0.986387847701716,0.436221121706597,DUSP5
delta,3,organophosphate biosynthetic process (GO:0090407),1/37,1,37,0.642594768688099,0.76274540345475,0,0,0.986387847701716,0.436221121706597,DGKE
delta,3,vesicle-mediated transport in synapse (GO:0099003),1/37,1,37,0.642594768688099,0.76274540345475,0,0,0.986387847701716,0.436221121706597,TMEM230
delta,3,zymogen activation (GO:0031638),1/37,1,37,0.642594768688099,0.76274540345475,0,0,0.986387847701716,0.436221121706597,TBC1D10A
delta,3,endosome organization (GO:0007032),1/37,1,37,0.642594768688099,0.76274540345475,0,0,0.986387847701716,0.436221121706597,HOOK3
delta,3,ferric iron transport (GO:0015682),1/37,1,37,0.642594768688099,0.76274540345475,0,0,0.986387847701716,0.436221121706597,ATP6V1H
delta,3,regulation of ubiquitin protein ligase activity (GO:1904666),1/37,1,37,0.642594768688099,0.76274540345475,0,0,0.986387847701716,0.436221121706597,ANAPC10
delta,3,secondary alcohol biosynthetic process (GO:1902653),1/37,1,37,0.642594768688099,0.76274540345475,0,0,0.986387847701716,0.436221121706597,FDFT1
delta,3,protein monoubiquitination (GO:0006513),1/38,1,38,0.652405786362654,0.768879180013401,0,0,0.960430272762197,0.410188761934866,PAF1
delta,3,myelination (GO:0042552),1/38,1,38,0.652405786362654,0.768879180013401,0,0,0.960430272762197,0.410188761934866,EIF2B5
delta,3,regulation of dendrite development (GO:0050773),1/38,1,38,0.652405786362654,0.768879180013401,0,0,0.960430272762197,0.410188761934866,CPEB3
delta,3,regulation of sodium ion transmembrane transporter activity (GO:2000649),1/38,1,38,0.652405786362654,0.768879180013401,0,0,0.960430272762197,0.410188761934866,UTRN
delta,3,positive regulation of axonogenesis (GO:0050772),1/38,1,38,0.652405786362654,0.768879180013401,0,0,0.960430272762197,0.410188761934866,RUFY3
delta,3,regulation of peptidyl-threonine phosphorylation (GO:0010799),1/38,1,38,0.652405786362654,0.768879180013401,0,0,0.960430272762197,0.410188761934866,APP
delta,3,positive regulation of stress fiber assembly (GO:0051496),1/38,1,38,0.652405786362654,0.768879180013401,0,0,0.960430272762197,0.410188761934866,EVL
delta,3,negative regulation of G0 to G1 transition (GO:0070317),1/38,1,38,0.652405786362654,0.768879180013401,0,0,0.960430272762197,0.410188761934866,RBBP8
delta,3,regulation of metal ion transport (GO:0010959),1/38,1,38,0.652405786362654,0.768879180013401,0,0,0.960430272762197,0.410188761934866,ORAI1
delta,3,response to steroid hormone (GO:0048545),1/38,1,38,0.652405786362654,0.768879180013401,0,0,0.960430272762197,0.410188761934866,WBP2
delta,3,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",1/38,1,38,0.652405786362654,0.768879180013401,0,0,0.960430272762197,0.410188761934866,ERCC5
delta,3,organic cyclic compound biosynthetic process (GO:1901362),1/38,1,38,0.652405786362654,0.768879180013401,0,0,0.960430272762197,0.410188761934866,FDFT1
delta,3,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),2/81,2,81,0.654805914334689,0.770337094010081,0,0,0.901144453455889,0.381559341488143,PPP2R5C;JAK2
delta,3,cellular response to hormone stimulus (GO:0032870),2/81,2,81,0.654805914334689,0.770337094010081,0,0,0.901144453455889,0.381559341488143,NCOA1;SOCS2
delta,3,negative regulation of MAPK cascade (GO:0043409),2/81,2,81,0.654805914334689,0.770337094010081,0,0,0.901144453455889,0.381559341488143,DAG1;C3ORF33
delta,3,sulfur compound biosynthetic process (GO:0044272),3/123,3,123,0.659010507871922,0.774611660568785,0,0,0.890154886950329,0.371208651797516,SLC35B2;GCLM;EXTL3
delta,3,sensory perception of light stimulus (GO:0050953),2/82,2,82,0.661405219219338,0.774611660568785,0,0,0.890154886950329,0.367979871191326,RABGGTB;DRAM2
delta,3,negative regulation of cell death (GO:0060548),2/82,2,82,0.661405219219338,0.774611660568785,0,0,0.890154886950329,0.367979871191326,PDE12;CLU
delta,3,negative regulation of cell cycle process (GO:0010948),2/82,2,82,0.661405219219338,0.774611660568785,0,0,0.890154886950329,0.367979871191326,FBXW7;RBBP8
delta,3,positive regulation of binding (GO:0051099),2/82,2,82,0.661405219219338,0.774611660568785,0,0,0.890154886950329,0.367979871191326,APP;STMN1
delta,3,potassium ion import (GO:0010107),1/39,1,39,0.661947961573124,0.774611660568785,0,0,0.935803855511885,0.386083037647833,SLC12A1
delta,3,mitochondrion disassembly (GO:0061726),1/39,1,39,0.661947961573124,0.774611660568785,0,0,0.935803855511885,0.386083037647833,FBXO7
delta,3,membrane depolarization during action potential (GO:0086010),1/39,1,39,0.661947961573124,0.774611660568785,0,0,0.935803855511885,0.386083037647833,NALCN
delta,3,homotypic cell-cell adhesion (GO:0034109),1/39,1,39,0.661947961573124,0.774611660568785,0,0,0.935803855511885,0.386083037647833,ACTB
delta,3,modulation of chemical synaptic transmission (GO:0050804),2/83,2,83,0.667902860785066,0.780873140232112,0,0,0.879430129276229,0.354949022958526,APP;EIF4EBP2
delta,3,organic anion transport (GO:0015711),3/125,3,125,0.669681235696914,0.780873140232112,0,0,0.875912408759124,0.351200099936054,SLC35B2;OSBPL8;SLC35A1
delta,3,negative regulation of protein catabolic process (GO:0042177),1/40,1,40,0.671228647970029,0.780873140232112,0,0,0.912408759124088,0.363727593996923,SF3B3
delta,3,regulation of type I interferon-mediated signaling pathway (GO:0060338),1/40,1,40,0.671228647970029,0.780873140232112,0,0,0.912408759124088,0.363727593996923,ABCE1
delta,3,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",1/40,1,40,0.671228647970029,0.780873140232112,0,0,0.912408759124088,0.363727593996923,RBM4
delta,3,regulation of G0 to G1 transition (GO:0070316),1/40,1,40,0.671228647970029,0.780873140232112,0,0,0.912408759124088,0.363727593996923,RBBP8
delta,3,regulation of plasma membrane bounded cell projection assembly (GO:0120032),1/40,1,40,0.671228647970029,0.780873140232112,0,0,0.912408759124088,0.363727593996923,IFT140
delta,3,regulation of RNA metabolic process (GO:0051252),1/40,1,40,0.671228647970029,0.780873140232112,0,0,0.912408759124088,0.363727593996923,HNRNPF
delta,3,Golgi to plasma membrane transport (GO:0006893),1/40,1,40,0.671228647970029,0.780873140232112,0,0,0.912408759124088,0.363727593996923,LLGL1
delta,3,DNA replication-independent nucleosome assembly (GO:0006336),1/40,1,40,0.671228647970029,0.780873140232112,0,0,0.912408759124088,0.363727593996923,ASF1B
delta,3,negative regulation of neuron death (GO:1901215),2/84,2,84,0.67429944455679,0.783528068031779,0,0,0.868960722975321,0.342440899352634,FBXO7;SOD1
delta,3,positive regulation of peptidyl-serine phosphorylation (GO:0033138),2/84,2,84,0.67429944455679,0.783528068031779,0,0,0.868960722975321,0.342440899352634,APP;TERF2IP
delta,3,negative regulation of multicellular organismal process (GO:0051241),3/126,3,126,0.674924237532265,0.783795710097376,0,0,0.868960722975321,0.341636109751482,SDHAF2;FBXW7;EVL
delta,3,cytoskeleton organization (GO:0007010),3/127,3,127,0.680105707203477,0.783967243817513,0,0,0.862118512558193,0.332352756874137,FMNL3;DAG1;WASF3
delta,3,negative regulation of transport (GO:0051051),1/41,1,41,0.680254998707809,0.783967243817513,0,0,0.890154886950329,0.342965598189853,CTTNBP2NL
delta,3,negative regulation of TOR signaling (GO:0032007),1/41,1,41,0.680254998707809,0.783967243817513,0,0,0.890154886950329,0.342965598189853,SESN2
delta,3,"nucleotide-excision repair, DNA incision (GO:0033683)",1/41,1,41,0.680254998707809,0.783967243817513,0,0,0.890154886950329,0.342965598189853,ERCC5
delta,3,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),1/41,1,41,0.680254998707809,0.783967243817513,0,0,0.890154886950329,0.342965598189853,ARHGEF7
delta,3,autophagy of mitochondrion (GO:0000422),1/41,1,41,0.680254998707809,0.783967243817513,0,0,0.890154886950329,0.342965598189853,FBXO7
delta,3,tRNA aminoacylation (GO:0043039),1/41,1,41,0.680254998707809,0.783967243817513,0,0,0.890154886950329,0.342965598189853,KARS
delta,3,sterol biosynthetic process (GO:0016126),1/41,1,41,0.680254998707809,0.783967243817513,0,0,0.890154886950329,0.342965598189853,FDFT1
delta,3,negative regulation of ERK1 and ERK2 cascade (GO:0070373),1/41,1,41,0.680254998707809,0.783967243817513,0,0,0.890154886950329,0.342965598189853,C3ORF33
delta,3,regulation of intracellular transport (GO:0032386),1/41,1,41,0.680254998707809,0.783967243817513,0,0,0.890154886950329,0.342965598189853,RBM4
delta,3,regulation of viral transcription (GO:0046782),1/41,1,41,0.680254998707809,0.783967243817513,0,0,0.890154886950329,0.342965598189853,NELFA
delta,3,regulation of ATPase activity (GO:0043462),1/41,1,41,0.680254998707809,0.783967243817513,0,0,0.890154886950329,0.342965598189853,DNAJB2
delta,3,regulation of neuron differentiation (GO:0045664),2/85,2,85,0.680595619318173,0.783967243817513,0,0,0.8587376556462,0.330431046316822,ZEB1;FBXO7
delta,3,cellular response to molecule of bacterial origin (GO:0071219),2/85,2,85,0.680595619318173,0.783967243817513,0,0,0.8587376556462,0.330431046316822,PAF1;NFKB1
delta,3,protein lipidation (GO:0006497),3/128,3,128,0.685225709337231,0.788658122557631,0,0,0.855383211678832,0.323340835120817,PIGW;ZDHHC16;ZDHHC2
delta,3,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),2/86,2,86,0.686792074250345,0.788658122557631,0,0,0.848752334068919,0.318896358970016,APP;JAK2
delta,3,regulation of cholesterol metabolic process (GO:0090181),1/42,1,42,0.689033971192776,0.788658122557631,0,0,0.868960722975321,0.323657198570205,FDFT1
delta,3,DNA duplex unwinding (GO:0032508),1/42,1,42,0.689033971192776,0.788658122557631,0,0,0.868960722975321,0.323657198570205,PURA
delta,3,telomere organization (GO:0032200),1/42,1,42,0.689033971192776,0.788658122557631,0,0,0.868960722975321,0.323657198570205,TERF2IP
delta,3,positive regulation of receptor-mediated endocytosis (GO:0048260),1/42,1,42,0.689033971192776,0.788658122557631,0,0,0.868960722975321,0.323657198570205,CLU
delta,3,negative regulation of cell projection organization (GO:0031345),1/42,1,42,0.689033971192776,0.788658122557631,0,0,0.868960722975321,0.323657198570205,ITM2C
delta,3,regulation of substrate adhesion-dependent cell spreading (GO:1900024),1/42,1,42,0.689033971192776,0.788658122557631,0,0,0.868960722975321,0.323657198570205,ARHGEF7
delta,3,cellular response to peptide (GO:1901653),1/42,1,42,0.689033971192776,0.788658122557631,0,0,0.868960722975321,0.323657198570205,APP
delta,3,positive regulation of viral transcription (GO:0050434),1/42,1,42,0.689033971192776,0.788658122557631,0,0,0.868960722975321,0.323657198570205,NELFA
delta,3,gluconeogenesis (GO:0006094),1/42,1,42,0.689033971192776,0.788658122557631,0,0,0.868960722975321,0.323657198570205,CRY1
delta,3,toll-like receptor signaling pathway (GO:0002224),2/87,2,87,0.692889535934843,0.792614569892074,0,0,0.838996560114104,0.307814994800868,IRAK1;PIK3R4
delta,3,cellular response to calcium ion (GO:0071277),1/43,1,43,0.697572333194124,0.795680956404549,0,0,0.848752334068919,0.305677361364228,MEF2A
delta,3,regulation of protein modification process (GO:0031399),1/43,1,43,0.697572333194124,0.795680956404549,0,0,0.848752334068919,0.305677361364228,SESN2
delta,3,determination of left/right symmetry (GO:0007368),1/43,1,43,0.697572333194124,0.795680956404549,0,0,0.848752334068919,0.305677361364228,GALNT11
delta,3,regulation of telomerase activity (GO:0051972),1/43,1,43,0.697572333194124,0.795680956404549,0,0,0.848752334068919,0.305677361364228,MAP3K4
delta,3,cellular response to retinoic acid (GO:0071300),1/43,1,43,0.697572333194124,0.795680956404549,0,0,0.848752334068919,0.305677361364228,SETX
delta,3,calcium ion homeostasis (GO:0055074),2/88,2,88,0.698888766105274,0.795812021920447,0,0,0.829462508294625,0.29716629255799,STIM2;ATP13A3
delta,3,organic substance transport (GO:0071702),2/88,2,88,0.698888766105274,0.795812021920447,0,0,0.829462508294625,0.29716629255799,ABCA5;PSAP
delta,3,regulation of MAP kinase activity (GO:0043405),2/88,2,88,0.698888766105274,0.795812021920447,0,0,0.829462508294625,0.29716629255799,IRAK1;NEK10
delta,3,regulation of stem cell differentiation (GO:2000736),2/89,2,89,0.704790559147653,0.798734019510194,0,0,0.820142704830641,0.286930697555835,PSMA3;PSMA1
delta,3,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),2/89,2,89,0.704790559147653,0.798734019510194,0,0,0.820142704830641,0.286930697555835,ARIH2;CLU
delta,3,regulation of B cell proliferation (GO:0030888),1/44,1,44,0.705876667468495,0.798734019510194,0,0,0.829462508294625,0.288914025149539,IRS2
delta,3,negative regulation of ERBB signaling pathway (GO:1901185),1/44,1,44,0.705876667468495,0.798734019510194,0,0,0.829462508294625,0.288914025149539,ARHGEF7
delta,3,male gonad development (GO:0008584),1/44,1,44,0.705876667468495,0.798734019510194,0,0,0.829462508294625,0.288914025149539,MEA1
delta,3,membrane depolarization (GO:0051899),1/44,1,44,0.705876667468495,0.798734019510194,0,0,0.829462508294625,0.288914025149539,NALCN
delta,3,RNA catabolic process (GO:0006401),1/44,1,44,0.705876667468495,0.798734019510194,0,0,0.829462508294625,0.288914025149539,DXO
delta,3,development of primary male sexual characteristics (GO:0046546),1/44,1,44,0.705876667468495,0.798734019510194,0,0,0.829462508294625,0.288914025149539,MEA1
delta,3,negative regulation of DNA metabolic process (GO:0051053),1/44,1,44,0.705876667468495,0.798734019510194,0,0,0.829462508294625,0.288914025149539,TERF2IP
delta,3,positive regulation of protein localization to plasma membrane (GO:1903078),1/44,1,44,0.705876667468495,0.798734019510194,0,0,0.829462508294625,0.288914025149539,PRKCH
delta,3,substantia nigra development (GO:0021762),1/44,1,44,0.705876667468495,0.798734019510194,0,0,0.829462508294625,0.288914025149539,ACTB
delta,3,cellular response to hypoxia (GO:0071456),3/133,3,133,0.709907670427209,0.801936325735041,0,0,0.823225948081884,0.282053969914996,PSMA3;PSMA1;CPEB2
delta,3,peptidyl-threonine modification (GO:0018210),2/90,2,90,0.710595739631586,0.801936325735041,0,0,0.8110300081103,0.277089692510541,GALNT7;GALNT11
delta,3,positive regulation of viral life cycle (GO:1903902),1/45,1,45,0.713953377063557,0.801936325735041,0,0,0.8110300081103,0.273266518252139,PDE12
delta,3,hexose biosynthetic process (GO:0019319),1/45,1,45,0.713953377063557,0.801936325735041,0,0,0.8110300081103,0.273266518252139,CRY1
delta,3,regulation of smooth muscle cell proliferation (GO:0048660),1/45,1,45,0.713953377063557,0.801936325735041,0,0,0.8110300081103,0.273266518252139,ANG
delta,3,positive regulation of transport (GO:0051050),1/45,1,45,0.713953377063557,0.801936325735041,0,0,0.8110300081103,0.273266518252139,CD151
delta,3,heart contraction (GO:0060047),1/45,1,45,0.713953377063557,0.801936325735041,0,0,0.8110300081103,0.273266518252139,SOD1
delta,3,regulation of intracellular pH (GO:0051453),1/45,1,45,0.713953377063557,0.801936325735041,0,0,0.8110300081103,0.273266518252139,VPS33A
delta,3,carboxylic acid biosynthetic process (GO:0046394),1/45,1,45,0.713953377063557,0.801936325735041,0,0,0.8110300081103,0.273266518252139,ST20-MTHFS
delta,3,inorganic anion transport (GO:0015698),1/45,1,45,0.713953377063557,0.801936325735041,0,0,0.8110300081103,0.273266518252139,ANO10
delta,3,regulation of steroid biosynthetic process (GO:0050810),1/45,1,45,0.713953377063557,0.801936325735041,0,0,0.8110300081103,0.273266518252139,FDFT1
delta,3,positive regulation of actin filament bundle assembly (GO:0032233),1/45,1,45,0.713953377063557,0.801936325735041,0,0,0.8110300081103,0.273266518252139,EVL
delta,3,positive regulation of viral process (GO:0048524),1/45,1,45,0.713953377063557,0.801936325735041,0,0,0.8110300081103,0.273266518252139,NELFA
delta,3,positive regulation of response to external stimulus (GO:0032103),2/91,2,91,0.716305160066733,0.803669312847318,0,0,0.802117590438759,0.267625733222835,ANKRD17;PUM1
delta,3,regulation of Ras protein signal transduction (GO:0046578),2/91,2,91,0.716305160066733,0.803669312847318,0,0,0.802117590438759,0.267625733222835,APLP2;RASAL2
delta,3,mitochondrial gene expression (GO:0140053),1/46,1,46,0.721808690113818,0.808930551187906,0,0,0.793398920977467,0.258644198145158,MRPL2
delta,3,peptidyl-tyrosine autophosphorylation (GO:0038083),1/46,1,46,0.721808690113818,0.808930551187906,0,0,0.793398920977467,0.258644198145158,JAK2
delta,3,nucleocytoplasmic transport (GO:0006913),1/47,1,47,0.729448664700085,0.813820604581173,0,0,0.776518092871564,0.244965277234866,ATXN1
delta,3,positive regulation of protein localization to cell periphery (GO:1904377),1/47,1,47,0.729448664700085,0.813820604581173,0,0,0.776518092871564,0.244965277234866,PRKCH
delta,3,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),1/47,1,47,0.729448664700085,0.813820604581173,0,0,0.776518092871564,0.244965277234866,CRY1
delta,3,tRNA aminoacylation for protein translation (GO:0006418),1/47,1,47,0.729448664700085,0.813820604581173,0,0,0.776518092871564,0.244965277234866,KARS
delta,3,mitotic spindle assembly (GO:0090307),1/47,1,47,0.729448664700085,0.813820604581173,0,0,0.776518092871564,0.244965277234866,TUBGCP2
delta,3,regulation of cellular component movement (GO:0051270),1/47,1,47,0.729448664700085,0.813820604581173,0,0,0.776518092871564,0.244965277234866,ZSWIM8
delta,3,aminoglycan biosynthetic process (GO:0006023),1/47,1,47,0.729448664700085,0.813820604581173,0,0,0.776518092871564,0.244965277234866,NDST2
delta,3,negative regulation of autophagy (GO:0010507),1/47,1,47,0.729448664700085,0.813820604581173,0,0,0.776518092871564,0.244965277234866,SMCR8
delta,3,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),2/94,2,94,0.732867762777619,0.817176343793002,0,0,0.776518092871564,0.241334057196825,PSMA3;PSMA1
delta,3,regulation of intrinsic apoptotic signaling pathway (GO:2001242),1/48,1,48,0.736879193442933,0.820268323457204,0,0,0.760340632603406,0.232155806614679,EIF2AK3
delta,3,fatty acid biosynthetic process (GO:0006633),1/48,1,48,0.736879193442933,0.820268323457204,0,0,0.760340632603406,0.232155806614679,OXSM
delta,3,histone H4 acetylation (GO:0043967),1/48,1,48,0.736879193442933,0.820268323457204,0,0,0.760340632603406,0.232155806614679,ELP4
delta,3,response to cytokine (GO:0034097),3/139,3,139,0.737530617124961,0.820533782882026,0,0,0.787691015071155,0.239810699640943,IRAK1;REL;JAK2
delta,3,vesicle fusion (GO:0006906),2/95,2,95,0.738203155774924,0.820822423349062,0,0,0.768344218209758,0.233220294610925,TGFBRAP1;SNAP29
delta,3,negative regulation of mitotic cell cycle (GO:0045930),1/49,1,49,0.744106008047118,0.825077364949566,0,0,0.74482347683599,0.220148793657544,FZD3
delta,3,regulation of epithelial cell migration (GO:0010632),1/49,1,49,0.744106008047118,0.825077364949566,0,0,0.74482347683599,0.220148793657544,EVL
delta,3,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),1/49,1,49,0.744106008047118,0.825077364949566,0,0,0.74482347683599,0.220148793657544,MOAP1
delta,3,pattern recognition receptor signaling pathway (GO:0002221),1/49,1,49,0.744106008047118,0.825077364949566,0,0,0.74482347683599,0.220148793657544,IRAK1
delta,3,cellular response to mechanical stimulus (GO:0071260),1/49,1,49,0.744106008047118,0.825077364949566,0,0,0.74482347683599,0.220148793657544,NFKB1
delta,3,cellular metal ion homeostasis (GO:0006875),2/97,2,97,0.748601473526798,0.829599067427634,0,0,0.752502069380691,0.217885856826733,STIM2;ATP13A3
delta,3,non-recombinational repair (GO:0000726),1/50,1,50,0.751134683342253,0.829630136632049,0,0,0.72992700729927,0.208883434033443,PAXIP1
delta,3,protein heterooligomerization (GO:0051291),1/50,1,50,0.751134683342253,0.829630136632049,0,0,0.72992700729927,0.208883434033443,CPSF7
delta,3,regulation of reactive oxygen species metabolic process (GO:2000377),1/50,1,50,0.751134683342253,0.829630136632049,0,0,0.72992700729927,0.208883434033443,RNF41
delta,3,establishment of protein localization to mitochondrion (GO:0072655),1/50,1,50,0.751134683342253,0.829630136632049,0,0,0.72992700729927,0.208883434033443,FBXO7
delta,3,gonad development (GO:0008406),1/50,1,50,0.751134683342253,0.829630136632049,0,0,0.72992700729927,0.208883434033443,MEA1
delta,3,regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/50,1,50,0.751134683342253,0.829630136632049,0,0,0.72992700729927,0.208883434033443,TRPC1
delta,3,protein targeting to ER (GO:0045047),2/98,2,98,0.753666370473821,0.831040553902043,0,0,0.74482347683599,0.210640167119621,SPCS1;RPL35
delta,3,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),2/98,2,98,0.753666370473821,0.831040553902043,0,0,0.74482347683599,0.210640167119621,AP1G1;DYNC1I1
delta,3,antigen processing and presentation of exogenous peptide antigen (GO:0002478),2/98,2,98,0.753666370473821,0.831040553902043,0,0,0.74482347683599,0.210640167119621,AP1G1;DYNC1I1
delta,3,negative regulation of viral genome replication (GO:0045071),1/51,1,51,0.757970642378154,0.833291229971555,0,0,0.7156147130385,0.198304440004032,VAPA
delta,3,double-strand break repair via nonhomologous end joining (GO:0006303),1/51,1,51,0.757970642378154,0.833291229971555,0,0,0.7156147130385,0.198304440004032,PAXIP1
delta,3,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),2/99,2,99,0.758643097643957,0.833291229971555,0,0,0.737300007373,0.203659838723728,AP1G1;DYNC1I1
delta,3,histone modification (GO:0016570),2/99,2,99,0.758643097643957,0.833291229971555,0,0,0.737300007373,0.203659838723728,KAT6A;BAZ2A
delta,3,response to UV (GO:0009411),2/99,2,99,0.758643097643957,0.833291229971555,0,0,0.737300007373,0.203659838723728,ERCC5;MAP3K4
delta,3,positive regulation of neuron differentiation (GO:0045666),2/99,2,99,0.758643097643957,0.833291229971555,0,0,0.737300007373,0.203659838723728,SETX;ZEB1
delta,3,response to molecule of bacterial origin (GO:0002237),2/99,2,99,0.758643097643957,0.833291229971555,0,0,0.737300007373,0.203659838723728,IRAK1;JAK2
delta,3,peptidyl-tyrosine modification (GO:0018212),1/52,1,52,0.764619159489146,0.838464828865858,0,0,0.701852891633914,0.188361454132232,JAK2
delta,3,positive regulation of actin filament polymerization (GO:0030838),1/52,1,52,0.764619159489146,0.838464828865858,0,0,0.701852891633914,0.188361454132232,NCK2
delta,3,positive regulation of developmental growth (GO:0048639),1/52,1,52,0.764619159489146,0.838464828865858,0,0,0.701852891633914,0.188361454132232,RUFY3
delta,3,positive regulation of nervous system development (GO:0051962),1/53,1,53,0.771085365335759,0.843693073195019,0,0,0.688610384244594,0.17900853275582,ZNF335
delta,3,positive regulation of mitotic cell cycle (GO:0045931),1/53,1,53,0.771085365335759,0.843693073195019,0,0,0.688610384244594,0.17900853275582,APP
delta,3,regulation of DNA binding (GO:0051101),1/53,1,53,0.771085365335759,0.843693073195019,0,0,0.688610384244594,0.17900853275582,JAK2
delta,3,positive regulation of secretion by cell (GO:1903532),1/53,1,53,0.771085365335759,0.843693073195019,0,0,0.688610384244594,0.17900853275582,ANG
delta,3,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/54,1,54,0.777374250153329,0.849638413121378,0,0,0.675858340091917,0.170203692989082,JAK2
delta,3,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),1/54,1,54,0.777374250153329,0.849638413121378,0,0,0.675858340091917,0.170203692989082,JAK2
delta,3,negative regulation of canonical Wnt signaling pathway (GO:0090090),3/149,3,149,0.778890203183774,0.850827286270566,0,0,0.734825846274433,0.183622095400482,PSMA3;PSMA1;SDHAF2
delta,3,heart development (GO:0007507),3/150,3,150,0.782715844122709,0.854536473775726,0,0,0.72992700729927,0.178821573335764,MEF2A;CRELD1;ZDHHC16
delta,3,action potential (GO:0001508),1/55,1,55,0.783490667963313,0.854912661857826,0,0,0.6635700066357,0.16190851225025,NALCN
delta,3,fat cell differentiation (GO:0045444),1/56,1,56,0.789439340103415,0.860458567627804,0,0,0.651720542231491,0.154087774730297,OSBPL8
delta,3,Notch signaling pathway (GO:0007219),1/56,1,56,0.789439340103415,0.860458567627804,0,0,0.651720542231491,0.154087774730297,GALNT11
delta,3,ribosome assembly (GO:0042255),1/57,1,57,0.795224858935981,0.863175071860588,0,0,0.640286848508132,0.146709157952999,MDN1
delta,3,DNA-dependent DNA replication (GO:0006261),1/57,1,57,0.795224858935981,0.863175071860588,0,0,0.640286848508132,0.146709157952999,PURA
delta,3,cellular defense response (GO:0006968),1/57,1,57,0.795224858935981,0.863175071860588,0,0,0.640286848508132,0.146709157952999,RAB23
delta,3,organonitrogen compound catabolic process (GO:1901565),1/57,1,57,0.795224858935981,0.863175071860588,0,0,0.640286848508132,0.146709157952999,RNPEP
delta,3,cellular iron ion homeostasis (GO:0006879),1/57,1,57,0.795224858935981,0.863175071860588,0,0,0.640286848508132,0.146709157952999,SOD1
delta,3,autophagosome organization (GO:1905037),1/57,1,57,0.795224858935981,0.863175071860588,0,0,0.640286848508132,0.146709157952999,RAB23
delta,3,glycosaminoglycan catabolic process (GO:0006027),1/57,1,57,0.795224858935981,0.863175071860588,0,0,0.640286848508132,0.146709157952999,TMEM2
delta,3,fatty acid metabolic process (GO:0006631),2/107,2,107,0.795406923289752,0.863175071860588,0,0,0.682174773176888,0.15615078933441,ADIPOR2;LPIN2
delta,3,regulation of Rho protein signal transduction (GO:0035023),1/58,1,58,0.800851691106312,0.867189269879151,0,0,0.629247420085578,0.139742954776484,STMN1
delta,3,chloride transmembrane transport (GO:1902476),1/58,1,58,0.800851691106312,0.867189269879151,0,0,0.629247420085578,0.139742954776484,SLC12A1
delta,3,epidermal growth factor receptor signaling pathway (GO:0007173),1/58,1,58,0.800851691106312,0.867189269879151,0,0,0.629247420085578,0.139742954776484,NCK2
delta,3,tRNA modification (GO:0006400),1/58,1,58,0.800851691106312,0.867189269879151,0,0,0.629247420085578,0.139742954776484,RPUSD4
delta,3,negative regulation of hydrolase activity (GO:0051346),2/109,2,109,0.803789328598301,0.86989618514424,0,0,0.669657804861716,0.146265367471631,MYO1D;CPEB2
delta,3,response to light stimulus (GO:0009416),1/59,1,59,0.806324181543169,0.871215959068122,0,0,0.618582209575653,0.133161825429348,ERCC5
delta,3,autophagosome assembly (GO:0000045),1/59,1,59,0.806324181543169,0.871215959068122,0,0,0.618582209575653,0.133161825429348,RAB23
delta,3,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1/59,1,59,0.806324181543169,0.871215959068122,0,0,0.618582209575653,0.133161825429348,ARHGEF7
delta,3,circulatory system development (GO:0072359),2/110,2,110,0.807865113077677,0.871459272359036,0,0,0.6635700066357,0.141579411849536,MEF2A;ZDHHC16
delta,3,Wnt signaling pathway (GO:0016055),2/110,2,110,0.807865113077677,0.871459272359036,0,0,0.6635700066357,0.141579411849536,FZD3;TNKS2
delta,3,regulation of Wnt signaling pathway (GO:0030111),2/110,2,110,0.807865113077677,0.871459272359036,0,0,0.6635700066357,0.141579411849536,APP;SPIN1
delta,3,"regulation of mRNA splicing, via spliceosome (GO:0048024)",1/61,1,61,0.816822925486855,0.879689513789909,0,0,0.598300825655139,0.121055968100564,RBM4
delta,3,nucleosome assembly (GO:0006334),1/61,1,61,0.816822925486855,0.879689513789909,0,0,0.598300825655139,0.121055968100564,ASF1B
delta,3,positive regulation of protein binding (GO:0032092),1/61,1,61,0.816822925486855,0.879689513789909,0,0,0.598300825655139,0.121055968100564,APP
delta,3,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",2/113,2,113,0.819643630814665,0.882242263913974,0,0,0.645953103804664,0.12847078984289,SMG1;RPL35
delta,3,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),1/62,1,62,0.821857287621925,0.882242263913974,0,0,0.588650812338121,0.115486528744223,JAK2
delta,3,positive regulation of T cell proliferation (GO:0042102),1/62,1,62,0.821857287621925,0.882242263913974,0,0,0.588650812338121,0.115486528744223,NCK2
delta,3,positive regulation of leukocyte chemotaxis (GO:0002690),1/62,1,62,0.821857287621925,0.882242263913974,0,0,0.588650812338121,0.115486528744223,KARS
delta,3,glycosaminoglycan metabolic process (GO:0030203),1/62,1,62,0.821857287621925,0.882242263913974,0,0,0.588650812338121,0.115486528744223,NDST2
delta,3,protein targeting to membrane (GO:0006612),1/62,1,62,0.821857287621925,0.882242263913974,0,0,0.588650812338121,0.115486528744223,ZDHHC2
delta,3,positive regulation of kinase activity (GO:0033674),2/114,2,114,0.823423748900483,0.883446538372171,0,0,0.640286848508132,0.124397699820267,EPHA6;MAPRE3
delta,3,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),1/63,1,63,0.826753531443815,0.886062172049008,0,0,0.579307148650214,0.11021240624036,CLU
delta,3,second-messenger-mediated signaling (GO:0019932),1/63,1,63,0.826753531443815,0.886062172049008,0,0,0.579307148650214,0.11021240624036,EIF2AK3
delta,3,vesicle coating (GO:0006901),1/64,1,64,0.831515439424879,0.887336830363714,0,0,0.570255474452555,0.105215221465405,TRAPPC6A
delta,3,COPII vesicle coating (GO:0048208),1/64,1,64,0.831515439424879,0.887336830363714,0,0,0.570255474452555,0.105215221465405,TRAPPC6A
delta,3,iron ion homeostasis (GO:0055072),1/64,1,64,0.831515439424879,0.887336830363714,0,0,0.570255474452555,0.105215221465405,SOD1
delta,3,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",1/64,1,64,0.831515439424879,0.887336830363714,0,0,0.570255474452555,0.105215221465405,TRAPPC6A
delta,3,regulation of viral genome replication (GO:0045069),1/64,1,64,0.831515439424879,0.887336830363714,0,0,0.570255474452555,0.105215221465405,PDE12
delta,3,negative regulation of dephosphorylation (GO:0035305),1/64,1,64,0.831515439424879,0.887336830363714,0,0,0.570255474452555,0.105215221465405,MYO1D
delta,3,negative regulation of neuron apoptotic process (GO:0043524),1/64,1,64,0.831515439424879,0.887336830363714,0,0,0.570255474452555,0.105215221465405,SOD1
delta,3,positive regulation of cell projection organization (GO:0031346),1/64,1,64,0.831515439424879,0.887336830363714,0,0,0.570255474452555,0.105215221465405,SETX
delta,3,chromatin remodeling (GO:0006338),2/117,2,117,0.834340799897399,0.889412995039506,0,0,0.623869237007923,0.112991033202697,BAZ2A;ACTB
delta,3,positive regulation of protein polymerization (GO:0032273),1/65,1,65,0.836146690857472,0.889412995039506,0,0,0.561482313307131,0.100477941469512,NCK2
delta,3,positive regulation of JAK-STAT cascade (GO:0046427),1/65,1,65,0.836146690857472,0.889412995039506,0,0,0.561482313307131,0.100477941469512,JAK2
delta,3,cellular response to decreased oxygen levels (GO:0036294),1/65,1,65,0.836146690857472,0.889412995039506,0,0,0.561482313307131,0.100477941469512,CPEB2
delta,3,negative regulation of neuron differentiation (GO:0045665),1/65,1,65,0.836146690857472,0.889412995039506,0,0,0.561482313307131,0.100477941469512,ITM2C
delta,3,positive regulation of cell adhesion (GO:0045785),1/65,1,65,0.836146690857472,0.889412995039506,0,0,0.561482313307131,0.100477941469512,JAK2
delta,3,protein localization to cell periphery (GO:1990778),2/118,2,118,0.837842227233554,0.890739703324275,0,0,0.618582209575653,0.109442947678229,EFR3A;PIGW
delta,3,regulation of myeloid cell differentiation (GO:0045637),1/66,1,66,0.84065086420167,0.892293411949101,0,0,0.55297500552975,0.0959847648980896,PAF1
delta,3,negative regulation of blood vessel morphogenesis (GO:2000181),1/66,1,66,0.84065086420167,0.892293411949101,0,0,0.55297500552975,0.0959847648980896,PDE3B
delta,3,negative regulation of apoptotic signaling pathway (GO:2001234),1/66,1,66,0.84065086420167,0.892293411949101,0,0,0.55297500552975,0.0959847648980896,CLU
delta,3,positive regulation of B cell activation (GO:0050871),2/120,2,120,0.844644964508158,0.895030635167311,0,0,0.608272506082725,0.102700060986879,PAXIP1;IRS2
delta,3,brain development (GO:0007420),2/120,2,120,0.844644964508158,0.895030635167311,0,0,0.608272506082725,0.102700060986879,ATXN1;ZNF335
delta,3,purine ribonucleotide metabolic process (GO:0009150),1/67,1,67,0.845031440147899,0.895030635167311,0,0,0.544721647238261,0.0917210181073738,RAB23
delta,3,negative regulation of epithelial cell proliferation (GO:0050680),1/67,1,67,0.845031440147899,0.895030635167311,0,0,0.544721647238261,0.0917210181073738,FBXW7
delta,3,enzyme linked receptor protein signaling pathway (GO:0007167),2/121,2,121,0.847948342648787,0.89715194851716,0,0,0.603245460577909,0.0994966289035904,IRAK1;JAK2
delta,3,negative regulation of protein serine/threonine kinase activity (GO:0071901),1/68,1,68,0.849291804308393,0.89715194851716,0,0,0.536711034778875,0.0876730614962789,PRKAR1B
delta,3,positive regulation of endothelial cell proliferation (GO:0001938),1/68,1,68,0.849291804308393,0.89715194851716,0,0,0.536711034778875,0.0876730614962789,ANG
delta,3,regulation of cardiac conduction (GO:1903779),1/68,1,68,0.849291804308393,0.89715194851716,0,0,0.536711034778875,0.0876730614962789,TRPC1
delta,3,regulation of protein localization to plasma membrane (GO:1903076),1/68,1,68,0.849291804308393,0.89715194851716,0,0,0.536711034778875,0.0876730614962789,PRKCH
delta,3,regulation of cell differentiation (GO:0045595),2/122,2,122,0.851187761430157,0.89818635651811,0,0,0.598300825655139,0.0963997478264956,PHLDB1;DAG1
delta,3,negative regulation of phosphatase activity (GO:0010923),1/69,1,69,0.853435249675989,0.89818635651811,0,0,0.528932613984978,0.0838282048525161,MYO1D
delta,3,response to interferon-gamma (GO:0034341),1/69,1,69,0.853435249675989,0.89818635651811,0,0,0.528932613984978,0.0838282048525161,PDE12
delta,3,regulation of endopeptidase activity (GO:0052548),1/69,1,69,0.853435249675989,0.89818635651811,0,0,0.528932613984978,0.0838282048525161,PSMA3
delta,3,regulation of actin filament polymerization (GO:0030833),1/69,1,69,0.853435249675989,0.89818635651811,0,0,0.528932613984978,0.0838282048525161,NCK2
delta,3,cholesterol metabolic process (GO:0008203),1/69,1,69,0.853435249675989,0.89818635651811,0,0,0.528932613984978,0.0838282048525161,FDFT1
delta,3,positive regulation of T cell activation (GO:0050870),1/69,1,69,0.853435249675989,0.89818635651811,0,0,0.528932613984978,0.0838282048525161,NCK2
delta,3,regulation of endocytosis (GO:0030100),1/70,1,70,0.857464979085871,0.900043800023046,0,0,0.521376433785193,0.0801746306007466,CD151
delta,3,regulation of innate immune response (GO:0045088),1/70,1,70,0.857464979085871,0.900043800023046,0,0,0.521376433785193,0.0801746306007466,ABCE1
delta,3,negative regulation of angiogenesis (GO:0016525),1/70,1,70,0.857464979085871,0.900043800023046,0,0,0.521376433785193,0.0801746306007466,PDE3B
delta,3,response to organic cyclic compound (GO:0014070),1/70,1,70,0.857464979085871,0.900043800023046,0,0,0.521376433785193,0.0801746306007466,SOCS2
delta,3,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),1/70,1,70,0.857464979085871,0.900043800023046,0,0,0.521376433785193,0.0801746306007466,ARPC2
delta,3,Rab protein signal transduction (GO:0032482),1/71,1,71,0.86138410797981,0.90320328367065,0,0,0.51403310373188,0.0767013239396547,RAB23
delta,3,calcium-mediated signaling (GO:0019722),1/71,1,71,0.86138410797981,0.90320328367065,0,0,0.51403310373188,0.0767013239396547,EIF2AK3
delta,3,organelle membrane fusion (GO:0090174),1/72,1,72,0.865195666530513,0.90672140790935,0,0,0.506893755068938,0.0733980097065218,SNAP29
delta,3,regulation of phosphatase activity (GO:0010921),1/73,1,73,0.86890260194779,0.908665786645694,0,0,0.4999500049995,0.0702550947958634,MYO1D
delta,3,Rho protein signal transduction (GO:0007266),1/73,1,73,0.86890260194779,0.908665786645694,0,0,0.4999500049995,0.0702550947958634,RHOT1
delta,3,vesicle organization (GO:0016050),2/128,2,128,0.86933752411347,0.908665786645694,0,0,0.570255474452555,0.0798493521513747,HOOK3;SNAP29
delta,3,positive regulation of protein kinase B signaling (GO:0051897),2/128,2,128,0.86933752411347,0.908665786645694,0,0,0.570255474452555,0.0798493521513747,OSBPL8;IRS2
delta,3,negative regulation of response to stimulus (GO:0048585),2/128,2,128,0.86933752411347,0.908665786645694,0,0,0.570255474452555,0.0798493521513747,EPHA6;CLU
delta,3,positive regulation of inflammatory response (GO:0050729),1/74,1,74,0.872507780933157,0.910064546306658,0,0,0.493193923850858,0.0672636155900347,KARS
delta,3,transcription-coupled nucleotide-excision repair (GO:0006283),1/74,1,74,0.872507780933157,0.910064546306658,0,0,0.493193923850858,0.0672636155900347,ERCC5
delta,3,positive regulation of cytokine secretion (GO:0050715),1/74,1,74,0.872507780933157,0.910064546306658,0,0,0.493193923850858,0.0672636155900347,KARS
delta,3,canonical Wnt signaling pathway (GO:0060070),1/74,1,74,0.872507780933157,0.910064546306658,0,0,0.493193923850858,0.0672636155900347,FZD3
delta,3,regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),1/75,1,75,0.876013991730484,0.912285011304231,0,0,0.48661800486618,0.0644151902083836,CRY1
delta,3,mitotic nuclear division (GO:0140014),1/75,1,75,0.876013991730484,0.912285011304231,0,0,0.48661800486618,0.0644151902083836,TUBGCP2
delta,3,nitrogen compound transport (GO:0071705),1/75,1,75,0.876013991730484,0.912285011304231,0,0,0.48661800486618,0.0644151902083836,TMEM30B
delta,3,generation of neurons (GO:0048699),2/131,2,131,0.877629492255881,0.912965194140526,0,0,0.557196188778069,0.0727312447802172,FZD3;ITM2C
delta,3,protein localization to plasma membrane (GO:0072659),2/131,2,131,0.877629492255881,0.912965194140526,0,0,0.557196188778069,0.0727312447802172,EFR3A;PIGW
delta,3,regulation of defense response (GO:0031347),1/76,1,76,0.879423946444372,0.912965194140526,0,0,0.480215136381099,0.0617019747269298,JAK2
delta,3,gland development (GO:0048732),1/76,1,76,0.879423946444372,0.912965194140526,0,0,0.480215136381099,0.0617019747269298,SOD1
delta,3,purine ribonucleotide biosynthetic process (GO:0009152),1/76,1,76,0.879423946444372,0.912965194140526,0,0,0.480215136381099,0.0617019747269298,SLC35B2
delta,3,cAMP-mediated signaling (GO:0019933),1/76,1,76,0.879423946444372,0.912965194140526,0,0,0.480215136381099,0.0617019747269298,GNAL
delta,3,cellular response to organic substance (GO:0071310),2/134,2,134,0.88543387972876,0.918724344136317,0,0,0.544721647238261,0.0662803652531058,SOCS2;NCOA1
delta,3,positive regulation of cytoskeleton organization (GO:0051495),1/78,1,78,0.885965566480819,0.918796232044565,0,0,0.467901927755942,0.0566522520818902,NCK2
delta,3,adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),2/135,2,135,0.887931298021288,0.91945424863619,0,0,0.540686672073533,0.0642665077459306,GNAL;PSAP
delta,3,adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189),1/79,1,79,0.889102292956469,0.91945424863619,0,0,0.461979118543842,0.0543024045527329,GNAL
delta,3,sensory perception of mechanical stimulus (GO:0050954),1/79,1,79,0.889102292956469,0.91945424863619,0,0,0.461979118543842,0.0543024045527329,SOD1
delta,3,negative regulation of cell communication (GO:0010648),1/79,1,79,0.889102292956469,0.91945424863619,0,0,0.461979118543842,0.0543024045527329,EPHA6
delta,3,extracellular matrix disassembly (GO:0022617),1/79,1,79,0.889102292956469,0.91945424863619,0,0,0.461979118543842,0.0543024045527329,ADAM15
delta,3,mitochondrial transport (GO:0006839),2/136,2,136,0.890378198412935,0.91945424863619,0,0,0.536711034778875,0.0623169624738317,SLC25A40;FBXO7
delta,3,nucleosome organization (GO:0034728),1/80,1,80,0.892152889466822,0.91945424863619,0,0,0.456204379562044,0.052061022053832,PAF1
delta,3,cation transport (GO:0006812),1/80,1,80,0.892152889466822,0.91945424863619,0,0,0.456204379562044,0.052061022053832,ANO10
delta,3,peptidyl-tyrosine phosphorylation (GO:0018108),1/80,1,80,0.892152889466822,0.91945424863619,0,0,0.456204379562044,0.052061022053832,JAK2
delta,3,steroid biosynthetic process (GO:0006694),1/80,1,80,0.892152889466822,0.91945424863619,0,0,0.456204379562044,0.052061022053832,FDFT1
delta,3,regulation of endothelial cell proliferation (GO:0001936),1/80,1,80,0.892152889466822,0.91945424863619,0,0,0.456204379562044,0.052061022053832,ANG
delta,3,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),1/80,1,80,0.892152889466822,0.91945424863619,0,0,0.456204379562044,0.052061022053832,RNF111
delta,3,spindle assembly (GO:0051225),1/81,1,81,0.895119716711073,0.920601903263407,0,0,0.450572226727944,0.0499224150510177,TUBGCP2
delta,3,ERBB signaling pathway (GO:0038127),1/81,1,81,0.895119716711073,0.920601903263407,0,0,0.450572226727944,0.0499224150510177,NCK2
delta,3,regulation of protein serine/threonine kinase activity (GO:0071900),1/81,1,81,0.895119716711073,0.920601903263407,0,0,0.450572226727944,0.0499224150510177,SERTAD1
delta,3,negative regulation of defense response (GO:0031348),1/81,1,81,0.895119716711073,0.920601903263407,0,0,0.450572226727944,0.0499224150510177,TRAF3IP1
delta,3,BMP signaling pathway (GO:0030509),1/82,1,82,0.898005070947315,0.922614310223534,0,0,0.445077443475165,0.0478812372090229,SMAD5
delta,3,sensory perception of sound (GO:0007605),1/82,1,82,0.898005070947315,0.922614310223534,0,0,0.445077443475165,0.0478812372090229,SOD1
delta,3,neuron differentiation (GO:0030182),2/140,2,140,0.899678200697448,0.923110792078436,0,0,0.521376433785193,0.0551189438875868,FZD3;ITM2C
delta,3,negative regulation of NF-kappaB transcription factor activity (GO:0032088),1/83,1,83,0.900811185626616,0.923110792078436,0,0,0.439715064638115,0.0459324616293685,IRAK1
delta,3,"retrograde transport, endosome to Golgi (GO:0042147)",1/83,1,83,0.900811185626616,0.923110792078436,0,0,0.439715064638115,0.0459324616293685,TBC1D10A
delta,3,positive regulation of DNA metabolic process (GO:0051054),1/83,1,83,0.900811185626616,0.923110792078436,0,0,0.439715064638115,0.0459324616293685,DBF4
delta,3,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),1/83,1,83,0.900811185626616,0.923110792078436,0,0,0.439715064638115,0.0459324616293685,RNF111
delta,3,negative regulation of signaling (GO:0023057),1/84,1,84,0.903540232842074,0.924477055951184,0,0,0.434480361487661,0.0440713590352761,EPHA6
delta,3,establishment of protein localization to membrane (GO:0090150),1/84,1,84,0.903540232842074,0.924477055951184,0,0,0.434480361487661,0.0440713590352761,ZDHHC2
delta,3,positive regulation of homeostatic process (GO:0032846),1/84,1,84,0.903540232842074,0.924477055951184,0,0,0.434480361487661,0.0440713590352761,PPP3CB
delta,3,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),2/143,2,143,0.906165160394625,0.92668562722806,0,0,0.510438466642846,0.0502953873267267,CD164;CBLN1
delta,3,mitochondrial ATP synthesis coupled electron transport (GO:0042775),1/86,1,86,0.908775518624247,0.928877034725503,0,0,0.424376167034459,0.0405946229467067,SDHAF2
delta,3,cellular response to BMP stimulus (GO:0071773),1/88,1,88,0.913727146441836,0.932978335035935,0,0,0.414731254147313,0.037418413638392,SMAD5
delta,3,positive regulation of cellular component biogenesis (GO:0044089),1/88,1,88,0.913727146441836,0.932978335035935,0,0,0.414731254147313,0.037418413638392,PDCD6IP
delta,3,skeletal system development (GO:0001501),2/147,2,147,0.914205932762961,0.93298777010786,0,0,0.496548984557327,0.0445401576730047,IFT140;EIF2AK3
delta,3,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),1/90,1,90,0.918410458883149,0.93631687111381,0,0,0.40551500405515,0.0345137328973808,RPL35
delta,3,regulation of neuron apoptotic process (GO:0043523),1/90,1,90,0.918410458883149,0.93631687111381,0,0,0.40551500405515,0.0345137328973808,SOD1
delta,3,protein tetramerization (GO:0051262),1/91,1,91,0.920656063541129,0.938124922182679,0,0,0.401058795219379,0.0331550294931745,CPSF7
delta,3,phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200),1/92,1,92,0.922839969880762,0.939386793111207,0,0,0.396699460488734,0.0318547444947162,HOMER1
delta,3,protein-DNA complex assembly (GO:0065004),1/92,1,92,0.922839969880762,0.939386793111207,0,0,0.396699460488734,0.0318547444947162,ERCC5
delta,3,positive regulation of cellular metabolic process (GO:0031325),1/93,1,93,0.924963870053271,0.941066671682462,0,0,0.392433874892081,0.0306100783433088,RNF41
delta,3,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),1/94,1,94,0.927029410001819,0.94220329292768,0,0,0.388259046435782,0.0294183832581675,MAP3K5
delta,3,cotranslational protein targeting to membrane (GO:0006613),1/94,1,94,0.927029410001819,0.94220329292768,0,0,0.388259046435782,0.0294183832581675,RPL35
delta,3,skin development (GO:0043588),1/95,1,95,0.92903819029463,0.943279961224032,0,0,0.384172109104879,0.0282771540441994,STMN1
delta,3,respiratory electron transport chain (GO:0022904),1/95,1,95,0.92903819029463,0.943279961224032,0,0,0.384172109104879,0.0282771540441994,SDHAF2
delta,3,positive regulation of protein localization to membrane (GO:1905477),1/96,1,96,0.930991767986433,0.944298439504361,0,0,0.380170316301703,0.0271840191088797,PRKCH
delta,3,regulation of heart contraction (GO:0008016),1/96,1,96,0.930991767986433,0.944298439504361,0,0,0.380170316301703,0.0271840191088797,TRPC1
delta,3,positive regulation of neuron projection development (GO:0010976),1/98,1,98,0.934739331164362,0.947132611434771,0,0,0.372411738417995,0.0251331665280818,SETX
delta,3,response to tumor necrosis factor (GO:0034612),1/98,1,98,0.934739331164362,0.947132611434771,0,0,0.372411738417995,0.0251331665280818,JAK2
delta,3,positive regulation of cell growth (GO:0030307),1/99,1,99,0.936536222001831,0.948469660100733,0,0,0.3686500036865,0.0241713042053462,RUFY3
delta,3,glycosaminoglycan biosynthetic process (GO:0006024),1/100,1,100,0.938283723095903,0.949271770769633,0,0,0.364963503649635,0.0232492332352798,NDST2
delta,3,small GTPase mediated signal transduction (GO:0007264),1/100,1,100,0.938283723095903,0.949271770769633,0,0,0.364963503649635,0.0232492332352798,PLK2
delta,3,cellular response to metal ion (GO:0071248),1/101,1,101,0.939983189609067,0.950507174429117,0,0,0.3613500036135,0.022365139579608,MEF2A
delta,3,positive regulation of angiogenesis (GO:0045766),1/104,1,104,0.9448063819951,0.954898413542351,0,0,0.350926445816957,0.0199239399418269,AGO2
delta,3,positive regulation of vasculature development (GO:1904018),1/105,1,105,0.94632653396407,0.955462816558236,0,0,0.347584289190129,0.0191753896994522,AGO2
delta,3,positive regulation of lymphocyte activation (GO:0051251),1/105,1,105,0.94632653396407,0.955462816558236,0,0,0.347584289190129,0.0191753896994522,ZNF335
delta,3,regulation of response to external stimulus (GO:0032101),1/108,1,108,0.950640771926581,0.958357794935625,0,0,0.337929170045958,0.0171056451045676,JAK2
delta,3,positive regulation of epithelial cell proliferation (GO:0050679),1/108,1,108,0.950640771926581,0.958357794935625,0,0,0.337929170045958,0.0171056451045676,ANG
delta,3,negative regulation of response to external stimulus (GO:0032102),1/108,1,108,0.950640771926581,0.958357794935625,0,0,0.337929170045958,0.0171056451045676,TRAF3IP1
delta,3,regulation of protein activation cascade (GO:2000257),1/109,1,109,0.952000498344758,0.958755697015223,0,0,0.334828902430858,0.0164701401993987,CLU
delta,3,regulation of cytokine production (GO:0001817),1/109,1,109,0.952000498344758,0.958755697015223,0,0,0.334828902430858,0.0164701401993987,SOD1
delta,3,regulation of complement activation (GO:0030449),1/110,1,110,0.95332283224436,0.959601047451643,0,0,0.33178500331785,0.0158598802340111,CLU
delta,3,negative regulation of cytokine production (GO:0001818),1/111,1,111,0.954608799952203,0.96040895468609,0,0,0.328795949233905,0.0152737739140048,TRAF3IP1
delta,3,regulation of humoral immune response (GO:0002920),1/114,1,114,0.958258353953789,0.963592788110414,0,0,0.320143424254066,0.0136502294891221,CLU
delta,3,regulation of immune effector process (GO:0002697),1/115,1,115,0.959408570793125,0.964261421429408,0,0,0.317359568390987,0.0131508271853819,CLU
delta,3,epithelium development (GO:0060429),1/116,1,116,0.960527146990249,0.964897594069578,0,0,0.314623710042789,0.0126708513021027,JAK2
delta,3,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/117,1,117,0.9616149515225,0.965502227728755,0,0,0.311934618503962,0.0122094849129022,JAK2
delta,3,regulation of acute inflammatory response (GO:0002673),1/122,1,122,0.966621175026106,0.970038522614582,0,0,0.29915041282757,0.0101557416240501,CLU
delta,3,"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",1/126,1,126,0.970152530022457,0.973090902147715,0,0,0.289653574325107,0.00877707461503874,GNAL
delta,3,regulation of protein processing (GO:0070613),1/129,1,129,0.972554023459838,0.975007489714782,0,0,0.28291744468964,0.00787349457277401,CLU
delta,3,muscle contraction (GO:0006936),1/138,1,138,0.97866166296439,0.980141494107985,0,0,0.264466306992489,0.00570435065685945,UTRN
delta,3,regulation of cytosolic calcium ion concentration (GO:0051480),1/138,1,138,0.97866166296439,0.980141494107985,0,0,0.264466306992489,0.00570435065685945,TRPC1
delta,3,cellular response to growth factor stimulus (GO:0071363),1/140,1,140,0.979822782619495,0.980379468853575,0,0,0.260688216892596,0.00531375331900654,SETX
delta,3,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),1/141,1,141,0.980379468853575,0.980379468853575,0,0,0.258839364290521,0.00512904932165407,IRAK1
delta,3,regulation of cellular component organization (GO:0051128),1/141,1,141,0.980379468853575,0.980379468853575,0,0,0.258839364290521,0.00512904932165407,SOCS2
delta,4,I-kappaB kinase/NF-kappaB signaling (GO:0007249),8/58,8,58,1.10932324630907e-05,0.0200121913634156,0,0,7.43563528208941,84.8344665756383,TBK1;UBB;RIPK2;IKBKG;TANK;BIRC2;RELB;NFKB2
delta,4,NIK/NF-kappaB signaling (GO:0038061),8/81,8,81,0.000128564726675346,0.0579826917305809,0,0,5.3242820538418,47.700658591926,PSMA5;PSMD12;UBB;PSMD1;TANK;BIRC2;RELB;NFKB2
delta,4,innate immune response activating cell surface receptor signaling pathway (GO:0002220),10/125,10,125,0.000114421821532976,0.0579826917305809,0,0,4.31266846361186,39.1401347689174,PSMA5;PSMD12;PAK1;UBB;PRKCD;PSMD1;FYN;IKBKG;PAK2;RELB
delta,4,stimulatory C-type lectin receptor signaling pathway (GO:0002223),10/122,10,122,9.33762061030568e-05,0.0579826917305809,0,0,4.41871768812691,41.0007246601051,PSMA5;PSMD12;PAK1;UBB;PRKCD;PSMD1;FYN;IKBKG;PAK2;RELB
delta,4,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),5/30,5,30,0.000207939854760709,0.0734186628179977,0,0,8.98472596585804,76.174857860575,TBK1;UBB;IKBKG;TANK;BIRC2
delta,4,MyD88-independent toll-like receptor signaling pathway (GO:0002756),5/31,5,31,0.000244186239971168,0.0734186628179977,0,0,8.69489609599165,72.3204881771121,TBK1;UBB;IKBKG;TANK;BIRC2
delta,4,regulation of telomere maintenance via telomerase (GO:0032210),6/52,6,52,0.000387767083417696,0.0999331169265033,0,0,6.22019489944018,48.8602884038772,EXOSC10;TEN1;NEK7;MAPKAPK5;SMG6;CCT4
delta,4,phosphatidylinositol biosynthetic process (GO:0006661),8/99,8,99,0.000512861592266823,0.115650289056169,0,0,4.35623077132511,33.0006460283513,CDS1;PI4K2B;RAB4A;SACM1L;PIK3R1;PIK3C2A;RAB5A;PLEKHA8
delta,4,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),6/57,6,57,0.000639535235318369,0.128191284946038,0,0,5.67456376791034,41.7351047821409,UBB;SPHK1;TNFAIP3;IKBKG;TANK;BIRC2
delta,4,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",3/13,3,13,0.00157696239950215,0.167343539335404,0,0,12.4403897988804,80.268564972099,CPSF4;CSTF2;TSEN2
delta,4,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",4/26,4,26,0.00126081240022177,0.162464683571434,0,0,8.29359319925358,55.3680199353742,UBB;RIPK2;TNFAIP3;IKBKG
delta,4,regulation of necrotic cell death (GO:0010939),3/13,3,13,0.00157696239950215,0.167343539335404,0,0,12.4403897988804,80.268564972099,UBB;TANK;BIRC2
delta,4,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),4/25,4,25,0.00108253453266472,0.162464683571434,0,0,8.62533692722372,58.8976836463737,UBB;RIPK2;TNFAIP3;IKBKG
delta,4,pre-mRNA cleavage required for polyadenylation (GO:0098789),3/12,3,12,0.00122988278489087,0.162464683571434,0,0,13.4770889487871,90.3077683419883,CPSF4;NCBP2;CSTF2
delta,4,positive regulation of protein ubiquitination (GO:0031398),7/84,7,84,0.000950463748228497,0.162464683571434,0,0,4.49236298292902,31.2603797684146,KDM1A;UBB;RIPK2;SPHK1;COMMD1;BMI1;BIRC2
delta,4,mRNA cleavage involved in mRNA processing (GO:0098787),3/13,3,13,0.00157696239950215,0.167343539335404,0,0,12.4403897988804,80.268564972099,CPSF4;NCBP2;CSTF2
delta,4,stress-activated protein kinase signaling cascade (GO:0031098),6/71,6,71,0.00203227832334169,0.174582385490876,0,0,4.55563570099844,28.2385533814069,PAK1;SLK;UBB;STK39;IKBKG;PAK2
delta,4,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",3/14,3,14,0.00197959555853531,0.174582385490876,0,0,11.5517905275318,71.9083101868268,CPSF4;CSTF2;TSEN2
delta,4,phosphatidylinositol metabolic process (GO:0046488),8/113,8,113,0.00122589834659644,0.162464683571434,0,0,3.81652076425828,25.5862657141541,CDS1;PI4K2B;RAB4A;SACM1L;PIK3R1;PIK3C2A;RAB5A;PLEKHA8
delta,4,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),4/29,4,29,0.00191729730488261,0.174582385490876,0,0,7.43563528208941,46.5235708770305,UBB;RIPK2;TNFAIP3;IKBKG
delta,4,regulation of defense response to virus by virus (GO:0050690),4/29,4,29,0.00191729730488261,0.174582385490876,0,0,7.43563528208941,46.5235708770305,FYN;PAK2;B2M;AP1M1
delta,4,replication fork processing (GO:0031297),4/31,4,31,0.00246710579498377,0.202302675188669,0,0,6.95591687679332,41.7682605567604,SMARCAL1;ETAA1;ATRX;THOC1
delta,4,regulation of necroptotic process (GO:0060544),3/16,3,16,0.00296291613712698,0.213804028455083,0,0,10.1078167115903,58.843476895119,UBB;TANK;BIRC2
delta,4,positive regulation of transcription factor import into nucleus (GO:0042993),4/33,4,33,0.00311648122708811,0.216235851294883,0,0,6.53434615698767,37.710043129624,SPHK1;PIK3R1;DMAP1;CHERP
delta,4,negative regulation of response to wounding (GO:1903035),3/16,3,16,0.00296291613712698,0.213804028455083,0,0,10.1078167115903,58.843476895119,EPHA4;CRK;AJAP1
delta,4,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",6/76,6,76,0.00287193333744025,0.213804028455083,0,0,4.25592282593276,24.9089367538512,PSMA5;PSMD12;HLA-B;PSMD1;IKBKG;B2M
delta,4,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),6/79,6,79,0.00348662928756797,0.232958490176764,0,0,4.09430550342898,23.1689371714643,PSMA5;PSMD12;HLA-B;PSMD1;IKBKG;B2M
delta,4,positive regulation of protein localization to endosome (GO:1905668),2/6,2,6,0.00489970437099815,0.238893694196774,0,0,17.9694519317161,95.5719749889486,DTX3L;EZR
delta,4,cardiolipin acyl-chain remodeling (GO:0035965),2/6,2,6,0.00489970437099815,0.238893694196774,0,0,17.9694519317161,95.5719749889486,HADHB;HADHA
delta,4,positive regulation of protein localization to early endosome (GO:1902966),2/6,2,6,0.00489970437099815,0.238893694196774,0,0,17.9694519317161,95.5719749889486,DTX3L;EZR
delta,4,interleukin-1-mediated signaling pathway (GO:0070498),6/96,6,96,0.00895877908637576,0.244873295027604,0,0,3.36927223719677,15.8865273718369,PSMA5;PSMD12;UBB;RIPK2;PSMD1;IKBKG
delta,4,regulation of protein localization to early endosome (GO:1902965),2/6,2,6,0.00489970437099815,0.238893694196774,0,0,17.9694519317161,95.5719749889486,DTX3L;EZR
delta,4,glycerol-3-phosphate metabolic process (GO:0006072),2/8,2,8,0.00892403298225434,0.244873295027604,0,0,13.4770889487871,63.5984812198638,GNPAT;GPD2
delta,4,response to hydroperoxide (GO:0033194),2/8,2,8,0.00892403298225434,0.244873295027604,0,0,13.4770889487871,63.5984812198638,PRKCD;STX2
delta,4,regulation of cell morphogenesis involved in differentiation (GO:0010769),4/37,4,37,0.00474631075144408,0.238893694196774,0,0,5.82793035623224,31.181686583331,EPHA4;PAK1;SDC2;CORO1C
delta,4,positive regulation of protein binding (GO:0032092),5/61,5,61,0.00543521044717723,0.244873295027604,0,0,4.41871768812691,23.0429810367496,DTX3L;RIPK2;RAPGEF2;B2M;TANK
delta,4,regulation of protein binding (GO:0043393),7/112,7,112,0.00489927127802819,0.238893694196774,0,0,3.36927223719677,17.9200431391343,KDM1A;DTX3L;RIPK2;PRKCD;RAPGEF2;B2M;CRK
delta,4,axon extension involved in axon guidance (GO:0048846),2/8,2,8,0.00892403298225434,0.244873295027604,0,0,13.4770889487871,63.5984812198638,ALCAM;SLIT3
delta,4,non-canonical Wnt signaling pathway (GO:0035567),7/128,7,128,0.00996211153975036,0.252332990556316,0,0,2.94811320754717,13.587754209528,PSMA5;PSMD12;PLCB3;UBB;RYK;CLTC;PSMD1
delta,4,antigen processing and presentation of exogenous peptide antigen (GO:0002478),6/98,6,98,0.00986601688116349,0.252332990556316,0,0,3.30051157929479,15.2439377252689,DYNC1LI1;SEC23A;CLTC;DYNLL2;ACTR10;AP1M1
delta,4,negative regulation of type I interferon production (GO:0032480),4/45,4,45,0.00953815788386967,0.252332990556316,0,0,4.79185384845762,22.2938839465755,TBK1;UBB;TNFAIP3;RELB
delta,4,negative regulation of cell cycle G2/M phase transition (GO:1902750),5/70,5,70,0.0096647943634441,0.252332990556316,0,0,3.85059684251059,17.8639408662445,PSMA5;PSMD12;UBB;PSMD1;ATF5
delta,4,regulation of filopodium assembly (GO:0051489),4/37,4,37,0.00474631075144408,0.238893694196774,0,0,5.82793035623224,31.181686583331,DOCK11;NLGN1;PRKCD;RAB5A
delta,4,microvillus assembly (GO:0030033),2/8,2,8,0.00892403298225434,0.244873295027604,0,0,13.4770889487871,63.5984812198638,RAPGEF2;EZR
delta,4,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),6/98,6,98,0.00986601688116349,0.252332990556316,0,0,3.30051157929479,15.2439377252689,DYNC1LI1;SEC23A;CLTC;DYNLL2;ACTR10;AP1M1
delta,4,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),4/36,4,36,0.00429502117567637,0.238893694196774,0,0,5.98981731057203,32.6462940595942,SMARCAL1;ETAA1;ATRX;THOC1
delta,4,regulation of mRNA stability (GO:0043488),7/129,7,129,0.010371278332842,0.252332990556316,0,0,2.92525961679099,13.364677467093,PSMA5;PSMD12;UBB;PRKCD;PSMD1;IGF2BP2;TNPO1
delta,4,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),5/66,5,66,0.00757595752318092,0.244873295027604,0,0,4.08396634811729,19.9410909494192,UBB;RIPK2;SPHK1;COMMD1;TANK
delta,4,regulation of dendritic spine morphogenesis (GO:0061001),3/23,3,23,0.00851382271932449,0.244873295027604,0,0,7.03152466893238,33.5126982354216,CAMK2B;EPHA4;NLGN1
delta,4,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),5/73,5,73,0.0114696813889234,0.252332990556316,0,0,3.69235313665399,16.4976115127624,PSMA5;FBXL20;PSMD12;UBB;PSMD1
delta,4,ephrin receptor signaling pathway (GO:0048013),6/83,6,83,0.00445199709328344,0.238893694196774,0,0,3.89698957555289,21.0998700943864,EPHA4;PAK1;GPRIN1;SDC2;FYN;CRK
delta,4,positive regulation of chromatin binding (GO:0035563),2/8,2,8,0.00892403298225434,0.244873295027604,0,0,13.4770889487871,63.5984812198638,DTX3L;PARP9
delta,4,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),6/99,6,99,0.0103433306680417,0.252332990556316,0,0,3.26717307849383,14.9355986175678,DYNC1LI1;SEC23A;CLTC;DYNLL2;ACTR10;AP1M1
delta,4,regulation of phosphatase activity (GO:0010921),5/73,5,73,0.0114696813889234,0.252332990556316,0,0,3.69235313665399,16.4976115127624,PLEKHF2;PPP1R2;WDR81;TIPRL;ELFN2
delta,4,membrane assembly (GO:0071709),3/23,3,23,0.00851382271932449,0.244873295027604,0,0,7.03152466893238,33.5126982354216,GAK;NLGN1;STX2
delta,4,microvillus organization (GO:0032528),2/8,2,8,0.00892403298225434,0.244873295027604,0,0,13.4770889487871,63.5984812198638,RAPGEF2;EZR
delta,4,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",3/22,3,22,0.00750509354928705,0.244873295027604,0,0,7.35113942661112,35.9630483879888,UBB;XPA;CHD1L
delta,4,negative regulation of cell-substrate adhesion (GO:0010812),4/36,4,36,0.00429502117567637,0.238893694196774,0,0,5.98981731057203,32.6462940595942,TBCD;AP1AR;CORO1C;AJAP1
delta,4,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),6/101,6,101,0.0113467417016615,0.252332990556316,0,0,3.20247658188999,14.3433310592577,CPSF4;NCBP2;NUP62;THOC1;BUD13;SMG6
delta,4,regulation of neuron death (GO:1901214),5/73,5,73,0.0114696813889234,0.252332990556316,0,0,3.69235313665399,16.4976115127624,TBK1;UBB;FYN;IKBKG;TANK
delta,4,positive regulation of endopeptidase activity (GO:0010950),3/25,3,25,0.0107595100697567,0.252332990556316,0,0,6.46900269541779,29.3172954684785,EPHA4;GPRIN1;FYN
delta,4,regulation of telomerase activity (GO:0051972),4/43,4,43,0.00813155262342891,0.244873295027604,0,0,5.0147307716417,24.1309015185319,NEK7;MAPKAPK5;SMG6;CCT4
delta,4,regulation of telomere capping (GO:1904353),3/23,3,23,0.00851382271932449,0.244873295027604,0,0,7.03152466893238,33.5126982354216,NEK7;MAPKAPK5;SMG6
delta,4,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",2/9,2,9,0.0113339219045605,0.252332990556316,0,0,11.9796346211441,53.6682253564206,HLA-B;B2M
delta,4,neuron projection extension involved in neuron projection guidance (GO:1902284),2/8,2,8,0.00892403298225434,0.244873295027604,0,0,13.4770889487871,63.5984812198638,ALCAM;SLIT3
delta,4,"fatty acid elongation, monounsaturated fatty acid (GO:0034625)",2/7,2,7,0.00677572988456968,0.244873295027604,0,0,15.4023873700424,76.9258095645629,ELOVL4;ELOVL5
delta,4,regulation of calcium ion transport into cytosol (GO:0010522),3/22,3,22,0.00750509354928705,0.244873295027604,0,0,7.35113942661112,35.9630483879888,P2RX4;GPRIN1;FYN
delta,4,positive regulation of protein localization to nucleus (GO:1900182),4/43,4,43,0.00813155262342891,0.244873295027604,0,0,5.0147307716417,24.1309015185319,DTX3L;PRKCD;PARP9;CCT4
delta,4,positive regulation of ERBB signaling pathway (GO:1901186),3/23,3,23,0.00851382271932449,0.244873295027604,0,0,7.03152466893238,33.5126982354216,UBB;NUP62;RBPJ
delta,4,B cell homeostasis (GO:0001782),2/9,2,9,0.0113339219045605,0.252332990556316,0,0,11.9796346211441,53.6682253564206,DOCK11;TNFAIP3
delta,4,RNA secondary structure unwinding (GO:0010501),4/47,4,47,0.0110940307454595,0.252332990556316,0,0,4.58794517405517,20.6519382278772,EIF4A2;DDX17;DDX18;DDX46
delta,4,regulation of cytokine-mediated signaling pathway (GO:0001959),6/91,6,91,0.00695383612675239,0.244873295027604,0,0,3.55439708539439,17.6598861798972,UBB;SPHK1;TNFAIP3;IKBKG;TANK;BIRC2
delta,4,protein-DNA complex assembly (GO:0065004),6/92,6,92,0.00732590394650745,0.244873295027604,0,0,3.51576233446619,17.2846785164408,CHAF1B;UBB;ATRX;XPA;HIST3H2BB;CHD1L
delta,4,RNA export from nucleus (GO:0006405),7/120,7,120,0.00710068541186339,0.244873295027604,0,0,3.14465408805031,15.558377241233,CPSF4;RANBP1;NCBP2;NUP62;THOC1;BUD13;SMG6
delta,4,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",6/89,6,89,0.00625103550301034,0.244873295027604,0,0,3.63427117720101,18.4439558380654,PSMA5;PSMD12;UBB;RYK;CLTC;PSMD1
delta,4,DNA duplex unwinding (GO:0032508),4/42,4,42,0.00748240492273054,0.244873295027604,0,0,5.13412912334745,25.1325941467652,RECQL4;UBB;XPA;CHD1L
delta,4,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),6/94,6,94,0.00811284007687531,0.244873295027604,0,0,3.44095888054138,16.5658333809348,PSMA5;DNAJB1;PSMD12;UBB;PSMD1;ATF3
delta,4,Notch signaling involved in heart development (GO:0061314),2/9,2,9,0.0113339219045605,0.252332990556316,0,0,11.9796346211441,53.6682253564206,SNAI1;RBPJ
delta,4,"fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",2/7,2,7,0.00677572988456968,0.244873295027604,0,0,15.4023873700424,76.9258095645629,ELOVL4;ELOVL5
delta,4,"fatty acid elongation, saturated fatty acid (GO:0019367)",2/7,2,7,0.00677572988456968,0.244873295027604,0,0,15.4023873700424,76.9258095645629,ELOVL4;ELOVL5
delta,4,protein K48-linked ubiquitination (GO:0070936),4/49,4,49,0.0128045922302604,0.278307040763732,0,0,4.40068210572639,19.1779587630093,UBE2H;DTX3L;TNFAIP3;UBE2G1
delta,4,protein import into nucleus (GO:0006606),6/104,6,104,0.0129779123566216,0.278716117754111,0,0,3.11009744972009,13.5118383247963,RANBP1;TGS1;NUP62;KPNA6;TNPO1;TNPO3
delta,4,negative regulation of dendrite morphogenesis (GO:0050774),2/7,2,7,0.00677572988456968,0.244873295027604,0,0,15.4023873700424,76.9258095645629,NLGN1;RAPGEF2
delta,4,regulation of phospholipid metabolic process (GO:1903725),2/10,2,10,0.0139950059787147,0.283395493851115,0,0,10.7816711590296,46.0275442459428,WDR81;PIK3R1
delta,4,"DNA-templated transcription, termination (GO:0006353)",6/107,6,107,0.0147667275066546,0.283395493851115,0,0,3.02289845580271,12.7426619760229,CPSF4;NCBP2;POLR1A;CSTF2;THOC1;UBTF
delta,4,mRNA export from nucleus (GO:0006406),6/106,6,106,0.0141525067867522,0.283395493851115,0,0,3.05141636576311,12.9925144052561,CPSF4;NCBP2;NUP62;THOC1;BUD13;SMG6
delta,4,phosphatidylinositol phosphorylation (GO:0046854),3/28,3,28,0.0147126217439274,0.283395493851115,0,0,5.77589526376588,24.3687882069692,PI4K2B;PIK3R1;PIK3C2A
delta,4,regulation of mRNA 3'-end processing (GO:0031440),2/10,2,10,0.0139950059787147,0.283395493851115,0,0,10.7816711590296,46.0275442459428,BARD1;NCBP2
delta,4,fatty acid oxidation (GO:0019395),4/51,4,51,0.0146747924997318,0.283395493851115,0,0,4.22810633687437,17.849475410727,HADHB;HADHA;ACOX1;HACL1
delta,4,"fatty acid elongation, unsaturated fatty acid (GO:0019368)",2/7,2,7,0.00677572988456968,0.244873295027604,0,0,15.4023873700424,76.9258095645629,ELOVL4;ELOVL5
delta,4,mRNA transport (GO:0051028),6/105,6,105,0.0135563204474371,0.283395493851115,0,0,3.08047747400847,13.248832920221,CPSF4;NCBP2;NUP62;THOC1;BUD13;SMG6
delta,4,positive regulation of transferase activity (GO:0051347),7/138,7,138,0.0146213247253115,0.283395493851115,0,0,2.73448181569593,11.5539355162126,EPHA4;DTX3L;RYK;NEK7;MAPKAPK5;BMI1;CCT4
delta,4,regulation of DNA damage checkpoint (GO:2000001),2/10,2,10,0.0139950059787147,0.283395493851115,0,0,10.7816711590296,46.0275442459428,ETAA1;THOC1
delta,4,negative regulation of sodium ion transmembrane transport (GO:1902306),2/10,2,10,0.0139950059787147,0.283395493851115,0,0,10.7816711590296,46.0275442459428,STK39;COMMD1
delta,4,relaxation of muscle (GO:0090075),2/11,2,11,0.0168971881976708,0.290309785796172,0,0,9.8015192354815,39.9961582919054,P2RX4;ATP1A1
delta,4,regulation of chromatin binding (GO:0035561),2/11,2,11,0.0168971881976708,0.290309785796172,0,0,9.8015192354815,39.9961582919054,DTX3L;PARP9
delta,4,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),5/79,5,79,0.0157403848718027,0.290309785796172,0,0,3.41192125285748,14.1646783734072,PSMA5;PSMD12;UBB;PSMD1;RBPJ
delta,4,transcytosis (GO:0045056),2/11,2,11,0.0168971881976708,0.290309785796172,0,0,9.8015192354815,39.9961582919054,CLTC;RAB5A
delta,4,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),3/29,3,29,0.0161890088716411,0.290309785796172,0,0,5.57672646156706,22.9952006602025,SEC23A;HLA-B;B2M
delta,4,relaxation of cardiac muscle (GO:0055119),2/11,2,11,0.0168971881976708,0.290309785796172,0,0,9.8015192354815,39.9961582919054,P2RX4;ATP1A1
delta,4,very long-chain fatty acid metabolic process (GO:0000038),3/30,3,30,0.0177455382744544,0.29918645838426,0,0,5.39083557951483,21.7338067896367,ELOVL4;ELOVL5;ACOX1
delta,4,negative regulation of response to DNA damage stimulus (GO:2001021),3/29,3,29,0.0161890088716411,0.290309785796172,0,0,5.57672646156706,22.9952006602025,KDM1A;THOC1;SNAI1
delta,4,calcineurin-NFAT signaling cascade (GO:0033173),2/11,2,11,0.0168971881976708,0.290309785796172,0,0,9.8015192354815,39.9961582919054,NFAT5;NFATC3
delta,4,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",3/30,3,30,0.0177455382744544,0.29918645838426,0,0,5.39083557951483,21.7338067896367,UBB;XPA;CHD1L
delta,4,positive regulation of binding (GO:0051099),5/82,5,82,0.0182265355879789,0.29932809768612,0,0,3.28709486555782,13.1644097935998,DTX3L;RIPK2;RAPGEF2;PARP9;B2M
delta,4,DNA recombination (GO:0006310),4/56,4,56,0.0200768846008983,0.29932809768612,0,0,3.85059684251059,15.0488492320107,RECQL4;BARD1;ATRX;RBPJ
delta,4,UV-damage excision repair (GO:0070914),2/11,2,11,0.0168971881976708,0.290309785796172,0,0,9.8015192354815,39.9961582919054,HIST3H2A;XPA
delta,4,calcineurin-mediated signaling (GO:0097720),2/12,2,12,0.0200306579394611,0.29932809768612,0,0,8.98472596585804,35.1346925619261,NFAT5;NFATC3
delta,4,positive regulation of mitotic cell cycle (GO:0045931),4/53,4,53,0.0167091044825898,0.290309785796172,0,0,4.06855515435081,16.6477202034973,DYNC1LI1;SPHK1;NUP62;NUSAP1
delta,4,regulation of lipid kinase activity (GO:0043550),2/11,2,11,0.0168971881976708,0.290309785796172,0,0,9.8015192354815,39.9961582919054,WDR81;PIK3R1
delta,4,positive regulation of T cell cytokine production (GO:0002726),2/12,2,12,0.0200306579394611,0.29932809768612,0,0,8.98472596585804,35.1346925619261,TANK;B2M
delta,4,peptidyl-methionine modification (GO:0018206),2/12,2,12,0.0200306579394611,0.29932809768612,0,0,8.98472596585804,35.1346925619261,METAP1D;NAA16
delta,4,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",2/12,2,12,0.0200306579394611,0.29932809768612,0,0,8.98472596585804,35.1346925619261,KDM1A;SNAI1
delta,4,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),3/32,3,32,0.0211001431257073,0.309468765843707,0,0,5.05390835579515,19.5003813442432,PEA15;TNFAIP3;TANK
delta,4,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),2/12,2,12,0.0200306579394611,0.29932809768612,0,0,8.98472596585804,35.1346925619261,AP1AR;CORO1C
delta,4,negative regulation of canonical Wnt signaling pathway (GO:0090090),7/149,7,149,0.021345922881005,0.310206871420307,0,0,2.53260731923515,9.74267322604705,PSMA5;PSMD12;LATS2;UBB;PSMD1;KLHL12;TMEM64
delta,4,regulation of T cell cytokine production (GO:0002724),2/13,2,13,0.0233858838764755,0.310206871420307,0,0,8.29359319925358,31.1476068155998,TANK;B2M
delta,4,regulation of dendritic spine development (GO:0060998),3/32,3,32,0.0211001431257073,0.309468765843707,0,0,5.05390835579515,19.5003813442432,CAMK2B;EPHA4;NLGN1
delta,4,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),3/31,3,31,0.0193825167916761,0.29932809768612,0,0,5.21693765759499,20.5723875256399,RAPGEF2;AP1AR;CORO1C
delta,4,regulation of long-term neuronal synaptic plasticity (GO:0048169),2/12,2,12,0.0200306579394611,0.29932809768612,0,0,8.98472596585804,35.1346925619261,CAMK2B;RAB5A
delta,4,regulation of cAMP-dependent protein kinase activity (GO:2000479),2/13,2,13,0.0233858838764755,0.310206871420307,0,0,8.29359319925358,31.1476068155998,PKIA;RAPGEF2
delta,4,regulation of defense response to virus by host (GO:0050691),3/31,3,31,0.0193825167916761,0.29932809768612,0,0,5.21693765759499,20.5723875256399,DTX3L;TNFAIP3;PARP9
delta,4,fatty acid elongation (GO:0030497),2/12,2,12,0.0200306579394611,0.29932809768612,0,0,8.98472596585804,35.1346925619261,ELOVL4;ELOVL5
delta,4,cardiolipin metabolic process (GO:0032048),2/13,2,13,0.0233858838764755,0.310206871420307,0,0,8.29359319925358,31.1476068155998,HADHB;HADHA
delta,4,peptidyl-serine phosphorylation (GO:0018105),7/146,7,146,0.0193329574967404,0.29932809768612,0,0,2.58464719565779,10.19887308637,CAMK2B;TBK1;LATS2;PRKCD;STK39;MAPKAPK5;PAK2
delta,4,alpha-linolenic acid metabolic process (GO:0036109),2/13,2,13,0.0233858838764755,0.310206871420307,0,0,8.29359319925358,31.1476068155998,ELOVL5;ACOX1
delta,4,regulation of type I interferon production (GO:0032479),5/86,5,86,0.0219256271037608,0.310206871420307,0,0,3.13420673227606,11.9729804391304,XRCC6;TBK1;UBB;TNFAIP3;NFKB2
delta,4,histone H3-K9 demethylation (GO:0033169),2/12,2,12,0.0200306579394611,0.29932809768612,0,0,8.98472596585804,35.1346925619261,KDM4C;KDM1A
delta,4,synaptic vesicle cycle (GO:0099504),2/13,2,13,0.0233858838764755,0.310206871420307,0,0,8.29359319925358,31.1476068155998,NLGN1;RAB5A
delta,4,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),2/12,2,12,0.0200306579394611,0.29932809768612,0,0,8.98472596585804,35.1346925619261,DTX3L;PARP9
delta,4,global genome nucleotide-excision repair (GO:0070911),3/33,3,33,0.0228985129719465,0.310206871420307,0,0,4.90075961774075,18.5086170362814,UBB;XPA;CHD1L
delta,4,very long-chain fatty acid biosynthetic process (GO:0042761),2/13,2,13,0.0233858838764755,0.310206871420307,0,0,8.29359319925358,31.1476068155998,ELOVL4;ELOVL5
delta,4,positive regulation of telomere maintenance (GO:0032206),3/33,3,33,0.0228985129719465,0.310206871420307,0,0,4.90075961774075,18.5086170362814,NEK7;ATRX;MAPKAPK5
delta,4,DNA replication-independent nucleosome organization (GO:0034724),2/13,2,13,0.0233858838764755,0.310206871420307,0,0,8.29359319925358,31.1476068155998,ATRX;UBN1
delta,4,positive regulation of telomere maintenance via telomerase (GO:0032212),3/33,3,33,0.0228985129719465,0.310206871420307,0,0,4.90075961774075,18.5086170362814,NEK7;MAPKAPK5;CCT4
delta,4,response to iron ion (GO:0010039),2/13,2,13,0.0233858838764755,0.310206871420307,0,0,8.29359319925358,31.1476068155998,ACO1;B2M
delta,4,negative regulation of cation transmembrane transport (GO:1904063),2/14,2,14,0.0269536070437973,0.324162047380069,0,0,7.70119368502118,27.8293272892782,STK39;COMMD1
delta,4,positive regulation of transporter activity (GO:0032411),2/14,2,14,0.0269536070437973,0.324162047380069,0,0,7.70119368502118,27.8293272892782,PRKCD;STK39
delta,4,regulation of synapse organization (GO:0050807),2/14,2,14,0.0269536070437973,0.324162047380069,0,0,7.70119368502118,27.8293272892782,CAMK2B;EPHA4
delta,4,cellular response to osmotic stress (GO:0071470),2/14,2,14,0.0269536070437973,0.324162047380069,0,0,7.70119368502118,27.8293272892782,STK39;SERPINB6
delta,4,regulation of defense response to virus (GO:0050688),2/14,2,14,0.0269536070437973,0.324162047380069,0,0,7.70119368502118,27.8293272892782,ELMOD2;TNFAIP3
delta,4,RNA 3'-end processing (GO:0031123),4/62,4,62,0.0279902167794478,0.330758874976318,0,0,3.47795843839666,12.4368323818645,CPSF4;NCBP2;CSTF2;THOC1
delta,4,cell surface receptor signaling pathway involved in heart development (GO:0061311),2/14,2,14,0.0269536070437973,0.324162047380069,0,0,7.70119368502118,27.8293272892782,SNAI1;RBPJ
delta,4,tumor necrosis factor-mediated signaling pathway (GO:0033209),6/124,6,124,0.0281953439961252,0.330758874976318,0,0,2.6084688287975,9.30857774417016,PSMA5;PSMD12;UBB;PSMD1;TANK;BIRC2
delta,4,regulation of cellular ketone metabolic process (GO:0010565),4/62,4,62,0.0279902167794478,0.330758874976318,0,0,3.47795843839666,12.4368323818645,PSMA5;PSMD12;PSMD1;SIRT5
delta,4,iron ion homeostasis (GO:0055072),4/64,4,64,0.0309857260925708,0.330758874976318,0,0,3.36927223719677,11.7056220659123,UBB;NEDD8;ACO1;B2M
delta,4,regulation of phosphate metabolic process (GO:0019220),2/14,2,14,0.0269536070437973,0.324162047380069,0,0,7.70119368502118,27.8293272892782,BARD1;SMG6
delta,4,regulation of cell junction assembly (GO:1901888),2/15,2,15,0.030724834045175,0.330758874976318,0,0,7.18778077268643,25.0327692710929,SNAI1;RAPGEF2
delta,4,regulation of cysteine-type endopeptidase activity (GO:2000116),3/37,3,37,0.0308980103103202,0.330758874976318,0,0,4.37094776717418,15.1980628909598,GPRIN1;FYN;BIRC2
delta,4,regulation of interferon-beta production (GO:0032648),3/35,3,35,0.0267373806782062,0.324162047380069,0,0,4.62071621101271,16.734814019084,TBK1;RIPK2;RELB
delta,4,positive regulation of telomerase activity (GO:0051973),3/36,3,36,0.0287775988588464,0.330758874976318,0,0,4.49236298292902,15.939613710235,NEK7;MAPKAPK5;CCT4
delta,4,clathrin coat assembly (GO:0048268),2/14,2,14,0.0269536070437973,0.324162047380069,0,0,7.70119368502118,27.8293272892782,CLTC;PIK3C2A
delta,4,tRNA processing (GO:0008033),4/63,4,63,0.0294653489959557,0.330758874976318,0,0,3.4227527488983,12.0636300563499,CPSF4;PTCD1;CSTF2;TSEN2
delta,4,positive regulation of double-strand break repair (GO:2000781),2/15,2,15,0.030724834045175,0.330758874976318,0,0,7.18778077268643,25.0327692710929,DTX3L;PARP9
delta,4,regulation of establishment of planar polarity (GO:0090175),5/90,5,90,0.0260809276717641,0.324162047380069,0,0,2.99490865528601,10.9210870689426,PSMA5;PSMD12;UBB;CLTC;PSMD1
delta,4,lipid phosphorylation (GO:0046834),3/36,3,36,0.0287775988588464,0.330758874976318,0,0,4.49236298292902,15.939613710235,PI4K2B;PIK3R1;PIK3C2A
delta,4,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),3/35,3,35,0.0267373806782062,0.324162047380069,0,0,4.62071621101271,16.734814019084,NEK7;MAPKAPK5;CCT4
delta,4,negative regulation of signal transduction by p53 class mediator (GO:1901797),2/15,2,15,0.030724834045175,0.330758874976318,0,0,7.18778077268643,25.0327692710929,KDM1A;SNAI1
delta,4,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),4/63,4,63,0.0294653489959557,0.330758874976318,0,0,3.4227527488983,12.0636300563499,PSMA5;PSMD12;UBB;PSMD1
delta,4,membrane lipid biosynthetic process (GO:0046467),4/61,4,61,0.0265601385762625,0.324162047380069,0,0,3.53497415050152,12.826101319103,ELOVL4;ELOVL5;PRKD3;SPHK1
delta,4,regulation of wound healing (GO:0061041),3/35,3,35,0.0267373806782062,0.324162047380069,0,0,4.62071621101271,16.734814019084,TNFAIP3;CRK;AJAP1
delta,4,regulation of cell-substrate junction assembly (GO:0090109),2/15,2,15,0.030724834045175,0.330758874976318,0,0,7.18778077268643,25.0327692710929,SLK;CORO1C
delta,4,positive regulation of type I interferon production (GO:0032481),4/63,4,63,0.0294653489959557,0.330758874976318,0,0,3.4227527488983,12.0636300563499,XRCC6;TBK1;RIPK2;NFKB2
delta,4,nucleosome assembly (GO:0006334),4/61,4,61,0.0265601385762625,0.324162047380069,0,0,3.53497415050152,12.826101319103,CHAF1B;ATRX;UBN1;HIST3H2BB
delta,4,negative regulation of interleukin-2 production (GO:0032703),2/15,2,15,0.030724834045175,0.330758874976318,0,0,7.18778077268643,25.0327692710929,TNFAIP3;EZR
delta,4,positive regulation of cytokine production involved in immune response (GO:0002720),2/15,2,15,0.030724834045175,0.330758874976318,0,0,7.18778077268643,25.0327692710929,TANK;B2M
delta,4,selective autophagy (GO:0061912),2/15,2,15,0.030724834045175,0.330758874976318,0,0,7.18778077268643,25.0327692710929,WDR81;LGALS8
delta,4,proteolysis involved in cellular protein catabolic process (GO:0051603),5/94,5,94,0.0307083900133076,0.330758874976318,0,0,2.86746573378448,9.98801219071582,PSMA5;ATE1;TNFAIP3;NEDD8;IDE
delta,4,cellular transition metal ion homeostasis (GO:0046916),5/94,5,94,0.0307083900133076,0.330758874976318,0,0,2.86746573378448,9.98801219071582,UBB;SLC39A10;SLC30A1;NEDD8;ACO1
delta,4,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",3/38,3,38,0.0330982670096661,0.345140310320449,0,0,4.25592282593276,14.5053526209669,UBB;XPA;CHD1L
delta,4,positive regulation of NF-kappaB transcription factor activity (GO:0051092),6/129,6,129,0.0333054902511754,0.345305197776554,0,0,2.50736538582085,8.53013984373605,UBB;RIPK2;SPHK1;IKBKG;TANK;NFKB2
delta,4,regulation of metal ion transport (GO:0010959),3/38,3,38,0.0330982670096661,0.345140310320449,0,0,4.25592282593276,14.5053526209669,CAMK2B;P2RX4;ATP1A1
delta,4,regulation of interferon-alpha production (GO:0032647),2/16,2,16,0.0346908304556969,0.349621553866353,0,0,6.73854447439353,22.6501339551701,TBK1;RIPK2
delta,4,base-excision repair (GO:0006284),3/38,3,38,0.0330982670096661,0.345140310320449,0,0,4.25592282593276,14.5053526209669,RECQL4;XPA;POLG
delta,4,DNA methylation or demethylation (GO:0044728),2/16,2,16,0.0346908304556969,0.349621553866353,0,0,6.73854447439353,22.6501339551701,ATRX;DMAP1
delta,4,epithelial to mesenchymal transition (GO:0001837),3/38,3,38,0.0330982670096661,0.345140310320449,0,0,4.25592282593276,14.5053526209669,DDX17;SNAI1;RBPJ
delta,4,regulation of RIG-I signaling pathway (GO:0039535),2/16,2,16,0.0346908304556969,0.349621553866353,0,0,6.73854447439353,22.6501339551701,SEC14L1;BIRC2
delta,4,regulation of cell death (GO:0010941),5/97,5,97,0.0344967723228572,0.349621553866353,0,0,2.77878122655403,9.35584937666562,TBK1;UBB;RIPK2;FAF1;ADNP2
delta,4,DNA alkylation (GO:0006305),2/16,2,16,0.0346908304556969,0.349621553866353,0,0,6.73854447439353,22.6501339551701,ATRX;DMAP1
delta,4,positive regulation of cellular protein localization (GO:1903829),4/67,4,67,0.0358198193392106,0.357010796065945,0,0,3.21840930120288,10.7149018012968,DTX3L;NUP62;FYN;PARP9
delta,4,sphingolipid biosynthetic process (GO:0030148),4/67,4,67,0.0358198193392106,0.357010796065945,0,0,3.21840930120288,10.7149018012968,ELOVL4;ELOVL5;PRKD3;SPHK1
delta,4,peptidyl-threonine phosphorylation (GO:0018107),4/69,4,69,0.0392710344460736,0.368984094482899,0,0,3.12512207508106,10.1168579049113,CAMK2B;TBK1;PRKCD;STK39
delta,4,DNA replication-independent nucleosome assembly (GO:0006336),3/40,3,40,0.0377365499968439,0.367982357807061,0,0,4.04312668463612,13.2498362193329,UBN1;ATRX;OIP5
delta,4,termination of RNA polymerase II transcription (GO:0006369),4/69,4,69,0.0392710344460736,0.368984094482899,0,0,3.12512207508106,10.1168579049113,CPSF4;NCBP2;CSTF2;THOC1
delta,4,inositol lipid-mediated signaling (GO:0048017),3/40,3,40,0.0377365499968439,0.367982357807061,0,0,4.04312668463612,13.2498362193329,PIK3R1;PIK3C2A;EZR
delta,4,positive regulation of mitotic nuclear division (GO:0045840),3/41,3,41,0.0401735180974891,0.369760340040155,0,0,3.94451383866938,12.6798261293455,RANBP1;NUP62;NUSAP1
delta,4,positive regulation of telomere capping (GO:1904355),2/17,2,17,0.038843114317467,0.368984094482899,0,0,6.34215950531156,20.6007576059779,NEK7;MAPKAPK5
delta,4,monocarboxylic acid biosynthetic process (GO:0072330),4/69,4,69,0.0392710344460736,0.368984094482899,0,0,3.12512207508106,10.1168579049113,SRR;OSBPL6;ELOVL4;OSBP
delta,4,clathrin-dependent endocytosis (GO:0072583),3/40,3,40,0.0377365499968439,0.367982357807061,0,0,4.04312668463612,13.2498362193329,GAK;NLGN1;CLTC
delta,4,regulation of protein dephosphorylation (GO:0035304),3/41,3,41,0.0401735180974891,0.369760340040155,0,0,3.94451383866938,12.6798261293455,PPP1R2;PRKCD;TIPRL
delta,4,regulation of synaptic vesicle exocytosis (GO:2000300),2/17,2,17,0.038843114317467,0.368984094482899,0,0,6.34215950531156,20.6007576059779,NLGN1;RAB5A
delta,4,negative regulation of phosphatase activity (GO:0010923),4/69,4,69,0.0392710344460736,0.368984094482899,0,0,3.12512207508106,10.1168579049113,PLEKHF2;WDR81;TIPRL;ELFN2
delta,4,"nucleotide-excision repair, DNA incision (GO:0033683)",3/41,3,41,0.0401735180974891,0.369760340040155,0,0,3.94451383866938,12.6798261293455,UBB;XPA;CHD1L
delta,4,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),3/40,3,40,0.0377365499968439,0.367982357807061,0,0,4.04312668463612,13.2498362193329,PEA15;TNFAIP3;TANK
delta,4,N-terminal protein amino acid modification (GO:0031365),2/17,2,17,0.038843114317467,0.368984094482899,0,0,6.34215950531156,20.6007576059779,METAP1D;NAA16
delta,4,intraciliary transport involved in cilium assembly (GO:0035735),3/41,3,41,0.0401735180974891,0.369760340040155,0,0,3.94451383866938,12.6798261293455,TNPO1;DYNLL2;SSX2IP
delta,4,DNA methylation (GO:0006306),2/18,2,18,0.0431734498577369,0.372655040877308,0,0,5.98981731057203,18.8231779532453,ATRX;DMAP1
delta,4,glycogen biosynthetic process (GO:0005978),2/18,2,18,0.0431734498577369,0.372655040877308,0,0,5.98981731057203,18.8231779532453,UBB;PGM2L1
delta,4,glucan biosynthetic process (GO:0009250),2/18,2,18,0.0431734498577369,0.372655040877308,0,0,5.98981731057203,18.8231779532453,UBB;PGM2L1
delta,4,regulation of protein ubiquitination (GO:0031396),5/102,5,102,0.0414287742746068,0.372655040877308,0,0,2.64256646054648,8.41334921194785,UBB;RIPK2;SPHK1;TNFAIP3;COMMD1
delta,4,cellular response to gamma radiation (GO:0071480),2/18,2,18,0.0431734498577369,0.372655040877308,0,0,5.98981731057203,18.8231779532453,XRCC6;KDM1A
delta,4,regulation of spindle organization (GO:0090224),2/18,2,18,0.0431734498577369,0.372655040877308,0,0,5.98981731057203,18.8231779532453,CLTC;NUP62
delta,4,regulation of telomerase RNA localization to Cajal body (GO:1904872),2/18,2,18,0.0431734498577369,0.372655040877308,0,0,5.98981731057203,18.8231779532453,EXOSC10;CCT4
delta,4,interferon-gamma-mediated signaling pathway (GO:0060333),4/71,4,71,0.0429054961088232,0.372655040877308,0,0,3.0370904673323,9.56305484781697,CAMK2B;PRKCD;HLA-B;B2M
delta,4,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),4/72,4,72,0.04479143891873,0.382956188670089,0,0,2.99490865528601,9.30140237611963,PSMA5;PSMD12;UBB;PSMD1
delta,4,regulation of adherens junction organization (GO:1903391),2/18,2,18,0.0431734498577369,0.372655040877308,0,0,5.98981731057203,18.8231779532453,SLK;CORO1C
delta,4,regulation of substrate adhesion-dependent cell spreading (GO:1900024),3/42,3,42,0.0426882227038757,0.372655040877308,0,0,3.85059684251059,12.1441363561379,AP1AR;CRK;CORO1C
delta,4,vascular endothelial growth factor receptor signaling pathway (GO:0048010),4/71,4,71,0.0429054961088232,0.372655040877308,0,0,3.0370904673323,9.56305484781697,FYN;PIK3R1;CRK;PAK2
delta,4,regulation of cell communication (GO:0010646),4/72,4,72,0.04479143891873,0.382956188670089,0,0,2.99490865528601,9.30140237611963,NLGN1;NUP62;CRK;BIRC2
delta,4,negative regulation of cell projection organization (GO:0031345),3/42,3,42,0.0426882227038757,0.372655040877308,0,0,3.85059684251059,12.1441363561379,GAK;EPHA4;FYN
delta,4,mesenchymal cell differentiation (GO:0048762),3/42,3,42,0.0426882227038757,0.372655040877308,0,0,3.85059684251059,12.1441363561379,DDX17;SNAI1;RBPJ
delta,4,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),4/73,4,73,0.0467231372465527,0.397587450909345,0,0,2.95388250932319,9.04926571723251,PSMA5;PSMD12;UBB;PSMD1
delta,4,protein heterotetramerization (GO:0051290),2/19,2,19,0.0476738413005219,0.398164859750655,0,0,5.67456376791034,17.2698109344457,XRCC6;GPRIN1
delta,4,positive regulation of excitatory postsynaptic potential (GO:2000463),2/19,2,19,0.0476738413005219,0.398164859750655,0,0,5.67456376791034,17.2698109344457,NLGN1;GPRIN1
delta,4,regulation of transcription factor import into nucleus (GO:0042990),2/19,2,19,0.0476738413005219,0.398164859750655,0,0,5.67456376791034,17.2698109344457,PIK3R1;DMAP1
delta,4,endothelial cell development (GO:0001885),2/19,2,19,0.0476738413005219,0.398164859750655,0,0,5.67456376791034,17.2698109344457,RAPGEF2;EZR
delta,4,modification-dependent protein catabolic process (GO:0019941),6/142,6,142,0.049274602098105,0.409637705921574,0,0,2.27781785049922,6.85702099640075,RANBP1;UBE2H;WDR81;DTX3L;NEDD8;UBE2G1
delta,4,negative regulation of response to external stimulus (GO:0032102),5/108,5,108,0.0507832990961694,0.415925525864756,0,0,2.49575721273834,7.43782503843432,EPHA4;PRKCD;TNFAIP3;CRK;AJAP1
delta,4,mRNA 3'-end processing (GO:0031124),4/75,4,75,0.0507234989322193,0.415925525864756,0,0,2.87511230907457,8.57176204413542,CPSF4;NCBP2;CSTF2;THOC1
delta,4,inositol phosphate-mediated signaling (GO:0048016),2/20,2,20,0.0523365268133591,0.415925525864756,0,0,5.39083557951483,15.903292411064,NFAT5;NFATC3
delta,4,regulation of toll-like receptor signaling pathway (GO:0034121),2/20,2,20,0.0523365268133591,0.415925525864756,0,0,5.39083557951483,15.903292411064,LRRC14;BIRC2
delta,4,regulation of dendrite morphogenesis (GO:0048814),3/45,3,45,0.0506916015444051,0.415925525864756,0,0,3.59389038634322,10.7169632780529,EPHA4;SDC2;RAPGEF2
delta,4,positive regulation of interferon-alpha production (GO:0032727),2/20,2,20,0.0523365268133591,0.415925525864756,0,0,5.39083557951483,15.903292411064,TBK1;RIPK2
delta,4,regulation of vacuole organization (GO:0044088),2/20,2,20,0.0523365268133591,0.415925525864756,0,0,5.39083557951483,15.903292411064,LAPTM4B;RAB5A
delta,4,positive regulation of dendritic spine development (GO:0060999),2/20,2,20,0.0523365268133591,0.415925525864756,0,0,5.39083557951483,15.903292411064,CAMK2B;NLGN1
delta,4,axon extension (GO:0048675),2/20,2,20,0.0523365268133591,0.415925525864756,0,0,5.39083557951483,15.903292411064,ALCAM;SLIT3
delta,4,negative regulation of telomere maintenance via telomerase (GO:0032211),2/20,2,20,0.0523365268133591,0.415925525864756,0,0,5.39083557951483,15.903292411064,EXOSC10;TEN1
delta,4,nicotinamide nucleotide metabolic process (GO:0046496),3/46,3,46,0.0535098270064962,0.423384771577716,0,0,3.51576233446619,10.2937652393647,G6PD;PKM;NMNAT3
delta,4,regulation of hematopoietic stem cell differentiation (GO:1902036),4/77,4,77,0.0549057459922601,0.42605688716733,0,0,2.80043406728043,8.1272440874036,PSMA5;PSMD12;UBB;PSMD1
delta,4,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),4/77,4,77,0.0549057459922601,0.42605688716733,0,0,2.80043406728043,8.1272440874036,PSMA5;PSMD12;UBB;PSMD1
delta,4,macroautophagy (GO:0016236),5/111,5,111,0.0558880270463634,0.42605688716733,0,0,2.42830431509677,7.00421336776457,PLEKHF2;UBB;C6ORF106;WIPI2;DYNLL2
delta,4,intraciliary transport (GO:0042073),3/47,3,47,0.0564018165195309,0.42605688716733,0,0,3.44095888054138,9.89363048644956,TNPO1;DYNLL2;SSX2IP
delta,4,cellular response to ionizing radiation (GO:0071479),3/47,3,47,0.0564018165195309,0.42605688716733,0,0,3.44095888054138,9.89363048644956,XRCC6;KDM1A;TANK
delta,4,negative regulation of ubiquitin protein ligase activity (GO:1904667),4/78,4,78,0.057064716625256,0.42605688716733,0,0,2.76453106641786,7.91642622382434,PSMA5;PSMD12;UBB;PSMD1
delta,4,regulation of hematopoietic progenitor cell differentiation (GO:1901532),4/78,4,78,0.057064716625256,0.42605688716733,0,0,2.76453106641786,7.91642622382434,PSMA5;PSMD12;UBB;PSMD1
delta,4,histone lysine demethylation (GO:0070076),2/21,2,21,0.0571539726687882,0.42605688716733,0,0,5.13412912334745,14.6939102972279,KDM4C;KDM1A
delta,4,cellular protein complex localization (GO:0034629),2/21,2,21,0.0571539726687882,0.42605688716733,0,0,5.13412912334745,14.6939102972279,MIOS;EZR
delta,4,positive regulation of T cell mediated immunity (GO:0002711),2/21,2,21,0.0571539726687882,0.42605688716733,0,0,5.13412912334745,14.6939102972279,TANK;B2M
delta,4,establishment of endothelial barrier (GO:0061028),2/21,2,21,0.0571539726687882,0.42605688716733,0,0,5.13412912334745,14.6939102972279,RAPGEF2;EZR
delta,4,regulation of interleukin-2 production (GO:0032663),2/21,2,21,0.0571539726687882,0.42605688716733,0,0,5.13412912334745,14.6939102972279,TNFAIP3;TANK
delta,4,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",2/21,2,21,0.0571539726687882,0.42605688716733,0,0,5.13412912334745,14.6939102972279,XPA;CHD1L
delta,4,positive regulation of defense response to virus by host (GO:0002230),2/21,2,21,0.0571539726687882,0.42605688716733,0,0,5.13412912334745,14.6939102972279,DTX3L;PARP9
delta,4,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),3/48,3,48,0.0593666306594509,0.42733512607512,0,0,3.36927223719677,9.51490223678322,FAF1;TNFAIP3;TANK
delta,4,negative regulation of cellular biosynthetic process (GO:0031327),3/48,3,48,0.0593666306594509,0.42733512607512,0,0,3.36927223719677,9.51490223678322,CLTC;SNAI1;RAPGEF2
delta,4,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",5/113,5,113,0.0594497155144631,0.42733512607512,0,0,2.38532547766143,6.73287799333916,RPL30;RPL32;NCBP2;RPLP1;SMG6
delta,4,regulation of G2/M transition of mitotic cell cycle (GO:0010389),6/150,6,150,0.0610951796964446,0.42733512607512,0,0,2.15633423180593,6.02764918157472,PSMA5;RINT1;PSMD12;UBB;PSMD1;TUBA4A
delta,4,regulation of organelle organization (GO:0033043),5/114,5,114,0.0612780567434203,0.42733512607512,0,0,2.36440156996264,6.6021976288804,ZEB2;CLEC16A;RUNDC1;TBC1D9;EZR
delta,4,positive regulation of kinase activity (GO:0033674),5/114,5,114,0.0612780567434203,0.42733512607512,0,0,2.36440156996264,6.6021976288804,EPHA4;XRCC6;RYK;RPLP1;RAPGEF2
delta,4,nucleosome organization (GO:0034728),4/80,4,80,0.0615174425651563,0.42733512607512,0,0,2.69541778975741,7.51599602543473,CHAF1B;HIST3H2A;ATRX;HIST3H2BB
delta,4,negative regulation of mitotic cell cycle phase transition (GO:1901991),4/80,4,80,0.0615174425651563,0.42733512607512,0,0,2.69541778975741,7.51599602543473,PSMA5;PSMD12;UBB;PSMD1
delta,4,cation transport (GO:0006812),4/80,4,80,0.0615174425651563,0.42733512607512,0,0,2.69541778975741,7.51599602543473,P2RX4;GPRIN1;SLC1A4;SLC15A4
delta,4,anaphase-promoting complex-dependent catabolic process (GO:0031145),4/80,4,80,0.0615174425651563,0.42733512607512,0,0,2.69541778975741,7.51599602543473,PSMA5;PSMD12;UBB;PSMD1
delta,4,regulation of calcium ion import (GO:0090279),2/22,2,22,0.0621188674472011,0.42733512607512,0,0,4.90075961774075,13.6177677655542,SLC30A1;FYN
delta,4,negative regulation of protein polymerization (GO:0032272),2/22,2,22,0.0621188674472011,0.42733512607512,0,0,4.90075961774075,13.6177677655542,PRKCD;TBCD
delta,4,NAD biosynthetic process (GO:0009435),2/22,2,22,0.0621188674472011,0.42733512607512,0,0,4.90075961774075,13.6177677655542,NMNAT3;PARP9
delta,4,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),2/22,2,22,0.0621188674472011,0.42733512607512,0,0,4.90075961774075,13.6177677655542,ZDHHC9;ZDHHC4
delta,4,peptidyl-L-cysteine S-palmitoylation (GO:0018230),2/22,2,22,0.0621188674472011,0.42733512607512,0,0,4.90075961774075,13.6177677655542,ZDHHC9;ZDHHC4
delta,4,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",2/22,2,22,0.0621188674472011,0.42733512607512,0,0,4.90075961774075,13.6177677655542,XPA;CHD1L
delta,4,early endosome to late endosome transport (GO:0045022),2/22,2,22,0.0621188674472011,0.42733512607512,0,0,4.90075961774075,13.6177677655542,WDR81;RAB5A
delta,4,protein complex localization (GO:0031503),2/22,2,22,0.0621188674472011,0.42733512607512,0,0,4.90075961774075,13.6177677655542,MIOS;EZR
delta,4,NLS-bearing protein import into nucleus (GO:0006607),2/22,2,22,0.0621188674472011,0.42733512607512,0,0,4.90075961774075,13.6177677655542,KPNA6;TNPO1
delta,4,RNA transport (GO:0050658),4/81,4,81,0.0638107715185486,0.42733512607512,0,0,2.6621410269209,7.3257682481192,RANBP1;NCBP2;NUP62;THOC1
delta,4,negative regulation of cell death (GO:0060548),4/82,4,82,0.0661484267368592,0.42733512607512,0,0,2.62967589244626,7.14181624343287,NUP62;ADNP2;IKBKG;TANK
delta,4,protein catabolic process (GO:0030163),4/82,4,82,0.0661484267368592,0.42733512607512,0,0,2.62967589244626,7.14181624343287,PSMA5;ATE1;UBE2G1;IDE
delta,4,positive regulation of protein catabolic process (GO:0045732),4/82,4,82,0.0661484267368592,0.42733512607512,0,0,2.62967589244626,7.14181624343287,BARD1;TNFAIP3;IDE;EZR
delta,4,sphingolipid metabolic process (GO:0006665),5/117,5,117,0.0669525234624522,0.42733512607512,0,0,2.30377588868155,6.22888362662339,ELOVL4;PRKD3;ELOVL5;SPHK1;ESYT2
delta,4,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),2/23,2,23,0.0672241164250338,0.42733512607512,0,0,4.68768311262159,12.6554469493068,EPHA4;UBB
delta,4,zinc II ion transmembrane transport (GO:0071577),2/23,2,23,0.0672241164250338,0.42733512607512,0,0,4.68768311262159,12.6554469493068,SLC39A10;SLC30A1
delta,4,vesicle-mediated transport between endosomal compartments (GO:0098927),2/23,2,23,0.0672241164250338,0.42733512607512,0,0,4.68768311262159,12.6554469493068,WDR81;RAB5A
delta,4,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",2/23,2,23,0.0672241164250338,0.42733512607512,0,0,4.68768311262159,12.6554469493068,UBB;XPA
delta,4,positive regulation of ion transmembrane transporter activity (GO:0032414),2/23,2,23,0.0672241164250338,0.42733512607512,0,0,4.68768311262159,12.6554469493068,STK39;GLRX
delta,4,positive regulation of ubiquitin protein ligase activity (GO:1904668),4/83,4,83,0.0685301455849284,0.42733512607512,0,0,2.59799305036859,6.9638724359163,PSMA5;PSMD12;UBB;PSMD1
delta,4,fatty acid beta-oxidation (GO:0006635),3/51,3,51,0.068688023070329,0.42733512607512,0,0,3.17107975265578,8.4927237406966,HADHB;HADHA;ACOX1
delta,4,activation of MAPK activity (GO:0000187),5/118,5,118,0.0689069476192511,0.42733512607512,0,0,2.2842523642012,6.11037112196208,UBB;RIPK2;PEA15;STK39;IKBKG
delta,4,regulation of cellular amine metabolic process (GO:0033238),3/52,3,52,0.0719339557701792,0.42733512607512,0,0,3.11009744972009,8.18579782882682,PSMA5;PSMD12;PSMD1
delta,4,telomere maintenance (GO:0000723),3/52,3,52,0.0719339557701792,0.42733512607512,0,0,3.11009744972009,8.18579782882682,RECQL4;XRCC6;TEN1
delta,4,regulation of cellular amino acid metabolic process (GO:0006521),3/52,3,52,0.0719339557701792,0.42733512607512,0,0,3.11009744972009,8.18579782882682,PSMA5;PSMD12;PSMD1
delta,4,regulation of neuron projection development (GO:0010975),5/120,5,120,0.0729097090004651,0.42733512607512,0,0,2.24618149146451,5.88170140697987,GAK;CAMK2B;EPHA4;PAK1;RAPGEF2
delta,4,regulation of cell-matrix adhesion (GO:0001952),3/53,3,53,0.0752474499442252,0.42733512607512,0,0,3.05141636576311,7.8939325546816,SLK;AJAP1;CORO1C
delta,4,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),4/86,4,86,0.0759367786079846,0.42733512607512,0,0,2.50736538582085,6.4636222536324,RIPK2;PRKCD;FYN;PAK2
delta,4,histone mRNA metabolic process (GO:0008334),2/25,2,25,0.0778283488830627,0.42733512607512,0,0,4.31266846361186,11.0113187391407,EXOSC10;NCBP2
delta,4,cellular senescence (GO:0090398),2/25,2,25,0.0778283488830627,0.42733512607512,0,0,4.31266846361186,11.0113187391407,PRKCD;MAPKAPK5
delta,4,negative regulation of endothelial cell apoptotic process (GO:2000352),2/25,2,25,0.0778283488830627,0.42733512607512,0,0,4.31266846361186,11.0113187391407,KRIT1;TNFAIP3
delta,4,chaperone mediated protein folding requiring cofactor (GO:0051085),2/25,2,25,0.0778283488830627,0.42733512607512,0,0,4.31266846361186,11.0113187391407,GAK;DNAJB1
delta,4,regulation of neuronal synaptic plasticity (GO:0048168),2/25,2,25,0.0778283488830627,0.42733512607512,0,0,4.31266846361186,11.0113187391407,CAMK2B;RAB5A
delta,4,transition metal ion homeostasis (GO:0055076),2/25,2,25,0.0778283488830627,0.42733512607512,0,0,4.31266846361186,11.0113187391407,COMMD1;B2M
delta,4,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),2/25,2,25,0.0778283488830627,0.42733512607512,0,0,4.31266846361186,11.0113187391407,KDM1A;SNAI1
delta,4,calcium ion transmembrane transport (GO:0070588),4/87,4,87,0.0784917574005978,0.42733512607512,0,0,2.4785450940298,6.30730653027992,P2RX4;GPRIN1;ATP2A2;MICU3
delta,4,toll-like receptor signaling pathway (GO:0002224),4/87,4,87,0.0784917574005978,0.42733512607512,0,0,2.4785450940298,6.30730653027992,UBB;RIPK2;IKBKG;BIRC2
delta,4,positive regulation of protein import into nucleus (GO:0042307),3/54,3,54,0.0786273577476698,0.42733512607512,0,0,2.99490865528601,7.61615926073489,PRKCD;PIK3R1;DMAP1
delta,4,calcium ion homeostasis (GO:0055074),4/88,4,88,0.081089215138806,0.42733512607512,0,0,2.45037980887038,6.15585716481882,GPRIN1;ATP2A2;SLC30A1;CHERP
delta,4,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),4/88,4,88,0.081089215138806,0.42733512607512,0,0,2.45037980887038,6.15585716481882,PSMA5;PSMD12;UBB;PSMD1
delta,4,cytoplasmic translation (GO:0002181),3/55,3,55,0.0820725051540993,0.42733512607512,0,0,2.94045577064445,7.35158700280585,RPL30;RPL32;RPLP1
delta,4,glycolytic process through glucose-6-phosphate (GO:0061620),2/26,2,26,0.0833141776922,0.42733512607512,0,0,4.14679659962679,10.3053557698745,PKM;PGM2L1
delta,4,negative regulation of wound healing (GO:0061045),2/26,2,26,0.0833141776922,0.42733512607512,0,0,4.14679659962679,10.3053557698745,CRK;AJAP1
delta,4,canonical glycolysis (GO:0061621),2/26,2,26,0.0833141776922,0.42733512607512,0,0,4.14679659962679,10.3053557698745,PKM;PGM2L1
delta,4,glucose catabolic process to pyruvate (GO:0061718),2/26,2,26,0.0833141776922,0.42733512607512,0,0,4.14679659962679,10.3053557698745,PKM;PGM2L1
delta,4,regulation of telomere maintenance (GO:0032204),2/26,2,26,0.0833141776922,0.42733512607512,0,0,4.14679659962679,10.3053557698745,ATRX;SMG6
delta,4,"negative regulation of gene expression, epigenetic (GO:0045814)",2/26,2,26,0.0833141776922,0.42733512607512,0,0,4.14679659962679,10.3053557698745,CREBZF;BMI1
delta,4,response to amyloid-beta (GO:1904645),2/26,2,26,0.0833141776922,0.42733512607512,0,0,4.14679659962679,10.3053557698745,EPHA4;FYN
delta,4,positive regulation of nuclear division (GO:0051785),2/26,2,26,0.0833141776922,0.42733512607512,0,0,4.14679659962679,10.3053557698745,NUP62;NUSAP1
delta,4,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",2/26,2,26,0.0833141776922,0.42733512607512,0,0,4.14679659962679,10.3053557698745,KDM1A;SNAI1
delta,4,positive regulation of filopodium assembly (GO:0051491),2/26,2,26,0.0833141776922,0.42733512607512,0,0,4.14679659962679,10.3053557698745,DOCK11;NLGN1
delta,4,modulation of excitatory postsynaptic potential (GO:0098815),2/26,2,26,0.0833141776922,0.42733512607512,0,0,4.14679659962679,10.3053557698745,NLGN1;GPRIN1
delta,4,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),2/26,2,26,0.0833141776922,0.42733512607512,0,0,4.14679659962679,10.3053557698745,RIPK2;SPHK1
delta,4,regulation of stem cell differentiation (GO:2000736),4/89,4,89,0.0837287843377985,0.42733512607512,0,0,2.42284745146734,6.00907952804858,PSMA5;PSMD12;UBB;PSMD1
delta,4,positive regulation of protein complex assembly (GO:0031334),4/89,4,89,0.0837287843377985,0.42733512607512,0,0,2.42284745146734,6.00907952804858,FAF1;XPA;IDE;CHD1L
delta,4,positive regulation of cysteine-type endopeptidase activity (GO:2001056),3/56,3,56,0.0855816941369416,0.42733512607512,0,0,2.88794763188294,7.09939508734532,RIPK2;GPRIN1;FYN
delta,4,positive regulation of DNA biosynthetic process (GO:2000573),3/56,3,56,0.0855816941369416,0.42733512607512,0,0,2.88794763188294,7.09939508734532,NEK7;MAPKAPK5;CCT4
delta,4,Notch signaling pathway (GO:0007219),3/56,3,56,0.0855816941369416,0.42733512607512,0,0,2.88794763188294,7.09939508734532,UBB;SNAI1;RBPJ
delta,4,mitochondrial translational termination (GO:0070126),4/90,4,90,0.0864100818832118,0.42733512607512,0,0,2.39592692422881,5.86678867089931,PTCD3;MRPL48;MRRF;MRPL13
delta,4,peptidyl-threonine modification (GO:0018210),4/90,4,90,0.0864100818832118,0.42733512607512,0,0,2.39592692422881,5.86678867089931,CAMK2B;TBK1;PRKCD;STK39
delta,4,bile acid biosynthetic process (GO:0006699),2/27,2,27,0.0889140410613825,0.42733512607512,0,0,3.99321154038135,9.6639121762446,OSBPL6;OSBP
delta,4,response to gamma radiation (GO:0010332),2/27,2,27,0.0889140410613825,0.42733512607512,0,0,3.99321154038135,9.6639121762446,XRCC6;KDM1A
delta,4,positive regulation of interferon-beta production (GO:0032728),2/27,2,27,0.0889140410613825,0.42733512607512,0,0,3.99321154038135,9.6639121762446,TBK1;RIPK2
delta,4,regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),2/27,2,27,0.0889140410613825,0.42733512607512,0,0,3.99321154038135,9.6639121762446,NFATC3;TEAD1
delta,4,regulation of p38MAPK cascade (GO:1900744),2/27,2,27,0.0889140410613825,0.42733512607512,0,0,3.99321154038135,9.6639121762446,GADD45B;EZR
delta,4,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),2/27,2,27,0.0889140410613825,0.42733512607512,0,0,3.99321154038135,9.6639121762446,EXOSC10;TEN1
delta,4,protein import (GO:0017038),3/57,3,57,0.0891537047576088,0.42733512607512,0,0,2.83728188395517,6.85882644087221,RANBP1;NUP62;TNPO3
delta,4,phosphatidylinositol-mediated signaling (GO:0048015),3/57,3,57,0.0891537047576088,0.42733512607512,0,0,2.83728188395517,6.85882644087221,PIK3R1;PIK3C2A;EZR
delta,4,cellular iron ion homeostasis (GO:0006879),3/57,3,57,0.0891537047576088,0.42733512607512,0,0,2.83728188395517,6.85882644087221,UBB;NEDD8;ACO1
delta,4,regulation of protein catabolic process (GO:0042176),4/92,4,92,0.0918962547618159,0.42733512607512,0,0,2.34384155631079,5.59497246890617,BARD1;FAF1;TNFAIP3;IDE
delta,4,positive regulation of cell death (GO:0010942),3/58,3,58,0.092787297205204,0.42733512607512,0,0,2.78836323078353,6.62918170496516,RIPK2;FAF1;FYN
delta,4,regulation of protein localization to nucleus (GO:1900180),2/28,2,28,0.0946218479716245,0.42733512607512,0,0,3.85059684251059,9.07919475747071,DTX3L;PARP9
delta,4,negative regulation of cell-matrix adhesion (GO:0001953),2/28,2,28,0.0946218479716245,0.42733512607512,0,0,3.85059684251059,9.07919475747071,CORO1C;AJAP1
delta,4,regulation of neurotransmitter secretion (GO:0046928),2/28,2,28,0.0946218479716245,0.42733512607512,0,0,3.85059684251059,9.07919475747071,SLC30A1;RAB5A
delta,4,nuclear export (GO:0051168),4/93,4,93,0.0947002905798287,0.42733512607512,0,0,2.31863895893111,5.46512062225316,RANBP1;NCBP2;NUP62;THOC1
delta,4,cell cycle G1/S phase transition (GO:0044843),4/93,4,93,0.0947002905798287,0.42733512607512,0,0,2.31863895893111,5.46512062225316,ORC4;RANBP1;LATS2;CCNE2
delta,4,regulation of protein metabolic process (GO:0051246),3/60,3,60,0.100234180499607,0.42733512607512,0,0,2.69541778975741,6.20012405862519,FAF1;NEDD8;IGF2BP2
delta,4,cellular response to hydrogen peroxide (GO:0070301),2/29,2,29,0.100431693097861,0.42733512607512,0,0,3.71781764104471,8.54457645964077,PRKCD;TNFAIP3
delta,4,regulation of mRNA processing (GO:0050684),2/29,2,29,0.100431693097861,0.42733512607512,0,0,3.71781764104471,8.54457645964077,CPSF4;SLTM
delta,4,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),2/29,2,29,0.100431693097861,0.42733512607512,0,0,3.71781764104471,8.54457645964077,TANK;PAK2
delta,4,positive regulation of fibroblast proliferation (GO:0048146),2/29,2,29,0.100431693097861,0.42733512607512,0,0,3.71781764104471,8.54457645964077,SPHK1;BMI1
delta,4,transcription elongation from RNA polymerase I promoter (GO:0006362),2/29,2,29,0.100431693097861,0.42733512607512,0,0,3.71781764104471,8.54457645964077,POLR1A;UBTF
delta,4,cellular response to hypoxia (GO:0071456),5/133,5,133,0.101913548712998,0.42733512607512,0,0,2.02662991711084,4.62807366134728,PSMA5;PSMD12;TBL2;UBB;PSMD1
delta,4,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),5/134,5,134,0.104352793954226,0.42733512607512,0,0,2.0115058132518,4.54595862529772,PAK1;PRKCD;FYN;PIK3R1;CRK
delta,4,sphingosine-1-phosphate signaling pathway (GO:0003376),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,EZR
delta,4,positive regulation of nucleobase-containing compound transport (GO:0032241),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,NCBP2
delta,4,polyamine biosynthetic process (GO:0006596),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,SMS
delta,4,epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,RBPJ
delta,4,positive regulation of RNA binding (GO:1905216),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,LARP6
delta,4,nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,EXOSC10
delta,4,negative regulation of transforming growth factor beta production (GO:0071635),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,LAPTM4B
delta,4,regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,UBB
delta,4,protein retention in ER lumen (GO:0006621),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,GPAA1
delta,4,positive regulation of aspartic-type peptidase activity (GO:1905247),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,EPHA4
delta,4,cellular response to iron ion (GO:0071281),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,B2M
delta,4,positive regulation of icosanoid secretion (GO:0032305),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,P2RX4
delta,4,N-terminal peptidyl-methionine acetylation (GO:0017196),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,NAA16
delta,4,"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,UBB
delta,4,regulation of nuclear cell cycle DNA replication (GO:0033262),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,ATRX
delta,4,negative regulation of necroptotic process (GO:0060546),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,BIRC2
delta,4,astral microtubule organization (GO:0030953),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,EZR
delta,4,establishment of endothelial intestinal barrier (GO:0090557),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,RAPGEF2
delta,4,positive regulation of receptor binding (GO:1900122),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,B2M
delta,4,negative regulation of bone resorption (GO:0045779),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,TNFAIP3
delta,4,nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,EXOSC10
delta,4,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,ATF3
delta,4,ceramide transport (GO:0035627),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,PLEKHA8
delta,4,protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,TNFAIP3
delta,4,retinal ganglion cell axon guidance (GO:0031290),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,ALCAM
delta,4,azole transport (GO:0045117),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,SLC15A4
delta,4,spermine metabolic process (GO:0008215),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,SMS
delta,4,negative regulation of dendritic spine development (GO:0061000),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,NLGN1
delta,4,gap junction assembly (GO:0016264),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,GJD3
delta,4,intermediate filament bundle assembly (GO:0045110),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,NEFM
delta,4,citrate metabolic process (GO:0006101),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,ACO1
delta,4,regulation of glial cell apoptotic process (GO:0034350),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,PRKCD
delta,4,antigen processing and presentation of endogenous peptide antigen (GO:0002483),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,B2M
delta,4,regulation of protein K63-linked ubiquitination (GO:1900044),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,BIRC2
delta,4,regulation of chemokine-mediated signaling pathway (GO:0070099),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,SLIT3
delta,4,negative regulation of amino acid transport (GO:0051956),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,STK39
delta,4,positive regulation of RNA export from nucleus (GO:0046833),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,NCBP2
delta,4,regulation of hyaluronan biosynthetic process (GO:1900125),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,CLTC
delta,4,positive regulation of microtubule motor activity (GO:2000576),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,DYNLL2
delta,4,regulation of glial cell differentiation (GO:0045685),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,EPHA4
delta,4,regulation of cell cycle checkpoint (GO:1901976),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,ETAA1
delta,4,aggrephagy (GO:0035973),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,WDR81
delta,4,positive regulation of phospholipid transport (GO:2001140),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,PRKCD
delta,4,positive regulation of sodium ion transmembrane transport (GO:1902307),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,GLRX
delta,4,positive regulation of clathrin-dependent endocytosis (GO:2000370),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,NLGN1
delta,4,positive regulation of centrosome cycle (GO:0046607),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,RANBP1
delta,4,positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,PAK1
delta,4,regulation of lysosomal protein catabolic process (GO:1905165),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,LAPTM4B
delta,4,negative regulation of cell cycle phase transition (GO:1901988),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,ATF5
delta,4,regulation of NFAT protein import into nucleus (GO:0051532),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,CHERP
delta,4,positive regulation of protein localization to centrosome (GO:1904781),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,NUP62
delta,4,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,EPHA4
delta,4,dendritic spine maintenance (GO:0097062),1/6,1,6,0.106276709803964,0.42733512607512,0,0,8.98472596585804,20.1411421058367,FYN
delta,4,translational termination (GO:0006415),4/97,4,97,0.106312343418129,0.42733512607512,0,0,2.22302498124323,4.98263013126404,PTCD3;MRPL48;MRPL13;MRRF
delta,4,protein localization to nucleus (GO:0034504),4/97,4,97,0.106312343418129,0.42733512607512,0,0,2.22302498124323,4.98263013126404,RANBP1;NUP62;XPA;TNPO3
delta,4,cellular metal ion homeostasis (GO:0006875),4/97,4,97,0.106312343418129,0.42733512607512,0,0,2.22302498124323,4.98263013126404,ATP2A2;SLC30A1;ATP1A1;CHERP
delta,4,synaptic vesicle endocytosis (GO:0048488),2/30,2,30,0.10633785196542,0.42733512607512,0,0,3.59389038634322,8.05438983214983,GAK;NLGN1
delta,4,cortical cytoskeleton organization (GO:0030865),2/30,2,30,0.10633785196542,0.42733512607512,0,0,3.59389038634322,8.05438983214983,NLGN1;EZR
delta,4,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),2/30,2,30,0.10633785196542,0.42733512607512,0,0,3.59389038634322,8.05438983214983,RBPJ;ATF3
delta,4,negative regulation of epithelial cell apoptotic process (GO:1904036),2/30,2,30,0.10633785196542,0.42733512607512,0,0,3.59389038634322,8.05438983214983,KRIT1;TNFAIP3
delta,4,synaptic vesicle recycling (GO:0036465),2/30,2,30,0.10633785196542,0.42733512607512,0,0,3.59389038634322,8.05438983214983,NLGN1;RAB5A
delta,4,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),2/30,2,30,0.10633785196542,0.42733512607512,0,0,3.59389038634322,8.05438983214983,UBB;NUP62
delta,4,regulation of cellular biosynthetic process (GO:0031326),2/30,2,30,0.10633785196542,0.42733512607512,0,0,3.59389038634322,8.05438983214983,SIRT5;IGF2BP2
delta,4,Fc-gamma receptor signaling pathway (GO:0038094),5/135,5,135,0.106820770947366,0.42733512607512,0,0,1.99660577019068,4.46561422948948,PAK1;PRKCD;FYN;PIK3R1;CRK
delta,4,positive regulation of cellular amide metabolic process (GO:0034250),3/62,3,62,0.107912099648916,0.42733512607512,0,0,2.6084688287975,5.80759484059024,EPHA4;PRKCD;LARP6
delta,4,cell morphogenesis involved in neuron differentiation (GO:0048667),4/98,4,98,0.109311976327146,0.42733512607512,0,0,2.20034105286319,4.87056343433274,RYK;SDC2;TBCD;SLIT3
delta,4,cellular response to organic cyclic compound (GO:0071407),5/136,5,136,0.109317246779479,0.42733512607512,0,0,1.98192484540986,4.38699283178564,P2RX4;CASP6;RAPGEF2;ATP1A1;EZR
delta,4,Fc receptor mediated stimulatory signaling pathway (GO:0002431),5/136,5,136,0.109317246779479,0.42733512607512,0,0,1.98192484540986,4.38699283178564,PAK1;PRKCD;FYN;PIK3R1;CRK
delta,4,positive regulation of catabolic process (GO:0009896),3/63,3,63,0.111834439617355,0.42733512607512,0,0,2.56706456167373,5.62376002831706,BARD1;TNFAIP3;IDE
delta,4,cellular protein catabolic process (GO:0044257),3/63,3,63,0.111834439617355,0.42733512607512,0,0,2.56706456167373,5.62376002831706,CLTC;UBE2G1;IDE
delta,4,stress-activated MAPK cascade (GO:0051403),3/63,3,63,0.111834439617355,0.42733512607512,0,0,2.56706456167373,5.62376002831706,UBB;RIPK2;IKBKG
delta,4,establishment of protein localization to organelle (GO:0072594),3/63,3,63,0.111834439617355,0.42733512607512,0,0,2.56706456167373,5.62376002831706,RANBP1;NUP62;TNPO3
delta,4,hippo signaling (GO:0035329),2/31,2,31,0.112334776347287,0.42733512607512,0,0,3.47795843839666,7.60376242608067,LATS2;TEAD1
delta,4,cellular response to cAMP (GO:0071320),2/31,2,31,0.112334776347287,0.42733512607512,0,0,3.47795843839666,7.60376242608067,RAPGEF2;EZR
delta,4,negative regulation of transferase activity (GO:0051348),2/31,2,31,0.112334776347287,0.42733512607512,0,0,3.47795843839666,7.60376242608067,EIF4A2;DTX3L
delta,4,negative regulation of DNA biosynthetic process (GO:2000279),2/31,2,31,0.112334776347287,0.42733512607512,0,0,3.47795843839666,7.60376242608067,EXOSC10;TEN1
delta,4,protein palmitoylation (GO:0018345),2/31,2,31,0.112334776347287,0.42733512607512,0,0,3.47795843839666,7.60376242608067,ZDHHC9;ZDHHC4
delta,4,'de novo' posttranslational protein folding (GO:0051084),2/31,2,31,0.112334776347287,0.42733512607512,0,0,3.47795843839666,7.60376242608067,GAK;DNAJB1
delta,4,regulation of developmental growth (GO:0048638),2/31,2,31,0.112334776347287,0.42733512607512,0,0,3.47795843839666,7.60376242608067,MBD5;LATS2
delta,4,phosphatidylinositol 3-kinase signaling (GO:0014065),2/31,2,31,0.112334776347287,0.42733512607512,0,0,3.47795843839666,7.60376242608067,PIK3R1;PIK3C2A
delta,4,bile acid metabolic process (GO:0008206),2/31,2,31,0.112334776347287,0.42733512607512,0,0,3.47795843839666,7.60376242608067,OSBPL6;OSBP
delta,4,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),2/31,2,31,0.112334776347287,0.42733512607512,0,0,3.47795843839666,7.60376242608067,P2RX4;GPRIN1
delta,4,small GTPase mediated signal transduction (GO:0007264),4/100,4,100,0.115423724398975,0.42733512607512,0,0,2.15633423180593,4.65583905550633,ARHGAP32;KRIT1;RAPGEF2;MAPKAPK5
delta,4,vesicle coating (GO:0006901),3/64,3,64,0.115810608221919,0.42733512607512,0,0,2.52695417789757,5.4476055674823,ANKRD28;SEC23A;KLHL12
delta,4,COPII vesicle coating (GO:0048208),3/64,3,64,0.115810608221919,0.42733512607512,0,0,2.52695417789757,5.4476055674823,ANKRD28;SEC23A;KLHL12
delta,4,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",3/64,3,64,0.115810608221919,0.42733512607512,0,0,2.52695417789757,5.4476055674823,ANKRD28;SEC23A;KLHL12
delta,4,negative regulation of dephosphorylation (GO:0035305),3/64,3,64,0.115810608221919,0.42733512607512,0,0,2.52695417789757,5.4476055674823,PLEKHF2;WDR81;ELFN2
delta,4,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",3/64,3,64,0.115810608221919,0.42733512607512,0,0,2.52695417789757,5.4476055674823,EIF4A2;HBS1L;LSM6
delta,4,regulation of vesicle-mediated transport (GO:0060627),5/139,5,139,0.116975230783424,0.42733512607512,0,0,1.93914948903411,4.16101353391056,RINT1;RAB4A;RUNDC1;TBC1D9;RAB5A
delta,4,negative regulation of toll-like receptor signaling pathway (GO:0034122),2/32,2,32,0.118417089720849,0.42733512607512,0,0,3.36927223719677,7.1884845959891,LRRC14;TNFAIP3
delta,4,regulation of ubiquitin-protein transferase activity (GO:0051438),2/32,2,32,0.118417089720849,0.42733512607512,0,0,3.36927223719677,7.1884845959891,DTX3L;BMI1
delta,4,regulation of glucose import (GO:0046324),2/32,2,32,0.118417089720849,0.42733512607512,0,0,3.36927223719677,7.1884845959891,PEA15;PIK3R1
delta,4,zinc ion homeostasis (GO:0055069),2/32,2,32,0.118417089720849,0.42733512607512,0,0,3.36927223719677,7.1884845959891,SLC39A10;SLC30A1
delta,4,cellular zinc ion homeostasis (GO:0006882),2/32,2,32,0.118417089720849,0.42733512607512,0,0,3.36927223719677,7.1884845959891,SLC39A10;SLC30A1
delta,4,termination of RNA polymerase I transcription (GO:0006363),2/32,2,32,0.118417089720849,0.42733512607512,0,0,3.36927223719677,7.1884845959891,POLR1A;UBTF
delta,4,vesicle-mediated transport to the plasma membrane (GO:0098876),2/32,2,32,0.118417089720849,0.42733512607512,0,0,3.36927223719677,7.1884845959891,COMMD1;EXOC5
delta,4,regulation of primary metabolic process (GO:0080090),5/140,5,140,0.119583230997539,0.42733512607512,0,0,1.92529842125529,4.08883838341643,PSMA5;PSMD12;ACOX1;TGS1;PSMD1
delta,4,cellular divalent inorganic cation homeostasis (GO:0072503),4/102,4,102,0.121681994747213,0.42733512607512,0,0,2.11405316843719,4.45292370969703,ATP2A2;SLC39A10;SLC30A1;CHERP
delta,4,regulation of small GTPase mediated signal transduction (GO:0051056),5/141,5,141,0.122218460710852,0.42733512607512,0,0,1.91164382252299,4.01817050717365,ARHGAP32;DEPDC1B;ARHGEF12;NUP62;ARAP2
delta,4,positive regulation of Wnt signaling pathway (GO:0030177),5/141,5,141,0.122218460710852,0.42733512607512,0,0,1.91164382252299,4.01817050717365,PSMA5;DEPDC1B;PSMD12;UBB;PSMD1
delta,4,adherens junction assembly (GO:0034333),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,TBCD
delta,4,ATP hydrolysis coupled proton transport (GO:0015991),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,ATP1A1
delta,4,histone H3-K4 demethylation (GO:0034720),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,KDM1A
delta,4,cellular divalent inorganic anion homeostasis (GO:0072501),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,GPCPD1
delta,4,negative regulation of muscle hypertrophy (GO:0014741),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,P2RX4
delta,4,positive regulation of dendritic spine morphogenesis (GO:0061003),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,CAMK2B
delta,4,erythrocyte development (GO:0048821),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,G6PD
delta,4,ATP hydrolysis coupled cation transmembrane transport (GO:0099132),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,ATP1A1
delta,4,positive regulation of lamellipodium morphogenesis (GO:2000394),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,CORO1C
delta,4,positive regulation of sphingolipid biosynthetic process (GO:0090154),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,PRKCD
delta,4,cellular trivalent inorganic anion homeostasis (GO:0072502),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,GPCPD1
delta,4,negative regulation of glial cell apoptotic process (GO:0034351),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,PRKCD
delta,4,mitochondrial DNA metabolic process (GO:0032042),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,POLG
delta,4,regulation of dendritic spine maintenance (GO:1902950),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,FYN
delta,4,regulation of cardiac muscle cell membrane potential (GO:0086036),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,ATP2A2
delta,4,regulation of ER to Golgi vesicle-mediated transport (GO:0060628),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,RINT1
delta,4,dorsal aorta development (GO:0035907),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,RBPJ
delta,4,ribosomal protein import into nucleus (GO:0006610),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,TNPO1
delta,4,cytoplasmic sequestering of NF-kappaB (GO:0007253),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,FAF1
delta,4,death-inducing signaling complex assembly (GO:0071550),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,TANK
delta,4,nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,RIPK2
delta,4,negative regulation of telomere capping (GO:1904354),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,SMG6
delta,4,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,RBPJ
delta,4,L-alanine transport (GO:0015808),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,SLC1A4
delta,4,tRNA 3'-end processing (GO:0042780),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,PTCD1
delta,4,activation of MAPKKK activity (GO:0000185),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,GADD45B
delta,4,negative regulation of calcium ion import (GO:0090281),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,SLC30A1
delta,4,regulation of response to biotic stimulus (GO:0002831),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,ELMOD2
delta,4,positive regulation of protein deubiquitination (GO:1903003),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,TANK
delta,4,negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,CORO1C
delta,4,negative regulation of nitrogen compound metabolic process (GO:0051172),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,CLTC
delta,4,attachment of GPI anchor to protein (GO:0016255),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,GPAA1
delta,4,cellular response to hydroxyurea (GO:0072711),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,ATRX
delta,4,cellular lipid biosynthetic process (GO:0097384),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,GNPAT
delta,4,regulation of vitamin D biosynthetic process (GO:0060556),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,SNAI1
delta,4,regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901213),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,RBPJ
delta,4,zinc II ion transmembrane import (GO:0071578),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,SLC39A10
delta,4,regulation of toll-like receptor 3 signaling pathway (GO:0034139),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,TNFAIP3
delta,4,positive regulation of mRNA binding (GO:1902416),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,LARP6
delta,4,negative regulation of axon regeneration (GO:0048681),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,EPHA4
delta,4,positive regulation of ceramide biosynthetic process (GO:2000304),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,PRKCD
delta,4,dorsal aorta morphogenesis (GO:0035912),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,RBPJ
delta,4,vascular smooth muscle contraction (GO:0014829),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,PIK3C2A
delta,4,pentose metabolic process (GO:0019321),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,G6PD
delta,4,positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,DYNC1LI1
delta,4,cell differentiation in spinal cord (GO:0021515),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,MDGA1
delta,4,forebrain neuron differentiation (GO:0021879),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,RAPGEF2
delta,4,regulation of protein deubiquitination (GO:0090085),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,TANK
delta,4,negative regulation of RIG-I signaling pathway (GO:0039536),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,SEC14L1
delta,4,regulation of protein localization to centrosome (GO:1904779),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,NUP62
delta,4,excitatory chemical synaptic transmission (GO:0098976),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,GPRIN1
delta,4,glyoxylate metabolic process (GO:0046487),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,GRHPR
delta,4,negative regulation of necrotic cell death (GO:0060547),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,BIRC2
delta,4,negative regulation of dendrite development (GO:2000171),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,RAPGEF2
delta,4,marginal zone B cell differentiation (GO:0002315),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,DOCK11
delta,4,cellular phosphate ion homeostasis (GO:0030643),1/7,1,7,0.122860225884372,0.42733512607512,0,0,7.70119368502118,16.1471539830348,GPCPD1
delta,4,chromatin assembly (GO:0031497),3/66,3,66,0.123919109058392,0.42733512607512,0,0,2.45037980887038,5.1167024566303,CHAF1B;ATRX;HIST3H2BB
delta,4,fatty acid catabolic process (GO:0009062),3/66,3,66,0.123919109058392,0.42733512607512,0,0,2.45037980887038,5.1167024566303,HADHB;HADHA;HACL1
delta,4,positive regulation of calcium ion transport into cytosol (GO:0010524),2/33,2,33,0.124579582807152,0.42733512607512,0,0,3.26717307849383,6.80490254988639,P2RX4;GPRIN1
delta,4,central nervous system neuron differentiation (GO:0021953),2/33,2,33,0.124579582807152,0.42733512607512,0,0,3.26717307849383,6.80490254988639,RYK;MDGA1
delta,4,positive regulation of TOR signaling (GO:0032008),2/33,2,33,0.124579582807152,0.42733512607512,0,0,3.26717307849383,6.80490254988639,MIOS;CLEC16A
delta,4,double-strand break repair (GO:0006302),5/142,5,142,0.124880646420353,0.42733512607512,0,0,1.89818154208268,3.94897085618667,BARD1;RECQL4;XRCC6;DTX3L;PARP9
delta,4,JNK cascade (GO:0007254),3/67,3,67,0.128048765400159,0.42733512607512,0,0,2.41380697590216,4.96120394559627,UBB;RIPK2;IKBKG
delta,4,glycogen metabolic process (GO:0005977),2/34,2,34,0.130817209274134,0.42733512607512,0,0,3.17107975265578,6.4498312327237,UBB;PGM2L1
delta,4,positive regulation of calcium ion transport (GO:0051928),2/34,2,34,0.130817209274134,0.42733512607512,0,0,3.17107975265578,6.4498312327237,P2RX4;GPRIN1
delta,4,regulation of cell-substrate adhesion (GO:0010810),2/34,2,34,0.130817209274134,0.42733512607512,0,0,3.17107975265578,6.4498312327237,TBCD;CORO1C
delta,4,transcription initiation from RNA polymerase I promoter (GO:0006361),2/34,2,34,0.130817209274134,0.42733512607512,0,0,3.17107975265578,6.4498312327237,POLR1A;UBTF
delta,4,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay (GO:0043928),2/34,2,34,0.130817209274134,0.42733512607512,0,0,3.17107975265578,6.4498312327237,HBS1L;LSM6
delta,4,regulation of DNA recombination (GO:0000018),2/34,2,34,0.130817209274134,0.42733512607512,0,0,3.17107975265578,6.4498312327237,KDM1A;THOC1
delta,4,transcription from RNA polymerase I promoter (GO:0006360),2/34,2,34,0.130817209274134,0.42733512607512,0,0,3.17107975265578,6.4498312327237,POLR1A;UBTF
delta,4,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),2/34,2,34,0.130817209274134,0.42733512607512,0,0,3.17107975265578,6.4498312327237,WDR81;PIK3R1
delta,4,positive regulation of nucleocytoplasmic transport (GO:0046824),2/34,2,34,0.130817209274134,0.42733512607512,0,0,3.17107975265578,6.4498312327237,NCBP2;PRKCD
delta,4,negative regulation of protein serine/threonine kinase activity (GO:0071901),3/68,3,68,0.132226901288227,0.42733512607512,0,0,2.37830981449183,4.81188175743958,LATS2;PKIA;PRKCD
delta,4,negative regulation of protein binding (GO:0032091),3/68,3,68,0.132226901288227,0.42733512607512,0,0,2.37830981449183,4.81188175743958,KDM1A;PRKCD;B2M
delta,4,insulin receptor signaling pathway (GO:0008286),3/68,3,68,0.132226901288227,0.42733512607512,0,0,2.37830981449183,4.81188175743958,IDE;PIK3R1;PIK3C2A
delta,4,cellular response to UV (GO:0034644),3/68,3,68,0.132226901288227,0.42733512607512,0,0,2.37830981449183,4.81188175743958,HIST3H2A;KDM1A;XPA
delta,4,cellular protein complex assembly (GO:0043623),5/145,5,145,0.133026112997595,0.42733512607512,0,0,1.85890882052235,3.74980914899982,POGZ;CLTC;TBCD;PTGES3L;PIK3C2A
delta,4,neuron development (GO:0048666),5/145,5,145,0.133026112997595,0.42733512607512,0,0,1.85890882052235,3.74980914899982,NLGN1;RYK;GPRIN1;TBCD;RAPGEF2
delta,4,translational elongation (GO:0006414),4/106,4,106,0.134620857089142,0.42733512607512,0,0,2.03427757717541,4.07932241812585,PTCD3;MRPL48;GTPBP2;MRPL13
delta,4,G1/S transition of mitotic cell cycle (GO:0000082),4/106,4,106,0.134620857089142,0.42733512607512,0,0,2.03427757717541,4.07932241812585,ORC4;RANBP1;LATS2;CCNE2
delta,4,COPII-coated vesicle budding (GO:0090114),3/69,3,69,0.136452169945937,0.42733512607512,0,0,2.34384155631079,4.66841938143486,ANKRD28;SEC23A;KLHL12
delta,4,negative regulation of cellular metabolic process (GO:0031324),2/35,2,35,0.137125081495153,0.42733512607512,0,0,3.08047747400847,6.12048291435979,SIRT5;AP1AR
delta,4,regulation of JUN kinase activity (GO:0043506),2/35,2,35,0.137125081495153,0.42733512607512,0,0,3.08047747400847,6.12048291435979,PAK1;TANK
delta,4,response to endoplasmic reticulum stress (GO:0034976),4/107,4,107,0.137940303450521,0.42733512607512,0,0,2.0152656372018,3.9921087661196,ATP2A2;PIK3R1;TANK;ATF3
delta,4,positive regulation of cellular component organization (GO:0051130),4/107,4,107,0.137940303450521,0.42733512607512,0,0,2.0152656372018,3.9921087661196,CAMK2B;NLGN1;FAF1;PRKCD
delta,4,Golgi to lysosome transport (GO:0090160),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,GAK
delta,4,histone H2A-K119 monoubiquitination (GO:0036353),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,BMI1
delta,4,stress-induced premature senescence (GO:0090400),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,MAPKAPK5
delta,4,positive regulation of membrane potential (GO:0045838),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,GLRX
delta,4,cellular response to angiotensin (GO:1904385),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,PRKCD
delta,4,positive regulation of protein localization to Cajal body (GO:1904871),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,CCT4
delta,4,cellular response to interleukin-21 (GO:0098757),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,STAT4
delta,4,establishment of integrated proviral latency (GO:0075713),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,XRCC6
delta,4,negative regulation of anion transmembrane transport (GO:1903960),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,STK39
delta,4,negative regulation of platelet aggregation (GO:0090331),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,PRKCD
delta,4,positive regulation of behavior (GO:0048520),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,NLGN1
delta,4,translocation of molecules into host (GO:0044417),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,THOC1
delta,4,negative regulation of potassium ion transmembrane transporter activity (GO:1901017),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,STK39
delta,4,interleukin-21-mediated signaling pathway (GO:0038114),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,STAT4
delta,4,negative regulation of execution phase of apoptosis (GO:1900118),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,PAK2
delta,4,negative regulation of glucose import (GO:0046325),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,PEA15
delta,4,protein K6-linked ubiquitination (GO:0085020),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,BARD1
delta,4,negative regulation of protein complex disassembly (GO:0043242),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,CLEC16A
delta,4,regulation of endodeoxyribonuclease activity (GO:0032071),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,PRKCD
delta,4,positive regulation of early endosome to late endosome transport (GO:2000643),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,EZR
delta,4,excitatory synapse assembly (GO:1904861),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,NLGN1
delta,4,plasma membrane to endosome transport (GO:0048227),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,COMMD1
delta,4,positive regulation of cAMP-mediated signaling (GO:0043950),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,RAPGEF2
delta,4,positive regulation of spindle checkpoint (GO:0090232),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,DYNC1LI1
delta,4,insulin metabolic process (GO:1901142),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,IDE
delta,4,regulation of toll-like receptor 2 signaling pathway (GO:0034135),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,TNFAIP3
delta,4,TORC1 signaling (GO:0038202),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,CLEC16A
delta,4,response to hydroxyurea (GO:0072710),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,ATRX
delta,4,kinetochore assembly (GO:0051382),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,POGZ
delta,4,diol biosynthetic process (GO:0034312),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,SPHK1
delta,4,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,EPHA4
delta,4,sphingosine biosynthetic process (GO:0046512),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,SPHK1
delta,4,positive regulation of mRNA 3'-end processing (GO:0031442),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,NCBP2
delta,4,positive regulation of vasculogenesis (GO:2001214),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,RAPGEF2
delta,4,fatty acid alpha-oxidation (GO:0001561),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,HACL1
delta,4,ventricular trabecula myocardium morphogenesis (GO:0003222),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,RBPJ
delta,4,negative regulation of neuron projection regeneration (GO:0070571),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,EPHA4
delta,4,negative regulation of cAMP-dependent protein kinase activity (GO:2000480),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,PKIA
delta,4,negative regulation of bone remodeling (GO:0046851),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,TNFAIP3
delta,4,regulation of protein localization to Cajal body (GO:1904869),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,CCT4
delta,4,positive regulation of TORC1 signaling (GO:1904263),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,CLEC16A
delta,4,positive regulation of protein homodimerization activity (GO:0090073),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,TANK
delta,4,phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,PIK3C2A
delta,4,ribosome disassembly (GO:0032790),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,MRRF
delta,4,nose development (GO:0043584),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,SMCHD1
delta,4,histone H3-K36 demethylation (GO:0070544),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,KDM4C
delta,4,viral mRNA export from host cell nucleus (GO:0046784),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,THOC1
delta,4,telomeric D-loop disassembly (GO:0061820),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,RECQL4
delta,4,arginine catabolic process (GO:0006527),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,OAT
delta,4,regulation of receptor binding (GO:1900120),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,B2M
delta,4,cellular monovalent inorganic anion homeostasis (GO:0030320),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,GPCPD1
delta,4,regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),1/8,1,8,0.139136841071423,0.42733512607512,0,0,6.73854447439353,13.2904134904492,ATP2A2
delta,4,regulation of innate immune response (GO:0045088),3/70,3,70,0.140723223323905,0.42733512607512,0,0,2.31035810550635,4.53052046101264,TNFAIP3;PARP9;BIRC2
delta,4,mitochondrial translation (GO:0032543),4/108,4,108,0.141292497192007,0.42733512607512,0,0,1.99660577019068,3.90720393157682,PTCD3;MRPL48;MRPL13;MRRF
delta,4,cellular response to starvation (GO:0009267),4/108,4,108,0.141292497192007,0.42733512607512,0,0,1.99660577019068,3.90720393157682,PLEKHF2;TBL2;MIOS;CLEC16A
delta,4,positive regulation of cell cycle process (GO:0090068),4/108,4,108,0.141292497192007,0.42733512607512,0,0,1.99660577019068,3.90720393157682,DYNC1LI1;NUP62;ATRX;NUSAP1
delta,4,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",2/36,2,36,0.143498466422728,0.42733512607512,0,0,2.99490865528601,5.81440829826056,HBS1L;LSM6
delta,4,regulation of microtubule polymerization (GO:0031113),2/36,2,36,0.143498466422728,0.42733512607512,0,0,2.99490865528601,5.81440829826056,PAK1;TBCD
delta,4,regulation of endothelial cell apoptotic process (GO:2000351),2/36,2,36,0.143498466422728,0.42733512607512,0,0,2.99490865528601,5.81440829826056,KRIT1;TNFAIP3
delta,4,anatomical structure homeostasis (GO:0060249),2/36,2,36,0.143498466422728,0.42733512607512,0,0,2.99490865528601,5.81440829826056,RECQL4;XRCC6
delta,4,negative regulation of epithelial cell migration (GO:0010633),2/36,2,36,0.143498466422728,0.42733512607512,0,0,2.99490865528601,5.81440829826056,KRIT1;CORO1C
delta,4,regulation of mitotic spindle organization (GO:0060236),2/36,2,36,0.143498466422728,0.42733512607512,0,0,2.99490865528601,5.81440829826056,CLTC;NUP62
delta,4,regulation of sodium ion transport (GO:0002028),2/36,2,36,0.143498466422728,0.42733512607512,0,0,2.99490865528601,5.81440829826056,P2RX4;ATP1A1
delta,4,positive regulation of ATPase activity (GO:0032781),2/36,2,36,0.143498466422728,0.42733512607512,0,0,2.99490865528601,5.81440829826056,DNAJB1;DYNLL2
delta,4,regulation of phosphoprotein phosphatase activity (GO:0043666),2/36,2,36,0.143498466422728,0.42733512607512,0,0,2.99490865528601,5.81440829826056,PPP1R2;TIPRL
delta,4,regulation of cardiac muscle contraction (GO:0055117),2/36,2,36,0.143498466422728,0.42733512607512,0,0,2.99490865528601,5.81440829826056,P2RX4;ATP2A2
delta,4,neural crest cell development (GO:0014032),2/36,2,36,0.143498466422728,0.42733512607512,0,0,2.99490865528601,5.81440829826056,KLHL12;CORO1C
delta,4,actin filament bundle organization (GO:0061572),2/36,2,36,0.143498466422728,0.42733512607512,0,0,2.99490865528601,5.81440829826056,FSCN3;EZR
delta,4,Rab protein signal transduction (GO:0032482),3/71,3,71,0.145038713142121,0.42733512607512,0,0,2.27781785049922,4.39790725866731,RAB4A;RAB28;RAB5A
delta,4,nuclear import (GO:0051170),3/72,3,72,0.149397292057374,0.42733512607512,0,0,2.24618149146451,4.27031925404388,RANBP1;NUP62;TNPO3
delta,4,muscle cell differentiation (GO:0042692),2/37,2,37,0.149932781591855,0.42733512607512,0,0,2.91396517811612,5.52944768133996,DDX17;KDM1A
delta,4,regulation of response to DNA damage stimulus (GO:2001020),2/37,2,37,0.149932781591855,0.42733512607512,0,0,2.91396517811612,5.52944768133996,ETAA1;PRKCD
delta,4,organophosphate biosynthetic process (GO:0090407),2/37,2,37,0.149932781591855,0.42733512607512,0,0,2.91396517811612,5.52944768133996,GNPAT;G6PD
delta,4,calcium ion transmembrane import into cytosol (GO:0097553),2/37,2,37,0.149932781591855,0.42733512607512,0,0,2.91396517811612,5.52944768133996,GPRIN1;CHERP
delta,4,endosome organization (GO:0007032),2/37,2,37,0.149932781591855,0.42733512607512,0,0,2.91396517811612,5.52944768133996,PI4K2B;LAPTM4B
delta,4,centromere complex assembly (GO:0034508),2/37,2,37,0.149932781591855,0.42733512607512,0,0,2.91396517811612,5.52944768133996,POGZ;OIP5
delta,4,viral gene expression (GO:0019080),4/111,4,111,0.151539692462164,0.42733512607512,0,0,1.94264345207741,3.66558887233989,RPL30;RPL32;RPLP1;NUP62
delta,4,cellular response to insulin stimulus (GO:0032869),4/111,4,111,0.151539692462164,0.42733512607512,0,0,1.94264345207741,3.66558887233989,PKM;PIK3R1;IDE;PIK3C2A
delta,4,lysosomal transport (GO:0007041),3/73,3,73,0.153797614684665,0.42733512607512,0,0,2.21541188199239,4.1475118662629,GAK;DTX3L;CLEC16A
delta,4,Rho protein signal transduction (GO:0007266),3/73,3,73,0.153797614684665,0.42733512607512,0,0,2.21541188199239,4.1475118662629,PAK1;PAK2;CTNNAL1
delta,4,inositol metabolic process (GO:0006020),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,ITPK1
delta,4,alanine transport (GO:0032328),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,SLC1A4
delta,4,regulation of organ growth (GO:0046620),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,LATS2
delta,4,galactose catabolic process (GO:0019388),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,PGM2L1
delta,4,anoikis (GO:0043276),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,IKBKG
delta,4,negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,TNFAIP3
delta,4,postsynaptic membrane assembly (GO:0097104),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,NLGN1
delta,4,negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,NFATC3
delta,4,sarcoplasmic reticulum calcium ion transport (GO:0070296),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,ATP2A2
delta,4,mature B cell differentiation involved in immune response (GO:0002313),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,DOCK11
delta,4,positive regulation of synapse maturation (GO:0090129),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,CAMK2B
delta,4,regulation of morphogenesis of an epithelium (GO:1905330),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,AJAP1
delta,4,ionotropic glutamate receptor signaling pathway (GO:0035235),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,GPRIN1
delta,4,negative regulation of mRNA 3'-end processing (GO:0031441),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,BARD1
delta,4,positive regulation of ion transmembrane transport (GO:0034767),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,STK39
delta,4,positive regulation of leukocyte apoptotic process (GO:2000108),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,RAPGEF2
delta,4,maintenance of protein localization in endoplasmic reticulum (GO:0035437),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,GPAA1
delta,4,ATP synthesis coupled electron transport (GO:0042773),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,NDUFS2
delta,4,central nervous system neuron development (GO:0021954),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,RAPGEF2
delta,4,regulation of endoplasmic reticulum unfolded protein response (GO:1900101),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,PIK3R1
delta,4,sphingoid biosynthetic process (GO:0046520),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,SPHK1
delta,4,establishment of viral latency (GO:0019043),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,XRCC6
delta,4,endosome to pigment granule transport (GO:0043485),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,AP1M1
delta,4,nicotinamide nucleotide biosynthetic process (GO:0019359),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,NMNAT3
delta,4,heterochromatin organization (GO:0070828),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,SNAI1
delta,4,regulation of skeletal muscle cell differentiation (GO:2001014),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,DDX17
delta,4,peptidyl-amino acid modification (GO:0018193),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,METAP1D
delta,4,positive regulation of establishment of protein localization to telomere (GO:1904851),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,CCT4
delta,4,interleukin-23-mediated signaling pathway (GO:0038155),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,STAT4
delta,4,regulation of organ morphogenesis (GO:2000027),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,AJAP1
delta,4,postsynaptic density organization (GO:0097106),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,NLGN1
delta,4,negative regulation of interferon-beta production (GO:0032688),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,RELB
delta,4,protein hexamerization (GO:0034214),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,OAT
delta,4,granulocyte activation (GO:0036230),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,PRKCD
delta,4,ether lipid metabolic process (GO:0046485),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,GNPAT
delta,4,potassium ion import across plasma membrane (GO:1990573),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,ATP1A1
delta,4,hexose catabolic process (GO:0019320),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,PGM2L1
delta,4,endosome to melanosome transport (GO:0035646),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,AP1M1
delta,4,proline transport (GO:0015824),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,SLC1A4
delta,4,negative regulation of potassium ion transmembrane transport (GO:1901380),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,STK39
delta,4,negative regulation of microtubule polymerization (GO:0031115),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,TBCD
delta,4,nuclear RNA surveillance (GO:0071027),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,EXOSC10
delta,4,proton-transporting V-type ATPase complex assembly (GO:0070070),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,DMXL2
delta,4,lipoprotein biosynthetic process (GO:0042158),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,WIPI2
delta,4,cytoskeletal anchoring at plasma membrane (GO:0007016),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,EZR
delta,4,sphingosine metabolic process (GO:0006670),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,SPHK1
delta,4,histone phosphorylation (GO:0016572),1/9,1,9,0.155112219505861,0.42733512607512,0,0,5.98981731057203,11.1626620377966,PRKCD
delta,4,protein monoubiquitination (GO:0006513),2/38,2,38,0.156423591137485,0.42733512607512,0,0,2.83728188395517,5.26369023626313,DTX3L;KLHL12
delta,4,regulation of dendrite development (GO:0050773),2/38,2,38,0.156423591137485,0.42733512607512,0,0,2.83728188395517,5.26369023626313,CAMK2B;SDC2
delta,4,regulation of sodium ion transmembrane transporter activity (GO:2000649),2/38,2,38,0.156423591137485,0.42733512607512,0,0,2.83728188395517,5.26369023626313,STK39;GLRX
delta,4,protein K63-linked ubiquitination (GO:0070534),2/38,2,38,0.156423591137485,0.42733512607512,0,0,2.83728188395517,5.26369023626313,UBE2G1;TANK
delta,4,regulation of peptidyl-threonine phosphorylation (GO:0010799),2/38,2,38,0.156423591137485,0.42733512607512,0,0,2.83728188395517,5.26369023626313,RIPK2;SPHK1
delta,4,negative regulation of G0 to G1 transition (GO:0070317),2/38,2,38,0.156423591137485,0.42733512607512,0,0,2.83728188395517,5.26369023626313,MGA;BMI1
delta,4,regulation of carbohydrate catabolic process (GO:0043470),2/38,2,38,0.156423591137485,0.42733512607512,0,0,2.83728188395517,5.26369023626313,NUP62;ECD
delta,4,actin filament bundle assembly (GO:0051017),2/38,2,38,0.156423591137485,0.42733512607512,0,0,2.83728188395517,5.26369023626313,FSCN3;EZR
delta,4,nucleic acid phosphodiester bond hydrolysis (GO:0090305),3/74,3,74,0.158238338544118,0.42733512607512,0,0,2.18547388358709,4.02925528686019,UBB;XPA;CHD1L
delta,4,canonical Wnt signaling pathway (GO:0060070),3/74,3,74,0.158238338544118,0.42733512607512,0,0,2.18547388358709,4.02925528686019,RYK;TMEM64;RAB5A
delta,4,viral transcription (GO:0019083),4/114,4,114,0.162060252377146,0.42733512607512,0,0,1.89152125597011,3.44216595194389,RPL30;RPL32;RPLP1;NUP62
delta,4,positive regulation of canonical Wnt signaling pathway (GO:0090263),4/114,4,114,0.162060252377146,0.42733512607512,0,0,1.89152125597011,3.44216595194389,PSMA5;PSMD12;UBB;PSMD1
delta,4,"regulation of gene expression, epigenetic (GO:0040029)",3/75,3,75,0.162718125067199,0.42733512607512,0,0,2.15633423180593,3.91533341066664,CREBZF;POLR1A;BMI1
delta,4,glucose homeostasis (GO:0042593),3/75,3,75,0.162718125067199,0.42733512607512,0,0,2.15633423180593,3.91533341066664,MBD5;HECTD4;PIK3R1
delta,4,mitotic nuclear division (GO:0140014),3/75,3,75,0.162718125067199,0.42733512607512,0,0,2.15633423180593,3.91533341066664,NUP62;NUSAP1;BIRC2
delta,4,regulation of defense response (GO:0031347),3/76,3,76,0.167235640469119,0.42733512607512,0,0,2.12796141296638,3.80554285788036,ELMOD2;TNFAIP3;BIRC2
delta,4,regulation of proteasomal protein catabolic process (GO:0061136),2/40,2,40,0.169557660145673,0.42733512607512,0,0,2.69541778975741,4.78318660959143,UBB;COMMD1
delta,4,ERBB2 signaling pathway (GO:0038128),2/40,2,40,0.169557660145673,0.42733512607512,0,0,2.69541778975741,4.78318660959143,UBB;PIK3R1
delta,4,purine ribonucleoside monophosphate metabolic process (GO:0009167),2/40,2,40,0.169557660145673,0.42733512607512,0,0,2.69541778975741,4.78318660959143,ATIC;GMPR2
delta,4,positive regulation of reactive oxygen species metabolic process (GO:2000379),2/40,2,40,0.169557660145673,0.42733512607512,0,0,2.69541778975741,4.78318660959143,GPRIN1;PRKCD
delta,4,regulation of G0 to G1 transition (GO:0070316),2/40,2,40,0.169557660145673,0.42733512607512,0,0,2.69541778975741,4.78318660959143,MGA;BMI1
delta,4,Golgi to plasma membrane transport (GO:0006893),2/40,2,40,0.169557660145673,0.42733512607512,0,0,2.69541778975741,4.78318660959143,COMMD1;EXOC5
delta,4,regulation of coenzyme metabolic process (GO:0051196),2/40,2,40,0.169557660145673,0.42733512607512,0,0,2.69541778975741,4.78318660959143,NUP62;ECD
delta,4,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,SEC14L1
delta,4,low-density lipoprotein particle receptor catabolic process (GO:0032802),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,CLTC
delta,4,regulation of synapse maturation (GO:0090128),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,CAMK2B
delta,4,negative regulation of cellular protein catabolic process (GO:1903363),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,EPHA4
delta,4,vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,DMXL2
delta,4,cellular response to growth hormone stimulus (GO:0071378),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,PIK3R1
delta,4,regulation of sequestering of zinc ion (GO:0061088),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,SLC30A1
delta,4,positive regulation of cytoplasmic transport (GO:1903651),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,EZR
delta,4,"energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)",1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,ATP1A1
delta,4,protein K11-linked deubiquitination (GO:0035871),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,TNFAIP3
delta,4,phosphatidylglycerol biosynthetic process (GO:0006655),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,CDS1
delta,4,presynaptic membrane assembly (GO:0097105),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,NLGN1
delta,4,establishment of spindle localization (GO:0051293),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,NUSAP1
delta,4,N-acetylneuraminate metabolic process (GO:0006054),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,NANP
delta,4,cellular biogenic amine metabolic process (GO:0006576),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,SMS
delta,4,positive regulation of amyloid-beta formation (GO:1902004),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,EPHA4
delta,4,mesoderm morphogenesis (GO:0048332),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,SNAI1
delta,4,galactose metabolic process (GO:0006012),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,PGM2L1
delta,4,nerve growth factor signaling pathway (GO:0038180),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,RAPGEF2
delta,4,aspartate family amino acid metabolic process (GO:0009066),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,SMS
delta,4,positive regulation of glucose import in response to insulin stimulus (GO:2001275),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,PIK3R1
delta,4,negative regulation of inclusion body assembly (GO:0090084),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,DNAJB1
delta,4,positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,PAK1
delta,4,Rap protein signal transduction (GO:0032486),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,RAPGEF2
delta,4,protein localization to synapse (GO:0035418),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,NLGN1
delta,4,response to muramyl dipeptide (GO:0032495),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,RIPK2
delta,4,regulation of establishment of protein localization to telomere (GO:0070203),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,CCT4
delta,4,cellular response to ATP (GO:0071318),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,P2RX4
delta,4,central nervous system projection neuron axonogenesis (GO:0021952),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,EPHA4
delta,4,motor neuron axon guidance (GO:0008045),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,EPHA4
delta,4,nuclear mRNA surveillance (GO:0071028),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,EXOSC10
delta,4,insulin-like growth factor receptor signaling pathway (GO:0048009),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,PIK3R1
delta,4,DNA replication-dependent nucleosome assembly (GO:0006335),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,CHAF1B
delta,4,positive regulation of circadian rhythm (GO:0042753),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,NLGN1
delta,4,ectoderm development (GO:0007398),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,STX2
delta,4,neuron projection fasciculation (GO:0106030),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,EPHA4
delta,4,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,DNAJB1
delta,4,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,STK39
delta,4,UV protection (GO:0009650),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,XPA
delta,4,regulation of astrocyte differentiation (GO:0048710),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,EPHA4
delta,4,DNA replication-dependent nucleosome organization (GO:0034723),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,CHAF1B
delta,4,protein kinase A signaling (GO:0010737),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,EZR
delta,4,negative regulation of homotypic cell-cell adhesion (GO:0034111),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,PRKCD
delta,4,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,RYK
delta,4,endothelial tube morphogenesis (GO:0061154),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,RBPJ
delta,4,regulation of dendritic cell apoptotic process (GO:2000668),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,RAPGEF2
delta,4,telomeric loop disassembly (GO:0090657),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,RECQL4
delta,4,histone H2B ubiquitination (GO:0033523),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,DTX3L
delta,4,regulation of axon regeneration (GO:0048679),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,EPHA4
delta,4,negative regulation of glucose transport (GO:0010829),1/10,1,10,0.170791921230688,0.42733512607512,0,0,5.39083557951483,9.52727384545802,PEA15
delta,4,positive regulation of JNK cascade (GO:0046330),3/77,3,77,0.171789556497642,0.427861468538362,0,0,2.10032555046032,3.69969207827468,PAK1;GADD45B;TANK
delta,4,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),3/77,3,77,0.171789556497642,0.427861468538362,0,0,2.10032555046032,3.69969207827468,PEA15;TNFAIP3;TANK
delta,4,regulation of macroautophagy (GO:0016241),4/117,4,117,0.172837723998415,0.427861468538362,0,0,1.84302071094524,3.23524249316906,TBK1;CLEC16A;IKBKG;RAB5A
delta,4,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),4/117,4,117,0.172837723998415,0.427861468538362,0,0,1.84302071094524,3.23524249316906,EPHA4;RIPK2;PARP9;PAK2
delta,4,cellular response to interferon-gamma (GO:0071346),4/117,4,117,0.172837723998415,0.427861468538362,0,0,1.84302071094524,3.23524249316906,CAMK2B;PRKCD;HLA-B;B2M
delta,4,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),2/41,2,41,0.176192746915999,0.427861468538362,0,0,2.62967589244626,4.56558209257688,GPRC5A;UBB
delta,4,response to cAMP (GO:0051591),2/41,2,41,0.176192746915999,0.427861468538362,0,0,2.62967589244626,4.56558209257688,RAPGEF2;EZR
delta,4,neuron migration (GO:0001764),2/41,2,41,0.176192746915999,0.427861468538362,0,0,2.62967589244626,4.56558209257688,RAPGEF2;MDGA1
delta,4,plasma membrane bounded cell projection organization (GO:0120036),4/119,4,119,0.180157174776709,0.427861468538362,0,0,1.81204557294616,3.10571132464951,NLGN1;RYK;GPRIN1;RAPGEF2
delta,4,cytosolic transport (GO:0016482),4/119,4,119,0.180157174776709,0.427861468538362,0,0,1.81204557294616,3.10571132464951,GAK;WDR81;CLTC;RAB5A
delta,4,regulation of cellular response to heat (GO:1900034),3/79,3,79,0.181001310655243,0.427861468538362,0,0,2.04715275171449,3.49909790143643,CAMK2B;DNAJB1;NUP62
delta,4,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),2/42,2,42,0.182867975505825,0.427861468538362,0,0,2.56706456167373,4.36141915500189,NLGN1;CDH24
delta,4,telomere organization (GO:0032200),2/42,2,42,0.182867975505825,0.427861468538362,0,0,2.56706456167373,4.36141915500189,RECQL4;XRCC6
delta,4,cellular response to peptide (GO:1901653),2/42,2,42,0.182867975505825,0.427861468538362,0,0,2.56706456167373,4.36141915500189,EPHA4;RIPK2
delta,4,regulation of phosphorylation (GO:0042325),4/120,4,120,0.183855364046592,0.427861468538362,0,0,1.79694519317161,3.04331697295308,BARD1;ECD;NUP62;CORO1C
delta,4,brain development (GO:0007420),4/120,4,120,0.183855364046592,0.427861468538362,0,0,1.79694519317161,3.04331697295308,SRR;GPRIN1;RAPGEF2;MDGA1
delta,4,cell-cell junction assembly (GO:0007043),3/80,3,80,0.185656527492026,0.427861468538362,0,0,2.02156334231806,3.40402346113005,GJD3;TBCD;CDH24
delta,4,formation of extrachromosomal circular DNA (GO:0001325),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,SMARCAL1
delta,4,L-phenylalanine metabolic process (GO:0006558),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,IL4I1
delta,4,L-phenylalanine catabolic process (GO:0006559),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,IL4I1
delta,4,regulation of histone H3-K9 methylation (GO:0051570),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,ATRX
delta,4,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,CCT4
delta,4,postsynapse assembly (GO:0099068),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,NLGN1
delta,4,negative regulation of protein localization to nucleus (GO:1900181),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,POLR1A
delta,4,positive regulation by host of viral process (GO:0044794),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,YTHDC2
delta,4,positive regulation of superoxide anion generation (GO:0032930),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,PRKCD
delta,4,regulation of lamellipodium morphogenesis (GO:2000392),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,CORO1C
delta,4,protein localization to pre-autophagosomal structure (GO:0034497),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,WIPI2
delta,4,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,PRKCD
delta,4,cell-substrate junction assembly (GO:0007044),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,LAMC1
delta,4,regulation of mitotic centrosome separation (GO:0046602),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,RANBP1
delta,4,biotin metabolic process (GO:0006768),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,BTD
delta,4,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,TANK
delta,4,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,ATF3
delta,4,phosphatidylinositol dephosphorylation (GO:0046856),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,SACM1L
delta,4,regulation of ceramide biosynthetic process (GO:2000303),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,PRKCD
delta,4,sphingolipid catabolic process (GO:0030149),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,SPHK1
delta,4,negative regulation of protein localization to cell surface (GO:2000009),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,COMMD1
delta,4,negative regulation of nucleocytoplasmic transport (GO:0046823),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,BARD1
delta,4,histone mRNA catabolic process (GO:0071044),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,EXOSC10
delta,4,negative regulation of receptor binding (GO:1900121),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,B2M
delta,4,positive regulation of fatty acid biosynthetic process (GO:0045723),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,ELOVL5
delta,4,methionine metabolic process (GO:0006555),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,SMS
delta,4,negative regulation of potassium ion transport (GO:0043267),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,STK39
delta,4,phosphate ion homeostasis (GO:0055062),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,GPCPD1
delta,4,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,KDM1A
delta,4,t-circle formation (GO:0090656),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,SMARCAL1
delta,4,negative regulation of cardiac muscle hypertrophy (GO:0010614),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,P2RX4
delta,4,regulation of synaptic vesicle cycle (GO:0098693),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,RAB5A
delta,4,modulation by host of viral genome replication (GO:0044827),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,YTHDC2
delta,4,carbohydrate phosphorylation (GO:0046835),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,ITPK1
delta,4,inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,BIRC2
delta,4,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,GLRX
delta,4,"regulation of synaptic transmission, GABAergic (GO:0032228)",1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,NLGN1
delta,4,low-density lipoprotein receptor particle metabolic process (GO:0032799),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,CLTC
delta,4,hemidesmosome assembly (GO:0031581),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,LAMC1
delta,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,IL4I1
delta,4,regulation of autophagosome maturation (GO:1901096),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,CLEC16A
delta,4,telomere maintenance via telomere trimming (GO:0090737),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,SMARCAL1
delta,4,presynaptic membrane organization (GO:0097090),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,NLGN1
delta,4,midbrain dopaminergic neuron differentiation (GO:1904948),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,RYK
delta,4,interleukin-35-mediated signaling pathway (GO:0070757),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,STAT4
delta,4,cardiac muscle cell membrane repolarization (GO:0099622),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,ATP1A1
delta,4,hepatocyte growth factor receptor signaling pathway (GO:0048012),1/11,1,11,0.18618140399258,0.427861468538362,0,0,4.90075961774075,8.23834251542668,PAK1
delta,4,macromolecular complex assembly (GO:0065003),4/121,4,121,0.187578356798697,0.42997630961226,0,0,1.78209440645118,2.98243945190332,GPAA1;LAMC1;TEAD1;TANK
delta,4,DNA replication (GO:0006260),4/121,4,121,0.187578356798697,0.42997630961226,0,0,1.78209440645118,2.98243945190332,BARD1;RECQL4;ORC4;POLG
delta,4,ERBB signaling pathway (GO:0038127),3/81,3,81,0.19034290382332,0.435207349172711,0,0,1.99660577019068,3.31222536981902,UBB;PIK3R1;PIK3C2A
delta,4,nucleic acid metabolic process (GO:0090304),3/81,3,81,0.19034290382332,0.435207349172711,0,0,1.99660577019068,3.31222536981902,SMARCAL1;NCBP2;POLG
delta,4,response to hydrogen peroxide (GO:0042542),2/44,2,44,0.196323949063914,0.436967496161505,0,0,2.45037980887038,3.98919182253887,PRKCD;TNFAIP3
delta,4,regulation of ATP metabolic process (GO:1903578),2/44,2,44,0.196323949063914,0.436967496161505,0,0,2.45037980887038,3.98919182253887,NUP62;ECD
delta,4,substantia nigra development (GO:0021762),2/44,2,44,0.196323949063914,0.436967496161505,0,0,2.45037980887038,3.98919182253887,G6PD;ZNF148
delta,4,negative regulation of NF-kappaB transcription factor activity (GO:0032088),3/83,3,83,0.199803989487208,0.436967496161505,0,0,1.94849478777644,3.13789194731969,LRRC14;TNFAIP3;COMMD1
delta,4,mitotic sister chromatid segregation (GO:0000070),3/83,3,83,0.199803989487208,0.436967496161505,0,0,1.94849478777644,3.13789194731969,POGZ;NUP62;NUSAP1
delta,4,regulation of systemic arterial blood pressure (GO:0003073),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,PLCB3
delta,4,regulation of vasculogenesis (GO:2001212),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,RAPGEF2
delta,4,axonal fasciculation (GO:0007413),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,EPHA4
delta,4,regulation of inclusion body assembly (GO:0090083),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,DNAJB1
delta,4,import across plasma membrane (GO:0098739),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,ATP1A1
delta,4,ribose phosphate metabolic process (GO:0019693),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,G6PD
delta,4,protein localization to kinetochore (GO:0034501),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,MTBP
delta,4,positive regulation of establishment of protein localization (GO:1904951),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,CCT4
delta,4,pentose-phosphate shunt (GO:0006098),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,G6PD
delta,4,modification-dependent macromolecule catabolic process (GO:0043632),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,NEDD8
delta,4,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,KDM1A
delta,4,amino sugar biosynthetic process (GO:0046349),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,NANP
delta,4,regulation of cytokine biosynthetic process (GO:0042035),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,IGF2BP2
delta,4,viral RNA genome replication (GO:0039694),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,RAB5A
delta,4,entry of bacterium into host cell (GO:0035635),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,UBB
delta,4,cellular response to arsenic-containing substance (GO:0071243),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,ATF3
delta,4,mitochondrion transport along microtubule (GO:0047497),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,UBB
delta,4,positive regulation of amyloid precursor protein catabolic process (GO:1902993),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,EPHA4
delta,4,"alternative mRNA splicing, via spliceosome (GO:0000380)",1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,DDX17
delta,4,polyamine metabolic process (GO:0006595),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,SMS
delta,4,positive regulation of ruffle assembly (GO:1900029),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,NLGN1
delta,4,cargo loading into COPII-coated vesicle (GO:0090110),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,SEC23A
delta,4,vasoconstriction (GO:0042310),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,PIK3C2A
delta,4,regulation of skeletal muscle tissue development (GO:0048641),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,DDX17
delta,4,activation of cysteine-type endopeptidase activity (GO:0097202),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,RIPK2
delta,4,kinetochore organization (GO:0051383),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,POGZ
delta,4,positive regulation of peptidase activity (GO:0010952),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,TANK
delta,4,purine nucleoside monophosphate biosynthetic process (GO:0009127),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,ATIC
delta,4,positive regulation of DNA-dependent DNA replication (GO:2000105),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,ATRX
delta,4,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,PIK3R1
delta,4,L-serine metabolic process (GO:0006563),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,SRR
delta,4,PERK-mediated unfolded protein response (GO:0036499),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,ATF3
delta,4,prostanoid metabolic process (GO:0006692),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,ACOX1
delta,4,endosome transport via multivesicular body sorting pathway (GO:0032509),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,LAPTM4B
delta,4,membrane repolarization during action potential (GO:0086011),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,ATP1A1
delta,4,positive regulation of neuron migration (GO:2001224),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,RAPGEF2
delta,4,regulation of catabolic process (GO:0009894),1/12,1,12,0.201286025116525,0.436967496161505,0,0,4.49236298292902,7.20138531856731,FAF1
delta,4,regulation of focal adhesion assembly (GO:0051893),2/45,2,45,0.203097548444842,0.437217156795339,0,0,2.39592692422881,3.81927255141994,SLK;CORO1C
delta,4,adherens junction organization (GO:0034332),2/45,2,45,0.203097548444842,0.437217156795339,0,0,2.39592692422881,3.81927255141994,TBCD;CDH24
delta,4,unsaturated fatty acid metabolic process (GO:0033559),2/45,2,45,0.203097548444842,0.437217156795339,0,0,2.39592692422881,3.81927255141994,ELOVL5;ACOX1
delta,4,positive regulation of macroautophagy (GO:0016239),2/45,2,45,0.203097548444842,0.437217156795339,0,0,2.39592692422881,3.81927255141994,TBK1;IKBKG
delta,4,regulation of smooth muscle cell proliferation (GO:0048660),2/45,2,45,0.203097548444842,0.437217156795339,0,0,2.39592692422881,3.81927255141994,XRCC6;TNFAIP3
delta,4,carboxylic acid biosynthetic process (GO:0046394),2/45,2,45,0.203097548444842,0.437217156795339,0,0,2.39592692422881,3.81927255141994,NANP;OAT
delta,4,posttranscriptional regulation of gene expression (GO:0010608),2/45,2,45,0.203097548444842,0.437217156795339,0,0,2.39592692422881,3.81927255141994,MAPKAPK5;PARP9
delta,4,negative regulation of signaling (GO:0023057),3/84,3,84,0.204576151237255,0.438829223343647,0,0,1.92529842125529,3.05509240494101,EPHA4;RYK;AP1AR
delta,4,positive regulation of peptidyl-serine phosphorylation (GO:0033138),3/84,3,84,0.204576151237255,0.438829223343647,0,0,1.92529842125529,3.05509240494101,PAK1;TBK1;RIPK2
delta,4,positive regulation of homeostatic process (GO:0032846),3/84,3,84,0.204576151237255,0.438829223343647,0,0,1.92529842125529,3.05509240494101,P2RX4;GPRIN1;ATRX
delta,4,activation of GTPase activity (GO:0090630),3/85,3,85,0.20937437845145,0.444273952633863,0,0,1.90264785159347,2.97503981924332,RUNDC1;TBC1D9;CORO1C
delta,4,regulation of mitotic nuclear division (GO:0007088),3/85,3,85,0.20937437845145,0.444273952633863,0,0,1.90264785159347,2.97503981924332,NUP62;NUSAP1;MAD2L1BP
delta,4,positive regulation of blood vessel endothelial cell migration (GO:0043536),2/46,2,46,0.209896992007642,0.444273952633863,0,0,2.34384155631079,3.65906101688846,P2RX4;PIK3C2A
delta,4,negative regulation of ossification (GO:0030279),2/46,2,46,0.209896992007642,0.444273952633863,0,0,2.34384155631079,3.65906101688846,TMEM64;RBPJ
delta,4,vesicle organization (GO:0016050),4/128,4,128,0.214280671625303,0.444273952633863,0,0,1.68463611859838,2.59512899871848,PI4K2B;LAPTM4B;SYT12;STX2
delta,4,protein lipidation (GO:0006497),4/128,4,128,0.214280671625303,0.444273952633863,0,0,1.68463611859838,2.59512899871848,ZDHHC9;WIPI2;ULBP2;MDGA1
delta,4,sodium ion export from cell (GO:0036376),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,ATP1A1
delta,4,regulation of superoxide anion generation (GO:0032928),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,PRKCD
delta,4,glycerolipid catabolic process (GO:0046503),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,GPCPD1
delta,4,regulation of NMDA receptor activity (GO:2000310),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,NLGN1
delta,4,muscle cell development (GO:0055001),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,KDM1A
delta,4,chromatin assembly or disassembly (GO:0006333),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,CHAF1B
delta,4,regulation of glucose import in response to insulin stimulus (GO:2001273),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,PIK3R1
delta,4,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,GPRC5A
delta,4,regulation of macromolecule biosynthetic process (GO:0010556),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,IGF2BP2
delta,4,tricarboxylic acid metabolic process (GO:0072350),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,ACO1
delta,4,multivesicular body sorting pathway (GO:0071985),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,LAPTM4B
delta,4,serine family amino acid biosynthetic process (GO:0009070),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,SRR
delta,4,sodium ion export (GO:0071436),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,ATP1A1
delta,4,positive regulation of endothelial cell chemotaxis (GO:2001028),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,P2RX4
delta,4,cellular potassium ion homeostasis (GO:0030007),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,ATP1A1
delta,4,copper ion homeostasis (GO:0055070),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,COMMD1
delta,4,synaptic vesicle localization (GO:0097479),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,NLGN1
delta,4,leukocyte differentiation (GO:0002521),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,RELB
delta,4,positive regulation of muscle contraction (GO:0045933),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,SPHK1
delta,4,membrane repolarization (GO:0086009),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,ATP1A1
delta,4,protein neddylation (GO:0045116),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,NEDD8
delta,4,regulation of endothelial cell chemotaxis (GO:2001026),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,P2RX4
delta,4,negative regulation of ubiquitin-protein transferase activity (GO:0051444),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,DTX3L
delta,4,regulation of synaptic vesicle transport (GO:1902803),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,RAB5A
delta,4,ribonucleoprotein complex disassembly (GO:0032988),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,MRRF
delta,4,protein kinase C-activating G-protein coupled receptor signaling pathway (GO:0007205),1/13,1,13,0.216111043344056,0.444273952633863,0,0,4.14679659962679,6.35273860186987,PRKD3
delta,4,interleukin-12-mediated signaling pathway (GO:0035722),2/47,2,47,0.216719001284811,0.444273952633863,0,0,2.29397258702759,3.50783664514831,STAT4;PAK2
delta,4,tRNA aminoacylation for protein translation (GO:0006418),2/47,2,47,0.216719001284811,0.444273952633863,0,0,2.29397258702759,3.50783664514831,LRRC47;IARS
delta,4,pyruvate metabolic process (GO:0006090),2/47,2,47,0.216719001284811,0.444273952633863,0,0,2.29397258702759,3.50783664514831,SRR;PKM
delta,4,cellular response to interleukin-12 (GO:0071349),2/47,2,47,0.216719001284811,0.444273952633863,0,0,2.29397258702759,3.50783664514831,STAT4;PAK2
delta,4,regulation of generation of precursor metabolites and energy (GO:0043467),2/47,2,47,0.216719001284811,0.444273952633863,0,0,2.29397258702759,3.50783664514831,NUP62;ECD
delta,4,regulation of fibroblast proliferation (GO:0048145),2/47,2,47,0.216719001284811,0.444273952633863,0,0,2.29397258702759,3.50783664514831,SPHK1;BMI1
delta,4,regulation of DNA metabolic process (GO:0051052),2/47,2,47,0.216719001284811,0.444273952633863,0,0,2.29397258702759,3.50783664514831,THOC1;SMG6
delta,4,regulation of peptidyl-serine phosphorylation (GO:0033135),3/87,3,87,0.219044056664223,0.448530622272711,0,0,1.85890882052235,2.82272032236314,PAK1;TBK1;RIPK2
delta,4,regulation of macromolecule metabolic process (GO:0060255),4/130,4,130,0.222097051382817,0.451806257961377,0,0,1.65871863985072,2.49577578146225,EIF4A2;DDX46;MOK;BMI1
delta,4,polyol metabolic process (GO:0019751),2/48,2,48,0.223560410038433,0.451806257961377,0,0,2.24618149146451,3.36494521664611,PLCB3;ITPK1
delta,4,regulation of organelle assembly (GO:1902115),2/48,2,48,0.223560410038433,0.451806257961377,0,0,2.24618149146451,3.36494521664611,EZR;RAB5A
delta,4,fatty acid biosynthetic process (GO:0006633),2/48,2,48,0.223560410038433,0.451806257961377,0,0,2.24618149146451,3.36494521664611,ELOVL4;ELOVL5
delta,4,histone H4 acetylation (GO:0043967),2/48,2,48,0.223560410038433,0.451806257961377,0,0,2.24618149146451,3.36494521664611,MSL2;DMAP1
delta,4,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),2/48,2,48,0.223560410038433,0.451806257961377,0,0,2.24618149146451,3.36494521664611,NLGN1;ALCAM
delta,4,inositol phosphate metabolic process (GO:0043647),2/48,2,48,0.223560410038433,0.451806257961377,0,0,2.24618149146451,3.36494521664611,PLCB3;ITPK1
delta,4,mitochondrial translational elongation (GO:0070125),3/88,3,88,0.223913051709012,0.451806257961377,0,0,1.83778485665278,2.75024037826784,PTCD3;MRPL48;MRPL13
delta,4,generation of neurons (GO:0048699),4/131,4,131,0.226033269167479,0.451806257961377,0,0,1.64605666550071,2.44780655844667,RYK;ADNP2;RAPGEF2;MDGA1
delta,4,endosome to lysosome transport (GO:0008333),2/49,2,49,0.230418161072304,0.451806257961377,0,0,2.20034105286319,3.22979158186548,DTX3L;CLEC16A
delta,4,cytoplasmic microtubule organization (GO:0031122),2/49,2,49,0.230418161072304,0.451806257961377,0,0,2.20034105286319,3.22979158186548,SLK;EZR
delta,4,interstrand cross-link repair (GO:0036297),2/49,2,49,0.230418161072304,0.451806257961377,0,0,2.20034105286319,3.22979158186548,UBB;XPA
delta,4,amino acid transport (GO:0006865),2/49,2,49,0.230418161072304,0.451806257961377,0,0,2.20034105286319,3.22979158186548,SLC1A4;SLC7A11
delta,4,neuron cell-cell adhesion (GO:0007158),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,NLGN1
delta,4,regulation of fibroblast migration (GO:0010762),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,CORO1C
delta,4,ribonucleoside monophosphate biosynthetic process (GO:0009156),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,ATIC
delta,4,positive regulation of cardiac muscle cell proliferation (GO:0060045),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,RBPJ
delta,4,stem cell development (GO:0048864),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,KLHL12
delta,4,regulation of platelet aggregation (GO:0090330),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,PRKCD
delta,4,modified amino acid transport (GO:0072337),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,SLC1A4
delta,4,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,ATP1A1
delta,4,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,KDM1A
delta,4,negative regulation of focal adhesion assembly (GO:0051895),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,CORO1C
delta,4,cardiac left ventricle morphogenesis (GO:0003214),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,RBPJ
delta,4,purine-containing compound salvage (GO:0043101),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,GMPR2
delta,4,amyloid-beta metabolic process (GO:0050435),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,IDE
delta,4,smooth muscle contraction (GO:0006939),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,PIK3C2A
delta,4,response to ethanol (GO:0045471),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,GPRIN1
delta,4,neutrophil activation (GO:0042119),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,PRKCD
delta,4,Golgi to vacuole transport (GO:0006896),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,GAK
delta,4,regulation of transferase activity (GO:0051338),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,SMG6
delta,4,cellular response to nitrogen compound (GO:1901699),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,ATRX
delta,4,positive regulation of heart rate (GO:0010460),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,ATP2A2
delta,4,histone H4-K16 acetylation (GO:0043984),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,MSL2
delta,4,positive regulation of calcium ion-dependent exocytosis (GO:0045956),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,NLGN1
delta,4,regulation of response to interferon-gamma (GO:0060330),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,PARP9
delta,4,negative regulation of T cell receptor signaling pathway (GO:0050860),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,EZR
delta,4,positive regulation of smooth muscle contraction (GO:0045987),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,SPHK1
delta,4,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,DYNC1LI1
delta,4,response to ATP (GO:0033198),1/14,1,14,0.230661620611102,0.451806257961377,0,0,3.85059684251059,5.64806888038233,P2RX4
delta,4,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),3/90,3,90,0.233713309165878,0.454605817082968,0,0,1.79694519317161,2.61214750991751,RPL30;RPL32;RPLP1
delta,4,non-recombinational repair (GO:0000726),2/50,2,50,0.237289303335131,0.454605817082968,0,0,2.15633423180593,3.10183330049492,BARD1;XRCC6
delta,4,protein heterooligomerization (GO:0051291),2/50,2,50,0.237289303335131,0.454605817082968,0,0,2.15633423180593,3.10183330049492,XRCC6;GPRIN1
delta,4,organic hydroxy compound biosynthetic process (GO:1901617),2/50,2,50,0.237289303335131,0.454605817082968,0,0,2.15633423180593,3.10183330049492,OSBPL6;OSBP
delta,4,protein autoubiquitination (GO:0051865),2/50,2,50,0.237289303335131,0.454605817082968,0,0,2.15633423180593,3.10183330049492,DTX3L;TANK
delta,4,protein tetramerization (GO:0051262),3/91,3,91,0.238642193647414,0.454605817082968,0,0,1.7771985426972,2.54635220496556,SRR;XRCC6;GPRIN1
delta,4,lipid transport (GO:0006869),3/92,3,92,0.24358868633789,0.454605817082968,0,0,1.7578811672331,2.48261019775516,ABCA3;OSBP;PLEKHA8
delta,4,positive regulation of JUN kinase activity (GO:0043507),2/51,2,51,0.244170989093447,0.454605817082968,0,0,2.11405316843719,2.98057507350334,PAK1;TANK
delta,4,negative regulation of protein ubiquitination (GO:0031397),2/51,2,51,0.244170989093447,0.454605817082968,0,0,2.11405316843719,2.98057507350334,DTX3L;TNFAIP3
delta,4,receptor internalization (GO:0031623),2/51,2,51,0.244170989093447,0.454605817082968,0,0,2.11405316843719,2.98057507350334,CLTC;RAB5A
delta,4,double-strand break repair via nonhomologous end joining (GO:0006303),2/51,2,51,0.244170989093447,0.454605817082968,0,0,2.11405316843719,2.98057507350334,BARD1;XRCC6
delta,4,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,PARP9
delta,4,membrane repolarization during cardiac muscle cell action potential (GO:0086013),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,ATP1A1
delta,4,regulation of mRNA metabolic process (GO:1903311),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,SLTM
delta,4,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,ACOX1
delta,4,negative regulation of adherens junction organization (GO:1903392),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,CORO1C
delta,4,embryonic axis specification (GO:0000578),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,RIPPLY2
delta,4,mitotic sister chromatid cohesion (GO:0007064),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,POGZ
delta,4,response to X-ray (GO:0010165),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,XRCC6
delta,4,"protein localization to chromosome, telomeric region (GO:0070198)",1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,ATRX
delta,4,transport along microtubule (GO:0010970),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,DYNLL2
delta,4,positive regulation of protein import (GO:1904591),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,PRKCD
delta,4,"protein localization to chromosome, centromeric region (GO:0071459)",1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,MTBP
delta,4,regulation of establishment of cell polarity (GO:2000114),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,KRIT1
delta,4,intracellular lipid transport (GO:0032365),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,PLEKHA8
delta,4,glycerophospholipid catabolic process (GO:0046475),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,GPCPD1
delta,4,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,CCT4
delta,4,regulation of centriole replication (GO:0046599),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,NUP62
delta,4,presynapse assembly (GO:0099054),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,NLGN1
delta,4,mitotic chromosome condensation (GO:0007076),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,NUSAP1
delta,4,cellular response to virus (GO:0098586),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,LGALS8
delta,4,negative regulation of cellular component movement (GO:0051271),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,CRK
delta,4,cellular biogenic amine biosynthetic process (GO:0042401),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,SMS
delta,4,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,ACOX1
delta,4,neural crest cell differentiation (GO:0014033),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,KLHL12
delta,4,N-terminal protein amino acid acetylation (GO:0006474),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,NAA16
delta,4,regulation of exit from mitosis (GO:0007096),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,MAD2L1BP
delta,4,mesenchymal cell development (GO:0014031),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,KLHL12
delta,4,positive regulation of cellular response to insulin stimulus (GO:1900078),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,PIK3R1
delta,4,negative regulation of platelet activation (GO:0010544),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,PRKCD
delta,4,positive regulation of collagen metabolic process (GO:0010714),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,LARP6
delta,4,positive regulation of NF-kappaB import into nucleus (GO:0042346),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,SPHK1
delta,4,filopodium assembly (GO:0046847),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,EZR
delta,4,negative regulation of mRNA processing (GO:0050686),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,BARD1
delta,4,positive regulation of collagen biosynthetic process (GO:0032967),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,LARP6
delta,4,regulation of protein complex disassembly (GO:0043244),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,CLEC16A
delta,4,regulation of RNA export from nucleus (GO:0046831),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,NCBP2
delta,4,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,TANK
delta,4,endoderm development (GO:0007492),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,LAMC1
delta,4,inhibition of cysteine-type endopeptidase activity (GO:0097340),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,BIRC2
delta,4,cellular sodium ion homeostasis (GO:0006883),1/15,1,15,0.244942823838495,0.454605817082968,0,0,3.59389038634322,5.05563510426124,ATP1A1
delta,4,peptidyl-tyrosine modification (GO:0018212),2/52,2,52,0.251060471126623,0.464526246064029,0,0,2.07339829981339,2.86556385661189,EPHA4;FYN
delta,4,negative regulation of neuron projection development (GO:0010977),2/52,2,52,0.251060471126623,0.464526246064029,0,0,2.07339829981339,2.86556385661189,GAK;EPHA4
delta,4,carboxylic acid transport (GO:0046942),2/52,2,52,0.251060471126623,0.464526246064029,0,0,2.07339829981339,2.86556385661189,SLC1A4;SLC7A11
delta,4,cotranslational protein targeting to membrane (GO:0006613),3/94,3,94,0.253529894566245,0.465301958635673,0,0,1.72047944027069,2.36096840446308,RPL30;RPL32;RPLP1
delta,4,regulation of calcium ion transport (GO:0051924),2/53,2,53,0.257955099970207,0.465301958635673,0,0,2.03427757717541,2.75638456050231,CAMK2B;P2RX4
delta,4,plasma membrane bounded cell projection morphogenesis (GO:0120039),2/53,2,53,0.257955099970207,0.465301958635673,0,0,2.03427757717541,2.75638456050231,PAK1;UBB
delta,4,positive regulation of nervous system development (GO:0051962),2/53,2,53,0.257955099970207,0.465301958635673,0,0,2.03427757717541,2.75638456050231,CAMK2B;NLGN1
delta,4,positive regulation of secretion by cell (GO:1903532),2/53,2,53,0.257955099970207,0.465301958635673,0,0,2.03427757717541,2.75638456050231,EZR;RAB5A
delta,4,response to cytokine (GO:0034097),4/139,4,139,0.258112955905197,0.465301958635673,0,0,1.55131959122729,2.10104206214879,TBK1;YTHDC2;NFKB2;RELB
delta,4,negative regulation of NF-kappaB import into nucleus (GO:0042347),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,FAF1
delta,4,postsynaptic membrane organization (GO:0001941),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,NLGN1
delta,4,positive regulation of cardiac muscle tissue growth (GO:0055023),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,RBPJ
delta,4,positive regulation of dendrite morphogenesis (GO:0050775),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,CAMK2B
delta,4,glucose 6-phosphate metabolic process (GO:0051156),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,G6PD
delta,4,histone H2A acetylation (GO:0043968),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,DMAP1
delta,4,activation of NF-kappaB-inducing kinase activity (GO:0007250),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,TANK
delta,4,cytoplasmic sequestering of transcription factor (GO:0042994),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,FAF1
delta,4,regulation of reactive oxygen species biosynthetic process (GO:1903426),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,GPRIN1
delta,4,protein deacylation (GO:0035601),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,SIRT5
delta,4,negative regulation of steroid biosynthetic process (GO:0010894),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,SNAI1
delta,4,positive regulation of mRNA processing (GO:0050685),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,NCBP2
delta,4,guanosine-containing compound metabolic process (GO:1901068),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,GMPR2
delta,4,regulation of bicellular tight junction assembly (GO:2000810),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,SNAI1
delta,4,miRNA metabolic process (GO:0010586),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,DDX17
delta,4,regulation of protein homodimerization activity (GO:0043496),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,TANK
delta,4,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,PIK3C2A
delta,4,cardiac epithelial to mesenchymal transition (GO:0060317),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,RBPJ
delta,4,aorta morphogenesis (GO:0035909),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,RBPJ
delta,4,myoblast differentiation (GO:0045445),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,DDX17
delta,4,linoleic acid metabolic process (GO:0043651),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,ELOVL5
delta,4,positive regulation of response to endoplasmic reticulum stress (GO:1905898),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,PIK3R1
delta,4,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),1/16,1,16,0.258959626646461,0.465301958635673,0,0,3.36927223719677,4.55216681639928,SNAI1
delta,4,positive regulation of protein localization to membrane (GO:1905477),3/96,3,96,0.263527877224327,0.46677543410111,0,0,1.68463611859838,2.24662419251847,FYN;PIK3R1;DYNLL2
delta,4,regulation of heart contraction (GO:0008016),3/96,3,96,0.263527877224327,0.46677543410111,0,0,1.68463611859838,2.24662419251847,P2RX4;ATP2A2;ATP1A1
delta,4,regulation of calcium ion-dependent exocytosis (GO:0017158),2/54,2,54,0.264852321235012,0.46677543410111,0,0,1.99660577019068,2.65265625774515,SYT12;RAB5A
delta,4,embryonic organ development (GO:0048568),2/54,2,54,0.264852321235012,0.46677543410111,0,0,1.99660577019068,2.65265625774515,RBPJ;TEAD1
delta,4,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),4/141,4,141,0.26627404272504,0.46677543410111,0,0,1.52931505801839,2.023634439748,LRRC14;KDM1A;TNFAIP3;COMMD1
delta,4,regulation of cellular component organization (GO:0051128),4/141,4,141,0.26627404272504,0.46677543410111,0,0,1.52931505801839,2.023634439748,RAB4A;RAPGEF2;QRICH1;RAB5A
delta,4,positive regulation of protein metabolic process (GO:0051247),3/97,3,97,0.268545394326079,0.46677543410111,0,0,1.66726873593242,2.19201708327781,BARD1;TNFAIP3;IDE
delta,4,cell morphogenesis involved in differentiation (GO:0000904),2/55,2,55,0.271749673080095,0.46677543410111,0,0,1.9603038470963,2.55402882822577,TBCD;LAMC1
delta,4,cellular response to nutrient levels (GO:0031669),2/55,2,55,0.271749673080095,0.46677543410111,0,0,1.9603038470963,2.55402882822577,PLEKHF2;CLEC16A
delta,4,intracellular transport of virus (GO:0075733),2/55,2,55,0.271749673080095,0.46677543410111,0,0,1.9603038470963,2.55402882822577,UBB;NUP62
delta,4,transport of virus (GO:0046794),2/55,2,55,0.271749673080095,0.46677543410111,0,0,1.9603038470963,2.55402882822577,UBB;NUP62
delta,4,negative regulation of supramolecular fiber organization (GO:1902904),2/55,2,55,0.271749673080095,0.46677543410111,0,0,1.9603038470963,2.55402882822577,PRKCD;TBCD
delta,4,regulation of cellular protein catabolic process (GO:1903362),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,EZR
delta,4,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,EZR
delta,4,regulation of toll-like receptor 4 signaling pathway (GO:0034143),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,TNFAIP3
delta,4,regulation of telomere maintenance via telomere lengthening (GO:1904356),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,SMG6
delta,4,positive regulation of fatty acid metabolic process (GO:0045923),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,ELOVL5
delta,4,negative regulation of telomere maintenance (GO:0032205),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,SMG6
delta,4,histone H2A ubiquitination (GO:0033522),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,DTX3L
delta,4,negative regulation of B cell activation (GO:0050869),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,TNFAIP3
delta,4,DNA packaging (GO:0006323),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,CHAF1B
delta,4,"mRNA cis splicing, via spliceosome (GO:0045292)",1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,NCBP2
delta,4,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,SLC39A10
delta,4,histone H2A monoubiquitination (GO:0035518),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,BMI1
delta,4,negative regulation of reactive oxygen species metabolic process (GO:2000378),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,SIRT5
delta,4,maturation of 5.8S rRNA (GO:0000460),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,EXOSC10
delta,4,positive regulation of cellular protein catabolic process (GO:1903364),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,EZR
delta,4,negative regulation of phosphoprotein phosphatase activity (GO:0032515),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,TIPRL
delta,4,rRNA catabolic process (GO:0016075),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,EXOSC10
delta,4,regulation of collagen biosynthetic process (GO:0032965),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,LARP6
delta,4,regulation of receptor recycling (GO:0001919),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,AP1AR
delta,4,regulation of protein localization to membrane (GO:1905475),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,FYN
delta,4,response to purine-containing compound (GO:0014074),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,P2RX4
delta,4,phospholipid catabolic process (GO:0009395),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,GPCPD1
delta,4,positive regulation of signal transduction by p53 class mediator (GO:1901798),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,UBB
delta,4,regulation of transcription from RNA polymerase I promoter (GO:0006356),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,UBTF
delta,4,virion assembly (GO:0019068),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,UBB
delta,4,neurotrophin signaling pathway (GO:0038179),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,RAPGEF2
delta,4,serine family amino acid metabolic process (GO:0009069),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,SRR
delta,4,chaperone-mediated protein complex assembly (GO:0051131),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,PTGES3L
delta,4,regulation of establishment or maintenance of cell polarity (GO:0032878),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,KRIT1
delta,4,synaptic vesicle transport (GO:0048489),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,RAB5A
delta,4,regulation of B cell receptor signaling pathway (GO:0050855),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,SLC39A10
delta,4,detection of mechanical stimulus (GO:0050982),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,PKD2L2
delta,4,regulation of early endosome to late endosome transport (GO:2000641),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,EZR
delta,4,cellular response to inorganic substance (GO:0071241),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,ATRX
delta,4,nucleobase-containing compound biosynthetic process (GO:0034654),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,GMPR2
delta,4,platelet-derived growth factor receptor signaling pathway (GO:0048008),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,PIK3C2A
delta,4,positive regulation of transcription of Notch receptor target (GO:0007221),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,RBPJ
delta,4,cellular monovalent inorganic cation homeostasis (GO:0030004),1/17,1,17,0.27271691105464,0.46677543410111,0,0,3.17107975265578,4.12025044443209,ATP1A1
delta,4,protein targeting to ER (GO:0045047),3/98,3,98,0.273573818007895,0.467355272430154,0,0,1.6502557896474,2.13903480757192,RPL30;RPL32;RPLP1
delta,4,cellular response to organonitrogen compound (GO:0071417),3/98,3,98,0.273573818007895,0.467355272430154,0,0,1.6502557896474,2.13903480757192,P2RX4;RAPGEF2;EZR
delta,4,long-chain fatty acid metabolic process (GO:0001676),2/56,2,56,0.278644783556572,0.475118326593625,0,0,1.92529842125529,2.4601799875935,ELOVL5;ACOX1
delta,4,regulation of axonogenesis (GO:0050770),2/56,2,56,0.278644783556572,0.475118326593625,0,0,1.92529842125529,2.4601799875935,EPHA4;PAK1
delta,4,chromosome organization (GO:0051276),2/57,2,57,0.285535368265028,0.477208800950505,0,0,1.89152125597011,2.37081264618114,UBB;XPA
delta,4,DNA-dependent DNA replication (GO:0006261),2/57,2,57,0.285535368265028,0.477208800950505,0,0,1.89152125597011,2.37081264618114,ORC4;POLG
delta,4,glucan catabolic process (GO:0009251),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,PGM2L1
delta,4,regulation of multicellular organism growth (GO:0040014),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,MBD5
delta,4,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,ELOVL5
delta,4,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,NLGN1
delta,4,regulation of amyloid-beta formation (GO:1902003),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,EPHA4
delta,4,receptor localization to synapse (GO:0097120),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,NLGN1
delta,4,cardiac muscle cell contraction (GO:0086003),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,ATP1A1
delta,4,positive regulation of lipid catabolic process (GO:0050996),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,PRKCD
delta,4,endoplasmic reticulum calcium ion homeostasis (GO:0032469),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,ATP2A2
delta,4,anterior/posterior axis specification (GO:0009948),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,RIPPLY2
delta,4,establishment of mitotic spindle localization (GO:0040001),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,NUSAP1
delta,4,regulation of dephosphorylation (GO:0035303),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,SMG6
delta,4,negative regulation of protein dephosphorylation (GO:0035308),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,TIPRL
delta,4,regulation of cardiac muscle cell proliferation (GO:0060043),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,RBPJ
delta,4,heart trabecula morphogenesis (GO:0061384),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,RBPJ
delta,4,positive regulation of p38MAPK cascade (GO:1900745),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,GADD45B
delta,4,glycogen catabolic process (GO:0005980),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,PGM2L1
delta,4,regulation of cAMP-mediated signaling (GO:0043949),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,RAPGEF2
delta,4,regulation of epithelial cell differentiation (GO:0030856),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,AJAP1
delta,4,glyceraldehyde-3-phosphate metabolic process (GO:0019682),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,G6PD
delta,4,response to organophosphorus (GO:0046683),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,P2RX4
delta,4,DNA ligation (GO:0006266),1/18,1,18,0.286219469306234,0.477208800950505,0,0,2.99490865528601,3.74661990789898,XRCC6
delta,4,regulation of glycolytic process (GO:0006110),2/58,2,58,0.292419227811686,0.486646021192142,0,0,1.85890882052235,2.28565256004948,NUP62;ECD
delta,4,epidermal growth factor receptor signaling pathway (GO:0007173),2/58,2,58,0.292419227811686,0.486646021192142,0,0,1.85890882052235,2.28565256004948,PIK3R1;PIK3C2A
delta,4,regulation of protein kinase activity (GO:0045859),4/148,4,148,0.295174454759035,0.486709457091211,0,0,1.45698258905806,1.77779372822808,XRCC6;RPLP1;RAPGEF2;PAK2
delta,4,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),2/59,2,59,0.299294245641139,0.486709457091211,0,0,1.82740189136096,2.20444623393542,UBB;NUP62
delta,4,post-Golgi vesicle-mediated transport (GO:0006892),2/59,2,59,0.299294245641139,0.486709457091211,0,0,1.82740189136096,2.20444623393542,COMMD1;EXOC5
delta,4,positive regulation of chromosome organization (GO:2001252),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,ATRX
delta,4,negative regulation of lymphocyte activation (GO:0051250),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,TNFAIP3
delta,4,protein ADP-ribosylation (GO:0006471),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,PARP9
delta,4,error-free translesion synthesis (GO:0070987),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,UBB
delta,4,negative regulation of cell junction assembly (GO:1901889),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,CORO1C
delta,4,negative regulation of protein localization to plasma membrane (GO:1903077),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,CLTC
delta,4,positive regulation of heart contraction (GO:0045823),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,ATP2A2
delta,4,NADP metabolic process (GO:0006739),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,G6PD
delta,4,regulation of long-term synaptic potentiation (GO:1900271),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,EPHA4
delta,4,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,EPHA4
delta,4,acylglycerol biosynthetic process (GO:0046463),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,GNPAT
delta,4,purine ribonucleoside bisphosphate metabolic process (GO:0034035),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,BPNT1
delta,4,nucleosome disassembly (GO:0006337),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,HIST3H2A
delta,4,chromatin disassembly (GO:0031498),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,HIST3H2A
delta,4,intracellular estrogen receptor signaling pathway (GO:0030520),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,DDX17
delta,4,regulation of neuron migration (GO:2001222),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,RAPGEF2
delta,4,negative regulation of protein localization to cell periphery (GO:1904376),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,CLTC
delta,4,calcium ion transport into cytosol (GO:0060402),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,GPRIN1
delta,4,positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,TEAD1
delta,4,DNA double-strand break processing (GO:0000729),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,BARD1
delta,4,negative regulation of calcium ion transport (GO:0051926),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,SLC30A1
delta,4,telomere capping (GO:0016233),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,TEN1
delta,4,triglyceride biosynthetic process (GO:0019432),1/19,1,19,0.299472005194703,0.486709457091211,0,0,2.83728188395517,3.42100819293344,GNPAT
delta,4,cell junction assembly (GO:0034329),2/60,2,60,0.306158385423536,0.496225670268833,0,0,1.79694519317161,2.12695905034108,TBCD;CDH24
delta,4,regulation of extrinsic apoptotic signaling pathway (GO:2001236),2/60,2,60,0.306158385423536,0.496225670268833,0,0,1.79694519317161,2.12695905034108,TANK;PAK2
delta,4,regulation of cellular response to stress (GO:0080135),3/105,3,105,0.30899085074866,0.496225670268833,0,0,1.54023873700424,1.80892354524512,CAMK2B;DNAJB1;NUP62
delta,4,vacuolar acidification (GO:0007035),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,DMXL2
delta,4,negative regulation of innate immune response (GO:0045824),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,TNFAIP3
delta,4,positive regulation of interleukin-2 production (GO:0032743),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,TANK
delta,4,Golgi to endosome transport (GO:0006895),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,AP1AR
delta,4,mesoderm formation (GO:0001707),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,SNAI1
delta,4,negative regulation of intracellular protein transport (GO:0090317),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,BARD1
delta,4,negative regulation of macromolecule biosynthetic process (GO:0010558),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,CLTC
delta,4,cellular polysaccharide catabolic process (GO:0044247),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,PGM2L1
delta,4,endoplasmic reticulum mannose trimming (GO:1904380),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,UBB
delta,4,error-prone translesion synthesis (GO:0042276),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,UBB
delta,4,"regulation of DNA-templated transcription, elongation (GO:0032784)",1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,THOC1
delta,4,regulation of calcium ion transmembrane transport (GO:1903169),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,FYN
delta,4,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,RAPGEF2
delta,4,autophagy of nucleus (GO:0044804),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,WIPI2
delta,4,excitatory postsynaptic potential (GO:0060079),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,GPRIN1
delta,4,regulation of response to cytokine stimulus (GO:0060759),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,PARP9
delta,4,growth hormone receptor signaling pathway (GO:0060396),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,PIK3R1
delta,4,organelle disassembly (GO:1903008),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,MRRF
delta,4,adrenergic receptor signaling pathway (GO:0071875),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,RAPGEF2
delta,4,telomere maintenance via telomerase (GO:0007004),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,SMG6
delta,4,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,PRKCD
delta,4,cellular response to steroid hormone stimulus (GO:0071383),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,ATP1A1
delta,4,dopaminergic neuron differentiation (GO:0071542),1/20,1,20,0.312479136045119,0.496225670268833,0,0,2.69541778975741,3.13535734956917,RYK
delta,4,positive regulation of cellular catabolic process (GO:0031331),3/107,3,107,0.319150239802014,0.504942074882783,0,0,1.51144922790135,1.72621606051321,DTX3L;PRKCD;EZR
delta,4,fatty acid metabolic process (GO:0006631),3/107,3,107,0.319150239802014,0.504942074882783,0,0,1.51144922790135,1.72621606051321,GNPAT;ELOVL4;ACOX1
delta,4,actin cytoskeleton reorganization (GO:0031532),2/62,2,62,0.319846274971672,0.504942074882783,0,0,1.73897921919833,1.98228813029558,PAK1;EZR
delta,4,regulation of vesicle fusion (GO:0031338),2/62,2,62,0.319846274971672,0.504942074882783,0,0,1.73897921919833,1.98228813029558,RUNDC1;TBC1D9
delta,4,protein targeting to membrane (GO:0006612),2/62,2,62,0.319846274971672,0.504942074882783,0,0,1.73897921919833,1.98228813029558,ZDHHC9;ZDHHC4
delta,4,regulation of response to external stimulus (GO:0032101),3/108,3,108,0.324231888971199,0.504942074882783,0,0,1.49745432764301,1.68657728733824,ELMOD2;TNFAIP3;BIRC2
delta,4,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,RBPJ
delta,4,positive regulation of transcription from RNA polymerase I promoter (GO:0045943),1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,UBTF
delta,4,RNA-dependent DNA biosynthetic process (GO:0006278),1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,SMG6
delta,4,regulation of ruffle assembly (GO:1900027),1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,NLGN1
delta,4,histone ubiquitination (GO:0016574),1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,DTX3L
delta,4,negative regulation of ion transmembrane transporter activity (GO:0032413),1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,STK39
delta,4,negative regulation of macroautophagy (GO:0016242),1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,CLEC16A
delta,4,regulation of cardiac muscle hypertrophy (GO:0010611),1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,P2RX4
delta,4,zinc II ion transport (GO:0006829),1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,SLC30A1
delta,4,positive regulation of lamellipodium organization (GO:1902745),1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,CORO1C
delta,4,vesicle docking (GO:0048278),1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,STX2
delta,4,negative regulation of protein tyrosine kinase activity (GO:0061099),1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,GPRC5A
delta,4,aromatic amino acid family catabolic process (GO:0009074),1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,IL4I1
delta,4,positive regulation of BMP signaling pathway (GO:0030513),1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,RBPJ
delta,4,protein-DNA complex disassembly (GO:0032986),1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,HIST3H2A
delta,4,cellular response to alkaloid (GO:0071312),1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,CASP6
delta,4,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,LATS2
delta,4,mitochondrial calcium ion transmembrane transport (GO:0006851),1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,MICU3
delta,4,"synaptic transmission, glutamatergic (GO:0035249)",1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,SLC1A4
delta,4,glutamate metabolic process (GO:0006536),1/21,1,21,0.325245394131815,0.504942074882783,0,0,2.56706456167373,2.88326356744658,OAT
delta,4,regulation of actin filament-based process (GO:0032970),2/63,2,63,0.326666334457555,0.506276690173049,0,0,1.71137637444915,1.91471529192284,PRKCD;CRK
delta,4,regulation of translational initiation (GO:0006446),2/63,2,63,0.326666334457555,0.506276690173049,0,0,1.71137637444915,1.91471529192284,EIF4A2;NCBP2
delta,4,nucleotide-excision repair (GO:0006289),3/109,3,109,0.32931363457339,0.50819657550932,0,0,1.48371621454536,1.64802990045212,UBB;XPA;CHD1L
delta,4,"DNA-templated transcription, elongation (GO:0006354)",3/109,3,109,0.32931363457339,0.50819657550932,0,0,1.48371621454536,1.64802990045212,NCBP2;POLR1A;UBTF
delta,4,monocarboxylic acid metabolic process (GO:0032787),3/109,3,109,0.32931363457339,0.50819657550932,0,0,1.48371621454536,1.64802990045212,GNPAT;GRHPR;BTD
delta,4,regulation of cytokine production (GO:0001817),3/109,3,109,0.32931363457339,0.50819657550932,0,0,1.48371621454536,1.64802990045212,TBK1;UBB;IGF2BP2
delta,4,negative regulation of hydrolase activity (GO:0051346),3/109,3,109,0.32931363457339,0.50819657550932,0,0,1.48371621454536,1.64802990045212,PLEKHF2;WDR81;ELFN2
delta,4,synapse assembly (GO:0007416),2/64,2,64,0.333468131271059,0.510768241023169,0,0,1.68463611859838,1.85008082311333,NLGN1;RYK
delta,4,negative regulation of protein modification process (GO:0031400),2/64,2,64,0.333468131271059,0.510768241023169,0,0,1.68463611859838,1.85008082311333,G6PD;CORO1C
delta,4,carbohydrate homeostasis (GO:0033500),2/64,2,64,0.333468131271059,0.510768241023169,0,0,1.68463611859838,1.85008082311333,MBD5;HECTD4
delta,4,positive regulation of cell projection organization (GO:0031346),2/64,2,64,0.333468131271059,0.510768241023169,0,0,1.68463611859838,1.85008082311333,CAMK2B;RAPGEF2
delta,4,Wnt signaling pathway (GO:0016055),3/110,3,110,0.334394592273384,0.510768241023169,0,0,1.47022788532222,1.61053698015234,UBB;RYK;KLHL12
delta,4,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),1/22,1,22,0.337775228126741,0.510768241023169,0,0,2.45037980887038,2.6595800300308,PARP9
delta,4,cellular response to nerve growth factor stimulus (GO:1990090),1/22,1,22,0.337775228126741,0.510768241023169,0,0,2.45037980887038,2.6595800300308,RAPGEF2
delta,4,protein homotrimerization (GO:0070207),1/22,1,22,0.337775228126741,0.510768241023169,0,0,2.45037980887038,2.6595800300308,TANK
delta,4,positive regulation of protein targeting to membrane (GO:0090314),1/22,1,22,0.337775228126741,0.510768241023169,0,0,2.45037980887038,2.6595800300308,FYN
delta,4,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),1/22,1,22,0.337775228126741,0.510768241023169,0,0,2.45037980887038,2.6595800300308,ATP2A2
delta,4,sterol transport (GO:0015918),1/22,1,22,0.337775228126741,0.510768241023169,0,0,2.45037980887038,2.6595800300308,OSBP
delta,4,regulation of DNA biosynthetic process (GO:2000278),1/22,1,22,0.337775228126741,0.510768241023169,0,0,2.45037980887038,2.6595800300308,SMG6
delta,4,sulfur amino acid metabolic process (GO:0000096),1/22,1,22,0.337775228126741,0.510768241023169,0,0,2.45037980887038,2.6595800300308,SMS
delta,4,negative regulation of actin filament polymerization (GO:0030837),1/22,1,22,0.337775228126741,0.510768241023169,0,0,2.45037980887038,2.6595800300308,PRKCD
delta,4,cytosolic calcium ion transport (GO:0060401),1/22,1,22,0.337775228126741,0.510768241023169,0,0,2.45037980887038,2.6595800300308,ATP2A2
delta,4,phosphatidylglycerol metabolic process (GO:0046471),1/22,1,22,0.337775228126741,0.510768241023169,0,0,2.45037980887038,2.6595800300308,CDS1
delta,4,purine-containing compound biosynthetic process (GO:0072522),1/22,1,22,0.337775228126741,0.510768241023169,0,0,2.45037980887038,2.6595800300308,GMPR2
delta,4,STAT cascade (GO:0097696),1/22,1,22,0.337775228126741,0.510768241023169,0,0,2.45037980887038,2.6595800300308,STAT4
delta,4,positive regulation of biosynthetic process (GO:0009891),1/22,1,22,0.337775228126741,0.510768241023169,0,0,2.45037980887038,2.6595800300308,GPRIN1
delta,4,regulation of ERBB signaling pathway (GO:1901184),1/22,1,22,0.337775228126741,0.510768241023169,0,0,2.45037980887038,2.6595800300308,RBPJ
delta,4,viral genome replication (GO:0019079),1/22,1,22,0.337775228126741,0.510768241023169,0,0,2.45037980887038,2.6595800300308,RAB5A
delta,4,positive regulation of RNA splicing (GO:0033120),1/22,1,22,0.337775228126741,0.510768241023169,0,0,2.45037980887038,2.6595800300308,PIK3R1
delta,4,ncRNA catabolic process (GO:0034661),1/22,1,22,0.337775228126741,0.510768241023169,0,0,2.45037980887038,2.6595800300308,EXOSC10
delta,4,regulation of bone resorption (GO:0045124),1/22,1,22,0.337775228126741,0.510768241023169,0,0,2.45037980887038,2.6595800300308,TNFAIP3
delta,4,negative regulation of cytokine production (GO:0001818),3/111,3,111,0.339473894251518,0.511935777990443,0,0,1.45698258905806,1.57406313052167,TBK1;UBB;TNFAIP3
delta,4,cellular response to peptide hormone stimulus (GO:0071375),3/111,3,111,0.339473894251518,0.511935777990443,0,0,1.45698258905806,1.57406313052167,PKM;PRKCD;PIK3R1
delta,4,NADH dehydrogenase complex assembly (GO:0010257),2/65,2,65,0.340249998786331,0.511935777990443,0,0,1.65871863985072,1.78822250220618,NDUFAF4;NDUFS2
delta,4,mitochondrial respiratory chain complex I biogenesis (GO:0097031),2/65,2,65,0.340249998786331,0.511935777990443,0,0,1.65871863985072,1.78822250220618,NDUFAF4;NDUFS2
delta,4,mitochondrial respiratory chain complex I assembly (GO:0032981),2/65,2,65,0.340249998786331,0.511935777990443,0,0,1.65871863985072,1.78822250220618,NDUFAF4;NDUFS2
delta,4,negative regulation of neuron differentiation (GO:0045665),2/65,2,65,0.340249998786331,0.511935777990443,0,0,1.65871863985072,1.78822250220618,GAK;EPHA4
delta,4,cellular response to reactive oxygen species (GO:0034614),2/66,2,66,0.347010338036003,0.517224980130793,0,0,1.63358653924692,1.72898914786916,PRKCD;TNFAIP3
delta,4,DNA synthesis involved in DNA repair (GO:0000731),2/66,2,66,0.347010338036003,0.517224980130793,0,0,1.63358653924692,1.72898914786916,BARD1;UBB
delta,4,regulation of protein oligomerization (GO:0032459),1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,IDE
delta,4,chromosome condensation (GO:0030261),1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,NUSAP1
delta,4,"nucleotide-excision repair, DNA gap filling (GO:0006297)",1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,UBB
delta,4,melanosome organization (GO:0032438),1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,AP1M1
delta,4,glycolytic process (GO:0006096),1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,PKM
delta,4,cell-cell adhesion mediated by cadherin (GO:0044331),1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,CDH24
delta,4,positive regulation of protein oligomerization (GO:0032461),1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,IDE
delta,4,TOR signaling (GO:0031929),1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,TIPRL
delta,4,protein K48-linked deubiquitination (GO:0071108),1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,TNFAIP3
delta,4,cellular nitrogen compound biosynthetic process (GO:0044271),1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,SPHK1
delta,4,cellular response to ammonium ion (GO:0071242),1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,CASP6
delta,4,regulation of smooth muscle contraction (GO:0006940),1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,SPHK1
delta,4,protein localization to Golgi apparatus (GO:0034067),1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,GAK
delta,4,negative regulation of axonogenesis (GO:0050771),1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,EPHA4
delta,4,divalent inorganic cation homeostasis (GO:0072507),1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,GPRIN1
delta,4,cellular response to amyloid-beta (GO:1904646),1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,EPHA4
delta,4,regulation of microtubule cytoskeleton organization (GO:0070507),1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,ATF5
delta,4,NAD metabolic process (GO:0019674),1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,NMNAT3
delta,4,regulation of ion homeostasis (GO:2000021),1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,SLC30A1
delta,4,negative regulation of axon extension (GO:0030517),1/23,1,23,0.350073004844622,0.517224980130793,0,0,2.34384155631079,2.46012788229043,EPHA4
delta,4,purine ribonucleotide metabolic process (GO:0009150),2/67,2,67,0.353747616078066,0.522226431591514,0,0,1.60920465060144,1.67223972168698,GMPR2;BPNT1
delta,4,positive regulation of synaptic transmission (GO:0050806),2/68,2,68,0.360460363805721,0.529536234776483,0,0,1.58553987632789,1.61784251805324,NLGN1;GPRIN1
delta,4,regulation of TOR signaling (GO:0032006),2/68,2,68,0.360460363805721,0.529536234776483,0,0,1.58553987632789,1.61784251805324,MIOS;MAPKAPK5
delta,4,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),2/68,2,68,0.360460363805721,0.529536234776483,0,0,1.58553987632789,1.61784251805324,LATS2;CCNE2
delta,4,positive regulation of autophagy (GO:0010508),2/68,2,68,0.360460363805721,0.529536234776483,0,0,1.58553987632789,1.61784251805324,TBK1;IKBKG
delta,4,regulation of cardiac conduction (GO:1903779),2/68,2,68,0.360460363805721,0.529536234776483,0,0,1.58553987632789,1.61784251805324,ATP2A2;ATP1A1
delta,4,regulation of protein localization to plasma membrane (GO:1903076),2/68,2,68,0.360460363805721,0.529536234776483,0,0,1.58553987632789,1.61784251805324,CLTC;PIK3R1
delta,4,ammonium transport (GO:0015696),1/24,1,24,0.362143010756883,0.531143082443428,0,0,2.24618149146451,2.28148267706989,SEC14L1
delta,4,phospholipid dephosphorylation (GO:0046839),1/24,1,24,0.362143010756883,0.531143082443428,0,0,2.24618149146451,2.28148267706989,SACM1L
delta,4,cellular response to oxidative stress (GO:0034599),3/116,3,116,0.364816352114834,0.533341481075318,0,0,1.39418161539177,1.40583864240688,G6PD;PRKCD;ADNP2
delta,4,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),2/69,2,69,0.36714717425057,0.533341481075318,0,0,1.56256103754053,1.56567442721696,PAK2;BIRC2
delta,4,regulation of endopeptidase activity (GO:0052548),2/69,2,69,0.36714717425057,0.533341481075318,0,0,1.56256103754053,1.56567442721696,BIRC2;SERPINB6
delta,4,regulation of actin filament polymerization (GO:0030833),2/69,2,69,0.36714717425057,0.533341481075318,0,0,1.56256103754053,1.56567442721696,FCHSD2;PRKCD
delta,4,chromatin remodeling (GO:0006338),3/117,3,117,0.369868420185852,0.533341481075318,0,0,1.38226553320893,1.37481229899975,ATRX;UBTF;CHD1L
delta,4,regulation of endocytosis (GO:0030100),2/70,2,70,0.373806700807456,0.533341481075318,0,0,1.54023873700424,1.51562026636531,RAB4A;RAB5A
delta,4,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),2/70,2,70,0.373806700807456,0.533341481075318,0,0,1.54023873700424,1.51562026636531,DOCK11;NLGN1
delta,4,positive regulation of microtubule polymerization (GO:0031116),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,PAK1
delta,4,dendritic spine organization (GO:0097061),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,FYN
delta,4,negative regulation of protein localization to membrane (GO:1905476),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,CLTC
delta,4,negative regulation of cytoskeleton organization (GO:0051494),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,PRKCD
delta,4,histone monoubiquitination (GO:0010390),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,DTX3L
delta,4,regulation of chromosome organization (GO:0033044),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,SMG6
delta,4,response to glucocorticoid (GO:0051384),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,SLIT3
delta,4,receptor clustering (GO:0043113),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,NLGN1
delta,4,negative regulation of developmental growth (GO:0048640),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,EPHA4
delta,4,negative regulation of sequestering of calcium ion (GO:0051283),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,CHERP
delta,4,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,PSMA5
delta,4,ATP generation from ADP (GO:0006757),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,PKM
delta,4,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,THOC1
delta,4,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,TANK
delta,4,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,LATS2
delta,4,receptor catabolic process (GO:0032801),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,CLTC
delta,4,regulation of epidermal growth factor-activated receptor activity (GO:0007176),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,GPRC5A
delta,4,positive regulation of microtubule polymerization or depolymerization (GO:0031112),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,PAK1
delta,4,neuromuscular synaptic transmission (GO:0007274),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,FCHSD2
delta,4,sensory perception of pain (GO:0019233),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,P2RX4
delta,4,DNA geometric change (GO:0032392),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,RECQL4
delta,4,regulation of AMPA receptor activity (GO:2000311),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,NLGN1
delta,4,positive regulation of dephosphorylation (GO:0035306),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,PRKCD
delta,4,DNA replication initiation (GO:0006270),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,ORC4
delta,4,negative regulation of interleukin-6 production (GO:0032715),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,TNFAIP3
delta,4,"protein alpha-1,2-demannosylation (GO:0036508)",1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,UBB
delta,4,regulation of cardiac muscle cell action potential (GO:0098901),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,ATP2A2
delta,4,organic cation transport (GO:0015695),1/25,1,25,0.373989453193058,0.533341481075318,0,0,2.15633423180593,2.12081440859039,SEC14L1
delta,4,protein localization to cell periphery (GO:1990778),3/118,3,118,0.374913219097144,0.534236530214256,0,0,1.37055141852072,1.34459412791827,GAK;RAPGEF2;EZR
delta,4,calcium ion transport (GO:0006816),3/119,3,119,0.37995001214241,0.537598220725599,0,0,1.35903417970962,1.31515855205114,P2RX4;ATP2A2;FYN
delta,4,positive regulation of protein serine/threonine kinase activity (GO:0071902),3/119,3,119,0.37995001214241,0.537598220725599,0,0,1.35903417970962,1.31515855205114,ETAA1;RAPGEF2;TANK
delta,4,regulation of Notch signaling pathway (GO:0008593),2/71,2,71,0.380437655517972,0.537598220725599,0,0,1.51854523366615,1.4675721710503,UBB;RBPJ
delta,4,snRNA transcription (GO:0009301),2/71,2,71,0.380437655517972,0.537598220725599,0,0,1.51854523366615,1.4675721710503,NCBP2;ELL2
delta,4,snRNA transcription from RNA polymerase II promoter (GO:0042795),2/71,2,71,0.380437655517972,0.537598220725599,0,0,1.51854523366615,1.4675721710503,NCBP2;ELL2
delta,4,calcium-mediated signaling (GO:0019722),2/71,2,71,0.380437655517972,0.537598220725599,0,0,1.51854523366615,1.4675721710503,SPHK1;ATP2A2
delta,4,"protein import into nucleus, translocation (GO:0000060)",1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,TNPO1
delta,4,potassium ion homeostasis (GO:0055075),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,ATP1A1
delta,4,neutral amino acid transport (GO:0015804),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,SLC1A4
delta,4,positive regulation of interleukin-12 production (GO:0032735),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,RIPK2
delta,4,peptide catabolic process (GO:0043171),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,IDE
delta,4,prostaglandin metabolic process (GO:0006693),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,ACOX1
delta,4,response to alcohol (GO:0097305),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,GPRIN1
delta,4,positive regulation of glucose transport (GO:0010828),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,PIK3R1
delta,4,positive regulation of interleukin-1 beta secretion (GO:0050718),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,RIPK2
delta,4,negative regulation of cellular protein localization (GO:1903828),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,COMMD1
delta,4,regulation of potassium ion transmembrane transporter activity (GO:1901016),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,STK39
delta,4,ncRNA 3'-end processing (GO:0043628),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,PTCD1
delta,4,negative regulation of insulin receptor signaling pathway (GO:0046627),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,PRKCD
delta,4,long-chain fatty-acyl-CoA metabolic process (GO:0035336),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,ELOVL5
delta,4,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,BPNT1
delta,4,negative regulation of locomotion (GO:0040013),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,CRK
delta,4,regulation of cellular protein localization (GO:1903827),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,KDM1A
delta,4,L-amino acid transport (GO:0015807),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,SLC1A4
delta,4,positive regulation of nitric oxide biosynthetic process (GO:0045429),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,P2RX4
delta,4,signal transduction in response to DNA damage (GO:0042770),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,ATRX
delta,4,positive regulation of nitric oxide metabolic process (GO:1904407),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,P2RX4
delta,4,regulation of protein import into nucleus (GO:0042306),1/26,1,26,0.385616462094748,0.537598220725599,0,0,2.07339829981339,1.97576617251213,PRKCD
delta,4,positive regulation of growth (GO:0045927),2/72,2,72,0.387038807174972,0.538333082608828,0,0,1.49745432764301,1.42142904169188,SPHK1;ADNP2
delta,4,organelle membrane fusion (GO:0090174),2/72,2,72,0.387038807174972,0.538333082608828,0,0,1.49745432764301,1.42142904169188,SYT12;STX2
delta,4,response to insulin (GO:0032868),2/72,2,72,0.387038807174972,0.538333082608828,0,0,1.49745432764301,1.42142904169188,PKM;PIK3R1
delta,4,lipid biosynthetic process (GO:0008610),2/73,2,73,0.393608979972,0.546330035561135,0,0,1.4769412546616,1.37709603676813,GNPAT;ELOVL4
delta,4,sodium ion homeostasis (GO:0055078),1/27,1,27,0.397028091253131,0.546330035561135,0,0,1.99660577019068,1.84436107012924,ATP1A1
delta,4,positive regulation of glucose import (GO:0046326),1/27,1,27,0.397028091253131,0.546330035561135,0,0,1.99660577019068,1.84436107012924,PIK3R1
delta,4,positive regulation of synapse assembly (GO:0051965),1/27,1,27,0.397028091253131,0.546330035561135,0,0,1.99660577019068,1.84436107012924,NLGN1
delta,4,cytoskeleton-dependent intracellular transport (GO:0030705),1/27,1,27,0.397028091253131,0.546330035561135,0,0,1.99660577019068,1.84436107012924,DYNLL2
delta,4,regulation of centrosome cycle (GO:0046605),1/27,1,27,0.397028091253131,0.546330035561135,0,0,1.99660577019068,1.84436107012924,ATF5
delta,4,regulation of NF-kappaB import into nucleus (GO:0042345),1/27,1,27,0.397028091253131,0.546330035561135,0,0,1.99660577019068,1.84436107012924,SPHK1
delta,4,response to ketone (GO:1901654),1/27,1,27,0.397028091253131,0.546330035561135,0,0,1.99660577019068,1.84436107012924,SLIT3
delta,4,negative chemotaxis (GO:0050919),1/27,1,27,0.397028091253131,0.546330035561135,0,0,1.99660577019068,1.84436107012924,SLIT3
delta,4,negative regulation of catalytic activity (GO:0043086),1/27,1,27,0.397028091253131,0.546330035561135,0,0,1.99660577019068,1.84436107012924,PARP9
delta,4,negative regulation of cellular response to insulin stimulus (GO:1900077),1/27,1,27,0.397028091253131,0.546330035561135,0,0,1.99660577019068,1.84436107012924,PRKCD
delta,4,regulation of cardiac muscle cell contraction (GO:0086004),1/27,1,27,0.397028091253131,0.546330035561135,0,0,1.99660577019068,1.84436107012924,ATP2A2
delta,4,strand displacement (GO:0000732),1/27,1,27,0.397028091253131,0.546330035561135,0,0,1.99660577019068,1.84436107012924,BARD1
delta,4,regulation of T cell receptor signaling pathway (GO:0050856),1/27,1,27,0.397028091253131,0.546330035561135,0,0,1.99660577019068,1.84436107012924,EZR
delta,4,transcription-coupled nucleotide-excision repair (GO:0006283),2/74,2,74,0.400147051573028,0.550202195912913,0,0,1.45698258905806,1.33448411233415,UBB;XPA
delta,4,cellular calcium ion homeostasis (GO:0006874),3/124,3,124,0.404989228673882,0.553717209690593,0,0,1.30423441439875,1.17889071571546,ATP2A2;SLC30A1;CHERP
delta,4,nitrogen compound transport (GO:0071705),2/75,2,75,0.406651951820652,0.553717209690593,0,0,1.43755615453729,1.2935095987424,SLC1A4;SLC7A11
delta,4,mRNA polyadenylation (GO:0006378),1/28,1,28,0.408228319782976,0.553717209690593,0,0,1.92529842125529,1.72493002269646,CPSF4
delta,4,telomere maintenance via telomere lengthening (GO:0010833),1/28,1,28,0.408228319782976,0.553717209690593,0,0,1.92529842125529,1.72493002269646,SMG6
delta,4,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),1/28,1,28,0.408228319782976,0.553717209690593,0,0,1.92529842125529,1.72493002269646,PRKCD
delta,4,negative regulation of smooth muscle cell proliferation (GO:0048662),1/28,1,28,0.408228319782976,0.553717209690593,0,0,1.92529842125529,1.72493002269646,TNFAIP3
delta,4,negative regulation of synaptic transmission (GO:0050805),1/28,1,28,0.408228319782976,0.553717209690593,0,0,1.92529842125529,1.72493002269646,SLC30A1
delta,4,leukocyte cell-cell adhesion (GO:0007159),1/28,1,28,0.408228319782976,0.553717209690593,0,0,1.92529842125529,1.72493002269646,EZR
delta,4,negative regulation of microtubule polymerization or depolymerization (GO:0031111),1/28,1,28,0.408228319782976,0.553717209690593,0,0,1.92529842125529,1.72493002269646,TBCD
delta,4,regulation of double-strand break repair via homologous recombination (GO:0010569),1/28,1,28,0.408228319782976,0.553717209690593,0,0,1.92529842125529,1.72493002269646,KDM1A
delta,4,transition metal ion transport (GO:0000041),1/28,1,28,0.408228319782976,0.553717209690593,0,0,1.92529842125529,1.72493002269646,SLC30A1
delta,4,release of sequestered calcium ion into cytosol (GO:0051209),1/28,1,28,0.408228319782976,0.553717209690593,0,0,1.92529842125529,1.72493002269646,CHERP
delta,4,negative regulation of osteoblast differentiation (GO:0045668),1/28,1,28,0.408228319782976,0.553717209690593,0,0,1.92529842125529,1.72493002269646,TMEM64
delta,4,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),1/28,1,28,0.408228319782976,0.553717209690593,0,0,1.92529842125529,1.72493002269646,CRK
delta,4,regulation of protein targeting to membrane (GO:0090313),1/28,1,28,0.408228319782976,0.553717209690593,0,0,1.92529842125529,1.72493002269646,FYN
delta,4,cargo loading into vesicle (GO:0035459),1/28,1,28,0.408228319782976,0.553717209690593,0,0,1.92529842125529,1.72493002269646,SEC23A
delta,4,protein localization to chromosome (GO:0034502),1/28,1,28,0.408228319782976,0.553717209690593,0,0,1.92529842125529,1.72493002269646,ATRX
delta,4,regulation of protein localization to cell surface (GO:2000008),1/28,1,28,0.408228319782976,0.553717209690593,0,0,1.92529842125529,1.72493002269646,COMMD1
delta,4,negative regulation of macromolecule metabolic process (GO:0010605),3/125,3,125,0.409963411824357,0.555652888753674,0,0,1.29380053908356,1.15366559057938,AP1AR;ZNF148;PARP9
delta,4,C-terminal protein lipidation (GO:0006501),2/76,2,76,0.41312266105279,0.558173309868259,0,0,1.41864094197759,1.25409381471002,ULBP2;MDGA1
delta,4,regulation of actin cytoskeleton organization (GO:0032956),2/76,2,76,0.41312266105279,0.558173309868259,0,0,1.41864094197759,1.25409381471002,PRKCD;CRK
delta,4,RNA polyadenylation (GO:0043631),1/29,1,29,0.41922105348774,0.558173309868259,0,0,1.85890882052235,1.61605525461807,CPSF4
delta,4,neuron projection extension (GO:1990138),1/29,1,29,0.41922105348774,0.558173309868259,0,0,1.85890882052235,1.61605525461807,ALCAM
delta,4,regulation of TORC1 signaling (GO:1903432),1/29,1,29,0.41922105348774,0.558173309868259,0,0,1.85890882052235,1.61605525461807,CLEC16A
delta,4,negative regulation of homeostatic process (GO:0032845),1/29,1,29,0.41922105348774,0.558173309868259,0,0,1.85890882052235,1.61605525461807,TNFAIP3
delta,4,cellular amino acid biosynthetic process (GO:0008652),1/29,1,29,0.41922105348774,0.558173309868259,0,0,1.85890882052235,1.61605525461807,OAT
delta,4,positive regulation of sprouting angiogenesis (GO:1903672),1/29,1,29,0.41922105348774,0.558173309868259,0,0,1.85890882052235,1.61605525461807,PIK3C2A
delta,4,positive regulation of protein tyrosine kinase activity (GO:0061098),1/29,1,29,0.41922105348774,0.558173309868259,0,0,1.85890882052235,1.61605525461807,EPHA4
delta,4,protein K11-linked ubiquitination (GO:0070979),1/29,1,29,0.41922105348774,0.558173309868259,0,0,1.85890882052235,1.61605525461807,UBE2H
delta,4,cardiac muscle cell action potential involved in contraction (GO:0086002),1/29,1,29,0.41922105348774,0.558173309868259,0,0,1.85890882052235,1.61605525461807,ATP1A1
delta,4,positive regulation of calcium-mediated signaling (GO:0050850),1/29,1,29,0.41922105348774,0.558173309868259,0,0,1.85890882052235,1.61605525461807,P2RX4
delta,4,neural crest cell migration (GO:0001755),1/29,1,29,0.41922105348774,0.558173309868259,0,0,1.85890882052235,1.61605525461807,CORO1C
delta,4,regulation of fatty acid biosynthetic process (GO:0042304),1/29,1,29,0.41922105348774,0.558173309868259,0,0,1.85890882052235,1.61605525461807,ELOVL5
delta,4,positive regulation of lipid biosynthetic process (GO:0046889),1/29,1,29,0.41922105348774,0.558173309868259,0,0,1.85890882052235,1.61605525461807,ELOVL5
delta,4,calcium ion import (GO:0070509),1/29,1,29,0.41922105348774,0.558173309868259,0,0,1.85890882052235,1.61605525461807,ATP2A2
delta,4,protein K63-linked deubiquitination (GO:0070536),1/29,1,29,0.41922105348774,0.558173309868259,0,0,1.85890882052235,1.61605525461807,TNFAIP3
delta,4,regulation of cell morphogenesis (GO:0022604),1/29,1,29,0.41922105348774,0.558173309868259,0,0,1.85890882052235,1.61605525461807,QRICH1
delta,4,protein export from nucleus (GO:0006611),1/29,1,29,0.41922105348774,0.558173309868259,0,0,1.85890882052235,1.61605525461807,NUP62
delta,4,regulation of actin polymerization or depolymerization (GO:0008064),1/29,1,29,0.41922105348774,0.558173309868259,0,0,1.85890882052235,1.61605525461807,FCHSD2
delta,4,bicellular tight junction assembly (GO:0070830),1/29,1,29,0.41922105348774,0.558173309868259,0,0,1.85890882052235,1.61605525461807,TBCD
delta,4,transforming growth factor beta receptor signaling pathway (GO:0007179),2/77,2,77,0.419558208526252,0.558173309868259,0,0,1.40021703364021,1.21616271331921,UBB;NEDD8
delta,4,nucleic acid-templated transcription (GO:0097659),2/77,2,77,0.419558208526252,0.558173309868259,0,0,1.40021703364021,1.21616271331921,CREBZF;NUP62
delta,4,positive regulation of apoptotic signaling pathway (GO:2001235),2/77,2,77,0.419558208526252,0.558173309868259,0,0,1.40021703364021,1.21616271331921,TANK;PAK2
delta,4,response to interleukin-1 (GO:0070555),2/77,2,77,0.419558208526252,0.558173309868259,0,0,1.40021703364021,1.21616271331921,YTHDC2;TANK
delta,4,cytoskeleton organization (GO:0007010),3/127,3,127,0.419873015921429,0.558180486899233,0,0,1.27342572744445,1.10508261111337,QRICH1;EZR;BRWD3
delta,4,response to ionizing radiation (GO:0010212),2/78,2,78,0.425957671139236,0.56585245856788,0,0,1.38226553320893,1.17964655632396,TANK;INIP
delta,4,regulation of striated muscle contraction (GO:0006942),1/30,1,30,0.430010126209073,0.567060137193835,0,0,1.79694519317161,1.51652564465119,P2RX4
delta,4,cardiac muscle cell action potential (GO:0086001),1/30,1,30,0.430010126209073,0.567060137193835,0,0,1.79694519317161,1.51652564465119,ATP1A1
delta,4,positive regulation of histone modification (GO:0031058),1/30,1,30,0.430010126209073,0.567060137193835,0,0,1.79694519317161,1.51652564465119,KDM1A
delta,4,negative regulation of Notch signaling pathway (GO:0045746),1/30,1,30,0.430010126209073,0.567060137193835,0,0,1.79694519317161,1.51652564465119,UBB
delta,4,positive regulation of interleukin-1 secretion (GO:0050716),1/30,1,30,0.430010126209073,0.567060137193835,0,0,1.79694519317161,1.51652564465119,RIPK2
delta,4,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),1/30,1,30,0.430010126209073,0.567060137193835,0,0,1.79694519317161,1.51652564465119,EIF4A2
delta,4,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),1/30,1,30,0.430010126209073,0.567060137193835,0,0,1.79694519317161,1.51652564465119,UBB
delta,4,amino acid transmembrane transport (GO:0003333),1/30,1,30,0.430010126209073,0.567060137193835,0,0,1.79694519317161,1.51652564465119,SLC7A11
delta,4,respiratory system development (GO:0060541),1/30,1,30,0.430010126209073,0.567060137193835,0,0,1.79694519317161,1.51652564465119,SMCHD1
delta,4,carbohydrate derivative biosynthetic process (GO:1901137),1/30,1,30,0.430010126209073,0.567060137193835,0,0,1.79694519317161,1.51652564465119,G6PD
delta,4,negative regulation of cell communication (GO:0010648),2/79,2,79,0.432320171884414,0.568444307638107,0,0,1.36476850114299,1.14447961598731,EPHA4;RYK
delta,4,extracellular matrix disassembly (GO:0022617),2/79,2,79,0.432320171884414,0.568444307638107,0,0,1.36476850114299,1.14447961598731,LAMC1;MMP10
delta,4,fibroblast growth factor receptor signaling pathway (GO:0008543),2/79,2,79,0.432320171884414,0.568444307638107,0,0,1.36476850114299,1.14447961598731,UBB;NCBP2
delta,4,negative regulation of inflammatory response (GO:0050728),2/79,2,79,0.432320171884414,0.568444307638107,0,0,1.36476850114299,1.14447961598731,PRKCD;TNFAIP3
delta,4,peptidyl-tyrosine phosphorylation (GO:0018108),2/80,2,80,0.43864487852728,0.571417066236554,0,0,1.34770889487871,1.11059990028206,EPHA4;FYN
delta,4,steroid biosynthetic process (GO:0006694),2/80,2,80,0.43864487852728,0.571417066236554,0,0,1.34770889487871,1.11059990028206,OSBPL6;OSBP
delta,4,protein localization to plasma membrane (GO:0072659),3/131,3,131,0.439520604112475,0.571417066236554,0,0,1.23454249912553,1.01488119440396,GAK;RAPGEF2;EZR
delta,4,ribosomal large subunit assembly (GO:0000027),1/31,1,31,0.440599301072642,0.571417066236554,0,0,1.73897921919833,1.42530115802673,RSL24D1
delta,4,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),1/31,1,31,0.440599301072642,0.571417066236554,0,0,1.73897921919833,1.42530115802673,DYNLL2
delta,4,negative regulation of stress-activated MAPK cascade (GO:0032873),1/31,1,31,0.440599301072642,0.571417066236554,0,0,1.73897921919833,1.42530115802673,EZR
delta,4,smoothened signaling pathway (GO:0007224),1/31,1,31,0.440599301072642,0.571417066236554,0,0,1.73897921919833,1.42530115802673,TCTN2
delta,4,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),1/31,1,31,0.440599301072642,0.571417066236554,0,0,1.73897921919833,1.42530115802673,PIK3C2A
delta,4,negative regulation of endothelial cell proliferation (GO:0001937),1/31,1,31,0.440599301072642,0.571417066236554,0,0,1.73897921919833,1.42530115802673,KRIT1
delta,4,negative regulation of secretion by cell (GO:1903531),1/31,1,31,0.440599301072642,0.571417066236554,0,0,1.73897921919833,1.42530115802673,SLC30A1
delta,4,fatty-acyl-CoA biosynthetic process (GO:0046949),1/31,1,31,0.440599301072642,0.571417066236554,0,0,1.73897921919833,1.42530115802673,ELOVL5
delta,4,regulation of ARF protein signal transduction (GO:0032012),1/31,1,31,0.440599301072642,0.571417066236554,0,0,1.73897921919833,1.42530115802673,ARAP2
delta,4,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),1/31,1,31,0.440599301072642,0.571417066236554,0,0,1.73897921919833,1.42530115802673,PAK1
delta,4,aminoglycan metabolic process (GO:0006022),1/31,1,31,0.440599301072642,0.571417066236554,0,0,1.73897921919833,1.42530115802673,SDC2
delta,4,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),1/31,1,31,0.440599301072642,0.571417066236554,0,0,1.73897921919833,1.42530115802673,DYNLL2
delta,4,regulation of protein polymerization (GO:0032271),1/31,1,31,0.440599301072642,0.571417066236554,0,0,1.73897921919833,1.42530115802673,FCHSD2
delta,4,CENP-A containing nucleosome assembly (GO:0034080),1/31,1,31,0.440599301072642,0.571417066236554,0,0,1.73897921919833,1.42530115802673,OIP5
delta,4,CENP-A containing chromatin organization (GO:0061641),1/31,1,31,0.440599301072642,0.571417066236554,0,0,1.73897921919833,1.42530115802673,OIP5
delta,4,regulation of sodium ion transmembrane transport (GO:1902305),1/31,1,31,0.440599301072642,0.571417066236554,0,0,1.73897921919833,1.42530115802673,COMMD1
delta,4,spindle assembly (GO:0051225),2/81,2,81,0.444931002179719,0.574556569743889,0,0,1.33107051346045,1.07794890036155,NEK7;BIRC2
delta,4,regulation of hydrolase activity (GO:0051336),2/81,2,81,0.444931002179719,0.574556569743889,0,0,1.33107051346045,1.07794890036155,EPHA4;CRK
delta,4,regulation of protein serine/threonine kinase activity (GO:0071900),2/81,2,81,0.444931002179719,0.574556569743889,0,0,1.33107051346045,1.07794890036155,ETAA1;CCNE2
delta,4,cellular response to hormone stimulus (GO:0032870),2/81,2,81,0.444931002179719,0.574556569743889,0,0,1.33107051346045,1.07794890036155,SLIT3;ATP1A1
delta,4,negative regulation of MAPK cascade (GO:0043409),2/81,2,81,0.444931002179719,0.574556569743889,0,0,1.33107051346045,1.07794890036155,PRKCD;EZR
delta,4,negative regulation of defense response (GO:0031348),2/81,2,81,0.444931002179719,0.574556569743889,0,0,1.33107051346045,1.07794890036155,PRKCD;TNFAIP3
delta,4,positive regulation of ubiquitin-protein transferase activity (GO:0051443),1/32,1,32,0.450992272049161,0.578071551288,0,0,1.68463611859838,1.34148429038452,BMI1
delta,4,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),1/32,1,32,0.450992272049161,0.578071551288,0,0,1.68463611859838,1.34148429038452,TNFAIP3
delta,4,alpha-amino acid metabolic process (GO:1901605),1/32,1,32,0.450992272049161,0.578071551288,0,0,1.68463611859838,1.34148429038452,SRR
delta,4,organelle transport along microtubule (GO:0072384),1/32,1,32,0.450992272049161,0.578071551288,0,0,1.68463611859838,1.34148429038452,UBB
delta,4,positive regulation of protein dephosphorylation (GO:0035307),1/32,1,32,0.450992272049161,0.578071551288,0,0,1.68463611859838,1.34148429038452,PRKCD
delta,4,regulation of protein tyrosine kinase activity (GO:0061097),1/32,1,32,0.450992272049161,0.578071551288,0,0,1.68463611859838,1.34148429038452,EPHA4
delta,4,regulation of protein export from nucleus (GO:0046825),1/32,1,32,0.450992272049161,0.578071551288,0,0,1.68463611859838,1.34148429038452,BARD1
delta,4,positive regulation of viral genome replication (GO:0045070),1/32,1,32,0.450992272049161,0.578071551288,0,0,1.68463611859838,1.34148429038452,YTHDC2
delta,4,positive regulation of interleukin-1 beta production (GO:0032731),1/32,1,32,0.450992272049161,0.578071551288,0,0,1.68463611859838,1.34148429038452,RIPK2
delta,4,nucleobase-containing small molecule interconversion (GO:0015949),1/32,1,32,0.450992272049161,0.578071551288,0,0,1.68463611859838,1.34148429038452,GLRX
delta,4,negative regulation of cell cycle process (GO:0010948),2/82,2,82,0.45117779612722,0.578071551288,0,0,1.31483794622313,1.04647135720219,MGA;BMI1
delta,4,protein targeting (GO:0006605),3/134,3,134,0.454088658507331,0.580999697825506,0,0,1.20690348795108,0.95280542738494,NLGN1;ZDHHC9;ZDHHC4
delta,4,regulation of anatomical structure morphogenesis (GO:0022603),2/83,2,83,0.457384554368912,0.580999697825506,0,0,1.2989965251843,1.01611504729899,TNFAIP3;QRICH1
delta,4,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",2/83,2,83,0.457384554368912,0.580999697825506,0,0,1.2989965251843,1.01611504729899,UBB;ATRX
delta,4,C-terminal protein amino acid modification (GO:0018410),2/83,2,83,0.457384554368912,0.580999697825506,0,0,1.2989965251843,1.01611504729899,ULBP2;MDGA1
delta,4,negative regulation of binding (GO:0051100),2/83,2,83,0.457384554368912,0.580999697825506,0,0,1.2989965251843,1.01611504729899,KDM1A;PRKCD
delta,4,dendrite morphogenesis (GO:0048813),1/33,1,33,0.461192664792752,0.580999697825506,0,0,1.63358653924692,1.26429697839767,SDC2
delta,4,protein deacetylation (GO:0006476),1/33,1,33,0.461192664792752,0.580999697825506,0,0,1.63358653924692,1.26429697839767,SIRT5
delta,4,7-methylguanosine mRNA capping (GO:0006370),1/33,1,33,0.461192664792752,0.580999697825506,0,0,1.63358653924692,1.26429697839767,NCBP2
delta,4,cellular response to amino acid stimulus (GO:0071230),1/33,1,33,0.461192664792752,0.580999697825506,0,0,1.63358653924692,1.26429697839767,FYN
delta,4,response to zinc ion (GO:0010043),1/33,1,33,0.461192664792752,0.580999697825506,0,0,1.63358653924692,1.26429697839767,SLC30A1
delta,4,regulation of glutamate receptor signaling pathway (GO:1900449),1/33,1,33,0.461192664792752,0.580999697825506,0,0,1.63358653924692,1.26429697839767,NLGN1
delta,4,positive regulation of dendrite development (GO:1900006),1/33,1,33,0.461192664792752,0.580999697825506,0,0,1.63358653924692,1.26429697839767,NLGN1
delta,4,oxoacid metabolic process (GO:0043436),1/33,1,33,0.461192664792752,0.580999697825506,0,0,1.63358653924692,1.26429697839767,BPNT1
delta,4,sister chromatid segregation (GO:0000819),1/33,1,33,0.461192664792752,0.580999697825506,0,0,1.63358653924692,1.26429697839767,NUSAP1
delta,4,chromatin remodeling at centromere (GO:0031055),1/33,1,33,0.461192664792752,0.580999697825506,0,0,1.63358653924692,1.26429697839767,OIP5
delta,4,protein trimerization (GO:0070206),1/33,1,33,0.461192664792752,0.580999697825506,0,0,1.63358653924692,1.26429697839767,TANK
delta,4,cyclic-nucleotide-mediated signaling (GO:0019935),1/33,1,33,0.461192664792752,0.580999697825506,0,0,1.63358653924692,1.26429697839767,RAPGEF2
delta,4,7-methylguanosine RNA capping (GO:0009452),1/33,1,33,0.461192664792752,0.580999697825506,0,0,1.63358653924692,1.26429697839767,NCBP2
delta,4,regulation of potassium ion transmembrane transport (GO:1901379),1/33,1,33,0.461192664792752,0.580999697825506,0,0,1.63358653924692,1.26429697839767,STK39
delta,4,negative regulation of receptor activity (GO:2000272),1/33,1,33,0.461192664792752,0.580999697825506,0,0,1.63358653924692,1.26429697839767,GPRC5A
delta,4,GPI anchor biosynthetic process (GO:0006506),1/33,1,33,0.461192664792752,0.580999697825506,0,0,1.63358653924692,1.26429697839767,GPAA1
delta,4,substrate adhesion-dependent cell spreading (GO:0034446),1/33,1,33,0.461192664792752,0.580999697825506,0,0,1.63358653924692,1.26429697839767,LAMC1
delta,4,regulation of nitric oxide biosynthetic process (GO:0045428),1/33,1,33,0.461192664792752,0.580999697825506,0,0,1.63358653924692,1.26429697839767,P2RX4
delta,4,aminoglycan catabolic process (GO:0006026),1/33,1,33,0.461192664792752,0.580999697825506,0,0,1.63358653924692,1.26429697839767,SDC2
delta,4,establishment of protein localization to membrane (GO:0090150),2/84,2,84,0.463550610556549,0.583155719277556,0,0,1.28353228083686,0.986830583747902,ZDHHC9;ZDHHC4
delta,4,negative regulation of neuron death (GO:1901215),2/84,2,84,0.463550610556549,0.583155719277556,0,0,1.28353228083686,0.986830583747902,IKBKG;TANK
delta,4,regulation of cell cycle G2/M phase transition (GO:1902749),2/85,2,85,0.469675336533521,0.58543532029729,0,0,1.26843190106231,0.958571233619526,ATF5;TUBA4A
delta,4,intracellular pH reduction (GO:0051452),1/34,1,34,0.471204038288063,0.58543532029729,0,0,1.58553987632789,1.19306179873258,DMXL2
delta,4,activation of MAPKK activity (GO:0000186),1/34,1,34,0.471204038288063,0.58543532029729,0,0,1.58553987632789,1.19306179873258,CRK
delta,4,positive regulation of cytokine-mediated signaling pathway (GO:0001961),1/34,1,34,0.471204038288063,0.58543532029729,0,0,1.58553987632789,1.19306179873258,PARP9
delta,4,protein acetylation (GO:0006473),1/34,1,34,0.471204038288063,0.58543532029729,0,0,1.58553987632789,1.19306179873258,NAA16
delta,4,"chemical synaptic transmission, postsynaptic (GO:0099565)",1/34,1,34,0.471204038288063,0.58543532029729,0,0,1.58553987632789,1.19306179873258,GPRIN1
delta,4,entry into host cell (GO:0030260),1/34,1,34,0.471204038288063,0.58543532029729,0,0,1.58553987632789,1.19306179873258,UBB
delta,4,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),1/34,1,34,0.471204038288063,0.58543532029729,0,0,1.58553987632789,1.19306179873258,NUP62
delta,4,tRNA export from nucleus (GO:0006409),1/34,1,34,0.471204038288063,0.58543532029729,0,0,1.58553987632789,1.19306179873258,NUP62
delta,4,intra-Golgi vesicle-mediated transport (GO:0006891),1/34,1,34,0.471204038288063,0.58543532029729,0,0,1.58553987632789,1.19306179873258,GOLGA3
delta,4,regulation of autophagosome assembly (GO:2000785),1/34,1,34,0.471204038288063,0.58543532029729,0,0,1.58553987632789,1.19306179873258,RAB5A
delta,4,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),1/34,1,34,0.471204038288063,0.58543532029729,0,0,1.58553987632789,1.19306179873258,UBB
delta,4,cellular response to glucose starvation (GO:0042149),1/34,1,34,0.471204038288063,0.58543532029729,0,0,1.58553987632789,1.19306179873258,TBL2
delta,4,regulation of postsynaptic membrane potential (GO:0060078),1/34,1,34,0.471204038288063,0.58543532029729,0,0,1.58553987632789,1.19306179873258,GPRIN1
delta,4,positive regulation of Notch signaling pathway (GO:0045747),1/34,1,34,0.471204038288063,0.58543532029729,0,0,1.58553987632789,1.19306179873258,RBPJ
delta,4,cellular glucose homeostasis (GO:0001678),1/34,1,34,0.471204038288063,0.58543532029729,0,0,1.58553987632789,1.19306179873258,PIK3R1
delta,4,regulation of neurotransmitter receptor activity (GO:0099601),1/34,1,34,0.471204038288063,0.58543532029729,0,0,1.58553987632789,1.19306179873258,NLGN1
delta,4,regulation of interleukin-12 production (GO:0032655),1/34,1,34,0.471204038288063,0.58543532029729,0,0,1.58553987632789,1.19306179873258,RIPK2
delta,4,regulation of signal transduction by p53 class mediator (GO:1901796),3/139,3,139,0.478009122290635,0.591532320416106,0,0,1.16348969342047,0.85880136793355,BARD1;UBB;MAPKAPK5
delta,4,epithelial tube morphogenesis (GO:0060562),1/35,1,35,0.481029885837265,0.591532320416106,0,0,1.54023873700424,1.12718656617439,PAK1
delta,4,regulation of double-strand break repair (GO:2000779),1/35,1,35,0.481029885837265,0.591532320416106,0,0,1.54023873700424,1.12718656617439,KDM1A
delta,4,negative regulation of DNA binding (GO:0043392),1/35,1,35,0.481029885837265,0.591532320416106,0,0,1.54023873700424,1.12718656617439,KDM1A
delta,4,ncRNA metabolic process (GO:0034660),1/35,1,35,0.481029885837265,0.591532320416106,0,0,1.54023873700424,1.12718656617439,DDX17
delta,4,response to amino acid (GO:0043200),1/35,1,35,0.481029885837265,0.591532320416106,0,0,1.54023873700424,1.12718656617439,GPRIN1
delta,4,positive regulation of exocytosis (GO:0045921),1/35,1,35,0.481029885837265,0.591532320416106,0,0,1.54023873700424,1.12718656617439,RAB5A
delta,4,response to peptide (GO:1901652),1/35,1,35,0.481029885837265,0.591532320416106,0,0,1.54023873700424,1.12718656617439,FYN
delta,4,ventricular cardiac muscle tissue morphogenesis (GO:0055010),1/35,1,35,0.481029885837265,0.591532320416106,0,0,1.54023873700424,1.12718656617439,RBPJ
delta,4,regulation of axon extension (GO:0030516),1/35,1,35,0.481029885837265,0.591532320416106,0,0,1.54023873700424,1.12718656617439,EPHA4
delta,4,regulation of insulin receptor signaling pathway (GO:0046626),1/35,1,35,0.481029885837265,0.591532320416106,0,0,1.54023873700424,1.12718656617439,PRKCD
delta,4,negative regulation of endothelial cell migration (GO:0010596),1/35,1,35,0.481029885837265,0.591532320416106,0,0,1.54023873700424,1.12718656617439,KRIT1
delta,4,endoplasmic reticulum organization (GO:0007029),1/35,1,35,0.481029885837265,0.591532320416106,0,0,1.54023873700424,1.12718656617439,GAK
delta,4,regulation of interleukin-1 beta secretion (GO:0050706),1/35,1,35,0.481029885837265,0.591532320416106,0,0,1.54023873700424,1.12718656617439,RIPK2
delta,4,cellular macromolecular complex assembly (GO:0034622),1/35,1,35,0.481029885837265,0.591532320416106,0,0,1.54023873700424,1.12718656617439,TANK
delta,4,inorganic cation transmembrane transport (GO:0098662),3/141,3,141,0.487440818308897,0.596881483553217,0,0,1.14698629351379,0.824208744915219,P2RX4;ATP2A2;SLC30A1
delta,4,positive regulation of cellular component biogenesis (GO:0044089),2/88,2,88,0.487795802762677,0.596881483553217,0,0,1.22518990443519,0.879512861626919,NLGN1;FAF1
delta,4,organic substance transport (GO:0071702),2/88,2,88,0.487795802762677,0.596881483553217,0,0,1.22518990443519,0.879512861626919,ABCA3;PLEKHA8
delta,4,positive regulation of RNA metabolic process (GO:0051254),1/36,1,36,0.490673636424291,0.596881483553217,0,0,1.49745432764301,1.06615163790542,PIK3R1
delta,4,regulation of cyclin-dependent protein kinase activity (GO:1904029),1/36,1,36,0.490673636424291,0.596881483553217,0,0,1.49745432764301,1.06615163790542,CCNE2
delta,4,positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/36,1,36,0.490673636424291,0.596881483553217,0,0,1.49745432764301,1.06615163790542,TANK
delta,4,positive regulation of peptide secretion (GO:0002793),1/36,1,36,0.490673636424291,0.596881483553217,0,0,1.49745432764301,1.06615163790542,EZR
delta,4,endothelial cell migration (GO:0043542),1/36,1,36,0.490673636424291,0.596881483553217,0,0,1.49745432764301,1.06615163790542,LGALS8
delta,4,apical junction assembly (GO:0043297),1/36,1,36,0.490673636424291,0.596881483553217,0,0,1.49745432764301,1.06615163790542,TBCD
delta,4,tRNA transport (GO:0051031),1/36,1,36,0.490673636424291,0.596881483553217,0,0,1.49745432764301,1.06615163790542,NUP62
delta,4,cholesterol biosynthetic process (GO:0006695),1/36,1,36,0.490673636424291,0.596881483553217,0,0,1.49745432764301,1.06615163790542,G6PD
delta,4,regulation of synapse assembly (GO:0051963),1/36,1,36,0.490673636424291,0.596881483553217,0,0,1.49745432764301,1.06615163790542,NLGN1
delta,4,regulation of mitochondrial membrane potential (GO:0051881),1/36,1,36,0.490673636424291,0.596881483553217,0,0,1.49745432764301,1.06615163790542,UBB
delta,4,carboxylic acid transmembrane transport (GO:1905039),1/36,1,36,0.490673636424291,0.596881483553217,0,0,1.49745432764301,1.06615163790542,SLC7A11
delta,4,negative regulation of tumor necrosis factor production (GO:0032720),1/36,1,36,0.490673636424291,0.596881483553217,0,0,1.49745432764301,1.06615163790542,TNFAIP3
delta,4,carbohydrate catabolic process (GO:0016052),1/36,1,36,0.490673636424291,0.596881483553217,0,0,1.49745432764301,1.06615163790542,PKM
delta,4,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),2/89,2,89,0.493749652911376,0.599814393166412,0,0,1.21142372573367,0.854934026749877,ANKIB1;COMMD1
delta,4,divalent metal ion transport (GO:0070838),2/89,2,89,0.493749652911376,0.599814393166412,0,0,1.21142372573367,0.854934026749877,SLC30A1;FYN
delta,4,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),3/143,3,143,0.496789541943515,0.60109935708251,0,0,1.13094452717094,0.791196123977278,NLGN1;ALCAM;CDH24
delta,4,protein acylation (GO:0043543),1/37,1,37,0.50013865575435,0.60109935708251,0,0,1.45698258905806,1.00949939170245,ZDHHC9
delta,4,regulation of receptor-mediated endocytosis (GO:0048259),1/37,1,37,0.50013865575435,0.60109935708251,0,0,1.45698258905806,1.00949939170245,B2M
delta,4,histone exchange (GO:0043486),1/37,1,37,0.50013865575435,0.60109935708251,0,0,1.45698258905806,1.00949939170245,OIP5
delta,4,organic hydroxy compound transport (GO:0015850),1/37,1,37,0.50013865575435,0.60109935708251,0,0,1.45698258905806,1.00949939170245,OSBP
delta,4,transferrin transport (GO:0033572),1/37,1,37,0.50013865575435,0.60109935708251,0,0,1.45698258905806,1.00949939170245,CLTC
delta,4,natural killer cell activation (GO:0030101),1/37,1,37,0.50013865575435,0.60109935708251,0,0,1.45698258905806,1.00949939170245,ULBP2
delta,4,mRNA catabolic process (GO:0006402),1/37,1,37,0.50013865575435,0.60109935708251,0,0,1.45698258905806,1.00949939170245,EXOSC10
delta,4,plasma membrane organization (GO:0007009),1/37,1,37,0.50013865575435,0.60109935708251,0,0,1.45698258905806,1.00949939170245,STX2
delta,4,vesicle-mediated transport in synapse (GO:0099003),1/37,1,37,0.50013865575435,0.60109935708251,0,0,1.45698258905806,1.00949939170245,NLGN1
delta,4,zymogen activation (GO:0031638),1/37,1,37,0.50013865575435,0.60109935708251,0,0,1.45698258905806,1.00949939170245,RIPK2
delta,4,ferric iron transport (GO:0015682),1/37,1,37,0.50013865575435,0.60109935708251,0,0,1.45698258905806,1.00949939170245,CLTC
delta,4,epithelial cell migration (GO:0010631),1/37,1,37,0.50013865575435,0.60109935708251,0,0,1.45698258905806,1.00949939170245,ZEB2
delta,4,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",1/37,1,37,0.50013865575435,0.60109935708251,0,0,1.45698258905806,1.00949939170245,PLCB3
delta,4,glutamate receptor signaling pathway (GO:0007215),1/37,1,37,0.50013865575435,0.60109935708251,0,0,1.45698258905806,1.00949939170245,GPRIN1
delta,4,secondary alcohol biosynthetic process (GO:1902653),1/37,1,37,0.50013865575435,0.60109935708251,0,0,1.45698258905806,1.00949939170245,G6PD
delta,4,regulation of Ras protein signal transduction (GO:0046578),2/91,2,91,0.505525123078413,0.607168656480331,0,0,1.1847990284648,0.80821959336969,NUP62;ARAP2
delta,4,spliceosomal snRNP assembly (GO:0000387),1/38,1,38,0.509428247587848,0.60942212111968,0,0,1.41864094197759,0.956825457949552,TGS1
delta,4,regulation of regulated secretory pathway (GO:1903305),1/38,1,38,0.509428247587848,0.60942212111968,0,0,1.41864094197759,0.956825457949552,SYT12
delta,4,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),1/38,1,38,0.509428247587848,0.60942212111968,0,0,1.41864094197759,0.956825457949552,DYNLL2
delta,4,phospholipid biosynthetic process (GO:0008654),1/38,1,38,0.509428247587848,0.60942212111968,0,0,1.41864094197759,0.956825457949552,GNPAT
delta,4,positive regulation of stress fiber assembly (GO:0051496),1/38,1,38,0.509428247587848,0.60942212111968,0,0,1.41864094197759,0.956825457949552,PAK1
delta,4,response to steroid hormone (GO:0048545),1/38,1,38,0.509428247587848,0.60942212111968,0,0,1.41864094197759,0.956825457949552,ATP1A1
delta,4,positive regulation of cellular protein metabolic process (GO:0032270),2/92,2,92,0.51134592986684,0.611310839946838,0,0,1.1719207781554,0.786017756176682,EZR;LARP6
delta,4,potassium ion import (GO:0010107),1/39,1,39,0.518545654668927,0.616648886633319,0,0,1.38226553320893,0.907771378469953,ATP1A1
delta,4,positive regulation of neuron death (GO:1901216),1/39,1,39,0.518545654668927,0.616648886633319,0,0,1.38226553320893,0.907771378469953,FYN
delta,4,mitochondrion disassembly (GO:0061726),1/39,1,39,0.518545654668927,0.616648886633319,0,0,1.38226553320893,0.907771378469953,WIPI2
delta,4,regulation of cellular amide metabolic process (GO:0034248),1/39,1,39,0.518545654668927,0.616648886633319,0,0,1.38226553320893,0.907771378469953,MAPKAPK5
delta,4,DNA damage checkpoint (GO:0000077),1/39,1,39,0.518545654668927,0.616648886633319,0,0,1.38226553320893,0.907771378469953,TIPRL
delta,4,regulation of ossification (GO:0030278),1/39,1,39,0.518545654668927,0.616648886633319,0,0,1.38226553320893,0.907771378469953,RBPJ
delta,4,retina homeostasis (GO:0001895),1/39,1,39,0.518545654668927,0.616648886633319,0,0,1.38226553320893,0.907771378469953,B2M
delta,4,chemical homeostasis (GO:0048878),1/39,1,39,0.518545654668927,0.616648886633319,0,0,1.38226553320893,0.907771378469953,ACOX1
delta,4,signal transduction by p53 class mediator (GO:0072331),1/40,1,40,0.527494060011918,0.624004994004869,0,0,1.34770889487871,0.862018429024569,ATRX
delta,4,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",1/40,1,40,0.527494060011918,0.624004994004869,0,0,1.34770889487871,0.862018429024569,DDX17
delta,4,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),1/40,1,40,0.527494060011918,0.624004994004869,0,0,1.34770889487871,0.862018429024569,ATIC
delta,4,positive regulation of fat cell differentiation (GO:0045600),1/40,1,40,0.527494060011918,0.624004994004869,0,0,1.34770889487871,0.862018429024569,TMEM64
delta,4,regulation of plasma membrane bounded cell projection assembly (GO:0120032),1/40,1,40,0.527494060011918,0.624004994004869,0,0,1.34770889487871,0.862018429024569,RAB5A
delta,4,cellular response to amino acid starvation (GO:0034198),1/40,1,40,0.527494060011918,0.624004994004869,0,0,1.34770889487871,0.862018429024569,MIOS
delta,4,DNA biosynthetic process (GO:0071897),1/40,1,40,0.527494060011918,0.624004994004869,0,0,1.34770889487871,0.862018429024569,BARD1
delta,4,cellular response to fibroblast growth factor stimulus (GO:0044344),2/95,2,95,0.528536380731396,0.624004994004869,0,0,1.13491275358207,0.723669897378814,UBB;NCBP2
delta,4,vesicle fusion (GO:0006906),2/95,2,95,0.528536380731396,0.624004994004869,0,0,1.13491275358207,0.723669897378814,SYT12;STX2
delta,4,respiratory electron transport chain (GO:0022904),2/95,2,95,0.528536380731396,0.624004994004869,0,0,1.13491275358207,0.723669897378814,GPD2;NDUFS2
delta,4,axon development (GO:0061564),2/95,2,95,0.528536380731396,0.624004994004869,0,0,1.13491275358207,0.723669897378814,RYK;SLIT3
delta,4,regulation of cytoskeleton organization (GO:0051493),2/96,2,96,0.534174856385913,0.625771646010176,0,0,1.12309074573226,0.70421388949377,PRKCD;CRK
delta,4,negative regulation of TOR signaling (GO:0032007),1/41,1,41,0.536276587988765,0.625771646010176,0,0,1.31483794622313,0.819282399103272,MAPKAPK5
delta,4,regulation of cellular localization (GO:0060341),1/41,1,41,0.536276587988765,0.625771646010176,0,0,1.31483794622313,0.819282399103272,KDM1A
delta,4,positive regulation of epithelial to mesenchymal transition (GO:0010718),1/41,1,41,0.536276587988765,0.625771646010176,0,0,1.31483794622313,0.819282399103272,SNAI1
delta,4,cognition (GO:0050890),1/41,1,41,0.536276587988765,0.625771646010176,0,0,1.31483794622313,0.819282399103272,SLC1A4
delta,4,sensory organ development (GO:0007423),1/41,1,41,0.536276587988765,0.625771646010176,0,0,1.31483794622313,0.819282399103272,SMCHD1
delta,4,autophagy of mitochondrion (GO:0000422),1/41,1,41,0.536276587988765,0.625771646010176,0,0,1.31483794622313,0.819282399103272,WIPI2
delta,4,ameboidal-type cell migration (GO:0001667),1/41,1,41,0.536276587988765,0.625771646010176,0,0,1.31483794622313,0.819282399103272,CORO1C
delta,4,tRNA aminoacylation (GO:0043039),1/41,1,41,0.536276587988765,0.625771646010176,0,0,1.31483794622313,0.819282399103272,IARS
delta,4,sterol biosynthetic process (GO:0016126),1/41,1,41,0.536276587988765,0.625771646010176,0,0,1.31483794622313,0.819282399103272,G6PD
delta,4,negative regulation of cytokine secretion (GO:0050710),1/41,1,41,0.536276587988765,0.625771646010176,0,0,1.31483794622313,0.819282399103272,EZR
delta,4,androgen receptor signaling pathway (GO:0030521),1/41,1,41,0.536276587988765,0.625771646010176,0,0,1.31483794622313,0.819282399103272,DDX17
delta,4,negative regulation of ERK1 and ERK2 cascade (GO:0070373),1/41,1,41,0.536276587988765,0.625771646010176,0,0,1.31483794622313,0.819282399103272,EZR
delta,4,phosphatidic acid biosynthetic process (GO:0006654),1/41,1,41,0.536276587988765,0.625771646010176,0,0,1.31483794622313,0.819282399103272,GNPAT
delta,4,negative regulation of cytokine-mediated signaling pathway (GO:0001960),1/41,1,41,0.536276587988765,0.625771646010176,0,0,1.31483794622313,0.819282399103272,SLIT3
delta,4,regulation of intracellular transport (GO:0032386),1/41,1,41,0.536276587988765,0.625771646010176,0,0,1.31483794622313,0.819282399103272,RINT1
delta,4,regulation of ATPase activity (GO:0043462),1/41,1,41,0.536276587988765,0.625771646010176,0,0,1.31483794622313,0.819282399103272,DNAJB1
delta,4,JAK-STAT cascade (GO:0007259),1/41,1,41,0.536276587988765,0.625771646010176,0,0,1.31483794622313,0.819282399103272,STAT4
delta,4,ciliary basal body-plasma membrane docking (GO:0097711),2/97,2,97,0.539767052435933,0.629437467740416,0,0,1.11151249062161,0.685378183093591,TCTN2;TUBA4A
delta,4,phosphatidic acid metabolic process (GO:0046473),1/42,1,42,0.544896305237306,0.632226340544065,0,0,1.28353228083686,0.779309161906448,GNPAT
delta,4,regulation of calcium-mediated signaling (GO:0050848),1/42,1,42,0.544896305237306,0.632226340544065,0,0,1.28353228083686,0.779309161906448,P2RX4
delta,4,positive regulation of receptor-mediated endocytosis (GO:0048260),1/42,1,42,0.544896305237306,0.632226340544065,0,0,1.28353228083686,0.779309161906448,B2M
delta,4,regulation of protein localization (GO:0032880),1/42,1,42,0.544896305237306,0.632226340544065,0,0,1.28353228083686,0.779309161906448,KDM1A
delta,4,negative regulation of proteolysis (GO:0045861),1/42,1,42,0.544896305237306,0.632226340544065,0,0,1.28353228083686,0.779309161906448,EPHA4
delta,4,positive regulation of neuron projection development (GO:0010976),2/98,2,98,0.545312741622264,0.632226340544065,0,0,1.1001705264316,0.66713879868183,CAMK2B;RAPGEF2
delta,4,response to tumor necrosis factor (GO:0034612),2/98,2,98,0.545312741622264,0.632226340544065,0,0,1.1001705264316,0.66713879868183,YTHDC2;TANK
delta,4,protein localization to organelle (GO:0033365),2/98,2,98,0.545312741622264,0.632226340544065,0,0,1.1001705264316,0.66713879868183,GAK;XPA
delta,4,mitochondrial respiratory chain complex assembly (GO:0033108),2/98,2,98,0.545312741622264,0.632226340544065,0,0,1.1001705264316,0.66713879868183,NDUFAF4;NDUFS2
delta,4,response to UV (GO:0009411),2/99,2,99,0.550811720959036,0.636964323468013,0,0,1.08905769283128,0.649472876987663,KDM1A;XPA
delta,4,positive regulation of neuron differentiation (GO:0045666),2/99,2,99,0.550811720959036,0.636964323468013,0,0,1.08905769283128,0.649472876987663,CAMK2B;RAPGEF2
delta,4,positive regulation of cell growth (GO:0030307),2/99,2,99,0.550811720959036,0.636964323468013,0,0,1.08905769283128,0.649472876987663,SPHK1;ADNP2
delta,4,response to molecule of bacterial origin (GO:0002237),2/99,2,99,0.550811720959036,0.636964323468013,0,0,1.08905769283128,0.649472876987663,SRR;TNFAIP3
delta,4,regulation of interleukin-6 production (GO:0032675),1/43,1,43,0.553356222050865,0.637048260740115,0,0,1.25368269291042,0.74187089826742,TNFAIP3
delta,4,cellular response to calcium ion (GO:0071277),1/43,1,43,0.553356222050865,0.637048260740115,0,0,1.25368269291042,0.74187089826742,NLGN1
delta,4,regulation of protein modification process (GO:0031399),1/43,1,43,0.553356222050865,0.637048260740115,0,0,1.25368269291042,0.74187089826742,CORO1C
delta,4,cellular response to radiation (GO:0071478),1/43,1,43,0.553356222050865,0.637048260740115,0,0,1.25368269291042,0.74187089826742,TANK
delta,4,regulation of ion transmembrane transporter activity (GO:0032412),1/43,1,43,0.553356222050865,0.637048260740115,0,0,1.25368269291042,0.74187089826742,STK39
delta,4,cellular response to retinoic acid (GO:0071300),1/43,1,43,0.553356222050865,0.637048260740115,0,0,1.25368269291042,0.74187089826742,ADNP2
delta,4,translesion synthesis (GO:0019985),1/43,1,43,0.553356222050865,0.637048260740115,0,0,1.25368269291042,0.74187089826742,UBB
delta,4,cardiac ventricle morphogenesis (GO:0003208),1/44,1,44,0.561659293019178,0.64251782761466,0,0,1.22518990443519,0.7067628682991,RBPJ
delta,4,mitotic metaphase plate congression (GO:0007080),1/44,1,44,0.561659293019178,0.64251782761466,0,0,1.22518990443519,0.7067628682991,NUP62
delta,4,negative regulation of ERBB signaling pathway (GO:1901185),1/44,1,44,0.561659293019178,0.64251782761466,0,0,1.22518990443519,0.7067628682991,UBB
delta,4,membrane depolarization (GO:0051899),1/44,1,44,0.561659293019178,0.64251782761466,0,0,1.22518990443519,0.7067628682991,P2RX4
delta,4,response to unfolded protein (GO:0006986),1/44,1,44,0.561659293019178,0.64251782761466,0,0,1.22518990443519,0.7067628682991,DNAJB1
delta,4,positive regulation of protein localization to plasma membrane (GO:1903078),1/44,1,44,0.561659293019178,0.64251782761466,0,0,1.22518990443519,0.7067628682991,PIK3R1
delta,4,branching morphogenesis of an epithelial tube (GO:0048754),1/44,1,44,0.561659293019178,0.64251782761466,0,0,1.22518990443519,0.7067628682991,PAK1
delta,4,cellular response to metal ion (GO:0071248),2/101,2,101,0.561668854849401,0.64251782761466,0,0,1.06749219396333,0.615775217098097,NLGN1;B2M
delta,4,cellular response to transforming growth factor beta stimulus (GO:0071560),2/101,2,101,0.561668854849401,0.64251782761466,0,0,1.06749219396333,0.615775217098097,UBB;NEDD8
delta,4,regulation of lipid metabolic process (GO:0019216),2/101,2,101,0.561668854849401,0.64251782761466,0,0,1.06749219396333,0.615775217098097,ACOX1;TGS1
delta,4,regulation of kinase activity (GO:0043549),2/102,2,102,0.567026717662051,0.647825331641761,0,0,1.05702658421859,0.599702822543689,EPHA4;RYK
delta,4,intrinsic apoptotic signaling pathway (GO:0097193),2/102,2,102,0.567026717662051,0.647825331641761,0,0,1.05702658421859,0.599702822543689,PRKCD;TANK
delta,4,ribosomal small subunit biogenesis (GO:0042274),1/45,1,45,0.569808418348459,0.64813013032826,0,0,1.19796346211441,0.673800638288286,LSM6
delta,4,negative regulation of immune system process (GO:0002683),1/45,1,45,0.569808418348459,0.64813013032826,0,0,1.19796346211441,0.673800638288286,LRRC14
delta,4,microtubule cytoskeleton organization involved in mitosis (GO:1902850),1/45,1,45,0.569808418348459,0.64813013032826,0,0,1.19796346211441,0.673800638288286,NUSAP1
delta,4,mitotic nuclear envelope disassembly (GO:0007077),1/45,1,45,0.569808418348459,0.64813013032826,0,0,1.19796346211441,0.673800638288286,NUP62
delta,4,metaphase plate congression (GO:0051310),1/45,1,45,0.569808418348459,0.64813013032826,0,0,1.19796346211441,0.673800638288286,NUP62
delta,4,negative regulation of immune response (GO:0050777),1/45,1,45,0.569808418348459,0.64813013032826,0,0,1.19796346211441,0.673800638288286,TNFAIP3
delta,4,positive regulation of actin filament bundle assembly (GO:0032233),1/45,1,45,0.569808418348459,0.64813013032826,0,0,1.19796346211441,0.673800638288286,PAK1
delta,4,hexose metabolic process (GO:0019318),1/46,1,46,0.577806444767294,0.65516205302338,0,0,1.1719207781554,0.642817692530499,HECTD4
delta,4,"regulation of synaptic transmission, glutamatergic (GO:0051966)",1/46,1,46,0.577806444767294,0.65516205302338,0,0,1.1719207781554,0.642817692530499,NLGN1
delta,4,mitochondrial gene expression (GO:0140053),1/46,1,46,0.577806444767294,0.65516205302338,0,0,1.1719207781554,0.642817692530499,PTCD3
delta,4,metal ion homeostasis (GO:0055065),1/46,1,46,0.577806444767294,0.65516205302338,0,0,1.1719207781554,0.642817692530499,GPRIN1
delta,4,peptidyl-tyrosine autophosphorylation (GO:0038083),1/46,1,46,0.577806444767294,0.65516205302338,0,0,1.1719207781554,0.642817692530499,FYN
delta,4,peptide metabolic process (GO:0006518),2/105,2,105,0.582816181944537,0.659502948910005,0,0,1.02682582466949,0.554366257665791,G6PD;IDE
delta,4,positive regulation of vasculature development (GO:1904018),2/105,2,105,0.582816181944537,0.659502948910005,0,0,1.02682582466949,0.554366257665791,SPHK1;RAPGEF2
delta,4,nucleocytoplasmic transport (GO:0006913),1/47,1,47,0.585656166382388,0.659502948910005,0,0,1.14698629351379,0.613663369153086,NCBP2
delta,4,positive regulation of protein localization to cell periphery (GO:1904377),1/47,1,47,0.585656166382388,0.659502948910005,0,0,1.14698629351379,0.613663369153086,PIK3R1
delta,4,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),1/47,1,47,0.585656166382388,0.659502948910005,0,0,1.14698629351379,0.613663369153086,TNFAIP3
delta,4,nuclear envelope disassembly (GO:0051081),1/47,1,47,0.585656166382388,0.659502948910005,0,0,1.14698629351379,0.613663369153086,NUP62
delta,4,positive regulation of ion transport (GO:0043270),1/47,1,47,0.585656166382388,0.659502948910005,0,0,1.14698629351379,0.613663369153086,P2RX4
delta,4,maturation of SSU-rRNA (GO:0030490),1/47,1,47,0.585656166382388,0.659502948910005,0,0,1.14698629351379,0.613663369153086,LSM6
delta,4,mitotic spindle assembly (GO:0090307),1/47,1,47,0.585656166382388,0.659502948910005,0,0,1.14698629351379,0.613663369153086,BIRC2
delta,4,aminoglycan biosynthetic process (GO:0006023),1/47,1,47,0.585656166382388,0.659502948910005,0,0,1.14698629351379,0.613663369153086,SDC2
delta,4,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",1/47,1,47,0.585656166382388,0.659502948910005,0,0,1.14698629351379,0.613663369153086,NDUFS2
delta,4,RNA splicing (GO:0008380),2/107,2,107,0.593105028874651,0.66651433879569,0,0,1.0076328186009,0.526371041849553,LSM6;NCBP2
delta,4,postreplication repair (GO:0006301),1/48,1,48,0.593360326001041,0.66651433879569,0,0,1.12309074573226,0.586201069338187,UBB
delta,4,positive regulation of organelle assembly (GO:1902117),1/48,1,48,0.593360326001041,0.66651433879569,0,0,1.12309074573226,0.586201069338187,NUP62
delta,4,"positive regulation of gene expression, epigenetic (GO:0045815)",1/48,1,48,0.593360326001041,0.66651433879569,0,0,1.12309074573226,0.586201069338187,POLR1A
delta,4,viral life cycle (GO:0019058),2/108,2,108,0.59817810340772,0.671090359793238,0,0,0.998302885095338,0.51299464668973,UBB;NUP62
delta,4,regulation of protein secretion (GO:0050708),2/108,2,108,0.59817810340772,0.671090359793238,0,0,0.998302885095338,0.51299464668973,MARCKS;EZR
delta,4,regulation of epithelial cell migration (GO:0010632),1/49,1,49,0.600921615631088,0.672912845809114,0,0,1.1001705264316,0.560306701353828,CORO1C
delta,4,positive regulation of chemotaxis (GO:0050921),1/49,1,49,0.600921615631088,0.672912845809114,0,0,1.1001705264316,0.560306701353828,P2RX4
delta,4,cellular macromolecule catabolic process (GO:0044265),1/49,1,49,0.600921615631088,0.672912845809114,0,0,1.1001705264316,0.560306701353828,UBE2G1
delta,4,regulation of cell motility (GO:2000145),2/110,2,110,0.608181544845454,0.677856819315741,0,0,0.98015192354815,0.487411759951309,SLK;CRK
delta,4,negative regulation of protein kinase activity (GO:0006469),2/110,2,110,0.608181544845454,0.677856819315741,0,0,0.98015192354815,0.487411759951309,PAK2;CORO1C
delta,4,RNA methylation (GO:0001510),1/50,1,50,0.608342677645335,0.677856819315741,0,0,1.07816711590296,0.535867322090293,TGS1
delta,4,glutathione metabolic process (GO:0006749),1/50,1,50,0.608342677645335,0.677856819315741,0,0,1.07816711590296,0.535867322090293,G6PD
delta,4,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/50,1,50,0.608342677645335,0.677856819315741,0,0,1.07816711590296,0.535867322090293,RPL30
delta,4,regulation of reactive oxygen species metabolic process (GO:2000377),1/50,1,50,0.608342677645335,0.677856819315741,0,0,1.07816711590296,0.535867322090293,SIRT5
delta,4,positive regulation of response to DNA damage stimulus (GO:2001022),1/50,1,50,0.608342677645335,0.677856819315741,0,0,1.07816711590296,0.535867322090293,PRKCD
delta,4,lipid homeostasis (GO:0055088),1/50,1,50,0.608342677645335,0.677856819315741,0,0,1.07816711590296,0.535867322090293,ACOX1
delta,4,regulation of cellular protein metabolic process (GO:0032268),1/51,1,51,0.615626105770768,0.684281882199917,0,0,1.05702658421859,0.512779949137499,MAPKAPK5
delta,4,regulation of blood vessel endothelial cell migration (GO:0043535),1/51,1,51,0.615626105770768,0.684281882199917,0,0,1.05702658421859,0.512779949137499,P2RX4
delta,4,wound healing (GO:0042060),1/51,1,51,0.615626105770768,0.684281882199917,0,0,1.05702658421859,0.512779949137499,PAK1
delta,4,neurogenesis (GO:0022008),1/51,1,51,0.615626105770768,0.684281882199917,0,0,1.05702658421859,0.512779949137499,RYK
delta,4,regulation of exocytosis (GO:0017157),1/52,1,52,0.622774445843843,0.69180117013688,0,0,1.0366991499067,0.490950519327536,RAB5A
delta,4,positive regulation of developmental process (GO:0051094),2/114,2,114,0.627618546353107,0.696753143151387,0,0,0.945760627985057,0.440556776212269,RBPJ;CORO1C
delta,4,positive regulation of proteolysis (GO:0045862),1/53,1,53,0.629790196804045,0.697447216104664,0,0,1.0171387885877,0.470292972594526,TANK
delta,4,positive regulation of cell-substrate adhesion (GO:0010811),1/53,1,53,0.629790196804045,0.697447216104664,0,0,1.0171387885877,0.470292972594526,CRK
delta,4,regulation of DNA binding (GO:0051101),1/53,1,53,0.629790196804045,0.697447216104664,0,0,1.0171387885877,0.470292972594526,KDM1A
delta,4,triglyceride metabolic process (GO:0006641),1/53,1,53,0.629790196804045,0.697447216104664,0,0,1.0171387885877,0.470292972594526,GNPAT
delta,4,negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),1/54,1,54,0.636675811259075,0.703762357146128,0,0,0.998302885095338,0.450728445121866,UBB
delta,4,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),1/54,1,54,0.636675811259075,0.703762357146128,0,0,0.998302885095338,0.450728445121866,PARP9
delta,4,peptidyl-lysine modification (GO:0018205),2/116,2,116,0.637053175842365,0.703762357146128,0,0,0.929454410261177,0.4190929903659,NUP62;SIRT5
delta,4,negative regulation of cell growth (GO:0030308),2/116,2,116,0.637053175842365,0.703762357146128,0,0,0.929454410261177,0.4190929903659,EPHA4;SLIT3
delta,4,sensory perception (GO:0007600),1/55,1,55,0.643433696902998,0.709074153459383,0,0,0.98015192354815,0.432184555128854,P2RX4
delta,4,negative regulation of cellular component organization (GO:0051129),1/55,1,55,0.643433696902998,0.709074153459383,0,0,0.98015192354815,0.432184555128854,DNAJB1
delta,4,positive regulation of response to stimulus (GO:0048584),1/55,1,55,0.643433696902998,0.709074153459383,0,0,0.98015192354815,0.432184555128854,PRKCD
delta,4,glycosphingolipid metabolic process (GO:0006687),1/55,1,55,0.643433696902998,0.709074153459383,0,0,0.98015192354815,0.432184555128854,ESYT2
delta,4,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),1/56,1,56,0.65006621673487,0.714201860529662,0,0,0.962649210627647,0.414594772219142,UBB
delta,4,regulation of RNA splicing (GO:0043484),1/56,1,56,0.65006621673487,0.714201860529662,0,0,0.962649210627647,0.414594772219142,PIK3R1
delta,4,regulation of gene silencing by RNA (GO:0060966),1/56,1,56,0.65006621673487,0.714201860529662,0,0,0.962649210627647,0.414594772219142,NUP62
delta,4,regulation of posttranscriptional gene silencing (GO:0060147),1/56,1,56,0.65006621673487,0.714201860529662,0,0,0.962649210627647,0.414594772219142,NUP62
delta,4,fat cell differentiation (GO:0045444),1/56,1,56,0.65006621673487,0.714201860529662,0,0,0.962649210627647,0.414594772219142,ATF5
delta,4,ribosome assembly (GO:0042255),1/57,1,57,0.656575690246066,0.717856088002366,0,0,0.945760627985057,0.397897856233638,RSL24D1
delta,4,anion transport (GO:0006820),1/57,1,57,0.656575690246066,0.717856088002366,0,0,0.945760627985057,0.397897856233638,VDAC2
delta,4,cellular defense response (GO:0006968),1/57,1,57,0.656575690246066,0.717856088002366,0,0,0.945760627985057,0.397897856233638,ZNF148
delta,4,regulation of BMP signaling pathway (GO:0030510),1/57,1,57,0.656575690246066,0.717856088002366,0,0,0.945760627985057,0.397897856233638,RBPJ
delta,4,organonitrogen compound catabolic process (GO:1901565),1/57,1,57,0.656575690246066,0.717856088002366,0,0,0.945760627985057,0.397897856233638,IDE
delta,4,positive regulation of protein transport (GO:0051222),1/57,1,57,0.656575690246066,0.717856088002366,0,0,0.945760627985057,0.397897856233638,EZR
delta,4,autophagosome organization (GO:1905037),1/57,1,57,0.656575690246066,0.717856088002366,0,0,0.945760627985057,0.397897856233638,WIPI2
delta,4,glycosaminoglycan catabolic process (GO:0006027),1/57,1,57,0.656575690246066,0.717856088002366,0,0,0.945760627985057,0.397897856233638,SDC2
delta,4,regulation of Rho protein signal transduction (GO:0035023),1/58,1,58,0.662964394093748,0.723088129954729,0,0,0.929454410261177,0.382037358928391,ARAP2
delta,4,regulation of neurogenesis (GO:0050767),1/58,1,58,0.662964394093748,0.723088129954729,0,0,0.929454410261177,0.382037358928391,NLGN1
delta,4,protein homotetramerization (GO:0051289),1/58,1,58,0.662964394093748,0.723088129954729,0,0,0.929454410261177,0.382037358928391,SRR
delta,4,response to retinoic acid (GO:0032526),1/58,1,58,0.662964394093748,0.723088129954729,0,0,0.929454410261177,0.382037358928391,ADNP2
delta,4,Golgi organization (GO:0007030),2/122,2,122,0.664232375465124,0.723596138489785,0,0,0.883743537625381,0.361560008553402,GAK;PI4K2B
delta,4,regulation of cell differentiation (GO:0045595),2/122,2,122,0.664232375465124,0.723596138489785,0,0,0.883743537625381,0.361560008553402,DDX17;BIRC2
delta,4,receptor metabolic process (GO:0043112),1/59,1,59,0.669234563134007,0.727727035499547,0,0,0.913700945680479,0.366961179374346,CLTC
delta,4,autophagosome assembly (GO:0000045),1/59,1,59,0.669234563134007,0.727727035499547,0,0,0.913700945680479,0.366961179374346,WIPI2
delta,4,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1/59,1,59,0.669234563134007,0.727727035499547,0,0,0.913700945680479,0.366961179374346,CRK
delta,4,mitotic cytokinesis (GO:0000281),1/60,1,60,0.67538839054757,0.733534410925838,0,0,0.898472596585804,0.3526211681771,NUSAP1
delta,4,cell morphogenesis (GO:0000902),1/60,1,60,0.67538839054757,0.733534410925838,0,0,0.898472596585804,0.3526211681771,CDH24
delta,4,platelet degranulation (GO:0002576),2/125,2,125,0.677197014173655,0.735056205517012,0,0,0.862533692722372,0.336209628298861,GTPBP2;TUBA4A
delta,4,negative regulation of multicellular organismal process (GO:0051241),2/126,2,126,0.681427205724207,0.737430213106671,0,0,0.855688187224575,0.328212765443362,RBPJ;CORO1C
delta,4,"regulation of mRNA splicing, via spliceosome (GO:0048024)",1/61,1,61,0.681428029517084,0.737430213106671,0,0,0.883743537625381,0.338972771343137,DDX17
delta,4,cell chemotaxis (GO:0060326),1/61,1,61,0.681428029517084,0.737430213106671,0,0,0.883743537625381,0.338972771343137,PRKCD
delta,4,regulation of stress fiber assembly (GO:0051492),1/61,1,61,0.681428029517084,0.737430213106671,0,0,0.883743537625381,0.338972771343137,PAK1
delta,4,muscle organ development (GO:0007517),1/61,1,61,0.681428029517084,0.737430213106671,0,0,0.883743537625381,0.338972771343137,ZBTB42
delta,4,G2/M transition of mitotic cell cycle (GO:0000086),2/127,2,127,0.685612068652238,0.741177220552148,0,0,0.848950484962965,0.320430680053323,UBB;TUBA4A
delta,4,potassium ion transport (GO:0006813),1/62,1,62,0.687355593117375,0.741177220552148,0,0,0.869489609599165,0.325974713397938,KCNF1
delta,4,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),1/62,1,62,0.687355593117375,0.741177220552148,0,0,0.869489609599165,0.325974713397938,PARP9
delta,4,glycosaminoglycan metabolic process (GO:0030203),1/62,1,62,0.687355593117375,0.741177220552148,0,0,0.869489609599165,0.325974713397938,SDC2
delta,4,regulation of tumor necrosis factor production (GO:0032680),1/62,1,62,0.687355593117375,0.741177220552148,0,0,0.869489609599165,0.325974713397938,TNFAIP3
delta,4,negative regulation of MAP kinase activity (GO:0043407),1/62,1,62,0.687355593117375,0.741177220552148,0,0,0.869489609599165,0.325974713397938,PRKCD
delta,4,positive regulation of protein kinase B signaling (GO:0051897),2/128,2,128,0.689751823860918,0.742429767449341,0,0,0.842318059299191,0.312856655705432,FYN;PIK3R1
delta,4,negative regulation of response to stimulus (GO:0048585),2/128,2,128,0.689751823860918,0.742429767449341,0,0,0.842318059299191,0.312856655705432,EPHA4;RYK
delta,4,cell cycle G2/M phase transition (GO:0044839),2/128,2,128,0.689751823860918,0.742429767449341,0,0,0.842318059299191,0.312856655705432,UBB;TUBA4A
delta,4,diterpenoid metabolic process (GO:0016101),1/63,1,63,0.693173155678134,0.743450875650032,0,0,0.855688187224575,0.313588710999535,SDC2
delta,4,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),1/63,1,63,0.693173155678134,0.743450875650032,0,0,0.855688187224575,0.313588710999535,SNAI1
delta,4,cellular amide metabolic process (GO:0043603),1/63,1,63,0.693173155678134,0.743450875650032,0,0,0.855688187224575,0.313588710999535,BTD
delta,4,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",1/63,1,63,0.693173155678134,0.743450875650032,0,0,0.855688187224575,0.313588710999535,UBB
delta,4,negative regulation of peptidase activity (GO:0010466),1/63,1,63,0.693173155678134,0.743450875650032,0,0,0.855688187224575,0.313588710999535,SERPINB6
delta,4,second-messenger-mediated signaling (GO:0019932),1/63,1,63,0.693173155678134,0.743450875650032,0,0,0.855688187224575,0.313588710999535,SPHK1
delta,4,regulation of proteolysis (GO:0030162),1/64,1,64,0.698882753106937,0.748240051397576,0,0,0.842318059299191,0.301779216644756,NEDD8
delta,4,ribosomal large subunit biogenesis (GO:0042273),1/64,1,64,0.698882753106937,0.748240051397576,0,0,0.842318059299191,0.301779216644756,RSL24D1
delta,4,signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),1/64,1,64,0.698882753106937,0.748240051397576,0,0,0.842318059299191,0.301779216644756,UBB
delta,4,positive regulation of protein polymerization (GO:0032273),1/65,1,65,0.704486383691985,0.75111905211604,0,0,0.829359319925358,0.290513187186227,PAK1
delta,4,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/65,1,65,0.704486383691985,0.75111905211604,0,0,0.829359319925358,0.290513187186227,CDH24
delta,4,positive regulation of JAK-STAT cascade (GO:0046427),1/65,1,65,0.704486383691985,0.75111905211604,0,0,0.829359319925358,0.290513187186227,PARP9
delta,4,glycerophospholipid metabolic process (GO:0006650),1/65,1,65,0.704486383691985,0.75111905211604,0,0,0.829359319925358,0.290513187186227,GPCPD1
delta,4,positive regulation of endocytosis (GO:0045807),1/65,1,65,0.704486383691985,0.75111905211604,0,0,0.829359319925358,0.290513187186227,B2M
delta,4,glucose metabolic process (GO:0006006),1/65,1,65,0.704486383691985,0.75111905211604,0,0,0.829359319925358,0.290513187186227,HECTD4
delta,4,cellular response to decreased oxygen levels (GO:0036294),1/65,1,65,0.704486383691985,0.75111905211604,0,0,0.829359319925358,0.290513187186227,TBL2
delta,4,glycolipid metabolic process (GO:0006664),1/66,1,66,0.709986008872315,0.754752362996851,0,0,0.816793269623458,0.27975987499353,ESYT2
delta,4,cellular response to type I interferon (GO:0071357),1/66,1,66,0.709986008872315,0.754752362996851,0,0,0.816793269623458,0.27975987499353,HLA-B
delta,4,negative regulation of blood vessel morphogenesis (GO:2000181),1/66,1,66,0.709986008872315,0.754752362996851,0,0,0.816793269623458,0.27975987499353,KRIT1
delta,4,type I interferon signaling pathway (GO:0060337),1/66,1,66,0.709986008872315,0.754752362996851,0,0,0.816793269623458,0.27975987499353,HLA-B
delta,4,negative regulation of cell adhesion (GO:0007162),1/66,1,66,0.709986008872315,0.754752362996851,0,0,0.816793269623458,0.27975987499353,TBCD
delta,4,positive regulation of cytosolic calcium ion concentration (GO:0007204),2/134,2,134,0.713656358345614,0.75776107737227,0,0,0.80460232530072,0.271435590242294,P2RX4;GPRIN1
delta,4,cellular response to organic substance (GO:0071310),2/134,2,134,0.713656358345614,0.75776107737227,0,0,0.80460232530072,0.271435590242294,TBK1;SLIT3
delta,4,cellular response to light stimulus (GO:0071482),1/67,1,67,0.71538355401881,0.758256128936506,0,0,0.80460232530072,0.269490639202677,KDM1A
delta,4,intracellular steroid hormone receptor signaling pathway (GO:0030518),1/67,1,67,0.71538355401881,0.758256128936506,0,0,0.80460232530072,0.269490639202677,DDX17
delta,4,negative regulation of epithelial cell proliferation (GO:0050680),1/67,1,67,0.71538355401881,0.758256128936506,0,0,0.80460232530072,0.269490639202677,KRIT1
delta,4,regulation of gene silencing by miRNA (GO:0060964),1/68,1,68,0.720680908739039,0.762974389298841,0,0,0.792769938163945,0.259678775399376,NUP62
delta,4,extrinsic apoptotic signaling pathway (GO:0097191),1/68,1,68,0.720680908739039,0.762974389298841,0,0,0.792769938163945,0.259678775399376,TANK
delta,4,regulation of epithelial to mesenchymal transition (GO:0010717),1/69,1,69,0.725879927931984,0.767127937896484,0,0,0.781280518770265,0.250299360411711,SNAI1
delta,4,protein sumoylation (GO:0016925),1/69,1,69,0.725879927931984,0.767127937896484,0,0,0.781280518770265,0.250299360411711,NUP62
delta,4,cholesterol metabolic process (GO:0008203),1/69,1,69,0.725879927931984,0.767127937896484,0,0,0.781280518770265,0.250299360411711,G6PD
delta,4,regulation of endothelial cell migration (GO:0010594),1/70,1,70,0.730982432109994,0.770714381955832,0,0,0.770119368502118,0.241329112208252,KRIT1
delta,4,positive regulation of neurogenesis (GO:0050769),1/70,1,70,0.730982432109994,0.770714381955832,0,0,0.770119368502118,0.241329112208252,RAPGEF2
delta,4,negative regulation of angiogenesis (GO:0016525),1/70,1,70,0.730982432109994,0.770714381955832,0,0,0.770119368502118,0.241329112208252,KRIT1
delta,4,regulation of osteoblast differentiation (GO:0045667),1/70,1,70,0.730982432109994,0.770714381955832,0,0,0.770119368502118,0.241329112208252,TMEM64
delta,4,positive regulation of endothelial cell migration (GO:0010595),1/71,1,71,0.735990208317875,0.77284287613453,0,0,0.759272616833074,0.232746261916928,P2RX4
delta,4,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/71,1,71,0.735990208317875,0.77284287613453,0,0,0.759272616833074,0.232746261916928,ANKIB1
delta,4,cytoskeleton-dependent cytokinesis (GO:0061640),1/71,1,71,0.735990208317875,0.77284287613453,0,0,0.759272616833074,0.232746261916928,NUSAP1
delta,4,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),1/71,1,71,0.735990208317875,0.77284287613453,0,0,0.759272616833074,0.232746261916928,ANKIB1
delta,4,phospholipid metabolic process (GO:0006644),1/71,1,71,0.735990208317875,0.77284287613453,0,0,0.759272616833074,0.232746261916928,GNPAT
delta,4,neuropeptide signaling pathway (GO:0007218),1/71,1,71,0.735990208317875,0.77284287613453,0,0,0.759272616833074,0.232746261916928,RAPGEF2
delta,4,neuron differentiation (GO:0030182),2/140,2,140,0.736000033924126,0.77284287613453,0,0,0.770119368502118,0.236060927347478,RYK;ADNP2
delta,4,recombinational repair (GO:0000725),1/72,1,72,0.740905010386349,0.776186201357127,0,0,0.748727163821503,0.224530438016452,RECQL4
delta,4,histone acetylation (GO:0016573),1/72,1,72,0.740905010386349,0.776186201357127,0,0,0.748727163821503,0.224530438016452,DMAP1
delta,4,defense response to Gram-negative bacterium (GO:0050829),1/72,1,72,0.740905010386349,0.776186201357127,0,0,0.748727163821503,0.224530438016452,RPL30
delta,4,regulation of cation channel activity (GO:2001257),1/72,1,72,0.740905010386349,0.776186201357127,0,0,0.748727163821503,0.224530438016452,NLGN1
delta,4,cell-cell junction organization (GO:0045216),1/73,1,73,0.745728559954242,0.778977604028634,0,0,0.738470627330798,0.216662560013939,CDH24
delta,4,response to metal ion (GO:0010038),1/73,1,73,0.745728559954242,0.778977604028634,0,0,0.738470627330798,0.216662560013939,SLC30A1
delta,4,regulation of fat cell differentiation (GO:0045598),1/73,1,73,0.745728559954242,0.778977604028634,0,0,0.738470627330798,0.216662560013939,TMEM64
delta,4,regulation of epithelial cell proliferation (GO:0050678),1/73,1,73,0.745728559954242,0.778977604028634,0,0,0.738470627330798,0.216662560013939,LAMC1
delta,4,negative regulation of cell cycle (GO:0045786),1/73,1,73,0.745728559954242,0.778977604028634,0,0,0.738470627330798,0.216662560013939,LATS2
delta,4,lymphocyte differentiation (GO:0030098),1/74,1,74,0.750462546732616,0.782111169442888,0,0,0.72849129452903,0.209124742168077,RELB
delta,4,regulation of peptide hormone secretion (GO:0090276),1/74,1,74,0.750462546732616,0.782111169442888,0,0,0.72849129452903,0.209124742168077,MARCKS
delta,4,regulation of protein complex assembly (GO:0043254),1/74,1,74,0.750462546732616,0.782111169442888,0,0,0.72849129452903,0.209124742168077,FAF1
delta,4,positive regulation of proteasomal protein catabolic process (GO:1901800),1/74,1,74,0.750462546732616,0.782111169442888,0,0,0.72849129452903,0.209124742168077,ANKIB1
delta,4,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),2/145,2,145,0.753471162986616,0.784793289854421,0,0,0.743563528208941,0.210476462423835,UBB;NEDD8
delta,4,mitotic spindle organization (GO:0007052),1/75,1,75,0.75510862938648,0.786044989851823,0,0,0.718778077268643,0.20190020492417,BIRC2
delta,4,retinoid metabolic process (GO:0001523),1/76,1,76,0.759668435836812,0.788970557426373,0,0,0.709320470988793,0.194973194446292,SDC2
delta,4,negative regulation of phosphorylation (GO:0042326),1/76,1,76,0.759668435836812,0.788970557426373,0,0,0.709320470988793,0.194973194446292,CORO1C
delta,4,negative regulation of cellular amide metabolic process (GO:0034249),1/76,1,76,0.759668435836812,0.788970557426373,0,0,0.709320470988793,0.194973194446292,IGF2BP2
delta,4,cAMP-mediated signaling (GO:0019933),1/76,1,76,0.759668435836812,0.788970557426373,0,0,0.709320470988793,0.194973194446292,RAPGEF2
delta,4,double-strand break repair via homologous recombination (GO:0000724),1/77,1,77,0.764143563885613,0.792705571736426,0,0,0.700108516820107,0.188328908617359,RECQL4
delta,4,hemopoiesis (GO:0030097),1/77,1,77,0.764143563885613,0.792705571736426,0,0,0.700108516820107,0.188328908617359,BMI1
delta,4,regulated exocytosis (GO:0045055),2/149,2,149,0.766723314845542,0.794924632173195,0,0,0.723602091210044,0.192209902157195,GTPBP2;TUBA4A
delta,4,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),1/78,1,78,0.768535581982382,0.795888742764764,0,0,0.691132766604465,0.181953429063994,UBB
delta,4,water-soluble vitamin metabolic process (GO:0006767),1/78,1,78,0.768535581982382,0.795888742764764,0,0,0.691132766604465,0.181953429063994,BTD
delta,4,adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189),1/79,1,79,0.772846029443804,0.798519036149269,0,0,0.682384250571497,0.175833659249981,RAPGEF2
delta,4,sensory perception of mechanical stimulus (GO:0050954),1/79,1,79,0.772846029443804,0.798519036149269,0,0,0.682384250571497,0.175833659249981,SERPINB6
delta,4,positive regulation of translation (GO:0045727),1/79,1,79,0.772846029443804,0.798519036149269,0,0,0.682384250571497,0.175833659249981,LARP6
delta,4,visual perception (GO:0007601),1/79,1,79,0.772846029443804,0.798519036149269,0,0,0.682384250571497,0.175833659249981,OAT
delta,4,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),1/80,1,80,0.777076417222665,0.801054775239822,0,0,0.673854447439353,0.169957267106821,TANK
delta,4,regulation of endothelial cell proliferation (GO:0001936),1/80,1,80,0.777076417222665,0.801054775239822,0,0,0.673854447439353,0.169957267106821,KRIT1
delta,4,response to calcium ion (GO:0051592),1/80,1,80,0.777076417222665,0.801054775239822,0,0,0.673854447439353,0.169957267106821,NLGN1
delta,4,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),1/80,1,80,0.777076417222665,0.801054775239822,0,0,0.673854447439353,0.169957267106821,UBB
delta,4,"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",1/81,1,81,0.781228228327915,0.804415367524862,0,0,0.665535256730225,0.164312632564712,RINT1
delta,4,positive regulation of stress-activated MAPK cascade (GO:0032874),1/81,1,81,0.781228228327915,0.804415367524862,0,0,0.665535256730225,0.164312632564712,GADD45B
delta,4,epidermis development (GO:0008544),1/82,1,82,0.785302918456018,0.80722875492573,0,0,0.657418973111564,0.158888799059964,ATP2A2
delta,4,sensory perception of light stimulus (GO:0050953),1/82,1,82,0.785302918456018,0.80722875492573,0,0,0.657418973111564,0.158888799059964,OAT
delta,4,sensory perception of sound (GO:0007605),1/82,1,82,0.785302918456018,0.80722875492573,0,0,0.657418973111564,0.158888799059964,SERPINB6
delta,4,modulation of chemical synaptic transmission (GO:0050804),1/83,1,83,0.789301916244109,0.808116150343003,0,0,0.649498262592148,0.153675429152131,NLGN1
delta,4,positive regulation of cell cycle (GO:0045787),1/83,1,83,0.789301916244109,0.808116150343003,0,0,0.649498262592148,0.153675429152131,SPHK1
delta,4,positive regulation of protein secretion (GO:0050714),1/83,1,83,0.789301916244109,0.808116150343003,0,0,0.649498262592148,0.153675429152131,EZR
delta,4,"retrograde transport, endosome to Golgi (GO:0042147)",1/83,1,83,0.789301916244109,0.808116150343003,0,0,0.649498262592148,0.153675429152131,CLTC
delta,4,positive regulation of DNA metabolic process (GO:0051054),1/83,1,83,0.789301916244109,0.808116150343003,0,0,0.649498262592148,0.153675429152131,ATRX
delta,4,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),1/83,1,83,0.789301916244109,0.808116150343003,0,0,0.649498262592148,0.153675429152131,RBPJ
delta,4,positive regulation of cell cycle arrest (GO:0071158),1/83,1,83,0.789301916244109,0.808116150343003,0,0,0.649498262592148,0.153675429152131,UBB
delta,4,negative regulation of endopeptidase activity (GO:0010951),1/84,1,84,0.793226624253495,0.811673755050087,0,0,0.641766140418432,0.148662762979804,SERPINB6
delta,4,positive regulation of supramolecular fiber organization (GO:1902905),1/85,1,85,0.797078418677876,0.813768798695466,0,0,0.634215950531156,0.143841580918719,PAK1
delta,4,protein modification process (GO:0036211),1/85,1,85,0.797078418677876,0.813768798695466,0,0,0.634215950531156,0.143841580918719,NEDD8
delta,4,regulation of neuron differentiation (GO:0045664),1/85,1,85,0.797078418677876,0.813768798695466,0,0,0.634215950531156,0.143841580918719,NLGN1
delta,4,cellular response to molecule of bacterial origin (GO:0071219),1/85,1,85,0.797078418677876,0.813768798695466,0,0,0.634215950531156,0.143841580918719,TNFAIP3
delta,4,mitochondrial ATP synthesis coupled electron transport (GO:0042775),1/86,1,86,0.800858650577655,0.817165727173127,0,0,0.626841346455212,0.139203167856175,NDUFS2
delta,4,regulation of MAP kinase activity (GO:0043405),1/88,1,88,0.808209706658547,0.824200288757501,0,0,0.612594952217594,0.13044211969581,PRKCD
delta,4,T cell activation (GO:0042110),1/89,1,89,0.811783109700694,0.826909503049154,0,0,0.605711862866834,0.126304297997897,FYN
delta,4,negative regulation of translation (GO:0017148),1/89,1,89,0.811783109700694,0.826909503049154,0,0,0.605711862866834,0.126304297997897,IGF2BP2
delta,4,negative regulation of cellular protein metabolic process (GO:0032269),1/90,1,90,0.81529010910537,0.830013181053096,0,0,0.598981731057203,0.122318818202019,IGF2BP2
delta,4,regulation of cell cycle process (GO:0010564),1/91,1,91,0.818731935596984,0.832577458746876,0,0,0.592399514232398,0.11847904722554,ATF5
delta,4,regulation of JNK cascade (GO:0046328),1/91,1,91,0.818731935596984,0.832577458746876,0,0,0.592399514232398,0.11847904722554,GADD45B
delta,4,cellular response to acid chemical (GO:0071229),1/92,1,92,0.822109797154029,0.834601054623448,0,0,0.585960389077698,0.114778694284529,ADNP2
delta,4,cellular response to lipopolysaccharide (GO:0071222),1/92,1,92,0.822109797154029,0.834601054623448,0,0,0.585960389077698,0.114778694284529,TNFAIP3
delta,4,negative regulation of kinase activity (GO:0033673),1/92,1,92,0.822109797154029,0.834601054623448,0,0,0.585960389077698,0.114778694284529,PAK2
delta,4,regulation of B cell activation (GO:0050864),1/96,1,96,0.835004979057798,0.846739169319993,0,0,0.561545372866128,0.101256508987864,TNFAIP3
delta,4,transcription elongation from RNA polymerase II promoter (GO:0006368),1/96,1,96,0.835004979057798,0.846739169319993,0,0,0.561545372866128,0.101256508987864,NCBP2
delta,4,epithelial cell differentiation (GO:0030855),1/97,1,97,0.838080367430979,0.849380327441284,0,0,0.555756245310807,0.0981694941189602,CASP6
delta,4,mRNA metabolic process (GO:0016071),1/98,1,98,0.841098583679253,0.851482516811095,0,0,0.550085263215799,0.095190276641287,NCBP2
delta,4,negative regulation of cell motility (GO:2000146),1/98,1,98,0.841098583679253,0.851482516811095,0,0,0.550085263215799,0.095190276641287,CRK
delta,4,regulation of insulin secretion (GO:0050796),1/99,1,99,0.844060687810662,0.853523251575356,0,0,0.544528846415639,0.0923144555976386,MARCKS
delta,4,histone modification (GO:0016570),1/99,1,99,0.844060687810662,0.853523251575356,0,0,0.544528846415639,0.0923144555976386,PRKCD
delta,4,glycosaminoglycan biosynthetic process (GO:0006024),1/100,1,100,0.84696772026382,0.8559830629445,0,0,0.539083557951483,0.0895378413610596,SDC2
delta,4,protein processing (GO:0016485),1/102,1,102,0.85262063593216,0.860731744388145,0,0,0.528513292109297,0.0842664612922242,RCE1
delta,4,metal ion transport (GO:0030001),1/102,1,102,0.85262063593216,0.860731744388145,0,0,0.528513292109297,0.0842664612922242,KCNF1
delta,4,positive regulation of angiogenesis (GO:0045766),1/104,1,104,0.858065275519863,0.865743711989839,0,0,0.518349574953349,0.0793464149354828,SPHK1
delta,4,monovalent inorganic cation transport (GO:0015672),1/105,1,105,0.860711894710091,0.867928595895475,0,0,0.513412912334745,0.0770095995957583,KCNF1
delta,4,positive regulation of epithelial cell proliferation (GO:0050679),1/108,1,108,0.868360061091325,0.875151704027235,0,0,0.499151442547669,0.0704546438100489,LAMC1
delta,4,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),1/110,1,110,0.873224683141853,0.879072169859321,0,0,0.490075961774075,0.0664358673122749,TANK
delta,4,regulation of Wnt signaling pathway (GO:0030111),1/110,1,110,0.873224683141853,0.879072169859321,0,0,0.490075961774075,0.0664358673122749,DEPDC1B
delta,4,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),1/111,1,111,0.875589337587252,0.880961051314781,0,0,0.485660863019354,0.0645239749748756,DYNLL2
delta,4,regulation of immune effector process (GO:0002697),1/115,1,115,0.884616137975378,0.889547108644137,0,0,0.468768311262159,0.0574716842697083,ELMOD2
delta,4,epithelium development (GO:0060429),1/116,1,116,0.886768852747731,0.891215047552594,0,0,0.464727205130588,0.0558466981388297,CASP6
delta,4,enzyme linked receptor protein signaling pathway (GO:0007167),1/121,1,121,0.896946224067498,0.900440171517955,0,0,0.445523601612795,0.0484548660501308,FYN
delta,4,negative regulation of growth (GO:0045926),1/121,1,121,0.896946224067498,0.900440171517955,0,0,0.445523601612795,0.0484548660501308,SLIT3
delta,4,negative regulation of cell migration (GO:0030336),1/122,1,122,0.89886947242138,0.901869036845478,0,0,0.441871768812691,0.0471112399006719,CORO1C
delta,4,protein glycosylation (GO:0006486),1/131,1,131,0.914644990742826,0.917187083546447,0,0,0.411514166375178,0.0367149965032577,PARP9
delta,4,phagocytosis (GO:0006909),1/136,1,136,0.922322341126336,0.923858691500228,0,0,0.396384969081972,0.0320518890752558,CORO1C
delta,4,mitochondrial transport (GO:0006839),1/136,1,136,0.922322341126336,0.923858691500228,0,0,0.396384969081972,0.0320518890752558,SLC25A53
delta,4,cellular response to growth factor stimulus (GO:0071363),1/140,1,140,0.927965190124181,0.928995118193131,0,0,0.385059684251059,0.0287874692112148,RAPGEF2
delta,4,response to lipid (GO:0033993),1/141,1,141,0.929310817682049,0.929826242428407,0,0,0.382328764504597,0.0280292954860785,SRR
delta,4,positive regulation of macromolecule biosynthetic process (GO:0010557),1/143,1,143,0.931927325714505,0.931927325714505,0,0,0.376981509056981,0.0265773637826556,LARP6
